PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wu, JB; Hong, JT; Wang, XD; Sun, J; Lu, XY; Fan, JH; Cai, YJ				Wu, Jianbo; Hong, Jiangtao; Wang, Xiaodan; Sun, Jian; Lu, Xuyang; Fan, Jihui; Cai, Yanjiang			Biomass Partitioning and Its Relationship with the Environmental Factors at the Alpine Steppe in Northern Tibet	PLOS ONE			English	Article							BELOW-GROUND BIOMASS; CARBON ALLOCATION; ABOVEGROUND BIOMASS; NUTRIENT AVAILABILITY; SPECIES COMPOSITION; SOIL PROPERTIES; PLANT BIOMASS; GROWTH; ROOT; GRASSLANDS	Alpine steppe is considered to be the largest grassland type on the Tibetan Plateau. This grassland contributes to the global carbon cycle and is sensitive to climate changes. The allocation of biomass in an ecosystem affects plant growth and the overall functioning of the ecosystem. However, the mechanism by which plant biomass is allocated on the alpine steppe remains unclear. In this study, biomass allocation and its relationship to environmental factors on the alpine grassland were studied by a meta-analysis of 32 field sites across the alpine steppe of the northern Tibetan Plateau. We found that there is less above-ground biomass (M-A) and below-ground biomass (M-B) in the alpine steppe than there is in alpine meadows and temperate grasslands. By contrast, the root-to-shoot ratio (R:S) in the alpine steppe is higher than it is in alpine meadows and temperate grasslands. Although temperature maintained the biomass in the alpine steppe, precipitation was found to considerably influence M-A, M-B, and R:S, as shown by ordination space partitioning. After standardized major axis (SMA) analysis, we found that allocation of biomass on the alpine steppe is supported by the allometric biomass partitioning hypothesis rather than the isometric allocation hypothesis. Based on these results, we believe that M-A and M-B will decrease as a result of the increased aridity expected to occur in the future, which will reduce the landscape's capacity for carbon storage.	[Wu, Jianbo; Hong, Jiangtao; Wang, Xiaodan; Sun, Jian; Lu, Xuyang; Fan, Jihui; Cai, Yanjiang] Chinese Acad Sci, Inst Mt Hazard & Environm, Key Lab Mt Environm Evolut & Its Regulat, Chengdu, Peoples R China; [Hong, Jiangtao; Sun, Jian] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Mountain Hazards & Environment, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, XD (corresponding author), Chinese Acad Sci, Inst Mt Hazard & Environm, Key Lab Mt Environm Evolut & Its Regulat, Chengdu, Peoples R China.	wxd@imde.ac.cn	Sun, Jian/I-9740-2016; Cai, Yanjiang/N-6694-2013; Cai, Yanjiang/AAD-1470-2020	Sun, Jian/0000-0001-8765-5015; Cai, Yanjiang/0000-0002-5376-7884; Lu, Xuyang/0000-0001-6653-6009	CAS [XDB03030505, SDS-135-1203-01]; National science and technology support project [2011BAC09B03]; Program of the IMDE; Science Foundation for Young Scientists of IMDE, CAS	CAS(Chinese Academy of Sciences); National science and technology support project; Program of the IMDE; Science Foundation for Young Scientists of IMDE, CAS	This study was financially supported by the Strategic leading science and technology projects, CAS (XDB03030505), the National science and technology support project (2011BAC09B03), Program of the IMDE, CAS (SDS-135-1203-01), and the Science Foundation for Young Scientists of IMDE, CAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazzaz Fakhri A., 1997, P1, DOI 10.1016/B978-012083490-7/50002-5; BLOOM AJ, 1985, ANNU REV ECOL SYST, V16, P363, DOI 10.1146/annurev.es.16.110185.002051; Bradford JB, 2005, ECOLOGY, V86, P1863, DOI 10.1890/04-0493; Burke IC, 1997, ECOLOGY, V78, P1330, DOI 10.1890/0012-9658(1997)078[1330:RATVIN]2.0.CO;2; CHAPIN FS, 1987, BIOSCIENCE, V37, P49, DOI 10.2307/1310177; Cheng DL, 2007, ANN BOT-LONDON, V99, P95, DOI 10.1093/aob/mcl206; Cronin G, 2003, OECOLOGIA, V137, P32, DOI 10.1007/s00442-003-1315-3; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Fan JW, 2009, J ARID ENVIRON, V73, P521, DOI 10.1016/j.jaridenv.2008.12.004; Gao YZ, 2008, PLANT SOIL, V307, P41, DOI 10.1007/s11104-008-9579-3; Gao YZ, 2011, OECOLOGIA, V165, P855, DOI 10.1007/s00442-010-1890-z; Genard M, 2008, TREES-STRUCT FUNCT, V22, P269, DOI 10.1007/s00468-007-0176-5; Giese M, 2009, APPL SOIL ECOL, V41, P8, DOI 10.1016/j.apsoil.2008.08.002; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Gill RA, 2002, GLOBAL ECOL BIOGEOGR, V11, P79, DOI 10.1046/j.1466-822X.2001.00267.x; Glynn C, 2003, OIKOS, V101, P385, DOI 10.1034/j.1600-0706.2003.12089.x; Grechi I, 2007, ENVIRON EXP BOT, V59, P139, DOI 10.1016/j.envexpbot.2005.11.002; Gugerli F, 2001, BOT HELV, V111, P169; [韩文轩 Han Wenxuan], 2003, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V39, P583; Hui DF, 2006, NEW PHYTOL, V169, P85, DOI 10.1111/j.1469-8137.2005.01569.x; Huxman TE, 2004, NATURE, V429, P651, DOI 10.1038/nature02561; KORNER C, 1987, OECOLOGIA, V74, P411, DOI 10.1007/BF00378938; Korner C., 2003, ALPINE PLANT LIFE, V2, P101; Kuzyakov Y, 2000, J PLANT NUTR SOIL SC, V163, P421, DOI 10.1002/1522-2624(200008)163:4<421::AID-JPLN421>3.0.CO;2-R; Lacointe A, 2000, ANN FOREST SCI, V57, P521; Li W, 2011, J SOIL SCI PLANT NUT, V11, P27, DOI 10.4067/S0718-95162011000400003; Li XJ, 2011, ENVIRON EARTH SCI, V64, P1911, DOI 10.1007/s12665-011-1004-1; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Ma WH, 2008, SCI CHINA SER C, V51, P263, DOI 10.1007/s11427-008-0029-5; Marcelis LFM, 2007, WAG UR FRON, V22, P103; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Mony C, 2007, AQUAT BOT, V86, P236, DOI 10.1016/j.aquabot.2006.11.007; Muller Ivo, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P115, DOI 10.1078/1433-8319-00007; Niklas KJ, 2005, ANN BOT-LONDON, V95, P315, DOI 10.1093/aob/mci028; O'Connor TG, 2001, J ECOL, V89, P850, DOI 10.1046/j.0022-0477.2001.00605.x; Reynolds JF, 2002, GLOBAL DESERTIFICATI, P1; Schenk HJ, 2005, GEODERMA, V126, P129, DOI 10.1016/j.geoderma.2004.11.018; Shi FS, 2010, POL J ECOL, V58, P125; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; Solow AR, 2005, ECOL LETT, V8, P361, DOI 10.1111/j.1461-0248.2005.00738.x; STEPHENSON NL, 1990, AM NAT, V135, P649, DOI 10.1086/285067; Sun J, 2013, BIOGEOSCIENCES, V10, P1707, DOI 10.5194/bg-10-1707-2013; Vanninen P, 2005, TREE PHYSIOL, V25, P17, DOI 10.1093/treephys/25.1.17; Wang CT, 2008, SCI CHINA SER C, V51, P86, DOI 10.1007/s11427-008-0011-2; [王根绪 WANG Genxu], 2007, [冰川冻土, Journal of Glaciology and Geocryology], V29, P671; [王景升 WANG Jing-sheng], 2008, [资源科学, Resources Science], V30, P1852; Wang LA, 2010, SCI CHINA LIFE SCI, V53, P851, DOI 10.1007/s11427-010-4027-z; Warembourg FR, 2001, SOIL BIOL BIOCHEM, V33, P1291, DOI 10.1016/S0038-0717(01)00033-5; WOODWARD FI, 1987, VEGETATIO, V69, P189, DOI 10.1007/BF00038700; Wright I.J., 2003, S MATR STANDARDIZED; Wu JianShuang, 2012, Journal of Resources and Ecology, V3, P236; [鄢燕 YAN Yan], 2005, [生态学报, Acta Ecologica Sinica], V25, P2818; Yang YH, 2009, J ARID ENVIRON, V73, P91, DOI 10.1016/j.jaridenv.2008.09.027; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; Yu HY, 2010, P NATL ACAD SCI USA, V107, P22151, DOI 10.1073/pnas.1012490107; Zhang BC, 2013, CLIMATIC CHANGE, V118, P197, DOI 10.1007/s10584-012-0622-2; Zhou X. M, 2001, CHINESE KOBRESIA MEA; Zhou XM, 2001, KOBRESIA MEADOW CHIN, P136	61	205	228	7	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81986	10.1371/journal.pone.0081986	http://dx.doi.org/10.1371/journal.pone.0081986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349170	Green Submitted, gold, Green Published			2022-12-27	WOS:000328731800031
J	Wu, JF; Bi, HS; Wang, SM; Hu, YY; Wu, H; Sun, W; Lu, TL; Wang, XR; Jonas, JB				Wu, Jian Feng; Bi, Hong Sheng; Wang, Shu Mei; Hu, Yuan Yuan; Wu, Hui; Sun, Wei; Lu, Tai Liang; Wang, Xing Rong; Jonas, Jost B.			Refractive Error, Visual Acuity and Causes of Vision Loss in Children in Shandong, China. The Shandong Children Eye Study	PLOS ONE			English	Article							SCHOOL-AGE-CHILDREN; CHINESE CHILDREN; BEIJING EYE; PARENTAL MYOPIA; SOUTHERN CHINA; PREVALENCE; IMPAIRMENT; SCHOOLCHILDREN; POPULATION; PROGRESSION	Purpose: To examine the prevalence of refractive errors and prevalence and causes of vision loss among preschool and school children in East China. Methods: Using a random cluster sampling in a cross-sectional school-based study design, children with an age of 4-18 years were selected from kindergartens, primary schools, and junior and senior high schools in the rural Guanxian County and the city of Weihai. All children underwent a complete ocular examination including measurement of uncorrected (UCVA) and best corrected visual acuity (BCVA) and auto-refractometry under cycloplegia. Myopia was defined as refractive error of <=-0.5 diopters (D), high myopia as <=-6.0D, and amblyopia as BCVA <= 20/32 without any obvious reason for vision reduction and with strabismus or refractive errors as potential reasons. Results: Out of 6364 eligible children, 6026 (94.7%) children participated. Prevalence of myopia (overall: 36.9 +/- 0.6%; 95% confidence interval (CI): 36.0,38.0) increased (P<0.001) from 1.7 +/- 1.2% (95% CI: 0.0,4.0) in the 4-years olds to 84.6 +/- 3.2% (95% CI: 78.0,91.0) in 17-years olds. Myopia was associated with older age (OR: 1.56; 95% CI: 1.52,1.60; P<0.001), female gender (OR: 1.22; 95% CI: 1.08,1.39; P = 0.002) and urban region (OR: 2.88; 95% CI: 2.53,3.29; P<0.001). Prevalence of high myopia (2.0 +/- 0.2%) increased from 0.7 +/- 0.3% (95% CI: 0.1,1.3) in 10-years olds to 13.9 +/- 3.0 (95% CI: 7.8,19.9) in 17-years olds. It was associated with older age (OR: 1.50; 95% CI: 1.41,1.60; P<0.001) and urban region (OR: 3.11; 95% CI: 2.08,4.66); P<0.001). Astigmatism (>= 0.75D) (36.3 +/- 0.6%; 95% CI: 35.0,38.0) was associated with older age (P<0.001; OR: 1.06; 95% CI: 1.04,1.09), more myopic refractive error (P<0.001; OR: 0.94; 95% CI: 0.91,0.97) and urban region (P<0.001; OR: 1.47; 95% CI: 1.31,1.64). BCVA was <= 20/40 in the better eye in 19 (0.32%) children. UCVA <= 20/40 in at least one eye was found in 2046 (34.05%) children, with undercorrected refractive error as cause in 1975 (32.9%) children. Amblyopia (BCVA <= 20/32) was detected in 44 (0.7%) children (11 children with bilateral amblyopia). Conclusions: In coastal East China, about 14% of the 17-years olds were highly myopic, and 80% were myopic. Prevalence of myopia increased with older age, female gender and urban region. About 0.7% of pre-school children and school children were amblyopic.	[Wu, Jian Feng] Shandong Univ Tradit Chinese Med, Dept Ophthalmol, Jinan, Shandong, Peoples R China; [Bi, Hong Sheng; Wu, Hui; Wang, Xing Rong] Shandong Univ Tradit Chinese Med, Inst Eye, Jinan, Shandong, Peoples R China; [Wang, Shu Mei] Shandong Univ, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Hu, Yuan Yuan; Sun, Wei; Lu, Tai Liang] Shandong Univ Tradit Chinese Med, Affiliated Hosp 2, Jinan, Shandong, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Heidelberg, Germany	Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine; Shandong University; Shandong University of Traditional Chinese Medicine; Ruprecht Karls University Heidelberg	Bi, HS (corresponding author), Shandong Univ Tradit Chinese Med, Inst Eye, Jinan, Shandong, Peoples R China.	hongshengbi@126.com; jost.jonas@medma.ma.uni-heidelberg.de	Sun, Jian/I-9740-2016; Cai, Yanjiang/N-6694-2013; Cai, Yanjiang/AAD-1470-2020	Sun, Jian/0000-0001-8765-5015; Cai, Yanjiang/0000-0002-5376-7884; Lu, Xuyang/0000-0001-6653-6009	Shandong Science & Technology Department [2011GGB14097, 2011GGH21835, 2012YD18081]; Shandong Health Department [2011HD014]; Jinan Science & Technology Bureau [201102061]	Shandong Science & Technology Department; Shandong Health Department; Jinan Science & Technology Bureau	This study was supported by Shandong Science & Technology Department (2011GGB14097, 2011GGH21835, 2012YD18081), Shandong Health Department (2011HD014), Jinan Science & Technology Bureau (201102061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anera RG, 2009, CLIN EXP OPHTHALMOL, V37, P191, DOI 10.1111/j.1442-9071.2009.02001.x; Casson RJ, 2012, OPHTHALMOLOGY, V119, P2021, DOI 10.1016/j.ophtha.2012.03.049; Chia A, 2013, OPHTHAL EPIDEMIOL, V20, P138, DOI 10.3109/09286586.2013.767354; Congdon N, 2008, INVEST OPHTH VIS SCI, V49, P2888, DOI 10.1167/iovs.07-1160; Czepita D, 2007, OPHTHAL PHYSL OPT, V27, P60, DOI 10.1111/j.1475-1313.2006.00419.x; Fan DSP, 2004, INVEST OPHTH VIS SCI, V45, P1071, DOI 10.1167/iovs.03-1151; Fledelius HC, 2000, ACTA OPHTHALMOL SCAN, V78, P501, DOI 10.1034/j.1600-0420.2000.078005501.x; Fotouhi A, 2007, BRIT J OPHTHALMOL, V91, P287, DOI 10.1136/bjo.2006.099937; French AN, 2013, OPHTHALMOLOGY, V120, P1482, DOI 10.1016/j.ophtha.2012.12.018; Goh PP, 2005, OPHTHALMOLOGY, V112, P678, DOI 10.1016/j.ophtha.2004.10.048; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; He MG, 2007, OPHTHALMOLOGY, V114, P374, DOI 10.1016/j.ophtha.2006.08.020; He MG, 2009, INVEST OPHTH VIS SCI, V50, P5130, DOI 10.1167/iovs.09-3455; Ip JM, 2008, EYE, V22, P649, DOI 10.1038/sj.eye.6702701; Jamali P, 2009, OPTOMETRY VISION SCI, V86, P364, DOI 10.1097/OPX.0b013e3181993f42; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; Lee Sang Joon, 2011, J Prev Med Public Health, V44, P56, DOI 10.3961/jpmph.2011.44.1.56; Li Z, 2013, CLIN EXPT OPHTHALMOL, DOI [10.1111/ceo.12198, DOI 10.1111/CE0.12198.[]; Liang YB, 2013, BRIT J OPHTHALMOL, V97, P765, DOI 10.1136/bjophthalmol-2012-302468; Liu HH, 2010, OPHTHALMOLOGY, V117, P1763, DOI 10.1016/j.ophtha.2010.01.020; McKean-Cowdin R, 2013, OPHTHALMOLOGY, V120, P2117, DOI 10.1016/j.ophtha.2013.03.001; Midelfart A, 2002, ACTA OPHTHALMOL SCAN, V80, P501, DOI 10.1034/j.1600-0420.2002.800508.x; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Morgan IG, 2010, ACTA OPHTHALMOL, V88, P877, DOI 10.1111/j.1755-3768.2009.01800.x; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murthy GVS, 2002, INVEST OPHTH VIS SCI, V43, P623; Naidoo KS, 2003, INVEST OPHTH VIS SCI, V44, P3764, DOI 10.1167/iovs.03-0283; Negrel AD, 2000, AM J OPHTHALMOL, V129, P421, DOI 10.1016/S0002-9394(99)00455-9; O'Donoghue L, 2013, INVEST OPHTH VIS SCI, V54, P602, DOI 10.1167/iovs.12-11066; Ostadimoghaddam H, 2011, CLIN EXP OPHTHALMOL, V39, P743, DOI 10.1111/j.1442-9071.2011.02584.x; Pi LH, 2012, J EPIDEMIOL, V22, P37, DOI 10.2188/jea.JE20110063; Salomao SR, 2008, INVEST OPHTH VIS SCI, V49, P4308, DOI 10.1167/iovs.08-2073; Saw SM, 2006, BRIT J OPHTHALMOL, V90, P1230, DOI 10.1136/bjo.2006.093450; Sun J, 2012, INVEST OPHTH VIS SCI, V53, P7504, DOI 10.1167/iovs.11-8343; Tarczy-Hornoch K, 2013, OPHTHALMOLOGY, V120, P1220, DOI 10.1016/j.ophtha.2012.12.029; Tong L, 2004, AM J OPHTHALMOL, V137, P474, DOI 10.1016/j.ajo.2003.10.028; Villarreal GM, 2003, OPTOMETRY VISION SCI, V80, P369, DOI 10.1097/00006324-200305000-00011; Villarreal MG, 2000, ACTA OPHTHALMOL SCAN, V78, P177, DOI 10.1034/j.1600-0420.2000.078002177.x; Xiang F, 2013, EYE LOND, DOI [10.1038/eye.2013.194, DOI 10.1038/EYE.2013.194.[]; Xiang F, 2012, OPTOMETRY VISION SCI, V89, P1487, DOI 10.1097/OPX.0b013e31826912e0; Xiang F, 2012, OPTOMETRY VISION SCI, V89, P884, DOI 10.1097/OPX.0b013e318255dc33; Xu L, 2005, OPHTHALMOLOGY, V112, P1676, DOI 10.1016/j.ophtha.2005.05.015; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; Yekta A, 2010, CLIN EXP OPHTHALMOL, V38, P242, DOI 10.1111/j.1442-9071.2010.02247.x; You QS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052668; Zhao JL, 2000, AM J OPHTHALMOL, V129, P427, DOI 10.1016/S0002-9394(99)00452-3	47	205	228	7	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 23	2013	8	12							e82763	10.1371/journal.pone.0082763	http://dx.doi.org/10.1371/journal.pone.0082763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	278IG	24349170	Green Published, gold, Green Submitted			2022-12-27	WOS:000328882000028
J	Barraud, N; Buson, A; Jarolimek, W; Rice, SA				Barraud, Nicolas; Buson, Alberto; Jarolimek, Wolfgang; Rice, Scott A.			Mannitol Enhances Antibiotic Sensitivity of Persister Bacteria in Pseudomonas aeruginosa Biofilms	PLOS ONE			English	Article							DRY POWDER MANNITOL; NO-DONOR PRODRUGS; CYSTIC-FIBROSIS; INHALED MANNITOL; TOBRAMYCIN; CELLS; TOLERANCE; COLISTIN; DORMANCY; CULTURES	The failure of antibiotic therapies to clear Pseudomonas aeruginosa lung infection, the key mortality factor for cystic fibrosis (CF) patients, is partly attributed to the high tolerance of P. aeruginosa biofilms. Mannitol has previously been found to restore aminoglycoside sensitivity in Escherichia coli by generating a proton-motive force (PMF), suggesting a potential new strategy to improve antibiotic therapy and reduce disease progression in CF. Here, we used the commonly prescribed aminoglycoside tobramycin to select for P. aeruginosa persister cells during biofilm growth. Incubation with mannitol (10-40 mM) increased tobramycin sensitivity of persister cells up to 1,000-fold. Addition of mannitol to pre-grown biofilms was able to revert the persister phenotype and improve the efficacy of tobramycin. This effect was blocked by the addition of a PMF inhibitor or in a P. aeruginosa mutant strain unable to metabolise mannitol. Addition of glucose and NaCl at high osmolarity also improved the efficacy of tobramycin although to a lesser extent compared to mannitol. Therefore, the primary effect of mannitol in reverting biofilm associated persister cells appears to be an active, physiological response, associated with a minor contribution of osmotic stress. Mannitol was tested against clinically relevant strains, showing that biofilms containing a subpopulation of persister cells are better killed in the presence of mannitol, but a clinical strain with a high resistance to tobramycin was not affected by mannitol. Overall, these results suggest that in addition to improvements in lung function by facilitating mucus clearance in CF, mannitol also affects antibiotic sensitivity in biofilms and does so through an active, physiological response.	[Barraud, Nicolas; Rice, Scott A.] Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia; [Barraud, Nicolas; Rice, Scott A.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Buson, Alberto; Jarolimek, Wolfgang] Pharmaxis Ltd, Frenchs Forest, NSW, Australia; [Rice, Scott A.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 639798, Singapore; [Rice, Scott A.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	University of New South Wales Sydney; University of New South Wales Sydney; Pharmaxis; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Barraud, N (corresponding author), Univ New S Wales, Ctr Marine Bioinnovat, Sydney, NSW, Australia.	n.barraud@unsw.edu.au	Barraud, Nicolas/D-1569-2010; Rice, Scott/A-6084-2019	Barraud, Nicolas/0000-0002-1807-7765; Rice, Scott/0000-0002-9486-2343; Jarolimek, Wolfgang/0000-0002-1757-5420	Australian Research Council (ARC); Centre for Marine Bio-Innovation; Pharmaxis Ltd.; ARC [DE120101604]	Australian Research Council (ARC)(Australian Research Council); Centre for Marine Bio-Innovation; Pharmaxis Ltd.; ARC(Australian Research Council)	This work was partially supported by grants from the Australian Research Council (ARC), the Centre for Marine Bio-Innovation, and Pharmaxis Ltd. N.B. is supported by ARC grant DE120101604. Authors A. B. and W.J. work for Pharmaxis Ltd and were involved in study design, data analysis, decision to publish and preparation of the manuscript. Other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albesa I, 2004, BIOCHEM BIOPH RES CO, V317, P605, DOI 10.1016/j.bbrc.2004.03.085; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Amato SM, 2013, MOL CELL, V50, P475, DOI 10.1016/j.molcel.2013.04.002; Barraud N, 2012, ANGEW CHEM INT EDIT, V51, P9057, DOI 10.1002/anie.201202414; Barraud N, 2009, MICROB BIOTECHNOL, V2, P370, DOI 10.1111/j.1751-7915.2009.00098.x; Bernier SP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003144; Bilton D, 2011, EUR RESPIR J, V38, P1071, DOI 10.1183/09031936.00187510; Bilton D, 2013, J CYST FIBROS, V12, P367, DOI 10.1016/j.jcf.2012.11.002; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; Daviskas E, 1999, AM J RESP CRIT CARE, V159, P1843, DOI 10.1164/ajrccm.159.6.9809074; Daviskas E, 2010, CHEST, V137, P861, DOI 10.1378/chest.09-2017; Dawson CC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002121; Dorr T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000317; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Elliott D, 2010, ANTIMICROB AGENTS CH, V54, P3024, DOI 10.1128/AAC.00102-10; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Falagas ME, 2009, CLIN INFECT DIS, V48, P1729, DOI 10.1086/599226; Hentzer M., 2005, BIOFILMS, V2, P37, DOI DOI 10.1017/S1479050505001699; Herrmann G, 2010, J INFECT DIS, V202, P1585, DOI 10.1086/656788; HOBEN HJ, 1982, APPL ENVIRON MICROB, V44, P1246, DOI 10.1128/AEM.44.5.1246-1247.1982; Hoffman LR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000712; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jennings DB, 1998, P NATL ACAD SCI USA, V95, P15129, DOI 10.1073/pnas.95.25.15129; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Keren I, 2011, MBIO, V2, DOI 10.1128/mBio.00100-11; Kim JS, 2011, ANTIMICROB AGENTS CH, V55, P5380, DOI 10.1128/AAC.00708-11; Klapper I, 2007, MICROBIOL-SGM, V153, P3623, DOI 10.1099/mic.0.2007/006734-0; Leszczynska D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054737; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; McCollister BD, 2011, ANTIMICROB AGENTS CH, V55, P2189, DOI 10.1128/AAC.01203-10; Moreau-Marquis S, 2009, AM J RESP CELL MOL, V41, P305, DOI 10.1165/rcmb.2008-0299OC; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; O'May CY, 2006, FEMS IMMUNOL MED MIC, V48, P373, DOI 10.1111/j.1574-695X.2006.00157.x; OHMAN DE, 1981, INFECT IMMUN, V33, P142, DOI 10.1128/IAI.33.1.142-148.1981; Orman MA, 2013, ANTIMICROB AGENTS CH, V57, P3230, DOI 10.1128/AAC.00243-13; Pamp SJ, 2008, MOL MICROBIOL, V68, P223, DOI 10.1111/j.1365-2958.2008.06152.x; Pan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045778; Poole K, 2005, ANTIMICROB AGENTS CH, V49, P479, DOI 10.1128/AAC.49.2.479-487.2005; Sauer K, 2004, J BACTERIOL, V186, P7312, DOI 10.1128/JB.186.21.7312-7326.2004; Schleheck D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005513; Sternberg C, 1999, APPL ENVIRON MICROB, V65, P4108; Trampuz A, 2007, NEW ENGL J MED, V357, P654, DOI 10.1056/NEJMoa061588; Tre-Hardy M, 2009, INT J ANTIMICROB AG, V34, P370, DOI 10.1016/j.ijantimicag.2009.04.010; Vogt SL, 2011, INFECT IMMUN, V79, P4094, DOI 10.1128/IAI.00193-11; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Werner E, 2004, APPL ENVIRON MICROB, V70, P6188, DOI 10.1128/AEM.70.10.6188-6196.2004; Yepuri NR, 2013, CHEM COMMUN, V49, P4791, DOI 10.1039/c3cc40869h; Yu QR, 2012, J ANTIMICROB CHEMOTH, V67, P2673, DOI 10.1093/jac/dks296	51	103	108	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e84220	10.1371/journal.pone.0084220	http://dx.doi.org/10.1371/journal.pone.0084220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349568	Green Published, gold			2022-12-27	WOS:000328734200109
J	Cappa, P; Clerico, A; Nov, O; Porfiri, M				Cappa, Paolo; Clerico, Andrea; Nov, Oded; Porfiri, Maurizio			Can Force Feedback and Science Learning Enhance the Effectiveness of Neuro-Rehabilitation? An Experimental Study on Using a Low-Cost 3D Joystick and a Virtual Visit to a Zoo	PLOS ONE			English	Article							UPPER-LIMB; STROKE REHABILITATION; PATIENT MOTIVATION; ARM FUNCTION; THERAPY; CHILDREN; NEUROREHABILITATION; TECHNOLOGY; RECOVERY; ACCESS	In this paper, we demonstrate that healthy adults respond differentially to the administration of force feedback and the presentation of scientific content in a virtual environment, where they interact with a low-cost haptic device. Subjects are tasked with controlling the movement of a cursor on a predefined trajectory that is superimposed on a map of New York City's Bronx Zoo. The system is characterized in terms of a suite of objective indices quantifying the subjects' dexterity in planning and generating the multijoint visuomotor tasks. We find that force feedback regulates the smoothness, accuracy, and duration of the subject's movement, whereby converging or diverging force fields influence the range of variations of the hand speed. Finally, our findings provide preliminary evidence that using educational content increases subjects' satisfaction. Improving the level of interest through the inclusion of learning elements can increase the time spent performing rehabilitation tasks and promote learning in a new context.	[Cappa, Paolo; Clerico, Andrea] Univ Roma La Sapienza, Dept Mech & Aerosp Engn, I-00185 Rome, Italy; [Cappa, Paolo; Clerico, Andrea; Porfiri, Maurizio] NYU, Dept Mech & Aerosp Engn, Polytech Inst, Brooklyn, NY USA; [Cappa, Paolo] IRCCS Childrens Hosp Bambino Gesu, Movement Anal & Robot Lab MARLab, Neurorehabil Div, Rome, Italy; [Nov, Oded] NYU, Dept Technol Management & Innovat, Polytech Inst, Brooklyn, NY USA	Sapienza University Rome; New York University; New York University Tandon School of Engineering; IRCCS Bambino Gesu; New York University; New York University Tandon School of Engineering	Porfiri, M (corresponding author), NYU, Dept Mech & Aerosp Engn, Polytech Inst, Brooklyn, NY USA.	mporfiri@nyu.edu		Cappa, Paolo/0000-0002-4898-9589; Porfiri, Maurizio/0000-0002-1480-3539	National Science Foundation [BCS-1124795]; Italian Ministry of Health - Department of medical devices and drugs "Effectiveness of the robot mediated therapy for upper limb"; Honours Center of Italian Universities	National Science Foundation(National Science Foundation (NSF)); Italian Ministry of Health - Department of medical devices and drugs "Effectiveness of the robot mediated therapy for upper limb"; Honours Center of Italian Universities	This material is based upon work supported by the National Science Foundation under Grant # BCS-1124795, the Italian Ministry of Health - Department of medical devices and drugs "Effectiveness of the robot mediated therapy for upper limb" (Grant 2009), and the Honours Center of Italian Universities through a scholarship to Andrea Clerico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian S, 2012, IEEE T BIO-MED ENG, V59, P2126, DOI 10.1109/TBME.2011.2179545; Barreca S, 2003, NEUROREHAB NEURAL RE, V17, P220, DOI 10.1177/0888439003259415; Bhattacherjee A, 2001, MIS QUART, V25, P351, DOI 10.2307/3250921; Bosecker C, 2010, NEUROREHAB NEURAL RE, V24, P62, DOI 10.1177/1545968309343214; Bovolenta F, 2011, J NEUROENG REHABIL, V8, P1, DOI [10.1186/1743-0003-8-1, DOI 10.1186/1743-0003-8-1.PUBMED:21226898]; Casadio M, 2009, MEASUREMENT, V42, P1176, DOI 10.1016/j.measurement.2008.09.012; Clark MS, 1998, CLIN REHABIL, V12, P73, DOI 10.1191/026921598669567216; Coles T, 2010, THIRD INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTER-HUMAN INTERACTIONS: ACHI 2010, P148, DOI 10.1109/ACHI.2010.20; Colombo R, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-3; Coote S, 2008, CLIN REHABIL, V22, P395, DOI 10.1177/0269215507085060; de O Andrade K, 2013, BIOS BIOR C BRC 2013, P1, DOI DOI 10.1109/BRC.2013.6487455; De Pascale M, 2007, IEEE ROBOT AUTOM MAG, V14, P64, DOI 10.1109/M-RA.2007.905747; DIJKERS MP, 1991, J REHABIL RES DEV, V28, P33, DOI 10.1682/JRRD.1991.04.0033; Dipietro L, 2009, CORTEX, V45, P318, DOI 10.1016/j.cortex.2008.02.008; Frascarelli F, 2009, J REHABIL MED, V41, P988, DOI 10.2340/16501977-0412; Gouveia D, 2011, SERIOUS GAMING EXPER; Hogan N, 1992, WORKSTATION MANUAL T, P161; Krebs H I, 1998, IEEE Trans Rehabil Eng, V6, P75, DOI 10.1109/86.662623; Krebs HI, 2012, NEUROREHAB NEURAL RE, V26, P855, DOI 10.1177/1545968311433427; Krebs HI, 1999, P NATL ACAD SCI USA, V96, P4645, DOI 10.1073/pnas.96.8.4645; Lange B, 2009, PHYS THER REV, V14, P355, DOI 10.1179/108331909X12488667117258; Liebermann DG, 2006, CLIN BIOMECH, V21, P8, DOI 10.1016/j.clinbiomech.2005.08.006; Lin Y, 1374, FORCE CONTROL SYSTEM, P1379; Loureiro R, 2003, AUTON ROBOT, V15, P35, DOI 10.1023/A:1024436732030; Loureiro RCV, 2011, MED BIOL ENG COMPUT, V49, P1103, DOI 10.1007/s11517-011-0797-0; Lum PS, 2006, J REHABIL RES DEV, V43, P631, DOI 10.1682/JRRD.2005.02.0044; Maclean N, 2000, SOC SCI MED, V50, P495; Martin S, 2009, CHARACTERISATION NOV, P1; Masia L, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-28; Mehrholz J, 2008, COCHRANE DB SYST REV; Moritz E, 2005, CROSSROADS, V12, P5, DOI [10.1145/1144375.1144380., DOI 10.1145/1144375.1144380]; Nam CS, 2012, INT J HUM-COMPUT INT, V28, P784, DOI 10.1080/10447318.2012.661357; Nocchi F, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-49; Oujamaa L., 2009, Annals of Physical and Rehabilitation Medicine, V52, P269, DOI 10.1016/j.rehab.2008.10.003; Panarese A, 2011, MED ENG PHYS, V33, P386, DOI 10.1016/j.medengphy.2010.10.019; Patritti BL, 2010, PM&R, V2, P71, DOI 10.1016/j.pmrj.2009.10.012; Peter O, 2011, INT J REHABIL RES, V34, P196, DOI 10.1097/MRR.0b013e328346e8ad; Platz T, 2003, NERVENARZT, V74, P841, DOI 10.1007/s00115-003-1549-7; Pons JL, 2013, COMP INFLUENCE VISUA, P317; Prange GB, 2006, J REHABIL RES DEV, V43, P171, DOI 10.1682/JRRD.2005.04.0076; Riener R, 2005, MED BIOL ENG COMPUT, V43, P2, DOI 10.1007/BF02345116; Riener R, 2007, ACTA NEUROCHIR SUPPL, V97, P465; Rohrer B, 2002, J NEUROSCI, V22, P8297; TUPPER A, 1987, International Journal of Rehabilitation Research, V10, P119, DOI 10.1097/00004356-198700105-00024; van der Lee JH, 2001, CLIN REHABIL, V15, P20, DOI 10.1191/026921501677557755; VANVLIET P, 1991, PHYS THER, V71, P39, DOI 10.1093/ptj/71.1.39; Volpe BT, 2001, CURR OPIN NEUROL, V14, P745, DOI 10.1097/00019052-200112000-00011; Zhu SJ, 2011, INTERACT COMPUT, V23, P565, DOI 10.1016/j.intcom.2011.08.001; Zollo L, 2011, EUR J PHYS REHAB MED, V47, P223; Zollo L, 2011, MED BIOL ENG COMPUT, V49, P1131, DOI 10.1007/s11517-011-0808-1	50	19	20	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83945	10.1371/journal.pone.0083945	http://dx.doi.org/10.1371/journal.pone.0083945			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349562	Green Submitted, gold, Green Published			2022-12-27	WOS:000328734200106
J	Davis, IJ; Wallis, C; Deusch, O; Colyer, A; Milella, L; Loman, N; Harris, S				Davis, Ian J.; Wallis, Corrin; Deusch, Oliver; Colyer, Alison; Milella, Lisa; Loman, Nick; Harris, Stephen			A Cross-Sectional Survey of Bacterial Species in Plaque from Client Owned Dogs with Healthy Gingiva, Gingivitis or Mild Periodontitis	PLOS ONE			English	Article							INTERACTIVE TREE; DENTAL DISEASES; MICROBIOTA; DISPLAY; TOOL	Periodontal disease is the most widespread oral disease in dogs which if left untreated results in significant pain to the pet and loss of dentition. The objective of this study was to identify bacterial species in canine plaque that are significantly associated with health, gingivitis and mild periodontitis (<25% attachment loss). In this survey subgingival plaque samples were collected from 223 dogs with healthy gingiva, gingivitis and mild periodontitis with 72 to 77 samples per health status. DNA was extracted from the plaque samples and subjected to PCR amplification of the V1-V3 region of the 16S rDNA. Pyrosequencing of the PCR amplicons identified a total of 274 operational taxonomic units after bioinformatic and statistical analysis. Porphyromonas was the most abundant genus in all disease stages, particularly in health along with Moraxella and Bergeyella. Peptostreptococcus, Actinomyces, and Peptostreptococcaceae were the most abundant genera in mild periodontitis. Logistic regression analysis identified species from each of these genera that were significantly associated with health, gingivitis or mild periodontitis. Principal component analysis showed distinct community profiles in health and disease. The species identified show some similarities with health and periodontal disease in humans but also major differences. In contrast to human, healthy canine plaque was found to be dominated by Gram negative bacterial species whereas Gram positive anaerobic species predominate in disease. The scale of this study surpasses previously published research and enhances our understanding of the bacterial species present in canine subgingival plaque and their associations with health and early periodontal disease.	[Milella, Lisa] Vet Dent Surg, Surrey, England; [Loman, Nick] Univ Birmingham, Ctr Syst Biol, Birmingham, W Midlands, England	University of Birmingham		ian.davis@effem.com	Loman, Nicholas/Z-1573-2019	Wallis, Corrin/0000-0003-2260-7279; Harris, Stephen/0000-0002-4422-612X; Harris, Stephen/0000-0002-3843-159X; Deusch, Oliver/0000-0003-3378-6129; Loman, Nicholas/0000-0002-9843-8988	Mars Petcare UK; Medical Research Council [MR/J014370/1] Funding Source: researchfish; MRC [MR/J014370/1] Funding Source: UKRI	Mars Petcare UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Mars Petcare UK. The WALTHAM Institute of Pet Nutrition is the fundamental research center for Mars Petcare. The WALTHAM Institute was involved at all levels of this research including study design, data collection and analysis, decision to publish, or preparation of the manuscript. However there are no conflicts of interest, this survey represents an unbiased view (in the commercial sense) of the bacterial species present in canine plaque. The oligonucleotide primers used and the parameters used in subsequent analysis were chosen on guidance from external academic colleagues. No current external funding sources for this study.	Abusleme L, 2013, ISME J, V7, P1016, DOI 10.1038/ismej.2012.174; Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Butkovic V, 2001, ACTA VET BRNO, V70, P203, DOI 10.2754/avb200170020203; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Dahlen G, 2012, J PERIODONTAL RES, V47, P354, DOI 10.1111/j.1600-0765.2011.01440.x; Dewhirst FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036067; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haffajee AD, 2005, J CLIN PERIODONTOL, V32, P33, DOI 10.1111/j.1600-051X.2004.00624.x; HAMP SE, 1984, VET RADIOLOGY, V25, P86, DOI 10.1111/j.1740-8261.1984.tb01916.x; Kortegaard HE, 2008, J SMALL ANIM PRACT, V49, P610, DOI 10.1111/j.1748-5827.2008.00609.x; Kyllar M, 2005, VET MED-CZECH, V50, P496, DOI 10.17221/5654-VETMED; Lavy E, 2012, ISR J VET MED, V67, P244; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mydel P, 2006, PLOS PATHOG, V2, P712, DOI 10.1371/journal.ppat.0020076; Petersen PE, 2005, J PERIODONTOL, V76, P2187, DOI 10.1902/jop.2005.76.12.2187; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Riggio MP, 2011, VET MICROBIOL, V150, P394, DOI 10.1016/j.vetmic.2011.03.001; SOCRANSKY S S, 1988, Oral Microbiology and Immunology, V3, P1, DOI 10.1111/j.1399-302X.1988.tb00596.x; Sturgeon A, 2013, VET MICROBIOL, V162, P891, DOI 10.1016/j.vetmic.2012.11.018; Ten Cate JM, 2008, DENT CARIES DIS ITS, V2nd, P49; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Dyke TE, 2009, J APPL ORAL SCI, V17; Wiggs R., 1997, VET DENT PRINCIPLES, P152	31	51	56	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83158	10.1371/journal.pone.0083158	http://dx.doi.org/10.1371/journal.pone.0083158			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349448	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200063
J	Strempel, N; Neidig, A; Nusser, M; Geffers, R; Vieillard, J; Lesouhaitier, O; Brenner-Weiss, G; Overhage, J				Strempel, Nikola; Neidig, Anke; Nusser, Michael; Geffers, Robert; Vieillard, Julien; Lesouhaitier, Olivier; Brenner-Weiss, Gerald; Overhage, Joerg			Human Host Defense Peptide LL-37 Stimulates Virulence Factor Production and Adaptive Resistance in Pseudomonas aeruginosa	PLOS ONE			English	Article							MULTIDRUG EFFLUX SYSTEM; 2-COMPONENT REGULATORY SYSTEM; POLYMYXIN-B; QUINOLONE SIGNAL; ANTIMICROBIAL PEPTIDES; ANTIBIOTIC-RESISTANCE; CATIONIC PEPTIDES; BIOFILM FORMATION; MUTANT LIBRARY; MEXGHI-OPMD	A multitude of different virulence factors as well as the ability to rapidly adapt to adverse environmental conditions are important features for the high pathogenicity of Pseudomonas aeruginosa. Both virulence and adaptive resistance are tightly controlled by a complex regulatory network and respond to external stimuli, such as host signals or antibiotic stress, in a highly specific manner. Here, we demonstrate that physiological concentrations of the human host defense peptide LL-37 promote virulence factor production as well as an adaptive resistance against fluoroquinolone and aminoglycoside antibiotics in P. aeruginosa PAO1. Microarray analyses of P. aeruginosa cells exposed to LL-37 revealed an upregulation of gene clusters involved in the production of quorum sensing molecules and secreted virulence factors (PQS, phenazine, hydrogen cyanide (HCN), elastase and rhamnolipids) and in lipopolysaccharide (LPS) modification as well as an induction of genes encoding multidrug efflux pumps MexCD-OprJ and MexGHI-OpmD. Accordingly, we detected significantly elevated levels of toxic metabolites and proteases in bacterial supernatants after LL-37 treatment. Pre-incubation of bacteria with LL-37 for 2 h led to a decreased susceptibility towards gentamicin and ciprofloxacin. Quantitative Realtime PCR results using a PAO1-pqsE mutant strain present evidence that the quinolone response protein and virulence regulator PqsE may be implicated in the regulation of the observed phenotype in response to LL-37. Further experiments with synthetic cationic antimicrobial peptides IDR-1018, 1037 and HHC-36 showed no induction of pqsE expression, suggesting a new role of PqsE as highly specific host stress sensor.	[Strempel, Nikola; Neidig, Anke; Nusser, Michael; Brenner-Weiss, Gerald; Overhage, Joerg] Karlsruhe Inst Technol, Inst Funct Interfaces, D-76021 Karlsruhe, Germany; [Geffers, Robert] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Vieillard, Julien] Univ Rouen, UMR CNRS COBRA 6014, Evreux, France; [Lesouhaitier, Olivier] Univ Rouen, Lab Microbiol Signals & Microenvironm LMSM EA 431, Evreux, France	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Helmholtz-Center for Infection Research; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rouen Normandie; Universite de Rouen Normandie	Overhage, J (corresponding author), Karlsruhe Inst Technol, Inst Funct Interfaces, D-76021 Karlsruhe, Germany.	joerg.overhage@kit.edu	Overhage, Joerg/H-2033-2013; Brenner-Weiss, Gerald/H-2868-2013	Overhage, Joerg/0000-0001-5278-2479; Brenner-Weiss, Gerald/0000-0002-6728-5907; vieillard, julien/0000-0002-4590-6645	BioInterfaces (BIF) Program of Karlsruhe Institute of Technology (KIT) in the Helmholtz Association; "Concept for the Future" of KIT within the German Excellence Initiative; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of KIT	BioInterfaces (BIF) Program of Karlsruhe Institute of Technology (KIT) in the Helmholtz Association; "Concept for the Future" of KIT within the German Excellence Initiative; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of KIT	The authors gratefully acknowledge financial support by the BioInterfaces (BIF) Program of Karlsruhe Institute of Technology (KIT) in the Helmholtz Association, the "Concept for the Future" of KIT within the German Excellence Initiative, the Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of KIT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aendekerk S, 2005, MICROBIOL-SGM, V151, P1113, DOI 10.1099/mic.0.27631-0; Aendekerk S, 2002, MICROBIOL-SGM, V148, P2371, DOI 10.1099/00221287-148-8-2371; Bhardwaj Ashima K, 2013, Recent Pat Antiinfect Drug Discov, V8, P68; Blier AS, 2012, J MICROBIOL METH, V90, P20, DOI 10.1016/j.mimet.2012.04.005; Blier AS, 2011, MICROBIOL-SGM, V157, P1929, DOI 10.1099/mic.0.046755-0; Brazas MD, 2005, ANTIMICROB AGENTS CH, V49, P3222, DOI 10.1128/AAC.49.8.3222-3227.2005; Breidenstein EBM, 2008, ANTIMICROB AGENTS CH, V52, P4486, DOI 10.1128/AAC.00222-08; Breidenstein EBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049123; Cao H, 2001, P NATL ACAD SCI USA, V98, P14613, DOI 10.1073/pnas.251465298; Chen Christiane I-U, 2004, J Cyst Fibros, V3, P45, DOI 10.1016/j.jcf.2003.12.008; Cherkasov A, 2009, ACS CHEM BIOL, V4, P65, DOI 10.1021/cb800240j; Cummins J, 2009, MICROBIOL-SGM, V155, P2826, DOI 10.1099/mic.0.025643-0; de la Fuente-Nunez C, 2012, ANTIMICROB AGENTS CH, V56, P2696, DOI 10.1128/AAC.00064-12; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Farrow JM, 2008, J BACTERIOL, V190, P7043, DOI 10.1128/JB.00753-08; Fernandez L, 2012, ANTIMICROB AGENTS CH, V56, P6212, DOI 10.1128/AAC.01530-12; Fernandez L, 2010, ANTIMICROB AGENTS CH, V54, P3372, DOI 10.1128/AAC.00242-10; Fetar H, 2011, ANTIMICROB AGENTS CH, V55, P508, DOI 10.1128/AAC.00830-10; Fraud S, 2008, ANTIMICROB AGENTS CH, V52, P4478, DOI 10.1128/AAC.01072-08; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; GILLELAND HE, 1976, J BACTERIOL, V125, P267, DOI 10.1128/JB.125.1.267-281.1976; Gooderham WJ, 2009, MICROBIOL-SGM, V155, P699, DOI 10.1099/mic.0.024554-0; Gooderham WJ, 2009, FEMS MICROBIOL REV, V33, P279, DOI 10.1111/j.1574-6976.2008.00135.x; Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x; Hancock REW, 2000, DRUG RESIST UPDATE, V3, P247, DOI 10.1054/drup.2000.0152; Hazan R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000810; Herigstad B, 2001, J MICROBIOL METH, V44, P121, DOI 10.1016/S0167-7012(00)00241-4; Jacobsen AS, 2012, FUTURE MED CHEM, V4, P1587, DOI [10.4155/FMC.12.97, 10.4155/fmc.12.97]; Jeannot K, 2008, ANTIMICROB AGENTS CH, V52, P2455, DOI 10.1128/AAC.01107-07; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Lepine F, 2004, J AM SOC MASS SPECTR, V15, P862; Lewenza S, 2005, GENOME RES, V15, P583, DOI 10.1101/gr.3513905; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Macfarlane ELA, 2000, MICROBIOL-SGM, V146, P2543, DOI 10.1099/00221287-146-10-2543; Macfarlane ELA, 1999, MOL MICROBIOL, V34, P305, DOI 10.1046/j.1365-2958.1999.01600.x; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; Morita Y, 2006, J BACTERIOL, V188, P1847, DOI 10.1128/JB.188.5.1847-1855.2006; Morita Y, 2003, J ANTIMICROB CHEMOTH, V51, P991, DOI 10.1093/jac/dkg173; Neidig A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-77; NICAS TI, 1980, J BACTERIOL, V143, P872, DOI 10.1128/JB.143.2.872-878.1980; Ortori CA, 2011, ANAL BIOANAL CHEM, V399, P839, DOI 10.1007/s00216-010-4341-0; Pearson JP, 1997, J BACTERIOL, V179, P5756, DOI 10.1128/jb.179.18.5756-5767.1997; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poole K, 1996, MOL MICROBIOL, V21, P713, DOI 10.1046/j.1365-2958.1996.281397.x; Poole Keith, 2001, Current Topics in Medicinal Chemistry, V1, P59, DOI 10.2174/1568026013395605; Porcelli F, 2008, BIOCHEMISTRY-US, V47, P5565, DOI 10.1021/bi702036s; Rampioni G, 2010, ENVIRON MICROBIOL, V12, P1659, DOI 10.1111/j.1462-2920.2010.02214.x; Reis RS, 2011, BIORESOURCE TECHNOL, V102, P6377, DOI 10.1016/j.biortech.2011.03.074; Schaller-Bals S, 2002, AM J RESP CRIT CARE, V165, P992, DOI 10.1164/ajrccm.165.7.200110-020; Sekiya H, 2003, ANTIMICROB AGENTS CH, V47, P2990, DOI 10.1128/AAC.47.9.2990-2992.2003; Sochacki KA, 2011, P NATL ACAD SCI USA, V108, pE77, DOI 10.1073/pnas.1101130108; Srikumar R, 2000, J BACTERIOL, V182, P1410, DOI 10.1128/JB.182.5.1410-1414.2000; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Wieczorek M, 2010, CHEM BIOL, V17, P970, DOI 10.1016/j.chembiol.2010.07.007; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Yeung ATY, 2011, CELL MOL LIFE SCI, V68, P2161, DOI 10.1007/s00018-011-0710-x; Yu S, 2009, BIOCHEMISTRY-US, V48, P10298, DOI 10.1021/bi900123j; Zaborin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034883; Zaborina O, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030035; Zahner D, 2010, ANTIMICROB AGENTS CH, V54, P3516, DOI 10.1128/AAC.01756-09	67	36	37	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82240	10.1371/journal.pone.0082240	http://dx.doi.org/10.1371/journal.pone.0082240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349231	Green Published, gold			2022-12-27	WOS:000328734200030
J	Forrest, BM; Fletcher, LM; Atalah, J; Piola, RF; Hopkins, GA				Forrest, Barrie M.; Fletcher, Lauren M.; Atalah, Javier; Piola, Richard F.; Hopkins, Grant A.			Predation Limits Spread of Didemnum vexillum into Natural Habitats from Refuges on Anthropogenic Structures	PLOS ONE			English	Article							PROPAGULE PRESSURE; INVASION SUCCESS; POSTSETTLEMENT MORTALITY; ECOLOGICAL OBSERVATIONS; MARINE COMMUNITIES; SPECIES-DIVERSITY; SUBTIDAL EPIBIOTA; BIOTIC RESISTANCE; PIER PILINGS; RECRUITMENT	Non-indigenous species can dominate fouling assemblages on artificial structures in marine environments; however, the extent to which infected structures act as reservoirs for subsequent spread to natural habitats is poorly understood. Didemnum vexillum is one of few colonial ascidian species that is widely reported to be highly invasive in natural ecosystems, but which in New Zealand proliferates only on suspended structures. Experimental work revealed that D. vexillum established equally well on suspended artificial and natural substrata, and was able to overgrow suspended settlement plates that were completely covered in other cosmopolitan fouling species. Fragmentation led to a level of D. vexillum cover that was significantly greater than was achieved as a result of ambient larval recruitment. The species failed to establish following fragment transplants onto seabed cobbles and into beds of macroalgae. The establishment success of D. vexillum was greatest in summer compared with autumn, and on the underside of experimental settlement plates that were suspended off the seabed to avoid benthic predators. Where benthic predation pressure was reduced by caging, D. vexillum establishment success was broadly comparable to suspended treatments; by contrast, the species did not establish on the face-up aspect of uncaged plates. This study provides compelling evidence that benthic predation was a key mechanism that prevented D. vexillum's establishment in the cobble habitats of the study region. The widespread occurrence of D. vexillum on suspended anthropogenic structures is consistent with evidence for other sessile invertebrates that such habitats provide a refuge from benthic predation. For invasive species generally, anthropogenic structures are likely to be most important as propagule reservoirs for spread to natural habitats in situations where predation and other mechanisms do not limit their subsequent proliferation.	[Forrest, Barrie M.; Fletcher, Lauren M.; Atalah, Javier; Piola, Richard F.; Hopkins, Grant A.] Cawthron Inst, Coastal & Freshwater Grp, Nelson, New Zealand; [Piola, Richard F.] Def Sci & Technol Org, Maritime Div, Melbourne, Vic, Australia	Cawthron Institute; Defence Science & Technology	Forrest, BM (corresponding author), Cawthron Inst, Coastal & Freshwater Grp, Nelson, New Zealand.	barrie.forrest@cawthron.org.nz	Atalah, Javier/AAV-9077-2021	Atalah, Javier/0000-0003-0625-3431; Piola, Richard/0000-0001-5118-0118	NIWA under Coasts and Oceans Research Programme 4- Marine Biosecurity; New Zealand Ministry of Business Innovation and Employment (Effective Management of Marine Biodiversity and Biosecurity) [C01X0502]	NIWA under Coasts and Oceans Research Programme 4- Marine Biosecurity; New Zealand Ministry of Business Innovation and Employment (Effective Management of Marine Biodiversity and Biosecurity)	This research was funded by NIWA under Coasts and Oceans Research Programme 4- Marine Biosecurity (2012/13 SCI) and the New Zealand Ministry of Business Innovation and Employment (Contract C01X0502, Effective Management of Marine Biodiversity and Biosecurity). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Agius BP, 2007, J EXP MAR BIOL ECOL, V342, P30, DOI 10.1016/j.jembe.2006.10.012; Airoldi L, 2005, COAST ENG, V52, P1073, DOI 10.1016/j.coastaleng.2005.09.007; ANDERSON M. J., 2007, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Beveridge C., 2011, 413 SCOTT NAT HER CO; Bishop JDD, 2012, SURVEYS ASCIDIAN DID; BOYD HC, 1986, BIOL BULL, V170, P91, DOI 10.2307/1541383; Britton-Simmons KH, 2004, MAR ECOL PROG SER, V277, P61, DOI 10.3354/meps277061; Bullard SG, 2007, J EXP MAR BIOL ECOL, V342, P99, DOI 10.1016/j.jembe.2006.10.020; Bullard SG, 2007, J EXP MAR BIOL ECOL, V342, P166, DOI 10.1016/j.jembe.2006.10.034; Bulleri F, 2005, J APPL ECOL, V42, P1063, DOI 10.1111/j.1365-2664.2005.01096.x; Bulleri F, 2005, MAR ECOL PROG SER, V287, P53, DOI 10.3354/meps287053; Bulleri F, 2010, J APPL ECOL, V47, P26, DOI 10.1111/j.1365-2664.2009.01751.x; Campbell Marnie L., 2009, V204, P353; Carman MR, 2010, AQUAT INVASIONS, V5, P23, DOI 10.3391/ai.2010.5.1.4; Castilla JC, 2004, P NATL ACAD SCI USA, V101, P8517, DOI 10.1073/pnas.0401921101; Chadwell TB, 2008, J APPL ECOL, V45, P515, DOI 10.1111/j.1365-2664.2007.01384.x; Chapman MG, 2003, MAR ECOL PROG SER, V264, P21, DOI 10.3354/meps264021; Clark GF, 2009, OIKOS, V118, P1679, DOI 10.1111/j.1600-0706.2009.17564.x; Cloney R.A., 1987, P607; Cohen CS, 2011, AQUAT INVASIONS, V6, P263, DOI 10.3391/ai.2011.6.3.03; Connell SD, 1999, MAR ENVIRON RES, V47, P373, DOI 10.1016/S0141-1136(98)00126-3; Connell SD, 2000, J EXP MAR BIOL ECOL, V247, P183, DOI 10.1016/S0022-0981(00)00147-7; Coutts ADM, 2007, J EXP MAR BIOL ECOL, V342, P154, DOI 10.1016/j.jembe.2006.10.042; Currie DR, 2000, MAR BIOL, V136, P645, DOI 10.1007/s002270050724; Dafforn KA, 2009, BIOFOULING, V25, P277, DOI 10.1080/08927010802710618; Dumont CP, 2011, BIOL INVASIONS, V13, P2023, DOI 10.1007/s10530-011-0018-7; Epelbaum A, 2009, MAR BIOL, V156, P1311, DOI 10.1007/s00227-009-1172-7; Fletcher LM, 2013, AQUACULT ENV INTERAC, V4, P17, DOI 10.3354/aei00069; Fletcher LM, 2013, AQUACULT ENV INTERAC, V3, P197, DOI 10.3354/aei00063; Fletcher LM, 2013, BIOL INVASIONS, V15, P627, DOI 10.1007/s10530-012-0314-x; Fletcher LM, 2011, AQUAT INVASIONS, V6, P457, DOI 10.3391/ai.2011.6.4.11; Fletcher LM, 2013, THESIS VICTORIA U WE; Forrest BM, 2002, BIOL INVASIONS, V4, P375, DOI DOI 10.1023/A:1023613428351; Gittenberger A, 2007, J EXP MAR BIOL ECOL, V342, P122, DOI 10.1016/j.jembe.2006.10.022; Glasby TM, 2007, MAR BIOL, V151, P887, DOI 10.1007/s00227-006-0552-5; Glasby TM, 1999, ESTUAR COAST SHELF S, V48, P281, DOI 10.1006/ecss.1998.0417; Goulletquer P, 2002, INVASIVE AQUATIC SPECIES OF EUROPE: DISTRIBUTION, IMPACTS AND MANAGEMENT, P276; Hollebone AL, 2007, MAR ECOL PROG SER, V342, P191, DOI 10.3354/meps342191; Hopkins GA, 2011, J EXP MAR BIOL ECOL, V396, P233, DOI 10.1016/j.jembe.2010.10.027; Hunt HL, 1997, MAR ECOL PROG SER, V155, P269, DOI 10.3354/meps155269; Janiak DS, 2013, J EXP MAR BIOL ECOL, V443, P12, DOI 10.1016/j.jembe.2013.02.030; KAY AM, 1981, OECOLOGIA, V48, P123, DOI 10.1007/BF00346998; KEOUGH MJ, 1979, MAR BIOL, V51, P167, DOI 10.1007/BF00555196; KEOUGH MJ, 1986, MAR ECOL PROG SER, V33, P279, DOI 10.3354/meps033279; Kott P, 2002, J MAR BIOL ASSOC UK, V82, P625, DOI 10.1017/S0025315402005970; Lambert Gretchen, 2009, Aquatic Invasions, V4, P5, DOI 10.3391/ai.2009.4.1.2; Lengyel Nicole L., 2009, Aquatic Invasions, V4, P143, DOI 10.3391/ai.2009.4.1.15; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; Mercer Jeffery M., 2009, Aquatic Invasions, V4, P133, DOI 10.3391/ai.2009.4.1.14; Morris JA, 2012, BIOL INVASIONS, V14, P2133, DOI 10.1007/s10530-012-0219-8; Morton J. E., 1973, NZ SEA SHORE; Osman RW, 2007, J EXP MAR BIOL ECOL, V342, P40, DOI 10.1016/j.jembe.2006.10.013; OSMAN RW, 1995, J EXP MAR BIOL ECOL, V190, P199, DOI 10.1016/0022-0981(95)00036-Q; Osman RW, 2004, J EXP MAR BIOL ECOL, V311, P117, DOI 10.1016/j.jembe.2004.05.001; Reinhardt JF, 2012, MAR BIOL, V159, P2875, DOI 10.1007/s00227-012-2048-9; Rocha Rosana M., 2009, Aquatic Invasions, V4, P195, DOI 10.3391/ai.2009.4.1.20; Ruiz GM, 2000, ANNU REV ECOL SYST, V31, P481, DOI 10.1146/annurev.ecolsys.31.1.481; Ruiz GM, 2009, ECOL STUD-ANAL SYNTH, V206, P321, DOI 10.1007/978-3-540-92704-4_23; Simkanin C, 2013, J EXP MAR BIOL ECOL, V439, P76, DOI 10.1016/j.jembe.2012.10.004; Simkanin C, 2012, MAR ECOL-EVOL PERSP, V33, P499, DOI 10.1111/j.1439-0485.2012.00516.x; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Stachowicz JJ, 2006, MAR ECOL PROG SER, V311, P251, DOI 10.3354/meps311251; Svane I., 1989, Oceanography and Marine Biology an Annual Review, V27, P45; Tagliapietra Davide, 2012, BioInvasions Records, V1, P247, DOI 10.3391/bir.2012.1.4.02; Tyrrell MC, 2007, J EXP MAR BIOL ECOL, V342, P54, DOI 10.1016/j.jembe.2006.10.014; Valentine PC, 2007, J EXP MAR BIOL ECOL, V342, P109, DOI 10.1016/j.jembe.2006.10.021; Valentine PC, 2007, J EXP MAR BIOL ECOL, V342, P179, DOI 10.1016/j.jembe.2006.10.038; Valentine Page C., 2009, Aquatic Invasions, V4, P153, DOI 10.3391/ai.2009.4.1.16; Vervoort HC, 1998, MAR ECOL PROG SER, V164, P221, DOI 10.3354/meps164221; Von Holle B, 2005, ECOLOGY, V86, P3212, DOI 10.1890/05-0427; Whitlach Robert B., 2009, Aquatic Invasions, V4, P121, DOI 10.3391/ai.2009.4.1.13	74	36	36	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82229	10.1371/journal.pone.0082229	http://dx.doi.org/10.1371/journal.pone.0082229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349228	Green Submitted, gold, Green Published			2022-12-27	WOS:000328731800052
J	Hardoon, S; Hayes, JF; Blackburn, R; Petersen, I; Walters, K; Nazareth, I; Osborn, DPJ				Hardoon, Sarah; Hayes, Joseph F.; Blackburn, Ruth; Petersen, Irene; Walters, Kate; Nazareth, Irwin; Osborn, David P. J.			Recording of Severe Mental Illness in United Kingdom Primary Care, 2000-2010	PLOS ONE			English	Article							NATIONAL-COMORBIDITY-SURVEY; BIPOLAR I DISORDER; GENERAL-POPULATION; INCIDENCE RATES; NONAFFECTIVE PSYCHOSIS; LIFETIME PREVALENCE; GENDER-DIFFERENCES; SCHIZOPHRENIA; EPIDEMIOLOGY; STABILITY	Background: There is increasing emphasis on primary care services for individuals with severe mental illnesses (SMI), including schizophrenia, bipolar disorder, and other non-organic psychotic disorders. However we lack information on how many people receive these different diagnoses in primary care. Primary care databases offer an opportunity to explore the recording of new SMI diagnoses in representative general practices. Methods: We used data from The UK Health Improvement Network (THIN) primary care database including longitudinal patient records for individuals aged over 16 years from 437 general practices. We determined the annual GP recorded rate of first diagnosis of SMI by age, gender, social deprivation and urbanicity between 2000 and 2010. Results: We identified 10,520 individuals with a first record of schizophrenia, bipolar disorder or other non-organic psychosis among 4,164,794 patients. This corresponded to a rate of first diagnosis of 46.4 per 100,000 person years at risk (PYAR) (95% CI 45.4 to 47.4) in the 16-65 age group. The rate of first record of schizophrenia was 9.2 per 100,000 PYAR (95% CI 8.7 to 9.6) in this age group, bipolar disorder was 15.0 per 100,000 PYAR (95% CI 14.4 to 15.5) and other non-organic psychotic disorder was 22.3 per 100,000 PYAR (95% CI 21.6 to 23.0). Conclusions: The rates of GP recorded SMI in primary care records were broadly comparable to incidence rates from previous epidemiological studies of SMI and show similar patterns by socio-demographic characteristics. However there were some differences by specific diagnoses. GPs may be recording rates that are higher than those used to commission services.	[Hardoon, Sarah; Petersen, Irene; Walters, Kate; Nazareth, Irwin] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Hayes, Joseph F.; Blackburn, Ruth; Osborn, David P. J.] UCL, Mental Hlth Sci Unit, London, England	University of London; University College London; University of London; University College London	Hayes, JF (corresponding author), UCL, Mental Hlth Sci Unit, London, England.	joseph.hayes@ucl.ac.uk	Petersen, Irene/C-5702-2009; Osborn PhD FRCPsych, David/B-8165-2009	Petersen, Irene/0000-0002-0037-7524; Osborn PhD FRCPsych, David/0000-0003-2519-1539; Blackburn, Ruth/0000-0002-3491-7381; Nazareth, Irwin/0000-0003-2146-9628; Walters, Kate/0000-0003-2173-2430	National Institute for Health Research (NIHR) under its National Institute for Health Research's Programme Grants for Applied Research (PGfAR) Programme [RP-PG-0609-10156]; Medical Research Council [G0900701, MR/K021362/1] Funding Source: researchfish; MRC [MR/K021362/1, G0900701] Funding Source: UKRI	National Institute for Health Research (NIHR) under its National Institute for Health Research's Programme Grants for Applied Research (PGfAR) Programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This paper summarises independent research funded by the National Institute for Health Research (NIHR) under its National Institute for Health Research's Programme Grants for Applied Research (PGfAR) Programme (Grant Reference Number RP-PG-0609-10156). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEBBINGTON P, 1995, SOC PSYCH PSYCH EPID, V30, P279, DOI 10.1007/BF00805795; Blak B, 2006, NATL REPRESENTATIVEN; Blak Betina T, 2011, Inform Prim Care, V19, P251; Bourke Alison, 2004, Inform Prim Care, V12, P171; BOYD JH, 1981, ARCH GEN PSYCHIAT, V38, P1039; Bromet EJ, 2005, SCHIZOPHRENIA BULL, V31, P639, DOI 10.1093/schbul/sbi030; Cheng F, 2011, PSYCHOL MED, V41, P949, DOI 10.1017/S0033291710002461; Coid JW, 2008, ARCH GEN PSYCHIAT, V65, P1250, DOI 10.1001/archpsyc.65.11.1250; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; Department of Health, 2001, MENT HLTH POL IMPL G; Diflorio A, 2010, INT REV PSYCHIATR, V22, P437, DOI 10.3109/09540261.2010.514601; Drake RJ, 2005, CURRENT OPINION PSYC, V18; Frisher M, 2009, SCHIZOPHR RES, V113, P123, DOI 10.1016/j.schres.2009.05.031; Grant BF, 2005, J CLIN PSYCHIAT, V66, P1205, DOI 10.4088/JCP.v66n1001; Horsfall L, 2012, PHARMACOEPIDEM DRUG; Kawa I, 2005, BIPOLAR DISORD, V7, P119, DOI 10.1111/j.1399-5618.2004.00180.x; Kendler KS, 1996, ARCH GEN PSYCHIAT, V53, P1022; Kessler RC, 1997, PSYCHOL MED, V27, P1079, DOI 10.1017/S0033291797005333; Kessler RC, 2005, BIOL PSYCHIAT, V58, P668, DOI 10.1016/j.biopsych.2005.04.034; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kirkbride JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031660; Kirkbride JB, 2006, ARCH GEN PSYCHIAT, V63, P250, DOI 10.1001/archpsyc.63.3.250; LEFF JP, 1976, BRIT J PSYCHIAT, V129, P428, DOI 10.1192/bjp.129.5.428; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; McGorry PD, 2010, WORLD PSYCHIAT, V7, P148; McGrath J, 2008, EPIDEMIOL REV, V30, P67, DOI 10.1093/epirev/mxn001; McGrath J, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-13; Nazareth I, 1993, BMJ, V307; NHS employers, 2012, REV GMS CONTR 2006 7; Osborn DPJ, 2011, SCHIZOPHR RES, V129, P104, DOI 10.1016/j.schres.2011.04.003; Perala J, 2007, ARCH GEN PSYCHIAT, V64, P19, DOI 10.1001/archpsyc.64.1.19; Rajji TK, 2009, BRIT J PSYCHIAT, V195, P286, DOI 10.1192/bjp.bp.108.060723; Regeer EJ, 2004, ACTA PSYCHIAT SCAND, V110, P374, DOI 10.1111/j.1600-0447.2004.00363.x; REGIER DA, 1993, ARCH GEN PSYCHIAT, V50, P85; Singh S., 2003, PSYCHIAT B, V27, P254, DOI [10.1017/S0955603600002531, DOI 10.1017/S0955603600002531]; Singh S.P., 2005, ADV PSYCHIAT TREAT, V11, P71, DOI DOI 10.1192/APT.11.1.71; The NHS Information Centre, 2008, SUMM PUBL HLTH IND U; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; TSUANG MT, 1981, ARCH GEN PSYCHIAT, V38, P535; Tylee A, 2007, LANCET, V369, P1565, DOI 10.1016/S0140-6736(07)60371-7; van Os J, 2001, ARCH GEN PSYCHIAT, V58, P663, DOI 10.1001/archpsyc.58.7.663; Yatham LN, 2009, BIPOLAR DISORD, V11, P225, DOI 10.1111/j.1399-5618.2009.00672.x	44	59	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82365	10.1371/journal.pone.0082365	http://dx.doi.org/10.1371/journal.pone.0082365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EU	24349267	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800060
J	Lai, LJ; Zhang, MF; Song, YH; Rood, D				Lai, Laijun; Zhang, Mingfeng; Song, Yinhong; Rood, Debra			Recombinant IL-7/HGF beta Hybrid Cytokine Enhances T Cell Recovery in Mice Following Allogeneic Bone Marrow Transplantation	PLOS ONE			English	Article							VERSUS-HOST DISEASE; THYMOCYTE POSITIVE SELECTION; IMMUNE RECONSTITUTION; IL-7 RECEPTOR; INTERLEUKIN-7; PROGENITORS; EXPRESSION; SURVIVAL; PRECURSORS; REGENERATION	T cell immunodeficiency is a major complication of bone marrow (BM) transplantation (BMT). Therefore, approaches to enhance T cell reconstitution after BMT are required. We have purified a hybrid cytokine, consisting of IL-7 and the beta-chain of hepatocyte growth factor (HGF beta) (IL-7/HGF beta), from a unique long-term BM culture system. We have cloned and expressed the IL-7/HGF beta gene in which the IL-7 and HGF beta genes are connected by a flexible linker to generate rIL-7/HGF beta protein. Here, we show that rIL-7/HGF beta treatment enhances thymopoiesis after allogeneic BMT. Although rIL-7 treatment also enhances the number of thymocytes, rIL-7/HGF beta hybrid cytokine was more effective than was rIL-7 and the mechanisms by which rIL-7 and rIL-7/HGF beta increase the numbers of thymocytes are different. rIL-7 enhances the survival of double negative (DN), CD4 and CD8 single positive (SP) thymocytes. In contrast, rIL-7/HGF beta enhances the proliferation of the DN, SP thymocytes, as well as the survival of CD4 and CD8 double positive (DP) thymocytes. rIL-7/HGF beta treatment also increases the numbers of early thymocyte progenitors (ETPs) and thymic epithelial cells (TECs). The enhanced thymic reconstitution in the rIL-7/HGF beta-treated allogeneic BMT recipients results in increased number and functional activities of peripheral T cells. Graft-versus-host-disease (GVHD) is not induced in the rIL-7/HGF beta-treated BMT mice. Therefore, rIL-7/HGF beta may offer a new tool for the prevention and/or treatment of T cell immunodeficiency following BMT.	[Lai, Laijun; Zhang, Mingfeng; Song, Yinhong; Rood, Debra] Univ Connecticut, Dept Allied Hlth Sci, Storrs, CT 06269 USA; [Lai, Laijun] Univ Connecticut, Stem Cell Inst, Storrs, CT USA	University of Connecticut; University of Connecticut	Lai, LJ (corresponding author), Univ Connecticut, Dept Allied Hlth Sci, Storrs, CT 06269 USA.	laijun.lai@uconn.edu	Song, Yinhong/ABG-4971-2020	Song, Yinhong/0000-0003-4136-8744	Connecticut Stem Cell Research Program [10SCB12]	Connecticut Stem Cell Research Program	This work was supported by a grant from the Connecticut Stem Cell Research Program (10SCB12, to LL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Alpdogan O, 2001, BLOOD, V98, P2256, DOI 10.1182/blood.V98.7.2256; Anderson G, 2006, IMMUNOL REV, V209, P10, DOI 10.1111/j.0105-2896.2006.00347.x; ANDERSON G, 1994, J IMMUNOL, V153, P1915; Awong G, 2010, CURR OPIN HEMATOL, V17, P327, DOI 10.1097/MOH.0b013e3283395133; BERNSTEIN ID, 2008, BIOL BLOOD MARROW S1, V14, P94, DOI DOI 10.1016/J.BBMT.2007.10.003.PUBMED:18162228; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; BLATTER DD, 1990, TRANSPLANTATION, V50, P1011, DOI 10.1097/00007890-199012000-00023; Candeias S, 1997, IMMUNITY, V6, P501, DOI 10.1016/S1074-7613(00)80338-6; Chidgey A, 2007, SEMIN IMMUNOL, V19, P331, DOI 10.1016/j.smim.2007.10.006; Chu YW, 2008, BLOOD, V112, P2836, DOI 10.1182/blood-2008-04-149435; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Cosenza L, 2002, CELL SIGNAL, V14, P317, DOI 10.1016/S0898-6568(01)00245-5; El Kassar N, 2004, BLOOD, V104, P1419, DOI 10.1182/blood-2004-01-0201; Grad JM, 2000, CURR OPIN ONCOL, V12, P543, DOI 10.1097/00001622-200011000-00006; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; Hare KJ, 1999, J IMMUNOL, V162, P3978; Jin JJ, 2011, J IMMUNOL, V186, P1915, DOI 10.4049/jimmunol.1001238; Krenger W, 2011, BLOOD, V117, P6768, DOI 10.1182/blood-2011-02-334623; Lai LJ, 2012, J CLIN INVEST, V122, P3552, DOI 10.1172/JCI46055; Lai LJ, 2011, BLOOD, V118, P3410, DOI 10.1182/blood-2011-03-340794; Lai LJ, 2006, BLOOD, V107, P1776, DOI 10.1182/blood-2005-08-3470; Lynch HE, 2009, TRENDS IMMUNOL, V30, P366, DOI 10.1016/j.it.2009.04.003; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Oukka M, 1998, IMMUNITY, V9, P295, DOI 10.1016/S1074-7613(00)80612-3; Peggs Karl S., 2009, P131, DOI 10.1007/978-0-387-78580-6_6; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Sinha ML, 2002, BLOOD, V100, P2642, DOI 10.1182/blood-2002-04-1082; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; Wang RQ, 2011, CRIT REV IMMUNOL, V31, P447, DOI 10.1615/CritRevImmunol.v31.i6.10; WATSON JD, 1989, J IMMUNOL, V143, P1215; Xi HK, 2004, J IMMUNOL, V173, P340, DOI 10.4049/jimmunol.173.1.340; Yu Q, 2004, J EXP MED, V200, P797, DOI 10.1084/jem.20032183; Yuan J, 2010, J IMMUNOL, V184, P2793, DOI 10.4049/jimmunol.0902846; Zakrzewski JL, 2008, NAT BIOTECHNOL, V26, P453, DOI 10.1038/nbt1395; Zakrzewski JL, 2006, NAT MED, V12, P1039, DOI 10.1038/nm1463; Zediak VP, 2005, SEMIN IMMUNOL, V17, P337, DOI 10.1016/j.smim.2005.05.004	39	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82998	10.1371/journal.pone.0082998	http://dx.doi.org/10.1371/journal.pone.0082998			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349415	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800089
J	Bharathi, DG				Bharathi, D. Gnana			Evaluation and Ranking of Researchers - Bh Index	PLOS ONE			English	Article							H-INDEX; R-INDEX	Evaluation and ranking of every author is very crucial as it is widely used to evaluate the performance of the researcher. This article proposes a new method, called Bh-Index, to evaluate the researchers based on the publications and citations. The method is built on h-Index and only the h-core articles are taken into consideration. The method assigns value additions to those articles that receive significantly high citations in comparison to the h-Index of the researcher. It provides a wide range of values for a given h-Index and effective evaluation even for a short period. Use of Bh-Index along with the h-Index gives a powerful tool to evaluate the researchers.	Cent Leather Res Inst, Knowledge Resource Ctr, Madras 600020, Tamil Nadu, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Leather Research Institute (CLRI)	Bharathi, DG (corresponding author), Cent Leather Res Inst, Knowledge Resource Ctr, Madras 600020, Tamil Nadu, India.	dgbharathi@yahoo.com	Bharathi, D Gnana/B-6473-2008	Bharathi, D Gnana/0000-0002-8895-3871				Alonso S, 2010, SCIENTOMETRICS, V82, P391, DOI 10.1007/s11192-009-0047-5; Alonso S, 2009, J INFORMETR, V3, P273, DOI 10.1016/j.joi.2009.04.001; [Anonymous], 2006, SCI FOCUS, V1, P2; Bornmann L, 2008, J AM SOC INF SCI TEC, V59, P830, DOI 10.1002/asi.20806; Bornmann L, 2009, EMBO REP, V10, P2, DOI 10.1038/embor.2008.233; Costas R, 2007, J INFORMETR, V1, P193, DOI 10.1016/j.joi.2007.02.001; Egghe L, 2006, ISSI NEWSLETTER, V2, P2; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; Gelman A, 2002, STAT SCI, V17, P420; Gibb BC, 2012, NAT CHEM, V4, P513, DOI 10.1038/nchem.1388; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Jin BH, 2007, CHINESE SCI BULL, V52, P855, DOI 10.1007/s11434-007-0145-9; Prathap G, 2010, SCIENTOMETRICS, V84, P167, DOI 10.1007/s11192-009-0068-0; Schreiber M, 2008, J AM SOC INF SCI TEC, V59, P1513, DOI 10.1002/asi.20856; Stallings J, 2013, P NATL ACAD SCI USA; Vanclay JK, 2007, J AM SOC INF SCI TEC, V58, P1547, DOI 10.1002/asi.20616; Zhang CT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005429	17	5	5	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82050	10.1371/journal.pone.0082050	http://dx.doi.org/10.1371/journal.pone.0082050			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349183	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300072
J	Skalova, D; Zidkova, J; Vohanka, S; Mazanec, R; Musova, Z; Vondracek, P; Mrazova, L; Kraus, J; Reblova, K; Fajkusova, L				Skalova, Daniela; Zidkova, Jana; Vohanka, Stanislav; Mazanec, Radim; Musova, Zuzana; Vondracek, Petr; Mrazova, Lenka; Kraus, Josef; Reblova, Kamila; Fajkusova, Lenka			CLCN1 Mutations in Czech Patients with Myotonia Congenita, In Silico Analysis of Novel and Known Mutations in the Human Dimeric Skeletal Muscle Chloride Channel	PLOS ONE			English	Article							VARIABLE PENETRANCE; VOLTAGE-DEPENDENCE; MISSENSE MUTATIONS; GENE-MUTATIONS; DOMINANT; CLC-1; SPECTRUM; FAMILIES; HCLC-1; CIC-1	Myotonia congenita (MC) is a genetic disease caused by mutations in the skeletal muscle chloride channel gene (CLCN1) encoding the skeletal muscle chloride channel (ClC-1). Mutations of CLCN1 result in either autosomal dominant MC (Thomsen disease) or autosomal recessive MC (Becker disease). The ClC-1 protein is a homodimer with a separate ion pore within each monomer. Mutations causing recessive myotonia most likely affect properties of only the mutant monomer in the heterodimer, leaving the wild type monomer unaffected, while mutations causing dominant myotonia affect properties of both subunits in the heterodimer. Our study addresses two points: 1) molecular genetic diagnostics of MC by analysis of the CLCN1 gene and 2) structural analysis of mutations in the homology model of the human dimeric ClC-1 protein. In the first part, 34 different types of CLCN1 mutations were identified in 51 MC probands (14 mutations were new). In the second part, on the basis of the homology model we identified the amino acids which forming the dimer interface and those which form the Cl-ion pathway. In the literature, we searched for mutations of these amino acids for which functional analyses were performed to assess the correlation between localisation of a mutation and occurrence of a dominant-negative effect (corresponding to dominant MC). This revealed that both types of mutations, with and without a dominant-negative effect, are localised at the dimer interface while solely mutations without a dominant-negative effect occur inside the chloride channel. This work is complemented by structural analysis of the homology model which provides elucidation of the effects of mutations, including a description of impacts of newly detected missense mutations.	[Skalova, Daniela; Zidkova, Jana; Fajkusova, Lenka] Univ Hosp, Ctr Mol Biol & Gene Therapy, Brno, Czech Republic; [Skalova, Daniela; Zidkova, Jana; Reblova, Kamila; Fajkusova, Lenka] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Vohanka, Stanislav] Univ Hosp Brno, Dept Neurol, Brno, Czech Republic; [Mazanec, Radim] Charles Univ Prague, Fac Med 2, Dept Neurol, Prague, Czech Republic; [Mazanec, Radim; Musova, Zuzana; Kraus, Josef] Univ Hosp Motol, Prague, Czech Republic; [Musova, Zuzana] Charles Univ Prague, Fac Med 2, Dept Biol & Med Genet, Prague, Czech Republic; [Vondracek, Petr; Mrazova, Lenka] Univ Hosp Brno, Dept Child Neurol, Brno, Czech Republic; [Kraus, Josef] Charles Univ Prague, Sch Med 2, Dept Child Neurol, Prague, Czech Republic	University Hospital Brno; Masaryk University Brno; University Hospital Brno; Charles University Prague; Motol University Hospital; Charles University Prague; University Hospital Brno; Charles University Prague	Reblova, K (corresponding author), Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic.	kristina@physics.muni.cz; lfajkusova@fnbrno.cz	Fajkusova, Lenka/K-5217-2018; Vohanka, Stanislav/ABF-9821-2020	Vohanka, Stanislav/0000-0002-2229-624X	Czech Ministry of Education; project "CEITEC - Central European Institute of Technology" [CZ.1.05/1.1.00/02.0068]; project SuPReMMe [CZ.1.07/2.3.00/20.0045]; project of the Internal Grant Agency of the Czech Ministry of Health [NT/14574-3]; project (Ministry of Health, Czech Republic) [65269705]	Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); project "CEITEC - Central European Institute of Technology"; project SuPReMMe; project of the Internal Grant Agency of the Czech Ministry of Health; project (Ministry of Health, Czech Republic)	This work was funded by the Czech Ministry of Education, the project "CEITEC - Central European Institute of Technology" (CZ.1.05/1.1.00/02.0068), the project SuPReMMe (CZ.1.07/2.3.00/20.0045), and the project of the Internal Grant Agency of the Czech Ministry of Health (NT/14574-3) and supported by the project (Ministry of Health, Czech Republic) for conceptual development of research organization 65269705 (University Hospital Brno, Brno, Czech Republic). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi A, 2000, J GEN PHYSIOL, V116, P433, DOI 10.1085/jgp.116.3.433; Aromataris EC, 2001, MOL PHARMACOL, V60, P200, DOI 10.1124/mol.60.1.200; Berka K, 2012, NUCLEIC ACIDS RES, V40, pW222, DOI 10.1093/nar/gks363; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; Brugnoni R, 2013, J HUM GENET, V58, P581, DOI 10.1038/jhg.2013.58; Burgunder JM, 2008, NEUROMUSCULAR DISORD, V18, P633, DOI 10.1016/j.nmd.2008.05.007; Cederholm JM, 2010, INT J BIOCHEM CELL B, V42, P1182, DOI 10.1016/j.biocel.2010.04.004; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Colding-Jorgensen E, 2003, MUSCLE NERVE, V27, P449, DOI 10.1002/mus.10347; Duffield M, 2003, J GEN PHYSIOL, V121, P149, DOI 10.1085/jgp.20028741; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Fahlke C, 1997, P NATL ACAD SCI USA, V94, P2729, DOI 10.1073/pnas.94.6.2729; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Fialho D, 2007, BRAIN, V130, P3265, DOI 10.1093/brain/awm248; Gao F, 2010, NEUROL INDIA, V58, P743, DOI 10.4103/0028-3886.72163; GEORGE AL, 1994, HUM MOL GENET, V3, P2071; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ivanova EA, 2012, RUSS J GENET+, V48, P952, DOI 10.1134/S1022795412090049; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Koty PP, 1996, NEUROLOGY, V47, P963, DOI 10.1212/WNL.47.4.963; Kubisch C, 1998, HUM MOL GENET, V7, P1753, DOI 10.1093/hmg/7.11.1753; LehmannHorn F, 1996, REV PHYSIOL BIOCH P, V128, P195; LEHMANNHORN F, 1995, HUM MOL GENET, V4, P1397, DOI 10.1093/hmg/4.8.1397; LORENZ C, 1994, HUM MOL GENET, V3, P941, DOI 10.1093/hmg/3.6.941; Lossin C, 2008, ADV GENET, V63, P25, DOI 10.1016/S0065-2660(08)01002-X; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Ma L, 2008, BIOCHEM J, V413, P61, DOI 10.1042/BJ20071489; Ma LL, 2009, INT J BIOCHEM CELL B, V41, P1402, DOI 10.1016/j.biocel.2008.12.006; Mazon MJ, 2012, NEUROMUSCULAR DISORD, V22, P231, DOI 10.1016/j.nmd.2011.10.013; MEYERKLEINE C, 1995, AM J HUM GENET, V57, P1325; MIDDLETON RE, 1994, BIOCHEMISTRY-US, V33, P13189, DOI 10.1021/bi00249a005; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; Mindell JA, 2001, NATURE, V409, P219, DOI 10.1038/35051631; Pusch M, 2002, HUM MUTAT, V19, P423, DOI 10.1002/humu.10063; Pusch M, 1995, NEURON, V15, P1455, DOI 10.1016/0896-6273(95)90023-3; Reblova K, 2013, CLIN CHIM ACTA, V419, P1, DOI 10.1016/j.cca.2013.01.006; Richman DP, 2012, NEUROMOL MED, V14, P328, DOI 10.1007/s12017-012-8190-1; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Saviane C, 1999, J GEN PHYSIOL, V113, P457, DOI 10.1085/jgp.113.3.457; STEINMEYER K, 1994, EMBO J, V13, P737, DOI 10.1002/j.1460-2075.1994.tb06315.x; Sun C, 2001, EUR J HUM GENET, V9, P903, DOI 10.1038/sj.ejhg.5200736; Trip J, 2008, EUR J HUM GENET, V16, P921, DOI 10.1038/ejhg.2008.39; Ulzi G, 2012, J NEUROL SCI, V318, P65, DOI 10.1016/j.jns.2012.03.024; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; Wollnik B, 1997, HUM MOL GENET, V6, P805, DOI 10.1093/hmg/6.5.805; Wu FF, 2002, BRAIN, V125, P2392, DOI 10.1093/brain/awf246; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3; Zhang J, 2000, NEUROLOGY, V54, P937, DOI 10.1212/WNL.54.4.937	50	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82549	10.1371/journal.pone.0082549	http://dx.doi.org/10.1371/journal.pone.0082549			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349310	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300097
J	Weinberger, B; Schirmer, M; Gothe, RM; Siebert, U; Fuchs, D; Grubeck-Loebenstein, B				Weinberger, Birgit; Schirmer, Michael; Gothe, Raffaella Matteucci; Siebert, Uwe; Fuchs, Dietmar; Grubeck-Loebenstein, Beatrix			Recall Responses to Tetanus and Diphtheria Vaccination Are Frequently Insufficient in Elderly Persons	PLOS ONE			English	Article							CONJUGATED PNEUMOCOCCAL VACCINE; AGED 60 YEARS; CYTOMEGALOVIRUS-INFECTION; HUMORAL IMMUNITY; OLD-AGE; ASSOCIATION; ADULTS; LIFE; FRAILTY; IMMUNOSENESCENCE	Demographic changes and a more active life-style in older age have contributed to an increasing public awareness of the need for lifelong vaccination. Currently many older persons have been vaccinated against selected pathogens during childhood but lack regular booster immunizations. The impact of regular vaccinations when started late in life was analyzed in an open, explorative trial by evaluating the immune response against tetanus and diphtheria in healthy older individuals. 252 persons aged above 60 years received a booster vaccination against tetanus, diphtheria, pertussis and polio and a subcohort (n=87) was recruited to receive a second booster vaccination against tetanus, diphtheria and pertussis 5 years later. The percentage of unprotected individuals at the time of enrollment differed substantially for tetanus (12%) and diphtheria (65%). Despite protective antibody concentrations 4 weeks after the first vaccination in almost all vaccinees, antibodies had again dropped below protective levels in 10% (tetanus) and 45% (diphtheria) of the cohort after 5 years. Protection was restored in almost all vaccinees after the second vaccination. No correlation between tetanus-and diphtheria-specific responses was observed, and antibody concentrations were not associated with age-related changes in the T cell repertoire, inflammatory parameters, or CMV-seropositivity suggesting that there was no general biological "non-responder type." Post-vaccination antibody concentrations depended on pre-existing plasma cells and B cell memory as indicated by a strong positive relationship between post-vaccination antibodies and pre-vaccination antibodies as well as antibody-secreting cells. In contrast, antigen-specific T cell responses were not or only weakly associated with antibody concentrations. In conclusion, our findings demonstrate that single shot vaccinations against tetanus and/or diphtheria do not lead to long-lasting immunity in many elderly persons despite administration at relatively short intervals. Sufficient antigen-specific B cell memory B generated by adequate priming and consecutive booster vaccinations and/or exposure is a prerequisite for long-term protection.	[Weinberger, Birgit; Grubeck-Loebenstein, Beatrix] Univ Innsbruck, Inst Biomed Aging Res, A-6020 Innsbruck, Austria; [Schirmer, Michael] Med Univ Innsbruck, Dept Internal Med 4, A-6020 Innsbruck, Austria; [Gothe, Raffaella Matteucci; Siebert, Uwe] UMIT Univ Hlth Sci Med Informat & Technol, Dept Publ Hlth & Hlth Technol Assessment, Hall In Tirol, Austria; [Siebert, Uwe] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Inst Technol Assessment, Boston, MA USA; [Siebert, Uwe] Harvard Univ, Sch Med, Dept Radiol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Siebert, Uwe] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Fuchs, Dietmar] Med Univ Innsbruck, Div Biol Chem, Bioctr, A-6020 Innsbruck, Austria	University of Innsbruck; Medical University of Innsbruck; UMIT - Private University for Health Sciences, Medical Informatics & Technology GmbH; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Medical University of Innsbruck	Grubeck-Loebenstein, B (corresponding author), Univ Innsbruck, Inst Biomed Aging Res, A-6020 Innsbruck, Austria.	beatrix.grubeck@uibk.ac.at	Weinberger, Birgit/ABC-5233-2020; Siebert, Uwe/M-5057-2019; Schirmer, Michael/B-1893-2012; Fuchs, Dietmar/AAL-8011-2021	Siebert, Uwe/0000-0001-6425-7671; Schirmer, Michael/0000-0001-9208-7809; Fuchs, Dietmar/0000-0003-1627-9563; Weinberger, Birgit/0000-0002-7084-946X	Oesterreichische Nationalbank (Anniversery Fund) [13524]; Austrian Green Cross; European Union [280873 ADITEC]	Oesterreichische Nationalbank (Anniversery Fund); Austrian Green Cross; European Union(European Commission)	This work was supported by funds of the Oesterreichische Nationalbank (Anniversery Fund, project number 13524; www.oenb.at/de) and the Austrian Green Cross (www.grueneskreuz.org). The research leading to these results has received funding from the European Union's Seventh Framework Programme [FP7/2007-2013] under Grant Agreement No: 280873 ADITEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbera JP, 2007, EXPERT REV VACCINES, V6, P659, DOI 10.1586/14760584.6.5.659; Bayas JM, 2001, EPIDEMIOL INFECT, V127, P451, DOI 10.1017/S095026880100629X; Brunner S, 2011, AGEING RES REV, V10, P362, DOI 10.1016/j.arr.2010.08.003; Collerton J, 2012, MECH AGEING DEV, V133, P456, DOI 10.1016/j.mad.2012.05.005; De Donato S, 1999, VACCINE, V17, P3094, DOI 10.1016/S0264-410X(99)00138-3; Del GG, 2013, EXPERT OPIN BIOL TH, V13, P121, DOI [10.1517/14712598.2013.748030., DOI 10.1517/14712598.2013.748030.PUBMED:23189937]; Eleftheriadis T, 2011, VACCINE, V29, P2242, DOI 10.1016/j.vaccine.2011.01.051; Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Goronzy JJ, 2001, J VIROL, V75, P12182, DOI 10.1128/JVI.75.24.12182-12187.2001; Grubeck-Loebenstein B, 1998, NAT MED, V4, P870, DOI 10.1038/nm0898-870b; Gusmano MK, 2009, AGING CLIN EXP RES, V21, P258, DOI 10.1007/BF03324907; Hainz U, 2005, VACCINE, V23, P3232, DOI 10.1016/j.vaccine.2005.01.085; Haynes L, 2005, CURR OPIN IMMUNOL, V17, P476, DOI 10.1016/j.coi.2005.07.003; Haynes L, 2003, P NATL ACAD SCI USA, V100, P15053, DOI 10.1073/pnas.2433717100; Kaml M, 2006, VACCINE, V24, P6808, DOI 10.1016/j.vaccine.2006.06.037; Koch S, 2006, MECH AGEING DEV, V127, P538, DOI 10.1016/j.mad.2006.01.011; Laich A, 2002, CLIN CHEM, V48, P579; Launay O, 2009, HUM VACCINES, V5, P341, DOI 10.4161/hv.5.5.7575; Leng S, 2002, J AM GERIATR SOC, V50, P1268, DOI 10.1046/j.1532-5415.2002.50315.x; Leng SX, 2011, AGE AGEING, V40, P475, DOI 10.1093/ageing/afr047; Michel JP, 2011, REJUV RES, V14, P75, DOI 10.1089/rej.2010.1078; Michel JP, 2009, AGING CLIN EXP RES, V21, P254, DOI 10.1007/BF03324911; Michel JP, 2009, REJUV RES, V12, P127, DOI 10.1089/rej.2008.0813; Murr C, 2003, EXP GERONTOL, V38, P583, DOI 10.1016/S0531-5565(03)00062-7; Pertovaara M, 2006, MECH AGEING DEV, V127, P497, DOI 10.1016/j.mad.2006.01.020; Rabian C, 2010, CLIN INFECT DIS, V50, P1174, DOI 10.1086/651418; Ridda I, 2009, VACCINE, V27, P1628, DOI 10.1016/j.vaccine.2008.11.098; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Shelly MA, 2001, SCAND J INFECT DIS, V33, P542, DOI 10.1080/00365540110026502; Steger MM, 1996, LANCET, V348, P762, DOI 10.1016/S0140-6736(05)65680-2; Stubbe M, 2007, EUR J EMERG MED, V14, P14, DOI 10.1097/01.mej.0000228449.37974.7e; Tomovici A, 2012, VACCINE, V30, P2647, DOI 10.1016/j.vaccine.2012.02.013; Trzonkowski P, 2003, VACCINE, V21, P3826, DOI 10.1016/S0264-410X(03)00309-8; Van Damme P, 2004, VACCINE, V22, P305, DOI 10.1016/j.vaccine.2003.08.012; Wagner KS, 2012, VACCINE, V30, P7111, DOI 10.1016/j.vaccine.2012.09.029; Weinberger B, 2012, CLIN MICROBIOL INFEC, V18, P100, DOI 10.1111/j.1469-0691.2012.03944.x; Widner B, 1997, CLIN CHEM, V43, P2424; Wikby A, 2006, MECH AGEING DEV, V127, P695, DOI 10.1016/j.mad.2006.04.003; World Health Organization, VACC PREV DIS MON SY; Xie DX, 2007, MECH AGEING DEV, V128, P392, DOI 10.1016/j.mad.2007.05.001	41	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82967	10.1371/journal.pone.0082967	http://dx.doi.org/10.1371/journal.pone.0082967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349407	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300116
J	Tanca, A; Palomba, A; Deligios, M; Cubeddu, T; Fraumene, C; Biosa, G; Pagnozzi, D; Addis, MF; Uzzau, S				Tanca, Alessandro; Palomba, Antonio; Deligios, Massimo; Cubeddu, Tiziana; Fraumene, Cristina; Biosa, Grazia; Pagnozzi, Daniela; Addis, Maria Filippa; Uzzau, Sergio			Evaluating the Impact of Different Sequence Databases on Metaproteome Analysis: Insights from a Lab-Assembled Microbial Mixture	PLOS ONE			English	Article							PEPTIDE IDENTIFICATIONS; PROTEIN INFERENCE; METAGENOMICS; COMMUNITIES; GENERATION; PROTEOMICS; PROTEOGENOMICS; TECHNOLOGIES; CONFIDENCE; BLAST	Metaproteomics enables the investigation of the protein repertoire expressed by complex microbial communities. However, to unleash its full potential, refinements in bioinformatic approaches for data analysis are still needed. In this context, sequence databases selection represents a major challenge. This work assessed the impact of different databases in metaproteomic investigations by using a mock microbial mixture including nine diverse bacterial and eukaryotic species, which was subjected to shotgun metaproteomic analysis. Then, both the microbial mixture and the single microorganisms were subjected to next generation sequencing to obtain experimental metagenomic- and genomic-derived databases, which were used along with public databases (namely, NCBI, UniProtKB/SwissProt and UniProtKB/TrEMBL, parsed at different taxonomic levels) to analyze the metaproteomic dataset. First, a quantitative comparison in terms of number and overlap of peptide identifications was carried out among all databases. As a result, only 35% of peptides were common to all database classes; moreover, genus/species-specific databases provided up to 17% more identifications compared to databases with generic taxonomy, while the metagenomic database enabled a slight increment in respect to public databases. Then, database behavior in terms of false discovery rate and peptide degeneracy was critically evaluated. Public databases with generic taxonomy exhibited a markedly different trend compared to the counterparts. Finally, the reliability of taxonomic attribution according to the lowest common ancestor approach (using MEGAN and Unipept software) was assessed. The level of misassignments varied among the different databases, and specific thresholds based on the number of taxon-specific peptides were established to minimize false positives. This study confirms that database selection has a significant impact in metaproteomics, and provides critical indications for improving depth and reliability of metaproteomic results. Specifically, the use of iterative searches and of suitable filters for taxonomic assignments is proposed with the aim of increasing coverage and trustworthiness of metaproteomic data.	[Tanca, Alessandro; Deligios, Massimo; Cubeddu, Tiziana; Fraumene, Cristina; Biosa, Grazia; Pagnozzi, Daniela; Addis, Maria Filippa; Uzzau, Sergio] Porto Conte Ric Srl, Tramariglio, Alghero, Italy; [Tanca, Alessandro; Palomba, Antonio; Deligios, Massimo; Addis, Maria Filippa; Uzzau, Sergio] Univ Sassari, Dipartimento Sci Biomed, I-07100 Sassari, Italy	Porto Conte Ricerche; University of Sassari	Addis, MF (corresponding author), Porto Conte Ric Srl, Tramariglio, Alghero, Italy.	addis@portocontericerche.it; uzzau@uniss.it	Tanca, Alessandro/O-3734-2019; Uzzau, Sergio/F-3233-2015; Palomba, Antonio/AAA-6321-2020; Addis, Maria Filippa/I-5381-2019; Deligios, Massimo/O-2208-2019	Tanca, Alessandro/0000-0002-6066-7048; Uzzau, Sergio/0000-0001-6246-2794; Addis, Maria Filippa/0000-0001-6934-7748; Deligios, Massimo/0000-0002-3924-4753; Biosa, Grazia/0000-0002-0252-5439; Pagnozzi, Daniela/0000-0001-7764-1867; Palomba, Antonio/0000-0001-7380-2934	Sardegna Ricerche through the program "Progetto Strategico Biotecnologie (WP2 - Biomarker microbici)"; International PhD School in Biomolecular and Biotechnological Sciences, University of Sassari	Sardegna Ricerche through the program "Progetto Strategico Biotecnologie (WP2 - Biomarker microbici)"; International PhD School in Biomolecular and Biotechnological Sciences, University of Sassari	This work was financed by Sardegna Ricerche through the program "Progetto Strategico Biotecnologie (WP2 - Biomarker microbici)". AP was supported by a Doctoral Fellowship from the International PhD School in Biomolecular and Biotechnological Sciences, University of Sassari. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen LO, 2013, ISME J, V7, P1253, DOI 10.1038/ismej.2013.21; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Armengaud J, 2013, PROTEOMICS, V13, P2731, DOI 10.1002/pmic.201200576; Blakeley P, 2012, J PROTEOME RES, V11, P5221, DOI 10.1021/pr300411q; Cantarel BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027173; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Chourey K, 2010, J PROTEOME RES, V9, P6615, DOI 10.1021/pr100787q; Claassen M, 2012, MOL CELL PROTEOMICS, V11; Claassen M, 2012, MOL CELL PROTEOMICS, V11, P1097, DOI 10.1074/mcp.R111.014795; Colaert N, 2011, J PROTEOME RES, V10, P5555, DOI 10.1021/pr200913a; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Denef VJ, 2009, ENVIRON MICROBIOL, V11, P313, DOI 10.1111/j.1462-2920.2008.01769.x; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Erickson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049138; Ferrer M, 2013, ENVIRON MICROBIOL, V15, P211, DOI 10.1111/j.1462-2920.2012.02845.x; Gonzalez A, 2011, EMBO REP, V12, P775, DOI 10.1038/embor.2011.137; Granholm V, 2011, PROTEOMICS, V11, P1086, DOI 10.1002/pmic.201000432; Harju S, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-8; Hettich RL, 2012, CURR OPIN MICROBIOL, V15, P373, DOI 10.1016/j.mib.2012.04.008; Hood L, 2012, SCIENCE, V336, P1209, DOI 10.1126/science.1225475; Hoopmann MR, 2013, CURR OPIN BIOTECH, V24, P31, DOI 10.1016/j.copbio.2012.10.013; Huang T, 2012, BRIEF BIOINFORM, V13, P586, DOI 10.1093/bib/bbs004; Huffnagle GB, 2013, TRENDS MICROBIOL; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Huson DH, 2012, METHODS MOL BIOL, V856, P415, DOI 10.1007/978-1-61779-585-5_17; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Jabbour RE, 2011, J PROTEOME RES, V10, P907, DOI 10.1021/pr101086a; Jagtap P, 2013, PROTEOMICS, V13, P1352, DOI 10.1002/pmic.201200352; Jagtap P, 2012, PROTEOMICS, V12, P992, DOI 10.1002/pmic.201100503; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kolmeder CA, 2013, J PROTEOMIC IN PRESS; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Larsen P, 2012, J BIOTECHNOL, V160, P17, DOI 10.1016/j.jbiotec.2012.03.009; Mesuere B, 2012, J PROTEOME RES, V11, P5773, DOI 10.1021/pr300576s; Mikeskova H, 2012, APPL MICROBIOL BIOT, V95, P861, DOI 10.1007/s00253-012-4234-6; Minton K, 2012, NAT REV IMMUNOL, V12, P476, DOI 10.1038/nri3252; Morris BEL, 2012, ENV MICROBIOL REP, V4, P297, DOI 10.1111/j.1758-2229.2012.00333.x; Morris RM, 2010, ISME J, V4, P673, DOI 10.1038/ismej.2010.4; Muth T, 2013, MOL BIOSYST, V9, P578, DOI 10.1039/c2mb25415h; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Nesvizhskii AI, 2010, J PROTEOMICS, V73, P2092, DOI 10.1016/j.jprot.2010.08.009; Nielsen PH, 2012, CURR OPIN BIOTECH, V23, P452, DOI 10.1016/j.copbio.2011.11.027; Ottman N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00104; Pevtsov S, 2006, J PROTEOME RES, V5, P3018, DOI 10.1021/pr060222h; Prasad TSK, 2012, J PROTEOME RES, V11, P247, DOI 10.1021/pr200827k; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Renard BY, 2010, ANAL CHEM, V82, P4314, DOI 10.1021/ac902892j; Renuse S, 2011, PROTEOMICS, V11, P620, DOI 10.1002/pmic.201000615; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Roling WFM, 2010, CURR OPIN BIOTECH, V21, P532, DOI 10.1016/j.copbio.2010.06.007; Rooijers K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-6; Rudney JD, 2010, MOL ORAL MICROBIOL, V25, P38, DOI 10.1111/j.2041-1014.2009.00558.x; Seidler J, 2010, PROTEOMICS, V10, P634, DOI 10.1002/pmic.200900459; Seifert J, 2013, PROTEOMICS, V13, P2786, DOI 10.1002/pmic.201200566; Sharma R, 2012, J PROTEOME RES, V11, P6008, DOI 10.1021/pr300709k; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Siggins A, 2012, FEMS MICROBIOL ECOL, V80, P265, DOI 10.1111/j.1574-6941.2011.01284.x; Spivak M, 2009, J PROTEOME RES, V8, P3737, DOI 10.1021/pr801109k; Tanca A, 2013, PROTEOMICS, V13, P2597, DOI 10.1002/pmic.201200478; Tanca A, 2013, PROTEOM CLIN APPL, V7, P252, DOI 10.1002/prca.201200054; Temperton B, 2012, CURR OPIN MICROBIOL, V15, P605, DOI 10.1016/j.mib.2012.07.001; Vaudel M, 2011, PROTEOMICS, V11, P2105, DOI 10.1002/pmic.201000704; VerBerkmoes NC, 2009, NAT REV MICROBIOL, V7, P196, DOI 10.1038/nrmicro2080; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Vieites JM, 2009, FEMS MICROBIOL REV, V33, P236, DOI 10.1111/j.1574-6976.2008.00152.x; Wessel AK, 2013, NAT REV MICROBIOL, V11, P337, DOI 10.1038/nrmicro3010; Wilmes P, 2006, TRENDS MICROBIOL, V14, P92, DOI 10.1016/j.tim.2005.12.006; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wright JC, 2010, METHODS MOL BIOL, V604, P123, DOI 10.1007/978-1-60761-444-9_9; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	76	72	72	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82981	10.1371/journal.pone.0082981	http://dx.doi.org/10.1371/journal.pone.0082981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349410	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200119
J	Cheon, J; Fujioka, S; Dilkes, BP; Choe, S				Cheon, Jinyeong; Fujioka, Shozo; Dilkes, Brian P.; Choe, Sunghwa			Brassinosteroids Regulate Plant Growth through Distinct Signaling Pathways in Selaginella and Arabidopsis	PLOS ONE			English	Article							GSK3-LIKE KINASE BIN2; RECEPTOR KINASE; BIOSYNTHETIC-PATHWAY; DWARF MUTANTS; CYTOCHROME-P450; GENE; BRI1; TRANSDUCTION; EVOLUTION; PERCEPTION	Brassinosteroids (BRs) are growth-promoting steroid hormones that regulate diverse physiological processes in plants. Most BR biosynthetic enzymes belong to the cytochrome P450 (CYP) family. The gene encoding the ultimate step of BR biosynthesis in Arabidopsis likely evolved by gene duplication followed by functional specialization in a dicotyledonous plant-specific manner. To gain insight into the evolution of BRs, we performed a genomic reconstitution of Arabidopsis BR biosynthetic genes in an ancestral vascular plant, the lycophyte Selaginella moellendorffii. Selaginella contains four members of the CYP90 family that cluster together in the CYP85 clan. Similar to known BR biosynthetic genes, the Selaginella CYP90s exhibit eight or ten exons and Selaginella produces a putative BR biosynthetic intermediate. Therefore, we hypothesized that Selaginella CYP90 genes encode BR biosynthetic enzymes. In contrast to typical CYPs in Arabidopsis, Selaginella CYP90E2 and CYP90F1 do not possess amino-terminal signal peptides, suggesting that they do not localize to the endoplasmic reticulum. In addition, one of the three putative CYP reductases (CPRs) that is required for CYP enzyme function co-localized with CYP90E2 and CYP90F1. Treatments with a BR biosynthetic inhibitor, propiconazole, and epibrassinolide resulted in greatly retarded and increased growth, respectively. This suggests that BRs promote growth in Selaginella, as they do in Arabidopsis. However, BR signaling occurs through different pathways than in Arabidopsis. A sequence homologous to the Arabidopsis BR receptor BRI1 was absent in Selaginella, but downstream components, including BIN2, BSU1, and BZR1, were present. Thus, the mechanism that initiates BR signaling in Selaginella seems to differ from that in Arabidopsis. Our findings suggest that the basic physiological roles of BRs as growth-promoting hormones are conserved in both lycophytes and Arabidopsis; however, different BR molecules and BRI1-based membrane receptor complexes evolved in these plants.	[Cheon, Jinyeong; Choe, Sunghwa] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea; [Fujioka, Shozo] RIKEN Adv Sci Inst, Wako, Saitama, Japan; [Dilkes, Brian P.] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA; [Choe, Sunghwa] Adv Inst Convergence Technol, Convergence Res Ctr Funct Plant Prod, Suwon, Gyeonggi, South Korea; [Choe, Sunghwa] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul, South Korea	Seoul National University (SNU); RIKEN; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Seoul National University (SNU)	Dilkes, BP (corresponding author), Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47907 USA.	bdilkes@purdue.edu; shchoe@snu.ac.kr	Choe, Sunghwa/K-5650-2013; Dilkes, Brian/C-9293-2012	Choe, Sunghwa/0000-0001-5541-484X; Dilkes, Brian/0000-0003-2799-954X	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center) [PJ008051]; Cooperative Research Program for Agriculture Science & Technology Development [PJ906910]; Rural Development Administration; Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea [110033-5]; BK21 Research Fellowships; Ministry of Education, Republic of Korea; Ministry of Education, Culture, Sports, Science and Technology of Japan [19380069, 23380066]	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center)(Rural Development Administration (RDA), Republic of Korea); Cooperative Research Program for Agriculture Science & Technology Development(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Technology Development Program for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea; BK21 Research Fellowships(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Ministry of Education, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaMinistry of Education (MOE), Republic of Korea); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported, in part, by grants from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center No. PJ008051), Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ906910), funded by the Rural Development Administration (to S. C.); Technology Development Program (110033-5) for Agriculture and Forestry, Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea (to S. C.); the BK21 Research Fellowships (to J.C.), funded by the Ministry of Education, Republic of Korea; and a Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (19380069 and 23380066 to S. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Banks JA, 2009, ANNU REV PLANT BIOL, V60, P223, DOI 10.1146/annurev.arplant.59.032607.092851; Bishop GJ, 1999, P NATL ACAD SCI USA, V96, P1761, DOI 10.1073/pnas.96.4.1761; Choe S, 2000, PLANT J, V21, P431, DOI 10.1046/j.1365-313x.2000.00693.x; Choe S, 2002, PLANT PHYSIOL, V130, P1506, DOI 10.1104/pp.010496; Choe S, 2001, PLANT J, V26, P573, DOI 10.1046/j.1365-313x.2001.01055.x; Choe S, 1999, PLANT PHYSIOL, V119, P897, DOI 10.1104/pp.119.3.897; Choe SW, 1999, PLANT CELL, V11, P207, DOI 10.1105/tpc.11.2.207; Choe SW, 1998, PLANT CELL, V10, P231, DOI 10.1105/tpc.10.2.231; Chung Y, 2013, CRIT REV PLANT SCI, V32, P396, DOI 10.1080/07352689.2013.797856; Chung Y, 2012, PLANT MOL BIOL, V80, P489, DOI 10.1007/s11103-012-9963-5; Fujioka S, 2002, PLANT PHYSIOL, V130, P930, DOI 10.1104/pp.008722; Hamberger B, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0426; Hartwig T, 2011, P NATL ACAD SCI USA, V108, P19814, DOI 10.1073/pnas.1108359108; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; He ZH, 2000, SCIENCE, V288, P2360, DOI 10.1126/science.288.5475.2360; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hirano K, 2007, PLANT CELL, V19, P3058, DOI 10.1105/tpc.107.051524; Jensen K, 2010, PHYTOCHEMISTRY, V71, P132, DOI 10.1016/j.phytochem.2009.10.017; Kim BK, 2008, BIOCHEM BIOPH RES CO, V374, P614, DOI 10.1016/j.bbrc.2008.07.073; Kim B, 2012, MOL CELLS, V34, P77, DOI 10.1007/s10059-012-0102-6; Kim GT, 2005, PLANT J, V41, P710, DOI 10.1111/j.1365-313X.2004.02330.x; Kim HB, 2005, PLANT PHYSIOL, V138, P2033, DOI 10.1104/pp.105.061598; Kim TW, 2011, MOL CELL, V43, P561, DOI 10.1016/j.molcel.2011.05.037; Kim TW, 2010, ANNU REV PLANT BIOL, V61, P681, DOI 10.1146/annurev.arplant.043008.092057; Kim TW, 2005, PLANT CELL, V17, P2397, DOI 10.1105/tpc.105.033738; Kwon M, 2005, J PLANT BIOL, V48, P1, DOI 10.1007/BF03030559; Li JM, 1997, CELL, V90, P929, DOI 10.1016/S0092-8674(00)80357-8; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Maharjan PM, 2011, J PLANT BIOL, V54, P126, DOI 10.1007/s12374-010-9138-3; Mathur J, 1998, PLANT J, V14, P593, DOI 10.1046/j.1365-313X.1998.00158.x; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Ohnishi T, 2006, PLANT CELL, V18, P3275, DOI 10.1105/tpc.106.045443; Ohnishi T, 2009, PHYTOCHEMISTRY, V70, P1918, DOI 10.1016/j.phytochem.2009.09.015; Rambaut A., 2007, FIGTREE; She J, 2011, NATURE, V474, P472, DOI 10.1038/nature10178; Szczesna-Skorupa E, 1998, P NATL ACAD SCI USA, V95, P14793, DOI 10.1073/pnas.95.25.14793; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Tang WQ, 2008, SCIENCE, V321, P557, DOI 10.1126/science.1156973; Tang WQ, 2011, NAT CELL BIOL, V13, P124, DOI 10.1038/ncb2151; Vert G, 2005, ANNU REV CELL DEV BI, V21, P177, DOI 10.1146/annurev.cellbio.21.090704.151241; Wang XL, 2006, SCIENCE, V313, P1118, DOI 10.1126/science.1127593; Wang ZY, 2012, ANNU REV GENET, V46, P701, DOI 10.1146/annurev-genet-102209-163450; Weston SJ, 2005, HEPATOLOGY, V41, P72, DOI 10.1002/hep.20507	48	25	25	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e81938	10.1371/journal.pone.0081938	http://dx.doi.org/10.1371/journal.pone.0081938			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349155	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200019
J	da Rocha, UN; Plugge, CM; George, I; van Elsas, JD; van Overbeek, LS				da Rocha, Ulisses Nunes; Plugge, Caroline M.; George, Isabelle; van Elsas, Jan Dirk; van Overbeek, Leonard Simon			The Rhizosphere Selects for Particular Groups of Acidobacteria and Verrucomicrobia	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; BACTERIAL COMMUNITY STRUCTURE; HITHERTO-UNCULTURED BACTERIA; SOIL MICROBIAL COMMUNITY; GEN. NOV.; PHYLUM ACIDOBACTERIA; SUBDIVISION 1; DIVERSITY; CULTIVATION; MEMBERS	There is a lack in our current understanding on the putative interactions of species of the phyla of Acidobacteria and Verrucomicrobia with plants. Moreover, progress in this area is seriously hampered by the recalcitrance of members of these phyla to grow as pure cultures. The purpose of this study was to investigate whether particular members of Acidobacteria and Verrucomicrobia are avid colonizers of the rhizosphere. Based on previous work, rhizosphere competence was demonstrated for the Verrucomicrobia subdivision 1 groups of Luteolibacter and Candidatus genus Rhizospheria and it was hypothesized that the rhizosphere is a common habitat for Acidobacteria subdivision 8 (class Holophagae). We assessed the population densities of Bacteria, Verrucomicrobia subdivision 1 groups Luteolibacter and Candidatus genus Rhizospheria and Acidobacteria subdivisions 1, 3, 4, 6 and Holophagae in bulk soil and in the rhizospheres of grass, potato and leek in the same field at different points in time using real-time quantitative PCR. Primers of all seven verrucomicrobial, acidobacterial and holophagal PCR systems were based on 16S rRNA gene sequences of cultivable representatives of the different groups. Luteolibacter, Candidatus genus Rhizospheria, subdivision 6 acidobacteria and Holophaga showed preferences for one or more rhizospheres. In particular, the Holophaga 16S rRNA gene number were more abundant in the leek rhizosphere than in bulk soil and the rhizospheres of grass and potato. Attraction to, and colonization of, leek roots by Holophagae strain CHC25 was further shown in an experimental microcosm set-up. In the light of this remarkable capacity, we propose to coin strain CHC25 Candidatus Porrumbacterium oxyphilus (class Holophagae, Phylum Acidobacteria), the first cultured representative with rhizosphere competence.	[da Rocha, Ulisses Nunes; van Overbeek, Leonard Simon] Univ Wageningen & Res Ctr, Wageningen, Netherlands; [da Rocha, Ulisses Nunes] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Ctr Environm Biotechnol, Berkeley, CA 94720 USA; [Plugge, Caroline M.] Univ Wageningen & Res Ctr, Microbiol Lab, Wageningen, Netherlands; [George, Isabelle] Univ Libre Bruxelles, Lab Ecol Syst Aquat, Brussels, Belgium; [van Elsas, Jan Dirk] Univ Groningen, Dept Microbial Ecol, Ctr Ecol & Evolutionary Studies, Groningen, Netherlands	Wageningen University & Research; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Wageningen University & Research; Universite Libre de Bruxelles; University of Groningen	van Overbeek, LS (corresponding author), Univ Wageningen & Res Ctr, Wageningen, Netherlands.	leo.vanoverbeek@wur.nl	Nunes da Rocha, Ulisses/AAE-5158-2021; Nunes da Rocha, Ulisses/M-7467-2013	Nunes da Rocha, Ulisses/0000-0001-6972-6692; Nunes da Rocha, Ulisses/0000-0001-6972-6692	Netherlands Genomic Initiative(NGI); Dutch Ministry of Agriculture, Nature and Food Quality [KB4]	Netherlands Genomic Initiative(NGI); Dutch Ministry of Agriculture, Nature and Food Quality	This research was conducted within the Netherlands Genomic Initiative(NGI)-financed program of 'Ecogenomics', and the Research Program on Sustainable Agriculture (KB4), financed by the Dutch Ministry of Agriculture, Nature and Food Quality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Bruce T, 2010, MICROB ECOL, V60, P840, DOI 10.1007/s00248-010-9750-2; Buckley DH, 2001, FEMS MICROBIOL ECOL, V35, P105, DOI 10.1111/j.1574-6941.2001.tb00793.x; Chow ML, 2002, FEMS MICROBIOL ECOL, V42, P347, DOI 10.1111/j.1574-6941.2002.tb01024.x; Coates JD, 1999, INT J SYST BACTERIOL, V49, P1615, DOI 10.1099/00207713-49-4-1615; da Rocha UN, 2011, FEMS MICROBIOL ECOL, V78, P297, DOI 10.1111/j.1574-6941.2011.01156.x; da Rocha UN, 2010, J MICROBIOL METH, V83, P141, DOI 10.1016/j.mimet.2010.08.003; da Rocha UN, 2010, J SOIL SEDIMENT, V10, P326, DOI 10.1007/s11368-009-0160-3; da Rocha UN, 2009, FEMS MICROBIOL ECOL, V69, P313, DOI 10.1111/j.1574-6941.2009.00702.x; DeAngelis KM, 2009, ISME J, V3, P168, DOI 10.1038/ismej.2008.103; Eichorst SA, 2007, APPL ENVIRON MICROB, V73, P2708, DOI 10.1128/AEM.02140-06; Eichorst SA, 2011, APPL ENVIRON MICROB, V77, P586, DOI 10.1128/AEM.01080-10; Felske A, 2000, LETT APPL MICROBIOL, V31, P118, DOI 10.1046/j.1365-2672.2000.00780.x; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Figuerola ELM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051075; Fukunaga Y, 2008, INT J SYST EVOL MICR, V58, P2597, DOI 10.1099/ijs.0.65589-0; Ge Y, 2008, J SOIL SEDIMENT, V8, P43, DOI 10.1065/jss2008.01.270; George IF, 2011, APPL ENVIRON MICROB, V77, P8184, DOI 10.1128/AEM.05956-11; Hao DC, 2008, FEMS MICROBIOL LETT, V284, P204, DOI 10.1111/j.1574-6968.2008.01201.x; Houba VJG, 1998, COMMUN SOIL SCI PLAN, V29, P1083, DOI 10.1080/00103629809370010; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Idris R, 2004, APPL ENVIRON MICROB, V70, P2667, DOI 10.1128/AEM.70.5.2667-2677.2004; Inceoglu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023321; Janssen PH, 2002, APPL ENVIRON MICROB, V68, P2391, DOI 10.1128/AEM.68.5.2391-2396.2002; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Joseph SJ, 2003, APPL ENVIRON MICROB, V69, P7210, DOI 10.1128/AEM.69.12.7210-7215.2003; Kielak A, 2008, FEMS MICROBIOL ECOL, V63, P372, DOI 10.1111/j.1574-6941.2007.00428.x; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Kuske CR, 2002, APPL ENVIRON MICROB, V68, P1854, DOI 10.1128/AEM.68.4.1854-1863.2002; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lee SH, 2008, FEMS MICROBIOL LETT, V285, P263, DOI 10.1111/j.1574-6968.2008.01232.x; LIESACK W, 1994, ARCH MICROBIOL, V162, P85; Liles MR, 2010, SOIL BIOL BIOCHEM, V42, P739, DOI 10.1016/j.soilbio.2010.01.007; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Macrae A, 2000, ANTON LEEUW INT J G, V78, P13, DOI 10.1023/A:1002745312030; Marilley L, 1999, APPL SOIL ECOL, V13, P127, DOI 10.1016/S0929-1393(99)00028-1; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Navarrete AA, 2013, FEMS MICROBIOL ECOL, V83, P607, DOI 10.1111/1574-6941.12018; Pankratov TA, 2008, ISME J, V2, P551, DOI 10.1038/ismej.2008.7; Philippot L, 2010, NAT REV MICROBIOL, V8, P523, DOI 10.1038/nrmicro2367; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sait M, 2006, APPL ENVIRON MICROB, V72, P1852, DOI 10.1128/AEM.72.3.1852-1857.2006; Sanguin H, 2006, APPL ENVIRON MICROB, V72, P4302, DOI 10.1128/AEM.02686-05; Sangwan P, 2005, APPL ENVIRON MICROB, V71, P8402, DOI 10.1128/AEM.71.12.8402-8410.2005; Schlesner H., 2006, PROKARYOTES, V7, P881, DOI [10.1007/0-387-30747-8_37, DOI 10.1007/0-387-30747-8_37, DOI 10.1007/0-387-30747-8]; Smit E, 2001, APPL ENVIRON MICROB, V67, P2284, DOI 10.1128/AEM.67.5.2284-2291.2001; VANOVERBEEK LS, 2013, MOL MICROBIAL ECOLOG, pCH16; Wagner M, 2006, CURR OPIN BIOTECH, V17, P241, DOI 10.1016/j.copbio.2006.05.005; Ward NL, 2009, APPL ENVIRON MICROB, V75, P2046, DOI 10.1128/AEM.02294-08; Wertz JT, 2012, APPL ENVIRON MICROB, V78, P1544, DOI 10.1128/AEM.06466-11; Zul D, 2007, APPL ENVIRON MICROB, V73, P6916, DOI 10.1128/AEM.01533-07	55	57	57	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82443	10.1371/journal.pone.0082443	http://dx.doi.org/10.1371/journal.pone.0082443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349285	Green Submitted, Green Published, gold			2022-12-27	WOS:000328734200043
J	Shen, HL; Tao, DC; Ma, DF				Shen, Hualei; Tao, Dacheng; Ma, Dianfu			Multiview Locally Linear Embedding for Effective Medical Image Retrieval	PLOS ONE			English	Article							NONLINEAR DIMENSIONALITY REDUCTION; FEATURES; CLASSIFICATION; REGULARIZATION; SUBSPACE; SCALE	Content-based medical image retrieval continues to gain attention for its potential to assist radiological image interpretation and decision making. Many approaches have been proposed to improve the performance of medical image retrieval system, among which visual features such as SIFT, LBP, and intensity histogram play a critical role. Typically, these features are concatenated into a long vector to represent medical images, and thus traditional dimension reduction techniques such as locally linear embedding (LLE), principal component analysis (PCA), or laplacian eigenmaps (LE) can be employed to reduce the "curse of dimensionality''. Though these approaches show promising performance for medical image retrieval, the feature-concatenating method ignores the fact that different features have distinct physical meanings. In this paper, we propose a new method called multiview locally linear embedding (MLLE) for medical image retrieval. Following the patch alignment framework, MLLE preserves the geometric structure of the local patch in each feature space according to the LLE criterion. To explore complementary properties among a range of features, MLLE assigns different weights to local patches from different feature spaces. Finally, MLLE employs global coordinate alignment and alternating optimization techniques to learn a smooth low-dimensional embedding from different features. To justify the effectiveness of MLLE for medical image retrieval, we compare it with conventional spectral embedding methods. We conduct experiments on a subset of the IRMA medical image data set. Evaluation results show that MLLE outperforms state-of-the-art dimension reduction methods.	[Shen, Hualei; Ma, Dianfu] Beihang Univ, Sch Comp Sci & Engn, State Key Lab Software Dev Environm, Beijing, Peoples R China; [Tao, Dacheng] Univ Technol Sydney, Ctr Quantum Computat & Intelligent Syst, Fac Engn & Informat Technol, Sydney, NSW 2007, Australia	Beihang University; University of Technology Sydney	Tao, DC (corresponding author), Univ Technol Sydney, Ctr Quantum Computat & Intelligent Syst, Fac Engn & Informat Technol, Sydney, NSW 2007, Australia.	dacheng.tao@uts.edu.au; dfma@buaa.edu.cn			National Natural Science Foundation of China (NSFC) [61003017]; Project of Key Laboratory of Software Development Environment [SKLSDE-2013ZX-30]; ARC FT project [FT130101457]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Project of Key Laboratory of Software Development Environment; ARC FT project(Australian Research Council)	This work has been supported in part by the National Natural Science Foundation of China (NSFC) under Grant No.61003017, the Project of Key Laboratory of Software Development Environment under Grant No. SKLSDE-2013ZX-30, and the ARC FT project under Grant No. FT130101457. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akgul CB, 2011, J DIGIT IMAGING, V24, P208, DOI 10.1007/s10278-010-9290-9; Bagci U, 2013, COMPUT BIOL MED, V43, P1241, DOI 10.1016/j.compbiomed.2013.06.008; Barlow WE, 2004, JNCI-J NATL CANCER I, V96, P1840, DOI 10.1093/jnci/djh333; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Bezdek J. C., 2002, Advances in Soft Computing - AFSS 2002. 2002 AFSS International Conference on Fuzzy Systems. Proceedings (Lecture Notes in Artificial Intelligence Vol.2275), P288; Cai D., 2010, PROC 16 ACM SIGKDD I, P333, DOI 10.1145/1835804.1835848; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen DR, 2011, COMPUT MED IMAG GRAP, V35, P220, DOI 10.1016/j.compmedimag.2010.11.003; Cho HC, 2013, MED PHYS, V40, DOI 10.1118/1.4770277; Croskerry P., 2005, CAN J ANAESTH, V52, pR1, DOI [10.1007/BF03023077, DOI 10.1007/BF03023077]; Depeursinge A, 2012, IEEE T INF TECHNOL B, V16, P53, DOI 10.1109/TITB.2011.2173585; Deselaers T, 2008, INFORM RETRIEVAL, V11, P77, DOI 10.1007/s10791-007-9039-3; Deserno TM OB, 2009, 15 363 IRMA IMAGES 1; Dimitrovski I, 2011, PATTERN RECOGN, V44, P2436, DOI 10.1016/j.patcog.2011.03.026; Dy JG, 2003, IEEE T PATTERN ANAL, V25, P373, DOI 10.1109/TPAMI.2003.1182100; Fei-Fei L, 2005, PROC CVPR IEEE, P524; Ghosh P., 2011, 2011 24 INT S COMPUT, P1, DOI DOI 10.1109/CBMS.2011.5999142; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; He X., 2005, ADV NEURAL INFORM PR, V18; Huang YL, 2005, ULTRASOUND OBST GYN, V26, P558, DOI 10.1002/uog.1951; Jolliffe I.T., 2002, PRINCIPAL COMPONENT, V87, P513; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Lehmann TM, 2003, PROC SPIE, V5033, P440, DOI 10.1117/12.480677; Lehmann TM, 2005, COMPUT MED IMAG GRAP, V29, P143, DOI 10.1016/j.compmedimag.2004.09.010; Liu WF, 2013, IEEE T IMAGE PROCESS, V22, P2676, DOI 10.1109/TIP.2013.2255302; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Luo Y, 2013, IEEE T NEUR NET LEAR, V24, P709, DOI 10.1109/TNNLS.2013.2238682; Metz CE, 2008, RADIOL PHYS TECHNOL, V1, P2, DOI 10.1007/s12194-007-0002-1; Muller H, 2010, LECT NOTES COMPUT SC, V6388, P99, DOI 10.1007/978-3-642-17711-8_11; Muller H, 2004, INT J MED INFORM, V73, P1, DOI 10.1016/j.ijmedinf.2003.11.024; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Park D., 2000, EFFICIENT USE LOCAL, V2, P51, DOI DOI 10.1145/357744.357758; Quellec G, 2011, IEEE T MED IMAGING, V30, P108, DOI 10.1109/TMI.2010.2063711; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Saul LK, 2004, J MACH LEARN RES, V4, P119, DOI 10.1162/153244304322972667; Siegle RL, 1998, ACAD RADIOL, V5, P148, DOI 10.1016/S1076-6332(98)80277-8; Tao DC, 2007, IEEE T PATTERN ANAL, V29, P1700, DOI 10.1109/TPAMI.2007.1096; Tao DC, 2009, IEEE T PATTERN ANAL, V31, P260, DOI 10.1109/TPAMI.2008.70; Tao DC, 2006, IEEE T PATTERN ANAL, V28, P1088, DOI 10.1109/TPAMI.2006.134; Valente F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061888; Wang JY, 2011, IEEE T MED IMAGING, V30, P1996, DOI 10.1109/TMI.2011.2161673; Wu WJ, 2012, COMPUT MED IMAG GRAP, V36, P627, DOI 10.1016/j.compmedimag.2012.07.004; Xie B, 2011, IEEE T SYST MAN CY B, V41, P1088, DOI 10.1109/TSMCB.2011.2106208; Xu C., 2013, ARXIV13045634; Yang L, 2010, IEEE T PATTERN ANAL, V32, P30, DOI 10.1109/TPAMI.2008.273; Yu J, 2012, IEEE T IMAGE PROCESS, V21, P4636, DOI 10.1109/TIP.2012.2207395; Zamora Javier, 2006, BMC Med Res Methodol, V6, P31, DOI 10.1186/1471-2288-6-31; Zhang TH, 2009, IEEE T KNOWL DATA EN, V21, P1299, DOI 10.1109/TKDE.2008.212; Zhang Y, 2008, IEEE ENG MED BIO, P3916, DOI 10.1109/IEMBS.2008.4650066; Zhang ZY, 2004, SIAM J SCI COMPUT, V26, P313, DOI 10.1137/S1064827502419154	51	15	18	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82409	10.1371/journal.pone.0082409	http://dx.doi.org/10.1371/journal.pone.0082409			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349277	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200039
J	Sokolova, N; Pan, S; Provazza, S; Beutner, G; Vendelin, M; Birkedal, R; Sheu, SS				Sokolova, Niina; Pan, Shi; Provazza, Sarah; Beutner, Gisela; Vendelin, Marko; Birkedal, Rikke; Sheu, Shey-Shing			ADP Protects Cardiac Mitochondria under Severe Oxidative Stress	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; CA-2&-INDUCED MEMBRANE TRANSITION; ADENINE-NUCLEOTIDE TRANSLOCASE; ENERGY-METABOLISM; HYDROGEN-PEROXIDE; ATP SYNTHASE; GLUTATHIONE; INJURY; APOPTOSIS; CALCIUM	ADP is not only a key substrate for ATP generation, but also a potent inhibitor of mitochondrial permeability transition pore (mPTP). In this study, we assessed how oxidative stress affects the potency of ADP as an mPTP inhibitor and whether its reduction of reactive oxygen species (ROS) production might be involved. We determined quantitatively the effects of ADP on mitochondrial Ca2+ retention capacity (CRC) until the induction of mPTP in normal and stressed isolated cardiac mitochondria. We used two models of chronic oxidative stress (old and diabetic mice) and two models of acute oxidative stress (ischemia reperfusion (IR) and tert-butyl hydroperoxide (t-BH)). In control mitochondria, the CRC was 344 +/- 32 nmol/mg protein. 500 mu mol/L ADP increased CRC to 774 +/- 65 nmol/mg protein. This effect of ADP seemed to relate to its concentration as 50 mu mol/L had a significantly smaller effect. Also, oligomycin, which inhibits the conversion of ADP to ATP by F(0)F(1)ATPase, significantly increased the effect of 50 mu mol/L ADP. Chronic oxidative stress did not affect CRC or the effect of 500 mu mol/L ADP. After IR or t-BH exposure, CRC was drastically reduced to 1 +/- 0.2 and 32 +/- 4 nmol/mg protein, respectively. Surprisingly, ADP increased the CRC to 447 +/- 105 and 514 +/- 103 nmol/mg protein in IR and t-BH, respectively. Thus, it increased CRC by the same amount as in control. In control mitochondria, ADP decreased both substrate and Ca2+-induced increase of ROS. However, in t-BH mitochondria the effect of ADP on ROS was relatively small. We conclude that ADP potently restores CRC capacity in severely stressed mitochondria. This effect is most likely not related to a reduction in ROS production. As the effect of ADP relates to its concentration, increased ADP as occurs in the pathophysiological situation may protect mitochondrial integrity and function.	[Sokolova, Niina; Vendelin, Marko; Birkedal, Rikke] Tallinn Univ Technol, Inst Cybernet, EE-19086 Tallinn, Estonia; [Provazza, Sarah; Beutner, Gisela; Sheu, Shey-Shing] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY USA; [Pan, Shi; Sheu, Shey-Shing] Thomas Jefferson Univ, Ctr Translat Med, Philadelphia, PA 19107 USA	Tallinn University of Technology; University of Rochester; Jefferson University	Birkedal, R (corresponding author), Tallinn Univ Technol, Inst Cybernet, EE-19086 Tallinn, Estonia.	rikke@sysbio.ioc.ee; shey-shing.sheu@jefferson.edu	Vendelin, Marko/AAE-7137-2020; Karro, Niina/AAF-8185-2020; Sheu, Shey-Shing/Y-4009-2019; Karro, Niina/AAF-9037-2020; Birkedal, Rikke/AAG-4952-2020; Birkedal, Rikke/ABG-6623-2021	Vendelin, Marko/0000-0002-6459-0391; Sheu, Shey-Shing/0000-0003-3838-3601; Karro, Niina/0000-0002-3231-0789; Birkedal, Rikke/0000-0001-6777-7031; 	Estonian Science Foundation [ETF8041]; Wellcome Trust [081755]; Archimedes Foundation; NIH [RO1HL-033333, RO1HL-093671, R21HL-110371];  [HL-33333]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033333, R21HL110371, R01HL093671] Funding Source: NIH RePORTER	Estonian Science Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Archimedes Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	NS was supported by Estonian Science Foundation grant no. ETF8041, Wellcome Trust grant no. 081755 and a travel grant (Estonian Science foundation Dora programme activity 6) from the Archimedes Foundation. S. Provazza was supported by HL-33333 and an ARRA supplement award. GB and SSS were supported by NIH grant RO1HL-033333, RO1HL-093671, and R21HL-110371. MV and RB were supported by Wellcome Trust grant no. 081755. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baines CP, 2009, BASIC RES CARDIOL, V104, P181, DOI 10.1007/s00395-009-0004-8; Balaban RS, 2002, J MOL CELL CARDIOL, V34, P1259, DOI 10.1006/jmcc.2002.2082; Bonora M, 2013, CELL CYCLE, V12, P674, DOI 10.4161/cc.23599; Brdiczka DG, 2006, BBA-MOL BASIS DIS, V1762, P148, DOI 10.1016/j.bbadis.2005.09.007; CARAFOLI E, 1965, J BIOL CHEM, V240, P2254; Carafoli E, 2010, BBA-BIOENERGETICS, V1797, P595, DOI 10.1016/j.bbabio.2010.03.024; Chinopoulos C, 2010, FEBS J, V277, P3637, DOI 10.1111/j.1742-4658.2010.07755.x; Chinopoulos C, 2010, BBA-MOL BASIS DIS, V1802, P221, DOI 10.1016/j.bbadis.2009.08.008; Di Lisa F, 2011, BBA-MOL CELL RES, V1813, P1316, DOI 10.1016/j.bbamcr.2011.01.031; Endlicher R, 2009, PHYSIOL RES, V58, P685, DOI 10.33549/physiolres.931635; Fratelli M, 2003, PROTEOMICS, V3, P1154, DOI 10.1002/pmic.200300436; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Giorgio V, 2010, BBA-BIOENERGETICS, V1797, P1113, DOI 10.1016/j.bbabio.2009.12.006; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; Griffiths EJ, 2000, CELL CALCIUM, V27, P87, DOI 10.1054/ceca.1999.0094; Halestrap AP, 2010, BIOCHEM SOC T, V38, P841, DOI 10.1042/BST0380841; Haworth RA, 2000, J BIOENERG BIOMEMBR, V32, P91, DOI 10.1023/A:1005568630151; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; Hoffman DL, 2007, AM J PHYSIOL-HEART C, V292, pH101, DOI 10.1152/ajpheart.00699.2006; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P468, DOI 10.1016/0003-9861(79)90373-4; Hurd TR, 2005, ANTIOXID REDOX SIGN, V7, P999, DOI 10.1089/ars.2005.7.999; Juhaszova M, 2008, ANN NY ACAD SCI, V1123, P197, DOI 10.1196/annals.1420.023; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Lemasters JJ, 2009, BBA-BIOENERGETICS, V1787, P1395, DOI 10.1016/j.bbabio.2009.06.009; Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Metelkin E, 2009, FEBS J, V276, P6942, DOI 10.1111/j.1742-4658.2009.07394.x; Michailova A, 2001, BIOPHYS J, V81, P614, DOI 10.1016/S0006-3495(01)75727-X; Nadtochiy SM, 2006, BIOCHEM J, V395, P611, DOI 10.1042/BJ20051927; Nieminen AL, 1997, AM J PHYSIOL-CELL PH, V272, pC1286; Nulton-Persson AC, 2003, BIOCHEMISTRY-US, V42, P4235, DOI 10.1021/bi027370f; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; Odin JA, 2001, J CLIN INVEST, V108, P223, DOI 10.1172/JCI200110716; OLAFSDOTTIR K, 1988, BIOCHIM BIOPHYS ACTA, V964, P377, DOI 10.1016/0304-4165(88)90038-4; REHNCRONA S, 1979, STROKE, V10, P437, DOI 10.1161/01.STR.10.4.437; Saito A, 2010, NEUROCHEM RES, V35, P1667, DOI 10.1007/s11064-010-0228-x; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SIES H, 1978, EUR J BIOCHEM, V84, P377, DOI 10.1111/j.1432-1033.1978.tb12178.x; Taylor ER, 2003, J BIOL CHEM, V278, P19603, DOI 10.1074/jbc.M209359200; Traba J, 2012, CELL DEATH DIFFER, V19, P650, DOI 10.1038/cdd.2011.139; Treberg JR, 2010, FEBS J, V277, P2766, DOI 10.1111/j.1742-4658.2010.07693.x; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Vendelin M, 2000, AM J PHYSIOL-CELL PH, V278, pC747, DOI 10.1152/ajpcell.2000.278.4.C747; Wu KLH, 2009, J NEUROTRAUM, V26, P965, DOI 10.1089/neu.2008.0692	47	16	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83214	10.1371/journal.pone.0083214	http://dx.doi.org/10.1371/journal.pone.0083214			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349464	gold, Green Published, Green Submitted			2022-12-27	WOS:000328734200067
J	Wu, J; Liu, W; He, L; Huang, FL; Chen, JZ; Cui, P; Shen, YJ; Zhao, J; Wang, WJ; Zhang, Y; Zhu, M; Zhang, WH; Zhang, Y				Wu, Jing; Liu, Wei; He, Lei; Huang, Fuli; Chen, Jiazhen; Cui, Peng; Shen, Yaojie; Zhao, Jing; Wang, Wenjie; Zhang, Yan; Zhu, Min; Zhang, Wenhong; Zhang, Ying			Sputum Microbiota Associated with New, Recurrent and Treatment Failure Tuberculosis	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; CYSTIC-FIBROSIS; SEQUENCING DATA; CULTURE; DIVERSITY; TROPICS; SAMPLES; SPACE	Microbiota have recently been shown to be associated with many disease conditions. However, the microbiota associated with tuberculosis (TB) infection, recurrence and treatment outcome have not been systematically characterized. Here, we used high throughput 16S RNA sequencing to analyze the sputum microbiota associated with Mycobacterium tuberculosis infection and also to identify the microorganisms associated with different outcomes of TB treatment. We recruited 25 new TB patients, 30 recurrent TB patients and 20 TB patients with treatment failure, as well as 20 healthy controls. Streptococcus, Gramulicatella and Pseudomonas were more abundant in TB patients while Prevotella, Leptotrichia, Treponema, Catonella and Coprococcus were less abundant in TB patients than in the healthy controls. We found reduced frequency and abundance of some genera such as Bulleidia and Atopobium in recurrent TB patients compared with those in new TB patients. In addition, the ratio of Pseudomonas / Mycobacterium in recurrent TB was higher than that in new TB while the ratio of Treponema / Mycobacterium in recurrent TB was lower than that in new TB, indicating that disruption of these bacteria may be a risk factor of TB recurrence. Furthermore, Pseudomonas was more abundant and more frequently present in treatment failure patients than in cured new patients, and the ratio of Pseudomonas / Mycobacterium in treatment failure was higher than that in new TB. Our data suggest that the presence of certain bacteria and the disorder of lung microbiota may be associated with not only onset of TB but also its recurrence and treatment failure. These findings indicate that lung microbiota may play a role in pathogenesis and treatment outcome of TB and may need to be taken into consideration for improved treatment and control of TB in the future.	[Wu, Jing; He, Lei; Huang, Fuli; Chen, Jiazhen; Cui, Peng; Shen, Yaojie; Zhao, Jing; Wang, Wenjie; Zhang, Wenhong; Zhang, Ying] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; [Liu, Wei] Hangzhou Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Zhang, Yan; Zhu, Min] Hangzhou Red Cross Hosp, Dept TB Branch, Hangzhou, Zhejiang, Peoples R China; [Zhang, Wenhong; Zhang, Ying] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Zhang, Wenhong; Zhang, Ying] Fudan Univ, MOH, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhang, Wenhong; Zhang, Ying] Fudan Univ, MOE Key Lab Med Mol Virol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhang, Ying] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Fudan University; Fudan University; Fudan University; Fudan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhang, WH (corresponding author), Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China.	zhangwenhong@fudan.edu.cn; yzhang@jhsph.edu	He, Lei/AIC-2486-2022; Wu, Jing/GQI-1843-2022; He, Lei/GXH-0381-2022	He, Lei/0000-0003-4679-5462; He, Lei/0000-0003-4679-5462; He, Lei/0000-0002-0215-3102; Wu, Jing/0000-0002-1224-0912	Key Technologies Research and Development Program of China [2011ZX09102-008, 2013ZX10003008-003]; Shanghai Natural Science Foundation [12140903201, 12ZR1441500]	Key Technologies Research and Development Program of China(National Key Technology R&D Program); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This study was supported by grants from the Key Technologies Research and Development Program of China (2011ZX09102-008, 2013ZX10003008-003), and Shanghai Natural Science Foundation (12140903201, 12ZR1441500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Zahrani K, 2001, INT J TUBERC LUNG D, V5, P855; Bittar F, 2010, EMERG INFECT DIS, V16, P1231, DOI 10.3201/eid1608.100193; Bottieau E, 2011, ACTA CLIN BELG, V66, P191, DOI 10.2143/ACB.66.3.2062545; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chan ER, 2011, GENOMICS, V98, P253, DOI 10.1016/j.ygeno.2011.04.002; Charlson ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042786; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Cheung MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054574; Chu HT, 2013, NAT IMMUNOL, V14, P668, DOI 10.1038/ni.2635; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cui ZL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-276; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Gomez-Llorente C, 2010, P NUTR SOC, V69, P381, DOI 10.1017/S0029665110001527; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Han D, 2013, IMMUNITY, V38, P1211, DOI 10.1016/j.immuni.2013.05.012; Heifets L, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P49; Herbinger KH, 2012, J TRAVEL MED, V19, P150, DOI 10.1111/j.1708-8305.2011.00589.x; Holm JPY, 2013, DAN MED J, V60; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; JOYCE SM, 1986, ANN EMERG MED, V15, P325, DOI 10.1016/S0196-0644(86)80576-5; Kimizuka R, 2003, MICROBES INFECT, V5, P1357, DOI 10.1016/j.micinf.2003.09.015; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Manos J, 2013, EUR J CLIN MICROBIOL, V32, P1583, DOI 10.1007/s10096-013-1916-7; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Nelson A, 2010, LETT APPL MICROBIOL, V51, P272, DOI 10.1111/j.1472-765X.2010.02891.x; Salipante SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065226; Wagner KS, 2011, CLIN MICROBIOL INFEC, V17, P519, DOI 10.1111/j.1469-0691.2010.03269.x; Zakharkina T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068302; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhao JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033127; Zhou YH, 2010, ACTA BIOCH BIOPH SIN, V42, P754, DOI 10.1093/abbs/gmq081	37	40	43	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83445	10.1371/journal.pone.0083445	http://dx.doi.org/10.1371/journal.pone.0083445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349510	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200088
J	Wulf-Johansson, H; Johansson, SL; Schlosser, A; Holm, AT; Rasmussen, LM; Mickley, H; Diederichsen, ACP; Munkholm, H; Poulsen, TS; Tornoe, I; Nielsen, V; Marcussen, N; Vestbo, J; Saekmose, SG; Holmskov, U; Sorensen, GL				Wulf-Johansson, Helle; Johansson, Sofie Lock; Schlosser, Anders; Holm, Anne Trommelholt; Rasmussen, Lars Melholt; Mickley, Hans; Diederichsen, Axel C. P.; Munkholm, Henrik; Poulsen, Tina Svenstrup; Tornoe, Ida; Nielsen, Vicki; Marcussen, Niels; Vestbo, Jorgen; Saekmose, Susanne Gjorup; Holmskov, Uffe; Sorensen, Grith Lykke			Localization of Microfibrillar-Associated Protein 4 (MFAP4) in Human Tissues: Clinical Evaluation of Serum MFAP4 and Its Association with Various Cardiovascular Conditions	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; SMOOTH-MUSCLE-CELLS; GLYCOPROTEIN MAGP-36; EXTRACELLULAR-MATRIX; PROTEOMIC ANALYSIS; OSTEOPROTEGERIN; EXPRESSION; ELASTIN; BIOMARKERS; FIBULIN-1	Microfibrillar-associated protein 4 (MFAP4) is located in the extracellular matrix (ECM). We sought to identify tissues with high levels of MFAP4 mRNA and MFAP4 protein expression. Moreover, we aimed to evaluate the significance of MFAP4 as a marker of cardiovascular disease (CVD) and to correlate MFAP4 with other known ECM markers, such as fibulin-1, osteoprotegerin (OPG), and osteopontin (OPN). Quantitative real-time PCR demonstrated that MFAP4 mRNA was more highly expressed in the heart, lung, and intestine than in other elastic tissues. Immunohistochemical studies demonstrated high levels of MFAP4 protein mainly at sites rich in elastic fibers and within blood vessels in all tissues investigated. The AlphaLISA technique was used to determine serum MFAP4 levels in a clinical cohort of 172 patients consisting of 5 matched groups with varying degrees of CVD: 1: patients with ST elevation myocardial infarction (STEMI), 2: patients with non-STEMI, 3: patients destined for vascular surgery because of various atherosclerotic diseases (stable atherosclerotic disease), 4: apparently healthy individuals with documented coronary artery calcification (CAC-positive), and 5: apparently healthy individuals without signs of coronary artery calcification (CAC-negative). Serum MFAP4 levels were significantly lower in patients with stable atherosclerotic disease than CAC-negative individuals (p<0.05). Furthermore, lower serum MFAP4 levels were present in patients with stable atherosclerotic disease compared with STEMI and non-STEMI patients (p, 0.05). In patients with stable atherosclerotic disease, positive correlations between MFAP4 and both fibulin-1 (r = 0.50; p = 0.0244) and OPG (r = 0.62; p = 0.0014) were found. Together, these results indicate that MFAP4 is mainly located in elastic fibers and is highly expressed in blood vessels. The present study suggests that serum MFAP4 varies in groups of patients with different cardiovascular conditions. Further studies are warranted to describe the role of serum MFAP4 as a biomarker of stable atherosclerotic disease.	[Wulf-Johansson, Helle; Johansson, Sofie Lock; Schlosser, Anders; Holm, Anne Trommelholt; Rasmussen, Lars Melholt; Tornoe, Ida; Nielsen, Vicki; Saekmose, Susanne Gjorup; Holmskov, Uffe; Sorensen, Grith Lykke] Univ Southern Denmark, Inst Mol Med, Odense, Denmark; [Rasmussen, Lars Melholt] Odense Univ Hosp, Ctr Individualized Med Arterial Dis CIMA, Dept Clin Biochem & Pharmacol, DK-5000 Odense, Denmark; [Rasmussen, Lars Melholt; Mickley, Hans; Diederichsen, Axel C. P.] Odense Univ Hosp, Odense Patient Data Explorat Network OPEN, DK-5000 Odense, Denmark; [Mickley, Hans; Diederichsen, Axel C. P.; Poulsen, Tina Svenstrup] Odense Univ Hosp, Dept Cardiol, DK-5000 Odense, Denmark; [Munkholm, Henrik] Lillebaelt Hosp Vejle, Dept Cardiol, Vejle, Denmark; [Marcussen, Niels] Odense Univ Hosp, Dept Clin Pathol, DK-5000 Odense, Denmark; [Vestbo, Jorgen] Odense Univ Hosp, Dept Resp Med, DK-5000 Odense, Denmark; [Vestbo, Jorgen] Univ Hosp South Manchester NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Resp & Allergy Res Grp, Manchester, Lancs, England; [Saekmose, Susanne Gjorup] Naestved Hosp, Dept Clin Immunol, Naestved, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Naestved Hospital	Wulf-Johansson, H (corresponding author), Univ Southern Denmark, Inst Mol Med, Odense, Denmark.	hwulf@health.sdu.dk	Holmskov, Uffe/AAA-3056-2022; Vestbo, Jorgen/Y-2912-2019; Diederichsen, Axel Cosmus Pyndt/C-3355-2013	Holmskov, Uffe/0000-0002-2391-9445; Diederichsen, Axel Cosmus Pyndt/0000-0002-1285-4826; Saekmose, Susanne Gjorup/0000-0002-1346-0052; Holm, Anne Trommelholt/0000-0001-6090-9820; Sorensen, Grith Lykke/0000-0002-5273-1097; Vestbo, Jorgen/0000-0001-6355-6362; Rasmussen, Lars Melholt/0000-0001-5795-4794	Danish Strategic Research Council; Centre of COPD research; Carlsberg Foundation; Lundbeck Foundation [R67-2010-6409, R108-2012-10802] Funding Source: researchfish	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Centre of COPD research; Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden)	The project was supported by the Danish Strategic Research Council, Centre of COPD research (www.cekol.dk) and the Carlsberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Salam VB, 2010, CIRCULATION, V122, P2058, DOI 10.1161/CIRCULATIONAHA.110.972745; Agerskov U, 2011, STAT YB, P1; Cangemi C, 2011, CLIN CHEM, V57, P1556, DOI 10.1373/clinchem.2011.162966; Chan CWY, 2003, J IMMUNOL, V170, P4036, DOI 10.4049/jimmunol.170.8.4036; Dahl JS, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003889; de la Cuesta F, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003517; Diederichsen ACP, 2012, EUR J PREV CARDIOL, V19, P558, DOI 10.1177/1741826711409172; Doolittle RF, 2012, PROTEIN SCI, V21, P1808, DOI 10.1002/pro.2177; Farrell DH, 2004, CURR OPIN HEMATOL, V11, P151, DOI 10.1097/01.moh.0000131440.02397.a4; Hirano E, 2002, J DERMATOL SCI, V28, P60, DOI 10.1016/S0923-1811(01)00148-7; Hitz MP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002903; Kasamatsu S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00164; Kielty CM, 2002, J CELL SCI, V115, P2817; KOBAYASHI R, 1994, BIOCHEM BIOPH RES CO, V198, P1262, DOI 10.1006/bbrc.1994.1178; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kruger R, 2012, ATHEROSCLEROSIS, V222, P216, DOI 10.1016/j.atherosclerosis.2012.01.045; Kuznetsova T, 2009, CIRC-HEART FAIL, V2, P105, DOI 10.1161/CIRCHEARTFAILURE.108.822627; LaFleur DW, 1997, J BIOL CHEM, V272, P32798, DOI 10.1074/jbc.272.52.32798; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; Meza-Zepeda LA, 2006, CANCER RES, V66, P8984, DOI 10.1158/0008-5472.CAN-06-1972; Modrego J, 2012, J VASC SURG; Modrego J, 2012, J VASC SURG, V55, P1124, DOI 10.1016/j.jvs.2011.10.033; Molleken C, 2009, HEPATOLOGY, V49, P1257, DOI 10.1002/hep.22764; Olesen P, 2005, DIABETOLOGIA, V48, P561, DOI 10.1007/s00125-004-1652-8; Pilop C, 2009, CIRCULATION, V120, P983, DOI 10.1161/CIRCULATIONAHA.108.843516; Proudfoot D, 2001, HERZ, V26, P245, DOI 10.1007/PL00002027; ROBERT L, 1984, MECH AGEING DEV, V28, P155, DOI 10.1016/0047-6374(84)90015-0; ROBERT L, 1980, FRONTIERS MATRIX BIO, V8, P130; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Saaby L, 2013, AM J MED, V126, P789, DOI 10.1016/j.amjmed.2013.02.029; Schlosser A, 2006, SCAND J IMMUNOL, V64, P104, DOI 10.1111/j.1365-3083.2006.01778.x; Shaker OG, 2010, ANGIOLOGY, V61, P756, DOI 10.1177/0003319710370961; Suezawa C, 2005, J LAB CLIN MED, V145, P33, DOI 10.1016/j.lab.2004.08.007; Sundstrom J, 2006, CURR OPIN LIPIDOL, V17, P45, DOI 10.1097/01.mol.0000203891.34890.b5; Thomsen T, 2011, MOL IMMUNOL, V48, P369, DOI 10.1016/j.molimm.2010.09.019; Toyoshima T, 2005, EXP CELL RES, V307, P224, DOI 10.1016/j.yexcr.2005.03.005; Toyoshima T, 1999, J HISTOCHEM CYTOCHEM, V47, P1049, DOI 10.1177/002215549904700809; Toyoshima T, 2008, CELL TISSUE RES, V332, P271, DOI 10.1007/s00441-008-0587-7; Ueland T, 2004, J AM COLL CARDIOL, V44, P1970, DOI 10.1016/j.jacc.2004.06.076; Vinholt PJ, 2013, THROMB RES; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Zannad Faiez, 2009, Heart Fail Clin, V5, P589, DOI 10.1016/j.hfc.2009.04.010; ZHAO ZY, 1995, HUM MOL GENET, V4, P589, DOI 10.1093/hmg/4.4.589	44	58	61	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82243	10.1371/journal.pone.0082243	http://dx.doi.org/10.1371/journal.pone.0082243			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349233	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200032
J	Cao, XB; Wu, ZY; Li, L; Pang, L; Rou, KM; Wang, CH; Luo, W; Yin, WY; Li, JH; McGoogan, JM				Cao, Xiaobin; Wu, Zunyou; Li, Li; Pang, Lin; Rou, Keming; Wang, Changhe; Luo, Wei; Yin, Wenyuan; Li, Jianhua; McGoogan, Jennifer M.		Natl Methadone Maintenance	Mortality among Methadone Maintenance Clients in China: A Six-Year Cohort Study	PLOS ONE			English	Article							ADMINISTERED ANTIRETROVIRAL THERAPY; HEROIN USERS; DRUG-USERS; RECEIVING METHADONE; TREATMENT OUTCOMES; HIV PREVENTION; TREATMENT MMT; RETENTION; ADHERENCE; SURVIVAL	Objective: To assess the overall mortality of methadone maintenance treatment (MMT) clients in China and its associated factors. Methods: A total of 1,511 MMT clients, all of whom enrolled in China's first eight MMT clinics between March and December 2004, were included in this cohort study and followed for approximately six years, until June 2010. Mortality and its predictors were examined using Cox proportional hazards regression models. Results: A total of 154 deaths were observed within 5,391 person-years (PY) of follow-up for an all-cause mortality rate of 28.6 per 1,000 PY. The leading causes of death were drug overdose (33.8%), HIV/AIDS-unrelated disease (21.4%), and HIV/AIDS (16.9%). The all-cause mortality rate of clients engaged in MMT for one year or less was roughly three times that of clients who stayed in MMT for four years or more (14.0 vs. 4.6, p<0.0001), HIV-positive subjects was nearly four times mortality rate than that of HIV-negative individuals (28.1 vs. 6.8, p<0.0001). ART-naive HIV-positive subjects had approximately two times higher mortality rate than those receiving ART (31.2 vs. 17.3, <0.0001). After adjusting for confounding variables, we found that being male (HR = 1.63, CI: 1.03-2.57, p = 0.0355) and being HIV-positive (HR = 5.16, CI: 3.70-7.10, p<0.0001) were both associated with higher risk of death whereas increased durations of methadone treatment were associated with a lower risk of death (HR = 0.26, CI: 0.18-0.38, p<0.0001 for two to three years, HR = 0.08, CI: 0.05-0.14, p<0.0001 for four or more years). Conclusion: Overall mortality was high among MMT clients in China. Specific interventions aimed at decreasing mortality among MMT clients are needed. Our study supports the need for keeping client at MMT longer and for expanding ART coverage and suggests the potential benefits of integrated MMT and ART services for drug users in China.	[Cao, Xiaobin; Wu, Zunyou; Pang, Lin; Rou, Keming; Wang, Changhe; Luo, Wei; Yin, Wenyuan; McGoogan, Jennifer M.] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Li, Li] Univ Calif Los Angeles, Semel Inst Ctr Community Hlth, Los Angeles, CA USA; [Li, Jianhua] Yunnan Inst Drug Abuse, Kunming, Yunnan, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; University of California System; University of California Los Angeles	Wu, ZY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wuzunyou@chinaaids.cn			Chinese National Methadone Maintenance Treatment Program; Fogarty International Center, National Institute on Drug Abuse of the US National Institutes of Health [5U2RTW006918-08]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER	Chinese National Methadone Maintenance Treatment Program; Fogarty International Center, National Institute on Drug Abuse of the US National Institutes of Health; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this study was provided by the Chinese National Methadone Maintenance Treatment Program and the Fogarty International Center, National Institute on Drug Abuse of the US National Institutes of Health (Grant # 5U2RTW006918-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg KM, 2011, CLIN INFECT DIS, V53, P936, DOI 10.1093/cid/cir537; Brugal MT, 2005, ADDICTION, V100, P981, DOI 10.1111/j.1360-0443.2005.01089.x; Brust JCM, 2011, AIDS RES HUM RETROV, V27, P535, DOI 10.1089/aid.2010.0181; Celentano DD, 2007, CLIN INFECT DIS, V45, pS318, DOI 10.1086/522557; China Ministry of Health UNAIDS WHO, 2011, 2011 EST HIV AIDS EP; Clausen T, 2008, DRUG ALCOHOL DEPEN, V94, P151, DOI 10.1016/j.drugalcdep.2007.11.003; Degenhardt L, 2006, SEX TRANSM INFECT, V82, pIII56, DOI 10.1136/sti.2005.019273; Degenhardt L, 2011, ADDICTION, V106, P32, DOI 10.1111/j.1360-0443.2010.03140.x; Dolan KA, 2005, ADDICTION, V100, P820, DOI 10.1111/j.1360-0443.2005.01050.x; Dou ZH, 2010, INT J EPIDEMIOL, V39, pII56, DOI 10.1093/ije/dyq215; Esteban J, 2003, DRUG ALCOHOL DEPEN, V70, P193, DOI 10.1016/S0376-8716(03)00002-4; Fareed A, 2009, J PSYCHIATR PRACT, V15, P227, DOI 10.1097/01.pra.0000351884.83377.e2; Gibson A, 2008, ADDICTION, V103, P462, DOI 10.1111/j.1360-0443.2007.02090.x; Gowing L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub3; Gu J, 2012, ADDICTION; Hickman M, 2003, J URBAN HEALTH, V80, P274, DOI 10.1093/jurban/jtg030; Huang YF, 2011, ADDICTION, V106, P1437, DOI 10.1111/j.1360-0443.2011.03443.x; Hulse GK, 1999, ADDICTION, V94, P221, DOI 10.1046/j.1360-0443.1999.9422216.x; Langendam MW, 2001, AM J PUBLIC HEALTH, V91, P774, DOI 10.2105/AJPH.91.5.774; Li L, 2012, ADDICT BEHAV, V37, P264, DOI 10.1016/j.addbeh.2011.11.004; Lin CQ, 2011, DRUG ALCOHOL DEPEN, V117, P45, DOI 10.1016/j.drugalcdep.2011.01.004; Liu En-wu, 2011, Zhonghua Yu Fang Yi Xue Za Zhi, V45, P979; Lucas GM, 2006, CLIN INFECT DIS, V42, P1628, DOI 10.1086/503905; Maru DSR, 2009, JAIDS-J ACQ IMM DEF, V50, P176, DOI 10.1097/QAI.0b013e3181938e7e; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mattick RP, 2003, ADDICTION, V98, P387, DOI 10.1046/j.1360-0443.2003.00348.x; McCowan C, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2225; Metzger DS, 2010, JAIDS-J ACQ IMM DEF, V55, pS32, DOI 10.1097/QAI.0b013e3181f9c10b; Morgan OW, 2006, J PUBLIC HEALTH, V28, P318, DOI 10.1093/pubmed/fdl059; Nahvi S, 2012, DRUG ALCOHOL DEPEN, V120, P174, DOI 10.1016/j.drugalcdep.2011.07.025; Pang L, 2007, AIDS, V21, pS103, DOI 10.1097/01.aids.0000304704.71917.64; Peles E, 2010, DRUG ALCOHOL DEPEN, V107, P141, DOI 10.1016/j.drugalcdep.2009.09.013; Rosca P, 2012, DRUG ALCOHOL DEPEND; Sullivan S, 2013, ADDICTION UNPUB; Uhlmann S, 2010, ADDICTION, V105, P907, DOI 10.1111/j.1360-0443.2010.02905.x; Ward J, 1999, LANCET, V353, P221, DOI 10.1016/S0140-6736(98)05356-2; Wood E, 2008, AIDS, V22, P1247, DOI 10.1097/QAD.0b013e3282fbd1ed; World Health Organization, INT STAT CLASS DIS 1, P10; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Wu ZY, 2011, CHIN J AIDS STD, V17, P196; Xu HF, 2012, ADDICT BEHAV, V37, P657, DOI 10.1016/j.addbeh.2012.01.020; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhang FJ, 2007, AIDS, V21, pS143, DOI 10.1097/01.aids.0000304710.10036.2b; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4	44	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82476	10.1371/journal.pone.0082476	http://dx.doi.org/10.1371/journal.pone.0082476			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EU	24349294	Green Published, gold			2022-12-27	WOS:000328731800063
J	Han, MS; Che, X; Cho, GH; Park, HR; Lim, KE; Park, NR; Jin, JS; Jung, YK; Jeong, JH; Lee, IK; Kato, S; Choi, JY				Han, Min-Su; Che, Xiangguo; Cho, Gyoung-Ho; Park, Hye-Ri; Lim, Kyung-Eun; Park, Na-Rae; Jin, Jung-Sook; Jung, Youn-Kwan; Jeong, Jae-Hwan; Lee, In-Kyu; Kato, Shigeaki; Choi, Je-Yong			Functional Cooperation between Vitamin D Receptor and Runx2 in Vitamin D-Induced Vascular Calcification	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; MICE LACKING; OSTEOCLAST DIFFERENTIATION; OSTEOGENIC REGULATION; BONE-FORMATION; GENE; EXPRESSION; CALCIUM; CBFA1; OSTEOPOROSIS	The transdifferentiation of vascular smooth muscle cells (VSMCs) into osteoblast-like cells has been implicated in the context of vascular calcification. We investigated the roles of vitamin D receptor (Vdr) and runt-related transcription factor 2 (Runx2) in the osteoblastic differentiation of VSMCs in response to vitamin D-3 using in vitro VSMCs cultures and in vivo in Vdr knockout (Vdr(-/-)) and Runx2 carboxy-terminus truncated heterozygous (Runx2(+/Delta C)) mice. Treatment of VSMCs with active vitamin D-3 promoted matrix mineral deposition, and increased the expressions of Vdr, Runx2, and of osteoblastic genes but decreased the expression of smooth muscle myosin heavy chain in primary VSMCs cultures. Immunoprecipitation experiments suggested an interaction between Vdr and Runx2. Furthermore, silencing Vdr or Runx2 attenuated the procalcific effects of vitamin D-3. Functional cooperation between Vdr and Runx2 in vascular calcification was also confirmed in in vivo mouse models. Vascular calcification induced by high-dose vitamin D-3 was completely inhibited in Vdr(-/-) or Runx2(+/Delta C) mice, despite elevated levels of serum calcium or alkaline phosphatase. Collectively, these findings suggest that functional cooperation between Vdr and Runx2 is necessary for vascular calcification in response to vitamin D-3.	[Han, Min-Su; Che, Xiangguo; Cho, Gyoung-Ho; Park, Hye-Ri; Lim, Kyung-Eun; Park, Na-Rae; Jin, Jung-Sook; Jung, Youn-Kwan; Jeong, Jae-Hwan; Choi, Je-Yong] Kyungpook Natl Univ, Dept Biochem & Cell Biol, WCU Program, Daegu, South Korea; [Han, Min-Su; Che, Xiangguo; Cho, Gyoung-Ho; Park, Hye-Ri; Lim, Kyung-Eun; Park, Na-Rae; Jin, Jung-Sook; Jung, Youn-Kwan; Jeong, Jae-Hwan; Choi, Je-Yong] Kyungpook Natl Univ, Plus Program BK21, CMRC, Skeletal Dis Genome Res Ctr,Sch Med, Daegu, South Korea; [Lee, In-Kyu] Kyungpook Natl Univ, Dept Internal Med, Div Endocrinol, Sch Med, Daegu, South Korea; [Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan	Kyungpook National University; Kyungpook National University; Kyungpook National University; University of Tokyo	Choi, JY (corresponding author), Kyungpook Natl Univ, Dept Biochem & Cell Biol, WCU Program, Daegu, South Korea.	jechoi@knu.ac.kr	Lee, In-Kyu/AAR-6374-2021; Choi, Je-Yong/AAR-7334-2021	Choi, Je-Yong/0000-0002-5057-8842; Park, NA RAE/0000-0003-3651-7434	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111487]; WCU (World Class University) program [R32-10064]; Basic Science Research Program through the National Research Foundation of Korea [2012R1A6A3A01019166]; Korean Ministry of Education, Science and Technology	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; WCU (World Class University) program; Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A111487), the WCU (World Class University) program (Grant no. R32-10064), and Basic Science Research Program (Grant no. 2012R1A6A3A01019166) through the National Research Foundation of Korea funded by the Korean Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthel TK, 2007, J STEROID BIOCHEM, V103, P381, DOI 10.1016/j.jsbmb.2006.12.054; Bini A, 1999, ARTERIOSCL THROM VAS, V19, P1852, DOI 10.1161/01.ATV.19.8.1852; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Byon CH, 2011, ARTERIOSCL THROM VAS, V31, P1387, DOI 10.1161/ATVBAHA.110.222547; CAMPBELL JH, 1993, CLIN SCI, V85, P501, DOI 10.1042/cs0850501; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Clemens TL, 2011, J BONE MINER RES, V26, P677, DOI 10.1002/jbmr.321; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Dietrich H, 2000, AM J PATHOL, V157, P659, DOI 10.1016/S0002-9440(10)64576-2; Drissi H, 2002, EXP CELL RES, V274, P323, DOI 10.1006/excr.2002.5474; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Han MS, 2010, J CELL BIOCHEM, V110, P97, DOI 10.1002/jcb.22516; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Hoenderop JGJ, 2004, KIDNEY INT, V66, P1082, DOI 10.1111/j.1523-1755.2004.00858.x; Ignat M, 2008, P NATL ACAD SCI USA, V105, P2598, DOI 10.1073/pnas.0712030105; Jeong JH, 2010, MOL CELL BIOL, V30, P2365, DOI 10.1128/MCB.00672-09; Jung YK, 2012, J BONE MINER RES, V27, P2024, DOI 10.1002/jbmr.1632; Khosla S, 2011, NAT MED, V17, P430, DOI 10.1038/nm0411-430; Kim JE, 2007, MOL VIS, V13, P1942; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Luo XH, 2009, J BONE MINER RES, V24, P1461, DOI [10.1359/JBMR.090227, 10.1359/jbmr.090227]; Mathew S, 2008, J AM SOC NEPHROL, V19, P1509, DOI 10.1681/ASN.2007080902; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Mody N, 2003, J NUCL CARDIOL, V10, P177, DOI 10.1067/mnc.2003.0012; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Osako MK, 2010, CIRC RES, V107, P466, DOI 10.1161/CIRCRESAHA.110.216846; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Oury F, 2013, J CLIN INVEST, V123, P2421, DOI 10.1172/JCI65952; Paredes R, 2004, MOL CELL BIOL, V24, P8847, DOI 10.1128/MCB.24.20.8847-8861.2004; Parhami F, 1996, J Atheroscler Thromb, V3, P90; Price PA, 2006, KIDNEY INT, V70, P1577, DOI 10.1038/sj.ki.5001841; Price PA, 2001, J NUTR, V131, P2910, DOI 10.1093/jn/131.11.2910; Proudfoot D, 2002, CIRCULATION, V106, P3044, DOI 10.1161/01.CIR.0000041429.83465.41; Ross AC, 2011, J AM DIET ASSOC, V111, P524, DOI 10.1016/j.jada.2011.01.004; Sage AP, 2010, NAT REV CARDIOL, V7, P528, DOI 10.1038/nrcardio.2010.115; Schmidt N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035316; Shao JS, 2010, HYPERTENSION, V55, P579, DOI 10.1161/HYPERTENSIONAHA.109.134205; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Shroff R, 2008, J AM SOC NEPHROL, V19, P1239, DOI 10.1681/ASN.2007090993; Sierra OL, 2010, MOL ENDOCRINOL, V24, P1478, DOI 10.1210/me.2010-0029; Song YR, 2003, J NUTR, V133, P374, DOI 10.1093/jn/133.2.374; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Sun Y, 2012, CIRC RES, V111, P543, DOI 10.1161/CIRCRESAHA.112.267237; Tentori F, 2006, KIDNEY INT, V70, P1858, DOI 10.1038/sj.ki.5001868; Tintut Y, 2002, CIRCULATION, V105, P650, DOI 10.1161/hc0502.102969; Vattikuti R, 2004, AM J PHYSIOL-ENDOC M, V286, pE686, DOI 10.1152/ajpendo.00552.2003; Yamamoto Y, 2013, ENDOCRINOLOGY, V154, P1008, DOI 10.1210/en.2012-1542; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391	52	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83584	10.1371/journal.pone.0083584	http://dx.doi.org/10.1371/journal.pone.0083584			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349534	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800129
J	Hu, D; Lin, XD; Zhang, HJ; Zheng, XW; Niu, WQ				Hu, Dan; Lin, Xiandong; Zhang, Hejun; Zheng, Xiongwei; Niu, Wenquan			APEX Nuclease (Multifunctional DNA Repair Enzyme) 1 Gene Asp148Glu Polymorphism and Cancer Risk: A Meta-Analysis Involving 58 Articles and 48903 Participants	PLOS ONE			English	Article							BASE-EXCISION-REPAIR; NORTH INDIAN POPULATION; CELL LUNG-CANCER; BLADDER-CANCER; COLORECTAL-CANCER; PATHWAY GENES; CHINESE POPULATION; PROSTATE-CANCER; BREAST-CANCER; GASTRIC-CANCER	Background: Polymorphisms in the APEX nuclease (multifunctional DNA repair enzyme) 1 gene (APEX1) may be involved in the carcinogenesis by affecting DNA repair. We aimed to summarize available data on the association of the APEX1 Asp148Glu (rs1130409) polymorphism with risk of multiple types of cancer via a meta-analysis. Methods and Results: In total, 58 qualified articles including 22,398 cancer patients and 26,505 controls were analyzed, and the data were extracted independently by two investigators. Analyses of the full data set indicated a marginally significant association of the APEX1 Asp148Glu polymorphism with cancer risk under allelic (odds ratio (OR)=1.05; 95% confidence interval (95% CI): 0.99-1.11; P=0.071), dominant (OR=1.09; 95% CI: 1.01-1.17; P=0.028), and heterozygous genotypic (OR=1.08; 95% CI: 1.01-1.16; P=0.026) models, with significant heterogeneity and publication bias. In subgroup analyses by cancer type, with a Bonferroni corrected alpha of 0.05/6, significant association was observed for gastric cancer under both dominant (OR=1.74; 95% CI: 1.2-2.51; P=0.003) and heterozygous genotypic (OR=1.66; 95% CI: 1.2-2.31; P=0.002) models. In subgroup analysis by ethnicity, risk estimates were augmented in Caucasians, especially under dominant (OR=1.11; 95% CI: 1.0-1.24; P=0.049) and heterozygous genotypic (OR=1.11; 95% CI: 0.99-1.24; P=0.063) models. By study design, there were no significant differences between population-based and hospital-based studies. In subgroup analysis by sample size, risk estimates were remarkably overestimated in small studies, and no significance was reached in large studies except under the heterozygous genotypic model (OR=1.23; 95% CI: 1.06-1.43; P=0.006, significant at a Bonferroni corrected alpha of 0.05/2). By quality score, the risk estimates, albeit nonsignificant, were higher in low-quality studies than in high-quality studies. Further meta-regression analyses failed to identify any contributory confounders for the associated risk estimates. Conclusions: Our findings suggest that APEX1 Asp148Glu polymorphism might be a genetic risk factor for the development of gastric cancer. Further investigations on large populations are warranted.	[Hu, Dan; Lin, Xiandong; Zhang, Hejun; Zheng, Xiongwei] Fujian Med Univ, Teaching Hosp, Fujian Prov Tumor Hosp, Dept Pathol, Fuzhou, Fujian Province, Peoples R China; [Hu, Dan; Lin, Xiandong; Zhang, Hejun; Zheng, Xiongwei] Fujian Med Univ, Teaching Hosp, Fujian Prov Tumor Hosp, Fujian Prov Key Lab Translat Ctr Med, Fuzhou, Fujian Province, Peoples R China; [Niu, Wenquan] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China	Fujian Medical University; Fujian Medical University; Chinese Academy of Sciences; Shanghai Jiao Tong University	Zheng, XW (corresponding author), Fujian Med Univ, Teaching Hosp, Fujian Prov Tumor Hosp, Dept Pathol, Fuzhou, Fujian Province, Peoples R China.	agu1960@126.com; niuwenquan_shcn@163.com	Zhang, He/GXN-0028-2022		Natural Science Foundation of Fujian Province [2012J01328]	Natural Science Foundation of Fujian Province(Natural Science Foundation of Fujian Province)	This study was supported by the Natural Science Foundation of Fujian Province (2012J01328). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agachan B, 2009, ANTICANCER RES, V29, P2417; Agalliu I, 2010, CANCER CAUSE CONTROL, V21, P289, DOI 10.1007/s10552-009-9461-5; Andrew AS, 2008, HUM HERED, V65, P105, DOI 10.1159/000108942; Berndt SI, 2007, CANCER RES, V67, P1395, DOI 10.1158/0008-5472.CAN-06-1390; Bowden J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-41; Brevik A, 2010, CANCER EPIDEM BIOMAR, V19, P3167, DOI 10.1158/1055-9965.EPI-10-0606; Broberg K, 2005, CARCINOGENESIS, V26, P1263, DOI 10.1093/carcin/bgi063; Canbay E, 2011, CURR MED RES OPIN, V27, P1295, DOI 10.1185/03007995.2011.573544; Canbay E, 2010, ANTICANCER RES, V30, P1359; Cao Q, 2011, MOL CARCINOGEN, V50, P863, DOI 10.1002/mc.20791; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Chang JS, 2009, CARCINOGENESIS, V30, P78, DOI 10.1093/carcin/bgn261; Chen L, 2006, J UROLOGY, V175, P108, DOI 10.1016/S0022-5347(05)00042-X; Chiang FY, 2008, CLIN CANCER RES, V14, P5919, DOI 10.1158/1078-0432.CCR-08-0906; Cincin ZB, 2012, MED ONCOL, V29, P2949, DOI 10.1007/s12032-012-0162-7; De Ruyck K, 2007, MUTAT RES-GEN TOX EN, V631, P101, DOI 10.1016/j.mrgentox.2007.03.010; Deng QH, 2011, MED ONCOL, V28, P667, DOI 10.1007/s12032-010-9507-2; Figueroa JD, 2007, HUM GENET, V121, P233, DOI 10.1007/s00439-006-0294-y; Gangwar R, 2009, UROLOGY, V73, P675, DOI 10.1016/j.urology.2008.09.043; Gu DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028971; Hannah RR, 2005, PUBLICATION BIAS MET, pP105; [黄丽珍 Huang Lizhen], 2011, [中华流行病学杂志, Chinese Journal of Epidemiology], V32, P1179; Huang MS, 2007, CANCER EPIDEM BIOMAR, V16, P84, DOI 10.1158/1055-9965.EPI-06-0712; Huang WY, 2008, CARCINOGENESIS, V29, P100, DOI 10.1093/carcin/bgm247; Ito H, 2004, CARCINOGENESIS, V25, P1395, DOI 10.1093/carcin/bgh153; Jelonek K, 2010, J APPL GENET, V51, P343, DOI 10.1007/BF03208865; Ji L, 2009, SINGLE NUCLOTIDE POL; Kasahara M, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-49; Kuasne H, 2011, MOL BIOL REP, V38, P1585, DOI 10.1007/s11033-010-0267-z; Li CY, 2007, CANCER-AM CANCER SOC, V110, P867, DOI 10.1002/cncr.22861; Li CY, 2006, CARCINOGENESIS, V27, P1894, DOI 10.1093/carcin/bgl042; Li Y, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0505-z; Li ZH, 2011, ASS DNA REPAIR GENE; Li Z, 2011, ARCH MED RES, V42, P226, DOI 10.1016/j.arcmed.2011.04.005; Lin CH, 2012, J EPIDEMIOL, V22, P537, DOI 10.2188/jea.JE20120048; Liu YH, 2009, CANCER EPIDEM BIOMAR, V18, P204, DOI 10.1158/1055-9965.EPI-08-0632; LO YL, 2009, RISK CANC EPIDEMIOL, V18, P223; Lu J, 2009, FASEB J, V23, P3459, DOI 10.1096/fj.09-136549; Lv J, 2010, ASS STUDY FUNCTION A; Mandal RK, 2012, INDIAN J MED RES, V135, P64, DOI 10.4103/0971-5916.93426; Misra RR, 2003, CANCER LETT, V191, P171, DOI 10.1016/S0304-3835(02)00638-9; Mitra AK, 2008, ONCOL RES, V17, P127, DOI 10.3727/096504008785055567; Mittal RD, 2012, MECH AGEING DEV, V133, P127, DOI 10.1016/j.mad.2011.10.002; Moreno V, 2006, CLIN CANCER RES, V12, P2101, DOI 10.1158/1078-0432.CCR-05-1363; Nakao M, 2012, J EPIDEMIOL, V22, P477, DOI 10.2188/jea.JE20120010; Narter KF, 2009, ANTICANCER RES, V29, P1389; Osawa K, 2010, ASIAN PAC J CANCER P, V11, P1181; Palli D, 2010, MUTAGENESIS, V25, P569, DOI 10.1093/mutage/geq042; Pardini B, 2008, MUTAT RES-FUND MOL M, V638, P146, DOI 10.1016/j.mrfmmm.2007.09.008; Popanda O, 2004, CARCINOGENESIS, V25, P2433, DOI 10.1093/carcin/bgh264; Raffoul Julian J, 2012, J Oncol, V2012, P370481; Sangrajrang S, 2008, BREAST CANCER RES TR, V111, P279, DOI 10.1007/s10549-007-9773-7; Shekari M, 2008, CANCER BIOMARK, V4, P63, DOI 10.3233/CBM-2008-4202; Shen M, 2005, ANTICANCER RES, V25, P537; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Terry PD, 2006, INT J CANCER, V118, P3170, DOI 10.1002/ijc.21768; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Tse D, 2008, CANCER CAUSE CONTROL, V19, P1077, DOI 10.1007/s10552-008-9171-4; Wang M, 2010, GENETIC VARIANTS APE; Wang ML, 2010, DNA CELL BIOL, V29, P303, DOI 10.1089/dna.2009.0969; Ye CC, 2010, SHIJIE HUAREN XIAO H, V18, P1275; Zhang YW, 2006, CANCER EPIDEM BIOMAR, V15, P353, DOI 10.1158/1055-9965.EPI-05-0653; Zhou B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-521; Zhu R, 2008, EUR J ONCOL, V13, P187; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	66	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83527	10.1371/journal.pone.0083527	http://dx.doi.org/10.1371/journal.pone.0083527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349526	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800124
J	Koo, C; Malapi-Wight, M; Kim, HS; Cifci, OS; Vaughn-Diaz, VL; Ma, B; Kim, S; Abdel-Raziq, H; Ong, K; Jo, YK; Gross, DC; Shim, WB; Han, A				Koo, Chiwan; Malapi-Wight, Martha; Kim, Hyun Soo; Cifci, Osman S.; Vaughn-Diaz, Vanessa L.; Ma, Bo; Kim, Sungman; Abdel-Raziq, Haron; Ong, Kevin; Jo, Young-Ki; Gross, Dennis C.; Shim, Won-Bo; Han, Arum			Development of a Real-Time Microchip PCR System for Portable Plant Disease Diagnosis	PLOS ONE			English	Article							NUCLEIC-ACID AMPLIFICATION; BURKHOLDERIA-GLUMAE; PATHOGEN; SYRINGAE; RICE; GENE; CHIP; IDENTIFICATION; BIOSYNTHESIS; STRAINS	Rapid and accurate detection of plant pathogens in the field is crucial to prevent the proliferation of infected crops. Polymerase chain reaction (PCR) process is the most reliable and accepted method for plant pathogen diagnosis, however current conventional PCR machines are not portable and require additional post-processing steps to detect the amplified DNA (amplicon) of pathogens. Real-time PCR can directly quantify the amplicon during the DNA amplification without the need for post processing, thus more suitable for field operations, however still takes time and require large instruments that are costly and not portable. Microchip PCR systems have emerged in the past decade to miniaturize conventional PCR systems and to reduce operation time and cost. Real-time microchip PCR systems have also emerged, but unfortunately all reported portable real-time microchip PCR systems require various auxiliary instruments. Here we present a stand-alone real-time microchip PCR system composed of a PCR reaction chamber microchip with integrated thin-film heater, a compact fluorescence detector to detect amplified DNA, a microcontroller to control the entire thermocycling operation with data acquisition capability, and a battery. The entire system is 25x16x8 cm(3) in size and 843 g in weight. The disposable microchip requires only 8-mu l sample volume and a single PCR run consumes 110 mAh of power. A DNA extraction protocol, notably without the use of liquid nitrogen, chemicals, and other large lab equipment, was developed for field operations. The developed real-time microchip PCR system and the DNA extraction protocol were used to successfully detect six different fungal and bacterial plant pathogens with 100% success rate to a detection limit of 5 ng/8 mu l sample.	[Koo, Chiwan; Han, Arum] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA; [Malapi-Wight, Martha; Vaughn-Diaz, Vanessa L.; Ong, Kevin; Jo, Young-Ki; Gross, Dennis C.; Shim, Won-Bo] Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA; [Kim, Hyun Soo; Cifci, Osman S.; Ma, Bo; Kim, Sungman; Abdel-Raziq, Haron; Han, Arum] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Shim, WB (corresponding author), Texas A&M Univ, Dept Plant Pathol & Microbiol, College Stn, TX 77843 USA.	wbshim@tamu.edu; arum.han@ece.tamu.edu	Ong, Kevin/ABE-2603-2020; Han, Arum/C-7078-2013; Koo, Chiwan/A-3341-2011	Ong, Kevin/0000-0002-3137-5126; Han, Arum/0000-0002-9223-8301; Cifci, Osman/0000-0003-4431-0783; Koo, Chiwan/0000-0003-2880-1670; Malapi, Martha/0000-0003-2249-6257	United States Department of Agriculture (USDA) [2009-55605-05005]	United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA))	This work was supported by the United States Department of Agriculture (USDA) grant #2009-55605-05005. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Bender CL, 1999, MICROBIOL MOL BIOL R, V63, P266, DOI 10.1128/MMBR.63.2.266-292.1999; Boonham N, 2004, J VIROL METHODS, V116, P139, DOI 10.1016/j.jviromet.2003.11.005; Cady NC, 2004, MICROCHIP BASED DNA, V1193, P1191; Chang CM, 2013, LAB CHIP, V13, P1225, DOI 10.1039/c3lc41097h; Chen DF, 2010, BIOMED MICRODEVICES, V12, P705, DOI 10.1007/s10544-010-9423-4; Choi YE, 2008, J MICROBIOL BIOTECHN, V18, P648; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; Focke M, 2010, LAB CHIP, V10, P2519, DOI 10.1039/c004954a; Julich S, 2011, BIOSENS BIOELECTRON, V26, P4070, DOI 10.1016/j.bios.2011.03.035; Kim BK, 2012, PLANT DIS, V96, P577, DOI 10.1094/PDIS-03-11-0235; Kim J, 2006, GEOMETRIC OPTIMIZATI, P293; Lee JG, 2006, LAB CHIP, V6, P886, DOI 10.1039/b515876a; Lievens B, 2009, FEMS MICROBIOL LETT, V300, P201, DOI 10.1111/j.1574-6968.2009.01783.x; Liu CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042222; Lund-Olesen T, 2008, BIOMED MICRODEVICES, V10, P769, DOI 10.1007/s10544-008-9189-0; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Norman DJ, 2009, PHYTOPATHOLOGY, V99, P1070, DOI 10.1094/PHYTO-99-9-1070; Park S, 2011, BIOTECHNOL ADV, V29, P830, DOI 10.1016/j.biotechadv.2011.06.017; Qiu XB, 2011, BIOMED MICRODEVICES, V13, P809, DOI 10.1007/s10544-011-9551-5; QUIGLEY NB, 1994, MOL PLANT MICROBE IN, V7, P78, DOI 10.1094/MPMI-7-0078; Rep M, 2005, MOL PLANT MICROBE IN, V18, P15, DOI 10.1094/MPMI-18-0015; Sayler RJ, 2006, PLANT DIS, V90, P603, DOI 10.1094/PD-90-0603; Schaad NW, 2002, CAN J PLANT PATHOL, V24, P250; Shi X, 2011, LAB CHIP, V11, P2276, DOI 10.1039/c1lc20207c; Tooley PW, 2006, PHYTOPATHOLOGY, V96, P336, DOI 10.1094/PHYTO-96-0336; van den Boogert PHJF, 2005, EUR J PLANT PATHOL, V113, P47, DOI 10.1007/s10658-005-0297-x; van der Does HC, 2008, ENVIRON MICROBIOL, V10, P1475, DOI 10.1111/j.1462-2920.2007.01561.x; Verdoy D, 2012, BIOSENS BIOELECTRON, V32, P259, DOI 10.1016/j.bios.2011.12.032; Vincelli P, 2008, PLANT DIS, V92, P660, DOI 10.1094/PDIS-92-5-0660; Wilson K., 2001, PREPARATION GENOMIC; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; WOLOSHUK CP, 1995, APPL ENVIRON MICROB, V61, P3019, DOI 10.1128/AEM.61.8.3019-3023.1995; Xiang Q, 2007, BIOMED MICRODEVICES, V9, P443, DOI 10.1007/s10544-007-9048-4; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Zhang CS, 2007, NUCLEIC ACIDS RES, V35, P4223, DOI 10.1093/nar/gkm389; Zhang YH, 2009, ANAL CHIM ACTA, V638, P115, DOI 10.1016/j.aca.2009.02.038	37	53	55	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82704	10.1371/journal.pone.0082704	http://dx.doi.org/10.1371/journal.pone.0082704			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349341	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800075
J	Derlig, K; Giessl, A; Brandstatter, JH; Enz, R; Dahlhaus, R				Derlig, Kristin; Giessl, Andreas; Brandstaetter, Johann Helmut; Enz, Ralf; Dahlhaus, Regina			Identification and Characterisation of Simiate, a Novel Protein Linked to the Fragile X Syndrome	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; MESSENGER-RNA; SPLICING FACTOR; G-QUADRUPLEX; GENE-EXPRESSION; SC-35 DOMAINS; G-QUARTET; VCX-A; FMRP; BINDING	A strict regulation of protein expression during developmental stages and in response to environmental signals is essential to every cell and organism. Recent research has shown that the mammalian brain is particularly sensitive to alterations in expression patterns of specific proteins and cognitive deficits as well as autistic behaviours have been linked to dysregulated protein expression. An intellectual disability characterised by changes in the expression of a variety of proteins is the fragile X syndrome. Due to the loss of a single mRNA binding protein, the Fragile X Mental Retardation Protein FMRP, vast misregulation of the mRNA metabolism is taking place in the disease. Here, we present the identification and characterisation of a novel protein named Simiate, whose mRNA contains several FMRP recognition motifs and associates with FMRP upon co-precipitation. Sequence analysis revealed that the protein evolved app. 1.7 billion years ago when eukaryotes developed. Applying antibodies generated against Simiate, the protein is detected in a variety of tissues, including the mammalian brain. On the subcellular level, Simiate localises to somata and nuclear speckles. We show that Simiate and nuclear speckles experience specific alterations in FMR1(-/-) mice. An antibody-based block of endogenous Simiate revealed that the protein is essential for cell survival. These findings suggest not only an important role for Simiate in gene transcription and/or RNA splicing, but also provide evidence for a function of nuclear speckles in the fragile X syndrome. Indeed, transcription and splicing are two fundamental mechanisms to control protein expression, that underlie not only synaptic plasticity and memory formation, but are also affected in several diseases associated with mental disabilities.	[Derlig, Kristin; Enz, Ralf; Dahlhaus, Regina] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Ctr, D-91054 Erlangen, Germany; [Giessl, Andreas; Brandstaetter, Johann Helmut] Univ Erlangen Nurnberg, Dept Biol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Dahlhaus, R (corresponding author), Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Ctr, D-91054 Erlangen, Germany.	regina.dahlhaus@biochem.uni-erlangen.de		Giessl, Andreas/0000-0002-9768-2049	Canadian Institutes of Health Research / Fragile X Research Foundation of Canada partnership program [00517-000]; Interdisziplinares Zentrum fur klinische Forschung of the University Erlangen-Nuremberg: J17 Deutsche Forschungsgemeinschaft [DA 1320/1-1]	Canadian Institutes of Health Research / Fragile X Research Foundation of Canada partnership program(Canadian Institutes of Health Research (CIHR)); Interdisziplinares Zentrum fur klinische Forschung of the University Erlangen-Nuremberg: J17 Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding sources: Canadian Institutes of Health Research / Fragile X Research Foundation of Canada partnership program: : 00517-000 Interdisziplinares Zentrum fur klinische Forschung of the University Erlangen-Nuremberg: J17 Deutsche Forschungsgemeinschaft: DA 1320/1-1	Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Alvarez M, 2003, J CELL SCI, V116, P3099, DOI 10.1242/jcs.00618; Phan AT, 2011, NAT STRUCT MOL BIOL, V18, P796, DOI 10.1038/nsmb.2064; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Aspegren A, 1998, EXP CELL RES, V245, P203, DOI 10.1006/excr.1998.4264; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bechara EG, 2009, PLOS BIOL, V7, P133, DOI 10.1371/journal.pbio.1000016; Berry ML, 2007, MOUSE BIOMEDICAL RES, V1, P53, DOI [10.1016/b978012369454-6/500169, DOI 10.1016/B978012369454-6/500169]; Bjornerund M, 2005, READING ROCKS AUTOBI; Bole M, 2008, MOL BIOSYST, V4, P1212, DOI 10.1039/b812537f; BRIDGE E, 1995, J VIROL, V69, P281, DOI 10.1128/JVI.69.1.281-290.1995; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dahlhaus R, 2010, BEHAV BRAIN RES, V208, P96, DOI 10.1016/j.bbr.2009.11.019; Dahlhaus R, 2010, HIPPOCAMPUS, V20, P305, DOI 10.1002/hipo.20630; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; DAVIDSON EH, 1971, J THEOR BIOL, V32, P123, DOI 10.1016/0022-5193(71)90140-8; Denman RB, 2003, BIOCHEM BIOPH RES CO, V310, P1, DOI 10.1016/j.bbrc.2003.08.071; Dent MAR, 2010, FEBS LETT, V584, P2767, DOI 10.1016/j.febslet.2010.04.073; Didiot MC, 2008, NUCLEIC ACIDS RES, V36, P4902, DOI 10.1093/nar/gkn472; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Dolzhanskaya N, 2003, BIOCHEM BIOPH RES CO, V305, P434, DOI 10.1016/S0006-291X(03)00766-6; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Fukami M, 2000, AM J HUM GENET, V67, P563, DOI 10.1086/303047; Glansdorff N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-29; Greco CM, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-2; Hagerman PJ, 2008, J MED GENET, V45, P498, DOI 10.1136/jmg.2008.059055; HUANG S, 1994, J CELL BIOL, V126, P877, DOI 10.1083/jcb.126.4.877; Javaux EJ, 2010, NATURE, V463, P934, DOI 10.1038/nature08793; Jiao XF, 2006, MOL CELL, V24, P713, DOI 10.1016/j.molcel.2006.10.013; Kessels MM, 2001, J CELL BIOL, V153, P351, DOI 10.1083/jcb.153.2.351; Kim KK, 2009, J BIOL CHEM, V284, P31052, DOI 10.1074/jbc.M109.052969; Kim M, 2009, MOL CELL BIOL, V29, P214, DOI 10.1128/MCB.01377-08; Kim SH, 2008, P NATL ACAD SCI USA, V105, P4429, DOI 10.1073/pnas.0800257105; Kruhlak MJ, 2000, J CELL BIOL, V150, P41, DOI 10.1083/jcb.150.1.41; Liao LJ, 2008, P NATL ACAD SCI USA, V105, P15281, DOI 10.1073/pnas.0804678105; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Melcak I, 2000, MOL BIOL CELL, V11, P497, DOI 10.1091/mbc.11.2.497; Melko M, 2013, HUM MOL GENET, V22, P2984, DOI 10.1093/hmg/ddt155; Melko M, 2011, HUM MOL GENET, V20, P1873, DOI 10.1093/hmg/ddr069; Melko M, 2010, BIOCHIMIE, V92, P919, DOI 10.1016/j.biochi.2010.05.018; Mercaldo V, 2009, MOL CELLS, V28, P501, DOI 10.1007/s10059-009-0193-x; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; Moen PT, 2004, MOL BIOL CELL, V15, P197, DOI 10.1091/mbc.e03-06-0388; Phair RD, 2000, NATURE, V404, P604, DOI 10.1038/35007077; Ricciardi S, 2009, HUM MOL GENET, V18, P4590, DOI 10.1093/hmg/ddp426; Santoro MR, 2012, ANNU REV PATHOL-MECH, V7, P219, DOI 10.1146/annurev-pathol-011811-132457; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Shopland LS, 2003, J CELL BIOL, V162, P981, DOI 10.1083/jcb.200303131; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; Spector DL, 2011, COLD SPRING HARBOR P, V3, P12; Subramanian M, 2011, EMBO REP, V12, P697, DOI 10.1038/embor.2011.76; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Toiber D, 2010, NEUROBIOL DIS, V40, P348, DOI 10.1016/j.nbd.2010.06.011; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; Van Esch H, 2005, HUM MOL GENET, V14, P1795, DOI 10.1093/hmg/ddi186; White NM, 2009, BEHAV BRAIN RES, V199, P3, DOI 10.1016/j.bbr.2008.12.003	64	10	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83007	10.1371/journal.pone.0083007	http://dx.doi.org/10.1371/journal.pone.0083007			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349419	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300119
J	He, M; Wang, W; Huang, WY				He, Miao; Wang, Wei; Huang, Wenyong			Efficacy and Tolerability of the Fixed Combinations Latanoprost/Timolol versus Dorzolamide/Timolol in Patients with Elevated Intraocular Pressure: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; VISUAL-FIELD PROGRESSION; NORMAL-TENSION GLAUCOMA; OCULAR HYPERTENSION; CLINICAL-TRIALS; TIMOLOL; INTERVENTION; MONOTHERAPY; SAFETY; BIAS	Objective: To evaluate the efficacy and tolerability of the fixed combination of Latanoprost/Timolol versus Dorzolamide/Timolol in the treatment of patients with elevated intraocular pressure (IOP). Methods: A comprehensive literature meta-analysis was performed according to the Cochrane Collaboration methodology to identify randomized clinical trials comparing latanoprost/timolol FC (FCLT) with dorzolamide/timolol (FCDT) in patients with elevated IOP. The efficacy estimates were measured by the weight mean difference (WMD) for the IOP reduction (IOPR) from baseline to end point, including the diurnal mean IOPR, 8 AM IOPR, 12 PM IOPR, and 4 PM IOPR. The tolerability estimates were measured by RR for adverse events. All outcomes were reported with a 95% confidence interval (CI). The data were synthesized by Stata 12.0 SE for Windows. Results: Eight studies involving 841 patients (841 eyes) were included in the meta-analysis. With a WMD of IOPR in the diurnal mean of 0.16 mmHg (95% CI, -0.31 to 0.63), the FCLT was as effective as FCDT in lowering IOP in patients with elevated IOP (P = 0.51). The WMDs of IOPR were 0.58 mmHg (95% CI: -0.002 to 1.17) at 8 AM, -0.07 mmHg (95% CI: -0.50 to 0.36) at 12 PM, and 0.41 mmHg (95% CI: -0.18 to 1.00) at 4 PM, and there were no significant difference between FCLT and FCDT. FCLT was associated with a significantly lower incidence of eye pain, bitter taste, and irritation/stinging than FCDT, with pooled RRs of 0.34 (95% CI: 0.14 to 0.82), 0.06 (95% CI: 0.008 to 0.42), and 0.35 (95% CI: 0.14 to 0.85), respectively. Conclusion: FCLT was associated with equivalent efficacy in IOP lowering comparing with FCDT. However, FCLT was better tolerated than FCDT.	[He, Miao; Wang, Wei; Huang, Wenyong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Huang, WY (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	andyhwyz@aliyun.com		Huang, Wenyong/0000-0003-3167-0851				[Anonymous], 2011, **NON-TRADITIONAL**; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Beidoe G, 2012, CLIN OPHTHALMOL, V6, P1699, DOI 10.2147/OPTH.S32933; Calvo P, 2012, INVEST OPHTH VIS SCI, V53, P3875, DOI 10.1167/iovs.11-8817; Caprioli J, 2008, OPHTHALMOLOGY, V115, P1123, DOI 10.1016/j.ophtha.2007.10.031; Cheng JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045079; Cheng JW, 2009, OPHTHALMOLOGY, V116, P1243, DOI 10.1016/j.ophtha.2009.01.036; Cvenkel B, 2008, CURR EYE RES, V33, P163, DOI 10.1080/02713680701832480; De Moraes CG, 2012, INVEST OPHTH VIS SCI, V53, P1704, DOI 10.1167/iovs.11-8186; Deokule S, 2010, J GLAUCOMA, V19, P293, DOI 10.1097/IJG.0b013e3181b6e5b9; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eren MH, 2012, J OCUL PHARMACOL TH, V28, P381, DOI 10.1089/jop.2011.0105; Ernest PJG, 2012, ACTA OPHTHALMOL, V90, P10, DOI 10.1111/j.1755-3768.2010.01995.x; Fogagnolo P, 2011, EXPERT OPIN INV DRUG, V20, P947, DOI 10.1517/13543784.2011.579901; Heijl A, 2013, OPHTHALMOLOGY, V120, P1541, DOI 10.1016/j.ophtha.2013.01.043; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Januleviciene I, 2009, EUR J OPHTHALMOL, V19, P790, DOI 10.1177/112067210901900517; Konstas AGP, 2008, BRIT J OPHTHALMOL, V92, P1498, DOI 10.1136/bjo.2008.145219; Konstas AGP, 2004, EYE, V18, P1264, DOI 10.1038/sj.eye.6701446; Lambiase A, 2009, P NATL ACAD SCI USA, V106, P13469, DOI 10.1073/pnas.0906678106; Lee M, 2012, J GLAUCOMA, V21, P596, DOI 10.1097/IJG.0b013e31824cfbf7; Li TJ, 2013, OPHTHALMOLOGY, V120, P1113, DOI 10.1016/j.ophtha.2012.11.038; Martinez A, 2007, INT J CLIN PRACT, V61, P815, DOI 10.1111/j.1742-1241.2006.01126.x; Miglior S, 2010, EYE, V24, P1234, DOI 10.1038/eye.2009.307; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Orme M, 2010, CURR MED RES OPIN, V26, P511, DOI 10.1185/03007990903498786; Pajic B, 2010, CURR MED RES OPIN, V26, P2213, DOI 10.1185/03007995.2010.508702; Quaranta L, 2013, J OCUL PHARMACOL TH, V29, P382, DOI 10.1089/jop.2012.0186; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Rasmussen CA, 2011, DRUG FUTURE, V36, P287, DOI 10.1358/dof.2011.36.4.1587772; Razeghinejad MR, 2010, EXPERT OPIN PHARMACO, V11, P959, DOI 10.1517/14656561003667540; Shin DH, 2004, OPHTHALMOLOGY, V111, P276, DOI 10.1016/j.ophtha.2003.05.019; van der Valk R, 2005, OPHTHALMOLOGY, V112, P1177, DOI 10.1016/j.ophtha.2005.01.042; van der Valk R, 2009, J CLIN EPIDEMIOL, V62, P1279, DOI 10.1016/j.jclinepi.2008.04.012; Webers CAB, 2007, OPHTHALMOLOGY, V114, P40, DOI 10.1016/j.ophtha.2006.07.018; Yuce B, 2012, TURK OFTALMOL DERG, V42, P5, DOI 10.4274/tjo.42.30074	37	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83606	10.1371/journal.pone.0083606	http://dx.doi.org/10.1371/journal.pone.0083606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349536	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300150
J	Cain, MD; Vo, BQ; Kolesnikov, AV; Kefalov, VJ; Culican, SM; Kerschensteiner, D; Blumer, KJ				Cain, Matthew D.; Vo, Bradly Q.; Kolesnikov, Alexander V.; Kefalov, Vladimir J.; Culican, Susan M.; Kerschensteiner, Daniel; Blumer, Kendall J.			An Allosteric Regulator of R7-RGS Proteins Influences Light-Evoked Activity and Glutamatergic Waves in the Inner Retina	PLOS ONE			English	Article							ON-BIPOLAR CELLS; R7 RGS PROTEINS; MEMBRANE ANCHOR R7BP; GANGLION-CELLS; SIGNALING RGS7; TRANSFECTED CELLS; AMACRINE CELLS; RABBIT RETINA; ACTIVATION; COMPLEXES	In the outer retina, G protein-coupled receptor (GPCR) signaling mediates phototransduction and synaptic transmission between photoreceptors and ON bipolar cells. In contrast, the functions of modulatory GPCR signaling networks in the inner retina are less well understood. We addressed this question by determining the consequences of augmenting modulatory Gi/o signaling driven by endogenous transmitters. This was done by analyzing the effects of genetically ablating the R7 RGS-binding protein (R7BP), a membrane-targeting protein and positive allosteric modulator of R7-RGS (regulator of the G protein signaling 7) family that deactivates Gi/o alpha subunits. We found that R7BP is expressed highly in starburst amacrine cells and retinal ganglion cells (RGCs). As indicated by electroretinography and multielectrode array recordings of adult retina, ablation of R7BP preserved outer retina function, but altered the firing rate and latency of ON RGCs driven by rods and cones but not rods alone. In developing retina, R7BP ablation increased the burst duration of glutamatergic waves whereas cholinergic waves were unaffected. This effect on glutamatergic waves did not result in impaired segregation of RGC projections to eye-specific domains of the dorsal lateral geniculate nucleus. R7BP knockout mice exhibited normal spatial contrast sensitivity and visual acuity as assessed by optomotor reflexes. Taken together these findings indicate that R7BP-dependent regulation of R7-RGS proteins shapes specific aspects of light-evoked and spontaneous activity of RGCs in mature and developing retina.	[Cain, Matthew D.; Blumer, Kendall J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Vo, Bradly Q.; Kolesnikov, Alexander V.; Kefalov, Vladimir J.; Culican, Susan M.; Kerschensteiner, Daniel] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Blumer, KJ (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	kblumer@wustl.edu	Kolesnikov, Alexander V/O-1840-2016; Culican, Susan/F-4279-2019	Culican, Susan/0000-0002-0273-4310; Kefalov, Vladimir/0000-0002-1659-008X; Cain, Matthew D./0000-0003-1327-840X	National Institutes of Health [GM44592, HL075632, EY021855, EY019312, EY016336, EY02687]; Research to Prevent Blindness, Inc. (DOVS); Horncrest Foundation; Hope for Vision Foundation; Edward Mallinckrodt Jr. Foundation; Alfred P. Sloan Foundation; Whitehall Foundation;  [T32-EY013360]; NATIONAL EYE INSTITUTE [K12EY016336, T32EY013360, R01EY021855, R01EY019312, P30EY002687] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044592, T32GM007067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness, Inc. (DOVS); Horncrest Foundation; Hope for Vision Foundation; Edward Mallinckrodt Jr. Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Whitehall Foundation; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (GM44592 and HL075632 (K.J.B), EY021855 (DK), EY019312 (VJK), EY016336 (SMC), and EY02687 (Department of Ophthalmology and Visual Sciences, Washington University) and from Research to Prevent Blindness, Inc. (DOVS. MDC was supported in part by (T32-EY013360). SMC and DK also received funding from the following foundations: Horncrest Foundation (S. M. C.), Hope for Vision Foundation, Edward Mallinckrodt Jr. Foundation, Alfred P. Sloan Foundation, and Whitehall Foundation (DK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GR, 2007, J NEUROSCI, V27, P14117, DOI 10.1523/JNEUROSCI.3884-07.2007; Anderson GR, 2007, J BIOL CHEM, V282, P4772, DOI 10.1074/jbc.M610518200; Bansal A, 2000, J NEUROSCI, V20, P7672; Cao Y, 2008, J NEUROSCI, V28, P10443, DOI 10.1523/JNEUROSCI.3282-08.2008; Cao Y, 2012, P NATL ACAD SCI USA, V109, P7905, DOI 10.1073/pnas.1202332109; Catsicas M, 2001, J NEUROSCI, V21, P897, DOI 10.1523/JNEUROSCI.21-03-00897.2001; Chen FS, 2010, INVEST OPHTH VIS SCI, V51, P686, DOI 10.1167/iovs.09-4084; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Clark BD, 2009, J NEUROSCI, V29, P11237, DOI 10.1523/JNEUROSCI.2836-09.2009; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; Demas J, 2003, J NEUROSCI, V23, P2851; Dhingra A, 2000, J NEUROSCI, V20, P9053; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Drenan RM, 2006, J BIOL CHEM, V281, P28222, DOI 10.1074/jbc.M604428200; Garzon J, 2005, J BIOL CHEM, V280, P8951, DOI 10.1074/jbc.M407005200; Gleason E, 2012, VISUAL NEUROSCI, V29, P31, DOI 10.1017/S0952523811000204; Grabowska D, 2008, NEUROSCIENCE, V151, P969, DOI 10.1016/j.neuroscience.2007.11.045; Guimaraes-Souza EM, 2012, J NEUROSCI RES, V90, P2349, DOI 10.1002/jnr.23123; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Hooks SB, 2003, J BIOL CHEM, V278, P10087, DOI 10.1074/jbc.M211382200; Huang H, 2013, PROG RETIN EYE RES, V32, P64, DOI 10.1016/j.preteyeres.2012.07.003; Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533; Jensen RJ, 2006, BRAIN RES, V1122, P86, DOI 10.1016/j.brainres.2006.08.119; JENSEN RJ, 1986, NEUROSCIENCE, V17, P837, DOI 10.1016/0306-4522(86)90049-7; Jia LX, 2011, J BIOL CHEM, V286, P13695, DOI 10.1074/jbc.M110.193763; Kothmann WW, 2009, J NEUROSCI, V29, P14903, DOI 10.1523/JNEUROSCI.3436-09.2009; Liapis E, 2012, J NEUROCHEM, V122, P568, DOI 10.1111/j.1471-4159.2012.07811.x; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Masuho I, 2013, J BIOL CHEM, V288, P25129, DOI 10.1074/jbc.M113.462283; Mojumder DK, 2009, J NEUROSCI, V29, P7753, DOI 10.1523/JNEUROSCI.1794-09.2009; Morgans CW, 2007, EUR J NEUROSCI, V26, P2899, DOI 10.1111/j.1460-9568.2007.05867.x; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Narayanan V, 2007, BIOCHEMISTRY-US, V46, P6859, DOI 10.1021/bi700524w; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Rao A, 2007, J NEUROSCI, V27, P14199, DOI 10.1523/JNEUROSCI.4934-07.2007; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shim H, 2012, J BIOL CHEM, V287, P14873, DOI 10.1074/jbc.M112.345751; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Song JH, 2007, MOL CELL NEUROSCI, V35, P311, DOI 10.1016/j.mcn.2007.03.006; Song JH, 2006, J BIOL CHEM, V281, P15361, DOI 10.1074/jbc.M600749200; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; Syed MM, 2004, J PHYSIOL-LONDON, V560, P533, DOI 10.1113/jphysiol.2004.066597; Taylor WR, 2012, VISUAL NEUROSCI, V29, P73, DOI 10.1017/S0952523811000393; Torborg CL, 2005, PROG NEUROBIOL, V76, P213, DOI 10.1016/j.pneurobio.2005.09.002; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Umino Y, 2006, ADV EXP MED BIOL, V572, P169; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Witherow DS, 2000, J BIOL CHEM, V275, P24872, DOI 10.1074/jbc.M001535200; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Xie KQ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002922; Xie KQ, 2010, NAT NEUROSCI, V13, P661, DOI 10.1038/nn.2549; Zhang JH, 2011, J NEUROCHEM, V119, P544, DOI 10.1111/j.1471-4159.2011.07457.x; Zhang JM, 2010, INVEST OPHTH VIS SCI, V51, P1121, DOI 10.1167/iovs.09-4163; Zhou H, 2012, P NATL ACAD SCI USA, V109, P19977, DOI 10.1073/pnas.1214337109	55	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82276	10.1371/journal.pone.0082276	http://dx.doi.org/10.1371/journal.pone.0082276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349243	Green Published, gold			2022-12-27	WOS:000328705200070
J	Italia, K; Colah, R; Ghosh, K				Italia, Khushnooma; Colah, Roshan; Ghosh, Kanjaksha			Hydroxyurea Could Be a Good Clinically Relevant Iron Chelator	PLOS ONE			English	Article							SICKLE-CELL-ANEMIA; BETA-THALASSEMIA; MAGNETIC-RESONANCE; FETAL-HEMOGLOBIN; DETERMINANTS; INTERMEDIA	Our previous study showed a reduction in serum ferritin of beta-thalassemia patients on hydroxyurea therapy. Here we aimed to evaluate the efficacy of hydroxyurea alone and in combination with most widely used iron chelators like deferiprone and deferasirox for reducing iron from experimentally iron overloaded mice. 70 BALB/c mice received intraperitonial injections of iron-sucrose. The mice were then divided into 8 groups and were orally given hydroxyurea, deferiprone or deferasirox alone and their combinations for 4 months. CBC, serum-ferritin, TBARS, sTfr and hepcidin were evaluated before and after iron overload and subsequently after 4 months of drug therapy. All animals were then killed. Iron staining of the heart and liver tissue was done using Perl's Prussian Blue stain. Dry weight of iron in the heart and liver was determined by atomic absorption spectrometry. Increased serum-ferritin, TBARS, hepcidin and dry weight of iron in the liver and heart showed a significant reduction in groups treated with iron chelators with maximum reduction in the group treated with a combination of deferiprone, deferasirox and hydroxyurea. Thus hydroxyurea proves its role in reducing iron from iron overloaded mice. The iron chelating effect of these drugs can also be increased if given in combination.	[Italia, Khushnooma; Colah, Roshan] ICMR, Natl Inst Immunohaematol, Hematogenet Dept, Bombay, Maharashtra, India; [Ghosh, Kanjaksha] ICMR, Natl Inst Immunohaematol, Bombay, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH); Indian Council of Medical Research (ICMR); ICMR - National Institute of Immunohaemotology (NIIH)	Ghosh, K (corresponding author), ICMR, Natl Inst Immunohaematol, Bombay, Maharashtra, India.	kanjakshaghosh@hotmail.com	Ghosh, Kanjaksha/D-7621-2015	Ghosh, Kanjaksha/0000-0002-0645-6565	Indian Council of Medical Research, New Delhi, India [3/1/3/PDF-1/HRD-2010/1st batch]	Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR))	The authors acknowledge the Indian Council of Medical Research, New Delhi, India, for funding this project (Grant No. 3/1/3/PDF-1/HRD-2010/1st batch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M B, 2005, J Assoc Physicians India, V53, P1017; Alebouyeh M, 2004, ANN HEMATOL, V83, P430, DOI 10.1007/s00277-003-0836-5; CHARACHE S, 1992, BLOOD, V79, P2555; Dixit A, 2005, ANN HEMATOL, V84, P441, DOI 10.1007/s00277-005-1026-4; Higgs D.R., 2001, THALASSAEMIA SYNDROM, P133; Italia K, 2009, BLOOD CELL MOL DIS, V42, P25, DOI 10.1016/j.bcmd.2008.08.003; Italia KY, 2010, J CLIN PATHOL, V63, P147, DOI 10.1136/jcp.2009.070391; Italia KY, 2009, CLIN CHIM ACTA, V407, P10, DOI 10.1016/j.cca.2009.06.019; Kalmar J, 2012, DALTON T, V41, P11875, DOI 10.1039/c2dt31200j; Kayyali R, 1998, BIOCHEM PHARMACOL, V55, P1327, DOI 10.1016/S0006-2952(97)00602-3; Ma Q, 2007, PHARMACOGENOMICS J, V7, P386, DOI 10.1038/sj.tpj.6500433; Mladenka P, 2006, FREE RADICAL RES, V40, P263, DOI 10.1080/10715760500511484; Panigrahi I, 2005, HEMATOLOGY, V10, P61, DOI 10.1080/10245330400020439; Papanikolaou G, 2005, BLOOD, V105, P4103, DOI 10.1182/blood-2004-12-4844; Pepe A, 2006, J MAGN RESON IMAGING, V23, P662, DOI 10.1002/jmri.20566; Pepe A, 2011, HAEMATOL-HEMATOL J, V96, P41, DOI 10.3324/haematol.2009.019042; Prabhu R., 2009, J BIOSCI TECHNOL, P20; Steinberg MH, 1997, BLOOD, V89, P1078, DOI 10.1182/blood.V89.3.1078; Verma Ishwar C, 2011, Indian J Med Res, V134, P507; Zamani F, 2009, ARCH IRAN MED, V12, P295	20	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82928	10.1371/journal.pone.0082928	http://dx.doi.org/10.1371/journal.pone.0082928			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349400	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200116
J	Rios-Cardenas, O; Brewer, J; Morris, MR				Rios-Cardenas, Oscar; Brewer, Jason; Morris, Molly R.			Maternal Investment in the Swordtail Fish Xiphophorus multilineatus: Support for the Differential Allocation Hypothesis	PLOS ONE			English	Article							SEXUAL SELECTION; QUALITY; MALES; PREFERENCES; PLASTICITY; PATTERNS; SIZE	The differential allocation hypothesis predicts that reproductive investment will be influenced by mate attractiveness, given a cost to reproduction and a tradeoff between current and future reproduction. We tested the differential allocation hypothesis in the swordtail fish Xiphophorus multilineatus, where males have genetically influenced (patroclinous inheritance) alternative mating tactics (ARTs) maintained by a tradeoff between being more attractive to females (mature later as larger courting males) and a higher probability of reaching sexual maturity (mature earlier as smaller sneaker males). Males in X. multilineatus do not provide parental care or other resources to the offspring. Allelic variation and copy number of the Mc4R gene on the Y-chromosome influences the size differences between males, however there is no variation in this gene on the X-chromosome. Therefore, to determine if mothers invested more in offspring of the larger courter males, we examined age to sexual maturity for daughters. We confirmed a tradeoff between number of offspring and female offspring's age to sexual maturity, corroborating that there is a cost to reproduction. In addition, the ART of their fathers significantly influenced the age at which daughters reached sexual maturity, suggesting increased maternal investment to daughters of courter males. The differential allocation we detected was influenced by how long the wild-caught mother had been in the laboratory, as there was a brood order by father genotype (ART) interaction. These results suggest that females can adjust their reproductive investment strategy, and that differential allocation is context specific. We hypothesize that one of two aspects of laboratory conditions produced this shift: increased female condition due to higher quality diet, and/or assessment of future mating opportunities due to isolation from males.	[Rios-Cardenas, Oscar] Inst Ecol AC, Red Biol Evolut, Xalapa, Veracruz, Mexico; [Brewer, Jason; Morris, Molly R.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA	Instituto de Ecologia - Mexico; University System of Ohio; Ohio University	Rios-Cardenas, O (corresponding author), Inst Ecol AC, Red Biol Evolut, Xalapa, Veracruz, Mexico.	oscar.rios@inecol.edu.mx	Rios-Cardenas, Oscar/J-5434-2014	Rios-Cardenas, Oscar/0000-0003-3416-0814; Morris, Molly/0000-0001-9962-2982	National Science Foundation (NSF) [IBN 9983561]	National Science Foundation (NSF)(National Science Foundation (NSF))	Funding came from the National Science Foundation (NSF) IBN 9983561. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardo J, 1996, AM ZOOL, V36, P216; Bluhm CK, 2004, ANIM BEHAV, V68, P977, DOI 10.1016/j.anbehav.2004.01.013; Bono LM, 2011, J FISH BIOL, V78, P1311, DOI 10.1111/j.1095-8649.2011.02932.x; Braga Goncalves I, 2010, P ROY SOC B-BIOL SCI, V277, P1581, DOI 10.1098/rspb.2009.2290; BURLEY N, 1986, EVOLUTION, V40, P1191, DOI 10.1111/j.1558-5646.1986.tb05744.x; Byers JA, 2006, P NATL ACAD SCI USA, V103, P16343, DOI 10.1073/pnas.0608184103; Clutton-Brock T. H., 1991, EVOLUTION PARENTAL C, DOI [10.1046/j.1420-9101.1992.5040719.x, DOI 10.1046/J.1420-9101.1992.5040719.X]; Constantz G.D., 1989, P33; Crawley MJ., 2007, STAT PAP, V2, DOI [10.1002/9780470515075, DOI 10.1002/9780470515075]; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; EVANS J.P., 2011, ECOLOGY EVOLUTION PO; Fox CW, 1997, AM NAT, V149, P149, DOI 10.1086/285983; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Gowaty PA, 2007, P NATL ACAD SCI USA, V104, P15023, DOI 10.1073/pnas.0706622104; Harris WE, 2009, PHILOS T R SOC B, V364, P1039, DOI 10.1098/rstb.2008.0299; Kallman K.D., 1989, P163; Kindsvater HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048473; Kolm N, 2001, P ROY SOC B-BIOL SCI, V268, P2229, DOI 10.1098/rspb.2001.1792; Kotiaho JS, 2003, AM NAT, V161, P852, DOI 10.1086/375173; Lampert KP, 2010, CURR BIOL, V20, P1729, DOI 10.1016/j.cub.2010.08.029; Lancaster LT, 2007, ECOL LETT, V10, P798, DOI 10.1111/j.1461-0248.2007.01069.x; MCGINLEY MA, 1987, AM NAT, V130, P370, DOI 10.1086/284716; Meffe G.K., 1989, P13; Morris MR, 2010, ANIM BEHAV, V79, P673, DOI 10.1016/j.anbehav.2009.12.018; MORRIS MR, 1995, BEHAV ECOL, V6, P274, DOI 10.1093/beheco/6.3.274; MORRIS MR, 1992, COPEIA, P1074; MORRIS MR, 1995, BEHAV ECOL SOCIOBIOL, V37, P303, DOI 10.1007/BF00174134; Navara KJ, 2006, FUNCT ECOL, V20, P449, DOI 10.1111/j.1365-2435.2006.01114.x; Parker GA, 1986, AM NAT, V128, P576; Pryke SR, 2009, SCIENCE, V323, P1605, DOI 10.1126/science.1168928; Ratikainen II, 2010, BEHAV ECOL, V21, P195, DOI 10.1093/beheco/arp168; Reznick D, 1996, AM ZOOL, V36, P147; Reznick D.N., 1989, P125; Rios-Cardenas O, 2007, ANIM BEHAV, V74, P633, DOI 10.1016/j.anbehav.2007.01.002; Sargent Robert Craig, 1997, P292; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Stearns S.C., 1992, pi; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Tudor MS, 2011, ANIM BEHAV, V82, P1313, DOI 10.1016/j.anbehav.2011.09.014; Wiegmann DD, 2004, EVOLUTION, V58, P1530; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; ZIMMERER EJ, 1988, COPEIA, P299; ZIMMERER EJ, 1989, EVOLUTION, V43, P1298, DOI 10.1111/j.1558-5646.1989.tb02576.x	43	10	10	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82723	10.1371/journal.pone.0082723	http://dx.doi.org/10.1371/journal.pone.0082723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349348	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200094
J	Monniot, C; Boisrame, A; Da Costa, G; Chauvel, M; Sautour, M; Bougnoux, ME; Bellon-Fontaine, MN; Dalle, F; d'Enfert, C; Richard, ML				Monniot, Celine; Boisrame, Anita; Da Costa, Gregory; Chauvel, Muriel; Sautour, Marc; Bougnoux, Marie-Elisabeth; Bellon-Fontaine, Marie-Noelle; Dalle, Frederic; d'Enfert, Christophe; Richard, Mathias L.			Rbt1 Protein Domains Analysis in Candida albicans Brings Insights into Hyphal Surface Modifications and Rbt1 Potential Role during Adhesion and Biofilm Formation	PLOS ONE			English	Article							GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS; SACCHAROMYCES-CEREVISIAE; CELL-WALL; GENE-EXPRESSION; GENOME-WIDE; YEAST; ADHERENCE; FLO11; IDENTIFICATION; MORPHOGENESIS	Cell wall proteins are central to the virulence of Candida albicans. Hwp1, Hwp2 and Rbt1 form a family of hypha-associated cell surface proteins. Hwp1 and Hwp2 have been involved in adhesion and other virulence traits but Rbt1 is still poorly characterized. To assess the role of Rbt1 in the interaction of C. albicans with biotic and abiotic surfaces independently of its morphological state, heterologous expression and promoter swap strategies were applied. The N-terminal domain with features typical of the Flo11 superfamily was found to be essential for adhesiveness to polystyrene through an increase in cell surface hydrophobicity. A 42 amino acid-long domain localized in the central part of the protein was shown to enhance the aggregation function. We demonstrated that a VTTGVVVVT motif within the 42 amino acid domain displayed a high beta-aggregation potential and was responsible for cell-to-cell interactions by promoting the aggregation of hyphae. Finally, we showed through constitutive expression that while Rbt1 was directly accessible to antibodies in hyphae, it was not so in yeast. Similar results were obtained for another cell wall protein, namely Iff8, and suggested that modification of the cell wall structure between yeast and hyphae can regulate the extracellular accessibility of cell wall proteins independently of gene regulation.	[Monniot, Celine; Boisrame, Anita; Da Costa, Gregory; Bellon-Fontaine, Marie-Noelle; Richard, Mathias L.] INRA, Micalis UMR1319, Jouy En Josas, France; [Monniot, Celine; Boisrame, Anita; Da Costa, Gregory; Bellon-Fontaine, Marie-Noelle; Richard, Mathias L.] AgroParisTech, UMR Micalis, Thiverval Grignon, France; [Chauvel, Muriel; Bougnoux, Marie-Elisabeth; d'Enfert, Christophe] Inst Pasteur, Unite Biol & Pathogenicite Fong, Dept Genomes & Genet, Paris, France; [Chauvel, Muriel; Bougnoux, Marie-Elisabeth; d'Enfert, Christophe] INRA, USC2019, Paris, France; [Sautour, Marc; Dalle, Frederic] UMR Agroecol 1347 Agrosup INRA Univ Bourgogne, Lab Microbiol Environm & Risque Sanit MERS, Dijon, France; [Bougnoux, Marie-Elisabeth] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Bougnoux, Marie-Elisabeth] Hop Necker Enfants Malad, AP HP, Unite Parasitol Mycol, Microbiol Serv, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Richard, ML (corresponding author), INRA, Micalis UMR1319, Jouy En Josas, France.	mathias.lavie-richard@grignon.inra.fr	Richard, Mathias L./GRR-7524-2022	Richard, Mathias L./0000-0002-9256-8191; d'Enfert, Christophe/0000-0002-6235-3886; DA COSTA, Gregory/0000-0003-1436-916X	European Commission [FinSysB PITN-GA-2008-214004]; Agence Nationale de la Recherche (KANJI) [ANR-08-MIE-033-01]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; French Ministry of Research	European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de la Recherche (KANJI)(French National Research Agency (ANR)); French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases"(French National Research Agency (ANR)); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by a research grant from the European Commission (FinSysB PITN-GA-2008-214004) to MLR and CdE and Agence Nationale de la Recherche (KANJI, ANR-08-MIE-033-01) to CdE and FD. This study has received funding from the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant noANR-10-LABX-62-IBEID). CN was a recipient of a fellowship from the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsteens D, 2010, P NATL ACAD SCI USA, V107, P20744, DOI 10.1073/pnas.1013893107; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Boisrame A, 2009, APPL MICROBIOL BIOT, V82, P663, DOI 10.1007/s00253-008-1780-z; Boisrame A, 2011, EUKARYOT CELL, V10, P1317, DOI 10.1128/EC.05044-11; Brachmann CB, 1998, YEAST, V14, P115; Braun BR, 2000, GENETICS, V156, P31; Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105; Brown AJP, 1999, TRENDS MICROBIOL, V7, P333, DOI 10.1016/S0966-842X(99)01556-5; Chaffin WL, 2008, MICROBIOL MOL BIOL R, V72, P495, DOI 10.1128/MMBR.00032-07; Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702; Dalle F, 2003, INFECT IMMUN, V71, P7061, DOI 10.1128/IAI.71.12.7061-7068.2003; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Davis DA, 2002, GENETICS, V162, P1573; de Groot PWJ, 2003, YEAST, V20, P781, DOI 10.1002/yea.1007; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Ene IV, 2009, EUKARYOT CELL, V8, P1909, DOI 10.1128/EC.00245-09; Enoch DA, 2006, J MED MICROBIOL, V55, P809, DOI 10.1099/jmm.0.46548-0; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; FONZI WA, 1993, GENETICS, V134, P717; Garcia MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017632; Garcia-Sanchez S, 2004, EUKARYOT CELL, V3, P536, DOI 10.1128/EC.3.2.536-545.2004; Goossens KVY, 2012, FEMS YEAST RES, V12, P78, DOI 10.1111/j.1567-1364.2011.00766.x; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Hayek P, 2010, MICROBIOL RES, V165, P250, DOI 10.1016/j.micres.2009.03.006; HAZEN KC, 1989, INFECT IMMUN, V57, P1894, DOI 10.1128/IAI.57.7.1894-1900.1989; HAZEN KC, 1992, INFECT IMMUN, V60, P1499, DOI 10.1128/IAI.60.4.1499-1508.1992; Jacobsen Ilse D, 2012, Methods Mol Biol, V845, P487, DOI 10.1007/978-1-61779-539-8_34; Li F, 2008, MICROBIOL-SGM, V154, P1193, DOI 10.1099/mic.0.2007/013789-0; Liu YP, 2011, EUKARYOT CELL, V10, P168, DOI 10.1128/EC.00279-10; Lo WS, 1996, J BACTERIOL, V178, P7144, DOI 10.1128/jb.178.24.7144-7151.1996; Lo WS, 1998, MOL BIOL CELL, V9, P161, DOI 10.1091/mbc.9.1.161; Mao YX, 2008, EUKARYOT CELL, V7, P1906, DOI 10.1128/EC.00148-08; Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742; Nobbs AH, 2010, EUKARYOT CELL, V9, P1622, DOI 10.1128/EC.00103-10; Nobile CJ, 2006, CELL MICROBIOL, V8, P1382, DOI 10.1111/j.1462-5822.2006.00761.x; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Padovan ACB, 2009, MED MYCOL, V47, P824, DOI 10.3109/13693780802669574; Pelletier C, 1997, APPL ENVIRON MICROB, V63, P1725, DOI 10.1128/AEM.63.5.1725-1731.1997; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Ramsook CB, 2010, EUKARYOT CELL, V9, P393, DOI 10.1128/EC.00068-09; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; RICHARD CMM, 2012, CANDIDA CANDIDIASIS, P197; Richard ML, 2007, EUKARYOT CELL, V6, P119, DOI 10.1128/EC.00297-06; Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003; Sheppard DC, 2004, J BIOL CHEM, V279, P30480, DOI 10.1074/jbc.M401929200; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Vialas V, 2012, PROTEOMICS, V12, P2331, DOI 10.1002/pmic.201100588; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227; Whiteway M, 2007, ANNU REV MICROBIOL, V61, P529, DOI 10.1146/annurev.micro.61.080706.093341; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Younes S, 2011, MICROBIOL RES, V166, P430, DOI 10.1016/j.micres.2010.08.004; Zupancic ML, 2008, MOL MICROBIOL, V68, P547, DOI 10.1111/j.1365-2958.2008.06184.x	52	20	21	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82395	10.1371/journal.pone.0082395	http://dx.doi.org/10.1371/journal.pone.0082395			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349274	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100103
J	Peterson, EC; Celikel, R; Gokulan, K; Varughese, KI				Peterson, Eric C.; Celikel, Reha; Gokulan, Kuppan; Varughese, Kottayil I.			Structural Characterization of a Therapeutic Anti-Methamphetamine Antibody Fragment: Oligomerization and Binding of Active Metabolites	PLOS ONE			English	Article							SINGLE-CHAIN ANTIBODY; MONOCLONAL-ANTIBODIES; CRYSTAL-STRUCTURES; (+)-METHAMPHETAMINE; PHARMACOKINETICS; AMPHETAMINE; ANTAGONISM; MULTIMERS; AFFINITY; VACCINE	Vaccines and monoclonal antibodies (mAb) for treatment of (+)-methamphetamine (METH) abuse are in late stage preclinical and early clinical trial phases, respectively. These immunotherapies work as pharmacokinetic antagonists, sequestering METH and its metabolites away from sites of action in the brain and reduce the rewarding and toxic effects of the drug. A key aspect of these immunotherapy strategies is the understanding of the subtle molecular interactions important for generating antibodies with high affinity and specificity for METH. We previously determined crystal structures of a high affinity anti-METH therapeutic single chain antibody fragment (scFv6H4, K-D = 10 nM) in complex with METH and the (+) stereoisomer of 3,4-methylenedioxymethamphetamine (MDMA, or "ecstasy"). Here we report the crystal structure of scFv6H4 in homo-trimeric unbound (apo) form (2.60 angstrom), as well as monomeric forms in complex with two active metabolites; (+)-amphetamine (AMP, 2.38 angstrom) and (+)-4-hydroxy methamphetamine (p-OH-METH, 2.33 angstrom). The apo structure forms a trimer in the crystal lattice and it results in the formation of an intermolecular composite beta-sheet with a three-fold symmetry. We were also able to structurally characterize the coordination of the His-tags with Ni2+. Two of the histidine residues of each C-terminal His-tag interact with Ni2+ in an octahedral geometry. In the apo state the CDR loops of scFv6H4 form an open conformation of the binding pocket. Upon ligand binding, the CDR loops adopt a closed formation, encasing the drug almost completely. The structural information reported here elucidates key molecular interactions important in anti-methamphetamine abuse immunotherapy.	[Celikel, Reha; Gokulan, Kuppan; Varughese, Kottayil I.] Univ Arkansas Med Sci, Dept Physiol & Biophys, Coll Med, Little Rock, AR 72205 USA; [Peterson, Eric C.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Coll Med, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Varughese, KI (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Biophys, Coll Med, Little Rock, AR 72205 USA.	KIVarughese@uams.edu		Gokulan, Kuppan/0000-0003-4045-5993	National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute [HL55375]; NIH/National Institute on Drug Abuse [DA018039]; Arkansas Biosciences Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA018039, R01DA026423] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Arkansas Biosciences Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by grants National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute HL55375 (KIV) http://www.nhlbi.nih.gov/, and NIH/National Institute on Drug Abuse DA018039 (ECP) http://www.drugabuse.gov/, and a grant from the Arkansas Biosciences Institute (KIV) http://arbiosciences.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan R, 1997, P NATL ACAD SCI USA, V94, P9620, DOI 10.1073/pnas.94.18.9620; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Byrnes-Blake KA, 2005, EUR J PHARMACOL, V521, P86, DOI 10.1016/j.ejphar.2005.08.016; Byrnes-Blake KA, 2003, EUR J PHARMACOL, V461, P119, DOI 10.1016/S0014-2999(03)01313-X; Carson M, 2007, ACTA CRYSTALLOGR D, V63, P295, DOI 10.1107/S0907444906052024; Celikel R, 2009, PROTEIN SCI, V18, P2336, DOI 10.1002/pro.244; Dolezal O, 2003, PROTEIN ENG, V16, P47, DOI 10.1093/proeng/gzg006; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Hu GD, 2011, J MOL MODEL, V17, P1919, DOI 10.1007/s00894-010-0892-4; Hu GD, 2010, BIOPHYS CHEM, V153, P97, DOI 10.1016/j.bpc.2010.10.008; Hudson PJ, 2003, NAT MED, V9, P129, DOI 10.1038/nm0103-129; Hudson PJ, 1999, J IMMUNOL METHODS, V231, P177, DOI 10.1016/S0022-1759(99)00157-X; Johnson G, 2001, NUCLEIC ACIDS RES, V29, P205, DOI 10.1093/nar/29.1.205; Kinsey BM, 2010, EXPERT REV VACCINES, V9, P1109, DOI 10.1586/ERV.10.102; Kosten T, 2005, PHARMACOL THERAPEUT, V108, P76, DOI 10.1016/j.pharmthera.2005.06.009; Laganowsky A, 2011, PROTEIN SCI, V20, P1876, DOI 10.1002/pro.727; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; McMillan DE, 2004, J PHARMACOL EXP THER, V309, P1248, DOI 10.1124/jpet.103.061762; Miller ML, 2013, BIOL PSYCHIAT, V73, P721, DOI 10.1016/j.biopsych.2012.09.010; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nanaware-Kharade N, 2012, BIOCONJUGATE CHEM, V23, P1864, DOI 10.1021/bc300204n; Norman AB, 2009, J PHARMACOL EXP THER, V328, P873, DOI 10.1124/jpet.108.146407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pentel P, 2002, RESPIRATION, V69, P193, DOI 10.1159/000063617; Peterson EC, 2008, J PHARMACOL EXP THER, V325, P124, DOI 10.1124/jpet.107.134395; Peterson EC, 2007, J PHARMACOL EXP THER, V322, P30, DOI 10.1124/jpet.106.117150; Peterson EC, 2009, MOL INTERV, V9, P119, DOI 10.1124/mi.9.3.5; Riviere GJ, 1999, J PHARMACOL EXP THER, V291, P1220; Schepers RJF, 2003, CLIN CHEM, V49, P121, DOI 10.1373/49.1.121; Valentine JL, 1996, J PHARMACOL EXP THER, V278, P709	30	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82690	10.1371/journal.pone.0082690	http://dx.doi.org/10.1371/journal.pone.0082690			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349338	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100124
J	Meersman, E; Steensels, J; Mathawan, M; Wittocx, PJ; Saels, V; Struyf, N; Bernaert, H; Vrancken, G; Verstrepen, KJ				Meersman, Esther; Steensels, Jan; Mathawan, Melissa; Wittocx, Pieter-Jan; Saels, Veerle; Struyf, Nore; Bernaert, Herwig; Vrancken, Gino; Verstrepen, Kevin J.			Detailed Analysis of the Microbial Population in Malaysian Spontaneous Cocoa Pulp Fermentations Reveals a Core and Variable Microbiota	PLOS ONE			English	Article							ACETIC-ACID BACTERIA; LACTIC-ACID; BEAN FERMENTATIONS; SPECIES-DIVERSITY; HEAP FERMENTATION; RIBOSOMAL-RNA; SP-NOV; IDENTIFICATION; DYNAMICS; SEQUENCE	The fermentation of cocoa pulp is one of the few remaining large-scale spontaneous microbial processes in today's food industry. The microbiota involved in cocoa pulp fermentations is complex and variable, which leads to inconsistent production efficiency and cocoa quality. Despite intensive research in the field, a detailed and comprehensive analysis of the microbiota is still lacking, especially for the expanding Asian production region. Here, we report a large-scale, comprehensive analysis of four spontaneous Malaysian cocoa pulp fermentations across two time points in the harvest season and two fermentation methods. Our results show that the cocoa microbiota consists of a "core'' and a "variable'' part. The bacterial populations show a remarkable consistency, with only two dominant species, Lactobacillus fermentum and Acetobacter pasteurianus. The fungal diversity is much larger, with four dominant species occurring in all fermentations ("core'' yeasts), and a large number of yeasts that only occur in lower numbers and specific fermentations ("variable'' yeasts). Despite this diversity, a clear pattern emerges, with early dominance of apiculate yeasts and late dominance of Saccharomyces cerevisiae. Our results provide new insights into the microbial diversity in Malaysian cocoa pulp fermentations and pave the way for the selection of starter cultures to increase efficiency and consistency.	[Meersman, Esther; Steensels, Jan; Wittocx, Pieter-Jan; Saels, Veerle; Struyf, Nore; Verstrepen, Kevin J.] Katholieke Univ Leuven, Lab Genet & Genom, CMPG, Louvain, Belgium; [Meersman, Esther; Steensels, Jan; Wittocx, Pieter-Jan; Saels, Veerle; Struyf, Nore; Verstrepen, Kevin J.] VIB, Lab Syst Biol, Louvain, Belgium; [Mathawan, Melissa; Bernaert, Herwig; Vrancken, Gino] Barry Callebaut AG, Zurich, Switzerland	KU Leuven; Flanders Institute for Biotechnology (VIB)	Verstrepen, KJ (corresponding author), Katholieke Univ Leuven, Lab Genet & Genom, CMPG, Louvain, Belgium.	kevin.verstrepen@biw.vib-kuleuven.be	Verstrepen, Kevin/AAA-4343-2021	Saels, Veerle/0000-0001-9989-1605; Verstrepen, Kevin/0000-0002-3077-6219	Barry-Callebaut; ERC Starting Grant [241426]; VIB; EMBO; YIP program; FWO; IWT	Barry-Callebaut; ERC Starting Grant(European Research Council (ERC)); VIB; EMBO(European Molecular Biology Organization (EMBO)); YIP program; FWO(FWO); IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	Research in the lab of KJV is supported by Barry-Callebaut, ERC Starting Grant 241426, VIB, EMBO YIP program, FWO, and IWT. Some of the funders (Barry-Callebaut) provided expertise for the setup of cocoa fermentations in Malaysia. They had no role in data collection, data analysis and preparation of the manuscript.	Ardhana MM, 2003, INT J FOOD MICROBIOL, V86, P87, DOI 10.1016/S0168-1605(03)00081-3; Bokulich NA, 2013, APPL ENVIRON MICROB, V79, P2519, DOI 10.1128/AEM.03870-12; Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035507; Cadez N, 2003, INT J SYST EVOL MICR, V53, P1671, DOI 10.1099/ijs.0.02618-0; Cadez N, 2006, INT J SYST EVOL MICR, V56, P1157, DOI 10.1099/ijs.0.64052-0; Camu N, 2008, APPL ENVIRON MICROB, V74, P86, DOI 10.1128/AEM.01512-07; Camu N, 2007, APPL ENVIRON MICROB, V73, P1809, DOI 10.1128/AEM.02189-06; Carr J.G., 1979, COCOA FERMENTATION G; Carr J. G., 1980, COCOA FERMENTATION G; Cocolin L, 2008, MOL TECHNIQUES MICRO; Daniel HM, 2009, FEMS YEAST RES, V9, P774, DOI 10.1111/j.1567-1364.2009.00520.x; Daniel HM, 2003, INT J FOOD MICROBIOL, V86, P61, DOI 10.1016/S0168-1605(03)00248-4; De Vuyst L, 2008, INT J FOOD MICROBIOL, V125, P79, DOI 10.1016/j.ijfoodmicro.2007.02.030; Delmont TO, 2011, APPL ENVIRON MICROB, V77, P1315, DOI 10.1128/AEM.01526-10; Diaz C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/540465; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gevers D, 2001, FEMS MICROBIOL LETT, V205, P31, DOI 10.1016/S0378-1097(01)00439-6; Gonzalez SS, 2007, J APPL MICROBIOL, V102, P1018, DOI 10.1111/j.1365-2672.2006.03150.x; Illeghems K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038040; Jespersen L, 2005, FEMS YEAST RES, V5, P441, DOI 10.1016/j.femsyr.2004.11.002; Juste A, 2008, FOOD MICROBIOL, V25, P745, DOI 10.1016/j.fm.2008.04.009; Kersters K, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P163, DOI 10.1007/0-387-30745-1_9; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; Lan L, 2006, MICROBIOL-SGM, V152, P1539, DOI 10.1099/mic.0.28626-0; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Lefeber T, 2012, FOOD MICROBIOL, V30, P379, DOI 10.1016/j.fm.2011.12.021; Lima LJR, 2011, CRIT REV FOOD SCI, V51, P731, DOI 10.1080/10408391003799913; Lopandic K, 2008, FEMS YEAST RES, V8, P1063, DOI 10.1111/j.1567-1364.2008.00385.x; Lopez SA, 1995, BIOTECHNOLOGY ENZYME, P562; Misnawi J., 2010, COCOA CHEM TECHNOLOG; Nielsen DS, 2007, INT J FOOD MICROBIOL, V114, P168, DOI 10.1016/j.ijfoodmicro.2006.09.010; Nielsen DS, 2005, YEAST, V22, P271, DOI 10.1002/yea.1207; Papalexandratou Z, 2011, APPL ENVIRON MICROB, V77, P7698, DOI 10.1128/AEM.05523-11; Papalexandratou Z, 2011, FEMS YEAST RES, V11, P564, DOI 10.1111/j.1567-1364.2011.00747.x; Papalexandratou Z, 2011, FOOD MICROBIOL, V28, P1326, DOI 10.1016/j.fm.2011.06.003; Papalexandratou Z, 2011, FOOD MICROBIOL, V28, P964, DOI 10.1016/j.fm.2011.01.010; Salminen S., 2004, LACTIC ACID BACTERIA, DOI [10.1201/9780824752033, DOI 10.1201/9780824752033]; Schwan RF, 1998, APPL ENVIRON MICROB, V64, P1477; Schwan RF, 2004, CRIT REV FOOD SCI, V44, P205, DOI 10.1080/10408690490464104; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; Tristezza M, 2012, J IND MICROBIOL BIOT, V39, P81, DOI 10.1007/s10295-011-1002-z; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Nova MXV, 2009, FOOD MICROBIOL, V26, P460, DOI 10.1016/j.fm.2009.02.005; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wu ZW, 2005, J GEN APPL MICROBIOL, V51, P319, DOI 10.2323/jgam.51.319	47	59	59	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81559	10.1371/journal.pone.0081559	http://dx.doi.org/10.1371/journal.pone.0081559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358116	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700012
J	Chacon, B; Ballester, R; Birlanga, V; Rolland-Lagan, AG; Perez, JM				Chacon, Borja; Ballester, Roberto; Birlanga, Virginia; Rolland-Lagan, Anne-Gaelle; Manuel Perez, Jose			A Quantitative Framework for Flower Phenotyping in Cultivated Carnation (Dianthus caryophyllus L.)	PLOS ONE			English	Article							PETAL SHAPE VARIATION; ARABIDOPSIS-THALIANA; GENETIC ARCHITECTURE; PRIMULA-SIEBOLDII; COMPONENT; TRAITS	Most important breeding goals in ornamental crops are plant appearance and flower characteristics where selection is visually performed on direct offspring of crossings. We developed an image analysis toolbox for the acquisition of flower and petal images from cultivated carnation (Dianthus caryophyllus L.) that was validated by a detailed analysis of flower and petal size and shape in 78 commercial cultivars of D. caryophyllus, including 55 standard, 22 spray and 1 pot carnation cultivars. Correlation analyses allowed us to reduce the number of parameters accounting for the observed variation in flower and petal morphology. Convexity was used as a descriptor for the level of serration in flowers and petals. We used a landmark-based approach that allowed us to identify eight main principal components (PCs) accounting for most of the variance observed in petal shape. The effect and the strength of these PCs in standard and spray carnation cultivars are consistent with shared underlying mechanisms involved in the morphological diversification of petals in both subpopulations. Our results also indicate that neighbor-joining trees built with morphological data might infer certain phylogenetic relationships among carnation cultivars. Based on estimated broad-sense heritability values for some flower and petal features, different genetic determinants shall modulate the responses of flower and petal morphology to environmental cues in this species. We believe our image analysis toolbox could allow capturing flower variation in other species of high ornamental value.	[Chacon, Borja; Ballester, Roberto; Birlanga, Virginia; Manuel Perez, Jose] Univ Miguel Hernandez, Inst Bioingn, Elche, Spain; [Rolland-Lagan, Anne-Gaelle] Univ Ottawa, Dept Biol, Ottawa, ON, Canada	Universidad Miguel Hernandez de Elche; University of Ottawa	Perez, JM (corresponding author), Univ Miguel Hernandez, Inst Bioingn, Elche, Spain.	jmperez@umh.es	Perez-Perez, Jose Manuel/B-4247-2011	Perez-Perez, Jose Manuel/0000-0003-2848-4919	Ministerio de Economia y Competitividad (MINECO) of Spain [AGL2012-33610]; FEDER funds (European Union)	Ministerio de Economia y Competitividad (MINECO) of Spain; FEDER funds (European Union)(European Commission)	This work was supported by the Ministerio de Economia y Competitividad (MINECO) of Spain (AGL2012-33610) and by FEDER funds (European Union). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056743; Anastasiou E, 2007, CURR OPIN PLANT BIOL, V10, P63, DOI 10.1016/j.pbi.2006.11.002; Agullo-Anton MA, 2013, PLANT SCI, V201, P1, DOI 10.1016/j.plantsci.2012.11.006; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Juenger T, 2005, EVOL DEV, V7, P259, DOI 10.1111/j.1525-142X.2005.05028.x; KELLER K. R., 1955, AGRON JOUR, V47, P518; Kelly JK, 2011, GENETICS, V189, P1461, DOI 10.1534/genetics.111.132423; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mojica JP, 2010, P ROY SOC B-BIOL SCI, V277, P2945, DOI 10.1098/rspb.2010.0568; Perez-Perez JM, 2002, GENETICS, V162, P893; Roy SJ, 2011, CURR OPIN PLANT BIOL, V14, P232, DOI 10.1016/j.pbi.2011.03.002; Sheela VL, 2008, CARNATION FLOWERS TR, P95; VAINSTEIN A, 1991, EUPHYTICA, V56, P225, DOI 10.1007/BF00042368; Valente LM, 2010, P ROY SOC B-BIOL SCI, V277, P1489, DOI 10.1098/rspb.2009.2163; Weight C, 2008, PLANT J, V53, P578, DOI 10.1111/j.1365-313X.2007.03330.x; Weiss H, 2002, NEW PHYTOL, V156, P85, DOI 10.1046/j.1469-8137.2002.00500.x; Yagi M, 2012, MOL BREEDING, V30, P495, DOI 10.1007/s11032-011-9639-x; Yoshioka Y, 2005, HEREDITY, V94, P657, DOI 10.1038/sj.hdy.6800678; Yoshioka Y, 2004, ANN BOT-LONDON, V94, P657, DOI 10.1093/aob/mch190	20	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82165	10.1371/journal.pone.0082165	http://dx.doi.org/10.1371/journal.pone.0082165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349209	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200028
J	Fillebeen, C; Pantopoulos, K				Fillebeen, Carine; Pantopoulos, Kostas			Hepatitis C Virus Infection Causes Iron Deficiency in Huh7.5.1 Cells	PLOS ONE			English	Article							REGULATORY PROTEIN-1; OXIDATIVE STRESS; TRANSCRIPTION; REPLICATION; INHIBITION; EXPRESSION	Patients with chronic hepatitis C virus (HCV) infection frequently develop systemic iron overload, which exacerbates morbidity. Nevertheless, iron inhibits HCV replication in cell culture models and thereby exerts antiviral activity. We hypothesized that the cellular iron status is crucial for the establishment of HCV infection. We show that HCV infection of permissive Huh7.5.1 hepatoma cells promotes an iron deficient phenotype. Thus, HCV leads to increased iron regulatory protein (IRP) activity, accumulation of IRP2 and suppression of transferrin receptor 1 (TfR1) and divalent metal transporter 1 (DMT1) in the host. These data suggest that HCV regulates cellular iron levels to bypass iron-mediated inhibition in viral replication.	[Fillebeen, Carine; Pantopoulos, Kostas] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Pantopoulos, Kostas] McGill Univ, Dept Med, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University	Pantopoulos, K (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.	kostas.pantopoulos@mcgill.ca	Pantopoulos, Kostas/A-9668-2008	Pantopoulos, Kostas/0000-0002-2305-0057	Natural Sciences and Engineering Research Council of Canada [RGPIN 288283-2011]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN 288283-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fillebeen C, 2005, J BIOL CHEM, V280, P9049, DOI 10.1074/jbc.M412687200; Fillebeen C, 2007, J HEPATOL, V47, P12, DOI 10.1016/j.jhep.2007.01.035; Fillebeen C, 2010, J HEPATOL, V53, P995, DOI 10.1016/j.jhep.2010.04.044; Ganz T, 2012, BBA-MOL CELL RES, V1823, P1434, DOI 10.1016/j.bbamcr.2012.01.014; Girelli D, 2009, J HEPATOL, V51, P845, DOI 10.1016/j.jhep.2009.06.027; Goodnough JB, 2012, HEPATOLOGY, V56, P291, DOI 10.1002/hep.25615; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Liu HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046631; Martin DN, 2013, P NATL ACAD SCI USA, V110, P10777, DOI 10.1073/pnas.1301764110; Miura K, 2008, HEPATOLOGY, V48, P1420, DOI 10.1002/hep.22486; Mueller S, 2002, METHOD ENZYMOL, V348, P324, DOI 10.1016/S0076-6879(02)48651-X; Mueller S, 2010, J HEPATOL; Popovic Z, 2012, METALLOMICS, V4, P693, DOI 10.1039/c2mt20027a; Sebastiani G, 2011, METALLOMICS, V3, P971, DOI 10.1039/c1mt00082a; Wang J, 2005, BIOCHEM J, V392, P383, DOI 10.1042/BJ20050492; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825	16	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83307	10.1371/journal.pone.0083307	http://dx.doi.org/10.1371/journal.pone.0083307			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349485	Green Submitted, Green Published, gold			2022-12-27	WOS:000328734200075
J	Sun, YW; Wang, Z; Ding, WN; Wan, JQ; Zhuang, ZG; Zhang, Y; Liu, YJ; Zhou, Y; Xu, JR				Sun, Yawen; Wang, Zhen; Ding, Weina; Wan, Jieqing; Zhuang, Zhiguo; Zhang, Yong; Liu, Yijun; Zhou, Yan; Xu, Jianrong			Alterations in White Matter Microstructure as Vulnerabilit y Factors and Acquired Signs of Traffic Accident-Induced PTSD	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; ANTERIOR CINGULATE; HIPPOCAMPAL VOLUME; NETWORK CONNECTIVITY; ANXIETY DISORDER; INTEGRITY; BRAIN; TRAUMA; ABNORMALITIES; METAANALYSIS	It remains unclear whether white matter (WM) changes found in post-traumatic stress disorder (PTSD) patients are stress-induced or precursors for vulnerability. The current study aimed to identify susceptibility factors relating to the development of PTSD and to examine the ability of these factors to predict the course of longitudinal PTSD. Sixty two victims who had experienced traffic accidents underwent diffusion tensor imaging using a 3.0T MRI system within 2 days after their accidents. Of these, 21 were diagnosed with PTSD at 1 or 6 months using the Clinician-Administered Ptsd Scale (CAPS). Then, 11 trauma-exposed victims with PTSD underwent the second MRI scan. Compared with the victims without PTSD, the victims with PTSD showed decreased fractional anisotropy (FA) in WM of the anterior cingulate cortex, ventromedial prefrontal cortex (vmPFC), temporal lobes and midbrain, and increased mean diffusivity (MD) in the vmPFC within 2 days after the traumatic event. Importantly, decreased FA of the vmPFC in the acute phase predicted greater future CAPS scores. In addition, we found decreased FA in the insula in the follow-up scan in the victims with PTSD, which correlated with the decreased FA of the vmPFC in their baseline scan. These results suggested that the WM might have changed within 2 days after the traumatic event in the individuals who would later develop PTSD. Furthermore, decreased FA of the vmPFC could be a possible vulnerability marker predicting future development of PTSD and may provide an outcome prediction of the acquired signs.	[Sun, Yawen; Ding, Weina; Zhuang, Zhiguo; Zhou, Yan; Xu, Jianrong] Shanghai Jiao Tong Univ, Dept Radiol, Ren Ji Hosp, Sch Med, Shanghai 200030, Peoples R China; [Wang, Zhen] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China; [Wan, Jieqing] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurosurg, Shanghai 200030, Peoples R China; [Zhang, Yong] GE Healthcare, Appl Sci Lab, Shanghai, Peoples R China; [Liu, Yijun] Univ Florida, Dept Psychiat, Coll Med, Gainesville, FL 32611 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; General Electric; State University System of Florida; University of Florida	Zhou, Y (corresponding author), Shanghai Jiao Tong Univ, Dept Radiol, Ren Ji Hosp, Sch Med, Shanghai 200030, Peoples R China.	clare1475@hotmail.com; xujianr@hotmail.com	Wang, Zhen/A-2389-2011	Wang, Zhen/0000-0003-4319-5314	National Natural Science Foundation of China [81201172]; Pu Jiang talent Project [09PJ408900]; Shanghai Science and Technology Committee Medical guide project [114119a0900]; Shanghai Science and Technology Committee Project [13QA1403200]; Shanghai Leading Academic Discipline Project [S30203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Pu Jiang talent Project; Shanghai Science and Technology Committee Medical guide project; Shanghai Science and Technology Committee Project(Shanghai Science & Technology Committee); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	National Natural Science Foundation of China (81201172), Pu Jiang talent Project (09PJ408900), Shanghai Science and Technology Committee Medical guide project (114119a0900), Shanghai Science and Technology Committee Project (13QA1403200) and the Shanghai Leading Academic Discipline Project (S30203). The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; Admon R, 2013, HUM BRAIN MAPP; Afifi TO, 2010, CLIN PSYCHOL REV, V30, P101, DOI 10.1016/j.cpr.2009.10.002; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Bryant RA, 1998, PSYCHOL ASSESSMENT, V10, P215, DOI 10.1037/1040-3590.10.3.215; Bryant RA, 1998, AM J PSYCHIAT, V155, P625, DOI 10.1176/ajp.155.5.625; Chen L, 2013, HUM BRAIN MAPP, V34, P367, DOI 10.1002/hbm.21438; Chen SL, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-39; Eckart C, 2011, J PSYCHIATR NEUROSCI, V36, P176, DOI 10.1503/jpn.100010; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Hamanaka S, 2006, GEN HOSP PSYCHIAT, V28, P234, DOI 10.1016/j.genhosppsych.2006.02.007; Hedges DW, 2007, NEUROCASE, V13, P402, DOI 10.1080/13554790701851551; Herringa R, 2012, PSYCHIAT RES-NEUROIM, V203, P139, DOI 10.1016/j.pscychresns.2012.02.005; Jackowski AP, 2008, PSYCHIAT RES-NEUROIM, V162, P256, DOI 10.1016/j.pscychresns.2007.08.006; Kasai K, 2008, BIOL PSYCHIAT, V63, P550, DOI 10.1016/j.biopsych.2007.06.022; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Kim SJ, 2006, NEUROPSYCHOBIOLOGY, V54, P120, DOI 10.1159/000098262; Koenigs M, 2009, NEUROSCIENTIST, V15, P540, DOI 10.1177/1073858409333072; Kroes MCW, 2011, EUR PSYCHIAT, V26, P525, DOI 10.1016/j.eurpsy.2011.03.002; Lanius RA, 2010, ACTA PSYCHIAT SCAND, V121, P33, DOI 10.1111/j.1600-0447.2009.01391.x; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Mesulam M-M., 1985, CEREB CORTEX, P179, DOI DOI 10.1007/978-1-4757-9619-3_5; Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438; Mizoguchi K, 2000, J NEUROSCI, V20, P1568; Pacheco J, 2009, J NEUROSCI, V29, P6229, DOI 10.1523/JNEUROSCI.0896-09.2009; Peden M., 2004, WORLD REPORT ROAD TR; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Qin LD, 2012, BRAIN RES, V1484, P50, DOI 10.1016/j.brainres.2012.09.029; Rao HY, 2007, BIOL PSYCHIAT, V62, P600, DOI 10.1016/j.biopsych.2006.11.028; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Sekiguchi A, 2013, MOL PSYCHIATR, V18, P618, DOI 10.1038/mp.2012.51; Shah SG, 2009, J PSYCHIATR NEUROSCI, V34; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shin LM, 2011, AM J PSYCHIAT, V168, P979, DOI 10.1176/appi.ajp.2011.09121812; Song SB, 2012, CEREB CORTEX, V22, P1671, DOI 10.1093/cercor/bhr247; Stefanacci L, 2002, J COMP NEUROL, V451, P301, DOI 10.1002/cne.10339; Stimpson NJ, 2003, BRIT J PSYCHIAT, V182, P391, DOI 10.1192/bjp.182.5.391; Sullivan EV, 2006, NEUROSCI BIOBEHAV R, V30, P749, DOI 10.1016/j.neubiorev.2006.06.002; van Wingen GA, 2012, P NATL ACAD SCI USA, V109, P15508, DOI 10.1073/pnas.1206330109; Villarreal G, 2004, PSYCHIAT RES-NEUROIM, V131, P227, DOI 10.1016/j.pscychresns.2004.05.002; Wang ZW, 2011, DEPRESS ANXIETY, V28, P1067, DOI 10.1002/da.20872; Williams LM, 2006, NEUROIMAGE, V29, P347, DOI 10.1016/j.neuroimage.2005.03.047; Woon FL, 2010, PROG NEURO-PSYCHOPH, V34, P1181, DOI 10.1016/j.pnpbp.2010.06.016; Yasan A, 2009, PSYCHOPATHOLOGY, V42, P236, DOI 10.1159/000218521; Zhang L, 2011, J AFFECT DISORDERS, V133, P294, DOI 10.1016/j.jad.2011.03.040; Zhou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046833	50	25	26	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83473	10.1371/journal.pone.0083473	http://dx.doi.org/10.1371/journal.pone.0083473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349515	gold, Green Published			2022-12-27	WOS:000328734200090
J	Huang, Y; Yu, X; Wang, LY; Zhou, SJ; Sun, J; Feng, N; Nie, S; Wu, JM; Gao, F; Fei, B; Wang, JY; Lin, ZQ; Li, XR; Xu, LT; Gao, X; Ye, M; Duan, SW				Huang, Yi; Yu, Xi; Wang, Lingyan; Zhou, Shengjun; Sun, Jie; Feng, Nan; Nie, Sheng; Wu, Jingmi; Gao, Feng; Fei, Bing; Wang, Jianyong; Lin, Zhiqing; Li, Xianru; Xu, Leiting; Gao, Xiang; Ye, Meng; Duan, Shiwei			Four Genetic Polymorphisms of Lymphotoxin-Alpha Gene and Cancer Risk: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NON-HODGKIN-LYMPHOMA; BREAST-CANCER; FACTOR TNF; COLORECTAL-CANCER; CERVICAL-CANCER; SUSCEPTIBILITY; ASSOCIATION; INFLAMMATION; VARIANTS	Lymphotoxin-alpha (LTA) is a pro-inflammatory cytokine that plays an important role in the inflammatory and immunologic response. Numerous studies have shown LTA polymorphisms as risk factors for cancers, but the results remain inconclusive. The goal of the present meta-analyses is to establish the associations between cancers and four LTA variants (rs1041981, rs2239704, rs2229094 and rs746868). A total of 30 case-control studies involving 58,649 participants were included in the current meta-analyses. Our results showed significant associations with increased cancer risk for rs1041981 (odd ratio (OR) = 1.15, 99% confidential interval (CI) = 1.07-1.25, P < 0.0001, I-2 = 12.2%), rs2239704 (OR = 1.08, 99% CI = 1.01-1.16, P = 0.021, I-2 = 0.0%) and rs2229094 (OR = 1.28, 99% CI = 1.09-1.50, P = 0.003, I-2 = 0.0%). No evidence was found for the association between rs746868 and cancer risk (OR = 1.01, 99% CI = 0.93-1.10, P = 0.771, I-2 = 0.0%). Subgroup meta-analysis suggested that rs2239704 was likely to increase the risk of hematological malignancy (OR = 1.10, 99% CI = 1.01-1.20, P = 0.023, I-2 = 0.0%), and rs2229094 was specific for the increased risk of adenocarcinoma (OR = 1.33, 99% CI = 1.11-1.59, P = 0.002, I-2 = 0.0%). In conclusion, our meta-analyses suggested that the LTA rs1041981, rs2239704 and rs2229094 polymorphisms contributed to the increased risk of cancers. Future functional studies were needed to clarify the mechanistic roles of the three variants in the cancer risk.	[Huang, Yi; Zhou, Shengjun; Sun, Jie; Feng, Nan; Nie, Sheng; Wu, Jingmi; Gao, Feng; Fei, Bing; Wang, Jianyong; Lin, Zhiqing; Li, Xianru; Gao, Xiang] Ningbo First Hosp, Dept Neurosurg, Ningbo, Zhejiang, Peoples R China; [Yu, Xi] Lihuili Hosp, Ningbo Med Ctr, Ningbo, Zhejiang, Peoples R China; [Wang, Lingyan] Ningbo 2 Hosp, Bank Blood Prod, Ningbo, Zhejiang, Peoples R China; [Ye, Meng] Ningbo Univ, Sch Med, Affiliated Hosp, Ningbo 315211, Zhejiang, Peoples R China; [Xu, Leiting; Duan, Shiwei] Ningbo Univ, Sch Med, Zhejiang Prov Key Lab Pathophysiol, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University; Ningbo University	Gao, X (corresponding author), Ningbo First Hosp, Dept Neurosurg, Ningbo, Zhejiang, Peoples R China.	13906629076@139.com; yemeng@nbu.edu.cn; duanshiwei@nbu.edu.cn	FENG, NAN/HGD-3255-2022; Duan, Shiwei/AAA-4782-2022	Duan, Shiwei/0000-0001-7682-2877; Huang, Yi/0000-0003-3598-9747	National Natural Science Foundation of China [31100919]; Natural Science Foundation of Zhejiang Province [LR13H020003]; Medicine and health science and technology projects of Zhejiang province [2010KYB094, 2013KYB233]; K.C. Wong Magna Fund in Ningbo University; Ningbo social development research projects [2011C50028, 2012C50027, 2012C50032]; Scientific Innovation Team Project of Ningbo [2011B82014]; Advanced key Scientific and Technological Programs of Ningbo [2011C51005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Medicine and health science and technology projects of Zhejiang province; K.C. Wong Magna Fund in Ningbo University; Ningbo social development research projects; Scientific Innovation Team Project of Ningbo; Advanced key Scientific and Technological Programs of Ningbo	The research was supported by grants from the National Natural Science Foundation of China (31100919), Natural Science Foundation of Zhejiang Province (LR13H020003), Medicine and health science and technology projects of Zhejiang province(2010KYB094, 2013KYB233), K.C. Wong Magna Fund in Ningbo University, Ningbo social development research projects (2011C50028, 2012C50027, 2012C50032), and Scientific Innovation Team Project of Ningbo (2011B82014), and Advanced key Scientific and Technological Programs of Ningbo (2011C51005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2010, BREAST CANCER RES TR, V120, P727, DOI 10.1007/s10549-009-0489-8; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Aissani B, 2009, JAIDS-J ACQ IMM DEF, V52, P170, DOI 10.1097/QAI.0b013e3181b017d5; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Alexander DD, 2007, INT J CANCER, P1, DOI 10.1002/ijc.22719; Allensworth JL, 2013, BREAST CANCER RES TR, V137, P359, DOI 10.1007/s10549-012-2352-6; Garcia-Gonzalez MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046179; Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Barzan D, 2013, EUR J HUM GENET, V21, P1286, DOI 10.1038/ejhg.2013.38; Belfer I, 2004, GENES IMMUN, V5, P505, DOI 10.1038/sj.gene.6364118; Boraska V, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-69; CARROLL MC, 1987, P NATL ACAD SCI USA, V84, P8535, DOI 10.1073/pnas.84.23.8535; Castro FA, 2009, INT J CANCER, V125, P1851, DOI 10.1002/ijc.24529; Cerhan JR, 2008, CANCER EPIDEM BIOMAR, V17, P3161, DOI 10.1158/1055-9965.EPI-08-0536; Cerhan JR, 2007, BLOOD, V110, P4455, DOI 10.1182/blood-2007-05-088682; Clarke R, 2006, PLOS GENET, V2, P990, DOI 10.1371/journal.pgen.0020107; Clouston D, 2012, BJU INT, V109, P22, DOI 10.1111/j.1464-410X.2012.11040.x; Cope AP, 1998, CURR OPIN IMMUNOL, V10, P669, DOI 10.1016/S0952-7915(98)80087-3; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crusius JBA, 2008, ANN ONCOL, V19, P1894, DOI 10.1093/annonc/mdn400; CUTURI MC, 1987, J EXP MED, V165, P1581, DOI 10.1084/jem.165.6.1581; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ennas MG, 2008, HEMATOL ONCOL, V26, P98, DOI 10.1002/hon.843; Nieves-Ramirez ME, 2011, TRANSL ONCOL, V4, P336, DOI 10.1593/tlo.11226; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Feller L, 2013, ORAL ONCOL, V49, P887, DOI 10.1016/j.oraloncology.2013.07.003; Garcia-Gonzalez MA, 2009, HUM IMMUNOL, V70, P935, DOI 10.1016/j.humimm.2009.07.024; Garcia-Gonzalez MA, 2007, AM J GASTROENTEROL, V102, P1878, DOI 10.1111/j.1572-0241.2007.01423.x; Gaudet MM, 2007, HUM GENET, V121, P483, DOI 10.1007/s00439-006-0315-x; Gunter MJ, 2006, CANCER EPIDEM BIOMAR, V15, P1126, DOI 10.1158/1055-9965.EPI-06-0042; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jacobs EJ, 2008, CANCER EPIDEM BIOMAR, V17, P972, DOI 10.1158/1055-9965.EPI-07-2787; Kimman M, 2012, ASIAN PAC J CANCER P, V13, P411, DOI 10.7314/APJCP.2012.13.2.411; Knight JC, 2004, NAT GENET, V36, P394, DOI 10.1038/ng1331; Lan Q, 2006, BLOOD, V107, P4101, DOI 10.1182/blood-2005-10-4160; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Lee SG, 2004, CYTOKINE, V28, P75, DOI 10.1016/j.cyto.2004.06.009; Liu X, 2006, AM J EPIDEMIOL, V164, P984, DOI 10.1093/aje/kwj294; Liu Y, 2011, TOHOKU J EXP MED, V224, P119, DOI 10.1620/tjem.224.119; Lu RQ, 2012, CANCER EPIDEMIOL, V36, pE380, DOI 10.1016/j.canep.2012.05.014; Madeleine MM, 2011, BREAST CANCER RES TR, V129, P887, DOI 10.1007/s10549-011-1520-4; Mahajan R, 2008, JPN J CLIN ONCOL, V38, P626, DOI 10.1093/jjco/hyn075; MESSER G, 1991, J EXP MED, V173, P209, DOI 10.1084/jem.173.1.209; Morishige T, 2013, CYTOKINE, V61, P578, DOI 10.1016/j.cyto.2012.11.005; Niwa Y, 2005, CANCER LETT, V218, P63, DOI 10.1016/j.canlet.2004.09.021; Niwa Y, 2007, GYNECOL ONCOL, V104, P586, DOI 10.1016/j.ygyno.2006.09.007; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Purdue MP, 2007, CARCINOGENESIS, V28, P704, DOI 10.1093/carcin/bgl200; Purdue MP, 2007, CANCER EPIDEM BIOMAR, V16, P77, DOI 10.1158/1055-9965.EPI-06-0573; Rausch SM, 2012, LUNG CANCER, V77, P217, DOI 10.1016/j.lungcan.2012.02.017; Sainz J, 2012, J CLIN ENDOCR METAB, V97, pE845, DOI 10.1210/jc.2011-2565; Seagroatt V, 1998, BRIT MED J, V316, P470; Shih CM, 2006, LUNG CANCER, V52, P15, DOI 10.1016/j.lungcan.2005.11.011; Skibola CF, 2010, AM J EPIDEMIOL, V171, P267, DOI 10.1093/aje/kwp383; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Takei K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-235; Tan JH, 2011, TISSUE ANTIGENS, V77, P100, DOI 10.1111/j.1399-0039.2010.01582.x; VASSALLI P, 1992, ANNU REV IMMUNOL, V10, P411, DOI 10.1146/annurev.iy.10.040192.002211; Wang KP, 2013, ANN RHEUM DIS, V72, P100, DOI 10.1136/annrheumdis-2012-202201; Wang SS, 2006, CANCER RES, V66, P9771, DOI 10.1158/0008-5472.CAN-06-0324; Wang SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005360; WEINSTEIN IB, 1988, CANCER RES, V48, P4135; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037846; Zhou P, 2012, ASIAN PAC J CANCER P, V13, P1949, DOI 10.7314/APJCP.2012.13.5.1949	65	19	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82519	10.1371/journal.pone.0082519	http://dx.doi.org/10.1371/journal.pone.0082519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349304	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800067
J	Kuhlwilm, M; Davierwala, A; Paabo, S				Kuhlwilm, Martin; Davierwala, Armaity; Paeaebo, Svante			Identification of Putative Target Genes of the Transcription Factor RUNX2	PLOS ONE			English	Article							NF-KAPPA-B; BONE-FORMATION; OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; EXPRESSION; CBFA1; SEQUENCE; GENOME; DEPHOSPHORYLATION; EVOLUTION	Comparisons of the genomes of Neandertals and Denisovans with present-day human genomes have suggested that the gene RUNX2, which encodes a transcription factor, may have been positively selected during early human evolution. Here, we overexpress RUNX2 in ten human cell lines and identify genes that are directly or indirectly affected by RUNX2 expression. We find a number of genes not previously known to be affected by RUNX2 expression, in particular BIRC3, genes encoded on the mitochondrial genome, and several genes involved in bone and tooth formation. These genes are likely to provide inroads into pathways affected by RUNX2 and potentially by the evolutionary changes that affected RUNX2 in modern humans.	[Kuhlwilm, Martin; Davierwala, Armaity; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	Max Planck Society	Paabo, S (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	paabo@eva.mpg.de		Kuhlwilm, Martin/0000-0002-0115-1797	Max Planck Society	Max Planck Society(Max Planck Society)	This study was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Brush MH, 2003, MOL CELL BIOL, V23, P1292, DOI 10.1128/MCB.23.4.1292-1303.2003; Bufalino A, 2012, ORAL DIS, V18, P184, DOI 10.1111/j.1601-0825.2011.01862.x; Bustamante M, 2007, CALCIFIED TISSUE INT, V81, P327, DOI 10.1007/s00223-007-9069-2; Doecke JD, 2006, J BONE MINER RES, V21, P265, DOI 10.1359/JBMR; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Falk D, 2012, P NATL ACAD SCI USA, V109, P8467, DOI 10.1073/pnas.1119752109; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guenebeaud C, 2010, MOL CELL, V40, P863, DOI 10.1016/j.molcel.2010.11.021; Gunz P, 2010, CURR BIOL, V20, pR921, DOI 10.1016/j.cub.2010.10.018; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Hayami T, 2011, MATRIX BIOL, V30, P281, DOI 10.1016/j.matbio.2011.04.003; Hollander MC, 1997, J BIOL CHEM, V272, P13731, DOI 10.1074/jbc.272.21.13731; Jimenez MJG, 1999, MOL CELL BIOL, V19, P4431; KALLIALA E., 1962, ORAL SURG ORAL MED AND ORAL PHATOL, V15, P808, DOI 10.1016/0030-4220(62)90331-6; Kawata K, 2010, J CELL PHYSIOL, V222, P138, DOI 10.1002/jcp.21930; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Krum SA, 2010, NAT REV RHEUMATOL, V6, P607, DOI 10.1038/nrrheum.2010.133; Lee HJ, 2009, CALCIFIED TISSUE INT, V84, P439, DOI 10.1007/s00223-009-9246-6; Lieberman DE, 2002, P NATL ACAD SCI USA, V99, P1134, DOI 10.1073/pnas.022440799; Ma O, 2009, CANCER RES, V69, P2559, DOI 10.1158/0008-5472.CAN-08-2929; Meyer M., 2010, COLD SPRING HARB PRO; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nieminen P, 2011, AM J HUM GENET, V89, P67, DOI 10.1016/j.ajhg.2011.05.024; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pagel JI, 2011, INDIAN J BIOCHEM BIO, V48, P226; Park MH, 2001, J BONE MINER RES, V16, P885, DOI 10.1359/jbmr.2001.16.5.885; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; Prufer K, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-41; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Schlebusch CM, 2012, SCIENCE, V338, P374, DOI 10.1126/science.1227721; Suzuki E, 2007, EXP CELL RES, V313, P3729, DOI 10.1016/j.yexcr.2007.06.015; Tanaka Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026848; Team RC, 2012, R LANG ENV STAT COMP; van der Deen M, 2012, J BIOL CHEM, V287, P4503, DOI 10.1074/jbc.M111.287771; Voisin JL, 2008, J HUM EVOL, V55, P438, DOI 10.1016/j.jhevol.2008.06.001; Xiao ZS, 1998, GENE, V214, P187, DOI 10.1016/S0378-1119(98)00227-3; Zhang SQ, 2009, J BONE MINER RES, V24, P1889, DOI [10.1359/JBMR.090502, 10.1359/jbmr.090502]; Zheng C, 2010, MOL CELL, V38, P101, DOI 10.1016/j.molcel.2010.03.009	44	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83218	10.1371/journal.pone.0083218	http://dx.doi.org/10.1371/journal.pone.0083218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349465				2022-12-27	WOS:000328731800104
J	Bordenave, CD; Escaray, FJ; Menendez, AB; Serna, E; Carrasco, P; Ruiz, OA; Garriz, A				Bordenave, Cesar D.; Escaray, Francisco J.; Menendez, Ana B.; Serna, Eva; Carrasco, Pedro; Ruiz, Oscar A.; Garriz, Andres			Defense Responses in Two Ecotypes of Lotus japonicus against Non-Pathogenic Pseudomonas syringae	PLOS ONE			English	Article							PLANT DEFENSE; SALICYLIC-ACID; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTORS; DISEASE RESISTANCE; PV. TOMATO; NEGATIVE REGULATION; CELL-DEATH; RECEPTOR; PATHOGEN	Lotus japonicus is a model legume broadly used to study many important processes as nitrogen fixing nodule formation and adaptation to salt stress. However, no studies on the defense responses occurring in this species against invading microorganisms have been carried out at the present. Understanding how this model plant protects itself against pathogens will certainly help to develop more tolerant cultivars in economically important Lotus species as well as in other legumes. In order to uncover the most important defense mechanisms activated upon bacterial attack, we explored in this work the main responses occurring in the phenotypically contrasting ecotypes MG-20 and Gifu B-129 of L. japonicus after inoculation with Pseudomonas syringae DC3000 pv. tomato. Our analysis demonstrated that this bacterial strain is unable to cause disease in these accessions, even though the defense mechanisms triggered in these ecotypes might differ. Thus, disease tolerance in MG-20 was characterized by bacterial multiplication, chlorosis and desiccation at the infiltrated tissues. In turn, Gifu B-129 plants did not show any symptom at all and were completely successful in restricting bacterial growth. We performed a microarray based analysis of these responses and determined the regulation of several genes that could play important roles in plant defense. Interestingly, we were also able to identify a set of defense genes with a relative high expression in Gifu B-129 plants under non-stress conditions, what could explain its higher tolerance. The participation of these genes in plant defense is discussed. Our results position the L. japonicus-P. syringae interaction as a interesting model to study defense mechanisms in legume species.	[Bordenave, Cesar D.; Escaray, Francisco J.; Menendez, Ana B.; Ruiz, Oscar A.; Garriz, Andres] Univ Nacl Gen San Martin, Consejo Nacl Invest Cient & Tecn IIB INTECH UNSAM, Inst Tecnol Chascomus, Inst Invest Biotecnol, Chascomus, Argentina; [Serna, Eva] Univ Valencia, Unidad Cent Invest Med INCLIVA, Valencia, Spain; [Carrasco, Pedro] Univ Valencia, Dept Bioquim & Biol Vegetal, Valencia, Spain	University of Valencia; University of Valencia	Garriz, A (corresponding author), Univ Nacl Gen San Martin, Consejo Nacl Invest Cient & Tecn IIB INTECH UNSAM, Inst Tecnol Chascomus, Inst Invest Biotecnol, Chascomus, Argentina.	garriz@intech.gov.ar	Carrasco, Pedro/P-3333-2014; Bordenave, César Daniel/AAB-5407-2021; serna, eva/Z-1433-2019	Carrasco, Pedro/0000-0001-7900-6146; Bordenave, César Daniel/0000-0002-5582-4942; serna, eva/0000-0002-2968-3349; Escaray, Francisco Jose/0000-0001-7413-3541	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PICT 2007-02034]; PTA contract from the Ministry of Science and Innovation of Spain	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT); PTA contract from the Ministry of Science and Innovation of Spain	This work was partly funded by and Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2007-02034, Argentina). ES acknowledges a 2009 PTA contract from the Ministry of Science and Innovation of Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruscato P, 2012, MOL PLANT PATHOL, V13, P828, DOI 10.1111/j.1364-3703.2012.00795.x; Afzal AJ, 2008, MOL PLANT MICROBE IN, V21, P507, DOI 10.1094/MPMI-21-5-0507; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Avila CA, 2013, MOL PLANT MICROBE IN, V26, P977, DOI 10.1094/MPMI-01-13-0031-R; Barah P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058987; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bernoux M, 2011, CURR OPIN PLANT BIOL, V14, P512, DOI 10.1016/j.pbi.2011.05.005; Bhuiyan NH, 2009, PLANT SIGNAL BEHAV, V4, P158, DOI 10.4161/psb.4.2.7688; Bozso Z, 2009, PLANT MOL BIOL, V70, P627, DOI 10.1007/s11103-009-9496-8; Brown RL, 2003, PLANT PHYSIOL, V132, P1020, DOI 10.1104/pp.102.017814; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Chen LT, 2010, CELL HOST MICROBE, V7, P185, DOI 10.1016/j.chom.2010.02.008; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Chen ZX, 2009, PLANT SIGNAL BEHAV, V4, P493, DOI 10.4161/psb.4.6.8392; Clement M, 2011, PLANT PHYSIOL, V156, P1481, DOI 10.1104/pp.111.174425; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Cummins I, 2011, DRUG METAB REV, V43, P266, DOI 10.3109/03602532.2011.552910; de Torres-Zabala M, 2007, EMBO J, V26, P1434, DOI 10.1038/sj.emboj.7601575; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; Du LQ, 2000, PLANT J, V24, P837, DOI 10.1046/j.1365-313x.2000.00923.x; Escaray FJ, 2012, PLANT SCI, V182, P121, DOI 10.1016/j.plantsci.2011.03.016; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Fraser Christopher M, 2011, Arabidopsis Book, V9, pe0152, DOI 10.1199/tab.0152; Fukai E, 2012, PLANT J, V69, P720, DOI 10.1111/j.1365-313X.2011.04826.x; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gondo T, 2007, GENOME, V50, P627, DOI 10.1139/G07-040; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Jelenska J, 2010, P NATL ACAD SCI USA, V107, P13177, DOI 10.1073/pnas.0910943107; Katagiri Fumiaki, 2002, Arabidopsis Book, V1, pe0039, DOI 10.1199/tab.0039; Kesarwani M, 2007, PLANT PHYSIOL, V144, P336, DOI 10.1104/pp.106.095299; Kim HS, 2009, BIOCHEM BIOPH RES CO, V381, P424, DOI 10.1016/j.bbrc.2009.02.050; Kim MG, 2008, MOL CELLS, V25, P323; KING EO, 1954, J LAB CLIN MED, V44, P301; Klessig DF, 2000, P NATL ACAD SCI USA, V97, P8849, DOI 10.1073/pnas.97.16.8849; Knepper C, 2011, PLANT SIGNAL BEHAV, V6, P1114, DOI 10.4161/psb.6.8.15843; Kombrink E, 2012, PLANTA, V236, P1351, DOI 10.1007/s00425-012-1705-z; Lai ZB, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-68; LeClere S, 2002, J BIOL CHEM, V277, P20446, DOI 10.1074/jbc.M111955200; Liu JZ, 2013, PLANT J, V74, P110, DOI 10.1111/tpj.12108; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Lodha TD, 2012, MOL BIOTECHNOL, V50, P87, DOI 10.1007/s12033-011-9418-2; Lohse M, 2010, PLANT PHYSIOL, V153, P642, DOI 10.1104/pp.109.152553; Ma Y, 2012, P NATL ACAD SCI USA, V109, P19852, DOI 10.1073/pnas.1205448109; Moffat CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035995; MUTKA AM, 2013, PLANT J; Nakashima K, 2013, PLANT CELL REP, V32, P959, DOI 10.1007/s00299-013-1418-1; Nanda AK, 2010, J INTEGR PLANT BIOL, V52, P195, DOI 10.1111/j.1744-7909.2010.00933.x; Nawrath C, 2002, PLANT CELL, V14, P275, DOI 10.1105/tpc.010376; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Paolocci F, 2011, J EXP BOT, V62, P1189, DOI 10.1093/jxb/erq344; Perry JA, 2003, PLANT PHYSIOL, V131, P866, DOI 10.1104/pp.102.017384; Postel S, 2009, SEMIN CELL DEV BIOL, V20, P1025, DOI 10.1016/j.semcdb.2009.06.002; Preston GM, 2000, MOL PLANT PATHOL, V1, P263, DOI 10.1046/j.1364-3703.2000.00036.x; Pretty J, 2008, PHILOS T R SOC B, V363, P447, DOI 10.1098/rstb.2007.2163; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Samac DA, 2007, PLANT PHYSIOL, V144, P582, DOI 10.1104/pp.107.096503; Sato S, 2006, CURR OPIN PLANT BIOL, V9, P128, DOI 10.1016/j.pbi.2006.01.008; Shimada N, 2000, PLANT SCI, V160, P37, DOI 10.1016/S0168-9452(00)00355-1; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; SPAEPEN S, 2011, COLD SPRING HARB PER, V3, P84388; Stotz HU, 2011, PLANT CELL PHYSIOL, V52, P1941, DOI 10.1093/pcp/pcr127; Teves SS, 2013, BIOCHEM CELL BIOL, V91, P42, DOI 10.1139/bcb-2012-0075; Thaler JS, 2012, TRENDS PLANT SCI, V17, P260, DOI 10.1016/j.tplants.2012.02.010; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thurow C, 2005, PLANT J, V44, P100, DOI 10.1111/j.1365-313X.2005.02513.x; Udvardi MK, 2005, TRENDS PLANT SCI, V10, P222, DOI 10.1016/j.tplants.2005.03.008; Uppalapati SR, 2009, MOL PLANT MICROBE IN, V22, P7, DOI 10.1094/MPMI-22-1-0007; Urbanski DF, 2013, METHODS MOL BIOL, V1069, P119, DOI 10.1007/978-1-62703-613-9_10; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Vatsa P, 2011, BIOCHIMIE, V93, P2095, DOI 10.1016/j.biochi.2011.04.006; Wasternack C, 2012, PLANT SIGNAL BEHAV, V7, P1349, DOI 10.4161/psb.21551; Wiermer M, 2005, CURR OPIN PLANT BIOL, V8, P383, DOI 10.1016/j.pbi.2005.05.010; Wise RP, 2007, ANNU REV PHYTOPATHOL, V45, P329, DOI 10.1146/annurev.phyto.45.011107.143944; Wu Y, 2012, CELL REPORTS, V1, P639, DOI 10.1016/j.celrep.2012.05.008; Xu ZS, 2011, J INTEGR PLANT BIOL, V53, P570, DOI 10.1111/j.1744-7909.2011.01062.x; Zabala G, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-26; Zander M, 2012, MOL PLANT, V5, P831, DOI 10.1093/mp/ssr113; Zhang YL, 2006, PLANT J, V48, P647, DOI 10.1111/j.1365-313X.2006.02903.x; Zhang ZQ, 2007, PLANT PHYSIOL, V145, P450, DOI 10.1104/pp.107.106021; Zhu HY, 2005, PLANT PHYSIOL, V137, P1189, DOI 10.1104/pp.104.058891; Zou JJ, 2005, MOL PLANT MICROBE IN, V18, P1161, DOI 10.1094/MPMI-18-1161	87	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83199	10.1371/journal.pone.0083199	http://dx.doi.org/10.1371/journal.pone.0083199			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349460	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300138
J	Di Penta, A; Chiba, A; Alloza, I; Wyssenbach, A; Yamamura, T; Villoslada, P; Miyake, S; Vandenbroeck, K				Di Penta, Alessandra; Chiba, Asako; Alloza, Iraide; Wyssenbach, Ane; Yamamura, Takashi; Villoslada, Pablo; Miyake, Sachiko; Vandenbroeck, Koen			A Trifluoromethyl Analogue of Celecoxib Exerts Beneficial Effects in Neuroinflammation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; NECROSIS-FACTOR-ALPHA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MULTIPLE-SCLEROSIS; INTRACELLULAR CALCIUM; GLUTAMATE RELEASE; FACTOR TNF; IFN-GAMMA; PROTEIN	Celecoxib is a selective cyclooxygenase-2 (COX2) inhibitor. We have previously shown that celecoxib inhibits experimental autoimmune encephalomyelitis (EAE) in COX-2-deficient mice, suggestive for a mode of action involving COX2-independent pathways. In the present study, we tested the effect of a trifluoromethyl analogue of celecoxib (TFM-C) with 205-fold lower COX-2 inhibitory activity in two models of neuroinflammation, i.e. cerebellar organotypic cultures challenged with LPS and the EAE mouse model for multiple sclerosis. TFM-C inhibited secretion of IL-1 beta, IL-12 and IL-17, enhanced that of TNF-alpha and RANTES, reduced neuronal axonal damage and protected from oxidative stress in the organotypic model. TFM-C blocked TNF-alpha release in microglial cells through a process involving intracellular retention, but induced TNF-alpha secretion in primary astrocyte cultures. Finally, we demonstrate that TFM-C and celecoxib ameliorated EAE with equal potency. This coincided with reduced secretion of IL-17 and IFN-Y by MOG-reactive T-cells and of IL-23 and inflammatory cytokines by bone marrow-derived dendritic cells. Our study reveals that non-coxib analogues of celecoxib may have translational value in the treatment of neuroinflammatory conditions.	[Di Penta, Alessandra; Alloza, Iraide; Vandenbroeck, Koen] Univ Basque Country UPV EHU, Neurogen Lab, Zamudio, Spain; [Di Penta, Alessandra; Alloza, Iraide; Vandenbroeck, Koen] Achucarro Basque Ctr Neurosci, Zamudio, Spain; [Chiba, Asako; Yamamura, Takashi; Miyake, Sachiko] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Immunol, Tokyo, Japan; [Chiba, Asako; Miyake, Sachiko] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan; [Alloza, Iraide; Vandenbroeck, Koen] Basque Fdn Sci, IKERBASQUE, Bilbao, Spain; [Wyssenbach, Ane] Univ Basque Country UPV EHU, Neurotek Lab, Zamudio, Spain; [Villoslada, Pablo] Hosp Clin Barcelona, Inst Biomed Res August Pi Sunyer IDIBAPS, Ctr Neuroimmunol, Barcelona, Spain	University of Basque Country; National Center for Neurology & Psychiatry - Japan; Juntendo University; Basque Foundation for Science; University of Basque Country; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Vandenbroeck, K (corresponding author), Univ Basque Country UPV EHU, Neurogen Lab, Zamudio, Spain.	k.vandenbroeck@ikerbasque.org	Vandenbroeck, Koen/D-6845-2012; Villoslada, Pablo/O-1757-2019; Villoslada, Pablo/AAF-9547-2019	Vandenbroeck, Koen/0000-0002-6967-6485; Villoslada, Pablo/0000-0002-8735-6119; Alloza, Iraide/0000-0002-8949-7732	Grant Grupos de Investigacion (UPV/EHU) [IT512-10]; Ministerio de Ciencia e Inovacion (MICINN, Madrid, Spain) [SAF2008-00433, SAF2012-32118]; Gobierno Vasco's SAIOTEK Program ['ERtek' S-PE09UN33]; Instituto de Salud Carlos III: FIS [PI041445]; Juan de la Cierva program of the Ministerio de Ciencia y Innovacion (MICINN) [JCI-2009-04462]	Grant Grupos de Investigacion (UPV/EHU); Ministerio de Ciencia e Inovacion (MICINN, Madrid, Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Gobierno Vasco's SAIOTEK Program; Instituto de Salud Carlos III: FIS(Instituto de Salud Carlos IIIEuropean Commission); Juan de la Cierva program of the Ministerio de Ciencia y Innovacion (MICINN)	This study was supported by Grant Grupos de Investigacion (UPV/EHU; ref. IT512-10) to KV; Ministerio de Ciencia e Inovacion (MICINN, Madrid, Spain; ref. SAF2008-00433 and SAF2012-32118) and by the Gobierno Vasco's SAIOTEK Program (ref. 'ERtek' S-PE09UN33) to KV; Instituto de Salud Carlos III: FIS PI041445 (MIOTRED) to PV; Juan de la Cierva program of the Ministerio de Ciencia y Innovacion (MICINN, ref. JCI-2009-04462) to AdP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; Alloza I, 2006, MOL PHARMACOL, V69, P1579, DOI 10.1124/mol.105.020669; BAKER D, 1994, EUR J IMMUNOL, V24, P2040, DOI 10.1002/eji.1830240916; Barnes DA, 1996, J NEUROIMMUNOL, V71, P207, DOI 10.1016/S0165-5728(96)00154-3; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BRETT FM, 1995, J NEUROPATH EXP NEUR, V54, P766, DOI 10.1097/00005072-199511000-00003; Buerkle MA, 2004, CIRCULATION, V110, P2053, DOI 10.1161/01.CIR.0000143234.51796.A9; Caminero A, 2011, J NEUROIMMUNOL, V234, P1, DOI 10.1016/j.jneuroim.2011.03.004; CANNELLA B, 1995, ANN NEUROL, V37, P424, DOI 10.1002/ana.410370404; Castro-Borrero W, 2012, THER ADV NEUROL DISO, V5, P205, DOI 10.1177/1756285612450936; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; Chiba A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3683; CHUNG IY, 1990, J IMMUNOL, V144, P2999; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Conti P, 1998, FASEB J, V12, P1693, DOI 10.1096/fasebj.12.15.1693; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; Das AM, 1999, CLIN EXP IMMUNOL, V117, P223, DOI 10.1046/j.1365-2249.1999.00978.x; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; DeWitt DL, 1999, MOL PHARMACOL, V55, P625; di Penta A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054722; Dusart I, 1997, J NEUROSCI, V17, P3710; Eugster HP, 1998, EUR J IMMUNOL, V28, P2178, DOI 10.1002/(SICI)1521-4141(199807)28:07<2178::AID-IMMU2178>3.0.CO;2-D; Fan LW, 2008, EUR J NEUROSCI, V27, P1475, DOI 10.1111/j.1460-9568.2008.06121.x; Feng GS, 2008, WORLD J GASTROENTERO, V14, P4535, DOI 10.3748/wjg.14.4535; Grell M, 1998, P NATL ACAD SCI USA, V95, P570, DOI 10.1073/pnas.95.2.570; Grosch S, 2001, FASEB J, V15, P2742, DOI 10.1096/fj.01-0299fje; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Haag MDM, 2008, ARCH INTERN MED, V168, P1219, DOI 10.1001/archinte.168.11.1219; Hoffmann A, 2003, J NEUROSCI, V23, P4410; HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607; Innocenti B, 2000, J NEUROSCI, V20, P1800; Johnson AJ, 2002, BIOCHEM J, V366, P831, DOI 10.1042/BJ20020279; Kardosh A, 2008, CANCER RES, V68, P843, DOI 10.1158/0008-5472.CAN-07-5555; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Kim JY, 2010, NAT NEUROSCI, V13, P180, DOI 10.1038/nn.2471; Kulp SK, 2004, CANCER RES, V64, P1444, DOI 10.1158/0008-5472.CAN-03-2396; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; McLaughlin M, 2011, BRIT J PHARMACOL, V162, P328, DOI 10.1111/j.1476-5381.2010.01064.x; McLaughlin M, 2010, J BIOL CHEM, V285, P6960, DOI 10.1074/jbc.M109.056614; MEURER R, 1993, J EXP MED, V178, P1913, DOI 10.1084/jem.178.6.1913; Miyamoto K, 2006, BRAIN, V129, P1984, DOI 10.1093/brain/awl170; Newman EA, 1997, SCIENCE, V275, P844, DOI 10.1126/science.275.5301.844; Ni J, 2007, J NEUROIMMUNOL, V186, P94, DOI 10.1016/j.jneuroim.2007.03.012; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pasti L, 1997, J NEUROSCI, V17, P7817; Pidgeon GP, 2004, CIRCULATION, V110, P2701, DOI 10.1161/01.CIR.0000145613.01188.0B; PROBERT L, 1995, P NATL ACAD SCI USA, V92, P11294, DOI 10.1073/pnas.92.24.11294; Ray WA, 2009, CIRC-CARDIOVASC QUAL, V2, P155, DOI 10.1161/CIRCOUTCOMES.108.805689; REDER AT, 1994, J NEUROIMMUNOL, V54, P117, DOI 10.1016/0165-5728(94)90238-0; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; SELMAJ K, 1991, ANN NEUROL, V30, P694, DOI 10.1002/ana.410300510; SHARIEF MK, 1991, NEW ENGL J MED, V325, P467, DOI 10.1056/NEJM199108153250704; Sherwin C, 2005, J IMMUNOL, V175, P155, DOI 10.4049/jimmunol.175.1.155; Shi SJ, 2008, EUR J CLIN PHARMACOL, V64, P233, DOI 10.1007/s00228-007-0400-7; Solomon SD, 2008, CIRCULATION, V117, P2104, DOI 10.1161/CIRCULATIONAHA.108.764530; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Suvannavejh GC, 2000, CELL IMMUNOL, V205, P24, DOI 10.1006/cimm.2000.1706; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Vandenbroeck K, 2006, CYTOKINE, V33, P264, DOI 10.1016/j.cyto.2006.02.004; Vandenbroeck K, 2002, J BIOL CHEM, V277, P25668, DOI 10.1074/jbc.M202984200; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weber C, 2001, BLOOD, V97, P1144, DOI 10.1182/blood.V97.4.1144; Wheeler MC, 2008, J IMMUNOL, V181, P256, DOI 10.4049/jimmunol.181.1.256; WOODROOFE MN, 1993, CYTOKINE, V5, P583, DOI 10.1016/S1043-4666(05)80008-0; Yang LB, 2002, J NEUROSCI, V22, P3025, DOI 10.1523/JNEUROSCI.22-08-03025.2002	72	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83119	10.1371/journal.pone.0083119	http://dx.doi.org/10.1371/journal.pone.0083119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349442	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300134
J	Ratzinger, F; Schuardt, M; Eichbichler, K; Tsirkinidou, I; Bauer, M; Haslacher, H; Mitteregger, D; Binder, M; Burgmann, H				Ratzinger, Franz; Schuardt, Michael; Eichbichler, Katherina; Tsirkinidou, Irene; Bauer, Marlene; Haslacher, Helmuth; Mitteregger, Dieter; Binder, Michael; Burgmann, Heinz			Utility of Sepsis Biomarkers and the Infection Probability Score to Discriminate Sepsis and Systemic Inflammatory Response Syndrome in Standard Care Patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; COAGULASE-NEGATIVE STAPHYLOCOCCI; CRITICALLY-ILL PATIENTS; DIAGNOSTIC MARKER; EMERGENCY-ROOM; BLOOD CULTURES; ORGAN FAILURE; PROCALCITONIN; BACTEREMIA; CONTAMINATION	Physicians are regularly faced with severely ill patients at risk of developing infections. In literature, standard care wards are often neglected, although their patients frequently suffer from a systemic inflammatory response syndrome (SIRS) of unknown origin. Fast identification of patients with infections is vital, as they immediately require appropriate therapy. Further, tools with a high negative predictive value (NPV) to exclude infection or bacteremia are important to increase the cost effectiveness of microbiological examinations and to avoid inappropriate antibiotic treatment. In this prospective cohort study, 2,384 patients with suspected infections were screened for suffering from two or more SIRS criteria on standard care wards. The infection probability score (IPS) and sepsis biomarkers with discriminatory power were assessed regarding their capacity to identify infection or bacteremia. In this cohort finally consisting of 298 SIRS-patients, the infection prevalence was 72%. Bacteremia was found in 25% of cases. For the prediction of infection, the IPS yielded 0.51 ROC-AUC (30.1% sensitivity, 64.6% specificity). Among sepsis biomarkers, lipopolysaccharide binding protein (LBP) was the best parameter with 0.63 ROC-AUC (57.5% sensitivity, 67.1% specificity). For the prediction of bacteremia, the IPS performed slightly better with a ROC-AUC of 0.58 (21.3% sensitivity, 65% specificity). Procalcitonin was the best discriminator with 0.78 ROC-AUC, 86.3% sensitivity, 59.6% specificity and 92.9% NPV. Furthermore, bilirubin and LBP (ROC-AUC: 0.65, 0.62) might also be considered as useful parameters. In summary, the IPS and widely used infection parameters, including CRP or WBC, yielded a poor diagnostic performance for the detection of infection or bacteremia. Additional sepsis biomarkers do not aid in discriminating inflammation from infection. For the prediction of bacteremia procalcitonin, and bilirubin were the most promising parameters, which might be used as a rule for when to take blood cultures or using nucleic acid amplification tests for microbiological diagnostics.	[Burgmann, Heinz] Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria; [Ratzinger, Franz; Haslacher, Helmuth] Med Univ Vienna, Dept Lab Med, Div Med & Chem Lab Diagnost, Vienna, Austria; [Schuardt, Michael; Eichbichler, Katherina; Tsirkinidou, Irene; Bauer, Marlene; Burgmann, Heinz] Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria; [Mitteregger, Dieter] Med Univ Vienna, Dept Lab Med, Div Clin Microbiol, Vienna, Austria; [Binder, Michael] Med Univ Vienna, Dept Dermatol, Div Gen Dermatol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Burgmann, H (corresponding author), Med Univ Vienna, Dept Med 1, Div Infect Dis & Trop Med, Vienna, Austria.	heinz.burgmann@meduniwien.ac.at	Haslacher, Helmuth/D-4233-2013	Haslacher, Helmuth/0000-0003-4605-2503; Burgmann, Heinz/0000-0002-2114-0999; Ratzinger, Franz/0000-0002-1910-1018	Austrian Sepsis Society	Austrian Sepsis Society	This work received support from the Austrian Sepsis Society http://www.sepsis-gesellschaft.eu/en/information/oesterrsepsis-gesellschaft.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahmadi YM, 2011, J HOSP INFECT, V77, P233, DOI 10.1016/j.jhin.2010.09.033; Apostolopoulou E, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-135; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bota DP, 2003, CRIT CARE MED, V31, P2579, DOI 10.1097/01.CCM.0000094223.92746.56; Byvatov Evgeny, 2003, Appl Bioinformatics, V2, P67; Castelli GP, 2004, CRIT CARE, V8, pR234, DOI 10.1186/cc2877; Chirouze C, 2002, CLIN INFECT DIS, V35, P156, DOI 10.1086/341023; Cicarelli DD, 2009, SAO PAULO MED J, V127, P350, DOI 10.1590/S1516-31802009000600006; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; Dreiseitl S, 2002, J BIOMED INFORM, V35, P352, DOI 10.1016/S1532-0464(03)00034-0; Durila M, 2012, BMC ANESTHESIOL, V12, DOI 10.1186/1471-2253-12-12; ECDC. protocol for point prevalence surveys, 2012, PPS PROT COD V4 3 IN; FRANSON TR, 1985, REV INFECT DIS, V7, P1; Freund Y, 2012, BIOMARKERS, V17, P590, DOI 10.3109/1354750X.2012.704645; Gaini S, 2006, CRIT CARE, V10, DOI 10.1186/cc4866; Gander RM, 2009, J CLIN MICROBIOL, V47, P1021, DOI 10.1128/JCM.02162-08; Garcia P, 2004, J MED MICROBIOL, V53, P67, DOI 10.1099/jmm.0.04994-0; Gibot S, 2012, AM J RESP CRIT CARE, V186, P65, DOI 10.1164/rccm.201201-0037OC; Gille-Johnson P, 2012, SCAND J INFECT DIS, V44, P745, DOI 10.3109/00365548.2012.689846; Gustot T, 2011, CURR OPIN CRIT CARE, V17, P153, DOI 10.1097/MCC.0b013e328344b446; Hamblin S, 2012, J TRAUMA ACUTE CARE, V73, P1484, DOI 10.1097/TA.0b013e318267cd80; Harbarth S, 2001, AM J RESP CRIT CARE, V164, P396, DOI 10.1164/ajrccm.164.3.2009052; Jeong S, 2012, CLIN CHIM ACTA, V413, P1731, DOI 10.1016/j.cca.2012.06.030; Kofoed K, 2007, CRIT CARE, V11, DOI 10.1186/cc5723; Kosters A, 2010, SEMIN LIVER DIS, V30, P186, DOI 10.1055/s-0030-1253227; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lichtenstern C, 2012, CURR OPIN INFECT DIS, V25, P328, DOI 10.1097/QCO.0b013e3283522038; Luzzani A, 2003, CRIT CARE MED, V31, P1737, DOI 10.1097/01.CCM.0000063440.19188.ED; Martini A, 2008, J INFECTION, V56, P313, DOI 10.1016/j.jinf.2008.02.015; Mitteregger D, 2013, J CLIN MICROBIOL, V51, P1534, DOI 10.1128/JCM.00103-13; MOTULSKY HJ, 1987, FASEB J, V1, P365, DOI 10.1096/fasebj.1.5.3315805; Musher DM, 2000, MEDICINE, V79, P210, DOI 10.1097/00005792-200007000-00002; Nierhaus A, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-8; OSLER W, 1901, PRINCIPLES PRACTICE; Pierrakos C., 2010, CRITICAL CARE, V14; Poeze M, 2004, CRIT CARE, V8, pR409, DOI 10.1186/cc2959; Ratzinger F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049658; Riedel S, 2011, AM J CLIN PATHOL, V135, P182, DOI 10.1309/AJCP1MFYINQLECV2; Roque P, 2012, AM J EMERG MED, V30, P110, DOI 10.1016/j.ajem.2010.10.022; Ryan T, 1997, CRIT CARE MED, V25, P2009, DOI 10.1097/00003246-199712000-00018; Schumann RR, 1999, CLIN CHEM LAB MED, V37, P271, DOI 10.1515/CCLM.1999.047; Self WH, 2013, ACAD EMERG MED, V20, P89, DOI 10.1111/acem.12057; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Standiford HC, 2012, INFECT CONT HOSP EP, V33, P338, DOI 10.1086/664909; Szabo G, 2002, CLIN LIVER DIS, V6; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Tromp M, 2012, J INFECTION, V65, P292, DOI 10.1016/j.jinf.2012.06.004; Uusitalo-Seppala R, 2011, SCAND J INFECT DIS, V43, P883, DOI 10.3109/00365548.2011.600325; Van Hal SJ, 2008, SCAND J INFECT DIS, V40, P551, DOI 10.1080/00365540701877304; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Zwang O, 2006, J HOSP MED, V1, P272, DOI 10.1002/jhm.115	52	39	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82946	10.1371/journal.pone.0082946	http://dx.doi.org/10.1371/journal.pone.0082946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349403	gold, Green Submitted, Green Published			2022-12-27	WOS:000328730300115
J	Elmholdt, TR; Olesen, ABB; Jorgensen, B; Kvist, S; Skov, L; Thomsen, HS; Marckmann, P; Pedersen, M				Elmholdt, Tina R.; Olesen, Anne B. B.; Jorgensen, Bettina; Kvist, Stinne; Skov, Lone; Thomsen, Henrik S.; Marckmann, Peter; Pedersen, Michael			Nephrogenic Systemic Fibrosis in Denmark - A Nationwide Investigation	PLOS ONE			English	Article							GADOLINIUM EXPOSURE; KIDNEY-DISEASE; RENAL-FAILURE; DERMOPATHY; GADODIAMIDE; DIALYSIS; SKIN; MANIFESTATIONS; INVOLVEMENT; DEPOSITION	Background: Nephrogenic systemic fibrosis is a debilitating and painful disorder with an increased stimulation of the connective tissue in the skin and systemic tissues. The disease is associated with exposure to gadolinium-based contrast agent used in magnetic resonance imaging in patients with renal impairment. Methods: The prevalence of nephrogenic systemic fibrosis has so far never been determined at a national level. In 2009, Denmark was the first country to design a guideline for the tracing of nephrogenic systemic fibrosis patients. The aim of this paper is to communicate the main findings of this quest. Results: The outcome of the nationwide investigation revealed that Denmark had 65 patients with nephrogenic systemic fibrosis and thereby the highest prevalence of nephrogenic systemic fibrosis worldwide with 65 per 5.6 million inhabitants, or 12 per million. Conclusions: The nationwide investigation in Denmark revealed the highest prevalence of NSF worldwide. This may be rooted in a high level of awareness of NSF both among doctors, politicians and, not least, the media, combined with the fact that a nationwide NSF investigation was initiated.	[Elmholdt, Tina R.; Pedersen, Michael] Aarhus Univ, Inst Clin Med, Aarhus Univ Hosp, Aarhus, Denmark; [Elmholdt, Tina R.; Olesen, Anne B. B.] Aarhus Univ Hosp, Dept Dermatol, DK-8000 Aarhus, Denmark; [Jorgensen, Bettina; Kvist, Stinne] Aarhus Univ Hosp, Dept Nephrol, DK-8000 Aarhus, Denmark; [Skov, Lone] Copenhagen Univ Hosp, Dept Dermatoallergol, Gentofte, Denmark; [Thomsen, Henrik S.] Copenhagen Univ Hosp, Dept Diagnost Radiol, Herlev, Denmark; [Marckmann, Peter] Copenhagen Univ Hosp, Dept Internal Med, Roskilde, Denmark; [Marckmann, Peter] Odense Univ Hosp, Dept Nephrol, DK-5000 Odense, Denmark; [Pedersen, Michael] Aarhus Univ, MR Res Ctr, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; Aarhus University	Elmholdt, TR (corresponding author), Aarhus Univ, Inst Clin Med, Aarhus Univ Hosp, Aarhus, Denmark.	tina.elmholdt@mr.au.dk	Skov, Lone/W-3575-2018	Skov, Lone/0000-0002-4784-9680				Abujudeh HH, 2009, RADIOLOGY, V253, P81, DOI 10.1148/radiol.2531082160; Alhadad A, 2012, SCAND J UROL NEPHROL, V46, P48, DOI 10.3109/00365599.2011.621142; Bangsgaard N, 2009, ARCH DERMATOL, V145, P183, DOI 10.1001/archdermatol.2008.551; Bennett CL, 2012, J GEN INTERN MED, V27, P1697, DOI 10.1007/s11606-012-2098-1; Bernstein EJ, 2012, BEST PRACT RES CL RH, V26, P489, DOI 10.1016/j.berh.2012.07.008; Canavese C, 2008, J NEPHROL, V21, P324; Collidge TA, 2007, RADIOLOGY, V245, P168, DOI 10.1148/radiol.2451070353; Cowper SE, 2001, AM J DERMATOPATH, V23, P383, DOI 10.1097/00000372-200110000-00001; Cowper SE, 2000, LANCET, V356, P1000, DOI 10.1016/S0140-6736(00)02694-5; Cowper SE, 2008, EUR J RADIOL, V66, P191, DOI 10.1016/j.ejrad.2008.01.016; Elmholdt TR, 2011, BRIT J DERMATOL, V165, P828, DOI 10.1111/j.1365-2133.2011.10465.x; From the Centers for Disease Control and Prevention, 1997, JAMA, V287, P838; Furst DE, 1998, J RHEUMATOL, V25, P84; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1104, DOI 10.1093/ndt/gfk062; Hope TA, 2009, INVEST RADIOL, V44, P135, DOI 10.1097/RLI.0b013e31819343ba; Hoppe H, 2010, EUR RADIOL, V20, P595, DOI 10.1007/s00330-009-1586-0; Kay J, 2008, NEW ENGL J MED, V358, P827, DOI 10.1056/NEJMcpc0708697; Kendrick-Jones JC, 2011, NEPHROLOGY, V16, P243, DOI 10.1111/j.1440-1797.2010.01397.x; Lee CU, 2009, ARCH DERMATOL, V145, P1095, DOI 10.1001/archdermatol.2009.232; Levine JM, 2004, MUSCLE NERVE, V30, P569, DOI 10.1002/mus.20153; Marckmann P, 2008, CLIN NEPHROL, V69, P161; Marckmann P, 2006, J AM SOC NEPHROL, V17, P2359, DOI 10.1681/ASN.2006060601; Marckmann P, 2009, RADIOL CLIN N AM, V47, P833, DOI 10.1016/j.rcl.2009.05.004; Matthesen Solveig Klok, 2008, Ugeskr Laeger, V170, P655; Mendoza FA, 2006, SEMIN ARTHRITIS RHEU, V35, P238, DOI 10.1016/j.semarthrit.2005.08.002; Perez-Rodriguez J, 2009, RADIOLOGY, V250, P371, DOI 10.1148/radiol.2502080498; Rydahl C, 2008, INVEST RADIOL, V43, P141, DOI 10.1097/RLI.0b013e31815a3407; Sanyal S, 2011, NEPHROL DIAL TRANSPL, V26, P3616, DOI 10.1093/ndt/gfr085; Shabana WM, 2008, AM J ROENTGENOL, V190, P736, DOI 10.2214/AJR.07.3115; Swaminathan S, 2008, KIDNEY INT, V73, P1413, DOI 10.1038/ki.2008.76; Ting WW, 2003, ARCH DERMATOL, V139, P903, DOI 10.1001/archderm.139.7.903; Todd DJ, 2007, ARTHRITIS RHEUM, V56, P3433, DOI 10.1002/art.22925	32	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82037	10.1371/journal.pone.0082037	http://dx.doi.org/10.1371/journal.pone.0082037			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349178	gold, Green Submitted, Green Published			2022-12-27	WOS:000328705200060
J	Huang, KH; Kuo, KL; Ho, IL; Chang, HC; Chuang, YT; Lin, WC; Lee, PY; Chang, SC; Chiang, CK; Pu, YS; Chou, CT; Hsu, CH; Liu, SH				Huang, Kuo-How; Kuo, Kuan-Lin; Ho, I-Lin; Chang, Hong-Chiang; Chuang, Yuan-Ting; Lin, Wei-Chou; Lee, Ping-Yi; Chang, Shih-Chen; Chiang, Chih-Kang; Pu, Yeong-Shiau; Chou, Chien-Tso; Hsu, Chen-Hsun; Liu, Shing-Hwa			Celecoxib-Induced Cytotoxic Effect Is Potentiated by Inhibition of Autophagy in Human Urothelial Carcinoma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; BLADDER-CANCER; CYCLOOXYGENASE-2 INHIBITORS; INDUCED APOPTOSIS; IN-VITRO; CISPLATIN; GROWTH; METHOTREXATE; GEMCITABINE; VINBLASTINE	Celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, can elicit anti-tumor effects in various malignancies. Here, we sought to clarify the role of autophagy in celecoxib-induced cytotoxicity in human urothelial carcinoma (UC) cells. The results shows celecoxib induced cellular stress response such as endoplasmic reticulum (ER) stress, phosopho-SAPK/JNK, and phosopho-c-Jun as well as autophagosome formation in UC cells. Inhibition of autophagy by 3-methyladenine (3-MA), bafilomycin A1 or ATG7 knockdown potentiated celecoxib-induced apoptosis. Up-regulation of autophagy by rapamycin or GFP-LC3B-transfection alleviated celecoxib-induced cytotoxicity in UC cells. Taken together, the inhibition of autophagy enhances therapeutic efficacy of celecoxib in UC cells, suggesting a novel therapeutic strategy against UC.	[Huang, Kuo-How; Liu, Shing-Hwa] Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei 10764, Taiwan; [Huang, Kuo-How; Kuo, Kuan-Lin; Ho, I-Lin; Chang, Hong-Chiang; Chuang, Yuan-Ting; Lee, Ping-Yi; Chang, Shih-Chen; Pu, Yeong-Shiau; Chou, Chien-Tso; Hsu, Chen-Hsun] Natl Taiwan Univ Hosp, Dept Urol, Taipei, Taiwan; [Lin, Wei-Chou] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Chiang, Chih-Kang] Natl Taiwan Univ Hosp, Dept Integrated Diagnost & Therapeut, Taipei, Taiwan; [Chang, Shih-Chen] Natl Taiwan Univ, Dept Chem Engn, Coll Engn, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Huang, KH (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Toxicol, Taipei 10764, Taiwan.	kuohowhuang@gmail.com; shinghwaliu@ntu.edu.tw		Kuo, Kuan-Lin/0000-0001-7204-3032; CHIANG, CHIH-KANG/0000-0001-9021-4616; LIU, SHING-HWA/0000-0002-9976-1197; LIN, WEI-CHOU/0000-0003-2857-3479; Huang, Kuo-How/0000-0002-0989-0578; CHANG, HONG-CHIANG/0000-0001-5411-6680; Ho, I-Lin/0000-0002-8914-710X; PU, YEONG-SHIAU/0000-0002-2859-3966	Taiwan National Science Council [NSC 98-2314-B-002-056, 101-2314-B-002-025-]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from Taiwan National Science Council (NSC 98-2314-B-002-056 and 101-2314-B-002-025-). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; BUBENIK J, 1973, INT J CANCER, V11, P765, DOI 10.1002/ijc.2910110327; Cheng JH, 2011, EUR J MED CHEM, V46, P1222, DOI 10.1016/j.ejmech.2011.01.043; Cohen MH, 2001, J CLIN ONCOL, V19, P1229, DOI 10.1200/JCO.2001.19.4.1229; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; Davies NM, 2000, CLIN PHARMACOKINET, V38, P225, DOI 10.2165/00003088-200038030-00003; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Dhawan D, 2008, MOL CANCER THER, V7, P897, DOI 10.1158/1535-7163.MCT-07-0313; Dovedi SJ, 2005, J UROLOGY, V174, P332, DOI 10.1097/01.ju.0000161589.85869.ae; Gao M, 2008, CANCER RES, V68, P9348, DOI 10.1158/0008-5472.CAN-08-1642; Gee J, 2006, ONCOL REP, V15, P471; Grubbs CJ, 2000, CANCER RES, V60, P5599; Han C, 2004, CANCER RES, V64, P1369, DOI 10.1158/0008-5472.CAN-03-1086; Hanada T, 2005, AUTOPHAGY, V1, P110, DOI 10.4161/auto.1.2.1858; HARKER WG, 1985, J CLIN ONCOL, V3, P1463, DOI 10.1200/JCO.1985.3.11.1463; Hour TC, 2000, ANTICANCER RES, V20, P3221; Hour TC, 2010, BIOCHEM PHARMACOL, V80, P325, DOI 10.1016/j.bcp.2010.04.007; Huang AM, 2011, BIOCHEM PHARMACOL, V82, P35, DOI 10.1016/j.bcp.2011.03.026; Huang KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033615; Huang SB, 2010, AUTOPHAGY, V6, P256, DOI 10.4161/auto.6.2.11124; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jendrossek V, 2003, FASEB J, V17, P1547, DOI 10.1096/fj.02-0947fje; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Latini DM, 2010, UROLOGY, V75, P334, DOI 10.1016/j.urology.2009.09.051; Lee PC, 2010, NEOPLASIA, V12, P376, DOI 10.1593/neo.10110; Leese PT, 2000, J CLIN PHARMACOL, V40, P124, DOI 10.1177/00912700022008766; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li JR, 2013, TOXICOL LETT, V220, P267, DOI 10.1016/j.toxlet.2013.04.021; Lin KW, 2012, FOOD CHEM, V135, P851, DOI 10.1016/j.foodchem.2012.04.133; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Maier TJ, 2004, BIOCHEM PHARMACOL, V67, P1469, DOI 10.1016/j.bcp.2003.12.014; Menter DG, 2010, CLIN CANCER RES, V16, P1384, DOI 10.1158/1078-0432.CCR-09-0788; Pyrko P, 2007, MOL CANCER THER, V6, P1262, DOI 10.1158/1535-7163.MCT-06-0629; Qin J, 2009, BIOMED PHARMACOTHER, V63, P241, DOI 10.1016/j.biopha.2008.04.007; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Sakagami H, 2009, ANTICANCER RES, V29, P343; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Schonthal AH, 2009, CANCER LETT, V275, P163, DOI 10.1016/j.canlet.2008.07.005; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; STERNBERG CN, 1988, J UROLOGY, V139, P461, DOI 10.1016/S0022-5347(17)42494-3; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; von der Maase H, 2000, J CLIN ONCOL, V18, P3068, DOI 10.1200/JCO.2000.18.17.3068; Williams CS, 2000, CANCER RES, V60, P6045; Xia HG, 2010, AUTOPHAGY, V6, P61, DOI 10.4161/auto.6.1.10326; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yorimitsu T, 2007, AUTOPHAGY, V3, P160, DOI 10.4161/auto.3653; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yu Hong-Jeng, 1992, Journal of the Formosan Medical Association, V91, P608	52	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82034	10.1371/journal.pone.0082034	http://dx.doi.org/10.1371/journal.pone.0082034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349176	Green Published, Green Submitted			2022-12-27	WOS:000328705200059
J	Park, HJ; Kim, MK; Kim, SR; Bae, SK; Bae, MK				Park, Hyun-Joo; Kim, Mi-Kyoung; Kim, Su-Ryun; Bae, Soo-Kyung; Bae, Moon-Kyoung			Hypoxia Regulates the Expression of the Neuromedin B Receptor through a Mechanism Dependent on Hypoxia-Inducible Factor-1 alpha	PLOS ONE			English	Article							GASTRIN-RELEASING-PEPTIDE; BOMBESIN-LIKE PEPTIDES; CANCER PROGRESSION; GENE-EXPRESSION; TUMOR-GROWTH; RAT-1 CELLS; ANGIOGENESIS; THERAPY; COLON; PROLIFERATION	The neuromedin B receptor (NMB-R), a member of the mammalian bombesin receptor family, is frequently overexpressed in various tumors. In the present study, we found that exposure to hypoxic conditions increases the levels of NMBR mRNA and protein in breast cancer cells, which are tightly regulated by hypoxia-inducible factor-1 alpha (HIF-1 alpha). We confirmed the effect of HIF-1 alpha on NMBR transcription by performing an NMBR promoter-driven reporter assay and then identified a functional hypoxia-responsive element (HRE) in the human NMBR promoter region. Further, the binding of HIF-1 alpha to the NMBR promoter was corroborated by electrophoretic mobility shift and chromatin immunoprecipitation assays, which showed that HIF-1 alpha specifically and directly bound to the NMBR promoter in response to hypoxia. Immunohistochemical analysis of a xenograft and a human breast cancer tissue array revealed a significant correlation between NMB-R and HIF-1 alpha expression. Taken together, our findings indicate that hypoxia induces NMB-R expression through a novel mechanism to regulate HIF-1 alpha expression in breast cancer cells.	[Park, Hyun-Joo; Kim, Mi-Kyoung; Kim, Su-Ryun; Bae, Moon-Kyoung] Pusan Natl Univ, Sch Dent, Dept Oral Physiol, Yangsan, South Korea; [Park, Hyun-Joo; Kim, Su-Ryun; Bae, Soo-Kyung] Pusan Natl Univ, Sch Dent, Dept Dent Pharmacol, Yangsan, South Korea	Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Bae, MK (corresponding author), Pusan Natl Univ, Sch Dent, Dept Oral Physiol, Yangsan, South Korea.	mkbae@pusan.ac.kr			National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [1220080]	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1220080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airley RE, 2007, CHEMOTHERAPY, V53, P233, DOI 10.1159/000104457; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Carroll RE, 1999, AM J PHYSIOL-GASTR L, V276, pG655, DOI 10.1152/ajpgi.1999.276.3.G655; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Chao C, 2009, J SURG RES, V156, P26, DOI 10.1016/j.jss.2009.03.072; Charlesworth A, 1997, ONCOGENE, V14, P2323, DOI 10.1038/sj.onc.1201075; Chinnappan D, 2008, AM J PHYSIOL-GASTR L, V295, pG153, DOI 10.1152/ajpgi.00036.2008; Cornelio DB, 2007, ANN ONCOL, V18, P1457, DOI 10.1093/annonc/mdm058; Dimitrakopoulou-Strauss A, 2007, J NUCL MED, V48, P1245, DOI 10.2967/jnumed.106.038091; Du J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025213, 10.1371/journal.pone.0026204]; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Gugger M, 1999, AM J PATHOL, V155, P2067, DOI 10.1016/S0002-9440(10)65525-3; Hohla F, 2010, CELL CYCLE, V9, P1738, DOI 10.4161/cc.9.9.11347; Jensen JAG, 2001, PEPTIDES, V22, P689, DOI 10.1016/S0196-9781(01)00380-1; Jensen RT, 2008, PHARMACOL REV, V60, P1, DOI 10.1124/pr.107.07108; Jokilehto T, 2010, J CELL MOL MED, V14, P758, DOI 10.1111/j.1582-4934.2010.01030.x; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; LACH EB, 1995, CELL GROWTH DIFFER, V6, P1427; Li XQ, 2010, J CANCER RES CLIN, V136, P483, DOI 10.1007/s00432-010-0766-2; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Majumdar ID, 2011, CURR OPIN ENDOCRINOL, V18, P68, DOI 10.1097/MED.0b013e328340ff93; Matusiak D, 2005, AM J PHYSIOL-GASTR L, V288, pG718, DOI 10.1152/ajpgi.00156.2004; Moody TW, 2010, EUR J PHARMACOL, V637, P38, DOI 10.1016/j.ejphar.2010.03.057; MOODY TW, 1995, PEPTIDES, V16, P1133, DOI 10.1016/0196-9781(95)00085-X; Moody TW, 2000, EUR J PHARMACOL, V409, P133, DOI 10.1016/S0014-2999(00)00828-1; Ohki-Hamazaki H, 2000, PROG NEUROBIOL, V62, P297, DOI 10.1016/S0301-0082(00)00004-6; Park HJ, 2011, CANCER LETT, V312, P117, DOI 10.1016/j.canlet.2011.08.014; Park HJ, 2009, EXP CELL RES, V315, P3359, DOI 10.1016/j.yexcr.2009.08.009; Patel O, 2006, BBA-REV CANCER, V1766, P23, DOI 10.1016/j.bbcan.2006.01.003; Preston SR, 1996, CRIT REV ONCOL HEMAT, V23, P225, DOI 10.1016/1040-8428(96)00204-1; Qu XP, 2004, J MOL NEUROSCI, V22, P75, DOI 10.1385/JMN:22:1-2:75; Saito H, 2013, J ENDOCRINOL, V217, P141, DOI 10.1530/JOE-12-0488; Schwartsmann G, 2006, INVEST NEW DRUG, V24, P403, DOI 10.1007/s10637-006-6886-5; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; Sullivan R, 2007, CANCER METAST REV, V26, P319, DOI 10.1007/s10555-007-9062-2; Tell R, 2011, AM J PATHOL, V178, P672, DOI 10.1016/j.ajpath.2010.10.017; Tsai YP, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-102; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Yang YZ, 2013, J CELL BIOCHEM, V114, P967, DOI 10.1002/jcb.24438; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516; Zhou JH, 2004, ANTI-CANCER DRUG, V15, P921, DOI 10.1097/00001813-200411000-00001	42	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82868	10.1371/journal.pone.0082868	http://dx.doi.org/10.1371/journal.pone.0082868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349381	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200108
J	Kato, T; Tanaka, M; Oba, M				Kato, Takuma; Tanaka, Masakazu; Oba, Makoto			Protein Transfection Study Using Multicellular Tumor Spheroids of Human Hepatoma Huh-7 Cells	PLOS ONE			English	Article							NONVIRAL GENE DELIVERY; IN-VIVO; DRUG; TISSUE; MODEL; TRANSCYTOSIS; TRAFFICKING; EXPRESSION; MICELLES; CAVEOLAE	Several protein transfection reagents are commercially available and are powerful tools for elucidating function of a protein in a cell. Here we described protein transfection studies of the commercially available reagents, Pro-DeliverIN, Xfect, and TuboFect, using Huh-7 multicellular tumor spheroid (MCTS) as a three-dimensional in vitro tumor model. A cellular uptake study using specific endocytosis inhibitors revealed that each reagent was internalized into Huh-7 MCTS by different mechanisms, which were the same as monolayer cultured Huh-7 cells. A certain amount of Pro-DeliverIN and Xfect was uptaken by Huh-7 cells through caveolae-mediated endocytosis, which may lead to transcytosis through the surface-first layered cells of MCTS. The results presented here will help in the choice and use of protein transfection reagents for evaluating anti-tumor therapeutic proteins against MCTS models.	[Kato, Takuma; Tanaka, Masakazu; Oba, Makoto] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan	Nagasaki University	Oba, M (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan.	moba@nagasaki-u.ac.jp		Oba, Makoto/0000-0002-3691-3608; Kato, Takuma/0000-0002-2561-8582	JSPS KAKENHI [25713008, 25560226]; Takeda Science Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Grants-in-Aid for Scientific Research [25560226] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by JSPS KAKENHI Grant Number 25713008 and 25560226, by a Grant from the Takeda Science Foundation, and by a Grant from the Mochida Memorial Foundation for Medical and Pharmaceutical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae Y, 2005, BIOCONJUGATE CHEM, V16, P122, DOI 10.1021/bc0498166; Bromberg LE, 1998, ADV DRUG DELIVER REV, V31, P197, DOI 10.1016/S0169-409X(97)00121-X; De Clercq E, 2004, J CLIN VIROL, V30, P115, DOI 10.1016/j.jcv.2004.02.009; De Groot AS, 2007, TRENDS IMMUNOL, V28, P482, DOI 10.1016/j.it.2007.07.011; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; Fiedrich J, 2009, NAT PROTC, V4, P309, DOI [10.1038/nprot.2008.226, DOI 10.1038/NPR0T.2008.226]; Han M, 2007, J CONTROL RELEASE, V121, P38, DOI 10.1016/j.jconrel.2007.05.012; Han M, 2009, MOL THER, V17, P1404, DOI 10.1038/mt.2009.119; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Lee Y, 2009, ANGEW CHEM INT EDIT, V48, P5309, DOI 10.1002/anie.200900064; McIntosh DP, 2002, P NATL ACAD SCI USA, V99, P1996, DOI 10.1073/pnas.251662398; Mellert K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052473; Mellor HR, 2006, J GENE MED, V8, P1160, DOI 10.1002/jgm.947; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Oba M, 2012, BIOL PHARM BULL, V35, P1064, DOI 10.1248/bpb.b12-00001; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Schnitzer JE, 2001, ADV DRUG DELIVER REV, V49, P265, DOI 10.1016/S0169-409X(01)00141-7; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; van der Gun BTF, 2007, J CONTROL RELEASE, V123, P228, DOI 10.1016/j.jconrel.2007.08.014; von Gersdorff K, 2006, MOL THER, V14, P745, DOI 10.1016/j.ymthe.2006.07.006	24	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82876	10.1371/journal.pone.0082876	http://dx.doi.org/10.1371/journal.pone.0082876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349384	Green Published, gold			2022-12-27	WOS:000328566100129
J	Michel, V; Shen, GJ; Shen, CC; Wu, CC; Verati, C; Gallet, S; Moncel, MH; Combier, J; Khatib, S; Manetti, M				Michel, Veronique; Shen, Guanjun; Shen, Chuan-Chou; Wu, Chung-Che; Verati, Chrystele; Gallet, Sylvain; Moncel, Marie-Helene; Combier, Jean; Khatib, Samir; Manetti, Michel			Application of U/Th and 40Ar/39Ar Dating to Orgnac 3, a Late Acheulean and Early Middle Palaeolithic Site in Ardeche, France	PLOS ONE			English	Article							DECAY CONSTANTS; HIGH-PRECISION; PLEISTOCENE; STANDARD; BEHAVIOR; URANIUM; TH-230; AR	Refined radio-isotopic dating techniques have been applied to Orgnac 3, a Late Acheulean and Early Middle Palaeolithic site in France. Evidence of Levallois core technology appeared in level 4b in the middle of the sequence, became predominant in the upper horizons, and was best represented in uppermost level 1, making the site one of the oldest examples of Levallois technology. In our dating study, fourteen speleothem samples from levels 7, 6 and 5b, were U/Th-dated. Four pure calcite samples from the speleothem PL1 (levels 5b, 6) yield ages between 265 +/- 4 (PL1-3) and 312 +/- 15 (PL1-6) thousand years ago (ka). Three samples from the top of a second stalagmite, PL2, yield dates ranging from 288 +/- 10 ka (PL2-1) to 298 +/- 17 ka (PL2-3). Three samples from the base of PL2 (level 7) yield much younger U/Th dates between 267 and 283 ka. These dates show that the speleothems PL1 and PL2 are contemporaneous and formed during marine isotope stage (MIS) 9 and MIS 8. Volcanic minerals in level 2, the upper sequence, were dated by the 40Ar/39Ar method, giving a weighted mean of 302.9 +/- 2.5 ka (2 sigma) and an inverse isochron age of 302.9 +/- 5.9 ka (2 sigma). Both 40Ar/39Ar dating of volcanic sanidines and U/Th dating of relatively pure and dense cave calcites are known to be well established. The first parallel application of the two geochronometers to Orgnac 3 yields generally consistent results, which point to the reliability of the two methods. The difference between their age results is discussed.	[Michel, Veronique] Univ Nice Sophia Antipolis, SJA3, CEPAM, UMR CNRS 7264, F-06189 Nice, France; [Michel, Veronique; Verati, Chrystele; Gallet, Sylvain] Geoazur, UMR7329, UNS, CNRS,IRD,OCA, Valbonne, France; [Shen, Guanjun] Nanjing Normal Univ, Coll Geog Sci, Nanjing, Jiangsu, Peoples R China; [Shen, Chuan-Chou; Wu, Chung-Che] Natl Taiwan Univ 1, High Precis Mass Spectrometry & Environm Change L, Dept Geosci, Taipei, Taiwan; [Moncel, Marie-Helene] IPH, Dept Prehist, UMR 7194, MNHN, Paris, France; [Combier, Jean] CNRS, Macon, France; [Khatib, Samir] Lab Dept Prehist Lazaret, Nice, France; [Manetti, Michel] Univ Nice Sophia Antipolis, Dept Terre Environm Espace, F-06189 Nice 2, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; Nanjing Normal University; National Taiwan University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Michel, V (corresponding author), Univ Nice Sophia Antipolis, SJA3, CEPAM, UMR CNRS 7264, Campus St Jean dAngely, F-06189 Nice, France.	veronique.michel@cepam.cnrs.fr	Shen, Chuan-Chou/H-9642-2013; Wu, Chung-Che/AFO-7404-2022; lin, ke/GZM-8300-2022	Shen, Chuan-Chou/0000-0003-2833-2771; Wu, Dr. Chung-Che/0000-0003-0189-5208; Michel, Veronique/0000-0002-8900-7190	Taiwan ROC NSC; NTU [101-2923-M-002-008-MY2, 101-2116-M-002-009, 101R7625]	Taiwan ROC NSC; NTU(Nanyang Technological University)	U/Th isotopic measurements and dating were supported by Taiwan ROC NSC and NTU grants (101-2923-M-002-008-MY2, 101-2116-M-002-009, and 101R7625 to CCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouraghe H, 1992, THESIS MUSEUM NATL H; Cheng H, 2013, EARTH PLANET SC LETT, V371, P82, DOI 10.1016/j.epsl.2013.04.006; Combier J, 2000, MOYENNE VALLEE RHONE, P66; Combier J., 1967, MEMOIRE U BORDEAU; de Lumley M-A, 1981, PREMIERS HABITANTS E, P143; DEBARD E, 1988, CR ACAD SCI II, V306, P1515; FALGUERES C, 1988, ANTHROPOLOGIE, V92, P727; Hiess J, 2012, SCIENCE, V335, P1610, DOI 10.1126/science.1215507; Hora JM, 2010, GEOLOGY, V38, P923, DOI 10.1130/G31064.1; JAFFEY AH, 1971, PHYS REV C, V4, P1889, DOI 10.1103/PhysRevC.4.1889; Kelley S, 2002, CHEM GEOL, V188, P1, DOI 10.1016/S0009-2541(02)00064-5; Khatib S., 1994, QUATERNAIRE, V5, P13, DOI DOI 10.3406/QUATE.1994.2010; Koppers AAP, 2002, COMPUT GEOSCI-UK, V28, P605, DOI 10.1016/S0098-3004(01)00095-4; Kuiper KF, 2008, SCIENCE, V320, P500, DOI 10.1126/science.1154339; Lee JY, 2006, GEOCHIM COSMOCHIM AC, V70, P4507, DOI 10.1016/j.gca.2006.06.1563; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Ludwig K., 2003, ISOPLOT 3 00 GEOCHRO, P1; Masaoudi H, 1995, THESIS MUSEUM NATL H; Michel V, 2011, CR PALEVOL, V10, P577, DOI 10.1016/j.crpv.2011.06.002; Moncel MH, 2011, CURR ANTHROPOL, V52, P37, DOI 10.1086/658179; Moncel MH, 2005, J ARCHAEOL SCI, V32, P1283, DOI 10.1016/j.jas.2005.03.014; Nomade S, 2005, CHEM GEOL, V218, P315, DOI 10.1016/j.chemgeo.2005.01.005; Nomade S, 2012, J VOLCANOL GEOTH RES, V225, P1, DOI 10.1016/j.jvolgeores.2012.02.006; Renne PR, 2010, GEOCHIM COSMOCHIM AC, V74, P5349, DOI 10.1016/j.gca.2010.06.017; Renne PR, 2009, QUAT GEOCHRONOL, V4, P346, DOI 10.1016/j.quageo.2009.06.005; Renne PR, 1997, SCIENCE, V277, P1279, DOI 10.1126/science.277.5330.1279; Roger S, 1999, EARTH PLANET SC LETT, V170, P287, DOI 10.1016/S0012-821X(99)00115-6; Scaillet S, 2008, EARTH PLANET SC LETT, V275, P320, DOI 10.1016/j.epsl.2008.08.026; Shen CC, 2003, ANAL CHEM, V75, P1075, DOI 10.1021/ac026247r; Shen CC, 2002, CHEM GEOL, V185, P165, DOI 10.1016/S0009-2541(01)00404-1; Shen CC, 2008, GEOCHIM COSMOCHIM AC, V72, P4201, DOI 10.1016/j.gca.2008.06.011; Shen CC, 2012, GEOCHIM COSMOCHIM AC, V99, P71, DOI 10.1016/j.gca.2012.09.018; Shen G., 1985, DATATION PLANCHERS S; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7	34	22	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82394	10.1371/journal.pone.0082394	http://dx.doi.org/10.1371/journal.pone.0082394			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349273	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100102
J	Wang, Q; Cui, K; Espin-Garcia, O; Cheng, D; Qiu, X; Chen, Z; Moore, M; Bristow, RG; Xu, W; Der, S; Liu, G				Wang, Qi; Cui, Kangping; Espin-Garcia, Osvaldo; Cheng, Dangxiao; Qiu, Xiaoping; Chen, Zhuo; Moore, Malcolm; Bristow, Robert G.; Xu, Wei; Der, Sandy; Liu, Geoffrey			Resistance to Bleomycin in Cancer Cell Lines Is Characterized by Prolonged Doubling Time, Reduced DNA Damage and Evasion of G2/M Arrest and Apoptosis	PLOS ONE			English	Article							ANTIOXIDANT ENZYMES; CHECKPOINT; GAMMA-H2AX; ACTIVATION; REPAIR; ASSAY	Background: To establish, characterize and elucidate potential mechanisms of acquired bleomycin (BLM) resistance using human cancer cell lines. Seven BLM-resistant cell lines were established by exposure to escalating BLM concentrations over a period of 16-24 months. IC50 values and cell doubling times were quantified using a real time cytotoxicity assay. COMET and gamma-H2AX assays, cell cycle analysis, and apoptosis assessment further investigated the mechanisms of BLM resistance in these cell lines. Results: Compared with parental cell lines, real time cytotoxicity assays revealed 7 to 49 fold increases in IC50 and a mean doubling time increase of 147 % (range 64 %-352%) in BLM-resistant sub-clones (p<0.05 for both). Higher maintenance BLM concentrations were associated with higher IC50 and increased doubling times (p<0.05). Significantly reduced DNA damage (COMET and gamma-H2AX assays), G2/M arrest, and apoptosis (p<0.05 for each set of comparison) following high-dose acute BLM exposure was observed in resistant sub-clones, compared with their BLM-sensitive parental counterparts. Three weeks of BLM-free culturing resulted in a partial return to BLM sensitivity in 3/7 BLM-resistant sub-clones (p<0.05). Conclusion: Bleomycin resistance may be associated with reduced DNA damage after bleomycin exposure, resulting in reduced G2/M arrest, and reduced apoptosis.	[Wang, Qi; Cheng, Dangxiao; Chen, Zhuo; Bristow, Robert G.; Der, Sandy] Princess Margaret Hosp, Ontario Canc Inst, Dept Appl Mol Oncol, Toronto, ON M4X 1K9, Canada; [Cui, Kangping] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Espin-Garcia, Osvaldo] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON N2L 3G1, Canada; [Espin-Garcia, Osvaldo; Xu, Wei] Princess Margaret Hosp, Dept Biostat, Toronto, ON M4X 1K9, Canada; [Qiu, Xiaoping] Wuhan Univ, Sch Med, Inst Virol, Wuhan 430072, Hubei, Peoples R China; [Moore, Malcolm] Univ Toronto, Dept Med & Pharmacol, Toronto, ON, Canada; [Moore, Malcolm; Liu, Geoffrey] Princess Margaret Hosp, Div Med Oncol & Hematol, Toronto, ON M4X 1K9, Canada; [Bristow, Robert G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Bristow, Robert G.] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Xu, Wei; Liu, Geoffrey] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Waterloo; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Wuhan University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto	Liu, G (corresponding author), Princess Margaret Hosp, Div Med Oncol & Hematol, Toronto, ON M4X 1K9, Canada.	Geoffrey.Liu@uhn.ca	Liu, Geoffrey/N-4421-2016	Bristow, Robert/0000-0002-8553-9544; Liu, Geoffrey/0000-0002-2603-7296	Princess Margaret Hospital Foundation	Princess Margaret Hospital Foundation	This study was supported by the Princess Margaret Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouida M, 2010, J BIOL CHEM, V285, P6275, DOI 10.1074/jbc.M109.046151; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; BOKEMEYER C, 2008, J CLIN ONCOL, V26, P1817, DOI DOI 10.1200/JC0.2007.14.1606.PUBMED:18398143; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen JG, 2012, INT J ONCOL, V41, P2245, DOI 10.3892/ijo.2012.1668; Chen JY, 2008, NUCLEIC ACIDS RES, V36, P3781, DOI 10.1093/nar/gkn302; Chen JY, 2005, NAT REV CANCER, V5, P102, DOI 10.1038/nrc1547; Cloos J, 2002, ENVIRON MOL MUTAGEN, V40, P79, DOI 10.1002/em.10093; Cort A, 2012, J PHYSIOL BIOCHEM, V68, P555, DOI 10.1007/s13105-012-0173-z; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; *GEN BIO GROUP, 2012, CELLMINERTM; Hagimori K, 2007, BIOL PHARM BULL, V30, P1379, DOI 10.1248/bpb.30.1379; Ivashkevich A, 2012, CANCER LETT, V327, P123, DOI 10.1016/j.canlet.2011.12.025; Kaneko M, 2012, BIOL PHARM BULL, V35, P18, DOI 10.1248/bpb.35.18; Khaidakov M, 2002, MUTAT RES-FUND MOL M, V500, P1, DOI 10.1016/S0027-5107(01)00270-6; Kuntz K, 2009, CANCER BIOL THER, V8, P1433, DOI 10.4161/cbt.8.15.9081; Lazo J S, 1999, Cancer Chemother Biol Response Modif, V18, P39; Liu SK, 2011, TOXICOLOGY, V281, P63, DOI 10.1016/j.tox.2011.01.008; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Muslimovic A, 2008, NAT PROTOC, V3, P1187, DOI 10.1038/nprot.2008.93; Nakayama Y, 2009, EXP CELL RES, V315, P2515, DOI 10.1016/j.yexcr.2009.06.007; Povirk LF, 1996, MUTAT RES-FUND MOL M, V355, P71, DOI 10.1016/0027-5107(96)00023-1; Pron G, 1999, BIOCHEM PHARMACOL, V57, P45, DOI 10.1016/S0006-2952(98)00282-2; PRON G, 1994, BIOCHEM PHARMACOL, V48, P301, DOI 10.1016/0006-2952(94)90101-5; Robertson KA, 2001, CANCER RES, V61, P2220; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Tuimala J, 2002, CARCINOGENESIS, V23, P1003, DOI 10.1093/carcin/23.6.1003; Umezawa H, 1965, Antimicrob Agents Chemother (Bethesda), V5, P1079; UMEZAWA H, 1966, J ANTIBIOT, V19, P200; Uphoff CC, 2011, METHODS MOL BIOL, V731, P93, DOI 10.1007/978-1-61779-080-5_8; Yen HC, 2005, FREE RADICAL BIO MED, V38, P950, DOI 10.1016/j.freeradbiomed.2004.12.022; Yen HC, 2011, FREE RADICAL RES, V45, P707, DOI 10.3109/10715762.2011.572969; P NATL ACAD SCI USA, V96, P4680, DOI DOI 10.1073/PNAS.96.8.4680.PUBMED:10200322	34	26	26	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82363	10.1371/journal.pone.0082363	http://dx.doi.org/10.1371/journal.pone.0082363			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24349265	gold, Green Published, Green Submitted			2022-12-27	WOS:000327949300141
J	Budvytyte, R; Pleckaityte, M; Zvirbliene, A; Vanderah, DJ; Valincius, G				Budvytyte, Rima; Pleckaityte, Milda; Zvirbliene, Aurelija; Vanderah, David J.; Valincius, Gintaras			Reconstitution of Cholesterol-Dependent Vaginolysin into Tethered Phospholipid Bilayers: Implications for Bioanalysis	PLOS ONE			English	Article							GARDNERELLA-VAGINALIS; IMPEDANCE SPECTROSCOPY; HUMAN CD59; MEMBRANES; CYTOLYSIN; INTERMEDILYSIN; RECEPTOR; PNEUMOLYSIN; BIOSENSOR; INSERTION	Functional reconstitution of the cholesterol-dependent cytolysin vaginolysin (VLY) from Gardnerella vaginalis into artificial tethered bilayer membranes (tBLMs) has been accomplished. The reconstitution of VLY was followed in real-time by electrochemical impedance spectroscopy (EIS). Changes of the EIS parameters of the tBLMs upon exposure to VLY solutions were consistent with the formation of water-filled pores in the membranes. It was found that reconstitution of VLY is a strictly cholesterol-dependent, irreversible process. At a constant cholesterol concentration reconstitution of VLY occurred in a concentration-dependent manner, thus allowing the monitoring of VLY concentration and activity in vitro and opening possibilities for tBLM utilization in bioanalysis. EIS methodology allowed us to detect VLY down to 0.5 nM (28 ng/mL) concentration. Inactivation of VLY by certain amino acid substitutions led to noticeably lesser tBLM damage. Pre-incubation of VLY with the neutralizing monoclonal antibody 9B4 inactivated the VLY membrane damage in a concentration-dependent manner, while the non-neutralizing antibody 21A5 exhibited no effect. These findings demonstrate the biological relevance of the interaction between VLY and the tBLM. The membrane-damaging interaction between VLY and tBLM was observed in the absence of the human CD59 receptor, known to strongly facilitate the hemolytic activity of VLY. Taken together, our study demonstrates the applicability of tBLMs as a bioanalytical platform for the detection of the activity of VLY and possibly other cholesterol-dependent cytolysins.	[Budvytyte, Rima; Valincius, Gintaras] Vilnius State Univ, Inst Biochem, Dept Bioelectrochem & Biospectroscopy, Vilnius, Lithuania; [Pleckaityte, Milda; Zvirbliene, Aurelija] Vilnius State Univ, Inst Biotechnol, Dept Immunol & Cell Biol, Vilnius, Lithuania; [Vanderah, David J.] NIST, Biomol Struct & Funct Grp, Inst Biosci & Biotechnol Res, Rockville, MD USA; [Budvytyte, Rima] Univ Copenhagen, Niels Bohr Inst, Bio Complex Dept, DK-2100 Copenhagen, Denmark	Vilnius University; Vilnius University; National Institute of Standards & Technology (NIST) - USA; University of Copenhagen; Niels Bohr Institute	Valincius, G (corresponding author), Vilnius State Univ, Inst Biochem, Dept Bioelectrochem & Biospectroscopy, Vilnius, Lithuania.	gintaras.valincius@bchi.vu.lt	Budvytyte, Rima/AAC-3044-2019; Budvytyte, Rima/F-5115-2014	Budvytyte, Rima/0000-0002-5063-5878; Budvytyte, Rima/0000-0002-5063-5878; Pleckaityte, Milda/0000-0002-3291-9033	Research Council of Lithuania [MIP-114/2012]	Research Council of Lithuania(Research Council of Lithuania (LMTLT))	This study was supported in part by a research grant from the Research Council of Lithuania (grant number MIP-114/2012), http://www.lmt.lt/en/en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Awad MM, 2001, INFECT IMMUN, V69, P7904, DOI 10.1128/IAI.69.12.7904-7910.2001; Boden N, 1997, TETRAHEDRON, V53, P10939, DOI 10.1016/S0040-4020(97)00698-4; Braha O, 1997, CHEM BIOL, V4, P497, DOI 10.1016/S1074-5521(97)90321-5; Budvytyte R, 2013, LANGMUIR, V29, P4320, DOI 10.1021/la304613a; CATLIN BW, 1992, CLIN MICROBIOL REV, V5, P213, DOI 10.1128/CMR.5.3.213-237.1992; Cizas P, 2010, ARCH BIOCHEM BIOPHYS, V496, P84, DOI 10.1016/j.abb.2010.02.001; Cornell BA, 1997, NATURE, V387, P580, DOI 10.1038/42432; Cornell BA, 2001, BIOCHEM SOC T, V29, P613, DOI 10.1042/BST0290613; delosToyos JR, 1996, INFECT IMMUN, V64, P480, DOI 10.1128/IAI.64.2.480-484.1996; Farkas I, 2002, J PHYSIOL-LONDON, V539, P537, DOI 10.1113/jphysiol.2001.013381; Farrand AJ, 2010, P NATL ACAD SCI USA, V107, P4341, DOI 10.1073/pnas.0911581107; Garcia-Suarez MD, 2007, J CLIN MICROBIOL, V45, P3549, DOI 10.1128/JCM.01030-07; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Halverson KM, 2005, J BIOL CHEM, V280, P34056, DOI 10.1074/jbc.M507928200; Hotze EM, 2013, INFECT IMMUN, V81, P216, DOI 10.1128/IAI.00927-12; Hotze EM, 2012, BBA-BIOMEMBRANES, V1818, P1028, DOI 10.1016/j.bbamem.2011.07.036; Junghans A, 2011, LANGMUIR, V27, P2709, DOI 10.1021/la103200k; Kozuch J, 2012, ANGEW CHEM INT EDIT, V51, P8114, DOI 10.1002/anie.201203214; Krishna G, 2001, LANGMUIR, V17, P4858, DOI 10.1021/la001480a; LaChapelle S, 2009, J BIOL CHEM, V284, P12719, DOI 10.1074/jbc.M900772200; Lewis WG, 2013, J BIOL CHEM, V288, P12067, DOI 10.1074/jbc.M113.453654; McGillivray DJ, 2007, BIOINTERPHASES, V2, P21, DOI 10.1116/1.2709308; McGillivray DJ, 2009, BIOPHYS J, V96, P1547, DOI 10.1016/j.bpj.2008.11.020; Menard JP, 2010, OBSTET GYNECOL, V115, P134, DOI 10.1097/AOG.0b013e3181c391d7; MENESTRINA G, 1986, J MEMBRANE BIOL, V90, P177, DOI 10.1007/BF01869935; Pleckaityte M, 2012, FEMS IMMUNOL MED MIC, V65, P69, DOI 10.1111/j.1574-695X.2012.00940.x; Raguse B, 1998, LANGMUIR, V14, P648, DOI 10.1021/la9711239; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Randis TM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005207; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Srinivasan Sujatha, 2008, Interdiscip Perspect Infect Dis, V2008, P750479, DOI 10.1155/2008/750479; Sukeno A, 2005, MICROBIOL IMMUNOL, V49, P681, DOI 10.1111/j.1348-0421.2005.tb03647.x; Swidsinski A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053997; Taylor JD, 2009, ANAL CHEM, V81, P1146, DOI 10.1021/ac8023137; Tun TN, 2011, BIOSENS BIOELECTRON, V28, P227, DOI 10.1016/j.bios.2011.07.023; Tun TN, 2010, ELECTROCHEM COMMUN, V12, P1411, DOI 10.1016/j.elecom.2010.07.034; Valincius G, 2008, BIOPHYS J, V95, P4845, DOI 10.1529/biophysj.108.130997; Valincius G, 2006, J PHYS CHEM B, V110, P10213, DOI 10.1021/jp0616516; Valincius G, 2012, LANGMUIR, V28, P977, DOI 10.1021/la204054g; Wickham SE, 2011, J BIOL CHEM, V286, P20952, DOI 10.1074/jbc.M111.237446; Wilkop T, 2008, LANGMUIR, V24, P5615, DOI 10.1021/la704027c; Xu DK, 2002, J AM CHEM SOC, V124, P14314, DOI 10.1021/ja027897f; Zvirbliene A, 2007, ARCH VIROL, V152, P25, DOI 10.1007/s00705-006-0837-5; Zvirbliene A, 2010, TOXICON, V56, P19, DOI 10.1016/j.toxicon.2010.03.007	46	22	22	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82536	10.1371/journal.pone.0082536	http://dx.doi.org/10.1371/journal.pone.0082536			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349307	gold, Green Published, Green Submitted			2022-12-27	WOS:000328734200050
J	Huang, HL; Nie, X; Cai, B; Tang, JT; He, Y; Miao, Q; Song, HL; Luo, TX; Gao, BX; Wang, LL; Li, GX				Huang, Hua-Lan; Nie, Xin; Cai, Bei; Tang, Jiang-Tao; He, Yong; Miao, Qiang; Song, Hao-Lan; Luo, Tong-Xing; Gao, Bao-Xiu; Wang, Lan-Lan; Li, Gui-Xing			Procalcitonin Levels Predict Acute Kidney Injury and Prognosis in Acute Pancreatitis: A Prospective Study	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; INTERNATIONAL CONSENSUS CONFERENCE; SERIOUS BACTERIAL-INFECTION; INTENSIVE-CARE UNITS; CALCITONIN PRECURSORS; SEPTIC SHOCK; SEPSIS; CHILDREN; MARKERS; RISK	Background: Acute kidney injury (AKI) has been proposed as a leading cause of mortality for acute pancreatitis (AP) patients admitted to the intensive care unit (ICU). This study investigated the predictive value of procalcitonin (PCT) for AKI development and relevant prognosis in patients with AP, and compared PCT's predictive power with that of other inflammation-related variables. Methods: Between January 2011 and March 2013, we enrolled 305 cases with acute pancreatitis admitted to ICU. Serum levels of PCT, serum amyloid A (SAA), interleukin-6 (IL-6), and C reactive protein (CRP) were determined on admission. Serum PCT was tested in patients who developed AKI on the day of AKI occurrence and on either day 28 after occurrence (for survivors) or on the day of death (for those who died within 28 days). Results: Serum PCT levels were 100-fold higher in the AKI group than in the non-AKI group on the day of ICU admission (p<0.05). The area under the receiver-operating characteristic (ROC) curve of PCT for predicting AKI was 0.986, which was superior to SAA, CRP, and IL-6 (p<0.05). ROC analysis revealed all variables tested had lower predictive performance for AKI prognosis. The average serum PCT level on day 28 (2.67 (0.89, 7.99) ng/ml) was significantly (p<0.0001) lower than on the day of AKI occurrence (43.71 (19.24,65.69) ng/ml) in survivors, but the serum PCT level on death (63.73 (34.22,94.30) ng/ml) was higher than on the day of AKI occurrence (37.55 (18.70,74.12) ng/ml) in non-survivors, although there was no significant difference between the two days in the latter group (p = 0.1365). Conclusion: Serum PCT is superior to CRP, IL-6, and SAA for predicting the development of AKI in patients with AP, and also can be used for dynamic evaluation of AKI prognosis.	[Huang, Hua-Lan; Nie, Xin; Cai, Bei; Tang, Jiang-Tao; He, Yong; Miao, Qiang; Song, Hao-Lan; Luo, Tong-Xing; Gao, Bao-Xiu; Wang, Lan-Lan; Li, Gui-Xing] Sichuan Univ, Dept Lab Med, West China Hosp, Chengdu 610064, Peoples R China	Sichuan University	Wang, LL (corresponding author), Sichuan Univ, Dept Lab Med, West China Hosp, Chengdu 610064, Peoples R China.	wangll87@126.com; liguixing27@163.com			Sichuan Province-Supporting Technology Project [2010SZ0252]	Sichuan Province-Supporting Technology Project	Sichuan Province-Supporting Technology Project, No. 2010SZ0252. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammori BJ, 2003, PANCREAS, V27, P239, DOI 10.1097/00006676-200310000-00008; [Anonymous], 2009, CHEST; Araujo M, 2013, INFLAMM RES, V62, P887, DOI 10.1007/s00011-013-0646-8; ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-N; Bagshaw SM, 2008, CRIT CARE, V12, DOI [10.1186/cc6863, 10.1186/cc6268]; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bollen FL, 2008, BRIT J SURG, V95, P6, DOI 10.1002/bjs.6010; Bouadma L, 2010, LANCET, V375, P463, DOI 10.1016/S0140-6736(09)61879-1; Bressan S, 2010, PEDIATR INFECT DIS J, V29, P227, DOI 10.1097/INF.0b013e3181b9a086; Cicalese L, 2001, DIGEST DIS SCI, V46, P1127, DOI 10.1023/A:1010786701289; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; Devarajan P, 2010, AM J KIDNEY DIS, V56, P632, DOI 10.1053/j.ajkd.2010.04.014; deWerra I, 1997, CRIT CARE MED, V25, P607, DOI 10.1097/00003246-199704000-00009; Dirkes S, 2013, NEPHROL NURS J, V40, P125; El-Achkar TM, 2008, EUR J CLIN INVEST, V38, P39, DOI 10.1111/j.1365-2362.2008.02007.x; Gutierrez MEH, 2000, MED CLIN-BARCELONA, V115, P721, DOI 10.1016/S0025-7753(00)71674-5; Hatzistilianou M, 2007, CLIN INVEST MED, V30, pE75; Hatzistilianou M, 2010, INFLAMM RES, V59, P339, DOI 10.1007/s00011-009-0100-0; Jensen JU, 2011, CRIT CARE MED, V39, P2048, DOI 10.1097/CCM.0b013e31821e8791; Kellum JA, 2005, INT J ARTIF ORGANS, V28, P441, DOI 10.1177/039139880502800503; Kes P, 1996, RENAL FAILURE, V18, P621, DOI 10.3109/08860229609047686; Lavrentieva A, 2012, BURNS, V38, P356, DOI 10.1016/j.burns.2011.08.021; Li H, 2010, J CRIT CARE, V25, P225, DOI 10.1016/j.jcrc.2009.07.009; Lopes JA, 2007, CRIT CARE, V11, DOI 10.1186/cc5735; Marotta F, 1996, DIGESTION, V57, P446, DOI 10.1159/000201373; Martinez J M, 2001, Surg Infect (Larchmt), V2, P193, DOI 10.1089/109629601317202678; MEDICH DS, 1993, AM J SURG, V165, P46, DOI 10.1016/S0002-9610(05)80403-9; Mishra Jaya, 2005, Lancet, V365, P1231, DOI 10.1016/S0140-6736(05)74811-X; Morgenthaler Nils G, 2002, Clin Lab, V48, P263; MOYA F, 1975, EUR J BIOCHEM, V55, P407, DOI 10.1111/j.1432-1033.1975.tb02176.x; Nie X, 2013, CLIN CHEM LAB MED, V51, P1655, DOI 10.1515/cclm-2012-0822; Oberhoffer M, 1999, J LAB CLIN MED, V134, P49, DOI 10.1016/S0022-2143(99)90053-7; Olaciregui I, 2009, ARCH DIS CHILD, V94, P501, DOI 10.1136/adc.2008.146530; Oppert M, 2008, NEPHROL DIAL TRANSPL, V23, P904, DOI 10.1093/ndt/gfm610; Oppert M, 2013, CRIT CARE MED, V41, P1155, DOI 10.1097/CCM.0b013e31828042c6; Parikh CR, 2011, J AM SOC NEPHROL, V22, P1737, DOI 10.1681/ASN.2010111163; Parmar A, 2009, CURR DRUG TARGETS, V10, P1169, DOI 10.2174/138945009789753183; Pavlidis TE, 2010, HEPATOB PANCREAT DIS, V9, P482; Pinto CF, 2012, REV ESC ENFERM USP, V46, P86, DOI 10.1590/S0080-62342012000700013; Pulliam PN, 2001, PEDIATRICS, V108, P1275, DOI 10.1542/peds.108.6.1275; Theodorou VP, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-247; Trautner BW, 2006, PEDIATRICS, V118, P34, DOI 10.1542/peds.2005-2823; Uchino S, 2010, CURR OPIN CRIT CARE, V16, P562, DOI 10.1097/MCC.0b013e32833ea7f3; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Wagner KE, 2002, CRIT CARE MED, V30, P2313, DOI 10.1097/00003246-200210000-00021; Wang XD, 1996, WORLD J SURG, V20, P299, DOI 10.1007/s002689900048; WIDDISON AL, 1994, GUT, V35, P1306, DOI 10.1136/gut.35.9.1306	47	28	36	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82250	10.1371/journal.pone.0082250	http://dx.doi.org/10.1371/journal.pone.0082250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349237	Green Submitted, Green Published, gold			2022-12-27	WOS:000328734200034
J	Masseret, E; Banack, S; Boumediene, F; Abadie, E; Brient, L; Pernet, F; Juntas-Morales, R; Pageot, N; Metcalf, J; Cox, P; Camu, W				Masseret, Estelle; Banack, Sandra; Boumediene, Farid; Abadie, Eric; Brient, Luc; Pernet, Fabrice; Juntas-Morales, Raoul; Pageot, Nicolas; Metcalf, James; Cox, Paul; Camu, William		French Network ALS Clusters	Dietary BMAA Exposure in an Amyotrophic Lateral Sclerosis Cluster from Southern France	PLOS ONE			English	Article							METHYLAMINO-L-ALANINE; NEUROTOXIC AMINO-ACID; THAU LAGOON; CYANOBACTERIAL NEUROTOXINS; NEURODEGENERATIVE DISEASE; GUAM; ALS; ENERGETICS; DEMENTIA; ALS/PDC	Background: Dietary exposure to the cyanotoxin BMAA is suspected to be the cause of amyotrophic lateral sclerosis in the Western Pacific Islands. In Europe and North America, this toxin has been identified in the marine environment of amyotrophic lateral sclerosis clusters but, to date, only few dietary exposures have been described. Objectives: We aimed at identifying cluster(s) of amyotrophic lateral sclerosis in the Herault district, a coastal district from Southern France, and to search, in the identified area(s), for the existence of a potential dietary source of BMAA. Methods: A spatio-temporal cluster analysis was performed in the district, considering all incident amyotrophic lateral sclerosis cases identified from 1994 to 2009 by our expert center. We investigated the cluster area with serial collections of oysters and mussels that were subsequently analyzed blind for BMAA concentrations. Results: We found one significant amyotrophic lateral sclerosis cluster (p = 0.0024), surrounding the Thau lagoon, the most important area of shellfish production and consumption along the French Mediterranean coast. BMAA was identified in mussels (1.8 mu g/g to 6.0 mu g/g) and oysters (0.6 mu g/g to 1.6 mu g/g). The highest concentrations of BMAA were measured during summer when the highest picocyanobacteria abundances were recorded. Conclusions: While it is not possible to ascertain a direct link between shellfish consumption and the existence of this ALS cluster, these results add new data to the potential association of BMAA with sporadic amyotrophic lateral sclerosis, one of the most severe neurodegenerative disorder.	[Masseret, Estelle] Univ Montpellier 2, Inst Rech Dev, Unite Mixte Rech 5119, Ecol Syst Marins Cotiers, Montpellier, France; [Banack, Sandra; Metcalf, James; Cox, Paul] Inst Ethnomed, Jackson, WY USA; [Boumediene, Farid] Univ Limoges, Unite Mixte Rech 1094, Limoges, France; [Abadie, Eric; Pernet, Fabrice] IFREMER, Lab Environm Ressources Languedoc Roussillon, Sete, France; [Brient, Luc] Univ Rennes 1, Unite Mixte Rech 6553, Rennes, France; [Juntas-Morales, Raoul; Pageot, Nicolas; Camu, William] Ctr Hosp Univ Gui de Chauliac, Amyotroph Lateral Sclerosis Ctr, Montpellier, France; [Juntas-Morales, Raoul; Pageot, Nicolas; Camu, William] Univ Montpellier I, INSERM, U1051, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite de Limoges; Ifremer; Universite de Rennes; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Camu, W (corresponding author), Ctr Hosp Univ Gui de Chauliac, Amyotroph Lateral Sclerosis Ctr, Montpellier, France.	w-camu@chu-montpellier.fr	camu, william/AAB-4727-2020; Pernet, Fabrice/B-4051-2008; MARIN, Benoit/E-2356-2015; MARIN, Benoit/HHZ-4976-2022; Preux, Pierre-Marie/B-8393-2014	Pernet, Fabrice/0000-0001-8886-0184; MARIN, Benoit/0000-0001-8857-0910; MARIN, Benoit/0000-0001-8857-0910; Juntas Morales, Raul/0000-0003-2205-1741; Preux, Pierre-Marie/0000-0002-2171-2977; metcalf, james/0000-0003-3011-3973; ABADIE, Eric/0000-0001-9431-2010; Masseret, Estelle/0000-0001-6856-8637; Cox, Paul/0000-0001-6401-2981	INSERM; Ifremer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ifremer	This work was supported by INSERM and Ifremer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banack SA, 2011, TOXICON, V57, P730, DOI 10.1016/j.toxicon.2011.02.005; Banack SA, 2006, J ETHNOPHARMACOL, V201, P244; Banack SA, 2010, TOXINS, V2, P2837, DOI 10.3390/toxins2122837; Banack SA, 2009, AMYOTROPH LATERAL SC, V10, P34, DOI 10.3109/17482960903278451; Boumediene F, 2011, J NEUROL SCI, V309, P115, DOI 10.1016/j.jns.2011.07.002; Bradley WG, 2009, AMYOTROPH LATERAL SC, V10, P7, DOI 10.3109/17482960903286009; Brand LE, 2010, HARMFUL ALGAE, V9, P620, DOI 10.1016/j.hal.2010.05.002; Caller TA, 2009, AMYOTROPH LATERAL SC, V10, P101, DOI 10.3109/17482960903278485; Collos Y, 2009, J SEA RES, V61, P68, DOI 10.1016/j.seares.2008.05.008; Cox PA, 2003, P NATL ACAD SCI USA, V100, P13380, DOI 10.1073/pnas.2235808100; Cox PA, 2005, P NATL ACAD SCI USA, V102, P5074, DOI 10.1073/pnas.0501526102; Cox PA, 2009, AMYOTROPH LATERAL SC, V10, P109, DOI 10.3109/17482960903286066; Dupuy C, 2000, MAR ECOL PROG SER, V205, P171, DOI 10.3354/meps205171; Field NC, 2013, TOXICON, V70, P179, DOI 10.1016/j.toxicon.2013.04.010; Gangnery A, 2004, AQUACULTURE, V229, P289, DOI 10.1016/S0044-8486(03)00360-0; Germonneau P., 2005, ENV RISQUES SANT, V4, P329; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Hawkins AJS, 1998, J EXP MAR BIOL ECOL, V219, P87, DOI 10.1016/S0022-0981(97)00176-7; Jonasson S, 2010, P NATL ACAD SCI USA, V107, P9252, DOI 10.1073/pnas.0914417107; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Martin-Creuzburg D, 2005, AQUAT MICROB ECOL, V41, P271, DOI 10.3354/ame041271; Metcalf JS, 2008, ENVIRON MICROBIOL, V10, P702, DOI 10.1111/j.1462-2920.2007.01492.x; Murch SJ, 2004, P NATL ACAD SCI USA, V101, P12228, DOI 10.1073/pnas.0404926101; Murch SJ, 2004, ACTA NEUROL SCAND, V110, P267, DOI 10.1111/j.1600-0404.2004.00320.x; Pablo J, 2009, ACTA NEUROL SCAND, V120, P216, DOI 10.1111/j.1600-0404.2008.01150.x; Pernet F, 2007, J EXP BIOL, V210, P2999, DOI 10.1242/jeb.006007; Pernet F, 2012, J SEA RES, V68, P20, DOI 10.1016/j.seares.2011.11.004; Personnic S, 2009, J PLANKTON RES, V31, P1161, DOI 10.1093/plankt/fbp057; Roney BR, 2009, AMYOTROPH LATERAL SC, V10, P44, DOI 10.3109/17482960903273031; SPENCER PS, 1987, SCIENCE, V237, P517, DOI 10.1126/science.3603037; STONE RA, 1988, STAT MED, V7, P649, DOI 10.1002/sim.4780070604; Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P1171, DOI 10.1001/archneur.57.8.1171; Trottet A, 2007, MAR BIOL, V151, P377, DOI 10.1007/s00227-006-0494-y; Weisskopf MG, 2009, J NEUROL NEUROSUR PS, V80, P558, DOI 10.1136/jnnp.2008.156976; WIDDOWS J, 1988, MAR ECOL PROG SER, V46, P113, DOI 10.3354/meps046113; Zaganas I, 2013, TOXICOLOGY, V307, P3, DOI 10.1016/j.tox.2013.02.002	36	95	98	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83406	10.1371/journal.pone.0083406	http://dx.doi.org/10.1371/journal.pone.0083406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349504	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200083
J	Parry, M; Rose-Zerilli, MJJ; Gibson, J; Ennis, S; Walewska, R; Forster, J; Parker, H; Davis, Z; Gardiner, A; Collins, A; Oscier, DG; Strefford, JC				Parry, Marina; Rose-Zerilli, Matthew J. J.; Gibson, Jane; Ennis, Sarah; Walewska, Renata; Forster, Jade; Parker, Helen; Davis, Zadie; Gardiner, Anne; Collins, Andrew; Oscier, David G.; Strefford, Jonathan C.			Whole Exome Sequencing Identifies Novel Recurrently Mutated Genes in Patients with Splenic Marginal Zone Lymphoma	PLOS ONE			English	Article							B-CELL LYMPHOMA; INACTIVATING MUTATIONS; SOMATIC MUTATIONS; GENOME; CANCER; METHYLATION; NOTCH2; EZH2	The pathogenesis of splenic marginal zone lymphoma (SMZL) remains largely unknown. Recent high-throughput sequencing studies have identified recurrent mutations in key pathways, most notably NOTCH2 mutations in >25% of patients. These studies are based on small, heterogeneous discovery cohorts, and therefore only captured a fraction of the lesions present in the SMZL genome. To identify further novel pathogenic mutations within related biochemical pathways, we applied whole exome sequencing (WES) and copy number (CN) analysis to a biologically and clinically homogeneous cohort of seven SMZL patients with 7q abnormalities and IGHV1-2*04 gene usage. We identified 173 somatic non-silent variants, affecting 160 distinct genes. In additional to providing independent validation of the presence of mutation in several previously reported genes (NOTCH2, TNFAIP3, MAP3K14, MLL2 and SPEN), our study defined eight additional recurrently mutated genes in SMZL; these genes are CREBBP, CBFA2T3, AMOTL1, FAT4, FBXO11, PLA2G4D, TRRAP and USH2A. By integrating our WES and CN data we identified three mutated putative candidate genes targeted by 7q deletions (CUL1, EZH2 and FLNC), with FLNC positioned within the well-characterized 7q minimally deleted region. Taken together, this work expands the reported directory of recurrently mutated cancer genes in this disease, thereby expanding our understanding of SMZL pathogenesis. Ultimately, this work will help to establish a stratified approach to care including the possibility of targeted therapy.	[Parry, Marina; Rose-Zerilli, Matthew J. J.; Gibson, Jane; Ennis, Sarah; Forster, Jade; Parker, Helen; Collins, Andrew; Oscier, David G.; Strefford, Jonathan C.] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Walewska, Renata; Davis, Zadie; Gardiner, Anne; Oscier, David G.] Royal Bournemouth Hosp, Dept Pathol, Bournemouth, Dorset, England	University of Southampton	Strefford, JC (corresponding author), Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England.	JCS@soton.ac.uk	Gibson, Jane/I-1630-2012; Collins, Andrew/A-6595-2010; Strefford, Jonathan/B-2826-2009; Collins, Andrew/S-2196-2019	Gibson, Jane/0000-0002-0973-8285; Collins, Andrew/0000-0001-7108-0771; Strefford, Jonathan/0000-0002-0972-2881; Collins, Andrew/0000-0001-7108-0771; Rose-Zerilli, Matthew/0000-0002-1064-5350; Forster, Jade/0000-0002-0107-1009	Leukaemia and Lymphoma Research; Cancer Research UK; Kay Kendall Leukaemia Fund; Wessex Medical Research; Bournemouth Leukaemia Fund	Leukaemia and Lymphoma Research; Cancer Research UK(Cancer Research UK); Kay Kendall Leukaemia Fund; Wessex Medical Research; Bournemouth Leukaemia Fund	The manuscript was supported by: Leukaemia and Lymphoma Research, Cancer Research UK, Kay Kendall Leukaemia Fund, Wessex Medical Research, Bournemouth Leukaemia Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bikos V, 2012, LEUKEMIA, V26, P1638, DOI 10.1038/leu.2012.3; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Fresquet V, 2012, BRIT J HAEMATOL, V158, P712, DOI 10.1111/j.1365-2141.2012.09226.x; Gruber TA, 2012, CANCER CELL, V22, P683, DOI 10.1016/j.ccr.2012.10.007; Imura M, 2006, CANCER LETT, V241, P213, DOI 10.1016/j.canlet.2005.10.010; Kiel MJ, 2012, J EXP MED, V209, P1553, DOI 10.1084/jem.20120910; Kim JH, 2009, ONCOL REP, V21, P1251, DOI 10.3892/or_00000348; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Matthews C, 2004, LEUKEMIA LYMPHOMA, V45, P1899, DOI 10.1080/10428190410001710812; Matutes E, 2008, LEUKEMIA, V22, P487, DOI 10.1038/sj.leu.2405068; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Novak U, 2009, BLOOD, V113, P4918, DOI 10.1182/blood-2008-08-174110; Parker H, 2011, LEUKEMIA, V25, P489, DOI 10.1038/leu.2010.288; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rossi D, 2012, J EXP MED, V209, P1537, DOI 10.1084/jem.20120904; Rossi D, 2011, BLOOD, V118, P4930, DOI 10.1182/blood-2011-06-359166; Salaverria I, 2012, GENE CHROMOSOME CANC, V51, P338, DOI 10.1002/gcc.21919; Salido M, 2010, BLOOD, V116, P1479, DOI 10.1182/blood-2010-02-267476; Shaffer LG, 2009, INT SYST HUM CYT NOM; Vanaja DK, 2009, CANCER INVEST, V27, P549, DOI 10.1080/07357900802620794; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Watkins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044997; Yi JM, 2011, CLIN CANCER RES, V17, P1535, DOI 10.1158/1078-0432.CCR-10-2509	26	57	59	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83244	10.1371/journal.pone.0083244	http://dx.doi.org/10.1371/journal.pone.0083244			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349473	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200071
J	Schamp, BS; Aarssen, LW; Wight, S				Schamp, Brandon S.; Aarssen, Lonnie W.; Wight, Stephanie			Effects of 'Target' Plant Species Body Size on Neighbourhood Species Richness and Composition in Old-Field Vegetation	PLOS ONE			English	Article							COMPETITIVE ABILITY; JUNIPER; BIOMASS; TRAITS; HETEROGENEITY; DEPENDENCE; DISPERSION; PATTERNS; RESOURCE	Competition is generally regarded as an important force in organizing the structure of vegetation, and evidence from several experimental studies of species mixtures suggests that larger mature plant size elicits a competitive advantage. However, these findings are at odds with the fact that large and small plant species generally coexist, and relatively smaller species are more common in virtually all plant communities. Here, we use replicates of ten relatively large old-field plant species to explore the competitive impact of target individual size on their surrounding neighbourhoods compared to nearby neighbourhoods of the same size that are not centred by a large target individual. While target individuals of the largest of our test species, Centaurea jacea L., had a strong impact on neighbouring species, in general, target species size was a weak predictor of the number of other resident species growing within its immediate neighbourhood, as well as the number of resident species that were reproductive. Thus, the presence of a large competitor did not restrict the ability of neighbouring species to reproduce. Lastly, target species size did not have any impact on the species size structure of neighbouring species; i.e. they did not restrict smaller, supposedly poorer competitors, from growing and reproducing close by. Taken together, these results provide no support for a size-advantage in competition restricting local species richness or the ability of small species to coexist and successfully reproduce in the immediate neighbourhood of a large species.	[Schamp, Brandon S.] Algoma Univ, Dept Biol, Sault Ste Marie, ON, Canada; [Aarssen, Lonnie W.; Wight, Stephanie] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Algoma University; Queens University - Canada	Schamp, BS (corresponding author), Algoma Univ, Dept Biol, Sault Ste Marie, ON, Canada.	Brandon.Schamp@algomau.ca			Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by Natural Sciences and Engineering Research Council of Canada Discovery Grants to B. Schamp and L. Aarssen. Link: http://www.nserc-crsng.gc.ca/index_eng.asp. NSERC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarssen LW, 2008, EVOL ECOL, V22, P279, DOI 10.1007/s10682-007-9170-z; Aarssen LW, 2006, J ECOL, V94, P569, DOI 10.1111/j.1365-2745.2006.01128.x; Aarssen LW, 2002, OIKOS, V96, P531, DOI 10.1034/j.1600-0706.2002.960314.x; Abella SR, 2008, J TORREY BOT SOC, V135, P26, DOI 10.3159/07-RA-019R1.1; [Anonymous], 2001, PLANT STRATEGIES VEG; ARMENTROUT SM, 1988, J RANGE MANAGE, V41, P139, DOI 10.2307/3898949; BEATTY SW, 1984, ECOLOGY, V65, P1406, DOI 10.2307/1939121; Bonser SP, 2013, FUNCT ECOL, V27, P876, DOI 10.1111/1365-2435.12064; Breshears DD, 1997, ECOL APPL, V7, P1201, DOI 10.1890/1051-0761(1997)007[1201:OIHISR]2.0.CO;2; Cahill JF, 2000, OIKOS, V90, P311, DOI 10.1034/j.1600-0706.2000.900211.x; Caley MJ, 1997, ECOLOGY, V78, P70; Chambers J, 2009, EVOL ECOL, V23, P737, DOI 10.1007/s10682-008-9269-x; EVERETT RL, 1983, B TORREY BOT CLUB, V110, P454, DOI 10.2307/2996279; Forgo P, 2012, FITOTERAPIA, V83, P921, DOI 10.1016/j.fitote.2012.04.006; FROST WE, 1991, J RANGE MANAGE, V44, P286, DOI 10.2307/4002959; GAUDET CL, 1988, NATURE, V334, P242, DOI 10.1038/334242a0; GERRY AK, 1995, ECOLOGY, V76, P272, DOI 10.2307/1940648; Gleason H.A., 1991, MANUAL VASCULAR PLAN, V2nd ed.; Goldberg DE, 1996, PHILOS T R SOC B, V351, P1377, DOI 10.1098/rstb.1996.0121; GOLDBERG DE, 1991, J ECOL, V79, P1013, DOI 10.2307/2261095; Grace J. B., 1990, Perspectives on plant competition., P51; GRACE JB, 1985, ECOLOGY, V66, P1630, DOI 10.2307/1938025; Hierro JL, 2003, PLANT SOIL, V256, P29, DOI 10.1023/A:1026208327014; Keating LM, 2009, J PLANT ECOL, V2, P119, DOI 10.1093/jpe/rtp012; Keddy P, 2002, J VEG SCI, V13, P5, DOI 10.1111/j.1654-1103.2002.tb02018.x; Keddy P., 2001, COMPETITION; KEDDY PA, 1989, OIKOS, V54, P234, DOI 10.2307/3565272; Keddy Paul A., 1994, Journal of Ecology, V82, P635, DOI 10.2307/2261270; Kiaer LP, 2013, J ECOL, V101, P1298, DOI 10.1111/1365-2745.12129; Lamb EG, 2006, ECOLOGY, V87, P1452, DOI 10.1890/0012-9658(2006)87[1452:ANRATT]2.0.CO;2; Lankau RA, 2011, J ECOL, V99, P176, DOI 10.1111/j.1365-2745.2010.01736.x; Lopez-Pintor A, 2006, ACTA OECOL, V29, P247, DOI 10.1016/j.actao.2005.11.001; Neytcheva MS, 2008, OIKOS, V117, P1298, DOI 10.1111/j.0030-1299.2008.16695.x; Oksanen J, 1996, J ECOL, V84, P293, DOI 10.2307/2261364; Perry LG, 2005, J ECOL, V93, P1126, DOI 10.1111/j.1365-2745.2005.01044.x; Ren H, 2008, PROG NAT SCI-MATER, V18, P137, DOI 10.1016/j.pnsc.2007.07.008; Rosch H, 1997, J VEG SCI, V8, P489, DOI 10.2307/3237200; Schamp B, 2011, PRESLIA, V83, P329; Schamp BS, 2008, J ECOL, V96, P204, DOI 10.1111/j.1365-2745.2007.01328.x; Schamp BS, 2010, OECOLOGIA, V162, P995, DOI 10.1007/s00442-009-1499-2; Schamp BS, 2009, OIKOS, V118, P564, DOI 10.1111/j.1600-0706.2009.16589.x; SCHOTT MR, 1985, J RANGE MANAGE, V38, P328, DOI 10.2307/3899414; Song YB, 2013, OECOLOGIA, V171, P317, DOI 10.1007/s00442-012-2430-9; Stubbs WJ, 2004, J ECOL, V92, P557, DOI 10.1111/j.0022-0477.2004.00898.x; TAYLOR DR, 1990, AM NAT, V136, P305, DOI 10.1086/285100; Tracey AJ, 2011, J PLANT ECOL, V4, P115, DOI 10.1093/jpe/rtr008; Violle C, 2009, OECOLOGIA, V160, P747, DOI 10.1007/s00442-009-1333-x; Wang P, 2010, FUNCT ECOL, V24, P196, DOI 10.1111/j.1365-2435.2009.01612.x; Waugh JM, 2012, ECOL EVOL, V2, P719, DOI 10.1002/ece3.62; Weiher E, 1998, OIKOS, V81, P309, DOI 10.2307/3547051; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; Weiner J, 2009, J ECOL, V97, P1220, DOI 10.1111/j.1365-2745.2009.01559.x; Zhang ST, 2012, PLANT ECOL, V213, P15, DOI 10.1007/s11258-011-0002-4	53	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82036	10.1371/journal.pone.0082036	http://dx.doi.org/10.1371/journal.pone.0082036			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349177	Green Submitted, Green Published, gold			2022-12-27	WOS:000328734200022
J	Tiziani, S; Kang, YY; Harjanto, R; Axelrod, J; Piermarocchi, C; Roberts, W; Paternostro, G				Tiziani, Stefano; Kang, Yunyi; Harjanto, Ricky; Axelrod, Joshua; Piermarocchi, Carlo; Roberts, William; Paternostro, Giovanni			Metabolomics of the Tumor Microenvironment in Pediatric Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							L-ASPARAGINASE ACTIVITY; REGULATORY NETWORKS; CANCER; METABOLISM; SERUM; RISK; SENSITIVITY; RESISTANCE; GLUTAMINE; ONCOLOGY	The tumor microenvironment is emerging as an important therapeutic target. Most studies, however, are focused on the protein components, and relatively little is known of how the microenvironmental metabolome might influence tumor survival. In this study, we examined the metabolic profiles of paired bone marrow (BM) and peripheral blood (PB) samples from 10 children with acute lymphoblastic leukemia (ALL). BM and PB samples from the same patient were collected at the time of diagnosis and after 29 days of induction therapy, at which point all patients were in remission. We employed two analytical platforms, high-resolution magnetic resonance spectroscopy and gas chromatography-mass spectrometry, to identify and quantify 102 metabolites in the BM and PB. Standard ALL therapy, which includes l-asparaginase, completely removed circulating asparagine, but not glutamine. Statistical analyses of metabolite correlations and network reconstructions showed that the untreated BM microenvironment was characterized by a significant network-level signature: a cluster of highly correlated lipids and metabolites involved in lipid metabolism (p<0.006). In contrast, the strongest correlations in the BM upon remission were observed among amino acid metabolites and derivatives (p<9.2x10(-10)). This study provides evidence that metabolic characterization of the cancer niche could generate new hypotheses for the development of cancer therapies.	[Tiziani, Stefano; Kang, Yunyi; Harjanto, Ricky; Axelrod, Joshua; Paternostro, Giovanni] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Piermarocchi, Carlo] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [Roberts, William] Univ Calif San Diego, Dept Pediat, Rady Childrens Hosp, San Diego, CA 92103 USA; [Tiziani, Stefano] Univ Texas Austin, Dept Nutr Sci, Dell Pediat Res Inst, Austin, TX 78712 USA	Sanford Burnham Prebys Medical Discovery Institute; Michigan State University; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Austin	Tiziani, S (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA USA.	tiziani@austin.utexas.edu; giovanni@sanfordburnham.org	Piermarocchi, Carlo/AAH-2162-2019; Piermarocchi, Carlo/A-2427-2008	Piermarocchi, Carlo/0000-0003-2762-8562; Piermarocchi, Carlo/0000-0003-2762-8562; Axelrod, Joshua/0000-0002-4307-8452	National Science Foundation [0829891]	National Science Foundation(National Science Foundation (NSF))	This work was funded by the National Science Foundation (Grant No. 0829891). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; Asiago VM, 2010, CANCER RES, V70, P8309, DOI 10.1158/0008-5472.CAN-10-1319; Avramis VI, 2006, INT J NANOMED, V1, P241; Avramis VI, 2002, BLOOD, V99, P1986, DOI 10.1182/blood.V99.6.1986; Ayala F, 2009, LEUKEMIA, V23, P2233, DOI 10.1038/leu.2009.175; BARNES D, 1980, CELL, V22, P649, DOI 10.1016/0092-8674(80)90540-1; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolann BJ, 2007, SCAND J CLIN LAB INV, V67, P353, DOI 10.1080/00365510601095281; BROOME JD, 1961, NATURE, V191, P1114, DOI 10.1038/1911114a0; Burstein HJ, 2011, J CLIN ONCOL, V29, P3328, DOI 10.1200/JCO.2011.36.0354; Butte A J, 2000, Pac Symp Biocomput, P418; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chen SH, 2011, LEUKEMIA, V25, P66, DOI 10.1038/leu.2010.256; D'Onofrio G, 1998, LAB HEMATOLOGY, V4, P71; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Escherich G, 2011, HAEMATOL-HEMATOL J, V96, P854, DOI 10.3324/haematol.2010.039735; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gaynon PS, 2005, BRIT J HAEMATOL, V131, P579, DOI 10.1111/j.1365-2141.2005.05773.x; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Grigoryan RS, 2004, IN VIVO, V18, P107; Hiller K, 2013, CURR OPIN BIOTECH, V24, P60, DOI 10.1016/j.copbio.2012.11.001; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Kawedia JD, 2012, BLOOD, V119, P1658, DOI 10.1182/blood-2011-09-381731; Lodi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056422; Lodi A, 2011, ACS CHEM BIOL, V6, P169, DOI 10.1021/cb900300j; Ludwig C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-366; MacIntyre DA, 2010, LEUKEMIA, V24, P788, DOI 10.1038/leu.2009.295; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Nielsen SF, 2012, NEW ENGL J MED, V367, P1792, DOI 10.1056/NEJMoa1201735; Offman MN, 2011, BLOOD, V117, P1614, DOI 10.1182/blood-2010-07-298422; Panosyan EH, 2004, ANTICANCER RES, V24, P1121; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Richards NGJ, 2006, ANNU REV BIOCHEM, V75, P629, DOI 10.1146/annurev.biochem.75.103004.142520; Rosenberg S.A., 2008, DEVITA HELLMAN ROSEN; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Schrappe M, 2012, NEW ENGL J MED, V366, P1371, DOI 10.1056/NEJMoa1110169; Serkova NJ, 2011, AM J RESP CRIT CARE, V184, P647, DOI 10.1164/rccm.201103-0474CI; Spratlin JL, 2009, CLIN CANCER RES, V15, P431, DOI 10.1158/1078-0432.CCR-08-1059; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Telang S, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-77; Tiziani S, 2008, ANAL BIOCHEM, V377, P16, DOI 10.1016/j.ab.2008.01.037; Tiziani S, 2009, NEOPLASIA, V11, P269, DOI 10.1593/neo.81396; Travlos GS, 2006, TOXICOL PATHOL, V34, P548, DOI 10.1080/01926230600939856; Tsurusawa M, 2004, CANCER CHEMOTH PHARM, V53, P204, DOI 10.1007/s00280-003-0734-5; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; WATERWORTH PM, 1978, J ANTIMICROB CHEMOTH, V4, P4, DOI 10.1093/jac/4.1.4; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065	54	39	48	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82859	10.1371/journal.pone.0082859	http://dx.doi.org/10.1371/journal.pone.0082859			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349380	gold, Green Published, Green Submitted			2022-12-27	WOS:000328734200058
J	Wang, SS; Liu, YF; Ou, YC; Chen, CS; Li, JR; Yang, SF				Wang, Shian-Shiang; Liu, Yu-Fan; Ou, Yen-Chuan; Chen, Chuan-Shu; Li, Jian-Ri; Yang, Shun-Fa			Impacts of CA9 Gene Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Characteristics in Taiwan	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-IX; HUMAN HEPATOCELLULAR-CARCINOMA; INVASIVE BLADDER-CANCER; DNA-REPAIR GENES; URINARY-TRACT; EXPRESSION; HYPOXIA; ASSOCIATION; RISK; PROGNOSIS	Background: Carbonic anhydrase 9 (CA9) is reportedly overexpressed in several types of carcinomas and is generally considered a marker of malignancy. The current study explored the effect of CA9 gene polymorphisms on the susceptibility of developing urothelial cell carcinoma (UCC) and the clinicopathological status. Methodology and Principal Findings: A total of 442 participants, including 221 healthy people and 221 patients with UCC, were recruited for this study. Four single-nucleotide polymorphisms (SNPs) of the CA9 gene were assessed by a real-time PCR with the TaqMan assay. After adjusting for other co-variants, the individuals carrying at least one A allele at CA9 rs1048638 had a 2.303-fold risk of developing UCC than did wild-type (CC) carriers. Furthermore, UCC patients who carried at least one A allele at rs1048638 had a higher invasive stage risk (p < 0.05) than did patients carrying the wild-type allele. Moreover, among the UCC patients with smoker, people with at least one A allele of CA9 polymorphisms (rs1048638) had a 4.75-fold (95% CI = 1.204-18.746) increased risk of invasive cancer. Conclusion: The rs1048638 polymorphic genotypes of CA9 might contribute to the prediction of susceptibility to and pathological development of UCC. This is the first study to provide insight into risk factors associated with CA9 variants in carcinogenesis of UCC in Taiwan.	[Wang, Shian-Shiang; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Wang, Shian-Shiang; Ou, Yen-Chuan; Chen, Chuan-Shu; Li, Jian-Ri] Taichung Vet Gen Hosp, Div Urol, Dept Surg, Taichung, Taiwan; [Liu, Yu-Fan] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan	Chung Shan Medical University; Taichung Veterans General Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Yang, SF (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	ysf@csmu.edu.tw	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927	National Science Council, Taiwan [NSC 96-2628-B-040-021-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a research grant from National Science Council, Taiwan (NSC 96-2628-B-040-021-MY3). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051301; Brockton NT, 2012, ORAL ONCOL, V48, P615, DOI 10.1016/j.oraloncology.2012.01.018; Bui MHT, 2003, CLIN CANCER RES, V9, P802; Chen M, 2010, CANCER PREV RES, V3, P1235, DOI 10.1158/1940-6207.CAPR-10-0035; Chien MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051051; Chung CJ, 2013, TOXICOL LETT, V216, P16, DOI 10.1016/j.toxlet.2012.11.002; Chung CJ, 2011, SCI TOTAL ENVIRON, V409, P465, DOI 10.1016/j.scitotenv.2010.10.053; Colin P, 2009, BJU INT, V104, P1436, DOI 10.1111/j.1464-410X.2009.08838.x; de Martino M, 2009, J UROLOGY, V182, P728, DOI 10.1016/j.juro.2009.03.077; Garcia-Closas M, 2005, LANCET, V366, P649, DOI 10.1016/S0140-6736(05)67137-1; Genega EM, 2010, AM J CLIN PATHOL, V134, P873, DOI 10.1309/AJCPPPR57HNJMSLZ; Giatromanolaki A, 2001, CANCER RES, V61, P7992; Guirado M, 2012, HUM IMMUNOL, V73, P668, DOI 10.1016/j.humimm.2012.03.006; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Health Do, 2010, CANC RESG ANN REP; Hedley D, 2003, CLIN CANCER RES, V9, P5666; Ivanov S, 2001, AM J PATHOL, V158, P905, DOI 10.1016/S0002-9440(10)64038-2; Jacobs BL, 2010, CA-CANCER J CLIN, V60, P244, DOI 10.3322/caac.20077; Klatte T, 2009, CANCER-AM CANCER SOC, V115, P1448, DOI 10.1002/cncr.24163; Koukourakis MI, 2001, CLIN CANCER RES, V7, P3399; Liao SY, 2010, GYNECOL ONCOL, V116, P452, DOI 10.1016/j.ygyno.2009.10.062; Mittal RD, 2012, MOL BIOL REP, V39, P1667, DOI 10.1007/s11033-011-0906-z; Peridis S, 2011, EUR ARCH OTO-RHINO-L, V268, P661, DOI 10.1007/s00405-011-1488-z; Potter CPS, 2003, BRIT J CANCER, V89, P2, DOI 10.1038/sj.bjc.6600936; Rouissi K, 2011, B CANCER, V98, pE1, DOI 10.1684/bdc.2011.1312; Safarinejad MR, 2011, ARCH TOXICOL, V85, P1209, DOI 10.1007/s00204-011-0671-8; Sagalowsky A I JT, 2011, UROTHELIAL TUMORS UP, P1526; Sakano S, 2006, BRIT J CANCER, V95, P561, DOI 10.1038/sj.bjc.6603290; Shastry BS, 2009, METHODS MOL BIOL, V578, P3, DOI 10.1007/978-1-60327-411-1_1; Stern MC, 2009, CANCER RES, V69, P6857, DOI 10.1158/0008-5472.CAN-09-1091; Stillebroer AB, 2010, EUR UROL, V58, P75, DOI 10.1016/j.eururo.2010.03.015; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; VAUPEL P, 1989, CANCER RES, V49, P6449; Wang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040219; Wang YH, 2011, ANTICANCER RES, V31, P3939; Wang YH, 2009, UROLOGY, V73, P670, DOI 10.1016/j.urology.2008.09.048; Wei CW, 2009, ACTA PHARMACOL SIN, V30, P1297, DOI 10.1038/aps.2009.124; Wu CC, 2013, TOXICOL APPL PHARM; Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039466; Yu YL, 2012, J CELL PHYSIOL, V227, P213, DOI 10.1002/jcp.22719; Yu YL, 2010, J AGR FOOD CHEM, V58, P1630, DOI 10.1021/jf903043r; Zeegers MPA, 2000, CANCER-AM CANCER SOC, V89, P630, DOI 10.1002/1097-0142(20000801)89:3<630::AID-CNCR19>3.0.CO;2-Q	42	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82804	10.1371/journal.pone.0082804	http://dx.doi.org/10.1371/journal.pone.0082804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349364	Green Published, gold			2022-12-27	WOS:000328734200055
J	Wilkinson, C; Weitkamp, E				Wilkinson, Clare; Weitkamp, Emma			A Case Study in Serendipity: Environmental Researchers Use of Traditional and Social Media for Dissemination	PLOS ONE			English	Article							SCIENCE COMMUNICATION; JOURNALISM	In the face of demands for researchers to engage more actively with a wider range of publics and to capture different kinds of research impacts and engagements, we explored the ways a small number of environmental researchers use traditional and social media to disseminate research. A questionnaire was developed to investigate the impact of different media as a tool to broker contact between researchers and a variety of different stakeholders (for example, publics, other researchers, policymakers, journalists) as well as how researchers perceive that their use of these media has changed over the past five years. The questionnaire was sent to 504 researchers whose work had featured in a policy-oriented e-news service. 149 valid responses were received (29%). Coverage in traditional media (newspapers, broadcast) not only brokers contact with other journalists, but is a good source of contact from other researchers (n=47, 62%) and members of the public (n=36, 26%). Although the use of social media was limited amongst our sample, it did broker contact with other researchers (n=17, 47%) and the public (n=10, 28%). Nevertheless, few environmental researchers were actively using social media to disseminate their research findings, with many continuing to rely on academic journals and face-to-face communication to reach both academic and public audiences.	[Wilkinson, Clare; Weitkamp, Emma] Univ W England, Sci Commun Unit, Bristol BS16 1QY, Avon, England	University of West England	Wilkinson, C (corresponding author), Univ W England, Sci Commun Unit, Bristol BS16 1QY, Avon, England.	Clare.Wilkinson@uwe.ac.uk		weitkamp, emma/0000-0003-1296-5822; Wilkinson, Clare/0000-0002-7465-8142	European Commission, Directorate General Environment [070307/2010/576689/SER/0034]	European Commission, Directorate General Environment	The survey was undertaken in the context of a project supported by the European Commission, Directorate General Environment through contract no: 070307/2010/576689/SER/0034 (http://ec.europa.eu/dgs/environment/index_en.htm). The funders approved the survey design and the manuscript before submission.	Allan S, 2002, MEDIA RISK SCI; Allgaier J, 2013, BIOSCIENCE, V63, P284, DOI 10.1525/bio.2013.63.4.8; Bauer MW, 2009, SCI TECHNOL SOC, V14, P221, DOI 10.1177/097172180901400202; Berkowitz D., 1994, PUBLIC OPINION PRESS, P81; Brossard D, 2013, SCIENCE, V339, P40, DOI 10.1126/science.1232329; Bultitude K, 2012, J SCI COMMUNICATION, V11, pC01; Davies Nick., 2008, FLAT EARTH NEWS; Ecklund EH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036240; European Commission, 2012, SCI ENV POL; Finch Janet, 2012, REPORT WORKING GROUP; Harley D., 2010, CALIFORNIA J POLITIC, V2, P1; Holliman R, 2011, JOURNALISM, V12, P832, DOI 10.1177/1464884911412707; Khot A, 2011, THESIS UWE BRISTOL; Napu MH, 2012, THESIS TILBURG U NET; Nisbet MC, 2009, AM J BOT, V96, P1767, DOI 10.3732/ajb.0900041; Nisbet MC, 2002, SCI COMMUN, V23, P359, DOI 10.1177/107554700202300401; Peters HP, 2008, SCIENCE, V321, P204, DOI 10.1126/science.1157780; Peters HP, 2012, SOCIOLOGY SCI YB, V28, P266; Petersen A, 2009, PUBLIC UNDERST SCI, V18, P512, DOI 10.1177/0963662507084202; Pew Research Center for the People & the Press, 2008, AUD SEG CHANG NEWS E; Royal Society, 2006, SCI PUBL INT; Russell M, 2010, INDEPENDENT CLIMATE; Sardo AM, 2012, JCOM-J SCI COMMUN, V11; The royal society, 2012, SCI OP ENT; Trench B, 2012, SOCIOL SCI YEARB, V28, P273, DOI 10.1007/978-94-007-2085-5_14; Van Eperen L, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-199; Weitkamp E., 2010, INTRO SCI COMMUNICAT, P79	27	22	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e84339	10.1371/journal.pone.0084339	http://dx.doi.org/10.1371/journal.pone.0084339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349571	gold, Green Published, Green Submitted			2022-12-27	WOS:000328734200112
J	Bennett, BT; Mohamed, JS; Alway, SE				Bennett, Brian T.; Mohamed, Junaith S.; Alway, Stephen E.			Effects of Resveratrol on the Recovery of Muscle Mass Following Disuse in the Plantaris Muscle of Aged Rats	PLOS ONE			English	Article							SKELETAL-MUSCLE; OXIDATIVE STRESS; GASTROCNEMIUS-MUSCLES; UBIQUITIN-PROTEASOME; PROTEIN-DEGRADATION; OLD RATS; SARCOPENIA; APOPTOSIS; INDUCTION; CELLS	Aging is associated with poor skeletal muscle regenerative ability following extended periods of hospitalization and other forms of muscular disuse. Resveratrol (3,5,4'-trihydroxystilbene) is a natural phytoalexin which has been shown in skeletal muscle to improve oxidative stress levels in muscles of aged rats. As muscle disuse and reloading after disuse increases oxidative stress, we hypothesized that resveratrol supplementation would improve muscle regeneration after disuse. A total of thirty-six male Fisher 344 x Brown Norway rats (32 mo.) were treated with either a water vehicle or resveratrol via oral gavage. The animals received hindlimb suspension for 14 days. Thereafter, they were either sacrificed or allowed an additional 14 day period of cage ambulation during reloading. A total of six rats from the vehicle and the resveratrol treated groups were used for the hindlimb suspension and recovery protocols. Furthermore, two groups of 6 vehicle treated animals maintained normal ambulation throughout the experiment, and were used as control animals for the hindlimb suspension and reloading groups. The data show that resveratrol supplementation was unable to attenuate the decreases in plantaris muscle wet weight during hindlimb suspension but it improved muscle mass during reloading after hindlimb suspension. Although resveratrol did not prevent fiber atrophy during the period of disuse, it increased the fiber cross sectional area of type IIA and IIB fibers in response to reloading after hindlimb suspension. There was a modest enhancement of myogenic precursor cell proliferation in resveratrol-treated muscles after reloading, but this failed to reach statistical significance. The resveratrol-associated improvement in type II fiber size and muscle mass recovery after disuse may have been due to decreases in the abundance of pro-apoptotic proteins Bax, cleaved caspase 3 and cleaved caspase 9 in reloaded muscles. Resveratrol appears to have modest therapeutic benefits for improving muscle mass after disuse in aging.	[Bennett, Brian T.; Mohamed, Junaith S.; Alway, Stephen E.] W Virginia Univ, Sch Med, Muscle Biol Lab, Morgantown, WV 26506 USA; [Bennett, Brian T.; Mohamed, Junaith S.; Alway, Stephen E.] W Virginia Univ, Sch Med, Sarcopenia Div Exercise Physiol, Morgantown, WV 26506 USA; [Bennett, Brian T.; Mohamed, Junaith S.; Alway, Stephen E.] West Virginia Ctr Clin & Translat Sci Inst, Morgantown, WV USA; [Alway, Stephen E.] W Virginia Univ, Sch Med, Ctr Cardiovasc & Resp Sci, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University	Alway, SE (corresponding author), W Virginia Univ, Sch Med, Muscle Biol Lab, Morgantown, WV 26506 USA.	salway@hsc.wvu.edu	Mohamed, Junaith/AAC-4050-2020; Alway, Stephen E./AAF-8834-2020	Alway, Stephen/0000-0002-0378-4707; Bennett, Brian T/0000-0001-7795-6260	National Institute of General Medical Sciences of the National Institutes of Health [U54GM104942]; Mary Babb Randolph Cancer Center; NIH [5P20RR016440-09]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942, P30GM103488] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Mary Babb Randolph Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number U54GM104942. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The West Virginia University Microscope Imaging Facility is supported by the Mary Babb Randolph Cancer Center and NIH grant 5P20RR016440-09. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamdari N, 2012, BIOCHEM BIOPH RES CO, V417, P528, DOI 10.1016/j.bbrc.2011.11.154; Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alway SE, 2002, EXP GERONTOL, V37, P665, DOI 10.1016/S0531-5565(02)00003-7; ALWAY SE, 2011, HDB BIOL AGING, P64; Alway SE, 2008, EXERC SPORT SCI REV, V36, P51, DOI 10.1097/JES.0b013e318168e9dc; Alway SE, 2013, EXP GERONTOL, V48, P973, DOI 10.1016/j.exger.2013.06.005; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Boldrin L, 2007, CURR OPIN NEUROL, V20, P577, DOI 10.1097/WCO.0b013e3282ef5919; Burton LA, 2010, CLIN INTERV AGING, V5, P217; Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1; Chakravarthy MV, 2000, J APPL PHYSIOL, V89, P1365, DOI 10.1152/jappl.2000.89.4.1365; Chen CZ, 2013, FOOD CHEM TOXICOL, V59, P8, DOI 10.1016/j.fct.2013.05.030; Chen KD, 2001, MUSCLE NERVE, V24, P211, DOI 10.1002/1097-4598(200102)24:2<211::AID-MUS60>3.0.CO;2-D; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dolinsky VW, 2012, J PHYSIOL-LONDON, V590, P2783, DOI 10.1113/jphysiol.2012.230490; Gorbunov N, 2012, J CELL MOL MED, V16, P174, DOI 10.1111/j.1582-4934.2011.01281.x; Gu J, 2012, CARDIOVASC TOXICOL, V12, P341, DOI 10.1007/s12012-012-9178-7; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hao YL, 2011, AM J PHYSIOL-REG I, V301, pR701, DOI 10.1152/ajpregu.00840.2010; Hwee DT, 2009, J GERONTOL A-BIOL, V64, P618, DOI 10.1093/gerona/glp026; Jackson JR, 2011, J GERONTOL A-BIOL, V66, P751, DOI 10.1093/gerona/glr047; Jackson JR, 2010, AM J PHYSIOL-REG I, V299, pR1572, DOI 10.1152/ajpregu.00489.2010; Karagounis LG, 2010, INT J BIOCHEM CELL B, V42, P1376, DOI 10.1016/j.biocel.2010.05.013; Magne H, 2011, J PHYSIOL-LONDON, V589, P511, DOI 10.1113/jphysiol.2010.201707; Marzetti E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032829; Marzetti E, 2012, GERONTOLOGY, V58, P99, DOI 10.1159/000330064; Momken I, 2011, FASEB J, V25, P3646, DOI 10.1096/fj.10-177295; Pierno S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065167; Pierno S, 2012, AMINO ACIDS, V43, P431, DOI 10.1007/s00726-011-1099-4; Pistilli EE, 2007, AM J PHYSIOL-CELL PH, V292, pC1298, DOI 10.1152/ajpcell.00496.2006; Rathbone CR, 2009, EUR J CELL BIOL, V88, P35, DOI 10.1016/j.ejcb.2008.08.003; Russell ST, 2006, CELL SIGNAL, V18, P1087, DOI 10.1016/j.cellsig.2005.09.009; Ryan MJ, 2010, J GERONTOL A-BIOL, V65, P815, DOI 10.1093/gerona/glq080; Selsby JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030063; Siu PM, 2005, AM J PHYSIOL-CELL PH, V288, pC338, DOI 10.1152/ajpcell.00239.2004; Suetta C, 2009, J APPL PHYSIOL, V107, P1172, DOI 10.1152/japplphysiol.00290.2009; Wang Y, 2013, CELL TISSUE RES, V351, P183, DOI 10.1007/s00441-012-1515-4; Waters DL, 2010, CLIN INTERV AGING, V5, P259, DOI 10.2147/CIA.S6920; Wyke SM, 2006, LIFE SCI, V78, P2898, DOI 10.1016/j.lfs.2005.11.014; Wyke SM, 2004, BRIT J CANCER, V91, P1742, DOI 10.1038/sj.bjc.6602165; Xu JZ, 2012, EXP GERONTOL, V47, P100, DOI 10.1016/j.exger.2011.10.011; Yuan HF, 2012, J MOL MED, V90, P389, DOI 10.1007/s00109-011-0825-4; Yuan HT, 2013, NEUROCHEM INT, V63, P146, DOI 10.1016/j.neuint.2013.05.011; Zhang JY, 2012, DIABETES RES CLIN PR, V97, P474, DOI 10.1016/j.diabres.2012.02.029	44	72	75	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83518	10.1371/journal.pone.0083518	http://dx.doi.org/10.1371/journal.pone.0083518			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349525	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800123
J	Parassol, N; Bienvenu, C; Boglio, C; Fiorucci, S; Cerezo, D; Yu, XM; Godeau, G; Greiner, J; Vierling, P; Noselli, S; Di Giorgio, C; Van De Bor, V				Parassol, Nadege; Bienvenu, Celine; Boglio, Cecile; Fiorucci, Sebastien; Cerezo, Delphine; Yu, Xiao-Min; Godeau, Guilhem; Greiner, Jacques; Vierling, Pierre; Noselli, Stephane; Di Giorgio, Christophe; Van De Bor, Veronique			In Vivo Characterization of Dynein-Driven nanovectors Using Drosophila Oocytes	PLOS ONE			English	Article							SINGLE-PARTICLE TRACKING; LIGHT-CHAIN LC8; INTRACELLULAR TRAFFICKING; LOCALIZATION SIGNALS; CARGO TRANSPORT; RNA; MOTOR; MICROTUBULES; COMPLEX; PROTEIN	Molecular motors transport various cargoes including vesicles, proteins and mRNAs, to distinct intracellular compartments. A significant challenge in the field of nanotechnology is to improve drug nuclear delivery by engineering nanocarriers transported by cytoskeletal motors. However, suitable in vivo models to assay transport and delivery efficiency remain very limited. Here, we develop a fast and genetically tractable assay to test the efficiency and dynamics of fluospheres (FS) using microinjection into Drosophila oocytes coupled with time-lapse microscopy. We designed dynein motor driven FS using a collection of dynein light chain 8 (LC8) peptide binding motifs as molecular linkers and characterized in real time the efficiency of the FS movement according to its linker's sequence. Results show that the conserved LC8 binding motif allows fast perinuclear nanoparticle's accumulation in a microtubule and dynein dependent mechanism. These data reveal the Drosophila oocyte as a new valuable tool for the design of motor driven nanovectors.	[Parassol, Nadege; Cerezo, Delphine; Noselli, Stephane; Van De Bor, Veronique] Univ Nice Sophia Antipolis, Inst Biol Valrose, UMR CNRS 7277, UMR INSERM 1091, F-06189 Nice, France; [Bienvenu, Celine; Boglio, Cecile; Fiorucci, Sebastien; Yu, Xiao-Min; Godeau, Guilhem; Greiner, Jacques; Vierling, Pierre; Di Giorgio, Christophe] Univ Nice Sophia Antipolis, ICN, UMR CNRS 7272, F-06189 Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Di Giorgio, C (corresponding author), Univ Nice Sophia Antipolis, ICN, UMR CNRS 7272, F-06189 Nice, France.	Christophe.DI-GIORGIO@unice.fr; Veronique.VAN-DE-BOR@unice.fr	Godeau, Guilhem/AAE-3426-2022; Fiorucci, Sebastien/A-2060-2010	Godeau, Guilhem/0000-0002-2111-9858; Fiorucci, Sebastien/0000-0003-2245-0478; Noselli, stephane/0000-0002-7296-324X; Van De Bor, Veronique/0000-0001-7157-4456	Centre National de la Recherche Scientifique; Ministere de la Recherche et de l'Enseignement Superieur; Agence Nationale de la Recherche [ANR-09-BLAN-0113]; Association Francaise contre les Myopathies	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Ministere de la Recherche et de l'Enseignement Superieur; Agence Nationale de la Recherche(French National Research Agency (ANR)); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	The authors acknowledge research support from the "Centre National de la Recherche Scientifique", the "Ministere de la Recherche et de l'Enseignement Superieur", the "Agence Nationale de la Recherche" (program ANR-09-BLAN-0113), the "Association Francaise contre les Myopathies". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita H, 2013, MOL THER, V21, P309, DOI 10.1038/mt.2012.235; Amrute-Nayak M, 2012, NAT CELL BIOL, V14, P416, DOI 10.1038/ncb2446; Bacher CP, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-45; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Bergen JM, 2007, MOL PHARMACEUT, V4, P119, DOI 10.1021/mp060086o; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Delanoue R, 2005, CELL, V122, P97, DOI 10.1016/j.cell.2005.04.033; Dick T, 1996, MOL CELL BIOL, V16, P1966; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Goodman BS, 2012, TRENDS CELL BIOL, V22, P644, DOI 10.1016/j.tcb.2012.09.005; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Januschke J, 2006, DEVELOPMENT, V133, P129, DOI 10.1242/dev.02179; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lasko P, 1999, FASEB J, V13, P421, DOI 10.1096/fasebj.13.3.421; Leopold PL, 2006, TRAFFIC, V7, P516, DOI 10.1111/j.1600-0854.2006.00408.x; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Martinez-Moreno M, 2003, FEBS LETT, V544, P262, DOI 10.1016/S0014-5793(03)00516-7; Navarro C, 2004, NAT CELL BIOL, V6, P427, DOI 10.1038/ncb1122; Palacios IM, 2007, SEMIN CELL DEV BIOL, V18, P163, DOI 10.1016/j.semcdb.2007.01.008; Parton RM, 2011, J CELL BIOL, V194, P121, DOI 10.1083/jcb.201103160; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; Rapali P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018818; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Saxton WM, 2001, CELL, V107, P707, DOI 10.1016/S0092-8674(01)00602-X; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Silvanovich A, 2003, MOL BIOL CELL, V14, P1355, DOI 10.1091/mbc.E02-10-0675; Stelter P, 2007, NAT CELL BIOL, V9, P788, DOI 10.1038/ncb1604; Toledo MAS, 2012, J CONTROL RELEASE, V159, P222, DOI 10.1016/j.jconrel.2012.01.011; Van De Bor V, 2005, DEV CELL, V9, P51, DOI 10.1016/j.devcel.2005.04.012; Wang L, 2004, BIOCHEMISTRY-US, V43, P4611, DOI 10.1021/bi036328x; Wilkie GS, 2001, CELL, V105, P209, DOI 10.1016/S0092-8674(01)00312-9	38	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82908	10.1371/journal.pone.0082908	http://dx.doi.org/10.1371/journal.pone.0082908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349395	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800084
J	Carvalho, NR; da Rosa, EF; da Silva, MH; Tassi, CC; Dalla Corte, CL; Carbajo-Pescador, S; Mauriz, JL; Gonzalez-Gallego, J; Soares, FA				Carvalho, Nelson R.; da Rosa, Edovando F.; da Silva, Michele H.; Tassi, Cintia C.; Dalla Corte, Cristiane L.; Carbajo-Pescador, Sara; Mauriz, Jose L.; Gonzalez-Gallego, Javier; Soares, Felix A.			New Therapeutic Approach: Diphenyl Diselenide Reduces Mitochondrial Dysfunction in Acetaminophen-Induced Acute Liver Failure	PLOS ONE			English	Article							RAT-BRAIN MITOCHONDRIA; INDUCED HEPATOTOXICITY; OXIDANT STRESS; OXIDATIVE STRESS; THIOREDOXIN REDUCTASE; ENERGY-METABOLISM; GLUTATHIONE; EBSELEN; INJURY; MODEL	The acute liver failure (ALF) induced by acetaminophen (APAP) is closely related to oxidative damage and depletion of hepatic glutathione, consequently changes in cell energy metabolism and mitochondrial dysfunction have been observed after APAP overdose. Diphenyl diselenide [(PhSe)(2)], a simple organoselenium compound with antioxidant properties, previously demonstrated to confer hepatoprotection. However, little is known about the protective mechanism on mitochondria. The main objective of this study was to investigate the effects (PhSe)(2) to reduce mitochondrial dysfunction and, secondly, compare in the liver homogenate the hepatoprotective effects of the (PhSe)(2) to the N-acetylcysteine (NAC) during APAP-induced ALF to validate our model. Mice were injected intraperitoneal with APAP (600 mg/kg), (PhSe)(2) (15.6 mg/kg), NAC (1200 mg/kg), APAP+(PhSe)(2) or APAP+NAC, where the (PhSe)(2) or NAC treatment were given 1 h following APAP. The liver was collected 4 h after overdose. The plasma alanine and aspartate aminotransferase activities increased after APAP administration. APAP caused a remarkable increase of oxidative stress markers (lipid peroxidation, reactive species and protein carbonylation) and decrease of the antioxidant defense in the liver homogenate and mitochondria. APAP caused a marked loss in the mitochondrial membrane potential, the mitochondrial ATPase activity, and the rate of mitochondrial oxygen consumption and increased the mitochondrial swelling. All these effects were significantly prevented by (PhSe)(2). The effectiveness of (PhSe)(2) was similar at a lower dose than NAC. In summary, (PhSe)(2) provided a significant improvement to the mitochondrial redox homeostasis and the mitochondrial bioenergetics dysfunction caused by membrane permeability transition in the hepatotoxicity APAP-induced.	[Carvalho, Nelson R.; da Rosa, Edovando F.; da Silva, Michele H.; Tassi, Cintia C.; Dalla Corte, Cristiane L.; Soares, Felix A.] Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Dept Quim, BR-97119900 Santa Maria, RS, Brazil; [Carbajo-Pescador, Sara; Mauriz, Jose L.; Gonzalez-Gallego, Javier] Univ Leon, Inst Biomed IBIOMED, E-24071 Leon, Spain; [Carbajo-Pescador, Sara; Mauriz, Jose L.; Gonzalez-Gallego, Javier] Univ Leon, Ctr Invest Biomed Red Enfermedades Hepat & Digest, E-24071 Leon, Spain	Universidade Federal de Santa Maria (UFSM); Universidad de Leon; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Universidad de Leon	Soares, FA (corresponding author), Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Dept Quim, Campus UFSM, BR-97119900 Santa Maria, RS, Brazil.	felix@ufsm.br	Soares, Félix/AAE-6251-2020; Corte, Cristiane Dalla/J-3050-2012; Mauriz, Jose L/G-9970-2014; Gonzalez-Gallego, Javier/D-8219-2012; Soares, Félix AA/K-7611-2012	Soares, Félix/0000-0002-6453-7902; Corte, Cristiane Dalla/0000-0003-3478-626X; Mauriz, Jose L/0000-0003-3160-8599; Gonzalez-Gallego, Javier/0000-0002-4386-9342; Soares, Félix AA/0000-0002-6453-7902; Carbajo-Pescador, Sara/0000-0002-6751-4597; Carvalho, Nelson/0000-0001-9882-2050	FINEP research grant "Rede Instituto Brasileiro de Neurociencia (IBN-Net)" [01.06.0842-00]; Instituto Nacional de Ciencia e Tecnologia (INCT); CNPq; CAPES; Consejeria de Educacion (Junta de Castilla y Leon, Spain); European Social Fund; CNPq/FAPERGS/DECIT/SCTIE-MS/PRONEM [11/2029-1]	FINEP research grant "Rede Instituto Brasileiro de Neurociencia (IBN-Net)"(Financiadora de Inovacao e Pesquisa (Finep)); Instituto Nacional de Ciencia e Tecnologia (INCT); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Consejeria de Educacion (Junta de Castilla y Leon, Spain)(Junta de Castilla y Leon); European Social Fund(European Social Fund (ESF)); CNPq/FAPERGS/DECIT/SCTIE-MS/PRONEM	This study was supported by the FINEP research grant "Rede Instituto Brasileiro de Neurociencia (IBN-Net)" #01.06.0842-00 and "Instituto Nacional de Ciencia e Tecnologia (INCT)" for excitotoxicity and neuroprotection-MCT/CNPq. F. A. A. S. received a fellowship by CNPq. M. H. S. and N.R.C. received a fellowship by CAPES. S. C. P. is funded by the Consejeria de Educacion (Junta de Castilla y Leon, Spain) and European Social Fund. Additional support was given by CNPq/FAPERGS/DECIT/SCTIE-MS/PRONEM #11/2029-1. CIBERehd is funded by the Instituto de Salud Carlos IIII, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Arakawa S, 2012, J TOXICOL SCI, V37, P595; ATKINSON A, 1973, BIOCHIM BIOPHYS ACTA, V320, P195, DOI 10.1016/0304-4165(73)90178-5; Bajt ML, 2011, TOXICOL SCI, V122, P598, DOI 10.1093/toxsci/kfr116; Bernas T, 2002, CYTOMETRY, V47, P236, DOI 10.1002/cyto.10080; BHATTACHARYA SK, 1991, ANAL BIOCHEM, V192, P344, DOI 10.1016/0003-2697(91)90546-6; Boireau A, 2000, NEUROSCI LETT, V289, P95, DOI 10.1016/S0304-3940(00)01267-2; Boireau A, 1999, ANN NY ACAD SCI, V893, P254, DOI 10.1111/j.1749-6632.1999.tb07830.x; Borges LP, 2006, CHEM-BIOL INTERACT, V160, P99, DOI 10.1016/j.cbi.2005.12.010; Bottje W, 2002, POULTRY SCI, V81, P546, DOI 10.1093/ps/81.4.546; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandao R, 2009, J TRACE ELEM MED BIO, V23, P324, DOI 10.1016/j.jtemb.2009.06.006; Brown JM, 2010, TOXICOL APPL PHARM, V247, P1, DOI 10.1016/j.taap.2010.04.018; CARLBERG I, 1985, METHOD ENZYMOL, V113, P484; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; da Rosa EJF, 2012, TOXICOL PATHOL, V40, P605, DOI 10.1177/0192623311436179; da Silva MH, 2012, NEUROTOX RES, V21, P334, DOI 10.1007/s12640-011-9288-1; de Achaval S, 2011, PHARMACOEPIDEM DR S, V20, P827, DOI 10.1002/pds.2162; de Freitas AS, 2011, NEUROSCI LETT, V503, P1, DOI 10.1016/j.neulet.2011.07.050; de Freitas AS, 2010, MOLECULES, V15, P7699, DOI [10.3390/molecules15117700, 10.3390/molecules15117699]; Dionisio N, 2009, J HEPATOL, V50, P872, DOI 10.1016/j.jhep.2008.12.026; Femandez-Checa JC, 2005, TOXICOL APPL PHARM, V204, P263, DOI 10.1016/j.taap.2004.10.001; FISCHER JC, 1985, CLIN CHIM ACTA, V153, P23, DOI 10.1016/0009-8981(85)90135-4; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; Galante Y M, 1978, Methods Enzymol, V53, P15; GELLER BL, 1984, METHOD ENZYMOL, V105, P105; HABIG WH, 1974, J BIOL CHEM, V249, P7130; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Hong SW, 2012, ARCH PHARM RES, V35, P1099, DOI 10.1007/s12272-012-0618-5; Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336; JAESCHKE H, 1990, J PHARMACOL EXP THER, V255, P935; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; KATYARE SS, 1989, BRIT J PHARMACOL, V96, P51, DOI 10.1111/j.1476-5381.1989.tb11783.x; Kim JY, 2003, FEBS LETT, V549, P94, DOI 10.1016/S0014-5793(03)00795-6; Kruglov AG, 2007, BIOCHEM PHARMACOL, V74, P545, DOI 10.1016/j.bcp.2007.05.012; KUHNVELTEN N, 1989, BIOCHEM PHARMACOL, V38, P619, DOI 10.1016/0006-2952(89)90207-4; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; LI QJ, 1994, BIOCHEM PHARMACOL, V48, P1631; McGill MR, 2012, TOXICOL APPL PHARM, V264, P387, DOI 10.1016/j.taap.2012.08.015; Meotti FC, 2004, ENVIRON RES, V94, P276, DOI 10.1016/S0013-9351(03)00114-2; MISRA HP, 1972, J BIOL CHEM, V247, P6960; Morin C, 2000, FUND CLIN PHARMACOL, V14, P493, DOI 10.1111/j.1472-8206.2000.tb00432.x; Morin D, 2003, BIOCHEM PHARMACOL, V65, P1643, DOI 10.1016/S0006-2952(03)00114-X; Moyer AM, 2011, TOXICOL SCI, V120, P33, DOI 10.1093/toxsci/kfq375; Nogueira CW, 2011, ARCH TOXICOL, V85, P1313, DOI 10.1007/s00204-011-0720-3; Nogueira CW, 2004, CHEM REV, V104, P6255, DOI 10.1021/cr0406559; Nourjah P, 2006, PHARMACOEPIDEM DR S, V15, P398, DOI 10.1002/pds.1191; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Prigol M, 2012, CHEM-BIOL INTERACT, V200, P65, DOI 10.1016/j.cbi.2012.09.007; Puntel RL, 2010, TOXICOL SCI, V117, P133, DOI 10.1093/toxsci/kfq185; Raghavendran HRB, 2005, CHEMOSPHERE, V61, P276, DOI 10.1016/j.chemosphere.2005.01.049; Ramachandran A, 2011, TOXICOL APPL PHARM, V251, P226, DOI 10.1016/j.taap.2011.01.004; San-Miguel B, 2006, APOPTOSIS, V11, P1945, DOI 10.1007/s10495-006-0090-0; SCHNELL RC, 1988, TOXICOL APPL PHARM, V95, P1, DOI 10.1016/S0041-008X(88)80002-4; Ueda S, 2002, ANTIOXID REDOX SIGN, V4, P405, DOI 10.1089/15230860260196209; Vendemiale G, 1996, BIOCHEM PHARMACOL, V52, P1147, DOI 10.1016/0006-2952(96)00414-5; Votyakova TV, 2005, J NEUROCHEM, V93, P526, DOI 10.1111/j.1471-4159.2005.03042.x; Woodhead JL, 2012, J PHARMACOL EXP THER, V342, P529, DOI 10.1124/jpet.112.192930; Zhao P, 2002, HEPATOLOGY, V36, P326, DOI 10.1053/jhep.2002.34943	61	37	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81961	10.1371/journal.pone.0081961	http://dx.doi.org/10.1371/journal.pone.0081961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349162	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300064
J	Gebruers, E; Cordero-Maldonado, ML; Gray, AI; Clements, C; Harvey, AL; Edrada-Ebel, R; de Witte, PAM; Crawford, AD; Esguerra, CV				Gebruers, Evelien; Lorena Cordero-Maldonado, Maria; Gray, Alexander I.; Clements, Carol; Harvey, Alan L.; Edrada-Ebel, Ruangelie; de Witte, Peter A. M.; Crawford, Alexander D.; Esguerra, Camila V.			A Phenotypic Screen in Zebrafish Identifies a Novel Small-Molecule Inducer of Ectopic Tail Formation Suggestive of Alterations in Non-Canonical Wnt/PCP Signaling	PLOS ONE			English	Article							BMP; INHIBITION; EXPRESSION; APOPTOSIS; ACID; PROTEINS; CELLS	Zebrafish have recently emerged as an attractive model for the in vivo bioassay-guided isolation and characterization of pharmacologically active small molecules of natural origin. We carried out a zebrafish-based phenotypic screen of over 3000 plant-derived secondary metabolite extracts with the goal of identifying novel small-molecule modulators of the BMP and Wnt signaling pathways. One of the bioactive plant extracts identified in this screen - Jasminum gilgianum, an Oleaceae species native to Papua New Guinea - induced ectopic tails during zebrafish embryonic development. As ectopic tail formation occurs when BMP or non-canonical Wnt signaling is inhibited during the tail protrusion process, we suspected a constituent of this extract to act as a modulator of these pathways. A bioassay-guided isolation was carried out on the basis of this zebrafish phenotype, identifying para-coumaric acid methyl ester (pCAME) as the active compound. We then performed an in-depth phenotypic analysis of pCAME-treated zebrafish embryos, including a tissue-specific marker analysis of the secondary tails. We found pCAME to synergize with the BMP-inhibitors dorsomorphin and LDN-193189 in inducing ectopic tails, and causing convergence-extension defects in compound-treated embryos. These results indicate that pCAME may interfere with non-canonical Wnt signaling. Inhibition of Jnk, a downstream target of Wnt/PCP signaling (via morpholino antisense knockdown and pharmacological inhibition with the kinase inhibitor SP600125) phenocopied pCAME-treated embryos. However, immunoblotting experiments revealed pCAME to not directly inhibit Jnk-mediated phosphorylation of c-Jun, suggesting additional targets of SP600125, and/or other pathways, as possibly being involved in the ectopic tail formation activity of pCAME. Further investigation of pCAME's mechanism of action will help determine this compound's pharmacological utility.	[Gebruers, Evelien; Lorena Cordero-Maldonado, Maria; de Witte, Peter A. M.; Crawford, Alexander D.; Esguerra, Camila V.] Univ Louvain, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, Louvain, Belgium; [Lorena Cordero-Maldonado, Maria] Univ Cuenca, Sch Biochem & Pharm, Fac Chem Sci, Cuenca, Ecuador; [Gray, Alexander I.; Clements, Carol; Harvey, Alan L.; Edrada-Ebel, Ruangelie] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Lorena Cordero-Maldonado, Maria; Crawford, Alexander D.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Chem Biol Grp, Esch Sur Alzette, Luxembourg	Universidad de Cuenca; University of Strathclyde; University of Luxembourg	Esguerra, CV (corresponding author), Univ Louvain, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, Louvain, Belgium.	camila.esguerra@pharm.kuleuven.be	Edrada-Ebel, RuAngelie/G-6127-2015; Esguerra, Camila/N-6159-2015; Esguerra, Camila/D-7657-2014	Edrada-Ebel, RuAngelie/0000-0003-2420-1117; Esguerra, Camila/0000-0002-2271-8094; Esguerra, Camila/0000-0001-7891-1427; de Witte, Peter/0000-0002-9989-9567	Agency for Innovation by Science and Technology in Flanders (IWT); Vlaamse Interuniversitaire Raad (VLIR)	Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Vlaamse Interuniversitaire Raad (VLIR)	This research was funded by a grant from the Agency for Innovation by Science and Technology in Flanders (IWT). MLCM was funded by a PhD fellowship from the Vlaamse Interuniversitaire Raad (VLIR) linked to the VLIR-UOS project "Pharmacological Characterization of Medicinal Plants from the South of Ecuador." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathon A, 2003, NATURE, V424, P448, DOI 10.1038/nature01822; Asai N, 2006, DEVELOPMENT, V133, P4507, DOI 10.1242/dev.02616; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bill BR, 2009, ZEBRAFISH, V6, P69, DOI 10.1089/zeb.2008.0555; Boergermann JH, 2010, INT J BIOCHEM CELL B, V42, P1802, DOI 10.1016/j.biocel.2010.07.018; Bohni N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064006; Challal S, 2012, CHIMIA, V66, P229, DOI 10.2533/chimia.2012.229; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Crawford AD, 2008, PLANTA MED, V74, P624, DOI 10.1055/s-2008-1034374; Crawford AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014694; Deng ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036739; Faris M, 1998, J IMMUNOL, V160, P134; Hong CC, 2009, CYTOKINE GROWTH F R, V20, P409, DOI 10.1016/j.cytogfr.2009.10.021; Huang QS, 2009, J AGR FOOD CHEM, V57, P2565, DOI 10.1021/jf8036227; James Richard G., 2008, V468, P131, DOI 10.1007/978-1-59745-249-6_10; Jing LL, 2011, DIS MODEL MECH, V4, P433, DOI 10.1242/dmm.006791; Kang NJ, 2009, CARCINOGENESIS, V30, P321, DOI 10.1093/carcin/bgn282; Kaufman CK, 2009, NAT PROTOC, V4, P1422, DOI 10.1038/nprot.2009.144; Kim HY, 2012, EUR J PHARM SCI, V45, P708, DOI 10.1016/j.ejps.2012.01.010; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Komisarczuk AZ, 2008, DEV DYNAM, V237, P2594, DOI 10.1002/dvdy.21689; Kondo M, 2007, FEBS J, V274, P2960, DOI 10.1111/j.1742-4658.2007.05838.x; Kubo I, 2004, BIOORGAN MED CHEM, V12, P5349, DOI 10.1016/j.bmc.2004.07.052; Langdon YG, 2011, ANNU REV GENET, V45, P357, DOI 10.1146/annurev-genet-110410-132517; Lenhart KF, 2011, DEVELOPMENT, V138, P4405, DOI 10.1242/dev.071092; Orellana-Paucar AM, 2012, EPILEPSY BEHAV, V24, P14, DOI 10.1016/j.yebeh.2012.02.020; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Moore FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037877; Mullins MC, 1996, DEVELOPMENT, V123, P81; Myers DC, 2002, TRENDS GENET, V18, P447, DOI 10.1016/S0168-9525(02)02725-7; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Nys K, 2012, FREE RADICAL BIO MED, V52, P1111, DOI 10.1016/j.freeradbiomed.2011.12.017; Pyati UJ, 2005, DEVELOPMENT, V132, P2333, DOI 10.1242/dev.01806; Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004; Row RH, 2009, DEV BIOL, V329, P55, DOI 10.1016/j.ydbio.2009.02.016; Seo J, 2010, J CELL BIOCHEM, V110, P1022, DOI 10.1002/jcb.22616; Sharkey J, 2007, BLOOD, V109, P1712, DOI 10.1182/blood-2006-05-014092; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Song K, 2011, J DERMATOL SCI, V63, P17, DOI 10.1016/j.jdermsci.2011.03.012; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; Yang Y, 2011, DEVELOPMENT, V138, P2601, DOI 10.1242/dev.058404; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	45	16	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83293	10.1371/journal.pone.0083293	http://dx.doi.org/10.1371/journal.pone.0083293			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349481	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300143
J	Aguert, M; Laval, V; Lacroix, A; Gil, S; Le Bigot, L				Aguert, Marc; Laval, Virginie; Lacroix, Agnes; Gil, Sandrine; Le Bigot, Ludovic			Inferring Emotions from Speech Prosody: Not So Easy at Age Five	PLOS ONE			English	Article							VOCAL EXPRESSIONS; PERCEPTION; CUES; DISCRIMINATION; COMMUNICATION; PRESCHOOLERS; SENSITIVITY; 6-YEAR-OLDS; CONTEXT; PREFER	Previous research has suggested that children do not rely on prosody to infer a speaker's emotional state because of biases toward lexical content or situational context. We hypothesized that there are actually no such biases and that young children simply have trouble in using emotional prosody. Sixty children from 5 to 13 years of age had to judge the emotional state of a happy or sad speaker and then to verbally explain their judgment. Lexical content and situational context were devoid of emotional valence. Results showed that prosody alone did not enable the children to infer emotions at age 5, and was still not fully mastered at age 13. Instead, they relied on contextual information despite the fact that this cue had no emotional valence. These results support the hypothesis that prosody is difficult to interpret for young children and that this cue plays only a subordinate role up until adolescence to infer others' emotions.	[Aguert, Marc] Univ Caen Basse Normandie, PALM EA 4649, Caen, France; [Laval, Virginie; Gil, Sandrine; Le Bigot, Ludovic] Univ Poitiers, CeRCA UMR CNRS 7295, Poitiers, France; [Lacroix, Agnes] Univ Rennes 2, CRP2C EA 1285, F-35043 Rennes, France	Universite de Caen Normandie; Universite de Poitiers; Universite Rennes 2	Aguert, M (corresponding author), Univ Caen Basse Normandie, PALM EA 4649, Caen, France.	marc.aguert@unicaen.fr	LE BIGOT, Ludovic/N-1320-2013	LE BIGOT, Ludovic/0000-0003-1951-8793				Achim AM, 2013, PSYCHOL ASSESSMENT, V25, P117, DOI 10.1037/a0029137; Aguert M, 2010, J SPEECH LANG HEAR R, V53, P1629, DOI 10.1044/1092-4388(2010/08-0078); Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; BALTAXE CAM, 1991, PERCEPT MOTOR SKILL, V72, P1187, DOI 10.2466/PMS.72.4.1187-1202; Barrett LF, 2011, CURR DIR PSYCHOL SCI, V20, P286, DOI 10.1177/0963721411422522; Berman JMJ, 2010, J EXP CHILD PSYCHOL, V107, P87, DOI 10.1016/j.jecp.2010.04.012; BROSGOLE L, 1995, INT J NEUROSCI, V82, P169, DOI 10.3109/00207459508999800; BROWN P, 1979, EUROPEAN STUDIES SOC, P33; Bugental D E, 1970, J Pers Soc Psychol, V16, P647, DOI 10.1037/h0030254; DECASPER AJ, 1980, SCIENCE, V208, P1174, DOI 10.1126/science.7375928; Dimitrovsky L., 1964, COMMUNICATION EMOTIO, P69; FERNALD A, 1992, ADAPTED MIND EVOLUTI, P392; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Friend M, 2000, MERRILL PALMER QUART, V46, P342; Friend Margaret, 2001, First Lang, V21, P219, DOI 10.1177/014272370102106302; Friend M, 2000, DEVELOPMENTAL SCI, V3, P148, DOI 10.1111/1467-7687.00108; GNEPP J, 1983, DEV PSYCHOL, V19, P805, DOI 10.1037/0012-1649.19.6.805; Gosselin P, 2005, CAN PSYCHOL, V46, P126, DOI 10.1037/h0087016; Grossmann T, 2010, RESTOR NEUROL NEUROS, V28, P219, DOI 10.3233/RNN-2010-0499; GUIDETTI M, 1991, ANN PSYCHOL, V91, P383; Hepper P. G., 1993, J REPRODUCTIVE INFAN, V11, P147, DOI [DOI 10.1080/02646839308403210, 10.1080/02646839308403210]; Herold DS, 2011, J EXP CHILD PSYCHOL, V108, P229, DOI 10.1016/j.jecp.2010.09.005; HOFFNER C, 1989, CHILD DEV, V60, P411, DOI 10.1111/j.1467-8624.1989.tb02725.x; HORTACSU N, 1992, J NONVERBAL BEHAV, V16, P231, DOI 10.1007/BF01462004; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Kisilevsky BS, 2009, INFANT BEHAV DEV, V32, P59, DOI 10.1016/j.infbeh.2008.10.002; Kuhn D, 2000, CURR DIR PSYCHOL SCI, V9, P178, DOI 10.1111/1467-8721.00088; Lindstrom R, 2012, INT J PSYCHOPHYSIOL, V86, P229, DOI 10.1016/j.ijpsycho.2012.09.010; Mastropieri D, 1999, DEV PSYCHOBIOL, V35, P204, DOI 10.1002/(SICI)1098-2302(199911)35:3<204::AID-DEV5>3.0.CO;2-V; MCCLUSKEY KW, 1981, INT J PSYCHOL, V16, P119, DOI 10.1080/00207598108247409; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; Mondloch CJ, 2006, CHILD DEV, V77, P234, DOI 10.1111/j.1467-8624.2006.00867.x; MONDLOCH CJ, 2010, DISPLAYS J VIS, V10, P579, DOI DOI 10.1167/10.7.579; MOON C, 1993, INFANT BEHAV DEV, V16, P495, DOI 10.1016/0163-6383(93)80007-U; Morton JB, 2003, CHILD DEV, V74, P1857, DOI 10.1046/j.1467-8624.2003.00642.x; Morton JB, 2001, CHILD DEV, V72, P834, DOI 10.1111/1467-8624.00318; Mumme DL, 1996, CHILD DEV, V67, P3219, DOI 10.1111/j.1467-8624.1996.tb01910.x; Nazzi T, 2000, INFANCY, V1, P123, DOI 10.1207/S15327078IN0101_11; Nelson NL, 2011, J EXP CHILD PSYCHOL, V110, P52, DOI 10.1016/j.jecp.2011.03.014; Nygaard LC, 2008, J EXP PSYCHOL HUMAN, V34, P1017, DOI 10.1037/0096-1523.34.4.1017; Pell MD, 2011, COGNITION EMOTION, V25, P834, DOI 10.1080/02699931.2010.516915; Quam C, 2012, CHILD DEV, V83, P236, DOI 10.1111/j.1467-8624.2011.01700.x; REILLY SS, 1986, COMMUNICATION Q, V34, P79, DOI DOI 10.1080/01463378609369622; RUSSELL JA, 1985, J PERS SOC PSYCHOL, V48, P1290, DOI 10.1037/0022-3514.48.5.1290; Schwartz R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047279; SOLOMON D, 1972, DEV PSYCHOL, V7, P238, DOI 10.1037/h0033354; STIFTER CA, 1987, J NONVERBAL BEHAV, V11, P43, DOI 10.1007/BF00999606; Vaish A, 2004, DEVELOPMENTAL SCI, V7, P261, DOI 10.1111/j.1467-7687.2004.00344.x; Vaissiere J, 2005, BLACKW HBK LINGUIST, P236, DOI 10.1002/9780470757024.ch10; WalkerAndrews AS, 1997, PSYCHOL BULL, V121, P437, DOI 10.1037/0033-2909.121.3.437; WALKERANDREWS AS, 1983, INFANT BEHAV DEV, V6, P491, DOI 10.1016/S0163-6383(83)90331-4; WALKERANDREWS AS, 1991, INFANT BEHAV DEV, V14, P131, DOI 10.1016/0163-6383(91)90001-9; Waxer M, 2011, CHILD DEV, V82, P1648, DOI 10.1111/j.1467-8624.2011.01624.x; Wells B, 2004, J CHILD LANG, V31, P749, DOI 10.1017/S030500090400652X	55	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e83657	10.1371/journal.pone.0083657	http://dx.doi.org/10.1371/journal.pone.0083657			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VD	24349539	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200133
J	Heise, EA; Marozas, LM; Grafton, SA; Green, KM; Kirwin, SJ; Fort, PE				Heise, Erich A.; Marozas, Lauren M.; Grafton, Sean A.; Green, Katelyn M.; Kirwin, Stefanie J.; Fort, Patrice E.			Strain-Independent Increases of Crystallin Proteins in the Retina of Type 1 Diabetic Rats	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; ENDOTHELIAL GROWTH-FACTOR; INDUCED RETINOPATHY; GANGLION-CELLS; A-CRYSTALLIN; STREPTOZOTOCIN; EXPRESSION; INSULIN; MICE; PHOTORECEPTORS	Diabetic retinopathy is the leading cause of vision loss in working-age individuals in the United States and is expected to continue growing with the increased prevalence of diabetes. Streptozotocin-induced hyperglycemia in rats is the most commonly used model for diabetic retinopathy. Previous studies have shown that this model can lead to different inflammatory changes in the retina depending on the strain of rat. Our previous work has shown that crystallin proteins, including members of the alpha- and beta/gamma-crystallin subfamilies, are upregulated in the STZ rat retina. Crystallin proteins have been implicated in a number of cellular processes, such as neuroprotection, non-native protein folding and vascular remodeling. In this current study, we have demonstrated that unlike other strain-dependent changes, such as inflammatory cytokines and growth factor levels, in the STZ rat, the protein upregulation of crystallins is consistent across the Brown Norway, Long-Evans and Sprague-Dawley rat strains in the context of diabetes. Taken together, these data illustrate the potential critical role played by crystallins, and especially alpha-crystallins, in the retina in the context of diabetes.	[Heise, Erich A.; Marozas, Lauren M.; Grafton, Sean A.; Green, Katelyn M.; Fort, Patrice E.] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Kirwin, Stefanie J.] Allergan Pharmaceut Inc, Biol Sci, Irvine, CA 92715 USA	University of Michigan System; University of Michigan; AbbVie; Allergan	Fort, PE (corresponding author), Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	patricef@umich.edu		Fort, Patrice/0000-0003-3956-1908	Fight For Sight; National Eye Institute [NEI R01EY020895]; NATIONAL EYE INSTITUTE [R01EY020895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	Fight For Sight; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by Fight For Sight (www.fightforsight.org) and the National Eye Institute (NEI R01EY020895; www.nei.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonetti DA, 1998, DIABETES, V47, P1953, DOI 10.2337/diabetes.47.12.1953; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Bohm MRR, 2012, INVEST OPHTH VIS SCI, V53, P8265, DOI 10.1167/iovs.12-10334; Douglas RM, 2005, VISUAL NEUROSCI, V22, P677, DOI 10.1017/S0952523805225166; Fort PE, 2009, MOL CELL PROTEOMICS, V8, P767, DOI 10.1074/mcp.M800326-MCP200; Gao GQ, 2002, DIABETES, V51, P1218, DOI 10.2337/diabetes.51.4.1218; Gastinger MJ, 2008, INVEST OPHTH VIS SCI, V49, P2635, DOI 10.1167/iovs.07-0683; Kim YH, 2007, NEUROBIOL DIS, V28, P293, DOI 10.1016/j.nbd.2007.07.017; Kirwin SJ, 2009, INVEST OPHTH VIS SCI, V50, P5396, DOI 10.1167/iovs.09-3474; Kumar PA, 2005, ARCH BIOCHEM BIOPHYS, V444, P77, DOI 10.1016/j.abb.2005.09.021; Launay N, 2010, J BIOL CHEM, V285, P37324, DOI 10.1074/jbc.M110.124388; Liedtke T, 2007, MOL CELL PROTEOMICS, V6, P895, DOI 10.1074/mcp.M600245-MCP200; Losiewicz MK, 2011, INVEST OPHTH VIS SCI, V52, P5034, DOI 10.1167/iovs.10-6931; Lu KM, 2007, J MOL ENDOCRINOL, V38, P423, DOI 10.1677/JME-06-0015; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Masilamoni JG, 2005, BBA-MOL BASIS DIS, V1740, P411, DOI 10.1016/j.bbadis.2004.11.002; MELMED RN, 1973, J CELL SCI, V13, P297; Nguyen TT, 2009, CURR DIABETES REP, V9, P277, DOI 10.1007/s11892-009-0043-4; Park SH, 2003, DIABETOLOGIA, V46, P1260, DOI 10.1007/s00125-003-1177-6; Parthasarathy G, 2011, J MOL HISTOL, V42, P59, DOI 10.1007/s10735-010-9307-1; Rao G, 2008, MOL VIS, V14, P666; Rao NA, 2008, INVEST OPHTH VIS SCI, V49, P1161, DOI 10.1167/iovs.07-1259; Reiter CEN, 2006, DIABETES, V55, P1148, DOI 10.2337/diabetes.55.04.06.db05-0744; Reiter CEN, 2003, PROG RETIN EYE RES, V22, P545, DOI 10.1016/S1350-9462(03)00035-1; Saraswathy S, 2011, MOL VIS, V17, P1814; Sinha D, 2008, MOL CELL NEUROSCI, V37, P85, DOI 10.1016/j.mcn.2007.08.016; Whiston EA, 2008, INFECT IMMUN, V76, P1781, DOI 10.1128/IAI.01285-07; Wu XH, 2004, J BIOL CHEM, V279, P9167, DOI 10.1074/jbc.M312397200; Zeng XX, 2000, VISUAL NEUROSCI, V17, P463, DOI 10.1017/S0952523800173122; Zhang C, 2005, DEV DYNAM, V234, P36, DOI 10.1002/dvdy.20494; Zhang SX, 2005, AM J PATHOL, V166, P313, DOI 10.1016/S0002-9440(10)62255-9	34	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82520	10.1371/journal.pone.0082520	http://dx.doi.org/10.1371/journal.pone.0082520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349305	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200049
J	Huang, XD; Williams, G; Clements, ACA; Hu, WB				Huang, Xiaodong; Williams, Gail; Clements, Archie C. A.; Hu, Wenbiao			Imported Dengue Cases, Weather Variation and Autochthonous Dengue Incidence in Cairns, Australia	PLOS ONE			English	Article							AEDES-AEGYPTI DIPTERA; CLIMATE-CHANGE; HURDLE MODELS; COUNT DATA; FEVER; TRANSMISSION; TEMPERATURE; POPULATION; QUEENSLAND; POISSON	Background: Dengue fever (DF) outbreaks often arise from imported DF cases in Cairns, Australia. Few studies have incorporated imported DF cases in the estimation of the relationship between weather variability and incidence of autochthonous DF. The study aimed to examine the impact of weather variability on autochthonous DF infection after accounting for imported DF cases and then to explore the possibility of developing an empirical forecast system. Methodology/principal finds: Data on weather variables, notified DF cases (including those acquired locally and overseas), and population size in Cairns were supplied by the Australian Bureau of Meteorology, Queensland Health, and Australian Bureau of Statistics. A time-series negative-binomial hurdle model was used to assess the effects of imported DF cases and weather variability on autochthonous DF incidence. Our results showed that monthly autochthonous DF incidences were significantly associated with monthly imported DF cases (Relative Risk (RR): 1.52; 95% confidence interval (CI): 1.01-2.28), monthly minimum temperature (degrees C) (RR: 2.28; 95% CI: 1.77-2.93), monthly relative humidity (%) (RR: 1.21; 95% CI: 1.06-1.37), monthly rainfall (mm) (RR: 0.50; 95% CI: 0.31-0.81) and monthly standard deviation of daily relative humidity (%) (RR: 1.27; 95% CI: 1.08-1.50). In the zero hurdle component, the occurrence of monthly autochthonous DF cases was significantly associated with monthly minimum temperature (Odds Ratio (OR): 1.64; 95% CI: 1.01-2.67). Conclusions/significance: Our research suggested that incidences of monthly autochthonous DF were strongly positively associated with monthly imported DF cases, local minimum temperature and inter-month relative humidity variability in Cairns. Moreover, DF outbreak in Cairns was driven by imported DF cases only under favourable seasons and weather conditions in the study.	[Huang, Xiaodong; Williams, Gail; Clements, Archie C. A.; Hu, Wenbiao] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Hu, Wenbiao] Queensland Univ Technol, Sch Publ Hlth & Social Work, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	University of Queensland; Queensland University of Technology (QUT)	Huang, XD (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.	x.huang5@uq.edu.au	Williams, Gail/S-8833-2019; Clements, Archie/ABD-1615-2020	Williams, Gail/0000-0002-4822-5263; Hu, Wenbiao/0000-0001-6422-9240	National Health and Medical Research Council, Australia [1002608]	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	The authors received financial support from the National Health and Medical Research Council, Australia (#1002608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Arcari P, 2007, SINGAPORE J TROP GEO, V28, P251, DOI 10.1111/j.1467-9493.2007.00300.x; Australian Bureau of Statistics, 2011, NAT REG PROF CAIRNS; Bannister-Tyrrell M, 2013, AM J TROP MED HYG, V88, P65, DOI 10.4269/ajtmh.2012.11-0451; Banu S, 2011, TROP MED INT HEALTH, V16, P598, DOI 10.1111/j.1365-3156.2011.02734.x; Bi P, 2001, ENV HLTH, V1, P54; Bureau of Meteorology, 2012, CLIM CAIRNS; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Dalrymple ML, 2003, COMPUT STAT DATA AN, V41, P491, DOI 10.1016/S0167-9473(02)00187-1; Degallier N, 2009, REV SAUDE PUBL, V43, P1, DOI 10.1590/S0034-89102009000100001; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11; Gray BR, 2005, ECOL MODEL, V185, P1, DOI 10.1016/j.ecolmodel.2004.11.006; Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6; Halide H, 2008, INT J ENVIRON HEAL R, V18, P253, DOI 10.1080/09603120801966043; Hii YL, 2009, GLOBAL HEALTH ACTION, V2, P124, DOI 10.3402/gha.v2i0.2036; Hu WB, 2012, ENVIRON HEALTH PERSP, V120, P260, DOI 10.1289/ehp.1003270; Hu WB, 2010, OCCUP ENVIRON MED, V67, P307, DOI 10.1136/oem.2008.044966; Jalava K, 2012, EPIDEMIOLOGY INFECT, P1, DOI [10.1017/S095026881200249X, DOI 10.1017/S095026881200249X:1-10]; Jalava K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-275; JONES AM, 1989, J APPL ECONOM, V4, P23, DOI 10.1002/jae.3950040103; KAY BH, 1984, MED J AUSTRALIA, V140, P264, DOI 10.5694/j.1326-5377.1984.tb104033.x; Knope K, 2013, COMMUN DIS INTELL, V37, pE55; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; Li C F, 1985, Southeast Asian J Trop Med Public Health, V16, P560; Martens WJM, 1997, CLIMATIC CHANGE, V35, P145, DOI 10.1023/A:1005365413932; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; MULLAHY J, 1986, J ECONOMETRICS, V33, P341, DOI 10.1016/0304-4076(86)90002-3; Nakhapakorn Kanchana, 2005, Int J Health Geogr, V4, P13; Neelon BH, 2010, STAT MODEL, V10, P421, DOI 10.1177/1471082X0901000404; NICHOLLS N, 1993, LANCET, V342, P1284, DOI 10.1016/0140-6736(93)92368-4; Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147; Phillips ML, 2008, ENVIRON HEALTH PERSP, V116, pA382, DOI 10.1289/ehp.116-a382; Queensland Government, 2011, QUEENSL DENG MAN PLA; Racloz V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001648; Ritchie S. A., 2002, Dengue Bulletin, V26, P7; Rose CE, 2006, J BIOPHARM STAT, V16, P463, DOI 10.1080/10543400600719384; RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892; Seed CR, 2009, TRANSFUSION, V49, P1482, DOI 10.1111/j.1537-2995.2009.02159.x; Sturman A.P., 1996, WEATHER CLIMATE AUST; Thammapalo Suwich, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P191; Thu Hlaing Myat, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P280; Vargas REM, 2010, INFECT GENET EVOL, V10, P580, DOI 10.1016/j.meegid.2010.01.004; VUONG QH, 1989, ECONOMETRICA, V57, P307, DOI 10.2307/1912557; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; WHO, 2013, SUSTAINING THE DRIVE TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: SECOND WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; Williams CR, 2013, MED VET ENTOMOL, V27, P313, DOI 10.1111/j.1365-2915.2012.01051.x; Wu PC, 2007, ACTA TROP, V103, P50, DOI 10.1016/j.actatropica.2007.05.014; Wu PC, 2009, SCI TOTAL ENVIRON, V407, P2224, DOI 10.1016/j.scitotenv.2008.11.034; YEN ST, 1994, CAN J AGR ECON, V42, P65, DOI 10.1111/j.1744-7976.1994.tb00006.x	50	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e81887	10.1371/journal.pone.0081887	http://dx.doi.org/10.1371/journal.pone.0081887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349148	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200017
J	Hung, TH; Hsieh, TT; Chen, SF; Li, MJ; Yeh, YL				Hung, Tai-Ho; Hsieh, T'sang-T'ang; Chen, Szu-Fu; Li, Meng-Jen; Yeh, Yi-Lin			Autophagy in the Human Placenta throughout Gestation	PLOS ONE			English	Article							GROWTH RESTRICTION; FETAL-GROWTH; CELL-DEATH; HYPOXIA; TROPHOBLAST; PREECLAMPSIA; PREGNANCIES	Background: Autophagy has been reported to be essential for pre-implantation development and embryo survival. However, its role in placental development and regulation of autophagy during pregnancy remain unclear. The aims of this study were to (1) study autophagy by characterizing changes in levels of beclin-1, DRAM, and LC3B in human placenta throughout gestation; (2) determine whether autophagy is involved in regulation of trophoblast invasion in JEG-3 cells (a choriocarcinoma cell line); (3) examine the effects of reduced oxygen and glucose on the autophagic changes; and (4) investigate the effect of reoxygenation and supplementation of glucose after oxygen-glucose deprivation (OGD) on the autophagic changes in primary cytotrophoblasts obtained from normal term pregnancy. Methodology/Principal Findings: An analysis of 40 placental samples representing different gestational stages showed (1) no significant differences in beclin-1, DRAM, and LC3B-II levels in placentas between early and mid-gestation, and late gestation with vaginal delivery; (2) placentas from late gestation with cesarean section had lower levels of LC3B-II compared to early and mid-gestation, and late gestation with vaginal delivery; levels of DRAM were also lower compared to placentas from early and mid-gestation; and (3) using explant cultures, villous tissues from early and late gestation had similar rates of autophagic flux under physiological oxygen concentrations. Knockdown of BECN1, DRAM, and LC3B had no effects on viability and invasion activity of JEG-3 cells. On the other hand, OGD caused a significant increase in the levels of LC3B-II in primary cytotrophoblasts, while re-supplementation of oxygen and glucose reduced these changes. Furthermore, there were differential changes in levels of beclin-1, DRAM, and LC3B-II in response to changes in oxygen and glucose levels. Conclusions/Significance: Our results indicate that autophagy is involved in development of the human placenta and that changes in oxygen and glucose levels participate in regulation of autophagic changes in cytotrophoblast cells.	[Hung, Tai-Ho; Hsieh, T'sang-T'ang; Li, Meng-Jen; Yeh, Yi-Lin] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taipei 10591, Taiwan; [Hung, Tai-Ho] Chang Gung Univ, Coll Med, Dept Chinese Med, Tao Yuan, Taiwan; [Chen, Szu-Fu] Cheng Hsin Rehabil Med Ctr, Dept Phys Med & Rehabil, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Hung, TH (corresponding author), Chang Gung Mem Hosp, Dept Obstet & Gynecol, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	thh20@adm.cgmh.org.tw; doctor_placenta@yahoo.com.tw	Hung, Tai-Ho/C-7584-2011; Hung, Tai-Ho/ABD-1800-2020	Hung, Tai-Ho/0000-0003-2354-7060; 	National Science Council, Taiwan [NSC 100-2314-B-182A-082]; Chang Gung Memorial Hospital [CMRPG100021, CMRPG100022]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by the National Science Council, Taiwan (NSC 100-2314-B-182A-082) and Chang Gung Memorial Hospital (CMRPG100021, CMRPG100022) to THH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armant DR, 2011, ENDOCRINOLOGY, V152, P1739, DOI 10.1210/en.2011-0220; Burton GJ, 2009, PLACENTA, V30, P473, DOI 10.1016/j.placenta.2009.02.009; Burton GJ, 2010, INT J DEV BIOL, V54, P303, DOI 10.1387/ijdb.082764gb; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Chen BS, 2012, ENDOCRINOLOGY, V153, P4946, DOI 10.1210/en.2012-1472; Choi Jong-Ho, 2012, Clin Exp Reprod Med, V39, P73, DOI 10.5653/cerm.2012.39.2.73; Crighton D, 2007, AUTOPHAGY, V3, P72, DOI 10.4161/auto.3438; Curtis S, 2013, J MATERN-FETAL NEO M, V26, P339, DOI 10.3109/14767058.2012.733764; Hung TH, 2008, REPROD SCI, V15, P195, DOI 10.1177/1933719107310709; Hung TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040957; Hung TH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012202; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Mehrpour M, 2010, CELL RES, V20, P748, DOI 10.1038/cr.2010.82; Nakashima A, 2013, AUTOPHAGY, V9, P303, DOI 10.4161/auto.22927; Oh SY, 2008, REPROD SCI, V15, P912, DOI 10.1177/1933719108319159; Roos S, 2009, AM J PHYSIOL-CELL PH, V297, pC723, DOI 10.1152/ajpcell.00191.2009; Roos S, 2007, J PHYSIOL-LONDON, V582, P449, DOI 10.1113/jphysiol.2007.129676; Saito S, 2013, PLACENTA, V34, pS79, DOI 10.1016/j.placenta.2012.11.026; Shen ZY, 2008, PLACENTA, V29, P956, DOI 10.1016/j.placenta.2008.09.001; Wheaton WW, 2011, AM J PHYSIOL-CELL PH, V300, pC385, DOI 10.1152/ajpcell.00485.2010; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193	22	70	72	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83475	10.1371/journal.pone.0083475	http://dx.doi.org/10.1371/journal.pone.0083475			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349516	gold, Green Published, Green Submitted			2022-12-27	WOS:000328734200091
J	Ardisson-Araujo, DMP; Morgado, FD; Schwartz, EF; Corzo, G; Ribeiro, BM				Pereira Ardisson-Araujo, Daniel Mendes; Morgado, Fabricio Da Silva; Schwartz, Elisabeth Ferroni; Corzo, Gerardo; Ribeiro, Bergmann Morais			A New theraphosid Spider Toxin Causes Early Insect Cell Death by Necrosis When Expressed In Vitro during Recombinant Baculovirus Infection	PLOS ONE			English	Article							VENOM PEPTIDES; NUCLEAR-LOCALIZATION; SCORPION NEUROTOXIN; CAPSAICIN RECEPTOR; ARTHROPOD VENOMS; APOPTOSIS; GENE; CHANNELS; VIRUS; BLOCK	Baculoviruses are the most studied insect viruses in the world and are used for biological control of agricultural and forest insect pests. They are also used as versatile vectors for expression of heterologous proteins. One of the major problems of their use as biopesticides is their slow speed to kill insects. Thus, to address this shortcoming, insect-specific neurotoxins from arachnids have been introduced into the baculovirus genome solely aiming to improve its virulence. In this work, an insecticide-like toxin gene was obtained from a cDNA derived from the venom glands of the theraphosid spider Brachypelma albiceps. The mature form of the peptide toxin (called Ba3) has a high content of basic amino acid residues, potential for three possible disulfide bonds, and a predicted three-stranded beta-sheetDifferent constructions of the gene were engineered for recombinant baculovirus Autographa californica multiple nuclepolyhedrovirus (AcMNPV) expression. Five different forms of Ba3 were assessed; (1) the full-length sequence, (2) the pro-peptide and mature region, (3) only the mature region, and the mature region fused to an (4) insect or a (5) virus-derived signal peptide were inserted separately into the genome of the baculovirus. All the recombinant viruses induced cell death by necrosis earlier in infection relative to a control virus lacking the toxin gene. However, the recombinant virus containing the mature portion of the toxin gene induced a faster cell death than the other recombinants. We found that the toxin construct with the signal peptide and/or pro-peptide regions delayed the necrosis phenotype. When infected cells were subjected to ultrastructural analysis, the cells showed loss of plasma membrane integrity and structural changes in mitochondria before death. Our results suggest this use of baculovirus is a potential tool to help understand or to identify the effect of insect-specific toxic peptides when produced during infection of insect cells.	[Pereira Ardisson-Araujo, Daniel Mendes; Morgado, Fabricio Da Silva; Ribeiro, Bergmann Morais] Univ Brasilia, Dept Biol Celular, Brasilia, DF, Brazil; [Schwartz, Elisabeth Ferroni] Univ Brasilia, Dept Ciencais Fisiol, Brasilia, DF, Brazil; [Corzo, Gerardo] Univ Nacl Autonoma Mexico, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico	Universidade de Brasilia; Universidade de Brasilia; Universidad Nacional Autonoma de Mexico	Ribeiro, BM (corresponding author), Univ Brasilia, Dept Biol Celular, Brasilia, DF, Brazil.	bergmann@unb.br	Ardisson-Araújo, Daniel Mendes Pereira/AAM-6320-2020; Schwartz, Elisabeth Ferroni/AGE-4234-2022; Ribeiro, Bergmann Morais/C-7114-2015; Corzo, Gerardo/B-3778-2014; Schwartz, Elisabeth/G-4531-2012	Schwartz, Elisabeth Ferroni/0000-0001-8239-4055; Ribeiro, Bergmann Morais/0000-0002-1061-196X; Corzo, Gerardo/0000-0002-9513-1622; Schwartz, Elisabeth/0000-0001-8239-4055; da Silva Morgado, Fabricio/0000-0002-4612-5613	Consenho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [303354/2009-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [AUXPE-PROCAD/NF 886/2010]; Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF) [193.000.583/2009]	Consenho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This work was supported by Consenho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, www.cnpq.br), project number 303354/2009-7; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, www.capes.gov.br), project number AUXPE-PROCAD/NF 886/2010; and Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF, www.fap.df.gov.br), project number 193.000.583/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI T, 1989, J BIOL CHEM, V264, P7681; Ailor E, 1999, BIOCHEM BIOPH RES CO, V255, P444, DOI 10.1006/bbrc.1999.0233; Alami M, 2003, BIOCHEM J, V375, P551, DOI 10.1042/BJ20030688; ALTMAN SA, 1993, BIOTECHNOL PROGR, V9, P671, DOI 10.1021/bp00024a017; BALE JS, 2008, PHIL T R SOC, V363, P16; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; CARBONELL LF, 1988, GENE, V73, P409, DOI 10.1016/0378-1119(88)90505-7; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Chattopadhyay A, 2004, CRIT REV MICROBIOL, V30, P33, DOI 10.1080/10408410490270712; CHEJANOVSKY N, 1995, FEBS LETT, V376, P181, DOI 10.1016/0014-5793(95)01263-4; Chen YR, 2013, J VIROL, V87, P6391, DOI 10.1128/JVI.00194-13; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; Cohen E, 1998, TOXICON, V36, P353, DOI 10.1016/S0041-0101(97)00075-5; Corzo G, 2008, PEPTIDES, V29, P1901, DOI 10.1016/j.peptides.2008.07.003; Corzo G, 2009, BBA-PROTEINS PROTEOM, V1794, P1190, DOI 10.1016/j.bbapap.2009.04.004; Da Silveira RB, 2007, BIOCHEM J, V406, P355, DOI 10.1042/BJ20070363; DAVIS TR, 1993, IN VITRO CELL DEV-AN, V29A, P388; Oliveira JVD, 2006, J GEN VIROL, V87, P3233, DOI 10.1099/vir.0.82161-0; De Lima ME, 2007, COMP BIOCHEM PHYS C, V146, P264, DOI 10.1016/j.cbpc.2006.10.010; Ding WX, 2012, J BIOL CHEM, V287, P42373, DOI 10.1074/jbc.M112.413674; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; Escoubas P, 2006, TOXICON, V47, P650, DOI 10.1016/j.toxicon.2006.01.018; Escoubas P, 2007, EXPERT OPIN DRUG DIS, V2, P823, DOI 10.1517/17460441.2.6.823; Estrada G, 2007, NAT PROD REP, V24, P145, DOI 10.1039/b603083c; Florea A, 2011, MICRON, V42, P434, DOI 10.1016/j.micron.2010.12.006; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gentz MC, 2009, TOXICON, V53, P496, DOI 10.1016/j.toxicon.2009.01.025; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; GRANADOS RR, 1994, VIRUS J INVERTEBRATE, V64, P7; Greene GL, 1976, J ECON ENTOMOL, V69, P2; Gurevitz M, 2007, TOXICON, V49, P473, DOI 10.1016/j.toxicon.2006.11.015; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Hughes PR, 1997, J INVERTEBR PATHOL, V69, P112, DOI 10.1006/jipa.1996.4643; Ibanez S, 2012, TOXINS, V4, P228, DOI 10.3390/toxins4040228; JARVIS DL, 1991, VIROLOGY, V185, P795, DOI 10.1016/0042-6822(91)90551-L; JARVIS DL, 1992, J VIROL, V66, P6903, DOI 10.1128/JVI.66.12.6903-6911.1992; Ji WJ, 2005, PROTEIN EXPRES PURIF, V41, P454, DOI 10.1016/j.pep.2005.02.012; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; Kourie JI, 2000, AM J PHYSIOL-CELL PH, V278, pC1063, DOI 10.1152/ajpcell.2000.278.6.C1063; Krammer F, 2010, MOL BIOTECHNOL, V45, P226, DOI 10.1007/s12033-010-9268-3; Kumarswamy R, 2009, INT J BIOCHEM CELL B, V41, P1430, DOI 10.1016/j.biocel.2008.12.009; Li G, 2005, J NEUROSCI, V25, P10188, DOI 10.1523/JNEUROSCI.3560-05.2005; LOCHT A, 2005, B SOC ENTOMOLOGICA A, V37, P4; Lu HM, 1996, EMBO J, V15, P429, DOI 10.1002/j.1460-2075.1996.tb00373.x; MCCUTCHEN BF, 1991, BIO-TECHNOL, V9, P848, DOI 10.1038/nbt0991-848; Meng E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021608; MINTZ IM, 1994, J NEUROSCI, V14, P2844; MINTZ IM, 1993, NEUROPHARMACOLOGY, V32, P1161, DOI 10.1016/0028-3908(93)90010-Z; Nowatzki J, 2010, TOXICON, V56, P535, DOI 10.1016/j.toxicon.2010.03.027; OERKE EC, 2006, J AGR SCI, V144, P13; Oomens AGP, 1999, VIROLOGY, V254, P297, DOI 10.1006/viro.1998.9523; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Ardisson-Araujo DMP, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-262; Pimentel C, 2006, PROTEIN SCI, V15, P628, DOI 10.1110/ps.051860606; Polyansky AA, 2009, FEBS LETT, V583, P2425, DOI 10.1016/j.febslet.2009.06.044; Prikhod'ko EA, 1999, J VIROL, V73, P6691; Prikhodko EA, 1996, J VIROL, V70, P7116, DOI 10.1128/JVI.70.10.7116-7124.1996; Quintero-Hernandez V, 2011, TOXICON, V58, P644, DOI 10.1016/j.toxicon.2011.09.015; Rodrigues JCM, 2001, VIRUS GENES, V22, P103, DOI 10.1023/A:1008142621359; Rohrmann G.F., 2019, BACULOVIRUS MOL BIOL; Saarinen MA, 1999, BIOTECHNOL BIOENG, V63, P612, DOI 10.1002/(SICI)1097-0290(19990605)63:5&lt;612::AID-BIT11&gt;3.0.CO;2-C; Sambrook J., 2001, MOL CLONING LAB MANU; Sanguinetti MC, 1997, MOL PHARMACOL, V51, P491; Schwartz EF, 2012, BIOPOLYMERS, V98, P385, DOI 10.1002/bip.22100; Seshagiri S, 1997, P NATL ACAD SCI USA, V94, P13606, DOI 10.1073/pnas.94.25.13606; Siemens J, 2006, NATURE, V444, P208, DOI 10.1038/nature05285; Slack J, 2007, ADV VIRUS RES, V69, P99, DOI 10.1016/S0065-3527(06)69003-9; Summers MD, 2006, ADV VIRUS RES, V68, P3, DOI 10.1016/S0065-3527(06)68001-9; Tang Xinxin, 2011, Weishengwu Xuebao, V51, P1502; Correa RFT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046121; TESSIER DC, 1991, GENE, V98, P177, DOI 10.1016/0378-1119(91)90171-7; TOMALSKI MD, 1993, TOXICON, V31, P319, DOI 10.1016/0041-0101(93)90149-D; TOMALSKI MD, 1991, NATURE, V352, P82, DOI 10.1038/352082a0; van Beek N, 2003, BIOL CONTROL, V27, P53, DOI 10.1016/S1049-9644(02)00172-X; van Beek Nikolai, 2007, V388, P367; van Oers MM, 2011, J INVERTEBR PATHOL, V107, pS3, DOI 10.1016/j.jip.2011.05.001; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vassilevski AA, 2010, J BIOL CHEM, V285, P32293, DOI 10.1074/jbc.M110.104265; Vorontsova OV, 2011, BIOCHIMIE, V93, P227, DOI 10.1016/j.biochi.2010.09.016; Wan H, 2013, COMP BIOCHEM PHYS B, V165, P36, DOI 10.1016/j.cbpb.2013.03.004; Wan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053343; Wang RR, 2010, J VIROL, V84, P7233, DOI 10.1128/JVI.00040-10; Wang XH, 2000, NAT STRUCT BIOL, V7, P505, DOI 10.1038/75921; WANG XZ, 1991, GENE, V100, P131, DOI 10.1016/0378-1119(91)90358-I; WICKHAM TJ, 1992, BIOTECHNOL PROGR, V8, P391, DOI 10.1021/bp00017a003; Windley MJ, 2012, TOXINS, V4, P191, DOI 10.3390/toxins4030191; Yao B, 1996, SCI CHINA SER C, V39, P199; 2002, BIOCHEM BIOPH RES CO, V298, P638, DOI DOI 10.1016/S0006-291X(02)02521-4.PUBMED:12419302	90	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e84404	10.1371/journal.pone.0084404	http://dx.doi.org/10.1371/journal.pone.0084404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349574	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200115
J	De Oca, CSM; Martinez-Ruiz, F; Rodriguez-Tovar, FJ				Sosa-Montes De Oca, Claudia; Martinez-Ruiz, Francisca; Javier Rodriguez-Tovar, Francisco			Bottom-Water Conditions in a Marine Basin after the Cretaceous-Paleogene Impact Event: Timing the Recovery of Oxygen Levels and Productivity	PLOS ONE			English	Article							K-T BOUNDARY; TERTIARY BOUNDARY; MASS EXTINCTION; SPHERULES; LAYER; CONSEQUENCES; CARAVACA; DECREASE; SECTION; PROXIES	An ultra-high-resolution analysis of major and trace element contents from the Cretaceous-Paleogene boundary interval in the Caravaca section, southeast Spain, reveals a quick recovery of depositional conditions after the impact event. Enrichment/depletion profiles of redox sensitive elements indicate significant geochemical anomalies just within the boundary ejecta layer, supporting an instantaneous recovery - some 10(2) years- of pre-impact conditions in terms of oxygenation. Geochemical redox proxies point to oxygen levels comparable to those at the end of the Cretaceous shortly after impact, which is further evidenced by the contemporary macrobenthic colonization of opportunistic tracemakers. Recovery of the oxygen conditions was therefore several orders shorter than traditional proposals (10(4) - 10(5) years), suggesting a probable rapid recovery of deep-sea ecosystems at bottom and in intermediate waters.	[Sosa-Montes De Oca, Claudia; Martinez-Ruiz, Francisca] Univ Granada, Inst Andaluz Ciencias Tierra, Consejo Super Invest Cient, Granada, Spain; [Javier Rodriguez-Tovar, Francisco] Univ Granada, Dept Estratig & Paleontol, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT); University of Granada; University of Granada	Martinez-Ruiz, F (corresponding author), Univ Granada, Inst Andaluz Ciencias Tierra, Consejo Super Invest Cient, Granada, Spain.	fmruiz@ugr.es	Martinez-Ruiz, Francisca/C-5908-2014; de oca, Claudia sosa-montes/T-6604-2018; Rodríguez-Tovar, Francisco/AAA-9041-2020	Martinez-Ruiz, Francisca/0000-0002-8301-4453; Rodríguez-Tovar, Francisco/0000-0002-1400-2715; Sosa Montes de Oca, Claudia/0000-0003-4451-6458	Secretaria de Estado de I+D+I, Spain [CGL2009-07603, CGL2008-03007, CGL2012-33281, CGL2012-32659]; Research Groups (Junta de Andalucia) [RNM-178, 0179];  [RNM-3715];  [RNM 05212]	Secretaria de Estado de I+D+I, Spain; Research Groups (Junta de Andalucia); ; 	This research was supported by Projects CGL2009-07603, CGL2008-03007, CGL2012-33281 and CGL2012-32659 (Secretaria de Estado de I+D+I, Spain), Projects RNM-3715 and RNM 05212, and Research Groups RNM-178 and 0179 (Junta de Andalucia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JB, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2002PA000849; Alegret L, 2005, PALAEOGEOGR PALAEOCL, V224, P53, DOI 10.1016/j.palaeo.2005.03.031; Algeo TJ, 2009, CHEM GEOL, V268, P211, DOI 10.1016/j.chemgeo.2009.09.001; ALVAREZ LW, 1980, SCIENCE, V208, P1095, DOI 10.1126/science.208.4448.1095; [Anonymous], [No title captured], DOI [10.1016/S15725480(07)01019-6, DOI 10.1016/S15725480(07)01019-6]; Arenillas I, 2006, EARTH PLANET SC LETT, V249, P241, DOI 10.1016/j.epsl.2006.07.020; Arinobu T, 1999, GEOLOGY, V27, P723, DOI 10.1130/0091-7613(1999)027<0723:SOPPAH>2.3.CO;2; Artemieva N, 2009, ICARUS, V201, P768, DOI 10.1016/j.icarus.2009.01.021; Bea F, 1996, J PETROL, V37, P521, DOI 10.1093/petrology/37.3.521; Berndt J, 2011, GEOLOGY, V39, P279, DOI 10.1130/G31599.1; Chenet AL, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005644; COCCIONI R, 1994, GEOLOGY, V22, P779, DOI 10.1130/0091-7613(1994)022<0779:KTBEGI>2.3.CO;2; Courtillot V, 1999, EARTH PLANET SC LETT, V166, P177, DOI 10.1016/S0012-821X(98)00282-9; Coxall HK, 2006, GEOLOGY, V34, P297, DOI 10.1130/G21702.1; Culver SJ, 2003, MAR MICROPALEONTOL, V47, P177, DOI 10.1016/S0377-8398(02)00117-2; D'Hondt S, 2005, ANNU REV ECOL EVOL S, V36, P295, DOI 10.1146/annurev.ecolsys.35.021103.105715; HILDEBRAND AR, 1991, GEOLOGY, V19, P867, DOI 10.1130/0091-7613(1991)019<0867:CCAPCT>2.3.CO;2; Rodriguez-Tovar FJ, 2008, GEOBIOS-LYON, V41, P661, DOI 10.1016/j.geobios.2008.01.003; Kaiho K, 1999, PALEOCEANOGRAPHY, V14, P511, DOI 10.1029/1999PA900022; Keller G, 2011, J GEOL SOC INDIA, V78, P399, DOI 10.1007/s12594-011-0107-3; Keller G, 2013, T AM GEOPHYS UNION, V94, P200, DOI [10.1002/2013EO220004, DOI 10.1002/2013E0220004]; Kring DA, 2007, PALAEOGEOGR PALAEOCL, V255, P4, DOI 10.1016/j.palaeo.2007.02.037; MACLEOD N, 1991, GEOLOGY, V19, P497, DOI 10.1130/0091-7613(1991)019<0497:HDAMEA>2.3.CO;2; MACLEOD N, 1994, PALEOBIOLOGY, V20, P143, DOI 10.1017/S0094837300012653; MACLEOD N, 1991, GEOL SOC AM BULL, V103, P1439, DOI 10.1130/0016-7606(1991)103<1439:HCACTB>2.3.CO;2; Martinez-Ruiz F, 1999, TERRA NOVA, V11, P290, DOI 10.1046/j.1365-3121.1999.00261.x; Martinez-Ruiz F, 2006, CHEM GEOL, V232, P1, DOI 10.1016/j.chemgeo.2006.02.013; Martinez-Ruiz F, 2001, GEOL SOC SPEC PUBL, V183, P131, DOI 10.1144/GSL.SP.2001.183.01.07; MartinezRuiz F, 1997, SEDIMENT GEOL, V113, P137, DOI 10.1016/S0037-0738(97)00057-2; Mizukami T, 2013, PALAEOGEOGR PALAEOCL, V369, P41, DOI 10.1016/j.palaeo.2012.09.020; Molina E, 2006, EPISODES, V29, P263, DOI 10.18814/epiiugs/2006/v29i4/004; Renne PR, 2013, SCIENCE, V339, P684, DOI 10.1126/science.1230492; Rodriguez-Tovar FJ, 2009, GEOBIOLOGY, V7, P533, DOI 10.1111/j.1472-4669.2009.00213.x; Rodriguez-Tovar FJ, 2005, GEOLOGY, V33, P585, DOI 10.1130/G21527.1; Rodriguez-Tovar FJ, 2011, MIN MAG GOLDSCHM C; Schulte P, 2010, SCIENCE, V327, P1214, DOI 10.1126/science.1177265; Shukolyukov A, 1998, SCIENCE, V282, P927, DOI 10.1126/science.282.5390.927; SMIT J, 1981, NATURE, V292, P47, DOI 10.1038/292047a0; SMIT J, 1980, NATURE, V285, P198, DOI 10.1038/285198a0; Smit J, 1999, ANNU REV EARTH PL SC, V27, P75, DOI 10.1146/annurev.earth.27.1.75; Smit J., 1982, CRETACEOUS RES, V3, P307, DOI [10.1016/0195-6671(82)90031-3, DOI 10.1016/0195-6671(82)90031-3]; Smit J, 1990, 28 INT GEOL C, V3, P136; SMIT J., 1982, GEOLOGICAL SOC AM SP, V190, P329, DOI DOI 10.1130/SPE190; Smit Jan, 2005, Journal of Iberian Geology, V31, P179; Smith A. G., 1981, PHANEROZOIC PALEOCON; Taylor S.R., 1985, CONTINENTAL CRUST IT; Tribovillard N, 2012, CHEM GEOL, V324, P46, DOI 10.1016/j.chemgeo.2011.09.009; Tribovillard N, 2006, CHEM GEOL, V232, P12, DOI 10.1016/j.chemgeo.2006.02.012; Zhou L, 2012, CHEM GEOL, V324, P99, DOI 10.1016/j.chemgeo.2012.03.020	49	21	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82242	10.1371/journal.pone.0082242	http://dx.doi.org/10.1371/journal.pone.0082242			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349232	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200031
J	Konopinski, MK; Amirowicz, A; Kotlik, P; Kukula, K; Bylak, A; Pekarik, L; Sediva, A				Konopinski, Maciej K.; Amirowicz, Antoni; Kotlik, Petr; Kukula, Krzysztof; Bylak, Aneta; Pekarik, Ladislav; Sediva, Alena			Back from the Brink: The Holocene History of the Carpathian Barbel Barbus carpathicus	PLOS ONE			English	Article							CROSS-SPECIES AMPLIFICATION; COTTUS-GOBIO L; POPULATION-STRUCTURE; COMPARATIVE PHYLOGEOGRAPHY; POSTGLACIAL COLONIZATION; COMPUTER-PROGRAM; FISH; MITOCHONDRIAL; BIOGEOGRAPHY; CYPRINIDAE	As a result of specific adaptations and habitat preferences strongly rheophilic fish species may show high levels of endemism. Many temperate rheophilic fish species were subjected to a series of range contractions during the Pleistocene, and then successfully expanded during the Holocene, colonising previously abandoned areas. The Carpathian barbel (Barbus carpathicus Kotlik, Tsigenopoulos, Rab et Berrebi 2002) occurs in the montane streams in three basins of the main Central European rivers in the northern part of the Carpathian range. We used genetic variation within 3 mitochondrial and 9 microsatellite loci to determine a pattern of postglacial expansion in B. carpathicus. We found that overall genetic variation within the species is relatively low. Estimate of time to the most recent common ancestor (tMRCA) of mitochondrial sequences falls within the Holocene. The highest levels of genetic variation found in upper reaches of the Tisa river in the Danube basin suggest that glacial refugia were located in the south-eastern part of the species range. Our data suggest that the species crossed different watersheds at least six times as three genetically distinct groups (probably established in different expansion episodes) were found in northern part of the species range. Clines of genetic variation were observed in both the Danube and Vistula basins, which probably resulted from subsequent bottlenecks while colonizing successive habitats (south eastern populations) or due to the admixture of genetically diverse individuals to a previously uniform population (Vistula basin). Therefore, B. carpathicus underwent both demographic breakdowns and expansions during the Holocene, showing its distribution and demography are sensitive to environmental change. Our findings are important in the light of the current human-induced habitats alterations.	[Konopinski, Maciej K.; Amirowicz, Antoni] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland; [Kotlik, Petr] AS CR, Inst Anim Physiol & Genet, Libechov, Czech Republic; [Kukula, Krzysztof; Bylak, Aneta] Univ Rzeszow, Dept Environm Biol, Rzeszow, Poland; [Pekarik, Ladislav; Sediva, Alena] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia	Polish Academy of Sciences; Czech Academy of Sciences; Institute of Animal Physiology & Genetics of the Czech Academy of Sciences; University of Rzeszow; Slovak Academy of Sciences	Konopinski, MK (corresponding author), Polish Acad Sci, Inst Nat Conservat, Krakow, Poland.	konopinski@iop.krakow.pl	Konopiński, Maciej/G-9982-2011; Sediva, Alena/G-7204-2014; Pekárik, Ladislav/E-6218-2011; Kotlík, Petr/AAP-1342-2021; Kotlik, Petr/B-4633-2009	Konopiński, Maciej/0000-0003-0893-0846; Pekárik, Ladislav/0000-0002-7253-2837; Kotlík, Petr/0000-0001-9429-0667; Kotlik, Petr/0000-0001-9429-0667; Amirowicz, Antoni/0000-0002-9549-5944; Bylak, Aneta/0000-0002-7617-5814; Kukula, Krzysztof/0000-0002-9685-7994	National Science Centre, Poland [NN 304 229035]; Institute of Nature Conservation PAS; Institutional Research Concept RVO (IAPG, AS CR, v.v.i.) [67985904]	National Science Centre, Poland(National Science Centre, Poland); Institute of Nature Conservation PAS; Institutional Research Concept RVO (IAPG, AS CR, v.v.i.)	The study was financed by a grant from the National Science Centre, Poland (grant no. NN 304 229035) and partly by the Institute of Nature Conservation PAS. Additional support to PK was provided by the Institutional Research Concept RVO 67985904 (IAPG, AS CR, v.v.i.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belkhir K., 2004, GENETIX 4 05 LOGICIE; Bernatchez L, 1998, MOL ECOL, V7, P431, DOI 10.1046/j.1365-294x.1998.00319.x; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Chenuil A, 1999, HEREDITY, V82, P373, DOI 10.1038/sj.hdy.6884890; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hanfling B, 1998, HEREDITY, V80, P110; Hasselman DJ, 2013, MOL ECOL, V22, P1558, DOI 10.1111/mec.12197; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; HOCUTT CH, 1979, GEOL SOC AM BULL, V90, P129, DOI 10.1130/0016-7606(1979)90<129:DEAFDI>2.0.CO;2; Houston DD, 2010, MOL PHYLOGENET EVOL, V55, P259, DOI 10.1016/j.ympev.2009.10.017; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Janko K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-220; Konopinski MK, 2007, J FISH BIOL, V70, P406, DOI 10.1111/j.1095-8649.2007.01479.x; Kotlik P, 2002, FOLIA ZOOL, V51, P227; Kotlik P, 2002, MOL PHYLOGENET EVOL, V24, P10, DOI 10.1016/S1055-7903(02)00264-6; Kotlik P, 2008, MOL ECOL, V17, P1076, DOI 10.1111/j.1365-294X.2007.03638.x; Kotlik P, 2006, P NATL ACAD SCI USA, V103, P14860, DOI 10.1073/pnas.0603237103; Kottelat M, 2007, HDB FRESHWATER EUROP, P646; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Machordom A, 2001, MOL PHYLOGENET EVOL, V18, P252, DOI 10.1006/mpev.2000.0876; Pritchard JK, 2000, GENETICS, V155, P945; Rembiszewski M, 1975, CYCLOSTOMATA PISCES, VXXXVIII, P249; Riffel M, 1995, J ZOOL SYST EVOL RES, V33, P173; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schmitt T, 2012, FRONT ZOOL, V9, DOI 10.1186/1742-9994-9-22; SLATKIN M, 1991, GENETICS, V129, P555; Slechtova V, 2004, MOL PHYLOGENET EVOL, V33, P225, DOI 10.1016/j.ympev.2004.05.005; Strona G, 2012, FISH PLOS ONE, V7, DOI [10.1371/journal.pone.0049465, DOI 10.1371/J0URNAL.P0NE.0049465]; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tong J, 2002, MOL ECOL NOTES, V2, P245, DOI 10.1046/j.1471-8286.2002.00214.x; Turner TF, 2004, CONSERV GENET, V5, P279, DOI 10.1023/B:COGE.0000029998.11426.ab; Urdea P, 2009, GEOGR PANNONICA, V13, P41, DOI 10.5937/GeoPan0902041U; Vyskocilova M, 2007, MOL ECOL NOTES, V7, P1150, DOI 10.1111/j.1471-8286.2007.01813.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Wofford JEB, 2005, ECOL APPL, V15, P628, DOI 10.1890/04-0095; Wong BBM, 2004, MOL ECOL, V13, P391, DOI 10.1046/j.1365-294X.2003.02085.x; Xiao WH, 2001, MOL PHYLOGENET EVOL, V18, P163, DOI 10.1006/mpev.2000.0879	51	5	5	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82464	10.1371/journal.pone.0082464	http://dx.doi.org/10.1371/journal.pone.0082464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349291	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800062
J	Li, HZ; Gao, X; Li, XY; Chen, QJ; Dong, J; Zhao, WC				Li, Huai-Zhu; Gao, Xiang; Li, Xiao-Yan; Chen, Qi-Jiao; Dong, Jian; Zhao, Wan-Chun			Evaluation of Assembly Strategies Using RNA-Seq Data Associated with Grain Development of Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							FRUIT-DEVELOPMENT; SNP DISCOVERY; TRANSCRIPTOME; GENE; ULTRAFAST; SEQUENCES; ALIGNMENT; REVEALS; BIAS; TOOL	Wheat (Triticum aestivum L.) is one of the most important crops cultivated worldwide. Identifying the complete transcriptome of wheat grain could serve as foundation for further study of wheat seed development. However, the relatively large size and the polyploid complexity of the genome have been substantial barriers to molecular genetics and transcriptome analysis of wheat. Alternatively, RNA sequencing has provided some useful information about wheat genes. However, because of the large number of short reads generated by RNA sequencing, factors that are crucial to transcriptome assembly, including software, candidate parameters and assembly strategies, need to be optimized and evaluated for wheat data. In the present study, four cDNA libraries associated with wheat grain development were constructed and sequenced. A total of 14.17 Gb of high-quality reads were obtained and used to assess different assembly strategies. The most successful approach was to filter the reads with Q30 prior to de novo assembly using Trinity, merge the assembled contigs with genes available in wheat cDNA reference data sets, and combine the resulting assembly with an assembly from a reference-based strategy. Using this approach, a relatively accurate and nearly complete transcriptome associated with wheat grain development was obtained, suggesting that this is an effective strategy for generation of a high-quality transcriptome from RNA sequencing data.	[Li, Huai-Zhu; Gao, Xiang; Li, Xiao-Yan; Chen, Qi-Jiao; Dong, Jian; Zhao, Wan-Chun] Northwest A&F Univ, Coll Agron, Dept Seed Sci, Yangling, Shaanxi Provinc, Peoples R China; [Gao, Xiang; Li, Xiao-Yan; Chen, Qi-Jiao; Dong, Jian; Zhao, Wan-Chun] Wheat Engn Res Ctr Shaanxi Prov, Yangling, Shaanxi Provinc, Peoples R China	Northwest A&F University - China	Gao, X (corresponding author), Northwest A&F Univ, Coll Agron, Dept Seed Sci, Yangling, Shaanxi Provinc, Peoples R China.	gx@nwsuaf.edu.cn; xiaoyanli@nwsuaf.edu.cn	Li, Huaizhu/AAE-1585-2022; Li, Huaizhu/GWN-4445-2022	Li, Huaizhu/0000-0003-0212-822X; 	National Natural Science Foundation of China [31101138]; Special Funds for Basic Research [QN2012003]; Special Funds for Talents in Northwest AF University [2010BSJJ033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Funds for Basic Research; Special Funds for Talents in Northwest AF University	This work was supported, in part, by the National Natural Science Foundation of China (31101138), Special Funds for Basic Research (QN2012003) and the Special Funds for Talents in Northwest A&F University (2010BSJJ033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Bundock PC, 2009, PLANT BIOTECHNOL J, V7, P347, DOI 10.1111/j.1467-7652.2009.00401.x; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Duan JL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-392; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Garg R, 2011, PLANT PHYSIOL, V156, P1661, DOI 10.1104/pp.111.178616; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; Haznedaroglu BZ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-170; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jia J, 2013, NATURE; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kiss I, 2013, SIGNIFICANCE WHEAT P; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Ling H-Q, 2013, NATURE, DOI 105524/100050; Martin J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-663; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mochida K, 2009, PLANT PHYSIOL, V150, P1135, DOI 10.1104/pp.109.138214; Ness RW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-298; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Paux E, 2008, SCIENCE, V322, P101, DOI 10.1126/science.1161847; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Sadamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042546; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Vijay N, 2012, MOL ECOL; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Xu SB, 2008, PLANT PHYSIOL, V148, P908, DOI 10.1104/pp.108.125633; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang GJ, 2010, GENOME RES, V20, P646, DOI 10.1101/gr.100677.109; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	45	20	20	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83530	10.1371/journal.pone.0083530	http://dx.doi.org/10.1371/journal.pone.0083530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349528	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800125
J	Luddecke, J; Forchhammer, K				Lueddecke, Jan; Forchhammer, Karl			From P-II Signaling to Metabolite Sensing: A Novel 2-Oxoglutarate Sensor That Details P-II - NAGK Complex Formation	PLOS ONE			English	Article							TRANSDUCTION PROTEIN; FLUORESCENT PROTEIN; NITROGEN; VARIANT; CYANOBACTERIA; ACTIVATION; KINASE	The widespread P-II signal transduction proteins are known for integrating signals of nitrogen and energy supply and regulating cellular behavior by interacting with a multitude of target proteins. The P-II protein of the cyanobacterium Synechococcus elongatus forms complexes with the controlling enzyme of arginine synthesis, N-acetyl-L-glutamate kinase (NAGK) in a 2-oxoglutarate- and ATP/ADP-dependent manner. Fusing NAGK and P-II proteins to either CFP or YFP yielded a FRET sensor that specifically responded to 2-oxoglutarate. The impact of the fluorescent tags on P-II and NAGK was evaluated by enzyme assays, surface plasmon resonance spectroscopy and isothermal calorimetric experiments. The developed FRET sensor provides real-time data on P-II - NAGK interaction and its modulation by the effector molecules ATP, ADP and 2-oxoglutarate in vitro. Additionally to its utility to monitor 2-oxoglutarate levels, the FRET assay provided novel insights into P-II - NAGK complex formation: (i) It revealed the formation of an encounter-complex between P-II and NAGK, which holds the proteins in proximity even in the presence of inhibitors of complex formation; (ii) It revealed that the P-II T-loop residue Ser49 is neither essential for complex formation with NAGK nor for activation of the enzyme but necessary to form a stable complex and efficiently relieve NAGK from arginine inhibition; (iii) It showed that arginine stabilizes the NAGK hexamer and stimulates P-II NAGK interaction.	[Lueddecke, Jan; Forchhammer, Karl] Univ Tubingen, Interfac Inst Microbiol & Infect Med IMIT, Tubingen, Germany	Eberhard Karls University of Tubingen	Forchhammer, K (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med IMIT, Tubingen, Germany.	karl.forchhammer@uni-tuebingen.de			Deutsche Forschungsgemeinschaft DFG [Fo195/9-1]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft DFG Fo195/9-1. www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Beez S, 2009, J MOL BIOL, V389, P748, DOI 10.1016/j.jmb.2009.04.053; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; BUENO R, 1985, J BACTERIOL, V164, P816, DOI 10.1128/JB.164.2.816-822.1985; Fokina O, 2011, BIOCHEM J, V440, P147, DOI 10.1042/BJ20110536; Fokina O, 2010, P NATL ACAD SCI USA, V107, P19760, DOI 10.1073/pnas.1007653107; Fokina O, 2010, J MOL BIOL, V399, P410, DOI 10.1016/j.jmb.2010.04.018; Forchhammer K, 1997, EUR J BIOCHEM, V244, P869, DOI 10.1111/j.1432-1033.1997.00869.x; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Heinrich A, 2004, MOL MICROBIOL, V52, P1303, DOI 10.1111/j.1365-2958.2004.04058.x; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Jiang P, 1999, J BACTERIOL, V181, P1906, DOI 10.1128/JB.181.6.1906-1911.1999; Jiang P, 2007, BIOCHEMISTRY-US, V46, P12979, DOI 10.1021/bi701062t; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Llacer JL, 2007, P NATL ACAD SCI USA, V104, P17644, DOI 10.1073/pnas.0705987104; Maheswaran M, 2004, J BIOL CHEM, V279, P55202, DOI 10.1074/jbc.M410971200; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Xu YB, 2003, ACTA CRYSTALLOGR D, V59, P2183, DOI 10.1107/S0907444903019589; Zeth K, 2012, ACTA CRYSTALLOGR D, V68, P901, DOI 10.1107/S0907444912016447	24	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83181	10.1371/journal.pone.0083181	http://dx.doi.org/10.1371/journal.pone.0083181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349456	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800100
J	Wiringa, AE; Shutt, KA; Marsh, JW; Cohn, AC; Messonnier, NE; Zansky, SM; Petit, S; Farley, MM; Gershman, K; Lynfield, R; Reingold, A; Schaffner, W; Thompson, J; Brown, ST; Lee, BY; Harrison, LH				Wiringa, Ann E.; Shutt, Kathleen A.; Marsh, Jane W.; Cohn, Amanda C.; Messonnier, Nancy E.; Zansky, Shelley M.; Petit, Susan; Farley, Monica M.; Gershman, Ken; Lynfield, Ruth; Reingold, Arthur; Schaffner, William; Thompson, Jamie; Brown, Shawn T.; Lee, Bruce Y.; Harrison, Lee H.			Geotemporal Analysis of Neisseria meningitidis Clones in the United States: 2000-2005	PLOS ONE			English	Article							INVASIVE MENINGOCOCCAL DISEASE; OUTBREAK DETECTION; SURVEILLANCE; INFECTION; RISK	Background: The detection of meningococcal outbreaks relies on serogrouping and epidemiologic definitions. Advances in molecular epidemiology have improved the ability to distinguish unique Neisseria meningitidis strains, enabling the classification of isolates into clones. Around 98% of meningococcal cases in the United States are believed to be sporadic. Methods: Meningococcal isolates from 9 Active Bacterial Core surveillance sites throughout the United States from 2000 through 2005 were classified according to serogroup, multilocus sequence typing, and outer membrane protein (porA, porB, and fetA) genotyping. Clones were defined as isolates that were indistinguishable according to this characterization. Case data were aggregated to the census tract level and all non-singleton clones were assessed for non-random spatial and temporal clustering using retrospective space-time analyses with a discrete Poisson probability model. Results: Among 1,062 geocoded cases with available isolates, 438 unique clones were identified, 78 of which had >= 2 isolates. 702 cases were attributable to non-singleton clones, accounting for 66.0% of all geocoded cases. 32 statistically significant clusters comprised of 107 cases (10.1% of all geocoded cases) were identified. Clusters had the following attributes: included 2 to 11 cases; 1 day to 33 months duration; radius of 0 to 61.7 km; and attack rate of 0.7 to 57.8 cases per 100,000 population. Serogroups represented among the clusters were: B (n = 12 clusters, 45 cases), C (n = 11 clusters, 27 cases), and Y (n = 9 clusters, 35 cases); 20 clusters (62.5%) were caused by serogroups represented in meningococcal vaccines that are commercially available in the United States. Conclusions: Around 10% of meningococcal disease cases in the U.S. could be assigned to a geotemporal cluster. Molecular characterization of isolates, combined with geotemporal analysis, is a useful tool for understanding the spread of virulent meningococcal clones and patterns of transmission in populations.	[Wiringa, Ann E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [Shutt, Kathleen A.; Marsh, Jane W.; Harrison, Lee H.] Univ Pittsburgh, Grad Sch Publ Hlth, Infect Dis Epidemiol Res Unit, Pittsburgh, PA 15260 USA; [Shutt, Kathleen A.; Marsh, Jane W.; Harrison, Lee H.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Cohn, Amanda C.; Messonnier, Nancy E.] Ctr Dis Control & Prevent, Meningitis & Vaccine Preventable Dis Branch, Div Bacterial Dis, Atlanta, GA USA; [Zansky, Shelley M.] New York State Dept Hlth, Albany, NY USA; [Petit, Susan] Connecticut Dept Publ Hlth, Hartford, CT USA; [Farley, Monica M.] Emory Univ, Atlanta, GA 30322 USA; [Farley, Monica M.] VA Med Ctr, Atlanta, GA USA; [Gershman, Ken] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Lynfield, Ruth] Minnesota Dept Hlth, St Paul, MN USA; [Reingold, Arthur] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Schaffner, William] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Thompson, Jamie] Oregon Publ Hlth Div, Portland, OR USA; [Brown, Shawn T.] Carnegie Mellon Univ, Pittsburgh Supercomp Ctr, Pittsburgh, PA 15213 USA; [Lee, Bruce Y.] Univ Pittsburgh, Sch Med, Publ Hlth Computat & Operat Res PHICOR, Pittsburgh, PA USA; [Lee, Bruce Y.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Harrison, Lee H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA; State University of New York (SUNY) System; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Colorado Department of Public Health & Environment; Minnesota Department of Health (MHD); University of California System; University of California Berkeley; Vanderbilt University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Harrison, LH (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Infect Dis Epidemiol Res Unit, Pittsburgh, PA 15260 USA.	lharriso@edc.pitt.edu		Shutt, Kathleen/0000-0003-3376-6152; Brown, Shawn/0000-0001-6980-8372; Wiringa, Ann/0000-0002-6600-3592	US Centers for Disease Control and Prevention [DHM 99-006042]	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by the US Centers for Disease Control and Prevention grant DHM 99-006042. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CDC coauthors participated in various aspects of the study and manuscript reparation.	[Anonymous], 1997, MMWR Recomm Rep, V46, P13; Brehony C, 2007, FEMS MICROBIOL REV, V31, P15, DOI 10.1111/j.1574-6976.2006.00056.x; Brooks R, 2006, CLIN INFECT DIS, V43, P49, DOI 10.1086/504804; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; Elias J, 2006, EMERG INFECT DIS, V12, P1689, DOI 10.3201/eid1211.060682; Elias J, 2010, EMERG INFECT DIS, V16, P464, DOI 10.3201/eid1603.091102; Halperin SA, 2012, VACCINE, V30, pB26, DOI 10.1016/j.vaccine.2011.12.032; Harrison LH, 2010, J INFECT DIS, V201, P1208, DOI 10.1086/651505; Harrison LH, 2006, J INFECT DIS, V193, P1266, DOI 10.1086/501371; Harrison LH, 2006, CLIN MICROBIOL REV, V19, P142, DOI 10.1128/CMR.19.1.142-164.2006; Harrison LH, 1999, JAMA-J AM MED ASSOC, V281, P1906, DOI 10.1001/jama.281.20.1906; Harrison LH, 2001, JAMA-J AM MED ASSOC, V286, P694, DOI 10.1001/jama.286.6.694; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jung I, 2010, STAT MED, V29, P1910, DOI 10.1002/sim.3951; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M., 2011, SATSCAN SOFTWARE SPA; Kulldorff M, 2010, SATSCAN TECHNICAL DO; Mainassara HB, 2010, GEOSPATIAL HEALTH, V5, P93, DOI 10.4081/gh.2010.190; Meyer S, 2012, BIOMETRICS, V68, P607, DOI 10.1111/j.1541-0420.2011.01684.x; National Center for Health Statistics, 2006, VINT 2005 BRIDG RAC; Reinhardt M, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-33; Schuchat A, 2001, EMERG INFECT DIS, V7, P92, DOI 10.3201/eid0701.010114; Takahashi K, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-14; U.S. Census Bureau Geography Division, 2005, US CENS BUR CART BOU; US Census Bureau, 2000, AM FACTFINDER CENS 2; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	32	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82048	10.1371/journal.pone.0082048	http://dx.doi.org/10.1371/journal.pone.0082048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349182	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000328731800035
J	Bacallao, K; Monje, PV				Bacallao, Ketty; Monje, Paula V.			Opposing Roles of pka and epac in the cAMP-Dependent Regulation of Schwann Cell Proliferation and Differentiation	PLOS ONE			English	Article							PROTEIN-KINASE-A; CYCLIC-AMP; MYELINATION; SIGNAL; ACTIVATION; RESPONSES; GROWTH; TRANSCRIPTION; PROGRESSION; INHIBITION	In Schwann cells (SCs), cyclic adenosine monophosphate (cAMP) not only induces differentiation into a myelinating SC-related phenotype, but also synergistically enhances the mitogenic action of growth factors such as neuregulin. To better understand the molecular mechanism by which cAMP exerts these apparently contradictory functions, we investigated the role of the two main effectors of cAMP, protein kinase A (PKA) and the exchange protein activated by cAMP (EPAC), on the proliferation and differentiation of both isolated and axon-related SCs. For these studies, a variety of PKA and EPAC agonists and antagonists were used, including pathway-selective analogs of cAMP and pharmacological inhibitors. Our studies indicated that the activity of PKA rather than EPAC was required for the adjuvant effect of cAMP on S-phase entry, whereas the activity of EPAC rather than PKA was required for SC differentiation and myelin formation. Even though selective EPAC activation had an overall anti-proliferative effect in SCs, it failed to drive the expression of Krox-20, a master regulator of myelination, and that of myelin-specific proteins and lipids, suggesting that EPAC activation was insufficient to drive a full differentiating response. Interestingly, inhibition of EPAC activity resulted in a drastic impairment of SC differentiation and myelin formation but not Krox-20 expression, which indicates an independent mechanism of Krox-20 regulation in response to cAMP. In conclusion, our data supports the idea that the outcome of cAMP signaling in SCs depends on the particular set of effectors activated. Whereas the mitogenic action of cAMP relies exclusively on PKA activity, the differentiating action of cAMP requires a PKA-independent (non-canonical) cAMP-specific pathway that is partially transduced by EPAC.	[Bacallao, Ketty; Monje, Paula V.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA; [Monje, Paula V.] Univ Miami, Miller Sch Med, Dept Neurol Surg, Miami, FL 33136 USA	University of Miami; University of Miami	Monje, PV (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA.	pmonje@med.miami.edu	Monje, Paula/AAB-9099-2020		NIH-NINDS [NS009923]; Miami Project to Cure Paralysis; Buoniconti Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS009923, R21NS084326] Funding Source: NIH RePORTER	NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Miami Project to Cure Paralysis; Buoniconti Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH-NINDS Grant NS009923, The Miami Project to Cure Paralysis, and The Buoniconti Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almahariq M, 2013, MOL PHARMACOL, V83, P122, DOI 10.1124/mol.112.080689; Arthur-Farraj P, 2011, GLIA, V59, P720, DOI 10.1002/glia.21144; Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Crawford AT, 2008, GLIA, V56, P1637, DOI 10.1002/glia.20716; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; ELDRIDGE CF, 1987, J CELL BIOL, V105, P1023, DOI 10.1083/jcb.105.2.1023; ELDRIDGE CF, 1989, J NEUROSCI, V9, P625; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; GADBOIS DM, 1992, P NATL ACAD SCI USA, V89, P8626, DOI 10.1073/pnas.89.18.8626; Gerdin Matthew J, 2007, Sci STKE, V2007, ppe15; GLASS DB, 1989, J BIOL CHEM, V264, P8802; Gloerich M, 2010, ANNU REV PHARMACOL, V50, P355, DOI 10.1146/annurev.pharmtox.010909.105714; Guo L, 2012, J NEUROSCI, V32, P17251, DOI 10.1523/JNEUROSCI.2461-12.2012; Holz GG, 2008, CELL SIGNAL, V20, P10, DOI 10.1016/j.cellsig.2007.07.009; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Howe DG, 2000, J NEUROSCI, V20, P3513, DOI 10.1523/JNEUROSCI.20-10-03513.2000; Iyengar R, 1996, SCIENCE, V271, P461, DOI 10.1126/science.271.5248.461; JESSEN KR, 1991, ANN NY ACAD SCI, V633, P78; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; Kim HA, 1997, J NEUROSCI RES, V49, P236; Kim HA, 2001, J NEUROSCI, V21, P1110; Kopperud R, 2003, FEBS LETT, V546, P121, DOI 10.1016/S0014-5793(03)00563-5; Leitman EM, 2011, J CELL SCI, V124, P3784, DOI 10.1242/jcs.080200; LEMKE G, 1991, ANN NY ACAD SCI, V633, P189; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Monje PV, 2010, J BIOL CHEM, V285, P31024, DOI 10.1074/jbc.M110.116970; Monje PV, 2009, GLIA, V57, P947, DOI 10.1002/glia.20819; Monje PV, 2008, J BIOL CHEM, V283, P34087, DOI 10.1074/jbc.M802318200; Monje PV, 2006, GLIA, V53, P649, DOI 10.1002/glia.20330; Monk KR, 2011, DEVELOPMENT, V138, P2673, DOI 10.1242/dev.062224; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; MORRISSEY TK, 1995, P NATL ACAD SCI USA, V92, P1431, DOI 10.1073/pnas.92.5.1431; MORRISSEY TK, 1991, J NEUROSCI, V11, P2433; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; Parkinson DB, 2003, MOL CELL NEUROSCI, V23, P13, DOI 10.1016/S1044-7431(03)00024-1; PORTER S, 1986, J NEUROSCI, V6, P3070; RAFF MC, 1978, NATURE, V273, P672, DOI 10.1038/273672a0; Rahmatullah M, 1998, MOL CELL BIOL, V18, P6245, DOI 10.1128/MCB.18.11.6245; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; SALZER JL, 1980, J CELL BIOL, V84, P767, DOI 10.1083/jcb.84.3.767; Sands WA, 2008, CELL SIGNAL, V20, P460, DOI 10.1016/j.cellsig.2007.10.005; SOBUE G, 1986, BRAIN RES, V362, P23, DOI 10.1016/0006-8993(86)91394-6; SOBUE G, 1984, SCIENCE, V224, P72, DOI 10.1126/science.6322307; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; WOOD PM, 1976, BRAIN RES, V115, P361, DOI 10.1016/0006-8993(76)90355-3; WOOD PM, 1975, NATURE, V256, P662, DOI 10.1038/256662a0; YAMADA H, 1995, BRAIN RES, V681, P97, DOI 10.1016/0006-8993(95)00293-Y; Yoon C, 2008, J NEUROSCI, V28, P3738, DOI 10.1523/JNEUROSCI.4439-07.2008; Zorick TS, 1996, MOL CELL NEUROSCI, V8, P129, DOI 10.1006/mcne.1996.0052	54	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82354	10.1371/journal.pone.0082354	http://dx.doi.org/10.1371/journal.pone.0082354			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349260	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300088
J	Garseth, AH; Ekrem, T; Biering, E				Garseth, Ase Helen; Ekrem, Torbjorn; Biering, Eirik			Phylogenetic Evidence of Long Distance Dispersal and Transmission of Piscine Reovirus (PRV) between Farmed and Wild Atlantic Salmon	PLOS ONE			English	Article							SKELETAL-MUSCLE INFLAMMATION; MOLECULAR EPIDEMIOLOGY; SALAR L.; POST-SMOLTS; FISH; VIRUS; HEART; SEA; MIGRATION; INFERENCE	The extent and effect of disease interaction and pathogen exchange between wild and farmed fish populations is an ongoing debate and an area of research that is difficult to explore. The objective of this study was to investigate pathogen transmission between farmed and wild Atlantic salmon (Salmo salar L.) populations in Norway by means of molecular epidemiology. Piscine reovirus (PRV) was selected as the model organism as it is widely distributed in both farmed and wild Atlantic salmon in Norway, and because infection not necessarily will lead to mortality through development of disease. A matrix comprised of PRV protein coding sequences S1, S2 and S4 from wild, hatchery-reared and farmed Atlantic salmon in addition to one sea-trout (Salmo trutta L.) was examined. Phylogenetic analyses based on maximum likelihood and Bayesian inference indicate long distance transport of PRV and exchange of virus between populations. The results are discussed in the context of Atlantic salmon ecology and the structure of the Norwegian salmon industry. We conclude that the lack of a geographical pattern in the phylogenetic trees is caused by extensive exchange of PRV. In addition, the detailed topography of the trees indicates long distance transportation of PRV. Through its size, structure and infection status, the Atlantic salmon farming industry has the capacity to play a central role in both long distance transportation and transmission of pathogens. Despite extensive migration, wild salmon probably play a minor role as they are fewer in numbers, appear at lower densities and are less likely to be infected. An open question is the relationship between the PRV sequences found in marine fish and those originating from salmon.	[Garseth, Ase Helen; Biering, Eirik] Norwegian Vet Inst, Dept Hlth Surveillance, Trondheim, Norway; [Garseth, Ase Helen; Ekrem, Torbjorn] Norwegian Univ Sci & Technol, Univ Museum, Dept Nat Hist, N-7034 Trondheim, Norway	Norwegian Veterinary Institute; Norwegian University of Science & Technology (NTNU)	Garseth, AH (corresponding author), Norwegian Vet Inst, Dept Hlth Surveillance, Trondheim, Norway.	ase-helen.garseth@vetinst.no	Ekrem, Torbjørn/AAC-4087-2021	Ekrem, Torbjørn/0000-0003-3469-9211	Norwegian Directorate for Nature Management	Norwegian Directorate for Nature Management	The project was funded by The Norwegian Directorate for Nature Management (www.dirnat.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon M, 2012, HLTH SITUATION NORWE; Aldrin M, 2010, PREV VET MED, V93, P51, DOI 10.1016/j.prevetmed.2009.09.010; Anderson ED, 2000, J AQUAT ANIM HEALTH, V12, P85, DOI 10.1577/1548-8667(200006)012&lt;0085:MEREOA&gt;2.0.CO;2; [Anonymous], 2011, EFFECTIV SUSTAINABLE; [Anonymous], 2009, STATUS NORWEGIAN SAL; Antere I., 1983, International Council for the Exploration of the Sea C.M., V1983/M:26, P1; Beaugrand G, 2003, GLOBAL CHANGE BIOL, V9, P801, DOI 10.1046/j.1365-2486.2003.00632.x; Bergh O, 2007, DIS AQUAT ORGAN, V75, P159, DOI 10.3354/dao075159; Biering E., 2013, ANN REPORT HLTH MONI; Carstens EB, 2009, ARCH VIROL, V154, P1181, DOI 10.1007/s00705-009-0400-2; Dadswell MJ, 2010, J FISH BIOL, V77, P435, DOI 10.1111/j.1095-8649.2010.02673.x; Day JM, 2009, INFECT GENET EVOL, V9, P390, DOI 10.1016/j.meegid.2009.01.011; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferguson HW, 2005, J FISH DIS, V28, P119, DOI 10.1111/j.1365-2761.2004.00602.x; Finstad B, 2012, AQUACULTURE, V362, P193, DOI 10.1016/j.aquaculture.2010.10.037; Finstad OW, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-27; Fiske Peder, 2005, P659, DOI 10.1016/B978-012154351-8/50032-0; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Fringuelli E, 2008, J FISH DIS, V31, P811, DOI 10.1111/j.1365-2761.2008.00944.x; Garseth AH, 2013, J FISH DIS, V36, P483, DOI 10.1111/j.1365-2761.2012.01450.x; Garseth AH, 2013, PREV VET MED, V112, P138, DOI 10.1016/j.prevetmed.2013.06.007; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hansen LP, 2010, FISHERIES MANAG ECOL, V17, P28, DOI 10.1111/j.1365-2400.2009.00709.x; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Haugland M, 2006, ICES J MAR SCI, V63, P1488, DOI 10.1016/j.icesjms.2006.06.004; HEGGBERGET TG, 1993, FISH RES, V18, P123, DOI 10.1016/0165-7836(93)90044-8; Heuch PA, 2009, INTEGR COMP BIOL, V49, pE74; Heuch PA, 2005, AQUACULTURE, V250, P535, DOI 10.1016/j.aquaculture.2005.10.003; HINDAR K, 1991, CAN J FISH AQUAT SCI, V48, P945, DOI 10.1139/f91-111; Hindar K, 2006, ICES J MAR SCI, V63, P1234, DOI 10.1016/j.icesjms.2006.04.025; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hungnes O, 2000, APMIS, V108, P81, DOI 10.1034/j.1600-0463.2000.d01-31.x; Jensen O, 2010, AQUACULT ENV INTERAC, V1, P71, DOI 10.3354/aei00008; Johansen LH, 2011, AQUACULTURE, V315, P167, DOI 10.1016/j.aquaculture.2011.02.014; JOHNSEN BO, 1991, AQUACULTURE, V98, P289, DOI 10.1016/0044-8486(91)90393-L; JOHNSEN BO, 1994, J FISH BIOL, V45, P47, DOI 10.1111/j.1095-8649.1994.tb01285.x; Jones RC, 2000, REV SCI TECH OIE, V19, P614, DOI 10.20506/rst.19.2.1237; Jonsson B, 2003, J FISH BIOL, V62, P641, DOI 10.1046/j.1095-8649.2003.00053.x; Karlsen M, 2006, ARCH VIROL, V151, P861, DOI 10.1007/s00705-005-0687-6; Key T, 2013, J GEN VIROL, V94, P1039, DOI 10.1099/vir.0.048637-0; Kibenge MJT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-230; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kongtorp RT, 2004, DIS AQUAT ORGAN, V59, P217, DOI 10.3354/dao059217; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lovoll M, 2012, DIS AQUAT ORGAN, V99, P7, DOI 10.3354/dao02451; LUND R A, 1991, Aquaculture and Fisheries Management, V22, P499, DOI 10.1111/j.1365-2109.1991.tb00763.x; Lyngstad TM, 2011, EPIDEMICS-NETH, V3, P1, DOI 10.1016/j.epidem.2010.11.001; Markussen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070075; Mennerat A, 2010, EVOL BIOL, V37, P59, DOI 10.1007/s11692-010-9089-0; Mikalsen AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037269; Mladineo I, 2009, AQUACULTURE, V295, P160, DOI 10.1016/j.aquaculture.2009.07.017; Mo T.A., 1994, P43; Naylor R, 2005, BIOSCIENCE, V55, P427, DOI 10.1641/0006-3568(2005)055[0427:FSATRO]2.0.CO;2; Nylund A, 2008, ARCH VIROL, V153, P541, DOI 10.1007/s00705-007-0015-4; Olesen I, 2011, J AGR ENVIRON ETHIC, V24, P381, DOI 10.1007/s10806-010-9269-z; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Peeler EJ, 2004, DIS AQUAT ORGAN, V62, P103, DOI 10.3354/dao062103; Peyronnet A, 2008, J FISH BIOL, V73, P945, DOI 10.1111/j.1095-8649.2008.01984.x; Rambaut A., 2009, MOL EVOLUTION PHYLOG; Raynard R.S., 2007, REV DIS INTERACTION; Rikardsen AH, 2008, J FISH BIOL, V72, P1792, DOI 10.1111/j.1095-8649.2008.01823.x; RIVAS C, 1994, APPL ENVIRON MICROB, V60, P2168, DOI 10.1128/AEM.60.6.2168-2169.1994; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruane NM, 2009, J FISH DIS, V32, P979, DOI 10.1111/j.1365-2761.2009.01080.x; S&AELIG;ther PA, 2004, NORWEGIAN VET B, V7, P548; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Skilbrei OT, 2010, AQUACULT ENV INTERAC, V1, P117, DOI 10.3354/aei00013; STABELL OB, 1984, BIOL REV, V59, P333, DOI 10.1111/j.1469-185X.1984.tb00709.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; The Norwegian Directorate of Fisheries, 2013, STATISTICS; Thorstad EB, 2012, REPORT SCI ADVISORY, P103; Uglem I, 2009, MAR ECOL PROG SER, V384, P251, DOI 10.3354/meps08001; Urke HA, 2013, J FISH BIOL, V82, P206, DOI 10.1111/j.1095-8649.2012.03481.x; Vendramin N, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-20; Verspoor E, 2005, J FISH BIOL, V67, P3, DOI 10.1111/j.0022-1112.2005.00838.x; Wiik-Nielsen CR, 2012, DIS AQUAT ORGAN, V97, P255, DOI 10.3354/dao02425; Wiik-Nielsen J, 2013, J FISH DIS, V36, P129, DOI 10.1111/jfd.12008	80	43	45	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82202	10.1371/journal.pone.0082202	http://dx.doi.org/10.1371/journal.pone.0082202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349221	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300085
J	Lee, H; Jee, Y; Hong, K; Hwang, GS; Chun, KH				Lee, Hyunjoo; Jee, Yuna; Hong, Kyungki; Hwang, Gwi Seo; Chun, Kwang-Hoon			MicroRNA-494, Upregulated by Tumor Necrosis Factor-alpha, Desensitizes Insulin Effect in C2C12 Muscle Cells	PLOS ONE			English	Article							KAPPA-B KINASE; ADIPOSE-TISSUE; 3T3-L1 ADIPOCYTES; RECEPTOR SUBSTRATE-1; SKELETAL-MUSCLE; GENE-EXPRESSION; TNF-ALPHA; TRANSLATION INITIATION; TARGETED DISRUPTION; GLUCOSE-METABOLISM	Chronic inflammation is fundamental for the induction of insulin resistance in the muscle tissue of vertebrates. Although several miRNAs are thought to be involved in the development of insulin resistance, the role of miRNAs in the association between inflammation and insulin resistance in muscle tissue is poorly understood. Herein, we investigated the aberrant expression of miRNAs by conducting miRNA microarray analysis of TNF-alpha-treated mouse C2C12 myotubes. We identified two miRNAs that were upregulated and six that were downregulated by a > 1.5-fold change compared to normal cells. Among the findings, qRT-PCR analysis confirmed that miR-494 is consistently upregulated by TNF-alpha-induced inflammation. Overexpression of miR-494 in CHOIR/IRS1 and C2C12 myoblasts suppressed insulin action by down-regulating phosphorylations of GSK-3 alpha/beta, AS160 and p70S6K, downstream of Akt. Moreover, overexpression of miR-494 did not regulate TNF-alpha-mediated inflammation. Among genes bearing the seed site for miR-494, RT-PCR analysis showed that the expression of Stxbp5, an inhibitor of glucose transport, was downregulated following miR-494 inhibition. In contrast, the expression of PTEN decreased in the cells analyzed, thus showing that both positive and negative regulators of insulin action may be simultaneously controlled by miR-494. To investigate the overall effect of miR-494 on insulin signaling, we performed a PCR array analysis containing 84 genes related to the insulin signaling pathway, and we observed that 25% of genes were downregulated ( P<0.05) and 11% were upregulated ( P<0.05). These results confirm that miR-494 might contribute to insulin sensitivity by positive and negative regulation of the expression of diverse genes. Of note, PCR array data showed downregulation of Slc2A4, a coding gene for Glut4. Altogether, the present study concludes that the upregulation of miR-494 expression by TNF-alpha-mediated inflammation exacerbates insulin resistance. Therefore, we suggest that miR-494 could prove an important target for the diagnosis and therapy of inflammation-mediated insulin resistance in muscle.	[Lee, Hyunjoo; Jee, Yuna; Hong, Kyungki; Chun, Kwang-Hoon] Gachon Univ, Coll Pharm, Gachon Inst Pharmaceut Sci, Inchon, South Korea; [Hwang, Gwi Seo] Gachon Univ, Coll Oriental Med, Lab Cell Differentiat Res, Songnam, South Korea	Gachon University; Gachon University	Chun, KH (corresponding author), Gachon Univ, Coll Pharm, Gachon Inst Pharmaceut Sci, Inchon, South Korea.	khchun@gachon.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (KRF); Ministry of Education, Science and Technology [2010-0025409]	Basic Science Research Program through the National Research Foundation of Korea (KRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (KRF) funded by the Ministry of Education, Science and Technology (2010-0025409). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Bouzakri K, 2007, J BIOL CHEM, V282, P7783, DOI 10.1074/jbc.M608602200; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Cheung AT, 1998, ENDOCRINOLOGY, V139, P4928, DOI 10.1210/en.139.12.4928; Davey JR, 2012, TRAFFIC, V13, P1429, DOI 10.1111/j.1600-0854.2012.01397.x; de Alvaro C, 2004, J BIOL CHEM, V279, P17070, DOI 10.1074/jbc.M312021200; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Denley A, 2007, MOL CELL BIOL, V27, P3569, DOI 10.1128/MCB.01447-06; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Engelman JA, 2000, MOL ENDOCRINOL, V14, P1557, DOI 10.1210/me.14.10.1557; Faraonio R, 2012, CELL DEATH DIFFER, V19, P713, DOI 10.1038/cdd.2011.143; FEINGOLD KR, 1992, ENDOCRINOLOGY, V130, P10, DOI 10.1210/en.130.1.10; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gao ZG, 2002, J BIOL CHEM, V277, P48115, DOI 10.1074/jbc.M209459200; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HOFMANN C, 1994, ENDOCRINOLOGY, V134, P264, DOI 10.1210/en.134.1.264; Horie T, 2009, BIOCHEM BIOPH RES CO, V389, P315, DOI 10.1016/j.bbrc.2009.08.136; Horng T, 2011, NAT MED, V17, P164, DOI 10.1038/nm0211-164; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Katsuki A, 1998, J CLIN ENDOCR METAB, V83, P859, DOI 10.1210/jc.83.3.859; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim WK, 2011, CLIN CANCER RES, V17, P7584, DOI 10.1158/1078-0432.CCR-11-0166; Klover PJ, 2003, DIABETES, V52, P2784, DOI 10.2337/diabetes.52.11.2784; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li GL, 2007, ENDOCRINOLOGY, V148, P3356, DOI 10.1210/en.2006-1441; Lim L, 2013, HEPATOLOGY; Ling HY, 2009, CLIN EXP PHARMACOL P, V36, pe32, DOI 10.1111/j.1440-1681.2009.05207.x; Liu LH, 2010, LIFE SCI, V86, P192, DOI 10.1016/j.lfs.2009.12.002; Liu Y, 2012, J IMMUNOL, V188, P5500, DOI 10.4049/jimmunol.1103505; Liu YY, 2010, HUM GENET, V128, P609, DOI 10.1007/s00439-010-0886-4; Lorenzo M, 2008, J Anim Sci, V86, pE94; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Ohdaira H, 2012, CELL PROLIFERAT, V45, P32, DOI 10.1111/j.1365-2184.2011.00798.x; Olaru AV, 2011, HEPATOLOGY, V54, P2089, DOI 10.1002/hep.24591; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; PAPE ME, 1988, MOL ENDOCRINOL, V2, P395, DOI 10.1210/mend-2-5-395; Pendergrass M, 2007, AM J PHYSIOL-ENDOC M, V292, pE92, DOI 10.1152/ajpendo.00617.2005; Powell K, 2007, NATURE, V447, P525, DOI 10.1038/447525a; Ravichandran LV, 2001, MOL ENDOCRINOL, V15, P1768, DOI 10.1210/me.15.10.1768; RODIN J, 1985, METABOLISM, V34, P826, DOI 10.1016/0026-0495(85)90106-4; Romano G, 2012, P NATL ACAD SCI USA, V109, P16570, DOI 10.1073/pnas.1207917109; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504; Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; STEPHENS JM, 1991, J BIOL CHEM, V266, P21839; Takahashi K, 2003, J BIOL CHEM, V278, P46654, DOI 10.1074/jbc.M309895200; Taubes G, 2009, SCIENCE, V325, P256, DOI 10.1126/science.325_256; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Uysal KT, 1998, ENDOCRINOLOGY, V139, P4832, DOI 10.1210/en.139.12.4832; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamamoto H, 2012, AM J PHYSIOL-ENDOC M, V303, pE1419, DOI 10.1152/ajpendo.00097.2012; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhao EP, 2009, MAMM GENOME, V20, P476, DOI 10.1007/s00335-009-9217-2	80	10	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83471	10.1371/journal.pone.0083471	http://dx.doi.org/10.1371/journal.pone.0083471			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349514	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300147
J	Lim, CHL; Riau, AK; Lwin, NC; Chaurasia, SS; Tan, DT; Mehta, JS				Lim, Chris H. L.; Riau, Andri K.; Lwin, Nyein C.; Chaurasia, Shyam S.; Tan, Donald T.; Mehta, Jodhbir S.			LASIK following Small Incision Lenticule Extraction (SMILE) Lenticule Re-Implantation: A Feasibility Study of a Novel Method for Treatment of Presbyopia	PLOS ONE			English	Article							IN-SITU KERATOMILEUSIS; LASER FLAP CREATION; FEMTOSECOND LASER; REFRACTIVE SURGERY; MYOPIA; RELEX; CORNEA	Presbyopia remains a major visual impairment for patients, who have previously undergone laser refractive correction and enjoyed unaided distance vision prior to the onset of presbyopia. Corneal stromal volume restoration through small incision lenticule extraction (SMILE) lenticule re-implantation presents an opportunity for restoring the patients' non-dominant eye to previous low myopia to achieve a monovision. In this study, we investigated the feasibility of performing LASIK after lenticule re-implantation as a method to create presbyopic monovision. A -6.00D SMILE correction was performed in 9 rabbit eyes. The lenticules were cryopreserved for 14 days and re-implanted. Five weeks later, 3 of these eyes underwent LASIK for -5.00D correction (RL group); 3 underwent LASIK flap creation, which was not lifted (RN); and no further procedures were performed on the remaining 3 eyes. These groups were compared with 3 eyes that underwent standard LASIK for a -5.00D correction (LO); 3 that underwent creation of non-lifted flap (LN); and 3 non-operated eyes. Rabbits were euthanized 1 day post-surgery. Tissue responses were analyzed by immunohistochemistry, slit lamp and in vivo confocal microscopy (IVCM). Intrastromal irregularities and elevated reflectivity levels of the excimer-ablated plane were observed on slit lamp and IVCM, respectively in the RL group. The results were comparable (P = 0.310) to IVCM findings in the LO group. RL and LO groups showed similar fibronectin expression levels, number of CD11b-positive cells (P = 0.304) and apoptotic cells (P = 0.198). There was no difference between the RN and LN groups in reflectivity levels (P = 0.627), fibronectin expression levels, CD11b-positive cells (P = 0.135) and apoptotic cells (P = 0.128). LASIK can be performed following lenticule re-implantation to create presbyopic monovision. The tissue responses elicited after performing LASIK on corneas that have undergone SMILE and subsequent lenticule re-implantation are similar to primary procedure.	[Lim, Chris H. L.] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Lim, Chris H. L.; Riau, Andri K.; Lwin, Nyein C.; Chaurasia, Shyam S.; Tan, Donald T.; Mehta, Jodhbir S.] Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore; [Lim, Chris H. L.; Tan, Donald T.; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Chaurasia, Shyam S.; Tan, Donald T.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Ophthalmol, Singapore 117595, Singapore; [Chaurasia, Shyam S.] Duke NUS Grad Med Sch, SRP Neurosci & Behav Disorders, Singapore, Singapore; [Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore	University of New South Wales Sydney; National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; National University of Singapore; National University of Singapore; National University of Singapore	Mehta, JS (corresponding author), Singapore Eye Res Inst, Tissue Engn & Stem Cell Grp, Singapore, Singapore.	jodmehta@gmail.com	Riau, Andri/P-9693-2019; Lim, Chris/ABH-2772-2021; Chaurasia, Shyam/AAB-4709-2019; Lim, Chris/ABE-1727-2021	Riau, Andri/0000-0002-5105-0484; Lim, Chris/0000-0003-2219-3184; Chaurasia, Shyam/0000-0001-8725-676X; 	National Research Foundation of Singapore-Funded Translational and Clinical Research Programme Grant [NMRC/TCR002-SERI/2008]	National Research Foundation of Singapore-Funded Translational and Clinical Research Programme Grant(National Research Foundation, Singapore)	The work was supported by National Research Foundation of Singapore-Funded Translational and Clinical Research Programme Grant (NMRC/TCR002-SERI/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alio JL, 2006, J REFRACT SURG, V22, P453; American Academy of Ophthalmology, 2008, IS LASIK ME PAT GUID; Ang M, 2012, INVEST OPHTH VIS SCI, V53, P1414, DOI 10.1167/iovs.11-8808; Ang RT, 2001, CURR OPIN OPHTHALMOL, V12, P318, DOI 10.1097/00055735-200108000-00013; Angunawela RI, 2012, INVEST OPHTH VIS SCI, V53, P4975, DOI 10.1167/iovs.12-10170; Barraquer J I, 1972, Trans Ophthalmol Soc U K, V92, P499; Blum M, 2010, GRAEF ARCH CLIN EXP, V248, P1019, DOI 10.1007/s00417-009-1293-1; Calvo R, 2010, AM J OPHTHALMOL, V149, P785, DOI 10.1016/j.ajo.2009.12.023; Cavanagh, 1988, CORNEA, P187; Dexl AK, 2011, J REFRACT SURG, V27, P876, DOI 10.3928/1081597X-20110802-02; Mulet ME, 2009, OPHTHALMOLOGY, V116, P1455, DOI 10.1016/j.ophtha.2009.05.019; Evans MDM, 2011, BIOMATERIALS, V32, P3158, DOI 10.1016/j.biomaterials.2011.01.047; Fares U, 2012, J CATARACT REFR SURG, V38, P2131, DOI 10.1016/j.jcrs.2012.07.041; GIPSON IK, 1987, INVEST OPHTH VIS SCI, V28, P212; Goldberg DB, 2001, J CATARACT REFR SURG, V27, P1449, DOI 10.1016/S0886-3350(01)01001-X; Juhasz T, 1996, LASER SURG MED, V19, P23, DOI 10.1002/(SICI)1096-9101(1996)19:1<23::AID-LSM4>3.3.CO;2-2; Kezirian GM, 2004, J CATARACT REFR SURG, V30, P804, DOI 10.1016/j.jcrs.2003.10.026; Kullman G, 2010, SEMIN OPHTHALMOL, V25, P256, DOI 10.3109/08820538.2010.518507; Lawless Michael, 2013, Int Ophthalmol Clin, V53, P111, DOI 10.1097/IIO.0b013e318271346e; Lifshitz T, 2005, J REFRACT SURG, V21, P494; Maldonado MJ, 2008, EXPERT REV MED DEVIC, V5, P209, DOI 10.1586/17434440.5.2.209; MAURICE DM, 1990, EXP EYE RES, V50, P59, DOI 10.1016/0014-4835(90)90011-I; Mohamed-Noriega K, 2011, MOL VIS, V17, P3437; Montes-Mico R, 2007, OPHTHALMOLOGY, V114, P62, DOI 10.1016/j.ophtha.2006.07.019; Nordan LT, 2003, J REFRACT SURG, V19, P8; Riau AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067058; Riau AK, 2012, J CATARACT REFR SURG, V38, P1467, DOI 10.1016/j.jcrs.2012.03.037; Riau AK, 2011, INVEST OPHTH VIS SCI, V52, P6213, DOI 10.1167/iovs.11-7439; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Skevas C, 2013, GRAEFES ARCH CLIN EX, V251, P1; Stonecipher KG, 2006, J CATARACT REFR SURG, V32, P91, DOI 10.1016/j.jcrs.2005.11.015; Vestergaard AH, 2013, GRAEFES ARCH CLIN EX	32	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83046	10.1371/journal.pone.0083046	http://dx.doi.org/10.1371/journal.pone.0083046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349429	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300126
J	Adams, MA; Sallis, JF; Norman, GJ; Hovell, MF; Hekler, EB; Perata, E				Adams, Marc A.; Sallis, James F.; Norman, Gregory J.; Hovell, Melbourne F.; Hekler, Eric B.; Perata, Elyse			An Adaptive Physical Activity Intervention for Overweight Adults: A Randomized Controlled Trial	PLOS ONE			English	Article							FINANCIAL INCENTIVES; SEDENTARY BEHAVIOR; PEDOMETER; WALKING; HEALTH; PROGRAM; INDIVIDUALS; STEPS/DAY; ENOUGH	Background: Physical activity (PA) interventions typically include components or doses that are static across participants. Adaptive interventions are dynamic; components or doses change in response to short-term variations in participant's performance. Emerging theory and technologies make adaptive goal setting and feedback interventions feasible. Objective: To test an adaptive intervention for PA based on Operant and Behavior Economic principles and a percentile-based algorithm. The adaptive intervention was hypothesized to result in greater increases in steps per day than the static intervention. Methods: Participants (N = 20) were randomized to one of two 6-month treatments: 1) static intervention (SI) or 2) adaptive intervention (AI). Inactive overweight adults (85% women, M=36.9+/-9.2 years, 35% non-white) in both groups received a pedometer, email and text message communication, brief health information, and biweekly motivational prompts. The AI group received daily step goals that adjusted up and down based on the percentile-rank algorithm and micro-incentives for goal attainment. This algorithm adjusted goals based on a moving window; an approach that responded to each individual's performance and ensured goals were always challenging but within participants' abilities. The SI group received a static 10,000 steps/day goal with incentives linked to uploading the pedometer's data. Results: A random-effects repeated-measures model accounted for 180 repeated measures and autocorrelation. After adjusting for covariates, the treatment phase showed greater steps/day relative to the baseline phase (p<.001) and a group by study phase interaction was observed (p = .017). The SI group increased by 1,598 steps/day on average between baseline and treatment while the AI group increased by 2,728 steps/day on average between baseline and treatment; a significant between-group difference of 1,130 steps/day (Cohen's d = .74). Conclusions: The adaptive intervention outperformed the static intervention for increasing PA. The adaptive goal and feedback algorithm is a "behavior change technology" that could be incorporated into mHealth technologies and scaled to reach large populations.	[Adams, Marc A.; Hekler, Eric B.] Arizona State Univ, Sch Nutr & Hlth Promot, Phoenix, AZ USA; [Sallis, James F.; Norman, Gregory J.] Univ Calif San Diego, Dept Family & Prevent Med, San Diego, CA 92103 USA; [Adams, Marc A.; Hovell, Melbourne F.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Sallis, James F.] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Perata, Elyse] Calif State Univ East Bay, Coll Educ & Allied Studies, Hayward, CA USA	Arizona State University; Arizona State University-Downtown Phoenix; University of California System; University of California San Diego; California State University System; San Diego State University; California State University System; San Diego State University; California State University System; California State University East Bay	Adams, MA (corresponding author), Arizona State Univ, Sch Nutr & Hlth Promot, Phoenix, AZ USA.	marc.adams@asu.edu	Adams, Marc/C-3513-2013; Sallis, James F/D-3001-2014	Adams, Marc/0000-0001-6310-1472; Sallis, James F/0000-0003-2555-9452; Norman, Gregory/0000-0001-7989-9597; Hekler, Eric B/0000-0002-7434-0775	National Heart, Lung and Blood Institute [T32HL079891]; Dr. James Sallis and San Diego State University	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Dr. James Sallis and San Diego State University	The first author's effort was supported in part by grants from the National Heart, Lung and Blood Institute (T32HL079891) and supplies supported by intra-mural funds from Dr. James Sallis and San Diego State University. The NIH funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Sallis participated in all aspects of the study.	Adams M. A., 2009, P 4 INT C PERS TECHN, DOI [10.1145/1541948.1542006, DOI 10.1145/1541948.1542006]; ADAMS MA, 2009, THESIS U CALIFORNIA; Adams MA, 2009, HEALTH PSYCHOL, V28, P217, DOI 10.1037/a0012989; Araiza P, 2006, METABOLISM, V55, P1382, DOI 10.1016/j.metabol.2006.06.009; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Bickel WK, 2000, REFRAMING HLTH BEHAV; Biglan Anthony, 2003, Prev Sci, V4, P213, DOI 10.1023/A:1026064014562; Boyce C., 2009, VIRGIN HEALTHMILES P; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Centers for Medicare and Medicaid Services, 2011, MED INC PREV CHRON D; Chan CB, 2004, PREV MED, V39, P1215, DOI 10.1016/j.ypmed.2004.04.053; Coleman KJ, 1997, BEHAV RES METH INS C, V29, P286, DOI 10.3758/BF03204828; Collins LM, 2004, PREV SCI, V5, P185, DOI 10.1023/B:PREV.0000037641.26017.00; Conn VS, 2011, AM J PUBLIC HEALTH, V101, P751, DOI 10.2105/AJPH.2010.194381; Cooper J. O., 2006, APPL BEHAV ANAL; Craig CL, 2007, HEALTH EDUC RES, V22, P406, DOI 10.1093/her/cyl093; De Greef K, 2010, HEALTH EDUC RES, V25, P724, DOI 10.1093/her/cyq017; De Greef K, 2011, INT J BEHAV MED, V18, P188, DOI 10.1007/s12529-010-9124-7; Diedrich A, 2010, DIABETES EDUCATOR, V36, P132, DOI 10.1177/0145721709352382; Engel L, 2006, DIABETES EDUCATOR, V32, P98, DOI 10.1177/0145721705284373; Epstein L H, 2001, Exerc Sport Sci Rev, V29, P103, DOI 10.1097/00003677-200107000-00003; Epstein LH, 1998, AM J PREV MED, V15, P257, DOI 10.1016/S0749-3797(98)00083-X; Epstein LH, 2005, ANN BEHAV MED, V29, P200, DOI 10.1207/s15324796abm2903_6; Finkelstein EA, 2008, PREV MED, V47, P182, DOI 10.1016/j.ypmed.2008.05.002; Finkelstein EA, 2007, J OCCUP ENVIRON MED, V49, P981, DOI 10.1097/JOM.0b013e31813c6dcb; GALBICKA G, 1994, J APPL BEHAV ANAL, V27, P739, DOI 10.1901/jaba.1994.27-739; Giannakidou DM, 2012, EUR J APPL PHYSIOL, V112, P49, DOI 10.1007/s00421-011-1951-y; Hekler E.B., 2013, P SIGCHI C HUMAN FAC, P3307, DOI DOI 10.1145/2470654.2466452; Higgins ST, 2012, PREV MED, V55, pS2, DOI 10.1016/j.ypmed.2012.04.008; Hill JO, 2005, DIABETES CARE, V28, P1524, DOI 10.2337/diacare.28.6.1524; Holbrook EA, 2009, MED SCI SPORT EXER, V41, P669, DOI 10.1249/MSS.0b013e3181886095; Hopson J., 2001, GAMASUTRA BEHAV GAME; Hovell M, 2009, EMERGING THEORIES HL, P415; Hovell MF, 2011, CHEST, V140, P681, DOI 10.1378/chest.10-2609; Jeffery RW, 2012, PREV MED, V55, pS61, DOI 10.1016/j.ypmed.2011.12.024; Johnson ST, 2009, DIABETES OBES METAB, V11, P836, DOI 10.1111/j.1463-1326.2009.01050.x; KAZDIN AE, 1982, J APPL BEHAV ANAL, V15, P431, DOI 10.1901/jaba.1982.15-431; Lamb RJ, 2004, DRUG ALCOHOL DEPEN, V76, P247, DOI 10.1016/j.drugalcdep.2004.05.008; Lee IM, 2008, MED SCI SPORT EXER, V40, pS512, DOI 10.1249/MSS.0b013e31817c65d0; Miles A, 2011, LOS ANGELES TIMES; Murphy SA, 2007, DRUG ALCOHOL DEPEN, V88, pS1, DOI 10.1016/j.drugalcdep.2007.02.001; Norman GJ, 2007, AM J PREV MED, V33, P336, DOI 10.1016/j.amepre.2007.05.007; Paul-Ebhohimhen V, 2008, OBES REV, V9, P355, DOI 10.1111/j.1467-789X.2007.00409.x; Prochaska JO, 1997, HLTH BEHAV HLTH ED T, P60; RACHLIN H, 2004, SCI SELF CONTROL; Rachlin H., 1994, BEHAV MIND ROOTS MOD; Riley WT, 2011, TRANSL BEHAV MED, V1, P53, DOI 10.1007/s13142-011-0021-7; Sallis JF, 2009, HLTH BEHAV HLTH ED T, V4, P465; Schneider PL, 2006, AM J HEALTH PROMOT, V21, P85, DOI 10.4278/0890-1171-21.2.85; Sidman CL, 2004, RES Q EXERCISE SPORT, V75, P122, DOI 10.1080/02701367.2004.10609143; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Tudor-Locke C, 2004, INT J OBESITY, V28, P113, DOI 10.1038/sj.ijo.0802485; Tudor-Locke C, 2008, MED SCI SPORT EXER, V40, pS537, DOI 10.1249/MSS.0b013e31817c7133; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-79; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Wadden TA, 2006, OBESITY, V14, P737; Wilde BE, 2001, RES Q EXERCISE SPORT, V72, P411, DOI 10.1080/02701367.2001.10608977; Wing R, 1996, DIABETES PREVENTION; Yates T, 2008, PATIENT EDUC COUNS, V73, P264, DOI 10.1016/j.pec.2008.06.010; YMCA, 2008, AM MOV 100 WAYS ADD	62	68	68	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82901	10.1371/journal.pone.0082901	http://dx.doi.org/10.1371/journal.pone.0082901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VD	24349392	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200112
J	Brand, JS; Czene, K; Eriksson, L; Trinh, T; Bhoo-Pathy, N; Hall, P; Celebioglu, F				Brand, Judith S.; Czene, Kamila; Eriksson, Louise; Thang Trinh; Bhoo-Pathy, Nirmala; Hall, Per; Celebioglu, Fuat			Influence of Lifestyle Factors on Mammographic Density in Postmenopausal Women	PLOS ONE			English	Article							BREAST-CANCER RISK; RECREATIONAL PHYSICAL-ACTIVITY; HORMONE REPLACEMENT THERAPY; ALCOHOL-CONSUMPTION; PARENCHYMAL PATTERNS; CIGARETTE-SMOKING; ASSOCIATION; ESTROGENS; DIET	Background: Mammographic density is a strong risk factor for breast cancer. Apart from hormone replacement therapy (HRT), little is known about lifestyle factors that influence breast density. Methods: We examined the effect of smoking, alcohol and physical activity on mammographic density in a population-based sample of postmenopausal women without breast cancer. Lifestyle factors were assessed by a questionnaire and percentage and area measures of mammographic density were measured using computer-assisted software. General linear models were used to assess the association between lifestyle factors and mammographic density and effect modification by body mass index (BMI) and HRT was studied. Results: Overall, alcohol intake was positively associated with percent mammographic density (P trend = 0.07). This association was modified by HRT use (P interaction = 0.06): increasing alcohol intake was associated with increasing percent density in current HRT users (P trend = 0.01) but not in non-current users (P trend = 0.82). A similar interaction between alcohol and HRT was found for the absolute dense area, with a positive association being present in current HRT users only (P interaction = 0.04). No differences in mammographic density were observed across categories of smoking and physical activity, neither overall nor in stratified analyses by BMI and HRT use. Conclusions: Increasing alcohol intake is associated with an increase in mammography density, whereas smoking and physical activity do not seem to influence density. The observed interaction between alcohol and HRT may pose an opportunity for HRT users to lower their mammographic density and breast cancer risk.	[Brand, Judith S.; Czene, Kamila; Eriksson, Louise; Thang Trinh; Hall, Per] Karolinska Inst, Inst Med Epidemiol & Biostat, Stockholm, Sweden; [Bhoo-Pathy, Nirmala] Hosp Kuala Lumpur, Natl Clin Res Ctr, Kuala Lumpur, Malaysia; [Bhoo-Pathy, Nirmala] Univ Malaya, Fac Med, Julius Ctr Univ Malaya, Kuala Lumpur, Malaysia; [Celebioglu, Fuat] Sodersjukhuset KI SOS, Dept Clin Sci & Educ, Stockholm, Sweden	Karolinska Institutet; Universiti Malaya	Brand, JS (corresponding author), Karolinska Inst, Inst Med Epidemiol & Biostat, Nobels Vag 12A, Stockholm, Sweden.	judith.brand@ki.se	Pathy, Nirmala Bhoo/C-1228-2010	Pathy, Nirmala Bhoo/0000-0003-0568-8863; Brand, Judith S./0000-0002-3720-1274; Czene, Kamila/0000-0002-3233-5695	Marit and Hans Rausing's Initiative against Breast Cancer; Swedish Cancer Society [5128-B07-01PAF, CAN 2010/807]	Marit and Hans Rausing's Initiative against Breast Cancer; Swedish Cancer Society(Swedish Cancer Society)	This work was supported by Marit and Hans Rausing's Initiative against Breast Cancer and the Swedish Cancer Society [grant no: CAN 2010/807]. Kamila Czene was supported by the Swedish Cancer Society (grant number 5128-B07-01PAF). The funding resources had no role in the study design, data collection, analysis and interpretation of the data, writing of the manuscript or the decision to submit the manuscript for publication.	Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Boyd N, 2002, CANCER EPIDEM BIOMAR, V11, P1048; Bremnes Y, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1782; Butler LM, 2010, CANCER CAUSE CONTROL, V21, P301, DOI 10.1007/s10552-009-9462-4; BYNG JW, 1994, PHYS MED BIOL, V39, P1629, DOI 10.1088/0031-9155/39/10/008; Cabanes A, 2011, BREAST CANCER RES TR, V129, P135, DOI 10.1007/s10549-011-1414-5; Chen WY, 2002, ANN INTERN MED, V137, P798, DOI 10.7326/0003-4819-137-10-200211190-00008; Colditz GA, 1998, JNCI-J NATL CANCER I, V90, P814, DOI 10.1093/jnci/90.11.814; Dorgan JF, 2001, JNCI-J NATL CANCER I, V93, P710, DOI 10.1093/jnci/93.9.710; Eriksson L, 2012, BREAST CANCER RES TR, V134, P859, DOI 10.1007/s10549-012-2127-0; Gapstur SM, 2003, CANCER EPIDEM BIOMAR, V12, P1074; Ginsburg ES, 1996, JAMA-J AM MED ASSOC, V276, P1747, DOI 10.1001/jama.276.21.1747; Irwin ML, 2006, BREAST CANCER RES TR, V95, P171, DOI 10.1007/s10549-005-9063-1; LANDS WEM, 1991, AM J CLIN NUTR, V54, P47, DOI 10.1093/ajcn/54.1.47; Li CI, 2010, J NATL CANCER I, V102, P1422, DOI 10.1093/jnci/djq316; Li Y, 2009, EUR J CANCER, V45, P843, DOI 10.1016/j.ejca.2008.11.001; Luo JH, 2011, AM J EPIDEMIOL, V174, P919, DOI 10.1093/aje/kwr192; Magnusson C, 1998, INT J CANCER, V76, P29, DOI 10.1002/(SICI)1097-0215(19980330)76:1<29::AID-IJC6>3.3.CO;2-1; Masala G, 2006, INT J CANCER, V118, P1782, DOI 10.1002/ijc.21558; Masala G, 2009, INT J CANCER, V124, P1654, DOI 10.1002/ijc.24099; Maskarinec G, 2006, INT J CANCER, V118, P2579, DOI 10.1002/ijc.21705; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; McTiernan A, 2004, CANCER RES, V64, P2923, DOI 10.1158/0008-5472.CAN-03-3393; Modugno F, 2006, BREAST CANCER RES TR, V97, P157, DOI 10.1007/s10549-005-9105-8; Narod SA, 2011, NAT REV CLIN ONCOL, V8, P669, DOI 10.1038/nrclinonc.2011.110; Nielsen NR, 2008, INT J CANCER, V122, P1109, DOI 10.1002/ijc.23195; Onland-Moret NC, 2005, J CLIN ENDOCR METAB, V90, P1414, DOI 10.1210/jc.2004-0614; Peters TM, 2008, AM J EPIDEMIOL, V167, P579, DOI 10.1093/aje/kwm350; Qureshi SA, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-75; Qureshi SA, 2012, BREAST CANCER RES TR, V131, P993, DOI 10.1007/s10549-011-1812-8; Reeves KW, 2007, CANCER EPIDEM BIOMAR, V16, P934, DOI 10.1158/1055-9965.EPI-06-0732; Royston P, 2009, STATA J, V9, P466, DOI 10.1177/1536867X0900900308; Rutter CM, 2001, JAMA-J AM MED ASSOC, V285, P171, DOI 10.1001/jama.285.2.171; Sala E, 2000, BRIT J CANCER, V83, P121, DOI 10.1054/bjoc.2000.1151; Shepherd JA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3081; Singletary KW, 2001, JAMA-J AM MED ASSOC, V286, P2143, DOI 10.1001/jama.286.17.2143; Siozon CC, 2006, INT J CANCER, V119, P1695, DOI 10.1002/ijc.22020; Slattery ML, 2007, ANN EPIDEMIOL, V17, P342, DOI 10.1016/j.annepidem.2006.10.017; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Vachon CM, 2000, CANCER EPIDEM BIOMAR, V9, P151; Vachon CM, 2000, CANCER CAUSE CONTROL, V11, P653, DOI 10.1023/A:1008926607428; Westerterp Klaas R, 2004, Nutr Metab (Lond), V1, P5; Wu YL, 2013, BREAST CANCER RES TR, V137, P869, DOI 10.1007/s10549-012-2396-7; Xue F, 2011, ARCH INTERN MED, V171, P125, DOI 10.1001/archinternmed.2010.503; Yaghjyan L, 2012, BRIT J CANCER, V106, P996, DOI 10.1038/bjc.2012.1; Yaghjyan L, 2012, BREAST CANCER RES TR, V135, P367, DOI 10.1007/s10549-012-2152-z; Zhang SMM, 2007, AM J EPIDEMIOL, V165, P667, DOI 10.1093/aje/kwk054	48	33	33	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81876	10.1371/journal.pone.0081876	http://dx.doi.org/10.1371/journal.pone.0081876			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349146	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200054
J	Hoang, SA; Bekiranov, S				Hoang, Stephen A.; Bekiranov, Stefan			The Network Architecture of the Saccharomyces cerevisiae Genome	PLOS ONE			English	Article							DNA-REPLICATION; FUNCTIONAL-ORGANIZATION; CHROMATIN INTERACTIONS; YEAST; PRINCIPLES; SITES; GENE; ASSOCIATION; LANDSCAPE; PROTEINS	We propose a network-based approach for surmising the spatial organization of genomes from high-throughput interaction data. Our strategy is based on methods for inferring architectural features of networks. Specifically, we employ a community detection algorithm to partition networks of genomic interactions. These community partitions represent an intuitive interpretation of genomic organization from interaction data. Furthermore, they are able to recapitulate known aspects of the spatial organization of the Saccharomyces cerevisiae genome, such as the rosette conformation of the genome, the clustering of centromeres, as well as tRNAs, and telomeres. We also demonstrate that simple architectural features of genomic interaction networks, such as cliques, can give meaningful insight into the functional role of the spatial organization of the genome. We show that there is a correlation between inter-chromosomal clique size and replication timing, as well as cohesin enrichment. Together, our network-based approach represents an effective and intuitive framework for interpreting high-throughput genomic interaction data. Importantly, there is a great potential for this strategy, given the rich literature and extensive set of existing tools in the field of network analysis.	[Hoang, Stephen A.; Bekiranov, Stefan] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Hoang, SA (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	sah9b@virginia.edu; sb3de@virginia.edu			University of Virginia Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080186] Funding Source: NIH RePORTER	University of Virginia Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was entirely funded by Dr. Bekiranov's internal start up package, which was made available by the University of Virginia Medical School when he joined the Department of Biochemistry and Molecular Genetics. There was and is no current external funding source for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brandes U, 2008, IEEE T KNOWL DATA EN, V20, P172, DOI 10.1109/TKDE.2007.190689; Bystricky K, 2004, P NATL ACAD SCI USA, V101, P16495, DOI 10.1073/pnas.0402766101; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Di Stefano M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003019; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dorier J, 2010, NUCLEIC ACIDS RES, V38, P7410, DOI 10.1093/nar/gkq666; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Feng WY, 2009, GENETICS, V183, P1249, DOI 10.1534/genetics.109.107508; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Gard S, 2009, J CELL BIOL, V187, P455, DOI 10.1083/jcb.200906075; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Guillou E, 2010, GENE DEV, V24, P2812, DOI 10.1101/gad.608210; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Haeusler RA, 2008, GENE DEV, V22, P2204, DOI 10.1101/gad.1675908; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6; Hu B, 2011, CURR BIOL, V21, P12, DOI 10.1016/j.cub.2010.12.004; Jin QW, 2000, J CELL SCI, V113, P1903; Khadivi A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046104; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leger-Silvestre I, 1999, CHROMOSOMA, V108, P103, DOI 10.1007/s004120050357; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; MCCARROLL RM, 1988, CELL, V54, P505, DOI 10.1016/0092-8674(88)90072-4; McCune HJ, 2008, GENETICS, V180, P1833, DOI 10.1534/genetics.108.094359; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Mishiro T, 2009, EMBO J, V28, P1234, DOI 10.1038/emboj.2009.81; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nativio R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000739; Natsume T, 2013, MOL CELL, V50, P661, DOI 10.1016/j.molcel.2013.05.011; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reichardt J, 2006, PHYSICA D, V224, P20, DOI 10.1016/j.physd.2006.09.009; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Sandhu KS, 2012, CELL REP, V2, P1207, DOI 10.1016/j.celrep.2012.09.022; Schober H, 2008, GENOME RES, V18, P261, DOI 10.1101/gr.6687808; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sherwood R, 2010, GENE DEV, V24, P2723, DOI 10.1101/gad.1976710; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Taddei A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000612; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Tittel-Elmer M, 2012, MOL CELL, V48, P98, DOI 10.1016/j.molcel.2012.07.004; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tomita E, 2006, THEOR COMPUT SCI, V363, P28, DOI 10.1016/j.tcs.2006.06.015; Uhlmann F, 2009, EMBO REP, V10, P1095, DOI 10.1038/embor.2009.207; van Steensel B, 2010, NAT BIOTECHNOL, V28, P1089, DOI 10.1038/nbt.1680; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Wang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056459	59	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81972	10.1371/journal.pone.0081972	http://dx.doi.org/10.1371/journal.pone.0081972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349163	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200057
J	Suzuki, T; Oshiumi, H; Miyashita, M; Aly, HH; Matsumoto, M; Seya, T				Suzuki, Takayuki; Oshiumi, Hiroyuki; Miyashita, Moeko; Aly, Hussein Hassan; Matsumoto, Misako; Seya, Tsukasa			Cell Type-Specific Subcellular Localization of Phospho-TBK1 in Response to Cytoplasmic Viral DNA	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; INNATE IMMUNE-RESPONSES; TANK-BINDING KINASE-1; NF-KAPPA-B; RIG-I; CYTOSOLIC DNA; ADAPTER PROTEIN; DAI DLM-1/ZBP1; INTERFERON; SENSOR	Cytoplasmic viral RNA and DNA are recognized by RIG-I-like receptors and DNA sensors that include DAI, IFI16, DDX41, and cGAS. The RNA and DNA sensors evoke innate immune responses through the IPS-1 and STING adaptors. IPS-1 and STING activate TBK1 kinase. TBK1 is phosphorylated in its activation loop, leading to IRF3/7 activation and Type I interferon (IFN) production. IPS-1 and STING localize to the mitochondria and endoplasmic reticulum, respectively, whereas it is unclear where phosphorylated TBK1 is localized in response to cytoplasmic viral DNA. Here, we investigated phospho-TBK1 (p-TBK1) subcellular localization using a p-TBK1-specific antibody. Stimulation with vertebrate DNA by transfection increased p-TBK1 levels. Interestingly, stimulation-induced p-TBK1 exhibited mitochondrial localization in HeLa and HepG2 cells and colocalized with mitochondrial IPS-1 and MFN-1. Hepatitis B virus DNA stimulation or herpes simplex virus type-1 infection also induced p-TBK1 mitochondrial localization in HeLa cells, indicating that cytoplasmic viral DNA induces p-TBK1 mitochondrial localization in HeLa cells. In contrast, p-TBK1 did not show mitochondrial localization in RAW264.7, L929, or T-23 cells, and most of p-TBK1 colocalized with STING in response to cytoplasmic DNA in those mammalian cells, indicating cell type-specific localization of p-TBK1 in response to cytoplasmic viral DNA. A previous knockout study showed that mouse IPS-1 was dispensable for Type I IFN production in response to cytoplasmic DNA. However, we found that knockdown of IPS-1 markedly reduced p-TBK1 levels in HeLa cells. Taken together, our data elucidated the cell type-specific subcellular localization of p-TBK1 and a cell type-specific role of IPS-1 in TBK1 activation in response to cytoplasmic viral DNA.	[Suzuki, Takayuki; Oshiumi, Hiroyuki; Miyashita, Moeko; Aly, Hussein Hassan; Matsumoto, Misako; Seya, Tsukasa] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan	Hokkaido University	Oshiumi, H (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan.	oshiumi@med.hokudai.ac.jp; seya-tu@pop.med.hokudai.ac.jp	Seya, Tsukasa/A-4336-2012; Oshiumi, Hiroyuki/G-1645-2012; Aly, Hussein Hassan/GWV-0669-2022	Aly, Hussein H/0000-0002-2455-0694; Oshiumi, Hiroyuki/0000-0003-1567-8722	Ministry of Education, Science, and Culture of Japan; Ministry of Health Labor and Welfare of Japan; Kato Memorial Bioscience Foundation; Yasuda Cancer Foundation; Ono Foundation; MEXT; Natinal Cancer Center Research and Development Fund [23-A-44]; Japan Initiative for Global Research Network on Infectious Disease (J-GRID)	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Kato Memorial Bioscience Foundation; Yasuda Cancer Foundation; Ono Foundation; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Natinal Cancer Center Research and Development Fund; Japan Initiative for Global Research Network on Infectious Disease (J-GRID)	This work was supported in part by grants-in-aid from the Ministry of Education, Science, and Culture of Japan, and the Ministry of Health Labor and Welfare of Japan, the Kato Memorial Bioscience Foundation, Yasuda Cancer Foundation, and the Ono Foundation. Financial supports by a MEXT Gran-in-Project "the Carcinogenic Spiral", the Natinal Cancer Center Research and Development Fund (23-A-44), and the Japan Initiative for Global Research Network on Infectious Disease (J-GRID) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aly HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021284; Cheng GF, 2007, P NATL ACAD SCI USA, V104, P9035, DOI 10.1073/pnas.0703285104; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Choi MK, 2009, P NATL ACAD SCI USA, V106, P17870, DOI 10.1073/pnas.0909545106; Desmet CJ, 2012, NAT REV IMMUNOL, V12, P479, DOI 10.1038/nri3247; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishii KJ, 2006, NAT IMMUNOL, V7, P40, DOI 10.1038/ni1282; Ishikawa H, 2008, NATURE; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kondo T, 2013, P NATL ACAD SCI USA, V110, P2969, DOI 10.1073/pnas.1222694110; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Kumar M, 2011, J VIROL, V85, P987, DOI 10.1128/JVI.01825-10; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Oshiumi H, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003533; Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; TAKETOMI M, 1986, MUTAGENESIS, V1, P359, DOI 10.1093/mutage/1.5.359; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yasukawa K, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000287; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	41	23	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e83639	10.1371/journal.pone.0083639	http://dx.doi.org/10.1371/journal.pone.0083639			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349538	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200132
J	Zhuang, JH; Peng, WH; Li, HL; Lu, YY; Wang, K; Fan, F; Li, S; Xu, YW				Zhuang, Jianhui; Peng, Wenhui; Li, Hailing; Lu, Yuyan; Wang, Ke; Fan, Fan; Li, Shuang; Xu, Yawei			Inhibitory Effects of Vinpocetine on the Progression of Atherosclerosis Are Mediated by Akt/NF-kappa B Dependent Mechanisms in apoE(-/-) Mice	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; METALLOPROTEINASE INHIBITION; PHOSPHODIESTERASE 1C; PLAQUE; EXPRESSION; SODIUM; INFLAMMATION; MACROPHAGES; CYTOKINES; DISEASE	Background: Recent studies have found additional roles for vinpocetine, a potent phosphodiesterase type I inhibitor, in anti-proliferation and anti-inflammation of vascular smooth muscle cells and cancer cells via different mechanisms. In this study, we attempted to investigate whether vinpocetine protected against atherosclerotic development in apoE(-/-) mice and explore the underlying anti-atherogenic mechanisms in macrophages. Methodology/Principal Findings: Vinpocetine markedly decreased atherosclerotic lesion size in apoE(-/-) mice measured by oil red O. Masson's trichrome staining and immunohistochemical analyses revealed that vinpocetine significantly increased the thickness of fibrous cap, reduced the size of lipid-rich necrotic core and attenuated inflammation. In vitro experiments exhibited a significant decrease in monocyte adhesion treated with vinpocetine. Further, active TNF-alpha, IL-6, monocyte chemoattractant protein-1and matrix metalloproteinase-9 expression induced by ox-LDL were attenuated by vinpocetine in a dose-dependent manner. Similarly, ox-LDL-induced reactive oxygen species were significantly repressed by vinpocetine. Both western blot and luciferase activity assay showed that vinpocetine inhibited the enhanced Akt, IKK alpha/beta, I kappa B alpha phosphorylation and NF-kappa B activity induced by ox-LDL, and the inhibition of NF-kappa B activity was partly caused by Akt dephosphorylation. However, knockdown of PDE1B did not affect Akt, IKK alpha/beta and I kappa B alpha phosphorylation. Conclusions: These results suggest that vinpocetine exerts anti-atherogenic effects through inhibition of monocyte adhesion, oxidative stress and inflammatory response, which are mediated by Akt/NF-kappa B dependent pathway but independent of PDE1 blockade in macrophages.	[Zhuang, Jianhui; Peng, Wenhui; Li, Hailing; Lu, Yuyan; Wang, Ke; Li, Shuang; Xu, Yawei] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Cardiol, Shanghai 200092, Peoples R China; [Fan, Fan] Fudan Univ, Sch Med, Eye & ENT Hosp, Dept Ophthalmol, Shanghai 200433, Peoples R China	Tongji University; Fudan University	Peng, WH (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Cardiol, Shanghai 200092, Peoples R China.	pwenhui@tongji.edu.cn; xuyawei@tongji.edu.cn			National Natural Science Foundation of China [30900520, 81070107]; Shanghai Rising-Star Program [10QA1405500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program	This work was supported by grants from National Natural Science Foundation of China (Grant No. 30900520; 81070107) and Shanghai Rising-Star Program (No. 10QA1405500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Bagoly Edit, 2007, Orvosi Hetilap, V148, P1353, DOI 10.1556/OH.2007.28115; Bonoczk P, 2000, BRAIN RES BULL, V53, P245, DOI 10.1016/S0361-9230(00)00354-3; Brown DL, 2004, ARTERIOSCL THROM VAS, V24, P733, DOI 10.1161/01.ATV.0000121571.78696.dc; Cai YJ, 2012, J PHARMACOL EXP THER, V343, P479, DOI 10.1124/jpet.112.195446; Cai YJ, 2011, ARTERIOSCL THROM VAS, V31, P616, DOI 10.1161/ATVBAHA.110.212621; Dunkern TR, 2007, FEBS J, V274, P4812, DOI 10.1111/j.1742-4658.2007.06001.x; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Holvoet P, 2000, ARTERIOSCL THROM VAS, V20, P698, DOI 10.1161/01.ATV.20.3.698; Huang EW, 2012, APOPTOSIS, V17, P1120, DOI 10.1007/s10495-012-0743-0; Jeon KI, 2010, P NATL ACAD SCI USA, V107, P9795, DOI 10.1073/pnas.0914414107; Johnson JL, 2006, CARDIOVASC RES, V71, P586, DOI 10.1016/j.cardiores.2006.05.009; Kemeny V, 2005, J CLIN PHARMACOL, V45, P1048, DOI 10.1177/0091270005279363; Kukreja RC, 2012, J AM COLL CARDIOL, V59, P1921, DOI 10.1016/j.jacc.2011.09.086; Lee JH, 2005, J PHARMACOL EXP THER, V313, P502, DOI 10.1124/jpet.104.079780; Lee SW, 2011, J AM COLL CARDIOL, V57, P1264, DOI 10.1016/j.jacc.2010.10.035; Li HL, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-65; LORINCZ C, 1976, ARZNEIMITTEL-FORSCH, V26, P1907; Manduteanu I, 2003, EUR J PHARMACOL, V477, P269, DOI 10.1016/j.ejphar.2003.08.016; Medina AE, 2010, P NATL ACAD SCI USA, V107, P9921, DOI 10.1073/pnas.1005138107; MISKOLCZI P, 1987, EUR J CLIN PHARMACOL, V33, P185, DOI 10.1007/BF00544565; Mitra S, 2011, AM J PHYSIOL-HEART C, V301, pH506, DOI 10.1152/ajpheart.00252.2011; Mohamed JS, 2012, FASEB J, V26, P757, DOI 10.1096/fj.10-160291; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rybalkin SD, 2002, CIRC RES, V90, P151, DOI 10.1161/hh0202.104108; Schaar JA, 2004, EUR HEART J, V25, P1077, DOI 10.1016/j.ehj.2004.01.002; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Shah PK, 2003, J AM COLL CARDIOL, V41, p15S, DOI 10.1016/S0735-1097(02)02834-6; Shao RP, 2001, CANCER RES, V61, P7413; Sitges M, 2005, NEUROCHEM INT, V46, P533, DOI 10.1016/j.neuint.2005.02.001; Sluijter JPG, 2006, STROKE, V37, P235, DOI 10.1161/01.STR.0000196986.50059.e0; Steinberg D, 1997, CIRCULATION, V95, P1062; Szilagyi G, 2005, J NEUROL SCI, V229, P275, DOI 10.1016/j.jns.2004.11.053; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Xu J, 2009, CIRCULATION, V120, P1266, DOI 10.1161/CIRCULATIONAHA.108.835223; Yla-Herttuala S, 2011, THROMB HAEMOSTASIS, V106, P1, DOI 10.1160/TH10-12-0784; Zhou XP, 2003, J PHARMACOL EXP THER, V306, P498, DOI 10.1124/jpet.103.051086; Zhuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047193	41	33	34	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82509	10.1371/journal.pone.0082509	http://dx.doi.org/10.1371/journal.pone.0082509			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349299	Green Submitted, gold, Green Published			2022-12-27	WOS:000328705200082
J	Poddar, R; Kawai, R; Olveczky, BP				Poddar, Rajesh; Kawai, Risa; Oelveczky, Bence P.			A Fully Automated High-Throughput Training System for Rodents	PLOS ONE			English	Article							DECISION; PERFORMANCE; BEHAVIOR; MODEL; SPEED; RATS; MICE	Addressing the neural mechanisms underlying complex learned behaviors requires training animals in well-controlled tasks, an often time-consuming and labor-intensive process that can severely limit the feasibility of such studies. To overcome this constraint, we developed a fully computer-controlled general purpose system for high-throughput training of rodents. By standardizing and automating the implementation of predefined training protocols within the animal's home-cage our system dramatically reduces the efforts involved in animal training while also removing human errors and biases from the process. We deployed this system to train rats in a variety of sensorimotor tasks, achieving learning rates comparable to existing, but more laborious, methods. By incrementally and systematically increasing the difficulty of the task over weeks of training, rats were able to master motor tasks that, in complexity and structure, resemble ones used in primate studies of motor sequence learning. By enabling fully automated training of rodents in a home-cage setting this low-cost and modular system increases the utility of rodents for studying the neural underpinnings of a variety of complex behaviors.	[Poddar, Rajesh; Kawai, Risa; Oelveczky, Bence P.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Poddar, Rajesh; Kawai, Risa; Oelveczky, Bence P.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Olveczky, BP (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	olveczky@fas.harvard.edu	PODDAR, RAJU/R-1671-2018	Olveczky, Bence/0000-0003-2499-2705	McKnight Scholars Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313] Funding Source: NIH RePORTER	McKnight Scholars Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a McKnight Scholars Award to BPO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bari A, 2008, NAT PROTOC, V3, P759, DOI 10.1038/nprot.2008.41; Blaisdell AP, 2006, SCIENCE, V311, P1020, DOI 10.1126/science.1121872; Brown VJ, 2002, TRENDS NEUROSCI, V25, P340, DOI 10.1016/S0166-2236(02)02164-1; Chida Y, 2006, BRAIN RES, V1067, P201, DOI 10.1016/j.brainres.2005.10.042; Clark RE, 2011, NEURON, V70, P132, DOI 10.1016/j.neuron.2011.03.007; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Erlich JC, 2011, NEURON, V72, P330, DOI 10.1016/j.neuron.2011.07.010; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gess A, 2011, ANIM BEHAV, V82, P285, DOI 10.1016/j.anbehav.2011.05.003; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Goodman S, 2002, NATURE, V417, P684, DOI 10.1038/417684a; HAREL D, 1987, SCI COMPUT PROGRAM, V8, P231, DOI 10.1016/0167-6423(87)90035-9; Hurst JL, 2010, NAT METHODS, V7, P825, DOI [10.1038/nmeth.1500, 10.1038/NMETH.1500]; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Mechan AO, 2009, J NEUROSCI METH, V180, P43, DOI 10.1016/j.jneumeth.2009.02.018; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Murphy RA, 2008, SCIENCE, V319, P1849, DOI 10.1126/science.1151564; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Nudo RJ, 2009, EVOLUTION MOTOR CORT; Olveczky BP, 2011, CURR OPIN NEUROBIOL, V21, P571, DOI 10.1016/j.conb.2011.05.002; Ouchi H, 2013, BEHAV BRAIN RES, V238, P146, DOI 10.1016/j.bbr.2012.10.029; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; Schaefer AT, 2012, CURR OPIN NEUROBIOL, V22, P170, DOI 10.1016/j.conb.2011.11.004; Sereno MI, 1991, CORTICAL VISUAL AREA, P160; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Slutzky MW, 2010, J NEUROSCI METH, V192, P228, DOI 10.1016/j.jneumeth.2010.07.040; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Viana DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008483; Zeeb FD, 2009, NEUROPSYCHOPHARMACOL, V34, P2329, DOI 10.1038/npp.2009.62; Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192; Zoccolan D, 2009, P NATL ACAD SCI USA, V106, P8748, DOI 10.1073/pnas.0811583106	37	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e83171	10.1371/journal.pone.0083171	http://dx.doi.org/10.1371/journal.pone.0083171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24349451	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566700121
J	Chiang, DY; Cuthbertson, DW; Ruiz, FR; Li, N; Pereira, FA				Chiang, David Y.; Cuthbertson, David W.; Ruiz, Fernanda R.; Li, Na; Pereira, Fred A.			A Coregulatory Network of NR2F1 and microRNA-140	PLOS ONE			English	Article							COUP-TFI; NUCLEAR RECEPTORS; THYROID-HORMONE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; HAIR-CELLS; HEARING-LOSS; MOUSE; IDENTIFICATION; MUTATIONS	Background: Both nuclear receptor subfamily 2 group F member 1 (NR2F1) and microRNAs (miRNAs) have been shown to play critical roles in the developing and functional inner ear. Based on previous studies suggesting interplay between NR2F1 and miRNAs, we investigated the coregulation between NR2F1 and miRNAs to better understand the regulatory mechanisms of inner ear development and functional maturation. Results: Using a bioinformatic approach, we identified 11 potential miRNAs that might coregulate target genes with NR2F1 and analyzed their targets and potential roles in physiology and disease. We selected 6 miRNAs to analyze using quantitative real-time (qRT)-PCR and found that miR-140 is significantly down-regulated by 4.5-fold (P=0.004) in the inner ear of NR2F1 knockout (Nr2f1-/-) mice compared to wild-type littermates but is unchanged in the brain. Based on this, we performed chromatin-immunoprecipitation followed by qRT-PCR and confirmed that NR2F1 directly binds and regulates both miR-140 and Klf9 in vivo. Furthermore, we performed luciferase reporter assay and showed that miR-140 mimic directly regulates KLF9-3'UTR, thereby establishing and validating an example coregulatory network involving NR2F1, miR-140, and Klf9. Conclusions: We have described and experimentally validated a novel tissue-dependent coregulatory network for NR2F1, miR-140, and Klf9 in the inner ear and we propose the existence of many such coregulatory networks important for both inner ear development and function.	[Chiang, David Y.; Li, Na] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Chiang, David Y.] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Cuthbertson, David W.; Pereira, Fred A.] Baylor Coll Med, Bobby R Alford Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Ruiz, Fernanda R.; Pereira, Fred A.] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Ruiz, Fernanda R.; Pereira, Fred A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Li, N (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	nal@bcm.edu; fpereira@bcm.edu		Chiang, David/0000-0002-5883-6383	National Institutes of Health [T32AG00183]; American Heart Association [12BGIA12050207, 12PRE11700012]; Huffington Center on Aging and Department of Otolaryngology-HNS [DC04585]; Baylor College of Medicine Medical Scientist Training Program Caskey Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC004585, R01DC004585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Huffington Center on Aging and Department of Otolaryngology-HNS; Baylor College of Medicine Medical Scientist Training Program Caskey Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by grants T32AG00183 (to FRR) from the National Institutes of Health, 12BGIA12050207 (to NL) and 12PRE11700012 (to DYC) from the American Heart Association, and DC04585 and support from the Huffington Center on Aging and Department of Otolaryngology-HNS (to FAP). DYC was also supported by the Baylor College of Medicine Medical Scientist Training Program Caskey Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2003, J HUM GENET, V48, P142, DOI 10.1007/s100380300022; Abe S, 2003, AM J HUM GENET, V72, P73, DOI 10.1086/345398; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Aldred SF, 2011, JOVE-J VIS EXP, DOI 10.3791/3343; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; Armentano M, 2007, NAT NEUROSCI, V10, P1277, DOI 10.1038/nn1958; Armentano M, 2006, DEVELOPMENT, V133, P4151, DOI 10.1242/dev.02600; Bekris LM, 2010, J GERIATR PSYCH NEUR, V23, P213, DOI 10.1177/0891988710383571; Brown Kerry K, 2012, Curr Protoc Hum Genet, VChapter 9, DOI 10.1002/0471142905.hg0916s72; Brown KK, 2009, AM J MED GENET A, V149A, P931, DOI 10.1002/ajmg.a.32764; Chan CM, 2013, NUCLEIC ACIDS RES, V41, P9663, DOI 10.1093/nar/gkt761; Charitidi K, 2012, ENDOCRINOLOGY, V153, P4412, DOI 10.1210/en.2012-1416; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Chen ZY, 2002, JARO-J ASSOC RES OTO, V3, P140, DOI 10.1007/s101620020029; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; COONEY AJ, 1992, MOL CELL BIOL, V12, P4153, DOI 10.1128/MCB.12.9.4153; Dai KZ, 2010, ARTERIOSCL THROM VAS, V30, P568, DOI 10.1161/ATVBAHA.109.198135; Davarnia B, 2012, INT J PEDIATR OTORHI, V76, P268, DOI 10.1016/j.ijporl.2011.11.019; Deblois G, 2013, ONCOGENE, V32, P3483, DOI 10.1038/onc.2012.529; Denver RJ, 2009, ENDOCRINOLOGY, V150, P3935, DOI 10.1210/en.2009-0050; Dettling J, 2014, MOL CELL ENDOCRINOL, V382, P26, DOI 10.1016/j.mce.2013.08.025; Dogini DB, 2008, J MOL NEUROSCI, V35, P331, DOI 10.1007/s12031-008-9068-4; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Eberhart JK, 2008, NAT GENET, V40, P290, DOI 10.1038/ng.82; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Foulds CE, 2013, MOL CELL, V51, P185, DOI 10.1016/j.molcel.2013.06.007; Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fu LC, 2011, J BIOL CHEM, V286, P36724, DOI 10.1074/jbc.M111.277673; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hinske LCG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-533; Houlden H, 2006, NEUROMOL MED, V8, P43, DOI 10.1385/NMM:8:1:43; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inoue KI, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-20; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kopecky B, 2011, PHARMACEUTICALS, V4, P848, DOI 10.3390/ph4060848; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; KRISHNAN R, 1990, CANCER RES, V50, P2164; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lapis K, 2002, SEMIN CANCER BIOL, V12, P209, DOI 10.1016/S1044-579X(02)00024-X; Le Dily F, 2008, BREAST CANCER RES TR, V110, P69, DOI 10.1007/s10549-007-9693-6; Levic S, 2011, J BIOL CHEM, V286, P5768, DOI 10.1074/jbc.M110.186486; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Liu Y, 2013, J BIOL CHEM, V288, P8222, DOI 10.1074/jbc.M112.426163; Mak ACY, 2009, GENE EXPR PATTERNS, V9, P444, DOI 10.1016/j.gep.2009.04.003; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Meltser I, 2008, J CLIN INVEST, V118, P1563, DOI 10.1172/JCI32796; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; Miyaki S, 2009, ARTHRITIS RHEUM-US, V60, P2723, DOI 10.1002/art.24745; Montemayor C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008910; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Olefsky JM, 2001, J BIOL CHEM, V276, P36863, DOI 10.1074/jbc.R100047200; Oshima A, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.034397; Pandey DP, 2010, CURR OPIN PHARMACOL, V10, P637, DOI 10.1016/j.coph.2010.08.009; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Pei H, 2011, CELL DEATH DIFFER, V18, P315, DOI 10.1038/cdd.2010.100; Pierce ML, 2008, EVOL DEV, V10, P106, DOI 10.1111/j.1525-142X.2007.00217.x; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Purcell EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026289; Qiu YH, 1997, GENE DEV, V11, P1925, DOI 10.1101/gad.11.15.1925; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Rudnicki A, 2012, EMBO MOL MED, V4, P849, DOI 10.1002/emmm.201100922; Rusch A, 1998, P NATL ACAD SCI USA, V95, P15758, DOI 10.1073/pnas.95.26.15758; Schimmang T, 2007, INT J DEV BIOL, V51, P473, DOI 10.1387/ijdb.072334ts; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seron-Ferre Maria, 2007, Birth Defects Research, V81, P204, DOI 10.1002/bdrc.20101; Simmons CD, 2010, J ENDOCRINOL, V205, P147, DOI 10.1677/JOE-09-0474; Simonoska R, 2009, J ENDOCRINOL, V201, P397, DOI 10.1677/JOE-09-0060; Soukup GA, 2009, DEV BIOL, V328, P328, DOI 10.1016/j.ydbio.2009.01.037; Sporl F, 2012, P NATL ACAD SCI USA, V109, P10903, DOI 10.1073/pnas.1118641109; Subramanyam D, 2011, CURR OPIN GENET DEV, V21, P498, DOI 10.1016/j.gde.2011.04.011; Takata A, 2013, HEPATOLOGY, V57, P162, DOI 10.1002/hep.26011; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Tang LS, 2006, DEVELOPMENT, V133, P3683, DOI 10.1242/dev.02536; Tang LS, 2006, IUBMB LIFE, V58, P525, DOI 10.1080/15216540600913258; Tang LS, 2005, GENE EXPR PATTERNS, V5, P587, DOI 10.1016/j.modgep.2005.03.012; Tripodi M, 2004, DEVELOPMENT, V131, P6119, DOI 10.1242/dev.01530; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Wang XR, 2010, NEUROREPORT, V21, P611, DOI 10.1097/WNR.0b013e328338864b; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Weston MD, 2011, DEV DYNAM, V240, P808, DOI 10.1002/dvdy.22591; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yang J, 2011, FEBS LETT, V585, P2992, DOI 10.1016/j.febslet.2011.08.013; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Ying MY, 2011, STEM CELLS, V29, P20, DOI 10.1002/stem.561; Zhang YS, 2012, J BIOL CHEM, V287, P41514, DOI 10.1074/jbc.M112.404871; Zhang ZD, 2004, GENOME RES, V14, P580, DOI 10.1101/gr.2160004; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	99	7	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e83358	10.1371/journal.pone.0083358	http://dx.doi.org/10.1371/journal.pone.0083358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24349493	Green Published, Green Submitted, gold			2022-12-27	WOS:000327947800107
J	Komyakova, V; Munday, PL; Jones, GP				Komyakova, Valeriya; Munday, Philip L.; Jones, Geoffrey P.			Relative Importance of Coral Cover, Habitat Complexity and Diversity in Determining the Structure of Reef Fish Communities	PLOS ONE			English	Article							CHAETODONTID FISHES; HERMATYPIC CORALS; PHASE-SHIFTS; ABUNDANCE; ASSEMBLAGES; DEGRADATION; PATTERNS; SCALE; SPECIALIZATION; BIODIVERSITY	The structure of coral reef habitat has a pronounced influence on the diversity, composition and abundance of reef-associated fishes. However, the particular features of the habitat that are most critical are not always known. Coral habitats can vary in many characteristics, notably live coral cover, topographic complexity and coral diversity, but the relative effects of these habitat characteristics are often not distinguished. Here, we investigate the strength of the relationships between these habitat features and local fish diversity, abundance and community structure in the lagoon of Lizard Island, Great Barrier Reef. In a spatial comparison using sixty-six 2m(2) quadrats, fish species richness, total abundance and community structure were examined in relation to a wide range of habitat variables, including topographic complexity, habitat diversity, coral diversity, coral species richness, hard coral cover, branching coral cover and the cover of corymbose corals. Fish species richness and total abundance were strongly associated with coral species richness and cover, but only weakly associated with topographic complexity. Regression tree analysis showed that coral species richness accounted for most of the variation in fish species richness (63.6%), while hard coral cover explained more variation in total fish abundance (17.4%), than any other variable. In contrast, topographic complexity accounted for little spatial variation in reef fish assemblages. In degrading coral reef environments, the potential effects of loss of coral cover and topographic complexity are often emphasized, but these findings suggest that reduced coral biodiversity may ultimately have an equal, or greater, impact on reef-associated fish communities.	[Komyakova, Valeriya] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Komyakova, V (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	Valeriya.Komyakova@gmail.com	Komyakova, Valeriya/H-4632-2013; Munday, Philip L/F-5443-2011; Jones, Geoffrey P./E-9306-2010	Komyakova, Valeriya/0000-0003-3755-1546; Munday, Philip L/0000-0001-9725-2498; Jones, Geoffrey P./0000-0002-6244-1245	Australian Research Council Centre of Excellence for Coral Reef Studies	Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council)	This research was supported by the Australian Research Council Centre of Excellence for Coral Reef Studies (www.coralcoe.org.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2004, OIKOS, V106, P275, DOI 10.1111/j.0030-1299.2004.13193.x; Almany GR, 2004, OECOLOGIA, V141, P105, DOI 10.1007/s00442-004-1617-0; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; BELL JD, 1984, MAR ECOL PROG SER, V15, P265, DOI 10.3354/meps015265; Bellwood DR, 2006, GLOBAL CHANGE BIOL, V12, P1587, DOI 10.1111/j.1365-2486.2006.01204.x; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Beukers JS, 1998, OECOLOGIA, V114, P50, DOI 10.1007/s004420050419; Bonin MC, 2012, CORAL REEFS, V31, P287, DOI 10.1007/s00338-011-0843-2; BOOTH DJ, 1994, CORAL REEFS, V13, P81, DOI 10.1007/BF00300765; BOUCHONNAVARO Y, 1989, ENVIRON BIOL FISH, V25, P47, DOI 10.1007/BF00002200; Bozec YM, 2005, J FISH BIOL, V66, P966, DOI 10.1111/j.0022-1112.2005.00652.x; Caley MJ, 2001, ECOLOGY, V82, P3435, DOI 10.2307/2680163; Chabanet P, 1997, CORAL REEFS, V16, P93, DOI 10.1007/s003380050063; Choat J.H., 1991, P39; Clua E, 2006, J EXP MAR BIOL ECOL, V333, P219, DOI 10.1016/j.jembe.2005.12.010; CONNELL SD, 1991, J EXP MAR BIOL ECOL, V151, P271, DOI 10.1016/0022-0981(91)90129-K; COX EF, 1994, B MAR SCI, V54, P535; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Depczynski M, 2004, MAR BIOL, V145, P455, DOI 10.1007/s002270004-1342-6; Dominici-Arosemena A, 2005, CARIBB J SCI, V41, P613; Dorenbosch M, 2004, ESTUAR COAST SHELF S, V60, P37, DOI 10.1016/j.ecss.2003.11.018; Edinger EN, 1998, MAR POLLUT BULL, V36, P617, DOI 10.1016/S0025-326X(98)00047-2; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Gardiner NM, 2005, MAR ECOL PROG SER, V305, P163, DOI 10.3354/meps305163; Garpe KC, 2006, MAR ECOL PROG SER, V315, P237, DOI 10.3354/meps315237; Glynn P.W., 2003, P 10 INT COR REEF S; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; HIXON MA, 1989, B MAR SCI, V44, P666; HIXON MA, 1991, THEOR POPUL BIOL, V39, P178, DOI 10.1016/0040-5809(91)90035-E; Hoegh-Guldberg O., 2007, CLIMATE CHANGE GREAT; Holbrook SJ, 2002, MAR FRESHWATER RES, V53, P1045, DOI 10.1071/MF02063; Holbrook SJ, 2002, MAR FRESHWATER RES, V53, P181, DOI 10.1071/MF01137; HOLBROOK SJ, 1990, AUST J ECOL, V15, P489, DOI 10.1111/j.1442-9993.1990.tb01473.x; Holbrook SJ, 2000, OECOLOGIA, V122, P109, DOI 10.1007/PL00008826; HOLBROOK SJ, 2006, P 10 INT COR REEF S, V1, P241; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; JONES GP, 1984, ENVIRON BIOL FISH, V10, P43, DOI 10.1007/BF00001661; Jones GP, 1998, AUST J ECOL, V23, P287, DOI 10.1111/j.1442-9993.1998.tb00733.x; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Kokita T, 2001, CORAL REEFS, V20, P155, DOI 10.1007/s003380100153; KUWAMURA T, 1994, MAR ECOL PROG SER, V103, P17, DOI 10.3354/meps103017; LIBERMAN T, 1995, MAR BIOL, V121, P741, DOI 10.1007/BF00349310; LUCKHURST BE, 1978, MAR BIOL, V49, P317, DOI 10.1007/BF00455026; Mac Nally R, 2001, ECOL MODEL, V144, P139, DOI 10.1016/S0304-3800(01)00367-2; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Messmer V, 2011, ECOLOGY, V92, P2285, DOI 10.1890/11-0037.1; Munday PL, 1998, OCEANOGR MAR BIOL<D>, V36, P373; Munday PL, 2004, GLOBAL CHANGE BIOL, V10, P1642, DOI 10.1111/j.1365-2486.2004.00839.x; Munday PL, 1997, MAR ECOL PROG SER, V152, P227, DOI 10.3354/meps152227; Munday PL, 2002, CORAL REEFS, V21, P105, DOI 10.1007/s00338-001-0200-y; Munday PL, 2001, OECOLOGIA, V128, P585, DOI 10.1007/s004420100690; Nanami A, 2005, ENVIRON BIOL FISH, V72, P55, DOI 10.1007/s10641-004-4188-3; Ohman MC, 1998, J EXP MAR BIOL ECOL, V225, P219, DOI 10.1016/S0022-0981(97)00224-4; Ormond RFG, 1996, J EXP MAR BIOL ECOL, V202, P85, DOI 10.1016/0022-0981(96)00033-0; Pratchett MS, 2006, J FISH BIOL, V69, P1269, DOI 10.1111/j.1095-8649.2006.01161.x; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett MS, 2005, MAR BIOL, V148, P373, DOI 10.1007/s00227-005-0084-4; Risk M.J., 1972, Atoll Res Bull, VNo. 153, P1; ROBERTS CM, 1987, MAR ECOL PROG SER, V41, P1, DOI 10.3354/meps041001; SALE P F, 1978, Environmental Biology of Fishes, V3, P85, DOI 10.1007/BF00006310; SALE PF, 1977, AM NAT, V111, P337, DOI 10.1086/283164; SALE PF, 1984, ECOLOGY, V65, P409, DOI 10.2307/1941404; SANO M, 1987, MAR ECOL PROG SER, V37, P191, DOI 10.3354/meps037191; SANO M, 1984, PAC SCI, V38, P51; Sheppard CRC, 2002, AMBIO, V31, P40, DOI 10.1639/0044-7447(2002)031[0040:EVROCR]2.0.CO;2; Spalding MD, 2002, MAR POLLUT BULL, V44, P309, DOI 10.1016/S0025-326X(01)00281-8; Syms C, 1999, ECOLOGY, V80, P921, DOI 10.1890/0012-9658(1999)080[0921:SODATS]2.0.CO;2; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; TYLER JC, 1971, P ACAD NAT SCI PHILA, V123, P1; Veron J.E.N., 2000, CORALS WORLD, V1-3; WILLIAMS DM, 1986, MAR ECOL PROG SER, V28, P157, DOI 10.3354/meps028157; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Wilson SK, 2009, CORAL REEFS, V28, P3, DOI 10.1007/s00338-008-0431-2; Wilson SK, 2008, J ANIM ECOL, V77, P220, DOI 10.1111/j.1365-2656.2007.01341.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	77	113	120	11	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83178	10.1371/journal.pone.0083178	http://dx.doi.org/10.1371/journal.pone.0083178			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349455	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000328734200066
J	Aziz-Boaron, O; Leibovitz, K; Gelman, B; Kedmi, M; Klement, E				Aziz-Boaron, Orly; Leibovitz, Keren; Gelman, Boris; Kedmi, Maor; Klement, Eyal			Safety, Immunogenicity and Duration of Immunity Elicited by an Inactivated Bovine Ephemeral Fever Vaccine	PLOS ONE			English	Article							VIRUS-VACCINE; GENE; GEL	Bovine ephemeral fever (BEF) is an economically important viral vector-borne cattle disease. Several live-attenuated, inactivated and recombinant vaccines have been tested, demonstrating varying efficacy. However, to the best of our knowledge, duration of immunity conferred by an inactivated vaccine has never been reported. In the last decade, Israel has faced an increasing number of BEF outbreaks. The need for an effective vaccine compatible with strains circulating in the Middle East region led to the development of a MONTANIDE (TM) ISA 206 VG (water-in-oil-in-water), inactivated vaccine based on a local strain. We tested the safety, immunogenicity and duration of immunity conferred by this vaccine. The induced neutralizing antibody (NA) response was followed for 493 days in 40 cows vaccinated by different protocols. The vaccine did not cause adverse reactions or a decrease in milk production. All cows [except 2 (6.7%) which did not respond to vaccination] showed a significant rise in NA titer of up to 1:256 following the second, third or fourth booster vaccination. Neutralizing antibody levels declined gradually to 1:16 up to 120 days post vaccination. This decline continued in cows vaccinated only twice, whereas cows vaccinated 3 or 4 times showed stable titers of approximately 1:16 for up to 267 days post vaccination. At least three vaccinations with the inactivated BEF vaccine were needed to confer long-lasting immunity. These results may have significant implications for the choice of vaccination protocol with inactivated BEF vaccines. Complementary challenge data should however be added to the above results in order to determine what is the minimal NA response conferring protection from clinical disease.	[Aziz-Boaron, Orly; Leibovitz, Keren; Klement, Eyal] Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, Jerusalem, Israel; [Gelman, Boris] Kimron Vet Inst, Bet Dagan, Israel; [Kedmi, Maor] Hachaklait Vet Serv Ltd, Ceasarea, Israel	Hebrew University of Jerusalem; Kimron Veterinary Institute	Klement, E (corresponding author), Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, Jerusalem, Israel.	eyal.klement@gmail.com	Klement, Eyal/H-8388-2019	Klement, Eyal/0000-0002-2384-2345	Israeli Dairy Board [705-0016-08]; Israel Science Foundation [1009/11]; Hebrew University of Jerusalem, Israel	Israeli Dairy Board; Israel Science Foundation(Israel Science Foundation); Hebrew University of Jerusalem, Israel	This study was supported by grants from the Israeli Dairy Board (grant no. 705-0016-08) and from the Israel Science Foundation (grant no. 1009/11). OAB was partly supported by the "Hoffman Leadership and Responsibility" fellowship program at the Hebrew University of Jerusalem, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WKLY EPIDEMIOL REC, V82, P285; Aziz-Boaron O, 2013, TRANSBOUNDARY EMERGI; Aziz-Boaron O, 2012, VET MICROBIOL, V158, P300, DOI 10.1016/j.vetmic.2012.03.003; Bai W.Y.J., 1992, ACIAR P, V44, P111; Bergeron R, 2008, VET THER, V9, P141; BURGESS GW, 1977, AUST VET J, V53, P363, DOI 10.1111/j.1751-0813.1977.tb07952.x; DELLAPORTA AJ, 1979, VET MICROBIOL, V4, P197, DOI 10.1016/0378-1135(79)90056-7; DELLAPORTA AJ, 1977, AUST VET J, V53, P50, DOI 10.1111/j.1751-0813.1977.tb15824.x; Hsieh YC, 2006, J VET MED SCI, V68, P543, DOI 10.1292/jvms.68.543; INABA Y, 1973, ARCH GES VIRUSFORSCH, V42, P42, DOI 10.1007/BF01250506; Lee NH, 2012, VACCINE RES, V1, P18; MUSKETT JC, 1985, VACCINE, V3, P309, DOI 10.1016/S0264-410X(85)90161-6; Pastoret PP, 2010, BIOLOGICALS, V38, P332, DOI 10.1016/j.biologicals.2010.02.015; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Sadoff JC, 2007, J INFECT DIS, V196, P1279, DOI 10.1086/522432; Snowdon WA, 1970, VET J, V46, P258; Studer E, 2002, BIOLOGICALS, V30, P289, DOI 10.1006/biol.2002.0343; THEODORIDIS A, 1973, Onderstepoort Journal of Veterinary Research, V40, P77; THEODORIDIS A, 1973, Onderstepoort Journal of Veterinary Research, V40, P83; TZIPORI S, 1978, AUST VET J, V54, P323, DOI 10.1111/j.1751-0813.1978.tb02480.x; TZIPORI S, 1973, AUST VET J, V49, P183, DOI 10.1111/j.1751-0813.1973.tb06783.x; UREN MF, 1994, VACCINE, V12, P845, DOI 10.1016/0264-410X(94)90295-X; VAN DERWESTHUIZEN B., 1967, ONDESTEPOORT J VET RES, V34, P29; VANSELOW BA, 1995, VET MICROBIOL, V46, P117, DOI 10.1016/0378-1135(95)00077-N; VANSELOW BA, 1985, VET REC, V117, P37, DOI 10.1136/vr.117.2.37; Walker PJ, 2005, CURR TOP MICROBIOL, V292, P57; Wallace DB, 2005, VACCINE, V23, P3061, DOI 10.1016/j.vaccine.2004.10.006; Wang FI, 2001, J VET DIAGN INVEST, V13, P462, DOI 10.1177/104063870101300602; Yeruham I, 2007, VET J, V173, P190, DOI 10.1016/j.tvjl.2005.09.008; Yeruham I, 2005, VET REC, V156, P284, DOI 10.1136/vr.156.9.284; Yeruham I, 2002, VET REC, V151, P117, DOI 10.1136/vr.151.4.117	31	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82217	10.1371/journal.pone.0082217	http://dx.doi.org/10.1371/journal.pone.0082217			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349225	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800051
J	Culligan, EP; Sleator, RD; Marchesi, JR; Hill, C				Culligan, Eamonn P.; Sleator, Roy D.; Marchesi, Julian R.; Hill, Colin			Functional Environmental Screening of a Metagenomic Library Identifies stlA; A Unique Salt Tolerance Locus from the Human Gut Microbiome	PLOS ONE			English	Article							PROTEIN-STRUCTURE; OSMOTIC-STRESS; BENZODIAZEPINE-RECEPTOR; AKKERMANSIA-MUCINIPHILA; MEMBRANE-PROTEINS; SEQUENCE-ANALYSIS; ESCHERICHIA-COLI; ANKYRIN REPEAT; I-TASSER; RESPONSES	Functional environmental screening of metagenomic libraries is a powerful means to identify and assign function to novel genes and their encoded proteins without any prior sequence knowledge. In the current study we describe the identification and subsequent analysis of a salt-tolerant clone from a human gut metagenomic library. Following transposon mutagenesis we identified an unknown gene (stlA, for "salt tolerance locus A") with no current known homologues in the databases. Subsequent cloning and expression in Escherichia coli MKH13 revealed that stlA confers a salt tolerance phenotype in its surrogate host. Furthermore, a detailed in silico analysis was also conducted to gain additional information on the properties of the encoded StlA protein. The stlA gene is rare when searched against human metagenome datasets such as MetaHit and the Human Microbiome Project and represents a novel and unique salt tolerance determinant which appears to be found exclusively in the human gut environment.	[Culligan, Eamonn P.; Sleator, Roy D.; Marchesi, Julian R.; Hill, Colin] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Culligan, Eamonn P.; Hill, Colin] Natl Univ Ireland Univ Coll Cork, Sch Microbiol, Cork, Ireland; [Sleator, Roy D.] Cork Inst Technol, Dept Biol Sci, Cork, Ireland; [Marchesi, Julian R.] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Marchesi, Julian R.] Univ London Imperial Coll Sci Technol & Med, Dept Hepatol & Gastroenterol, London, England	University College Cork; University College Cork; Cork Institute of Technology; Cardiff University; Imperial College London	Sleator, RD (corresponding author), Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland.	roy.sleator@cit.ie; marchesijr@cardiff.ac.uk; c.hill@ucc.ie	Marchesi, Julian/AAC-9021-2020; Hill, Colin/A-5611-2012; Marchesi, Julian/D-3731-2009	Hill, Colin/0000-0002-8527-1445; Marchesi, Julian/0000-0002-7994-5239; Sleator, Roy/0000-0001-5846-3938; Culligan, Eamonn/0000-0003-4722-2121	Science Foundation Ireland under the CSET Uplift Grant; Alimentary Pharmabiotic Centre; Science Foundation Ireland; Royal Society	Science Foundation Ireland under the CSET Uplift Grant(Science Foundation Ireland); Alimentary Pharmabiotic Centre(Science Foundation Ireland); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Royal Society(Royal Society of London)	EPC is funded by Science Foundation Ireland under the CSET Uplift Grant. We acknowledge the continued financial assistance of the Alimentary Pharmabiotic Centre, funded by Science Foundation Ireland. JRM acknowledges funding from The Royal Society which supports the bioinformatic cluster (Hive) at Cardiff University, School of Biosciences. RDS is an ESCMID Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal L, 2013, GENOME ANNOUNC, V1; Akhter S, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks406; Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bennett V, 2001, CURR OPIN CELL BIOL, V13, P61, DOI 10.1016/S0955-0674(00)00175-7; Bochner BR, 2009, FEMS MICROBIOL REV, V33, P191, DOI 10.1111/j.1574-6976.2008.00149.x; Bork P, 2000, GENOME RES, V10, P398, DOI 10.1101/gr.10.4.398; Cameron A, 2012, J BACTERIOL; Chinchilla D, 2003, PLANT MOL BIOL, V51, P555, DOI 10.1023/A:1022337221225; Chintakayala K, 2011, J MOL BIOL, V411, P313, DOI 10.1016/j.jmb.2011.05.043; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Collison M, 2012, BRIEF BIOINFORM, V13, P751, DOI 10.1093/bib/bbs002; Culligan EP, 2012, ISME J, V6, P1916, DOI 10.1038/ismej.2012.38; Culligan EP, 2012, GUT MICROBES, V3, P394, DOI 10.4161/gmic.20984; Culligan EP, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-19; Cytryn EJ, 2007, J BACTERIOL, V189, P6751, DOI 10.1128/JB.00533-07; Delavat F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00354; Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Flint A, 2012, J BACTERIOL, V194, P334, DOI 10.1128/JB.05740-11; GASSON MJ, 1983, J BACTERIOL, V154, P1; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108; HAARDT M, 1995, MOL GEN GENET, V246, P783, DOI 10.1007/BF00290728; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; HAYES F, 1990, APPL ENVIRON MICROB, V56, P202, DOI 10.1128/AEM.56.1.202-209.1990; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Jones BV, 2007, NAT METHODS, V4, P55, DOI 10.1038/NMETH964; Joshi MN, 2012, J BACTERIOL, V194, P6329, DOI 10.1128/JB.01550-12; Kao DY, 2009, J APPL MICROBIOL, V106, P2079, DOI 10.1111/j.1365-2672.2009.04178.x; Kapardar RK, 2010, INDIAN J MICROBIOL, V50, P212, DOI 10.1007/s12088-010-0041-x; Kapardar RK, 2010, BIORESOURCE TECHNOL, V101, P3917, DOI 10.1016/j.biortech.2010.01.017; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Knopp S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000681; Kovatcheva-Datchary Petia, 2009, Therap Adv Gastroenterol, V2, P9, DOI 10.1177/1756283X09337646; Kunte HJ, 2006, ENVIRON CHEM, V3, P94, DOI 10.1071/EN06016; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Llamas I, 2006, ANTON LEEUW INT J G, V89, P395, DOI 10.1007/s10482-005-9043-9; Louis Petra, 2010, Science Progress, V93, P7, DOI 10.3184/003685009X12605525292307; Lund PA, 2001, ADV MICROB PHYSIOL, V44, P93, DOI 10.1016/S0065-2911(01)44012-4; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Markowitz VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040151; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Prasad J, 2003, APPL ENVIRON MICROB, V69, P917, DOI 10.1128/AEM.69.2.917-925.2003; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sakamoto T, 2002, CURR OPIN MICROBIOL, V5, P206, DOI 10.1016/S1369-5274(02)00306-5; Seong ES, 2007, J BIOCHEM MOL BIOL, V40, P952; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Sleator RD, 2008, LETT APPL MICROBIOL, V47, P361, DOI 10.1111/j.1472-765X.2008.02444.x; Sleator RD, 2005, CLIN MICROBIOL INFEC, V11, P599, DOI 10.1111/j.1469-0691.2005.01176.x; Sleator RD, 2002, FEMS MICROBIOL REV, V26, P49, DOI 10.1111/j.1574-6976.2002.tb00598.x; Sleator RD, 2009, MICROBIOL-SGM, V155, P2463, DOI 10.1099/mic.0.030205-0; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stevens DA, 2009, MEDICINE, V88, P244, DOI 10.1097/MD.0b013e3181aede29; STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F; van Passel MWJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016876; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Wexler HM, 2009, MICROBIOL-SGM, V155, P2694, DOI 10.1099/mic.0.025858-0; Wilkins MR, 1999, METH MOL B, V112, P531; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Yang JY, 2011, CURR OPIN CHEM BIOL, V15, P79, DOI 10.1016/j.cbpa.2010.10.025; Yang XX, 2006, FEMS YEAST RES, V6, P195, DOI 10.1111/j.1567-1364.2006.00026.x; YELISEEV AA, 1995, J BIOL CHEM, V270, P21167, DOI 10.1074/jbc.270.36.21167; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	77	19	20	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82985	10.1371/journal.pone.0082985	http://dx.doi.org/10.1371/journal.pone.0082985			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349412	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800087
J	Gonzalez-Escobedo, G; La Perle, KMD; Gunn, JS				Gonzalez-Escobedo, Geoffrey; La Perle, Krista M. D.; Gunn, John S.			Histopathological Analysis of Salmonella Chronic Carriage in the Mouse Hepatopancreatobiliary System	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; TYPHOID-FEVER; GALLBLADDER CARCINOMA; CHRONIC INFLAMMATION; BILE; MACROPHAGES; CARRIERS; BILIARY; CANCER; RISK	Salmonella Typhi asymptomatic chronic carriage represents a challenge for the diagnosis and prevention of typhoid fever in endemic areas. Such carriers are thought to be reservoirs for further spread of the disease. Gallbladder carriage has been demonstrated to be mediated by biofilm formation on gallstones and by intracellular persistence in the gallbladder epithelium of mice. In addition, both gallstones and chronic carriage have been associated with chronic inflammation and the development of gallbladder carcinoma. However, the pathogenic relationship between typhoid carriage and the development of pre-malignant and/or malignant lesions in the hepatopancreatobiliary system as well as the host-pathogen interactions occurring during chronic carriage remains unclear. In this study, we monitored the histopathological features of chronic carriage up to 1 year post-infection. Chronic cholecystitis and hepatitis ranging from mild to severe were present in infected mice regardless of the presence of gallstones. Biliary epithelial hyperplasia was observed more commonly in the gallbladder of mice with gallstones (uninfected or infected). However, pre-malignant lesions, atypical hyperplasia and metaplasia of the gallbladder and exocrine pancreas, respectively, were only associated with chronic Salmonella carriage. This study has implications regarding the role of Salmonella chronic infection and inflammation in the development of pre-malignant lesions in the epithelium of the gallbladder and pancreas that could lead to oncogenesis.	[Gonzalez-Escobedo, Geoffrey; Gunn, John S.] Ohio State Univ, Dept Microbiol, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Gonzalez-Escobedo, Geoffrey; Gunn, John S.] Ohio State Univ, Dept Microbial Infect & Immun, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [La Perle, Krista M. D.] Ohio State Univ, Dept Vet Biosci Comparat Pathol & Mouse Phenotypi, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gunn, JS (corresponding author), Ohio State Univ, Dept Microbiol, Ctr Microbial Interface Biol, 484 W 12th Ave, Columbus, OH 43210 USA.	gunn.43@osu.edu	La Perle, Krista Marie DuBray/B-3099-2015; Gunn, John/E-3167-2011		Pelotonia Graduate Fellowship; US National Institutes of Health [AI066208]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066208] Funding Source: NIH RePORTER	Pelotonia Graduate Fellowship; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Pelotonia Graduate Fellowship (http://cancer.osu.edu/research/researcheducation/pelotoniafellowshipprogram/pages/index.aspx?ref=go) and a grant from the US National Institutes of Health (AI066208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD L, 1971, J AMER MED ASSOC, V217, P83, DOI 10.1001/jama.1971.03190010065032; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Cao WQ, 2010, HUM PATHOL, V41, P513, DOI 10.1016/j.humpath.2009.05.017; Cappelli G, 2005, NEPHROL DIAL TRANSPL, V20, P266, DOI 10.1093/ndt/gfh571; CAYGILL CPJ, 1994, LANCET, V343, P83, DOI 10.1016/S0140-6736(94)90816-8; Chang HJ, 1999, J KOREAN MED SCI, V14, P286, DOI 10.3346/jkms.1999.14.3.286; CHANG HR, 1992, METABOLISM, V41, P1, DOI 10.1016/0026-0495(92)90181-9; COHEN JI, 1987, MEDICINE, V66, P349, DOI 10.1097/00005792-198709000-00003; Crawford RW, 2010, P NATL ACAD SCI USA, V107, P4353, DOI 10.1073/pnas.1000862107; Crum Nancy F, 2003, Curr Gastroenterol Rep, V5, P279, DOI 10.1007/s11894-003-0064-0; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; CSENDES A, 1975, AM J SURG, V129, P629, DOI 10.1016/0002-9610(75)90334-7; Dutta U, 2000, AM J GASTROENTEROL, V95, P784, DOI 10.1111/j.1572-0241.2000.01860.x; ELZAYADI A, 1991, HEPATO-GASTROENTEROL, V38, P337; Everest P, 2001, TRENDS MICROBIOL, V9, P316, DOI 10.1016/S0966-842X(01)02067-4; Fadl AA, 2005, INFECT IMMUN, V73, P1081, DOI 10.1128/IAI.73.2.1081-1096.2005; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Fritsche G, 2012, J LEUKOCYTE BIOL, V92, P353, DOI 10.1189/jlb.1111554; Goldin RD, 2009, HISTOPATHOLOGY, V55, P218, DOI 10.1111/j.1365-2559.2008.03192.x; Gonzalez-Escobedo G, 2013, INFECT IMMUN, V81, P2920, DOI 10.1128/IAI.00258-13; Gosbell I, 1995, AUST NZ J SURG, V65, P898, DOI 10.1111/j.1445-2197.1995.tb00588.x; Harbord M, 2002, J BIOL CHEM, V277, P5468, DOI 10.1074/jbc.M110635200; Haschek WM, 2010, FUNDAMENTALS OF TOXICOLOGIC PATHOLOGY, 2ND EDITION, P1; HERMANS P, 1990, AM J MED, V89, P546, DOI 10.1016/0002-9343(90)90401-X; HORNICK RB, 1970, NEW ENGL J MED, V283, P686, DOI 10.1056/NEJM197009242831306; Ichikawa H, 2009, J HEPATO-BILIARY-PAN, V16, P197, DOI 10.1007/s00534-009-0043-4; Jepson MA, 2001, MICROBES INFECT, V3, P1183, DOI 10.1016/S1286-4579(01)01478-2; Kadappu Krishna Kishor, 2002, Indian J Gastroenterol, V21, P32; Karaki K, 1984, Nihon Shokakibyo Gakkai Zasshi, V81, P2978; Khan FY, 2009, INT J INFECT DIS, V13, pE282, DOI 10.1016/j.ijid.2008.11.009; KHOSLA SN, 1990, POSTGRAD MED J, V66, P923, DOI 10.1136/pgmj.66.781.923; Khosla SN, 2008, TYPHOID FEVER ITS CA; Knodler LA, 2010, P NATL ACAD SCI USA, V107, P17733, DOI 10.1073/pnas.1006098107; Kumar S, 2006, J SURG ONCOL, V93, P633, DOI 10.1002/jso.20530; LAI CW, 1992, AM J GASTROENTEROL, V87, P1198; Lavoie B, 2012, NEUROGASTROENT MOTIL, V24, pe313, DOI 10.1111/j.1365-2982.2012.01935.x; Lazcano-Ponce EC, 2001, CA-CANCER J CLIN, V51, P349, DOI 10.3322/canjclin.51.6.349; Legan M, 2010, BOSNIAN J BASIC MED, V10, P192, DOI 10.17305/bjbms.2010.2684; LEVINE MM, 1982, J INFECT DIS, V146, P724, DOI 10.1093/infdis/146.6.724; Mateen M. A., 2006, Indian Journal of Pediatrics, V73, P681, DOI 10.1007/BF02898444; Mathur S K, 2012, Trop Gastroenterol, V33, P39; Menendez A, 2009, J INFECT DIS, V200, P1703, DOI 10.1086/646608; MERSELIS JG, 1964, AM J TROP MED HYG, V13, P425, DOI 10.4269/ajtmh.1964.13.425; Mert A, 2004, INTERNAL MED, V43, P436, DOI 10.2169/internalmedicine.43.436; Miller G, 2008, EJSO-EUR J SURG ONC, V34, P306, DOI 10.1016/j.ejso.2007.07.206; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Monga Satdarshan., 2011, MOL PATHOLOGY LIVER; Nath G, 1997, EUR J CANCER PREV, V6, P557, DOI 10.1097/00008469-199712000-00011; Nath G, 2008, J INFECT DEV COUNTR, V2, P302; NNALUE NA, 1992, INFECT IMMUN, V60, P2758, DOI 10.1128/IAI.60.7.2758-2768.1992; Parenti DM, 1996, PANCREAS, V13, P356, DOI 10.1097/00006676-199611000-00005; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; PILGRIM CH, 2013, MODERN PERSPECTIVES; Pramoolsinsap C, 1998, J GASTROEN HEPATOL, V13, P745, DOI 10.1111/j.1440-1746.1998.tb00726.x; Rai R, 2011, EUR J CANCER PREV, V20, P77, DOI 10.1097/CEJ.0b013e328341e371; RAMACHANDRAN S, 1974, JAMA-J AM MED ASSOC, V230, P236, DOI 10.1001/jama.230.2.236; Randi G, 2006, INT J CANCER, V118, P1591, DOI 10.1002/ijc.21683; Rege RV, 1998, J SURG RES, V74, P81, DOI 10.1006/jsre.1997.5213; RichterDahlfors A, 1997, J EXP MED, V186, P569, DOI 10.1084/jem.186.4.569; Roa I, 1999, REV MED CHILE, V127, P1049; ROVITO V, 1982, AM J GASTROENTEROL, V77, P338; Rustagi Tarun, 2012, J Gastrointest Cancer, V43, P137, DOI 10.1007/s12029-011-9284-y; Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2; SCHIOLER H, 1983, SCAND J INFECT DIS, V15, P17, DOI 10.3109/inf.1983.15.issue-1.04; SCOTT AJ, 1971, GUT, V12, P487, DOI 10.1136/gut.12.6.487; Shetty PB, 1998, J ULTRAS MED, V17, P231, DOI 10.7863/jum.1998.17.4.231; SHPARGEL JS, 1985, AM J INFECT CONTROL, V13, P122, DOI 10.1016/S0196-6553(85)80013-4; Shukla VK, 2000, DIGEST DIS SCI, V45, P900, DOI 10.1023/A:1005564822630; SINNOTT CR, 1987, LANCET, V1, P976; Sosnik Katarzyna, 2005, Wiad Lek, V58, P678; Tazuma S, 2001, LANGENBECK ARCH SURG, V386, P224, DOI 10.1007/s004230100220; Vaishnavi C, 2005, JPN J INFECT DIS, V58, P363; Vaishnavi C, 2005, MICROBIOL IMMUNOL, V49, P107, DOI 10.1111/j.1348-0421.2005.tb03709.x; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; VLADOIANU IR, 1990, MICROB PATHOGENESIS, V8, P83, DOI 10.1016/0882-4010(90)90072-X; VOGELSANG TM, 1948, J HYG-CAMBRIDGE, V46, P252, DOI 10.1017/S0022172400036378; Wain J, 1998, J CLIN MICROBIOL, V36, P1683, DOI 10.1128/JCM.36.6.1683-1687.1998; Ward JM, 2001, AM J PATHOL, V158, P323, DOI 10.1016/S0002-9440(10)63972-7; WEE A, 1994, J CLIN PATHOL, V47, P453, DOI 10.1136/jcp.47.5.453; WELTON JC, 1979, LANCET, V1, P791; WISTUBA II, 1995, CANCER RES, V55, P2511	81	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e84058	10.1371/journal.pone.0084058	http://dx.doi.org/10.1371/journal.pone.0084058			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349565	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800136
J	Marepally, S; Boakye, CHA; Shah, PP; Etukala, JR; Vemuri, A; Singh, M				Marepally, Srujan; Boakye, Cedar H. A.; Shah, Punit P.; Etukala, Jagan Reddy; Vemuri, Adithi; Singh, Mandip			Design, Synthesis of Novel Lipids as Chemical Permeation Enhancers and Development of Nanoparticle System for Transdermal Drug Delivery	PLOS ONE			English	Article							PENETRATION ENHANCERS; SKIN PENETRATION; STRATUM-CORNEUM; OLEIC-ACID; MECHANISMS; IMMUNE	In the present study, we designed and developed novel lipids that include (Z)-1-(Octadec-9-en-1-yl)-pyrrolidine (Cy5T), 1, 1-Di-((Z)-octadec-9-en-1-yl)pyrrolidin-1-ium iodide (Cy5), (Z)-1-(Octadec-9-en-1-yl)-piperidine (Cy6T), and 1, 1-Di-((Z)-octadec-9-en-1-yl) piperidin-1-ium iodide (Cy6) to enhance the transdermal permeation of some selected drugs. Firstly, we evaluated the transdermal permeation efficacies of these lipids as chemical permeation enhancers in vehicle formulations for melatonin, beta-estradiol, caffeine, alpha-MSH, and spantide using franz diffusion cells. Among them Cy5 lipid was determined to be the most efficient by increasing the transdermal permeation of melatonin, beta-estradiol, caffeine, alpha-MSH, and spantide by 1.5 to 3.26-fold more at the epidermal layer and 1.3 to 2.5-fold more at the dermal layer, in comparison to either NMP or OA. Hence we developed a nanoparticle system (cy5 lipid ethanol drug nanoparticles) to evaluate any further improvement in the drug penetration. Cy5 lipid formed uniformly sized nanoparticles ranging from 150-200 nm depending on the type of drug. Further, Cy5 based nanoparticle system significantly (p<0.05) increased the permeation of all the drugs in comparison to the lipid solution and standard permeation enhancers. There were about 1.54 to 22-fold more of drug retained in the dermis for the Cy5 based nanoparticles compared to OA/NMP standard enhancers and 3.87 to 66.67-fold more than lipid solution. In addition, epifluorescent microscopic analysis in rhodamine-PE permeation studies confirmed the superior permeation enhancement of LEDs (detection of fluorescence up to skin depth of 340 mu m) more than lipid solution, which revealed fluorescence up to skin depth of only 260 mu m. In summary the present findings demonstrate that i) cationic lipid with 5 membered amine heterocyclic ring has higher permeating efficacy than the 6 membered amine hertocyclic ring. ii) The nanoparticle system prepared with Cy5 showed significant (p<0.05) increase in the permeation of the drugs than the control penetration enhancers, oleic acid and NMP.	[Marepally, Srujan; Boakye, Cedar H. A.; Shah, Punit P.; Etukala, Jagan Reddy; Vemuri, Adithi; Singh, Mandip] Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA	State University System of Florida; Florida A&M University	Singh, M (corresponding author), Florida A&M Univ, Coll Pharm & Pharmaceut Sci, Tallahassee, FL 32307 USA.	mandip.sachdeva@gmail.com			National Center for Research Resources; National Institute of Minority Health and Health Disparities of the National Institutes of Health [8 G12 MD007582-28, 2 G12 RR003020]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003020] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007582] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Minority Health and Health Disparities of the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project was supported by the National Center for Research Resources and the National Institute of Minority Health and Health Disparities of the National Institutes of Health through Grant Number 8 G12 MD007582-28 and 2 G12 RR003020. The funders of the project had no role in the study design, data collection and analysis, decision to publish or the preparation of the manuscript.	AUNGST BJ, 1989, PHARM RES-DORDR, V6, P244, DOI 10.1023/A:1015921702258; Benson Heather A. E., 2005, Current Drug Delivery, V2, P23, DOI 10.2174/1567201052772915; Bos JD, 2000, EXP DERMATOL, V9, P165, DOI 10.1034/j.1600-0625.2000.009003165.x; Brychtova K, 2012, BIOORGAN MED CHEM, V20, P86, DOI 10.1016/j.bmc.2011.11.033; Ghafourian T, 2004, J CONTROL RELEASE, V99, P113, DOI 10.1016/j.jconrel.2004.06.010; GOODMAN M, 1989, INT J PHARM, V57, P29, DOI 10.1016/0378-5173(89)90260-3; Guo SQ, 2011, J CONTROL RELEASE, V151, P256, DOI 10.1016/j.jconrel.2011.01.014; Gwak HS, 2002, ARCH PHARM RES, V25, P392, DOI 10.1007/BF02976645; Heller LC, 2007, GENE THER, V14, P275, DOI 10.1038/sj.gt.3302867; Jampilek J, 2012, MED RES REV, V32, P907, DOI 10.1002/med.20227; Jungbauer FHW, 2001, CONTACT DERMATITIS, V45, P303, DOI 10.1034/j.1600-0536.2001.450514.x; Kanikkannan N, 2002, INT J PHARM, V248, P219, DOI 10.1016/S0378-5173(02)00454-4; Kanikkannan N, 2000, CURR MED CHEM, V7, P593, DOI 10.2174/0929867003374840; Kikwai L, 2005, AAPS PHARMSCITECH, V6; KIM CK, 1993, INT J PHARMACEUT, V95, P43, DOI 10.1016/0378-5173(93)90388-V; Kim DD, 1996, J PHARM SCI, V85, P1191, DOI 10.1021/js9601041; KUPPER TS, 1990, J CLIN INVEST, V86, P1783, DOI 10.1172/JCI114907; Mayes S, 2006, ANN PHARMACOTHER, V40, P2178, DOI 10.1345/aph.1H135; Menon GK, 1997, SKIN PHARMACOL, V10, P235; Novotny M, 2009, BIOORG MED CHEM LETT, V19, P344, DOI 10.1016/j.bmcl.2008.11.083; Oh HJ, 2001, INT J PHARM, V212, P63, DOI 10.1016/S0378-5173(00)00598-6; Park ES, 2001, DRUG DEV IND PHARM, V27, P975, DOI 10.1081/DDC-100107679; Prausnitz MR, 2008, NAT BIOTECHNOL, V26, P1261, DOI 10.1038/nbt.1504; Shah PP, 2012, J CONTROL RELEASE, V158, P336, DOI 10.1016/j.jconrel.2011.11.016; SOUTHWELL D, 1983, J INVEST DERMATOL, V80, P507, DOI 10.1111/1523-1747.ep12535090; Suhonen TM, 1999, J CONTROL RELEASE, V59, P149, DOI 10.1016/S0168-3659(98)00187-4; Tanojo H, 1999, J CONTROL RELEASE, V58, P97, DOI 10.1016/S0168-3659(98)00144-8; Thong HY, 2007, SKIN PHARMACOL PHYS, V20, P272, DOI 10.1159/000107575; TOUITOU EB, 2006, CHEM PERMEATION ENHA; Trommer H, 2006, SKIN PHARMACOL PHYS, V19, P106, DOI 10.1159/000091978; Williams AC, 2004, ADV DRUG DELIVER REV, V56, P603, DOI 10.1016/j.addr.2003.10.025; Williams IR, 1996, LIFE SCI, V58, P1485, DOI 10.1016/0024-3205(96)00042-2	32	32	32	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82581	10.1371/journal.pone.0082581	http://dx.doi.org/10.1371/journal.pone.0082581			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349315	gold, Green Published			2022-12-27	WOS:000328731800068
J	Chen, J; Peng, HQ; Xiao, L; Zhang, K; Yuan, ZM; Chen, JP; Wang, ZY; Wang, JF; Huang, H				Chen, Jie; Peng, Hongquan; Xiao, Long; Zhang, Kun; Yuan, Zhimin; Chen, Jianping; Wang, Zhiyu; Wang, Jingfeng; Huang, Hui			Inflammation but Not Dietary Macronutrients Insufficiency Associated with the Malnutrition-Inflammation Score in Hemodialysis Population	PLOS ONE			English	Article							NUTRITIONAL-STATUS; ALBUMIN CONCENTRATION; MORBIDITY; MORTALITY; DETERMINANTS	Malnutrition is associated with increased risk of mortality in hemodialysis patients. And insufficient dietary intake is the common cause for malnutrition. So, in order to survey the dietary intake of hemodialysis patients and study the relationship between the dietary feature and nutritional status, a cross-sectional study was performed. 75 hemodialysis patients from South China participated in the dietary intake survey and nutrition assessment. A three-day diet diary record was used to estimate the major dietary macronutrients. Nutritional status was assessed by malnutrition-inflammation score (MIS) in addition to several related anthropometric measurements. Serum albumin, transferrin, and high-sensitivity C-reactive protein (CRP) were measured. Receiver operating characteristic (ROC) curve analysis was used to quantify the assessing value of independent parameters for nutritional status. The results showed that 48% patients were malnourished according to the MIS. The malnourished patients had a lower body mass index (BMI), fat mass (FM), albumin and a higher level of CRP, compared with normal nourished patients (P < 0.05). However, no significant differences of macronutrients (calories, protein, fat, carbohydrates, etc) were found between the two nutrition groups (P > 0.05). The multivariate regression analysis showed that the major macronutrients had no significant association with MIS (P > 0.05). In conclusion, malnutrition is very common in South China hemodialysis population and these data indicated that inflammation but not dietary macronutrients insufficiency might be the candidate cause for malnutrition in hemodialysis population.	[Chen, Jie; Zhang, Kun; Wang, Jingfeng; Huang, Hui] Guangdong Prov Key Lab Arrhythmia & Electrophysio, Guangzhou, Guangdong, Peoples R China; [Zhang, Kun; Wang, Jingfeng; Huang, Hui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Jie] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Xiao, Long] Guangzhou Med Univ, Affiliated Hosp 2, Dept Blood Purificat, Guangzhou, Guangdong, Peoples R China; [Yuan, Zhimin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Nutr, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Jianping; Wang, Zhiyu] Univ Hong Kong, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University; University of Hong Kong	Huang, H (corresponding author), Guangdong Prov Key Lab Arrhythmia & Electrophysio, Guangzhou, Guangdong, Peoples R China.	huanghui765@hotmail.com	wang, jing/GRS-7509-2022; Peng, Hongquan/AAI-6239-2021	Peng, Hongquan/0000-0003-4893-7903	Science & technology star of Zhujiang city project, Yat-Sen Scholarship for Young Scientist, NSFC [81170647, 91029742, 30973207]; Guangdong Province Key Laboratory of Computational Science at the Sun Yat-sen University; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China [132030]	Science & technology star of Zhujiang city project, Yat-Sen Scholarship for Young Scientist, NSFC; Guangdong Province Key Laboratory of Computational Science at the Sun Yat-sen University; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China(Fok Ying Tung Education Foundation)	This work was supported in part by the Science & technology star of Zhujiang city project, Yat-Sen Scholarship for Young Scientist, NSFC [81170647, 91029742 and 30973207], Guangdong Province Key Laboratory of Computational Science at the Sun Yat-sen University, and Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China (132030) to Hui Huang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellizzi V, 2003, NEPHROL DIAL TRANSPL, V18, P1874, DOI 10.1093/ndt/gfg239; Bossola M, 2005, J RENAL NUTR, V15, P244, DOI 10.1053/j.jrn.2005.01.004; Caglar K, 2002, NUTR REV, V60, P378, DOI 10.1301/00296640260385928; Chen JX, 2013, COMPUT SCI ENG, V15, P8, DOI 10.1109/MCSE.2013.29; DETSKY AS, 1987, JPEN-PARENTER ENTER, V11, P8, DOI 10.1177/014860718701100108; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Hou Y, 2012, NUTR RES, V32, P266, DOI 10.1016/j.nutres.2012.02.006; Kalantar-Zadeh K, 2005, AM J CLIN NUTR, V81, P543; Kalantar-Zadeh K, 2001, AM J KIDNEY DIS, V38, P1251, DOI 10.1053/ajkd.2001.29222; Kaysen GA, 1997, AM J KIDNEY DIS, V29, P658, DOI 10.1016/S0272-6386(97)90117-7; KOHLMEIER L, 1995, ANNU REV PUBL HEALTH, V16, P43; Kopple JD, 1997, ASAIO J, V43, P246; Kopple JD, 2001, AM J KIDNEY DIS, V37, pS66, DOI 10.1053/ajkd.2001.20748; Lacson E, 2010, CLIN J AM SOC NEPHRO, V5, P252, DOI 10.2215/CJN.07231009; Mei ZG, 2002, AM J CLIN NUTR, V75, P978, DOI 10.1093/ajcn/75.6.978; Rambod M, 2009, AM J KIDNEY DIS, V53, P298, DOI 10.1053/j.ajkd.2008.09.018; Salehi M, 2013, NEPHROL DIAL TRANSPL, V28, P716, DOI 10.1093/ndt/gfs170; SCHAKEL SF, 1988, J AM DIET ASSOC, V88, P1268; Sen D, 2000, J Assoc Physicians India, V48, P724; SIRI WE, 1993, NUTRITION, V9, P481; Steiber AL, 2003, J RENAL NUTR, V13, P186, DOI 10.1016/S1051-2276(03)00078-5; Thijssen S, 2007, J RENAL NUTR, V17, P70, DOI 10.1053/j.jrn.2006.10.011; Valenzuela Rolando Guilhermo Vermehren, 2003, Rev. Assoc. Med. Bras., V49, P72, DOI 10.1590/S0104-42302003000100037; Zhang KY, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-18	24	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83233	10.1371/journal.pone.0083233	http://dx.doi.org/10.1371/journal.pone.0083233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349471	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300141
J	Demirci, S; Bastanlar, EK; Dagtas, ND; Piskin, E; Engin, A; Ozer, F; Yuncu, E; Dogan, SA; Togan, I				Demirci, Sevgin; Bastanlar, Evren Koban; Dagtas, Nihan Dilsad; Piskin, Evangelia; Engin, Atilla; Ozer, Fusun; Yuncu, Eren; Dogan, Sukru Anil; Togan, Inci			Mitochondrial DNA Diversity of Modern, Ancient and Wild Sheep (Ovis gmelinii anatolica) from Turkey: New Insights on the Evolutionary History of Sheep	PLOS ONE			English	Article							DOMESTIC SHEEP; GENETIC DIVERSITY; SPATIAL AUTOCORRELATION; POPULATION-STRUCTURE; CONTROL REGION; SOFTWARE; SEQUENCE; LINEAGES; REVEALS; MOUFLON	In the present study, to contribute to the understanding of the evolutionary history of sheep, the mitochondrial (mt) DNA polymorphisms occurring in modern Turkish native domestic (n = 628), modern wild (Ovis gmelinii anatolica) (n = 30) and ancient domestic sheep from Oylum Hoyuk in Kilis (n = 33) were examined comparatively with the accumulated data in the literature. The lengths (75 bp/76 bp) of the second and subsequent repeat units of the mtDNA control region (CR) sequences differentiated the five haplogroups (HPGs) observed in the domestic sheep into two genetic clusters as was already implied by other mtDNA markers: the first cluster being composed of HPGs A, B, D and the second cluster harboring HPGs C, E. To manifest genetic relatedness between wild Ovis gmelinii and domestic sheep haplogroups, their partial cytochrome B sequences were examined together on a median-joining network. The two parallel but wider aforementioned clusters were observed also on the network of Ovis gmelenii individuals, within which domestic haplogroups were embedded. The Ovis gmelinii wilds of the present day appeared to be distributed on two partially overlapping geographic areas parallel to the genetic clusters that they belong to (the first cluster being in the western part of the overall distribution). Thus, the analyses suggested that the domestic sheep may be the products of two maternally distinct ancestral Ovis gmelinii populations. Furthermore, Ovis gmelinii anatolica individuals exhibited a haplotype of HPG A (n = 22) and another haplotype (n = 8) from the second cluster which was not observed among the modern domestic sheep. HPG E, with the newly observed members (n = 11), showed signs of expansion. Studies of ancient and modern mtDNA suggest that HPG C frequency increased in the Southeast Anatolia from 6% to 22% some time after the beginning of the Hellenistic period, 500 years Before Common Era (BCE).	[Demirci, Sevgin; Dagtas, Nihan Dilsad; Ozer, Fusun; Yuncu, Eren; Dogan, Sukru Anil; Togan, Inci] Middle E Tech Univ, Dept Biol Sci, TR-06531 Ankara, Turkey; [Bastanlar, Evren Koban] TUBITAK Marmara Res Ctr, Genet Engn & Biotechnol Inst, Kocaeli, Turkey; [Piskin, Evangelia] Middle E Tech Univ, Dept Settlement Archaeol, TR-06531 Ankara, Turkey; [Engin, Atilla] Cumhuriyet Univ, Dept Archaeol, Sivas, Turkey	Middle East Technical University; Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK); Middle East Technical University; Cumhuriyet University	Togan, I (corresponding author), Middle E Tech Univ, Dept Biol Sci, TR-06531 Ankara, Turkey.	togan@metu.edu.tr	Yüncü, Eren/AAH-5714-2021; Dogan, Sukru Anil/A-7830-2018; Engin, Atilla/AAG-6916-2020; Pişkin, Evangelia/ABA-3921-2020; Ozer, Fusun/ABH-2640-2021; BAŞTANLAR, Evren KOBAN/AAH-1488-2021	Dogan, Sukru Anil/0000-0002-1800-2923; Engin, Atilla/0000-0003-3165-1562; Pişkin, Evangelia/0000-0001-7727-3013; BAŞTANLAR, Evren KOBAN/0000-0002-6296-9728; Dagtas, Nihan/0000-0003-2658-7295; Ozer, Fusun/0000-0003-0443-5805	Turkish Scientific Council (TUBITAK) [106G115, 111T464]	Turkish Scientific Council (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This study has been supported by Turkish Scientific Council (TUBITAK, grant no: 106G115 and 111T464). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J. M., 1997, GLOBAL LAND ENV LAST; Arslan S, 2011, TURK J BIOL, V35, P647, DOI 10.3906/biy-1007-35; Barbanera F, 2012, FORENSIC SCI INT-GEN, V6, P671, DOI 10.1016/j.fsigen.2011.12.001; Bruford MW, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P306; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Bunch TD, 2006, J HERED, V97, P21, DOI 10.1093/jhered/esi127; Cai DW, 2007, J ARCHAEOL SCI, V34, P1347, DOI 10.1016/j.jas.2006.10.020; Chen SY, 2006, GENE, V376, P216, DOI 10.1016/j.gene.2006.03.009; Chessa B, 2009, SCIENCE, V324, P532, DOI 10.1126/science.1170587; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Festa-Bianchet M, 2000, SUMMARY DISCUSSION T; Fu YX, 1997, GENETICS, V147, P915; Guo J, 2005, ANIM GENET, V36, P331, DOI 10.1111/j.1365-2052.2005.01310.x; Hiendleder S, 1998, J HERED, V89, P113, DOI 10.1093/jhered/89.2.113; Hiendleder S, 1998, J MOL EVOL, V47, P441, DOI 10.1007/PL00006401; Hiendleder S, 2002, P ROY SOC B-BIOL SCI, V269, P893, DOI 10.1098/rspb.2002.1975; Horsburgh KA, 2010, J ARCHAEOL SCI, V37, P2906, DOI 10.1016/j.jas.2010.06.035; IUCN/SSC Caprine Specialist Group, 2000, WORKSH CAPR TAX ANK; Kaya MA, 2004, MAMMALIA, V68, P229, DOI 10.1515/mamm.2004.022; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Meadows JRS, 2011, HEREDITY, V106, P700, DOI 10.1038/hdy.2010.122; Meadows JRS, 2009, ANIM GENET, V40, P119, DOI 10.1111/j.1365-2052.2008.01799.x; Meadows JRS, 2007, GENETICS, V175, P1371, DOI 10.1534/genetics.106.068353; Meadows JRS, 2005, J HERED, V96, P494, DOI 10.1093/jhered/esi100; Naderi S, 2008, P NATL ACAD SCI USA, V105, P17659, DOI 10.1073/pnas.0804782105; Olivieri C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033792; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pedrosa S, 2005, P ROY SOC B-BIOL SCI, V272, P2211, DOI 10.1098/rspb.2005.3204; Pereira F, 2006, MOL BIOL EVOL, V23, P1420, DOI 10.1093/molbev/msl007; Peter C, 2007, ANIM GENET, V38, P37, DOI 10.1111/j.1365-2052.2007.01561.x; POPLIN F, 1979, ANN GENET SEL ANIM, V11, P133, DOI 10.1186/1297-9686-11-2-133; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Rezaei HR, 2010, MOL PHYLOGENET EVOL, V54, P315, DOI 10.1016/j.ympev.2009.10.037; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rohland N, 2010, MOL ECOL RESOUR, V10, P677, DOI 10.1111/j.1755-0998.2009.02824.x; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schneider S, 1999, GENETICS, V152, P1079; SOKAL RR, 1978, BIOL J LINN SOC, V10, P199, DOI 10.1111/j.1095-8312.1978.tb00013.x; Sokal RR., 1979, STATISTICAL ECOLOGY, V695, P167; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapio M, 2006, MOL BIOL EVOL, V23, P1776, DOI 10.1093/molbev/msl043; Tapio M, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-76; Uerpmann HP, 1987, ANCIENT DISTRIBUTION; Wood NJ, 1996, ANIM GENET, V27, P25, DOI 10.1111/j.1365-2052.1996.tb01173.x; Yuncu E, 2013, SMALL RUMINANT RES, V114, P64, DOI 10.1016/j.smallrumres.2013.05.014; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zeder MA, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P181; Ziaie H., 1997, P49	54	63	65	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81952	10.1371/journal.pone.0081952	http://dx.doi.org/10.1371/journal.pone.0081952			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349158	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300062
J	Maatallah, M; Bakhrouf, A; Habeeb, MA; Turlej-Rogacka, A; Iversen, A; Pourcel, C; Sioud, O; Giske, CG				Maatallah, Makaoui; Bakhrouf, Amina; Habeeb, Muhammed Asif; Turlej-Rogacka, Agata; Iversen, Aina; Pourcel, Christine; Sioud, Olfa; Giske, Christian G.			Four Genotyping Schemes for Phylogenetic Analysis of Pseudomonas aeruginosa: Comparison of Their Congruence with Multi-Locus Sequence Typing	PLOS ONE			English	Article							TANDEM-REPEAT ANALYSIS; FIELD GEL-ELECTROPHORESIS; LOCUS VARIABLE-NUMBER; INTENSIVE-CARE-UNIT; POPULATION-STRUCTURE; BETA-LACTAMASE; STAPHYLOCOCCUS-AUREUS; MOLECULAR EPIDEMIOLOGY; DISCRIMINATORY POWER; EUROPEAN COUNTRIES	Several molecular typing schemes have been proposed to differentiate among isolates and clonal groups, and hence establish epidemiological or phylogenetic links. It has been widely accepted that multi-locus sequence typing (MLST) is the gold standard for phylogenetic typing/long-term epidemiological surveillance, but other recently described methods may be easier to carry out, especially in settings with limited access to DNA sequencing. Comparing the performance of such techniques to MLST is therefore of relevance. A study was therefore carried out with a collection of P. aeruginosa strains (n = 133) typed by four typing schemes: MLST, multiple-locus variable number tandem repeat analysis (MLVA), pulsed-field gel electrophoresis (PFGE) and the commercial DiversiLab microbial typing system (DL). The aim of this study was to compare the results of each typing method with MLST. The Simpson's indices of diversity were 0.989, 0.980, 0.961 and 0.906 respectively for PFGE, MLVA, DL and MLST. The congruence between techniques was measured by the adjusted Wallace index (W): this coefficient indicates the probability that a pair of isolates which is assigned to the same type by one typing method is also typed as identical by the other. In this context, the congruence between techniques was recorded as follow: MLVA-type to predict MLST-type (93%), PFGE to MLST (92%), DL to MLST (64.2%), PFGE to MLVA (63.5%) and PFGE to DL (61.7%). Conversely, for all above combinations, prediction was very poor. The congruence was increased at the clonal complex (CC) level. MLST is regarded the gold standard for phylogenetic classification of bacteria, but is rather laborious to carry out in many settings. Our data suggest that MLVA can predict the MLST-type with high accuracy, and even higher when studying the clonal complex level. Of the studied three techniques MLVA was therefore the best surrogate method to predict MLST.	[Maatallah, Makaoui; Bakhrouf, Amina] Fac Pharm, Lab Anal Traitement & Valorisat Polluants Environ, Monastir, Tunisia; [Habeeb, Muhammed Asif; Turlej-Rogacka, Agata; Iversen, Aina; Giske, Christian G.] Karolinska Univ Hosp Solna, MTC Karolinska Inst, Stockholm, Sweden; [Pourcel, Christine] Univ Paris 11, Inst Genet & Microbiol, F-91405 Orsay, France; [Pourcel, Christine] CNRS, F-91405 Orsay, France; [Sioud, Olfa] Lab Microbiol CHU Fattouma Bourguiba, Monastir, Tunisia	Universite de Monastir; Karolinska Institutet; Karolinska University Hospital; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Universite de Monastir; Hopital Fattouma Bourguiba	Giske, CG (corresponding author), Karolinska Univ Hosp Solna, MTC Karolinska Inst, Stockholm, Sweden.	christian.giske@karolinska.se	Pourcel, Christine/E-4949-2017	Pourcel, Christine/0000-0002-8951-466X	Karolinska University Hospital; Ministry of Higher Education and Scientific Research in Tunisia	Karolinska University Hospital(Karolinska Institutet); Ministry of Higher Education and Scientific Research in Tunisia	The work was financed through internal funding at Karolinska University Hospital and from the Ministry of Higher Education and Scientific Research in Tunisia. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Beres SB, 2010, P NATL ACAD SCI USA, V107, P4371, DOI 10.1073/pnas.0911295107; BLANC DS, 1993, J CLIN MICROBIOL, V31, P71, DOI 10.1128/JCM.31.1.71-77.1993; Boers SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039630; Botes J, 2003, J MICROBIOL METH, V55, P231, DOI 10.1016/S0167-7012(03)00156-8; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Chiou CS, 2010, EXPERT REV MOL DIAGN, V10, P5, DOI 10.1586/ERM.09.76; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Denoeud F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-4; Deplano A, 2011, J CLIN MICROBIOL, V49, P3616, DOI 10.1128/JCM.00528-11; Didelot X, 2009, SYST APPL MICROBIOL, V32, P81, DOI 10.1016/j.syapm.2009.01.001; Doleans-Jordheim A, 2009, EUR J CLIN MICROBIOL, V28, P1105, DOI 10.1007/s10096-009-0755-z; Duljasz W, 2009, ANTIMICROB AGENTS CH, V53, P2221, DOI 10.1128/AAC.01573-08; Empel J, 2007, J CLIN MICROBIOL, V45, P2829, DOI 10.1128/JCM.00997-07; Feil EJ, 2004, CURR OPIN MICROBIOL, V7, P308, DOI 10.1016/j.mib.2004.04.002; Finnan S, 2004, J CLIN MICROBIOL, V42, P5783, DOI 10.1128/JCM.42.12.5783-5792.2004; Fluit AC, 2010, J CLIN MICROBIOL, V48, P3979, DOI 10.1128/JCM.01191-10; Foxman Betsy, 2005, Epidemiol Perspect Innov, V2, P10, DOI 10.1186/1742-5573-2-10; Giske CG, 2012, ANTIMICROB AGENTS CH, V56, P2735, DOI 10.1128/AAC.06142-11; Giske CG, 2006, J CLIN MICROBIOL, V44, P4309, DOI 10.1128/JCM.00817-06; GRUNDMANN H, 1995, J CLIN MICROBIOL, V33, P528, DOI 10.1128/JCM.33.3.528-534.1995; Hall BG, 2006, ANN EPIDEMIOL, V16, P157, DOI 10.1016/j.annepidem.2005.04.010; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hasan CM, 2013, CLIN MICROBIOL INFEC, V147; Holmes EC, 1999, MICROBIOLOGY TODAY, V26, P162; Holt KE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-144; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Johnson JK, 2007, J CLIN MICROBIOL, V45, P3707, DOI 10.1128/JCM.00560-07; Joseph SJ, 2010, TRENDS BIOTECHNOL, V28, P611, DOI 10.1016/j.tibtech.2010.09.001; Juan C, 2010, J ANTIMICROB CHEMOTH, V65, P474, DOI 10.1093/jac/dkp491; Keim P, 2004, INFECT GENET EVOL, V4, P205, DOI 10.1016/j.meegid.2004.02.005; KERSULYTE D, 1995, J CLIN MICROBIOL, V33, P2216, DOI 10.1128/JCM.33.8.2216-2219.1995; KHAN AA, 1994, APPL ENVIRON MICROB, V60, P3739, DOI 10.1128/AEM.60.10.3739-3745.1994; Khan NH, 2007, MICROB ECOL, V53, P173, DOI 10.1007/s00248-006-9059-3; Kidd TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044199; Koh TH, 2010, J CLIN MICROBIOL, V48, P2563, DOI 10.1128/JCM.01905-09; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Kouda S, 2009, J ANTIMICROB CHEMOTH, V64, P46, DOI 10.1093/jac/dkp142; Kuroda M, 2010, J CLIN MICROBIOL, V48, P2821, DOI 10.1128/JCM.00137-10; Larche J, 2012, ANTIMICROB AGENTS CH, V56, P6175, DOI 10.1128/AAC.01233-12; Lepsanovic Z, 2008, ACTA MICROBIOL IMM H, V55, P447, DOI 10.1556/AMicr.55.2008.4.9; Lewis T, 2010, J HOSP INFECT, V75, P37, DOI 10.1016/j.jhin.2010.01.012; Libisch B, 2008, RES MICROBIOL, V159, P162, DOI 10.1016/j.resmic.2007.12.008; Lindstedt BA, 2013, EUROSURVEILLANCE, V18, P7; LOUTIT JS, 1991, J CLIN MICROBIOL, V29, P2897, DOI 10.1128/JCM.29.12.2897-2900.1991; Maatallah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025617; Mahenthiralingam E, 1996, J CLIN MICROBIOL, V34, P1129, DOI 10.1128/JCM.34.5.1129-1135.1996; Malachowa N, 2005, J CLIN MICROBIOL, V43, P3095, DOI 10.1128/JCM.43.7.3095-3100.2005; Minandri F, 2012, J CLIN MICROBIOL, V50, P590, DOI 10.1128/JCM.05555-11; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Morgan U, 2001, INFECT GENET EVOL, V1, P161, DOI 10.1016/S1567-1348(01)00023-5; Naze F, 2010, J CLIN MICROBIOL, V48, P3146, DOI 10.1128/JCM.00402-10; Obritsch MD, 2004, ANTIMICROB AGENTS CH, V48, P4606, DOI 10.1128/AAC.48.12.4606-4610.2004; Onteniente L, 2003, J CLIN MICROBIOL, V41, P4991, DOI 10.1128/JCM.41.11.4991-4997.2003; Panagea S, 2005, J HOSP INFECT, V59, P102, DOI 10.1016/j.jhin.2004.09.018; Pearson T, 2009, INFECT GENET EVOL, V9, P1010, DOI 10.1016/j.meegid.2009.05.014; PICARD B, 1994, J MED MICROBIOL, V40, P313, DOI 10.1099/00222615-40-5-313; Pirnay JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007740; Ratkai C, 2010, DIAGN MICR INFEC DIS, V67, P202, DOI 10.1016/j.diagmicrobio.2010.01.010; Read TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010595; Romling U, 2005, ENVIRON MICROBIOL, V7, P1029, DOI 10.1111/j.1462-2920.2005.00780.x; ROMLING U, 1994, APPL ENVIRON MICROB, V60, P1734; Romling U, 2000, J CLIN MICROBIOL, V38, P464; Sabat AJ, 2013, EUROSURVEILLANCE, V18, P17; Samuelsen O, 2009, ANTIMICROB AGENTS CH, V54, P346; Silva FM, 2011, MICROB DRUG RESIST, V17, P215, DOI 10.1089/mdr.2010.0140; Smyth DS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008582; Sobral D, 2012, EUR J CLIN MICROBIOL, V31, P2247, DOI 10.1007/s10096-012-1562-5; Speijer H, 1999, J CLIN MICROBIOL, V37, P3654, DOI 10.1128/JCM.37.11.3654-3661.1999; Syrmis MW, 2004, J MED MICROBIOL, V53, P1089, DOI 10.1099/jmm.0.45611-0; Tenover FC, 1997, INFECT CONT HOSP EP, V18, P426; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Trautmann M, 2005, AM J INFECT CONTROL, V33, pS41, DOI 10.1016/j.ajic.2005.03.006; Turton JF, 2010, CLIN MICROBIOL INFEC, V16, P1111, DOI 10.1111/j.1469-0691.2009.03049.x; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; van Mansfeld R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013482; Viedma E, 2009, ANTIMICROB AGENTS CH, V53, P4930, DOI 10.1128/AAC.00900-09; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vu-Thien H, 2007, J CLIN MICROBIOL, V45, P3175, DOI 10.1128/JCM.00702-07; Wang YW, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-278; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Witte W SB, 2006, GRAM POSITIVE PATHOG	84	30	31	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82069	10.1371/journal.pone.0082069	http://dx.doi.org/10.1371/journal.pone.0082069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349186	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300073
J	Yuan, JL; Yue, JJ; Wu, XL; Gu, XP				Yuan, Jin-Ling; Yue, Jin-Jun; Wu, Xiao-Li; Gu, Xiao-Ping			Protocol for Callus Induction and Somatic Embryogenesis in Moso Bamboo	PLOS ONE			English	Article							DENDROCALAMUS-HAMILTONII; PLANT-REGENERATION; BAMBUSA-EDULIS; MUNRO; ORGANOGENESIS; CULTURE	Moso bamboo [Phyllostachys heterocycla var. pubescens (Mazel ex J. Houz.) Ohwi] is one of the most important forest crops in China and the rest of Asia. Although many sympodial bamboo tissue culture protocols have been established, there is no protocol available for plantlet regeneration as indicated by callus induction for monopodial bamboos, such as Moso bamboo. In the present report, embryogenic callus induction, embryoid development, and germination were established for Moso bamboo from zygotic seed embryos. Callus was initiated from zygotic embryos after 10-20 d culture on MS media supplemented with 4.0 mg/L 2, 4-D and 0.1 mg/L zeatin (ZT). About 50% of the explants produced calli, and nearly 15% of the calli were found to be embryogenic in nature. These embryogenic calli can be subcultured for proliferation in the Murashige and Skoog media (MS) supplemented with 0.5-2.0 mg/L 2, 4-D. These calli were found to have maintained their capacity for regeneration even after one year of subculture. The viable somatic embryoids regenerated in medium containing 5.0-7.0 mg/L ZT. Nearly 5% of the calli were found capable of regenerating into plantlets directly in MS medium containing 5.0-7.0 mg/L ZT. Root growth was more pronounced when the plantlets were transferred to medium containing 2.0 mg/L NAA. After 30 days of subculture, the plantlets were transferred to a greenhouse.	[Yuan, Jin-Ling; Yue, Jin-Jun; Wu, Xiao-Li; Gu, Xiao-Ping] Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang, Zhejiang, Peoples R China	Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Gu, XP (corresponding author), Chinese Acad Forestry, Res Inst Subtrop Forestry, Fuyang, Zhejiang, Peoples R China.	guxpzj@163.com			State Forestry Administration of the People's Republic of China [948 (2011-4-49)]; Key Science and Technique Item of Zhejiang Province, Wood and Bamboo Breeding [2012C12908-3]; Natural Science Foundation of Zhejiang Province [LQ12C16006]	State Forestry Administration of the People's Republic of China; Key Science and Technique Item of Zhejiang Province, Wood and Bamboo Breeding; Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This research was supported by State Forestry Administration of the People's Republic of China, Project 948 (2011-4-49); Key Science and Technique Item of Zhejiang Province, Wood and Bamboo Breeding (2012C12908-3); Natural Science Foundation of Zhejiang Province (LQ12C16006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHAMBERS SM, 1991, PLANT CELL TISS ORG, V27, P45, DOI 10.1007/BF00048205; DUNCAN DB, 1955, BIOMETRICS, V11, P1, DOI 10.2307/3001478; Flachowsky H, 2009, PLANT BREEDING, V128, P217, DOI 10.1111/j.1439-0523.2008.01591.x; Fu J., 2001, BAMBOO, V22, P5; Gillis K, 2007, PLANT CELL TISS ORG, V91, P115, DOI 10.1007/s11240-007-9236-1; Godbole S, 2002, CURR SCI INDIA, V83, P885; Han WJ, 2004, J HUNAN FOR SCI TECH, V31, P4; Hassan A., 1987, PLANT CELL TISSUE OR, V10, P73; HUANG LC, 1989, ENVIRON EXP BOT, V29, P307, DOI 10.1016/0098-8472(89)90004-X; Isagi Y, 2004, MOL ECOL, V13, P2017, DOI 10.1111/j.1365-294X.2004.02197.x; Kumar, 2010, J FOOD LEGUMES, V23, P169; Lai CC, 1997, BOT BULL ACAD SINICA, V38, P145; Li Nan, 2009, Journal of Zhejiang Forestry Science and Technology, V29, P73; Lin CS, 2007, NEW FOREST, V34, P177, DOI 10.1007/s11056-007-9045-8; Lin CS, 2004, PLANT CELL TISS ORG, V76, P75, DOI 10.1023/A:1025848016557; Lin CS, 2003, PLANT CELL TISS ORG, V72, P71, DOI 10.1023/A:1021281217589; Lo TY, 2005, ENGINE STRUC, V27, P61; MCCLURE FA, 1925, LINGNAN AGR REV, V3, P40; Mehta U., 1982, P 1982 5 INT C PLANT, P109, DOI [10.1078/0176-1617-01219, DOI 10.1078/0176-1617-01219]; Ogita S, 2011, PLANT BIOTECHNOL, V28, P119; Ogita S, 2005, PLANT BIOTECHNOLOGY, V22, P119, DOI DOI 10.5511/plantbiotechnology.22.119; RAO IU, 1985, PLANT CELL REP, V4, P191, DOI 10.1007/BF00269286; ROUT GR, 1994, PLANT CELL REP, V13, P683, DOI 10.1007/BF00231624; Scurlock JMO, 2000, BIOMASS BIOENERG, V19, P229, DOI 10.1016/S0961-9534(00)00038-6; TSAY HS, 1990, PLANT CELL REP, V9, P349, DOI 10.1007/BF00232396; YEH ML, 1986, PLANT CELL REP, V5, P409, DOI 10.1007/BF00269628; Yuan JL, 2009, SCI SILVAE SINICA, V45, P38; Zhang N, 2010, PLANT CELL TISS ORG, V103, P325, DOI 10.1007/s11240-010-9783-8; Zhou H, 2005, J HUNAN SCI TECH, V32, P41	29	9	14	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81954	10.1371/journal.pone.0081954	http://dx.doi.org/10.1371/journal.pone.0081954			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349159	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300063
J	Jennings, DE; Gould, JR; Vandenberg, JD; Duan, JJ; Shrewsbury, PM				Jennings, David E.; Gould, Juli R.; Vandenberg, John D.; Duan, Jian J.; Shrewsbury, Paula M.			Quantifying the Impact of Woodpecker Predation on Population Dynamics of the Emerald Ash Borer (Agrilus planipennis)	PLOS ONE			English	Article							COLEOPTERA BUPRESTIDAE; HYMENOPTERA EULOPHIDAE; PARASITOIDS ATTACKING; FORAGING ECOLOGY; NORTH-AMERICAN; BIOTIC FACTORS; NESTING BIRDS; INVASION; SUCCESS; WESTERN	The emerald ash borer (EAB), Agrilus planipennis, is an invasive beetle that has killed millions of ash trees (Fraxinus spp.) since it was accidentally introduced to North America in the 1990s. Understanding how predators such as woodpeckers (Picidae) affect the population dynamics of EAB should enable us to more effectively manage the spread of this beetle, and toward this end we combined two experimental approaches to elucidate the relative importance of woodpecker predation on EAB populations. First, we examined wild populations of EAB in ash trees in New York, with each tree having a section screened to exclude woodpeckers. Second, we established experimental cohorts of EAB in ash trees in Maryland, and the cohorts on half of these trees were caged to exclude woodpeckers. The following spring these trees were debarked and the fates of the EAB larvae were determined. We found that trees from which woodpeckers were excluded consistently had significantly lower levels of predation, and that woodpecker predation comprised a greater source of mortality at sites with a more established wild infestation of EAB. Additionally, there was a considerable difference between New York and Maryland in the effect that woodpecker predation had on EAB population growth, suggesting that predation alone may not be a substantial factor in controlling EAB. In our experimental cohorts we also observed that trees from which woodpeckers were excluded had a significantly higher level of parasitism. The lower level of parasitism on EAB larvae found when exposed to woodpeckers has implications for EAB biological control, suggesting that it might be prudent to exclude woodpeckers from trees when attempting to establish parasitoid populations. Future studies may include utilizing EAB larval cohorts with a range of densities to explore the functional response of woodpeckers.	[Jennings, David E.; Shrewsbury, Paula M.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Gould, Juli R.] Anim & Plant Hlth Inspect Serv, USDA, Ctr Plant Hlth Sci & Technol, Buzzards Bay, MA USA; [Vandenberg, John D.] ARS, USDA, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA; [Duan, Jian J.] ARS, USDA, Beneficial Insects Intro Res Unit, Newark, DE USA	University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Jennings, DE (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	dejennin@umd.edu		Jennings, David/0000-0001-7179-3069	USDA-ARS [58-1926-1-167]; University of Maryland	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); University of Maryland	This research was supported by the USDA-ARS under the Specific Cooperative Agreement (#58-1926-1-167) with the University of Maryland. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anulewicz Andrea C., 2007, Arboriculture & Urban Forestry, V33, P338; Bauer LS, 2005, P EM ASH BOR RES TEC, P71; Bauer LS, 2004, P EM ASH BOR RES TEC, V2004-02, P8; Burr SJ, 2012, P EM ASH BOR RES TEC, P57; Cappaert D, 2005, P EM ASH BOR RES TEC, P69; Cappaert David, 2005, American Entomologist, V51, P152; Chamorro ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033185; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; CONNER RN, 1994, WILSON BULL, V106, P242; CONNER RN, 1975, J WILDLIFE MANAGE, V39, P144, DOI 10.2307/3800477; DICKSON JG, 1983, J WILDLIFE MANAGE, V47, P799, DOI 10.2307/3808615; Duan JJ, 2009, FLA ENTOMOL, V92, P588, DOI 10.1653/024.092.0409; Duan JJ, 2013, J ECON ENTOMOL, V106, P1145, DOI 10.1603/EC13047; Duan JJ, 2013, FLA ENTOMOL, V96, P166, DOI 10.1653/024.096.0122; Duan JJ, 2012, ENVIRON ENTOMOL, V41, P245, DOI 10.1603/EN11318; Duan JJ, 2012, BIOCONTROL, V57, P199, DOI 10.1007/s10526-011-9408-0; Duan JJ, 2011, FLA ENTOMOL, V94, P933, DOI 10.1653/024.094.0430; Duan JJ, 2010, ENVIRON ENTOMOL, V39, P1513, DOI 10.1603/EN10023; Edworthy AB, 2011, FOREST ECOL MANAG, V261, P203, DOI 10.1016/j.foreco.2010.10.006; Fayt P, 2005, FOREST ECOL MANAG, V206, P1, DOI 10.1016/j.foreco.2004.10.054; Fox J., 2019, R COMPANION APPL REG, V.; Gould JR, 2005, P EM ASH BOR RES TEC, P73; HARCOMBE PA, 1987, BIOSCIENCE, V37, P557, DOI 10.2307/1310666; HASSELL MP, 1985, J ANIM ECOL, V54, P323, DOI 10.2307/4641; Hawkins BA, 1997, ECOLOGY, V78, P2145, DOI 10.1890/0012-9658(1997)078[2145:PPAPAM]2.0.CO;2; JACKSON JA, 1970, ECOLOGY, V51, P318, DOI 10.2307/1933671; Jiao Zhen-Biao, 2008, Acta Zoologica Sinica, V54, P1106; Koenig WD, 2013, BIOL INVASIONS, V15, P2095, DOI 10.1007/s10530-013-0435-x; Kovacs KF, 2010, ECOL ECON, V69, P569, DOI 10.1016/j.ecolecon.2009.09.004; Levin L, 1996, ECOL APPL, V6, P1295, DOI 10.2307/2269608; LI PJ, 1991, AUK, V108, P405; Lindell CA, 2008, AM MIDL NAT, V159, P434, DOI 10.1674/0003-0031(2008)159[434:FIWPOE]2.0.CO;2; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Nielsen AL, 2008, ENVIRON ENTOMOL, V37, P348, DOI 10.1603/0046-225X(2008)37[348:DREALT]2.0.CO;2; Parker IM, 2000, ECOL APPL, V10, P726, DOI 10.1890/1051-0761(2000)010[0726:IDOCSA]2.0.CO;2; Poland TM, 2006, J FOREST, V104, P118; R Core Team, 2012, R LANG ENV STAT COMP; Rebek EJ, 2008, ENVIRON ENTOMOL, V37, P242, DOI 10.1603/0046-225X(2008)37[242:IVIRTE]2.0.CO;2; Smith A., 2006, THESIS OHIO STATE U; Southwood R., 2000, ECOLOGICAL METHODS; Venables WN., 2002, MODERN APPL STAT S 4; Wang XY, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.12801; Yang ZQ, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.3001	43	25	28	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e83491	10.1371/journal.pone.0083491	http://dx.doi.org/10.1371/journal.pone.0083491			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349520	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200129
J	Punab, M; Kullisaar, T; Mandar, R				Punab, Margus; Kullisaar, Tiiu; Maendar, Reet			Male Infertility Workup Needs Additional Testing of Expressed Prostatic Secretion and/or Post-Massage Urine	PLOS ONE			English	Article							OXIDATIVE STRESS; SEMEN; MEN; F-2-ISOPROSTANES; ASSOCIATION	The male factor accounts for almost 50% of infertility cases. Inflammation may reduce semen quality via several pathways, including oxidative stress (OxS). As male infertility routinely is assessed using semen analysis only, the possible presence of non-leukocytospermic asymptomatic inflammatory prostatitis may be overlooked. We compared local and systemic OxS levels in male partners of infertile couples with different inflammation patterns in their genital tract and/or oligospermia. Subjects (n=143) were grouped according to inflammation in their semen, expressed prostatic secretion (EPS), and/or post-massage urine (post-M). Systemic (8-isoprostanes in urine) and local (diene conjugates and total antioxidant capacity in seminal plasma) OxS was measured The levels of OxS markers were significantly elevated in both severe inflammation groups - leukocytospermic men and subjects whose inflammation was limited only to EPS and/or post-M. Comparison between oligospermic and non-oligospermic men with genital tract inflammation, and oligozoospermic men with or without inflammation in the genital tract indicated that inflammation but not oligospermia status had significant impact on the measured OxS markers. Hence, a high leukocyte count in prostate-specific materials (EPS, post-M), even in absence of clear leukocytopsermia, is an important source of local and systemic OxS that may be associated with male infertility and affect general health. We suggest including the tests for detection of inflammation of the prostate into the workup of infertile men as was suggested in the WHO 1993 recommendation.	[Punab, Margus] Tartu Univ Hosp, Androl Ctr, Tartu, Estonia; [Kullisaar, Tiiu] Univ Tartu, Dept Biochem, EE-50090 Tartu, Estonia; [Maendar, Reet] Univ Tartu, Dept Microbiol, EE-50090 Tartu, Estonia	University of Tartu; University of Tartu	Mandar, R (corresponding author), Univ Tartu, Dept Microbiol, Ulikooli 18, EE-50090 Tartu, Estonia.	reet.mandar@ut.ee	Mändar, Reet/AAL-9685-2020; Mändar, Reet/J-9246-2012	Mändar, Reet/0000-0002-9747-3618; Punab, Margus/0000-0001-9601-6311	Estonian Science Foundation [8022]; Estonian Ministry of Education and Research [SF0180132s08]	Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This study was supported by Estonian Science Foundation (grant no. 8022) and by Estonian Ministry of Education and Research (target financing no. SF0180132s08) - regular financing of academic research (including salary for researchers and technicians and cost of laboratory materials). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal Ashok, 2011, J Indian Med Assoc, V109, P184; Agarwal A, 2010, HUM FERTIL, V13, P217, DOI 10.3109/14647273.2010.532279; Aitken RJ, 2010, HUM REPROD, V25, P2415, DOI 10.1093/humrep/deq214; AITKEN RJ, 1990, INT J ANDROL, V13, P433, DOI 10.1111/j.1365-2605.1990.tb01051.x; [Anonymous], 1995, NAT I HLTH NAT I DIA; Basu S, 2008, ANTIOXID REDOX SIGN, V10, P1405, DOI 10.1089/ars.2007.1956; Gharagozloo P, 2011, HUM REPROD, V26, P1628, DOI 10.1093/humrep/der132; Hamada A, 2012, INT BRAZ J UROL, V38, P576, DOI 10.1590/S1677-55382012000500002; Henkel R, 2005, FERTIL STERIL, V83, P635, DOI 10.1016/j.fertnstert.2004.11.022; Henkel RR, 2011, ASIAN J ANDROL, V13, P43, DOI 10.1038/aja.2010.76; Jungwirth A, 2012, EUR UROL, V62, P324, DOI 10.1016/j.eururo.2012.04.048; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Kullisaar T, 2008, ANDROLOGIA, V40, P161, DOI 10.1111/j.1439-0272.2007.00816.x; Kullisaar T, 2012, PROSTATE, V72, P977, DOI 10.1002/pros.21502; Lavranos G, 2012, REPROD TOXICOL, V34, P298, DOI 10.1016/j.reprotox.2012.06.007; Ludwig M, 2003, ANDROLOGIA, V35, P152, DOI 10.1046/j.1439-0272.2003.00553.x; Mandar R, 2013, ANDROLOGY-US, V1, P464, DOI 10.1111/j.2047-2927.2012.00052.x; Morrow JD, 2006, CURR PHARM DESIGN, V12, P895, DOI 10.2174/138161206776055985; Pasqualotto FF, 2000, UROLOGY, V55, P881, DOI 10.1016/S0090-4295(99)00613-5; Pelliccione F, 2009, INT J ANDROL, V32, P623, DOI 10.1111/j.1365-2605.2008.00909.x; Punab M, 2003, ANDROLOGIA, V35, P271, DOI 10.1046/j.1439-0272.2003.00555.x; Rowe PJ., 1993, WHO MANUAL STANDARDI; Tremellen K, 2010, INT J ANDROL, V33, P823, DOI 10.1111/j.1365-2605.2009.01037.x; Turk S, 2011, MED HYPOTHESES, V77, P837, DOI 10.1016/j.mehy.2011.07.050; World Health Organization, 1999, WHO LAB MAN EX HUM S; Zhang ZJ, 2013, ANN CLIN BIOCHEM, V50, P108, DOI 10.1258/acb.2012.011263; Zorn B, 2010, REPROD BIOMED ONLINE, V21, P84, DOI 10.1016/j.rbmo.2010.03.016	27	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82776	10.1371/journal.pone.0082776	http://dx.doi.org/10.1371/journal.pone.0082776			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349358	Green Published, gold			2022-12-27	WOS:000328705200099
J	Song, XW; Wang, YJ; Tang, YZ				Song, Xiaowei; Wang, Yajun; Tang, Yezhong			Rapid Diversification of FoxP2 in Teleosts through Gene Duplication in the Teleost-Specific Whole Genome Duplication Event	PLOS ONE			English	Article							SEVERE SPEECH; EVOLUTION; LANGUAGE; EXPRESSION; ALIGNMENT; PHYLOGENIES; GENERATION; KNOCKDOWN; INFERENCE; SITES	As one of the most conserved genes in vertebrates, FoxP2 is widely involved in a number of important physiological and developmental processes. We systematically studied the evolutionary history and functional adaptations of FoxP2 in teleosts. The duplicated FoxP2 genes (FoxP2a and FoxP2b), which were identified in teleosts using synteny and paralogon analysis on genome databases of eight organisms, were probably generated in the teleost-specific whole genome duplication event. A credible classification with FoxP2, FoxP2a and FoxP2b in phylogenetic reconstructions confirmed the teleost-specific FoxP2 duplication. The unavailability of FoxP2b in Danio rerio suggests that the gene was deleted through nonfunctionalization of the redundant copy after the Otocephala-Euteleostei split. Heterogeneity in evolutionary rates among clusters consisting of FoxP2 in Sarcopterygii (Cluster 1), FoxP2a in Teleostei (Cluster 2) and FoxP2b in Teleostei (Cluster 3), particularly between Clusters 2 and 3, reveals asymmetric functional divergence after the gene duplication. Hierarchical cluster analyses of hydrophobicity profiles demonstrated significant structural divergence among the three clusters with verification of subsequent stepwise discriminant analysis, in which FoxP2 of Leucoraja erinacea and Lepisosteus oculatus were classified into Cluster 1, whereas FoxP2b of Salmo salar was grouped into Cluster 2 rather than Cluster 3. The simulated thermodynamic stability variations of the forkhead box domain (monomer and homodimer) showed remarkable divergence in FoxP2, FoxP2a and FoxP2b clusters. Relaxed purifying selection and positive Darwinian selection probably were complementary driving forces for the accelerated evolution of FoxP2 in ray-finned fishes, especially for the adaptive evolution of FoxP2a and FoxP2b in teleosts subsequent to the teleost-specific gene duplication.	[Song, Xiaowei; Tang, Yezhong] Chinese Acad Sci, Chengdu Inst Biol, Dept Herpetol, Chengdu, Sichuan, Peoples R China; [Song, Xiaowei; Wang, Yajun] Sichuan Univ, Coll Life Sci, Chengdu 610064, Sichuan, Peoples R China; [Song, Xiaowei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Sichuan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, YJ (corresponding author), Sichuan Univ, Coll Life Sci, Chengdu 610064, Sichuan, Peoples R China.	cdwyjhk@gmail.com; tangyz@cib.ac.cn	Song, Xiaowei/ABA-5026-2021	Song, Xiaowei/0000-0001-6146-3381; Song, Xiaowei/0000-0002-0632-4220	Chinese Academy of Sciences [KSCX2-YW-R-077]; National Natural Science Foundation of China [NSFC 31272304]; NSFC [31172202]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC(National Natural Science Foundation of China (NSFC))	Funding came from the Chinese Academy of Sciences Bairen Jihua (KSCX2-YW-R-077) and the National Natural Science Foundation of China (NSFC 31272304) to YZT and NSFC 31172202 to YJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bonkowsky JL, 2005, DEV DYNAM, V234, P740, DOI 10.1002/dvdy.20504; Bonkowsky Joshua L, 2008, BMC Dev Biol, V8, P103, DOI 10.1186/1471-213X-8-103; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Daniels CB, 2004, PHYSIOL BIOCHEM ZOOL, V77, P732, DOI 10.1086/422058; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fisher SE, 2006, NAT REV GENET, V7, P9, DOI 10.1038/nrg1747; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Frazer KA, 2003, GENOME RES, V13, P1, DOI 10.1101/gr.222003; Gaub S, 2010, GENES BRAIN BEHAV, V9, P390, DOI 10.1111/j.1601-183X.2010.00570.x; Gregory T. R., 2011, EVOLUTION GENOME; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Itakura T, 2008, J BIOCHEM, V143, P407, DOI 10.1093/jb/mvm235; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Li G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000900; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; NORSWORTHY M, 2011, NOVEL EXPRESSION SIT; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scharff C, 2011, PHILOS T R SOC B, V366, P2124, DOI 10.1098/rstb.2011.0001; Schon C, 2006, DEV GENES EVOL, V216, P641, DOI 10.1007/s00427-006-0073-8; Schulz SB, 2010, GENES BRAIN BEHAV, V9, P732, DOI 10.1111/j.1601-183X.2010.00607.x; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shah R, 2006, INT J DEV BIOL, V50, P435, DOI 10.1387/ijdb.052065rs; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Spiteri E, 2007, AM J HUM GENET, V81, P1144, DOI 10.1086/522237; Takahashi H, 2009, ADV EXP MED BIOL, V665, P117; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Webb DM, 2005, J HERED, V96, P212, DOI 10.1093/jhered/esi025; Wood TC, 1999, J MOL BIOL, V291, P977, DOI 10.1006/jmbi.1999.2972; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang Z, 2010, LIFE SCI, V87, P17, DOI 10.1016/j.lfs.2010.05.009; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018431; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang JZ, 2002, GENETICS, V162, P1825; Zheng WL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024019	60	6	6	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e83858	10.1371/journal.pone.0083858	http://dx.doi.org/10.1371/journal.pone.0083858			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349554	gold, Green Submitted, Green Published			2022-12-27	WOS:000328705200136
J	Boeker, M; Andel, P; Vach, W; Frankenschmidt, A				Boeker, Martin; Andel, Peter; Vach, Werner; Frankenschmidt, Alexander			Game-Based E-Learning Is More Effective than a Conventional Instructional Method: A Randomized Controlled Trial with Third-Year Medical Students	PLOS ONE			English	Article							ONLINE SPACED-EDUCATION; INSTRUMENTAL VARIABLES; PHYSICIAN; UROLOGY; TEACH; WANTS; TOOL	Background: When compared with more traditional instructional methods, Game-based e-learning (GbEl) promises a higher motivation of learners by presenting contents in an interactive, rule-based and competitive way. Most recent systematic reviews and meta-analysis of studies on Game-based learning and GbEl in the medical professions have shown limited effects of these instructional methods. Objectives: To compare the effectiveness on the learning outcome of a Game-based e-learning (GbEl) instruction with a conventional script-based instruction in the teaching of phase contrast microscopy urinalysis under routine training conditions of undergraduate medical students. Methods: A randomized controlled trial was conducted with 145 medical students in their third year of training in the Department of Urology at the University Medical Center Freiburg, Germany. 82 subjects where allocated for training with an educational adventure-game (GbEl group) and 69 subjects for conventional training with a written script-based approach (script group). Learning outcome was measured with a 34 item single choice test. Students' attitudes were collected by a questionnaire regarding fun with the training, motivation to continue the training and self-assessment of acquired knowledge. Results: The students in the GbEl group achieved significantly better results in the cognitive knowledge test than the students in the script group: the mean score was 28.6 for the GbEl group and 26.0 for the script group of a total of 34.0 points with a Cohen's d effect size of 0.71 (ITT analysis). Attitudes towards the recent learning experience were significantly more positive with GbEl. Students reported to have more fun while learning with the game when compared to the script-based approach. Conclusions: Game-based e-learning is more effective than a script-based approach for the training of urinalysis in regard to cognitive learning outcome and has a high positive motivational impact on learning. Game-based e-learning can be used as an effective teaching method for self-instruction.	[Boeker, Martin; Vach, Werner] Univ Med Ctr Freiburg, Dept Med Biometry & Med Informat, Freiburg, Baden Wurttembe, Germany; [Andel, Peter] Ctr Sanda, Maria, Grisons, Switzerland; [Frankenschmidt, Alexander] Univ Med Ctr Freiburg, Dept Urol, Freiburg, Baden Wurttembe, Germany	University of Freiburg; University of Freiburg	Boeker, M (corresponding author), Univ Med Ctr Freiburg, Dept Med Biometry & Med Informat, Freiburg, Baden Wurttembe, Germany.	martin.boeker@uniklinik-freiburg.de	Boeker, Martin/N-3854-2016; Vach, Werner/F-2512-2011	Boeker, Martin/0000-0003-2972-2042; Vach, Werner/0000-0003-1865-8399; Andel, Peter Michael/0000-0002-6176-4165	German Research Foundation; Albert Ludwigs University Freiburg	German Research Foundation(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	The article processing charge was funded by the German Research Foundation and the Albert Ludwigs University Freiburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admiraal W, 2011, COMPUT HUM BEHAV, V27, P1185, DOI 10.1016/j.chb.2010.12.013; Adventure game, 2012, ADV GAM; Akl EA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006411.pub2; Akl EA, 2010, MED TEACH, V32, P16, DOI 10.3109/01421590903473969; American Urological Association, 2013, AUA ED AM UROLOGICAL; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Begg M, 2008, MED TEACH, V30, P155, DOI 10.1080/01421590701874041; Bhoopathi PS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001471.pub2; Blakely G, 2009, J ADV NURS, V65, P259, DOI 10.1111/j.1365-2648.2008.04843.x; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Boeker M, 2009, GMS MED INFORM BIOM, V5, pDoc03, DOI [10.3205/mibe000082, DOI 10.3205/MIBE000082]; Cook DA, 2005, ACAD MED, V80, P541, DOI 10.1097/00001888-200506000-00005; dead:code, 2010, WINT ENG; DEDOMBAL FT, 1969, BRIT J SURG, V56, P625; Fukuchi SG, 2000, AM J SURG, V179, P337, DOI 10.1016/S0002-9610(00)00339-1; Girard C, 2013, J COMPUT ASSIST LEAR, V29, P207, DOI 10.1111/j.1365-2729.2012.00489.x; Greenland S, 2000, INT J EPIDEMIOL, V29, P722, DOI 10.1093/ije/29.4.722; Gros B, 2007, ENV J RES TECHNOLOGY, V40; Howard MG, 2002, ADV PHYSIOL EDUC, V26, P30, DOI 10.1152/advan.00014.2001; Hudson JN, 2006, ADV PHYSIOL EDUC, V30, P33, DOI 10.1152/advan.00040.2005; Kaupins G, 2005, USING POPULAR GAME R; Kerfoot BP, 2007, J UROLOGY, V177, P1481, DOI 10.1016/j.juro.2006.11.074; Kerfoot BP, 2012, ACAD MED, V87, P1443, DOI 10.1097/ACM.0b013e318267743a; Kerfoot BP, 2009, AM J SURG, V197, P89, DOI 10.1016/j.amjsurg.2007.10.026; Kern D, 1998, CURRICULUM DEV MED E; Lin Chao-Cheng, 2005, AMIA Annu Symp Proc, P1032; Mann BD, 2002, AM J SURG, V183, P305, DOI 10.1016/S0002-9610(02)00800-0; Da Rosa ACM, 2006, EDUC HEALTH, V19, P14, DOI 10.1080/13576280500524330; Mitchell A., 2004, USE COMPUTER VIDEO G; Moher D, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c869; Moy JR, 2000, ADV PHYSIOL EDUC, V24, P30, DOI 10.1152/advances.2000.24.1.30; O'Leary S, 2005, AM J OBSTET GYNECOL, V193, P1848, DOI 10.1016/j.ajog.2005.07.059; Parker CL, 2005, PUBLIC HEALTH REP, V120, P504, DOI 10.1177/003335490512000505; Rondon S, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-30; Salen K., 2003, RULES PLAY GAME DESI; Schuwirth L, 2005, PRACTICAL GUIDE MED, P311; SCHWARTZMAN R, 1997, EDUCATION, V118, P9; Seabra D, 2004, J UROLOGY, V171, P1220, DOI 10.1097/01.ju.0000114303.17198.37; Sealover Pamela, 2005, Nurse Educ, V30, P247, DOI 10.1097/00006223-200511000-00008; Sussman JB, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2073; Tietze KJ, 2007, AM J PHARM EDUC, V71, DOI 10.5688/aj710479; Vogel JJ, 2006, J RES TECHNOL EDUC, V39, P105, DOI 10.1080/15391523.2006.10782475; Woermann U, 2006, Ther Umsch, V63, P575, DOI 10.1024/0040-5930.63.9.575	43	69	71	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82328	10.1371/journal.pone.0082328	http://dx.doi.org/10.1371/journal.pone.0082328			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273WD	24349257	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100099
J	Qian, LY; Yuan, FH; Rodriguez-Tello, P; Padgaonkar, S; Zhang, YB				Qian, Liangyue; Yuan, Fenghua; Rodriguez-Tello, Paola; Padgaonkar, Suyog; Zhang, Yanbin			Human Fanconi Anemia Complementation Group A Protein Stimulates the 5 ' Flap Endonuclease Activity of FEN1	PLOS ONE			English	Article							CALF RTH-1 NUCLEASE; DNA-REPLICATION; OKAZAKI FRAGMENTS; TNF-ALPHA; REPAIR; EXCISION; COMPLEX; GENE; MUTATIONS; PATHWAYS	In eukaryotic cells, Flap endonuclease 1 (FEN1) is a major structure-specific endonuclease that processes 5' flapped structures during maturation of lagging strand DNA synthesis, long patch base excision repair, and rescue of stalled replication forks. Here we report that fanconi anemia complementation group A protein (FANCA), a protein that recognizes 5' flap structures and is involved in DNA repair and maintenance of replication forks, constantly stimulates FEN1-mediated incision of both DNA and RNA flaps. Kinetic analyses indicate that FANCA stimulates FEN1 by increasing the turnover rate of FEN1 and altering its substrate affinity. More importantly, six pathogenic FANCA mutants are significantly less efficient than the wild-type at stimulating FEN1 endonuclease activity, implicating that regulation of FEN1 by FANCA contributes to the maintenance of genomic stability.	[Qian, Liangyue; Yuan, Fenghua; Rodriguez-Tello, Paola; Padgaonkar, Suyog; Zhang, Yanbin] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA	University of Miami	Zhang, YB (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA.	yzhang4@med.miami.edu	Zhang, Yanbin/F-2998-2011	Zhang, Yanbin/0000-0002-7263-5510; Padgaonkar, Suyog/0000-0002-0910-3407	National Institutes of Health [R01HL105631]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a National Institutes of Health grant R01HL105631 to YZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi D, 2002, HUM MOL GENET, V11, P3125, DOI 10.1093/hmg/11.25.3125; Auerbach AD, 2009, MUTAT RES-FUND MOL M, V668, P4, DOI 10.1016/j.mrfmmm.2009.01.013; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; BENITEZ A, 2013, NUCLEIC ACIDS RES, P70812; Bogliolo M, 2013, AM J HUM GENET, V92, P800, DOI 10.1016/j.ajhg.2013.04.002; Briot D, 2008, BLOOD, V111, P1913, DOI 10.1182/blood-2007-07-099218; Brosh RM, 2002, BIOCHEMISTRY-US, V41, P12204, DOI 10.1021/bi026031j; Cho IT, 2009, J BIOL CHEM, V284, P10387, DOI 10.1074/jbc.M808893200; de Winter JP, 2009, MUTAT RES-FUND MOL M, V668, P11, DOI 10.1016/j.mrfmmm.2008.11.004; DeMott MS, 1996, J BIOL CHEM, V271, P30068, DOI 10.1074/jbc.271.47.30068; Dianova II, 2001, BIOCHEMISTRY-US, V40, P12639, DOI 10.1021/bi011117i; Dorsman JC, 2007, CELL ONCOL, V29, P211; DU W, 2013, BLOOD CELLS MOL DIS; Dufour C, 2003, BLOOD, V102, P2053, DOI 10.1182/blood-2003-01-0114; Fisher LA, 2008, J BIOL CHEM, V283, P1275, DOI 10.1074/jbc.M708072200; Garg P, 2004, GENE DEV, V18, P2764, DOI 10.1101/gad.1252304; Gary R, 1999, J BIOL CHEM, V274, P4354, DOI 10.1074/jbc.274.7.4354; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Huang L, 1996, BIOCHEMISTRY-US, V35, P9266, DOI 10.1021/bi9603074; Imamura O, 2003, P NATL ACAD SCI USA, V100, P8193, DOI 10.1073/pnas.1431624100; Kee Y, 2012, J CLIN INVEST, V122, P3799, DOI 10.1172/JCI58321; Kim K, 1998, J BIOL CHEM, V273, P8842, DOI 10.1074/jbc.273.15.8842; Kim Y, 2013, BLOOD, V121, P54, DOI 10.1182/blood-2012-07-441212; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; Levitus M, 2006, CELL ONCOL, V28, P3; Levran O, 2005, HUM MUTAT, V25, P142, DOI 10.1002/humu.20125; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Liu R, 2006, NUCLEIC ACIDS RES, V34, P1772, DOI 10.1093/nar/gkl106; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Lodish H., 2004, MOL BIOL CELL; LoTenFoe JR, 1996, NAT GENET, V14, P320, DOI 10.1038/ng1196-320; Mace-Aime G, 2010, ENVIRON MOL MUTAGEN, V51, P508, DOI 10.1002/em.20548; Mao GG, 2007, NUCLEIC ACIDS RES, V35, P2759, DOI 10.1093/nar/gkm189; Mathew CG, 2006, ONCOGENE, V25, P5875, DOI 10.1038/sj.onc.1209878; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; MURANTE RS, 1994, J BIOL CHEM, V269, P1191; Murante RS, 1996, J BIOL CHEM, V271, P25888, DOI 10.1074/jbc.271.42.25888; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Otsuki T, 2001, HUM MOL GENET, V10, P2651, DOI 10.1093/hmg/10.23.2651; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Qiao FY, 2001, J BIOL CHEM, V276, P23391, DOI 10.1074/jbc.M101855200; SASAKI MS, 1975, NATURE, V257, P501, DOI 10.1038/257501a0; Shin YK, 2012, FEBS J, V279, P2412, DOI 10.1111/j.1742-4658.2012.08620.x; Sobeck A, 2006, MOL CELL BIOL, V26, P425, DOI 10.1128/MCB.26.2.425-437.2006; Thompson LH, 2005, ENVIRON MOL MUTAGEN, V45, P128, DOI 10.1002/em.20109; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Wang LC, 2008, DNA REPAIR, V7, P1973, DOI 10.1016/j.dnarep.2008.08.005; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wu XT, 1999, P NATL ACAD SCI USA, V96, P1303, DOI 10.1073/pnas.96.4.1303; Wu XT, 1996, NUCLEIC ACIDS RES, V24, P2036, DOI 10.1093/nar/24.11.2036; Yuan FH, 2012, J BIOL CHEM, V287, P4800, DOI 10.1074/jbc.M111.315366; Yuan FH, 2010, FRONT BIOSCI-LANDMRK, V15, P1131, DOI 10.2741/3666; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313; Zheng L, 2002, BIOCHEMISTRY-US, V41, P10323, DOI 10.1021/bi025841s; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599; Zheng L, 2011, NUCLEIC ACIDS RES, V39, P781, DOI 10.1093/nar/gkq884; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048	64	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82666	10.1371/journal.pone.0082666	http://dx.doi.org/10.1371/journal.pone.0082666			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24349332	Green Published, gold, Green Submitted			2022-12-27	WOS:000327949300165
J	Kant, S; Kumar, A; Singh, SM				Kant, Shiva; Kumar, Ajay; Singh, Sukh Mahendra			Myelopoietic Efficacy of Orlistat in Murine Hosts Bearing T Cell Lymphoma: Implication in Macrophage Differentiation and Activation	PLOS ONE			English	Article							FATTY-ACID SYNTHASE; MARROW PRECURSOR CELLS; NECROSIS-FACTOR-ALPHA; MYELOID DIFFERENTIATION; MOLECULAR-MECHANISMS; LIPASE INHIBITOR; LIPID-METABOLISM; CSF PRODUCTION; CANCER; APOPTOSIS	Orlistat, an inhibitor of fatty acid synthase (FASN), acts as an antitumor agent by blocking de novo fatty acid synthesis of tumor cells. Although, myelopoiesis also depends on de novo fatty acid synthesis, the effect of orlistat on differentiation of macrophages, which play a central role in host's antitumor defence, remains unexplored in a tumor-bearing host. Therefore, the present investigation was undertaken to examine the effect of orlistat administration on macrophage differentiation in a T cell lymphoma bearing host. Administration of orlistat (240 mg/kg/day/mice) to tumor-bearing mice resulted in a decline of tumor load accompanied by an augmentation of bone marrow cellularity and survival of bone marrow cells (BMC). The expression of apoptosis regulatory caspase-3, Bax and Bcl2 was modulated in the BMC of orlistat-administered tumor-bearing mice. Orlistat administration also resulted in an increase in serum level of IFN-gamma along with decreased TGF-beta and IL-10. BMC of orlistat-administered tumor-bearing mice showed augmented differentiation into macrophages accompanied by enhanced expression of macrophage colony stimulating factor (M-CSF) and its receptor (M-CSFR). The macrophages differentiated from BMC of orlistat-administered mice showed characteristic features of M-1 macrophage phenotype confirmed by expression of CD11c, TLR-2, generation of reactive oxygen species, phagocytosis, tumor cell cytotoxicity, production of IL-1, TNF-alpha and nitric oxide. These novel findings indicate that orlistat could be useful to support myelopoesis in a tumor-bearing host.	[Kant, Shiva; Kumar, Ajay; Singh, Sukh Mahendra] Banaras Hindu Univ, Sch Biotechnol, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Singh, SM (corresponding author), Banaras Hindu Univ, Sch Biotechnol, Varanasi 221005, Uttar Pradesh, India.	sukhmahendrasingh@yahoo.com	Kumar, Ajay/AER-0947-2022; kant, shiva/AAC-5429-2020	Kumar, Ajay/0000-0002-6635-0586	DBT; UGC University; DST-PURSE program, Government of India, New Delhi; Council of Scientific & Industrial Research (CSIR) New Delhi [DBT-JRF/2010-11/79, 09/013(0329)/2010-EMR-I]	DBT(Department of Biotechnology (DBT) India); UGC University; DST-PURSE program, Government of India, New Delhi; Council of Scientific & Industrial Research (CSIR) New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The financial support to the School of Biotechnology from DBT, UGC University with potential for excellence program and the DST-PURSE program, Government of India, New Delhi is acknowledged. The authors express gratitude to DBT and Council of Scientific & Industrial Research (CSIR) New Delhi, for fellowship support to Shiva Kant (DBT-JRF/2010-11/79) and Ajay Kumar (09/013(0329)/2010-EMR-I) respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batard P, 2000, J CELL SCI, V113, P383; Bharti AC, 2001, INT IMMUNOPHARMACOL, V1, P155, DOI 10.1016/S1567-5769(00)00004-7; Bharti AC, 2000, IMMUNOL LETT, V72, P39, DOI 10.1016/S0165-2478(00)00156-5; BIESMA B, 1992, CRIT REV ONCOL HEMAT, V13, P107, DOI 10.1016/1040-8428(92)90020-Q; Carvalho MA, 2008, INT J CANCER, V123, P2557, DOI 10.1002/ijc.23835; Chow MT, 2012, SEMIN CANCER BIOL, V22, P23, DOI 10.1016/j.semcancer.2011.12.004; Chuang HY, 2011, BIOMED PHARMACOTHER, V65, P286, DOI 10.1016/j.biopha.2011.02.016; Delneste Y, 2003, BLOOD, V101, P143, DOI 10.1182/blood-2002-04-1164; DUBINETT SM, 1993, J IMMUNOL, V151, P6670; Ecker J, 2010, P NATL ACAD SCI USA, V107, P7817, DOI 10.1073/pnas.0912059107; Flavin R, 2010, FUTURE ONCOL, V6, P551, DOI [10.2217/fon.10.11, 10.2217/FON.10.11]; Fujiwara J, 2012, INT J ONCOL, V40, P1483, DOI 10.3892/ijo.2012.1353; Furuta E, 2008, CANCER RES, V68, P1003, DOI 10.1158/0008-5472.CAN-07-2489; Gea-Sorli S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041933; GOLDIE H, 1951, CANCER RES, V11, P73; Gupta V, 2007, J REPROD IMMUNOL, V74, P90, DOI 10.1016/j.jri.2007.01.003; HAMILTON JA, 1993, GROWTH FACTORS, V9, P157; Hauton D, 2002, CELL PHYSIOL BIOCHEM, V12, P293, DOI 10.1159/000067899; Held TK, 1999, INFECT IMMUN, V67, P206, DOI 10.1128/IAI.67.1.206-212.1999; JANSEN JH, 1989, J EXP MED, V170, P577, DOI 10.1084/jem.170.2.577; Kant S, 2014, BBA-GEN SUBJECTS, V1840, P294, DOI 10.1016/j.bbagen.2013.09.020; Kant S, 2012, BBA-GEN SUBJECTS, V1820, P1764, DOI 10.1016/j.bbagen.2012.07.010; Kim R, 2006, CANCER RES, V66, P5527, DOI 10.1158/0008-5472.CAN-05-4128; KLEIN G, 1951, EXP CELL RES, V2, P518, DOI 10.1016/0014-4827(51)90038-9; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Kumar A, 2013, ANTI-CANCER DRUG, V24, P158, DOI 10.1097/CAD.0b013e3283586743; Kumar A, 2012, CHEM-BIOL INTERACT, V199, P29, DOI 10.1016/j.cbi.2012.06.005; Kumar A, 2012, BLOOD CELL MOL DIS, V48, P238, DOI 10.1016/j.bcmd.2012.02.006; Kurokawa J, 2010, CELL METAB, V11, P479, DOI 10.1016/j.cmet.2010.04.013; Kusakabe T, 2000, J HISTOCHEM CYTOCHEM, V48, P613, DOI 10.1177/002215540004800505; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Liu Hailan, 2010, Int J Biochem Mol Biol, V1, P69; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; Maxwell M B, 1992, Semin Oncol Nurs, V8, P113, DOI 10.1016/0749-2081(92)90027-Z; Menendez JA, 2010, BBA-MOL CELL BIOL L, V1801, P381, DOI 10.1016/j.bbalip.2009.09.005; Messmer UK, 1996, J BIOL CHEM, V271, P20192, DOI 10.1074/jbc.271.33.20192; Murphy BS, 2008, J ANTIMICROB CHEMOTH, V61, P554, DOI 10.1093/jac/dkn007; Naama HA, 2001, ARCH SURG-CHICAGO, V136, P804, DOI 10.1001/archsurg.136.7.804; NEMUNAITIS J, 1993, CRIT REV ONCOL HEMAT, V14, P153, DOI 10.1016/1040-8428(93)90022-V; Nicolaou G, 2012, J ATHEROSCLER THROMB, V19, P137, DOI 10.5551/jat.10249; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; Ohno M, 2012, ADV EXP MED BIOL, V746, P86, DOI 10.1007/978-1-4614-3146-6_7; OSWALD IP, 1992, P NATL ACAD SCI USA, V89, P8676, DOI 10.1073/pnas.89.18.8676; Pallasch CP, 2008, LEUKEMIA, V22, P585, DOI 10.1038/sj.leu.2405058; Popova A, 2011, IMMUNOBIOLOGY, V216, P164, DOI 10.1016/j.imbio.2010.06.003; Rorby E, 2012, BLOOD, V120, P4343, DOI 10.1182/blood-2012-02-408658; Rostad M E, 1990, Oncol Nurs Forum, V17, P4; Roth P, 1992, Curr Top Microbiol Immunol, V181, P141; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; SAWADA KI, 1995, LEUKEMIA LYMPHOMA, V19, P33, DOI 10.3109/10428199509059661; Shanker A, 2000, TUMOR BIOL, V21, P288, DOI 10.1159/000030134; Singh MP, 2005, COMP IMMUNOL MICROB, V28, P231, DOI 10.1016/j.cimid.2005.02.001; Singh SM, 2006, FITOTERAPIA, V77, P1, DOI 10.1016/j.fitote.2005.05.002; Singh V, 2008, ANTI-CANCER DRUG, V19, P793, DOI 10.1097/CAD.0b013e32830ce4f5; Stanley ER, 1997, MOL REPROD DEV, V46, P4, DOI 10.1002/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Toh B, 2012, IMMUNOL RES, V53, P229, DOI 10.1007/s12026-012-8288-4; TOMIDA M, 1984, J BIOL CHEM, V259, P978; Tsuchimoto D, 2004, IMMUNOL INVEST, V33, P397, DOI 10.1081/IMM-200038662; Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237; Vishvakarma NK, 2012, TOXICOL APPL PHARM, V263, P111, DOI 10.1016/j.taap.2012.06.004; Vishvakarma NK, 2011, BIOCHIMIE, V93, P1786, DOI 10.1016/j.biochi.2011.06.022; Vishvakarma NK, 2010, IMMUNOL LETT, V134, P83, DOI 10.1016/j.imlet.2010.09.002; Wang YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028081; Winston BW, 1999, CLIN INVEST MED, V22, P236; Woo KM, 2002, EXP MOL MED, V34, P340, DOI 10.1038/emm.2002.48; ZHI JG, 1995, J CLIN PHARMACOL, V35, P1103, DOI 10.1002/j.1552-4604.1995.tb04034.x; Zhou L, 2008, BLOOD, V112, P3434, DOI 10.1182/blood-2008-02-139824	70	9	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82396	10.1371/journal.pone.0082396	http://dx.doi.org/10.1371/journal.pone.0082396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24349275	gold, Green Published, Green Submitted			2022-12-27	WOS:000327947800098
J	Bahlai, CA; Colunga-Garcia, M; Gage, SH; Landis, DA				Bahlai, Christine A.; Colunga-Garcia, Manuel; Gage, Stuart H.; Landis, Douglas A.			Long-Term Functional Dynamics of an Aphidophagous Coccinellid Community Remain Unchanged despite Repeated Invasions	PLOS ONE			English	Article							HARMONIA-AXYRIDIS COLEOPTERA; NATIVE COCCINELLIDS; SOYBEAN APHID; LADY BEETLE; MAIZE FIELDS; SOUTH-DAKOTA; SEPTEMPUNCTATA; DISPLACEMENT; LADYBIRDS; LARVAL	Aphidophagous coccinellids (ladybeetles) are important providers of herbivore suppression ecosystem services. In the last 30 years, the invasion of exotic coccinellid species, coupled with observed declines in native species, has led to considerable interest in the community dynamics and ecosystem function of this guild. Here we examined a 24-year dataset of coccinellid communities in nine habitats in southwestern Michigan for changes in community function in response to invasion. Specifically we analyzed their temporal population dynamics and species diversity, and we modeled the community's potential to suppress pests. Abundance of coccinellids varied widely between 1989 and 2012 and became increasingly exotic-dominated. More than 71% of 57,813 adult coccinellids captured over the 24-year study were exotic species. Shannon diversity increased slightly over time, but herbivore suppression potential of the community remained roughly constant over the course of the study. However, both Shannon diversity and herbivore suppression potential due to native species declined over time in all habitats. The relationship between Shannon diversity and herbivore suppression potential varied with habitat type: a positive relationship in forest and perennial habitats, but was uncorrelated in annual habitats. This trend may have been because annual habitats were dominated by a few, highly voracious exotic species. Our results indicated that although the composition of the coccinellid community in southwestern Michigan has changed dramatically in the past several decades, its function has remained relatively unchanged in both agricultural and natural habitats. While this is encouraging from the perspective of pest management, it should be noted that losses of one of the dominant exotic coccinellids could result in a rapid decline in pest suppression services if the remaining community is unable to respond.	[Bahlai, Christine A.; Landis, Douglas A.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Colunga-Garcia, Manuel] Michigan State Univ, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA; [Bahlai, Christine A.; Gage, Stuart H.] Michigan State Univ, Global Observ Ecosyst Serv, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Bahlai, CA (corresponding author), Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA.	cbahlai@msu.edu	Bahlai, Christie/L-5500-2019; Landis, Douglas A./L-7991-2019	Bahlai, Christie/0000-0002-8937-8709; 	National Science Foundation [1027253]	National Science Foundation(National Science Foundation (NSF))	This work was funded by grant #1027253 from the National Science Foundation's Long Term Ecological Research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acorn John, 2007, American Entomologist, V53; Alyokhin A, 2004, BIOL INVASIONS, V6, P463, DOI 10.1023/B:BINV.0000041554.14539.74; Bahlai CA, 2013, ECOL MODEL, V254, P54, DOI 10.1016/j.ecolmodel.2013.01.014; Bahlai CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011250; Brown MW, 1998, ENTOMOL NEWS, V109, P143; Brown MW, 2003, BIOCONTROL, V48, P141, DOI 10.1023/A:1022660005948; Brown PMJ, 2011, ECOL ENTOMOL, V36, P231, DOI 10.1111/j.1365-2311.2011.01264.x; DYSART RJ, 1988, J NEW YORK ENTOMOL S, V96, P119; ELLINGSEN I-J, 1969, Norsk Entomologisk Tidsskrift, V16, P91; Elliott N, 1996, OECOLOGIA, V105, P537, DOI 10.1007/BF00330017; ELLIOTT NC, 1990, ENVIRON ENTOMOL, V19, P1320, DOI 10.1093/ee/19.5.1320; Evans EW, 2011, BIOCONTROL, V56, P597, DOI 10.1007/s10526-011-9374-6; Evans EW, 2004, ECOLOGY, V85, P637, DOI 10.1890/03-0230; Finke DL, 2008, SCIENCE, V321, P1488, DOI 10.1126/science.1160854; Finlayson CJ, 2008, ANN ENTOMOL SOC AM, V101, P1078, DOI 10.1603/0013-8746-101.6.1078; FOOTT WH, 1973, P ENTOMOL SOC ONT, V104, P16; GAGNE WC, 1968, CAN ENTOMOL, V100, P835, DOI 10.4039/Ent100835-8; Gardiner MM, 2012, FRONT ECOL ENVIRON, V10, P471, DOI 10.1890/110185; Gordon R. D., 1985, Journal of the New York Entomological Society, V93; GORDON RD, 1987, J NEW YORK ENTOMOL S, V95, P307; Harmon JP, 2007, J INSECT CONSERV, V11, P85, DOI 10.1007/s10841-006-9021-1; Heimpel GE, 2010, BIOL INVASIONS, V12, P2913, DOI 10.1007/s10530-010-9736-5; Hesler LS, 2008, J KANSAS ENTOMOL SOC, V81, P29, DOI 10.2317/JKES-704.11.1; Hesler LS, 2001, ENTOMOL NEWS, V112, P264; HODEK I, 1973, P260; Hodek I, 1996, ECOLOGY COCCINELLIDA; Hodek I, 2008, EUR J ENTOMOL, V105, P1, DOI 10.14411/eje.2008.001; KIECKHEFER RW, 1990, CAN ENTOMOL, V122, P579, DOI 10.4039/Ent122579-5; KIECKHEFER RW, 1992, GREAT LAKES ENTOMOL, V25, P15; Knapp AK, 2012, BIOSCIENCE, V62, P377, DOI 10.1525/bio.2012.62.4.9; Koch RL, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.32; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Lucas E, 2002, EUR J ENTOMOL, V99, P457, DOI 10.14411/eje.2002.058; MAREDIA KM, 1992, GREAT LAKES ENTOMOL, V25, P265; MARSHALL SA, 2006, INSECTS THEIR NATURA, P720; MICHELS GJ, 1992, SOUTHWEST ENTOMOL, V17, P233; MORALES J, 1985, ENVIRON ENTOMOL, V14, P520, DOI 10.1093/ee/14.4.520; MUMA MARTIN H., 1955, ANN ENT SOC AMER, V48, P493; Musser FR, 2004, J ECON ENTOMOL, V97, P136, DOI 10.1603/0022-0493-97.1.136; PUTMAN WL, 1964, CAN ENTOMOL, V96, P925, DOI 10.4039/Ent96925-7; R Development Core Team, 2012, R LANG ENV STAT COMP; RADWAN Z, 1983, Z ANGEW ENTOMOL, V96, P396; Ragsdale DW, 2004, ANN ENTOMOL SOC AM, V97, P204, DOI 10.1603/0013-8746(2004)097[0204:SABINA]2.0.CO;2; Reitz SR, 2002, ANNU REV ENTOMOL, V47, P435, DOI 10.1146/annurev.ento.47.091201.145227; Ricciardi A, 2004, ECOL LETT, V7, P781, DOI 10.1111/j.1461-0248.2004.00642.x; Ricciardi A, 2013, ECOL MONOGR, V83, P263, DOI 10.1890/13-0183.1; SMITH BC, 1971, CAN ENTOMOL, V103, P1115, DOI 10.4039/Ent1031115-8; Snyder WE, 2009, BIOL CONTROL, V51, P323, DOI 10.1016/j.biocontrol.2009.05.010; Soares AO, 2004, J ANIM ECOL, V73, P478, DOI 10.1111/j.0021-8790.2004.00822.x; Straub CS, 2008, ECOLOGY, V89, P1605, DOI 10.1890/07-0657.1; Turnock WJ, 2003, CAN ENTOMOL, V135, P391; Williams T, 1996, BIOCONTROL SCI TECHN, V6, P603, DOI 10.1080/09583159631244; Xue Y, 2009, ENVIRON ENTOMOL, V38, P708, DOI 10.1603/022.038.0322; YADAVA CP, 1968, J ECON ENTOMOL, V61, P1104, DOI 10.1093/jee/61.4.1104; YAO DS, 1989, OECOLOGIA, V80, P443, DOI 10.1007/BF00380065; Zuur A.F., 2007, ANAL ECOLOGICAL DATA, P672, DOI DOI 10.1007/978-0-387-45972-1	56	19	19	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83407	10.1371/journal.pone.0083407	http://dx.doi.org/10.1371/journal.pone.0083407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349505	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200084
J	Dogovski, C; Gorman, MA; Ketaren, NE; Praszkier, J; Zammit, LM; Mertens, HD; Bryant, G; Yang, J; Griffin, MDW; Pearce, FG; Gerrard, JA; Jameson, GB; Parker, MW; Robins-Browne, RM; Perugini, MA				Dogovski, Con; Gorman, Michael A.; Ketaren, Natalia E.; Praszkier, Judy; Zammit, Leanne M.; Mertens, Haydyn D.; Bryant, Gary; Yang, Ji; Griffin, Michael D. W.; Pearce, F. Grant; Gerrard, Juliet A.; Jameson, Geoffrey B.; Parker, Michael W.; Robins-Browne, Roy M.; Perugini, Matthew A.			From Knock-Out Phenotype to Three-Dimensional Structure of a Promising Antibiotic Target from Streptococcus pneumoniae	PLOS ONE			English	Article							COLI DIHYDRODIPICOLINATE SYNTHASE; PNEUMOCOCCAL CONJUGATE VACCINE; PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; SIZE-DISTRIBUTION ANALYSIS; HUMAN APOLIPOPROTEIN E3; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CORYNEBACTERIUM-GLUTAMICUM; ALLOSTERIC INHIBITION	Given the rise in drug-resistant Streptococcus pneumoniae, there is an urgent need to discover new antimicrobials targeting this pathogen and an equally urgent need to characterize new drug targets. A promising antibiotic target is dihydrodipicolinate synthase (DHDPS), which catalyzes the rate-limiting step in lysine biosynthesis. In this study, we firstly show by gene knock out studies that S. pneumoniae (sp) lacking the DHDPS gene is unable to grow unless supplemented with lysine-rich media. We subsequently set out to characterize the structure, function and stability of the enzyme drug target. Our studies show that sp-DHDPS is folded and active with a k(cat) = 22 s(-1), K-M(PYR) = 2.55 +/- 0.05 mM and K-M(ASA) = 0.044 +/- 0.003 mM. Thermal denaturation experiments demonstrate sp-DHDPS exhibits an apparent melting temperature (T-M(app)) of 72 degrees C, which is significantly greater than Escherichia coli DHDPS (Ec-DHDPS) (T-M(app) = 59 degrees C). Sedimentation studies show that sp-DHDPS exists in a dimer-tetramer equilibrium with a K-D(4-2) = 1.7 nM, which is considerably tighter than its E. coli ortholog (K-D(4-2) = 76 nM). To further characterize the structure of the enzyme and probe its enhanced stability, we solved the high resolution (1.9 angstrom) crystal structure of sp-DHDPS (PDB ID 3VFL). The enzyme is tetrameric in the crystal state, consistent with biophysical measurements in solution. Although the sp-DHDPS and Ec-DHDPS active sites are almost identical, the tetramerization interface of the s. pneumoniae enzyme is significantly different in composition and has greater buried surface area (800 angstrom(2)) compared to its E. coli counterpart (500 angstrom(2)). This larger interface area is consistent with our solution studies demonstrating that sp-DHDPS is considerably more thermally and thermodynamically stable than Ec-DHDPS. Our study describe for the first time the knock-out phenotype, solution properties, stability and crystal structure of DHDPS from S. pneumoniae, a promising antimicrobial target.	[Dogovski, Con; Zammit, Leanne M.; Perugini, Matthew A.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic, Australia; [Dogovski, Con; Ketaren, Natalia E.; Griffin, Michael D. W.; Parker, Michael W.; Perugini, Matthew A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Gorman, Michael A.; Parker, Michael W.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Praszkier, Judy; Yang, Ji; Robins-Browne, Roy M.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Mertens, Haydyn D.] Australian Synchrotron, Clayton, Vic, Australia; [Bryant, Gary] RMIT Univ, Sch Appl Sci, Melbourne, Vic, Australia; [Pearce, F. Grant; Gerrard, Juliet A.] Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand; [Pearce, F. Grant; Gerrard, Juliet A.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Gerrard, Juliet A.] Callaghan Innovat, Lower Hutt, New Zealand; [Jameson, Geoffrey B.] Massey Univ, Struct Biol Ctr, Inst Fundamental Sci, Palmerston North, New Zealand	La Trobe University; University of Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; Royal Melbourne Institute of Technology (RMIT); University of Canterbury; University of Canterbury; Callaghan Innovation; Massey University	Perugini, MA (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem, Melbourne, Vic, Australia.	M.Perugini@latrobe.edu.au	Bryant, Gary/A-4186-2008; Parker, Michael W/F-9069-2013; Robinsbrowne, Roy/ABF-8434-2020	Bryant, Gary/0000-0001-5483-7592; Parker, Michael W/0000-0002-3101-1138; Robinsbrowne, Roy/0000-0001-9179-7884; Griffin, Michael/0000-0001-9845-7735; Pearce, Frederick/0000-0002-2683-0331; Mertens, Haydyn/0000-0002-5664-744X; Jameson, Geoffrey/0000-0003-4839-0784; Perugini, Matthew/0000-0001-8052-5584	Australian Research Council [FT0991245]; National Health & Medical Research Council (NHMRC) [628681I, APP1021645]	Australian Research Council(Australian Research Council); National Health & Medical Research Council (NHMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council (NHMRC) of Australia)	Funding provided by (1) Australian Research Council Future Fellowship FT0991245, (2) National Health & Medical Research Council (NHMRC) Project Grant 628681I (3) NHMRC Fellowship APP1021645. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], [No title captured]; Atkinson SC, 2013, PLANT MOL BIOL, V81, P431, DOI 10.1007/s11103-013-0014-7; Atkinson SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038318; Blagova E, 2006, PROTEINS, V62, P297, DOI 10.1002/prot.20684; Blickling S, 1997, BIOCHEMISTRY-US, V36, P24, DOI 10.1021/bi962272d; Blickling S, 1997, J MOL BIOL, V274, P608, DOI 10.1006/jmbi.1997.1393; Burgess BR, 2008, J BIOL CHEM, V283, P27598, DOI 10.1074/jbc.M804231200; Cartwright K, 2002, EUR J PEDIATR, V161, P188, DOI 10.1007/s00431-001-0907-3; Chalker AF, 2001, J BACTERIOL, V183, P1259, DOI 10.1128/JB.183.4.1259-1268.2001; Davis AJ, 2004, J BIOL CHEM, V279, P12462, DOI 10.1074/jbc.M312365200; Devenish SRA, 2009, BBA-PROTEINS PROTEOM, V1794, P1168, DOI 10.1016/j.bbapap.2009.02.003; Dietrich C, 2009, MICROBIOL-SGM, V155, P1360, DOI 10.1099/mic.0.022004-0; Dobson RCJ, 2005, ACTA CRYSTALLOGR D, V61, P1116, DOI 10.1107/S0907444905016318; Dobson RCJ, 2004, J MOL BIOL, V338, P329, DOI 10.1016/j.jmb.2004.02.060; Dogovski C, 2012, BIOCHEMISTRY-US, P225, DOI DOI 10.85772/34121; Dogovski C., 2009, ENCY LIFE SUPPORT SY, V11, P116; Domigan LJ, 2009, BBA-PROTEINS PROTEOM, V1794, P1510, DOI 10.1016/j.bbapap.2009.06.020; DOWD SR, 1995, BBA-PROTEIN STRUCT M, V1252, P278, DOI 10.1016/0167-4838(95)00121-A; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GARVIE EI, 1980, MICROBIOL REV, V44, P106, DOI 10.1128/MMBR.44.1.106-139.1980; Gerrard JA, 2007, MINI-REV MED CHEM, V7, P151, DOI 10.2174/138955707779802561; Girish TS, 2008, FEBS LETT, V582, P2923, DOI 10.1016/j.febslet.2008.07.035; Griffin MDW, 2008, J MOL BIOL, V380, P691, DOI 10.1016/j.jmb.2008.05.038; Griffin MDW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040318; Griffin MDW, 2010, ARCH BIOCHEM BIOPHYS, V494, P58, DOI 10.1016/j.abb.2009.11.014; Hayes DB, 2003, SEDIMENTATION INTERP; Hutton CA, 2007, MOL BIOSYST, V3, P458, DOI 10.1039/b705624a; Hutton CA, 2003, MINI-REV MED CHEM, V3, P115, DOI 10.2174/1389557033405359; Janssens JP, 2004, LANCET INFECT DIS, V4, P112, DOI 10.1016/S1473-3099(04)00931-4; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kang BS, 2010, INT J BIOL MACROMOL, V46, P512, DOI 10.1016/j.ijbiomac.2010.03.005; Karsten WE, 1997, BIOCHEMISTRY-US, V36, P1730, DOI 10.1021/bi962264x; Kaur N, 2011, INT J BIOL MACROMOL, V48, P779, DOI 10.1016/j.ijbiomac.2011.03.002; Kefala G, 2008, BIOCHEM J, V411, P351, DOI 10.1042/BJ20071360; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; LABER B, 1992, BIOCHEM J, V288, P691, DOI 10.1042/bj2880691; Laue TN, 1992, ANAL ULTRACENTRIFUGA, V224, P90; MACRINA FL, 1982, GENE, V19, P345, DOI 10.1016/0378-1119(82)90025-7; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; MIRWALDT C, 1995, J MOL BIOL, V246, P227, DOI 10.1006/jmbi.1994.0078; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordberg P, 2005, ANTIBACTERIAL RESIST; Novak R, 1999, NATURE, V399, P590, DOI 10.1038/21202; Nunes S, 2005, J CLIN MICROBIOL, V43, P1285, DOI 10.1128/JCM.43.3.1285-1293.2005; Ostendorp R, 1996, PROTEIN SCI, V5, P862; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padmanabhan B, 2009, ACTA CRYSTALLOGR F, V65, P1222, DOI 10.1107/S174430910904651X; Pearce FG, 2006, BIOCHEM J, V400, P359, DOI 10.1042/BJ20060771; Perugini MA, 2000, J BIOL CHEM, V275, P36758, DOI 10.1074/jbc.M005565200; Perugini MA, 2005, EUR BIOPHYS J BIOPHY, V34, P469, DOI 10.1007/s00249-005-0491-y; Perugini MA, 2002, EUR J BIOCHEM, V269, P5939, DOI 10.1046/j.1432-1033.2002.03319.x; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; Reboul CF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002537; Rice EA, 2008, ARCH BIOCHEM BIOPHYS, V480, P111, DOI 10.1016/j.abb.2008.09.018; Roberts SJ, 2003, BIOORG MED CHEM LETT, V13, P265, DOI 10.1016/S0960-894X(02)00923-X; Sambrook J., 2002, MOL CLONING LAB MANU; Schnell R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031133; Schrag SJ, 2004, ANTIMICROB AGENTS CH, V48, P3016, DOI 10.1128/AAC.48.8.3016-3023.2004; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sibarani NE, 2010, ACTA CRYSTALLOGR F, V66, P32, DOI 10.1107/S174430910904771X; Sorum H, 2002, INT J FOOD MICROBIOL, V78, P43, DOI 10.1016/S0168-1605(02)00241-6; Sreerama N, 2000, ANAL BIOCHEM, V287, P243, DOI 10.1006/abio.2000.4879; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stephens DS, 2005, LANCET, V365, P855, DOI 10.1016/S0140-6736(05)71043-6; Sun ZT, 2012, MICROBIOL-SGM, V158, P1350, DOI 10.1099/mic.0.055590-0; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Voss JE, 2010, J BIOL CHEM, V285, P5188, DOI 10.1074/jbc.M109.038166; Wegener HC, 2003, CURR OPIN MICROBIOL, V6, P439, DOI 10.1016/j.mib.2003.09.009; Wei BPC, 2006, OTOL NEUROTOL, V27, P844, DOI 10.1097/01.mao.0000231603.25961.f1; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; YUGARI YASUMI, 1965, J BIOL CHEM, V240, P4710	81	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83419	10.1371/journal.pone.0083419	http://dx.doi.org/10.1371/journal.pone.0083419			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349508	gold, Green Published			2022-12-27	WOS:000328734200087
J	Brun, T; Scarcia, P; Li, N; Gaudet, P; Duhamel, D; Palmieri, F; Maechler, P				Brun, Thierry; Scarcia, Pasquale; Li, Ning; Gaudet, Pascale; Duhamel, Dominique; Palmieri, Ferdinando; Maechler, Pierre			Changes in Mitochondrial Carriers Exhibit Stress-Specific Signatures in INS-1E beta-Cells Exposed to Glucose Versus Fatty Acids	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CARBOXYLASE GENE-EXPRESSION; LONG-TERM EXPOSURE; INSULIN-SECRETION; PANCREATIC-ISLETS; GLUTAMATE PATHWAYS; DYSFUNCTION; METABOLISM; ACTIVATION; PALMITATE	Chronic exposure of beta-cells to metabolic stresses impairs their function and potentially induces apoptosis. Mitochondria play a central role in coupling glucose metabolism to insulin secretion. However, little is known on mitochondrial responses to specific stresses; i.e. low versus high glucose, saturated versus unsaturated fatty acids, or oxidative stress. INS-1E cells were exposed for 3 days to 5.6 mM glucose, 25 mM glucose, 0.4 mM palmitate, and 0.4 mM oleate. Culture at standard 11.1 mM glucose served as no-stress control and transient oxidative stress (200 mu M H2O2 for 10 min at day 0) served as positive stressful condition. Mito-array analyzed transcripts of 60 mitochondrion-associated genes with special focus on members of the Slc25 family. Transcripts of interest were evaluated at the protein level by immunoblotting. Bioinformatics analyzed the expression profiles to delineate comprehensive networks. Chronic exposure to the different metabolic stresses impaired glucose-stimulated insulin secretion; revealing glucotoxicity and lipo-dysfunction. Both saturated and unsaturated fatty acids increased expression of the carnitine/acylcarnitine carrier CAC, whereas the citrate carrier CIC and energy sensor SIRT1 were specifically upregulated by palmitate and oleate, respectively. High glucose upregulated CIC, the dicarboxylate carrier DIC and glutamate carrier GC1. Conversely, it reduced expression of energy sensors (AMPK, SIRT1, SIRT4), metabolic genes, transcription factor PDX1, and anti-apoptotic Bcl2. This was associated with caspase-3 cleavage and cell death. Expression levels of GC1 and SIRT4 exhibited positive and negative glucose dose-response, respectively. Expression profiles of energy sensors and mitochondrial carriers were selectively modified by the different conditions, exhibiting stress-specific signatures.	[Brun, Thierry; Li, Ning; Duhamel, Dominique; Maechler, Pierre] Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Scarcia, Pasquale; Palmieri, Ferdinando] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Palmieri, Ferdinando] Univ Bari, Ctr Excellence Comparat Genom CEGBA, Bari, Italy; [Gaudet, Pascale] SIB, Geneva, Switzerland; [Gaudet, Pascale] Univ Geneva, Med Ctr, CH-1211 Geneva, Switzerland	University of Geneva; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Swiss Institute of Bioinformatics; University of Geneva	Brun, T (corresponding author), Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland.	Thierry.Brun@unige.ch; Pierre.Maechler@unige.ch	Scarcia, Pasquale/A-8830-2010; Scarcia, Pasquale/O-9550-2019	Scarcia, Pasquale/0000-0001-6216-0411; Scarcia, Pasquale/0000-0001-6216-0411; LI, Ning/0000-0002-1626-5519; Maechler, Pierre/0000-0002-2005-1433; BRUN, Thierry/0000-0002-1659-4283	State of Geneva; Swiss National Science Foundation [310030B_135704]; Desiree and Niels Yde Foundation; Ministero dell'Universita e della Ricerca (MIUR); Italian Human ProteomeNet [RBRN07BMCT_009]	State of Geneva; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Desiree and Niels Yde Foundation; Ministero dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Italian Human ProteomeNet	This study was supported by the State of Geneva, the Swiss National Science Foundation (310030B_135704 to P. M.), the Desiree and Niels Yde Foundation (to P. M.), the Ministero dell'Universita e della Ricerca (MIUR), and the Italian Human ProteomeNet No. RBRN07BMCT_009 (to F. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrimi G, 2004, BIOCHEM J, V379, P183, DOI 10.1042/BJ20031664; Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bender K, 2006, BIOCHEM SOC T, V34, P811, DOI 10.1042/BST0340811; Bender K, 2009, CLIN SCI, V117, P321, DOI 10.1042/CS20090126; Bensellam M, 2009, DIABETOLOGIA, V52, P463, DOI 10.1007/s00125-008-1245-z; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Biden TJ, 2004, DIABETES, V53, pS159, DOI 10.2337/diabetes.53.2007.S159; Brun T, 1997, DIABETES, V46, P393, DOI 10.2337/diabetes.46.3.393; BRUN T, 1993, J BIOL CHEM, V268, P18905; Busch AK, 2002, DIABETES, V51, P977, DOI 10.2337/diabetes.51.4.977; Casimir M, 2009, BIOCHEM J, V424, P459, DOI 10.1042/BJ20090729; Casimir M, 2009, J BIOL CHEM, V284, P25004, DOI 10.1074/jbc.M109.015495; Caton PW, 2013, DIABETOLOGIA, V56, P1068, DOI 10.1007/s00125-013-2851-y; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Coute Y, 2010, PROTEOMICS, V10, P59, DOI 10.1002/pmic.200900080; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; El-Assaad W, 2010, ENDOCRINOLOGY, V151, P3061, DOI 10.1210/en.2009-1238; Frigerio F, 2010, DIABETOLOGIA, V53, P331, DOI 10.1007/s00125-009-1590-6; Frigerio F, 2008, BBA-BIOENERGETICS, V1777, P965, DOI 10.1016/j.bbabio.2008.04.031; Frigerio F, 2006, BIOCHEM PHARMACOL, V72, P965, DOI 10.1016/j.bcp.2006.07.013; Gaudet P, 2013, J PROTEOME RES, V12, P293, DOI 10.1021/pr300830v; Huypens P, 2011, DIABETOLOGIA, V54, P135, DOI 10.1007/s00125-010-1923-5; Huypens PR, 2012, ISLETS, V4, DOI 10.4161/isl.18338; Iacobazzi V, 2009, BIOCHEM BIOPH RES CO, V388, P643, DOI 10.1016/j.bbrc.2009.08.008; Janjic D, 1999, BIOCHEM PHARMACOL, V57, P639, DOI 10.1016/S0006-2952(98)00346-3; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Koyama T, 2011, FREE RADICAL BIO MED, V51, P1258, DOI 10.1016/j.freeradbiomed.2011.05.028; Li N, 2008, BIOCHEM SOC T, V36, P930, DOI 10.1042/BST0360930; Li N, 2009, J BIOL CHEM, V284, P23602, DOI 10.1074/jbc.M109.024323; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; Maechler P, 2010, ADV EXP MED BIOL, V654, P193, DOI 10.1007/978-90-481-3271-3_9; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; Malmgren S, 2013, J BIOL CHEM, V288, P11973, DOI 10.1074/jbc.M112.422527; Maris M, 2013, J PROTEOME RES, V12, P347, DOI 10.1021/pr300596g; Maris M, 2010, J PROTEOME RES, V9, P6274, DOI 10.1021/pr100557w; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Nishi Y, 2011, BIOCHEM J, V435, P421, DOI 10.1042/BJ20101708; Odegaard ML, 2010, J BIOL CHEM, V285, P16530, DOI 10.1074/jbc.M109.092593; Palmieri F, 2008, BBA-BIOENERGETICS, V1777, P564, DOI 10.1016/j.bbabio.2008.03.008; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Palmieri F, 2011, PLANT J, V66, P161, DOI 10.1111/j.1365-313X.2011.04516.x; PORTE D, 1991, DIABETES, V40, P166, DOI 10.2337/diabetes.40.2.166; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; Roche E, 1998, DIABETES, V47, P1086, DOI 10.2337/diabetes.47.7.1086; Rubi B, 2004, J BIOL CHEM, V279, P55659, DOI 10.1074/jbc.M409303200; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; Vetterli L, 2012, MOL BIOL CELL, V23, P3851, DOI 10.1091/mbc.E11-08-0676; Vetterli L, 2011, AGING-US, V3, P444, DOI 10.18632/aging.100304; Vetterli L, 2011, J BIOL CHEM, V286, P6049, DOI 10.1074/jbc.M110.176842; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wang HY, 2001, J BIOL CHEM, V276, P25279, DOI 10.1074/jbc.M101233200; Xiao JZ, 2001, ENDOCRINOLOGY, V142, P4777, DOI 10.1210/en.142.11.4777; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042	64	21	21	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82364	10.1371/journal.pone.0082364	http://dx.doi.org/10.1371/journal.pone.0082364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349266	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800059
J	Qiu, F; Cole, MH; Davids, KW; Hennig, EM; Silburn, PA; Netscher, H; Kerr, GK				Qiu, Feng; Cole, Michael H.; Davids, Keith W.; Hennig, Ewald M.; Silburn, Peter A.; Netscher, Heather; Kerr, Graham K.			Effects of Textured Insoles on Balance in People with Parkinson's Disease	PLOS ONE			English	Article							INDUCED BODY-SWAY; POSTURAL CONTROL; OLDER-ADULTS; STOCHASTIC RESONANCE; PRESSOR INPUT; SPIKE INSOLES; HUMAN FEET; NOISE; FALLS; PROPRIOCEPTION	Background: Degradation of the somatosensory system has been implicated in postural instability and increased falls risk for older people and Parkinson's disease (PD) patients. Here we demonstrate that textured insoles provide a passive intervention that is an inexpensive and accessible means to enhance the somatosensory input from the plantar surface of the feet. Methods: 20 healthy older adults (controls) and 20 participants with PD were recruited for the study. We evaluated effects of manipulating somatosensory information from the plantar surface of the feet using textured insoles. Participants performed standing tests, on two different surfaces (firm and foam), under three footwear conditions: 1) barefoot; 2) smooth insoles; and 3) textured insoles. Standing balance was evaluated using a force plate yielding data on the range of anterior-posterior and medial-lateral sway, as well as standard deviations for anterior-posterior and medial-lateral sway. Results: On the firm surface with eyes open both the smooth and textured insoles reduced medial-lateral sway in the PD group to a similar level as the controls. Only the textured insole decreased medial-lateral sway and medial-lateral sway standard deviation in the PD group on both surfaces, with and without visual input. Greatest benefits were observed in the PD group while wearing the textured insoles, and when standing on the foam surface with eyes closed. Conclusions: Data suggested that textured insoles may provide a low-cost means of improving postural stability in high falls-risk groups, such as people with PD.	[Qiu, Feng] Nanjing Med Univ, Nanjing Brain Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China; [Qiu, Feng; Cole, Michael H.; Davids, Keith W.; Silburn, Peter A.; Kerr, Graham K.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Movement Neurosci Program, Brisbane, Qld 4001, Australia; [Qiu, Feng; Kerr, Graham K.] Queensland Univ Technol, Sch Exercise & Nutr Sci, Brisbane, Qld 4001, Australia; [Cole, Michael H.] Australian Catholic Univ, Sch Exercise Sci, Brisbane, Qld, Australia; [Davids, Keith W.] Sheffield Hallam Univ, Ctr Sports Engn Res, Sheffield S1 1WB, S Yorkshire, England; [Hennig, Ewald M.] Univ Duisburg Essen, Biomech Lab, Essen, Germany; [Silburn, Peter A.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Netscher, Heather] Int Childrens Orthot Lab, Brisbane, Qld, Australia	Nanjing Medical University; Queensland University of Technology (QUT); Queensland University of Technology (QUT); Australian Catholic University; Sheffield Hallam University; University of Duisburg Essen; University of Queensland	Qiu, F (corresponding author), Nanjing Med Univ, Nanjing Brain Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China.	qiufeng1980@hotmail.com; g.kerr@qut.edu.au	Cole, Michael H/O-6816-2018	Cole, Michael/0000-0003-1817-7528; Kerr, Graham/0000-0002-1008-256X; Hennig, Ewald/0000-0002-2799-8590; Davids, Keith/0000-0003-1398-6123	Queensland University of Technology; Parkinson's Queensland Inc.; China Scholarship Council (CSC) scholarship	Queensland University of Technology; Parkinson's Queensland Inc.; China Scholarship Council (CSC) scholarship(China Scholarship Council)	This work was supported by grants from Queensland University of Technology and Parkinson's Queensland Inc. Feng Qiu was also supported by a China Scholarship Council (CSC) scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkin AL, 2005, GAIT POSTURE, V22, P240, DOI 10.1016/j.gaitpost.2004.09.009; Carpenter MG, 2011, EXP NEUROL, V227, P26, DOI 10.1016/j.expneurol.2010.11.007; Corbin DM, 2007, J SPORT REHABIL, V16, P363, DOI 10.1123/jsr.16.4.363; DIENER HC, 1984, BRAIN RES, V296, P103, DOI 10.1016/0006-8993(84)90515-8; Fahn S, 1987, RECENT DEV PARKINSON; Hatton AL, 2011, AGE AGEING, V40, P363, DOI 10.1093/ageing/afr026; Hidaka I, 2000, PHYS REV LETT, V85, P3740, DOI 10.1103/PhysRevLett.85.3740; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Jenkins ME, 2009, PARKINSONISM RELAT D, V15, P697, DOI 10.1016/j.parkreldis.2009.04.004; Kerr GK, 2010, NEUROLOGY, V75, P116, DOI 10.1212/WNL.0b013e3181e7b688; Latt MD, 2009, MOVEMENT DISORD, V24, P1280, DOI 10.1002/mds.22561; Lord S, 2001, FALLS OLDER PEOPLE R; MAGNUSSON M, 1990, ACTA OTO-LARYNGOL, V110, P321, DOI 10.3109/00016489009122555; MAGNUSSON M, 1990, ACTA OTO-LARYNGOL, V110, P182, DOI 10.3109/00016489009122535; Maki BE, 2008, J ELECTROMYOGR KINES, V18, P243, DOI 10.1016/j.jelekin.2007.06.005; Manjarrez E, 2003, J NEUROSCI, V23, P1997; Mathuranath PS, 2000, NEUROLOGY, V55, P1613, DOI 10.1212/01.wnl.0000434309.85312.19; MITCHELL S, 1995, NEUROSCI LETT, V197, P133, DOI 10.1016/0304-3940(95)11924-L; Newell KM, 2001, PSYCHOL REV, V108, P57, DOI 10.1037//0033-295X.108.1.57; Nolano M, 2008, BRAIN, V131, P1903, DOI 10.1093/brain/awn102; Novak P, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-9; Palluel E, 2008, AGE, V30, P53, DOI 10.1007/s11357-008-9047-2; Palluel E, 2009, BEHAV NEUROSCI, V123, P1141, DOI 10.1037/a0017115; Patel M, 2008, GAIT POSTURE, V28, P649, DOI 10.1016/j.gaitpost.2008.04.018; Perry SD, 2000, BRAIN RES, V877, P401, DOI 10.1016/S0006-8993(00)02712-8; Qiu F, 2012, GAIT POSTURE, V35, P630, DOI 10.1016/j.gaitpost.2011.12.013; Simoneau GG, 1997, J ATHL TRAINING, V32, P141; Vuillerme N, 2007, EXP BRAIN RES, V183, P323, DOI 10.1007/s00221-007-1047-4; Wu FF, 2007, LECT NOTES COMPUT SC, V4561, P483	30	39	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83309	10.1371/journal.pone.0083309	http://dx.doi.org/10.1371/journal.pone.0083309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349486	Green Published, gold			2022-12-27	WOS:000328731800110
J	Stroh, S; Sonntag, S; Janssen-Bienhold, U; Schultz, K; Cimiotti, K; Weiler, R; Willecke, K; Dedek, K				Stroeh, Sebastian; Sonntag, Stephan; Janssen-Bienhold, Ulrike; Schultz, Konrad; Cimiotti, Kerstin; Weiler, Reto; Willecke, Klaus; Dedek, Karin			Cell-Specific Cre Recombinase Expression Allows Selective Ablation of Glutamate Receptors from Mouse Horizontal Cells	PLOS ONE			English	Article							OUTER PLEXIFORM LAYER; BIPOLAR CELLS; INTRACELLULAR CALCIUM; AMPA; RAT; ROD; RETINA; LOCALIZATION; CONNEXIN57; SUBUNITS	In the mouse retina, horizontal cells form an electrically coupled network and provide feedback signals to photoreceptors and feedforward signals to bipolar cells. Thereby, horizontal cells contribute to gain control at the first visual synapse and to the antagonistic organization of bipolar and ganglion cell receptive fields. However, the nature of horizontal cell output remains a matter of debate, just as the exact contribution of horizontal cells to center-surround antagonism. To facilitate studying horizontal cell function, we developed a knockin mouse line which allows ablating genes exclusively in horizontal cells. This knockin line expresses a Cre recombinase under the promoter of connexin57 (Cx57), a gap junction protein only expressed in horizontal cells. Consistently, in Cx57+/Cre mice, Cre recombinase is expressed in almost all horizontal cells (>99%) and no other retinal neurons. To test Cre activity, we crossbred Cx57+/Cre mice with a mouse line in which exon 11 of the coding sequence for the ionotropic glutamate receptor subunit GluA4 was flanked by two loxP sites (GluA4fl/fl). In GluA4fl/fl: Cx57+/Cre mice, GluA4 immunoreactivity was significantly reduced (similar to 50%) in the outer retina where horizontal cells receive photoreceptor inputs, confirming the functionality of the Cre/loxP system. Whole-cell patch-clamp recordings from isolated horizontal cell somata showed a reduction of glutamate-induced inward currents by similar to 75%, suggesting that the GluA4 subunit plays a major role in mediating photoreceptor inputs. The persistent current in GluA4-deficient cells is mostly driven by AMPA and to a very small extent by kainate receptors as revealed by application of the AMPA receptor antagonist GYKI52466 and concanavalin A, a potentiator of kainate receptor-mediated currents. In summary, the Cx57+/Cre mouse line provides a versatile tool for studying horizontal cell function. GluA4fl/fl: Cx57+/Cre mice, in which horizontal cells receive less excitatory input, can thus be used to analyze the contribution of horizontal cells to retinal processing.	[Stroeh, Sebastian; Janssen-Bienhold, Ulrike; Schultz, Konrad; Weiler, Reto; Dedek, Karin] Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-26111 Oldenburg, Germany; [Janssen-Bienhold, Ulrike; Weiler, Reto; Dedek, Karin] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany; [Sonntag, Stephan; Cimiotti, Kerstin; Willecke, Klaus] Univ Bonn, Life & Med Sci Inst, Bonn, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; University of Bonn	Dedek, K (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Neurobiol, D-26111 Oldenburg, Germany.	karin.dedek@uni-oldenburg.de	Dedek, Karin/R-6948-2018	Dedek, Karin/0000-0003-1490-0141; Stroh, Sebastian/0000-0001-8128-2617	Deutsche Forschungsgemeinschaft [DE1154-3/1, Wi270/31-1, SFB 645-B2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (www.dfg.de; grant DE1154-3/1 to KD and UJB, and grants Wi270/31-1 and SFB 645-B2 to KW for generating the Cx57+/Cre mouse line). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babai N, 2010, J NEUROSCI, V30, P15866, DOI 10.1523/JNEUROSCI.2891-10.2010; Blanco R, 1999, EUR J NEUROSCI, V11, P867, DOI 10.1046/j.1460-9568.1999.t01-1-00499.x; Brandstatter JH, 1996, J NEUROSCI, V16, P4749; Brandstatter JH, 1997, J NEUROSCI, V17, P9298; Dedek K, 2009, EUR J NEUROSCI, V30, P217, DOI 10.1111/j.1460-9568.2009.06808.x; Feigenspan A, 2009, PFLUG ARCH EUR J PHY, V458, P359, DOI 10.1007/s00424-008-0609-z; Fuchs EC, 2007, NEURON, V53, P591, DOI 10.1016/j.neuron.2007.01.031; Grunder T, 2000, INVEST OPHTH VIS SCI, V41, P3600; Guo CY, 2010, J COMP NEUROL, V518, P1647, DOI 10.1002/cne.22294; Hack I, 2001, EUR J NEUROSCI, V13, P15, DOI 10.1046/j.1460-9568.2001.01357.x; HAMMANG JP, 1993, NEURON, V10, P1197, DOI 10.1016/0896-6273(93)90067-2; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Herrmann R, 2011, NEURON, V72, P101, DOI 10.1016/j.neuron.2011.07.030; Hilgen G, 2011, J COMP NEUROL, V519, P433, DOI 10.1002/cne.22526; Hirano AA, 2011, J COMP NEUROL, V519, P972, DOI 10.1002/cne.22562; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Hombach S, 2004, EUR J NEUROSCI, V19, P2633, DOI 10.1111/j.0953-816X.2004.03360.x; Iacovelli J, 2011, INVEST OPHTH VIS SCI, V52, P1378, DOI 10.1167/iovs.10-6347; Ivanova E, 2010, NEUROSCIENCE, V165, P233, DOI 10.1016/j.neuroscience.2009.10.021; Ivanova E, 2013, J COMP NEUROL, V521, P2165, DOI 10.1002/cne.23279; Jackman SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001057; Jakobs TC, 2007, MOL VIS, V13, P933; Janssen-Bienhoid U, 2009, J COMP NEUROL, V513, P363, DOI 10.1002/cne.21965; Kamermans M, 1999, VISION RES, V39, P2449, DOI 10.1016/S0042-6989(99)00043-7; Koulen P, 1996, EUR J NEUROSCI, V8, P2177, DOI 10.1111/j.1460-9568.1996.tb00739.x; Koulen P, 1999, P NATL ACAD SCI USA, V96, P9909, DOI 10.1073/pnas.96.17.9909; Kranz K, 2013, J COMP NEUROL, V521, P1119, DOI 10.1002/cne.23223; Le YZ, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/806783; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Lu T, 1998, NEUROSCI RES, V31, P123, DOI 10.1016/S0168-0102(98)00031-5; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; MESSERSMITH EK, 1990, INT J DEV NEUROSCI, V8, P447, DOI 10.1016/0736-5748(90)90077-F; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nakhai H, 2007, DEVELOPMENT, V134, P1151, DOI 10.1242/dev.02781; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; Peachey NS, 1997, VISUAL NEUROSCI, V14, P627, DOI 10.1017/S0952523800012591; PEICHL L, 1994, VISUAL NEUROSCI, V11, P501, DOI 10.1017/S095252380000242X; Poche RA, 2008, EUR J NEUROSCI, V27, P1607, DOI 10.1111/j.1460-9568.2008.06132.x; Puthussery T, 2010, J COMP NEUROL, V518, P513, DOI 10.1002/cne.22234; Raven MA, 2005, VISUAL NEUROSCI, V22, P461, DOI 10.1017/S0952523805224070; Rivera L, 2001, VISUAL NEUROSCI, V18, P995, DOI 10.1017/S0952523801186165; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rowan S, 2004, DEV BIOL, V271, P388, DOI 10.1016/j.ydbio.2004.03.039; Schubert T, 2006, J NEUROPHYSIOL, V96, P1278, DOI 10.1152/jn.00191.2006; Schubert T, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-15; Shelley J, 2006, EUR J NEUROSCI, V23, P3176, DOI 10.1111/j.1460-9568.2006.04848.x; Sonntag S, 2012, J NEUROSCI, V32, P10713, DOI 10.1523/JNEUROSCI.0442-12.2012; Thoreson WB, 2012, PROG RETIN EYE RES, V31, P407, DOI 10.1016/j.preteyeres.2012.04.003; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Trumpler J, 2008, J NEUROSCI, V28, P6818, DOI 10.1523/JNEUROSCI.1564-08.2008; Tykocinski LO, 2010, P NATL ACAD SCI USA, V107, P19426, DOI 10.1073/pnas.1009265107; Zappala A, 2010, NEUROSCIENCE, V171, P1, DOI 10.1016/j.neuroscience.2010.09.010; Zhang XM, 2005, INVEST OPHTH VIS SCI, V46, P3515, DOI 10.1167/iovs.04-1201	56	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83076	10.1371/journal.pone.0083076	http://dx.doi.org/10.1371/journal.pone.0083076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349437	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800093
J	Labonte, D; Federle, W				Labonte, David; Federle, Walter			Functionally Different Pads on the Same Foot Allow Control of Attachment: Stick Insects Have Load-Sensitive "Heel" Pads for Friction and Shear-Sensitive "Toe" Pads for Adhesion	PLOS ONE			English	Article							COLORADO POTATO BEETLES; DIVISION-OF-LABOR; SMOOTH; ULTRASTRUCTURE; LOCOMOTION; EVOLUTION; FIBRILLAR; CONTACT; SURFACE; MECHANISMS	Stick insects (Carausius morosus) have two distinct types of attachment pad per leg, tarsal "heel" pads (euplantulae) and a pre-tarsal "toe" pad (arolium). Here we show that these two pad types are specialised for fundamentally different functions. When standing upright, stick insects rested on their proximal euplantulae, while arolia were the only pads in surface contact when hanging upside down. Single-pad force measurements showed that the adhesion of euplantulae was extremely small, but friction forces strongly increased with normal load and coefficients of friction were > 1. The pre-tarsal arolium, in contrast, generated adhesion that strongly increased with pulling forces, allowing adhesion to be activated and deactivated by shear forces, which can be produced actively, or passively as a result of the insects' sprawled posture. The shear-sensitivity of the arolium was present even when corrected for contact area, and was independent of normal preloads covering nearly an order of magnitude. Attachment of both heel and toe pads is thus activated partly by the forces that arise passively in the situations in which they are used by the insects, ensuring safe attachment. Our results suggest that stick insect euplantulae are specialised "friction pads" that produce traction when pressed against the substrate, while arolia are "true" adhesive pads that stick to the substrate when activated by pulling forces.	[Labonte, David; Federle, Walter] Univ Cambridge, Dept Zool, Cambridge, England	University of Cambridge	Labonte, D (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.	dl416@cam.ac.uk	Federle, Walter/K-8263-2014	Federle, Walter/0000-0002-6375-3005; Labonte, David/0000-0002-1952-8732	Cusanuswerk; Biotechnology and Biological Sciences Research Council [BB/I008667/1]; Human Frontier Science Program [RGP0034/2012]; Biotechnology and Biological Sciences Research Council [BB/E004156/1] Funding Source: researchfish; BBSRC [BB/E004156/1, BB/I008667/1] Funding Source: UKRI	Cusanuswerk; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Human Frontier Science Program(Human Frontier Science Program); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by a scholarship from the Cusanuswerk to D. L., as well as by research grants from the Biotechnology and Biological Sciences Research Council (BB/I008667/1) and the Human Frontier Science Program (RGP0034/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD J W, 1974, International Journal of Insect Morphology and Embryology, V3, P317, DOI 10.1016/0020-7322(74)90026-9; Asbeck AT, 2006, INT J ROBOT RES, V25, P1165, DOI 10.1177/0278364906072511; Autumn K, 2006, J EXP BIOL, V209, P3569, DOI 10.1242/jeb.02486; Autumn K, 2000, NATURE, V405, P681, DOI 10.1038/35015073; Betz O, 2003, J MORPHOL, V255, P24, DOI 10.1002/jmor.10044; Beutel RG, 2001, J ZOOL SYST EVOL RES, V39, P177, DOI 10.1046/j.1439-0469.2001.00155.x; Beutel RG, 2008, SYST ENTOMOL, V33, P501, DOI 10.1111/j.1365-3113.2008.00428.x; Beutel Rolf G., 2006, Arthropod Systematics & Phylogeny, V64, P3; Bowden FP, 1939, PROC R SOC LON SER-A, V169, P391, DOI 10.1098/rspa.1939.0005; Bullock JMR, 2008, J EXP BIOL, V211, P3333, DOI 10.1242/jeb.020941; Bullock JMR, 2011, NATURWISSENSCHAFTEN, V98, P381, DOI 10.1007/s00114-011-0781-4; Bullock JMR, 2011, INSECT SCI, V18, P298, DOI 10.1111/j.1744-7917.2010.01369.x; Bullock JMR, 2009, J EXP BIOL, V212, P1876, DOI 10.1242/jeb.030551; Busshardt P, 2012, ZOOLOGY, V115, P135, DOI 10.1016/j.zool.2011.11.002; Clemente CJ, 2008, P ROY SOC B-BIOL SCI, V275, P1329, DOI 10.1098/rspb.2007.1660; Clemente CJ, 2010, J EXP BIOL, V213, P635, DOI 10.1242/jeb.038232; Clemente CJ, 2009, J COMP PHYSIOL A, V195, P805, DOI 10.1007/s00359-009-0457-0; CRUSE H, 1976, J COMP PHYSIOL, V112, P235, DOI 10.1007/BF00606541; Dai ZD, 2002, J EXP BIOL, V205, P2479; Derjaguin B, 1934, Z PHYS, V88, P661, DOI 10.1007/BF01333114; Dirks JH, 2012, ACTA BIOMATER, V8, P2730, DOI 10.1016/j.actbio.2012.04.008; Dirks JH, 2011, J R SOC INTERFACE, V8, P952, DOI 10.1098/rsif.2010.0575; Drechsler P, 2006, J COMP PHYSIOL A, V192, P1213, DOI 10.1007/s00359-006-0150-5; Eberhard MJB, 2009, J MORPHOL, V270, P1247, DOI 10.1002/jmor.10754; EDWARDS JS, 1970, PROC R ENTOMOL SOC A, V45, P1; Eisner T, 2000, P NATL ACAD SCI USA, V97, P6568, DOI 10.1073/pnas.97.12.6568; Endlein T, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0838; Federle W, 2004, ARTHROPOD STRUCT DEV, V33, P67, DOI 10.1016/j.asd.2003.11.001; Federle W, 2004, J EXP BIOL, V207, P67, DOI 10.1242/jeb.00716; Federle W, 2001, P NATL ACAD SCI USA, V98, P6215, DOI 10.1073/pnas.111139298; Frazier SF, 1999, J COMP PHYSIOL A, V185, P157, DOI 10.1007/s003590050374; FULL RJ, 1991, J EXP BIOL, V158, P369; Gao HJ, 2004, P NATL ACAD SCI USA, V101, P7851, DOI 10.1073/pnas.0400757101; Goldman DI, 2006, J EXP BIOL, V209, P2990, DOI 10.1242/jeb.02322; Gorb EV, 2002, ENTOMOL EXP APPL, V105, P13, DOI 10.1023/A:1021777517981; Gorb S, 2000, J COMP PHYSIOL A, V186, P821, DOI 10.1007/s003590000135; Gorb SN, 2001, NATURWISSENSCHAFTEN, V88, P530, DOI 10.1007/s00114-001-0274-y; GREENWOOD JA, 1966, PROC R SOC LON SER-A, V295, P300, DOI 10.1098/rspa.1966.0242; Haas F, 2004, ARTHROPOD STRUCT DEV, V33, P45, DOI 10.1016/j.asd.2003.11.003; HANNA G, 1991, J EXP BIOL, V155, P103; HILL DE, 1977, ZOOL J LINN SOC-LOND, V60, P319, DOI 10.1111/j.1096-3642.1977.tb00838.x; HUANG LK, 1995, PATTERN RECOGN, V28, P41, DOI 10.1016/0031-3203(94)E0043-K; Kumar A, 2011, P ROY SOC A-MATH PHY, V467, P1372, DOI 10.1098/rspa.2010.0449; Labonte D, 2013, J ROYAL SOC IN UNPUB; LARSEN GS, 1995, J COMP PHYSIOL A, V176, P229, DOI 10.1007/BF00239925; Lee DH, 2011, LANGMUIR, V27, P11008, DOI 10.1021/la201498u; Majidi C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.076103; Majidi C, 2009, MECH RES COMMUN, V36, P369, DOI 10.1016/j.mechrescom.2008.10.010; Majidi CS, 2005, J APPL PHYS, V98, DOI 10.1063/1.2128697; Marshall IK, 2003, ZOOL J LINN SOC-LOND, V138, P39, DOI 10.1046/j.1096-3642.2003.00057.x; Moon MJ, 2012, ENTOMOL RES, V42, P196, DOI 10.1111/j.1748-5967.2012.00459.x; Nadermann N, 2010, J R SOC INTERFACE, V7, P1581, DOI 10.1098/rsif.2010.0147; Nelson CH, 2009, AQUAT INSECT, V31, P523, DOI 10.1080/01650420802598210; Niederegger S, 2003, J INSECT PHYSIOL, V49, P611, DOI 10.1016/S0022-1910(03)00048-9; Niederegger S, 2002, J COMP PHYSIOL A, V187, P961, DOI 10.1007/s00359-001-0265-7; PAGE EB, 1963, J AM STAT ASSOC, V58, P216, DOI 10.2307/2282965; Peattie AM, 2007, P NATL ACAD SCI USA, V104, P18595, DOI 10.1073/pnas.0707591104; PELLETIER Y, 1987, CAN ENTOMOL, V119, P1139, DOI 10.4039/Ent1191139-12; Pesika NS, 2007, J ADHESION, V83, P383, DOI 10.1080/00218460701282539; Qu LT, 2008, SCIENCE, V322, P238, DOI 10.1126/science.1159503; R Development Core Team, 2011, R LANG ENV STAT COMP; Radhakrishnan V, 1998, P NATL ACAD SCI USA, V95, P5448, DOI 10.1073/pnas.95.10.5448; RICHARDS AG, 1979, INT J INSECT MORPHOL, V8, P143, DOI 10.1016/0020-7322(79)90013-8; Ridgel AL, 2003, J EXP BIOL, V206, P4453, DOI 10.1242/jeb.00714; ROTH LM, 1952, J EXP ZOOL, V119, P483, DOI 10.1002/jez.1401190307; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scholz I, 2008, J COMP PHYSIOL A, V194, P373, DOI 10.1007/s00359-008-0314-6; Schubert B, 2008, J R SOC INTERFACE, V5, P845, DOI 10.1098/rsif.2007.1309; Schulmeister S, 2003, ZOOLOGICA SCRIPTA, V32; SLIFER ELEANOR H., 1950, ANN ENT SOC AMERICA, V43, P173, DOI 10.1093/aesa/43.2.173; STORK NE, 1983, J NAT HIST, V17, P829, DOI 10.1080/00222938300770641; Sukontason KL, 2006, PARASITOL RES, V98, P477, DOI 10.1007/s00436-005-0100-0; Tian Y, 2006, P NATL ACAD SCI USA, V103, P19320, DOI 10.1073/pnas.0608841103; Voigt D, 2010, J ZOOL, V281, P227, DOI 10.1111/j.1469-7998.2010.00704.x; WHITTEN JM, 1969, J MORPHOL, V127, P73, DOI 10.1002/jmor.1051270105; WIGGLESWORTH VB, 1987, J EXP BIOL, V129, P373; Wolff JO, 2012, J EXP BIOL, V215, P179, DOI 10.1242/jeb.061507; YOSHIZAWA H, 1993, J PHYS CHEM-US, V97, P4128, DOI 10.1021/j100118a033	78	50	51	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81943	10.1371/journal.pone.0081943	http://dx.doi.org/10.1371/journal.pone.0081943			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349156	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300060
J	Lavasani, M; Pollett, JB; Usas, A; Thompson, SD; Pollett, AF; Huard, J				Lavasani, Mitra; Pollett, Jonathan B.; Usas, Arvydas; Thompson, Seth D.; Pollett, Aaron F.; Huard, Johnny			The Microenvironment-Specific Transformation of Adult Stem Cells Models Malignant Triton Tumors	PLOS ONE			English	Article							MUSCLE-DERIVED CELLS; NERVE SHEATH TUMOR; SKELETAL-MUSCLE; PERIPHERAL-NERVE; RHABDOMYOSARCOMATOUS DIFFERENTIATION; NATURAL-HISTORY; BONE-MARROW; GERM-CELL; REGENERATION; MOUSE	Here, we demonstrated the differentiation potential of murine muscle-derived stem/progenitor cells (MDSPCs) toward myogenic, neuronal, and glial lineages. MDSPCs, following transplantation into a critical-sized sciatic nerve defect in mice, showed full regeneration with complete functional recovery of the injured peripheral nerve at 6 weeks post-implantation. However, several weeks after regeneration of the sciatic nerve, neoplastic growths were observed. The resulting tumors were malignant peripheral nerve sheath tumors (MPNSTs) with rhabdomyoblastic differentiation, expressing myogenic, neurogenic, and glial markers, common markers of human malignant triton tumors (MTTs). No signs of tumorigenesis were observed 17 weeks post-implantation of MDSPCs into the gastrocnemius muscles of dystrophic/mdx mice, or 1 year following subcutaneous or intravenous injection. While MDSPCs were not oncogenic in nature, the neoplasias were composed almost entirely of donor cells. Furthermore, cells isolated from the tumors were serially transplantable, generating tumors when reimplanted into mice. However, this transformation could be abrogated by differentiation of the cells toward the neurogenic lineage prior to implantation. These results establish that MDSPCs participated in the regeneration of the injured peripheral nerve but transformed in a microenvironment-and time-dependent manner, when they likely received concomitant neurogenic and myogenic differentiation signals. This microenvironment-specific transformation provides a useful mouse model for human MTTs and potentially some insight into the origins of this disease.	[Lavasani, Mitra; Pollett, Jonathan B.; Usas, Arvydas; Thompson, Seth D.; Huard, Johnny] Childrens Hosp Pittsburgh, Stem Cell Res Ctr, Pittsburgh, PA 15213 USA; [Lavasani, Mitra; Huard, Johnny] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Lavasani, Mitra; Pollett, Jonathan B.; Usas, Arvydas; Thompson, Seth D.; Huard, Johnny] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Pollett, Jonathan B.] Allegheny Singer Res Inst, Pittsburgh, PA 15212 USA; [Pollett, Aaron F.] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Pollett, Aaron F.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Huard, Johnny] Univ Pittsburgh, Dept Mol Genet & Biochem, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lavasani, M (corresponding author), Childrens Hosp Pittsburgh, Stem Cell Res Ctr, Pittsburgh, PA 15213 USA.	mil39@pitt.edu; jhuard@pitt.edu	Pollett, Aaron/J-2308-2016; Pollett, Aaron/AAQ-2540-2021	Pollett, Aaron/0000-0001-5121-8788; Pollett, Aaron/0000-0001-5121-8788; Thompson, Seth/0000-0002-6769-6941	Henry J. Mankin Endowed Chair for Orthopaedic Research at the University of Pittsburgh; William F. and Jean W. Donaldson Chair at Children's Hospital of Pittsburgh; Hirtzel Foundation; NIH [R01AR049684, R01AR047973, P30CA47904]; Department of Defense [W81XWH04-0003]; NATIONAL CANCER INSTITUTE [P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047973, R01AR049684] Funding Source: NIH RePORTER	Henry J. Mankin Endowed Chair for Orthopaedic Research at the University of Pittsburgh(University of Pittsburgh); William F. and Jean W. Donaldson Chair at Children's Hospital of Pittsburgh; Hirtzel Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by funding from the Henry J. Mankin Endowed Chair for Orthopaedic Research at the University of Pittsburgh, the William F. and Jean W. Donaldson Chair at Children's Hospital of Pittsburgh, the Hirtzel Foundation, and grants from the NIH (R01AR049684, and R01AR047973) and the Department of Defense (W81XWH04-0003). Cytogenetic analyses were carried out in the UPCI Cytogenetics Facility, supported in part by NIH grant P30CA47904 to Drs. Susanne M. Gollin and Ronald B. Herberman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessandri G, 2004, LANCET, V364, P1872, DOI 10.1016/S0140-6736(04)17443-6; ANDREWS PW, 1980, INT J CANCER, V26, P269, DOI 10.1002/ijc.2910260304; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Bridge RS, 2004, J CLIN PATHOL, V57, P1172, DOI 10.1136/jcp.2004.019026; BROOKS JSJ, 1985, CANCER-AM CANCER SOC, V55, P2543, DOI 10.1002/1097-0142(19850601)55:11<2543::AID-CNCR2820551105>3.0.CO;2-4; Cao BH, 2003, NAT CELL BIOL, V5, P640, DOI 10.1038/ncb1008; Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240; Colucci-D'Amato GL, 1999, EXP CELL RES, V252, P383, DOI 10.1006/excr.1999.4636; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; DAMJANOV I, 1993, INT J DEV BIOL, V37, P39; Damjanov I, 2004, VERH DEUT G, V88, P39; Dijkstra JR, 2000, J NEUROSCI METH, V96, P89, DOI 10.1016/S0165-0270(99)00174-0; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Feldman DH, 1996, EXP NEUROL, V140, P206, DOI 10.1006/exnr.1996.0130; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gharaibeh B, 2008, NAT PROTOC, V3, P1501, DOI 10.1038/nprot.2008.142; Gollin SM, 2005, SEMIN CANCER BIOL, V15, P33, DOI 10.1016/j.semcancer.2004.09.004; Greaves M, 1999, EUR J CANCER, V35, P1941, DOI 10.1016/S0959-8049(99)00296-8; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Inserra MM, 1998, MICROSURG, V18, P119, DOI 10.1002/(SICI)1098-2752(1998)18:2<119::AID-MICR10>3.3.CO;2-Z; Kuroda R, 2006, ARTHRITIS RHEUM-US, V54, P433, DOI 10.1002/art.21632; Lavasani Mitra, 2013, Methods Mol Biol, V976, P53, DOI 10.1007/978-1-62703-317-6_5; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Lewin-Kowalik J, 2006, NEUROL MED-CHIR, V46, P62, DOI 10.2176/nmc.46.62; Masson P, 1932, RECKLINGHAUSENS NEUR, P793; Meek MF, 2001, BIOMATERIALS, V22, P1177, DOI 10.1016/S0142-9612(00)00340-9; Oshima H, 2005, MOL THER, V12, P1130, DOI 10.1016/j.ymthe.2005.07.686; Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153; PIERCE GB, 1959, CANCER, V12, P573, DOI 10.1002/1097-0142(195905/06)12:3<573::AID-CNCR2820120316>3.0.CO;2-M; Pollett JB, 2007, STEM CELLS, V25, P2302, DOI 10.1634/stemcells.2006-0773; Powell K, 2005, NATURE, V435, P268, DOI 10.1038/435268a; Prindull G, 2004, BLOOD, V103, P2892, DOI 10.1182/blood-2003-08-2807; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Ribeiro S, 2013, CELL REP, V5, P126, DOI 10.1016/j.celrep.2013.08.033; Rizo A, 2006, HUM MOL GENET, V15, pR210, DOI 10.1093/hmg/ddl175; Romero-Ramos M, 2002, J NEUROSCI RES, V69, P894, DOI 10.1002/jnr.10374; ROSSANT J, 1984, CELL DIFFER DEV, V15, P155, DOI 10.1016/0045-6039(84)90068-X; Rosser AE, 1997, DEV BRAIN RES, V98, P291, DOI 10.1016/S0165-3806(96)00189-7; Rotter W, 1921, HISTOGENESE MALIGNEN, V18, P171; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42; Schultz SS, 2006, J NEUROSCI METH, V152, P144, DOI 10.1016/j.jneumeth.2005.08.022; Serakinci N, 2004, ONCOGENE, V23, P5095, DOI 10.1038/sj.onc.1207651; Shih CC, 2007, STEM CELLS DEV, V16, P893, DOI 10.1089/scd.2007.0070; Solter D, 2006, NAT REV GENET, V7, P319, DOI 10.1038/nrg1827; STARK A, 1983, ULTRASTRUCT PATHOL, V4, P311, DOI 10.3109/01913128309140584; Stasik CJ, 2006, ARCH PATHOL LAB MED, V130, P1878; Sterne GD, 1997, EUR J NEUROSCI, V9, P1388, DOI 10.1111/j.1460-9568.1997.tb01493.x; Strauss BL, 1999, HUM PATHOL, V30, P984, DOI 10.1016/S0046-8177(99)90255-1; Suzuki T, 1996, THORAC CARDIOV SURG, V44, P319, DOI 10.1055/s-2007-1012047; Tamaki T, 2005, CIRCULATION, V112, P2857, DOI 10.1161/CIRCULATIONAHA.105.554832; Tamaki T, 2007, STEM CELLS, V25, P2283, DOI 10.1634/stemcells.2006-0746; Taussig DC, 2005, BLOOD, V106, P4086, DOI 10.1182/blood-2005-03-1072; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; van Deutekom JCT, 1998, NEUROMUSCULAR DISORD, V8, P135, DOI 10.1016/S0960-8966(98)00019-4; Verdijk RM, 2010, J NEUROPATH EXP NEUR, V69, P16, DOI 10.1097/NEN.0b013e3181c55d55; Vourc'h P, 2004, BIOCHEM BIOPH RES CO, V317, P893, DOI 10.1016/j.bbrc.2004.03.121; WEISS SW, 2001, ENZINGER WEISSS SOFT; WOODRUFF JM, 1973, CANCER, V32, P426, DOI 10.1002/1097-0142(197308)32:2<426::AID-CNCR2820320221>3.0.CO;2-W; WOODRUFF JM, 1994, SEMIN DIAGN PATHOL, V11, P69; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041; Zheng B, 2007, NAT BIOTECHNOL, V25, P1025, DOI 10.1038/nbt1334; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	68	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82173	10.1371/journal.pone.0082173	http://dx.doi.org/10.1371/journal.pone.0082173			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349213	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000328705200066
J	Zhang, C; Zhang, LB; Chen, SL; Feng, B; Lu, XM; Bai, Y; Liang, G; Tan, Y; Shao, ML; Skibba, M; Jin, LT; Li, XK; Chakrabarti, S; Cai, L				Zhang, Chi; Zhang, Linbo; Chen, Shali; Feng, Biao; Lu, Xuemian; Bai, Yang; Liang, Guang; Tan, Yi; Shao, Minglong; Skibba, Melissa; Jin, Litai; Li, Xiaokun; Chakrabarti, Subrata; Cai, Lu			The Prevention of Diabetic Cardiomyopathy by Non-Mitogenic Acidic Fibroblast Growth Factor Is Probably Mediated by the Suppression of Oxidative Stress and Damage	PLOS ONE			English	Article							NF-KAPPA-B; CARDIAC MYOCYTES; MYOCARDIAL FIBROSIS; FACTOR FAMILY; DNA-DAMAGE; APOPTOSIS; HEART; HYPERTROPHY; DYSFUNCTION; RATS	Background: Emerging evidence showed the beneficial effect of acidic fibroblast growth factor (aFGF) on heart diseases. The present study investigated whether non-mitogenic aFGF (nm-aFGF) can prevent diabetic cardiomyopathy and the underlying mechanisms, if any. Methodology/Principal Findings: Type 1 diabetes was induced in mice by multiple intraperitoneal injections of low-dose streptozotocin. Hyperglycemic and age-matched control mice were treated with or without nm-aFGF at 10 mu g/kg daily for 1 and 6 months. Blood pressure and cardiac function were assessed. Cardiac H9c2 cell, human microvascular endothelial cells, and rat cardiomyocytes were exposed to high glucose (25 mM) for mimicking an in vitro diabetic condition for mechanistic studies. Oxidative stress, DNA damage, cardiac hypertrophy and fibrosis were assessed by real-time qPCR, immunofluorescent staining, Western blotting, and pathological examination. Nm-aFGF significantly prevented diabetes-induced hypertension and cardiac dysfunction at 6 months. Mechanistic studies demonstrated that nm-aFGF showed the similar preventive effect as the native aFGF on high glucose-induced oxidative stress (increase generation of reactive oxygen species) and damage (cellular DNA oxidation), cell hypertrophy, and fibrotic response (increased mRNA expression of fibronectin) in three kinds of cells. These in vitro findings were recaptured by examining the heart of the diabetic mice with and without nm-aFGF. Conclusions: These results suggest that nm-aFGF can prevent diabetic cardiomyopathy, probably through attenuation of cardiac oxidative stress, hypertrophy, and fibrosis.	[Zhang, Chi; Liang, Guang; Tan, Yi; Shao, Minglong; Jin, Litai; Li, Xiaokun; Cai, Lu] Wenzhou Med Univ, Chinese Amer Res Inst Diabet Complicat, Wenzhou, Zhejiang, Peoples R China; [Zhang, Chi; Lu, Xuemian; Shao, Minglong] Wenzhou Med Univ, Chinese Amer Res Inst Diabet Complicat, Ruian Ctr, Affiliated Hosp 3, Wenzhou, Zhejiang, Peoples R China; [Zhang, Linbo; Chen, Shali; Feng, Biao; Chakrabarti, Subrata] Univ Western Ontario, Dept Pathol, London, ON, Canada; [Zhang, Linbo] Jilin Agr Univ, Dept Pharmaceut Engn, Changchun, Jilin, Peoples R China; [Bai, Yang; Li, Xiaokun] Jilin Agr Univ, Hosp 1, Dept Cardiac Surg, Changchun, Jilin, Peoples R China; [Liang, Guang; Jin, Litai] Wenzhou Med Univ, Sch Pharm, Wenzhou, Zhejiang, Peoples R China; [Tan, Yi; Skibba, Melissa; Cai, Lu] Univ Louisville, Dept Pharmacol, Louisville, KY 40292 USA; [Tan, Yi; Skibba, Melissa; Cai, Lu] Univ Louisville, Dept Toxicol, Louisville, KY 40292 USA; [Tan, Yi; Cai, Lu] Univ Louisville, Dept Pediat, Kosair Childrens Hosp, Res Inst, Louisville, KY 40292 USA	Wenzhou Medical University; Wenzhou Medical University; Western University (University of Western Ontario); Jilin Agricultural University; Jilin Agricultural University; Wenzhou Medical University; University of Louisville; University of Louisville; University of Louisville	Chakrabarti, S (corresponding author), Univ Western Ontario, Dept Pathol, London, ON, Canada.	subrata.chakrabarti@lhsc.on.ca; l0cai001@louisville.edu	Cai, Lu/AAG-9920-2019; ZHANG, LIN/GYD-9123-2022	Chakrabarti, Subrata/0000-0002-0208-1401	National Science Foundation of China [81000294]; Wenzhou Medical University [QTJ13005]; China-Canada Joint Health Research Initiative [81061120517]; Starting-Up Fund for Chinese-American Research Institute for Diabetic Complications from Wenzhou Medical University	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Medical University; China-Canada Joint Health Research Initiative; Starting-Up Fund for Chinese-American Research Institute for Diabetic Complications from Wenzhou Medical University	This study was supported in part by a Young Scientist Award from National Science Foundation of China (81000294, to C. Zhang), Research Development Fund of Wenzhou Medical University (QTJ13005, to C. Zhang), China-Canada Joint Health Research Initiative (81061120517, to S. Chakrabarti and X. Li) and a Starting-Up Fund for Chinese-American Research Institute for Diabetic Complications from Wenzhou Medical University (to X. Li and L. Cai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2005, BJU INT, V95, P503, DOI 10.1111/j.1464-410X.2005.05328.x; Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Basu R, 2009, AM J PHYSIOL-HEART C, V297, pH2096, DOI 10.1152/ajpheart.00452.2009; Cai L, 2005, DIABETES, V54, P1829, DOI 10.2337/diabetes.54.6.1829; Cassina P, 2005, J NEUROCHEM, V93, P38, DOI 10.1111/j.1471-4159.2004.02984.x; Cave A, 2005, PHILOS T R SOC B, V360, P2327, DOI 10.1098/rstb.2005.1772; Chen JW, 2003, AM J PHYSIOL-ENDOC M, V284, pE1149, DOI 10.1152/ajpendo.00410.2002; Chen SL, 2003, AM J PHYSIOL-CELL PH, V284, pC263, DOI 10.1152/ajpcell.00192.2002; Chen WW, 2009, J OCUL PHARMACOL TH, V25, P315, DOI 10.1089/jop.2009.0015; Chong ZZ, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-45; Chung CY, 2011, FASEB J, V25, P851, DOI 10.1096/fj.10-168625; CONRAD CH, 1995, CIRCULATION, V91, P161, DOI 10.1161/01.CIR.91.1.161; Detillieux KA, 2003, CARDIOVASC RES, V57, P8, DOI 10.1016/S0008-6363(02)00708-3; ENGELMANN GL, 1993, CIRC RES, V72, P7, DOI 10.1161/01.RES.72.1.7; Feng BA, 2010, DIABETES-METAB RES, V26, P40, DOI 10.1002/dmrr.1054; Fu XB, 2004, WORLD J GASTROENTERO, V10, P3590, DOI 10.3748/wjg.v10.i24.3590; Gan XHT, 2003, CAN J PHYSIOL PHARM, V81, P105, DOI 10.1139/Y03-030; Guan SJ, 2012, FOOD CHEM TOXICOL, V50, P1874, DOI 10.1016/j.fct.2012.03.006; Hicks K K, 1996, P R Health Sci J, V15, P179; Ho CY, 2010, NEW ENGL J MED, V363, P552, DOI 10.1056/NEJMoa1002659; Horio T, 2000, HYPERTENSION, V35, P19, DOI 10.1161/01.HYP.35.1.19; House SL, 2003, CIRCULATION, V108, P3140, DOI 10.1161/01.CIR.0000105723.91637.1C; INGBER DE, 1989, CELL, V58, P803, DOI 10.1016/0092-8674(89)90928-8; Ito J, 2013, BRAIN RES, V1522, P12, DOI 10.1016/j.brainres.2013.05.035; Iwai-Kanai E, 2002, J CELL PHYSIOL, V190, P54, DOI 10.1002/jcp.10036; Khan ZA, 2004, INVEST OPHTH VIS SCI, V45, P287, DOI 10.1167/iovs.03-0540; Krejci P, 2009, HUM MUTAT, V30, P1245, DOI 10.1002/humu.21067; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li HH, 2007, J GASTROEN HEPATOL, V22, P363, DOI 10.1111/j.1440-1746.2006.04457.x; MATUSZEWSKA B, 1994, PHARM RES-DORDR, V11, P65, DOI 10.1023/A:1018993610801; Maulik SK, 2012, TOXICOL MECH METHOD, V22, P359, DOI 10.3109/15376516.2012.666650; MELLIN TN, 1995, J INVEST DERMATOL, V104, P850, DOI 10.1111/1523-1747.ep12607026; Mezzetti A, 2000, CARDIOVASC RES, V47, P475, DOI 10.1016/S0008-6363(00)00118-8; Miao JY, 2002, ACTA PHARMACOL SIN, V23, P323; Shen H, 2007, J NUTR, V137, P2339, DOI 10.1093/jn/137.11.2339; SPEIR E, 1992, CIRC RES, V71, P251, DOI 10.1161/01.RES.71.2.251; Suematsu N, 2003, CIRCULATION, V107, P1418, DOI 10.1161/01.CIR.0000055318.09997.1F; Suzuki YJ, 2003, ANTIOXID REDOX SIGN, V5, P741, DOI 10.1089/152308603770380043; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Tan Y, 2012, J AM COLL CARDIOL, V59, P1477, DOI 10.1016/j.jacc.2011.12.034; Turner CA, 2012, NEURON, V76, P160, DOI 10.1016/j.neuron.2012.08.037; VLODAVSKY I, 1991, J CELL BIOCHEM, V45, P167, DOI 10.1002/jcb.240450208; Waltenberger J, 1997, CIRCULATION, V96, P4083; Wang YH, 2013, AM J PHYSIOL-HEART C, V304, pH567, DOI 10.1152/ajpheart.00650.2012; Watanabe K, 2010, CURR CARDIOL REV, V6, P280, DOI 10.2174/157340310793566145; Wu XP, 2005, PROTEIN EXPRES PURIF, V42, P7, DOI 10.1016/j.pep.2004.07.021; Xiao J, 2010, BIOL PHARM BULL, V33, P444, DOI 10.1248/bpb.33.444; Xie LY, 2011, DIABETES RES CLIN PR, V93, P396, DOI 10.1016/j.diabres.2011.05.016; Yeboah J, 2007, DIS MARKERS, V23, P173, DOI 10.1155/2007/962892; Zhao YZ, 2012, J DRUG TARGET, V20, P623, DOI 10.3109/1061186X.2012.702771; Zhou GH, 2008, J AM COLL CARDIOL, V52, P655, DOI 10.1016/j.jacc.2008.05.019	52	29	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82287	10.1371/journal.pone.0082287	http://dx.doi.org/10.1371/journal.pone.0082287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349248	Green Submitted, gold, Green Published			2022-12-27	WOS:000328705200073
J	Mealer, M; Kittelson, J; Thompson, BT; Wheeler, AP; Magee, JC; Sokol, RJ; Moss, M; Kahn, MG				Mealer, Meredith; Kittelson, John; Thompson, B. Taylor; Wheeler, Arthur P.; Magee, John C.; Sokol, Ronald J.; Moss, Marc; Kahn, Michael G.			Remote Source Document Verification in Two National Clinical Trials Networks: A Pilot Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DATA QUALITY; BARRIERS; VALIDITY	Objective: Barriers to executing large-scale randomized controlled trials include costs, complexity, and regulatory requirements. We hypothesized that source document verification (SDV) via remote electronic monitoring is feasible. Methods: Five hospitals from two NIH sponsored networks provided remote electronic access to study monitors. We evaluated pre-visit remote SDV compared to traditional on-site SDV using a randomized convenience sample of all study subjects due for a monitoring visit. The number of data values verified and the time to perform remote and on-site SDV was collected. Results: Thirty-two study subjects were randomized to either remote SDV (N=16) or traditional on-site SDV (N=16). Technical capabilities, remote access policies and regulatory requirements varied widely across sites. In the adult network, only 14 of 2965 data values (0.47%) could not be located remotely. In the traditional on-site SDV arm, 3 of 2608 data values (0.12%) required coordinator help. In the pediatric network, all 198 data values in the remote SDV arm and all 183 data values in the on-site SDV arm were located. Although not statistically significant there was a consistent trend for more time consumed per data value (minutes +/- SD): Adult 0.50 +/- 0.17 min vs. 0.39 +/- 0.10 min (two-tailed t-test p=0.11); Pediatric 0.99 +/- 1.07 min vs. 0.56 +/- 0.61 min (p=0.37) and time per case report form: Adult: 4.60 +/- 1.42 min vs. 3.60 +/- 0.96 min (p=0.10); Pediatric: 11.64 +/- 7.54 min vs. 6.07 +/- 3.18 min (p=0.10) using remote SDV. Conclusions: Because each site had different policies, requirements, and technologies, a common approach to assimilating monitors into the access management system could not be implemented. Despite substantial technology differences, more than 99% of data values were successfully monitored remotely. This pilot study demonstrates the feasibility of remote monitoring and the need to develop consistent access policies for remote study monitoring.	[Mealer, Meredith; Moss, Marc] Univ Colorado, Sch Med, Div Pulm Sci & Crit Care Med, Dept Med, Aurora, CO 80045 USA; [Kittelson, John] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Kittelson, John; Sokol, Ronald J.; Moss, Marc; Kahn, Michael G.] Univ Colorado, Anschutz Med Ctr, Colorado Clin & Translat Sci Inst, Aurora, CO USA; [Thompson, B. Taylor] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Wheeler, Arthur P.] Vanderbilt Univ, Med Ctr, Sch Med, Nashville, TN 37232 USA; [Magee, John C.] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Sokol, Ronald J.; Kahn, Michael G.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Massachusetts General Hospital; Vanderbilt University; University of Michigan System; University of Michigan; University of Colorado System; University of Colorado Anschutz Medical Campus	Mealer, M (corresponding author), Univ Colorado, Sch Med, Div Pulm Sci & Crit Care Med, Dept Med, Aurora, CO 80045 USA.	Meredith.Mealer@ucdenver.edu			NIH/NCATS Colorado CTSI Grant [UL1 TR000154]; University of Colorado [HHSN268200536-179C, N01-56167, 2U01DK06243-08]; University of Michigan [CCC: 5U01DK062456-11]	NIH/NCATS Colorado CTSI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of Colorado; University of Michigan(University of Michigan System)	This work was supported by NIH/NCATS Colorado CTSI Grant Number UL1 TR000154. The ARDS network was supported by HHSN268200536-179C (MGH) and N01-56167 (University of Colorado). The ChilDREN network is supported by CCC: 5U01DK062456-11 (University of Michigan) and 2U01DK06243-08 (University of Colorado). Contents are the authors' sole responsibility and do not necessarily represent official NIH views. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent C, 2008, CLIN TRIALS, V5, P49, DOI 10.1177/1740774507087554; Breslauer C., 2006, MONITOR, P43; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Davis JR Institute of Medicine (U.S.), 1999, ASS DAT QUAL VAL CLI, Vxii; Duley L, 2008, CLIN TRIALS, V5, P40, DOI 10.1177/1740774507087704; Edge Cutting. Information, 2013, PER PAT CLIN TRIAL C; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; HORBAR JD, 1995, CONTROL CLIN TRIALS, V16, P51, DOI 10.1016/0197-2456(94)00019-Y; ICH Harmonised Tripartite Guideline, 1996, GUILD GOOD CLIN PRAC; Nahm ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003049; Relton C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1066; Spaar A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-14; Spilker B., 1991, GUIDE CLIN TRIALS; Stafford PB, 2011, DRUG INF J, V45, P495, DOI 10.1177/009286151104500410; Thorpe KE, 2009, CAN MED ASSOC J, V180, pE47, DOI 10.1503/cmaj.090523; VANTONGELEN K, 1989, EUR J CANCER CLIN ON, V25, P1241, DOI 10.1016/0277-5379(89)90421-5; Williams GW, 2006, CLIN TRIALS, V3, P530, DOI 10.1177/1740774506073104	17	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81890	10.1371/journal.pone.0081890	http://dx.doi.org/10.1371/journal.pone.0081890			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349149	Green Published, gold			2022-12-27	WOS:000328566100074
J	Zhong, CB; Talmage, DA; Role, LW				Zhong, Chongbo; Talmage, David A.; Role, Lorna W.			Nicotine Elicits Prolonged Calcium Signaling along Ventral Hippocampal Axons	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; LONG-TERM POTENTIATION; ACETYLCHOLINE-RECEPTORS; SYNAPTIC-TRANSMISSION; CA2+ PERMEABILITY; GLUTAMATE RELEASE; SH-SY5Y CELLS; ALPHA-7; ENHANCEMENT; FACILITATION	Presynaptic nicotinic acetylcholine receptors (nAChRs) have long been implicated in the modulation of CNS circuits. We previously reported that brief exposure to low concentrations of nicotine induced sustained potentiation of glutamatergic transmission at ventral hippocampal (vHipp)-striatal synapses. Here, we exploited nAChR subtype-selective antagonists and agonists and alpha 7*nAChR knockout mutant mice (alpha 7-/-) to elucidate the signaling mechanisms underlying nAChR-mediated modulation of synaptic transmission. Using a combination of micro-slices culture from WT and alpha 7-/-mice, calcium imaging, and immuno-histochemical techniques, we found that nicotine elicits localized and oscillatory increases in intracellular Ca2+ along vHipp axons that persists for up to 30 minutes. The sustained phase of the nicotine-induced Ca2+ response was blocked by alpha-BgTx but not by DH beta E and was mimicked by alpha 7*nAChR agonists but not by non-alpha 7*nAChR agonists. In vHipp slices from alpha 7-/-mice, nicotine elicited only transient increases of axonal Ca2+ signals and did not activate CaMKII. The sustained phase of the nicotine-induced Ca2+ response required localized activation of CaMKII, phospholipase C, and IP3 receptor mediated Ca2+-induced Ca2+ release (CICR). In conclusion, activation of presynaptic nAChRs by nicotine elicits Ca2+ influx into the presynaptic axons, the sustained phase of the nicotine-induced Ca2+ response requires that axonal alpha 7*nAChR activate a downstream signaling network in the vHipp axons.	[Zhong, Chongbo; Role, Lorna W.] SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; [Zhong, Chongbo; Talmage, David A.; Role, Lorna W.] SUNY Stony Brook, Ctr Nervous Syst Disorder, Stony Brook, NY 11794 USA; [Talmage, David A.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Role, Lorna W.] SUNY Stony Brook, Inst Neurosci, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Zhong, CB (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.	chongbo.zhong@stonybrook.edu	Role, LW/Q-7371-2018	Role, LW/0000-0001-5851-212X; Talmage, David/0000-0003-4627-3007	NIH [NS22061]; NARSAD Distinguished Investigator Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022061] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD Distinguished Investigator Award(NARSAD); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by a grant from the NIH (NS22061) and a NARSAD Distinguished Investigator Award to LWR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; CASTRO NG, 1993, NEUROSCI LETT, V164, P137, DOI 10.1016/0304-3940(93)90876-M; Chang KT, 2001, NEURON, V32, P855, DOI 10.1016/S0896-6273(01)00516-5; Changeux JP, 1998, BRAIN RES REV, V26, P198, DOI 10.1016/S0165-0173(97)00040-4; Cox ME, 1997, J NEUROCHEM, V69, P1119; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; Dajas-Bailador FA, 2002, J NEUROCHEM, V81, P606, DOI 10.1046/j.1471-4159.2002.00846.x; Dajas-Bailador FA, 2002, J NEUROCHEM, V80, P520, DOI 10.1046/j.0022-3042.2001.00725.x; Damaj MI, 2007, J PHARMACOL EXP THER, V320, P244, DOI 10.1124/jpet.106.111336; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; del Barrio L, 2011, BRIT J PHARMACOL, V162, P94, DOI 10.1111/j.1476-5381.2010.01034.x; Dineley KT, 2001, J NEUROSCI, V21, P4125, DOI 10.1523/JNEUROSCI.21-12-04125.2001; Exley R, 2012, J NEUROSCI, V32, P2352, DOI 10.1523/JNEUROSCI.4985-11.2012; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; Fayuk D, 2005, J PHYSIOL-LONDON, V566, P759, DOI 10.1113/jphysiol.2005.089789; de Sevilla DF, 2008, J NEUROSCI, V28, P1469, DOI 10.1523/JNEUROSCI.2723-07.2008; Freedman Robert, 2003, Curr Psychiatry Rep, V5, P155, DOI 10.1007/s11920-003-0032-2; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; Gilbert D, 2009, CELL CALCIUM, V45, P198, DOI 10.1016/j.ceca.2008.10.003; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Haydar SN, 2010, CURR TOP MED CHEM, V10, P144, DOI 10.2174/156802610790410983; Hellstrom-Lindahl E, 1999, MOL BRAIN RES, V66, P94, DOI 10.1016/S0169-328X(99)00030-3; Hogg RC, 2004, CNS NEUROL DISORD-DR, V3, P123, DOI 10.2174/1568007043482507; Jaldety Y, 2012, J BIOL CHEM, V287, P22328, DOI 10.1074/jbc.M111.292292; Jiang L, 2008, J NEUROPHYSIOL, V99, P1988, DOI 10.1152/jn.00933.2007; Jones IW, 2004, J NEUROSCI, V24, P11244, DOI 10.1523/JNEUROSCI.3009-04.2004; Kalappa BI, 2011, AM J PHYSIOL-CELL PH, V301, pC347, DOI 10.1152/ajpcell.00473.2010; Kawai H, 2002, J NEUROSCI, V22, P7903; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Levin ED, 2002, J NEUROBIOL, V53, P633, DOI 10.1002/neu.10151; LIU G, 1995, NEUROPHARMACOLOGY, V34, P1407, DOI 10.1016/0028-3908(95)00143-T; Mansvelder HD, 2009, SEMIN CELL DEV BIOL, V20, P432, DOI 10.1016/j.semcdb.2009.01.007; Mao DY, 2011, J NEUROSCI, V31, P6710, DOI 10.1523/JNEUROSCI.5671-10.2011; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; Mckay BE, 2007, BIOCHEM PHARMACOL, V74, P1120, DOI 10.1016/j.bcp.2007.07.001; Mineur YS, 2010, TRENDS PHARMACOL SCI, V31, P580, DOI 10.1016/j.tips.2010.09.004; Miwa JM, 2011, NEURON, V70, P20, DOI 10.1016/j.neuron.2011.03.014; Nakauchi S, 2012, EUR J NEUROSCI, V35, P1381, DOI 10.1111/j.1460-9568.2012.08056.x; Navarrete M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001259; Newhouse P, 2004, CURR TOP MED CHEM, V4, P267, DOI 10.2174/1568026043451401; Nordman JC, 2012, J CELL SCI, V125, P5502, DOI 10.1242/jcs.110379; Parikh V, 2010, J NEUROSCI, V30, P3518, DOI 10.1523/JNEUROSCI.5712-09.2010; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Philip NS, 2010, PSYCHOPHARMACOLOGY, V212, P1, DOI 10.1007/s00213-010-1932-6; Radcliffe KA, 1999, ANN NY ACAD SCI, V868, P591, DOI 10.1111/j.1749-6632.1999.tb11332.x; Razani-Boroujerdi S, 2007, J IMMUNOL, V179, P2889, DOI 10.4049/jimmunol.179.5.2889; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; Sabbagh MN, 2002, J ALZHEIMERS DIS, V4, P317, DOI 10.3233/JAD-2002-4407; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Sharma G, 2001, P NATL ACAD SCI USA, V98, P4148, DOI 10.1073/pnas.071540198; Sharma G, 2008, J NEUROSCI, V28, P2563, DOI 10.1523/JNEUROSCI.5407-07.2008; Shuai JW, 2007, BIOPHYS J, V93, P1151, DOI 10.1529/biophysj.107.108795; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002/jnr.20850; Szabo SI, 2008, HIPPOCAMPUS, V18, P376, DOI 10.1002/hipo.20401; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Tregellas JR, 2011, BIOL PSYCHIAT, V69, P7, DOI 10.1016/j.biopsych.2010.07.004; Wang BW, 2006, SYNAPSE, V59, P491, DOI 10.1002/syn.20267; WANG SSH, 1995, J GEN PHYSIOL, V105, P149, DOI 10.1085/jgp.105.1.149; Welsby P, 2006, EUR J NEUROSCI, V24, P3109, DOI 10.1111/j.1460-9568.2006.05187.x; Williams DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029209; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; Wonnacott S, 2006, J MOL NEUROSCI, V30, P137, DOI 10.1385/JMN:30:1:137; Yakel JL, 2010, J PHYSIOL-LONDON, V588, P597, DOI 10.1113/jphysiol.2009.182691; Zhong CB, 2008, J NEUROSCI, V28, P9111, DOI 10.1523/JNEUROSCI.0381-08.2008	65	35	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82719	10.1371/journal.pone.0082719	http://dx.doi.org/10.1371/journal.pone.0082719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349346	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100127
J	Chen, C; Liu, Q; Zhu, LM; Yang, HT; Lu, W				Chen, Cheng; Liu, Qiao; Zhu, Limei; Yang, Haitao; Lu, Wei			Vitamin D Receptor Gene Polymorphisms on the Risk of Tuberculosis, a Meta-Analysis of 29 Case-Control Studies	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; FOKI POLYMORPHISMS; MYCOBACTERIUM-TUBERCULOSIS; REGULATORY ROLE; VDR GENE; SUSCEPTIBILITY; VARIANTS; ASSOCIATION; APAI; BSMI	The relationship of four potentially functional polymorphisms of the vitamin D receptor (VDR) gene, ApaI, BsmI, FokI and TaqI, with tuberculosis susceptibility were considered. The aim of this meta-analysis was to explore the association between the four polymorphisms and tuberculosis risk in different ethnic backgrounds. Eligible case-control studies that were catalogued before April 1st 2013 were enrolled, and the heterogeneity between the studies was evaluated using a chi(2) based Q-test. Fixed and random effect models were built to evaluate the association of the four polymorphisms with the risk of tuberculosis, and the association between the four polymorphisms and tuberculosis was expressed as the odds ratio (OR) and 95% confidence interval (CI). Finally, twenty nine qualified studies were enrolled for this meta-analysis that included 6179 tuberculosis cases and 6585 healthy controls. The variant homozygote genotype of the FokI polymorphism was associated with a significantly increased risk of tuberculosis when compared to the heterozygote and wild type homozygote genotypes in the Chinese population (ff vs. Ff+FF: ORrecessive=1.97, 95% CI: 1.32-2.93, P-bonferroni=0.0032; heterogeneity test: chi(2)=0.24, P=0.62). For European subjects, the homozygote and heterozygote genotypes of the BsmI polymorphism were associated with a significantly decreased risk of tuberculosis when compared to the wild type homozygote (bb+Bb vs. BB: ORdominant=0.41, 95% CI, 0.22-0.76, P-bonferroni=0.02; heterogeneity test: chi(2)=2.59, P=0.11). Based on the above results, we conclude that variants of the VDR gene that are homozygous for the FokI polymorphism might be more susceptible to tuberculosis in Chinese. Furthermore, larger sample studies are warranted to confirm the protective effects of BsmI variants on tuberculosis in the Europeans.	[Chen, Cheng; Liu, Qiao; Zhu, Limei; Yang, Haitao; Lu, Wei] Ctr Dis Control & Prevent Jiangsu Prov, Dept Chron Communicable Dis, Nanjing, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention	Lu, W (corresponding author), Ctr Dis Control & Prevent Jiangsu Prov, Dept Chron Communicable Dis, Nanjing, Jiangsu, Peoples R China.	lwjscdc@gmail.com			project of Jiangsu preventive medicine [Y201030]; Ministry of Health [W201208]	project of Jiangsu preventive medicine; Ministry of Health	This study was supported by project of Jiangsu preventive medicine (Y201030) and research funds of Ministry of Health (W201208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagarasu K, 2009, J CLIN IMMUNOL, V29, P196, DOI 10.1007/s10875-008-9234-z; Alexandra SG, 2013, ROM BIOTECH LETT, V18, P7956; Arai H, 1997, J BONE MINER RES, V12, P915, DOI 10.1359/jbmr.1997.12.6.915; Ates O, 2011, MOL BIOL REP, V38, P2633, DOI 10.1007/s11033-010-0404-8; Babb C, 2007, TUBERCULOSIS, V87, P295, DOI 10.1016/j.tube.2007.03.001; Banoei MM, 2010, INT J INFECT DIS, V14, pE84, DOI 10.1016/j.ijid.2009.05.001; Bellamy R, 1999, J INFECT DIS, V179, P721, DOI 10.1086/314614; Bornman L, 2004, J INFECT DIS, V190, P1631, DOI 10.1086/424462; Delgado JC, 2002, J INFECT DIS, V186, P1463, DOI 10.1086/344891; Desai NS, 2012, NUTRITION, V28, P362, DOI 10.1016/j.nut.2011.08.012; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Fibla J, 2002, XIV INTERNATIONAL AIDS CONFERENCE: BASIC SCIENCES, P87; Fitness J, 2004, AM J TROP MED HYG, V71, P341, DOI 10.4269/ajtmh.2004.71.341; Gao L, 2010, INT J TUBERC LUNG D, V14, P15; Gibney KB, 2009, AFRICA CLIN INFECT D, V46, P443; HARRISON JR, 1994, J BONE MINER RES, V9, P817; Khanh VQL, 2011, AM J MED SCI, V341, P493, DOI 10.1097/MAJ.0b013e3182070f47; Lewis SJ, 2005, INT J TUBERC LUNG D, V9, P1174; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Liu W, 2004, INT J TUBERC LUNG D, V8, P428; Lombard Z, 2006, HUM IMMUNOL, V67, P643, DOI 10.1016/j.humimm.2006.04.008; Marashian SM, 2010, TUBERK TORAK, V58, P147; Merza M, 2009, BRAZ J INFECT DIS, V13, P252, DOI 10.1590/S1413-86702009000400002; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; Olesen R, 2007, GENES IMMUN, V8, P456, DOI 10.1038/sj.gene.6364410; Rathored J, 2012, INT J TUBERC LUNG D, V16, P1522, DOI 10.5588/ijtld.12.0122; Roth DE, 2004, J INFECT DIS, V190, P920, DOI 10.1086/423212; Sato S, 2012, RESPIR INVESTIG, V50, P40, DOI 10.1016/j.resinv.2012.05.002; Selvaraj P, 2008, J CLIN IMMUNOL, V28, P306, DOI 10.1007/s10875-007-9152-5; Selvaraj P, 2000, CURR SCI INDIA, V79, P986; Selvaraj P, 2004, J CLIN IMMUNOL, V24, P523, DOI 10.1023/B:JOCI.0000040923.07879.31; Selvaraj P, 2004, CLIN GENET, V65, P73, DOI 10.1111/j..2004.00183.x; Selvaraj P, 2003, CURR SCI INDIA, V84, P1564; Selvaraj P, 2009, J CLIN IMMUNOL, V29, P470, DOI 10.1007/s10875-009-9277-9; Sharma PR, 2011, INFECT GENET EVOL, V11, P1456, DOI 10.1016/j.meegid.2011.05.019; Singh A, 2011, INT J TUBERC LUNG D, V15, P1468, DOI 10.5588/ijtld.11.0089; Soborg C, 2007, MOL IMMUNOL, V44, P2213, DOI 10.1016/j.molimm.2006.11.002; Talat N, 2010, EMERG INFECT DIS, V16, P853, DOI 10.3201/eid1605.091693; Uitterlinden AG, 2004, GENE, V338, P143, DOI 10.1016/j.gene.2004.05.014; Vidyarani M, 2009, EXP MOL PATHOL, V86, P69, DOI 10.1016/j.yexmp.2008.10.002; Wilbur AK, 2007, TUBERCULOSIS, V87, P329, DOI 10.1016/j.tube.2007.01.001; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; Zasloff M, 2006, NAT MED, V12, P388, DOI 10.1038/nm0406-388; Zhang HQ, 2010, ARCH MED RES, V41, P46, DOI 10.1016/j.arcmed.2009.12.004	44	45	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83843	10.1371/journal.pone.0083843	http://dx.doi.org/10.1371/journal.pone.0083843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349552	Green Submitted, Green Published, gold			2022-12-27	WOS:000328734200103
J	Nadkarni, R; Barkley, S; Fradin, C				Nadkarni, Rohan; Barkley, Solomon; Fradin, Cecile			A Comparison of Methods to Measure the Magnetic Moment of Magnetotactic Bacteria through Analysis of Their Trajectories in External Magnetic Fields	PLOS ONE			English	Article							STRAIN AMB-1; MAGNETOSOMES; MOTION; DYNAMICS; TRACKING; SURFACE; CELLS; IMAGE; WATER; ZONE	Magnetotactic bacteria possess organelles called magnetosomes that confer a magnetic moment on the cells, resulting in their partial alignment with external magnetic fields. Here we show that analysis of the trajectories of cells exposed to an external magnetic field can be used to measure the average magnetic dipole moment of a cell population in at least five different ways. We apply this analysis to movies of Magnetospirillum magneticum AMB-1 cells, and compare the values of the magnetic moment obtained in this way to that obtained by direct measurements of magnetosome dimension from electron micrographs. We find that methods relying on the viscous relaxation of the cell orientation give results comparable to that obtained by magnetosome measurements, whereas methods relying on statistical mechanics assumptions give systematically lower values of the magnetic moment. Since the observed distribution of magnetic moments in the population is not sufficient to explain this discrepancy, our results suggest that non-thermal random noise is present in the system, implying that a magnetotactic bacterial population should not be considered as similar to a paramagnetic material.	[Nadkarni, Rohan; Fradin, Cecile] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Barkley, Solomon; Fradin, Cecile] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada	McMaster University; McMaster University	Fradin, C (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	fradin@physics.mcmaster.ca	Fradin, Cécile/D-9302-2011	Fradin, Cécile/0000-0001-8329-4953	Imperial Oil; Natural Sciences and Engineering Research Council of Canada (NSERC)	Imperial Oil; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was funded partially by a training grant from Imperial Oil, and partially by a discovery grant from the Natural Sciences and Engineering Research Council of Canada (NSERC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphandery E, 2012, INT J PHARMACEUT, V434, P444, DOI 10.1016/j.ijpharm.2012.06.015; Amann R., 2007, MAGNETORECEPTION MAG, P25, DOI DOI 10.1007/7171_037; Bahaj AS, 1996, IEEE T MAGN, V32, P5133, DOI 10.1109/20.539514; BAHAJ AS, 1993, J APPL PHYS, V73, P5394, DOI 10.1063/1.353743; BAHAJ AS, 1993, IEEE T MAGN, V29, P3358, DOI 10.1109/20.281175; Berke AP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.038102; Betz T, 2009, P NATL ACAD SCI USA, V106, P15320, DOI 10.1073/pnas.0904614106; BLAKEMORE R, 1975, SCIENCE, V190, P377, DOI 10.1126/science.170679; BLAKEMORE RP, 1982, ANNU REV MICROBIOL, V36, P217, DOI 10.1146/annurev.mi.36.100182.001245; Brangwynne CP, 2008, J CELL BIOL, V183, P583, DOI 10.1083/jcb.200806149; BRENNER H, 1961, CHEM ENG SCI, V16, P242, DOI 10.1016/0009-2509(61)80035-3; Chattopadhyay S, 2006, P NATL ACAD SCI USA, V103, P13712, DOI 10.1073/pnas.0602043103; Chemla YR, 1999, BIOPHYS J, V76, P3323, DOI 10.1016/S0006-3495(99)77485-0; Chen YF, 2010, PHYS REV LETT, V104; DEARAUJO FFT, 1986, BIOPHYS J, V50, P375, DOI 10.1016/S0006-3495(86)83471-3; Dunin-Borkowski RE, 1998, SCIENCE, V282, P1868, DOI 10.1126/science.282.5395.1868; ESOUIVEL DMS, 1986, J EXP BIOL, V121, P153; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Frankel RB, 1997, BIOPHYS J, V73, P994, DOI 10.1016/S0006-3495(97)78132-3; FRANKEL RB, 1984, ANNU REV BIOPHYS BIO, V13, P85; FRANKEL RB, 1980, J MAGN MAGN MATER, V15-8, P1562, DOI 10.1016/0304-8853(80)90409-6; Frankel RB, 2009, MAGNETOSOMES MAGNETO; FRYMIER PD, 1995, P NATL ACAD SCI USA, V92, P6195, DOI 10.1073/pnas.92.13.6195; Gallet F, 2009, SOFT MATTER, V5, P2947, DOI 10.1039/b901311c; Happel J., 1981, LOW REYNOLDS NUMBER; Haynes WM, 2012, CRC HDB CHEM PHYS 20; Kalirai SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053368; KALMIJN AJ, 1981, IEEE T MAGN, V17, P1113, DOI 10.1109/TMAG.1981.1061156; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Krichevsky A, 2007, J APPL PHYS, V101, DOI 10.1063/1.2405730; Le Sage D, 2013, NATURE, V496, P486, DOI 10.1038/nature12072; Lefevre CT, 2011, METAL NANOPARTICLES IN MICROBIOLOGY, P75, DOI 10.1007/978-3-642-18312-6_4; LOVELY PS, 1975, J THEOR BIOL, V50, P477, DOI 10.1016/0022-5193(75)90094-6; Lu T, 2006, BIOPHYS J, V91, P84, DOI 10.1529/biophysj.105.074914; MATSUNAGA T, 1991, APPL MICROBIOL BIOT, V35, P651; Matsunaga T, 2005, DNA RES, V12, P157, DOI 10.1093/dnares/dsi002; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Pan HM, 2008, ENVIRON MICROBIOL, V10, P1158, DOI 10.1111/j.1462-2920.2007.01532.x; ROSENBLATT C, 1982, J APPL PHYS, V53, P2727, DOI 10.1063/1.330948; ROSENBLATT C, 1982, BIOPHYS J, V40, P83, DOI 10.1016/S0006-3495(82)84461-5; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schueler D., 2002, International Microbiology, V5, P209; Seong S, 2001, BIOTECHNOL BIOENG, V76, P11, DOI 10.1002/bit.1021; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Smith MJ, 2006, BIOPHYS J, V91, P1098, DOI 10.1529/biophysj.106.085167; SPORMANN AM, 1984, FEMS MICROBIOL LETT, V22, P171; SPRING S, 1993, APPL ENVIRON MICROB, V59, P2397, DOI 10.1128/AEM.59.8.2397-2403.1993; SWINDELLS JF, 1952, J RES NAT BUR STAND, V48, P1, DOI 10.6028/jres.048.001; TIRADO MM, 1980, J CHEM PHYS, V73, P1986, DOI 10.1063/1.440288; WAJNBERG E, 1986, BIOPHYS J, V50, P451, DOI 10.1016/S0006-3495(86)83481-6; Weber SC, 2012, P NATL ACAD SCI USA, V109, P7338, DOI 10.1073/pnas.1119505109; Yan L, 2012, MICROBIOL RES, V167, P507, DOI 10.1016/j.micres.2012.04.002	52	30	30	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82064	10.1371/journal.pone.0082064	http://dx.doi.org/10.1371/journal.pone.0082064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349185	gold, Green Submitted, Green Published			2022-12-27	WOS:000328731800036
J	Zheng, WX; Yan, CH; Wang, XH; Luo, ZR; Chen, FP; Yang, YH; Liu, DL; Gai, XB; Hou, JP; Huang, MF				Zheng, Weixing; Yan, Chenghui; Wang, Xiaohu; Luo, Zhurong; Chen, Fengping; Yang, Yuhui; Liu, Donglin; Gai, Xiaobo; Hou, Jianping; Huang, Mingfang			TheTGFB1 Functional Polymorphism rs1800469 and Susceptibility to Atrial Fibrillation in Two Chinese Han Populations	PLOS ONE			English	Article							TRANSFORMING GROWTH-FACTOR-BETA-1 GENE; GROWTH-FACTOR BETA-1; MYOCARDIAL-INFARCTION; COLORECTAL-CANCER; TGF-BETA-1 GENE; RARE VARIANTS; FIBROSIS; RISK; ASSOCIATION; SUBSTRATE	Transforming growth factor-beta 1 (TGF-beta 1) is related to the degree of atrial fibrosis and plays critical roles in the induction and perpetuation of atrial fibrillation (AF). To investigate the association of the common promoter polymorphism rs1800469 in the TGF-beta 1 gene (TGFB1) with the risk of AF in Chinese Han population, we carried out a case-control study of two hospital-based independent populations: Southeast Chinese population (581 patients with AF and 723 controls), and Northeast Chinese population (308 AF patients and 292 controls). Two hundred and seventy-eight cases of AF were lone AF and 334 cases of AF were diagnosed as paroxysmal AF. In both populations, AF patients had larger left atrial diameters than the controls did. The rs1800469 genotypes in the TGFB1 gene were determined by polymerase chain reaction-restriction fragment length polymorphism. The genotype and allele frequencies of rs1800469 were not different between AF patients and controls of the Southeast Chinese population, Northeast Chinese population, and total Study Population. After adjustment for age, sex, hypertension and LAD, there was no association between the rs1800469 polymorphism and the risk of AF under the dominant, recessive and additive genetic models. Similar results were obtained from subanalysis of the lone and paroxymal AF subgroups. Our results do not support the role of the TGFB1 rs1800469 functional gene variant in the development of AF in the Chinese Han population.	[Zheng, Weixing; Luo, Zhurong; Chen, Fengping; Yang, Yuhui; Liu, Donglin; Gai, Xiaobo; Hou, Jianping; Huang, Mingfang] Fujian Med Univ, Fuzhou Gen Hosp, Dept Cardiol, Fuzhou, Peoples R China; [Yan, Chenghui] Shenyang Gen Hosp, Dept Cardiol, Shenyang, Peoples R China; [Wang, Xiaohu] Fujian Prov Hosp, Dept Cardiol, Fuzhou, Peoples R China	Fujian Medical University; Fujian Provincial Hospital	Huang, MF (corresponding author), Fujian Med Univ, Fuzhou Gen Hosp, Dept Cardiol, Fuzhou, Peoples R China.	huangmf30@aliyun.com			Natural Science Foundation of Fujian Province, China [2009J01182, 2013J01342]; Key Programs of Science and Technology Commission Foundation of Fujian Province, China [2007Y0029]	Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province); Key Programs of Science and Technology Commission Foundation of Fujian Province, China	The present study was supported by the Natural Science Foundation of Fujian Province, China (Grant No. 2009J01182 and 2013J01342) and the Key Programs of Science and Technology Commission Foundation of Fujian Province, China (Grant No.2007Y0029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama-Uchida Y, 2002, HYPERTENSION, V40, P148, DOI 10.1161/01.HYP.0000025443.61926.12; Aldhoon B, 2010, PHYSIOL RES, V59, P1, DOI 10.33549/physiolres.931651; [Anonymous], 2001, CIRCULATION, V104, P2118; Awad MR, 1998, TRANSPLANTATION, V66, P1014, DOI 10.1097/00007890-199810270-00009; Barth AS, 2005, CIRC RES, V96, P1022, DOI 10.1161/01.RES.0000165480.82737.33; Benjamin EJ, 2009, NAT GENET, V41, P879, DOI 10.1038/ng.416; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Cambien F, 1996, HYPERTENSION, V28, P881, DOI 10.1161/01.HYP.28.5.881; Choi EK, 2012, CIRC J, V76, P1354, DOI 10.1253/circj.CJ-11-1301; Cifkova R, 2003, J Hypertens, V21, P1779; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Cuculich PS, 2010, CIRCULATION, V122, P1364, DOI 10.1161/CIRCULATIONAHA.110.945709; Dunning AM, 2003, CANCER RES, V63, P2610; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Gai XB, 2009, CLIN CHIM ACTA, V408, P105, DOI 10.1016/j.cca.2009.07.020; Genuth S, 2003, DIABETES CARE, V26, P3160; Grainger DJ, 1999, HUM MOL GENET, V8, P93, DOI 10.1093/hmg/8.1.93; Gramley F, 2010, INT J CARDIOL, V143, P405, DOI 10.1016/j.ijcard.2009.03.110; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Gudbjartsson DF, 2009, NAT GENET, V41, P876, DOI 10.1038/ng.417; Guo W, 2011, INT J IMMUNOGENET, V38, P215, DOI 10.1111/j.1744-313X.2010.00991.x; Hanna N, 2004, CARDIOVASC RES, V63, P236, DOI 10.1016/j.cardiores.2004.03.026; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Jin GF, 2008, J CANCER RES CLIN, V134, P345, DOI 10.1007/s00432-007-0290-1; Kottkamp H, 2013, EUR HEART J, V34, P2731, DOI 10.1093/eurheartj/eht194; Lee KW, 2006, CIRCULATION, V114, P1703, DOI 10.1161/CIRCULATIONAHA.106.624320; Li DS, 1999, CIRCULATION, V100, P87, DOI 10.1161/01.CIR.100.1.87; Li DS, 2001, CIRCULATION, V104, P2608, DOI 10.1161/hc4601.099402; Liu DS, 2010, CHINESE MED J-PEKING, V123, P390, DOI 10.3760/cma.j.issn.0366-6999.2010.04.002; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Nakajima H, 2000, CIRC RES, V86, P571, DOI 10.1161/01.RES.86.5.571; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; On YK, 2009, J THORAC CARDIOV SUR, V137, P1515, DOI 10.1016/j.jtcvs.2008.10.022; Polyakova V, 2008, J CELL MOL MED, V12, P189, DOI 10.1111/j.1582-4934.2008.00219.x; Qi P, 2010, COLORECTAL DIS, V12, P1153, DOI 10.1111/j.1463-1318.2009.02079.x; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shu XO, 2004, CANCER RES, V64, P836, DOI 10.1158/0008-5472.CAN-03-3492; Silverman ES, 2004, AM J RESP CRIT CARE, V169, P214, DOI 10.1164/rccm.200307-973OC; Suthanthiran M, 2000, P NATL ACAD SCI USA, V97, P3479, DOI 10.1073/pnas.050420897; Thys M, 2007, HUM MOL GENET, V16, P2021, DOI 10.1093/hmg/ddm150; Verheule S, 2004, CIRC RES, V94, P1458, DOI 10.1161/01.RES.0000129579.59664.9d; Wang H, 2008, CYTOKINE, V43, P20, DOI 10.1016/j.cyto.2008.04.013; Wang YZ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-23; Warnick GR, 2002, CLIN CHEM, V48, P11; WU CH, 2012, HEART RHYTHM; Yokota M, 2000, CIRCULATION, V101, P2783, DOI 10.1161/01.CIR.101.24.2783; Zhang YJ, 2009, CANCER LETT, V275, P102, DOI 10.1016/j.canlet.2008.10.017	48	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83033	10.1371/journal.pone.0083033	http://dx.doi.org/10.1371/journal.pone.0083033			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349426	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800092
J	Bulf, H; Valenza, E; Turati, C				Bulf, Hermann; Valenza, Eloisa; Turati, Chiara			How a Hat May Affect 3-Month-Olds' Recognition of a Face: An Eye-Tracking Study	PLOS ONE			English	Article							NEWBORNS; REPRESENTATION; PREFERENCE	Recent studies have shown that infants' face recognition rests on a robust face representation that is resilient to a variety of facial transformations such as rotations in depth, motion, occlusion or deprivation of inner/outer features. Here, we investigated whether 3-month-old infants' ability to represent the invariant aspects of a face is affected by the presence of an external add-on element, i.e. a hat. Using a visual habituation task, three experiments were carried out in which face recognition was investigated by manipulating the presence/absence of a hat during face encoding (i.e. habituation phase) and face recognition (i.e. test phase). An eye-tracker system was used to record the time infants spent looking at face-relevant information compared to the hat. The results showed that infants' face recognition was not affected by the presence of the external element when the type of the hat did not vary between the habituation and test phases, and when both the novel and the familiar face wore the same hat during the test phase (Experiment 1). Infants' ability to recognize the invariant aspects of a face was preserved also when the hat was absent in the habituation phase and the same hat was shown only during the test phase (Experiment 2). Conversely, when the novel face identity competed with a novel hat, the hat triggered the infants' attention, interfering with the recognition process and preventing the infants' preference for the novel face during the test phase (Experiment 3). Findings from the current study shed light on how faces and objects are processed when they are simultaneously presented in the same visual scene, contributing to an understanding of how infants respond to the multiple and composite information available in their surrounding environment.	[Bulf, Hermann; Turati, Chiara] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Valenza, Eloisa] Univ Padua, Dept Dev & Socializat Psychol, Padua, Italy; [Valenza, Eloisa] Univ Padua, Interdept Ctr Cognit Sci, Padua, Italy	University of Milano-Bicocca; University of Padua; University of Padua	Bulf, H (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	hermann.bulf@unimib.it			Universita degli Studi di Padova, Progetti di Ricerca di Ateneo [CPDA113109/11]; European Research Council Starting Grant [241176]	Universita degli Studi di Padova, Progetti di Ricerca di Ateneo; European Research Council Starting Grant(European Research Council (ERC))	This research project was supported by a grant from Universita degli Studi di Padova, Progetti di Ricerca di Ateneo (code CPDA113109/11), and by a European Research Council Starting Grant to Dr Chiara Turati - ODMIR No. 241176. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAENNINGER M, 1994, J EXP CHILD PSYCHOL, V57, P377, DOI 10.1006/jecp.1994.1018; Bushnell IWR, 2001, INFANT CHILD DEV, V10, P67, DOI 10.1002/icd.248; BUSHNELL IWR, 1989, BRIT J DEV PSYCHOL, V7, P3, DOI 10.1111/j.2044-835X.1989.tb00784.x; CAREY S, 1977, SCIENCE, V195, P312, DOI 10.1126/science.831281; Cassia VM, 2004, PSYCHOL SCI, V15, P379, DOI 10.1111/j.0956-7976.2004.00688.x; DIAMOND R, 1977, J EXP CHILD PSYCHOL, V23, P1, DOI 10.1016/0022-0965(77)90069-8; FIELD TM, 1984, INFANT BEHAV DEV, V7, P19, DOI 10.1016/S0163-6383(84)80019-3; FLIN RH, 1985, BRIT J PSYCHOL, V76, P123, DOI 10.1111/j.2044-8295.1985.tb01936.x; Frank MC, 2009, COGNITION, V110, P160, DOI 10.1016/j.cognition.2008.11.010; Freire A, 2001, J EXP CHILD PSYCHOL, V80, P347, DOI 10.1006/jecp.2001.2639; Gava L, 2008, DEVELOPMENTAL SCI, V11, P563, DOI 10.1111/j.1467-7687.2008.00702.x; Johnson MH, 1991, BIOL COGNITIVE DEV C; Kleiner KA, 1993, DEV NEUROCOGNITION S, P125; Lundy BL, 2001, PERCEPT MOTOR SKILL, V92, P919, DOI 10.2466/PMS.92.3.919-929; Lundy BL, 2000, INFANT BEHAV DEV, V23, P125, DOI 10.1016/S0163-6383(01)00041-8; Otsuka Y, 2009, CHILD DEV, V80, P1259, DOI 10.1111/j.1467-8624.2009.01330.x; PASCALIS O, 1995, INFANT BEHAV DEV, V18, P79, DOI 10.1016/0163-6383(95)90009-8; PASCALIS O, 1994, NEUROREPORT, V5, P1721, DOI 10.1097/00001756-199409080-00008; Simion F, 2003, DEVELOPMENT OF FACE PROCESSING IN INFACY AND EARLY CHILDHOOD: CURRENT PERSPECTIVES, P13; SLATER A, 1984, INFANT BEHAV DEV, V7, P183, DOI 10.1016/S0163-6383(84)80057-0; Turati C, 2004, INFANCY, V6, P275, DOI 10.1207/s15327078in0602_8; Turati C, 2006, CHILD DEV, V77, P297, DOI 10.1111/j.1467-8624.2006.00871.x; Turati C, 2004, CURR DIR PSYCHOL SCI, V13, P5, DOI 10.1111/j.0963-7214.2004.01301002.x; Turati C, 2008, COGNITION, V106, P1300, DOI 10.1016/j.cognition.2007.06.005; Valenza E, 1996, J EXP PSYCHOL HUMAN, V22, P892, DOI 10.1037/0096-1523.22.4.892	25	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82839	10.1371/journal.pone.0082839	http://dx.doi.org/10.1371/journal.pone.0082839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349378	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300110
J	Lepore, I; Dell'Aversana, C; Pilyugin, M; Conte, M; Nebbioso, A; De Bellis, F; Tambaro, FP; Izzo, T; Garcia-Manero, G; Ferrara, F; Irminger-Finger, I; Altucci, L				Lepore, Ilaria; Dell'Aversana, Carmela; Pilyugin, Maxim; Conte, Mariarosaria; Nebbioso, Angela; De Bellis, Floriana; Tambaro, Francesco P.; Izzo, Tiziana; Garcia-Manero, Guillermo; Ferrara, Felicetto; Irminger-Finger, Irmgard; Altucci, Lucia			HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITOR; MS-275; IDENTIFICATION; VORINOSTAT; MICRORNAS; CANCER; TRANSLOCATION; INTERFERENCE; CARCINOMA; APOPTOSIS	Over the past years BARD1 (BRCA1-associated RING domain 1) has been considered as both a BRCA1 (BReast Cancer susceptibility gene 1, early onset) interactor and tumor suppressor gene mutated in breast and ovarian cancers. Despite its role as a stable heterodimer with BRCA1, increasing evidence indicates that BARD1 also has BRCA1-independent oncogenic functions. Here, we investigate BARD1 expression and function in human acute myeloid leukemias and its modulation by epigenetic mechanism(s) and microRNAs. We show that the HDACi (histone deacetylase inhibitor) Vorinostat reduces BARD1 mRNA levels by increasing miR-19a and miR-19b expression levels. Moreover, we identify a specific BARD1 isoform, which might act as tumor diagnostic and prognostic markers.	[Lepore, Ilaria; Dell'Aversana, Carmela; Conte, Mariarosaria; Nebbioso, Angela; De Bellis, Floriana; Tambaro, Francesco P.; Altucci, Lucia] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy; [Dell'Aversana, Carmela; Altucci, Lucia] Inst Genet & Biophys IGB, Naples, Italy; [Tambaro, Francesco P.; Garcia-Manero, Guillermo] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Pilyugin, Maxim; Irminger-Finger, Irmgard] HUG, Univ Hosp Geneva, Mol Gynecol & Obstet Lab, Dept Gynecol & Obstet, Geneva, Switzerland; [Pilyugin, Maxim; Irminger-Finger, Irmgard] HUG, Univ Hosp Geneva, Dept Genet & Lab Med, Geneva, Switzerland; [Izzo, Tiziana; Ferrara, Felicetto] Cardarelli Hosp, Div Hematol, Naples, Italy; [Izzo, Tiziana; Ferrara, Felicetto] Cardarelli Hosp, Stem Cell Transplantat Unit, Naples, Italy	Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Texas System; UTMD Anderson Cancer Center; University of Geneva; University of Geneva; Antonio Cardarelli Hospital; Antonio Cardarelli Hospital	Altucci, L (corresponding author), Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy.	lucia.altucci@unina2.it	Altucci, Lucia/S-8031-2019; Conte, Mariarorosaria/K-7352-2016; Dell'Aversana, Carmela/P-7829-2018; Tambaro, Francesco Paolo/AAN-4408-2021; NEBBIOSO, ANGELA/GVS-1294-2022; NEBBIOSO, Angela/C-3566-2016	Conte, Mariarorosaria/0000-0002-3622-1476; Dell'Aversana, Carmela/0000-0001-6588-698X; Tambaro, Francesco Paolo/0000-0002-9145-3691; NEBBIOSO, Angela/0000-0001-5374-3527; altucci, lucia/0000-0002-7312-5387	EU: Blueprint [282510]; Italian IHEC (Flag Project: EPIGEN); Italian Association for Cancer Research (AIRC) [11812]; Italian Ministry of University and Research [PRIN_2009PX2T2E_004]; Swiss National Research Foundations [NF 3100A0-122353]; Ligue SuisseContre le Cancer [KLS 01962-10-2006]; LigueGenevoiseContre le Cancer [(LGCC 1117];  [PON0101227]	EU: Blueprint; Italian IHEC (Flag Project: EPIGEN); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Swiss National Research Foundations; Ligue SuisseContre le Cancer; LigueGenevoiseContre le Cancer; 	Grant Support. This work was supported by EU: Blueprint (contract no. 282510); Italian IHEC (Flag Project: EPIGEN); the Italian Association for Cancer Research (AIRC no. 11812); Italian Ministry of University and Research (PRIN_2009PX2T2E_004); PON0101227; Swiss National Research Foundations (NF 3100A0-122353), Ligue SuisseContre le Cancer (KLS 01962-10-2006), and LigueGenevoiseContre le Cancer (LGCC 1117) to IIF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bosse KR, 2012, CANCER RES, V72, P2068, DOI 10.1158/0008-5472.CAN-11-3703; Bracker TU, 2009, INT J ONCOL, V35, P909, DOI 10.3892/ijo_00000406; Breving K, 2010, INT J BIOCHEM CELL B, V42, P1316, DOI 10.1016/j.biocel.2009.09.016; Brueckner B, 2007, CANCER RES, V67, P1419, DOI 10.1158/0008-5472.CAN-06-4074; Chan SP, 2007, DEV CELL, V13, P605, DOI 10.1016/j.devcel.2007.10.010; Choudhury AD, 2005, J BIOL CHEM, V280, P24669, DOI 10.1074/jbc.M502446200; Conte M, 2012, CLIN CANCER RES, V18, P5526, DOI 10.1158/1078-0432.CCR-12-2037; Edwards RA, 2008, BIOCHEMISTRY-US, V47, P11446, DOI 10.1021/bi801115g; Feki A, 2005, ONCOGENE, V24, P3726, DOI 10.1038/sj.onc.1208491; Garcia-Manero G, 2012, J CLIN ONCOL, V30, P2204, DOI 10.1200/JCO.2011.38.3265; Gautier F, 2000, CANCER RES, V60, P6895; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Henderson BR, 2005, BIOESSAYS, V27, P884, DOI 10.1002/bies.20277; Hess-Stumpp H, 2007, INT J BIOCHEM CELL B, V39, P1388, DOI 10.1016/j.biocel.2007.02.009; Irminger-Finger I, 2006, NAT REV CANCER, V6, P382, DOI 10.1038/nrc1878; Irminger-Finger I, 2001, MOL CELL, V8, P1255, DOI 10.1016/S1097-2765(01)00406-3; Irminger-Finger I, 2010, GYNECOL ONCOL, V117, P211, DOI 10.1016/j.ygyno.2009.10.079; Jefford CE, 2004, ONCOGENE, V23, P3509, DOI 10.1038/sj.onc.1207427; Li L, 2007, CANCER RES, V67, P11876, DOI 10.1158/0008-5472.CAN-07-2370; Lin YW, 1999, EUR J CANCER, V35, P1730, DOI 10.1016/S0959-8049(99)00205-1; Mahadevan D, 2006, AM J HEMATOL, V81, P779, DOI 10.1002/ajh.20690; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Mann BS, 2007, CLIN CANCER RES, V13, P2318, DOI 10.1158/1078-0432.CCR-06-2672; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Mavrakis KJ, 2010, NAT CELL BIOL, V12, P372, DOI 10.1038/ncb2037; Mercurio C, 2010, PHARMACOL RES, V62, P18, DOI 10.1016/j.phrs.2010.02.010; Nebbioso A, 2020, EMBO REP, V21, DOI [10.1038/embor.2009.88, 10.15252/embr.202051028]; O'Connor OA, 2006, J CLIN ONCOL, V24, P166, DOI 10.1200/JCO.2005.01.9679; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Rosato RR, 2003, CANCER RES, V63, P3637; Ryan QC, 2005, J CLIN ONCOL, V23, P3912, DOI 10.1200/JCO.2005.02.188; Ryser S, 2009, CANCER RES, V69, P1125, DOI 10.1158/0008-5472.CAN-08-2134; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Scott GK, 2008, MOL CANCER RES, V6, P1250, DOI 10.1158/1541-7786.MCR-07-2110; Shan G, 2010, INT J BIOCHEM CELL B, V42, P1243, DOI 10.1016/j.biocel.2009.04.023; Sporn JC, 2011, CLIN CANCER RES, V17, P5451, DOI 10.1158/1078-0432.CCR-11-0263; Tembe V, 2007, J BIOL CHEM, V282, P20513, DOI 10.1074/jbc.M702627200; Wang YM, 2011, RESULTS PROBL CELL D, V53, P459, DOI 10.1007/978-3-642-19065-0_19; Wu JY, 2006, INT J CANCER, V118, P1215, DOI 10.1002/ijc.21428; Xu XM, 2012, CANCER LETT, V322, P148, DOI 10.1016/j.canlet.2012.02.038; Zhang YQ, 2012, INT J CANCER, V131, P83, DOI 10.1002/ijc.26346	45	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83018	10.1371/journal.pone.0083018	http://dx.doi.org/10.1371/journal.pone.0083018			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349422	Green Submitted, gold, Green Published			2022-12-27	WOS:000328730300122
J	Lester, LA; Avery, HW; Harrison, AS; Standora, EA				Lester, Lori A.; Avery, Harold W.; Harrison, Andrew S.; Standora, Edward A.			Recreational Boats and Turtles: Behavioral Mismatches Result in High Rates of Injury	PLOS ONE			English	Article							DIAMONDBACK TERRAPINS; CONSERVATION; DEMOGRAPHICS; MANAGEMENT; UNDERWATER	Recreational boats are a dominant feature of estuarine waters in the United States. Boat strike injury and mortality may have a detrimental effect on populations of diamondback terrapins (Malaclemys terrapin), a keystone species in estuarine ecosystems. In Barnegat Bay, New Jersey, 11% of terrapins (n = 2,644) have scars consistent with injuries from boats. Conservative estimates of injury rates from boats increased from 2006 to 2011. When exposed to playback recordings of approaching boat engines of varying sizes and speeds in situ, terrapins did not significantly change their behavior in response to sounds of boat engines of different sizes. The lack of behavioral response of terrapins to boat sounds helps explain high rates of injury and mortality of terrapins and may threaten the viability of terrapin populations. Boater education courses that discuss impacts of boats to wildlife, combined with closure of areas of high terrapin densities to boating, are necessary to protect terrapins and other aquatic species from injury and mortality caused by motorized boats.	[Lester, Lori A.] Delaware State Univ, Dept Agr & Nat Resources, Dover, DE USA; [Lester, Lori A.; Avery, Harold W.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Avery, Harold W.] Leatherback Trust, Haddonfield, NJ USA; [Harrison, Andrew S.; Standora, Edward A.] SUNY Coll Buffalo, Dept Biol, Buffalo, NY 14222 USA; [Harrison, Andrew S.] Williamsville Cent Sch, Williamsville, NY USA	Delaware State University; Drexel University; State University of New York (SUNY) System; Buffalo State College	Lester, LA (corresponding author), Delaware State Univ, Dept Agr & Nat Resources, Dover, DE USA.	llester@desu.edu						Akamatsu T, 2002, J ACOUST SOC AM, V112, P3073, DOI 10.1121/1.1515799; Bartol SM, 1999, COPEIA, P836, DOI 10.2307/1447625; Bates D, 2012, LME4 LINEAR MIXED EF; BBP, 2011, STAT BAY REP; BISHOP JM, 1983, ESTUARIES, V6, P426, DOI 10.2307/1351402; Butler Joseph A., 2006, Chelonian Research Monographs, V3, P279; Cecala KK, 2009, AQUAT CONSERV, V19, P421, DOI 10.1002/aqc.999; Christensen-Dalsgaard J, 2012, P ROY SOC B-BIOL SCI, V279, P2816, DOI 10.1098/rspb.2012.0290; CONGDON JD, 1993, CONSERV BIOL, V7, P826, DOI 10.1046/j.1523-1739.1993.740826.x; CONGDON JD, 1994, AM ZOOL, V34, P397; Draud M, 2004, J HERPETOL, V38, P467, DOI 10.1670/29-04N; Gibbons J.W., 1990, Herpetological Monographs, P1; Grant PBC, 2010, HERPETOL CONSERV BIO, V5, P456; Harrison AS, 2010, THESIS BUFFALO STATE; Hart KM, 2008, COPEIA, P200, DOI 10.1643/CE-06-161; Heinrich GL, 2012, HERPETOL CONSERV BIO, V7, P349; Lenhardt Martin L., 1994, NOAA Technical Memorandum NMFS-SEFSC, V351, P238; Lester L. A, 2012, THESIS DREXEL U PHIL; Lester LA, 2012, ADV EXP MED BIOL, V730, P361, DOI 10.1007/978-1-4419-7311-5_81; McCauley R.D., 2000, APPEA J, V40, P692, DOI DOI 10.1071/AJ99048; McGregor Peter K., 2000, Acta Ethologica, V3, P3, DOI 10.1007/s102110000023; MIKOLA J, 1994, BIOL CONSERV, V67, P119, DOI 10.1016/0006-3207(94)90356-5; Miksis-Olds JL, 2007, MAR MAMMAL SCI, V23, P629, DOI 10.1111/j.1748-7692.2007.00133.x; Moein SE, 1994, AUDITORY BEHAV LOGGE, P89; MTA (Marine Trades Association of New Jersey), 2008, RECR BOAT NEW JERS E; NMMA, 2008, US RECR BOAT REG STA; OHARA J, 1990, COPEIA, P564; Popper AN, 2009, J FISH BIOL, V75, P455, DOI 10.1111/j.1095-8649.2009.02319.x; Richardson WJ, 1995, MARINE MAMMALS NOISE, V1st; Roosenburg WM, 2004, CONSERVATION ECOLOGY; Roosenburg WM, 1991, NEW PERSPECTIVES CHE; Saba VS, 2012, NATURE; Samuel Y., 2004, THESIS CORNELL U ITH; Scholik AR, 2002, ENVIRON BIOL FISH, V63, P203, DOI 10.1023/A:1014266531390; Schwimmer RA, 2001, J COASTAL RES, V17, P672; Seigel Richard A., 1995, Chelonian Conservation and Biology, V1, P240; SHERIDAN C.M., 2010, THESIS DREXEL U PHIL; Southall BL, 2000, J ACOUST SOC AM, V108, P1322, DOI 10.1121/1.1288409; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Steen DA, 2004, CONSERV BIOL, V18, P1143, DOI 10.1111/j.1523-1739.2004.00240.x; Willis KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054086; Wood R. C., 1997, P CONS REST MAN TORT, P46, DOI DOI 10.1111/JORS.12253	42	13	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82370	10.1371/journal.pone.0082370	http://dx.doi.org/10.1371/journal.pone.0082370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349269	gold, Green Submitted, Green Published			2022-12-27	WOS:000328730300090
J	Samikannu, B; Chen, CG; Lingwal, N; Padmasekar, M; Engel, FB; Linn, T				Samikannu, Balaji; Chen, Chunguang; Lingwal, Neelam; Padmasekar, Manju; Engel, Felix B.; Linn, Thomas			Dipeptidyl Peptidase IV Inhibition Activates CREB and Improves Islet Vascularization through VEGF-A/VEGFR-2 Signaling Pathway	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PANCREATIC BETA-CELLS; IN-VITRO; TRANSPLANTED ISLETS; GLP-1 RECEPTOR; DIABETIC MICE; VEGF; RATS; REVASCULARIZATION; PROLIFERATION	Substitution of pancreatic islets is a potential therapy to treat diabetes and it depends on reconstitution of islet's capillary network. In this study, we addressed the question whether stabilization of Glucagon-Like-Peptide-1 (GLP-1) by inhibiting Dipeptidyl Peptidase-IV (DPP-IV) increases beta-cell mass by modulating vascularization. Mouse or porcine donor islets were implanted under kidney capsule of diabetic mice treated with DPP-IV inhibitor sitagliptin. Grafts were analyzed for insulin production, beta-cell proliferation and vascularization. In addition, the effect of sitagliptin on sprouting and Vascular Endothelial Growth Factor (VEGF)-A expression was examined ex vivo. The cAMP response element-binding (CREB) and VEGF-A/ Vascular Endothelial Growth Factor Receptor (VEGFR)-2 signaling pathway leading to islet vascularization was explored. Sitagliptin increased mean insulin content of islet grafts and area of insulin-positive tissue as well as beta-cell proliferation. Interestingly, sitagliptin treatment also markedly increased endothelial cell proliferation, microvessel density and blood flow. Finally, GLP-1 (7-36) stimulated sprouting and VEGF expression, which was significantly enhanced by sitagliptin-mediated inhibition of DPP-IV. Our in vivo data demonstrate that sitagliptin treatment phosphorylated CREB and induced islet vascularization through VEGF-A/VEGFR-2 signaling pathway. This study paves a new pathway for improvement of islet transplantation in treating diabetes mellitus.	[Samikannu, Balaji; Lingwal, Neelam; Padmasekar, Manju; Linn, Thomas] Univ Giessen, Med Clin & Policlin 3, D-35390 Giessen, Germany; [Chen, Chunguang] Paul Langerhans Inst Dresden, CRTD DFG Ctr Regenerat Therapies Dresden, Dresden, Germany; [Engel, Felix B.] Univ Hosp Erlangen, Dept Pathol, Nephropathol Div, Erlangen, Germany	Justus Liebig University Giessen; Technische Universitat Dresden; University of Erlangen Nuremberg	Samikannu, B (corresponding author), Univ Giessen, Med Clin & Policlin 3, D-35390 Giessen, Germany.	balajisamikannu@gmail.com	Engel, Felix/A-1767-2008	Engel, Felix/0000-0003-2605-3429; Nandigama, Manju Padmasekar/0000-0001-7060-8319	Deutsche Forschungsgemeinschaft [KFO 181]; Excellence Cluster Cardiopulmonary System (Area G); von Behring-Roentgen-Stiftung; Landes-Offensive zur Entwicklung Wissenschaftlich-Mannliche Infertilitat bei Infektionen und Entzundungen (LOEWE-MIBIE)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster Cardiopulmonary System (Area G); von Behring-Roentgen-Stiftung; Landes-Offensive zur Entwicklung Wissenschaftlich-Mannliche Infertilitat bei Infektionen und Entzundungen (LOEWE-MIBIE)	This work was supported by grants from Deutsche Forschungsgemeinschaft (KFO 181), Excellence Cluster Cardiopulmonary System (Area G), von Behring-Roentgen-Stiftung, and Landes-Offensive zur Entwicklung Wissenschaftlich-Mannliche Infertilitat bei Infektionen und Entzundungen (LOEWE-MIBIE) to Thomas Linn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertgeerts K, 2004, PROTEIN SCI, V13, P145, DOI 10.1110/ps.03352504; Brandhorst H, 1998, CELL TRANSPLANT, V7, P489, DOI 10.1016/S0963-6897(98)00028-1; Brandhorst H, 1999, TRANSPLANTATION, V68, P355, DOI 10.1097/00007890-199908150-00006; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Brissova M, 2008, DIABETES, V57, P2269, DOI 10.2337/db08-0814; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Conarello SL, 2003, P NATL ACAD SCI USA, V100, P6825, DOI 10.1073/pnas.0631828100; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; Eguchi M, 2008, J MOL CELL CARDIOL, V45, P661, DOI 10.1016/j.yjmcc.2008.08.002; Erdogdu O, 2010, MOL CELL ENDOCRINOL, V325, P26, DOI 10.1016/j.mce.2010.04.022; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; GOKE R, 1993, J BIOL CHEM, V268, P19650; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Kim SJ, 2008, DIABETES, V57, P1331, DOI 10.2337/db07-1639; Kim YS, 2011, PANCREAS, V40, P855, DOI 10.1097/MPA.0b013e318214832d; Kinugasa M, 2012, CIRC RES; Kirino Y, 2009, J ENDOCRINOL, V200, P53, DOI 10.1677/JOE-08-0424; Lai Y, 2005, TRANSPLANTATION, V79, P1530, DOI 10.1097/01.TP.0000163506.40189.65; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Langlois A, 2011, CELL TRANSPLANT, V20, P1333, DOI 10.3727/096368910X557182; Lee HT, 2010, J NEUROCHEM, V113, P79, DOI 10.1111/j.1471-4159.2010.06584.x; Linn T, 2003, FASEB J, V17, P881, DOI 10.1096/fj.02-0615fje; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; MENGER MD, 1989, DIABETES, V38, P199, DOI 10.2337/diab.38.1.S199; Mortensen K, 2003, REGUL PEPTIDES, V114, P189, DOI 10.1016/S0167-0115(03)00125-3; Mu J, 2009, EUR J PHARMACOL, V623, P148, DOI 10.1016/j.ejphar.2009.09.027; Nakayama S, 2009, DIABETOLOGIA, V52, P115, DOI 10.1007/s00125-008-1172-z; Nathanson D, 2009, REGUL PEPTIDES, V157, P8, DOI 10.1016/j.regpep.2009.07.003; ObergWelsh C, 1997, MOL CELL ENDOCRINOL, V126, P125, DOI 10.1016/S0303-7207(96)03977-9; Pospisilik JA, 2003, DIABETES, V52, P741, DOI 10.2337/diabetes.52.3.741; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Robinson CJ, 2001, J CELL SCI, V114, P853; Toyoda K, 2008, BIOCHEM BIOPH RES CO, V367, P793, DOI 10.1016/j.bbrc.2008.01.046; Van de Velde S, 2011, P NATL ACAD SCI USA, V108, P16876, DOI 10.1073/pnas.1114228108; Vasir B, 2001, TRANSPLANTATION, V71, P924, DOI 10.1097/00007890-200104150-00018; Wu L, 2012, REGUL PEPTIDES, V177, P92, DOI 10.1016/j.regpep.2012.05.091; Zhang N, 2004, DIABETES, V53, P963, DOI 10.2337/diabetes.53.4.963	41	25	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82639	10.1371/journal.pone.0082639	http://dx.doi.org/10.1371/journal.pone.0082639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349326	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300101
J	Uppalapati, SR; Kingston, JJ; Qureshi, IA; Murali, HS; Batra, HV				Uppalapati, Siva Ramakrishna; Kingston, Joseph Jeyabalaji; Qureshi, Insaf Ahmed; Murali, Harishchandra Sripathy; Batra, Harsh Vardhan			In Silico, In Vitro and In Vivo Analysis of Binding Affinity between N and C-Domains of Clostridium perfringens Alpha Toxin	PLOS ONE			English	Article							TERMINAL DOMAIN; PHOSPHOLIPASE-C; WEB SERVER; SEQUENCE; HOMOLOGY; SITE	Clostridium perfringens alpha toxin/phospholipase C (CP-PLC) is one of the most potent bacterial toxins known to cause soft tissue infections like gas gangrene in humans and animals. It is the first bacterial toxin demonstrated to be an enzyme with phospholipase, sphingomyelinase and lecithinase activities. The toxin is comprised of an enzymatic N-domain and a binding C-domain interconnected by a flexible linker. The N-domain alone is non-toxic to mammalian cells, but incubation with C-domain restores the toxicity, the mechanism of which is still not elucidated. The objectives of the current study were to investigate the formation of a stable N and C-domain complex, to determine possible interactions between the two domains in silico and to characterize the in vitro and in vivo correlates of the interaction. To establish the existence of a stable N and C-domain hybrid, in vitro pull down assay and dot-Far Western blotting assays were employed, where it was clearly revealed that the two domains bound to each other to form an intermediate. Using bioinformatics tools like MetaPPISP, PatchDock and FireDock, we predicted that the two domains may interact with each other through electrostatic interactions between at least six pairs of amino acids. This N and C-domains interacted with each other in 1: 1 ratio and the hybrid lysed mouse erythrocytes in a slower kinetics when compared with wild type native Cp-PLC. BALB/c mice when challenged with N and C-domain hybrid demonstrated severe myonecrosis at the site of injection while no death was observed. Our results provide further insight into better understanding the mechanism for the toxicity of Cp-PLC N and C-domain mixture.	[Uppalapati, Siva Ramakrishna; Kingston, Joseph Jeyabalaji; Murali, Harishchandra Sripathy; Batra, Harsh Vardhan] Def Food Res Lab, Div Microbiol, Mysore 570011, Karnataka, India; [Qureshi, Insaf Ahmed] Univ Hyderabad, Sch Life Sci, Dept Biotechnol, Hyderabad 500134, Andhra Pradesh, India	Defence Research & Development Organisation (DRDO); Defence Food Research Laboratory (DFRL); University of Hyderabad	Batra, HV (corresponding author), Def Food Res Lab, Div Microbiol, Mysore 570011, Karnataka, India.	drharshvardhanbatra@gmail.com	Qureshi, Insaf Ahmed/W-1957-2019; Uppalapati, Siva/X-8192-2019	Qureshi, Insaf Ahmed/0000-0001-7720-7067; Uppalapati, Siva/0000-0002-4743-7248	Council for Scientific and Industrial Research, Government of India [EMR 00831/3]	Council for Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	S.R.U. is supported by the Senior Research Fellowship of Council for Scientific and Industrial Research, Government of India (Grant No. EMR 00831/3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alape-Giron A, 2000, EUR J BIOCHEM, V267, P5191, DOI 10.1046/j.1432-1327.2000.01588.x; Brynestad S, 2002, INT J FOOD MICROBIOL, V74, P195, DOI 10.1016/S0168-1605(01)00680-8; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Elion EA, 2006, CURR PROTOC NEUROSCI, V35; Jepson M, 1999, INFECT IMMUN, V67, P3297, DOI 10.1128/IAI.67.7.3297-3301.1999; Job P, 1928, ANN CHIM FRANCE, V9, P113; LESLIE D, 1989, MOL MICROBIOL, V3, P383, DOI 10.1111/j.1365-2958.1989.tb00183.x; MacFarlane MG, 1941, BIOCHEM J, V35, P884, DOI 10.1042/bj0350884; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Mizuguchi K, 1998, BIOINFORMATICS, V14, P617, DOI 10.1093/bioinformatics/14.7.617; Nagahama M, 2006, BBA-MOL BASIS DIS, V1762, P110, DOI 10.1016/j.bbadis.2005.10.002; Nagahama M, 2002, MICROBIOL IMMUNOL, V46, P647, DOI 10.1111/j.1348-0421.2002.tb02748.x; Naylor CE, 1999, J MOL BIOL, V294, P757, DOI 10.1006/jmbi.1999.3279; Naylor CE, 1998, NAT STRUCT BIOL, V5, P738, DOI 10.1038/1447; Ochi S, 2004, J BIOL CHEM, V279, P12181, DOI 10.1074/jbc.M307046200; Oda M, 2011, BIOCHEM BIOPH RES CO, V411, P241, DOI 10.1016/j.bbrc.2011.06.103; Ohba T, 1998, ANAL BIOCHEM, V262, P185, DOI 10.1006/abio.1998.2772; OKABE A, 1989, BIOCHEM BIOPH RES CO, V160, P33, DOI 10.1016/0006-291X(89)91616-1; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; Popoff MR, 2013, TOXICON, DOI [10.1016/j.toxicon.2013.05.003, DOI 10.1016/J.T0XIC0N.2013.05.003.PUBMED:23707611]; Qin S, 2007, BIOINFORMATICS, V23, P3386, DOI 10.1093/bioinformatics/btm434; ROOD JI, 1991, MICROBIOL REV, V55, P621, DOI 10.1128/MMBR.55.4.621-648.1991; Sakurai J, 2004, J BIOCHEM, V136, P569, DOI 10.1093/jb/mvh161; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; TITBALL RW, 1993, FEMS MICROBIOL LETT, V110, P45, DOI 10.1016/0378-1097(93)90240-3; Titball RW, 2000, INT J MED MICROBIOL, V290, P357; Uppalapati SR, 2012, J APPL MICROBIOL, V113, P448, DOI 10.1111/j.1365-2672.2012.05333.x; Walker N, 2000, ARCH BIOCHEM BIOPHYS, V384, P24, DOI 10.1006/abbi.2000.2065	29	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82024	10.1371/journal.pone.0082024	http://dx.doi.org/10.1371/journal.pone.0082024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349173	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300069
J	Zhang, F; Chen, SM; Jiang, JF; Guan, ZY; Fang, WM; Chen, FD				Zhang, Fei; Chen, Sumei; Jiang, Jiafu; Guan, Zhiyong; Fang, Weimin; Chen, Fadi			Genetic Mapping of Quantitative Trait Loci Underlying Flowering Time in Chrysanthemum (Chrysanthemum morifolium)	PLOS ONE			English	Article							INDUCTION; RESPONSES; LINKAGE; NUMBER	Flowering time is an important trait in chrysanthemum, but its genetic basis remains poorly understood. An intra-specific mapping population bred from the cross between the autumn-flowering cultivar 'Yuhualuoying' and the summer-flowering 'Aoyunhanxiao' was used to determine the number and relative effect of QTL segregating for five measures of flowering time. From flowering time data recorded over two consecutive seasons, 35 additive QTL were detected, each explaining between 5.8% and 22.7% of the overall phenotypic variance. Of these, 13 were detected in both years. Nine genomic regions harboring QTL for at least two of the five traits were identified. Ten pairs of loci epistatically determined the flowering time, but their contribution to the overall phenotypic variance was less than for the additive QTL. The results suggest that flowering time in chrysanthemum is principally governed by main effect QTL but that epistasis also contributes to the genetic architecture of the trait, and the major QTL identified herein are useful in our ongoing efforts to streamline the improvement of chrysanthemum via the use of molecular methodology.	[Zhang, Fei; Chen, Sumei; Jiang, Jiafu; Guan, Zhiyong; Fang, Weimin; Chen, Fadi] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China; [Chen, Fadi] Jiangsu Prov Engn Lab Modern Facil Agr Technol &, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Chen, FD (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	chenfd@njau.edu.cn			National Nature Science Foundation of China [30871724, 31272196]; 863 project by Ministry of Science and Technology of China [2011AA100208]; Non-profit Industry Financial Program of the Ministry of Science and Technology of the P. R. China [200903020]; Program for New Century Excellent Talents in University of the Chinese Ministry of Education [NCET-10-0492, NCET-12-0890]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 project by Ministry of Science and Technology of China; Non-profit Industry Financial Program of the Ministry of Science and Technology of the P. R. China; Program for New Century Excellent Talents in University of the Chinese Ministry of Education	This project was financed, in part, by the National Nature Science Foundation of China (Grant No. 30871724 and 31272196), 863 project by Ministry of Science and Technology of China (2011AA100208), Non-profit Industry Financial Program of the Ministry of Science and Technology of the P. R. China (200903020), and the Program for New Century Excellent Talents in University of the Chinese Ministry of Education (Grant No. NCET-10-0492 and NCET-12-0890). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NO, 2000, J AM SOC HORTIC SCI, V125, P619, DOI 10.21273/JASHS.125.5.619; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Cadic E, 2013, THEOR APPL GENET, V126, P1337, DOI 10.1007/s00122-013-2056-2; Campoy JA, 2011, PLANT MOL BIOL REP, V29, P404, DOI 10.1007/s11105-010-0242-9; da Silva JAT, 2013, CRIT REV PLANT SCI, V32, P21, DOI 10.1080/07352689.2012.696461; da Silva JAT, 2003, BIOTECHNOL ADV, V21, P715, DOI 10.1016/S0734-9750(03)00117-4; DEJONG J, 1984, EUPHYTICA, V33, P455, DOI 10.1007/BF00021145; Dugo ML, 2005, THEOR APPL GENET, V111, P511, DOI 10.1007/s00122-005-2042-4; Durand E, 2012, GENETICS, V190, P1547, DOI 10.1534/genetics.111.136903; Ergon A, 2006, THEOR APPL GENET, V112, P232, DOI 10.1007/s00122-005-0115-z; GRAVES CJ, 1977, ANN BOT-LONDON, V41, P747, DOI 10.1093/oxfordjournals.aob.a085349; Gu XY, 2007, THEOR APPL GENET, V114, P745, DOI 10.1007/s00122-006-0475-z; Higuchi Y, 2013, P NATL ACAD SCI USA, V110, P17137, DOI 10.1073/pnas.1307617110; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Kawamura K, 2011, THEOR APPL GENET, V122, P661, DOI 10.1007/s00122-010-1476-5; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; LANGTON FA, 1977, SCI HORTIC-AMSTERDAM, V7, P277, DOI 10.1016/0304-4238(77)90024-3; Li Zhikang, 1998, P119; Liu W, 2011, THEOR APPL GENET, V123, P545, DOI 10.1007/s00122-011-1606-8; Mace ES, 2013, THEOR APPL GENET, V126, P1377, DOI 10.1007/s00122-013-2059-z; McAdam EL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-360; Muchero W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054468; Nakano Y, 2013, J EXP BOT, V64, P909, DOI 10.1093/jxb/ers370; Nozaki K., 2008, Journal of Applied Horticulture (Lucknow), V10, P8; Oda A, 2012, J EXP BOT, V63, P1461, DOI 10.1093/jxb/err387; Oyant LHS, 2008, TREE GENET GENOMES, V4, P11, DOI 10.1007/s11295-007-0084-2; Ravi K, 2011, THEOR APPL GENET, V122, P1119, DOI 10.1007/s00122-010-1517-0; Remay A, 2009, THEOR APPL GENET, V119, P767, DOI 10.1007/s00122-009-1087-1; Shulga OA, 2011, IN VITRO CELL DEV-PL, V47, P553, DOI 10.1007/s11627-011-9393-0; Song XL, 2009, PLANT SCI, V177, P317, DOI 10.1016/j.plantsci.2009.05.015; Steinhoff J, 2012, THEOR APPL GENET, V125, P1539, DOI 10.1007/s00122-012-1933-4; Sumitomo K, 2009, PLANT SCI, V176, P643, DOI 10.1016/j.plantsci.2009.02.003; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang P, 2012, MOL BREEDING, V29, P99, DOI 10.1007/s11032-010-9529-7; Wang S, 2007, WINDOW QTL CARTOGRAP; WATANABE K, 1977, JPN J GENET, V52, P125, DOI 10.1266/jjg.52.125; Watanabe S, 2011, BREEDING SCI, V61, P531, DOI 10.1270/jsbbs.61.531; Wurschum T, 2012, THEOR APPL GENET, V125, P201, DOI 10.1007/s00122-012-1887-6; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang F, 2012, J HORTIC SCI BIOTECH, V87, P613, DOI 10.1080/14620316.2012.11512920; Zhang F, 2012, MOL BREEDING, V30, P1027, DOI 10.1007/s11032-011-9686-3; Zhang Fei, 2011, Acta Horticulturae Sinica, V38, P1557; [张飞 ZHANG Fei], 2011, [南京农业大学学报, Journal of Nanjing Agricultural University], V34, P31; Zhang F, 2011, MOL BREEDING, V27, P11, DOI 10.1007/s11032-010-9409-1; Zhang F, 2011, EUPHYTICA, V177, P15, DOI 10.1007/s10681-010-0239-3; Zhang YM, 2013, PLANT BIOTECHNOL J, V11, P373, DOI 10.1111/pbi.12026	48	17	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83023	10.1371/journal.pone.0083023	http://dx.doi.org/10.1371/journal.pone.0083023			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349424	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300123
J	Zheng, GX; Wang, HY; Zhang, X; Yang, YM; Wang, LL; Du, LT; Li, W; Li, J; Qu, AL; Liu, YM; Wang, CX				Zheng, Guixi; Wang, Haiyan; Zhang, Xin; Yang, Yongmei; Wang, Lili; Du, Lutao; Li, Wei; Li, Juan; Qu, Ailin; Liu, Yimin; Wang, Chuanxin			Identification and Validation of Reference Genes for qPCR Detection of Serum microRNAs in Colorectal Adenocarcinoma Patients	PLOS ONE			English	Article							ENDOGENOUS CONTROL GENES; EXPRESSION PROFILE; BIOMARKERS; CANCER	Serum microRNAs (miRNAs) have become a highlighted research hotspot, especially for their great potential as a novel promising non-invasive biomarker in cancer diagnosis. The most frequently used approach for serum miRNAs detection is quantitative real time polymerase chain reaction (qPCR). In order to obtain reliable qPCR data of miRNAs expression, the use of reference genes as endogenous control is undoubtly necessary. However, no systematic evaluation and validation of reference genes for normalizing qPCR analysis of serum miRNAs has been reported in colorectal adenocarcinoma. We firstly profiled pooled serum of colorectal adenocarcinoma, colorectal adenoma and healthy controls and selected a list of 13 miRNAs as candidate reference genes. U6 snRNA (U6) and above-mentioned 13 miRNAs were included in further confirmation by qPCR. As a result, 5 miRNAs (miR-151a-3p, miR-4446-3p, miR-221-3p, miR-93-5p and miR-3184-3p) were not detected in all samples and 2 miRNAs (miR-197-3p and miR-26a-5p) were relatively low with median Cq more than 35, and were excluded from further stability analysis. Then variable stability of other 6 miRNAs (miR-103b, miR-484, miR-16-5p, miR-3615, miR-18a-3p and miR-191-5p) and U6 were evaluated using two algorithms: geNorm and NormFinder which both identified miR-191-5p as the most stably expressed reference gene and selected miR-191-5p and U6 as the most stable pair of reference genes. After validating in an independent large cohorts and selecting miR-92a-3p as target miRNA to evaluate the effect of reference gene, we propose that combination of miR-191-5p and U6 could be used as reference genes for serum microRNAs qPCR data in colorectal adenocarcinoma, colorectal adenoma and healthy controls.	[Zheng, Guixi; Wang, Haiyan; Zhang, Xin; Yang, Yongmei; Wang, Lili; Du, Lutao; Li, Wei; Li, Juan; Qu, Ailin; Liu, Yimin; Wang, Chuanxin] Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250100, Shandong, Peoples R China	Shandong University	Wang, CX (corresponding author), Shandong Univ, Qilu Hosp, Dept Clin Lab, Jinan 250100, Shandong, Peoples R China.	cxwang@sdu.edu.cn	wang, lili/HDL-7210-2022	ZHENG, GUIXI/0000-0003-2856-9592	National Science Foundation for Yong Scholars of China [81301506]	National Science Foundation for Yong Scholars of China	This study was financially supported by National Science Foundation for Yong Scholars of China (Grant No. 81301506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Bargaje R, 2010, RNA, V16, P16, DOI 10.1261/rna.1688110; Bartley AN, 2011, CLIN CANCER RES, V17, P7283, DOI 10.1158/1078-0432.CCR-11-1452; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Genovesi Laura A, 2012, BMC Res Notes, V5, P507, DOI 10.1186/1756-0500-5-507; Hu ZB, 2012, CARCINOGENESIS, V33, P828, DOI 10.1093/carcin/bgs030; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Jones CI, 2012, BRIT J CANCER, V107, P1987, DOI 10.1038/bjc.2012.525; Kreth S, 2010, NEURO-ONCOLOGY, V12, P570, DOI 10.1093/neuonc/nop072; Lardizabal MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036323; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Mo MH, 2012, J CANCER, V3, P432, DOI 10.7150/jca.4919; Murakami Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048366; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Oberg AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020465; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Wang Yu-Xin, 2009, Chinese Journal of Natural Medicines, V7, P394, DOI 10.3724/SP.J.1009.2009.00394; Zhang CN, 2010, CLIN CHEM, V56, P1871, DOI 10.1373/clinchem.2010.147553; Zhu HT, 2012, MOL BIOTECHNOL, V50, P49, DOI 10.1007/s12033-011-9414-6	25	86	92	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83025	10.1371/journal.pone.0083025	http://dx.doi.org/10.1371/journal.pone.0083025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349425	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300124
J	Araujo, LCC; Aguiar, JS; Napoleao, TH; Mota, FVB; Barros, ALS; Moura, MC; Coriolano, MC; Coelho, LCBB; Silva, TG; Paiva, PMG				Correa Araujo, Larissa Cardoso; Aguiar, Jaciana Santos; Napoleao, Thiago Henrique; Barreto Mota, Fernanda Virginia; Souza Barros, Andre Luiz; Moura, Maiara Celine; Coriolano, Marilia Cavalcanti; Breitenbach Barroso Coelho, Luana Cassandra; Silva, Teresinha Goncalves; Guedes Paiva, Patricia Maria			Evaluation of Cytotoxic and Anti-Inflammatory Activities of Extracts and Lectins from Moringa oleifera Seeds	PLOS ONE			English	Article							NITRIC-OXIDE; MACROPHAGE CELLS; OXIDATIVE STRESS; BINDING LECTIN; MURINE MODEL; EXPRESSION; PROLIFERATION; INFLAMMATION; PLANTS; ASSAY	Background: The extract from Moringa oleifera seeds is used worldwide, especially in rural areas of developing countries, to treat drinking water. M. oleifera seeds contain the lectins cmol and WSMoL, which are carbohydrate-binding proteins that are able to reduce water turbidity because of their coagulant activity. Studies investigating the ability of natural products to damage normal cells are essential for the safe use of these substances. This study evaluated the cytotoxic and anti-inflammatory properties of the aqueous seed extract, the extract used by population to treat water (named diluted seed extract in this work), and the isolated lectins cmol and WSMoL. Methodology/Principal Findings: The data showed that the aqueous seed extract and cmol were potentially cytotoxic to human peripheral blood mononuclear cells, while WSMoL and diluted seed extract were not cytotoxic. The M. oleifera aqueous seed extract and the lectins cmol and WSMoL were weakly/moderately cytotoxic to the NCI-H292, HT-29 and HEp-2 cancer cell lines and were not hemolytic to murine erythrocytes. Evaluation of acute toxicity in mice revealed that the aqueous seed extract (2.000 mg/kg) did not cause systemic toxicity. The aqueous seed extract, cmol and WSMoL (6.25 mu g/mL) and diluted seed extract at 50 mu g/mL exhibited anti-inflammatory activity on lipopolyssaccharide-stimulated murine macrophages by regulating the production of nitric oxide, TNF-alpha and IL-1 beta. The aqueous seed extract reduced leukocyte migration in a mouse model of carrageenan-induced pleurisy; the myeloperoxidase activity and nitric oxide, TNF-alpha and IL-1 beta levels were similarly reduced. Histological analysis of the lungs showed that the extract reduced the number of leukocytes. Conclusion/Significance: This study shows that the extract prepared according to folk use and WSMoL may be non-toxic to mammalian cells; however, the aqueous seed extract and cmol may be cytotoxic to immune cells which may explain the immunosuppressive potential of the extract.	[Correa Araujo, Larissa Cardoso; Aguiar, Jaciana Santos; Barreto Mota, Fernanda Virginia; Souza Barros, Andre Luiz; Silva, Teresinha Goncalves] Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Antibiot, Recife, PE, Brazil; [Correa Araujo, Larissa Cardoso; Napoleao, Thiago Henrique; Moura, Maiara Celine; Coriolano, Marilia Cavalcanti; Breitenbach Barroso Coelho, Luana Cassandra; Guedes Paiva, Patricia Maria] Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Bioquim, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco	Silva, TG (corresponding author), Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Antibiot, Recife, PE, Brazil.	teresinha.goncalves@pq.cnpq.br	Gonçalves-Silva, TERESINHA/ABE-4945-2021; Aguiar, Jaciana/W-7804-2019; Napoleao, Thiago Henrique/P-2364-2019; Paiva, Patricia Maria Guedes/S-4038-2019	Aguiar, Jaciana/0000-0002-6097-8065; Napoleao, Thiago Henrique/0000-0002-0065-2602; Paiva, Patricia Maria Guedes/0000-0003-3467-708X; Coriolano, Marilia Cavalcanti/0000-0002-0365-4101	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	The authors thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE) for scholarships and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adejumo OE, 2012, J PHARM BIOALLIED SC, V4, P118, DOI 10.4103/0975-7406.94812; Agrawal B, 2008, INDIAN J PHARMACOL, V40, P28, DOI 10.4103/0253-7613.40486; Aida Y, 2006, LIFE SCI, V79, P764, DOI 10.1016/j.lfs.2006.02.038; ALLEY MC, 1988, CANCER RES, V48, P589; Ampasavate C, 2010, AFR J PHARM PHARMACO, V4, P13; BING DH, 1967, P SOC EXP BIOL MED, V124, P1166; Brown V, 2003, THORAX, V58, P311, DOI 10.1136/thorax.58.4.311; CACERES A, 1992, J ETHNOPHARMACOL, V36, P233, DOI 10.1016/0378-8741(92)90049-W; Coelho JS, 2009, CHEMOSPHERE, V77, P934, DOI 10.1016/j.chemosphere.2009.08.022; Costa-Lotufo LV, 2005, J ETHNOPHARMACOL, V99, P21, DOI 10.1016/j.jep.2005.01.041; Dalmarco EM, 2004, TRANSPL IMMUNOL, V12, P151, DOI 10.1016/j.trim.2003.09.001; Santos NDD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044840; Deb DD, 2011, CHEM-BIOL INTERACT, V193, P97, DOI 10.1016/j.cbi.2011.05.009; Elgavish S, 1997, TRENDS BIOCHEM SCI, V22, P462, DOI 10.1016/S0968-0004(97)01146-8; Fahy John V, 2009, Proc Am Thorac Soc, V6, P256, DOI 10.1513/pats.200808-087RM; Ferreira PMP, 2009, AN ACAD BRAS CIENC, V81, P207, DOI 10.1590/S0001-37652009000200007; Ferreira RS, 2011, LETT APPL MICROBIOL, V53, P186, DOI 10.1111/j.1472-765X.2011.03089.x; Fouche G, 2008, J ETHNOPHARMACOL, V119, P455, DOI 10.1016/j.jep.2008.07.005; Frode TS, 2001, MEDIAT INFLAMM, V10, P223; Gad S, 1993, GEN APPL TOXICOLOGY, V1993, P179; Grotzke JE, 2005, MICROBES INFECT, V7, P776, DOI 10.1016/j.micinf.2005.03.001; Hamza AA, 2010, FOOD CHEM TOXICOL, V48, P345, DOI 10.1016/j.fct.2009.10.022; Houser KR, 2012, J INFLAMM-LOND, V9, DOI 10.1186/1476-9255-9-6; Hsieh TC, 2010, ANTICANCER RES, V30, P4169; Impellizzeri D, 2011, BIOCHEM PHARMACOL, V81, P636, DOI 10.1016/j.bcp.2010.12.006; Kalaivani T, 2011, FREE RADICAL SCAVENG; KAWO AH, 2010, BAYERO J PURE APPL S, V2, P96, DOI DOI 10.4314/BAJOPAS.V2I1.58476; KENNEDY JF, 1995, CARBOHYD POLYM, V26, P219, DOI 10.1016/0144-8617(94)00091-7; Ko HJ, 2011, J ETHNOPHARMACOL, V138, P762, DOI 10.1016/j.jep.2011.10.022; KOKATE A, 1999, PHYTOTHERAPY, V78, P126; Lea Michael, 2010, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01g02s16; Lee TH, 2012, INT IMMUNOPHARMACOL, V13, P264, DOI 10.1016/j.intimp.2012.05.005; Liu CP, 2004, LIFE SCI, V75, P699, DOI 10.1016/j.lfs.2004.01.019; Liu Z, 2008, PHYTOMEDICINE, V15, P867, DOI 10.1016/j.phymed.2008.02.025; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu HT, 1999, EMBO J, V18, P1845, DOI 10.1093/emboj/18.7.1845; Mahajan S, 2011, NATION, V293, P2; Mahajan SG, 2010, J ETHNOPHARMACOL, V130, P183, DOI 10.1016/j.jep.2010.04.024; Margareth FFMD, 2006, REV BRAS CIEN SAUDE, V10, P171; Mehta Anita, 2008, Oriental Pharmacy and Experimental Medicine, V8, P24; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagy G, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3045; Ngai PHK, 2004, BIOCHEM BIOPH RES CO, V314, P988, DOI 10.1016/j.bbrc.2003.12.196; Nilsson O, 2006, EUR J PHARMACOL, V547, P165, DOI 10.1016/j.ejphar.2006.07.016; Nunes BS, 2009, N-S ARCH PHARMACOL, V379, P609, DOI 10.1007/s00210-009-0397-9; Oliveira JTA, 1999, J SCI FOOD AGR, V79, P815, DOI [10.1002/(SICI)1097-0010(19990501)79:6&lt;815::AID-JSFA290&gt;3.0.CO;2-P, 10.1002/(SICI)1097-0010(19990501)79:6<815::AID-JSFA290>3.0.CO;2-P]; Vanderlei ESO, 2010, INT IMMUNOPHARMACOL, V10, P1113, DOI 10.1016/j.intimp.2010.06.014; PAIVA PMG, 1992, APPL BIOCHEM BIOTECH, V36, P113, DOI 10.1007/BF02929691; Ragasa C.Y., 2012, PHILIPP SCI LETT, V5, P46; Raja SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016231; de Oliveira CFR, 2011, PROCESS BIOCHEM, V46, P498, DOI 10.1016/j.procbio.2010.09.025; Rogerio AP, 2007, GLYCOBIOLOGY, V17, P795, DOI 10.1093/glycob/cwm053; Rolim LADMM, 2011, J FOOD SCI, V76, pT53, DOI 10.1111/j.1750-3841.2010.01990.x; Roopan SM, 2009, ARKIVOC, P161, DOI 10.3998/ark.5550190.0010.d14; Saleh TSF, 1996, BRIT J PHARMACOL, V118, P811, DOI 10.1111/j.1476-5381.1996.tb15472.x; Santos AFS, 2005, WATER RES, V39, P975, DOI 10.1016/j.watres.2004.12.016; Santos AFS, 2009, PROCESS BIOCHEM, V44, P504, DOI 10.1016/j.procbio.2009.01.002; Sung NY, 2013, FEBS OPEN BIO, V3, P106, DOI 10.1016/j.fob.2013.01.003; Takacs T, 2002, PANCREAS, V25, P277, DOI 10.1097/00006676-200210000-00010; ter Steege JC, 1998, CYTOKINE, V10, P115, DOI DOI 10.1006/CYT0.1997.0263.PUBMED:9512901; Tiwari M, 2010, FOOD CHEM TOXICOL, V48, P2913, DOI 10.1016/j.fct.2010.07.027; Usman M.R.M., 2012, INT J PHARM RES DEV, V3, P114; VILLASENOR IM, 1989, MUTAT RES, V224, P209, DOI 10.1016/0165-1218(89)90157-2; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yoo HJ, 2008, J ETHNOPHARMACOL, V120, P282, DOI 10.1016/j.jep.2008.08.016; Yu YM, 2007, BRIT J NUTR, V97, P692, DOI 10.1017/S0007114507666409; Zang JJ, 2006, ARCH ANIM NUTR, V60, P245, DOI 10.1080/17450390600679082	68	59	64	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81973	10.1371/journal.pone.0081973	http://dx.doi.org/10.1371/journal.pone.0081973			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349164	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200058
J	Peng, H; Zhong, MR; Zhao, WB; Wang, C; Zhang, J; Liu, X; Li, YQ; Paudel, SD; Wang, QQ; Lou, TQ				Peng, Hui; Zhong, Meirong; Zhao, Wenbo; Wang, Cheng; Zhang, Jun; Liu, Xun; Li, Yuanqing; Paudel, Sujay Dutta; Wang, Qianqian; Lou, Tanqi			Urinary miR-29 Correlates with Albuminuria and Carotid Intima-Media Thickness in Type 2 Diabetes Patients	PLOS ONE			English	Article							INSULIN-RESISTANCE; SKELETAL-MUSCLE; MICRORNAS; BIOMARKERS; DISEASE; NEPHROPATHY; RETINOPATHY; EXPRESSION; FIBROSIS; PLASMA	Background: Cell-free microRNAs stably and abundantly exist in body fluids and emerging evidence suggests cell-free microRNAs as novel and non-invasive disease biomarker. Deregulation of miR-29 is involved in the pathogenesis of diabetic nephropathy and insulin resistance thus may be implicated in diabetic vascular complication. Therefore, we investigated the possibility of urinary miR-29 as biomarker for diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Methods: 83 patients with type 2 diabetes were enrolled in this study, miR-29a, miR-29b and miR-29c levels in urine supernatant was determined by TaqMan qRT-PCR, and a synthetic cel-miR-39 was added to the urine as a spike-in control before miRNAs extraction. Urinary albumin excretion rate and urine albumin/creatinine ratio, funduscopy and carotid ultrasound were used for evaluation of diabetic vascular complication. The laboratory parameters indicating blood glucose level, renal function and serum lipids were also collected. Results: Patients with albuminuria (n = 42, age 60.62 +/- 12.00yrs) showed significantly higher comorbidity of diabetic retinopathy (p = 0.015) and higher levels of urinary miR-29a (p = 0.035) compared with those with normoalbuminuria (n = 41, age 58.54 +/- 14.40yrs). There was no significant difference in urinary miR-29b (p = 0.148) or miR-29c level (p = 0.321) between groups. Urinary albumin excretion rate significantly correlated with urinary miR-29a level (r = 0.286, p = 0.016), while urinary miR-29b significantly correlated with carotid intima-media thickness (cIMT) (r = 0.286, p = 0.046). Conclusion: Urinary miR-29a correlated with albuminuria while urinary miR-29b correlated with carotid intima-media thickness (cIMT) in patients with type 2 diabetes. Therefore, they may have the potential to serve as alternative biomarker for diabetic nephropathy and atherosclerosis in type 2 diabetes.	[Peng, Hui; Zhong, Meirong; Zhao, Wenbo; Wang, Cheng; Zhang, Jun; Liu, Xun; Li, Yuanqing; Paudel, Sujay Dutta; Wang, Qianqian; Lou, Tanqi] Sun Yat Sen Univ, Affiliated Hosp 3, Div Nephrol, Dept Internal Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Lou, TQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Div Nephrol, Dept Internal Med, Guangzhou 510275, Guangdong, Peoples R China.	Lou.tq@163.com	wang, cheng/A-4225-2017		Fundamental Research Funds for the Central Universities [10ykpy03]; National Natural Science Funds of China [30800408, 30771011, 81170678]; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2011BAI10B00]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program)	This work was supported by the Fundamental Research Funds for the Central Universities (grant 10ykpy03) (http://jkw.mof.gov.cn/zhengwuxinxi/zhengcefabu/201106/t20110620_563835.html); the National Natural Science Funds of China (No. 30800408, No. 30771011, and No. 81170678) (http://www.nsfc.gov.cn/Portal0/default152.htm) and the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (grant 2011BAI10B00) (http://kjzc.jhgl.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Brozinick JT, 2003, DIABETES, V52, P935, DOI 10.2337/diabetes.52.4.935; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen YH, 2012, DIABETES CARE, V35, P803, DOI 10.2337/dc11-1955; Cheng YH, 2012, J MOL CELL CARDIOL, V53, P668, DOI 10.1016/j.yjmcc.2012.08.010; Cooper ME, 1997, CLIN EXP PHARMACOL P, V24, P770, DOI 10.1111/j.1440-1681.1997.tb02130.x; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fang Y, 2013, AM J PHYSIOL-RENAL, V304, pF1274, DOI 10.1152/ajprenal.00287.2012; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; He F, 2013, DIABETOLOGIA, V56, P457, DOI 10.1007/s00125-012-2796-6; He Y, 2013, BIOCHIMIE, V95, P1355, DOI 10.1016/j.biochi.2013.03.010; Kanter JE, 2013, CIRC RES, V113, P352, DOI 10.1161/CIRCRESAHA.113.301998; Kramer CK, 2013, DIABETIC MED, V35, P803; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P237, DOI 10.1152/physiolgenomics.00141.2011; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Long JY, 2011, J BIOL CHEM, V286, P11837, DOI 10.1074/jbc.M110.194969; Lou QL, 2012, DIABETES METAB J, V36, P433, DOI 10.4093/dmj.2012.36.6.433; Lupattelli G, 2013, J ATHEROSCLER THROMB, V21, P2785; Lv L.L., 2013, AM J PHYSIOL-RENAL, V36, P412; McKittrick IB, 2011, AM J PHYSIOL-RENAL, V301, pF1326, DOI 10.1152/ajprenal.00267.2011; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; Natarajan R, 2012, J CARDIOVASC TRANSL, V5, P413, DOI 10.1007/s12265-012-9368-5; Rask-Madsen C, 2013, CELL METAB, V17, P20, DOI 10.1016/j.cmet.2012.11.012; Rask-Madsen C, 2010, CELL METAB, V11, P379, DOI 10.1016/j.cmet.2010.03.013; Rosenson RS, 2011, ATHEROSCLEROSIS, V218, P13, DOI 10.1016/j.atherosclerosis.2011.06.029; Tan SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069193; van Dam EM, 2005, MOL ENDOCRINOL, V19, P1067, DOI 10.1210/me.2004-0413; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang B, 2012, J AM SOC NEPHROL, V23, P252, DOI 10.1681/ASN.2011010055; Wang G, 2012, AM J NEPHROL, V36, P412, DOI 10.1159/000343452; Wang G, 2012, CLIN GENITOURIN CANC, V10, P106, DOI 10.1016/j.clgc.2012.01.001; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wei W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.184; Welsh GI, 2010, CELL METAB, V12, P329, DOI 10.1016/j.cmet.2010.08.015; Zen K, 2012, MED RES REV, V32, P326, DOI 10.1002/med.20215	37	71	77	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82607	10.1371/journal.pone.0082607	http://dx.doi.org/10.1371/journal.pone.0082607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349318	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200084
J	Schieber, TA; Ravetti, MG				Schieber, Tiago Alves; Ravetti, Martin Gomez			Simulating the Dynamics of Scale-Free Networks via Optimization	PLOS ONE			English	Article							EVOLUTION	We deal here with the issue of complex network evolution. The analysis of topological evolution of complex networks plays a crucial role in predicting their future. While an impressive amount of work has been done on the issue, very little attention has been so far devoted to the investigation of how information theory quantifiers can be applied to characterize networks evolution. With the objective of dynamically capture the topological changes of a network's evolution, we propose a model able to quantify and reproduce several characteristics of a given network, by using the square root of the Jensen-Shannon divergence in combination with the mean degree and the clustering coefficient. To support our hypothesis, we test the model by copying the evolution of well-known models and real systems. The results show that the methodology was able to mimic the test-networks. By using this copycat model, the user is able to analyze the networks behavior over time, and also to conjecture about the main drivers of its evolution, also providing a framework to predict its evolution.	[Schieber, Tiago Alves; Ravetti, Martin Gomez] Univ Fed Minas Gerais, Dept Engn Prod, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais	Schieber, TA (corresponding author), Univ Fed Minas Gerais, Dept Engn Prod, Belo Horizonte, MG, Brazil.	tiagoschieber@eng-pro.dout.ufmg.br; martin.ravetti@dep.ufmg.br	Ravetti, Martin/K-1108-2012	Ravetti, Martin/0000-0001-7781-0034; Schieber, Tiago/0000-0002-4923-7047	CNPq; FAPEMIG	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	We thank Dra. Laura Carpi, Dr. Osvaldo Rosso and Dr. Carlos Riveros for useful discussions. We also would like to thank the reviewers and editor for their valuable feedback; their comments greatly improved the article. M. G. R. acknowledges partial support from CNPq and FAPEMIG.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2012, NATURE, V489, P507, DOI 10.1038/nature11486; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Carpi LC, 2011, PHYS LETT A, V375, P801, DOI 10.1016/j.physleta.2010.12.038; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Dorogovtsev SN, 2000, PHYS REV E, V62, P1842, DOI 10.1103/PhysRevE.62.1842; Dorogovtsev SN, 2000, PHYS REV LETT, V85, P4633, DOI 10.1103/PhysRevLett.85.4633; Endres DM, 2003, IEEE T INFORM THEORY, V49, P1858, DOI 10.1109/TIT.2003.813506; FEO TA, 1989, OPER RES LETT, V8, P67, DOI 10.1016/0167-6377(89)90002-3; Ghoshal G, 2007, EUR PHYS J B, V58, P175, DOI 10.1140/epjb/e2007-00208-2; Herrera Carlos, 2011, 2011 IEEE First International Network Science Workshop (NSW 2011), P167, DOI 10.1109/NSW.2011.6004642; Isella L, 2011, J THEOR BIOL, V271, P166, DOI 10.1016/j.jtbi.2010.11.033; Iyer SV, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053532, 10.1371/journal.pone.0059613]; Krapivsky PL, 2000, PHYS REV LETT, V85, P4629, DOI 10.1103/PhysRevLett.85.4629; Leskovec J., 2008, P 14 ACM SIGKDD INT, P462, DOI DOI 10.1145/1401890.1401948; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Opsahl T, 2011, SOCIAL NETW IN PRESS, V0; Opsahl T, 2009, SOC NETWORKS, V31, P155, DOI 10.1016/j.socnet.2009.02.002; Osterreicher F, 2003, ANN I STAT MATH, V55, P639, DOI 10.1007/BF02517812; Papadopoulos F, 2012, NATURE, V489, P537, DOI 10.1038/nature11459; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Wang B, 2006, PHYSICA A, V363, P591, DOI 10.1016/j.physa.2005.08.025; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	25	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80783	10.1371/journal.pone.0080783	http://dx.doi.org/10.1371/journal.pone.0080783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24353752	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566700014
J	Zhuo, XM; Haeri, M; Solessio, E; Knox, BE				Zhuo, Xinming; Haeri, Mohammad; Solessio, Eduardo; Knox, Barry E.			An Inducible Expression System to Measure Rhodopsin Transport in Transgenic Xenopus Rod Outer Segments	PLOS ONE			English	Article							RETINAL PHOTORECEPTORS; MEMBRANE ADDITION; GENE-EXPRESSION; IN-VIVO; VESICLES; COMPLEX; OPSIN; DISK; DEGENERATION; TRAFFICKING	We developed an inducible transgene expression system in Xenopus rod photoreceptors. Using a transgene containing mCherry fused to the carboxyl terminus of rhodopsin (Rho-mCherry), we characterized the displacement of rhodopsin (Rho) from the base to the tip of rod outer segment (OS) membranes. Quantitative confocal imaging of live rods showed very tight regulation of Rho-mCherry expression, with undetectable expression in the absence of dexamethasone (Dex) and an average of 16.5 mu M of Rho-mCherry peak concentration after induction for several days (equivalent to >150-fold increase). Using repetitive inductions, we found the axial rate of disk displacement to be 1.0 mu m/day for tadpoles at 20 degrees C in a 12 h dark /12 h light lighting cycle. The average distance to peak following Dex addition was 3.2 mu m, which is equivalent to similar to 3 days. Rods treated for longer times showed more variable expression patterns, with most showing a reduction in Rho-mCherry concentration after 3 days. Using a simple model, we find that stochastic variation in transgene expression can account for the shape of the induction response.	[Knox, Barry E.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; SUNY Upstate Med Univ, Dept Ophthalmol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Knox, BE (corresponding author), SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA.	knoxb@upstate.edu			National Institutes of Health [EY-11256, EY-12975]; Lions of CNY; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY011256, R01EY012975] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lions of CNY; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by the National Institutes of Health grants EY-11256 and EY-12975 (B.E.K.), Research to Prevent Blindness (Unrestricted Grant to SUNY UMU Department of Ophthalmology) and the Lions of CNY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya E, 1999, METH MOL B, V97, P393, DOI 10.1385/1-59259-270-8:393; ANDREWS LD, 1984, CURR EYE RES, V3, P1265, DOI 10.3109/02713688409007412; Baker SA, 2008, J CELL BIOL, V183, P485, DOI 10.1083/jcb.200806009; Batni S, 1996, J BIOL CHEM, V271, P3179, DOI 10.1074/jbc.271.6.3179; BESHARSE JC, 1977, J CELL BIOL, V75, P507, DOI 10.1083/jcb.75.2.507; BESHARSE JC, 1985, J NEUROSCI, V5, P1035; BESHARSE JC, 1980, J CELL BIOL, V87, P451, DOI 10.1083/jcb.87.2.451; Besharse JC, 2003, ADV EXP MED BIOL, V533, P157; Chae J, 2002, MECH DEVELOP, V117, P235, DOI 10.1016/S0925-4773(02)00219-8; DEFOE DM, 1985, J NEUROSCI, V5, P1023; Denayer T, 2006, FEBS LETT, V580, P393, DOI 10.1016/j.febslet.2005.11.084; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; deTurco EBR, 1997, J BIOL CHEM, V272, P10491; Echeverria PC, 2009, MOL CELL BIOL, V29, P4788, DOI 10.1128/MCB.00649-09; FL H, 1975, J GEN PHYSIOL, V66, P357, DOI DOI 10.1085/JGP.66.3.357.PUBMED:808586; Haeri M, 2013, BIOPHYS J, V104, P300, DOI 10.1016/j.bpj.2012.11.3835; Haeri Mohammad, 2012, Methods Mol Biol, V884, P17, DOI 10.1007/978-1-61779-848-1_2; Haeri M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030101; Hartley KO, 2002, P NATL ACAD SCI USA, V99, P1377, DOI 10.1073/pnas.022646899; HOLLYFIELD JG, 1982, EXP EYE RES, V34, P115, DOI 10.1016/0014-4835(82)90013-6; HOLLYFIELD JG, 1977, J CELL BIOL, V75, P490, DOI 10.1083/jcb.75.2.490; HOLLYFIELD JG, 1982, INVEST OPHTH VIS SCI, V22, P417; HOLSBOER F, 1986, ARCH GEN PSYCHIAT, V43, P813; HSU YT, 1993, BIOCHIM BIOPHYS ACTA, V1145, P85, DOI 10.1016/0005-2736(93)90384-C; Imhof MO, 2000, J GENE MED, V2, P107; KAPLAN MW, 1989, EXP EYE RES, V49, P1045, DOI 10.1016/S0014-4835(89)80025-9; Keyvani K, 1999, LIFE SCI, V64, P1719, DOI 10.1016/S0024-3205(99)00109-5; KINNEY MS, 1978, PROC R SOC SER B-BIO, V201, P169, DOI 10.1098/rspb.1978.0038; KINNEY MS, 1978, PROC R SOC SER B-BIO, V201, P149, DOI 10.1098/rspb.1978.0037; Knox BE, 1998, FEBS LETT, V423, P117, DOI 10.1016/S0014-5793(98)00018-0; Kroll KL, 1996, DEVELOPMENT, V122, P3173; MATSUMOTO B, 1985, INVEST OPHTH VIS SCI, V26, P628; MCGHEE CNJ, 1992, BRIT J OPHTHALMOL, V76, P681, DOI 10.1136/bjo.76.11.681; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Moritz OL, 1999, INVEST OPHTH VIS SCI, V40, P3276; Najafi M, 2012, J GEN PHYSIOL, V140, P249, DOI 10.1085/jgp.201210818; Najafi M, 2012, P NATL ACAD SCI USA, V109, P203, DOI 10.1073/pnas.1115109109; PAPERMASTER DS, 1985, INVEST OPHTH VIS SCI, V26, P1386; PAPERMASTER DS, 1986, J HISTOCHEM CYTOCHEM, V34, P5, DOI 10.1177/34.1.2934469; Peet JA, 2004, J CELL SCI, V117, P3049, DOI 10.1242/jcs.01167; PICARD D, 1987, EMBO J, V6, P3333, DOI 10.1002/j.1460-2075.1987.tb02654.x; Rankin SA, 2011, DEV DYNAM, V240, P1467, DOI 10.1002/dvdy.22642; Roose M, 2009, TRANSGENIC RES, V18, P595, DOI 10.1007/s11248-009-9253-4; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Tam BM, 2007, J NEUROSCI, V27, P9043, DOI 10.1523/JNEUROSCI.2245-07.2007; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; WANG WD, 1992, SCIENCE, V255, P450, DOI 10.1126/science.1310361; Wheeler GN, 2000, CURR BIOL, V10, P849, DOI 10.1016/S0960-9822(00)00596-0; Wheeler Grant N., 2008, V469, P431, DOI 10.1007/978-1-59745-249_27; WITKOVSKY P, 1976, J NEUROPHYSIOL, V39, P1272, DOI 10.1152/jn.1976.39.6.1272; Yotov WV, 1998, MOL CELL BIOL, V18, P1303, DOI 10.1128/MCB.18.3.1303; YOUNG RW, 1971, J CELL BIOL, V49, P303, DOI 10.1083/jcb.49.2.303; YOUNG RW, 1968, J CELL BIOL, V39, P169, DOI 10.1083/jcb.39.1.169	53	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82629	10.1371/journal.pone.0082629	http://dx.doi.org/10.1371/journal.pone.0082629			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24349323	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566700093
J	Loh, DA; Moy, FM; Zaharan, NL; Mohamed, Z				Loh, Debbie Ann; Moy, Foong Ming; Zaharan, Nur Lisa; Mohamed, Zahurin			Eating Behaviour among Multi-Ethnic Adolescents in a Middle-Income Country as Measured by the Self-Reported Children's Eating Behaviour Questionnaire	PLOS ONE			English	Article							FACTORIAL VALIDATION; CHILDHOOD OVERWEIGHT; PRESCHOOL-CHILDREN; RELATIVE WEIGHT; OBESITY; ASSOCIATION; PATTERNS; FOOD; SUSCEPTIBILITY; DETERMINANTS	Background: Escalating weight gain among the Malaysian paediatric population necessitates identifying modifiable behaviours in the obesity pathway. Objectives: This study describes the adaptation and validation of the Children's Eating Behaviour Questionnaire (CEBQ) as a self-report for adolescents, investigates gender and ethnic differences in eating behaviour and examines associations between eating behaviour and body mass index (BMI) z-scores among multi-ethnic Malaysian adolescents. Methodology: This two-phase study involved validation of the Malay self-reported CEBQ in Phase 1 (n = 362). Principal Axis Factoring with Promax rotation, confirmatory factor analysis and reliability tests were performed. In Phase 2, adolescents completed the questionnaire (n = 646). Weight and height were measured. Gender and ethnic differences in eating behaviour were investigated. Associations between eating behaviour and BMI z-scores were examined with complex samples general linear model (GLM) analyses, adjusted for gender, ethnicity and maternal educational level. Results: Exploratory factor analysis revealed a 35-item, 9-factor structure with 'food fussiness' scale split into two. In confirmatory factor analysis, a 30-item, 8-factor structure yielded an improved model fit. Reliability estimates of the eight factors were acceptable. Eating behaviours did not differ between genders. Malay adolescents reported higher Food Responsiveness, Enjoyment of Food, Emotional Overeating, Slowness in Eating, Emotional Undereating and Food Fussiness 1 scores (p<0.05) compared to Chinese and Indians. A significant negative association was observed between BMI z-scores and Food Fussiness 1 ('dislike towards food') when adjusted for confounders. Conclusion: Although CEBQ is a valuable psychometric instrument, adjustments were required due to age and cultural differences in our sample. With the self-report, our findings present that gender, ethnic and weight status influenced eating behaviours. Obese adolescents were found to display a lack of dislike towards food. Future longitudinal and qualitative studies are warranted to further understand behavioural phenotypes of obesity to guide prevention and intervention strategies.	[Loh, Debbie Ann; Moy, Foong Ming] Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia; [Zaharan, Nur Lisa; Mohamed, Zahurin] Univ Malaya, Fac Med, Dept Pharmacol, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Loh, DA (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Julius Ctr, Kuala Lumpur, Malaysia.	debbieloh@siswa.um.edu.my	Mohamed, Zahurin/C-1112-2010; Zaharan, Nur Lisa/F-8835-2012; Moy, Foong Ming/B-7899-2010	Mohamed, Zahurin/0000-0002-4396-0517; Zaharan, Nur Lisa/0000-0002-8150-0642; Moy, Foong Ming/0000-0002-0306-4419	Ministry of Higher Education, Malaysia [HIR MOHE E000049-20001]; University of Malaya [RG466/12HTM]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia); University of Malaya(Universiti Malaya)	This study was supported by the High Impact Research (HIR) Grant from the Ministry of Higher Education, Malaysia (HIR MOHE E000049-20001) and the University of Malaya Research Grant (RG466/12HTM) from University of Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EN, 2007, ECOL FOOD NUTR, V46, P205, DOI 10.1080/03670240701407590; Ashcroft J, 2008, EUR J CLIN NUTR, V62, P985, DOI 10.1038/sj.ejcn.1602855; Birch LL, 1998, PEDIATRICS, V101, P539; Cao YT, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-5; Carnell S, 2007, APPETITE, V48, P104, DOI 10.1016/j.appet.2006.07.075; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Costello AB, 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [DOI 10.7275/JYJ1-4868, DOI 10.1316/S0782-051X03024046-9]; De Moura SL, 2007, APPETITE, V49, P716, DOI 10.1016/j.appet.2007.08.006; Dean A, 2011, OPENEPI OPEN SOURCE; Farah Wahida Z, 2011, Malays J Nutr, V17, P325; Field A, 2013, DISCOVERING STAT USI; Galloway AT, 2005, J AM DIET ASSOC, V105, P541, DOI 10.1016/j.jada.2005.01.029; Gibson EL, 2006, PHYSIOL BEHAV, V89, P53, DOI 10.1016/j.physbeh.2006.01.024; Hair J.F., 2010, MULTIVARIATE DATA AN, V7th ed; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Haycraft E, 2011, APPETITE, V56, P689, DOI 10.1016/j.appet.2011.02.005; Heshmat S, 2011, EATING BEHAVIOR AND OBESITY: BEHAVIORAL ECONOMICS STRATEGIES FOR HEALTH PROFESSIONALS, P1; Institute for Public Health Malaysia, 2011, NAT HLTH MORB SURV 2; Lekhraj Rampal G R, 2007, Malays J Nutr, V13, P1; Ludwig DS, 2007, NEW ENGL J MED, V357, P2325, DOI 10.1056/NEJMp0706538; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Mastor KA, 2000, AM BEHAV SCI, V44, P95, DOI 10.1177/00027640021956116; Matsunaga M, 2010, INT J PSYCHOL RES, V3, P97, DOI 10.21500/20112084.854; Moy F. M., 2006, MALAYSIAN J NUTR, V12, P1; Moy FM, 2004, ASIA PAC J CLIN NUTR, V13, P324; Ng TP, 2005, QUAL LIFE RES, V14, P1755, DOI 10.1007/s11136-005-1741-2; O'Rahilly S, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.239; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Poh BK, 2011, INT J PEDIATR OBES, V6, P229, DOI 10.3109/17477166.2011.583658; Raykov T., 2011, INTRO PSYCHOMETRIC T; Rodenburg G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050642; ROZIN P, 1987, PSYCHOL REV, V94, P23, DOI 10.1037/0033-295X.94.1.23; Salleh L.M., 2005, P 2005 ASS BUS COMM, P1; Santos JL, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-108; Scaglioni S, 2011, AM J CLIN NUTR, V94, p2006S, DOI 10.3945/ajcn.110.001685; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; SH Global Education, 2011, MAL DIN ET ADV INT B; Sleddens EFC, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-49; Spence JC, 2011, INT J PEDIATR OBES, V6, pE501, DOI 10.3109/17477166.2010.512087; Steiger JH, 2007, PERS INDIV DIFFER, V42, P893, DOI 10.1016/j.paid.2006.09.017; Svensson V, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-134; Tabachnick B. G., 2019, USING MULTIVARIATE S, V5; Uauy R., 2004, OBES REV S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Viana V, 2008, BRIT J NUTR, V100, P445, DOI 10.1017/S0007114508894391; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Wardle J, 2001, J CHILD PSYCHOL PSYC, V42, P963, DOI 10.1111/1469-7610.00792; Wardle J, 2007, OBES REV, V8, P73, DOI 10.1111/j.1467-789X.2007.00322.x; Wardle J, 2001, INT J OBESITY, V25, P971, DOI 10.1038/sj.ijo.0801661; Webber L, 2009, INT J OBESITY, V33, P21, DOI 10.1038/ijo.2008.219; Zainal A., 2010, J HOSP TOURISM CULIN, V2, P15; Zalilah M. S., 2006, SMJ Singapore Medical Journal, V47, P491	51	36	37	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82885	10.1371/journal.pone.0082885	http://dx.doi.org/10.1371/journal.pone.0082885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273WD	24349385	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100130
J	McGreevy, PD; Georgevsky, D; Carrasco, J; Valenzuela, M; Duffy, DL; Serpell, JA				McGreevy, Paul D.; Georgevsky, Dana; Carrasco, Johanna; Valenzuela, Michael; Duffy, Deborah L.; Serpell, James A.			Dog Behavior Co-Varies with Height, Bodyweight and Skull Shape	PLOS ONE			English	Article							BREED; TEMPERAMENT	Dogs offer unique opportunities to study correlations between morphology and behavior because skull shapes and body shape are so diverse among breeds. Several studies have shown relationships between canine cephalic index (CI: the ratio of skull width to skull length) and neural architecture. Data on the CI of adult, show-quality dogs (six males and six females) were sourced in Australia along with existing data on the breeds' height, bodyweight and related to data on 36 behavioral traits of companion dogs (n = 8,301) of various common breeds (n = 49) collected internationally using the Canine Behavioral Assessment and Research Questionnaire (C-BARQ). Stepwise backward elimination regressions revealed that, across the breeds, 33 behavioral traits all but one of which are undesirable in companion animals correlated with either height alone (n = 14), bodyweight alone (n = 5), CI alone (n = 3), bodyweight-and-skull shape combined (n = 2), height-and-skull shape combined (n = 3) or height-and-bodyweight combined (n = 6). For example, breed average height showed strongly significant inverse relationships (p < 0.001) with mounting persons or objects, touch sensitivity, urination when left alone, dog-directed fear, separation-related problems, non-social fear, defecation when left alone, owner-directed aggression, begging for food, urine marking and attachment/attention-seeking, while bodyweight showed strongly significant inverse relationships (p < 0.001) with excitability and being reported as hyperactive. Apart from trainability, all regression coefficients with height were negative indicating that, across the breeds, behavior becomes more problematic as height decreases. Allogrooming increased strongly (p < 0.001) with CI and inversely with height. CI alone showed a strong significant positive relationship with self-grooming (p < 0.001) but a negative relationship with chasing (p = 0.020). The current study demonstrates how aspects of CI (and therefore brain shape), bodyweight and height co-vary with behavior. The biological basis for, and significance of, these associations remain to be determined.	[McGreevy, Paul D.; Georgevsky, Dana; Carrasco, Johanna] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Valenzuela, Michael] Univ Sydney, Fac Med, Brain & Mind Res Inst, Sydney, NSW 2006, Australia; [Duffy, Deborah L.; Serpell, James A.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA	University of Sydney; University of Sydney; University of Pennsylvania	McGreevy, PD (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	paul.mcgreevy@sydney.edu.au		Valenzuela, Michael/0000-0001-7162-6607; McGreevy, Paul/0000-0001-7220-8378				Coppinger Raymond, 1995, P21; Darwin C, 1859, ORIGIN SPECIES MEANS; Das D, 2012, THESIS PRINCETON U; Duffy DL, 2008, APPL ANIM BEHAV SCI, V114, P441, DOI 10.1016/j.applanim.2008.04.006; Duffy DL, 2012, APPL ANIM BEHAV SCI, V138, P99, DOI 10.1016/j.applanim.2012.02.011; Gacsi M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-31; Gould S. J., 1977, ONTOGENY PHYLOGENY; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Masters AM, 2008, AUST VET J, V86, P18, DOI 10.1111/j.1751-0813.2007.00248.x; McGreevy P, 2004, BRAIN BEHAV EVOLUT, V63, P13, DOI 10.1159/000073756; McGreevy PD, 2010, ANIM WELFARE, V19, P11; McGreevy P.D., 2009, MODERN DOGS LIFE; Otto CM, 2004, JAVMA-J AM VET MED A, V225, P861, DOI 10.2460/javma.2004.225.861; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Roberts T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011946; SERPELL J, 1995, DOMESTIC DOG ITS EVO, P00080; Serpell JA, 2005, ANTHROZOOS, V18, P196, DOI 10.2752/089279305785594135; Snedecor GW, 1980, STATISTICAL METHODS, P361; Tiira K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041684; van den Berg SM, 2010, APPL ANIM BEHAV SCI, V124, P136, DOI 10.1016/j.applanim.2010.02.005; Vonholdt BM, 2011, GENOME RES	21	100	101	5	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e80529	10.1371/journal.pone.0080529	http://dx.doi.org/10.1371/journal.pone.0080529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358107	Green Published, gold			2022-12-27	WOS:000328735700003
J	Djeddi, DD; Kongolo, G; Stephan-Blanchard, E; Ammari, M; Leke, A; Delanaud, S; Bach, V; Telliez, F				Djeddi, Djamal-Dine; Kongolo, Guy; Stephan-Blanchard, Erwan; Ammari, Mohamed; Leke, Andre; Delanaud, Stephane; Bach, Veronique; Telliez, Frederic			Involvement of Autonomic Nervous Activity Changes in Gastroesophageal Reflux in Neonates during Sleep and Wakefulness	PLOS ONE			English	Article							ESOPHAGEAL SPHINCTER PRESSURE; PRETERM; INFANTS; HEALTHY; ACID; PREVALENCE; MECHANISMS; ATROPINE; REFLEXES	Background: It has been suggested that disturbed activity of the autonomic nervous system is one of the factors involved in gastroesophageal reflux (GER) in adults. We sought to establish whether transient ANS dysfunction (as assessed by heart rate variability) is associated with the occurrence of GER events in neonates during sleep and wakefulness. Methods: Nineteen neonates with suspected GER underwent simultaneous, synchronized 12-hour polysomnography and esophageal multichannel impedance-pH monitoring. We compared changes in HRV parameters during three types of periods (control and prior to and during reflux) with respect to the vigilance state. Results: The vigilance state influenced the distribution of GER events (P<0.001), with 53.4% observed during wakefulness, 37.6% observed during active sleep and only 9% observed during quiet sleep. A significant increase in the sympathovagal ratio (+32%, P=0.013) was observed in the period immediately prior to reflux (due to a 15% reduction in parasympathetic activity (P=0.017)), relative to the control period. This phenomenon was observed during both wakefulness and active sleep. Conclusion: Our results showed that GER events were preceded by a vigilance-state-independent decrease in parasympathetic tone. This suggests that a pre-reflux change in ANS activity is one of the factors contributing to the mechanism of reflux in neonates.	[Djeddi, Djamal-Dine; Stephan-Blanchard, Erwan; Ammari, Mohamed; Leke, Andre; Delanaud, Stephane; Bach, Veronique; Telliez, Frederic] Jules Verne Univ Picardy, Fac Med, PeriTox Lab, EA4285,UMI 01,INERIS, Amiens, France; [Djeddi, Djamal-Dine] Amiens Univ, Med Ctr, Pediat Gastroenterol Unit, Amiens, France; [Kongolo, Guy; Leke, Andre] Amiens Univ, Med Ctr, Neonatal & Pediat Intens Care Unit, Amiens, France; [Kongolo, Guy] Jules Verne Univ Picardy, Fac Med, INSERM, U1105,GRAMFC, Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Telliez, F (corresponding author), Jules Verne Univ Picardy, Fac Med, PeriTox Lab, EA4285,UMI 01,INERIS, Amiens, France.	frederic.telliez@u-picardie.fr	Bach, Veronique/AAD-5958-2022; stepahne, delanaud/AAD-2762-2022; Telliez, Frédéric/AFP-2594-2022	Stephan-Blanchard, Erwan/0000-0002-9427-4699; Djeddi, Djamal-Dine/0000-0002-9513-0275	Regional Council of Picardy	Regional Council of Picardy(Region Hauts-de-France)	This work was funded by grants from the Regional Council of Picardy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Ammari M, 2012, J SLEEP RES, V21, P80, DOI 10.1111/j.1365-2869.2011.00915.x; Anders T, 1971, MANUAL STANDARDIZED; BERGER RD, 1986, IEEE T BIO-MED ENG, V33, P900, DOI 10.1109/TBME.1986.325789; Camm AJ, 1996, EUR HEART J, V17, P354; Campanozzi A, 2009, PEDIATRICS, V123, P779, DOI 10.1542/peds.2007-3569; CHAKRABORTY TK, 1989, GUT, V30, P46, DOI 10.1136/gut.30.1.46; CORVAGLIA L, 2009, NEUROGASTROENT MOTIL, V21, pE1027, DOI DOI 10.1111/J.1365-2982.2009.01301.X.PUBMED:19368657; Dobrek L, 2004, J Physiol Pharmacol, V55 Suppl 2, P77; Emerenziani S, 2005, CURR OPIN GASTROEN, V21, P450; Fallen EL, 2001, AUTON NEUROSCI-BASIC, V90, P35, DOI 10.1016/S1566-0702(01)00265-X; Horne RSC, 2010, SLEEP MED, V11, P615, DOI 10.1016/j.sleep.2009.10.008; Jadcherla SR, 2012, AM J PHYSIOL-GASTR L, V302, pG134, DOI 10.1152/ajpgi.00067.2011; JEFFERY HE, 1991, ARCH DIS CHILD-FETAL, V66, P1136, DOI 10.1136/adc.66.10_Spec_No.1136; Kiatchoosakun P, 2002, PEDIATR RES, V52, P50, DOI 10.1203/00006450-200207000-00011; Lopez-Alonso M, 2006, PEDIATRICS, V118, pE299, DOI 10.1542/peds.2005-3140; Machado R, 2013, J PEDIATR GASTR NUTR, V56, P431, DOI 10.1097/MPG.0b013e31827f02f2; MENON AP, 1985, J PEDIATR-US, V106, P625, DOI 10.1016/S0022-3476(85)80091-3; MITTAL RK, 1995, GASTROENTEROLOGY, V109, P1547, DOI 10.1016/0016-5085(95)90643-6; Nelson SP, 1997, ARCH PEDIAT ADOL MED, V151, P569, DOI 10.1001/archpedi.1997.02170430035007; Omari TI, 2002, GUT, V51, P475, DOI 10.1136/gut.51.4.475; Omari TI, 1998, J PEDIATR-US, V133, P650, DOI 10.1016/S0022-3476(98)70106-4; OPIE JC, 1987, ANESTHESIOLOGY, V67, P989, DOI 10.1097/00000542-198712000-00021; Poets CF, 2011, SEMIN FETAL NEONAT M, V16, P259, DOI 10.1016/j.siny.2011.05.001; Sengupta J. N., 2000, American Journal of Medicine, V108, p87S; STROBEL CT, 1979, J PEDIATR-US, V94, P81, DOI 10.1016/S0022-3476(79)80361-3; Tirosh E, 2010, CLIN AUTON RES, V20, P161, DOI 10.1007/s10286-010-0054-x; Tougas G, 2001, GUT, V49, P706, DOI 10.1136/gut.49.5.706; van Wijk MP, 2009, J PEDIATR GASTR NUTR, V48, P2, DOI 10.1097/MPG.0b013e31818f0902; Vandenplas Y, 2009, J PEDIATR GASTR NUTR, V49, P498, DOI 10.1097/MPG.0b013e3181b7f563; Weinberg DS, 1996, MED CLIN N AM, V80, P411, DOI 10.1016/S0025-7125(05)70446-6; Wenzl TG, 2012, J PEDIATR GASTR NUTR, V55, P230, DOI 10.1097/MPG.0b013e3182592b65; Wenzl TG, 2011, GASTROENT RES PRACT, V2011, P1, DOI 10.1155/2011/271404	33	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83464	10.1371/journal.pone.0083464	http://dx.doi.org/10.1371/journal.pone.0083464			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349512	gold, Green Published			2022-12-27	WOS:000328734200089
J	Mu, CJ; Zhang, SJ; Yu, GZ; Chen, N; Li, XF; Liu, H				Mu, Changjun; Zhang, Shijia; Yu, Guanzhong; Chen, Ni; Li, Xiaofeng; Liu, Heng			Overexpression of Small Heat Shock Protein LimHSP16.45 in Arabidopsis Enhances Tolerance to Abiotic Stresses	PLOS ONE			English	Article							MEIOTIC PROPHASE I; ALPHA-CRYSTALLIN; TRANSGENIC TOBACCO; OXIDATIVE STRESS; PACHYTENE STAGES; LATE ZYGOTENE; EXPRESSION; SUBSTRATE; GRANULES; CADMIUM	Small heat shock proteins (smHSPs) play important and extensive roles in plant defenses against abiotic stresses. We cloned a gene for a smHSP from the David Lily (Lilium davidii (E. H. Wilson) Raffill var. Willmottiae), which we named LimHSP16.45 based on its protein molecular weight. Its expression was induced by many kinds of abiotic stresses in both the lily and transgenic plants of Arabidopsis. Heterologous expression enhanced cell viability of the latter under high temperatures, high salt, and oxidative stress, and heat shock granules (HSGs) formed under heat or salinity treatment. Assays of enzymes showed that LimHSP16.45 overexpression was related to greater activity by superoxide dismutase and catalase in transgenic lines. Therefore, we conclude that heterologous expression can protect plants against abiotic stresses by preventing irreversible protein aggregation, and by scavenging cellular reactive oxygen species.	[Mu, Changjun; Zhang, Shijia; Yu, Guanzhong; Chen, Ni; Li, Xiaofeng; Liu, Heng] Lanzhou Univ, Inst Cell Biol, Sch Life Sci, Lanzhou 730000, Peoples R China	Lanzhou University	Liu, H (corresponding author), Lanzhou Univ, Inst Cell Biol, Sch Life Sci, Lanzhou 730000, Peoples R China.	mucj@lzu.edu.cn			National Natural Science Foundation of China [31300229, 31201062]; Natural Science Foundation of Gansu Province [1208RJZA260]; Fundamental Research Funds for the Central Universities [lzujbky-2013-k11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Gansu Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by grants from the National Natural Science Foundation of China (No. 31300229, No. 31201062), the Natural Science Foundation of Gansu Province (No. 1208RJZA260), and Fundamental Research Funds for the Central Universities (No. lzujbky-2013-k11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrman E, 2007, PROTEIN SCI, V16, P1464, DOI 10.1110/ps.072831607; Azpilicueta CE, 2007, PLANT PHYSIOL BIOCH, V45, P589, DOI 10.1016/j.plaphy.2007.04.005; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; BEAUMONT F, 1990, PLANT SCI, V72, P19, DOI 10.1016/0168-9452(90)90182-N; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; CABANE M, 1993, PLANTA, V190, P346, DOI 10.1007/BF00196963; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Garg N, 2009, PLANT BIOSYST, V143, P81, DOI 10.1080/11263500802633626; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Guo SJ, 2007, J PLANT PHYSIOL, V164, P126, DOI 10.1016/j.jplph.2006.01.004; Hamilton EW, 2001, PLANT PHYSIOL, V126, P1266, DOI 10.1104/pp.126.3.1266; HELM KW, 1993, MOL CELL BIOL, V13, P238, DOI 10.1128/MCB.13.1.238; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Keeler SJ, 2000, PLANT PHYSIOL, V123, P1121, DOI 10.1104/pp.123.3.1121; Kirschner M, 2000, PLANT J, V24, P397, DOI 10.1046/j.1365-313x.2000.00887.x; KRISHNA P, 1995, PLANT PHYSIOL, V107, P915, DOI 10.1104/pp.107.3.915; Lee BH, 2000, GENE, V245, P283, DOI 10.1016/S0378-1119(00)00043-3; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Low D, 2000, PLANTA, V211, P575, DOI 10.1007/s004250000315; Malik MK, 1999, PLANT J, V20, P89, DOI 10.1046/j.1365-313X.1999.00581.x; MERCK KB, 1993, J BIOL CHEM, V268, P1046; Mobin M, 2007, J PLANT PHYSIOL, V164, P601, DOI 10.1016/j.jplph.2006.03.003; Mu C, 2012, RUSS J PLANT PHYSL+, V59, P389, DOI 10.1134/S1021443712020094; Mu CJ, 2011, PLANT CELL REP, V30, P1981, DOI 10.1007/s00299-011-1106-y; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Neta-Sharir I, 2005, PLANT CELL, V17, P1829, DOI 10.1105/tpc.105.031914; NOVER L, 1989, MOL CELL BIOL, V9, P1298, DOI 10.1128/MCB.9.3.1298; NOVER L, 1983, MOL CELL BIOL, V3, P1648, DOI 10.1128/MCB.3.9.1648; OSTERYOUNG KW, 1994, J BIOL CHEM, V269, P28676; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Perez DE, 2009, PLANT PHYSIOL, V151, P241, DOI 10.1104/pp.109.142125; PRANDL R, 1995, PLANT MOL BIOL, V28, P73, DOI 10.1007/BF00042039; Prieto-Dapena P, 2006, PLANT PHYSIOL, V142, P1102, DOI 10.1104/pp.106.087817; Sanmiya K, 2004, FEBS LETT, V557, P265, DOI 10.1016/S0014-5793(03)01494-7; Sarvajeet Singh, 2008, American Journal of Plant Physiology, V3, P25; Sato Y, 2008, PLANT CELL REP, V27, P329, DOI 10.1007/s00299-007-0470-0; Scharf KD, 2001, CELL STRESS CHAPERON, V6, P225, DOI 10.1379/1466-1268(2001)006<0225:TEFOAT>2.0.CO;2; Smykal P, 2000, EUR J BIOCHEM, V267, P2195, DOI 10.1046/j.1432-1327.2000.01223.x; Sun WN, 2001, PLANT J, V27, P407, DOI 10.1046/j.1365-313X.2001.01107.x; VIERLING E, 1991, ANNU REV PLANT PHYS, V42, P579, DOI 10.1146/annurev.pp.42.060191.003051; Volkov RA, 2005, PLANT MOL BIOL, V57, P487, DOI 10.1007/s11103-005-0339-y; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; Weber C, 2008, PLANT J, V56, P517, DOI 10.1111/j.1365-313X.2008.03623.x; Zou J, 2009, J PLANT PHYSIOL, V166, P851, DOI 10.1016/j.jplph.2008.11.007; Zou JJ, 2010, PLANT PHYSIOL, V154, P1232, DOI 10.1104/pp.110.157545	46	69	73	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82264	10.1371/journal.pone.0082264	http://dx.doi.org/10.1371/journal.pone.0082264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349240	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200035
J	Pi, EX; Mantri, N; Ngai, SM; Lu, HF; Du, LQ				Pi, Erxu; Mantri, Nitin; Ngai, Sai Ming; Lu, Hongfei; Du, Liqun			BP-ANN for Fitting the Temperature-Germination Model and Its Application in Predicting Sowing Time and Region for Bermudagrass	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORK; CYNODON-DACTYLON L.; SEED-GERMINATION; OXIDATIVE STRESS; AQUEOUS EXTRACT; AERIAL PARTS; PERS.; ADSORPTION; RESISTANCE; REGRESSION	Temperature is one of the most significant environmental factors that affects germination of grass seeds. Reliable prediction of the optimal temperature for seed germination is crucial for determining the suitable regions and favorable sowing timing for turf grass cultivation. In this study, a back-propagation-artificial-neural-network-aided dual quintic equation (BP-ANN-QE) model was developed to improve the prediction of the optimal temperature for seed germination. This BP-ANN-QE model was used to determine optimal sowing times and suitable regions for three Cynodon dactylon cultivars (C. dactylon, 'Savannah' and 'Princess VII'). Prediction of the optimal temperature for these seeds was based on comprehensive germination tests using 36 day/night (high/low) temperature regimes (both ranging from 5/5 to 40/40 degrees C with 5 degrees C increments). Seed germination data from these temperature regimes were used to construct temperature-germination correlation models for estimating germination percentage with confidence intervals. Our tests revealed that the optimal high/low temperature regimes required for all the three bermudagrass cultivars are 30/5, 30/10, 35/5, 35/10, 35/15, 35/20, 40/15 and 40/20 degrees C; constant temperatures ranging from 5 to 40 degrees C inhibited the germination of all three cultivars. While comparing different simulating methods, including DQEM, Bisquare ANN-QE, and BP-ANN-QE in establishing temperature based germination percentage rules, we found that the R-2 values of germination prediction function could be significantly improved from about 0.6940-0.8177 (DQEM approach) to 0.9439-0.9813 (BP-ANN-QE). These results indicated that our BP-ANN-QE model has better performance than the rests of the compared models. Furthermore, data of the national temperature grids generated from monthly-average temperature for 25 years were fit into these functions and we were able to map the germination percentage of these C. dactylon cultivars in the national scale of China, and suggested the optimum sowing regions and times for them.	[Pi, Erxu; Du, Liqun] Hangzhou Normal Univ, Coll Life & Environm, Hangzhou, Zhejiang, Peoples R China; [Lu, Hongfei] Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Mantri, Nitin] RMIT Univ, Hlth Innovat Res Inst, Sch Appl Sci, Melbourne, Vic, Australia; [Ngai, Sai Ming] Chinese Univ Hong Kong, Dept Biol, Shatin, Hong Kong, Peoples R China	Hangzhou Normal University; Zhejiang Sci-Tech University; Royal Melbourne Institute of Technology (RMIT); Chinese University of Hong Kong	Lu, HF (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.	luhongfei63@yahoo.com.cn; liqundu@hznu.edu.cn	Ngai, Sai Ming/S-4898-2018	Ngai, Sai Ming/0000-0002-4484-2483; Mantri, Nitin/0000-0002-7621-035X	National Science Foundation of China [U1130304, 31301053]; Technology Research and Development Program of Jiangsu Province [BE2012416]; Six Key Talents Program of Jiangsu [2011NY032]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Research and Development Program of Jiangsu Province; Six Key Talents Program of Jiangsu	This work was supported by grant U1130304 and 31301053 from National Science Foundation of China, and the Technology Research and Development Program of Jiangsu Province (BE2012416) and Six Key Talents Program of Jiangsu (2011NY032). No additional external funding received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowski J, 2012, WATER RESOUR RES, V48, DOI 10.1029/2010WR009945; Adebiyi FM, 2010, ANAL LETT, V43, P1879, DOI 10.1080/00032711003686981; Ahmadi H, 2010, POULTRY SCI, V89, P173, DOI 10.3382/ps.2009-00125; Akdemir B, 2009, J MED SYST, V33, P379, DOI 10.1007/s10916-008-9200-6; Alam M, 2011, VALUE HEALTH, V14, pA234, DOI 10.1016/j.jval.2011.08.1732; Alvarez R, 2011, SOIL SCI SOC AM J, V75, P965, DOI 10.2136/sssaj2009.0427; Arjunan N, 2012, PARASITOL RES, V110, P1435, DOI 10.1007/s00436-011-2646-3; Babu DSR, 2009, PHARMACOGN MAG, V5, P23; Balasubramanian G, 2008, AQUACULTURE, V279, P2, DOI 10.1016/j.aquaculture.2008.03.052; Barnhart BL, 2012, AGR FOREST METEOROL, V162, P58, DOI 10.1016/j.agrformet.2012.04.003; Bradford KJ, 2002, WEED SCI, V50, P248, DOI 10.1614/0043-1745(2002)050[0248:AOHTTQ]2.0.CO;2; Caglar BK, 2013, INT J AGRIC BIOL, V15, P90; Castillo AM, 2009, ABSTR PAP AM CHEM S, V237; Catalogna M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044587; CHANG W, 1993, IEEE T NEURAL NETWOR, V4, P993, DOI 10.1109/72.286895; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; Devi KMS, 2011, J MED PLANTS RES, V5, P992; Dhoke V, 2008, INDIAN J PHARMACOL, V40, P69; Evrendilek F, 2013, AGR FOREST METEOROL, V171, P1, DOI 10.1016/j.agrformet.2012.11.002; Falamaki A, 2013, J ENVIRON RADIOACTIV, V115, P6, DOI 10.1016/j.jenvrad.2012.06.008; Farsani TM, 2012, INT J MOL SCI, V13, P383, DOI 10.3390/ijms13010383; Garcia-Mozo H, 2009, AGR FOREST METEOROL, V149, P256, DOI 10.1016/j.agrformet.2008.08.013; Garg VK, 2011, INT J PHARMACOL, V7, P370, DOI 10.3923/ijp.2011.370.375; Gayathri U, 2011, E-J CHEM, V8, pS377, DOI 10.1155/2011/435482; Gazola S, 2011, CIENC RURAL, V41, P551, DOI 10.1590/S0103-84782011005000022; Hameed M, 2013, PAK J BOT, V45, P133; Hampel F, 2011, COMPUT STAT DATA AN, V55, P324, DOI 10.1016/j.csda.2010.05.001; Hardegree SP, 1999, ENVIRON EXP BOT, V41, P209, DOI 10.1016/S0098-8472(99)00004-0; Hardegree SP, 1999, J RANGE MANAGE, V52, P83, DOI 10.2307/4003496; Hardegree SP, 2006, ANN BOT-LONDON, V97, P1115, DOI 10.1093/aob/mcl071; Hardegree SP, 2006, ANN BOT-LONDON, V98, P403, DOI 10.1093/aob/mcl112; Hardegree SP, 2006, ANN BOT-LONDON, V98, P827, DOI 10.1093/aob/mcl163; Hema M., 2011, Journal of Environmental Science & Engineering, V53, P237; Heshmati GA, 2011, J PLANT NUTR, V34, P2183, DOI 10.1080/01904167.2011.618577; Huang CQ, 2010, TROP GRASSLANDS, V44, P274; Ji J, 2012, EXPLOR GEOPHYS, V43, P70, DOI 10.1071/EG12014; Kaleeswaran B, 2011, FISH SHELLFISH IMMUN, V31, P953, DOI 10.1016/j.fsi.2011.08.013; Karnin E D, 1990, IEEE Trans Neural Netw, V1, P239, DOI 10.1109/72.80236; Larsen PE, 2012, NAT METHODS, V9, P621, DOI [10.1038/NMETH.1975, 10.1038/nmeth.1975]; Lu HF, 2008, AGR FOREST METEOROL, V148, P931, DOI 10.1016/j.agrformet.2008.01.004; Maddahi A, 2011, INT J ADV MANUF TECH, V56, P711, DOI 10.1007/s00170-011-3226-5; Mangathayaru K, 2009, J ETHNOPHARMACOL, V123, P181, DOI 10.1016/j.jep.2009.02.036; Modi YK, 2012, S AFR J IND ENG, V23, P230; Omelka M, 2010, ANN I STAT MATH, V62, P897, DOI 10.1007/s10463-008-0189-x; Onofri A, 2010, WEED RES, V50, P5, DOI 10.1111/j.1365-3180.2009.00758.x; Pal DK, 2008, ASIAN J CHEM, V20, P2479; Pal D, 2008, ACTA POL PHARM, V65, P37; Pan Y, 2007, J HAZARD MATER, V147, P424, DOI 10.1016/j.jhazmat.2007.01.025; Poonnoy P, 2007, J FOOD SCI, V72, pE42, DOI 10.1111/j.1750-3841.2006.00220.x; Rad AK, 2011, UROL J, V8, P179; Rai DK, 2011, CELL MOL BIOL, V57, P135, DOI 10.1170/T912; Rasul G, 2012, PLANT BREEDING, V131, P244, DOI 10.1111/j.1439-0523.2011.01931.x; Recio M, 2010, AGR FOREST METEOROL, V150, P931, DOI 10.1016/j.agrformet.2010.02.012; Rivera-Reyes JG, 2009, PHYTON-INT J EXP BOT, V78, P37; ROBERTS EH, 1988, SYM SOC EXP BIOL, V42, P109; Shen JB, 2008, GRASS FORAGE SCI, V63, P249, DOI 10.1111/j.1365-2494.2008.00630.x; Shetty N, 2012, J CHEMOMETR, V26, P462, DOI 10.1002/cem.1415; Sindhu G, 2009, IMMUNOPHARM IMMUNOT, V31, P647, DOI 10.3109/08923970902947325; THOMPSON K, 1977, NATURE, V267, P147, DOI 10.1038/267147a0; Torrecilla JS, 2007, J AGR FOOD CHEM, V55, P7418, DOI 10.1021/jf0703351; van Oort PAJ, 2011, AGR FOREST METEOROL, V151, P1545, DOI 10.1016/j.agrformet.2011.06.012; Vandelook F, 2008, ANN BOT-LONDON, V102, P865, DOI 10.1093/aob/mcn165; Wang YB, 2009, B ENVIRON CONTAM TOX, V82, P454, DOI 10.1007/s00128-009-9640-9; Wu FY, 2010, APPL SOIL ECOL, V44, P213, DOI 10.1016/j.apsoil.2009.12.008; Yun JY, 2012, MED PHYS, V39, P4423, DOI 10.1118/1.4730294; Zhao X, 2014, J BIOMED RES, V28, P114, DOI 10.7555/JBR.27.20120061; Zheng H, 2011, J AGR FOOD CHEM, V59, P592, DOI 10.1021/jf1032476	67	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82413	10.1371/journal.pone.0082413	http://dx.doi.org/10.1371/journal.pone.0082413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349278	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200040
J	Neto, JRCF; Pandolfi, V; Guimaraes, FCM; Benko-Iseppon, AM; Romero, C; Silva, RLD; Rodrigues, FA; Abdelnoor, RV; Nepomuceno, AL; Kido, EA				Ferreira Neto, Jose Ribamar Costa; Pandolfi, Valesca; Marcelino Guimaraes, Francismar Correa; Benko-Iseppon, Ana Maria; Romero, Cynara; de Oliveira Silva, Roberta Lane; Rodrigues, Fabiana Aparecida; Abdelnoor, Ricardo Vilela; Nepomuceno, Alexandre Lima; Kido, Ederson Akio			Early Transcriptional Response of Soybean Contrasting Accessions to Root Dehydration	PLOS ONE			English	Article							STRESS-INDUCED CHANGES; BETA-AMYLASE ACTIVITY; GENE-EXPRESSION; DROUGHT-STRESS; ABSCISIC-ACID; ABIOTIC STRESS; WATER-STRESS; XYLOGLUCAN ENDOTRANSGLYCOSYLASE; GLYCINE-MAX; SUPEROXIDE-DISMUTASE	Drought is a significant constraint to yield increase in soybean. The early perception of water deprivation is critical for recruitment of genes that promote plant tolerance. DeepSuperSAGE libraries, including one control and a bulk of six stress times imposed (from 25 to 150 min of root dehydration) for drought-tolerant and sensitive soybean accessions, allowed to identify new molecular targets for drought tolerance. The survey uncovered 120,770 unique transcripts expressed by the contrasting accessions. Of these, 57,610 aligned with known cDNA sequences, allowing the annotation of 32,373 unitags. A total of 1,127 unitags were up-regulated only in the tolerant accession, whereas 1,557 were up-regulated in both as compared to their controls. An expression profile concerning the most representative Gene Ontology (GO) categories for the tolerant accession revealed the expression "protein binding" as the most represented for "Molecular Function", whereas CDPK and CBL were the most up-regulated protein families in this category. Furthermore, particular genes expressed different isoforms according to the accession, showing the potential to operate in the distinction of physiological behaviors. Besides, heat maps comprising GO categories related to abiotic stress response and the unitags regulation observed in the expression contrasts covering tolerant and sensitive accessions, revealed the unitags potential for plant breeding. Candidate genes related to "hormone response" (LOX, ERF1b, XET), "water response" (PUB, BMY), "salt stress response" (WRKY, MYB) and "oxidative stress response" (PER) figured among the most promising molecular targets. Additionally, nine transcripts (HMGR, XET, WRKY20, RAP2-4, EREBP, NAC3, PER, GPX5 and BMY) validated by RT-qPCR (four different time points) confirmed their differential expression and pointed that already after 25 minutes a transcriptional reorganization started in response to the new condition, with important differences between both accessions.	[Ferreira Neto, Jose Ribamar Costa; de Oliveira Silva, Roberta Lane; Kido, Ederson Akio] Univ Fed Pernambuco, Dept Genet, Mol Genet Lab, Recife, PE, Brazil; [Pandolfi, Valesca; Benko-Iseppon, Ana Maria] Univ Fed Pernambuco, Dept Genet, Lab Genet & Vegetal Biotechnol, Recife, PE, Brazil; [Marcelino Guimaraes, Francismar Correa; Romero, Cynara; Rodrigues, Fabiana Aparecida; Abdelnoor, Ricardo Vilela] Brazilian Enterprise Agr Res Embrapa Soybean, Londrina, Brazil; [Nepomuceno, Alexandre Lima] ARS, LABEX Plant Biotechnol, USDA, Ctr Plant Gene Express, Albany, CA USA	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); United States Department of Agriculture (USDA)	Kido, EA (corresponding author), Univ Fed Pernambuco, Dept Genet, Mol Genet Lab, Recife, PE, Brazil.	kido.ufpe@gmail.com	Kido, Ederson A/E-2489-2016; Abdelnoor, Ricardo V/F-7011-2012; AKIO KIDO, EDERSON/P-9932-2019; Silva, Roberta Lane de Oliveira/B-5866-2014; Iseppon, Ana Maria Benko/M-5527-2019; Abdelnoor, Ricardo V/F-7707-2017; Pandolfi, Valesca/L-1637-2016; Marcelino Guimaraes, Francismar/F-9973-2017; Costa Ferreira Neto, Jose Ribamar/Q-1132-2016	Kido, Ederson A/0000-0001-5484-993X; AKIO KIDO, EDERSON/0000-0001-5484-993X; Silva, Roberta Lane de Oliveira/0000-0003-1876-0094; Iseppon, Ana Maria Benko/0000-0002-0575-3197; Pandolfi, Valesca/0000-0003-2283-5669; Marcelino Guimaraes, Francismar/0000-0002-5828-7249; Costa Ferreira Neto, Jose Ribamar/0000-0003-0935-203X	CNPq (National Council for Scientific and Technological Development, Brazil); Edital CT-Agronegocio/MCT/CNPq-Genosoja [38/2007]; JRCFN; FACEPE (The Foundation for Science and Technology of Pernambuco State	CNPq (National Council for Scientific and Technological Development, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Edital CT-Agronegocio/MCT/CNPq-Genosoja; JRCFN; FACEPE (The Foundation for Science and Technology of Pernambuco State	This work was supported by the following Brazilian funding agencies: CNPq (National Council for Scientific and Technological Development, Brazil; http://www.cnpq.br/; Edital CT-Agronegocio/MCT/CNPq-Genosoja-no 38/2007), responsible for the financial support for all the experimental assays and fellowship (JRCFN); FACEPE (The Foundation for Science and Technology of Pernambuco State; http://www.facepe.br) for the RLOS's fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaya I, 1999, FEBS LETT, V457, P80, DOI 10.1016/S0014-5793(99)01011-X; [Anonymous], 1977, **NON-TRADITIONAL**; Antosiewicz DM, 1997, PLANT PHYSIOL, V115, P1319, DOI 10.1104/pp.115.4.1319; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Asano T, 2012, PLANT SIGNAL BEHAV, V7, P817, DOI 10.4161/psb.20351; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BARTELS D, 2004, MOL RESPONSES HIGHER, P9; BELL E, 1991, MOL GEN GENET, V230, P456, DOI 10.1007/BF00280303; Brosche M, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P91, DOI 10.1007/978-90-481-3112-9_5; Camon E, 2003, COMP FUNCT GENOM, V4, P71, DOI 10.1002/cfg.235; Campbell P, 1999, TRENDS PLANT SCI, V4, P361, DOI 10.1016/S1360-1385(99)01468-5; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chen M, 2007, BIOCHEM BIOPH RES CO, V353, P299, DOI 10.1016/j.bbrc.2006.12.027; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Cho SK, 2008, PLANT CELL, V20, P1899, DOI 10.1105/tpc.108.060699; Choudhury SR, 2013, PLANT SIGNAL BEHAV, V8, DOI [10.4161/psb.23000, 10.4161/psb.23681]; Close Timothy J., 2007, V406, P161; Cominelli E, 2009, CELL RES, V19, P1231, DOI 10.1038/cr.2009.123; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; Datta R, 1999, J PLANT PHYSIOL, V154, P657, DOI 10.1016/S0176-1617(99)80241-7; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; do Nascimento LC, 2012, GENET MOL BIOL, V35, P203, DOI 10.1590/S1415-47572012000200002; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Doyle JJ, 2003, PLANT PHYSIOL, V131, P900, DOI 10.1104/pp.102.018150; DREIER W, 1995, J PLANT PHYSIOL, V145, P342, DOI 10.1016/S0176-1617(11)81900-0; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Duvick J, 2008, NUCLEIC ACIDS RES, V36, pD959, DOI 10.1093/nar/gkm1041; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El-Sharkawy I, 2009, J EXP BOT, V60, P907, DOI 10.1093/jxb/ern354; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Fan XD, 2013, GENE, V512, P392, DOI 10.1016/j.gene.2012.09.100; FRY SC, 1992, BIOCHEM J, V282, P821, DOI 10.1042/bj2820821; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Hao QN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-525; Hara M, 2005, J EXP BOT, V56, P2695, DOI 10.1093/jxb/eri262; Hassanein R. A., 2009, Australian Journal of Basic and Applied Sciences, V3, P904; Hay A, 2004, BIOESSAYS, V26, P395, DOI 10.1002/bies.20016; HSIAO TC, 1973, ANNU REV PLANT PHYS, V24, P519, DOI 10.1146/annurev.pp.24.060173.002511; Huang T, 2002, PLANT MOL BIOL, V48, P339, DOI 10.1023/A:1014062714786; Hunt M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-145; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KANG J, 2011, PLANT ABC TRANSPORTE; Kido EA, 2010, CURR PROTEIN PEPT SC, V11, P220, DOI 10.2174/138920310791112110; Kim KS, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-49; Kirby J, 2009, ANNU REV PLANT BIOL, V60, P335, DOI 10.1146/annurev.arplant.043008.091955; Knight H, 1998, PLANT J, V16, P681, DOI 10.1046/j.1365-313x.1998.00332.x; Koca H, 2006, BIOL PLANTARUM, V50, P745, DOI 10.1007/s10535-006-0121-2; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; LE D, 2012, PLOS ONE, V24, DOI DOI 10.1371/J0URNAL.P0NE.0049522.PUBMED:23189148; Li HY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-170; Liao ZhiHua, 2006, Journal of Biological Sciences, V6, P209; Libault M, 2010, PLANT J, V63, P86, DOI 10.1111/j.1365-313X.2010.04222.x; Libault M, 2010, PLANT PHYSIOL, V152, P541, DOI 10.1104/pp.109.148379; Lin RC, 2008, MOL PLANT, V1, P42, DOI 10.1093/mp/ssm004; Liu X, 2013, PLANT PHYSIOL BIOCH, V70, P354, DOI 10.1016/j.plaphy.2013.05.018; Luan S, 2002, PLANT CELL, V14, pS389, DOI 10.1105/tpc.001115; Luo X, 2013, J EXP BOT, V64, P2155, DOI 10.1093/jxb/ert073; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Manavalan LP, 2009, PLANT CELL PHYSIOL, V50, P1260, DOI 10.1093/pcp/pcp082; Martins PK, 2008, GENET MOL BIOL, V31, P512, DOI 10.1590/S1415-47572008000300019; MATSUMURA H, 2012, TAG BASED NEXT GENER, P3; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Mohammadkhani N., 2008, World Applied Sciences Journal, V3, P448; Narusaka Y, 2004, PLANT MOL BIOL, V55, P327, DOI 10.1007/s11103-004-0685-1; NISHITANI K, 1992, J BIOL CHEM, V267, P21058; Ocampo E. T. M., 2000, Philippine Journal of Crop Science, V25, P1; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Onate-Sanchez L, 2007, PLANT PHYSIOL, V143, P400, DOI 10.1104/pp.106.086637; Oya T, 2004, PLANT PROD SCI, V7, P129, DOI 10.1626/pps.7.129; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pandey GK, 2004, PLANT CELL, V16, P1912, DOI 10.1105/tpc.021311; Pathan S., 2007, ADV MOL BREEDING DRO, P739, DOI [10.1007/978-1-4020-5578-2_30, DOI 10.1007/978-1-4020-5578-2_30]; Peiffer GA, 2012, PLANT PHYSIOL, V158, P1745, DOI 10.1104/pp.111.189860; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pospisilova J, 2005, BIOL PLANTARUM, V49, P533, DOI 10.1007/s10535-005-0047-0; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Quan RD, 2010, PLANT BIOTECHNOL J, V8, P476, DOI 10.1111/j.1467-7652.2009.00492.x; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Rae L, 2011, PLANTA, V234, P429, DOI 10.1007/s00425-011-1414-z; Reid DE, 2012, PLANT BIOTECHNOL J, V10, P680, DOI 10.1111/j.1467-7652.2012.00706.x; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Robertson N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r6; Rock CD, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P33, DOI 10.1007/978-90-481-3112-9_3; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Sekmen AH, 2007, PHYSIOL PLANTARUM, V131, P399, DOI 10.1111/j.1399-3054.2007.00970.x; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Shin YK, 2006, PLANTA, V224, P32, DOI 10.1007/s00425-005-0189-5; Smalle J, 2004, ANNU REV PLANT BIOL, V55, P555, DOI 10.1146/annurev.arplant.55.031903.141801; Specht JE, 1999, CROP SCI, V39, P1560, DOI 10.2135/cropsci1999.3961560x; STERMER BA, 1994, J LIPID RES, V35, P1133; Stolf-Moreira R, 2011, PESQUI AGROPECU BRAS, V46, P58, DOI 10.1590/S0100-204X2011000100008; Todaka D, 2000, J EXP BOT, V51, P739, DOI 10.1093/jexbot/51.345.739; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Toumi I, 2008, BIOL PLANTARUM, V52, P161, DOI 10.1007/s10535-008-0035-2; Valliyodan Babu, 2008, V2, P343; Vassilev A, 2004, BIOL PLANTARUM, V48, P153, DOI 10.1023/B:BIOP.0000024295.27419.89; Vissenberg K, 2000, PLANT CELL, V12, P1229, DOI 10.1105/tpc.12.7.1229; Vodkin Lila, 2008, V2, P163; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilson Richard F., 2008, V2, P3; Wu LJ, 2008, PLANT PHYSIOL, V148, P1953, DOI 10.1104/pp.108.126813; Wu XL, 2009, PLANT CELL REP, V28, P21, DOI 10.1007/s00299-008-0614-x; Wu YJ, 2000, J EXP BOT, V51, P1543, DOI 10.1093/jexbot/51.350.1543; Yang DF, 2012, PHYSIOL PLANTARUM, V146, P173, DOI 10.1111/j.1399-3054.2012.01603.x; Yang JC, 2001, J EXP BOT, V52, P2169, DOI 10.1093/jexbot/52.364.2169; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; Yoshimura K, 2004, PLANT J, V37, P21, DOI 10.1046/j.1365-313X.2003.01930.x; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; ZHANG JX, 1994, PLANT CELL PHYSIOL, V35, P785, DOI 10.1093/oxfordjournals.pcp.a078658; ZIMMERMAN J, 2012, BRAZIL OILSEEDS PROD	124	18	20	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83466	10.1371/journal.pone.0083466	http://dx.doi.org/10.1371/journal.pone.0083466			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349513	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800120
J	Lin, MH; Chang, YC; Hsiao, CD; Huang, SH; Wang, MS; Ko, YC; Yang, CW; Sun, YJ				Lin, Ming-Hsing; Chang, Yuan-Chih; Hsiao, Chwan-Deng; Huang, Shih-Hsun; Wang, Min-Shi; Ko, Yi-Ching; Yang, Chih-Wei; Sun, Yuh-Ju			LipL41, a Hemin Binding Protein from Leptospira santarosai serovar Shermani	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; PROXIMAL TUBULE CELLS; PATHOGENIC LEPTOSPIRA; SEQUENCE-ANALYSIS; RENAL-DISEASE; INTERROGANS; IRON; EXPRESSION; GENE; LIPOPROTEIN	Leptospirosis is one of the most widespread zoonotic diseases in the world. It is caused by the pathogen Leptospira that results in multiple-organ failure, in particular of the kidney. Outer membrane lipoprotein is the suspected virulence factor of Leptospira. In Leptospira spp LipL41 is one major lipoprotein and is highly conserved. Previous study suggests that LipL41 bears hemin-binding ability and might play a possible role in iron regulation and storage. However, the characterization of hemin-binding ability of LipL41 is still unclear. Here the hemin-binding ability of LipL41 was examined, yielding a K-d = 0.59 +/- 0.14 mu M. Two possible heme regulatory motifs (HRMs), C[P/S], were found in LipL41 at (140)Cys-Ser and (220)Cys-Pro. The mutation study indicates that Cys140 and Cys220 might be cooperatively involved in hemin binding. A supramolecular assembly of LipL41 was determined by transmission electron microscopy. The LipL41 oligomer consists of 36 molecules and folds as a double-layered particle. At the C-terminus of LipL41, there are two tetratricopeptide repeats (TPRs), which might be involved in the protein-protein interaction of the supramolecular assembly.	[Lin, Ming-Hsing; Huang, Shih-Hsun; Wang, Min-Shi; Sun, Yuh-Ju] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Chang, Yuan-Chih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Hsiao, Chwan-Deng] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Ko, Yi-Ching; Yang, Chih-Wei] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Nephrol,Kidney Res Ctr, Tao Yuan, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Chang Gung Memorial Hospital; Chang Gung University	Sun, YJ (corresponding author), Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan.	yjsun@life.nthu.edu.tw	CHANG, Yuan-Chih/J-2609-2016; Hsiao, Chwan-Deng/AAZ-8869-2021	CHANG, Yuan-Chih/0000-0002-0289-3768; Hsiao, Chwan-Deng/0000-0002-7012-1532	National Science Council of Taiwan, Republic of China [NSC 101-2311-B-007-009-MY3]; National Tsing Hua University Taiwan, Republic of China [102N2787E1]	National Science Council of Taiwan, Republic of China(Ministry of Science and Technology, Taiwan); National Tsing Hua University Taiwan, Republic of China	This work was supported by grants from the National Science Council of Taiwan, Republic of China (NSC 101-2311-B-007-009-MY3 to YJS) and National Tsing Hua University Taiwan, Republic of China (102N2787E1 to YJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asuthkar S, 2007, INFECT IMMUN, V75, P4582, DOI 10.1128/IAI.00324-07; Barnett JK, 1999, INFECT IMMUN, V67, P853, DOI 10.1128/IAI.67.2.853-861.1999; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Binet R, 1996, MOL MICROBIOL, V22, P265, DOI 10.1046/j.1365-2958.1996.00103.x; Braun V, 2002, CURR OPIN MICROBIOL, V5, P194, DOI 10.1016/S1369-5274(02)00298-9; CAUGHEY WS, 1975, J BIOL CHEM, V250, P7602; Cullen PA, 2004, FEMS MICROBIOL REV, V28, P291, DOI 10.1016/j.femsre.2003.10.004; Cullen PA, 2002, INFECT IMMUN, V70, P2311, DOI 10.1128/IAI.70.5.2311-2318.2002; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Davis BJ, 1964, P NY ACAD SCI, V121, P404; Dolhnikoff M, 2007, BRAZ J INFECT DIS, V11, P142, DOI 10.1590/S1413-86702007000100029; FAINE S, 1959, J GEN MICROBIOL, V20, P246, DOI 10.1099/00221287-20-2-246; FARR RW, 1995, CLIN INFECT DIS, V21, P1, DOI 10.1093/clinids/21.1.1; Fischer H, 2004, PROTEIN SCI, V13, P2825, DOI 10.1110/ps.04688204; FROLOW F, 1994, NAT STRUCT BIOL, V1, P453, DOI 10.1038/nsb0794-453; Griffiths E, 1999, IRON INFECT MOL PHYS, P1; Haake DA, 2000, INFECT IMMUN, V68, P2276, DOI 10.1128/IAI.68.4.2276-2285.2000; HAAKE DA, 1991, INFECT IMMUN, V59, P1131, DOI 10.1128/IAI.59.3.1131-1140.1991; HANTKE K, 1973, EUR J BIOCHEM, V34, P284, DOI 10.1111/j.1432-1033.1973.tb02757.x; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; HENDERSON DP, 1994, J BACTERIOL, V176, P3269, DOI 10.1128/jb.176.11.3269-3277.1994; Huang TJ, 2001, ANTIOXID REDOX SIGN, V3, P685, DOI 10.1089/15230860152543023; King AM, 2013, INFECT IMMUN, V81, P2768, DOI 10.1128/IAI.00531-13; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Kuhl T, 2011, CHEMBIOCHEM, V12, P2846, DOI 10.1002/cbic.201100556; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; LEE BC, 1992, INFECT IMMUN, V60, P810, DOI 10.1128/IAI.60.3.810-816.1992; Letoffe S, 1998, MOL MICROBIOL, V28, P1223, DOI 10.1046/j.1365-2958.1998.00885.x; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Lewin A, 2005, DALTON T, P3597, DOI 10.1039/b506071k; Lin HH, 2010, NUCLEIC ACIDS RES, V38, pW503, DOI 10.1093/nar/gkq514; Lo M, 2010, INFECT IMMUN, V78, P4850, DOI 10.1128/IAI.00435-10; Lo YY, 2013, J BIOL CHEM, V288, P12335, DOI 10.1074/jbc.M112.418699; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mariya R, 2006, COMP IMMUNOL MICROB, V29, P269, DOI 10.1016/j.cimid.2006.06.007; Mills M, 1997, INFECT IMMUN, V65, P5358, DOI 10.1128/IAI.65.12.5358-5363.1997; Murray GL, 2009, MICROBES INFECT, V11, P311, DOI 10.1016/j.micinf.2008.11.014; Natarajaseenivasan K, 2008, ANN TROP MED PARASIT, V102, P699, DOI 10.1179/136485908X355229; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Shang ES, 1996, INFECT IMMUN, V64, P2322, DOI 10.1128/IAI.64.6.2322-2330.1996; Sritharan M, 2000, WORLD J MICROB BIOT, V16, P769, DOI 10.1023/A:1008995313232; SUTCLIFFE IC, 1995, J BACTERIOL, V177, P1123, DOI 10.1128/jb.177.5.1123-1128.1995; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tian YC, 2006, J AM SOC NEPHROL, V17, P2792, DOI 10.1681/ASN.2006020159; Torres AG, 1997, MOL MICROBIOL, V23, P825, DOI 10.1046/j.1365-2958.1997.2641628.x; Tung JY, 2010, J BIOL CHEM, V285, P3245, DOI 10.1074/jbc.M109.006320; Valcu M, 2011, NAT METHODS, V8, P104, DOI 10.1038/nmeth0211-104; VINH T, 1986, J GEN MICROBIOL, V132, P103; Westberg JA, 2011, BIOCHEM BIOPH RES CO, V409, P266, DOI 10.1016/j.bbrc.2011.05.002; Yang CW, 2007, KIDNEY INT, V72, P918, DOI 10.1038/sj.ki.5002393; Yang CW, 2000, J AM SOC NEPHROL, V11, P2017, DOI 10.1681/ASN.V11112017; Yang CW, 2006, KIDNEY INT, V69, P815, DOI 10.1038/sj.ki.5000119; Yang CW, 2002, J AM SOC NEPHROL, V13, P2037, DOI 10.1097/01.ASN.0000022007.91733.62; Yang CW, 2001, NEPHROL DIAL TRANSPL, V16, P73, DOI 10.1093/ndt/16.suppl_5.73; Yang F, 2010, J BIOL CHEM, V285, P39437, DOI 10.1074/jbc.M110.159913; Yi L, 2010, J BIOL CHEM, V285, P20117, DOI 10.1074/jbc.M110.116483; Zeytuni N, 2012, STRUCTURE, V20, P397, DOI 10.1016/j.str.2012.01.006; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x	62	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83246	10.1371/journal.pone.0083246	http://dx.doi.org/10.1371/journal.pone.0083246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349474	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800106
J	Celis-Morales, CA; Ghouri, N; Bailey, MES; Sattar, N; Gill, JMR				Celis-Morales, Carlos A.; Ghouri, Nazim; Bailey, Mark E. S.; Sattar, Naveed; Gill, Jason M. R.			Should Physical Activity Recommendations Be Ethnicity-Specific? Evidence from a Cross-Sectional Study of South Asian and European Men	PLOS ONE			English	Article							INSULIN-RESISTANCE; CUT-POINTS; PREDICTION; BIOMARKERS; DIAGNOSIS; MORTALITY; GLYCEMIA; FITNESS; OBESITY; DISEASE	Background: Expert bodies and health organisations recommend that adults undertake at least 150 min.week(-1) of moderate-intensity physical activity (MPA). However, the underpinning data largely emanate from studies of populations of European descent. It is unclear whether this level of activity is appropriate for other ethnic groups, particularly South Asians, who have increased cardio-metabolic disease risk compared to Europeans. The aim of this study was to explore the level of MPA required in South Asians to confer a similar cardio-metabolic risk profile to that observed in Europeans undertaking the currently recommended MPA level of 150 min.week(-1). Methods: Seventy-five South Asian and 83 European men, aged 40-70, without cardiovascular disease or diabetes had fasted blood taken, blood pressure measured, physical activity assessed objectively (using accelerometry), and anthropometric measures made. Factor analysis was used to summarise measured risk biomarkers into underlying latent 'factors' for glycaemia, insulin resistance, lipid metabolism, blood pressure, and overall cardio-metabolic risk. Age-adjusted regression models were used to determine the equivalent level of MPA (in bouts of >= 10 minutes) in South Asians needed to elicit the same value in each factor as Europeans undertaking 150 min.week(-1) MPA. Findings: For all factors, except blood pressure, equivalent MPA values in South Asians were significantly higher than 150 min.week(-1); the equivalent MPA value for the overall cardio-metabolic risk factor was 266 (95% CI 185-347) min. week(-1). Conclusions: South Asian men may need to undertake greater levels of MPA than Europeans to exhibit a similar cardio-metabolic risk profile, suggesting that a conceptual case can be made for ethnicity-specific physical activity guidance. Further study is needed to extend these findings to women and to replicate them prospectively in a larger cohort.	[Celis-Morales, Carlos A.; Ghouri, Nazim; Sattar, Naveed; Gill, Jason M. R.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Celis-Morales, Carlos A.] Newcastle Univ, Inst Ageing & Hlth, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Bailey, Mark E. S.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Life Sci, Glasgow, Lanark, Scotland	University of Glasgow; Newcastle University - UK; University of Glasgow	Gill, JMR (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	jason.gill@glasgow.ac.uk	Celis-Morales, Carlos/AAJ-5103-2020	Celis-Morales, Carlos/0000-0003-2612-3917; Bailey, Mark E. S./0000-0002-9788-2278; Ghouri, Noushima/0000-0002-8202-3913	Chest, Heart and Stroke Scotland	Chest, Heart and Stroke Scotland	Nazim Ghouri was supported by a Fellowship from Chest, Heart and Stroke Scotland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Atienza AA, 2011, MED SCI SPORT EXER, V43, P815, DOI 10.1249/MSS.0b013e3181fdfc32; Cameron AJ, 2010, OBESITY, V18, P2039, DOI 10.1038/oby.2009.455; Celis-Morales CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036345; Celis-Morales CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024690; Davey GJG, 2000, J EXERC PHYSL, V3, P12; Department of Health Physical Activity Health Improvement and Protection, 2011, START ACT STAY ACT R, P1; El Assaad MA, 2003, BLOOD PRESS MONIT, V8, P127, DOI 10.1097/00126097-200306000-00006; Fischbacher CM, 2004, J PUBLIC HEALTH-UK, V26, P250, DOI 10.1093/pubmed/fdh158; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Ghouri N, 2013, DIABETOLOGIA, V56, P2238, DOI 10.1007/s00125-013-2969-y; Gill JMR, 2008, SPORTS MED, V38, P807, DOI 10.2165/00007256-200838100-00002; Gill JMR, 2006, CLIN SCI, V110, P409, DOI 10.1042/CS20050207; Gray LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026464; Hall LML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014197; Hall LML, 2008, FUTURE LIPIDOL, V3, P411, DOI 10.2217/17460875.3.4.411; Hardy C P, 1985, Br J Sports Med, V19, P217; Herder C, 2011, CLIN PHARMACOL THER, V90, P52, DOI 10.1038/clpt.2011.93; Herman WH, 2012, J CLIN ENDOCR METAB, V97, P1067, DOI 10.1210/jc.2011-1894; Kumar S, 2011, INT J CLIN PRACT, V65, P378, DOI 10.1111/j.1742-1241.2010.02548.x; Marfell-Jones M, 2006, INT STANDARDS ANTHRO; Mcgee DL, 2005, ANN EPIDEMIOL, V15, P87, DOI 10.1016/j.annepidem.2004.05.012; Misra A, 2009, J Assoc Physicians India, V57, P163; Mostafa SA, 2012, DIABETES CARE, V35, P1746, DOI 10.2337/dc11-2079; National Health and Medical Research Council, 2013, AUSTR COD PRACT CAR, P1; Nocon M, 2008, EUR J CARDIOV PREV R, V15, P239, DOI 10.1097/HJR.0b013e3282f55e09; Organization WH, 1998, WELLB MEAS PRIM HLTH; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; Sattar N, 2012, DIABETIC MED, V29, P5, DOI 10.1111/j.1464-5491.2011.03480.x; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; U.S. Department of Health and Human Services, 2008, 2008 PHYS ACT GUID A; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; Wen CP, 2012, LANCET, V380, P192, DOI 10.1016/S0140-6736(12)60954-4; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	35	29	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82568	10.1371/journal.pone.0082568	http://dx.doi.org/10.1371/journal.pone.0082568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349313	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000328730300099
J	Ferla, MP; Thrash, JC; Giovannoni, SJ; Patrick, WM				Ferla, Matteo P.; Thrash, J. Cameron; Giovannoni, Stephen J.; Patrick, Wayne M.			New rRNA Gene-Based Phylogenies of the Alphaproteobacteria Provide Perspective on Major Groups, Mitochondrial Ancestry and Phylogenetic Instability	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; LONG-BRANCH ATTRACTION; SP NOV.; FAM. NOV; TREE; LIFE	Bacteria in the class Alphaproteobacteria have a wide variety of lifestyles and physiologies. They include pathogens of humans and livestock, agriculturally valuable strains, and several highly abundant marine groups. The ancestor of mitochondria also originated in this clade. Despite significant effort to investigate the phylogeny of the Alphaproteobacteria with a variety of methods, there remains considerable disparity in the placement of several groups. Recent emphasis on phylogenies derived from multiple protein-coding genes remains contentious due to disagreement over appropriate gene selection and the potential influences of systematic error. We revisited previous investigations in this area using concatenated alignments of the small and large subunit (SSU and LSU) rRNA genes, as we show here that these loci have much lower GC bias than whole genomes. This approach has allowed us to update the canonical 16S rRNA gene tree of the Alphaproteobacteria with additional important taxa that were not previously included, and with added resolution provided by concatenating the SSU and LSU genes. We investigated the topological stability of the Alphaproteobacteria by varying alignment methods, rate models, taxon selection and RY-recoding to circumvent GC content bias. We also introduce RYMK-recoding and show that it avoids some of the information loss in RY-recoding. We demonstrate that the topology of the Alphaproteobacteria is sensitive to inclusion of several groups of taxa, but it is less affected by the choice of alignment and rate methods. The majority of topologies and comparative results from Approximately Unbiased tests provide support for positioning the Rickettsiales and the mitochondrial branch within a clade. This composite clade is a sister group to the abundant marine SAR11 clade (Pelagibacterales). Furthermore, we add support for taxonomic assignment of several recently sequenced taxa. Accordingly, we propose three subclasses within the Alphaproteobacteria: the Caulobacteridae, the Rickettsidae, and the Magnetococcidae.	[Ferla, Matteo P.; Patrick, Wayne M.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Thrash, J. Cameron; Giovannoni, Stephen J.] Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; [Thrash, J. Cameron] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	University of Otago; Oregon State University; Louisiana State University System; Louisiana State University	Patrick, WM (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.	wayne.patrick@otago.ac.nz	; Ferla, Matteo/K-1870-2015	Thrash, Cameron/0000-0003-0896-9986; Ferla, Matteo/0000-0002-5508-4673; Patrick, Wayne/0000-0002-2718-8053	Marsden Fund; Marine Microbiology Initiative of the Gordon and Betty Moore Foundation (SJG); NSF [DBI-1003269]	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Marine Microbiology Initiative of the Gordon and Betty Moore Foundation (SJG); NSF(National Science Foundation (NSF))	MPF and WMP were supported by a grant from the Marsden Fund. This work was also supported by a grant from the Marine Microbiology Initiative of the Gordon and Betty Moore Foundation (SJG), and is based on work supported by the NSF under Award no. DBI-1003269 (JCT). WMP is a Rutherford Discovery Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battistuzzi FU, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-44; Bazylinski DA, 2013, INT J SYST EVOL MICR, V63, P801, DOI 10.1099/ijs.0.038927-0; Brindefalk B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024457; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Garrity G.M., 2005, BERGEYS MANUAL SYSTE, V2; Georgiades K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024857; Grote J, 2012, MBIO, V3, DOI 10.1128/mBio.00252-12; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Kolaczkowski B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007891; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Kurahashi M, 2008, INT J SYST EVOL MICR, V58, P548, DOI 10.1099/ijs.0.65328-0; Kwon KK, 2005, INT J SYST EVOL MICR, V55, P2033, DOI 10.1099/ijs.0.63684-0; Lee KB, 2005, INT J SYST EVOL MICR, V55, P1907, DOI 10.1099/ijs.0.63663-0; Lefevre CT, 2009, ENVIRON MICROBIOL, V11, P1646, DOI 10.1111/j.1462-2920.2009.01887.x; McInerney JO, 2008, TRENDS ECOL EVOL, V23, P276, DOI 10.1016/j.tree.2008.01.008; Montagna M, 2013, APPL ENVIRON MICROB, V79, P3241, DOI 10.1128/AEM.03971-12; Pace NR, 2009, MICROBIOL MOL BIOL R, V73, P565, DOI 10.1128/MMBR.00033-09; Philippe H, 2000, MOL BIOL EVOL, V17, P830, DOI 10.1093/oxfordjournals.molbev.a026362; Phillips MJ, 2003, MOL PHYLOGENET EVOL, V28, P171, DOI 10.1016/S1055-7903(03)00057-5; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; Quinn RA, 2012, DIS AQUAT ORGAN, V98, P221, DOI 10.3354/dao02446; Rodriguez-Ezpeleta N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030520; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Sassera D, 2011, MOL BIOL EVOL, V28, P3285, DOI 10.1093/molbev/msr159; Schubbe S, 2009, APPL ENVIRON MICROB, V75, P4835, DOI 10.1128/AEM.02874-08; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013; Viklund J, 2012, MOL BIOL EVOL, V29, P599, DOI 10.1093/molbev/msr203; Wiese J, 2009, INT J SYST EVOL MICR, V59, P350, DOI 10.1099/ijs.0.001651-0; Williams KP, 2007, J BACTERIOL, V189, P4578, DOI 10.1128/JB.00269-07; WOESE CR, 1991, SYST APPL MICROBIOL, V14, P364, DOI 10.1016/S0723-2020(11)80311-5; Xu Y, 2012, J AM CHEM SOC, V134, P8625, DOI 10.1021/ja301735a	37	66	67	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83383	10.1371/journal.pone.0083383	http://dx.doi.org/10.1371/journal.pone.0083383			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349502	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300146
J	Kontham, V; von Holst, S; Lindblom, A				Kontham, Vinaykumar; von Holst, Susanna; Lindblom, Annika			Linkage Analysis in Familial Non-Lynch Syndrome Colorectal Cancer Families from Sweden	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCUS; COLON-CANCER; RISK; SCAN; LOCALIZATION; METAANALYSIS; GENETICS; KINDREDS; ASSAY	Family history is a major risk factor for colorectal cancer and many families segregate the disease as a seemingly monogenic trait. A minority of familial colorectal cancer could be explained by known monogenic genes and genetic loci. Familial polyposis and Lynch syndrome are two syndromes where the predisposing genes are known but numerous families have been tested without finding the predisposing gene. We performed a genome wide linkage analysis in 121 colorectal families with an increased risk of colorectal cancer. The families were ascertained from the department of clinical genetics at the Karolinska University Hospital in Stockholm, Sweden and were considered negative for Familial Polyposis and Lynch syndrome. In total 600 subjects were genotyped using single nucleotide polymorphism array chips. Parametric-and non-parametric linkage analyses were computed using MERLIN in all and subsets of families. No statistically significant result was seen, however, there were suggestive positive HLODs above two in parametric linkage analysis. This was observed in a recessive model for high-risk families, at locus 9q31.1 (HLOD=2.2, rs1338121) and for moderate-risk families, at locus Xp22.33 (LOD=2.2 and HLOD=2.5, rs2306737). Using families with early-onset, recessive analysis suggested one locus on 4p16.3 (LOD=2.2, rs920683) and one on 17p13.2 (LOD/HLOD=2.0, rs884250). No NPL score above two was seen for any of the families. Our linkage study provided additional support for the previously suggested region on chromosome 9 and suggested additional loci to be involved in colorectal cancer risk. Sequencing of genes in the regions will be done in future studies.	[Kontham, Vinaykumar; von Holst, Susanna; Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden	Karolinska Institutet	Lindblom, A (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.	Annika.Lindblom@ki.se			Stockholm County Council; Karolinska Institutet [20110483]; Swedish Cancer Society [110439]; Swedish research council [20103543]; Stockholm Cancer Foundation [111232]; Nilsson-Ehle Foundation; Knut & Alice Wallenberg Foundation via the Wallenberg Consortium; Uppsala University	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Cancer Society(Swedish Cancer Society); Swedish research council(Swedish Research CouncilEuropean Commission); Stockholm Cancer Foundation; Nilsson-Ehle Foundation; Knut & Alice Wallenberg Foundation via the Wallenberg Consortium; Uppsala University	Financial support was provided through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet (20110483), the Swedish Cancer Society (110439), The Swedish research council (20103543), The Stockholm Cancer Foundation (111232) and Nilsson-Ehle Foundation. The SNP technology platform in Uppsala is supported by Knut & Alice Wallenberg Foundation via the Wallenberg Consortium and Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; BODMER WF, 1987, NATURE, V328, P614, DOI 10.1038/328614a0; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Cicek MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038175; Djureinovic T, 2006, GUT, V55, P362, DOI 10.1136/gut.2005.075333; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Goode EL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S82; Gray-McGuire C, 2010, CANCER RES, V70, P5409, DOI 10.1158/0008-5472.CAN-10-0188; Guda K, 2009, P NATL ACAD SCI USA, V106, P12921, DOI 10.1073/pnas.0901454106; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Kemp ZE, 2006, CANCER RES, V66, P5003, DOI 10.1158/0008-5472.CAN-05-4074; Kemp Z, 2006, HUM MOL GENET, V15, P2903, DOI 10.1093/hmg/ddl231; LINDBLOM A, 1993, NAT GENET, V5, P279, DOI 10.1038/ng1193-279; Lindor NM, 2005, JAMA-J AM MED ASSOC, V293, P1979, DOI 10.1001/jama.293.16.1979; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; Middeldorp A, 2010, GENE CHROMOSOME CANC, V49, P539, DOI 10.1002/gcc.20763; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Olsson Louise, 2003, Fam Cancer, V2, P87, DOI 10.1023/A:1025734200635; PELTOMAKI P, 1993, SCIENCE, V260, P810, DOI 10.1126/science.8484120; Penegar S, 2007, BRIT J CANCER, V97, P1305, DOI 10.1038/sj.bjc.6603997; Picelli S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-87; Roberts A, 2011, FAM CANCER, V10, P245, DOI 10.1007/s10689-010-9408-8; Robinson KL, 2007, J NATL CANCER I, V99, P291, DOI 10.1093/jnci/djk051; Saunders IW, 2012, EUR J HUM GENET, V20, P91, DOI 10.1038/ejhg.2011.149; Skoglund J, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.033928; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Valle L, 2008, SCIENCE, V321, P1361, DOI 10.1126/science.1159397; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Wiesner GL, 2003, P NATL ACAD SCI USA, V100, P12961, DOI 10.1073/pnas.2132286100; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83936	10.1371/journal.pone.0083936	http://dx.doi.org/10.1371/journal.pone.0083936			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349560	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300154
J	Mehr, SA; Schachner, A; Katz, RC; Spelke, ES				Mehr, Samuel A.; Schachner, Adena; Katz, Rachel C.; Spelke, Elizabeth S.			Two Randomized Trials Provide No Consistent Evidence for Nonmusical Cognitive Benefits of Brief Preschool Music Enrichment	PLOS ONE			English	Article							LESSONS; INTELLIGENCE; SAMPLE; IQ	Young children regularly engage in musical activities, but the effects of early music education on children's cognitive development are unknown. While some studies have found associations between musical training in childhood and later nonmusical cognitive outcomes, few randomized controlled trials (RCTs) have been employed to assess causal effects of music lessons on child cognition and no clear pattern of results has emerged. We conducted two RCTs with preschool children investigating the cognitive effects of a brief series of music classes, as compared to a similar but non-musical form of arts instruction (visual arts classes, Experiment 1) or to a no-treatment control (Experiment 2). Consistent with typical preschool arts enrichment programs, parents attended classes with their children, participating in a variety of developmentally appropriate arts activities. After six weeks of class, we assessed children's skills in four distinct cognitive areas in which older arts-trained students have been reported to excel: spatial-navigational reasoning, visual form analysis, numerical discrimination, and receptive vocabulary. We initially found that children from the music class showed greater spatial-navigational ability than did children from the visual arts class, while children from the visual arts class showed greater visual form analysis ability than children from the music class (Experiment 1). However, a partial replication attempt comparing music training to a no-treatment control failed to confirm these findings (Experiment 2), and the combined results of the two experiments were negative: overall, children provided with music classes performed no better than those with visual arts or no classes on any assessment. Our findings underscore the need for replication in RCTs, and suggest caution in interpreting the positive findings from past studies of cognitive effects of music instruction.	[Mehr, Samuel A.; Schachner, Adena; Katz, Rachel C.; Spelke, Elizabeth S.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Mehr, Samuel A.] Harvard Univ, Grad Sch Educ, Cambridge, MA 02138 USA	Harvard University; Harvard University	Mehr, SA (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.	smehr@wjh.harvard.edu		Schachner, Adena/0000-0001-6886-7098; Mehr, Samuel/0000-0002-9400-7718	Dana Foundation	Dana Foundation	This research was supported by a grant from the Dana Foundation awarded to ESS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, KAUFMAN TEST ED ACHI; [Anonymous], 2009, DEV APPROPRIATE PRAC; Beggs D. L., 1980, DEV COGNITIVE ABILIT; BERGER A., 2003, J RES MUSIC EDUC, V51, P151; Bilhartz TD, 1999, J APPL DEV PSYCHOL, V20, P615, DOI 10.1016/S0193-3973(99)00033-7; Bruininks R. H, 2005, BRUININKS OSERETSKY; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Canadian Test Centre Inc, 1992, CAN ACH TESTS; Chosky L, 1999, KODALY METHOD; Consortium of National Arts Education Associations, 1994, NAT STAND ARTS ED WH; Coopersmith S., 1981, COOPERSMITH SELF EST; Costa-Giomi E, 1999, J RES MUSIC EDUC, V47, P198, DOI 10.2307/3345779; Cumming G., 2010, REV GUIDE QUANTITATI, P79, DOI DOI 10.4324/9780203861554; Deater-Deckard K, 2005, DEVELOPMENTAL SCI, V8, pF21, DOI 10.1111/j.1467-7687.2005.00407.x; Dege F, 2011, MUSIC PERCEPT, V29, P195, DOI 10.1525/MP.2011.29.2.195; Dunn L.M., 1981, PEABODY PICTURE VOCA; Elpus K, 2013, J RES MUSIC EDUC, V61, P175, DOI 10.1177/0022429413485601; Feierabend J. M., 1996, EARLY CHILDHOOD CONN, V2, P19; Flohr J.W., 2005, MUSICAL LIVES YOUNG; Fox D. B., 1989, PROMISING PRACTICES, P12; Fox DB, 1991, AM MUSIC TEACHER, V40, P20; Gilmore CK, 2010, COGNITION, V115, P394, DOI 10.1016/j.cognition.2010.02.002; Gordon E. E., 1988, MUSICAL APTITUDE PRO; Gordon Edwin, 1989, ADV MEASURES MUSIC A; Guilmartin Ken, 2000, AM MUSIC TEACHER; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2012, P NATL ACAD SCI USA, V109, P11116, DOI 10.1073/pnas.1200196109; Hanna-Pladdy B, 2011, NEUROPSYCHOLOGY, V25, P378, DOI 10.1037/a0021895; Hartshorne JK, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00008; Izard V, 2011, ATTENTION PERFORM, P319, DOI 10.1016/B978-0-12-385948-8.00019-0; Izard Veronique, 2009, Hum Evol, V23, P213; Kaufman A.S., 1994, INTELLIGENT TESTING; Libertus ME, 2011, DEVELOPMENTAL SCI, V14, P1292, DOI 10.1111/j.1467-7687.2011.01080.x; Marques C, 2007, J COGNITIVE NEUROSCI, V19, P1453, DOI 10.1162/jocn.2007.19.9.1453; McClelland MM, 2013, EARLY CHILD RES Q, V28, P314, DOI 10.1016/j.ecresq.2012.07.008; MCDERMOTT PA, 1992, J SPEC EDUC, V25, P504, DOI 10.1177/002246699202500407; MCDERMOTT PA, 1990, J PSYCHOEDUC ASSESS, V8, P290, DOI 10.1177/073428299000800307; Mehr SA, 2010, EARL CHILDH MUS ED C; MENC: The National Association for Music Education, 2000, SPOTL EARL CHILDH MU; Moreno S, 2011, PSYCHOL SCI, V22, P1425, DOI 10.1177/0956797611416999; Moreno S, 2009, CEREB CORTEX, V19, P712, DOI 10.1093/cercor/bhn120; Orff C, 1982, MUSIC CHILDREN ORFF; Piazza M, 2013, PSYCHOL SCI IN PRESS; Reynolds C. R., 1992, BEHAV ASSESSMENT SYS; Sattler, 2018, ASSESSMENT CHILDREN; Sattler, 1986, STANFORD BINET INTEL; Schellenberg EG, 2006, J EDUC PSYCHOL, V98, P457, DOI 10.1037/0022-0663.98.2.457; Schellenberg EG, 2004, PSYCHOL SCI, V15, P511, DOI 10.1111/j.0956-7976.2004.00711.x; Schiller M, 1995, ART ED, V48, P45, DOI DOI 10.1080/00043125.1995.11652329; Shusterman A, 2008, DEVELOPMENTAL SCI, V11, pF1, DOI 10.1111/j.1467-7687.2007.00670.x; Spelke Elizabeth., 2008, LEARNING ARTS BRAIN, P17; Sternberg R. J., 1985, IQ TRIARCHIC THEORY; Succena A, 2010, BATERIA AVALIACAO LE; Swears L, 1998, KINDERMUSIK YOUNG CH; Wechsler D, 1974, WECHSLER INTELLIGENC; Wechsler D., 2012, WECHSLER PRESCHOOL P, VFourth; Wechsler D., 2003, ESCALA INTELIGENCIA; Winner E, 1999, NY TIMES, P25; Wuytack Jos, 1995, AUDICAO MUSICAL ACTI	59	65	67	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82007	10.1371/journal.pone.0082007	http://dx.doi.org/10.1371/journal.pone.0082007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349171	Green Published, gold			2022-12-27	WOS:000328730300068
J	Cui, GX; Leng, HJ; Wang, K; Wang, JW; Zhu, SN; Jia, J; Chen, X; Zhang, WG; Qin, LH; Bai, WP				Cui, Guangxia; Leng, Huijie; Wang, Ke; Wang, Jianwei; Zhu, Sainan; Jia, Jing; Chen, Xing; Zhang, Weiguang; Qin, Lihua; Bai, Wenpei			Effects of Remifemin Treatment on Bone Integrity and Remodeling in Rats with Ovariectomy-Induced Osteoporosis	PLOS ONE			English	Article							BLACK COHOSH EXTRACT; HORMONE REPLACEMENT THERAPY; CIMICIFUGA-RACEMOSA; ISOPROPANOLIC EXTRACT; MODEL; ESTROGEN; DIFFERENTIATION; OSTEONECROSIS; PREVENTION; INCREASES	This study aims to evaluate the effects of Remifemin (isopropanolic extract of Cimicifuga Racemosa) on postmenopausal osteoporosis. 120 female Sprague-Dawley rats were randomly assigned to four groups: sham surgery with vehicle, ovariectomy with vehicle, ovariectomy with estradiol valerate, or ovariectomy with Remifemin. Daily oral administrations of the vehicle, estradiol valerate, or Remifemin began 2 weeks after surgery and lasted to 4, 8, or 12 weeks. Ten rats in each group were sacrificed at each timestep with assessment of bone mineral density, trabecular bone structure, and biomechanical parameters of the femur and lumbar vertebra. Bone turnover markers were evaluated 12 weeks after surgery. Both drugs prevented bone density loss in the distal end of the femur and preserved the trabecular bone structure in both the lumbar vertebra and distal end of the femur following ovariectomy. Both drugs protected bone stiffness at the tested regions and reduced bone reabsorption in ovariectomized rats. The preventive effects of Remifemin against bone-loss can rival those of estradiol valerate if treatment duration is adequately extended. In conclusion, Remifemin may demonstrate equivalent effects to estradiol valerate in terms of preventing postmenopausal osteoporosis.	[Cui, Guangxia; Chen, Xing; Bai, Wenpei] Peking Univ, Hosp 1, Dept Obstet & Gynecol, Beijing 100871, Peoples R China; [Leng, Huijie] Peking Univ, Hosp 3, Dept Orthopaed, Beijing 100871, Peoples R China; [Wang, Ke; Wang, Jianwei; Zhang, Weiguang; Qin, Lihua] Peking Univ, Hlth Sci Ctr, Dept Anat & Embryol, Beijing 100871, Peoples R China; [Zhu, Sainan] Peking Univ, Hosp 1, Stat Off, Beijing 100871, Peoples R China; [Jia, Jing] Gen Hosp Armed Police, Dept Stomatol, Beijing, Peoples R China	Peking University; Peking University; Peking University; Peking University	Qin, LH (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Anat & Embryol, Beijing 100871, Peoples R China.	qinlihua88@163.com; bwp66@163.com	Leng, Huijie/AGQ-9574-2022	Leng, Huijie/0000-0002-4436-061X	National Natural Science Foundation of China [NSFC 11002004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (NSFC 11002004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai WP, 2007, MATURITAS, V58, P31, DOI 10.1016/j.maturitas.2007.04.009; Baqain ZH, 2010, ANN ROY COLL SURG, V92, P489, DOI 10.1308/003588410X12699663903395; BEER AM, 2013, GYNECOL END IN PRESS; Bhattacharyya S, 2008, J BONE MINER RES, V23, P1106, DOI 10.1359/JBMR.080235; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brzoska M, 2005, ARCH TOXICOL, V79, P277, DOI 10.1007/s00204-005-0650-z; CAULEY JA, 1995, ANN INTERN MED, V122, P9, DOI 10.7326/0003-4819-122-1-199501010-00002; Cetinkaya MB, 2002, J BONE MINER METAB, V20, P44, DOI 10.1007/s774-002-8446-8; Choi So-Young, 2011, Lab Anim Res, V27, P301, DOI 10.5625/lar.2011.27.4.301; Colditz GA, 1997, ANN NY ACAD SCI, V833, P129, DOI 10.1111/j.1749-6632.1997.tb48598.x; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Devareddy L, 2006, BONE, V38, P686, DOI 10.1016/j.bone.2005.10.024; Dog TL, 2003, MENOPAUSE, V10, P299, DOI 10.1097/01.GME.0000056039.51813.21; EINHORN TA, 1992, BOTTOM LINE CALCIF T, V51, P333, DOI DOI 10.1007/BF00316875; Firenzuoli F., 2011, EVID-BASED COMPL ALT, V2011; Genant HK, 2007, OSTEOPOROSIS INT, V18, P69, DOI 10.1007/s00198-006-0199-6; Hadji P, 2012, CLIMACTERIC, V15, P513, DOI 10.3109/13697137.2012.688079; Jakubowitz E, 2009, MED SCI MONITOR, V15, pBR307; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; Laib A, 2001, OSTEOPOROSIS INT, V12, P936, DOI 10.1007/s001980170022; Li XD, 2010, J BONE MINER RES, V25, P2371, DOI 10.1002/jbmr.182; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Liske E, 1998, ADV THER, V15, P45; Liu ZG, 2009, J ETHNOPHARMACOL, V123, P74, DOI 10.1016/j.jep.2009.02.025; Ma B, 2012, ACTA PHARMACOL SIN, V33, P479, DOI 10.1038/aps.2011.177; Ma XY, 2011, J ETHNOPHARMACOL, V138, P156, DOI 10.1016/j.jep.2011.08.076; Muratore M, 2011, DRUG DES DEV THER, V5, P445, DOI 10.2147/DDDT.S12139; Nadaoka I, 2012, BIOMED RES-TOKYO, V33, P133, DOI 10.2220/biomedres.33.133; Nadaoka I, 2012, NAT PROD COMMUN, V7, P15; Naser B, 2011, MENOPAUSE, V18, P366, DOI 10.1097/gme.0b013e3181fcb2a6; Nenonen A, 2005, J BONE MINER RES, V20, P1804, DOI 10.1359/JBMR.050403; Nisslein T, 2003, J BONE MINER METAB, V21, P370, DOI 10.1007/s00774-003-0431-9; Petitti DB, 2002, JAMA-J AM MED ASSOC, V288, P99, DOI 10.1001/jama.288.1.99; PETROVIC O, 1993, ANN INTERN MED, V118, P155, DOI 10.7326/0003-4819-118-2-199301150-00018; Rachon D, 2008, MATURITAS, V60, P209, DOI 10.1016/j.maturitas.2008.06.001; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Ross SM, 2012, HOLIST NURS PRACT, V26, P58, DOI 10.1097/HNP.0b013e31823d1f67; Sharir A, 2008, VET J, V177, P8, DOI 10.1016/j.tvjl.2007.09.012; Tang DZ, 2010, J BONE MINER RES, V25, P1234, DOI 10.1002/jbmr.21; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Ulrich D, 1999, BONE, V25, P55, DOI 10.1016/S8756-3282(99)00098-8; Viereck V, 2005, J BONE MINER RES, V20, P2036, DOI 10.1359/JBMR.050716; Wade C, 1999, J Am Med Womens Assoc (1972), V54, P181; WRONSKI TJ, 1989, CALCIFIED TISSUE INT, V45, P360, DOI 10.1007/BF02556007; YAMAZAKI I, 1989, J BONE MINER RES, V4, P13; Zhao X, 2011, J ETHNOPHARMACOL, V137, P1083, DOI 10.1016/j.jep.2011.07.017	46	21	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82815	10.1371/journal.pone.0082815	http://dx.doi.org/10.1371/journal.pone.0082815			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349369	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200102
J	Williams, CR; Dustin, ML; Sauer, JD				Williams, Cassandra R.; Dustin, Michael L.; Sauer, John-Demian			Inflammasome-Mediated Inhibition of Listeria monocytogenes-Stimulated Immunity Is Independent of Myelomonocytic Function	PLOS ONE			English	Article							DENDRITIC CELLS; ANTIGEN PRESENTATION; NLRC4 INFLAMMASOME; WHITE PULP; NEUTROPHILS; INNATE; RECOGNITION; CASPASE-1; INFECTION; ENTRY	Activation of the Nlrc4 inflammasome results in the secretion of IL-1 beta and IL-18 through caspase-1 and induction of pyroptosis. L. monocytogenes engineered to activate Nlrc4 by expression of Legionella pneumophilia flagellin (L. monocytogenes L. p. FlaA) are less immunogenic for CD8(+) T cell responses than wt L. monocytogenes. It is also known that IL-1 beta orchestrates recruitment of myelomonocytic cells (MMC), which have been shown to interfere with T cell-dendritic cells (DC) interactions in splenic white pulp (WP), limiting T cell priming and protective immunity. We have further analyzed the role of MMCs in the immunogenicity of L. monocytogenes L. p. FlaA. We confirmed that MMCs infiltrate the WP between 24-48 hours in response to wt L. monocytogenes infection and that depletion of MMCs enhances CD8(+) T cell priming and protective memory. L. monocytogenes L. p. FlaA elicited accelerated recruitment of MMCs into the WP. While MMCs contribute to control of L. monocytogenes L. p. FlaA, MMC depletion did not increase immunogenicity of L. p. FlaA expressing strains. There was a significant decrease in L. monocytogenes L. p. FlaA in CD8 alpha(+) DCs independent of MMCs. These findings suggest that limiting inflammasome activation is important for bacterial accumulation in CD8 alpha(+) DCs, which are known to be critical for T cell response to L. monocytogenes.	[Williams, Cassandra R.; Dustin, Michael L.] Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, Mol Pathogenesis Program, New York, NY USA; [Sauer, John-Demian] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Dustin, ML (corresponding author), Skirball Inst Biomol Med, Helen L & Martin S Kimmel Ctr Biol & Med, Mol Pathogenesis Program, New York, NY USA.	michael.dustin@med.nyu.edu; sauer3@wisc.edu	Sauer, John-Demian/AAV-8538-2020; Dustin, Michael/AAM-4611-2020	Sauer, John-Demian/0000-0001-9367-794X; Dustin, Michael/0000-0003-4983-6389	National Institutes of Health [AI055037, AI071195]; American Cancer Society [PF-07-066-01-LIB]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI055037, R01AI055037, P01AI071195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research is supported by National Institutes of Health grants AI055037, AI071195 (C. R. W. and M. L. D.) and the American Cancer Society grant PF-07-066-01-LIB (J-D.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; Bahjat KS, 2006, INFECT IMMUN, V74, P6387, DOI 10.1128/IAI.01088-06; Brockstedt DG, 2004, P NATL ACAD SCI USA, V101, P13832, DOI 10.1073/pnas.0406035101; Busse WW, 1998, AM J RESP CRIT CARE, V157, pS210, DOI 10.1164/ajrccm.157.6.mar-1; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Carrero JA, 2004, J IMMUNOL, V172, P4866, DOI 10.4049/jimmunol.172.8.4866; Case CL, 2009, INFECT IMMUN, V77, P1981, DOI 10.1128/IAI.01382-08; Conlan JW, 1996, J MED MICROBIOL, V44, P295, DOI 10.1099/00222615-44-4-295; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Faust N, 2000, BLOOD, V96, P719; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Harizi H, 2002, J IMMUNOL, V168, P2255, DOI 10.4049/jimmunol.168.5.2255; HOOVER RL, 1984, P NATL ACAD SCI-BIOL, V81, P2191, DOI 10.1073/pnas.81.7.2191; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Kofoed EM, 2011, NATURE, V477, P592, DOI 10.1038/nature10394; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Marcinkiewicz J, 2003, IMMUNOL LETT, V89, P187, DOI 10.1016/S0165-2478(03)00140-8; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Molne L, 2000, INFECT IMMUN, V68, P6162, DOI 10.1128/IAI.68.11.6162-6167.2000; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nolte MA, 2000, EUR J IMMUNOL, V30, P626; PALMER RMJ, 1980, PROSTAGLANDINS, V20, P411, DOI 10.1016/S0090-6980(80)80058-X; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; ROGERS HW, 1993, INFECT IMMUN, V61, P5090, DOI 10.1128/IAI.61.12.5090-5096.1993; Sauer JD, 2011, P NATL ACAD SCI USA, V108, P12419, DOI 10.1073/pnas.1019041108; Schnorrer P, 2006, P NATL ACAD SCI USA, V103, P10729, DOI 10.1073/pnas.0601956103; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Seveau S, 2007, MICROBES INFECT, V9, P1167, DOI 10.1016/j.micinf.2007.05.004; SHAAFI RI, 1981, J CELL PHYSIOL, V108, P401, DOI 10.1002/jcp.1041080314; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Shi C, 2011, J IMMUNOL, V187, P5293, DOI 10.4049/jimmunol.1101721; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Tvinnereim AR, 2004, J IMMUNOL, V173, P1994, DOI 10.4049/jimmunol.173.3.1994; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; Verdrengh M, 1997, INFECT IMMUN, V65, P2517, DOI 10.1128/IAI.65.7.2517-2521.1997; von Moltke J, 2012, NATURE, V490, P107, DOI 10.1038/nature11351; Waite JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001326; Warren SE, 2011, EUR J IMMUNOL, V41, P1934, DOI 10.1002/eji.201041214; Witte CE, 2012, ADV IMMUNOL, V113, P135, DOI 10.1016/B978-0-12-394590-7.00002-6; Yang CW, 2010, J IMMUNOL, V185, P2927, DOI 10.4049/jimmunol.1001289; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	52	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e83191	10.1371/journal.pone.0083191	http://dx.doi.org/10.1371/journal.pone.0083191			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349458	gold, Green Submitted, Green Published			2022-12-27	WOS:000328705200125
J	Ohs, I; Windmann, S; Wildner, O; Dittmer, U; Bayer, W				Ohs, Inga; Windmann, Sonja; Wildner, Oliver; Dittmer, Ulf; Bayer, Wibke			Interleukin-Encoding Adenoviral Vectors as Genetic Adjuvant for Vaccination against Retroviral Infection	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; HIV-1/SIV CHIMERIC VIRUS; ENVELOPE PROTEIN; SIV INFECTION; NEUTRALIZING ANTIBODIES; PASSIVE-IMMUNIZATION; IMMUNE-RESPONSE; DOUBLE-BLIND; T-CELLS; IN-VIVO	Interleukins (IL) are cytokines with stimulatory and modulatory functions in the immune system. In this study, we have chosen interleukins which are involved in the enhancement of T(H)2 responses and B cell functions to analyze their potential to improve a prophylactic adenovirus-based anti-retroviral vaccine with regard to antibody and virus-specific CD4(+) T cell responses. Mice were vaccinated with an adenoviral vector which encodes and displays the Friend Virus (FV) surface envelope protein gp70 (Ad. pIXgp70) in combination with adenoviral vectors encoding the interleukins IL4, IL5, IL6, IL7 or IL23. Co-application of Ad. pIXgp70 with Ad. IL5, Ad. IL6 or Ad. IL23 resulted in improved protection with high control over FV-induced splenomegaly and reduced viral loads. Mice co-immunized with adenoviral vectors encoding IL5 or IL23 showed increased neutralizing antibody responses while mice co-immunized with Ad. IL6 or Ad. IL23 showed improved FV-specific CD4(+) T cell responses compared to mice immunized with Ad. pIXgp70 alone. We show that the co-application of adenoviral vectors encoding specific interleukins is suitable to improve the vaccination efficacy of an anti-retroviral vaccine. Improved protection correlated with improved CD4(+) T cell responses and especially with higher neutralizing antibody titers. The co-application of selected interleukin-encoding adenoviral vectors is a valuable tool for vaccination with regard to enhancement of antibody mediated immunity.	[Ohs, Inga; Windmann, Sonja; Dittmer, Ulf; Bayer, Wibke] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany; [Wildner, Oliver] Paul Ehrlich Inst, Div Pharmacovigilance, Langen, Germany	University of Duisburg Essen; Paul Ehrlich Institute	Bayer, W (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany.	wibke.bayer@uni-due.de		Wildner, Oliver/0000-0001-7001-2451; Bayer, Wibke/0000-0002-5885-5592	Mercator Research Center Ruhr; Deutsche Forschungsgemeinschaft [Wi 1329/6-1]	Mercator Research Center Ruhr; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was funded by a grant from the Mercator Research Center Ruhr (www.mercur-research.de) to UD, and by a grant from the Deutsche Forschungsgemeinschaft (www.dfg.de) to UD and WB (Wi 1329/6-1; to OW initially). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer W, 2008, VACCINE, V26, P716, DOI 10.1016/j.vaccine.2007.11.050; Bayer W, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-75; Bayer W, 2010, J VIROL, V84, P1967, DOI 10.1128/JVI.01840-09; Boniface K, 2008, IMMUNOL REV, V226, P132, DOI 10.1111/j.1600-065X.2008.00714.x; Brenchley JM, 2006, J VIROL, V80, P6801, DOI 10.1128/JVI.00070-06; Brocker Chad, 2010, Human Genomics, V5, P30; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; CHESEBRO B, 1974, J EXP MED, V140, P1457, DOI 10.1084/jem.140.6.1457; Corfe SA, 2012, SEMIN IMMUNOL, V24, P198, DOI 10.1016/j.smim.2012.02.001; Dittmer U, 1999, NAT MED, V5, P189, DOI 10.1038/5550; Eto D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017739; FAUCI AS, 1988, PUBLIC HEALTH REP, V103, P230; FRIEND C, 1957, J EXP MED, V105, P307, DOI 10.1084/jem.105.4.307; Fry TJ, 2001, BLOOD, V97, P2983, DOI 10.1182/blood.V97.10.2983; GARDNER M, 1995, AIDS RES HUM RETROV, V11, P843, DOI 10.1089/aid.1995.11.843; GARDNER MB, 1994, J MED PRIMATOL, V23, P164, DOI 10.1111/j.1600-0684.1994.tb00118.x; Gilmour J, 2008, IMMUNOLOGY, V124, P437, DOI 10.1111/j.1365-2567.2008.02845.x; Godel P, 2012, J VIROL, V86, P12422, DOI 10.1128/JVI.01607-12; GRABSTEIN KH, 1993, J EXP MED, V178, P257, DOI 10.1084/jem.178.1.257; Ha SJ, 2004, J IMMUNOL, V172, P525, DOI 10.4049/jimmunol.172.1.525; Hasenkrug KJ, 1998, VIROLOGY, V248, P66, DOI 10.1006/viro.1998.9264; ISHIHARA C, 1991, J IMMUNOL, V146, P3958; IWASHIRO M, 1993, J VIROL, V67, P4533, DOI 10.1128/JVI.67.8.4533-4542.1993; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Kittipatarin C, 2007, CYTOKINE, V39, P75, DOI 10.1016/j.cyto.2007.07.183; Kouro T, 2009, INT IMMUNOL, V21, P1303, DOI 10.1093/intimm/dxp102; LANDER MR, 1984, J VIROL, V52, P695, DOI 10.1128/JVI.52.2.695-698.1984; Lietz R, 2012, J VIROL, V86, P1706, DOI 10.1128/JVI.06244-11; Lynch RM, 2013, CURR OPIN HIV AIDS, V8, P288, DOI 10.1097/COH.0b013e328361cfe8; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Masek-Hammerman K, 2010, J VIROL, V84, P9810, DOI 10.1128/JVI.01157-10; Messer RJ, 2004, P NATL ACAD SCI USA, V101, P12260, DOI 10.1073/pnas.0404769101; Mittereder N, 1996, J VIROL, V70, P7498, DOI 10.1128/JVI.70.11.7498-7509.1996; Murray R, 1989, Int Immunol, V1, P526, DOI 10.1093/intimm/1.5.526; NIAID, 2013, NIH DISC IMM HIV VAC; Nilsson M, 2004, J GENE MED, V6, P631, DOI 10.1002/jgm.543; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; ROBERTSON MN, 1991, J VIROL METHODS, V34, P255, DOI 10.1016/0166-0934(91)90105-9; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; SITBON M, 1985, VIROLOGY, V141, P110, DOI 10.1016/0042-6822(85)90187-4; Stahl-Hennig C, 2003, VIROLOGY, V305, P473, DOI 10.1006/viro.2002.1763; Sun CJ, 2010, J INFECTION, V60, P371, DOI 10.1016/j.jinf.2010.03.005; Tenbusch M, 2012, J VIROL, V86, P10533, DOI 10.1128/JVI.00796-12; Uberla K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000114; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Williman J, 2006, VACCINE, V24, P4471, DOI 10.1016/j.vaccine.2005.08.011; Zhang Y, 2001, MOL THER, V3, P697, DOI 10.1006/mthe.2001.0329	49	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82528	10.1371/journal.pone.0082528	http://dx.doi.org/10.1371/journal.pone.0082528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24349306	Green Published, Green Submitted, gold			2022-12-27	WOS:000327949300159
J	Hua, R; Liu, LM; Wang, XL; Chen, L				Hua, Rui; Liu, Limin; Wang, Xinling; Chen, Lei			Imaging Evidence of Diabetic Choroidopathy In Vivo: Angiographic Pathoanatomy and Choroidal-Enhanced Depth Imaging	PLOS ONE			English	Article							OCULAR BLOOD-FLOW; THICKNESS; VELOCITY	Purpose: To describe the pathoanatomy of diabetic choroidopathy (DC) in pre-diagnosed diabetic retinopathy (DR) cases and to provide angiographic and optical evidence for DC using indocyanine green angiography (ICGA) and enhanced depth imaging spectral-domain optical coherence tomography (EDI SD-OCT). Methods: A retrospective analysis of 80 eyes from 40 DR patients was conducted. In Group One, choroidal vascular abnormalities were evaluated by comparing angiographic findings from simultaneous ICGA with those from fundus fluorescein angiography (FFA). In Group Two, EDI SD-OCT was used to evaluate the subfoveal choroidal thickness (SFCT) and define the choroid boundary in order to acquire the bilateral and symmetric choroidal area (CA). Data were then analyzed by Image Pro Plus 6.0. Results: In Group One, choroidal abnormalities that were evident using ICGA but not FFA included early hypofluorescent spots in 47 eyes (75.81%), late hyperfluorescent spots in 37 eyes (59.68%), and late choroidal non-perfusion regions in 32 eyes (51.61%). In particular, a significant difference between proliferative DR (PDR) in 17 of 23 eyes (73.91%) and non-PDR in 16 of 39 eyes (41.03%) was observed in late choroidal non-perfusion regions. Eighteen of 31 eyes (58.06%) also exhibited "inverted inflow phenomena." In Group Two, both the SFCT and CA of eyes with diabetic macular edema and serous macular detachment were significantly greater than those in the other eyes. The CA in panretinal photocoagulation (PRP) treated cases was also greater than that in non-PRP treated cases. Conclusions: Early hypofluorescent spots, late choroidal non-perfusion regions, inverted inflow phenomena, higher SFCT, and larger CA are qualitative and quantitative indexes for DC. Moreover, the late choroidal non-perfusion region is a risk factor for DC with DR. Our study suggests that the supplemental use of ICGA and EDI SD-OCT with FFA is a better choice for DR patients.	[Hua, Rui; Liu, Limin; Chen, Lei] China Med Univ, Hosp 1, Dept Ophthalmol, Shenyang, Peoples R China; [Hua, Rui; Chen, Lei] China Med Univ, Hosp 1, Key Lab Endocrine Dis Liaoning Prov, Shenyang, Peoples R China; [Wang, Xinling] China Med Univ, Hosp 4, Dept Ophthalmol, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Chen, L (corresponding author), China Med Univ, Hosp 1, Dept Ophthalmol, Shenyang, Peoples R China.	LeiChen51@126.com	liu, li/HGC-0900-2022	Wang, Xinling/0000-0003-2332-8714				[Anonymous], 1991, Ophthalmology, V98, P786; Cao JT, 1998, ARCH OPHTHALMOL-CHIC, V116, P589, DOI 10.1001/archopht.116.5.589; Freeman WR, 1998, ARCH OPHTHALMOL-CHIC, V116, P455, DOI 10.1001/archopht.116.4.455; FREYLER H, 1986, KLIN MONATSBL AUGENH, V189, P144, DOI 10.1055/s-2008-1050772; Fukushima I, 1997, AM J OPHTHALMOL, V124, P473, DOI 10.1016/S0002-9394(14)70863-3; HIDAYAT AA, 1985, OPHTHALMOLOGY, V92, P512; Iida Tomohiro, 2011, Nippon Ganka Gakkai Zasshi, V115, P238; Imamura Y, 2009, RETINA-J RET VIT DIS, V29, P1469, DOI 10.1097/IAE.0b013e3181be0a83; Kaur C, 2008, PROG RETIN EYE RES, V27, P622, DOI 10.1016/j.preteyeres.2008.09.003; KAWAGISHI T, 1995, DIABETES CARE, V18, P1544, DOI 10.2337/diacare.18.12.1544; Koleva-Georgieva D, 2009, GRAEF ARCH CLIN EXP, V247, P1461, DOI 10.1007/s00417-009-1124-4; LEGARTH J, 1990, J ULTRAS MED, V9, P449; Li SQ, 2011, MOL VIS, V17, P3566; Lutty GA, 1997, AM J PATHOL, V151, P707; Lutty GA, 2005, VISION RES, V45, P3504, DOI 10.1016/j.visres.2005.08.022; MCLEOD DS, 1994, INVEST OPHTH VIS SCI, V35, P3799; Mori F, 2003, JPN J OPHTHALMOL, V47, P621, DOI 10.1016/j.jjo.2003.08.004; Muir ER, 2012, INVEST OPHTH VIS SCI, V53, P6488, DOI 10.1167/iovs.12-9758; Neubauer AS, 2008, ACTA OPHTHALMOL, V86, P177, DOI 10.1111/j.1600-0420.2007.01029.x; Nishiyama Y, 2001, RETINA-J RET VIT DIS, V21, P237, DOI 10.1097/00006982-200106000-00007; Sakurai M, 2002, CURR EYE RES, V24, P139, DOI 10.1076/ceyr.24.2.139.8163; Salinas-Navarro M, 2009, VISION RES, V49, P637, DOI 10.1016/j.visres.2009.01.010; SARACCO JB, 1982, J FR OPHTALMOL, V5, P231; Shiragami C, 2002, GRAEF ARCH CLIN EXP, V240, P436, DOI 10.1007/s00417-002-0451-5; Shiraki Kunihiko, 1999, International Ophthalmology, V23, P105, DOI 10.1023/A:1026571327117; Sogawa K, 2012, AM J OPHTHALMOL, V153, P1129, DOI 10.1016/j.ajo.2011.11.005; STROMAN GA, 1995, ARCH OPHTHALMOL-CHIC, V113, P168, DOI 10.1001/archopht.1995.01100020050027; TAMAKI Y, 1993, JPN J OPHTHALMOL, V37, P385; Toma HS, 2010, MICROVASC RES, V80, P295, DOI 10.1016/j.mvr.2010.05.011; Xu J, 2013, OPHTHALMOLOGY, V120, P2023, DOI 10.1016/j.ophtha.2013.03.009	30	56	58	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83494	10.1371/journal.pone.0083494	http://dx.doi.org/10.1371/journal.pone.0083494			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349522	Green Submitted, Green Published, gold			2022-12-27	WOS:000328734200093
J	Madeira, A; dos Santos, SC; Santos, PM; Coutinho, CP; Tyrrell, J; McClean, S; Callaghan, M; Sa-Correia, I				Madeira, Andreia; dos Santos, Sandra C.; Santos, Pedro M.; Coutinho, Carla P.; Tyrrell, Jean; McClean, Siobhan; Callaghan, Maire; Sa-Correia, Isabel			Proteomic Profiling of Burkholderia cenocepacia Clonal Isolates with Different Virulence Potential Retrieved from a Cystic Fibrosis Patient during Chronic Lung Infection	PLOS ONE			English	Article							EPITHELIAL-CELL LINE; PSEUDOMONAS-AERUGINOSA; CEPACIA COMPLEX; GENE-EXPRESSION; IDENTIFICATION; PROTEIN; BIOSYNTHESIS; ELECTROPHORESIS; RESISTANCE; STRAINS	Respiratory infections with Burkholderia cepacia complex (Bcc) bacteria in cystic fibrosis (CF) are associated with a worse prognosis and increased risk of death. In this work, we assessed the virulence potential of three B. cenocepacia clonal isolates obtained from a CF patient between the onset of infection (isolate IST439) and before death with cepacia syndrome 3.5 years later (isolate IST4113 followed by IST4134), based on their ability to invade epithelial cells and compromise epithelial monolayer integrity. The two clonal isolates retrieved during late-stage disease were significantly more virulent than IST439. Proteomic profiling by 2-D DIGE of the last isolate recovered before the patient's death, IST4134, and clonal isolate IST439, was performed and compared with a prior analysis of IST4113 vs. IST439. The cytoplasmic and membrane-associated enriched fractions were examined and 52 proteins were found to be similarly altered in the two last isolates compared with IST439. These proteins are involved in metabolic functions, nucleotide synthesis, translation and protein folding, cell envelope biogenesis and iron homeostasis. Results are suggestive of the important role played by metabolic reprogramming in the virulence potential and persistence of B. cenocepacia, in particular regarding bacterial adaptation to microaerophilic conditions. Also, the content of the virulence determinant AidA was higher in the last 2 isolates. Significant levels of siderophores were found to be secreted by the three clonal isolates in an iron-depleted environment, but the two late isolates were more tolerant to low iron concentrations than IST439, consistent with the relative abundance of proteins involved in iron uptake.	[Madeira, Andreia; dos Santos, Sandra C.; Santos, Pedro M.; Coutinho, Carla P.; Sa-Correia, Isabel] Univ Lisbon, Inst Biotechnol & Bioengn, Ctr Biol & Chem Engn, Dept Bioengn,Inst Super Tecn, P-1699 Lisbon, Portugal; [Tyrrell, Jean; McClean, Siobhan; Callaghan, Maire] ITT Dublin, Ctr Microbial Host Interact, Dept Sci, Dublin, Ireland	Universidade de Lisboa; Instituto Superior Tecnico; Technological University Dublin	Sa-Correia, I (corresponding author), Univ Lisbon, Inst Biotechnol & Bioengn, Ctr Biol & Chem Engn, Dept Bioengn,Inst Super Tecn, P-1699 Lisbon, Portugal.	isacorreia@tecnico.ulisboa.pt	Coutinho, Carla P. S./F-5975-2010; Santos, Pedro M/B-5908-2009; Santos, Sandra dos/F-7889-2014; Sá-Correia, Isabel/H-4054-2011; Coutinho, Carla P./F-7867-2014	Coutinho, Carla P. S./0000-0002-9222-0339; Santos, Pedro M/0000-0003-3234-4265; Santos, Sandra dos/0000-0002-2906-1021; Sá-Correia, Isabel/0000-0003-2208-5183; Coutinho, Carla P./0000-0002-9222-0339; McClean, Siobhan/0000-0001-6389-2542	FEDER; FCT - Fundacao para a Ciencia e a Tecnologia [PEst-OE/EQB/LA0023/2011, SFRH/BD/37012/2007, SFRH/BPD/75483/2010, SFRH/BPD/81220/2011]	FEDER(European Commission); FCT - Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology)	This work was supported by FEDER and FCT - Fundacao para a Ciencia e a Tecnologia (contract PEst-OE/EQB/LA0023/2011_ research line: Systems and Synthetic Biology; PhD grant to A. M. - SFRH/BD/37012/2007, and PD grants to S. S. - SFRH/BPD/75483/2010 and C. C. - SFRH/BPD/81220/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnoli K, 2006, J BACTERIOL, V188, P3631, DOI 10.1128/JB.188.10.3631-3644.2006; Bevivino A, 2012, MICROBIOL-SGM, V158, P1325, DOI 10.1099/mic.0.056986-0; Burns JL, 2007, BUKHOLDERIA MOL MICR; Cieri MV, 2002, INFECT IMMUN, V70, P1081, DOI 10.1128/IAI.70.3.1081-1086.2002; Coutinho CP, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00012; Coutinho CP, 2011, INFECT IMMUN, V79, P2950, DOI 10.1128/IAI.01366-10; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Cunha MV, 2004, J CLIN MICROBIOL, V42, P3052, DOI 10.1128/JCM.42.7.3052-3058.2004; Cunha MV, 2003, J CLIN MICROBIOL, V41, P4113, DOI 10.1128/JCM.41.9.4113-4120.2003; Doring G, 2011, FEMS MICROBIOL REV, V35, P124, DOI 10.1111/j.1574-6976.2010.00237.x; Doyle SM, 2007, P NATL ACAD SCI USA, V104, P11138, DOI 10.1073/pnas.0703980104; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Drevinek P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-121; Ehrhardt C, 2006, CELL TISSUE RES, V323, P405, DOI 10.1007/s00441-005-0062-7; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; Huber B, 2004, INFECT IMMUN, V72, P7220, DOI 10.1128/IAI.72.12.7220-7230.2004; Hunt TA, 2004, INFECT IMMUN, V72, P4010, DOI 10.1128/IAI.72.7.4010-4022.2004; Kohler S, 2002, INFECT IMMUN, V70, P1631, DOI 10.1128/IAI.70.3.1631-1634.2002; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Loutet SA, 2010, INFECT IMMUN, V78, P4088, DOI 10.1128/IAI.00212-10; Madeira A, 2011, PROTEOMICS, V11, P1313, DOI 10.1002/pmic.201000457; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Mahenthiralingam E, 2002, J MED MICROBIOL, V51, P533, DOI 10.1099/0022-1317-51-7-533; Malinverni JC, 2006, MOL MICROBIOL, V61, P151, DOI 10.1111/j.1365-2958.2006.05211.x; Mariappan V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026518; Mariappan V, 2010, VACCINE, V28, P1318, DOI 10.1016/j.vaccine.2009.11.027; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Mira NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028831; Molloy MP, 2000, ANAL BIOCHEM, V280, P1, DOI 10.1006/abio.2000.4514; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nouwens AS, 2000, ELECTROPHORESIS, V21, P3797, DOI 10.1002/1522-2683(200011)21:17<3797::AID-ELPS3797>3.0.CO;2-P; Oberhardt MA, 2010, J BACTERIOL, V192, P5534, DOI 10.1128/JB.00900-10; Pier GB, 1997, P NATL ACAD SCI USA, V94, P12088, DOI 10.1073/pnas.94.22.12088; PIETTE J, 1984, P NATL ACAD SCI-BIOL, V81, P4134, DOI 10.1073/pnas.81.13.4134; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Richau JA, 2000, J CLIN MICROBIOL, V38, P1651, DOI 10.1128/JCM.38.4.1651-1655.2000; Samant S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040037; Sass AM, 2013, ISME J; Sass A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-373; Schwager S, 2013, INFECT IMMUN, V81, P143, DOI 10.1128/IAI.00768-12; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Tolman JS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-63; Traverse CC, 2013, P NATL ACAD SCI USA, V110, pE250, DOI 10.1073/pnas.1207025110; Uehlinger S, 2009, INFECT IMMUN, V77, P4102, DOI 10.1128/IAI.00398-09; Vellasamy KM, 2012, J ANAL SCI TECHNOL, V3, P72; Wilkins MR, 1999, METH MOL B, V112, P531; Wilkins MR, 1998, ELECTROPHORESIS, V19, P1501, DOI 10.1002/elps.1150190847; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524; Wongtrakoongate P, 2007, MOL CELL PROBE, V21, P81, DOI 10.1016/j.mcp.2006.08.006; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313	54	20	20	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83065	10.1371/journal.pone.0083065	http://dx.doi.org/10.1371/journal.pone.0083065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349432	Green Published, gold			2022-12-27	WOS:000328734200062
J	Pinchas, M; Baranes, D				Pinchas, Monika; Baranes, Danny			Dendritic Branch Intersections Are Structurally Regulated Targets for Efficient Axonal Wiring and Synaptic Clustering	PLOS ONE			English	Article							PLASTICITY; CONVERGENCE; NEURONS; MORPHOMETRY; MECHANISMS; MORPHOLOGY; RECEPTOR; CULTURE; STORAGE; IMPACT	Synaptic clustering on dendritic branches enhances plasticity, input integration and neuronal firing. However, the mechanisms guiding axons to cluster synapses at appropriate sites along dendritic branches are poorly understood. We searched for such a mechanism by investigating the structural overlap between dendritic branches and axons in a simplified model of neuronal networks - the hippocampal cell culture. Using newly developed software, we converted images of meshes of overlapping axonal and dendrites into topological maps of intersections, enabling quantitative study of overlapping neuritic geometry at the resolution of single dendritic branch-to-branch and axon-to-branch crossings. Among dendro-dendritic crossing configurations, it was revealed that the orientations through which dendritic branches cross is a regulated attribute. While crossing angle distribution among branches thinner than 1 mu m appeared to be random, dendritic branches 1 mu m or wider showed a preference for crossing each other at angle ranges of either 50 degrees-70 degrees or 80 degrees-90 degrees. It was then found that the dendro-dendritic crossings themselves, as well as their selective angles, both affected the path of axonal growth. Axons displayed 4 fold stronger tendency to traverse within 2 mu m of dendro-dendritic intersections than at farther distances, probably to minimize wiring length. Moreover, almost 70% of the 50 degrees-70 degrees dendro-denritic crossings were traversed by axons from the obtuse angle's zone, whereas only 15% traversed through the acute angle's zone. By contrast, axons showed no orientation restriction when traversing 80 degrees-90 degrees crossings. When such traverse behavior was repeated by many axons, they converged in the vicinity of dendro-dendritic intersections, thereby clustering their synaptic connections. Thus, the vicinity of dendritic branch-to-branch crossings appears to be a regulated structure used by axons as a target for efficient wiring and as a preferred site for synaptic clustering. This synaptic clustering mechanism may enhance synaptic co-activity and plasticity.	[Pinchas, Monika] Ariel Univ, Dept Elect & Elect Engn, Ariel, Israel; [Baranes, Danny] Ariel Univ, Dept Mol Biol, Ariel, Israel	Ariel University; Ariel University	Baranes, D (corresponding author), Ariel Univ, Dept Mol Biol, Ariel, Israel.	dannyb@ariel.ac.il		Pinchas, Monika/0000-0003-1839-9489				Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Ascoli GA, 2001, PHILOS T R SOC B, V356, P1131, DOI 10.1098/rstb.2001.0905; Ascoli GA, 2009, J COMP NEUROL, V515, P677, DOI 10.1002/cne.22082; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; Blinder P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003782; Branco T, 2010, CURR OPIN NEUROBIOL, V20, P494, DOI 10.1016/j.conb.2010.07.009; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Campbell RE, 2009, P NATL ACAD SCI USA, V106, P10835, DOI 10.1073/pnas.0903463106; Chesler AT, 2007, P NATL ACAD SCI USA, V104, P1039, DOI 10.1073/pnas.0609215104; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Corty MM, 2009, DEVELOPMENT, V136, P1049, DOI 10.1242/dev.014423; Cove J, 2006, CEREB CORTEX, V16, P83, DOI 10.1093/cercor/bhi086; Cove J, 2009, BRAIN RES, V1251, P30, DOI 10.1016/j.brainres.2008.11.028; Cuntz H, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-21; Ferrante M, 2013, J NEUROSCI, V33, P2156, DOI 10.1523/JNEUROSCI.3495-12.2013; Flasque N, 2001, MED IMAGE ANAL, V5, P173, DOI 10.1016/S1361-8415(01)00038-X; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Govindarajan A, 2011, NEURON, V69, P132, DOI 10.1016/j.neuron.2010.12.008; Grueber WB, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001750; Harvey CD, 2008, SCIENCE, V321, P136, DOI 10.1126/science.1159675; Harvey CD, 2007, NATURE, V450, P1195, DOI 10.1038/nature06416; He W, 2003, MICROSC MICROANAL, V9, P296, DOI 10.1017/S143192760303040X; Hill SL, 2012, P NATL ACAD SCI USA, V109, pE2885, DOI 10.1073/pnas.1202128109; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Klassen MP, 2013, CURR BIOL, V23, pR687, DOI 10.1016/j.cub.2013.07.036; Kleindienst T, 2011, NEURON, V72, P1012, DOI 10.1016/j.neuron.2011.10.015; LaBerge D, 2006, CONSCIOUS COGN, V15, P235, DOI 10.1016/j.concog.2005.09.007; Larkum ME, 2008, CURR OPIN NEUROBIOL, V18, P321, DOI 10.1016/j.conb.2008.08.013; Lattemann M, 2007, NEURON, V53, P169, DOI 10.1016/j.neuron.2006.12.024; Li WC, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-17; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Makino H, 2011, NEURON, V72, P1001, DOI 10.1016/j.neuron.2011.09.036; McBride TJ, 2008, J NEUROSCI, V28, P6960, DOI 10.1523/JNEUROSCI.1352-08.2008; Mehta MR, 2004, TRENDS NEUROSCI, V27, P69, DOI 10.1016/j.tins.2003.12.004; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Metzger F, 2010, Curr Mol Pharmacol, V3, P1; Oztokatli H, 2012, FASEB J, V26, P617, DOI 10.1096/fj.11-192450; Packer AM, 2013, CEREB CORTEX, V23, P2790, DOI 10.1093/cercor/bhs210; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; RAYPORT S, 1992, J NEUROSCI, V12, P4264; Reese BE, 2011, DEV NEUROBIOL, DOI [10.1002/dneu.20903, DOI 10.1002/DNEU.20903.[]; Schmitt S, 2004, NEUROIMAGE, V23, P1283, DOI 10.1016/j.neuroimage.2004.06.047; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Uylings HBM, 2002, NETWORK-COMP NEURAL, V13, P397, DOI 10.1088/0954-898X/13/3/309; Weaver CM, 2004, NEURAL COMPUT, V16, P1353, DOI 10.1162/089976604323057425; Wink O, 2004, IEEE T MED IMAGING, V23, P130, DOI 10.1109/TMI.2003.819920; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	51	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82083	10.1371/journal.pone.0082083	http://dx.doi.org/10.1371/journal.pone.0082083			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349189	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200025
J	Franko, A; Baris, OR; Bergschneider, E; von Toerne, C; Hauck, SM; Aichler, M; Walch, AK; Wurst, W; Wiesner, RJ; Johnston, ICD; de Angelis, MH				Franko, Andras; Baris, Olivier R.; Bergschneider, Eva; von Toerne, Christine; Hauck, Stefanie M.; Aichler, Michaela; Walch, Axel K.; Wurst, Wolfgang; Wiesner, Rudolf J.; Johnston, Ian C. D.; de Angelis, Martin Hrabe			Efficient Isolation of Pure and Functional Mitochondria from Mouse Tissues Using Automated Tissue Disruption and Enrichment with Anti-TOM22 Magnetic Beads	PLOS ONE			English	Article							DENSITY GRADIENT CENTRIFUGATION; SKELETAL-MUSCLE; LABEL-FREE; RAT-BRAIN; DYSFUNCTION; MICE; HOMEOSTASIS; DISORDERS; ORGANELLE; NEURONS	To better understand molecular mechanisms regulating changes in metabolism, as observed e. g. in diabetes or neuronal disorders, the function of mitochondria needs to be precisely determined. The usual isolation methods such as differential centrifugation result in isolates of highly variable quality and quantity. To fulfill the need of a reproducible isolation method from solid tissues, which is suitable to handle parallel samples simultaneously, we developed a protocol based on anti-TOM22 (translocase of outer mitochondrial membrane 22 homolog) antibody-coupled magnetic beads. To measure oxygen consumption rate in isolated mitochondria from various mouse tissues, a traditional Clark electrode and the high-throughput XF Extracellular Flux Analyzer were used. Furthermore, Western blots, transmission electron microscopic and proteomic studies were performed to analyze the purity and integrity of the mitochondrial preparations. Mitochondrial fractions isolated from liver, brain and skeletal muscle by anti-TOM22 magnetic beads showed oxygen consumption capacities comparable to previously reported values and little contamination with other organelles. The purity and quality of isolated mitochondria using anti-TOM22 magnetic beads was compared to traditional differential centrifugation protocol in liver and the results indicated an obvious advantage of the magnetic beads method compared to the traditional differential centrifugation technique.	[Franko, Andras; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, Neuherberg, Germany; [Baris, Olivier R.; Wiesner, Rudolf J.] Univ Cologne, Fac Med, Inst Vegetat Physiol, D-50931 Cologne, Germany; [Bergschneider, Eva; Johnston, Ian C. D.] Miltenyi Biotec GmbH, Bergisch Gladbach, Germany; [von Toerne, Christine; Hauck, Stefanie M.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Prot Sci, Neuherberg, Germany; [Aichler, Michaela; Walch, Axel K.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Pathol, Res Unit Analyt Pathol, Neuherberg, Germany; [Wurst, Wolfgang] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Dev Genet, Neuherberg, Germany; [Wurst, Wolfgang] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Wurst, Wolfgang] Tech Univ Munich, Helmholtz Zentrum Munchen, Lehrstuhl Entwicklungsgenet, Neuherberg, Germany; [Wurst, Wolfgang] DZNE, Bonn, Germany; [Wiesner, Rudolf J.] Univ Cologne, Ctr Mol Med CMMC, D-50931 Cologne, Germany; [Wiesner, Rudolf J.] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [de Angelis, Martin Hrabe] Tech Univ Munich, WZW Ctr Life & Food Sci Weihenstephan, Chair Expt Genet, Freising Weihenstephan, Germany; [de Angelis, Martin Hrabe] German Ctr Diabet Res DZD, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Cologne; Miltenyi Biotec; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Cologne; University of Cologne; Technical University of Munich	de Angelis, MH (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, Neuherberg, Germany.	hrabe@helmholtz-muenchen.de	Franko, Andras/B-7222-2013; Aichler, Michaela/B-5356-2014; Hauck, Stefanie/B-3300-2013; Baris, Olivier R/L-3463-2016; von Toerne, Christine/B-2233-2013; Walch, Axel/B-4554-2012; de Angelis, Martin Hrabe/F-5531-2012	Franko, Andras/0000-0003-0485-5439; Hauck, Stefanie/0000-0002-1630-6827; Baris, Olivier R/0000-0003-0974-6856; von Toerne, Christine/0000-0002-4132-4322; Walch, Axel/0000-0001-5578-4023; de Angelis, Martin Hrabe/0000-0002-7898-2353; Wurst, Wolfgang/0000-0003-4422-7410	Bundesministerium fur Bildung und Forschung (BMBF) within the project NGFNPlus [01GS08174, 01GS0858]; Helmholtz Association (Helmholtz Alliance "MentalHealth in an Ageing Society") [HelMA HA215]	Bundesministerium fur Bildung und Forschung (BMBF) within the project NGFNPlus; Helmholtz Association (Helmholtz Alliance "MentalHealth in an Ageing Society")	This work was supported by the Bundesministerium fur Bildung und Forschung (BMBF) within the project NGFNPlus under the grant No. 01GS08174 (NGFN Parkinson) and 01GS0858 (DIGTOP) and the Helmholtz Association (Helmholtz Alliance "MentalHealth in an Ageing Society") (HelMA HA215) to W. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Brosch M, 2009, J PROTEOME RES, V8, P3176, DOI 10.1021/pr800982s; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Fernandez-Vizarra E, 2010, MITOCHONDRION, V10, P253, DOI 10.1016/j.mito.2009.12.148; Franko A, 2012, J MOL MED, V90, P1145, DOI 10.1007/s00109-012-0887-y; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Gross VS, 2011, ANAL BIOCHEM, V418, P213, DOI 10.1016/j.ab.2011.07.017; Hartwig S, 2009, PROTEOMICS, V9, P3209, DOI 10.1002/pmic.200800344; Hauck SM, 2010, MOL CELL PROTEOMICS, V9, P2292, DOI 10.1074/mcp.M110.001073; Horan MP, 2012, J GERONTOL A-BIOL, V67, P1022, DOI 10.1093/gerona/glr263; Hornig-Do HT, 2009, ANAL BIOCHEM, V389, P1, DOI 10.1016/j.ab.2009.02.040; Kristian T, 2006, J NEUROSCI METH, V152, P136, DOI 10.1016/j.jneumeth.2005.08.018; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; Merl J, 2012, PROTEOMICS, V12, P1902, DOI 10.1002/pmic.201100549; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024; Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038; Rasmussen HN, 1997, ANAL BIOCHEM, V252, P153, DOI 10.1006/abio.1997.2304; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Szendroedi J, 2007, PLOS MED, V4, P858, DOI 10.1371/journal.pmed.0040154; Szendroedi J, 2009, HEPATOLOGY, V50, P1079, DOI 10.1002/hep.23093; Vafai SB, 2012, NATURE, V491, P374, DOI 10.1038/nature11707; von Toerne C, 2013, J PROTEOME RES, V12, P1331, DOI 10.1021/pr3009836; Zsurka G, 2010, J BIOENERG BIOMEMBR, V42, P443, DOI 10.1007/s10863-010-9314-7	27	58	60	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82392	10.1371/journal.pone.0082392	http://dx.doi.org/10.1371/journal.pone.0082392			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349272	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800061
J	Hatteland, BA; Haukeland, S; Roth, S; Brurberg, MB; Vaughan, IP; Symondson, WOC				Hatteland, Bjorn Arild; Haukeland, Solveig; Roth, Steffen; Brurberg, May Bente; Vaughan, Ian P.; Symondson, William O. C.			Spatiotemporal Analysis of Predation by Carabid Beetles (Carabidae) on Nematode Infected and Uninfected Slugs in the Field	PLOS ONE			English	Article							PHASMARHABDITIS-HERMAPHRODITA; BIOLOGICAL-CONTROL; ARION-LUSITANICUS; PTEROSTICHUS-MELANARIUS; DEROCERAS-RETICULATUM; INTRAGUILD PREDATION; ARTHROPOD PREDATORS; MOLECULAR ANALYSIS; PREY CHOICE; COLEOPTERA	The dynamics of predation on parasites within prey has received relatively little attention despite the profound effects this is likely to have on both prey and parasite numbers and hence on biological control programmes where parasites are employed. The nematode Phasmarhabditis hermaphrodita is a commercially available biological agent against slugs. Predation on these slugs may, at the same time, result in intraguild predation on slug-parasitic nematodes. This study describes, for the first time, predation by carabid beetles on slugs and their nematode parasites on both spatial and temporal scales, using PCR-based methods. The highest nematode infection levels were found in the slugs Deroceras reticulatum and Arion silvaticus. Numbers of infected slugs decreased over time and no infected slugs were found four months after nematode application. The density of the most abundant slug, the invasive Arion vulgaris, was positively related to the activity-density of the carabid beetle, Carabus nemoralis. Predation on slugs was density and size related, with highest predation levels also on A. vulgaris. Predation on A. vulgaris decreased significantly in summer when these slugs were larger than one gram. Predation by C. nemoralis on slugs was opportunistic, without any preferences for specific species. Intraguild predation on the nematodes was low, suggesting that carabid beetles such as C. nemoralis probably do not have a significant impact on the success of biological control using P. hermaphrodita.	[Hatteland, Bjorn Arild; Roth, Steffen] Univ Bergen, Dept Biol, Bergen, Norway; [Hatteland, Bjorn Arild] Bioforsk Norwegian Inst Agr & Environm Res, Ullensvang, Norway; [Haukeland, Solveig; Brurberg, May Bente] Bioforsk Norwegian Inst Agr & Environm Res, Plant Hlth & Plant Protect Div, As, Norway; [Roth, Steffen] Univ Bergen, Univ Museum Bergen, Bergen, Norway; [Vaughan, Ian P.; Symondson, William O. C.] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	University of Bergen; Bioforsk; Bioforsk; University of Bergen; Cardiff University	Hatteland, BA (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	bjorn.hatteland@bio.uib.no	Vaughan, Ian/A-4782-2010; Brurberg, May Bente/HFI-2864-2022	Vaughan, Ian/0000-0002-7263-3822; Symondson, William/0000-0002-3343-4679	University of Bergen; Bioforsk; Research Council of Norway [803194]	University of Bergen; Bioforsk(Bioforsk); Research Council of Norway(Research Council of Norway)	This study was partly funded by the University of Bergen, Bioforsk and the Research Council of Norway (project number 803194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti N, 2003, MOL ECOL, V12, P3467, DOI 10.1046/j.1365-294X.2003.02014.x; Armsworth CG, 2005, ANIM BEHAV, V69, P805, DOI 10.1016/j.anbehav.2004.07.009; Ayre K, 1995, THESIS U NEWCASTLE U; Baddeley A, 2008, ANAL SPATIAL POINT; Bell JR, 2010, ECOGRAPHY, V33, P64, DOI 10.1111/j.1600-0587.2009.06046.x; Bivand RS, 2008, USE R, P1; Bohan DA, 2000, J ANIM ECOL, V69, P367, DOI 10.1046/j.1365-2656.2000.00399.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Chen Y, 2000, MOL ECOL, V9, P1887, DOI 10.1046/j.1365-294x.2000.01100.x; Davey JS, 2013, J APPL ECOL, V50, P271, DOI 10.1111/1365-2664.12008; DIGWEED SC, 1994, COLEOPTS BULL, V48, P361; Dodds CJ, 1997, J MOLLUS STUD, V63, P297, DOI 10.1093/mollus/63.2.297; Dolmen D, 1997, REPORT VITENSKAPSMUS, P4; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Ester A, 2005, NEMATODES AS BIOCONTROL AGENTS, P431, DOI 10.1079/9780851990170.0431; EVANS MEG, 1985, J ZOOL, V206, P113, DOI 10.1111/j.1469-7998.1985.tb05640.x; Foltan P, 2009, BEHAV PROCESS, V80, P76, DOI 10.1016/j.beproc.2008.09.012; Frank T, 1998, AGR ECOSYST ENVIRON, V67, P67, DOI 10.1016/S0167-8809(97)00108-4; Glen DM, 1997, AGRO FOOD IND HI TEC, V8, P23; Grimm B, 2001, ACTA OECOL, V22, P219, DOI 10.1016/S1146-609X(01)01115-8; Grimm B, 2000, J MOLLUS STUD, V66, P125, DOI 10.1093/mollus/66.1.125; Harper GL, 2005, MOL ECOL, V14, P819, DOI [10.1111/j.1365-294X.2005.02442.x, 10.1111/j.1365-294x.2005.02442.x]; Hatteland BA, 2011, B ENTOMOL RES, V101, P675, DOI 10.1017/S0007485311000034; Hatteland BA, 2010, B ENTOMOL RES, V100, P559, DOI 10.1017/S0007485309990629; HENGEVELD R, 1980, NETH J ZOOL, V30, P555, DOI 10.1163/002829679X00188; HENGEVELD R, 1980, NETH J ZOOL, V30, P564, DOI 10.1163/002829679X00197; Holland J. M., 2002, AGROECOLOGY CARABID; Holland JM, 1999, B ENTOMOL RES, V89, P499, DOI 10.1017/S0007485399000656; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; King RA, 2010, MOL ECOL, V19, P1721, DOI 10.1111/j.1365-294X.2010.04602.x; Kinnunen H, 1999, THESIS U HELSINKI HE; Lang A, 2001, J APPL ENTOMOL, V125, P53, DOI 10.1046/j.1439-0418.2001.00511.x; Larochelle A., 1990, FOOD CARABID BEETLES; Lindroth C.H., 1985, Fauna Entomologica Scandinavica, V15, P1; Lovei GL, 1996, ANNU REV ENTOMOL, V41, P231, DOI 10.1146/annurev.en.41.010196.001311; MacMillan K, 2006, INT J PARASITOL, V36, P1453, DOI 10.1016/j.ijpara.2006.08.005; Mengert H., 1953, Zeitschrift fuer Morphologie und Oekologie der Tiere, V41, P311, DOI 10.1007/BF00407426; Paill W, 2004, J MOLLUS STUD, V70, P203, DOI 10.1093/mollus/70.2.203; Paill W, 2002, SOIL BIOL BIOCHEM, V34, P1333, DOI 10.1016/S0038-0717(02)00077-9; Paill Wolfgang, 2000, P221; PERRY JN, 1995, J ANIM ECOL, V64, P303, DOI 10.2307/5892; Pianezzola E, 2013, B ENTOMOL RES, V103, P225, DOI 10.1017/S0007485312000569; Powell W, 1995, ACT JUTLAND, V70, P235; R Core Team, 2018, R LANG ENV STAT COMP; Rae R, 2007, PEST MANAG SCI, V63, P1153, DOI 10.1002/ps.1424; Read DS, 2006, MOL ECOL, V15, P1963, DOI 10.1111/j.1365-294X.2006.02901.x; Read DS, 2007, THESIS CARDIFF U; ROSENHEIM JA, 1995, BIOL CONTROL, V5, P303, DOI 10.1006/bcon.1995.1038; Seinhorst JW, 1962, NEMATOLOGICA, V1, P242; Sheppard SK, 2005, FUNCT ECOL, V19, P751, DOI 10.1111/j.1365-2435.2005.01041.x; Speiser B, 2002, CROP PROT, V21, P389, DOI 10.1016/S0261-2194(01)00120-X; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Symondson WOC, 2002, ECOLOGY, V83, P137, DOI 10.2307/2680127; Symondson WOC, 1996, J APPL ECOL, V33, P741, DOI 10.2307/2404945; Tan L, 2001, J PARASITOL, V87, P1349, DOI 10.1645/0022-3395(2001)087[1349:IBOTRN]2.0.CO;2; Traugott M, 2008, B ENTOMOL RES, V98, P223, DOI 10.1017/S0007485308005968; Wilson MJ, 2005, NEMATODES AS BIOCONTROL AGENTS, P421, DOI 10.1079/9780851990170.0421; WILSON MJ, 1993, BIOCONTROL SCI TECHN, V3, P503, DOI 10.1080/09583159309355306; WILSON MJ, 1995, BIOCONTROL SCI TECHN, V5, P233, DOI 10.1080/09583159550039954; WILSON MJ, 1994, ANN APPL BIOL, V125, P377, DOI 10.1111/j.1744-7348.1994.tb04978.x; WILSON MJ, 1995, FUND APPL NEMATOL, V18, P159; Wilson MJ, 1995, FUNDAM APPL NEMATOL, V18	62	8	9	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82142	10.1371/journal.pone.0082142	http://dx.doi.org/10.1371/journal.pone.0082142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349202	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800039
J	Liu, ZP; Chen, TL; Ma, LC; Zhao, ZG; Zhao, PX; Nan, ZB; Wang, YR				Liu, Zhipeng; Chen, Tianlong; Ma, Lichao; Zhao, Zhiguang; Zhao, Patrick X.; Nan, Zhibiao; Wang, Yanrong			Global Transcriptome Sequencing Using the Illumina Platform and the Development of EST-SSR Markers in Autotetraploid Alfalfa	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LINKAGE MAP; ROOT TRANSCRIPTOME; MEDICAGO-TRUNCATULA; ALUMINUM TOLERANCE; RNA-SEQ; GENE; IDENTIFICATION; ANNOTATION; MICROSATELLITE	Background: Alfalfa is the most widely cultivated forage legume and one of the most economically valuable crops in the world. The large size and complexity of the alfalfa genome has delayed the development of genomic resources for alfalfa research. Second-generation Illumina transcriptome sequencing is an efficient method for generating a global transcriptome sequence dataset for gene discovery and molecular marker development in alfalfa. Methodology/Principal Findings: More than 28 million sequencing reads (5.64 Gb of clean nucleotides) were generated by Illumina paired-end sequencing from 15 different alfalfa tissue samples. In total, 40,433 unigenes with an average length of 803 bp were obtained by de novo assembly. Based on a sequence similarity search of known proteins, a total of 36,684 (90.73%) unigenes were annotated. In addition, 1,649 potential EST-SSRs were identified as potential molecular markers from unigenes with lengths exceeding 1 kb. A total of 100 pairs of PCR primers were randomly selected to validate the assembly quality and develop EST-SSR markers from genomic DNA. Of these primer pairs, 82 were able to amplify sequences in initial screening tests, and 27 primer pairs successfully amplified DNA fragments and detected significant amounts of polymorphism among 10 alfalfa accessions. Conclusions/Significance: The present study provided global sequence data for autotetraploid alfalfa and demonstrates the Illumina platform is a fast and effective approach to EST-SSR markers development in alfalfa. The use of these transcriptome datasets will serve as a valuable public information platform to accelerate studies of the alfalfa genome.	[Liu, Zhipeng; Chen, Tianlong; Ma, Lichao; Nan, Zhibiao; Wang, Yanrong] Lanzhou Univ, Sch Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China; [Zhao, Zhiguang] Lanzhou Univ, Key Lab Cell Activ & Stress Adaptat, Minist Educ, Sch Life Sci, Lanzhou 730000, Peoples R China; [Zhao, Patrick X.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA	Lanzhou University; Lanzhou University; Noble Research Institute	Liu, ZP (corresponding author), Lanzhou Univ, Sch Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou 730000, Peoples R China.	lzp@lzu.edu.cn; yrwang@lzu.edu.cn	liu, zhipeng/HCI-3638-2022; Zhao, ZG/AAQ-5362-2021; Liu, Zhipeng/E-1532-2014	Zhao, ZG/0000-0001-8462-0933; Zhao, Patrick Xuechun/0000-0002-3460-5564; Liu, Zhipeng/0000-0001-7687-8256	National Basic Research Program of China [2014CB138704]; National Natural Science Foundation of China [31072072, 31272492]; Fundamental Research Funds for the Central Universities [lzujbky-2012-94]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Basic Research Program of China (2014CB138704), the National Natural Science Foundation of China (31072072 and 31272492), and the Fundamental Research Funds for the Central Universities (lzujbky-2012-94). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouton J, 2007, EUPHYTICA, V154, P263, DOI 10.1007/s10681-006-9220-6; Brouwer DJ, 2000, CROP SCI, V40, P1387, DOI 10.2135/cropsci2000.4051387x; Brouwer DJ, 1999, THEOR APPL GENET, V99, P1194, DOI 10.1007/s001220051324; BRUMMER EC, 1993, THEOR APPL GENET, V86, P329, DOI 10.1007/BF00222097; BRUMMER EC, 1991, THEOR APPL GENET, V83, P89, DOI 10.1007/BF00229230; Chen WH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-320; Choi HK, 2004, P NATL ACAD SCI USA, V101, P15289, DOI 10.1073/pnas.0402251101; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004; Doyle J. J., 1987, PHYTOCHEM B, P11; Eujayl I, 2004, THEOR APPL GENET, V108, P414, DOI 10.1007/s00122-003-1450-6; Giannattasio S, 1997, MOL CELL PROBE, V11, P81, DOI 10.1006/mcpr.1996.0082; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Han YH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-350; He C, 2009, CROP SCI, V49, P2176, DOI 10.2135/cropsci2007.04.0456; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Julier Bernadette, 2003, BMC Plant Biology, V3, P9, DOI 10.1186/1471-2229-3-9; Kalo P, 2000, THEOR APPL GENET, V100, P641, DOI 10.1007/s001220051335; Khu DM, 2013, CROP SCI, V53, P148, DOI 10.2135/cropsci2012.03.0181; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li XH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-568; Li XH, 2011, THEOR APPL GENET, V123, P667, DOI 10.1007/s00122-011-1617-5; Li XH, 2011, PLANT GENOME-US, V4, P24, DOI 10.3835/plantgenome2010.09.0022; Liu MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046766; Liu ZP, 2007, GENET MOL BIOL, V30, P385, DOI 10.1590/S1415-47572007000300015; Liu ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057338; LULIN H, 2012, PLOS ONE, V0007; Maureira-Butler IJ, 2007, THEOR APPL GENET, V115, P859, DOI 10.1007/s00122-007-0614-1; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Musial JM, 2007, THEOR APPL GENET, V114, P1427, DOI 10.1007/s00122-007-0528-y; Musial JM, 2005, AUST J AGR RES, V56, P333, DOI 10.1071/AR04317; Myhre S, 2006, BIOINFORMATICS, V22, P2020, DOI 10.1093/bioinformatics/btl334; Narasimhamoorthy B, 2007, THEOR APPL GENET, V114, P901, DOI 10.1007/s00122-006-0488-7; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Postnikova OA, 2013, PLANT CELL PHYSIOL, V54, P1041, DOI 10.1093/pcp/pct056; Robins JG, 2008, CROP SCI, V48, P1780, DOI 10.2135/cropsci2008.02.0101; Robins JG, 2007, CROP SCI, V47, P1, DOI 10.2135/cropsci2005.11.0401; Robins JG, 2007, CROP SCI, V47, P11, DOI 10.2135/cropsci2006.07.0447; Sledge MK, 2005, THEOR APPL GENET, V111, P980, DOI 10.1007/s00122-005-0038-8; Sun C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-262; Tavoletti S, 1996, J HERED, V87, P167, DOI 10.1093/oxfordjournals.jhered.a022978; Van Puyvelde K, 2010, MOL ECOL RESOUR, V10, P331, DOI 10.1111/j.1755-0998.2009.02748.x; Varshney RK, 2005, PLANT SCI, V168, P195, DOI 10.1016/j.plantsci.2004.08.001; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang Z, 2013, MOL BIOL REP, V40, P3291, DOI 10.1007/s11033-012-2404-3; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yeh FC, 1999, POPGENE VER 1 32 MIC; Zhou CE, 2011, PLANT PHYSIOL, V157, P1483, DOI 10.1104/pp.111.185140	49	51	64	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83549	10.1371/journal.pone.0083549	http://dx.doi.org/10.1371/journal.pone.0083549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349529	Green Published, gold			2022-12-27	WOS:000328731800126
J	Maubaret, CG; Salpea, KD; Romanoski, CE; Folkersen, L; Cooper, JA; Stephanou, C; Li, KW; Palmen, J; Hamsten, A; Neil, A; Stephens, JW; Lusis, AJ; Eriksson, P; Talmud, PJ; Humphries, SE				Maubaret, Cecilia G.; Salpea, Klelia D.; Romanoski, Casey E.; Folkersen, Lasse; Cooper, Jackie A.; Stephanou, Coralea; Li, Ka Wah; Palmen, Jutta; Hamsten, Anders; Neil, Andrew; Stephens, Jeffrey W.; Lusis, Aldons J.; Eriksson, Per; Talmud, Philippa J.; Humphries, Steve E.		Simon Broome Res Grp; EARSII Consortium	Association of TERC and OBFC1 Haplotypes with Mean Leukocyte Telomere Length and Risk for Coronary Heart Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MYOCARDIAL-INFARCTION; FUNCTIONAL POLYMORPHISM; CARDIOVASCULAR-DISEASE; INTERLEUKIN-6 GENE; COMMON VARIANTS; LOCI; ATHEROSCLEROSIS; SUSCEPTIBILITY; GENOTYPE	Objective: To replicate the associations of leukocyte telomere length (LTL) with variants at four loci and to investigate their associations with coronary heart disease (CHD) and type II diabetes (T2D), in order to examine possible causal effects of telomere maintenance machinery on disease aetiology. Methods: Four SNPs at three loci BICD1 (rs2630578 G gamma C), 18q12.2 (rs2162440 G gamma T), and OBFC1 (rs10786775 C gamma G, rs11591710 A gamma C) were genotyped in four studies comprised of 2353 subjects out of which 1148 had CHD and 566 T2D. Three SNPs (rs12696304 C gamma G, rs10936601G>T and rs16847897 G gamma C) at the TERC locus were genotyped in these four studies, in addition to an offspring study of 765 healthy students. For all samples, LTL had been measured using a real-time PCR-based method. Results: Only one SNP was associated with a significant effect on LTL, with the minor allele G of OBFC1 rs10786775 SNP being associated with longer LTL (beta=0.029, P=0.04). No SNPs were significantly associated with CHD or T2D. For OBFC1 the haplotype carrying both rare alleles (rs10786775G and rs11591710C, haplotype frequency 0.089) was associated with lower CHD prevalence (OR: 0.77; 95% CI: 0.61-0.97; P=0.03). The TERC haplotype GTC (rs12696304G, rs10936601T and rs16847897C, haplotype frequency 0.210) was associated with lower risk for both CHD (OR: 0.86; 95% CI: 0.75-0.99; P=0.04) and T2D (OR: 0.74; 95% CI: 0.61-0.91; P= 0.004), with no effect on LTL. Only the last association remained after adjusting for multiple testing. Conclusion: Of reported associations, only that between the OBFC1 rs10786775 SNP and LTL was confirmed, although our study has a limited power to detect modest effects. A 2-SNP OBFC1 haplotype was associated with higher risk of CHD, and a 3-SNP TERC haplotype was associated with both higher risk of CHD and T2D. Further work is required to confirm these results and explore the mechanisms of these effects.	[Maubaret, Cecilia G.; Salpea, Klelia D.; Cooper, Jackie A.; Stephanou, Coralea; Li, Ka Wah; Palmen, Jutta; Talmud, Philippa J.; Humphries, Steve E.] UCL, BHF Labs, London, England; [Maubaret, Cecilia G.] Univ Bordeaux Segalen, ISPED, INSERM, U897, Bordeaux, France; [Salpea, Klelia D.] Biomed Sci Res Ctr Alexander Fleming, Inst Mol Biol & Genet, Athens, Greece; [Romanoski, Casey E.; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Folkersen, Lasse; Eriksson, Per] Karolinska Inst, Atherosclerosis Res Unit, Ctr Mol Med, Dept Med, Stockholm, Sweden; [Hamsten, Anders] Karolinska Inst, Atherosclerosis Res Unit, Dept Med Solna, Stockholm, Sweden; [Neil, Andrew] Univ Oxford, Div Publ Hlth & Primary Hlth Care, Oxford, England; [Stephens, Jeffrey W.] Swansea Univ, Diabet Res Grp, Sch Med, Swansea, W Glam, Wales	University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Alexander Fleming Biomedical Sciences Research Center; University of California System; University of California Los Angeles; Karolinska Institutet; Karolinska Institutet; University of Oxford; Swansea University	Maubaret, CG (corresponding author), UCL, BHF Labs, London, England.	cecilia.maubaret@isped.u-bordeaux2.fr	Visvikis-Siest, Sophie/H-2324-2014; Gudnason, Vilmundur/K-6885-2015; MASANA, LUIS/M-7002-2019	Visvikis-Siest, Sophie/0000-0001-8104-8425; Gudnason, Vilmundur/0000-0001-5696-0084; MASANA, LUIS/0000-0002-0789-4954; Ribalta, Josep/0000-0002-8879-4719; Romanoski, Casey/0000-0002-0149-225X; Eriksson, Per/0000-0002-5635-2692; Folkersen, Lasse/0000-0003-0708-9530; MARGAGLIONE, MAURIZIO/0000-0001-5627-9221; Stephanou, Coralea/0000-0002-2546-6478; Talmud, Philippa/0000-0002-5560-1933; Humphries, Stephen E/0000-0002-8221-6547	Binks Trust; British Heart Foundation [RG2008/08, FS/06/053]; European Commission [BMH4-CT96-0272]; Swedish Medical Research Council; Swedish Heart-Lung Foundation [20090541]; INSERM; Universite de la Mediterranee (INSERM U626); Foundation pour la RechercheMedicale (FRM); ProgrammeHospitalier de Recherche Clinique (PHRC); Diabetes UK; Coronary Thrombosis Trust; Swedish Research Council [12660]; British Heart Foundation [RG/08/008/25291] Funding Source: researchfish	Binks Trust; British Heart Foundation(British Heart Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de la Mediterranee (INSERM U626); Foundation pour la RechercheMedicale (FRM)(Fondation pour la Recherche Medicale); ProgrammeHospitalier de Recherche Clinique (PHRC); Diabetes UK(Diabetes UK); Coronary Thrombosis Trust; Swedish Research Council(Swedish Research CouncilEuropean Commission); British Heart Foundation(British Heart Foundation)	CM was supported by the Binks Trust. SEH, JC and KDS are funded by the British Heart Foundation RG2008/08 and FS/06/053. The HIFMECH study was supported by the European Commission (BMH4-CT96-0272), the Swedish Medical Research Council, the Swedish Heart-Lung Foundation, INSERM, and Universite de la Mediterranee (INSERM U626), Foundation pour la RechercheMedicale (FRM) and ProgrammeHospitalier de Recherche Clinique (PHRC 1996). UDACS was supported by Diabetes UK and EDSC by the Coronary Thrombosis Trust. Gene expression analysis was supported by the Swedish Research Council [12660]; the Swedish Heart-Lung Foundation [20090541], and a donation by Fredrik Lundberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Aviv A, 2009, HYPERTENSION, V53, P590, DOI 10.1161/HYPERTENSIONAHA.109.128926; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brull DJ, 2001, ARTERIOSCL THROM VAS, V21, P1458, DOI 10.1161/hq0901.094280; Calado Rodrigo T, 2009, Hematology Am Soc Hematol Educ Program, P338, DOI 10.1182/asheducation-2009.1.338; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; Cox LS, 2010, REJUV RES, V13, P749, DOI 10.1089/rej.2010.1140; De Meyer T, 2011, AGEING RES REV, V10, P297, DOI 10.1016/j.arr.2010.11.001; ELBERS CC, 2013, J GERONTOL A-BIOL, P46336; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Flores I, 2010, FEBS LETT, V584, P3826, DOI 10.1016/j.febslet.2010.07.042; Folkersen L, 2010, CIRC-CARDIOVASC GENE, V3, P365, DOI 10.1161/CIRCGENETICS.110.948935; Giraud-Panis MJ, 2010, MOL CELL, V39, P665, DOI 10.1016/j.molcel.2010.08.024; Herbig U, 2006, MECH AGEING DEV, V127, P16, DOI 10.1016/j.mad.2005.09.002; Humphries SE, 2006, J MOL MED, V84, P1005, DOI 10.1007/s00109-006-0108-7; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Jeanclos E, 2000, HYPERTENSION, V36, P195, DOI 10.1161/01.HYP.36.2.195; Jones AM, 2012, GUT, V61, P248, DOI 10.1136/gut.2011.239772; Juhan-Vague I, 2002, ARTERIOSCL THROM VAS, V22, P867, DOI 10.1161/01.ATV.0000015445.22243.F4; Kaszubowska L, 2008, J PHYSIOL PHARMACOL, V59, P169; Kuhlow D, 2010, AGING-US, V2, P650, DOI 10.18632/aging.100200; Kuznetsova T, 2010, AM J EPIDEMIOL, V172, P440, DOI 10.1093/aje/kwq142; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Mangino M, 2009, J MED GENET, V46, P451, DOI 10.1136/jmg.2008.064956; Mangino M, 2008, HUM MOL GENET, V17, P2518, DOI 10.1093/hmg/ddn152; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Matsubara Y, 2006, BIOCHEM BIOPH RES CO, V341, P128, DOI 10.1016/j.bbrc.2005.12.163; Matsubara Y, 2006, BIOCHEM BIOPH RES CO, V348, P669, DOI 10.1016/j.bbrc.2006.07.103; Maubaret CG, 2010, J MOL MED, V88, P785, DOI 10.1007/s00109-010-0624-3; Neil HAW, 2004, HEART, V90, P1431, DOI 10.1136/hrt.2003.022764; Neil HAW, 2000, BRIT MED J, V321, P148, DOI 10.1136/bmj.321.7254.148; Nordfjall K, 2007, BIOCHEM BIOPH RES CO, V358, P215, DOI 10.1016/j.bbrc.2007.04.099; Oh H, 2001, P NATL ACAD SCI USA, V98, P10308, DOI 10.1073/pnas.191169098; Pooley KA, 2010, CANCER EPIDEM BIOMAR, V19, P1862, DOI 10.1158/1055-9965.EPI-10-0281; Portugal RD, 2008, BIOSYSTEMS, V91, P262, DOI 10.1016/j.biosystems.2007.10.003; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Salpea KD, 2008, J MOL MED, V86, P815, DOI 10.1007/s00109-008-0347-x; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Shen Q, 2011, EUR J HUM GENET, V19, P721, DOI 10.1038/ejhg.2011.4; Stephens JW, 2004, MOL GENET METAB, V82, P180, DOI 10.1016/j.ymgme.2004.04.001; Vasan RS, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S2; Wan M, 2009, J BIOL CHEM, V284, P26725, DOI 10.1074/jbc.M109.021105; Weischer M, 2012, ARTERIOSCL THROM VAS, V32, P822, DOI 10.1161/ATVBAHA.111.237271; Wilson WRW, 2008, EUR HEART J, V29, P2689, DOI 10.1093/eurheartj/ehn386; Wong LSM, 2009, CARDIOVASC RES, V81, P244, DOI 10.1093/cvr/cvn337; Zee RYL, 2011, ATHEROSCLEROSIS, V218, P144, DOI 10.1016/j.atherosclerosis.2011.05.013; Zee RYL, 2011, CLIN CHIM ACTA, V412, P199, DOI 10.1016/j.cca.2010.10.003; 1994, INT J EPIDEMIOL, V23, P465, DOI DOI 10.1093/IJE/23.3.465.PUBMED:7960370	55	37	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83122	10.1371/journal.pone.0083122	http://dx.doi.org/10.1371/journal.pone.0083122			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349443	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800095
J	Maza-Villalobos, S; Poorter, L; Martinez-Ramos, M				Maza-Villalobos, Susana; Poorter, Lourens; Martinez-Ramos, Miguel			Effects of ENSO and Temporal Rainfall Variation on the Dynamics of Successional Communities in Old-Field Succession of a Tropical Dry Forest	PLOS ONE			English	Article							SOIL SEED BANKS; DECIDUOUS FOREST; EL-NINO; CARBOHYDRATE STORAGE; SEVERE DROUGHT; WOODY-PLANTS; LAND-USE; TREE; GROWTH; CLIMATE	The effects of temporal variation of rainfall on secondary succession of tropical dry ecosystems are poorly understood. We studied effects of inter-seasonal and inter-year rainfall variation on the dynamics of regenerative successional communities of a tropical dry forest in Mexico. We emphasized the effects caused by the severe El Nino Southern Oscillation (ENSO) occurred in 2005. We established permanent plots in sites representing a chronosequence of Pasture (abandoned pastures, 0-1 years fallow age), Early (3-5), Intermediate (8-12), and Old-Growth Forest categories (n = 3 per category). In total, 8210 shrubs and trees 10 to 100-cm height were identified, measured, and monitored over four years. Rates of plant recruitment, growth and mortality, and gain and loss of species were quantified per season (dry vs. rainy), year, and successional category, considering whole communities and separating seedlings from sprouts and shrubs from trees. Community rates changed with rainfall variation without almost any effect of successional stage. Mortality and species loss rates peaked during the ENSO year and the following year; however, after two rainy years mortality peaked in the rainy season. Such changes could result from the severe drought in the ENSO year, and of the outbreak of biotic agents during the following rainy years. Growth, recruitment and species gain rates were higher in the rainy season but they were significantly reduced after the ENSO year. Seedlings exhibited higher recruitment and mortality rate than sprouts, and shrubs showed higher recruitment than trees. ENSO strongly impacted both the dynamics and trajectory of succession, creating transient fluctuations in the abundance and species richness of the communities. Overall, there was a net decline in plant and species density in most successional stages along the years. Therefore, strong drought events have critical consequences for regeneration dynamics, delaying the successional process and modifying the resilience of these systems.	[Maza-Villalobos, Susana] Univ Nacl Autonoma Mexico, Escuela Nacl Estudios Super, Unidad Morelia, Morelia, Michoacan, Mexico; [Poorter, Lourens] Wageningen Univ, Forest Ecol & Forest Management Grp, NL-6700 AP Wageningen, Netherlands; [Maza-Villalobos, Susana; Martinez-Ramos, Miguel] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico	Universidad Nacional Autonoma de Mexico; Wageningen University & Research; Universidad Nacional Autonoma de Mexico	Maza-Villalobos, S (corresponding author), Univ Nacl Autonoma Mexico, Escuela Nacl Estudios Super, Unidad Morelia, Morelia, Michoacan, Mexico.	smazavm@gmail.com	Méndez, Susana Dra. Maza Villalobos/F-5316-2014; Poorter, Lourens/AAL-1709-2021; Martínez-Ramos, Miguel/G-8451-2019	Méndez, Susana Dra. Maza Villalobos/0000-0002-0123-9756; Martínez-Ramos, Miguel/0000-0002-7785-1917; Poorter, Lourens/0000-0003-1391-4875	DGAPA-UNAM; SEMARNAT-CONACyT [2002-C01-0597]; Division Of Environmental Biology [1147429] Funding Source: National Science Foundation	DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); SEMARNAT-CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a DGAPA-UNAM Posdoctoral Fellowship (to SMV) and by SEMARNAT-CONACyT 2002-C01-0597 grant (to MMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, PLANT STRATEGIES VEG; Bellingham PJ, 2000, OIKOS, V89, P409, DOI 10.1034/j.1600-0706.2000.890224.x; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Brando PM, 2008, PHILOS T R SOC B, V363, P1839, DOI 10.1098/rstb.2007.0031; Brienen RJW, 2010, GLOBAL CHANGE BIOL, V16, P2001, DOI 10.1111/j.1365-2486.2009.02059.x; BROWN S, 1982, BIOTROPICA, V14, P161, DOI 10.2307/2388024; Bryla DR, 1997, PLANT CELL ENVIRON, V20, P1411, DOI 10.1046/j.1365-3040.1997.d01-36.x; Bullock S.H., 1995, SEASONALLY DRY TROPI; BULLOCK SH, 1990, BIOTROPICA, V22, P22, DOI 10.2307/2388716; Burgos A, 2004, AGR ECOSYST ENVIRON, V104, P475, DOI 10.1016/j.agee.2004.01.038; Busby PE, 2010, BIOTROPICA, V42, P80, DOI 10.1111/j.1744-7429.2009.00540.x; Camargo-Ricalde SL, 2004, J ARID ENVIRON, V58, P423, DOI 10.1016/j.jaridenv.2003.11.007; Castro-Diez P, 1998, OECOLOGIA, V116, P57, DOI 10.1007/s004420050563; Chapin III FS, 2009, ANNU REV ECOL SYST, V21, P423; Chazdon RL, 2005, ECOLOGY, V86, P1808, DOI 10.1890/04-0572; Chazdon RL, 2007, PHILOS T R SOC B, V362, P273, DOI 10.1098/rstb.2006.1990; CLARK DA, 1994, J ECOL, V82, P865, DOI 10.2307/2261450; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; COLEY PD, 1980, NATURE, V284, P545, DOI 10.1038/284545a0; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Cuevas-Reyes P, 2006, BIOTROPICA, V38, P107, DOI 10.1111/j.1744-7429.2006.00115.x; Curran LM, 1999, SCIENCE, V286, P2184, DOI 10.1126/science.286.5447.2184; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; DENSLOW JS, 1980, BIOTROPICA, V12, P47, DOI 10.2307/2388156; Dirzo R, 2011, SEASONALLY DRY TOPIC; DUNN JP, 1990, OECOLOGIA, V83, P458, DOI 10.1007/BF00317195; Duran E., 2002, HIST NATURAL CHAMELA, P443; Feeley KJ, 2011, ECOLOGY, V92, P871, DOI 10.1890/10-0724.1; FILIP V, 1995, BIOTROPICA, V27, P78, DOI 10.2307/2388905; FINEGAN B, 1984, NATURE, V312, P109, DOI 10.1038/312109a0; Garcia-Oliva F., 1991, Geografiska Annaler, Series A, Physical Geography, V73A, P179; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grombone-Guaratini MT, 2002, J TROP ECOL, V18, P759, DOI 10.1017/S0266467402002493; Hill JP, 2010, BIOTROPICA, V42, P271, DOI 10.1111/j.1744-7429.2009.00623.x; Horn H. S., 1974, Annual Review of Ecology and Systematics, V5, P25, DOI 10.1146/annurev.es.05.110174.000325; JANZEN DH, 1981, BIOTROPICA, V13, P271, DOI 10.2307/2387805; Kelly CK, 2002, NATURE, V417, P437, DOI 10.1038/417437a; Kennard DK, 2002, FOREST ECOL MANAG, V162, P197, DOI 10.1016/S0378-1127(01)00506-0; Khurana E, 2001, ENVIRON CONSERV, V28, P39, DOI 10.1017/S0376892901000042; Kozlowski T.T., 1997, GROWTH CONTROL WOODY, P352; Kozlowski TT, 2002, BOT REV, V68, P270, DOI 10.1663/0006-8101(2002)068[0270:AAAROW]2.0.CO;2; KUMAR N, 1994, AGROFOREST SYST, V25, P217, DOI 10.1007/BF00707461; Latt CR, 2000, AGROFOREST SYST, V50, P27, DOI 10.1023/A:1006427221557; Lebrija-Trejos E, 2008, BIOTROPICA, V40, P422, DOI 10.1111/j.1744-7429.2008.00398.x; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; LEE DW, 1989, J TROP ECOL, V5, P65, DOI 10.1017/S0266467400003229; LIEBERMAN D, 1992, J VEG SCI, V3, P375, DOI 10.2307/3235763; Lott E. J, 2002, HIST NATURAL CHAMELA, P99; Marod D, 2002, PLANT ECOL, V161, P41, DOI 10.1023/A:1020372401313; Martinez-Ramos M, 2009, J ECOL, V97, P1050, DOI 10.1111/j.1365-2745.2009.01531.x; Martins AM, 2007, ECOL ENG, V31, P165, DOI 10.1016/j.ecoleng.2007.05.008; Maza-Villalobos S, 2011, BIOTROPICA, V43, P666, DOI 10.1111/j.1744-7429.2011.00755.x; Maza-Villalobos S, 2011, J TROP ECOL, V27, P35, DOI 10.1017/S0266467410000611; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McLaren KP, 2003, FOREST ECOL MANAG, V183, P61, DOI 10.1016/S0378-1127(03)00100-2; Miller PM, 1998, BIOTROPICA, V30, P538, DOI 10.1111/j.1744-7429.1998.tb00094.x; MILTON K, 1979, AM NAT, V114, P362, DOI 10.1086/283485; Nakagawa M, 2000, J TROP ECOL, V16, P355, DOI 10.1017/S0266467400001450; Newell EA, 2002, OECOLOGIA, V131, P333, DOI 10.1007/s00442-002-0888-6; Phillips OL, 1998, SCIENCE, V282, P439, DOI 10.1126/science.282.5388.439; Pineda-Garcia F, 2013, PLANT CELL ENVIRON, V36, P405, DOI 10.1111/j.1365-3040.2012.02582.x; Poorter L, 2008, BIOTROPICA, V40, P321, DOI 10.1111/j.1744-7429.2007.00380.x; Poorter L, 2010, ECOLOGY, V91, P2613, DOI 10.1890/09-0862.1; REICH PB, 1984, J ECOL, V72, P61, DOI 10.2307/2260006; Rolim SG, 2005, OECOLOGIA, V142, P238, DOI 10.1007/s00442-004-1717-x; Romero-Duque LP, 2007, FOREST ECOL MANAG, V253, P38, DOI 10.1016/j.foreco.2007.07.002; Schumacher E, 2008, BIOTROPICA, V40, P543, DOI 10.1111/j.1744-7429.2008.00407.x; Sen Z, 2009, ENVIRON GEOL, V57, P321, DOI 10.1007/s00254-008-1569-5; Slot M, 2007, BIOTROPICA, V39, P683, DOI 10.1111/j.1744-7429.2007.00328.x; Suresh HS, 2010, FOREST ECOL MANAG, V259, P762, DOI 10.1016/j.foreco.2009.09.025; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Veenendaal EM, 1996, J ECOL, V84, P83, DOI 10.2307/2261702; Vieira DLM, 2006, RESTOR ECOL, V14, P11, DOI 10.1111/j.1526-100X.2006.00100.x; WARGO PM, 1972, PHYTOPATHOLOGY, V62, P1278, DOI 10.1094/Phyto-62-1278; Wright SJ, 2006, ECOL LETT, V9, P35, DOI 10.1111/j.1461-0248.2005.00851.x; Wright SJ, 1999, ECOLOGY, V80, P1632, DOI 10.2307/176552; Yu Y, 2008, PLANT ECOL, V197, P1, DOI 10.1007/s11258-007-9355-0	77	34	35	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82040	10.1371/journal.pone.0082040	http://dx.doi.org/10.1371/journal.pone.0082040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349179	Green Submitted, gold, Green Published			2022-12-27	WOS:000328731800032
J	Tanaka, T; Kai, S; Matsuyama, T; Adachi, T; Fukuda, K; Hirota, K				Tanaka, Tomoharu; Kai, Shinichi; Matsuyama, Tomonori; Adachi, Takehiko; Fukuda, Kazuhiko; Hirota, Kiichi			General Anesthetics Inhibit LPS-Induced IL-1 beta Expression in Glial Cells	PLOS ONE			English	Article							INDUCED SICKNESS BEHAVIOR; NF-KAPPA-B; INFLAMMATORY RESPONSES; IMMUNE-RESPONSES; CNS INFLAMMATION; ACTIVATION; INNATE; MECHANISMS; MICROGLIA; GLUCOCORTICOIDS	Background: Glial cells, including microglia and astrocytes, are considered the primary source of proinflammatory cytokines in the brain. Immune insults stimulate glial cells to secrete proinflammatory cytokines that modulate the acute systemic response, which includes fever, behavioral changes, and hypothalamic-pituitary-adrenal (HPA) axis activation. We investigated the effect of general anesthetics on proinflammatory cytokine expression in the primary cultured glial cells, the microglial cell line BV-2, the astrocytic cell line A-1 and mouse brain. Methodology/Principal Findings: Primary cultured glial cells were exposed to lipopolysaccharide (LPS) in combination with general anesthetics including isoflurane, pentobarbital, midazolam, ketamine, and propofol. Following this treatment, we examined glial cell expression of the proinflammatory cytokines interleukin (IL)-1 beta, IL-6, and tumor necrosis factor-alpha (TNF-alpha). LPS-induced expression of IL-1 beta mRNA and protein were significantly reduced by all the anesthetics tested, whereas IL-6 and TNF-alpha mRNA expression was unaffected. The anesthetics suppressed LPS-induced extracellular signal-regulated kinase 1/2 (ERK 1/2) phosphorylation, but did not affect nuclear factor-kappaB and activator protein-1 activation. The same effect was observed with BV-2, but not with A-1 cells. In the mouse experiments, LPS was injected intraperitoneally, and isoflurane suppressed IL-1 beta in the brain and adrenocorticotropic hormone in plasma, but not IL-1 beta in plasma. Conclusions/Significance: Taken together, our results indicate that general anesthetics inhibit LPS-induced IL-1 beta upregulation in glial cells, particularly microglia, and affects HPA axis participation in the stress response.	[Tanaka, Tomoharu; Kai, Shinichi; Matsuyama, Tomonori; Fukuda, Kazuhiko] Kyoto Univ Hosp, Dept Anesthesia, Kyoto 606, Japan; [Adachi, Takehiko] Kitano Hosp, Dept Anesthesia, Tazuke Kofukai Med Res Inst, Osaka, Japan; [Hirota, Kiichi] Kansai Med Univ, Dept Anesthesiol, Hirakata, Osaka, Japan	Kyoto University; Kitano Hospital; Kansai Medical University	Tanaka, T (corresponding author), Kyoto Univ Hosp, Dept Anesthesia, Kyoto 606, Japan.	665tana@kuhp.kyoto-u.ac.jp	Hirota, Kiichi/E-9181-2010	Hirota, Kiichi/0000-0003-1110-0827	Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan [25462432]; Grants-in-Aid for Scientific Research [24592322, 24659695] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding provided by a Grant-in-Aid for Scientific Research(C) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan. Research Project Number: 25462432, https://kaken.nii.ac.jp/d/p/25462432.en.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmone-Cat MA, 2003, J NEUROCHEM, V84, P413, DOI 10.1046/j.1471-4159.2003.01562.x; Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Anforth HR, 1998, EUR CYTOKINE NETW, V9, P279; ASOU H, 1989, NEUROSCI RES, V6, P369, DOI 10.1016/0168-0102(89)90030-8; Beishuizen A, 2003, J ENDOTOXIN RES, V9, P3, DOI 10.1179/096805103125001298; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Chakravarty S, 2005, J NEUROSCI, V25, P1788, DOI 10.1523/jneurosci.4268-04.2005; Chang Y, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/705379; Dai JN, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021891, 10.1371/journal.pone.0028903]; Dantzer R, 2004, EUR J PHARMACOL, V500, P399, DOI 10.1016/j.ejphar.2004.07.040; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Ek M, 1998, J NEUROSCI, V18, P9471; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2010, EUR J IMMUNOL, V40, P611, DOI 10.1002/eji.200940180; Franchimont D, 2004, ANN NY ACAD SCI, V1024, P124, DOI 10.1196/annals.1321.009; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Gadek-Michalska A, 2010, PHARMACOL REP, V62, P969, DOI 10.1016/s1734-1140(10)70359-5; Garwood CJ, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.50; Glezer I, 2004, NEUROSCIENTIST, V10, P538, DOI 10.1177/1073858404263494; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Hanamsagar R, 2012, TRENDS IMMUNOL, V33, P333, DOI 10.1016/j.it.2012.03.001; Hanamsagar R, 2011, J NEUROCHEM, V119, P736, DOI 10.1111/j.1471-4159.2011.07481.x; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; James ML, 2012, ANESTHESIOLOGY, V116, P1299, DOI 10.1097/ALN.0b013e318253a02a; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Kress HG, 1997, ANAESTHESIST, V46, pS8, DOI 10.1007/PL00002469; Lee HT, 2007, AM J PHYSIOL-RENAL, V293, pF713, DOI 10.1152/ajprenal.00161.2007; Lenczowski MJP, 1999, AM J PHYSIOL-REG I, V276, pR652, DOI 10.1152/ajpregu.1999.276.3.R652; Lu XF, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-46; Matsuda T, 2005, AM J TRANSPLANT, V5, P484, DOI 10.1046/j.1600-6143.2004.00716.x; McCusker RH, 2013, J EXP BIOL, V216, P84, DOI 10.1242/jeb.073411; Murray CL, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-50; Nakajima K, 1998, Hum Cell, V11, P141; Nishi K, 2008, ANTIOXID REDOX SIGN, V10, P983, DOI 10.1089/ars.2007.1825; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Park HY, 2012, TOXICOL APPL PHARM, V262, P177, DOI 10.1016/j.taap.2012.04.034; Peng M, 2013, J SURG RES, V179, pE219, DOI 10.1016/j.jss.2012.05.047; Rivest S, 2009, NAT REV IMMUNOL, V9, P429, DOI 10.1038/nri2565; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Sato Y, 2005, ANESTHESIOLOGY, V102, P557, DOI 10.1097/00000542-200503000-00013; Saura J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-26; Shibakawa YS, 2005, BRIT J ANAESTH, V95, P803, DOI 10.1093/bja/aei256; Spooren A, 2010, CELL SIGNAL, V22, P871, DOI 10.1016/j.cellsig.2010.01.018; Strom T, 2010, LANCET, V375, P475, DOI 10.1016/S0140-6736(09)62072-9; Tanaka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029378; Thompson WL, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-35; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002	48	51	52	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82930	10.1371/journal.pone.0082930	http://dx.doi.org/10.1371/journal.pone.0082930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349401	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300113
J	Felix, K; Hauck, O; Fritz, S; Hinz, U; Schnolzer, M; Kempf, T; Warnken, U; Michel, A; Pawlita, M; Werner, J				Felix, Klaus; Hauck, Oliver; Fritz, Stefan; Hinz, Ulf; Schnoelzer, Martina; Kempf, Tore; Warnken, Uwe; Michel, Angelika; Pawlita, Michael; Werner, Jens			Serum Protein Signatures Differentiating Autoimmune Pancreatitis versus Pancreatic Cancer	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; PRIMARY SCLEROSING CHOLANGITIS; CARBONIC-ANHYDRASE; MOLECULAR MIMICRY; FEATURES; EXPRESSION; TYPE-1; IDENTIFICATION; DIAGNOSIS; SEROLOGY	Autoimmune pancreatitis (AIP) is defined by characteristic lymphoplasmacytic infiltrate, ductal strictures and a pancreatic enlargement or mass that can mimic pancreatic cancer (PaCa). The distinction between this benign disease and pancreatic cancer can be challenging. However, an accurate diagnosis may pre-empt the misdiagnosis of cancer, allowing the appropriate medical treatment of AIP and, consequently, decreasing the number of unnecessary pancreatic resections. Mass spectrometry (MS) and two-dimensional differential gel electrophoresis (2D-DIGE) have been applied to analyse serum protein alterations associated with AIP and PaCa, and to identify protein signatures indicative of the diseases. Patients' sera were immunodepleted from the 20 most prominent serum proteins prior to further 2D-DIGE and image analysis. The identity of the most-discriminatory proteins detected, was performed by MS and ELISAs were applied to confirm their expression. Serum profiling data analysis with 2D-DIGE revealed 39 protein peaks able to discriminate between AIP and PaCa. Proteins were purified and further analysed by MALDI-TOF-MS. Peptide mass fingerprinting led to identification of eleven proteins. Among them apolipoprotein A-I, apolipoprotein A-II, transthyretin, and tetranectin were identified and found as 3.0-, 3.5-, 2-, and 1.6-fold decreased in PaCa sera, respectively, whereas haptoglobin and apolipoprotein E were found to be 3.8- and 1.6-fold elevated in PaCa sera. With the exception of haptoglobin the ELISA results of the identified proteins confirmed the 2D-DIGE image analysis characteristics. Integration of the identified serum proteins as AIP markers may have considerable potential to provide additional information for the diagnosis of AIP to choose the appropriate treatment.	[Felix, Klaus; Hauck, Oliver; Fritz, Stefan; Hinz, Ulf; Werner, Jens] Heidelberg Univ, Dept Gen Surg, Heidelberg, Germany; [Schnoelzer, Martina; Kempf, Tore; Warnken, Uwe] German Canc Res Ctr, Heidelberg, Germany; [Michel, Angelika; Pawlita, Michael] German Canc Res Ctr, Infect & Canc Program, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Felix, K (corresponding author), Heidelberg Univ, Dept Gen Surg, INF 110, Heidelberg, Germany.	klaus.felix@med.uni-heidelberg.de	Waterboer, Tim/G-1252-2010	Pawlita, Michael/0000-0002-4720-8306	German Research Foundation (DFG) [FE 940/2-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported in part by the German Research Foundation (DFG) FE 940/2-1. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chari ST, 2006, CLIN GASTROENTEROL H, V4, P1010, DOI 10.1016/j.cgh.2006.05.017; Chari ST, 2010, PANCREAS, V39, P549, DOI 10.1097/MPA.0b013e3181e4d9e5; Chen J, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0583-y; Detlefsen S, 2012, PANCREATOLOGY, V12, P276, DOI 10.1016/j.pan.2012.03.055; Ehmann M, 2007, PANCREAS, V34, P205, DOI 10.1097/01.mpa.0000250128.57026.b2; Fakelman Frederik, 2010, Archives of Physiology and Biochemistry, V116, P208, DOI 10.3109/13813455.2010.510891; Finkelberg DL, 2006, NEW ENGL J MED, V355, P2670, DOI 10.1056/NEJMra061200; Frulloni L, 2009, NEW ENGL J MED, V361, P2135, DOI 10.1056/NEJMoa0903068; Fung ET, 2005, INT J CANCER, V115, P783, DOI 10.1002/ijc.20928; Ghazale A, 2007, AM J GASTROENTEROL, V102, P1646, DOI 10.1111/j.1572-0241.2007.01264.x; Gobom J, 2001, ANAL CHEM, V73, P434, DOI 10.1021/ac001241s; Guarneri F, 2005, J CELL MOL MED, V9, P741, DOI 10.1111/j.1582-4934.2005.tb00506.x; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Hartmann D, 2007, PANCREAS, V35, P334, DOI 10.1097/mpa.0b013e3180cac723; Honda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046908; Horiuchi A, 2002, GASTROINTEST ENDOSC, V55, P494, DOI 10.1067/mge.2002.122653; Irie H, 1998, AM J ROENTGENOL, V170, P1323, DOI 10.2214/ajr.170.5.9574610; Jesnowski R, 2010, PANCREATOLOGY, V10, P462, DOI 10.1159/000264677; Kamisawa T, 2008, PANCREAS, V37, pE62, DOI 10.1097/MPA.0b013e318175e3a0; Kamisawa T, 2013, GUT, V62, P1373, DOI 10.1136/gutjnl-2012-304224; Kloppel G, 2007, J GASTROENTEROL, V42, P28, DOI 10.1007/s00535-007-2048-6; Kountouras J, 2005, AM J GASTROENTEROL, V100, P249, DOI 10.1111/j.1572-0241.2005.41277_4.x; Kountouras J, 2005, PANCREAS, V30, P192, DOI 10.1097/01.mpa.0000151576.91790.f8; Kountouras J, 2007, GASTROENTEROLOGY, V133, P368, DOI 10.1053/j.gastro.2007.05.044; Law R, 2009, CLEV CLIN J MED, V76, P607, DOI 10.3949/ccjm.76a.09039; Michel A, 2009, HELICOBACTER, V14, P525, DOI 10.1111/j.1523-5378.2009.00723.x; Nakazawa T, 2004, GASTROINTEST ENDOSC, V60, P937, DOI 10.1016/S0016-5107(04)02229-1; Nishino T, 2007, J GASTROENTEROL, V42, P550, DOI 10.1007/s00535-007-2038-8; Okazaki K, 2002, GUT, V51, P1, DOI 10.1136/gut.51.1.1; Procacci C, 2001, PANCREATOLOGY, V1, P246, DOI 10.1159/000055819; Qian WJ, 2005, PROTEOMICS, V5, P572, DOI 10.1002/pmic.200400942; Raina A, 2008, ARCH PATHOL LAB MED, V132, P48, DOI 10.1043/1543-2165(2008)132[48:SIGFLI]2.0.CO;2; Rieder G, 2007, WORLD J GASTROENTERO, V13, P3939, DOI 10.3748/wjg.v13.i29.3939; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Uchida K, 2002, LAB INVEST, V82, P411, DOI 10.1038/labinvest.3780435; vanGulik TM, 1997, GASTROINTEST ENDOSC, V46, P417, DOI 10.1016/S0016-5107(97)70034-8; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022; Waterboer T, 2006, J IMMUNOL METHODS, V309, P200, DOI 10.1016/j.jim.2005.11.008; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wiley JW, 2009, DIABETES, V58, P520, DOI 10.2337/db08-1655; Yu KH, 2005, J PROTEOME RES, V4, P1742, DOI 10.1021/pr050174l; Zamboni G, 2004, VIRCHOWS ARCH, V445, P552, DOI 10.1007/s00428-004-1140-z; Zen Y, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-82	44	18	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82755	10.1371/journal.pone.0082755	http://dx.doi.org/10.1371/journal.pone.0082755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349355	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200097
J	Nawroj, AI; Swensen, JP; Dollar, AM				Nawroj, Ahsan I.; Swensen, John P.; Dollar, Aaron M.			Electrically Conductive Bulk Composites through a Contact-Connected Aggregate	PLOS ONE			English	Article							PACKINGS	This paper introduces a concept that allows the creation of low-resistance composites using a network of compliant conductive aggregate units, connected through contact, embedded within the composite. Due to the straight-forward fabrication method of the aggregate, conductive composites can be created in nearly arbitrary shapes and sizes, with a lower bound near the length scale of the conductive cell used in the aggregate. The described instantiation involves aggregate cells that are approximately spherical copper coils-of-coils within a polymeric matrix, but the concept can be implemented with a wide range of conductor elements, cell geometries, and matrix materials due to its lack of reliance on specific material chemistries. The aggregate cell network provides a conductive pathway that can have orders of magnitude lower resistance than that of the matrix material - from 10(12) ohm-cm (approx.) for pure silicone rubber to as low as 1 ohm-cm for the silicone/copper composite at room temperature for the presented example. After describing the basic concept and key factors involved in its success, three methods of implementing the aggregate into a matrix are then addressed - unjammed packing, jammed packing, and pre-stressed jammed packing - with an analysis of the tradeoffs between increased stiffness and improved resistivity.	[Nawroj, Ahsan I.; Swensen, John P.; Dollar, Aaron M.] Yale Univ, Sch Engn & Appl Sci, New Haven, CT 06520 USA	Yale University	Nawroj, AI (corresponding author), Yale Univ, Sch Engn & Appl Sci, New Haven, CT 06520 USA.	ahsan.nawroj@yale.edu	Swensen, John/AAC-8194-2020	Swensen, John/0000-0003-4562-6309; Nawroj, Ahsan/0000-0002-3541-652X; Dollar, Aaron/0000-0002-2409-4668	United States Air Force Office of Scientific Research [FA9550-11-1-0093 URL]	United States Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work received support from the United States Air Force Office of Scientific Research under Grant #FA9550-11-1-0093 URL of grant agency. http://www.wpafb.af.mil/afrl/afosr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwin SS, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.061307; Boeger L, 2008, COMPOS SCI TECHNOL, V68, P1886, DOI 10.1016/j.compscitech.2008.01.001; CHIANG JC, 1986, SYNTHETIC MET, V13, P193, DOI 10.1016/0379-6779(86)90070-6; Chung DDL, 2004, J MATER SCI, V39, P2645, DOI 10.1023/B:JMSC.0000021439.18202.ea; Donev A, 2004, SCIENCE, V303, P990, DOI 10.1126/science.1093010; Gurland J, 1966, AIME MET SOC T, V236, P642; Jaeger H, 1998, NATO ASI SERIES E; Kupke M, 1998, MATER RES INNOV, V2, P164, DOI 10.1007/s100190050079; LUCK JM, 1991, PHYS REV B, V43, P3933, DOI 10.1103/PhysRevB.43.3933; MUKHOPADHYAY R, 1976, J APPL POLYM SCI, V20, P2575, DOI 10.1002/app.1976.070200927; Nowak ER, 1997, POWDER TECHNOL, V94, P79, DOI 10.1016/S0032-5910(97)03291-9; PENNER RM, 1986, J ELECTROCHEM SOC, V133, P310, DOI 10.1149/1.2108568; Pouliquen O, 1997, PHYS REV LETT, V79, P3640, DOI 10.1103/PhysRevLett.79.3640; SHIRAKAWA H, 1977, J CHEM SOC CHEM COMM, P578, DOI 10.1039/c39770000578; Sichel K. E., 1982, CARBON BLACK POLYM C; Smith KC, 2012, ARXIV12062990; Swensen JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051695; Torquato S, 2010, REV MOD PHYS, V82, P2633, DOI 10.1103/RevModPhys.82.2633; Xie P., 1995, ACI SPECIAL PUBLICAT, V154; Yehia S, 1999, ACI MAT J, V96	20	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82260	10.1371/journal.pone.0082260	http://dx.doi.org/10.1371/journal.pone.0082260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349239	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200068
J	Ning, BT; Zhang, CM; Lin, R; Tan, LH; Chen, ZJ; Yu, J; Liu, T; Yang, ZH; Ye, S				Ning, Botao; Zhang, Chenmei; Lin, Ru; Tan, Linhua; Chen, Zhenjie; Yu, Jia; Liu, Tao; Yang, Zihao; Ye, Sheng			Local Experience with Extracorporeal Membrane Oxygentaion in Children with Acute Fulminant Myocarditis	PLOS ONE			English	Article							SUPPORT ORGANIZATION REGISTRY; OXYGENATION; ADULTS	To analyze the clinical effect of extracorporeal membrane oxygenation (ECMO) in children with acute fulminant myocarditis, we retrospectively analyzed the data of five children with acute fulminant myocarditis in the intensive care unit (ICU) at the Affiliated Children's Hospital, Zhejiang University from February 2009 to November 2012. The study group included two boys and three girls ranging in age from 9 to 13 years (median 10 years). Body weight ranged from 25 to 33 kg (mean 29.6 kg). They underwent extracorporeal membrane oxygenation (ECMO) through a venous-arterial ECMO model with an average ECMO supporting time of 89.8 h (40-142 h). Extracorporeal circulation was established in all five children. After treatment with ECMO, the heart rate, blood pressure, and oxygen saturation were greatly improved in the four children who survived. These four children were successfully weaned from ECMO and discharged from hospital machine-free, for a survival rate of 80% (4/5). One child died still dependent on the machine. Cause of death was irrecoverable cardiac function and multiple organ failure. Complications during ECMO included three cases of suture bleeding, one case of acute hemolytic renal failure and suture bleeding, and one case of hyperglycemia. During the follow-up period of 4-50 months, the four surviving children recovered with normal cardiac function and no abnormal functions of other organs. The application of ECMO in acute fulminant myocarditis, even in local centers that experience low incidence of this disease, remains an effective approach. Larger studies to determine optimal timing of placement on ECMO to guide local centers are warranted.	[Ning, Botao; Zhang, Chenmei; Lin, Ru; Tan, Linhua; Chen, Zhenjie; Yu, Jia; Liu, Tao; Yang, Zihao; Ye, Sheng] Zhejiang Univ, Sch Med, Pediat Intens Care Unit, Childrens Hosp, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zhang, CM (corresponding author), Zhejiang Univ, Sch Med, Pediat Intens Care Unit, Childrens Hosp, Hangzhou 310003, Zhejiang, Peoples R China.	chzcm@zju.edu.cn			National Natural Science Foundation of China [81270045]; Special Fund for Basic Scientific Research of Central Colleges [2013QNA7024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Basic Scientific Research of Central Colleges	The Project was Supported by the National Natural Science Foundation of China (no. 81270045) and Special Fund for Basic Scientific Research of Central Colleges (no.2013QNA7024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond CS, 2011, CIRCULATION, V123, P2975, DOI 10.1161/CIRCULATIONAHA.110.991505; Cardarelli MG, 2009, ASAIO J, V55, P581, DOI 10.1097/MAT.0b013e3181bad907; Cooper LT, 2007, J AM COLL CARDIOL, V50, P1914, DOI 10.1016/j.jacc.2007.09.008; Cox GF, 2006, PEDIATRICS, V118, P1519, DOI 10.1542/peds.2006-0163; Duncan BW, 2001, J THORAC CARDIOV SUR, V122, P440, DOI 10.1067/mtc.2001.115243; Fleming GM, 2009, PEDIATR CRIT CARE ME, V10, P439, DOI 10.1097/PCC.0b013e318198b275; Freeman R, 2012, CRIT CARE NURS Q, V35, P39, DOI 10.1097/CNQ.0b013e31823b1fa1; HILL JD, 1972, NEW ENGL J MED, V286, P629, DOI 10.1056/NEJM197203232861204; Hintz Susan R, 2005, Pediatr Crit Care Med, V6, P33, DOI 10.1097/01.PCC.0000149135.95884.65; Kato S, 2004, CIRC J, V68, P734, DOI 10.1253/circj.68.734; Knowlton KU, 2009, J AM COLL CARDIOL, V53, P1227, DOI 10.1016/j.jacc.2008.12.035; Kodama M, 2001, JPN CIRC J, V65, P961, DOI 10.1253/jcj.65.961; LIEBERMAN EB, 1993, CLIN IMMUNOL IMMUNOP, V68, P191, DOI 10.1006/clin.1993.1117; Liu PP, 2001, CIRCULATION, V104, P1076, DOI 10.1161/hc3401.095198; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; Rajagopal SK, 2010, CRIT CARE MED, V38, P382, DOI 10.1097/CCM.0b013e3181bc8293; Teele SA, 2011, J PEDIATR-US, V158, P638, DOI 10.1016/j.jpeds.2010.10.015; Wang QB, 2012, ACTA CARDIOL, V67, P571, DOI 10.1080/AC.67.5.2174132; Wu ET, 2006, HEART, V92, P1325, DOI 10.1136/hrt.2005.077511	19	5	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82258	10.1371/journal.pone.0082258	http://dx.doi.org/10.1371/journal.pone.0082258			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349238	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200067
J	Silva-Gomes, S; Bouton, C; Silva, T; Santambrogio, P; Rodrigues, P; Appelberg, R; Gomes, MS				Silva-Gomes, Sandro; Bouton, Cecile; Silva, Tania; Santambrogio, Paolo; Rodrigues, Pedro; Appelberg, Rui; Gomes, Maria Salome			Mycobacterium avium Infection Induces H-Ferritin Expression in Mouse Primary Macrophages by Activating Toll-Like Receptor 2	PLOS ONE			English	Article							CELLULAR IRON HOMEOSTASIS; NF-KAPPA-B; INCREASED SUSCEPTIBILITY; MESSENGER-RNA; INDUCTION; MICE; HYPOFERREMIA; TUBERCULOSIS; MODULATION; ANEMIA	Important for both host and pathogen survivals, iron is a key factor in determining the outcome of an infectious process. Iron with-holding, including sequestration inside tissue macrophages, is considered an important strategy to fight infection. However, for intra-macrophagic pathogens, such as Mycobacterium avium, host defence may depend on intracellular iron sequestration mechanisms. Ferritin, the major intracellular iron storage protein, plays a critical role in this process. In the current study, we studied ferritin expression in mouse bone marrow-derived macrophages upon infection with M. avium. We found that H-ferritin is selectively increased in infected macrophages, through an up-regulation of gene transcription. This increase was mediated by the engagement of Toll like receptor-2, and was independent of TNF-alpha or nitric oxide production. The formation of H-rich ferritin proteins and the consequent iron sequestration may be an important part of the panoply of antimicrobial mechanisms of macrophages.	[Silva-Gomes, Sandro; Silva, Tania; Rodrigues, Pedro; Appelberg, Rui; Gomes, Maria Salome] Univ Porto, IBMC, P-4100 Porto, Portugal; [Silva-Gomes, Sandro; Silva, Tania; Rodrigues, Pedro; Appelberg, Rui; Gomes, Maria Salome] Univ Porto, ICBAS, P-4100 Porto, Portugal; [Bouton, Cecile] Ctr Rech Gif, CNRS UPR2301, Inst Chim Subst Nat, Gif Sur Yvette, France; [Santambrogio, Paolo] Ist Sci San Raffaele, DIBIT, I-20132 Milan, Italy	Universidade do Porto; Universidade do Porto; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Vita-Salute San Raffaele University	Gomes, MS (corresponding author), Univ Porto, IBMC, Rua Campo Alegre 823, P-4100 Porto, Portugal.	sgomes@ibmc.up.pt	Silva, Tânia/AAB-2131-2019; Santambrogio, Paolo/AAN-3837-2020; Rodrigues, Pedro/B-3228-2008; Appelberg Gaio Lima, Rui/J-6188-2012; Gomes, Maria Salome/J-6917-2013	Silva, Tânia/0000-0002-6087-1487; Santambrogio, Paolo/0000-0002-5481-2130; Rodrigues, Pedro/0000-0002-3799-1544; Appelberg Gaio Lima, Rui/0000-0002-9447-0665; Gomes, Maria Salome/0000-0001-7657-2118	FEDER funds through the Operational Competitiveness Programme - COMPETE; national funds through FCT Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-022718, PEst-C/SAU/LA0002/2011]	FEDER funds through the Operational Competitiveness Programme - COMPETE; national funds through FCT Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology)	This work is funded by FEDER funds through the Operational Competitiveness Programme - COMPETE and by national funds through FCT Fundacao para a Ciencia e a Tecnologia under the project FCOMP-01-0124-FEDER-022718 (PEst-C/SAU/LA0002/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZHERNANDEZ X, 1989, LAB INVEST, V61, P319; Andrews NC, 2004, J CLIN INVEST, V113, P1251, DOI 10.1172/JCI200421441; Appelberg R, 2006, J LEUKOCYTE BIOL, V79, P1117, DOI 10.1189/jlb.0206079; Arosio P, 2010, BBA-GEN SUBJECTS, V1800, P783, DOI 10.1016/j.bbagen.2010.02.005; Basaraba RJ, 2008, TUBERCULOSIS, V88, P69, DOI 10.1016/j.tube.2007.09.002; Carlyon JA, 2005, INFECT IMMUN, V73, P7629, DOI 10.1128/IAI.73.11.7629-7636.2005; Cozzi A, 2004, BLOOD, V103, P2377, DOI 10.1182/blood-2003-06-1842; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Gomes MS, 2008, EUR J IMMUNOL, V38, P2180, DOI 10.1002/eji.200737954; Gomes MS, 2001, J CLIN VIROL, V20, P117, DOI 10.1016/S1386-6532(00)00135-9; Gomes-Pereira S, 2008, INFECT IMMUN, V76, P4713, DOI 10.1128/IAI.00612-08; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Kakhlon O, 2001, BLOOD, V97, P2863, DOI 10.1182/blood.V97.9.2863; Kim SW, 2002, P NATL ACAD SCI USA, V99, P12214, DOI 10.1073/pnas.192316099; KWAK EL, 1995, J BIOL CHEM, V270, P15285, DOI 10.1074/jbc.270.25.15285; Laftah AH, 2006, BIOCHEM J, V397, P61, DOI 10.1042/BJ20060215; LEIBOLD EA, 1988, P NATL ACAD SCI USA, V85, P2171, DOI 10.1073/pnas.85.7.2171; Lounis N, 2001, J CLIN VIROL, V20, P123, DOI 10.1016/S1386-6532(00)00136-0; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; Mae M, 2007, FEMS IMMUNOL MED MIC, V49, P398, DOI 10.1111/j.1574-695X.2007.00218.x; McGarvey JA, 2004, CLIN EXP IMMUNOL, V136, P490, DOI 10.1111/j.1365-2249.2004.02490.x; Means TK, 1999, J IMMUNOL, V163, P3920; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; MULLNER EW, 1989, CELL, V58, P373, DOI 10.1016/0092-8674(89)90851-9; Nairz M, 2007, CELL MICROBIOL, V9, P2126, DOI 10.1111/j.1462-5822.2007.00942.x; Pan X, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-64; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pham CG, 2004, CELL, V119, P529, DOI 10.1016/j.cell.2004.10.017; Picard V, 1998, J BIOL CHEM, V273, P15382, DOI 10.1074/jbc.273.25.15382; Roach SK, 2002, INFECT IMMUN, V70, P3040, DOI 10.1128/IAI.70.6.3040-3052.2002; Rodrigues PN, 2011, IMMUNOBIOLOGY, V216, P1127, DOI 10.1016/j.imbio.2011.04.004; Santambrogio P, 2000, PROTEIN EXPRES PURIF, V19, P212, DOI 10.1006/prep.2000.1212; SARMENTO AM, 1995, INFECT IMMUN, V63, P3759, DOI 10.1128/IAI.63.10.3759-3764.1995; Schaible UE, 2002, J EXP MED, V196, P1507, DOI 10.1084/jem.20020897; Stys A, 2011, J BIOL CHEM, V286, P22846, DOI 10.1074/jbc.M111.231902; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; WEINBERG ED, 1993, PERSPECT BIOL MED, V36, P215; Weiss G, 2005, BEST PRACT RES CL HA, V18, P183, DOI 10.1016/j.beha.2004.09.001; Weiss G, 2009, BBA-GEN SUBJECTS, V1790, P682, DOI 10.1016/j.bbagen.2008.08.006	41	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82874	10.1371/journal.pone.0082874	http://dx.doi.org/10.1371/journal.pone.0082874			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349383	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200109
J	Textoris, J; Ivorra, D; Ben Amara, A; Sabatier, F; Menard, JP; Heckenroth, H; Bretelle, F; Mege, JL				Textoris, Julien; Ivorra, Delphine; Ben Amara, Amira; Sabatier, Florence; Menard, Jean-Pierre; Heckenroth, Helene; Bretelle, Florence; Mege, Jean-Louis			Evaluation of Current and New Biomarkers in Severe Preeclampsia: A Microarray Approach Reveals the VSIG4 Gene as a Potential Blood Biomarker	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; ENDOTHELIAL GROWTH-FACTOR; SOLUBLE ENDOGLIN; NORMAL-PREGNANCY; PLACENTAL TISSUE; EXPRESSION; WOMEN; 1ST; MICROPARTICLES; DISCOVERY	Preeclampsia is a placental disease characterized by hypertension and proteinuria in pregnant women, and it is associated with a high maternal and neonatal morbidity. However, circulating biomarkers that are able to predict the prognosis of preeclampsia are lacking. Thirty-eight women were included in the current study. They consisted of 19 patients with preeclampsia (13 with severe preeclampsia and 6 with non-severe preeclampsia) and 19 gestational age-matched women with normal pregnancies as controls. We measured circulating factors that are associated with the coagulation pathway (including fibrinogen, fibronectin, factor VIII, antithrombin, protein S and protein C), endothelial activation (such as soluble endoglin and CD146), and the release of total and platelet-derived microparticles. These markers enabled us to discriminate the preeclampsia condition from a normal pregnancy but were not sufficient to distinguish severe from non-severe preeclampsia. We then used a microarray to study the transcriptional signature of blood samples. Preeclampsia patients exhibited a specific transcriptional program distinct from that of the control group of women. Interestingly, we also identified a severity-related transcriptional signature. Functional annotation of the upmodulated signature in severe preeclampsia highlighted two main functions related to "ribosome" and "complement". Finally, we identified 8 genes that were specifically upmodulated in severe preeclampsia compared with non-severe preeclampsia and the normotensive controls. Among these genes, we identified VSIG4 as a potential diagnostic marker of severe preeclampsia. The determination of this gene may improve the prognostic assessment of severe preeclampsia.	[Textoris, Julien; Ben Amara, Amira; Bretelle, Florence; Mege, Jean-Louis] Aix Marseille Univ, Unite Rech Malad Infect Trop & Emergentes, CNRS UMR 7278, INSERM U1095, Marseille, France; [Ivorra, Delphine; Menard, Jean-Pierre; Bretelle, Florence] Aix Marseille Univ, Dept Gynecol & Obstet, Hop Nord, Marseille, France; [Sabatier, Florence] Aix Marseille Univ, Lab Physiopathol Endothelium, UMR, INSERM S 608, Marseille, France; [Heckenroth, Helene] Aix Marseille Univ, Dept Gynecol & Obstet, Hop Concept, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Textoris, J (corresponding author), Aix Marseille Univ, Unite Rech Malad Infect Trop & Emergentes, CNRS UMR 7278, INSERM U1095, Marseille, France.	julien.textoris@univ-amu.fr	MEGE, JEAN-LOUIS/O-6063-2016; Textoris, Julien/H-3317-2019	Textoris, Julien/0000-0002-3821-9337; Bretelle, Florence/0000-0002-0909-3202	Assistance Publique - Hopitaux de Marseille: Appel d'Offre Promotion [2010-04]	Assistance Publique - Hopitaux de Marseille: Appel d'Offre Promotion	This work was funded in part by a grant from Assistance Publique - Hopitaux de Marseille: Appel d'Offre Promotion 2010 (ref. 2010-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ACOG, 2002, OBSTET GYNECOL, V99, P869; Bell MJ, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-82; Bretelle F, 2003, THROMB HAEMOSTASIS, V89, P486, DOI 10.1055/s-0037-1613378; Brown MC, 2013, EUR J EPIDEMIOL, V28, P1, DOI 10.1007/s10654-013-9762-6; Carty DM, 2008, TRENDS CARDIOVAS MED, V18, P186, DOI 10.1016/j.tcm.2008.07.002; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Denny KJ, 2013, J REPROD IMMUNOL, V97, P211, DOI 10.1016/j.jri.2012.11.006; Desnues B, 2005, J IMMUNOL, V175, P4575, DOI 10.4049/jimmunol.175.7.4575; Drucker E, 2013, EPMA J, V4, DOI 10.1186/1878-5085-4-7; Eiland E, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/586578; Enquobahrie DA, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.020; Founds SA, 2009, PLACENTA, V30, P15, DOI 10.1016/j.placenta.2008.09.015; Founds SA, 2012, CTS-CLIN TRANSL SCI, V5, P333, DOI 10.1111/j.1752-8062.2012.00413.x; Founds SA, 2011, BIOL RES NURS, V13, P134, DOI 10.1177/1099800410385448; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Grill S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-70; GUIDOTTI R, 1988, AM J OBSTET GYNECOL, V158, P80; Hawfield Amret, 2009, Ther Adv Cardiovasc Dis, V3, P65, DOI 10.1177/1753944708097114; He JQ, 2008, MOL IMMUNOL, V45, P4041, DOI 10.1016/j.molimm.2008.07.011; Java A, 2013, ANNU REV MED, V64, P307, DOI 10.1146/annurev-med-072211-110606; Joyama S, 2001, AM J KIDNEY DIS, V37, part. no.; Kleinrouweler CE, 2012, BJOG-INT J OBSTET GY, V119, P778, DOI 10.1111/j.1471-0528.2012.03311.x; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Lynch AM, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.035; Marques FK, 2013, MOL BIOL REP, V40, P4553, DOI 10.1007/s11033-013-2536-0; McElrath TF, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.010; Moal V, 2013, J INFECT DIS, V207, P125, DOI 10.1093/infdis/jis632; Myatt L, 2013, BJOG-INT J OBSTET GY, V120, P1183, DOI 10.1111/1471-0528.12128; Nagamatsu T, 2010, REPROD SCI, V17, P209, DOI 10.1177/1933719109349962; Nishizawa H, 2007, PLACENTA, V28, P487, DOI 10.1016/j.placenta.2006.05.010; Parra-Cordero M, 2013, ULTRASOUND OBST GYN, V41, P538, DOI 10.1002/uog.12264; Prossnitz ER, 2009, PROSTAG OTH LIPID M, V89, P89, DOI 10.1016/j.prostaglandins.2009.05.001; Rajakumar A, 2011, PLACENTA, V32, P70, DOI 10.1016/j.placenta.2010.10.004; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Reimer T, 2002, MOL HUM REPROD, V8, P674, DOI 10.1093/molehr/8.7.674; Robert S, 2009, J THROMB HAEMOST, V7, P190, DOI 10.1111/j.1538-7836.2008.03200.x; Rolfo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059403; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Schnettler WT, 2013, BJOG, DOI [10.1111/1471-0528.12259, DOI 10.1111/1471-0528.12259.PUBMED:23647884]; Shetty S, 2013, EUR J OBSTET GYN R B, V169, P123, DOI 10.1016/j.ejogrb.2013.02.011; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Soto E, 2010, J MATERN-FETAL NEO M, V23, P1085, DOI 10.3109/14767051003649870; Sun CJ, 2009, J PERINAT MED, V37, P609, DOI 10.1515/JPM.2009.103; Thuny F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031490; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van Rijn BB, 2013, OBSTET GYNECOL, V121, P1040, DOI 10.1097/AOG.0b013e31828ea3b5; Villar K., 2003, ECLAMPSIA PREECLAMPS, P189; Vogt L, 2006, J CLIN INVEST, V116, P2817, DOI 10.1172/JCI25673	49	28	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82638	10.1371/journal.pone.0082638	http://dx.doi.org/10.1371/journal.pone.0082638			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349325	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200087
J	Zhang, C; Shao, ML; Yang, H; Chen, LM; Yu, LC; Cong, WT; Tian, HS; Zhang, FF; Cheng, P; Jin, LT; Tan, Y; Li, XK; Cai, L; Lu, XM				Zhang, Chi; Shao, Minglong; Yang, Hong; Chen, Liangmiao; Yu, Lechu; Cong, Weitao; Tian, Haishan; Zhang, Fangfang; Cheng, Peng; Jin, Litai; Tan, Yi; Li, Xiaokun; Cai, Lu; Lu, Xuemian			Attenuation of Hyperlipidemia- and Diabetes-Induced Early-Stage Apoptosis and Late-Stage Renal Dysfunction via Administration of Fibroblast Growth Factor-21 Is Associated with Suppression of Renal Inflammation	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CHRONIC KIDNEY-DISEASE; OXIDATIVE STRESS; FATTY-ACIDS; LIPID NEPHROTOXICITY; METABOLIC SYNDROME; SODIUM RETENTION; DB/DB MICE; KAPPA-B; NEPHROPATHY	Background: Lipotoxicity is a key feature of the pathogenesis of diabetic kidney disease, and is attributed to excessive lipid accumulation (hyperlipidemia). Increasing evidence suggests that fibroblast growth factor (FGF) 21 has a crucial role in lipid metabolism under diabetic conditions. Objective: The present study investigated whether FGF21 can prevent hyperlipidemia- or diabetes-induced renal damage, and if so, the possible mechanism. Methods: Mice were injected with free fatty acids (FFAs, 10 mg/10 g body weight) or streptozotocin (150 mg/kg) to establish a lipotoxic model or type 1 diabetic model, respectively. Simultaneously the mice were treated with FGF21 (100 mu g/kg) for 10 or 80 days. The kidney weight-to-tibia length ratio and renal function were assessed. Systematic and renal lipid levels were detected by ELISA and Oil Red O staining. Renal apoptosis was examined by TUNEL assay. Inflammation, oxidative stress, and fibrosis were assessed by Western blot. Results: Acute FFA administration and chronic diabetes were associated with lower kidney-to-tibia length ratio, higher lipid levels, severe renal apoptosis and renal dysfunction. Obvious inflammation, oxidative stress and fibrosis also observed in the kidney of both mice models. Deletion of the fgf21 gene further enhanced the above pathological changes, which were significantly prevented by administration of exogenous FGF21. Conclusion: These results suggest that FFA administration and diabetes induced renal damage, which was further enhanced in FGF21 knock-out mice. Administration of FGF21 significantly prevented both FFA- and diabetes-induced renal damage partially by decreasing renal lipid accumulation and suppressing inflammation, oxidative stress, and fibrosis.	[Zhang, Chi; Shao, Minglong; Yu, Lechu; Cong, Weitao; Zhang, Fangfang; Cheng, Peng; Jin, Litai; Tan, Yi; Li, Xiaokun; Cai, Lu; Lu, Xuemian] Wenzhou Med Univ, Chinese Amer Res Inst Diabet Complicat, Wenzhou, Zhejiang, Peoples R China; [Zhang, Chi; Shao, Minglong; Yang, Hong; Chen, Liangmiao; Yu, Lechu; Zhang, Fangfang; Cheng, Peng; Tan, Yi; Cai, Lu; Lu, Xuemian] Wenzhou Med Univ, Chinese Amer Res Inst Diabet Complicat, Affiliated Hosp 3, Ruian Ctr, Wenzhou, Zhejiang, Peoples R China; [Shao, Minglong; Cong, Weitao; Tian, Haishan; Jin, Litai; Li, Xiaokun] Wenzhou Med Univ, Sch Pharm, Wenzhou, Zhejiang, Peoples R China; [Tan, Yi; Cai, Lu] Univ Louisville, Dept Pediat, Kosair Childrens Hosp, Res Inst, Louisville, KY 40292 USA	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; University of Louisville	Cai, L (corresponding author), Wenzhou Med Univ, Chinese Amer Res Inst Diabet Complicat, Wenzhou, Zhejiang, Peoples R China.	lu89118@medmail.com.cn; lu.cai@louisville.edu	Cai, Lu/AAG-9920-2019		National Science Foundation of China [81370917, 81000294]; Wenzhou Medical University [QTJ13005]; China-Canada Joint Health Research Initiative [81061120517]; Starting-Up Fund for Chinese-American Research Institute for Diabetic Complications from Wenzhou Medical University	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wenzhou Medical University; China-Canada Joint Health Research Initiative; Starting-Up Fund for Chinese-American Research Institute for Diabetic Complications from Wenzhou Medical University	This study was supported in part by a Young Scientist Award from National Science Foundation of China (81000294 to CZ), National Science Foundation of China (81370917 to CZ), Research Development Fund of Wenzhou Medical University (QTJ13005 to CZ), China-Canada Joint Health Research Initiative (81061120517 to SC and XL) and a Starting-Up Fund for Chinese-American Research Institute for Diabetic Complications from Wenzhou Medical University (to XL and LC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AC, 2012, CURR DIABETES REV, V8, P285, DOI 10.2174/157339912800840505; Barroso E, 2013, CLIN INVEST ARTERIOS, V25, P63, DOI 10.1016/j.arteri.2013.01.001; Bobulescu IA, 2010, CURR OPIN NEPHROL HY, V19, P393, DOI 10.1097/MNH.0b013e32833aa4ac; Cai L, 2006, J AM COLL CARDIOL, V48, P1688, DOI 10.1016/j.jacc.2006.07.022; Carroll Wenting X, 2013, Front Endocrinol (Lausanne), V4, P10, DOI 10.3389/fendo.2013.00010; Chang CC, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-47; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Crasto C, 2012, J AM GERIATR SOC, V60, P792, DOI 10.1111/j.1532-5415.2011.03879.x; Cuevas-Ramos D, 2009, CURR DIABETES REV, V5, P216, DOI 10.2174/157339909789804396; DiPetrillo K, 2003, AM J PHYSIOL-RENAL, V284, pF113, DOI 10.1152/ajprenal.00026.2002; DiPetrillo K, 2004, KIDNEY INT, V65, P1676, DOI 10.1111/j.1523-1755.2004.00606.x; Dominguez J, 2007, AM J PHYSIOL-RENAL, V293, pF670, DOI 10.1152/ajprenal.00021.2007; Fang F, 2013, AM J PHYSIOL-RENAL, V304, pF1366, DOI 10.1152/ajprenal.00137.2012; Feingold KR, 2012, ENDOCRINOLOGY, V153, P2689, DOI 10.1210/en.2011-1496; Giunti S, 2006, Minerva Med, V97, P241; Habib SL, 2013, WORLD J DIABETES, V4, P27, DOI 10.4239/wjd.v4.i2.27; Hakim FA, 2010, MED SCI MONITOR, V16, pRA37; Han SH, 2010, METABOLISM, V59, P1656, DOI 10.1016/j.metabol.2010.03.018; Ichinose K, 2007, AM J NEPHROL, V27, P554, DOI 10.1159/000107758; Jung JE, 2004, NEUROSCI LETT, V354, P197, DOI 10.1016/j.neulet.2003.10.012; Kamijo A, 2002, KIDNEY INT, V62, P1628, DOI 10.1046/j.1523-1755.2002.00618.x; Kewalramani G, 2007, J MOL CELL CARDIOL, V42, P333, DOI 10.1016/j.yjmcc.2006.11.010; Kim HW, 2013, ENDOCRINOLOGY, V154, P3366, DOI 10.1210/en.2012-2276; Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2; Kim MJ, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/510212; Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386; Lee HB, 2005, NEPHROLOGY, V10, pS11, DOI 10.1111/j.1440-1797.2005.00449.x; Leite JO, 2010, ATHEROSCLEROSIS, V209, P442, DOI 10.1016/j.atherosclerosis.2009.10.005; Leung RKK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-162; Lin JL, 2008, DIABETES CARE, V31, P2338, DOI 10.2337/dc08-0277; Lin ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018398; Min DQ, 2009, AM J PHYSIOL-RENAL, V297, pF1229, DOI 10.1152/ajprenal.00074.2009; MOORHEAD JF, 1982, LANCET, V2, P1309; Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x; Murea M, 2010, CLIN J AM SOC NEPHRO, V5, P2373, DOI 10.2215/CJN.08160910; Navarro-Gonzalez JF, 2008, J AM SOC NEPHROL, V19, P433, DOI 10.1681/ASN.2007091048; OSTERBY R, 1990, DIABETES, V39, P1057, DOI 10.2337/diabetes.39.9.1057; Planavila A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3019; Proctor G, 2006, DIABETES, V55, P2502, DOI 10.2337/db05-0603; Ramjiawan A, 2013, AM J PHYSIOL-CELL PH, V304, pC1064, DOI 10.1152/ajpcell.00262.2012; Rerolle JP, 2000, KIDNEY INT, V58, P1841, DOI 10.1046/j.1523-1755.2000.00355.x; Rivero A, 2009, CLIN SCI, V116, P479, DOI 10.1042/CS20080394; Ruan XZ, 2009, NAT REV NEPHROL, V5, P713, DOI 10.1038/nrneph.2009.184; Rutkowski P, 2006, J RENAL NUTR, V16, P216, DOI 10.1053/j.jrn.2006.04.017; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Satriano J, 2013, AM J PHYSIOL-RENAL, V305, pF727, DOI 10.1152/ajprenal.00293.2013; Savary S, 2012, CURR DRUG METAB, V13, P1358, DOI 10.2174/138920012803762729; Shapiro H, 2011, NAT REV NEPHROL, V7, P110, DOI 10.1038/nrneph.2010.156; Stanton RC, 2011, CURR DIABETES REP, V11, P330, DOI 10.1007/s11892-011-0196-9; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Thomas ME, 1999, KIDNEY INT, V55, P890, DOI 10.1046/j.1523-1755.1999.055003890.x; Thomas ME, 2002, AM J PHYSIOL-RENAL, V283, pF640, DOI 10.1152/ajprenal.00001.2002; Vlassara H, 2012, CLIN J AM SOC NEPHRO, V7, P934, DOI 10.2215/CJN.12891211; Wahba IM, 2007, CLIN J AM SOC NEPHRO, V2, P550, DOI 10.2215/CJN.04071206; Wang HY, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-14; Wang XX, 2009, AM J PHYSIOL-RENAL, V297, pF1587, DOI 10.1152/ajprenal.00404.2009; Weinberg JM, 2006, KIDNEY INT, V70, P1560, DOI 10.1038/sj.ki.5001834; Wu J, 2011, LAB INVEST, V91, P1459, DOI 10.1038/labinvest.2011.93; Zhang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049257; Zhang C, 2009, AM J PHYSIOL-ENDOC M, V297, pE1366, DOI 10.1152/ajpendo.00478.2009; Zhang GF, 2011, INFLAMMATION, V34, P645, DOI 10.1007/s10753-010-9274-4; Zhao YG, 2011, TOXICOL LETT, V200, P100, DOI 10.1016/j.toxlet.2010.11.001	62	59	64	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82275	10.1371/journal.pone.0082275	http://dx.doi.org/10.1371/journal.pone.0082275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349242	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200069
J	Lin, HP; Lin, CY; Hsiao, PH; Wang, HD; Jiang, SS; Hsu, JM; Jim, WT; Chen, M; Kung, HJ; Chuu, CP				Lin, Hui-Ping; Lin, Ching-Yu; Hsiao, Ping-Hsuan; Wang, Horng-Dar; Jiang, Shih Sheng; Hsu, Jong-Ming; Jim, Wai-Tim; Chen, Marcelo; Kung, Hsing-Jien; Chuu, Chih-Pin			Difference in Protein Expression Profile and Chemotherapy Drugs Response of Different Progression Stages of LNCaP Sublines and Other Human Prostate Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ANDROGEN-INDEPENDENT GROWTH; PHENETHYL ESTER SUPPRESSES; PI3K/AKT PATHWAY; TUMOR-GROWTH; IMMUNOHISTOCHEMICAL DETECTION; TESTOSTERONE REPLACEMENT; GENE AMPLIFICATION; HORMONAL-THERAPY; MOLECULAR SWITCH	Androgen ablation therapy is the primary treatment for metastatic prostate cancer. However, 80-90% of the patients who receive androgen ablation therapy ultimately develop recurrent tumors in 12-33 months after treatment with a median overall survival time of 1-2 years after relapse. LNCaP is a commonly used cell line established from a human lymph node metastatic lesion of prostatic adenocarcinoma. We previously established two relapsed androgen receptor (AR)-rich androgen-independent LNCaP sublines 104-R1 (androgen depleted for 12 months) and 104-R2 cells (androgen depleted for 24 months) from AR-positive androgen-dependent LNCaP 104-S cells. LNCaP 104-R1 and 104-R2 mimics the AR-positive hormone-refractory relapsed tumors in patients receiving androgen ablation therapy. Androgen treatment stimulates proliferation of 104-S cells, but causes growth inhibition and G1 cell cycle arrest in 104-R1 and 104-R2 cells. We investigated the protein expression profile difference between LNCaP 104-S vs. LNCaP 104-R1, 104-R2, PC-3, and DU-145 cells as well as examined the sensitivity of these prostate cancer cells to different chemotherapy drugs and small molecule inhibitors. Compared to 104-S cells, 104-R1 and 104-R2 cells express higher protein levels of AR, PSA, c-Myc, Skp2, BCL-2, P53, p-MDM2 S166, Rb, and p-Rb S807/811. The 104-R1 and 104-R2 cells express higher ratio of p-Akt S473/Akt, p-EGFR/EGFR, and p-Src/Src, but lower ratio of p-ERK/ERK than 104-S cells. PC-3 and DU-145 cells express higher c-Myc, Skp2, Akt, Akt1, and phospho-EGFR but less phospho-Akt and phospho-ERK. Overexpression of Skp2 increased resistance of LNCaP cells to chemotherapy drugs. Paclitaxel, androgen, and inhibitors for PI3K/Akt, EGFR, Src, or Bcl-2 seem to be potential choices for treatment of advanced prostate cancers. Our study provides rationale for targeting Akt, EGFR, Src, Bcl-2, and AR signaling as a treatment for AR-positive relapsed prostate tumors after hormone therapy.	[Lin, Hui-Ping; Lin, Ching-Yu; Chuu, Chih-Pin] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan; [Lin, Hui-Ping; Lin, Ching-Yu; Jiang, Shih Sheng; Chuu, Chih-Pin] Natl Hlth Res Inst, Translat Ctr Glandular Malignancies, Miaoli, Taiwan; [Lin, Ching-Yu; Jiang, Shih Sheng; Kung, Hsing-Jien] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Hsiao, Ping-Hsuan; Wang, Horng-Dar] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan; [Hsu, Jong-Ming; Chen, Marcelo] Mackay Mem Hosp, Dept Urol, Taipei, Taiwan; [Jim, Wai-Tim] Mackay Mem Hosp, Dept Pediat, Taipei, Taiwan; [Kung, Hsing-Jien] Natl Hlth Res Inst, Inst Mol & Genom Med, Miaoli, Taiwan; [Chuu, Chih-Pin] China Med Univ, Grad Program Aging, Taichung, Taiwan; [Chuu, Chih-Pin] Natl Chung Hsing Univ, PhD Program Tissue Engn & Regenerat Med, Taichung 40227, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Tsing Hua University; Mackay Memorial Hospital; Mackay Memorial Hospital; National Health Research Institutes - Taiwan; China Medical University Taiwan; National Chung Hsing University	Chuu, CP (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan.	cpchuu@nhri.org.tw	Chuu, Chih-Pin/N-6697-2019; Jiang, Shih Sheng/J-9671-2019; Chuu, Chih-Pin/B-1086-2010; Lin, Ching Yu/AAN-9581-2020; Kung, Hsing-Jien/C-7651-2013; Jiang, Shih Sheng/C-6187-2011	Jiang, Shih Sheng/0000-0003-1909-437X; Lin, Ching Yu/0000-0001-9041-5653; Wang, Horng-Dar/0000-0001-9570-3611	National Health Research Institutes [CS-101-PP-14, CS-102-PP-14]; National Science Council [NSC 99-2320-B-400-015-MY3, NSC 101-2325-B-400-014]; Department of Health from Taiwan [DOH101-TD-C-111-004]; Department of Health, Taiwan [DOH102-TD-M-111-102001]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan); Department of Health from Taiwan; Department of Health, Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants CS-101-PP-14 and CS-102-PP-14 (National Health Research Institutes), NSC 99-2320-B-400-015-MY3 and NSC 101-2325-B-400-014 (National Science Council), and DOH101-TD-C-111-004 (Department of Health) from Taiwan for CPC and DOH102-TD-M-111-102001 (Department of Health, Taiwan) for HJK. CYL is supported by DOH101-TD-C-111-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alimirah F, 2007, NEOPLASIA, V9, P1152, DOI 10.1593/neo.07769; Apakama I, 1996, BRIT J CANCER, V74, P1258, DOI 10.1038/bjc.1996.526; Ayala G, 2004, CLIN CANCER RES, V10, P6572, DOI 10.1158/1078-0432.CCR-04-0477; Bauer JJ, 1996, J UROLOGY, V156, P1511, DOI 10.1016/S0022-5347(01)65641-6; Bedolla R, 2007, CLIN CANCER RES, V13, P3860, DOI 10.1158/1078-0432.CCR-07-0091; Bonaccorsi L, 2004, INT J CANCER, V112, P78, DOI 10.1002/ijc.20362; Bonaccorsi L, 2007, J MOL ENDOCRINOL, V38, P51, DOI 10.1677/jme.1.02155; Brewster SF, 1999, J UROLOGY, V161, P1238, DOI 10.1016/S0022-5347(01)61646-X; Cai CM, 2009, CANCER RES, V69, P5202, DOI 10.1158/0008-5472.CAN-09-0026; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chang YM, 2008, ONCOGENE, V27, P6365, DOI 10.1038/onc.2008.250; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chuu CP, 2008, MOL CANCER RES, V6, P885, DOI 10.1158/1541-7786.MCR-07-0369; Chuu CP, 2007, J BIOMED SCI, V14, P543, DOI 10.1007/s11373-007-9160-8; Chuu CP, 2007, BIOCHEM BIOPH RES CO, V357, P341, DOI 10.1016/j.bbrc.2007.03.116; Chuu CP, 2006, CANCER RES, V66, P6482, DOI 10.1158/0008-5472.CAN-06-0632; Chuu CP, 2012, CANCER PREV RES, V5, P788, DOI 10.1158/1940-6207.CAPR-12-0004-T; Chuu CP, 2011, CANCER SCI, V102, P2022, DOI 10.1111/j.1349-7006.2011.02043.x; Chuu CP, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-63; Chuu CP, 2010, ANTICANCER RES, V30, P3643; Chuu CP, 2009, CANCER LETT, V275, P86, DOI 10.1016/j.canlet.2008.10.001; Chuu CP, 2005, CANCER RES, V65, P2082, DOI 10.1158/0008-5472.CAN-04-3992; Cinar B, 2001, CANCER RES, V61, P7310; Coffer PJ, 1998, BIOCHEM J, V335, P1; Cohen RJ, 1995, PATHOLOGY, V27, P229, DOI 10.1080/00313029500169033; Dai B, 2009, BJU INT, V104, P1009, DOI 10.1111/j.1464-410X.2009.08538.x; Desai SJ, 2006, CANCER RES, V66, P10449, DOI 10.1158/0008-5472.CAN-06-2582; Edwards J, 2003, CLIN CANCER RES, V9, P5271; Edwards J, 2003, BRIT J CANCER, V89, P552, DOI 10.1038/sj.bjc.6601127; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Festuccia C, 2005, INT J CANCER, V115, P630, DOI 10.1002/ijc.20917; Ford OH, 2003, J UROLOGY, V170, P1817, DOI 10.1097/01.ju.0000091873.09677.f4; Fukuchi J, 2004, CANCER RES, V64, P7682, DOI 10.1158/0008-5472.CAN-04-2647; Fukuchi J, 2004, CANCER RES, V64, P7686, DOI 10.1158/0008-5472.CAN-04-2332; Gelmini S, 2003, CLIN CHEM LAB MED, V41, P261, DOI 10.1515/CCLM.2003.040; Gilligan T, 2002, UROLOGY, V60, P94, DOI 10.1016/S0090-4295(02)01583-2; Gleave M, 1999, CLIN CANCER RES, V5, P2891; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Gregory CW, 2001, CANCER RES, V61, P2892; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Hammarsten P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047994; Hara T, 2003, CANCER RES, V63, P5622; Heisler LE, 1997, MOL CELL ENDOCRINOL, V126, P59, DOI 10.1016/S0303-7207(96)03970-6; Hellerstedt BA, 2002, CA-CANCER J CLIN, V52, P154, DOI 10.3322/canjclin.52.3.154; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Huang HJ, 2004, ONCOGENE, V23, P2161, DOI 10.1038/sj.onc.1207326; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kim D, 2002, AM J PATHOL, V160, P219, DOI 10.1016/S0002-9440(10)64365-9; Klotz L, 2004, BJU INT, V93, P1177, DOI 10.1111/j.1464-410X.2004.04803.x; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Kokontis J, 1991, Receptor, V1, P271; KOKONTIS J, 1994, CANCER RES, V54, P1566; Kokontis JM, 2005, PROSTATE, V65, P287, DOI 10.1002/pros.20285; Kokontis JM, 1998, MOL ENDOCRINOL, V12, P941, DOI 10.1210/me.12.7.941; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Kuo YY, 2013, INT J MOL SCI, V14, P8801, DOI 10.3390/ijms14058801; Lee LF, 2004, ONCOGENE, V23, P2197, DOI 10.1038/sj.onc.1207344; Leotoing L, 2007, J MOL ENDOCRINOL, V39, P151, DOI 10.1677/JME-07-0021; Lin CY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065734, 10.1371/journal.pone.0076885]; Lin HP, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031286, 10.1371/journal.pone.0035240]; Lin YT, 2007, CELL RES, V17, P531, DOI 10.1038/cr.2007.12; Linja MJ, 2001, CANCER RES, V61, P3550; Litvinov IV, 2004, PROSTATE, V61, P299, DOI 10.1002/pros.20187; Liu SC, 2010, ONCOL REP, V23, P165, DOI 10.3892/or_00000618; Ma W, 2013, J BIOL CHEM; Mathew P, 2008, ANN ONCOL, V19, P395, DOI 10.1093/annonc/mdm568; Matsushima H, 1997, J UROLOGY, V158, P2278, DOI 10.1016/S0022-5347(01)68235-1; McCall P, 2008, BRIT J CANCER, V98, P1094, DOI 10.1038/sj.bjc.6604152; Morgan TM, 2009, CURR CANCER DRUG TAR, V9, P237, DOI 10.2174/156800909787580999; Moro L, 2007, INT J ONCOL, V30, P217, DOI 10.3892/ijo.30.1.217; Moul JW, 1996, SURGERY, V120, P159, DOI 10.1016/S0039-6060(96)80283-2; Mukherjee B, 2008, INT J ONCOL, V33, P623, DOI 10.3892/ijo_00000048; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pfeil K, 2004, PROSTATE, V58, P259, DOI 10.1002/pros.10332; Pinto AC, 2011, PROSTATE, V71, P81, DOI 10.1002/pros.21224; Polito M, 1997, PROSTATE, V33, P208, DOI 10.1002/(SICI)1097-0045(19971101)33:3<208::AID-PROS10>3.0.CO;2-O; RAFFO AJ, 1995, CANCER RES, V55, P4438; Sadar MD, 1999, J BIOL CHEM, V274, P7777, DOI 10.1074/jbc.274.12.7777; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125; Seaton A, 2008, CARCINOGENESIS, V29, P1148, DOI 10.1093/carcin/bgn109; Sgambato A, 2004, J CELL PHYSIOL, V201, P97, DOI 10.1002/jcp.20045; Sherwood ER, 1998, BRIT J CANCER, V77, P855, DOI 10.1038/bjc.1998.142; Shi XB, 2004, PROSTATE, V60, P257, DOI 10.1002/pros.20039; Shimizu Y, 2007, BJU INT, V100, P685, DOI 10.1111/j.1464-410X.2007.07014.x; Singh SS, 2004, ANAL QUANT CYTOL, V26, P194; Sircar K, 2009, J PATHOL, V218, P505, DOI 10.1002/path.2559; Soto AM, 1995, ONCOL RES, V7, P545; Stattin P, 1998, BRIT J CANCER, V77, P670, DOI 10.1038/bjc.1998.107; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; Szmulewitz R, 2009, EUR UROL, V56, P97, DOI 10.1016/j.eururo.2009.02.022; Traish AM, 2009, BRIT J CANCER, V101, P1949, DOI 10.1038/sj.bjc.6605376; Tsuji M, 1998, BRIT J UROL, V81, P116; Tsvetkov LM, 1999, CURR BIOL, V9, P661, DOI 10.1016/S0960-9822(99)80290-5; Umekita Y, 1996, P NATL ACAD SCI USA, V93, P11802, DOI 10.1073/pnas.93.21.11802; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Vellaichamy A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010936; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wang LG, 2001, CANCER RES, V61, P7544; Wegiel B, 2008, INT J CANCER, V122, P1521, DOI 10.1002/ijc.23261; White RD, 1997, EUR UROL, V31, P1; YUAN SX, 1993, CANCER RES, V53, P1304; Zhang LQ, 2003, CANCER RES, V63, P4552	108	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82625	10.1371/journal.pone.0082625	http://dx.doi.org/10.1371/journal.pone.0082625			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349321	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100122
J	Cheong, KB; Zhang, JP; Huang, Y; Zhang, ZJ				Cheong, Kah Bik; Zhang, Ji-ping; Huang, Yong; Zhang, Zhang-jin			The Effectiveness of Acupuncture in Prevention and Treatment of Postoperative Nausea and Vomiting - A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							TRADITIONAL CHINESE ACUPUNCTURE; P6 ACUPUNCTURE; ELECTROACUPOINT STIMULATION; ANTIEMETIC PROPHYLAXIS; ACUPOINT STIMULATION; ACUPRESSURE; ACUSTIMULATION; CHILDREN; PATIENT; ONDANSETRON	Background: Acupuncture therapy for preventive and treatment of postoperative nausea and vomiting(PONV), a condition which commonly present after anaesthesia and surgery is a subject of growing interest. Objective: This paper included a systematic review and meta-analysis on the effect of different type of acupuncture and acupoint selection in PONV prevention and treatment. Methods: Randomised controlled trials(RCTs) comparing acupuncture with non-acupuncture treatment were identified from databases PubMed, Cochrane, EBSCO, Ovid, CNKI and Wanfangdata. Meta-analysis on eligible studies was performed using fixed-effects model with RevMan 5.2. Results were expressed as RR for dichotomous data, with 95%CI. Results: Thirty RCTs, 1276 patients (intervention) and 1258 patients (control) were identified. Meta-analysis showed that PC6 acupuncture significantly reduced the number of cases of early vomiting (postoperative 0-6h) (RR=0.36, 95% CI 0.19,0.71; P=0.003) and nausea (postoperative 0-24h) (RR=0.25, 95% CI 0.10,0.61; P=0.002), but not early nausea (postoperative 0-6h) (RR=0.64, 95% CI 0.34,1.19; P=0.150) and vomiting (postoperative 0-24h) (RR=0.82, 95% CI 0.48,1.38; P=0.450). PC6 acupressure significantly reduced the number of cases of nausea (RR=0.71, 95% CI 0.57,0.87; P=0.001) and vomiting (RR=0.62, 95% CI 0.49,0.80; P=0.000) at postoperative 0-24h. PC6 electroacupoint stimulation significantly reduced the number of cases of nausea (RR=0.49, 95% CI 0.38,0.63; P<0.000) and vomiting (RR=0.50, 95% CI 0.36,0.70; P<0.000) at postoperative 0-24h. Stimulation of PC6 with other acupoint(s) significantly reduced the number of cases of nausea and vomiting (RR=0.29, 95% CI 0.17,0.49; P<0.000) at postoperative 0-24h. Stimulation of other acupoint(s)(non PC6) also significantly reduced the number of cases of nausea and vomiting (RR=0.63, 95% CI 0.49,0.81; P=0.000) at postoperative 0-24h. However, the quality of study was generally low in studies of PC6 combined with other acupoint(s) and other acupoint(s). Details of blinding were not reported in most reports. Conclusions: Besides PC6, PC6 combined with other acupoint(s) and other alternative acupoint(s) might be beneficial in prevention and treatment of PONV, the evidence justifies future high-quality studies.	[Cheong, Kah Bik; Zhang, Ji-ping; Huang, Yong] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China; [Zhang, Zhang-jin] Univ Hong Kong, Sch Chinese Med, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China	Southern Medical University - China; University of Hong Kong	Huang, Y (corresponding author), Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China.	nanfanglihuang@163.com	zhang, zheng/HCH-9684-2022; zhang, zhang/GQZ-6804-2022; Cheong, Kah Bik/B-3545-2008	Cheong, Kah Bik/0000-0003-2062-6599	Committee of development and reform, Guangdong Province [431]	Committee of development and reform, Guangdong Province	This work was supported by Committee of development and reform, Guangdong Province [2009] 431. It was the 3rd-stage "211 project" key subject construction project of Guangdong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN DL, 1994, ANAESTH INTENS CARE, V22, P691, DOI 10.1177/0310057X9402200608; AlSadi M, 1997, ANAESTHESIA, V52, P658, DOI 10.1111/j.1365-2044.1997.143-az0147.x; AMIR SH, 2007, J ANAESTH CLIN PHARM, V23, P383; ANDRZEJOWSKI J, 1996, ACUPUNCT MED, V14, P68, DOI DOI 10.1136/AIM.14.2.68; Arnberger M, 2007, ANESTHESIOLOGY, V107, P903, DOI 10.1097/01.anes.0000290617.98058.d9; [白红梅 Bai Hongmei], 2012, [临床麻醉学杂志, The Journal of Clinical Anesthestology], V28, P1158; Boehler M, 2002, ANESTH ANALG, V94, P872, DOI 10.1097/00000539-200204000-00018; Chattopadhyay S, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr002; Chen M, 2006, CHIN J CLIN REHABIL, V10, P112; CHEN XH, 1992, BEHAV BRAIN RES, V47, P143, DOI 10.1016/S0166-4328(05)80120-2; Chu Y C, 1998, Acta Anaesthesiol Sin, V36, P11; Doran K, 2010, AM J CRIT CARE, V19, P553, DOI 10.4037/ajcc2010900; DUNDEE JW, 1986, BRIT MED J, V293, P583, DOI 10.1136/bmj.293.6547.583; DUNDEE JW, 1989, BRIT J ANAESTH, V63, pP630; El-Bandrawy A. M., 2013, British Journal of Medicine and Medical Research, V3, P2247; Gan TJ, 2004, ANESTH ANALG, V99, P1070, DOI [10.1213/01.ANE.0000130355.91214.9E, 10.1213/01.ane.0000130355.91214.9e]; Gan TJ, 2006, ANESTH ANALG, V102, P1884, DOI 10.1213/01.ANE.0000219597.16143.4D; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Habib AS, 2006, ANESTH ANALG, V102, P581, DOI 10.1213/01.ane.0000189217.19600.5c; Harmon D, 2000, BRIT J ANAESTH, V84, P463; Kim KS, 2002, ANESTH ANALG, V95, P1103, DOI 10.1097/00000539-200210000-00059; Klein AA, 2004, J CARDIOTHOR VASC AN, V18, P68, DOI 10.1053/j.jvca.2003.10.014; Lee A, 1999, ANESTH ANALG, V88, P1362, DOI 10.1097/00000539-199906000-00031; LEE A, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003281.PUB2; Lee A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003281.pub3; Li BG, 2011, J LIAONING U TCM, V13, P135; LI GP, 2013, CHINESE J ETHNOMEDIC, V22, P31; LI J, 2011, J QILU NURSING, V17, P122; Lin JG, 2002, PAIN, V99, P509, DOI 10.1016/S0304-3959(02)00261-0; Liodden I, 2011, ACUPUNCT MED, V29, P9, DOI 10.1136/aim.2010.002915; LIU SF, 2010, 2010 INT S OV PROSP, P335; Liu YY, 2008, CHIN J INTEGR MED, V14, P94, DOI 10.1007/s11655-008-0094-4; Lu ZX, 2009, J ZHEJIANG COLL TRAD, V33, P862; LV H, 2012, J TRADITIONAL CHINES, V31, P23; Lv JQ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-153; Ma Ting-Ting, 2010, Zhongguo Zhen Jiu, V30, P407; MacPherson Hugh, 2010, J Evid Based Med, V3, P140, DOI 10.1111/j.1756-5391.2010.01086.x; Majholm B, 2011, EUR J ANAESTH, V28, P412, DOI 10.1097/EJA.0b013e32833f6f42; MAYER DJ, 1977, BRAIN RES, V121, P368, DOI 10.1016/0006-8993(77)90161-5; Norheim AJ, 2010, ACUPUNCT MED, V28, P71, DOI 10.1136/aim.2009.002220; Ouyang Ming-wen, 2009, Zhongguo Zhen Jiu, V29, P915; PEI Y, 2010, J TRADITIONAL CHINES, V28, P36; Pettersson PH, 2012, J CLIN NURS, V21, P1799, DOI 10.1111/j.1365-2702.2012.04114.x; Schlager A, 1998, BRIT J ANAESTH, V81, P529, DOI 10.1093/bja/81.4.529; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Shenkman Z, 1999, ANESTHESIOLOGY, V90, P1311, DOI 10.1097/00000542-199905000-00015; Shiao SYPK, 2006, EXPLORE-NY, V2, P200, DOI 10.1016/j.explore.2006.02.004; Streitberger K, 2004, ANAESTHESIA, V59, P142, DOI 10.1111/j.1365-2044.2004.03577.x; Tang Wei, 2013, Zhongguo Zhen Jiu, V33, P159; Turgut S, 2007, EUR J ANAESTH, V24, P87, DOI 10.1017/S0265021506001190; Vickers AJ, 1996, J ROY SOC MED, V89, P303, DOI 10.1177/014107689608900602; WANG H, 2004, CHONGQING MED J, V33, P1647; WANG SQ, 2012, NURSING SCI, V27, P49; Wang XQ, 2010, J NEUROSURG ANESTH, V22, P128, DOI 10.1097/ANA.0b013e3181c9fbde; WANG ZY, 2009, CHINESE J MISDIAGNOS, V9, P5350; WEIGHTMAN WM, 1987, BRIT MED J, V295, P1379, DOI 10.1136/bmj.295.6610.1379; Wetzel B, 2011, CLIN J PAIN, V27, P262, DOI 10.1097/AJP.0b013e3181fd516c; White PF, 2005, ANESTH ANALG, V100, P367, DOI 10.1213/01.ANE.0000144425.16116.0A; Windle P E, 2001, J Perianesth Nurs, V16, P158, DOI 10.1053/jpan.2001.24040; Xu M, 2012, J NEUROSURG ANESTH, V24, P312, DOI 10.1097/ANA.0b013e31825eb5ef; YANG LC, 1993, ACTA ANAESTH SCAND, V37, P192, DOI 10.1111/j.1399-6576.1993.tb03699.x; Yang Wei, 2011, Zhen Ci Yan Jiu, V36, P292; YAO AJ, 2012, ASIA PACIFIC TRADITI, V8, P82; YENTIS SM, 1991, BRIT J ANAESTH, V67, P779, DOI 10.1093/bja/67.6.779; Yentis SM, 1998, ACUPUNCT MED, V16, P10, DOI DOI 10.1136/AIM.16.1.10; Yu Jian-ming, 2010, Zhen Ci Yan Jiu, V35, P43; YUAN J, 2000, MODERN J INTEGRATED, V9, P1358; ZENG QL, 1999, SHANGHAI J ACUPUNCTU, V18, P8; ZENG ZD, 2011, CHIN J MOD DRUG APPL, V5, P59; ZHANG ZY, 2010, GUIDE CHINA MED, V8, P209, DOI DOI 10.3969/J.ISSN.1671-8194.2010.33.149	70	68	77	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82474	10.1371/journal.pone.0082474	http://dx.doi.org/10.1371/journal.pone.0082474			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349293	Green Submitted, Green Published, gold			2022-12-27	WOS:000328734200046
J	Ciaranello, AL; Morris, BL; Walensky, RP; Weinstein, MC; Ayaya, S; Doherty, K; Leroy, V; Hou, TG; Desmonde, S; Lu, ZG; Noubary, F; Patel, K; Ramirez-Avila, L; Losina, E; Seage, GR; Freedberg, KA				Ciaranello, Andrea L.; Morris, Bethany L.; Walensky, Rochelle P.; Weinstein, Milton C.; Ayaya, Samuel; Doherty, Kathleen; Leroy, Valeriane; Hou, Taige; Desmonde, Sophie; Lu, Zhigang; Noubary, Farzad; Patel, Kunjal; Ramirez-Avila, Lynn; Losina, Elena; Seage, George R., III; Freedberg, Kenneth A.			Validation and Calibration of a Computer Simulation Model of Pediatric HIV Infection	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; COST-EFFECTIVENESS; ANTIRETROVIRAL THERAPY; COTRIMOXAZOLE PROPHYLAXIS; DISEASE PROGRESSION; ECONOMIC-EVALUATION; VIRUS-INFECTION; INFANTS BORN; COTE-DIVOIRE; MORTALITY	Background: Computer simulation models can project long-term patient outcomes and inform health policy. We internally validated and then calibrated a model of HIV disease in children before initiation of antiretroviral therapy to provide a framework against which to compare the impact of pediatric HIV treatment strategies. Methods: We developed a patient-level (Monte Carlo) model of HIV progression among untreated children <5 years of age, using the Cost-Effectiveness of Preventing AIDS Complications model framework: the CEPAC-Pediatric model. We populated the model with data on opportunistic infection and mortality risks from the International Epidemiologic Database to Evaluate AIDS (IeDEA), with mean CD4% at birth (42%) and mean CD4% decline (1.4%/month) from the Women and Infants' Transmission Study (WITS). We internally validated the model by varying WITS-derived CD4% data, comparing the corresponding model-generated survival curves to empirical survival curves from IeDEA, and identifying best-fitting parameter sets as those with a root-mean square error (RMSE) <0.01. We then calibrated the model to other African settings by systematically varying immunologic and HIV mortality-related input parameters. Model-generated survival curves for children aged 0-60 months were compared, again using RMSE, to UNAIDS data from >1,300 untreated, HIV-infected African children. Results: In internal validation analyses, model-generated survival curves fit IeDEA data well; modeled and observed survival at 16 months of age were 91.2% and 91.1%, respectively. RMSE varied widely with variations in CD4% parameters; the best fitting parameter set (RMSE = 0.00423) resulted when CD4% was 45% at birth and declined by 6%/month (ages 0-3 months) and 0.3%/month (ages > 3 months). In calibration analyses, increases in IeDEA-derived mortality risks were necessary to fit UNAIDS survival data. Conclusions: The CEPAC-Pediatric model performed well in internal validation analyses. Increases in modeled mortality risks required to match UNAIDS data highlight the importance of pre-enrollment mortality in many pediatric cohort studies.	[Ciaranello, Andrea L.; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Morris, Bethany L.; Walensky, Rochelle P.; Doherty, Kathleen; Hou, Taige; Lu, Zhigang; Noubary, Farzad; Losina, Elena; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Ciaranello, Andrea L.; Walensky, Rochelle P.; Ramirez-Avila, Lynn; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Ciaranello, Andrea L.; Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Losina, Elena] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Walensky, Rochelle P.; Losina, Elena; Freedberg, Kenneth A.] Harvard Univ, Ctr AIDS Res, Boston, MA 02115 USA; [Weinstein, Milton C.; Freedberg, Kenneth A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Patel, Kunjal; Seage, George R., III] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ayaya, Samuel] Moi Univ, Dept Child Hlth & Pediat, Eldoret, Kenya; [Leroy, Valeriane; Desmonde, Sophie] Univ Bordeaux 2, Inst Sante Publ & Dev, INSERM, U897, F-33076 Bordeaux, France; [Ramirez-Avila, Lynn] Childrens Hosp, Boston, MA 02115 USA; [Ramirez-Avila, Lynn] Univ Calif Los Angeles, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90024 USA; [Losina, Elena] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Moi University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Harvard University; Boston Children's Hospital; University of California System; University of California Los Angeles; Boston University; Boston University	Ciaranello, AL (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	aciaranello@partners.org	Desmonde, Sophie/AAC-3850-2019; Leroy, Valeriane/GQB-1102-2022; Leroy, Valeriane/AAO-5175-2020; Leroy, Valeriane/F-8129-2013; Desmonde, Sophie/E-4748-2019; , Andrea/ABB-3330-2021	Desmonde, Sophie/0000-0001-9372-2819; Leroy, Valeriane/0000-0003-3542-8616; Leroy, Valeriane/0000-0003-3542-8616; Leroy, Valeriane/0000-0003-3542-8616; Desmonde, Sophie/0000-0001-9372-2819; , Andrea/0000-0002-4268-3263; Walensky, Rochelle P./0000-0002-8795-379X; Losina, ELENA/0000-0002-3424-0892	National Institutes of Health (International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT); National Institute of Allergy and Infectious Diseases [K01 AI078754, K24 AI062476, R01 AI058736, R01 AI093269, U01 AI069911, U01AI09919]; Harvard Center for AIDS Research; Elizabeth Glaser Pediatric AIDS Foundation; March of Dimes Foundation; Massachusetts General Hospital Executive Committee on Research; National Institute of Allergy and Infectious Diseases (NIAID) [U01 AI068632]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Mental Health (NIMH) [AI068632]; Statistical and Data Analysis Center at Harvard School of Public Health, under the National Institute of Allergy and Infectious Diseases [5 U01 AI41110, 1 U01 AI068616]; National Institute of Allergy and Infectious Diseases (NIAID); NICHD International and Domestic Pediatric and Maternal HIV Clinical Trials Network; NICHD [N01-DK-9-001/HHSN267200800001C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI041110, U01AI069911, U01AI068632, UM1AI068632, K24AI062476, F32AI009919, U01AI068616, R01AI058736, K01AI078754, R01AI093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK009001] Funding Source: NIH RePORTER	National Institutes of Health (International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Harvard Center for AIDS Research; Elizabeth Glaser Pediatric AIDS Foundation; March of Dimes Foundation(March of Dimes); Massachusetts General Hospital Executive Committee on Research; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Statistical and Data Analysis Center at Harvard School of Public Health, under the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD International and Domestic Pediatric and Maternal HIV Clinical Trials Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT); National Institute of Allergy and Infectious Diseases, through K01 AI078754, K24 AI062476, R01 AI058736, R01 AI093269 (RPW), U01 AI069911, U01AI09919 (IeDEA West Africa); the Harvard Center for AIDS Research); the Elizabeth Glaser Pediatric AIDS Foundation, the March of Dimes Foundation, and the Massachusetts General Hospital Executive Committee on Research. Overall support for IMPAACT was provided by the National Institute of Allergy and Infectious Diseases (NIAID) [U01 AI068632], the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the National Institute of Mental Health (NIMH) [AI068632]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This work was supported by the Statistical and Data Analysis Center at Harvard School of Public Health, under the National Institute of Allergy and Infectious Diseases cooperative agreement #5 U01 AI41110 with the Pediatric AIDS Clinical Trials Group (PACTG) and #1 U01 AI068616 with the IMPAACT Group. Support of the sites was provided by the National Institute of Allergy and Infectious Diseases (NIAID) and the NICHD International and Domestic Pediatric and Maternal HIV Clinical Trials Network funded by NICHD (contract number N01-DK-9-001/HHSN267200800001C). Sophie Desmonde is a fellow of the Ecole des Hautes Etudes en Sante Publique (EHESP), Rennes, France. The funders had no role in study design, data analysis, interpretation of results, or decision to publish.	Adhikari M, 2006, INDIAN PEDIATR, V43, P804; Bagenda D, 2006, PEDIATRICS, V117, P729, DOI 10.1542/peds.2004-2699; Becquet R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028510; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Chearskul S, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.2.e25; CIARANELLO A, 2011, INCIDENCE WHO STAGE, P71222; Ciaranello AL, 2013, CLIN INFECT DIS, V56, P430, DOI 10.1093/cid/cis858; Ciaranello AL, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001156; Ciaranello AL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-59; Ciaranello AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020224; Ciaranello AL, 2011, AIDS, V25, P479, DOI 10.1097/QAD.0b013e3283428cbe; Desmonde S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-182; Eddy DM, 2012, VALUE HEALTH, V15, P843, DOI 10.1016/j.jval.2012.04.012; Egger M, 2008, LANCET, V371, P1558, DOI 10.1016/S0140-6736(08)60669-8; Ferrand RA, 2007, CLIN INFECT DIS, V44, P874, DOI 10.1086/511878; Foca M, 2006, PEDIATRICS, V118, P146, DOI 10.1542/peds.2005-0294; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; FRYBACK DG, 2006, JNCI MONOGRAPHS, V36, P11; Gibb DM, 2008, AIDS, V22, P97, DOI 10.1097/01.aids.0000302262.51286.a5; Goldhaber-Fiebert JD, 2010, VALUE HEALTH, V13, P667, DOI 10.1111/j.1524-4733.2010.00698.x; Goldie SJ, 2006, NEW ENGL J MED, V355, P1141, DOI 10.1056/NEJMsa060247; Graham SM, 2000, LANCET, V355, P369, DOI 10.1016/S0140-6736(98)11074-7; Hunink M, 2003, DECISION MAKING HLTH; Hussey GD, 1998, S AFR MED J, V88, P554; Johri Mira, 2011, Cost Eff Resour Alloc, V9, P3, DOI 10.1186/1478-7547-9-3; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Marston M, 2011, INT J EPIDEMIOL, V40, P385, DOI 10.1093/ije/dyq255; MCINTYRE JA, 2005, ADDITION SHORT COURS, P71222; Menzies NA, 2009, PEDIATR INFECT DIS J, V28, P819, DOI 10.1097/INF.0b013e3181a3954b; Mphatswe W, 2007, AIDS, V21, P1253, DOI 10.1097/QAD.0b013e3281a3bec2; Munyagwa M, 2012, TROP MED INT HEALTH, V17, P836, DOI 10.1111/j.1365-3156.2012.03000.x; *NAT I ALL INF DIS, 2012, INT EP DAT EV AIDS, P71222; *NAT TECHN INF, 2010, WOM INF TRANS STUD W, P71222; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Orlando S, 2010, JAIDS-J ACQ IMM DEF, V55, P631, DOI 10.1097/QAI.0b013e3181f9f9f5; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; PRENDERGAST A, 2008, FUTURE HIV THER, V2, P201; Prendergast A, 2008, AIDS, V22, P1333, DOI 10.1097/QAD.0b013e32830437df; Robberstad B, 2010, JAIDS-J ACQ IMM DEF, V55, P397, DOI 10.1097/QAI.0b013e3181eef4d3; Ryan M, 2008, AIDS, V22, P749, DOI 10.1097/QAD.0b013e3282f43519; Rydzak CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012647; Salomon JA, 2002, AM J EPIDEMIOL, V156, P761, DOI 10.1093/aje/kwf100; Sax PE, 2005, CLIN INFECT DIS, V41, P1316, DOI 10.1086/496984; Schneider K, 2011, AIDS, V25, P1143, DOI 10.1097/QAD.0b013e3283466fab; Shah M, 2011, AIDS, V25, P1093, DOI 10.1097/QAD.0b013e32834670b9; SHEON AR, 1996, J WOMENS HEALTH, V5, P69, DOI DOI 10.1089/JWH.1996.5.69; Spiegelhalter DJ, 2003, STAT MED, V22, P3687, DOI 10.1002/sim.1586; Spira R, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e56; Stout NK, 2009, PHARMACOECONOMICS, V27, P533, DOI 10.2165/11314830-000000000-00000; *UNAIDS CHILD SURV, 2010, SURV CHILDR HIV INF, P71222; United Nations, 2009, WORLD POP PROSP 2008; Vanni T, 2011, PHARMACOECONOMICS, V29, P35, DOI 10.2165/11584600-000000000-00000; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Walker AS, 2006, JAIDS-J ACQ IMM DEF, V42, P637, DOI 10.1097/01.qai.0000226334.34717.dc; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; World Health Organization, 2010, ANT THER HIV INF INF; Yazdanpanah Y, 2005, AIDS, V19, P1299, DOI 10.1097/01.aids.0000180101.80888.c6	58	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83389	10.1371/journal.pone.0083389	http://dx.doi.org/10.1371/journal.pone.0083389			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349503	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200082
J	Czeredys, M; Samluk, L; Michalec, K; Tulodziecka, K; Skowronek, K; Nalecz, KA				Czeredys, Magdalena; Samluk, Lukasz; Michalec, Katarzyna; Tulodziecka, Karolina; Skowronek, Krzysztof; Nalecz, Katarzyna A.			Caveolin-1-A Novel Interacting Partner of Organic Cation/Carnitine Transporter (Octn2): Effect of Protein Kinase C on This Interaction in Rat Astrocytes	PLOS ONE			English	Article							ENERGY-TRANSFER MICROSCOPY; CELL-SURFACE EXPRESSION; CARNITINE TRANSPORTER; CATION TRANSPORTERS; FUNCTIONAL-CHARACTERIZATION; NOREPINEPHRINE TRANSPORTER; GLUTAMATE TRANSPORTER; MEMBRANE RAFTS; LIVING CELLS; PHOSPHORYLATION	OCTN2 - the Organic Cation Transporter Novel family member 2 (SLC22A5) is known to be a xenobiotic/drug transporter. It transports as well carnitine - a compound necessary for oxidation of fatty acids and mutations of its gene cause primary carnitine deficiency. Octn2 regulation by protein kinase C (PKC) was studied in rat astrocytes - cells in which beta-oxidation takes place in the brain. Activation of PKC with phorbol ester stimulated L-carnitine transport and increased cell surface presence of the transporter, although no PKC-specific phosphorylation of Octn2 could be detected. PKC activation resulted in an augmented Octn2 presence in cholesterol/sphingolipid-rich microdomains of plasma membrane (rafts) and increased co-precipitation of Octn2 with raft-proteins, caveolin-1 and flotillin-1. Deletion of potential caveolin-1 binding motifs pointed to amino acids 14-22 and 447-454 as the caveolin-1 binding sites within Octn2 sequence. A direct interaction of Octn2 with caveolin-1 in astrocytes upon PKC activation was detected by proximity ligation assay, while such an interaction was excluded in case of flotillin-1. Functioning of a multi-protein complex regulated by PKC has been postulated in rOctn2 trafficking to the cell surface, a process which could be important both under physiological conditions, when carnitine facilitates fatty acids catabolism and controls free Coenzyme A pool as well as in pathology, when transport of several drugs can induce secondary carnitine deficiency.	[Czeredys, Magdalena; Samluk, Lukasz; Michalec, Katarzyna; Tulodziecka, Karolina; Nalecz, Katarzyna A.] M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland; [Skowronek, Krzysztof] Int Inst Mol & Cell Biol, Lab Bioinformat & Prot Engn, Warsaw, Poland; [Skowronek, Krzysztof] M Nencki Inst Expt Biol, Dept Biochem, PL-02093 Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Nalecz, KA (corresponding author), M Nencki Inst Expt Biol, Dept Mol & Cellular Neurobiol, PL-02093 Warsaw, Poland.	k.nalecz@nencki.gov.pl	Nalecz, Katarzyna Anna/R-4130-2016; Skowronek, Krzysztof/G-2855-2010	Nalecz, Katarzyna Anna/0000-0002-9928-890X; Skowronek, Krzysztof/0000-0001-9973-7085; Czeredys, Magdalena/0000-0001-5419-1234; Samluk, Lukasz/0000-0003-2092-123X	Polish Ministry of Science and Higher Education/National Science Centre [4427/B/P01/2010/38]; Nencki Institute; Foundation for Polish Science [MPD/2009/4]; European Union Innovative Economy Operational Programme	Polish Ministry of Science and Higher Education/National Science Centre; Nencki Institute; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union Innovative Economy Operational Programme	This work was financed by grant 4427/B/P01/2010/38 from the Polish Ministry of Science and Higher Education/National Science Centre (http://www.ncn.gov.pl) and by the Nencki Institute (http://www.nencki.gov.pl). KM receives a scholarship funded by the "International PhD Studies in Neurobiology'' - project MPD/2009/4 of the Foundation for Polish Science (http://www.fnp.org.pl), co-financed by the European Union Innovative Economy Operational Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Becker C, 2001, ENDOCRINOLOGY, V142, P5267, DOI 10.1210/en.142.12.5267; Butchbach MER, 2004, J BIOL CHEM, V279, P34388, DOI 10.1074/jbc.M403938200; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Cremona ML, 2011, NAT NEUROSCI, V14, P469, DOI 10.1038/nn.2781; Czeredys M, 2008, BIOCHEM BIOPH RES CO, V376, P267, DOI 10.1016/j.bbrc.2008.08.122; Ebert D, 2003, J NEUROSCI, V23, P5928; Eriksen J, 2010, J NEUROCHEM, V113, P27, DOI 10.1111/j.1471-4159.2010.06599.x; Fornes A, 2008, BIOCHEM J, V412, P495, DOI 10.1042/BJ20071018; Foster JD, 2008, J NEUROCHEM, V105, P1683, DOI 10.1111/j.1471-4159.2008.05262.x; Ganapathy ME, 2000, J BIOL CHEM, V275, P1699, DOI 10.1074/jbc.275.3.1699; Gonzalez MI, 2007, J BIOL CHEM, V282, P29855, DOI 10.1074/jbc.M704738200; Gonzalez MI, 2005, J NEUROCHEM, V94, P1180, DOI 10.1111/j.1471-4159.2005.03330.x; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Grundemann D, 2005, P NATL ACAD SCI USA, V102, P5256, DOI 10.1073/pnas.0408624102; Head BP, 2007, TRENDS CELL BIOL, V17, P51, DOI 10.1016/j.tcb.2006.11.008; Inazu M, 2006, J NEUROCHEM, V97, P424, DOI 10.1111/j.1471-4159.2006.03757.x; Ito J, 2006, J NEUROCHEM, V97, P1034, DOI 10.1111/j.1471-4159.2006.03805.x; Januszewicz E, 2009, INT J BIOCHEM CELL B, V41, P2599, DOI 10.1016/j.biocel.2009.08.020; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Kato Y, 2005, MOL PHARMACOL, V67, P734, DOI 10.1124/mol.104.002212; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; KIMURA S, 1990, BRAIN DEV-JPN, V12, P436, DOI 10.1016/S0387-7604(12)80079-9; Koepsell H, 2013, MOL ASPECTS MED, V34, P413, DOI 10.1016/j.mam.2012.10.010; Lamhonwah AM, 2005, BIOCHEM BIOPH RES CO, V338, P1966, DOI 10.1016/j.bbrc.2005.10.170; Lamhonwah AM, 2008, BRAIN DEV-JPN, V30, P31, DOI 10.1016/j.braindev.2007.05.005; Langhorst MF, 2005, CELL MOL LIFE SCI, V62, P2228, DOI 10.1007/s00018-005-5166-4; Luci S, 2006, BIOCHEM BIOPH RES CO, V350, P704, DOI 10.1016/j.bbrc.2006.09.099; MOORE SA, 1991, J NEUROCHEM, V56, P518, DOI 10.1111/j.1471-4159.1991.tb08180.x; Nagai K, 2006, ARCH BIOCHEM BIOPHYS, V452, P29, DOI 10.1016/j.abb.2006.06.006; Nakanishi T, 2001, J PHYSIOL-LONDON, V532, P297, DOI 10.1111/j.1469-7793.2001.0297f.x; NALECZ KA, 1995, ARCH BIOCHEM BIOPHYS, V322, P214, DOI 10.1006/abbi.1995.1454; Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030; Nieweg K, 2009, J NEUROCHEM, V109, P125, DOI 10.1111/j.1471-4159.2009.05917.x; Nothmann D, 2011, J BIOL CHEM, V286, P3935, DOI 10.1074/jbc.M110.187492; Nunez E, 2008, J NEUROCHEM, V105, P2080, DOI 10.1111/j.1471-4159.2008.05292.x; Ohashi R, 2001, MOL PHARMACOL, V59, P358, DOI 10.1124/mol.59.2.358; Pfrieger FW, 2011, PROG LIPID RES, V50, P357, DOI 10.1016/j.plipres.2011.06.002; Pochini L, 2013, J BIOMOL SCREEN, V18, P851, DOI 10.1177/1087057113493006; Qian Y, 1997, J NEUROSCI, V17, P45, DOI 10.1523/JNEUROSCI.17-01-00045.1997; Ramsay RR, 2000, BIOCHEM SOC T, V28, P182, DOI 10.1042/bst0280182; Rodriguez CM, 2002, BIOL REPROD, V67, P314, DOI 10.1095/biolreprod67.1.314; Rytting E, 2008, BIOCHEM PHARMACOL, V75, P745, DOI 10.1016/j.bcp.2007.09.015; Samluk L, 2012, BIOCHEM BIOPH RES CO, V422, P64, DOI 10.1016/j.bbrc.2012.04.106; Samluk L, 2010, J NEUROCHEM, V115, P1386, DOI 10.1111/j.1471-4159.2010.07040.x; SARGIACOMO M, 1995, P NATL ACAD SCI USA, V92, P9407, DOI 10.1073/pnas.92.20.9407; Scafidi S, 2010, J NEUROCHEM, V114, P820, DOI 10.1111/j.1471-4159.2010.06807.x; Schlegel A, 2001, J BIOL CHEM, V276, P4398, DOI 10.1074/jbc.M005448200; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Sekine T, 1998, BIOCHEM BIOPH RES CO, V251, P586, DOI 10.1006/bbrc.1998.9521; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Stuermer CAO, 2011, J NEUROCHEM, V116, P708, DOI 10.1111/j.1471-4159.2010.07007.x; Tamai I, 2000, J BIOL CHEM, V275, P40064, DOI 10.1074/jbc.M005340200; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Tamai I, 2013, BIOPHARM DRUG DISPOS, V34, P29, DOI 10.1002/bdd.1816; Tein I, 2013, HAND CLINIC, V113, P1675, DOI 10.1016/B978-0-444-59565-2.00035-6; Wagner CA, 2000, AM J PHYSIOL-RENAL, V279, pF584, DOI 10.1152/ajprenal.2000.279.3.F584; Watanabe C, 2006, DRUG METAB DISPOS, V34, P1927, DOI 10.1124/dmd.106.010207; WEISZ OA, 1993, J CELL BIOL, V122, P1185, DOI 10.1083/jcb.122.6.1185; Wu X, 1998, BIOCHEM BIOPH RES CO, V246, P589, DOI 10.1006/bbrc.1998.8669; Wu X, 1999, J PHARMACOL EXP THER, V290, P1482; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	65	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82105	10.1371/journal.pone.0082105	http://dx.doi.org/10.1371/journal.pone.0082105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349196	Green Submitted, gold, Green Published			2022-12-27	WOS:000328734200027
J	Neteler, M; Metz, M; Rocchini, D; Rizzoli, A; Flacio, E; Engeler, L; Guidi, V; Luthy, P; Tonolla, M				Neteler, Markus; Metz, Markus; Rocchini, Duccio; Rizzoli, Annapaola; Flacio, Eleonora; Engeler, Luca; Guidi, Valeria; Luethy, Peter; Tonolla, Mauro			Is Switzerland Suitable for the Invasion of Aedes albopictus?	PLOS ONE			English	Article							CULICIDAE; DIPTERA; CLIMATE; DENGUE; TEMPERATURE; CHIKUNGUNYA; MOSQUITOS; SURVIVAL; VECTOR; FRANCE	Background: Over the last 30 years, the Asian tiger mosquito, Aedes albopictus, has rapidly spread around the world. The European distribution comprises the Mediterranean basin with a first appearance in Switzerland in 2003. Early identification of the most suitable areas in Switzerland allowing progressive invasion by this species is considered crucial to suggest adequate surveillance and control plans. Methodology/Principal Findings: We identified the most suitable areas for invasion and establishment of Ae. albopictus in Switzerland. The potential distribution areas linked to the current climatic suitability were assessed using remotely sensed land surface temperature data recorded by the MODIS satellite sensors. Suitable areas for adult survival and overwintering of diapausing eggs were also identified for future climatic conditions, considering two different climate change scenarios (A1B, A2) for the periods 2020-2049 and 2045-2074. At present, the areas around Lake Geneva in western Switzerland provide suitable climatic conditions for Ae. albopictus. In northern Switzerland, parts of the Rhine valley, around Lake Constance, as well as the surroundings of Lake Neuchatel, appear to be suitable for the survival at least of adult Ae. albopictus. However, these areas are characterized by winters currently being too cold for survival and development of diapausing eggs. In southern Switzerland, Ae. albopictus is already well-established, especially in the Canton of Ticino. For the years 2020-2049, the predicted possible spread of the tiger mosquito does not differ significantly from its potential current distribution. However, important expansions are obtained if the period is extended to the years 2045-2074, when Ae. albopictus may invade large new areas. Conclusions/Significance: Several parts of Switzerland provide suitable climatic conditions for invasion and establishment of Ae. albopictus. The current distribution and rapid spread in other European countries suggest that the tiger mosquito will colonize new areas in Switzerland in the near future.	[Neteler, Markus; Metz, Markus; Rocchini, Duccio; Rizzoli, Annapaola] Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, San Michele All Adige, TN, Italy; [Flacio, Eleonora; Engeler, Luca; Luethy, Peter; Tonolla, Mauro] Dept Hlth, Mosquito Working Grp, Bellinzona, Switzerland; [Guidi, Valeria; Tonolla, Mauro] Inst Microbiol, Reg Lab Biosafety, Bellinzona, Switzerland; [Luethy, Peter] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Tonolla, Mauro] Univ Geneva, Microbial Ecol Grp, Microbiol Unit, Dept Plant Biol, Geneva, Switzerland	Fondazione Edmund Mach; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva	Neteler, M (corresponding author), Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, San Michele All Adige, TN, Italy.	markus.neteler@fmach.it	Rizzoli, Annapaola/J-2439-2012; Neteler, Markus/C-6328-2008	Rizzoli, Annapaola/0000-0003-3997-6783; Neteler, Markus/0000-0003-1916-1966; Rocchini, Duccio/0000-0003-0087-0594; Guidi, Valeria/0000-0001-5553-3136; Tonolla, Mauro/0000-0002-8861-7763	Swiss Federal Office for the Environment (FOEN); Autonomous Province of Trento (Italy), Research funds for Grandi Progetti, Project LExEM (Laboratory of excellence for epidemiology and modeling)	Swiss Federal Office for the Environment (FOEN); Autonomous Province of Trento (Italy), Research funds for Grandi Progetti, Project LExEM (Laboratory of excellence for epidemiology and modeling)	This study was financially supported by the Swiss Federal Office for the Environment (FOEN, http://www.bafu.admin.ch, Bern, Switzerland). It was also partially funded by the Autonomous Province of Trento (Italy), Research funds for Grandi Progetti, Project LExEM (Laboratory of excellence for epidemiology and modeling, http://www.lexem.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini R, 2007, EURO SURVEILL B EUR, V12; Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Eritja R, 2005, BIOL INVASIONS, V7, P87, DOI 10.1007/s10530-004-9637-6; *EUR CTR DIS PREV, 2009, DEV AED ALB RISK MAP; Fischer AM, 2012, INT J CLIMATOL, V32, P2348, DOI 10.1002/joc.3396; Fischer D, 2014, EUROSURVEILLANCE, V19, P34, DOI 10.2807/1560-7917.ES2014.19.6.20696; Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008; Flacio E, 2004, BOLL SOC TICIN SCI N, V92, P141; Gjenero-Margan I, 2011, EURO SURVEILL B EUR, V16; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Kampen H, 2013, PARASITOL RES, V112, P905, DOI 10.1007/s00436-012-3128-y; Kobayashi M, 2002, J MED ENTOMOL, V39, P4, DOI 10.1603/0022-2585-39.1.4; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Luthy P, 2006, B OFSP, V26, P501; Medlock JM, 2006, J VECTOR ECOL, V31, P292, DOI 10.3376/1081-1710(2006)31[292:AOTPFS]2.0.CO;2; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; MeteoSwiss ETH NCCR Climate OcCC, 2011, SWISS CLIM CHANG SCE; MITCHELL CJ, 1995, J VECTOR ECOL, V20, P44; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Neteler M, 2010, THESIS; Neteler M, 2012, ENVIRON MODELL SOFTW, V31, P124, DOI 10.1016/j.envsoft.2011.11.014; Neteler M, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-49; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Rocchini D, 2012, TRENDS ECOL EVOL, V27, P310, DOI 10.1016/j.tree.2012.03.009; Roiz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014800; Roiz D, 2010, VECTOR-BORNE ZOONOT, V10, P811, DOI 10.1089/vbz.2009.0098; Romi R., 2008, EUR INF DIS, V2, P98; Stephenson TS, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009127; van Vliet J, 2009, ENERG ECON, V31, pS152, DOI 10.1016/j.eneco.2009.06.010; Werner D, 2012, EURO SURVEILL B EUR, V17; Wymann MN, 2008, EURO SURVEILL B EUR, V13	34	27	27	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82090	10.1371/journal.pone.0082090	http://dx.doi.org/10.1371/journal.pone.0082090			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349190	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200026
J	Xue, C; Nie, W; Tang, D; Yi, LJ; Mei, CL				Xue, Cheng; Nie, Wei; Tang, Dan; Yi, Lujiang; Mei, Changlin			Apolipoprotein E Gene Variants on the Risk of End Stage Renal Disease	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; CHRONIC KIDNEY-DISEASE; E POLYMORPHISM; HEMODIALYSIS-PATIENTS; LIPOPROTEIN LEVELS; E PHENOTYPES; ASSOCIATION; ATHEROSCLEROSIS; METAANALYSIS; NEPHROPATHY	Objective: End-stage renal disease (ESRD) is a severe health concern over the world. Associations between apolipoprotein E (apoE) gene polymorphisms and the risk of ESRD remained inconclusive. This study aimed to investigate the association between apoE gene polymorphisms and ESRD susceptibility. Methods: Databases including PubMed, Embase, Web of Science and the Cochrane Library were searched to find relevant studies. Meta-analysis method was used synthesize the eligible studies. Results: Sixteen pertinent case-control studies which included 3510 cases and 13924 controls were analyzed. A significant association was found between epsilon 2 allele and the ESRD risk (odds ratio (OR) = 1.30, 95% confidence interval (CI) 1.15-1.46, P < 0.0001; I-2 = 18%, P for heterogeneity = 0.24). The epsilon(2)epsilon(3), epsilon(2)epsilon(4), epsilon(3)epsilon(3), epsilon(3)epsilon(4), epsilon(4)epsilon(4), epsilon(3) and epsilon(4) were not associated with the susceptibility of ESRD. In the subgroup analysis by ethnicity, there was a statistically significant association between epsilon 2 epsilon 3 or epsilon 2 allele and ESRD risk in East Asians (OR = 1.66, 95% CI 1.31-2.10, P < 0.0001; OR = 1.62, 95% CI 1.31-2.01, P < 0.0001, respectively), but not in Caucasians. E2 carriers had higher plasma apoE (mean difference = 16.24 mg/L, 95% CI 7.76-24.73, P = 0.0002) than the (epsilon 3 + epsilon 4) carriers in patients with ESRD. The publication bias was not significant. Conclusion: The epsilon 2 allele of apoE gene might increase the risk of ESRD. E2 carriers expressed higher level of plasma apoE in patients with ESRD. More well-designed studies are needed to confirm these associations in the future.	[Xue, Cheng; Mei, Changlin] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Nephrol, Shanghai, Peoples R China; [Nie, Wei] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Resp Dis, Shanghai, Peoples R China; [Tang, Dan] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Gastroenterol, Shanghai, Peoples R China; [Yi, Lujiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanjing, Jiangsu, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University; Nanjing Medical University	Mei, CL (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Nephrol, Shanghai, Peoples R China.	chlmei1954@126.com	Xue, Cheng/P-5629-2019	Xue, Cheng/0000-0002-4132-9406	Pujiang Talent Program of Shanghai Municipality [12PJ1403300]; Major Basic Research Project of Science and Technology Commission of Shanghai Municipality [12DJ1400300]	Pujiang Talent Program of Shanghai Municipality; Major Basic Research Project of Science and Technology Commission of Shanghai Municipality	The work was supported by Pujiang Talent Program of Shanghai Municipality (12PJ1403300) and Major Basic Research Project of Science and Technology Commission of Shanghai Municipality (12DJ1400300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Muhanna F, 2008, SAUDI J KIDNEY DIS T, V19, P937; Ali K, 2008, ATHEROSCLEROSIS, V196, P201, DOI 10.1016/j.atherosclerosis.2007.03.038; Araki S, 2000, DIABETES, V49, P2190, DOI 10.2337/diabetes.49.12.2190; Arikan H, 2007, RENAL FAILURE, V29, P713, DOI 10.1080/08860220701460129; Asakimori Y, 2003, AM J KIDNEY DIS, V41, P822, DOI 10.1016/S0272-6386(03)00030-1; BLUE ML, 1983, P NATL ACAD SCI-BIOL, V80, P283, DOI 10.1073/pnas.80.1.283; Chen GP, 2001, J BIOL CHEM, V276, P49142, DOI 10.1074/jbc.M104879200; Choi KH, 1999, ADV PERIT D, V15, P243; Chu AY, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-108; De Feo E, 2012, MOL BIOL REP, V39, P7381, DOI 10.1007/s11033-012-1570-7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eggertsen G, 1997, NEPHROL DIAL TRANSPL, V12, P141, DOI 10.1093/ndt/12.1.141; Eto M, 2002, AM J KIDNEY DIS, V40, P243, DOI 10.1053/ajkd.2002.34502; FEUSSNER G, 1992, HUM GENET, V88, P307; Freedman BI, 2000, CURR OPIN NEPHROL HY, V9, P273, DOI 10.1097/00041552-200005000-00011; Gejyo F, 1997, KIDNEY INT, V52, pS75; Guz G, 2000, AM J KIDNEY DIS, V36, P826, DOI 10.1053/ajkd.2000.17682; Hsu CC, 2005, JAMA-J AM MED ASSOC, V293, P2892, DOI 10.1001/jama.293.23.2892; HUANG ZH, 2005, CHONGQING MED, V34, P1455; Hubacek JA, 2009, BIOCHEM GENET, V47, P688, DOI 10.1007/s10528-009-9266-y; Imura T, 1999, KIDNEY INT, V56, pS245; Karavia EA, 2011, FEBS J, V278, P3119, DOI 10.1111/j.1742-4658.2011.08238.x; Kohlmeier M, 1998, CALCIFIED TISSUE INT, V62, P278, DOI 10.1007/s002239900430; Li HF, 2010, TRANSPL P, V42, P2513, DOI 10.1016/j.transproceed.2010.04.023; Liberopoulos E, 2004, AM J KIDNEY DIS, V43, P223, DOI 10.1053/j.ajkd.2003.10.013; Nie W, 2013, GENE, V528, P304, DOI 10.1016/j.gene.2013.06.049; Oda H, 1999, KIDNEY INT, V56, pS25, DOI 10.1046/j.1523-1755.1999.07107.x; Olmer M, 1997, NEPHROL DIAL TRANSPL, V12, P691, DOI 10.1093/ndt/12.4.691; Roussos L, 2004, SCAND J UROL NEPHROL, V38, P504, DOI 10.1080/00365590410033443; SAITO T, 1993, AM J NEPHROL, V13, P64, DOI 10.1159/000168591; Sakatsume M, 2001, KIDNEY INT, V59, P1911, DOI 10.1046/j.1523-1755.2001.0590051911.x; SRINIVASAN SR, 1991, ADV EXP MED BIOL, V285, P373; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Werle E, 1998, DIABETES CARE, V21, P994, DOI 10.2337/diacare.21.6.994; Yorioka N, 1999, NEPHRON, V83, P246, DOI 10.1159/000045517; Yoshida T, 2009, GENOMICS, V93, P221, DOI 10.1016/j.ygeno.2008.11.001; Zahalkova Jana, 2002, Biomedical Papers (Olomouc), V146, P73; Zhou TB, 2012, MOL BIOL REP, V39, P9347, DOI 10.1007/s11033-012-1751-4	38	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83367	10.1371/journal.pone.0083367	http://dx.doi.org/10.1371/journal.pone.0083367			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349494	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200080
J	Ching, JCH; Lobanova, L; Loewen, ME				Ching, John C. H.; Lobanova, Liubov; Loewen, Matthew E.			Secreted hCLCA1 Is a Signaling Molecule That Activates Airway Macrophages	PLOS ONE			English	Article							CHLORIDE CONDUCTANCE MEDIATOR; MUCUS OVERPRODUCTION; CHANNEL; DOMAIN; FAMILY; GOB-5; GENE; HYPERRESPONSIVENESS; METALLOPROTEASE; EXPRESSION	The CLCA gene family produces both secreted and membrane-associated proteins that modulate ion-channel function, drive mucus production and have a poorly understood pleiotropic effect on airway inflammation. The primary up-regulated human CLCA ortholog in airway inflammation is hCLCA1. Here we show that this protein can activate airway macrophages, inducing them to express cytokines and to undertake a pivotal role in airway inflammation. In a U-937 airway macrophage-monocyte cell line, conditioned media from HEK 293 cells heterologously expressing hCLCA1 (with or without fetal bovine serum) increased the levels of pro-inflammatory cytokines (IL-1 beta, IL-6, TNF-alpha and IL-8). This effect was independent of the metalloprotease domain of hCLCA1. Primary porcine alveolar macrophages were similarly activated, demonstrating the effect was not cell line dependent. Similarly, immuno-purified hCLCA1 at physiologically relevant concentration of similar to 100 pg/mL was able to activate macrophages and induce pro-inflammatory response. This cytokine response increased with higher concentration of immuno-purified hCLCA1. These findings demonstrate the ability of hCLCA1 to function as a signaling molecule and activate macrophages, central regulators of airway inflammation.	[Ching, John C. H.; Lobanova, Liubov; Loewen, Matthew E.] Univ Saskatchewan, Dept Vet Biomed Sci, Saskatoon, SK, Canada	University of Saskatchewan	Loewen, ME (corresponding author), Univ Saskatchewan, Dept Vet Biomed Sci, Saskatoon, SK, Canada.	matthew.loewen@usask.ca			Natural Sciences and Engineering Research Council of Canada [371364-2010]; Saskatchewan Health Research Foundation New Investigator Grant; Ryan Dube Equine Health Research Fund; Canada Foundation for Innovation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Saskatchewan Health Research Foundation New Investigator Grant; Ryan Dube Equine Health Research Fund; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	The work was supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant 371364-2010 (MEL), a Saskatchewan Health Research Foundation New Investigator Grant (MEL), the Ryan Dube Equine Health Research Fund and the Canada Foundation for Innovation (MEL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghany M, 2002, J BIOL CHEM, V277, P34391, DOI 10.1074/jbc.M205307200; Alevy YG, 2012, J CLIN INVEST, V122, P4555, DOI 10.1172/JCI64896; Bellodi C, 2010, EMBO J, V29, P1865, DOI 10.1038/emboj.2010.83; Blunck R, 2001, J IMMUNOL, V166, P1009, DOI 10.4049/jimmunol.166.2.1009; Bothe M, 2011, MOL CELLS, V32, P535, DOI 10.1007/s10059-011-0158-8; Brewer JP, 1999, AM J RESP CRIT CARE, V160, P1150, DOI 10.1164/ajrccm.160.4.9806034; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; Careau E, 2006, AM J PHYSIOL-LUNG C, V290, pL871, DOI 10.1152/ajplung.00219.2005; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Cunningham SA, 1995, J BIOL CHEM, V270, P31016, DOI 10.1074/jbc.270.52.31016; Furuya M, 2010, J IMMUNOL, V185, P5769, DOI 10.4049/jimmunol.1002226; Gaspar KJ, 2000, PHYSIOL GENOMICS, V3, P101, DOI 10.1152/physiolgenomics.2000.3.2.101; Gordon SB, 2002, BRIT MED BULL, V61, P45, DOI 10.1093/bmb/61.1.45; Gray T, 2004, AM J PHYSIOL-LUNG C, V286, pL320, DOI 10.1152/ajplung.00440.2002; Greenwood IA, 2002, J BIOL CHEM, V277, P22119, DOI 10.1074/jbc.C200215200; Gueders MM, 2009, INFLAMM RES, V58, P845, DOI 10.1007/s00011-009-0054-2; Hamann M, 2009, J PHYSIOL-LONDON, V587, P2255, DOI 10.1113/jphysiol.2009.170159; Hauber Hans-Peter, 2005, Can Respir J, V12, P143; Kamada F, 2004, GENES IMMUN, V5, P540, DOI 10.1038/sj.gene.6364124; Loewen ME, 2005, PHYSIOL REV, V85, P1061, DOI 10.1152/physrev.00016.2004; Loewen ME, 2004, AM J PHYSIOL-GASTR L, V287, pG33, DOI 10.1152/ajpgi.00023.2004; Loewen ME, 2002, AM J PHYSIOL-CELL PH, V283, pC412, DOI 10.1152/ajpcell.00477.2001; Loewen ME, 2002, BIOCHEM BIOPH RES CO, V298, P531, DOI 10.1016/S0006-291X(02)02498-1; Long AJ, 2006, AM J RESP CELL MOL, V35, P357, DOI 10.1165/rcmb.2005-0451OC; Lowry MAR, 1998, CLIN EXP IMMUNOL, V111, P597; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Milton RH, 2008, J NEUROSCI, V28, P11488, DOI 10.1523/JNEUROSCI.2431-08.2008; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakanishi A, 2001, P NATL ACAD SCI USA, V98, P5175, DOI 10.1073/pnas.081510898; O'Neill SM, 2011, ARCH BIOCHEM BIOPHYS, V511, P31, DOI 10.1016/j.abb.2011.04.009; Patel AC, 2006, PHYSIOL GENOMICS, V25, P502, DOI 10.1152/physiolgenomics.00321.2005; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pukelsheim K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014299; Robichaud A, 2005, AM J RESP CELL MOL, V33, P303, DOI 10.1165/rcmb.2004-0372OC; Sabo-Attwood T, 2005, AM J PATHOL, V167, P1243, DOI 10.1016/S0002-9440(10)61212-6; Stahlberg A, 2013, METHODS, V59, P80, DOI 10.1016/j.ymeth.2012.09.007; Taher YA, 2008, J ALLERGY CLIN IMMUN, V121, P983, DOI 10.1016/j.jaci.2007.11.021; TSUKAGOSHI H, 1994, J ALLERGY CLIN IMMUN, V93, P464, DOI 10.1016/0091-6749(94)90355-7; Winpenny John P., 2009, Inflammation & Allergy Drug Targets, V8, P146; Yurtsever Z, 2012, J BIOL CHEM, V287, P42138, DOI 10.1074/jbc.M112.410282; Zheng MZ, 2011, J CANCER, V2, P478, DOI 10.7150/jca.2.478	42	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83130	10.1371/journal.pone.0083130	http://dx.doi.org/10.1371/journal.pone.0083130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349445	Green Submitted, gold, Green Published			2022-12-27	WOS:000328731800097
J	Montirosso, R; Tronick, E; Morandi, F; Ciceri, F; Borgatti, R				Montirosso, Rosario; Tronick, Ed; Morandi, Francesco; Ciceri, Francesca; Borgatti, Renato			Four-Month-Old Infants' Long-Term Memory for a Stressful Social Event	PLOS ONE			English	Article							STILL-FACE; PHYSIOLOGICAL REACTIVITY; HIPPOCAMPAL-FORMATION; DECLARATIVE MEMORY; CORTISOL; MECHANISMS; RESPONSES; BEHAVIOR; AMYGDALA; GLUCOCORTICOIDS	Infants clearly show an early capacity for memory for inanimate emotionally neutral events. However, their memory for social stress events has received far less attention. The aim of the study was to investigate infants' memory for a stressful social event (i.e., maternal unresponsiveness during the Still-Face paradigm) after a 15-day recall interval using changes in behavioral responses and salivary post-stress cortisol reactivity as measures of memory. Thirty-seven infants were exposed to social stress two times (experimental condition); the first time when they were 4 months of age and second exposure after a 2 week interval. Infants in the control condition (N = 37) were exposed to social stress just one time, at the age corresponding to the second exposure for infants in the experimental condition (4 months plus 2 weeks). Given individual differences in infants' reactivity to social stress events, we categorized infants as increasers or decreasers based on their cortisol reactivity after their initial exposure to the stress of the maternal still-face. Infants in the experimental condition, both increasers and decreasers, showed a significant change in cortisol response after the second exposure to the maternal still-face, though change was different for each reactivity group. In contrast, age-matched infants with no prior exposure to the maternal still-face showed similar post-stress cortisol reactivity to the reactivity of the experimental infants at their first exposure. There were no behavioral differences between increasers and decreasers during the Still-Face paradigm and exposures to the social stress. Thus differences between the experimental and control groups' post-stress cortisol reactivity was associated with the experimental group having previous experience with the social stress. These findings indicate long-term memory for social stress in infants as young as 4 months of age.	[Montirosso, Rosario; Borgatti, Renato] IRCCS Eugenio Medea, Inst Sci, Ctr Study Social Emot Dev Risk Infant 0 3, Bosisio Parini, Lecco, Italy; [Tronick, Ed] Univ Massachusetts, Dept Psychol, Boston, MA 02125 USA; [Morandi, Francesco] Sacra Famiglia Hosp, Pediat Unit, Erba, Como, Italy; [Ciceri, Francesca] IRCCS Eugenio Medea, Inst Sci, Biol Lab, Bosisio Parini, Lecco, Italy; [Borgatti, Renato] IRCCS Eugenio Medea, Inst Sci, Neuropsychiat & Neurorehabil Unit, Bosisio Parini, Lecco, Italy	IRCCS Eugenio Medea; University of Massachusetts System; University of Massachusetts Boston; IRCCS Eugenio Medea; IRCCS Eugenio Medea	Montirosso, R (corresponding author), IRCCS Eugenio Medea, Inst Sci, Ctr Study Social Emot Dev Risk Infant 0 3, Bosisio Parini, Lecco, Italy.	rosario.montirosso@bp.lnf.it	Borgatti, Renato/AAA-4108-2022; Tronick, Edward/P-7220-2019; Montirosso, Rosario/J-3673-2016; Borgatti, Renato/AEY-4481-2022; Borgatti, Renato/K-5139-2018	Borgatti, Renato/0000-0001-8165-4994; Montirosso, Rosario/0000-0002-2175-3082; Borgatti, Renato/0000-0001-8165-4994; Borgatti, Renato/0000-0001-8165-4994	Italian Health Minister (Ricerca Corrente); NICHD [5R01HD050459]; NSF [0819839]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050459] Funding Source: NIH RePORTER	Italian Health Minister (Ricerca Corrente); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by funds from the Italian Health Minister (Ricerca Corrente 2007) and grants from NICHD 5R01HD050459 (E. T., PI) and NSF 0819839, (E. T., PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson LB, 2003, INFANCY, V4, P451, DOI 10.1207/S15327078IN0404_01; Al'Absi M, 2002, PSYCHOPHYSIOLOGY, V39, P95, DOI 10.1017/S0048577202001543; Bauer AM, 2002, J DEV BEHAV PEDIATR, V23, P102, DOI 10.1097/00004703-200204000-00007; Bauer P. J., 2013, INFANT MIND ORIGINS, P146; Bauer PJ, 2001, J EXP CHILD PSYCHOL, V80, P174, DOI 10.1006/jecp.2000.2628; Bornstein MH, 2004, INFANCY, V6, P407, DOI 10.1207/s15327078in0603_6; Buchanan TW, 2006, LEARN MEMORY, V13, P382, DOI 10.1101/lm.206306; Buchanan TW, 2001, PSYCHONEUROENDOCRINO, V26, P307, DOI 10.1016/S0306-4530(00)00058-5; Buss KA, 2003, BEHAV NEUROSCI, V117, P11, DOI 10.1037/0735-7044.117.1.11; Cicchetti D, 2010, CHILD DEV, V81, P1504, DOI 10.1111/j.1467-8624.2010.01488.x; Collie R, 1999, DEV PSYCHOBIOL, V35, P83, DOI 10.1002/(SICI)1098-2302(199909)35:2<83::AID-DEV1>3.0.CO;2-S; Courage ML, 2004, DEV REV, V24, P6, DOI 10.1016/j.dr.2003.09.005; Dawson G, 2000, DEV PSYCHOPATHOL, V12, P695, DOI 10.1017/S0954579400004089; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; DiCorcia JA, 2011, NEUROSCI BIOBEHAV R, V35, P1593, DOI 10.1016/j.neubiorev.2011.04.008; Feldman R, 2010, DEVELOPMENTAL SCI, V13, P271, DOI 10.1111/j.1467-7687.2009.00890.x; Grant KA, 2009, DEV PSYCHOBIOL, V51, P625, DOI 10.1002/dev.20397; Gunnar MR, 2009, PSYCHONEUROENDOCRINO, V34, P953, DOI 10.1016/j.psyneuen.2009.02.010; GUNNAR MR, 1989, DEV PSYCHOBIOL, V22, P221, DOI 10.1002/dev.420220304; GUNNAR MR, 1995, CHILD DEV, V66, P1; GUNNAR MR, 1989, DEV PSYCHOL, V25, P355, DOI 10.1037/0012-1649.25.3.355; Haley D. W., 2013, INFANT MIND ORIGINS, P248; Haley DW, 2011, STRESS, V14, P530, DOI 10.3109/10253890.2011.560308; Haley DW, 2011, BIOL LETTERS, V7, P136, DOI 10.1098/rsbl.2010.0565; Haley DW, 2003, CHILD DEV, V74, P1534, DOI 10.1111/1467-8624.00621; Haley DW, 2006, PSYCHONEUROENDOCRINO, V31, P108, DOI 10.1016/j.psyneuen.2005.06.007; Hamann S, 2001, TRENDS COGN SCI, V5, P394, DOI 10.1016/S1364-6613(00)01707-1; Hartshorn K, 1998, DEV PSYCHOBIOL, V33, P61, DOI 10.1002/(SICI)1098-2302(199807)33:1<61::AID-DEV6>3.0.CO;2-Q; Hayne H, 2004, DEV REV, V24, P33, DOI 10.1016/j.dr.2003.09.007; Hollingshead A. B., 1975, 4 FACTOR INDEX SOCIA; Jansen J, 2010, PSYCHONEUROENDOCRINO, V35, P329, DOI 10.1016/j.psyneuen.2009.07.008; Kirschbaum C, 1996, LIFE SCI, V58, P1475, DOI 10.1016/0024-3205(96)00118-X; Kopp F, 2012, SOC NEUROSCI-UK, V7, P458, DOI 10.1080/17470919.2011.631289; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Lester BM, 2011, ANN NY ACAD SCI, V1226, P14, DOI 10.1111/j.1749-6632.2011.06037.x; LEWIS M, 1995, CHILD DEV, V66, P657, DOI 10.1111/j.1467-8624.1995.tb00896.x; Lewis M, 2005, CHILD DEV, V76, P518, DOI 10.1111/j.1467-8624.2005.00860.x; Lewis M, 2004, INFANCY, V6, P121, DOI 10.1207/s15327078in0601_6; Ivorra JL, 2010, J DEV BEHAV PEDIATR, V31, P545, DOI 10.1097/DBP.0b013e3181ee4072; Lupien SJ, 2005, PSYCHONEUROENDOCRINO, V30, P225, DOI 10.1016/j.psyneuen.2004.08.003; Lupien SJ, 2001, BEHAV BRAIN RES, V127, P137, DOI 10.1016/S0166-4328(01)00361-8; Makara GB, 2001, PROG NEUROBIOL, V65, P367, DOI 10.1016/S0301-0082(01)00012-0; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Melinder A, 2010, INFANT BEHAV DEV, V33, P472, DOI 10.1016/j.infbeh.2010.05.003; Mesman J, 2009, DEV REV, V29, P120, DOI 10.1016/j.dr.2009.02.001; Mueller A, 2010, PSYCHONEUROENDOCRINO, V35, P289, DOI 10.1016/j.psyneuen.2009.07.002; Murray L, 2010, J AFFECT DISORDERS, V122, P218, DOI 10.1016/j.jad.2009.06.034; NADEL L, 1989, HIPPOCAMPUS NEW VIST, P17; Pascalis O, 1998, J EXP PSYCHOL LEARN, V24, P249, DOI 10.1037/0278-7393.24.1.249; Payne C, 2010, HIPPOCAMPUS, V20, P922, DOI 10.1002/hipo.20688; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Ramsay D, 2003, CHILD DEV, V74, P456, DOI 10.1111/1467-8624.7402009; Richmond J, 2007, DEV REV, V27, P349, DOI 10.1016/j.dr.2007.04.002; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Schwartz EB, 1998, CHILD DEV, V69, P1503, DOI 10.2307/1132128; Seress L, 2001, DEV COGN NEUROSCI, P45; Takahashi T, 2004, NEUROSCI LETT, V363, P125, DOI 10.1016/j.neulet.2004.03.062; Thompson LA, 2008, INFANT BEHAV DEV, V31, P92, DOI 10.1016/j.infbeh.2007.07.007; TRONICK E, 1978, J AM ACAD CHILD PSY, V17, P1, DOI 10.1016/S0002-7138(09)62273-1; Watamura SE, 2003, CHILD DEV, V74, P1006, DOI 10.1111/1467-8624.00583; Weinberg K. M., 1998, INFANT CAREGIV UNPUB; Wolf OT, 2003, BEST PRACT RES CL EN, V17, P287, DOI 10.1016/S1521-690X(02)00101-X	62	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82277	10.1371/journal.pone.0082277	http://dx.doi.org/10.1371/journal.pone.0082277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EU	24349244	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800055
J	Ortuno-Sierra, J; Badoud, D; Knecht, F; Paino, M; Eliez, S; Fonseca-Pedrero, E; Debbane, M				Ortuno-Sierra, Javier; Badoud, Deborah; Knecht, Francesca; Paino, Mercedes; Eliez, Stephan; Fonseca-Pedrero, Eduardo; Debbane, Martin			Testing Measurement Invariance of the Schizotypal Personality Questionnaire-Brief Scores across Spanish and Swiss Adolescents	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; PSYCHOTIC SYMPTOMS; HIGH-RISK; POSITIVE SCHIZOTYPY; 3-FACTOR STRUCTURE; FIT INDEXES; TRAITS; SCHIZOPHRENIA; AGE; EXPERIENCES	Background: Schizotypy is a complex construct intimately related to psychosis. Empirical evidence indicates that participants with high scores on schizotypal self-report are at a heightened risk for the later development of psychotic disorders. Schizotypal experiences represent the behavioural expression of liability for psychotic disorders. Previous factorial studies have shown that schizotypy is a multidimensional construct similar to that found in patients with schizophrenia. Specifically, using the Schizotypal Personality Questionnaire-Brief (SPQ-B), the three-dimensional model has been widely replicated. However, there has been no in-depth investigation of whether the dimensional structure underlying the SPQ-B scores is invariant across countries. Methods: The main goal of this study was to examine the measurement invariance of the SPQ-B scores across Spanish and Swiss adolescents. The final sample was made up of 261 Spanish participants (51.7% men; M= 16.04 years) and 241 Swiss participants (52.3% men; M= 15.94 years). Results: The results indicated that Raine et al.'s three-factor model presented adequate goodness-of-fit indices. Moreover, the results supported the measurement invariance (configural and partial strong invariance) of the SPQ-B scores across the two samples. Spanish participants scored higher on Interpersonal dimension than Swiss when latent means were compared. Discussion: The study of measurement equivalence across countries provides preliminary evidence for the Raine et al.'s three-factor model and of the cross-cultural validity of the SPQ-B scores in adolescent population. Future studies should continue to examine the measurement invariance of the schizotypy and psychosis-risk syndromes across cultures.	[Ortuno-Sierra, Javier; Fonseca-Pedrero, Eduardo] Univ La Rioja, Dept Educ Sci, La Rioja, Spain; [Badoud, Deborah; Knecht, Francesca; Debbane, Martin] Univ Geneva, Fac Psychol & Educ Sci, Adolescence Clin Psychol Res Unit, Geneva, Switzerland; [Paino, Mercedes; Fonseca-Pedrero, Eduardo] Ctr Biomed Res Mental Hlth Network CIBERSAM, Madrid, Spain; [Paino, Mercedes] Univ Oviedo, Dept Psychol, Oviedo, Spain; [Badoud, Deborah; Knecht, Francesca; Eliez, Stephan; Debbane, Martin] Univ Geneva, Sch Med, Dept Psychiat, Off Medicopedag Res Unit, CH-1211 Geneva, Switzerland; [Debbane, Martin] UCL, Res Dept Clin Educ & Hlth Psychol, London, England	Universidad de La Rioja; University of Geneva; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Oviedo; University of Geneva; University of London; University College London	Fonseca-Pedrero, E (corresponding author), Univ La Rioja, Dept Educ Sci, La Rioja, Spain.	eduardo.fonseca.pedrero@gmail.com	Fonseca, Eduardo/L-4848-2019; Fonseca-Pedrero, Eduardo/C-4171-2011; Paino, Mercedes/I-3659-2015	Fonseca-Pedrero, Eduardo/0000-0001-7453-5225; Paino, Mercedes/0000-0002-2913-0322; Debbane, Martin/0000-0002-4677-8753	Spanish Ministry of Science and Innovation (MICINN); Instituto Carlos III; Centro de Investigacion Biomedica en Red de Salud Mental (Center for Biomedical Research in the Mental Health Network, CIBERSAM); Swiss National Science Foundation [100014-135311/1]; National Center of Competence in Research (NCCR) [51AU40_125759]; Gertrude Von Meissner Foundation [ME 7871];  [PSI 2011-28638];  [PSI 2011-23818]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto Carlos III(Instituto de Salud Carlos III); Centro de Investigacion Biomedica en Red de Salud Mental (Center for Biomedical Research in the Mental Health Network, CIBERSAM); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); Gertrude Von Meissner Foundation; ; 	This research was funded by the Spanish Ministry of Science and Innovation (MICINN), by the Instituto Carlos III, Centro de Investigacion Biomedica en Red de Salud Mental (Center for Biomedical Research in the Mental Health Network, CIBERSAM). Project references: PSI 2011-28638, and PSI 2011-23818. This research was supported by research grants from the Swiss National Science Foundation (100014-135311/1) to MD and by the National Center of Competence in Research (NCCR) "Synapsy-The Synaptic Bases of Mental Diseases'' (SNF, Grant number: 51AU40_125759) to SE, as well as from the Gertrude Von Meissner Foundation (ME 7871) to SE and MD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Axelrod SR, 2001, J PERS DISORD, V15, P168, DOI 10.1521/pedi.15.2.168.19219; Badcock JC, 2006, PERS INDIV DIFFER, V40, P77, DOI 10.1016/j.paid.2005.06.015; Badoud D, 2011, ENCEPHALE, V37, P299, DOI 10.1016/j.encep.2010.08.017; Barrantes-Vidal N, 2013, PSYCHIAT RES, V206, P188, DOI 10.1016/j.psychres.2012.12.008; Bora E, 2009, TURK PSIKIYATR DERG, V20, P339; Boyda D, 2013, PSYCHOSIS, V5, P187, DOI 10.1080/17522439.2012.670259; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Byrne B.M., 2012, STRUCTURAL EQUATION; Byrne BM, 2008, PSICOTHEMA, V20, P872; Byrne BM, 2006, STRUCT EQU MODELING, V13, P287, DOI 10.1207/s15328007sem1302_7; BYRNE BM, 1989, PSYCHOL BULL, V105, P456, DOI 10.1037/0033-2909.105.3.456; Cella M, 2013, EUR PSYCHIAT, V28, P247, DOI 10.1016/j.eurpsy.2012.04.002; Chen WJ, 1997, J ABNORM PSYCHOL, V106, P649, DOI 10.1037/0021-843X.106.4.649; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Compton MT, 2007, SCHIZOPHR RES, V91, P122, DOI 10.1016/j.schres.2006.12.005; Compton MT, 2009, SCHIZOPHR RES, V115, P286, DOI 10.1016/j.schres.2009.04.012; Compton MT, 2009, SCHIZOPHR RES, V111, P46, DOI 10.1016/j.schres.2009.02.012; Debbane M, 2013, SCHIZOPHR RES, V147, P153, DOI 10.1016/j.schres.2013.03.012; Debbane M, 2012, J NERV MENT DIS, V200, P620, DOI 10.1097/NMD.0b013e31825bfc1a; Dominguez MDG, 2011, SCHIZOPHRENIA BULL, V37, P84, DOI 10.1093/schbul/sbp022; Fisher HL, 2013, PSYCHOL MED, V43, P2077, DOI 10.1017/S0033291712003091; Fonseca-Pedrero E, 2008, INT J CLIN HLTH PSYC, V8, P577; Fonseca-Pedrero E, 2013, PSICOTHEMA, V25, P171, DOI 10.7334/psicothema2012.74; Fonseca-Pedrero E, 2011, PSYCHIAT RES, V190, P309, DOI 10.1016/j.psychres.2011.05.021; Fonseca-Pedrero E, 2011, COMPR PSYCHIAT, V52, P293, DOI 10.1016/j.comppsych.2010.07.001; Fonseca-Pedrero E, 2011, PSICOTHEMA, V23, P87; Fonseca-Pedrero E, 2010, COMPR PSYCHIAT, V51, P71, DOI 10.1016/j.comppsych.2009.02.003; Fonseca-Pedrero E, 2009, SCHIZOPHR RES, V111, P53, DOI 10.1016/j.schres.2009.03.006; Fossati A, 2003, PERS INDIV DIFFER, V35, P1007, DOI 10.1016/S0191-8869(02)00314-8; Gooding DC, 2005, J ABNORM PSYCHOL, V114, P170, DOI 10.1037/0021-843X.114.1.170; Hambleton R.K., 2005, ADAPTING ED PSYCHOL, P7; Horan WP, 2008, SCHIZOPHRENIA BULL, V34, P856, DOI 10.1093/schbul/sbn083; HORN JL, 1992, EXP AGING RES, V18, P117, DOI 10.1080/03610739208253916; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kelleher I, 2011, PSYCHOL MED, V41, P1, DOI 10.1017/S0033291710001005; Kwapil T. R., 2013, OXFORD HDB PERSONALI, P437; Kwapil TR, 2008, SCHIZOPHRENIA BULL, V34, P444, DOI 10.1093/schbul/sbm098; Kwapil TR, 2013, J ABNORM PSYCHOL, V122, P807, DOI 10.1037/a0033759; Kwapil TR, 2012, J PSYCHOPATHOL BEHAV, V34, P145, DOI 10.1007/s10862-011-9258-1; Lenzenweger M.F., 2010, SCHIZOTYPY SCHIZOPHR; LIDDLE PF, 1987, BRIT J PSYCHIAT, V151, P145, DOI 10.1192/bjp.151.2.145; Linscott R.J., PSYCHOL MED IN PRESS; Mason O, 2006, SCHIZOPHR RES, V82, P203, DOI 10.1016/j.schres.2005.12.845; Mata I, 2005, PERS INDIV DIFFER, V38, P1183, DOI 10.1016/j.paid.2004.08.001; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Muniz J, 2013, PSICOTHEMA, V25, P151, DOI 10.7334/psicothema2013.24; Muthen B., 2010, MPLUS USERS GUIDE; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; RAINE A, 1994, SCHIZOPHRENIA BULL, V20, P191, DOI 10.1093/schbul/20.1.191; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Raine A, 1995, J PERS DISORD, V9, P346, DOI 10.1521/pedi.1995.9.4.346; Raine A, 2006, ANNU REV CLIN PSYCHO, V2, P291, DOI 10.1146/annurev.clinpsy.2.022305.095318; Reynolds CA, 2000, SCHIZOPHRENIA BULL, V26, P603, DOI 10.1093/oxfordjournals.schbul.a033481; Shah J, 2012, SCHIZOPHR RES, V141, P189, DOI 10.1016/j.schres.2012.08.012; SIEVER LJ, 1983, COMPR PSYCHIAT, V24, P199, DOI 10.1016/0010-440X(83)90070-6; SPSS, 2006, SPSS BAS 15 0 US GUI; Stefanis NC, 2004, SCHIZOPHRENIA BULL, V30, P335, DOI 10.1093/oxfordjournals.schbul.a007083; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; Walker E, 2002, SCHIZOPHR RES, V54, P17, DOI 10.1016/S0920-9964(01)00347-4; Welham J, 2009, PSYCHOL MED, V39, P625, DOI 10.1017/S0033291708003760; Werbeloff N, 2012, ARCH GEN PSYCHIAT, V69, P467, DOI 10.1001/archgenpsychiatry.2011.1580; Woods SW, 2009, SCHIZOPHRENIA BULL, V35, P894, DOI 10.1093/schbul/sbp027; Wuthrich VM, 2006, J PERS ASSESS, V87, P292, DOI 10.1207/s15327752jpa8703_10; Zammit S, 2013, AM J PSYCHIAT, V170, P742, DOI 10.1176/appi.ajp.2013.12060768	65	26	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82041	10.1371/journal.pone.0082041	http://dx.doi.org/10.1371/journal.pone.0082041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EU	24349180	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800033
J	Tsukaya, H				Tsukaya, Hirokazu			Does Ploidy Level Directly Control Cell Size? Counterevidence from Arabidopsis Genetics	PLOS ONE			English	Article							LEAF BLADE; EXPANSION; MUTANTS; ENDOREDUPLICATION; ENDOPOLYPLOIDY; PROLIFERATION; COMPENSATION; POLYPLOIDY; PLANTS; ORGAN	Ploidy level affects cell size in many organisms, and ploidy-dependent cell enlargement has been used to breed many useful organisms. However, how polyploidy affects cell size remains unknown. Previous studies have explored changes in transcriptome data caused by polyploidy, but have not been successful. The most naive theory explaining ploidy-dependent cell enlargement is that increases in gene copy number increase the amount of protein, which in turn increases the cell volume. This hypothesis can be evaluated by examining whether any strains, mutants, or transgenics show the same cell size before and after a tetraploidization event. I performed this experiment by tetraploidizing various mutants and transgenics of Arabidopsis thaliana, which show a wide range in cell size, and found that the ploidy-dependent increase in cell volume is genetically regulated. This result is not in agreement with the theory described above.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo	Tsukaya, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan.	tsukaya@biol.s.u-tokyo.ac.jp	Tsukaya, Hirokazu/A-2614-2013	Tsukaya, Hirokazu/0000-0002-4430-4538	Ministry of Education, Culture, Sports, Science and Technology, Japan [18GS0313, 19060002, 3503, 172070059]; Mitsubishi Foundation; Grants-in-Aid for Scientific Research [25113002] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Creative Scientific Research (No. 18GS0313), Scientific Research on Priority Areas (No. 19060002), Scientific Research on Innovative Areas (No. 3503), and Scientific Research (A) (No. 172070059) from the Ministry of Education, Culture, Sports, Science and Technology, Japan; a grant from the Mitsubishi Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2001, AQUACULTURE, V197, P205, DOI 10.1016/S0044-8486(01)00588-9; Barow M, 2003, PLANT CELL ENVIRON, V26, P571, DOI 10.1046/j.1365-3040.2003.00988.x; Blakeslee AF, 1937, J HERED, V28, P393, DOI 10.1093/oxfordjournals.jhered.a104294; Breuer C, 2007, PLANT CELL, V19, P3655, DOI 10.1105/tpc.107.054833; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; FANKHAUSER G, 1952, INT REV CYTOL, V1, P165, DOI 10.1016/S0074-7696(08)60010-8; Ferjani A, 2013, PLANT CELL IN PRESS; Ferjani A, 2007, PLANT PHYSIOL, V144, P988, DOI [10.1104/pp.107.099325, 10.1104/PP.107.099325]; Fujikura U, 2007, PLANT CELL PHYSIOL, V48, P278, DOI 10.1093/pcp/pcm002; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Hase Y, 2005, J EXP BOT, V56, P1263, DOI 10.1093/jxb/eri122; Hisanaga T, 2013, PLANT PHYSIOL, V162, P831, DOI 10.1104/pp.113.216796; Horiguchi G, 2006, PLANT J, V48, P638, DOI 10.1111/j.1365-313X.2006.02896.x; Imai KK, 2006, PLANT CELL, V18, P382, DOI 10.1105/tpc.105.037309; Kawade K, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-143; Kawade K, 2010, DEVELOPMENT, V137, P4221, DOI 10.1242/dev.057117; Kozuka T, 2005, PLANT CELL PHYSIOL, V46, P213, DOI 10.1093/pcp/pci016; Kurepa J, 2009, PLANT PHYSIOL, V150, P178, DOI 10.1104/pp.109.135970; Levan A, 1939, HEREDITAS, V25, P109; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Muntzing A., 1936, HEREDITAS, V21, P263, DOI DOI 10.1111/J.1601-5223.1936.TB03204.X; Okada Hiroshi, 2003, APG Acta Phytotaxonomica et Geobotanica, V54, P69; Ramanna MS, 2003, EUPHYTICA, V133, P3, DOI 10.1023/A:1025600824483; Ramirez-Parra E, 2007, PLANT PHYSIOL, V144, P105, DOI 10.1104/pp.106.094979; Simonet M, 1940, REV CYTOL CYTOPHYS V, V4, P231; Smith HH, 1939, J HERED, V30, P291, DOI 10.1093/oxfordjournals.jhered.a104748; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; Tsuge T, 1996, DEVELOPMENT, V122, P1589; Tsukaya H, 2002, INT REV CYTOL, V217, P1; Tsukaya H, 2008, PLOS BIOL, V6, P1373, DOI 10.1371/journal.pbio.0060174; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Wu CY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000523; Yu Z, 2010, P NATL ACAD SCI USA, V107, P17809, DOI 10.1073/pnas.1000852107	33	59	60	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83729	10.1371/journal.pone.0083729	http://dx.doi.org/10.1371/journal.pone.0083729			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349549	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800131
J	Costa, AG; Wyman, A; Siris, ES; Watts, NB; Silverman, S; Saag, KG; Roux, C; Rossini, M; Pfeilschifter, J; Nieves, JW; Netelenbos, JC; March, L; LaCroix, AZ; Hooven, FH; Greenspan, SL; Gehlbach, SH; Diez-Perez, A; Cooper, C; Compston, JE; Chapurlat, RD; Boonen, S; Anderson, FA; Adachi, JD; Adami, S				Costa, Aline G.; Wyman, Allison; Siris, Ethel S.; Watts, Nelson B.; Silverman, Stuart; Saag, Kenneth G.; Roux, Christian; Rossini, Maurizio; Pfeilschifter, Johannes; Nieves, Jeri W.; Netelenbos, J. Coen; March, Lyn; LaCroix, Andrea Z.; Hooven, Frederick H.; Greenspan, Susan L.; Gehlbach, Stephen H.; Diez-Perez, Adolfo; Cooper, Cyrus; Compston, Juliet E.; Chapurlat, Roland D.; Boonen, Steven; Anderson, Frederick A., Jr.; Adachi, Jonathan D.; Adami, Silvano			When, Where and How Osteoporosis-Associated Fractures Occur: An Analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW)	PLOS ONE			English	Article							AGED 65 YEARS; HIP FRACTURE; SEASONAL-VARIATION; UNITED-STATES; SELF-REPORT; VALIDITY; RISK; EPIDEMIOLOGY; POPULATION; WEATHER	Objective: To examine when, where and how fractures occur in postmenopausal women. Methods: We analyzed data from the Global Longitudinal Study of Osteoporosis in Women (GLOW), including women aged >= 55 years from the United States of America, Canada, Australia and seven European countries. Women completed questionnaires including fracture data at baseline and years 1, 2 and 3. Results: Among 60,393 postmenopausal women, 4122 incident fractures were reported (86% non-hip, non-vertebral [NHNV], 8% presumably clinical vertebral and 6% hip). Hip fractures were more likely to occur in spring, with little seasonal variation for NHNV or spine fractures. Hip fractures occurred equally inside or outside the home, whereas 65% of NHNV fractures occurred outside and 61% of vertebral fractures occurred inside the home. Falls preceded 68-86% of NHNV and 68-83% of hip fractures among women aged <= 64 to >= 85 years, increasing with age. About 45% of vertebral fractures were associated with falls in all age groups except those >= 85 years, when only 24% occurred after falling. Conclusion: In this multi-national cohort, fractures occurred throughout the year, with only hip fracture having a seasonal variation, with a higher proportion in spring. Hip fractures occurred equally within and outside the home, spine fractures more often in the home, and NHNV fractures outside the home. Falls were a proximate cause of most hip and NHNV fractures. Postmenopausal women at risk for fracture need counseling about reducing potentially modifiable fracture risk factors, particularly falls both inside and outside the home and during all seasons of the year.	[Costa, Aline G.] Columbia Univ, Coll Phys & Surg, Div Endocrinol, Dept Med, New York, NY USA; [Costa, Aline G.] Univ Fed Sao Paulo, Div Endocrinol, Dept Med, Sao Paulo, Brazil; [Wyman, Allison; Hooven, Frederick H.; Gehlbach, Stephen H.; Anderson, Frederick A., Jr.] Univ Massachusetts, Sch Med, Ctr Outcomes Res, Worcester, MA USA; [Siris, Ethel S.] Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA; [Watts, Nelson B.] Mercy Hlth Osteoporosis Serv, Cincinnati, OH USA; [Watts, Nelson B.] Mercy Bone Hlth Serv, Cincinnati, OH USA; [Silverman, Stuart] Cedars Sinai Med Ctr, Dept Rheumatol, Los Angeles, CA 90048 USA; [Saag, Kenneth G.] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Roux, Christian] Paris Descartes Univ, Cochin Hosp, Paris, France; [Rossini, Maurizio; Adami, Silvano] Univ Verona, Dept Med, Rheumatol Sect, I-37100 Verona, Italy; [Pfeilschifter, Johannes] Alfried Krupp Hosp, Dept Internal Med 3, Essen, Germany; [Nieves, Jeri W.] Helen Hayes Hosp, W Haverstraw, NY USA; [Nieves, Jeri W.] Columbia Univ, W Haverstraw, NY USA; [Netelenbos, J. Coen] Vrije Univ Amsterdam Med Ctr, Dept Endocrinol, Amsterdam, Netherlands; [March, Lyn] Univ Sydney, Inst Bone & Joint Res, Sydney, NSW 2006, Australia; [LaCroix, Andrea Z.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Greenspan, Susan L.] Univ Pittsburgh, Pittsburgh, PA USA; [Diez-Perez, Adolfo] Autonomous Univ Barcelona, Hosp del Mar, IMIM, Barcelona, Spain; [Diez-Perez, Adolfo] ISCIII, RETICEF, Madrid, Spain; [Cooper, Cyrus] Univ Southampton, MRC, Lifecourse Epidemiol Unit, Southampton, Hants, England; [Compston, Juliet E.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Chapurlat, Roland D.] Univ Lyon, Div Rheumatol, INSERM, Hosp Civils Lyon,Hop E Herriot,UMR 1033, Lyon, France; [Boonen, Steven] Univ Louvain, Louvain, Belgium; [Adachi, Jonathan D.] McMaster Univ, St Josephs Healthcare, Hamilton, ON, Canada; Univ Verona, Dept Rheumatol, I-37100 Verona, Valeggio, Italy	Columbia University; Universidade Federal de Sao Paulo (UNIFESP); University of Massachusetts System; University of Massachusetts Worcester; Columbia University; Cedars Sinai Medical Center; University of Alabama System; University of Alabama Birmingham; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Verona; Alfried Krupp Hospital; Columbia University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Sydney; Fred Hutchinson Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Instituto de Salud Carlos III; University of Southampton; University of Cambridge; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); McMaster University; University of Verona	Siris, ES (corresponding author), Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA.	es27@columbia.edu	CHAPURLAT, ROLAND/AAU-1165-2021; rossini, maurizio/D-6610-2011	Nieves, Jeri/0000-0001-8593-343X; Rossini, Maurizio/0000-0001-9692-2293; Cooper, Cyrus/0000-0003-3510-0709; Diez-Perez, Adolfo/0000-0001-8162-0209	Alliance for Better Bone Health (sanofi-aventis and Warner Chilcott); NATIONAL INSTITUTE ON AGING [P30AG024827] Funding Source: NIH RePORTER; MRC [MC_U147585819] Funding Source: UKRI; Medical Research Council [MC_U147585824, U1475000001, MC_UP_A620_1014, MC_U147585819, MC_UU_12011/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish	Alliance for Better Bone Health (sanofi-aventis and Warner Chilcott); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The GLOW study was supported by a grant from The Alliance for Better Bone Health (sanofi-aventis and Warner Chilcott) to The Center for Outcomes Research, University of Massachusetts Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki H, 2011, J BONE MINER METAB, V29, P309, DOI 10.1007/s00774-010-0218-8; Bischoff-Ferrari HA, 2007, OSTEOPOROSIS INT, V18, P1225, DOI 10.1007/s00198-007-0364-6; Bischoff-Ferrari Heike A, 2011, Curr Osteoporos Rep, V9, P116, DOI 10.1007/s11914-011-0059-y; Brazier JE, 1996, QUAL LIFE RES, V5, P195, DOI 10.1007/BF00434741; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Centers for Disease Control and Prevention, 2008, NAT HLTH NUTR EX SUR; Chen Z, 2004, MENOPAUSE, V11, P264, DOI 10.1097/01.GME.0000094210.15096.FD; COOPER C, 1992, J BONE MINER RES, V7, P221, DOI 10.1002/jbmr.5650070214; Emaus N, 2011, OSTEOPOROSIS INT, V22, P2603, DOI 10.1007/s00198-010-1485-x; Gronskag AB, 2010, BONE, V46, P1294, DOI 10.1016/j.bone.2009.11.024; Honkanen K, 1999, AM J EPIDEMIOL, V150, P511; Hooven FH, 2009, OSTEOPOROSIS INT, V20, P1107, DOI 10.1007/s00198-009-0958-2; Ismail AA, 2000, OSTEOPOROSIS INT, V11, P248, DOI 10.1007/s001980050288; JACOBSEN SJ, 1991, AM J EPIDEMIOL, V133, P996, DOI 10.1093/oxfordjournals.aje.a115819; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; KANIS JA, 1992, BONE, V13, pS1, DOI 10.1016/8756-3282(92)90189-4; Karantana A, 2011, J BONE JOINT SURG BR, V93B, P658, DOI 10.1302/0301-620X.93B5.24536; Levy AR, 1998, EPIDEMIOLOGY, V9, P172, DOI 10.1097/00001648-199803000-00012; Lofthus CM, 2001, BONE, V29, P413, DOI 10.1016/S8756-3282(01)00603-2; NEVITT MC, 1993, J AM GERIATR SOC, V41, P1226, DOI 10.1111/j.1532-5415.1993.tb07307.x; Rogmark C, 1999, ACTA ORTHOP SCAND, V70, P19, DOI 10.3109/17453679909000950	22	43	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83306	10.1371/journal.pone.0083306	http://dx.doi.org/10.1371/journal.pone.0083306			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349484	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000328730300144
J	Evensen, NA; Li, J; Yang, J; Yu, XJ; Sampson, NS; Zucker, S; Cao, J				Evensen, Nikki A.; Li, Jian; Yang, Jie; Yu, Xiaojun; Sampson, Nicole S.; Zucker, Stanley; Cao, Jian			Development of a High-Throughput Three-Dimensional Invasion Assay for Anti-Cancer Drug Discovery	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; CELL-MIGRATION; CANCER-CELLS; HUMAN BREAST; METALLOPROTEINASE; MODEL; CONTRACTION; VALIDATION; MICROARRAY; APOPTOSIS	The lack of three-dimensional (3-D) high-throughput (HT) screening assays designed to identify anti-cancer invasion drugs is a major hurdle in reducing cancer-related mortality, with the key challenge being assay standardization. Presented is the development of a novel 3-D invasion assay with HT potential that involves surrounding cell-collagen spheres within collagen to create a 3-D environment through which cells can invade. Standardization was achieved by designing a tooled 96-well plate to create a precisely designated location for the cell-collagen spheres and by using dialdehyde dextran to inhibit collagen contraction, maintaining uniform size and shape. This permits automated readout for determination of the effect of inhibitory compounds on cancer cell invasion. Sensitivity was demonstrated by the ability to distinguish varying levels of invasiveness of cancer cell lines, and robustness was determined by calculating the Z-factor. A Z-factor of 0.65 was obtained by comparing the effects of DMSO and anti-beta 1-integrin antibody, an inhibitory reagent, on the invasion of Du145 cancer cells, suggesting this novel assay is suitable for large scale drug discovery. As proof of principle, the NCI Diversity Compound Library was screened against human invasive cancer cells. Nine compounds exhibiting high potency and low toxicity were identified, including DX-52-1, a compound previously reported to inhibit cell migration, a critical determinant of cancer invasion. The results indicate that this innovative HT platform is a simple, precise, and easy to replicate 3-D invasion assay for anti-cancer drug discovery.	[Evensen, Nikki A.; Li, Jian; Cao, Jian] SUNY Stony Brook, Dept Med Canc Prevent, Stony Brook, NY 11794 USA; [Yang, Jie] SUNY Stony Brook, Dept Prevent Med, Stony Brook, NY 11794 USA; [Yu, Xiaojun] Stevens Inst Technol, Dept Tissue Engn, Hoboken, NJ 07030 USA; [Sampson, Nicole S.] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Zucker, Stanley] Vet Affair Med Ctr, Dept Res, Northport, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stevens Institute of Technology; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Cao, J (corresponding author), SUNY Stony Brook, Dept Med Canc Prevent, Stony Brook, NY 11794 USA.	jian.cao@sunysb.edu	Sampson, Nicole/C-4598-2014	Sampson, Nicole/0000-0002-2835-7760	Baldwin Breast Cancer Foundation; National Cancer Institute [1R01CA166936]; NATIONAL CANCER INSTITUTE [R01CA166936] Funding Source: NIH RePORTER	Baldwin Breast Cancer Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported in part by Baldwin Breast Cancer Foundation and National Cancer Institute (1R01CA166936). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adanja I, 2010, EXP CELL RES, V316, P181, DOI 10.1016/j.yexcr.2009.10.004; Butcher EC, 2005, NAT REV DRUG DISCOV, V4, P461, DOI 10.1038/nrd1754; Cao J, 2005, THROMB HAEMOSTASIS, V93, P770, DOI 10.1160/TH04-08-0555; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; Cao J, 2008, J BIOL CHEM, V283, P6232, DOI 10.1074/jbc.M705759200; Cheng K, 2008, BIOMATERIALS, V29, P2802, DOI 10.1016/j.biomaterials.2008.03.015; Cortesi R, 1999, EUR J PHARM BIOPHARM, V47, P153, DOI 10.1016/S0939-6411(98)00076-9; Draye JP, 1998, BIOMATERIALS, V19, P99, DOI 10.1016/S0142-9612(97)00164-6; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Echeverria V, 2010, J BIOMOL SCREEN, V15, P1144, DOI 10.1177/1087057110378890; ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626; Fernandes TG, 2010, BIOTECHNOL BIOENG, V106, P106, DOI 10.1002/bit.22661; Ghajar CM, 2007, MOL CANCER THER, V6, P552, DOI 10.1158/1535-7163.MCT-06-0593; Grinnell F, 2006, EXP CELL RES, V312, P86, DOI 10.1016/j.yexcr.2005.010.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hart CP, 2005, DRUG DISCOV TODAY, V10, P513, DOI 10.1016/S1359-6446(05)03415-X; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Kahsai AW, 2006, CHEM BIOL, V13, P973, DOI 10.1016/j.chembiol.2006.07.011; Kanth SV, 2009, PROCESS BIOCHEM, V44, P869, DOI 10.1016/j.procbio.2009.04.008; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Lauwaet T, 2000, MICROBES INFECT, V2, P923, DOI 10.1016/S1286-4579(00)00394-4; Lee MY, 2008, P NATL ACAD SCI USA, V105, P59, DOI 10.1073/pnas.0708756105; Li J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038403; Li Q, 2011, J BIOMOL SCREEN, V16, P141, DOI 10.1177/1087057110392995; Nien YD, 2003, WOUND REPAIR REGEN, V11, P380, DOI 10.1046/j.1524-475X.2003.11511.x; Normanno N, 2009, ENDOCR-RELAT CANCER, V16, P675, DOI 10.1677/ERC-08-0208; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Perret GY, 2008, FUND CLIN PHARMACOL, V22, P465, DOI 10.1111/j.1472-8206.2008.00614.x; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Schacht E, 1997, REACT FUNCT POLYM, V33, P109, DOI 10.1016/S1381-5148(97)00047-3; Terzis AJ, 1997, BRIT J CANCER, V75, P1744, DOI 10.1038/bjc.1997.298; TICKLE C, 1979, J CELL SCI, V40, P257; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; Wang P, 2004, J BIOL CHEM, V279, P51148, DOI 10.1074/jbc.M409074200; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xu F, 2011, BIOTECHNOL J, V6, P204, DOI 10.1002/biot.201000340; Xue LY, 2003, EXP CELL RES, V283, P135, DOI 10.1016/S0014-4827(02)00032-0; Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang XD, 2004, MOL CANCER THER, V3, P187; Zhang XD, 2011, J BIOTECHNOL, V151, P186, DOI 10.1016/j.jbiotec.2010.11.012; Zhu YK, 2001, IN VITRO CELL DEV-AN, V37, P10	43	27	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82811	10.1371/journal.pone.0082811	http://dx.doi.org/10.1371/journal.pone.0082811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349367	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300108
J	Maravall, M; Alenda, A; Bale, MR; Petersen, RS				Maravall, Miguel; Alenda, Andrea; Bale, Michael R.; Petersen, Rasmus S.			Transformation of Adaptation and Gain Rescaling along the Whisker Sensory Pathway	PLOS ONE			English	Article							RAT BARREL CORTEX; RETINAL GANGLION-CELLS; INFORMATION-TRANSMISSION; IN-VIVO; THALAMOCORTICAL SYNAPSES; SOMATOSENSORY CORTEX; RESPONSE PROPERTIES; TEMPORAL FREQUENCY; AUDITORY FOREBRAIN; RECEPTIVE-FIELDS	Neurons in all sensory systems have a remarkable ability to adapt their sensitivity to the statistical structure of the sensory signals to which they are tuned. In the barrel cortex, firing rate adapts to the variance of a whisker stimulus and neuronal sensitivity (gain) adjusts in inverse proportion to the stimulus standard deviation. To determine how adaptation might be transformed across the ascending lemniscal pathway, we measured the responses of single units in the first and last subcortical stages, the trigeminal ganglion (TRG) and ventral posterior medial thalamic nucleus (VPM), to controlled whisker stimulation in urethane-anesthetized rats. We probed adaptation using a filtered white noise stimulus that switched between low-and high-variance epochs. We found that the firing rate of both TRG and VPM neurons adapted to stimulus variance. By fitting the responses of each unit to a Linear-Nonlinear-Poisson model, we tested whether adaptation changed feature selectivity and/or sensitivity. We found that, whereas feature selectivity was unaffected by stimulus variance, units often exhibited a marked change in sensitivity. The extent of these sensitivity changes increased systematically along the pathway from TRG to barrel cortex. However, there was marked variability across units, especially in VPM. In sum, in the whisker system, the adaptation properties of subcortical neurons are surprisingly diverse. The significance of this diversity may be that it contributes to a rich population representation of whisker dynamics.	[Maravall, Miguel; Alenda, Andrea] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante, Spain; [Bale, Michael R.; Petersen, Rasmus S.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); University of Manchester	Maravall, M (corresponding author), Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante, Spain.	mmaravall@umh.es; r.petersen@manchester.ac.uk	Maravall, Miguel/AAW-4328-2021	Maravall, Miguel/0000-0002-8869-7206; Petersen, Rasmus/0000-0002-5607-977X; Bale, Michael/0000-0002-5325-1992	Spanish Ministry for Economy and Competitiveness [BFU2011-23049]; European Regional Development Fund; Consolider Program [CSD2007-00023]; Valencia Regional Government [PROMETEO/2011/086]; Spanish National Research Council (CSIC); CARMEN e-science project (EPSRC) [EP/E002331/1]; BBSRC [BB/G020094/1]; Royal Society Joint Project Grant; Biotechnology and Biological Sciences Research Council [BB/G020094/1] Funding Source: researchfish	Spanish Ministry for Economy and Competitiveness(Spanish Government); European Regional Development Fund(European Commission); Consolider Program(Spanish Government); Valencia Regional Government; Spanish National Research Council (CSIC); CARMEN e-science project (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society Joint Project Grant(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work received support from: Spanish Ministry for Economy and Competitiveness (BFU2011-23049, co-funded by the European Regional Development Fund; Consolider Program CSD2007-00023); Valencia Regional Government (PROMETEO/2011/086); Spanish National Research Council (CSIC); CARMEN e-science project (EPSRC grant EP/E002331/1); BBSRC grant BB/G020094/1 and a Royal Society Joint Project Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Ahissar E, 2001, J NEUROPHYSIOL, V86, P354, DOI 10.1152/jn.2001.86.1.354; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Arabzadeh E, 2004, J NEUROSCI, V24, P6011, DOI 10.1523/JNEUROSCI.1389-04.2004; Arabzadeh E, 2003, J NEUROSCI, V23, P9146; Atencio CA, 2012, J NEUROPHYSIOL, V107, P2594, DOI 10.1152/jn.01025.2011; Bale MR, 2013, J NEUROSCI, V33, P12003, DOI 10.1523/JNEUROSCI.0925-13.2013; Bale MR, 2009, J NEUROPHYSIOL, V102, P2771, DOI 10.1152/jn.00636.2009; Bialek W, 2005, FEATURES DIMENSIONS; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Castro-Alamancos MA, 2002, J NEUROSCI, V22, P9651; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V541, P319, DOI 10.1113/jphysiol.2002.016857; Castro-Alamancos MA, 2002, J NEUROPHYSIOL, V87, P946, DOI 10.1152/jn.00426.2001; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V539, P567, DOI 10.1113/jphysiol.2001.013283; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; DIAMOND ME, 1992, J COMP NEUROL, V318, P462, DOI 10.1002/cne.903180410; Diaz-Quesada M, 2008, J NEUROSCI, V28, P696, DOI 10.1523/JNEUROSCI.4931-07.2008; Estebanez L, 2012, NAT NEUROSCI, V15, P1691, DOI 10.1038/nn.3258; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fraser G, 2006, SOMATOSENS MOT RES, V23, P111, DOI 10.1080/08990220600906589; Ganmor E, 2010, NEURON, V66, P273, DOI 10.1016/j.neuron.2010.03.032; Garabedian CE, 2003, J NEUROPHYSIOL, V90, P1379, DOI 10.1152/jn.01158.2002; Garcia-Lazaro JA, 2007, EUR J NEUROSCI, V26, P2359, DOI 10.1111/j.1460-9568.2007.05847.x; Gerdjikov TV, 2010, NEURON, V65, P530, DOI 10.1016/j.neuron.2010.02.007; Jadhav SP, 2009, NAT NEUROSCI, V12, P792, DOI 10.1038/nn.2328; Jones LM, 2004, SCIENCE, V304, P1986, DOI 10.1126/science.1097779; Katz Y, 2006, J NEUROSCI, V26, P13363, DOI 10.1523/JNEUROSCI.4056-06.2006; Khatri V, 2004, J NEUROPHYSIOL, V92, P3244, DOI 10.1152/jn.00257.2004; Khatri V, 2007, CEREB CORTEX, V17, P599, DOI 10.1093/cercor/bhk006; Lundstrom BN, 2010, J NEUROSCI, V30, P5071, DOI 10.1523/JNEUROSCI.2193-09.2010; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mante V, 2008, NEURON, V58, P625, DOI 10.1016/j.neuron.2008.03.011; Maravall M, 2007, PLOS BIOL, V5, P323, DOI 10.1371/journal.pbio.0050019; Maravall M, 2013, PRINCIPLES OF NEURAL CODING, P357; Mease RA, 2013, J NEUROSCI, V33, P12154, DOI 10.1523/JNEUROSCI.3263-12.2013; Montemurro MA, 2007, J NEUROPHYSIOL, V98, P1871, DOI 10.1152/jn.00593.2007; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Petersen RS, 2009, BIOL CYBERN, V100, P427, DOI 10.1007/s00422-008-0290-5; Petersen RS, 2008, NEURON, V60, P890, DOI 10.1016/j.neuron.2008.09.041; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; Ringach DL, 2007, J NEUROSCI, V27, P7673, DOI 10.1523/JNEUROSCI.1048-07.2007; Rowekamp RJ, 2011, NETWORK-COMP NEURAL, V22, P45, DOI 10.3109/0954898X.2011.566303; Rust NC, 2005, NEURON, V46, P945, DOI 10.1016/j.neuron.2005.05.021; SHAPLEY R, 1972, NATURE, V236, P352, DOI 10.1038/236352a0; SHAPLEY RM, 1979, J PHYSIOL-LONDON, V290, P141, DOI 10.1113/jphysiol.1979.sp012765; SHAPLEY RM, 1978, J PHYSIOL-LONDON, V285, P275, DOI 10.1113/jphysiol.1978.sp012571; Sharpee TO, 2011, J NEUROPHYSIOL, V106, P1841, DOI 10.1152/jn.00905.2010; Sharpee TO, 2006, NATURE, V439, P936, DOI 10.1038/nature04519; Simoncelli EP, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P327; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Sosnik R, 2001, J NEUROPHYSIOL, V86, P339, DOI 10.1152/jn.2001.86.1.339; Storchi R, 2012, J NEUROPHYSIOL, V108, P1810, DOI 10.1152/jn.00921.2011; VICTOR J, 1980, BIOPHYS J, V29, P459, DOI 10.1016/S0006-3495(80)85146-0; Wainwright MJ, 1999, VISION RES, V39, P3960, DOI 10.1016/S0042-6989(99)00101-7; Wang Q, 2010, NAT NEUROSCI, V13, P1534, DOI 10.1038/nn.2670; Webber RM, 2006, J NEUROPHYSIOL, V95, P2923, DOI 10.1152/jn.01188.2005; Webber RM, 2004, J NEUROPHYSIOL, V91, P2010, DOI 10.1152/jn.00906.2003	61	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82418	10.1371/journal.pone.0082418	http://dx.doi.org/10.1371/journal.pone.0082418			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349279	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300092
J	Biadglegne, F; Tesfaye, W; Sack, U; Rodloff, AC				Biadglegne, Fantahun; Tesfaye, Weghata; Sack, Ulrich; Rodloff, Arne C.			Tuberculous Lymphadenitis in Northern Ethiopia: In a Public Health and Microbiological Perspectives	PLOS ONE			English	Article							NEEDLE-ASPIRATION-CYTOLOGY; POLYMERASE-CHAIN-REACTION; LIQUID CULTURE-SYSTEM; BACT/ALERT 3D; HUMAN-POPULATIONS; DIAGNOSIS; MYCOBACTERIA; RECOVERY; PCR; IDENTIFICATION	Background: The actual burden and causative agent of tuberculous lymphadenitis (TBLN) cases is not well known due to lack of strong surveillance system and diagnostic facilities in Ethiopia. This study was conducted to determine the prevalence of TBLN, its causative agent and risk factors for acquiring this infection. Methods: A cross-sectional study was conducted from April to May 2012 at four main hospitals and one diagnostic clinic located in northern Ethiopia. Fine needle aspirates (FNAs) from TBLN suspects were taken for acid fast bacilli (AFB) microscopy, culture and molecular typing. Results: Among 437 aspirates, culture yielded AFB in 226 (51.7%) of cases. Sixty one culture negative cases (30.5% of 200 cases) were positive by Xpert MTB/RIF test. Moreover, a rifampicin resistant AFB was detected from culture negative cases. The overall prevalence of FNAs positive TBLN cases was 65.8 %. The BacT/AlerT 3D system proved to be a more rapid method with higher recovery rate than Lowenstein-Jensen (L-J) and/or Gottsacker media (P<0.0001). Molecular typing identified all culture positive isolates as M. tuberculosis. The main risk factors for TBLN were pediatric age (OR 2.8, 95% CI, 1.09-7.05) and cough (OR 2, 95% CI, 1.09-3.7). Conclusions: The results of this study revealed a high prevalence of TBLN in the study sites and that pediatric age and cough are key predictors of the disease. TBLN is an important public health problem that needs to be addressed in the area. It is important to note that MDR strains of TB could be involved and aetiological confirmation and drug sensitivity testing of TBLN isolates should be expanded. Further studies on the M. tuberculosis lineages, circulating strains and transmission dynamics, are recommended.	[Biadglegne, Fantahun] Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Biadglegne, Fantahun; Rodloff, Arne C.] Univ Leipzig, Univ Hosp, Inst Med Microbiol & Epidemiol Infect Dis, D-04109 Leipzig, Germany; [Biadglegne, Fantahun; Sack, Ulrich] Univ Leipzig, Univ Hosp, Inst Clin Immunol, D-04109 Leipzig, Germany; [Tesfaye, Weghata] Univ Gondar, Coll Med & Hlth Sci, Gondar, Ethiopia; [Biadglegne, Fantahun; Sack, Ulrich] Univ Leipzig, Translat Ctr Regenerat Med TRM Leipzig, D-04109 Leipzig, Germany	Bahir Dar University; Leipzig University; Leipzig University; University of Gondar; Leipzig University	Biadglegne, F (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.	fantahun.degeneh@gmail.com	Sack, Ulrich/J-6301-2015; Degeneh, Fantahun/AAC-3138-2022; Degeneh, Fantahun/AAE-6826-2022	Sack, Ulrich/0000-0002-7813-0492; 	German Federal Ministry of Education and Research (BMBF, PtJ-Bio) [0315883]; Institute of Medical Microbiology and Epidemiology of Infectious diseases, University hospital Leipzig, Germany; Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany; German academic Exchange (DAAD); University of Bahir Dar, Ethiopia	German Federal Ministry of Education and Research (BMBF, PtJ-Bio)(Federal Ministry of Education & Research (BMBF)); Institute of Medical Microbiology and Epidemiology of Infectious diseases, University hospital Leipzig, Germany; Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany; German academic Exchange (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); University of Bahir Dar, Ethiopia	The work presented in this paper was made possible by funding from the German Federal Ministry of Education and Research (BMBF, PtJ-Bio, 0315883), the Institute of Medical Microbiology and Epidemiology of Infectious diseases, University hospital Leipzig, Germany, Fraunhofer Institute for Cell Therapy and Immunology, Leipzig, Germany, the German academic Exchange (DAAD) and University of Bahir Dar, Ethiopia. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abebe G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-504; Adler H, 2005, EUR J CLIN MICROBIOL, V24, P499, DOI 10.1007/s10096-005-1362-2; Alcaide F, 2003, J CLIN MICROBIOL, V41, P2867, DOI 10.1128/JCM.41.7.2867-2871.2003; Angeby KAK, 2003, CLIN MICROBIOL INFEC, V9, P1148, DOI 10.1046/j.1469-0691.2003.00783.x; Annam V, 2009, INDIAN J PATHOL MICR, V52, P349, DOI 10.4103/0377-4929.54991; Beyene D, 2008, INT J TUBERC LUNG D, V12, P1030; Beyene D, 2009, J INFECT DEV COUNTR, V3, P412, DOI 10.3855/jidc.411; Bezabih M, 2002, CYTOPATHOLOGY, V13, P284, DOI 10.1046/j.1365-2303.2002.00418.x; Biadglegne F, 2013, OPEN J MED MICROBIOL, V3, P18; Carricajo A, 2001, J CLIN MICROBIOL, V39, P3799, DOI 10.1128/JCM.39.10.3799-3800.2001; CLARRIDGE JE, 1993, J CLIN MICROBIOL, V31, P2049, DOI 10.1128/JCM.31.8.2049-2056.1993; Derese Y, 2012, J INFECT DEV COUNTR, V6, P53, DOI 10.3855/jidc.2050; Deutsces Institute fur Normung, 1986, DIN589433; Deutsces Institute fur Normung, 1995, DIN5894332; DEWIT D, 1992, INT J TUBERC LUNG D, V73, P262; Ersoz C, 1998, CYTOPATHOLOGY, V9, P201; Federal Ministry of Health of Ethiopia, 2006, HLTH HLTH REL IND; Fetene T, 2011, ZOONOSES PUBLIC HLTH, V58, P47, DOI 10.1111/j.1863-2378.2009.01265.x; Gadre DV, 1991, INDIAN J TUBER, V38, P25; Getachew A, 1999, E AFR MED J, V76, P260; Iwnetu R, 2009, SCAND J INFECT DIS, V41, P462, DOI 10.1080/00365540902897697; Jain A, 2005, ACTA CYTOL, V49, P17, DOI 10.1159/000326089; Kidane D, 2002, J CLIN MICROBIOL, V40, P4230, DOI 10.1128/JCM.40.11.4230-4234.2002; Legesse M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-157; Mesfin M. M., 2005, Ethiopian Journal of Health Development, V19, P13; Ministry of Health of Ethiopia (MOH), 2008, TUB LEPR TB HIV PREV, V4th; Osores F, 2006, CLIN INFECT DIS, V43, P855, DOI 10.1086/507536; Pahwa R, 2005, J MED MICROBIOL, V54, P873, DOI 10.1099/jmm.0.45904-0; Palacios JJ, 1999, EUR J CLIN MICROBIOL, V18, P265, DOI 10.1007/s100960050275; Sharma SK, 2004, INDIAN J MED RES, V120, P316; Shitaye JE, 2007, VET MED-CZECH, V52, P317, DOI 10.17221/1872-VETMED; Sreeramareddy CT, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-8; Sulaiman A, 2010, COMPREHENSIVE CYTOPA, V16, P707; Supiyaphun P, 2010, ASIAN BIOMED, V4, P787, DOI 10.2478/abm-2010-0102; Tuberculosis and Leprosy Control Program (TLCP) Ethiopia, 2003, CAS FIND TREATM OUTC; Yoon HJ, 2004, YONSEI MED J, V45, P453, DOI 10.3349/ymj.2004.45.3.453	36	23	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81918	10.1371/journal.pone.0081918	http://dx.doi.org/10.1371/journal.pone.0081918			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349151	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200056
J	Kim, C; Mwangi, M; Chung, M; Milheirico, C; de Lencastre, H; Tomasz, A				Kim, Choonkeun; Mwangi, Michael; Chung, Marilyn; Milheirico, Catarina; de Lencastre, Herminia; Tomasz, Alexander			The Mechanism of Heterogeneous Beta-Lactam Resistance in MRSA: Key Role of the Stringent Stress Response	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; GENETIC BACKGROUNDS; EPIDEMIC CLONES; EVOLUTION; EXPRESSION; PHENOTYPE; VIRULENCE; OUTBREAK; HOMOLOG	All methicillin resistant S. aureus (MRSA) strains carry an acquired genetic determinant - mecA or mecC - which encode for a low affinity penicillin binding protein - PBP2A or PBP2A' - that can continue the catalysis of peptidoglycan transpeptidation in the presence of high concentrations of beta-lactam antibiotics which would inhibit the native PBPs normally involved with the synthesis of staphylococcal cell wall peptidoglycan. In contrast to this common genetic and biochemical mechanism carried by all MRSA strains, the level of beta-lactam antibiotic resistance shows a very wide strain to strain variation, the mechanism of which has remained poorly understood. The overwhelming majority of MRSA strains produce a unique - heterogeneous - phenotype in which the great majority of the bacteria exhibit very poor resistance often close to the MIC value of susceptible S. aureus strains. However, cultures of such heterogeneously resistant MRSA strains also contain subpopulations of bacteria with extremely high beta-lactam MIC values and the resistance level and frequency of the highly resistant cells in such strain is a characteristic of the particular MRSA clone. In the study described in this communication, we used a variety of experimental models to understand the mechanism of heterogeneous beta-lactam resistance. Methicillin-susceptible S. aureus (MSSA) that received the mecA determinant in the laboratory either on a plasmid or in the form of a chromosomal SCCmec cassette, generated heterogeneously resistant cultures and the highly resistant subpopulations that emerged in these models had increased levels of PBP2A and were composed of bacteria in which the stringent stress response was induced. Each of the major heterogeneously resistant clones of MRSA clinical isolates could be converted to express high level and homogeneous resistance if the growth medium contained an inducer of the stringent stress response.	[Kim, Choonkeun; Chung, Marilyn; de Lencastre, Herminia; Tomasz, Alexander] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA; [Mwangi, Michael] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Milheirico, Catarina; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal	Rockefeller University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidade Nova de Lisboa	Tomasz, A (corresponding author), Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA.	tomasz@mail.rockefeller.edu	/AAT-3815-2021	Kim, Choon/0000-0003-0306-8935; Tomasz, Alexander/0000-0003-1520-1983; Milheirico, Catarina/0000-0002-2825-8850; /0000-0001-6816-8932	US Public Health Service [2 RO1 AI457838-14]; Fundacao para a Ciencia e Tecnologia (FCT), Portugal [Pest-OE/EQB/LA0004/2011]; FCT [SFRH/BPD/63992/2009]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045738] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the US Public Health Service 2 RO1 AI457838-14 awarded to A. Tomasz. Partial support for this study was also provided by project Pest-OE/EQB/LA0004/2011 from Fundacao para a Ciencia e Tecnologia (FCT), Portugal. C. Milheirico was supported by grant SFRH/BPD/63992/2009 from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KL, 2006, J BACTERIOL, V188, P6739, DOI 10.1128/JB.00609-06; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; CASSELS R, 1995, J BACTERIOL, V177, P5161, DOI 10.1128/jb.177.17.5161-5165.1995; Chung M, 2008, ANTIMICROB AGENTS CH, V52, P2709, DOI 10.1128/AAC.00266-08; COX RA, 1995, J HOSP INFECT, V29, P87, DOI 10.1016/0195-6701(95)90191-4; Crisostomo MI, 2001, P NATL ACAD SCI USA, V98, P9865, DOI 10.1073/pnas.161272898; Crosse AM, 2000, LETT APPL MICROBIOL, V31, P332, DOI 10.1046/j.1472-765x.2000.00822.x; De Lencastre H, 2000, MICROB DRUG RESIST, V6, P1, DOI 10.1089/mdr.2000.6.1; DELENCASTRE H, 1991, ANTIMICROB AGENTS CH, V35, P632, DOI 10.1128/AAC.35.4.632; DOMINGUEZ MA, 1994, J CLIN MICROBIOL, V32, P2081, DOI 10.1128/JCM.32.9.2081-2087.1994; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feil EJ, 2004, CURR OPIN MICROBIOL, V7, P308, DOI 10.1016/j.mib.2004.04.002; FIGUEIREDO AMS, 1991, J INFECT DIS, V164, P883, DOI 10.1093/infdis/164.5.883; Gao W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000944; Geiger T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003016; HACKBARTH CJ, 1993, ANTIMICROB AGENTS CH, V37, P1144, DOI 10.1128/AAC.37.5.1144; HIRAMATSU K, 1995, MICROBIOL IMMUNOL, V39, P531, DOI 10.1111/j.1348-0421.1995.tb02239.x; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Jain V, 2006, PROTEIN SCI, V15, P1449, DOI 10.1110/ps.062117006; Kim C, 2012, J BIOL CHEM, V287, P36854, DOI 10.1074/jbc.M112.395962; KORNBLUM J, 1986, EUR J CLIN MICROBIOL, V5, P714, DOI 10.1007/BF02013311; Kosowska-Shick K, 2010, ANTIMICROB AGENTS CH, V54, P1670, DOI 10.1128/AAC.00019-10; Mwangi MM, 2013, MICROB DRUG RESIST, V19, P153, DOI 10.1089/mdr.2013.0053; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Oliveira DC, 2001, MICROB DRUG RESIST, V7, P349, DOI 10.1089/10766290152773365; TEIXEIRA LA, 1995, J CLIN MICROBIOL, V33, P2400, DOI 10.1128/JCM.33.9.2400-2404.1995; TOMASZ A, 1991, ANTIMICROB AGENTS CH, V35, P124, DOI 10.1128/AAC.35.1.124; TOSA T, 1971, J BACTERIOL, V106, P972, DOI 10.1128/JB.106.3.972-982.1971; Wu SW, 2001, J BACTERIOL, V183, P2417, DOI 10.1128/JB.183.8.2417-2424.2001	29	56	61	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82814	10.1371/journal.pone.0082814	http://dx.doi.org/10.1371/journal.pone.0082814			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349368	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200101
J	Romao, JM; Jin, WW; He, ML; McAllister, T; Guan, LL				Romao, Josue Moura; Jin, Weiwu; He, Maolong; McAllister, Tim; Guan, Le Luo			Elucidation of Molecular Mechanisms of Physiological Variations between Bovine Subcutaneous and Visceral Fat Depots under Different Nutritional Regimes	PLOS ONE			English	Article							ADIPOSE-TISSUE; GENE-EXPRESSION; ADIPOCYTE DIFFERENTIATION; OBESITY; BEEF; ADIPOGENESIS; MICRORNAS; CATTLE; PROTEINS; IMPACT	Adipose tissue plays a critical role in energy homeostasis and metabolism. There is sparse understanding of the molecular regulation at the protein level of bovine adipose tissues, especially within different fat depots under different nutritional regimes. The objective of this study was to analyze the differences in protein expression between bovine subcutaneous and visceral fat depots in steers fed different diets and to identify the potential regulatory molecular mechanisms of protein expression. Subcutaneous and visceral fat tissues were collected from 16 British-continental steers (15.5 month old) fed a high-fat diet (7.1% fat, n=8) or a control diet (2.7% fat, n=8). Protein expression was profiled using label free quantification LC-MS/MS and expression of selected transcripts was evaluated using qRT-PCR. A total of 682 proteins were characterized and quantified with fat depot having more impact on protein expression, altering the level of 51.0% of the detected proteins, whereas diet affected only 5.3%. Functional analysis revealed that energy production and lipid metabolism were among the main functions associated with differentially expressed proteins between fat depots, with visceral fat being more metabolically active than subcutaneous fat as proteins associated with lipid and energy metabolism were upregulated. The expression of several proteins was significantly correlated to subcutaneous fat thickness and adipocyte size, indicating their potential as adiposity markers. A poor correlation (r=0.245) was observed between mRNA and protein levels for 9 genes, indicating that many proteins may be subjected to post-transcriptional regulation. A total of 8 miRNAs were predicted to regulate more than 20% of lipid metabolism proteins differentially expressed between fat depots, suggesting that miRNAs play a role in adipose tissue regulation. Our results show that proteomic changes support the distinct metabolic and physiological characteristics observed between subcutaneous and visceral adipose tissue depots in cattle.	[Romao, Josue Moura; Jin, Weiwu; Guan, Le Luo] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [He, Maolong; McAllister, Tim] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada	University of Alberta; Agriculture & Agri Food Canada	Guan, LL (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	lguan@ualberta.ca	; McAllister, Tim A./R-9201-2017	Romao, Josue/0000-0002-9308-2177; McAllister, Tim A./0000-0002-8266-6513	Alberta Livestock Meat Agency [2010R033R]; Alberta Innovates Bio Solutions [2010F110R]; Alberta Innovates-Technology Futures; Canadian Triticale Biorefinery Initiative (CTBI); Feed Opportunities from the Biofuels Industries (FOBI); Beef Cluster of Agriculture and Agri-Food Canada	Alberta Livestock Meat Agency; Alberta Innovates Bio Solutions; Alberta Innovates-Technology Futures; Canadian Triticale Biorefinery Initiative (CTBI); Feed Opportunities from the Biofuels Industries (FOBI); Beef Cluster of Agriculture and Agri-Food Canada	This work was supported by Alberta Livestock Meat Agency (2010R033R) and Alberta Innovates Bio Solutions (2010F110R). J.M.R. is supported by PhD graduate student scholarship from Alberta Innovates-Technology Futures. Provision of financial support from the Canadian Triticale Biorefinery Initiative (CTBI), Feed Opportunities from the Biofuels Industries (FOBI) and Beef Cluster of Agriculture and Agri-Food Canada are also gratefully appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baglioni S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036569; Basu U, 2012, J GENOMICS, V1, P22; Bjorndal B, 2011, J OBES, V2011, DOI 10.1155/2011/490650; Bordner Kelly A, 2011, Front Psychiatry, V2, P18, DOI 10.3389/fpsyt.2011.00018; Cartwright AL, 1987, BIOL ADIPOCYTE, P229; Catenacci VA, 2009, CLIN CHEST MED, V30, P415, DOI 10.1016/j.ccm.2009.05.001; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Dadson Keith, 2011, Front Endocrinol (Lausanne), V2, P62, DOI 10.3389/fendo.2011.00062; Dodson MV, 2010, J FOOD SCI, V75, pR1, DOI 10.1111/j.1750-3841.2009.01396.x; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Ferland-McCollough D, 2012, CELL DEATH DIFFER, V19, P1003, DOI 10.1038/cdd.2011.183; Food and Agriculture Organization (FAO), 2011, WORLD LIV 2011 LIV F, DOI DOI 10.1080/; Fujiki K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-38; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Hausman GJ, 2009, J ANIM SCI, V87, P1218, DOI 10.2527/jas.2008-1427; He ML, 2012, LIPIDS, V47, P1209, DOI 10.1007/s11745-012-3720-z; He ML, 2010, NUTR RES, V30, P125, DOI 10.1016/j.nutres.2009.09.009; He ML, 2012, J ANIMAL S IN PRESS, V90, P600; HIROSAWA M, 1993, COMPUT APPL BIOSCI, V9, P161; Hishikawa D, 2005, PHYSIOL GENOMICS, V21, P343, DOI 10.1152/physiolgenomics.00184.2004; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Jin W, 2012, J ANIM SCI, V90, P171, DOI 10.2527/jas.2011-4229; Jin WW, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-29; Jin WW, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-90; Joseph SJ, 2010, GENE REGUL SYST BIO, V4, P91, DOI 10.4137/GRSB.S5831; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1; Large V, 2004, DIABETES METAB, V30, P294, DOI 10.1016/S1262-3636(07)70121-0; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Mayilyan KR, 2012, PROTEIN CELL, V3, P487, DOI 10.1007/s13238-012-2924-6; McNeill SH, 2012, MEAT SCI, V90, P1, DOI 10.1016/j.meatsci.2011.05.023; miRBASE, 2012, MIRBASE SEQ DAT REL; Monaco E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032481; Nguyen T, 2012, CAN J CARDIOL, V28, P326, DOI 10.1016/j.cjca.2012.01.001; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Perez-Perez R, 2009, J PROTEOME RES, V8, P1682, DOI 10.1021/pr800942k; Poulos SP, 2010, MOL CELL ENDOCRINOL, V323, P20, DOI 10.1016/j.mce.2009.12.011; Rajesh RV, 2010, COMP BIOCHEM PHYS D, V5, P234, DOI 10.1016/j.cbd.2010.06.004; Romao JM, 2011, EXP BIOL MED, V236, P997, DOI 10.1258/ebm.2011.011101; Romao JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040605; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Samulin J, 2008, COMP BIOCHEM PHYS B, V151, P147, DOI 10.1016/j.cbpb.2008.06.010; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Smith SB, 2006, ANIM SCI J, V77, P478, DOI 10.1111/j.1740-0929.2006.00375.x; Taniguchi M, 2008, BIOCHEM BIOPH RES CO, V366, P54, DOI 10.1016/j.bbrc.2007.11.110; Taniguchi M, 2008, COMP BIOCHEM PHYS D, V3, P251, DOI 10.1016/j.cbd.2008.06.002; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wang Y, 2009, INT J OBESITY, V33, P621, DOI 10.1038/ijo.2009.45; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Xie HM, 2009, EXPERT OPIN THER TAR, V13, P1227, DOI 10.1517/14728220903190707; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Zhang L, 2011, AM J PHYSIOL-ENDOC M, V301, pE599, DOI 10.1152/ajpendo.00059.2011; Zhang Q, 2012, MOL BIOL REP, V39, P953, DOI 10.1007/s11033-011-0821-3; Zhao SM, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-6; Zhao YM, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-14	61	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e83211	10.1371/journal.pone.0083211	http://dx.doi.org/10.1371/journal.pone.0083211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349463	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200126
J	Slipczuk, L; Codolosa, JN; Davila, CD; Romero-Corral, A; Yun, J; Pressman, GS; Figueredo, VM				Slipczuk, Leandro; Codolosa, J. Nicolas; Davila, Carlos D.; Romero-Corral, Abel; Yun, Jeong; Pressman, Gregg S.; Figueredo, Vincent M.			Infective Endocarditis Epidemiology Over Five Decades: A Systematic Review	PLOS ONE			English	Review							TERTIARY CARE CENTER; BLOOD-STREAM INFECTIONS; LONG-TERM MORTALITY; BACTERIAL-ENDOCARDITIS; CLINICAL-FEATURES; RISK-FACTORS; CHANGING EPIDEMIOLOGY; PROGNOSTIC-FACTORS; OLMSTED COUNTY; TEMPORAL TRENDS	Aims: To Assess changes in infective endocarditis (IE) epidemiology over the last 5 decades. Methods and Results: We searched the published literature using PubMed, MEDLINE, and EMBASE from inception until December 2011. Data From: Einstein Medical Center, Philadelphia, PA were also included. Criteria for inclusion in this systematic review included studies with reported IE microbiology, IE definition, description of population studied, and time frame. Two authors independently extracted data and assessed manuscript quality. One hundred sixty studies (27,083 patients) met inclusion criteria. Among hospital-based studies (n=142; 23,606 patients) staphylococcal IE percentage increased over time, with coagulase-negative staphylococcus (CNS) increasing over each of the last 5 decades (p<0.001) and Staphylococcus aureus (SA) in the last decade (21% to 30%; p<0.05). Streptococcus viridans (SV) and culture negative (CN) IE frequency decreased over time (p<0.001), while enterococcal IE increased in the last decade (p<0.01). Patient age and male predominance increased over time as well. In subgroup analysis, SA frequency increased in North America, but not the rest of the world. This was due, in part, to an increase in intravenous drug abuse IE in North America (p<0.001). Among population-based studies (n=18; 3,477 patients) no significant changes were found. Conclusion: Important changes occurred in IE epidemiology over the last half-century, especially in the last decade. Staphylococcal and enterococcal IE percentage increased while SV and CN IE decreased. Moreover, mean age at diagnosis increased together with male: female ratio. These changes should be considered at the time of decision-making in treatment of and prophylaxis for IE.	[Slipczuk, Leandro; Davila, Carlos D.; Yun, Jeong] Albert Einstein Med Ctr, Dept Med, Philadelphia, PA 19141 USA; [Slipczuk, Leandro] Cedars Sinai Med Ctr, Inst Heart, Los Angeles, CA 90048 USA; [Codolosa, J. Nicolas; Romero-Corral, Abel; Pressman, Gregg S.; Figueredo, Vincent M.] Albert Einstein Med Ctr, Einstein Inst Heart & Vasc Hlth, Philadelphia, PA 19141 USA; [Yun, Jeong] Brigham & Womens Hosp, Pulm & Crit Care Med Div, Boston, MA 02115 USA; [Figueredo, Vincent M.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA	Yeshiva University; Cedars Sinai Medical Center; Yeshiva University; Harvard University; Brigham & Women's Hospital; Jefferson University	Figueredo, VM (corresponding author), Albert Einstein Med Ctr, Einstein Inst Heart & Vasc Hlth, Philadelphia, PA 19141 USA.	FigueredoV@einstein.edu	Pressman, Gregg/AAT-8289-2020; Davila, Carlos/GXG-7623-2022; Figueredo, Vincent/AAV-7610-2021	Pressman, Gregg/0000-0002-0992-1805; Yun, Jeong/0000-0002-4361-8295				AGUERO ME, 1982, REV MED CHILE, V110, P133; Ako J, 2003, CIRC J, V67, P3, DOI 10.1253/circj.67.3; Al-Tawfiq JA, 2009, ANN SAUDI MED, V29, P433, DOI 10.4103/0256-4947.57164; ALLAL J, 1985, ANN MED INTERNE, V136, P91; Anavekar NS, 2007, CLIN INFECT DIS, V44, P1180, DOI 10.1086/513197; Athan E, 2012, JAMA-J AM MED ASSOC, V307, P1727, DOI 10.1001/jama.2012.497; AUGER P, 1981, ACTA CARDIOL, V36, P105; BAILEY IK, 1975, AUST NZ J MED, V5, P413, DOI 10.1111/j.1445-5994.1975.tb03048.x; Bannay A, 2011, EUR HEART J, V32, P2003, DOI 10.1093/eurheartj/ehp008; Barrau K, 2004, CLIN MICROBIOL INFEC, V10, P302, DOI 10.1111/j.1198-743X.2004.00776.x; BAYER AS, 1993, CLIN INFECT DIS, V17, P313, DOI 10.1093/clinids/17.3.313; Benes J, 2011, Vnitr Lek, V57, P147; Benito N, 2009, ANN INTERN MED, V150, P586, DOI 10.7326/0003-4819-150-9-200905050-00004; Benn M, 1997, J INTERN MED, V242, P15, DOI 10.1046/j.1365-2796.1997.00153.x; BENNIS A, 1995, ANN CARDIOL ANGEIOL, V44, P339; Bishara J, 2001, CLIN INFECT DIS, V33, P1636, DOI 10.1086/323785; Bor DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060033; Borer A, 1998, Public Health Rev, V26, P317; BOURAMOUE C, 1990, ARCH MAL COEUR VAISS, V83, P2053; Bouza E, 2001, MEDICINE, V80, P298, DOI 10.1097/00005792-200109000-00003; Braun S, 2000, REV MED CHILE, V128, P708; Buchholtz K, 2009, EUR J INTERN MED, V20, P407, DOI 10.1016/j.ejim.2008.12.017; Cabell CH, 2004, AM HEART J, V147, P582, DOI 10.1016/j.ahj.2003.06.005; Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90; Casabe JH, 1996, REV ARGENT CARDIOL, V64, P39; Cecchi Enrico, 2004, Ital Heart J, V5, P249; Cetinkaya Y, 2001, INT J ANTIMICROB AG, V18, P1, DOI 10.1016/S0924-8579(01)00344-2; Chao TH, 1999, J FORMOS MED ASSOC, V98, P474; Chen Chang-Hua, 2001, Journal of Microbiology Immunology and Infection, V34, P119; CHEN SCA, 1992, AM J CARDIOL, V70, P1449, DOI 10.1016/0002-9149(92)90298-D; CHENG J-J, 1989, Taiwan yixuehui zazhi, V88, P213; CHOUDHURY R, 1992, AM J CARDIOL, V70, P1453, DOI 10.1016/0002-9149(92)90299-E; CHU J, 2004, NZ MED J, V117, P75991; Cicalini S, 2006, J INFECTION, V52, P140, DOI 10.1016/j.jinf.2005.02.025; Corral I, 2007, J NEUROL, V254, P1253, DOI 10.1007/s00415-006-0512-5; Couturier E, 2000, MED MALADIES INFECT, V30, P162; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; de Sa DDC, 2010, MAYO CLIN PROC, V85, P422, DOI 10.4065/mcp.2009.0585; DELAHAYE F, 1995, EUR HEART J, V16, P394, DOI 10.1093/oxfordjournals.eurheartj.a060923; Deprele C, 2004, CLIN MICROBIOL INFEC, V10, P46, DOI 10.1111/j.1469-0691.2004.00735.x; Di Salvo G, 2001, J AM COLL CARDIOL, V37, P1069, DOI 10.1016/S0735-1097(00)01206-7; DURACK DT, 1994, AM J MED, V96, P200, DOI 10.1016/0002-9343(94)90143-0; Durante-Mangoni E, 2008, ARCH INTERN MED, V168, P2095, DOI 10.1001/archinte.168.19.2095; Duval X, 2012, J AM COLL CARDIOL, V59, P1968, DOI 10.1016/j.jacc.2012.02.029; DWYER DE, 1994, MED J AUSTRALIA, V160, P709, DOI 10.5694/j.1326-5377.1994.tb125910.x; Dyson C, 1999, J INFECTION, V38, P87, DOI 10.1016/S0163-4453(99)90074-9; Exposito Ordonez E, 1998, An Med Interna, V15, P642; Federspiel JJ, 2012, ARCH INTERN MED, V172, P363, DOI 10.1001/archinternmed.2011.1027; Fedorova T A, 2008, Klin Med (Mosk), V86, P62; Fefer P, 2002, EUR J CLIN MICROBIOL, V21, P432, DOI 10.1007/s10096-002-0740-2; Ferreiros E, 2006, AM HEART J, V151, P545, DOI 10.1016/j.ahj.2005.04.008; FINLAND M, 1970, ANN INTERN MED, V72, P341, DOI 10.7326/0003-4819-72-3-341; Fluit AC, 2000, CLIN INFECT DIS, V30, P454, DOI 10.1086/313710; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; GARVEY GJ, 1978, MEDICINE, V57, P105, DOI 10.1097/00005792-197803000-00001; GERGAUD JM, 1994, ANN MED INTERNE, V145, P163; Giannitsioti E, 2007, CLIN MICROBIOL INFEC, V13, P763, DOI 10.1111/j.1469-0691.2007.01746.x; GOSSIUS G, 1985, ACTA MED SCAND, V217, P171; Gotsman I, 2007, ISRAEL MED ASSOC J, V9, P365; GOULET V, 1986, PRESSE MED, V15, P1855; Gracey M, 1968, Med J Aust, V1, P984; GRIFFIN MR, 1985, JAMA-J AM MED ASSOC, V254, P1199, DOI 10.1001/jama.254.9.1199; HADDY RI, 1981, J FAM PRACTICE, V13, P807; Hammami N, 2006, ARCH MAL COEUR VAISS, V99, P29; Heiro M, 2006, HEART, V92, P1457, DOI 10.1136/hrt.2005.084715; Heper G, 2002, ANGIOLOGY, V53, P191, DOI 10.1177/000331970205300210; Ameijeiras AH, 2007, REV MED CHILE, V135, P11; Hill EE, 2007, EUR HEART J, V28, P196, DOI 10.1093/eurheartj/ehl427; Hoen B, 2002, JAMA-J AM MED ASSOC, V288, P75, DOI 10.1001/jama.288.1.75; Hoffman C, 1996, JAMA-J AM MED ASSOC, V276, P1473, DOI 10.1001/jama.276.18.1473; HOGEVIK H, 1995, MEDICINE, V74, P324, DOI 10.1097/00005792-199511000-00003; Hricak V, 2007, J CHEMOTHERAPY, V19, P198, DOI 10.1179/joc.2007.19.2.198; Hsu CN, 2006, EPIDEMIOL INFECT, V134, P589, DOI 10.1017/S0950268805005224; Huang TY, 2009, J MICROBIOL IMMUNOL, V42, P154; Husebye Trygve, 1998, Tidsskrift for den Norske Laegeforening, V118, P222; Issa VS, 2003, INT J CARDIOL, V89, P63; JAFFE WM, 1990, J AM COLL CARDIOL, V15, P1227, DOI 10.1016/S0735-1097(10)80005-1; Jain V, 2008, J INFECTION, V57, P132, DOI 10.1016/j.jinf.2008.05.008; Jalal S, 1998, Indian Heart J, V50, P516; JULANDER I, 1987, INFECTION, V15, P177, DOI 10.1007/BF01646043; JUNIOR R, 2000, ARQ BRAS CARDIOL, V74, P217; Kanafani ZA, 2010, EUR J CLIN MICROBIOL, V29, P1203, DOI 10.1007/s10096-010-0983-2; Kanafani ZA, 2002, J INFECTION, V45, P152, DOI [10.1016/S0163-4453(02)91041-8, 10.1053/jinf.2002.1041]; KAZANJIAN PH, 1993, INFECT DIS CLIN PRAC, V2, P41, DOI 10.1097/00019048-199301000-00007; Khan KS, 2003, SYSTEMATIC REV SUPPO; Khanal B, 2002, TROP DOCT, V32, P83, DOI 10.1177/004947550203200208; KIM EL, 1990, AM J MED SCI, V299, P87, DOI 10.1097/00000441-199002000-00002; KING JW, 1988, AM J MED SCI, V295, P517, DOI 10.1097/00000441-198806000-00005; KING JW, 1986, SOUTHERN MED J, V79, P151, DOI 10.1097/00007611-198602000-00005; Kiwan Y A, 1990, Mater Med Pol, V22, P173; Knudsen JB, 2009, J HEART VALVE DIS, V18, P386; Koegelenberg CFN, 2003, QJM-INT J MED, V96, P217, DOI 10.1093/qjmed/hcg028; KOGA Y, 1985, JPN CIRC J, V49, P535, DOI 10.1253/jcj.49.535; Krecki Radoslaw, 2007, Pol Arch Med Wewn, V117, P512; Kurland S, 1999, SCAND J INFECT DIS, V31, P87, DOI 10.1080/00365549950161952; Leblebicioglu H, 2006, EUR J EPIDEMIOL, V21, P25, DOI 10.1007/s10654-005-4724-2; LEDERMAN MM, 1992, MEDICINE, V71, P52, DOI 10.1097/00005792-199201000-00005; LEITERSDORF E, 1983, ISRAEL J MED SCI, V19, P491; Letaief A, 2007, INT J INFECT DIS, V11, P430, DOI 10.1016/j.ijid.2006.10.006; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; LIEN EA, 1988, SCAND J INFECT DIS, V20, P239, DOI 10.3109/00365548809032446; LODE H, 1982, DEUT MED WOCHENSCHR, V107, P967, DOI 10.1055/s-2008-1070055; Lopez-Dupla M, 2006, REV ESP CARDIOL, V59, P1131, DOI 10.1157/13095782; Lou Xiu-fen, 2009, Zhonghua Nei Ke Za Zhi, V48, P35; Loupa C, 2004, CLIN MICROBIOL INFEC, V10, P556, DOI 10.1111/j.1469-0691.2004.00884.x; LOWES JA, 1980, LANCET, V1, P133, DOI 10.1016/S0140-6736(80)90614-5; Lupis Francesco, 2009, Infez Med, V17, P159; Manzano MC, 2007, REV ESP CARDIOL, V60, P24, DOI 10.1016/S1885-5857(07)60102-9; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Math RS, 2011, AM HEART J, V162, P633, DOI 10.1016/j.ahj.2011.07.014; McCarthy JT, 2000, MAYO CLIN PROC, V75, P1008, DOI 10.4065/75.10.1008; Mesa J M, 1990, Rev Esp Cardiol, V43, P142; MILLS J, 1974, CHEST, V66, P151, DOI 10.1378/chest.66.2.151; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Morelli Sergio, 1994, Recenti Progressi in Medicina, V85, P368; Mouly S, 2002, J INFECTION, V45, P246, DOI 10.1053/jinf.2002.1058; Munita JM, 2012, CURR INFECT DIS REP, V14, P339, DOI 10.1007/s11908-012-0270-8; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Nadji G, 2008, INT J CARDIOL, V129, P227, DOI 10.1016/j.ijcard.2007.07.087; NAKAMURA K, 1982, JPN CIRC J, V46, P352, DOI 10.1253/jcj.46.352; Nakatani S, 2003, CIRC J, V67, P901, DOI 10.1253/circj.67.901; Nashmi A., 2007, Eastern Mediterranean Health Journal, V13, P64; Netzer ROM, 2000, HEART, V84, P25, DOI 10.1136/heart.84.1.25; Nigro F S, 2001, Infez Med, V9, P232; NIHOYANNOPOULOS P, 1985, EUR HEART J, V6, P380, DOI 10.1093/oxfordjournals.eurheartj.a061876; Noskin GA, 2005, ARCH INTERN MED, V165, P1756, DOI 10.1001/archinte.165.15.1756; Okada Kaoru, 1998, Fukuoka Acta Medica, V89, P34; Olaison L, 1996, SCAND J INFECT DIS, V28, P399, DOI 10.3109/00365549609037927; Olds J, 1991, Iowa Med, V81, P218; Osler W, 1885, Br Med J, V1, P577; Pachirat Orathai, 2002, J Med Assoc Thai, V85, P1; Pazdernik M, 2009, J HEART VALVE DIS, V18, P395; PEAT EB, 1989, NEW ZEAL MED J, V102, P33; PELLETIER LL, 1977, MEDICINE, V56, P287, DOI 10.1097/00005792-197707000-00002; Nunes MCP, 2010, INT J INFECT DIS, V14, pE394, DOI 10.1016/j.ijid.2009.06.024; Proenca R, 1999, Acta Med Port, V12, P381; QUENZER RW, 1976, AM HEART J, V92, P15, DOI 10.1016/S0002-8703(76)80399-7; Roca B, 2007, INT J INFECT DIS, V11, P198, DOI 10.1016/j.ijid.2006.04.002; Rogers KL, 2009, INFECT DIS CLIN N AM, V23, P73, DOI 10.1016/j.idc.2008.10.001; ROMEROVIVAS J, 1985, MED CLIN-BARCELONA, V84, P637; Rostagno C, 2010, CARDIOL J, V17, P566; Rubin RJ, 1999, EMERG INFECT DIS, V5, P9, DOI 10.3201/eid0501.990102; SANABRIA TJ, 1990, ARCH INTERN MED, V150, P1305, DOI 10.1001/archinte.150.6.1305; Sandre RM, 1996, CLIN INFECT DIS, V22, P276, DOI 10.1093/clinids/22.2.276; SCHNURR LP, 1977, Q J MED, V46, P499; Scudeller L, 2009, ARCH INTERN MED, V169, P1720, DOI 10.1001/archinternmed.2009.307; Seibaek M B, 1994, Ugeskr Laeger, V156, P6028; Sekido M, 1999, J Cardiol, V33, P209; SHINEBOURNE EA, 1969, BRIT HEART J, V31, P536; SHIVELY BK, 1991, J AM COLL CARDIOL, V18, P391, DOI 10.1016/0735-1097(91)90591-V; Siddiq S, 1996, ARCH INTERN MED, V156, P2454, DOI 10.1001/archinte.156.21.2454; Singham K T, 1980, Ann Acad Med Singap, V9, P435; SMITH RH, 1976, THORAX, V31, P373, DOI 10.1136/thx.31.4.373; Souto Meirino C A, 1997, Arch Inst Cardiol Mex, V67, P46; STECKELBERG JM, 1990, AM J MED, V88, P582, DOI 10.1016/0002-9343(90)90521-E; STRATE M, 1987, Ugeskrift for Laeger, V149, P3031; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sucu M, 2010, TURK KARDIYOL DERN A, V38, P107; SVANBOM M, 1978, SCAND J INFECT DIS, V10, P193, DOI 10.3109/inf.1978.10.issue-3.07; Sy RW, 2011, EUR HEART J, V32, P2016, DOI 10.1093/eurheartj/ehp085; Tariq M, 2004, INT J INFECT DIS, V8, P163, DOI 10.1016/j.ijid.2004.02.001; TERPENNING MS, 1987, AM J MED, V83, P626, DOI 10.1016/0002-9343(87)90890-4; Thalme A, 2007, SCAND J INFECT DIS, V39, P197, DOI 10.1080/00365540600978856; THORNTON JB, 1981, ORAL SURG ORAL MED O, V52, P379, DOI 10.1016/0030-4220(81)90334-0; Tleyjeh IM, 2005, JAMA-J AM MED ASSOC, V293, P3022, DOI 10.1001/jama.293.24.3022; Tleyjeh IM, 2007, CHEST, V132, P1025, DOI 10.1378/chest.06-2048; Tornos P, 2005, HEART, V91, P571, DOI 10.1136/hrt.2003.032128; Tran CT, 2006, SCAND J INFECT DIS, V38, P664, DOI 10.1080/00365540600585180; VANDERMEER JTM, 1992, ARCH INTERN MED, V152, P1863, DOI 10.1001/archinte.152.9.1863; VENEZIO FR, 1982, ARCH INTERN MED, V142, P789, DOI 10.1001/archinte.142.4.789; Verhagen DWM, 2009, CLIN INFECT DIS, V48, P1559, DOI 10.1086/598930; VERHEUL HA, 1993, AM J CARDIOL, V72, P682, DOI 10.1016/0002-9149(93)90885-G; Vlessis AA, 1996, ANN THORAC SURG, V61, P1217, DOI 10.1016/0003-4975(96)00029-X; VONREYN CF, 1981, ANN INTERN MED, V94, P505, DOI 10.7326/0003-4819-94-4-505; Wang A, 2012, J AM COLL CARDIOL, V59, P1977, DOI 10.1016/j.jacc.2012.02.030; Wang Huan-ling, 2004, Zhonghua Nei Ke Za Zhi, V43, P33; WATANAKUNAKORN C, 1993, MEDICINE, V72, P90, DOI 10.1097/00005792-199303000-00003; WELLS AU, 1990, Q J MED, V76, P753; WELSBY PD, 1977, PRACTITIONER, V218, P382; Weng M C, 1996, Zhonghua Yi Xue Za Zhi (Taipei), V58, P18; Werner GS, 1996, AM J MED, V100, P90, DOI 10.1016/S0002-9343(96)90017-0; WHITBY M, 1985, INT J CARDIOL, V7, P391, DOI 10.1016/0167-5273(85)90093-2; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; WITCHITZ S, 1992, ARCH MAL COEUR VAISS, V85, P959; Wong CW, 2009, NEW ZEAL MED J, V122, P54; Yildirimturk O, 2009, TURK KARDIYOL DERN A, V37, P91; Zamorano J, 2005, J HEART VALVE DIS, V14, P303; 2003, ARCH MAL COEUR VAISS, V96, P111	189	258	273	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82665	10.1371/journal.pone.0082665	http://dx.doi.org/10.1371/journal.pone.0082665			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349331	Green Published, gold			2022-12-27	WOS:000328705200089
J	Wacker, K; Denker, S; Hildebrand, A; Eberwein, P; Reinhard, T; Schwartzkopff, J				Wacker, Katrin; Denker, Sophy; Hildebrand, Antonia; Eberwein, Philipp; Reinhard, Thomas; Schwartzkopff, Johannes			Short-Term Azithromycin Treatment Promotes Cornea Allograft Survival in the Rat	PLOS ONE			English	Article							SYSTEMIC MYCOPHENOLATE-MOFETIL; HIGH-RISK KERATOPLASTY; PENETRATING KERATOPLASTY; IMMUNE-REACTIONS; GRAFT-SURVIVAL; PHARMACOKINETICS; CLARITHROMYCIN; IMMUNOBIOLOGY; MACROLIDES; REJECTION	Background: Any inflammatory response following corneal transplantation may induce rejection and irreversible graft failure. The purpose of this study is to analyze the anti-inflammatory effect of azithromycin (AZM) following experimental keratoplasty in rats. Methods: Corneal transplants were performed between Fisher-donor and Lewis-recipient rats. Recipients were postoperatively treated three times daily with AZM, miglyol, ofloxacin or dexamethasone eye drops. As an additional control, AZM was applied following syngeneic keratoplasty. Furthermore, short-term treatments with AZM for seven days perioperatively or with AZM only three days prior to the transplantation were compared to appropriate controls. All transplants were monitored clinically for opacity, edema, and vascularization. Infiltrating CD45(+), CD4(+), CD8(+), CD25(+), CD161(+) and CD163(+) cells were quantified via immunohistochemistry. Results: AZM significantly promoted corneal graft survival compared with miglyol or ofloxacin treatment. This effect was comparable to topical dexamethasone. No adverse AZM effect was observed. Histology confirmed a significant reduction of infiltrating leukocytes. The short-term application of AZM for three days prior to transplantation or for seven days perioperatively reduced corneal graft rejection significantly compared with the controls. Conclusions: Along with antibiotic properties, topical AZM has a strong anti-inflammatory effect. Following keratoplasty, this effect is comparable to topical dexamethasone without the risk of steroid-induced adverse effects. Short-term treatment with AZM three days prior to the transplantation was sufficient to promote graft survival in the rat keratoplasty model. We therefore suggest further assessing the anti-inflammatory function of topical AZM following keratoplasty in humans.	[Wacker, Katrin; Denker, Sophy; Hildebrand, Antonia; Eberwein, Philipp; Reinhard, Thomas; Schwartzkopff, Johannes] Univ Freiburg, Ctr Eye, D-79106 Freiburg, Germany; [Schwartzkopff, Johannes] Dres Knapp & Schwartzkopff, Eye Clin, Lorrach, Germany	University of Freiburg	Wacker, K (corresponding author), Univ Freiburg, Ctr Eye, Hugstetter Str 55, D-79106 Freiburg, Germany.	katrin.wacker@uniklinik-freiburg.de; Johannes.schwartzkopff@googlemail.com	Denker, Sophy/AAB-7484-2022	Denker, Sophy/0000-0002-0736-6019; Wacker, Katrin/0000-0002-4164-561X	Laboratoires Thea, France	Laboratoires Thea, France	This study was supported by Laboratoires Thea, France. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Amar T, 2008, CURR EYE RES, V33, P149, DOI 10.1080/02713680701860499; Amsden GW, 2005, J ANTIMICROB CHEMOTH, V55, P10, DOI 10.1093/jac/dkh519; Barshes NR, 2004, FRONT BIOSCI-LANDMRK, V9, P411, DOI 10.2741/1249; Bertelmann E, 2004, OPHTHALMOLOGICA, V218, P359, DOI 10.1159/000080937; Blavin J, 2012, J OCUL PHARMACOL TH, V28, P428, DOI 10.1089/jop.2011.0171; Coster DJ, 2005, AM J OPHTHALMOL, V140, P1112, DOI 10.1016/j.ajo.2005.07.024; Evans JR, 2011, COCHRANE DB SYST REV, V16; Hamrah Pedram, 2007, Chem Immunol Allergy, V92, P58, DOI 10.1159/000099254; HE YG, 1991, INVEST OPHTH VIS SCI, V32, P2723; Hori Junko, 2008, J Ocul Biol Dis Infor, V1, P94, DOI 10.1007/s12177-008-9010-6; Hos D, 2011, ARCH OPHTHALMOL-CHIC, V129, P445, DOI 10.1001/archophthalmol.2011.42; Ianaro A, 2000, J PHARMACOL EXP THER, V292, P156; Kuehne JJ, 2004, AM J OPHTHALMOL, V138, P547, DOI 10.1016/j.ajo.2004.04.071; Maier P, 2007, GRAEF ARCH CLIN EXP, V245, P351, DOI 10.1007/s00417-006-0410-7; Medina CA, 2013, CORNEA, V32, P658, DOI 10.1097/ICO.0b013e318274a690; Niederkorn JY, 2010, CURR OPIN ALLERGY CL, V10, P493, DOI 10.1097/ACI.0b013e32833dfa11; Pleyer U, 2009, ACTA OPHTHALMOL, V87, P488, DOI 10.1111/j.1755-3768.2009.01596.x; Reidy JJ, 2001, CURR OPIN OPHTHALMOL, V12, P258, DOI 10.1097/00055735-200108000-00004; Reinhard T, 2005, TRANSPL INT, V18, P703, DOI 10.1111/j.1432-2277.2005.00126.x; Reinhard T, 1999, CORNEA, V18, P645, DOI 10.1097/00003226-199911000-00003; Reinhard T, 2001, GRAEF ARCH CLIN EXP, V239, P367, DOI 10.1007/s004170100285; Reis A, 2010, ESSENT OPHTHALMOL, P25, DOI 10.1007/978-3-540-85544-6_3; Sadrai Z, 2011, INVEST OPHTH VIS SCI, V52, P2525, DOI 10.1167/iovs.10-5658; Schwartzkopff J, 2010, BRIT J OPHTHALMOL, V94, P1062, DOI 10.1136/bjo.2008.154435; STAMM WE, 1991, AM J MED, V91, pS19, DOI 10.1016/0002-9343(91)90396-F; Stewart WC, 2010, AM J OPHTHALMOL, V150, P744, DOI 10.1016/j.ajo.2010.05.039; Sugiyama K, 2007, CLIN EXP IMMUNOL, V147, P540, DOI 10.1111/j.1365-2249.2007.03299.x; Tabbara KF, 2005, CURR EYE RES, V30, P915, DOI 10.1080/02713680500306223; Thompson RW, 2003, OPHTHALMOLOGY, V110, P1396, DOI 10.1016/S0161-6420(03)00463-9; van Eyk AD, 2009, CORNEA, V28, P441, DOI 10.1097/ICO.0b013e31818c901f; Veldman P, 2011, INT OPHTHALMOL CLIN, V51, P34; Wacker K, 2012, EXP EYE RES, V97, P24, DOI 10.1016/j.exer.2012.01.004; Williams KA, 2007, TRANSPLANTATION, V84, P806, DOI 10.1097/01.tp.0000285489.91595.13; Yamada J, 1999, INVEST OPHTH VIS SCI, V40, P2614; Zirm E., 1906, A VONGRAEFES ARCH OP, V64, P580, DOI [10.1007/BF01949227, DOI 10.1007/BF01949227]	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82687	10.1371/journal.pone.0082687	http://dx.doi.org/10.1371/journal.pone.0082687			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349336	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200092
J	Lee, S; Rojas, CM; Ishiga, Y; Pandey, S; Mysore, KS				Lee, Seonghee; Rojas, Clemencia M.; Ishiga, Yasuhiro; Pandey, Sona; Mysore, Kirankumar S.			Arabidopsis Heterotrimeric G-Proteins Play a Critical Role in Host and Nonhost Resistance againstPseudomonas syringae Pathogens	PLOS ONE			English	Article							ABSCISIC-ACID REGULATION; GTP-BINDING PROTEINS; G-BETA-DEFICIENT; GUARD-CELL K+; ALPHA-SUBUNIT; INNATE IMMUNITY; DISEASE RESISTANCE; GAMMA-SUBUNITS; SIGNAL-TRANSDUCTION; STOMATAL APERTURE	Heterotrimeric G-proteins have been proposed to be involved in many aspects of plant disease resistance but their precise role in mediating nonhost disease resistance is not well understood. We evaluated the roles of specific subunits of heterotrimeric G-proteins using knock-out mutants of Arabidopsis G alpha, G beta and G gamma subunits in response to host and nonhost Pseudomonas pathogens. Plants lacking functional G alpha, G beta and G gamma 1G gamma 2 proteins displayed enhanced bacterial growth and disease susceptibility in response to host and nonhost pathogens. Mutations of single G gamma subunits G gamma 1, G gamma 2 and G gamma 3 did not alter bacterial disease resistance. Some specificity of subunit usage was observed when comparing host pathogen versus nonhost pathogen. Overexpression of both G alpha and G beta led to reduced bacterial multiplication of nonhost pathogen P. syringae pv. tabaci whereas overexpression of G beta, but not of G alpha, resulted in reduced bacterial growth of host pathogen P. syringae pv. maculicola, compared to wild-type Col-0. Moreover, the regulation of stomatal aperture by bacterial pathogens was altered in G alpha and G beta mutants but not in any of the single or double G gamma mutants. Taken together, these data substantiate the critical role of heterotrimeric G-proteins in plant innate immunity and stomatal modulation in response to P. syringae.	[Lee, Seonghee; Rojas, Clemencia M.; Ishiga, Yasuhiro; Mysore, Kirankumar S.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73402 USA; [Pandey, Sona] Donald Danforth Plant Sci Ctr, St Louis, MO USA	Noble Research Institute; Donald Danforth Plant Science Center	Mysore, KS (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, POB 2180, Ardmore, OK 73402 USA.	ksmysore@noble.org	Pandey, Sona/M-2847-2013; Ishiga, Yasuhiro/L-2987-2017; Mysore, Kirankumar/AAG-7112-2020	Pandey, Sona/0000-0002-5570-3120; Mysore, Kirankumar/0000-0002-9805-5741; Ishiga, Yasuhiro/0000-0002-4449-3498	Samuel Roberts Noble Foundation	Samuel Roberts Noble Foundation	This work was supported by The Samuel Roberts Noble Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2012, P NATL ACAD SCI USA, V109, P303, DOI 10.1073/pnas.1109921108; Torres MA, 2013, MOL PLANT MICROBE IN, V26, P686, DOI 10.1094/MPMI-10-12-0236-R; [Anonymous], 2009, SEDIMENT REC, DOI [10.2110/sedred.2009.4.4, DOI 10.2110/SEDRED.2009.4.4]; Assmann SM, 2002, PLANT CELL, V14, pS355, DOI 10.1105/tpc.001792; Belkhadir Youssef, 2006, Sci STKE, V2006, pcm4, DOI 10.1126/stke.3642006cm4; Chakravorty D, 2011, PLANT J, V67, P840, DOI 10.1111/j.1365-313X.2011.04638.x; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; CHOUDHURY SR, 2013, PLANT BIOTECHNOLOGY; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Creelman RA, 1997, ANNU REV PLANT PHYS, V48, P355, DOI 10.1146/annurev.arplant.48.1.355; DEBENER T, 1991, PLANT J, V1, P289, DOI 10.1046/j.1365-313X.1991.t01-7-00999.x; Desclos-Theveniau M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002513; Fan LM, 2008, P NATL ACAD SCI USA, V105, P8476, DOI 10.1073/pnas.0800980105; Farfel Z, 1999, NEW ENGL J MED, V340, P1012, DOI 10.1056/NEJM199904013401306; Gao YJ, 2008, PLANT CELL PHYSIOL, V49, P1013, DOI 10.1093/pcp/pcn078; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Gudesblat GE, 2009, PLANT PHYSIOL, V149, P1017, DOI 10.1104/pp.108.126870; He YH, 2002, PLANT PHYSIOL, V128, P876, DOI 10.1104/pp.010843; Hurowitz EH, 2000, DNA RES, V7, P111, DOI 10.1093/dnares/7.2.111; Ishiga Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-32; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Kawasaki T, 2006, P NATL ACAD SCI USA, V103, P230, DOI 10.1073/pnas.0509875103; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Kwon C, 2008, NATURE, V451, P835, DOI 10.1038/nature06545; Lee S, 1999, PLANT PHYSIOL, V121, P147, DOI 10.1104/pp.121.1.147; Lee S, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-65; Lee S, 2013, PEERJ, V1, DOI 10.7717/peerj.34; LEGENDRE L, 1992, J BIOL CHEM, V267, P20140; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Li W, 2012, PLANT PHYSIOL, V159, P239, DOI 10.1104/pp.111.192617; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Lieberherr D, 2005, PLANT PHYSIOL, V138, P1644, DOI 10.1104/pp.104.057414; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Liu JM, 2013, PLANT PHYSIOL, V161, P2146, DOI 10.1104/pp.112.212431; Llorente F, 2005, PLANT J, V43, P165, DOI 10.1111/j.1365-313X.2005.02440.x; Lorek J, 2013, MOL PLANT MICROBE IN, V26, P991, DOI 10.1094/MPMI-03-13-0077-R; MA H, 1990, P NATL ACAD SCI USA, V87, P3821, DOI 10.1073/pnas.87.10.3821; Maeda K, 2010, PLANT SIGNAL BEHAV, V5, P755, DOI 10.4161/psb.5.6.11770; Melien Oyvind, 2007, Methods Mol Biol, V361, P119; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; Mishra G, 2006, SCIENCE, V312, P264, DOI 10.1126/science.1123769; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Nilson SE, 2010, PLANT PHYSIOL, V152, P2067, DOI 10.1104/pp.109.148262; Okamoto H, 2009, J EXP BOT, V60, P1991, DOI 10.1093/jxb/erp060; Oki K, 2009, PLANT CELL PHYSIOL, V50, P161, DOI 10.1093/pcp/pcn182; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pajerowska-Mukhtar KM, 2013, TRENDS PLANT SCI, V18, P402, DOI 10.1016/j.tplants.2013.04.004; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Pandey S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.28; Pinosa F, 2013, PLANT PHYSIOL, V163, P896, DOI 10.1104/pp.113.223503; Rojas CM, 2012, PLANT CELL, V24, P336, DOI 10.1105/tpc.111.093245; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Senthil-Kumar M, 2013, ANNU REV PHYTOPATHOL, V51, P407, DOI 10.1146/annurev-phyto-082712-102319; Senthil-Kumar M, 2012, PLANT CELL ENVIRON, V35, P1329, DOI 10.1111/j.1365-3040.2012.02492.x; Sharp GWG, 1971, NATURE, V229, P266, DOI 10.1038/229266a0; Spiegel AM, 1996, ANNU REV PHYSIOL, V58, P143, DOI 10.1146/annurev.ph.58.030196.001043; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Suharsono U, 2002, P NATL ACAD SCI USA, V99, P13307, DOI 10.1073/pnas.192244099; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Thung L, 2012, J PLANT PHYSIOL, V169, P542, DOI 10.1016/j.jplph.2011.11.010; Truman W, 2006, PLANT J, V46, P14, DOI 10.1111/j.1365-313X.2006.02672.x; Trusov Y, 2006, PLANT PHYSIOL, V140, P210, DOI 10.1104/pp.105.069625; Trusov Y, 2008, PLANT PHYSIOL, V147, P636, DOI 10.1104/pp.108.117655; Trusov Y, 2007, PLANT CELL, V19, P1235, DOI 10.1105/tpc.107.050096; Trusov Yuri, 2012, BMC Res Notes, V5, P608, DOI 10.1186/1756-0500-5-608; Underwood W, 2013, P NATL ACAD SCI USA, V110, P12492, DOI 10.1073/pnas.1218701110; WEISS CA, 1994, P NATL ACAD SCI USA, V91, P9554, DOI 10.1073/pnas.91.20.9554; Wong HL, 2004, PLANT PHYSIOL, V135, P1447, DOI 10.1104/pp.103.036384; Yang DL, 2013, MOL PLANT, V6, P675, DOI 10.1093/mp/sst056; Zeng WQ, 2010, CURR OPIN BIOTECH, V21, P599, DOI 10.1016/j.copbio.2010.05.006; Zeng WQ, 2010, PLANT PHYSIOL, V153, P1188, DOI 10.1104/pp.110.157016; Zhang HJ, 2012, PLANT SIGNAL BEHAV, V7, P1284, DOI 10.4161/psb.21431; Zhang HJ, 2012, PLANT CELL ENVIRON, V35, P72, DOI 10.1111/j.1365-3040.2011.02417.x; Zhang J, 2010, MOL PLANT MICROBE IN, V23, P940, DOI 10.1094/MPMI-23-7-0940; Zhang W, 2008, PLANT J, V56, P984, DOI 10.1111/j.1365-313X.2008.03657.x; Zurbriggen MD, 2009, PLANT J, V60, P962, DOI 10.1111/j.1365-313X.2009.04010.x	87	37	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82445	10.1371/journal.pone.0082445	http://dx.doi.org/10.1371/journal.pone.0082445			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349286	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100109
J	Raveh, A; Delekta, PC; Dobry, CJ; Peng, WP; Schultz, PJ; Blakely, PK; Tai, AW; Matainaho, T; Irani, DN; Sherman, DH; Miller, DJ				Raveh, Avi; Delekta, Phillip C.; Dobry, Craig J.; Peng, Weiping; Schultz, Pamela J.; Blakely, Pennelope K.; Tai, Andrew W.; Matainaho, Teatulohi; Irani, David N.; Sherman, David H.; Miller, David J.			Discovery of Potent Broad Spectrum Antivirals Derived from Marine Actinobacteria	PLOS ONE			English	Article							WESTERN EQUINE ENCEPHALITIS; ELECTRON-TRANSPORT CHAIN; HUMAN NEURONAL CELLS; ANTIMYCIN-A; VIRUS-INFECTION; MISCELLANEOUS MECHANISMS; NERVOUS SYSTEMS; CHEMICAL SPACE; DENGUE VIRUS; INHIBITORS	Natural products provide a vast array of chemical structures to explore in the discovery of new medicines. Although secondary metabolites produced by microbes have been developed to treat a variety of diseases, including bacterial and fungal infections, to date there has been limited investigation of natural products with antiviral activity. In this report, we used a phenotypic cell-based replicon assay coupled with an iterative biochemical fractionation process to identify, purify, and characterize antiviral compounds produced by marine microbes. We isolated a compound from Streptomyces kaviengensis, a novel actinomycetes isolated from marine sediments obtained off the coast of New Ireland, Papua New Guinea, which we identified as antimycin A1a. This compound displays potent activity against western equine encephalitis virus in cultured cells with half-maximal inhibitory concentrations of less than 4 nM and a selectivity index of greater than 550. Our efforts also revealed that several antimycin A analogues display antiviral activity, and mechanism of action studies confirmed that these Streptomyces-derived secondary metabolites function by inhibiting the cellular mitochondrial electron transport chain, thereby suppressing de novo pyrimidine synthesis. Furthermore, we found that antimycin A functions as a broad spectrum agent with activity against a wide range of RNA viruses in cultured cells, including members of the Togaviridae, Flaviviridae, Bunyaviridae, Picornaviridae, and Paramyxoviridae families. Finally, we demonstrate that antimycin A reduces central nervous system viral titers, improves clinical disease severity, and enhances survival in mice given a lethal challenge with western equine encephalitis virus. Our results provide conclusive validation for using natural product resources derived from marine microbes as source material for antiviral drug discovery, and they indicate that host mitochondrial electron transport is a viable target for the continued development of broadly active antiviral compounds.	[Raveh, Avi; Schultz, Pamela J.; Sherman, David H.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Delekta, Phillip C.; Dobry, Craig J.; Peng, Weiping; Tai, Andrew W.; Miller, David J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Blakely, Pennelope K.; Irani, David N.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Sherman, David H.; Miller, David J.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Sherman, David H.] Univ Michigan, Dept Chem & Med Chem, Ann Arbor, MI 48109 USA; [Matainaho, Teatulohi] Univ Papua New Guinea, Sch Med & Hlth Sci, Boroko, Papua N Guinea	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Papua New Guinea	Miller, DJ (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	milldavi@umich.edu	Tai, Andrew W./M-8380-2017	Tai, Andrew W./0000-0002-6877-450X; Raveh, Avi/0000-0002-9178-7675	National Institute of Allergy and Infectious Diseases (Region V "Great Lakes" Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research Career Development and Developmental Project Awards) [U54 AI057153, R21 AI076975, AI093642]; Hans W. Vahlteich Professorship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076975, R21AI093642, U54AI057153, K08AI083785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097374] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (Region V "Great Lakes" Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research Career Development and Developmental Project Awards); Hans W. Vahlteich Professorship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the National Institute of Allergy and Infectious Diseases grants U54 AI057153 (Region V "Great Lakes" Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research Career Development and Developmental Project Awards to DJM), R21 AI076975 and AI093642 (to DJM), and the Hans W. Vahlteich Professorship (to DHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAR M J, 1970, Infection and Immunity, V2, P533; Ando T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002561; Arnison PG, 2013, NAT PROD REP, V30, P108, DOI 10.1039/c2np20085f; Bhatnagar I, 2012, ENVIRON TOXICOL PHAR, V34, P631, DOI 10.1016/j.etap.2012.08.016; Bianchi TI, 1997, ACTA VIROL, V41, P13; Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019; Bronze Michael S, 2003, Curr Opin Investig Drugs, V4, P172; Sabini MC, 2012, NAT PROD RES, V26, P405, DOI 10.1080/14786419.2010.490216; Castorena KM, 2008, VIROLOGY, V372, P208, DOI 10.1016/j.virol.2007.10.025; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Deresiewicz RL, 1997, NEW ENGL J MED, V336, P1867, DOI 10.1056/NEJM199706263362604; Dobson CM, 2004, NATURE, V432, P824, DOI 10.1038/nature03192; Dreux M, 2010, CELL CYCLE, V9, P1295, DOI 10.4161/cc.9.7.11109; DUSHEE BR, 1949, J AM CHEM SOC, V71, P2436, DOI DOI 10.1021/JA01175A057; EARNEST MP, 1971, NEUROLOGY, V21, P969, DOI 10.1212/WNL.21.9.969; Enserink M, 2007, SCIENCE, V318, P1860, DOI 10.1126/science.318.5858.1860; Gerwick WH, 2013, MICROB ECOL, V65, P800, DOI 10.1007/s00248-012-0169-9; Griffin D.E., 2001, FIELDS VIROLOGY, P917; HAMILTON PB, 1969, APPL MICROBIOL, V17, P102, DOI 10.1128/AEM.17.1.102-105.1969; HERR F, 1967, T AM FISH SOC, V96, P320, DOI 10.1577/1548-8659(1967)96[320:TSOAAF]2.0.CO;2; Hoffmann HH, 2011, P NATL ACAD SCI USA, V108, P5777, DOI 10.1073/pnas.1101143108; HORWITZ JP, 1964, J ORG CHEM, V29, P2076, DOI 10.1021/jo01030a546; Hosotani N, 2005, J ANTIBIOT, V58, P460, DOI 10.1038/ja.2005.61; Hui EKW, 2001, VIROLOGY, V290, P329, DOI 10.1006/viro.2001.1181; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138; Julander JG, 2009, ANTIVIR RES, V82, P169, DOI 10.1016/j.antiviral.2009.02.201; Julander JG, 2008, ANTIVIR RES, V80, P309, DOI 10.1016/j.antiviral.2008.07.002; Karuppannan AK, 2012, ANTIVIR RES, V94, P188, DOI 10.1016/j.antiviral.2012.03.008; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Lennon R E, 1973, Adv Appl Microbiol, V16, P55, DOI 10.1016/S0065-2164(08)70023-6; Leyssen P, 2005, J VIROL, V79, P1943, DOI 10.1128/JVI.79.3.1943-1947.2005; Li YM, 2007, P NATL ACAD SCI USA, V104, P8083, DOI 10.1073/pnas.0702398104; Lin K, 2013, ANTIVIR RES, V99, P68, DOI 10.1016/j.antiviral.2013.03.020; Lipinski C, 2004, NATURE, V432, P855, DOI 10.1038/nature03193; LIU C, 1970, J INFECT DIS, V122, P53, DOI 10.1093/infdis/122.1-2.53; Loffler M, 1997, MOL CELL BIOCHEM, V174, P125, DOI 10.1023/A:1006859115450; Ma XQ, 2011, CHEM BIOL, V18, P1474, DOI 10.1016/j.chembiol.2011.08.009; Magarvey NA, 2004, APPL ENVIRON MICROB, V70, P7520, DOI 10.1128/AEM.70.12.7520-7529.2004; MALINOSKI F, 1981, VIROLOGY, V110, P281, DOI 10.1016/0042-6822(81)90060-X; Manivasagan P, 2013, MICROBIOL RES, V168, P311, DOI 10.1016/j.micres.2013.02.002; Mayer AMS, 2007, COMP BIOCHEM PHYS C, V145, P553, DOI 10.1016/j.cbpc.2007.01.015; Mayer AMS, 2011, COMP BIOCHEM PHYS C, V153, P191, DOI 10.1016/j.cbpc.2010.08.008; Mayer AMS, 2010, TRENDS PHARMACOL SCI, V31, P255, DOI 10.1016/j.tips.2010.02.005; Mayer AMS, 2009, BBA-GEN SUBJECTS, V1790, P283, DOI 10.1016/j.bbagen.2009.03.011; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; MIYOSHI H, 1995, BBA-BIOENERGETICS, V1229, P149, DOI 10.1016/0005-2728(94)00185-8; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Park WH, 2007, J CELL BIOCHEM, V102, P98, DOI 10.1002/jcb.21280; Peltier DC, 2013, J VIROL, V87, P1821, DOI 10.1128/JVI.02858-12; Peltier DC, 2010, J IMMUNOL, V184, P7010, DOI 10.4049/jimmunol.0904133; Peng WP, 2009, J INFECT DIS, V199, P950, DOI 10.1086/597275; Reichert E, 2009, BIOSECUR BIOTERROR, V7, P413, DOI 10.1089/bsp.2009.0032; Rodrigues T, 2010, CURR MED CHEM, V17, P929, DOI 10.2174/092986710790820660; Rohlena J, 2011, ANTIOXID REDOX SIGN, V15, P2951, DOI 10.1089/ars.2011.3990; Schneider G, 2005, NAT REV DRUG DISCOV, V4, P649, DOI 10.1038/nrd1799; Schoepp RJ, 2002, VIROLOGY, V302, P299, DOI 10.1006/viro.2002.1677; Seipke RF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022028; Shum D, 2010, ASSAY DRUG DEV TECHN, V8, P553, DOI 10.1089/adt.2010.0321; Sindac JA, 2012, J MED CHEM, V55, P3535, DOI 10.1021/jm300214e; Steele KE, 2010, VET PATHOL, V47, P790, DOI 10.1177/0300985810372508; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Thompson LA, 1996, CHEM REV, V96, P555, DOI 10.1021/cr9402081; TOKUTAKE N, 1994, BBA-BIOENERGETICS, V1185, P271, DOI 10.1016/0005-2728(94)90241-0; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; Tzung SP, 2001, NAT CELL BIOL, V3, P183, DOI 10.1038/35055095; Verdine GL, 1996, NATURE, V384, P11; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Wang H, 2005, CANCER CHEMOTH PHARM, V56, P291, DOI 10.1007/s00280-004-0978-8; Wang QY, 2011, J VIROL, V85, P6548, DOI 10.1128/JVI.02510-10; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; WOLFE DN, 2013, HUM VACC IMMUNOTHER, V9, P1, DOI DOI 10.4161/HV.23606.PUBMED:23442580; Xu LY, 2011, J ANTIBIOT, V64, P661, DOI 10.1038/ja.2011.65; ZLOTNIK I, 1972, BRIT J EXP PATHOL, V53, P59	76	58	60	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82318	10.1371/journal.pone.0082318	http://dx.doi.org/10.1371/journal.pone.0082318			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349254	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100098
J	Nakabachi, A; Nikoh, N; Oshima, K; Inoue, H; Ohkuma, M; Hongoh, Y; Miyagishima, S; Hattori, M; Fukatsu, T				Nakabachi, Atsushi; Nikoh, Naruo; Oshima, Kenshiro; Inoue, Hiromitsu; Ohkuma, Moriya; Hongoh, Yuichi; Miyagishima, Shin-ya; Hattori, Masahira; Fukatsu, Takema			Horizontal Gene Acquisition of Liberibacter Plant Pathogens from a Bacteriome-Confined Endosymbiont of Their Psyllid Vector	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; GREENING DISEASE; MIXED MODELS; CITRUS; EVOLUTION; SYMBIONTS; ASIATICUS	he Asian citrus psyllid Diaphorina citri is a notorious agricultural pest that transmits the phloem-inhabiting alphaproteobacterial 'Candidatus Liberibacter asiaticus' and allied plant pathogens, which cause the devastating citrus disease called Huanglongbing or greening disease. D. citri harbors two distinct bacterial mutualists in the symbiotic organ called bacteriome: the betaproteobacterium 'Candidatus Profftella armatura' in the syncytial cytoplasm at the center of the bacteriome, and the gammaproteobacterium 'Candidatus Carsonella ruddii' in uninucleate bacteriocytes. Here we report that a putative amino acid transporter LysE of Profftella forms a highly supported clade with proteins of L. asiaticus, L. americanus, and L. solanacearum. L. crescens, the most basal Liberibacter lineage currently known, lacked the corresponding gene. The Profftella-Liberibacter subclade of LysE formed a clade with proteins from betaproteobacteria of the order Burkholderiales, to which Profftella belongs. This phylogenetic pattern favors the hypothesis that the Liberibacter lineage acquired the gene from the Profftella lineage via horizontal gene transfer (HGT) after L. crescens diverged from other Liberibacter lineages. K-A/K-S analyses further supported the hypothesis that the genes encoded in the Liberibacter genomes are functional. These findings highlight the possible evolutionary importance of HGT between plant pathogens and their insect vector's symbionts that are confined in the symbiotic organ and seemingly sequestered from external microbial populations.	[Nakabachi, Atsushi] Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst, Toyohashi, Aichi, Japan; [Nakabachi, Atsushi; Ohkuma, Moriya] RIKEN, BioResource Ctr, Japan Collect Microorganisms, Tsukuba, Ibaraki, Japan; [Nikoh, Naruo] Open Univ Japan, Dept Liberal Arts, Chiba, Japan; [Oshima, Kenshiro] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Inoue, Hiromitsu] Natl Inst Fruit Tree Sci, Citrus Res Div, Kuchinotsu, Japan; [Hongoh, Yuichi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Tokyo 152, Japan; [Miyagishima, Shin-ya] Natl Inst Genet, Frontier Res Ctr, Mishima, Shizuoka 411, Japan; [Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan	Toyohashi University of Technology; RIKEN; University of Tokyo; National Agriculture & Food Research Organization - Japan; Tokyo Institute of Technology; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; National Institute of Advanced Industrial Science & Technology (AIST)	Nakabachi, A (corresponding author), Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst, Toyohashi, Aichi, Japan.	nakabachi@eiiris.tut.ac.jp	Hattori, Masahira/AAD-3785-2019; Nakabachi, Atsushi/H-1661-2011; Hongoh, Yuichi/A-2303-2014; Hattori, Masahira/C-6958-2016; Ohkuma, Moriya/A-8100-2011	Nakabachi, Atsushi/0000-0003-0281-1723; Hongoh, Yuichi/0000-0002-5901-9625; Hattori, Masahira/0000-0001-9467-0344; Miyagishima, Shin-ya/0000-0002-9111-0832	JSPS KAKENHI [21687020, 24117510]; Grants-in-Aid for Scientific Research [25440195] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grant numbers 21687020 and 24117510 to AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin VV, 1999, TRENDS BIOCHEM SCI, V24, P133, DOI 10.1016/S0968-0004(99)01367-5; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ammar ED, 2011, J PHYTOPATHOL, V159, P726, DOI 10.1111/j.1439-0434.2011.01836.x; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Eggeling L, 2003, ARCH MICROBIOL, V180, P155, DOI 10.1007/s00203-003-0581-0; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Leonard MT, 2012, STAND GENOMIC SCI, V7, P271, DOI 10.4056/sigs.3326772; Lin H, 2013, GENOME ANNOUNC, V1; Lin H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019135; McCutcheon JP, 2012, NAT REV MICROBIOL, V10, P13, DOI 10.1038/nrmicro2670; McCutcheon JP, 2010, GENOME BIOL EVOL, V2, P708, DOI 10.1093/gbe/evq055; McCutcheon JP, 2010, CURR OPIN MICROBIOL, V13, P73, DOI 10.1016/j.mib.2009.12.002; MIYATA T, 1980, J MOL EVOL, V16, P23, DOI 10.1007/BF01732067; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Nakabachi A, 2013, CURR BIOL, V23, P1478, DOI 10.1016/j.cub.2013.06.027; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Subandiyah S, 2000, ZOOL SCI, V17, P983, DOI 10.2108/zsj.17.983; Teixeira DD, 2005, INT J SYST EVOL MICR, V55, P1857, DOI 10.1099/ijs.0.63677-0; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09	27	37	38	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82612	10.1371/journal.pone.0082612	http://dx.doi.org/10.1371/journal.pone.0082612			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24349319	Green Published, Green Submitted, gold			2022-12-27	WOS:000327949300160
J	Illmann, G; Hammerschmidt, K; Spinka, M; Tallet, C				Illmann, Gudrun; Hammerschmidt, Kurt; Spinka, Marek; Tallet, Celine			Calling by Domestic Piglets during Simulated Crushing and Isolation: A Signal of Need?	PLOS ONE			English	Article							MATERNAL RESPONSIVENESS; VOCAL RESPONSE; SUS-SCROFA; BEHAVIOR; MORTALITY; SOWS; PIGS; NESTLINGS; YOUNG; COMMUNICATION	This study examined whether piglet distress vocalizations vary with age, body weight and health status, according to the predictions of the honest signalling of need evolutionary model. Vocalizations were recorded during manual squeezing (a simulation of being crushed by mother sow) and during isolation on Days 1 and 7 after birth in piglets from 15 litters. We predicted that during squeezing, younger, lighter and sick piglets would call more intensely because they are in higher risk of dying during crushing and therefore they benefit more from the sow's reaction to intensive vocalization. For isolation, we predicted that lighter and younger piglets would call more because they are more vulnerable to adverse effects of the separation. Calls were analyzed in their time and frequency domain. The rate of calling, call duration, proportion of high-pitched calls and eight acoustic parameters characterizing frequency distribution and tonality were used as indicators of acoustic signalling intensity. Piglets that experienced "squeezing" on Day 1 produced more intense acoustic distress signalling than on Day 7. Lighter piglets called more during squeezing than heavier piglets. Health status did not significantly affect any of the indicators of intensity of vocalization during squeezing. In isolation, none of the parameters of vocalization intensity were affected either by the age or by the weight of the piglets. In summary, the model of honest signalling of need was confirmed in the squeezed situation, but not in the isolation situation.	[Illmann, Gudrun; Spinka, Marek; Tallet, Celine] Inst Anim Sci, Dept Ethol, Prague, Czech Republic; [Hammerschmidt, Kurt] German Primate Ctr, Cognit Ethol Lab, Gottingen, Germany; [Tallet, Celine] INRA, PEGASE UMR1348, St Gilles, France; [Tallet, Celine] Agrocampus Rennes, UMR1348 PEGASE, Rennes, France	Czech Research Institute of Animal Science; Deutsches Primatenzentrum (DPZ); INRAE; Institut Agro; Agrocampus Ouest	Illmann, G (corresponding author), Inst Anim Sci, Dept Ethol, Prague, Czech Republic.	Gudrun.illmann@vuzv.cz	Illmann, Gudrun/B-9176-2019; Spinka, Marek/E-2395-2011	Illmann, Gudrun/0000-0001-7858-7516; Spinka, Marek/0000-0002-2506-9552; tallet, celine/0000-0002-1899-9233	Czech Science Foundation [P505/10/1411]; Ministry of Agriculture of the Czech Republic [MZe0002701404]	Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This study was supported by the Czech Science Foundation (Project Nos. P505/10/1411, http://www.gacr.cz/en/) and the Ministry of Agriculture of the Czech Republic (Project Nos. MZe0002701404, http://eagri.cz/public/web/en/mze/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen IL, 2011, BEHAV ECOL SOCIOBIOL, V65, P1159, DOI 10.1007/s00265-010-1128-4; Anderson MG, 2010, ETHOLOGY, V116, P357, DOI 10.1111/j.1439-0310.2010.01750.x; Christe P, 1996, BEHAV ECOL, V7, P127, DOI 10.1093/beheco/7.2.127; DROLET R, 1984, CAN J COMP MED, V48, P282; Edwards SA, 2002, LIVEST PROD SCI, V78, P3, DOI 10.1016/S0301-6226(02)00180-X; EVANS RM, 1994, BEHAVIOUR, V129, P13, DOI 10.1163/156853994X00334; Fischer J, 2013, AM J PRIMATOL, V75, P643, DOI 10.1002/ajp.22153; Fraser D., 1975, Applied Animal Ethology, V1, P387, DOI 10.1016/0304-3762(75)90075-9; GODFRAY HCJ, 1995, AM NAT, V146, P1, DOI 10.1086/285784; GODFRAY HCJ, 1991, NATURE, V352, P328, DOI 10.1038/352328a0; Held S, 2006, APPL ANIM BEHAV SCI, V98, P216, DOI 10.1016/j.applanim.2005.09.003; Herpin P, 2002, LIVEST PROD SCI, V78, P25, DOI 10.1016/S0301-6226(02)00183-5; Illmann G, 2002, BEHAVIOUR, V139, P487, DOI 10.1163/15685390260135970; Illmann G, 2008, APPL ANIM BEHAV SCI, V112, P248, DOI 10.1016/j.applanim.2007.08.012; Johnstone RA, 2002, MMWR-MORBID MORTAL W, P1; Kilner R, 1997, TRENDS ECOL EVOL, V12, P11, DOI 10.1016/S0169-5347(96)10061-6; Kirkden RD, 2013, J ANIM SCI, V91, P3361, DOI 10.2527/jas.2012-5637; Klingholz F, 1979, ZOOL GARTEN NF JENA, V49, P277; Kober M, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-13; Laiolo P, 2007, BEHAV ECOL, V18, P507, DOI 10.1093/beheco/arm008; Leonard ML, 2001, ANIM BEHAV, V61, P87, DOI 10.1006/anbe.2000.1575; Lingle S, 2012, CURR ZOOL, V58, P698, DOI 10.1093/czoolo/58.5.698; Lotem A, 1998, ANIM BEHAV, V55, P809, DOI 10.1006/anbe.1997.0675; Magrath RD, 2010, ADV STUD BEHAV, V41, P187, DOI 10.1016/S0065-3454(10)41006-2; Marchant JN, 2001, ANIM SCI, V72, P19, DOI 10.1017/S135772980005551X; Marx G, 2003, J SOUND VIB, V266, P687, DOI 10.1016/S0022-460X(03)00594-7; Porkert J, 2006, ETHOLOGY, V112, P398, DOI 10.1111/j.1439-0310.2005.01177.x; Puppe B, 2005, APPL ANIM BEHAV SCI, V95, P67, DOI 10.1016/j.applanim.2005.05.001; Rendall D, 2009, J ACOUST SOC AM, V125, P1792, DOI 10.1121/1.3068453; SPICER EM, 1986, AUST VET J, V63, P71, DOI 10.1111/j.1751-0813.1986.tb02933.x; Spinka M, 2000, APPL ANIM BEHAV SCI, V70, P99, DOI 10.1016/S0168-1591(00)00151-9; Tallet C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071841; Valros A, 2003, APPL ANIM BEHAV SCI, V83, P29, DOI 10.1016/S0168-1591(03)00109-6; Weary DM, 2009, J ANIM SCI, V87, P770, DOI 10.2527/jas.2008-1297; Weary DM, 1996, ANIM BEHAV, V52, P1247, DOI 10.1006/anbe.1996.0272; Weary DM, 1999, APPL ANIM BEHAV SCI, V63, P289, DOI 10.1016/S0168-1591(99)00021-0; Weary DM, 1998, APPL ANIM BEHAV SCI, V56, P161, DOI 10.1016/S0168-1591(97)00092-0; Weary DM, 1997, APPL ANIM BEHAV SCI, V54, P153, DOI 10.1016/S0168-1591(97)00066-X; WEARY DM, 1995, ANIM BEHAV, V50, P1047, DOI 10.1016/0003-3472(95)80105-7; Weary DM, 1996, APPL ANIM BEHAV SCI, V49, P149, DOI 10.1016/0168-1591(96)01042-8; Weary DM, 1996, ANIM BEHAV, V51, P619, DOI 10.1006/anbe.1996.0066	41	20	20	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83529	10.1371/journal.pone.0083529	http://dx.doi.org/10.1371/journal.pone.0083529			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349527	gold, Green Published, Green Submitted			2022-12-27	WOS:000328734200094
J	Lekawanvijit, S; Kumfu, S; Wang, BH; Manabe, M; Nishijima, F; Kelly, DJ; Krum, H; Kompa, AR				Lekawanvijit, Suree; Kumfu, Sirinart; Wang, Bing H.; Manabe, Minako; Nishijima, Fuyuhiko; Kelly, Darren J.; Krum, Henry; Kompa, Andrew R.			The Uremic Toxin Adsorbent AST-120 Abrogates Cardiorenal Injury Following Myocardial Infarction	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; INDOXYL SULFATE; RENAL-FUNCTION; MOLECULE-1 KIM-1; GENE-EXPRESSION; RAT; OVERLOAD; HYPERTROPHY; DYSFUNCTION; FIBROSIS	An accelerated progressive decline in renal function is a frequent accompaniment of myocardial infarction (MI). Indoxyl sulfate (IS), a uremic toxin that accumulates from the early stages of chronic kidney disease (CKD), is contributory to both renal and cardiac fibrosis. IS levels can be reduced by administration of the oral adsorbent AST-120, which has been shown to ameliorate pathological renal and cardiac fibrosis in moderate to severe CKD. However, the cardiorenal effect of AST-120 on less severe renal dysfunction in the post-MI setting has not previously been well studied. MI-induced Sprague-Dawley rats were randomized to receive either AST-120 (MI+ AST-120) or were untreated (MI+Vehicle) for 16 weeks. Serum IS levels were measured at baseline, 8 and 16 weeks. Echocardiography and glomerular filtration rate (GFR) were assessed prior to sacrifice. Renal and cardiac tissues were assessed for pathological changes using histological and immunohistochemical methods, Western blot analysis and real-time PCR. Compared with sham, MI+ Vehicle animals had a significant reduction in left ventricular ejection fraction (by 42%, p<0.001) and fractional shortening (by 52%, p<0.001) as well as lower GFR (p<0.05) and increased serum IS levels (p<0.05). A significant increase in interstitial fibrosis in the renal cortex was demonstrated in MI+Vehicle animals (p<0.001). Compared with MI+ Vehicle, MI+ AST-120 animals had increased GFR (by 13.35%, p<0.05) and reduced serum IS (p<0.001), renal interstitial fibrosis (p<0.05), and renal KIM-1, collagen-IV and TIMP-1 expression (p<0.05). Cardiac function did not change with AST-120 treatment, however gene expression of TGF-beta 1 and TNF-alpha as well as collagen-I and TIMP-1 protein expression was decreased in the non-infarcted myocardium (p<0.05). In conclusion, reduction of IS attenuates cardio-renal fibrotic processes in the post-MI kidney. KIM-1 appears to be a sensitive renal injury biomarker in this setting and is correlated with serum IS levels.	[Lekawanvijit, Suree; Wang, Bing H.; Krum, Henry; Kompa, Andrew R.] Monash Univ, Dept Epidemiol & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia; [Kelly, Darren J.; Kompa, Andrew R.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Lekawanvijit, Suree] Chiang Mai Univ, Fac Med, Dept Pathol, Chiang Mai 50000, Thailand; [Lekawanvijit, Suree; Kumfu, Sirinart] Chiang Mai Univ, Fac Med, Cardiac Electrophysiol Res & Training Ctr, Chiang Mai 50000, Thailand; [Manabe, Minako; Nishijima, Fuyuhiko] Kureha Corp, Dept Pharmaceut, Tokyo, Japan	Monash University; St Vincent's Hospital Melbourne; University of Melbourne; Chiang Mai University; Chiang Mai University	Krum, H (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia.	henry.krum@monash.edu		Kelly, Darren/0000-0003-4850-3929; Kompa, Andrew/0000-0003-1002-2302	National Health and Medical Research Council of Australia [334008, 546272]; Ananda Mahidol Foundation; Thailand Research Fund, Thailand; Prince Doctor Fund under the Royal Patronage of Her Royal Highness Princess Galyanivadhana, Chiang Mai University, Thailand; Thailand Research Fund Royal Golden Jubilee PhD project, Thailand	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Ananda Mahidol Foundation; Thailand Research Fund, Thailand(Thailand Research Fund (TRF)); Prince Doctor Fund under the Royal Patronage of Her Royal Highness Princess Galyanivadhana, Chiang Mai University, Thailand; Thailand Research Fund Royal Golden Jubilee PhD project, Thailand	This work was supported by National Health and Medical Research Council of Australia [Program Grants #334008 and 546272]. S. L. is supported by Ananda Mahidol Foundation and Thailand Research Fund, Thailand; and a recipient of a scholarship from Prince Doctor Fund under the Royal Patronage of Her Royal Highness Princess Galyanivadhana, Chiang Mai University, Thailand. S. K. is a recipient of a scholarship from Thailand Research Fund Royal Golden Jubilee PhD project, Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Atoh K, 2009, DIABETES RES CLIN PR, V83, P220, DOI 10.1016/j.diabres.2008.09.053; Frantz S, 2009, CARDIOVASC RES, V81, P474, DOI 10.1093/cvr/cvn292; Goldberg A, 2005, AM HEART J, V150, P330, DOI 10.1016/j.ahj.2004.09.055; Goldberg A, 2009, KIDNEY INT, V76, P900, DOI 10.1038/ki.2009.295; Goldman S, 1995, J Card Fail, V1, P169, DOI 10.1016/1071-9164(95)90019-5; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; JERUMS G, 1989, DIABETIC MED, V6, P772, DOI 10.1111/j.1464-5491.1989.tb01277.x; Jose P, 2006, J AM SOC NEPHROL, V17, P2886, DOI 10.1681/ASN.2006010063; Kelly DJ, 1998, KIDNEY INT, V54, P343, DOI 10.1046/j.1523-1755.1998.00019.x; KLOPPER JF, 1972, J NUCL MED, V13, P107; Kobayashi N, 2002, NEPHRON, V91, P480, DOI 10.1159/000064291; Kompa AR, 2010, PEPTIDES, V31, P1523, DOI 10.1016/j.peptides.2010.04.026; Lan RP, 2012, AM J PHYSIOL-RENAL, V302, pF1210, DOI 10.1152/ajprenal.00660.2011; Lekawanvijit S, 2012, CIRC RES, V111, P1470, DOI 10.1161/CIRCRESAHA.112.278457; Lekawanvijit S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041281; Lekawanvijit S, 2012, AM J PHYSIOL-HEART C, V302, pH1884, DOI 10.1152/ajpheart.00967.2011; Lekawanvijit S, 2010, EUR HEART J, V31, P1771, DOI 10.1093/eurheartj/ehp574; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Liao RL, 2005, CIRCULATION, V111, P2416, DOI 10.1161/01.CIR.0000167557.59069.D9; Mann DL, 2003, ANNU REV PHYSIOL, V65, P81, DOI 10.1146/annurev.physiol.65.092101.142249; Martin J, 2005, CARDIOVASC RES, V65, P694, DOI 10.1016/j.cardiores.2004.10.041; Miyazaki T, 1997, KIDNEY INT, V52, pS15; Miyazaki T, 2000, NEPHROL DIAL TRANSPL, V15, P1773, DOI 10.1093/ndt/15.11.1773; NIWA T, 1994, J LAB CLIN MED, V124, P96; Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987; Phrommintikul A, 2008, AM J PHYSIOL-HEART C, V294, pH1804, DOI 10.1152/ajpheart.01078.2007; Rached E, 2008, TOXICOL SCI, V103, P371, DOI 10.1093/toxsci/kfn040; Shibahara H, 2010, J NEPHROL, V23, P535; Shimizu H, 2011, AM J PHYSIOL-CELL PH, V301, pC1201, DOI 10.1152/ajpcell.00471.2010; Tamada S, 2006, J PHARMACOL SCI, V100, P17, DOI 10.1254/jphs.FMJ05003X4; Tzanidis A, 2001, J MOL CELL CARDIOL, V33, P969, DOI 10.1006/jmcc.2001.1361; van Timmeren MM, 2007, J PATHOL, V212, P209, DOI 10.1002/path.2175	33	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83687	10.1371/journal.pone.0083687	http://dx.doi.org/10.1371/journal.pone.0083687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349545	Green Published, gold			2022-12-27	WOS:000328734200099
J	Wu, Y; Wang, L; Zhou, MJ; You, YW; Zhu, XY; Qiang, YY; Qin, MY; Luo, SN; Ren, ZH; Xu, AL				Wu, Yun; Wang, Lei; Zhou, Maojun; You, Yuwen; Zhu, Xiaoyan; Qiang, Yuanyuan; Qin, Mengying; Luo, Shaonan; Ren, Zhenghua; Xu, Anlong			Molecular Evolution and Diversity of Conus Peptide Toxins, as Revealed by Gene Structure and Intron Sequence Analyses	PLOS ONE			English	Article							VENOM-DUCT TRANSCRIPTOME; UNIQUE CYSTEINE PATTERN; CONOTOXIN SUPERFAMILY; GAMMA-CARBOXYLATION; ALPHA-CONOTOXINS; MARINE SNAIL; IDENTIFICATION; DISCOVERY; CLONING; MICROSATELLITES	Cone snails, which are predatory marine gastropods, produce a cocktail of venoms used for predation, defense and competition. The major venom component, conotoxin, has received significant attention because it is useful in neuroscience research, drug development and molecular diversity studies. In this study, we report the genomic characterization of nine conotoxin gene superfamilies from 18 Conus species and investigate the relationships among conotoxin gene structure, molecular evolution and diversity. The I1, I2, M, O2, O3, P, S, and T superfamily precursors all contain three exons and two introns, while A superfamily members contain two exons and one intron. The introns are conserved within a certain gene superfamily, and also conserved across different Conus species, but divergent among different superfamilies. The intronic sequences contain many simple repeat sequences and regulatory elements that may influence conotoxin gene expression. Furthermore, due to the unique gene structure of conotoxins, the base substitution rates and the number of positively selected sites vary greatly among exons. Many more point mutations and trinucleotide indels were observed in the mature peptide exon than in the other exons. In addition, the first example of alternative splicing in conotoxin genes was found. These results suggest that the diversity of conotoxin genes has been shaped by point mutations and indels, as well as rare gene recombination or alternative splicing events, and that the unique gene structures could have made a contribution to the evolution of conotoxin genes.	[You, Yuwen; Zhu, Xiaoyan; Qiang, Yuanyuan; Qin, Mengying; Luo, Shaonan; Ren, Zhenghua; Xu, Anlong] Sun Yat Sen Univ, Natl Engn Res Ctr South China Sea Marine Biotechn, Guangdong Prov Key Lab Pharmaceut Funct Genes, State Key Lab Biocontrol,Dept Biochem,Coll Life S, Guangzhou 510275, Guangdong, Peoples R China; [Wu, Yun; Wang, Lei; Zhou, Maojun; Xu, Anlong] Beijing Univ Chinese Med, Beijing, Peoples R China	Sun Yat Sen University; Beijing University of Chinese Medicine	Xu, AL (corresponding author), Sun Yat Sen Univ, Natl Engn Res Ctr South China Sea Marine Biotechn, Guangdong Prov Key Lab Pharmaceut Funct Genes, State Key Lab Biocontrol,Dept Biochem,Coll Life S, Guangzhou 510275, Guangdong, Peoples R China.	lssxal@mail.sysu.edu.cn	Zhou, Maojun/ABD-4197-2020	zhou, Maojun/0000-0003-0603-5223	State National High-Tech Development Program (863 Program) from the Ministry of Science and Technology of China [2008AA09Z401]; National Science and technology support program [2012BAD117B02]; Natural Science Foundation of China [30871921]; Guangdong Natural Science Foundation [8151027501000083]	State National High-Tech Development Program (863 Program) from the Ministry of Science and Technology of China; National Science and technology support program; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by the State National High-Tech Development Program (863 Program) from the Ministry of Science and Technology of China (2008AA09Z401), National Science and technology support program (2012BAD117B02), Natural Science Foundation of China (30871921), Guangdong Natural Science Foundation (8151027501000083). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MB, 2009, PEPTIDES, V30, P467, DOI 10.1016/j.peptides.2008.09.016; Bandyopadhyay PK, 1998, J BIOL CHEM, V273, P5447, DOI 10.1074/jbc.273.10.5447; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; Biass D, 2009, J PROTEOMICS, V72, P210, DOI 10.1016/j.jprot.2009.01.019; Biggs JS, 2010, MOL PHYLOGENET EVOL, V56, P1, DOI 10.1016/j.ympev.2010.03.029; Brown MA, 2005, BIOCHEMISTRY-US, V44, P9150, DOI 10.1021/bi0503293; Buczek O, 2005, FEBS J, V272, P4178, DOI 10.1111/j.1742-4658.2005.04830.x; Buczek O, 2004, BIOCHEMISTRY-US, V43, P1093, DOI 10.1021/bi0354233; Buczek P, 2005, BIOPOLYMERS, V80, P50, DOI 10.1002/bip.20211; Cao ZJ, 2006, TOXICON, V47, P348, DOI 10.1016/j.toxicon.2005.11.013; Conticello SG, 2001, MOL BIOL EVOL, V18, P120, DOI 10.1093/oxfordjournals.molbev.a003786; Davis J, 2009, PEPTIDES, V30, P1222, DOI 10.1016/j.peptides.2009.03.019; Debrauwere H, 1997, BIOCHIMIE, V79, P577, DOI 10.1016/S0300-9084(97)82006-8; Douris V, 2010, MOL BIOL EVOL, V27, P684, DOI 10.1093/molbev/msp286; Duda TF, 1999, P NATL ACAD SCI USA, V96, P6820, DOI 10.1073/pnas.96.12.6820; Duda TF, 2001, BIOL J LINN SOC, V73, P391, DOI 10.1006/bijl.2001.0544; Dutertre S, 2013, MOL CELL PROTEOMICS, V12, P312, DOI 10.1074/mcp.M112.021469; Elliger CA, 2011, TOXICON, V57, P311, DOI 10.1016/j.toxicon.2010.12.008; Espiritu DJD, 2001, TOXICON, V39, P1899, DOI 10.1016/S0041-0101(01)00175-1; Fedorova L, 2003, GENETICA, V118, P123, DOI 10.1023/A:1024145407467; Fujimi TJ, 2003, GENE, V313, P111, DOI 10.1016/S0378-1119(03)00637-1; Gabellini N, 2001, EUR J BIOCHEM, V268, P1076, DOI 10.1046/j.1432-1327.2001.01974.x; Heralde FM, 2008, TOXICON, V51, P890, DOI 10.1016/j.toxicon.2007.12.022; Hu H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-60; Imperial JS, 2006, BIOCHEMISTRY-US, V45, P8331, DOI 10.1021/bi060263r; Janes RW, 2005, CURR OPIN PHARMACOL, V5, P280, DOI 10.1016/j.coph.2005.01.013; Kaas Q, 2012, NUCLEIC ACIDS RES, V40, pD325, DOI 10.1093/nar/gkr886; Kaas Q, 2010, TOXICON, V55, P1491, DOI 10.1016/j.toxicon.2010.03.002; Kim BS, 2010, J IMMUNOL, V185, P6866, DOI 10.4049/jimmunol.1001037; Kunkel TA, 2009, COLD SH Q B, V74, P91, DOI 10.1101/sqb.2009.74.027; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Lasda EL, 2011, WIRES RNA, V2, P417, DOI 10.1002/wrna.71; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Lirazan MB, 2000, BIOCHEMISTRY-US, V39, P1583, DOI 10.1021/bi9923712; Liu L, 2008, TOXICON, V51, P1331, DOI 10.1016/j.toxicon.2008.03.001; Lluisma AO, 2012, MAR GENOM, V5, P43, DOI 10.1016/j.margen.2011.09.002; Loughnan ML, 2009, BIOCHEMISTRY-US, V48, P3717, DOI 10.1021/bi9000326; Meloni R, 1998, HUM MOL GENET, V7, P423, DOI 10.1093/hmg/7.3.423; Olivera BM, 2007, MOL INTERV, V7, P251, DOI 10.1124/mi.7.5.7; Olivera BM, 2012, ANN NY ACAD SCI, V1267, P61, DOI 10.1111/j.1749-6632.2012.06603.x; Olivera BM, 1999, ANN NY ACAD SCI, V870, P223, DOI 10.1111/j.1749-6632.1999.tb08883.x; Olivera BM, 2002, ANNU REV ECOL SYST, V33, P25, DOI 10.1146/annurev.ecolsys.33.010802.150424; Peng C, 2008, PEPTIDES, V29, P985, DOI 10.1016/j.peptides.2008.01.007; Peng C, 2006, PEPTIDES, V27, P2174, DOI 10.1016/j.peptides.2006.04.016; Pi CH, 2006, GENOMICS, V88, P809, DOI 10.1016/j.ygeno.2006.06.014; Puillandre Nicolas, 2010, BMC Chemical Biology, V10, P7, DOI 10.1186/1472-6769-10-7; Puillandre N, 2010, J MOL EVOL, V70, P190, DOI 10.1007/s00239-010-9321-7; Radis-Baptista G, 2003, TOXICON, V42, P747, DOI 10.1016/j.toxicon.2003.10.019; Schoenfeld RA, 1999, THESIS U UTAH; Skoko N, 2011, MOL BIOTECHNOL, V48, P290, DOI 10.1007/s12033-011-9390-x; Tamiya T, 1999, TOXICON, V37, P181, DOI 10.1016/S0041-0101(98)00181-0; Terlau H, 1996, NATURE, V381, P148, DOI 10.1038/381148a0; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Watkins M, 2006, J MOL EVOL, V62, P247, DOI 10.1007/s00239-005-0010-x; Weill JC, 2008, NAT REV IMMUNOL, V8, P302, DOI 10.1038/nri2281; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yuan DD, 2008, PEPTIDES, V29, P1521, DOI 10.1016/j.peptides.2008.05.015; Yuan DD, 2007, TOXICON, V49, P1135, DOI 10.1016/j.toxicon.2007.02.011; Yuan DD, 2009, PEPTIDES, V30, P861, DOI 10.1016/j.peptides.2009.01.012; Zhao JQ, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-10	64	21	26	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82495	10.1371/journal.pone.0082495	http://dx.doi.org/10.1371/journal.pone.0082495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349297	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200047
J	Hu, J; Diao, YZ; Zhou, YX; Lin, D; Bi, Y; Pang, ZL; Fryxell, RT; Liu, XL; Lamour, K				Hu, Jian; Diao, Yongzhao; Zhou, Yuxin; Lin, Dong; Bi, Yang; Pang, Zhili; Fryxell, Rebecca Trout; Liu, Xili; Lamour, Kurt			Loss of Heterozygosity Drives Clonal Diversity of Phytophthora capsici in China	PLOS ONE			English	Article							MITOTIC GENE CONVERSION; MEFENOXAM INSENSITIVITY; POPULATION-STRUCTURE; LINEAGES; DNA; EVOLUTION; BLIGHT; PEPPERS; MARKERS; STEM	Phytophthora capsici causes significant loss to pepper (Capsicum annum) in China and our goal was to develop single nucleotide polymorphism (SNP) markers for P. capsici and characterize genetic diversity nationwide. Eighteen isolates of P. capsici from locations worldwide were re-sequenced and candidate nuclear and mitochondrial SNPs identified. From 2006 to 2012, 276 isolates of P. capsici were recovered from 136 locations in 27 provinces and genotyped using 45 nuclear and 2 mitochondrial SNPs. There were two main mitochondrial haplotypes and 95 multilocus genotypes (MLGs) identified. Genetic diversity was geographically structured with a high level of genotypic diversity in the north and on Hainan Island in the south, suggesting outcrossing contributes to diversity in these areas. The remaining areas of China are dominated by four clonal lineages that share mitochondrial haplotypes, are almost exclusively the A1 or A2 mating type and appear to exhibit extensive diversity based on loss of heterozygosity (LOH). Analysis of SNPs directly from infected peppers confirmed LOH in field populations. One clonal lineage is dominant throughout much of the country. The overall implications for long-lived genetically diverse clonal lineages amidst a widely dispersed sexual population are discussed.	[Hu, Jian; Diao, Yongzhao; Lin, Dong; Bi, Yang; Pang, Zhili; Liu, Xili] China Agr Univ, Coll Agr & Biotechnol, Dept Plant Pathol, Beijing 100094, Peoples R China; [Hu, Jian; Zhou, Yuxin; Fryxell, Rebecca Trout; Lamour, Kurt] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA	China Agricultural University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Liu, XL (corresponding author), China Agr Univ, Coll Agr & Biotechnol, Dept Plant Pathol, Beijing 100094, Peoples R China.	seedling@cau.edu.cn	Pang, Zhili/AFO-8248-2022	Pang, Zhili/0000-0001-8047-1272; Lamour, Kurt/0000-0001-6407-8825; Lin, Dong/0000-0003-4433-6342; Trout Fryxell, Rebecca/0000-0003-2133-0220	Chinese Fellowship Program; UTIA Innovation Grants Program	Chinese Fellowship Program; UTIA Innovation Grants Program	Chinese Fellowship Program; The UTIA Innovation Grants Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chamnanpunt J, 2001, P NATL ACAD SCI USA, V98, P14530, DOI 10.1073/pnas.251464498; Cooke DEL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002940; De La Vega FA, 2005, MUTAT RES-FUND MOL M, V573, P111, DOI 10.1016/j.mrfmmm.2005.01.008; Dobrowolski MP, 2003, PHYTOPATHOLOGY, V93, P695, DOI 10.1094/PHYTO.2003.93.6.695; Dunn AR, 2010, PLANT DIS, V94, P1461, DOI 10.1094/PDIS-03-10-0221; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Erwin DC, 1996, PHYTOPHTHORA DIS WOR; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FORSTER H, 1994, MOL PLANT MICROBE IN, V7, P780, DOI 10.1094/MPMI-7-0780; FREZZI MARIANO J., 1950, REV INVEST AGRIC, V4, P47; Gobena D, 2011, MYCOL PROG, V11, P1; Gobena D, 2012, MYCOLOGIA, V104, P102, DOI 10.3852/11-147; GOODWIN SB, 1995, PHYTOPATHOLOGY, V85, P669, DOI 10.1094/Phyto-85-669; Goodwin SB, 1997, PHYTOPATHOLOGY, V87, P462, DOI 10.1094/PHYTO.1997.87.4.462; GOODWIN SB, 1994, P NATL ACAD SCI USA, V91, P11591, DOI 10.1073/pnas.91.24.11591; Granke LL, 2009, PHYTOPATHOLOGY, V99, P1258, DOI 10.1094/PHYTO-99-11-1258; Hausbeck MK, 2004, PLANT DIS, V88, P1292, DOI 10.1094/PDIS.2004.88.12.1292; Hu J, 2013, PHYTOPATHOLOGY, V103, P920, DOI 10.1094/PHYTO-01-13-0016-R; HULBERT SH, 1988, GENETICS, V120, P947; Hurtado-Gonzales O, 2008, PHYTOPATHOLOGY, V98, P688, DOI 10.1094/PHYTO-98-6-0688; Hurtado-Gonzales OP, 2009, PLANT PATHOL, V58, P715, DOI 10.1111/j.1365-3059.2009.02059.x; Ivors K, 2006, MOL ECOL, V15, P1493, DOI 10.1111/j.1365-294X.2006.02864.x; KO WH, 1988, ANNU REV PHYTOPATHOL, V26, P57, DOI 10.1146/annurev.py.26.090188.000421; Kohli Y, 1998, FUNGAL GENET BIOL, V23, P139, DOI 10.1006/fgbi.1997.1026; Labuschagne N, 2003, PLANT DIS, V87, P1540, DOI 10.1094/PDIS.2003.87.12.1540A; Lamour K., 2009, OOMYCETE GENETICS GE, P165, DOI 10.1002/9780470475898.ch8; Lamour KH, 2000, PHYTOPATHOLOGY, V90, P396, DOI 10.1094/PHYTO.2000.90.4.396; Lamour KH, 2001, PHYTOPATHOLOGY, V91, P553, DOI 10.1094/PHYTO.2001.91.6.553; Lamour KH, 2012, MOL PLANT PATHOL; Lamour K, 2006, MYCOLOGIA, V98, P514, DOI 10.3852/mycologia.98.3.514; Lamour K, 2013, CABI PLANT PROT SER, P28, DOI 10.1079/9781780640938.0028; Lamour KH, 2012, MOL PLANT MICROBE IN, V25, P1350, DOI 10.1094/MPMI-02-12-0028-R; Leonian LH, 1922, PHYTOPATHOLOGY, V12, P401; LEVY M, 1991, PLANT CELL, V3, P95, DOI 10.1105/tpc.3.1.95; MASAGO H, 1977, PHYTOPATHOLOGY, V67, P425, DOI 10.1094/Phyto-67-425; Meitz JC, 2010, AUSTRALAS PLANT PATH, V39, P431, DOI 10.1071/AP09075; MOLLER EM, 1992, NUCLEIC ACIDS RES, V20, P6115, DOI 10.1093/nar/20.22.6115; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Ramsey P. A., 1982, ROME RENAISSANCE CIT, P395; Silvar C, 2006, PLANT DIS, V90, P1135, DOI 10.1094/PD-90-1135; Steele KA, 2001, PLANT PATHOL, V50, P174, DOI 10.1046/j.1365-3059.2001.00558.x; Sun WX, 2008, CAN J PLANT PATHOL, V30, P414, DOI 10.1080/07060660809507539; Tischfield JA, 1997, AM J HUM GENET, V61, P995, DOI 10.1086/301617; Tsang PWK, 1999, MICROBIOL-SGM, V145, P1623, DOI 10.1099/13500872-145-7-1623; Vossen RHAM, 2009, HUM MUTAT, V30, P860, DOI 10.1002/humu.21019; Wang ZY, 2009, APPL ENVIRON MICROB, V75, P5467, DOI 10.1128/AEM.00620-09; Weber GF, 1932, PHYTOPATHOLOGY, V22, P775; Xin ZG, 2003, BIOTECHNIQUES, V34, P820, DOI 10.2144/03344rr04; Yuen JE, 2013, PLANT PATHOL, V62, P485, DOI 10.1111/j.1365-3059.2012.02685.x	50	20	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82691	10.1371/journal.pone.0082691	http://dx.doi.org/10.1371/journal.pone.0082691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349339	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800074
J	Ulm, L; Wohlrapp, D; Meinzer, M; Steinicke, R; Schatz, A; Denzler, P; Klehmet, J; Dohle, C; Niedeggen, M; Meisel, A; Winter, Y				Ulm, Lena; Wohlrapp, Dorota; Meinzer, Marcus; Steinicke, Robert; Schatz, Alexej; Denzler, Petra; Klehmet, Juliane; Dohle, Christian; Niedeggen, Michael; Meisel, Andreas; Winter, York			A Circle-Monitor for Computerised Assessment of Visual Neglect in Peripersonal Space	PLOS ONE			English	Article							UNILATERAL SPATIAL NEGLECT; BAKING TRAY TASK; HEMISPATIAL NEGLECT; VISUOSPATIAL NEGLECT; VIRTUAL-REALITY; STROKE PATIENTS; LINE BISECTION; TEST BATTERY; REHABILITATION; DISABILITY	Current assessment of visual neglect involves paper-and-pencil tests or computer-based tasks. Both have been criticised because of their lack of ecological validity as target stimuli can only be presented in a restricted visual range. This study examined the user-friendliness and diagnostic strength of a new "Circle-Monitor" (CM), which enlarges the range of the peripersonal space, in comparison to a standard paper-and-pencil test (Neglect-Test, NET). Methods: Ten stroke patients with neglect and ten age-matched healthy controls were examined by the NET and the CM test comprising of four subtests (Star Cancellation, Line Bisection, Dice Task, and Puzzle Test). Results: The acceptance of the CM in elderly controls and neglect patients was high. Participants rated the examination by CM as clear, safe and more enjoyable than NET. Healthy controls performed at ceiling on all subtests, without any systematic differences between the visual fields. Both NET and CM revealed significant differences between controls and patients in Line Bisection, Star Cancellation and visuo-constructive tasks (NET: Figure Copying, CM: Puzzle Test). Discriminant analyses revealed cross-validated assignment of patients and controls to groups was more precise when based on the CM (hit rate 90%) as compared to the NET (hit rate 70%). Conclusion: The CM proved to be a sensitive novel tool to diagnose visual neglect symptoms quickly and accurately with superior diagnostic validity compared to a standard neglect test while being well accepted by patients. Due to its upgradable functions the system may also be a valuable tool not only to test for non-visual neglect symptoms, but also to provide treatment and assess its outcome.	[Ulm, Lena; Wohlrapp, Dorota; Klehmet, Juliane; Meisel, Andreas] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Ulm, Lena; Wohlrapp, Dorota; Klehmet, Juliane; Meisel, Andreas] Charite, Dept Neurol, D-13353 Berlin, Germany; [Meinzer, Marcus; Steinicke, Robert; Dohle, Christian; Meisel, Andreas] Charite, Ctr Stroke Res Berlin, D-13353 Berlin, Germany; [Schatz, Alexej; Winter, York] Humboldt Univ, Dept Biol, Berlin, Germany; [Schatz, Alexej] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany; [Denzler, Petra; Dohle, Christian] Median Klin Berlin Kladow, Berlin, Germany; [Dohle, Christian] Univ Potsdam, Rehabil Res Ctr, Potsdam, Germany; [Niedeggen, Michael] Free Univ Berlin, Dept Educ Sci & Psychol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Potsdam; Free University of Berlin	Niedeggen, M (corresponding author), Free Univ Berlin, Dept Educ Sci & Psychol, Berlin, Germany.	niedegg@zedat.fu-berlin.de; andreas.meisel@charite.de	Ulm, Lena/L-5305-2013; Meinzer, Marcus/I-3943-2013	Dohle, Christian/0000-0002-7212-8025; Ulm, Lena/0000-0002-3388-8785; Winter, York/0000-0002-7828-1872; Meisel, Andreas/0000-0001-7233-5342	Deutsche Forschungsgemeinschaft (NeuroCure Cluster of Excellence, Exc 257) [UL 423/1-1]; Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin) [01 EO 08 01]; Helmholtz Gemeinschaft [SO-022NG]	Deutsche Forschungsgemeinschaft (NeuroCure Cluster of Excellence, Exc 257); Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin)(Federal Ministry of Education & Research (BMBF)); Helmholtz Gemeinschaft(Helmholtz Association)	This work is supported by the Deutsche Forschungsgemeinschaft (NeuroCure Cluster of Excellence, Exc 257; UL 423/1-1); the Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin, 01 EO 08 01) and the Helmholtz Gemeinschaft (SO-022NG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appelros P, 2004, J REHABIL MED, V36, P258, DOI 10.1080/16501970410029852; Appelros P, 2002, J REHABIL MED, V34, P215, DOI 10.1080/165019702760279206; Azouvi P, 2002, J NEUROL NEUROSUR PS, V73, P160, DOI 10.1136/jnnp.73.2.160; Bailey MJ, 2000, NEUROREHABILITATION, V14, P139; BLACK SE, 1990, J CLIN EXP NEUROPSYC, V12, P109; Coskun Y, 2011, JAHR DTSCH GES KLIN; Dupuy D, 2007, BEHAVIORAL AND COGNITIVE NEUROLOGY OF STROKE, P254, DOI 10.1017/CBO9780511544880.013; Dyck E, 2012, J VIRTUAL REALITY BR, V9; Dyck E, 2010, GI VR AR WORKSH, P1; Dyck E, 2012, P VIRT REAL INT PHYS, P127; Ellis AW, 2006, CORTEX, V42, P861, DOI 10.1016/S0010-9452(08)70429-5; Fels M, 1997, NEGLECT TEST NET VER; Fordell H, 2011, ACTA NEUROL SCAND, V123, P167, DOI 10.1111/j.1600-0404.2010.01390.x; Geldmacher DS, 1996, BRAIN COGNITION, V32, P405, DOI 10.1006/brcg.1996.0073; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Grewe P, 2011, JAHR DTSCH GES NEUR; Grewe P, 2011, EVALUATION 360 VIRTU; Grewe P, J NEUROENGI IN PRESS; Halligan P.W., 1991, NEUROPSYCHOL REHABIL, V1, P5, DOI https://doi.org/10.1080/09602019108401377; Halligan PW, 1992, HDB NEUROPSYCHOLOGIC, P151; Heilman KM, 2004, FRONT BIOSCI-LANDMRK, V9, P694, DOI 10.2741/1261; HEILMAN KM, 1979, ANN NEUROL, V5, P166, DOI 10.1002/ana.410050210; Hooper E.H., 1983, HOOPER VISUAL ORG TE; Jacobs S, 2012, NEUROPSYCHOLOGIA, V50, P1029, DOI 10.1016/j.neuropsychologia.2012.03.018; Karnath HO, 2012, NEUROPSYCHOLOGIA, V50, P1010, DOI 10.1016/j.neuropsychologia.2011.06.027; Katz N, 1999, ARCH PHYS MED REHAB, V80, P379, DOI 10.1016/S0003-9993(99)90273-3; McIntosh RD, 2005, COGNITIVE BRAIN RES, V25, P833, DOI 10.1016/j.cogbrainres.2005.09.008; Meinzer M., 2012, NEUROIMAGE; MILNER AD, 1993, NEUROPSYCHOLOGIA, V31, P39, DOI 10.1016/0028-3932(93)90079-F; NICHELLI P, 1989, BRAIN COGNITION, V9, P57, DOI 10.1016/0278-2626(89)90044-4; Niedeggen M., 2005, VISUELLE WAHRNEHMUNG; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peru A, 2008, EXP BRAIN RES, V187, P447, DOI 10.1007/s00221-008-1315-y; Platner K, 2012, JAHR GES NEUR GNP; Potter J, 2000, CLIN REHABIL, V14, P441, DOI 10.1191/0269215500cr344oa; Rabuffetti M, 2002, MED BIOL ENG COMPUT, V40, P675, DOI 10.1007/BF02345306; Ringman JM, 2004, NEUROLOGY, V63, P468, DOI 10.1212/01.WNL.0000133011.10689.CE; SCHENKENBERG T, 1980, NEUROLOGY, V30, P509, DOI 10.1212/WNL.30.5.509; SMALL M, 1994, NEUROPSYCHOLOGIA, V32, P449, DOI 10.1016/0028-3932(94)90090-6; Tham K, 1996, NEUROPSYCHOL REHABIL, V6, P19, DOI 10.1080/713755496; Thareja T, 2012, BRAIN COGNITION, V79, P107, DOI 10.1016/j.bandc.2012.02.009; Tsirlin I, 2009, CYBERPSYCHOL BEHAV, V12, P175, DOI 10.1089/cpb.2008.0208; WILSON B, 1987, ARCH PHYS MED REHAB, V68, P98; Wojciulik E, 2001, NEUROPSYCHOLOGIA, V39, P390, DOI 10.1016/S0028-3932(00)00131-7; Zimmermann P., 1993, TESTBATTERIE AUFMERK	45	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82892	10.1371/journal.pone.0082892	http://dx.doi.org/10.1371/journal.pone.0082892			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349387	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800083
J	Everett, JAC				Everett, Jim A. C.			The 12 Item Social and Economic Conservatism Scale (SECS)	PLOS ONE			English	Article							POLITICAL CONSERVATISM; IDEOLOGY; THREAT; ORIENTATION; PREJUDICE; ATTITUDES; LIBERALS; INDEXES	Recent years have seen a surge in psychological research on the relationship between political ideology (particularly conservatism) and cognition, affect, behaviour, and even biology. Despite this flurry of investigation, however, there is as yet no accepted, validated, and widely used multi-item scale of conservatism that is concise, that is modern in its conceptualisation, and that includes both social and economic conservatism subscales. In this paper the 12-Item Social and Economic Conservatism Scale (SECS) is proposed and validated to help fill this gap. The SECS is suggested to be an important and useful tool for researchers working in political psychology.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Everett, JAC (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	jim.everett@psy.ox.ac.uk	Everett, Jim AC/L-4109-2019	Everett, Jim AC/0000-0003-2801-5426	Economic and Social Research Council (ESRC); Oxford Open Access	Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Oxford Open Access	Funding for this project was provided through the Economic and Social Research Council (ESRC: http://www.esrc.ac.uk/). Funding for the publication fee for open access was supported by the Economic and Social Research Council (ESRC: http://www.esrc.ac.uk/) and Oxford Open Access (http://openaccess.ox.ac.uk/). The data from this study can be accessed by an email request to the author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altemeyer B, 2002, J SOC PSYCHOL, V142, P713, DOI 10.1080/00224540209603931; Altemeyer R., 1981, RIGHT WING AUTHORITA; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Benoit K., 2006, PARTY POLICY MODERN; Bentler PM, 2007, PERS INDIV DIFFER, V42, P825, DOI 10.1016/j.paid.2006.09.024; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Cabrera-Nguyen P., 2010, J SOC SOC WORK RES, V1, P99, DOI [DOI 10.5243/JSSWR.2010.8, 10.5243/jsswr.2010.8]; Carey JM, 2013, J PERS, V81, P130, DOI 10.1111/j.1467-6494.2012.00799.x; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; Costello AB, 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [DOI 10.7275/JYJ1-4868, DOI 10.1316/S0782-051X03024046-9]; Crowson HM, 2009, J PSYCHOL, V143, P449, DOI 10.3200/JRL.143.5.449-463; Duckitt J, 2002, J PERS SOC PSYCHOL, V83, P75, DOI 10.1037//0022-3514.83.1.75; Eidelman S, 2012, PERS SOC PSYCHOL B, V38, P808, DOI 10.1177/0146167212439213; Federico CM, 2007, PUBLIC OPIN QUART, V71, P221, DOI 10.1093/poq/nfm010; Florida R, 2011, CONSERVATIVE STATES; FORD JK, 1986, PERS PSYCHOL, V39, P291, DOI 10.1111/j.1744-6570.1986.tb00583.x; Fuchs D., 1990, CONTINUITIES POLITIC, P203, DOI DOI 10.1057/AP.2011.10; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; HADDOCK G, 1993, J PERS SOC PSYCHOL, V65, P1105, DOI 10.1037/0022-3514.65.6.1105; Hatemi PK, 2011, J POLIT, V73, P271, DOI 10.1017/S0022381610001015; Henningham JP, 1996, PERS INDIV DIFFER, V20, P517, DOI 10.1016/0191-8869(95)00192-1; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jost JT, 2007, PERS SOC PSYCHOL B, V33, P989, DOI 10.1177/0146167207301028; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Jost JT, 2009, ANNU REV PSYCHOL, V60, P307, DOI 10.1146/annurev.psych.60.110707.163600; Jost JT, 2003, RES ORGAN BEHAV, V25, P53, DOI 10.1016/S0191-3085(03)25002-4; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kanai R, 2011, CURR BIOL, V21, P677, DOI 10.1016/j.cub.2011.03.017; Kandler C, 2012, J PERS SOC PSYCHOL, V102, P633, DOI 10.1037/a0025560; Kay AC, 2003, J PERS SOC PSYCHOL, V85, P823, DOI 10.1037/0022-3514.85.5.823; Kincaid H., 2007, VALUE FREE SCI; Kirk Russell., 1978, CONSERVATIVE MIND BU; KIRTON MJ, 1978, BRIT J SOC CLIN PSYC, V17, P319, DOI 10.1111/j.2044-8260.1978.tb00286.x; Mackie DM, 2004, PREJUDICE INTERGROUP; Morgan GS, 2010, PERS SOC PSYCHOL B, V36, P1241, DOI 10.1177/0146167210380605; Muthen L. K., 1998, MPLUS USERS GUIDE, V6; Onraet E, 2013, J PERS, V81, P233, DOI 10.1111/jopy.12011; Plaue N, 2012, AM ARE BECOMING MORE; Poteat VP, 2012, POLIT PSYCHOL, V33, P211, DOI 10.1111/j.1467-9221.2012.00871.x; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Sidanius J, 1996, J PERS SOC PSYCHOL, V70, P476, DOI 10.1037/0022-3514.70.3.476; Steiger JH, 2007, PERS INDIV DIFFER, V42, P893, DOI 10.1016/j.paid.2006.09.017; Stenner K, 2009, PSYCHOL INQ, V20, P142, DOI 10.1080/10478400903028615; Stern C, 2013, J PERS SOC PSYCHOL, V104, P520, DOI 10.1037/a0031187; Stimson J.A., 2004, TIDES CONSENT OPINIO; Tabachnick B. G., 2001, USING MULTIVARIATE S; Thorisdottir H, 2011, POLIT PSYCHOL, V32, P785, DOI 10.1111/j.1467-9221.2011.00840.x; Treier S, 2009, PUBLIC OPIN QUART, V73, P679, DOI 10.1093/poq/nfp067; Van Boven L, 2012, J PERS SOC PSYCHOL, V103, P84, DOI 10.1037/a0028145; Van Hiel A, 2007, INT J PSYCHOL, V42, P16, DOI 10.1080/00207590500411443; West SG, 1995, STRUCTURAL EQUATION; Wheaton B., 1977, SOCIOLOGICAL METHODO; WILSON GD, 1968, BRIT J SOC CLIN PSYC, V7, P264; Wood T, 2012, PUBLIC OPIN QUART, V76, P636, DOI 10.1093/poq/nfs045; Worthington RL, 2006, COUNS PSYCHOL, V34, P806, DOI 10.1177/0011000006288127; Zakrisson I, 2005, PERS INDIV DIFFER, V39, P863, DOI 10.1016/j.paid.2005.02.026; Zell E, 2013, SOC PSYCHOL PERSON S, DOI [10.1111/j.2044-8260.1968.tb00568.x., DOI 10.1111/J.2044-8260.1968.TB00568.X]; Zumbrunnen J, 2008, POLIT BEHAV, V30, P199, DOI 10.1007/s11109-007-9047-4	59	179	180	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82131	10.1371/journal.pone.0082131	http://dx.doi.org/10.1371/journal.pone.0082131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349200	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000328730300076
J	Platt, A; MacLeod, H; Massari, P; Liu, XP; Wetzler, L				Platt, Andrew; MacLeod, Heather; Massari, Paola; Liu, Xiuping; Wetzler, Lee			In Vivo and In Vitro Characterization of the Immune Stimulating Activity of the Neisserial Porin PorB	PLOS ONE			English	Article							VACCINE ADJUVANT SYSTEMS; INNATE IMMUNITY; CELL-ACTIVATION; IMMUNOLOGICAL MECHANISMS; SIGNALING PATHWAY; ADAPTIVE IMMUNITY; MENINGITIDIS PORB; B-CELLS; MYD88; TOLL	Vaccines play a vital role in modern medicine. The development of novel vaccines for emerging and resistant pathogens has been aided in recent years by the use of novel adjuvants in subunit vaccines. A deeper understanding of the molecular pathways behind adjuvanticity is required to better select immunostimulatory molecules for use in individual vaccines. To this end, we have undertaken a study of the essential signaling pathways involved in the innate and adaptive immune responses to the Neisseria meningitidis outer membrane protein Porin B (PorB). We have previously demonstrated that PorB is an agonist of Toll-Like Receptor 2 (TLR2) and acts as an adjuvant in vaccines for protein, carbohydrate and lipopolysaccharide antigens using murine models. Here we demonstrate NF kappa B translocation following stimulation with PorB only occurs in the presence of TLR2. IL-6 and TNF-alpha secretion was shown to be MAPK dependent. Surface expression of activation markers on macrophages, including CD40, CD69, and CD86, was increased following PorB stimulation in vitro. Interestingly, some upregulation of CD54 and CD69 was still observed in macrophages obtained from TLR2 KO mice, indicating a possible non-TLR2 mediated activation pathway induced by PorB. In a murine vaccination model, using ovalbumin as the antigen and PorB as the adjuvant, a decreased antigen-specific IgG production was observed in TLR2 KO mice; adjuvant-dependent increased IgG production was entirely ablated in MyD88 KO mice. These observations demonstrate the importance of the above pathways to the adjuvant activity of PorB. The potential TLR2 independent effect is currently being explored.	[Platt, Andrew; MacLeod, Heather; Wetzler, Lee] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA; [Massari, Paola; Liu, Xiuping; Wetzler, Lee] Boston Med Ctr, Dept Med, Infect Dis Sect, Boston, MA USA	Boston University; Boston Medical Center	Wetzler, L (corresponding author), Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.	lwetzler@bu.edu	Platt, Andrew/AAX-3736-2021	Massari, Paola/0000-0003-3106-0711; Wetzler, Lee/0000-0002-6596-2986	NIH [RO1 AI040944]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040944] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by NIH Grant RO1 AI040944. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Aguilar JC, 2007, VACCINE, V25, P3752, DOI 10.1016/j.vaccine.2007.01.111; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bogoyevitch MA, 2004, BBA-PROTEINS PROTEOM, V1697, P89, DOI 10.1016/j.bbapap.2003.11.016; Cekic C, 2011, J IMMUNOL, V186, P3858, DOI 10.4049/jimmunol.1001034; Chiavolini D, 2008, CLIN VACCINE IMMUNOL, V15, P1322, DOI 10.1128/CVI.00125-08; Clarke SRM, 2000, J LEUKOCYTE BIOL, V67, P607, DOI 10.1002/jlb.67.5.607; Coligan J, 2011, ANAL PROTEIN PHOSPHO, V18, p[12, 11, 12]; Coligan J, 2011, CURRENT PROTOCOLS IM, V5.0.1-5.8.8 and 11.10.11-11.10.16; DUNNE A, 2003, SCI STKE, V171, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Ehrentraut H, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/746532; Gowda NM, 2012, J IMMUNOL, V188, P5073, DOI 10.4049/jimmunol.1102143; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GUTTORMSEN HK, 1993, INFECT IMMUN, V61, P4734, DOI 10.1128/IAI.61.11.4734-4742.1993; Harris J, 2010, EUR J IMMUNOL, V40, P634, DOI 10.1002/eji.200940172; Hartman ZC, 2007, J VIROL, V81, P1796, DOI 10.1128/JVI.01936-06; Ishii KJ, 2007, J CLIN IMMUNOL, V27, P363, DOI 10.1007/s10875-007-9087-x; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jin CC, 2010, J CLIN IMMUNOL, V30, P628, DOI 10.1007/s10875-010-9440-3; Kang SM, 2011, J VIROL, V85, P11391, DOI 10.1128/JVI.00080-11; Kiura K, 2006, FEMS IMMUNOL MED MIC, V48, P44, DOI 10.1111/j.1574-695X.2006.00119.x; Korsholm KS, 2010, IMMUNOLOGY, V129, P75, DOI 10.1111/j.1365-2567.2009.03164.x; Lahiri A, 2008, VACCINE, V26, P6777, DOI 10.1016/j.vaccine.2008.09.045; Lell B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007611; Levitz SM, 2012, CELL, V148, P1284, DOI 10.1016/j.cell.2012.02.012; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; Liu XP, 2008, VACCINE, V26, P786, DOI 10.1016/j.vaccine.2007.11.080; Mackinnon FG, 1999, J INFECT DIS, V180, P755, DOI 10.1086/314966; MacLeod H, 2008, CLIN VACCINE IMMUNOL, V15, P630, DOI 10.1128/CVI.00435-07; Massari P, 2000, P NATL ACAD SCI USA, V97, P9070, DOI 10.1073/pnas.97.16.9070; Massari P, 2006, J IMMUNOL, V176, P2373, DOI 10.4049/jimmunol.176.4.2373; Massari P, 2005, PROTEIN EXPRES PURIF, V44, P136, DOI 10.1016/j.pep.2005.04.021; Massari P, 2003, TRENDS MICROBIOL, V11, P87, DOI 10.1016/S0966-842X(02)00037-9; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; Massari P, 2010, INFECT IMMUN, V78, P994, DOI 10.1128/IAI.00156-09; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; Mckee AS, 2009, J IMMUNOL, V183, P4403, DOI 10.4049/jimmunol.0900164; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; NettFiordalisi M, 1995, J LEUKOCYTE BIOL, V58, P717, DOI 10.1002/jlb.58.6.717; Olive C, 2012, EXPERT REV VACCINES, V11, P237, DOI [10.1586/erv.11.189, 10.1586/ERV.11.189]; Oyston P, 2012, J MED MICROBIOL, V61, P889, DOI 10.1099/jmm.0.039180-0; Perrie Y, 2008, INT J PHARMACEUT, V364, P272, DOI 10.1016/j.ijpharm.2008.04.036; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; Precioso AR, 2011, VACCINE, V29, P8974, DOI 10.1016/j.vaccine.2011.09.040; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Rynkiewicz D, 2011, VACCINE, V29, P6313, DOI 10.1016/j.vaccine.2011.05.047; Saalmuller A, 2006, VET MICROBIOL, V117, P32, DOI 10.1016/j.vetmic.2006.04.007; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; Shumilina E, 2011, AM J PHYSIOL-CELL PH, V300, pC1205, DOI 10.1152/ajpcell.00039.2011; Singleton TE, 2005, J IMMUNOL, V174, P3545, DOI 10.4049/jimmunol.174.6.3545; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tanabe M, 2010, P NATL ACAD SCI USA, V107, P6811, DOI 10.1073/pnas.0912115107; Uto T, 2011, BIOMATERIALS, V32, P5206, DOI 10.1016/j.biomaterials.2011.03.052; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Vandepapeliere P, 2008, VACCINE, V26, P1375, DOI 10.1016/j.vaccine.2007.12.038; Wetzler LM, 2010, FUTURE MICROBIOL, V5, P749, DOI 10.2217/FMB.10.41; WETZLER LM, 1992, J INFECT DIS, V166, P551, DOI 10.1093/infdis/166.3.551; Wetzler LW, 1996, J EXP MED, V183, P1151, DOI 10.1084/jem.183.3.1151; Wilson NS, 2012, IMMUNOL CELL BIOL, V90, P540, DOI 10.1038/icb.2011.71; Zhang X, 2008, CURRENT PROTOCOLS IM	66	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82171	10.1371/journal.pone.0082171	http://dx.doi.org/10.1371/journal.pone.0082171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349212	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300081
J	Sasaki, Y; Ohfuji, S; Fukushima, W; Tamori, A; Enomoto, M; Habu, D; Iwai, S; Uchida-Kobayashi, S; Fujii, H; Shiomi, S; Kawada, N; Hirota, Y				Sasaki, Yachiyo; Ohfuji, Satoko; Fukushima, Wakaba; Tamori, Akihiro; Enomoto, Masaru; Habu, Daiki; Iwai, Shuji; Uchida-Kobayashi, Sawako; Fujii, Hideki; Shiomi, Susumu; Kawada, Norifumi; Hirota, Yoshio			Effect of Caffeine-Containing Beverage Consumption on Serum Alanine Aminotransferase Levels in Patients with Chronic Hepatitis C Virus Infection: A Hospital-Based Cohort Study	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; LIVER FIBROSIS PROGRESSION; COFFEE CONSUMPTION; HEPATOCELLULAR-CARCINOMA; RISK; DETERMINANTS; POPULATION; DRINKING; ALCOHOL; ASSOCIATION	Introduction: To date, there have been no prospective studies examining the effect of coffee consumption on serum alanine aminotransferase (ALT) level among individuals infected with the hepatitis C virus (HCV). We conducted a hospital-based cohort study among patients with chronic HCV infection to assess an association between baseline coffee consumption and subsequent ALT levels for 12 months. Materials and Methods: From 1 August 2005 to 31 July 2006, total 376 HCV-RNA positive patients were recruited. A baseline questionnaire elicited information on the frequency of coffee consumption and other caffeine-containing beverages. ALT level as a study outcome was followed through the patients' medical records during 12 months. The association between baseline beverage consumption and subsequent ALT levels was evaluated separately among patients with baseline ALT levels within normal range (<= 45 IU/L) and among those with higher ALT levels (>45 IU/L). Results: Among 229 patients with baseline ALT levels within normal range, 186 (81%) retained normal ALT levels at 12 months after recruitment. Daily drinkers of filtered coffee were three times more likely to preserve a normal ALT level than non-drinkers (OR=2.74; P=0.037). However, decaffeinated coffee drinkers had a somewhat inverse effect for sustained normal ALT levels, with marginal significance (OR=0.26; P=0.076). In addition, among 147 patients with higher baseline ALT levels, 39 patients (27%) had ALT reductions of >= 20 IU/L at 12 months after recruitment. Daily drinkers of filtered coffee had a significantly increased OR for ALT reduction (OR=3.79; P=0.034). However, in decaffeinated coffee drinkers, OR could not be calculated because no patients had ALT reduction. Conclusion: Among patients with chronic HCV infection, daily consumption of filtered coffee may have a beneficial effect on the stabilization of ALT levels.	[Sasaki, Yachiyo] Osaka City Univ, Grad Sch Nursing, Dept Gerontol Nursing, Osaka 558, Japan; [Sasaki, Yachiyo; Ohfuji, Satoko; Fukushima, Wakaba; Hirota, Yoshio] Osaka City Univ, Grad Sch Med, Dept Publ Hlth, Osaka 558, Japan; [Tamori, Akihiro; Enomoto, Masaru; Habu, Daiki; Iwai, Shuji; Uchida-Kobayashi, Sawako; Fujii, Hideki; Kawada, Norifumi] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 558, Japan; [Habu, Daiki] Osaka City Univ, Grad Sch Human Life Sci, Dept Med Nutr, Osaka 558, Japan; [Shiomi, Susumu] Osaka City Univ, Grad Sch Med, Dept Nucl Med, Osaka 558, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Sasaki, Y (corresponding author), Osaka City Univ, Grad Sch Nursing, Dept Gerontol Nursing, Osaka 558, Japan.	y-sasaki@nurs.osaka-cu.ac.jp	ENOMOTO, Masaru/I-3864-2019; kawada, norifumi/AAS-1367-2020; Ohfuji, Satoko/AHB-4998-2022	ENOMOTO, Masaru/0000-0002-4028-4381; 	Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [19790429]	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a research grant for Research on Hepatitis from the Ministry of Health, Labor and Welfare of Japan (http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/), and a Grant-in-Aid for Scientific Research (19790429) form the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, J HEPATOL S1, V31, P3; ARNESEN E, 1986, SCAND J CLIN LAB INV, V46, P63, DOI 10.3109/00365518609086483; CASIGLIA E, 1993, EUR J EPIDEMIOL, V9, P293, DOI 10.1007/BF00146266; CHENG WSC, 1990, CLIN PHARMACOL THER, V47, P516, DOI 10.1038/clpt.1990.66; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Corrao G, 2001, ANN EPIDEMIOL, V11, P458, DOI 10.1016/S1047-2797(01)00223-X; Fleming DJ, 1998, AM J CLIN NUTR, V67, P722, DOI 10.1093/ajcn/67.4.722; Higuchi M, 2002, JPN J INFECT DIS, V55, P69; Honjo S, 2001, J CLIN EPIDEMIOL, V54, P823, DOI 10.1016/S0895-4356(01)00344-4; Honjo S, 1999, ANN EPIDEMIOL, V9, P325, DOI 10.1016/S1047-2797(99)00013-7; IMAI K, 1995, BRIT MED J, V310, P693, DOI 10.1136/bmj.310.6981.693; Inglesby TV, 1999, HEPATOLOGY, V29, P590, DOI 10.1002/hep.510290219; Inoue M, 2005, J NATL CANCER I, V97, P293, DOI 10.1093/jnci/dji040; KLATSKY AL, 1992, AM J EPIDEMIOL, V136, P1248, DOI 10.1093/oxfordjournals.aje.a116433; Meltzer AA, 1997, AM J EPIDEMIOL, V146, P565; Nakanishi N, 2000, EUR J EPIDEMIOL, V16, P419, DOI 10.1023/A:1007683626665; Nakanishi N, 2000, IND HEALTH, V38, P99, DOI 10.2486/indhealth.38.99; Nakanishi N, 2000, OCCUP MED-OXFORD, V50, P115, DOI 10.1093/occmed/50.2.115; NILSSEN O, 1990, AM J EPIDEMIOL, V132, P318, DOI 10.1093/oxfordjournals.aje.a115661; NILSSEN O, 1994, AM J EPIDEMIOL, V139, P787, DOI 10.1093/oxfordjournals.aje.a117075; Ohfuji S, 2006, HEPATOL RES, V36, P201, DOI 10.1016/j.hepres.2006.07.010; Park HS, 2005, AM J CLIN NUTR, V82, P1046, DOI 10.1093/ajcn/82.5.1046; Patrick L, 1999, Altern Med Rev, V4, P220; Poikolainen K, 1997, AM J EPIDEMIOL, V146, P1019, DOI 10.1093/oxfordjournals.aje.a009230; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0; Ruhl CE, 2005, GASTROENTEROLOGY, V128, P24, DOI 10.1053/j.gastro.2004.09.075; Suruki R, 2006, INT J CANCER, V119, P192, DOI 10.1002/ijc.21796; Tanaka K, 1998, INT J EPIDEMIOL, V27, P438, DOI 10.1093/ije/27.3.438; Tverdal A, 2003, ANN EPIDEMIOL, V13, P419, DOI 10.1016/S1047-2797(02)00462-3; URGERT R, 1995, J AGR FOOD CHEM, V43, P2167, DOI 10.1021/jf00056a039; URGERT R, 1995, AM J CLIN NUTR, V61, P149, DOI 10.1093/ajcn/61.1.149; WEUSTENVANDERWOUW MPME, 1994, J LIPID RES, V35, P721	33	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83382	10.1371/journal.pone.0083382	http://dx.doi.org/10.1371/journal.pone.0083382			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349501	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300145
J	Wu, MQ; Yang, CZ; Tao, BL; Bu, S; Guay-Woodford, LM				Wu, Maoqing; Yang, Chaozhe; Tao, Binli; Bu, Su; Guay-Woodford, Lisa M.			The Ciliary Protein Cystin Forms a Regulatory Complex with Necdin to Modulate Myc Expression	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; PRADER-WILLI-SYNDROME; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; GROWTH SUPPRESSOR NECDIN; C-MYC; TRANSCRIPTION FACTOR; PKHD1 MUTATIONS; CPK MOUSE; CHROMOSOMAL TRANSLOCATION; FUNCTIONAL INTERACTIONS	Cystin is a novel cilia-associated protein that is disrupted in the cpk mouse, a well-characterized mouse model of autosomal recessive polycystic kidney disease (ARPKD). Interestingly, overexpression of the Myc gene is evident in animal models of ARPKD and is thought to contribute to the renal cystic phenotype. Using a yeast two-hybrid approach, the growth suppressor protein necdin, known to modulate Myc expression, was found as an interacting partner of cystin. Deletion mapping demonstrated that the C-terminus of cystin and both termini of necdin are required for their mutual interaction. Speculating that these two proteins may function to regulate gene expression, we developed a luciferase reporter assay and observed that necdin strongly activated the Myc P1 promoter, and cystin did so more modestly. Interestingly, the necdin effect was significantly abrogated when cystin was co-transfected. Chromatin immunoprecipitation and electrophoretic mobility shift assays revealed a physical interaction with both necdin and cystin and the Myc P1 promoter, as well as between these proteins. The data suggest that these proteins likely function in a regulatory complex. Thus, we speculate that Myc overexpression in the cpk kidney results from the dysregulation of the cystin-necdin regulatory complex and c-Myc, in turn, contributes to cystogenesis in the cpk mouse.	[Wu, Maoqing; Yang, Chaozhe; Tao, Binli; Bu, Su; Guay-Woodford, Lisa M.] Univ Alabama Birmingham, Dept Genet, Div Res, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham	Guay-Woodford, LM (corresponding author), Childrens Natl Med Ctr, Ctr Translat Sci, Washington, DC 20010 USA.	LGuaywoo@childrensnational.org			National Institutes of Health [DK55534]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a National Institutes of Health grant to LGW (DK55534). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Adeva M, 2006, MEDICINE, V85, P1, DOI 10.1097/01.md.0000200165.90373.9a; Albert T, 2001, J BIOL CHEM, V276, P20482, DOI 10.1074/jbc.M100265200; AVNER ED, 1993, SEMIN NEPHROL, V13, P427; Bakeberg JL, 2011, J AM SOC NEPHROL, V22, P2266, DOI 10.1681/ASN.2010111173; Berbari NF, 2012, CYTOSKELETON HOBOKEN; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Bergmann C, 2005, KIDNEY INT, V67, P829, DOI 10.1111/j.1523-1755.2005.00148.x; Bergmann C, 2004, HUM MUTAT, V23, P453, DOI 10.1002/humu.20029; BORN TL, 1994, MOL CELL BIOL, V14, P5710, DOI 10.1128/MCB.14.9.5710; BURN TC, 1995, GENE, V161, P183, DOI 10.1016/0378-1119(95)00223-S; Calvet JP, 1998, J NEPHROL, V11, P24; Chapman EJ, 2009, MOL CARCINOGEN, V48, P975, DOI 10.1002/mc.20567; Cleary MA, 2001, NAT GENET, V29, P78, DOI 10.1038/ng715; Conacci-Sorrell M, 2010, CELL, V142, P480, DOI 10.1016/j.cell.2010.06.037; COWLEY BD, 1991, J AM SOC NEPHROL, V1, P1048; DAVISSON MT, 1991, GENOMICS, V9, P778, DOI 10.1016/0888-7543(91)90376-P; de Caestecker MP, 2000, J BIOL CHEM, V275, P2115, DOI 10.1074/jbc.275.3.2115; DECAMILLI P, 1986, J CELL BIOL, V103, P189, DOI 10.1083/jcb.103.1.189; Denamur E, 2010, KIDNEY INT, V77, P350, DOI 10.1038/ki.2009.440; Edelstein CL, 2008, CLIN J AM SOC NEPHRO, V3, P1219, DOI 10.2215/CJN.05611207; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; FRY JL, 1985, J UROLOGY, V134, P828, DOI 10.1016/S0022-5347(17)47448-9; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Gattone VH, 1996, ANAT REC, V245, P488; Gearhart J, 2007, NEW ENGL J MED, V357, P1469, DOI 10.1056/NEJMp078126; Gerdes JM, 2008, CURR TOP DEV BIOL, V85, P175, DOI 10.1016/S0070-2153(08)00807-7; Goilav B, 2008, PEDIATR NEPHROL, V23, P1473, DOI 10.1007/s00467-008-0851-9; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Guay-Woodford LM, 2003, PEDIATRICS, V111, P1072, DOI 10.1542/peds.111.5.1072; Gunay-Aygun M, 2010, CLIN J AM SOC NEPHRO, V5, P972, DOI 10.2215/CJN.07141009; Gunay-Aygun M, 2010, MOL GENET METAB, V99, P160, DOI 10.1016/j.ymgme.2009.10.010; Gustafson WC, 2010, ONCOGENE, V29, P1249, DOI 10.1038/onc.2009.512; Habbig S, 2011, J CELL BIOL, V193, P633, DOI 10.1083/jcb.201009069; HARDING MA, 1992, KIDNEY INT, V41, P317, DOI 10.1038/ki.1992.44; Harris PC, 1999, HUM MOL GENET, V8, P1861, DOI 10.1093/hmg/8.10.1861; Hasegawa K, 2008, J NEUROSCI, V28, P8772, DOI 10.1523/JNEUROSCI.3052-08.2008; HAYASHI Y, 1995, BIOCHEM BIOPH RES CO, V213, P317, DOI 10.1006/bbrc.1995.2132; Herold S, 2009, NAT REV CANCER, V9, P441, DOI 10.1038/nrc2640; Hiesberger T, 2004, J CLIN INVEST, V113, P814, DOI 10.1172/JCI200420083; Hiesberger T, 2005, J BIOL CHEM, V280, P10578, DOI 10.1074/jbc.M414121200; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; Hu HM, 2007, LEUKEMIA, V21, P747, DOI 10.1038/sj.leu.2404583; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Ibraghimov-Beskrovnaya O, 2008, CELL MOL LIFE SCI, V65, P605, DOI 10.1007/s00018-007-7362-x; Jay P, 1997, NAT GENET, V17, P357, DOI 10.1038/ng1197-357; Kim IY, 2008, J AM SOC NEPHROL, V19, P455, DOI 10.1681/ASN.2007070770; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Konda R, 2008, J UROLOGY, V180, P481, DOI 10.1016/j.juro.2008.04.006; Kurita M, 2006, J NEUROSCI, V26, P12003, DOI 10.1523/JNEUROSCI.3002-06.2006; Kuwako K, 2004, J BIOL CHEM, V279, P1703, DOI 10.1074/jbc.M308454200; Lafontaine J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031916; Lee S, 2005, HUM MOL GENET, V14, P627, DOI 10.1093/hmg/ddi059; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Lin FM, 2004, CURR OPIN PEDIATR, V16, P171, DOI 10.1097/00008480-200404000-00010; Liu XJ, 2009, MOL CELL NEUROSCI, V41, P51, DOI 10.1016/j.mcn.2009.01.009; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; MacDonald HR, 1997, HUM MOL GENET, V6, P1873, DOI 10.1093/hmg/6.11.1873; Maruyama E, 1996, BIOCHEM J, V314, P895, DOI 10.1042/bj3140895; MARUYAMA K, 1991, BIOCHEM BIOPH RES CO, V178, P291, DOI 10.1016/0006-291X(91)91812-Q; Matsumoto K, 2001, GENE, V272, P173, DOI 10.1016/S0378-1119(01)00544-3; Matsumura H, 2007, NAT METHODS, V4, P23, DOI 10.1038/NMETH973; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moon HE, 2005, FEBS LETT, V579, P3797, DOI 10.1016/j.febslet.2005.05.072; Moore SJ, 2005, AM J MED GENET A, V132A, P352, DOI 10.1002/ajmg.a.30406; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Ong ACM, 2003, LANCET, V361, P774, DOI 10.1016/S0140-6736(03)12662-1; Perez I, 1997, RNA, V3, P764; Pierreux CE, 2006, GASTROENTEROLOGY, V130, P532, DOI 10.1053/j.gastro.2005.12.005; Pollard PJ, 2007, CANCER CELL, V11, P311, DOI 10.1016/j.ccr.2007.02.005; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; REISMAN D, 1993, CELL GROWTH DIFFER, V4, P57; Ricker JL, 2000, J AM SOC NEPHROL, V11, P1837, DOI 10.1681/ASN.V11101837; Saifudeen Z, 2002, J CLIN INVEST, V109, P1021, DOI 10.1172/JCI200213972; Sears R, 1997, MOL CELL BIOL, V17, P5227, DOI 10.1128/MCB.17.9.5227; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; Sutcliffe JS, 1997, LANCET, V350, P1520, DOI 10.1016/S0140-6736(05)63943-8; Takazaki R, 2002, EXP CELL RES, V277, P220, DOI 10.1006/excr.2002.5558; Taniguchi N, 2000, J BIOL CHEM, V275, P31674, DOI 10.1074/jbc.M005103200; Taniura H, 1999, J BIOL CHEM, V274, P16242, DOI 10.1074/jbc.274.23.16242; Taniura H, 1998, J BIOL CHEM, V273, P720, DOI 10.1074/jbc.273.2.720; Tao BL, 2009, J AM SOC NEPHROL, V20, P2570, DOI 10.1681/ASN.2009020188; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Torra R, 1996, J AM SOC NEPHROL, V7, P2142; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Trudel M, 1998, AM J PATHOL, V152, P219; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; VANADELSBERG JS, 1995, NAT MED, V1, P359, DOI 10.1038/nm0495-359; Wang SX, 2007, MOL CELL BIOL, V27, P3241, DOI 10.1128/MCB.00072-07; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Watnick T, 1999, SEMIN NEPHROL, V19, P327; Williams SS, 2008, PEDIATR NEPHROL, V23, P733, DOI 10.1007/s00467-007-0735-4; Wu YL, 2006, HUM MOL GENET, V15, P3280, DOI 10.1093/hmg/ddl404; YAMADA T, 1995, KIDNEY INT, V48, P745, DOI 10.1038/ki.1995.346; Ye J, 2013, TRANSGENIC RES; Yeo G, 2004, P NATL ACAD SCI USA, V101, P15700, DOI 10.1073/pnas.0404901101; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Zerres K, 1998, AM J MED GENET, V76, P137, DOI 10.1002/(SICI)1096-8628(19980305)76:2<137::AID-AJMG6>3.0.CO;2-Q; Zhu JH, 2000, J BIOL CHEM, V275, P39927, DOI 10.1074/jbc.M005676200	103	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83062	10.1371/journal.pone.0083062	http://dx.doi.org/10.1371/journal.pone.0083062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349431	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300128
J	Xue, G; Xue, F; Droutman, V; Lu, ZL; Bechara, A; Read, S				Xue, Gui; Xue, Feng; Droutman, Vita; Lu, Zhong-Lin; Bechara, Antoine; Read, Stephen			Common Neural Mechanisms Underlying Reversal Learning by Reward and Punishment	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; HUMAN ORBITOFRONTAL CORTEX; DECISION-MAKING; RESPONSE REVERSAL; DORSAL STRIATUM; SEX-DIFFERENCES; FRONTAL-LOBE; ATTENTIONAL CONTROL; DEFAULT NETWORK; LESIONS	Impairments in flexible goal-directed decisions, often examined by reversal learning, are associated with behavioral abnormalities characterized by impulsiveness and disinhibition. Although the lateral orbital frontal cortex (OFC) has been consistently implicated in reversal learning, it is still unclear whether this region is involved in negative feedback processing, behavioral control, or both, and whether reward and punishment might have different effects on lateral OFC involvement. Using a relatively large sample (N = 47), and a categorical learning task with either monetary reward or moderate electric shock as feedback, we found overlapping activations in the right lateral OFC (and adjacent insula) for reward and punishment reversal learning when comparing correct reversal trials with correct acquisition trials, whereas we found overlapping activations in the right dorsolateral prefrontal cortex (DLPFC) when negative feedback signaled contingency change. The right lateral OFC and DLPFC also showed greater sensitivity to punishment than did their left homologues, indicating an asymmetry in how punishment is processed. We propose that the right lateral OFC and anterior insula are important for transforming affective feedback to behavioral adjustment, whereas the right DLPFC is involved in higher level attention control. These results provide insight into the neural mechanisms of reversal learning and behavioral flexibility, which can be leveraged to understand risky behaviors among vulnerable populations.	[Xue, Gui; Xue, Feng] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Xue, Gui; Xue, Feng] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Xue, Feng; Droutman, Vita; Bechara, Antoine; Read, Stephen] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Lu, Zhong-Lin] Ohio State Univ, Ctr Cognit & Behav Brain Imaging, Columbus, OH 43210 USA; [Lu, Zhong-Lin] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA; [Bechara, Antoine] Univ So Calif, Brain & Creat Inst, Los Angeles, CA USA	Beijing Normal University; Beijing Normal University; University of Southern California; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Southern California	Read, S (corresponding author), Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA.	read@usc.edu	Droutman, Vita/AAA-3379-2020; Xue, Gui/A-1762-2009; Xue, Feng/B-2304-2010	Xue, Gui/0000-0001-7891-8151; Xue, Feng/0000-0001-8286-3552; Lu, Zhong-Lin/0000-0002-7295-727X; Bechara, Antoine/0000-0001-5127-2549	National Institute on Drug Abuse of the National Institutes of Health [R01DA031626]; National Science Foundation of China [31130025]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031626] Funding Source: NIH RePORTER	National Institute on Drug Abuse of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Research reported in this publication was supported by the National Institute on Drug Abuse of the National Institutes of Health (R01DA031626), and the National Science Foundation of China (31130025). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2007, NONLINEAR REGISTRATI; ANDREASON PJ, 1994, PSYCHIAT RES, V51, P175, DOI 10.1016/0165-1781(94)90037-X; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Bechara A, 2005, GAME ECON BEHAV, V52, P336, DOI 10.1016/j.geb.2004.06.010; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Bolla KI, 2004, CEREB CORTEX, V14, P1226, DOI 10.1093/cercor/bhh083; Budhani S, 2007, NEUROIMAGE, V34, P1754, DOI 10.1016/j.neuroimage.2006.08.060; Budhani S, 2005, J CHILD PSYCHOL PSYC, V46, P972, DOI 10.1111/j.1469-7610.2004.00398.x; Budhani S, 2006, J ABNORM PSYCHOL, V115, P552, DOI 10.1037/0021-843X.115.3.552; Chamberlain SR, 2008, SCIENCE, V321, P421, DOI 10.1126/science.1154433; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Chudasama Y, 2003, J NEUROSCI, V23, P8771; Clarke HF, 2008, J NEUROSCI, V28, P10972, DOI 10.1523/JNEUROSCI.1521-08.2008; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Cools R, 2009, J NEUROSCI, V29, P1538, DOI 10.1523/JNEUROSCI.4467-08.2009; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dickstein DP, 2010, PSYCHOL MED, V40, P1089, DOI 10.1017/S0033291709991462; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Fellows LK, 2003, BRAIN, V126, P1830, DOI 10.1093/brain/awg180; Finger EC, 2008, ARCH GEN PSYCHIAT, V65, P586, DOI 10.1001/archpsyc.65.5.586; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Ghahremani DG, 2010, CEREB CORTEX, V20, P1843, DOI 10.1093/cercor/bhp247; Glascher J, 2009, CEREB CORTEX, V19, P483, DOI 10.1093/cercor/bhn098; Greening SG, 2011, NEUROIMAGE, V54, P1432, DOI 10.1016/j.neuroimage.2010.09.017; Hampshire A, 2011, NEUROIMAGE; Hampshire A, 2008, J COGNITIVE NEUROSCI, V20, P1670, DOI 10.1162/jocn.2008.20115; Hampshire A, 2006, CEREB CORTEX, V16, P1679, DOI 10.1093/cercor/bhj116; Hampton AN, 2007, P NATL ACAD SCI USA, V104, P1377, DOI 10.1073/pnas.0606297104; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Jaffe HW, 2007, JAMA-J AM MED ASSOC, V298, P2412, DOI 10.1001/jama.298.20.2412; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kim H, 2011, CEREB CORTEX, V21, P769, DOI 10.1093/cercor/bhq145; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Laakso A, 2002, BIOL PSYCHIAT, V52, P759, DOI 10.1016/S0006-3223(02)01369-0; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mattfeld AT, 2011, LEARN MEMORY, V18, P703, DOI 10.1101/lm.022889.111; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mesulam M, 2004, J COMP NEUROL, V212, P38; Mitchell DGV, 2008, BEHAV BRAIN RES, V187, P80, DOI 10.1016/j.bbr.2007.08.034; Mitchell DGV, 2006, NEUROCASE, V12, P164, DOI 10.1080/13554790600611288; Mitchell DGV, 2009, J NEUROSCI, V29, P10827, DOI 10.1523/JNEUROSCI.0963-09.2009; Mitchell DGV, 2002, NEUROPSYCHOLOGIA, V40, P2013, DOI 10.1016/S0028-3932(02)00056-8; Mullette-Gillman OA, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.023.2009; Mumford J., 2007, GUIDE CALCULAT UNPUB; Nagahama Y, 2001, CEREB CORTEX, V11, P85, DOI 10.1093/cercor/11.1.85; Nashiro K, 2012, J COGNITIVE NEUROSCI, V24, P1794, DOI 10.1162/jocn_a_00245; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, J NEUROSCI, V23, P7931; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Overman WH, 2004, BRAIN COGNITION, V55, P134, DOI 10.1016/s0278-2626(03)00279-3; Palminteri S, 2012, NEURON, V76, P998, DOI 10.1016/j.neuron.2012.10.017; Reavis R, 2001, BEHAV NEUROSCI, V115, P196, DOI 10.1037//0735-7044.115.1.196; Remijnse PL, 2006, ARCH GEN PSYCHIAT, V63, P1225, DOI 10.1001/archpsyc.63.11.1225; Remijnse PL, 2005, NEUROIMAGE, V26, P609, DOI 10.1016/j.neuroimage.2005.02.009; Robinson OJ, 2010, NEUROIMAGE, V51, P1459, DOI 10.1016/j.neuroimage.2010.03.036; Rogers RD, 2000, J COGNITIVE NEUROSCI, V12, P142, DOI 10.1162/089892900561931; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Schoenbaum G, 2002, NEUROREPORT, V13, P885, DOI 10.1097/00001756-200205070-00030; Seymour B, 2007, J NEUROSCI, V27, P4826, DOI 10.1523/JNEUROSCI.0400-07.2007; SOBOTKA SS, 1992, ELECTROEN CLIN NEURO, V83, P236, DOI 10.1016/0013-4694(92)90117-Z; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Tanaka SC, 2008, J NEUROSCI, V28, P6750, DOI 10.1523/JNEUROSCI.1808-08.2008; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Tsuchida A, 2010, J NEUROSCI, V30, P16868, DOI 10.1523/JNEUROSCI.1958-10.2010; Valentin VV, 2009, J NEUROPHYSIOL, V102, P3384, DOI 10.1152/jn.91195.2008; van der Plas EAA, 2009, J CLIN EXP NEUROPSYC, V31, P706, DOI 10.1080/13803390802484797; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Wager T. D., 2004, PSYCEXTRA; Wheeler EZ, 2008, BRAIN, V131, P1323, DOI 10.1093/brain/awn041; Woolrich M, 2008, NEUROIMAGE, V41, P286, DOI 10.1016/j.neuroimage.2008.02.042; Woolrich MW, 2004, NEUROIMAGE, V21, P1732, DOI 10.1016/j.neuroimage.2003.12.023; Xue G, 2008, J NEUROSCI, V28, P11196, DOI 10.1523/JNEUROSCI.4001-08.2008; Xue G, 2008, CEREB CORTEX, V18, P1923, DOI 10.1093/cercor/bhm220; Xue G, 2011, J COGNITIVE NEUROSCI, V23, P1624, DOI 10.1162/jocn.2010.21532; Xue G, 2009, CEREB CORTEX, V19, P1019, DOI 10.1093/cercor/bhn147; Yacubian J, 2006, J NEUROSCI, V26, P9530, DOI 10.1523/JNEUROSCI.2915-06.2006	87	27	27	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82169	10.1371/journal.pone.0082169	http://dx.doi.org/10.1371/journal.pone.0082169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349211	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300080
J	Dettrick, Z; Firth, S; Soto, EJ				Dettrick, Zoe; Firth, Sonja; Soto, Eliana Jimenez			Do Strategies to Improve Quality of Maternal and Child Health Care in Lower and Middle Income Countries Lead to Improved Outcomes? A Review of the Evidence	PLOS ONE			English	Review							EMERGENCY OBSTETRIC CARE; PRENATAL-CARE; INTEGRATED MANAGEMENT; PERINATAL-MORTALITY; NEONATAL HEALTH; SERVICES; DELIVERY; INTERVENTIONS; PERFORMANCE; IMPACT	Objectives: Efforts to scale-up maternal and child health services in lower and middle income countries will fail if services delivered are not of good quality. Although there is evidence of strategies to increase the quality of health services, less is known about the way these strategies affect health system goals and outcomes. We conducted a systematic review of the literature to examine this relationship. Methods: We undertook a search of MEDLINE, SCOPUS and CINAHL databases, limiting the results to studies including strategies specifically aimed at improving quality that also reported a measure of quality and at least one indicator related to health system outcomes. Variation in study methodologies prevented further quantitative analysis; instead we present a narrative review of the evidence. Findings: Methodologically, the quality of evidence was poor, and dominated by studies of individual facilities. Studies relied heavily on service utilisation as a measure of strategy success, which did not always correspond to improved quality. The majority of studies targeted the competency of staff and adequacy of facilities. No strategies addressed distribution systems, public-private partnership or equity. Key themes identified were the conflict between perceptions of patients and clinical measures of quality and the need for holistic approaches to health system interventions. Conclusion: Existing evidence linking quality improvement strategies to improved MNCH outcomes is extremely limited. Future research would benefit from the inclusion of more appropriate indicators and additional focus on nonfacility determinants of health service quality such as health policy, supply distribution, community acceptability and equity of care.	[Dettrick, Zoe; Firth, Sonja; Soto, Eliana Jimenez] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia	University of Queensland	Dettrick, Z (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.	z.dettrick@uq.edu.au	Dettrick, Zoe A/I-1479-2017; Dettrick, Zoe/AAP-2862-2021	Dettrick, Zoe A/0000-0003-1091-1820; Dettrick, Zoe/0000-0003-1091-1820	Australian Agency for International Development (AusAID, now part of the Department of Foreign Affairs and Trade)	Australian Agency for International Development (AusAID, now part of the Department of Foreign Affairs and Trade)	This paper is based upon research financed by The Australian Agency for International Development (AusAID, now part of the Department of Foreign Affairs and Trade) (http://aid.dfat.gov.au/Pages/home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghlmand Siamak, 2008, BMC Pregnancy Childbirth, V8, P20, DOI 10.1186/1471-2393-8-20; Althabe F, 2008, PAEDIATR PERINAT EP, V22, P42, DOI 10.1111/j.1365-3016.2007.00912.x; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Barua A, 2003, REPROD HEALTH MATTER, V11, P140, DOI 10.1016/S0968-8080(03)02162-1; Basinga P, 2011, LANCET, V377, P1421, DOI 10.1016/S0140-6736(11)60177-3; Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Bjorkman M, 2009, Q J ECON, V124, P735, DOI 10.1162/qjec.2009.124.2.735; Boschi-Pinto C, 2010, INT J EPIDEMIOL, V39, P3, DOI 10.1093/ije/dyq018; Bradley J, 2005, INT J QUAL HEALTH C, V17, P391, DOI 10.1093/intqhc/mzi057; Bravata DM, 2005, ANN INTERN MED, V142, P1056, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00005; Bryce J, 2010, LANCET, V375, P572, DOI 10.1016/S0140-6736(09)62060-2; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chan GJ, 2010, B WORLD HEALTH ORGAN, V88, P709, DOI 10.2471/BLT.09.064618; Chowdhury EK, 2008, LANCET, V372, P822, DOI 10.1016/S0140-6736(08)61166-6; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; El Arifeen S, 2004, LANCET, V364, P1595, DOI 10.1016/S0140-6736(04)17312-1; Entwistle V, 2012, J HEALTH SERV RES PO, V17, P70, DOI 10.1258/jhsrp.2011.011029; Figueras A, 2008, BIRTH-ISS PERINAT C, V35, P283, DOI 10.1111/j.1523-536X.2008.00255.x; Forsberg BC, 2011, HEALTH POLICY PLANN, V26, pi1, DOI 10.1093/heapol/czr050; Fort MP, 2011, REV PANAM SALUD PUBL, V30, P217, DOI 10.1590/S1020-49892011000900005; Goodburn EA, 2000, HEALTH POLICY PLANN, V15, P394, DOI 10.1093/heapol/15.4.394; Graham WJ, 2012, LANCET, V379, pE5, DOI 10.1016/S0140-6736(10)62267-2; Guliani H, 2012, SOC SCI MED, V74, P1882, DOI 10.1016/j.socscimed.2012.02.008; Haws RA, 2007, HEALTH POLICY PLANN, V22, P193, DOI 10.1093/heapol/czm009; Hermida J, 2002, INT J QUAL HEALTH C, V14, P25, DOI 10.1093/intqhc/14.suppl_1.25; Ifenne D, 1997, INT J GYNECOL OBSTET, V59, pS37, DOI 10.1016/S0020-7292(97)00146-X; Jafari F, 2010, IRAN J PUBLIC HEALTH, V39, P52; Jafari F, 2010, HEALTH CARE WOMEN IN, V31, P571, DOI 10.1080/07399331003646323; Kayongo M, 2006, INT J GYNECOL OBSTET, V92, P291, DOI 10.1016/j.ijgo.2005.10.030; Kayongo M, 2006, INT J GYNECOL OBSTET, V92, P308, DOI 10.1016/j.ijgo.2005.12.003; Kayongo M, 2006, INT J GYNECOL OBSTET, V92, P299, DOI 10.1016/j.ijgo.2005.12.005; Kongnyuy E J, 2008, Women Birth, V21, P149, DOI 10.1016/j.wombi.2008.08.002; Kongnyuy EJ, 2009, BJOG-INT J OBSTET GY, V116, P7, DOI 10.1111/j.1471-0528.2008.01994.x; Kongnyuy EJ, 2009, J OBSTET GYNAECOL RE, V35, P483, DOI 10.1111/j.1447-0756.2008.00990.x; LAGARDE M, 2011, COCHRANE DATABASE SY, V4; Leigh B, 1997, INT J GYNECOL OBSTET, V59, pS55, DOI 10.1016/S0020-7292(97)00148-3; Marin Gustavo H, 2011, Qual Prim Care, V19, P311; McNamee Paul, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P41, DOI 10.1586/14737167.9.1.41; McQuestion MJ, 2006, HEALTH POLICY, V77, P221, DOI 10.1016/j.healthpol.2005.07.007; Mekbib T, 2003, INT J GYNECOL OBSTET, V81, P93, DOI 10.1016/S0020-7292(03)00071-7; Nyamtema AS, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-30; Ohnishi M, 2007, ADV HEALTH SCI EDUC, V12, P147, DOI 10.1007/s10459-005-2329-x; Olukoya AA, 1997, INT J GYNECOL OBSTET, V59, pS67, DOI 10.1016/S0020-7292(97)00149-5; Opiyo N, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007071.pub2; OROURKE K, 1995, INT J GYNECOL OBSTET, V48, pS95, DOI 10.1016/0020-7292(95)02324-6; Otchere SA, 2007, INT J GYNECOL OBSTET, V99, P165, DOI 10.1016/j.ijgo.2007.07.005; Otchere SA, 2007, INT J GYNECOL OBSTET, V99, P173, DOI 10.1016/j.ijgo.2007.07.004; Ouma PO, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-1; Oyesola R, 1997, INT J GYNECOL OBSTET, V59, pS75, DOI 10.1016/S0020-7292(97)00150-1; Partnership for Maternal Newborn and Child Health, 2011, GLOB REV KEY INT REL; Pattinson RC, 2006, CLIN GOV, V11, P278, DOI DOI 10.1108/14777270610708814; Pattinson R, 2009, INT J GYNECOL OBSTET, V107, pS113, DOI 10.1016/j.ijgo.2009.07.011; Peabody JW, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1293; Pirkle CM, 2011, INT J QUAL HEALTH C, V23, P456, DOI 10.1093/intqhc/mzr033; Rana TG, 2007, INT J GYNECOL OBSTET, V98, P271, DOI 10.1016/j.ijgo.2007.05.017; Raven J, 2011, INT J GYNECOL OBSTET, V114, P4, DOI 10.1016/j.ijgo.2011.02.007; Raven JH, 2012, MIDWIFERY, V28, pE676, DOI 10.1016/j.midw.2011.09.003; Renaudin P, 2007, INT J GYNECOL OBSTET, V99, P183, DOI 10.1016/j.ijgo.2007.07.006; Robinson JS, 2001, B WORLD HEALTH ORGAN, V79, P150; Rowe AK, 2011, AM J PUBLIC HEALTH, V101, P2333, DOI 10.2105/AJPH.2010.300068; Sabitu K, 1997, INT J GYNECOL OBSTET, V59, pS99, DOI 10.1016/S0020-7292(97)00153-7; Santos C, 2006, INT J GYNECOL OBSTET, V94, P190, DOI 10.1016/j.ijgo.2006.05.024; Senarath U, 2007, JOGNN-J OBST GYN NEO, V36, P531, DOI 10.1111/j.1552-6909.2007.00183.x; Soeters R, 2011, HEALTH AFFAIR, V30, P1518, DOI 10.1377/hlthaff.2009.0019; Srofenyoh E, 2012, INT J GYNECOL OBSTET, V116, P17, DOI 10.1016/j.ijgo.2011.08.010; Strand R T, 2009, Afr J Reprod Health, V13, P75; Uskun E, 2008, PUBLIC HEALTH, V122, P949, DOI 10.1016/j.puhe.2007.10.005; van Lonkhuijzen L, 2010, BJOG-INT J OBSTET GY, V117, P777, DOI 10.1111/j.1471-0528.2010.02561.x; Wilkinson D, 1997, HEALTH POLICY PLANN, V12, P161, DOI 10.1093/heapol/12.2.161; Wong ST, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-91; World Health Organization, 2000, WORLD HLTH REP 2000; Youngleson MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013891	72	46	48	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e83070	10.1371/journal.pone.0083070	http://dx.doi.org/10.1371/journal.pone.0083070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VD	24349435	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200123
J	Levine, AC; Munyaneza, RM; Glavis-Bloom, J; Redditt, V; Cockrell, HC; Kalimba, B; Kabemba, V; Musavuli, J; Gakwerere, M; Umurungi, JPD; Shah, SP; Drobac, PC				Levine, Adam C.; Munyaneza, Richard M.; Glavis-Bloom, Justin; Redditt, Vanessa; Cockrell, Hannah C.; Kalimba, Bantu; Kabemba, Valentin; Musavuli, Juvenal; Gakwerere, Mathias; Umurungi, Jean Paul de Charles; Shah, Sachita P.; Drobac, Peter C.			Prediction of Severe Disease in Children with Diarrhea in a Resource-Limited Setting	PLOS ONE			English	Article							CLINICAL DEHYDRATION SCALE; GASTROENTERITIS; VALIDATION; ACCURACY; SIGNS	Objective: To investigate the accuracy of three clinical scales for predicting severe disease (severe dehydration or death) in children with diarrhea in a resource-limited setting. Methods: Participants included 178 children admitted to three Rwandan hospitals with diarrhea. A local physician or nurse assessed each child on arrival using the World Health Organization (WHO) severe dehydration scale and the Centers for Disease Control (CDC) scale. Children were weighed on arrival and daily until they achieved a stable weight, with a 10% increase between admission weight and stable weight considered severe dehydration. The Clinical Dehydration Scale was then constructed post-hoc using the data collected for the other two scales. Receiver Operator Characteristic (ROC) curves were constructed for each scale compared to the composite outcome of severe dehydration or death. Results: The WHO severe dehydration scale, CDC scale, and Clinical Dehydration Scale had areas under the ROC curves (AUCs) of 0.72 (95% CI 0.60, 0.85), 0.73 (95% CI 0.62, 0.84), and 0.80 (95% CI 0.71, 0.89), respectively, in the full cohort. Only the Clinical Dehydration Scale was a significant predictor of severe disease when used in infants, with an AUC of 0.77 (95% CI 0.61, 0.93), and when used by nurses, with an AUC of 0.78 (95% CI 0.63, 0.93). Conclusions: While all three scales were moderate predictors of severe disease in children with diarrhea, scale accuracy varied based on provider training and age of the child. Future research should focus on developing or validating clinical tools that can be used accurately by nurses and other less-skilled providers to assess all children with diarrhea in resource-limited settings.	[Levine, Adam C.; Glavis-Bloom, Justin] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Munyaneza, Richard M.] Rwanda Minist Hlth, Dept Community Hlth, Kigali, Rwanda; [Redditt, Vanessa] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Cockrell, Hannah C.] Brown Univ, Watson Inst Int Studies, Providence, RI 02912 USA; [Kalimba, Bantu; Kabemba, Valentin] Kirehe Hosp, Dept Med, Kirehe, Eastern Provinc, Rwanda; [Musavuli, Juvenal; Gakwerere, Mathias] Butaro Hosp, Dept Med, Butaro, Northern Provin, Rwanda; [Umurungi, Jean Paul de Charles] Univ New S Wales, Dept Publ Hlth, Randwick, NSW, Australia; [Shah, Sachita P.] Univ Washington, Med Ctr, Div Emergency Med, Seattle, WA 98195 USA; [Drobac, Peter C.] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Drobac, Peter C.] Partners Hlth Inshuti Mu Buzima, Res Dept, Rwinkwavu, Eastern Provinc, Rwanda	Brown University; University of Toronto; Brown University; University of New South Wales Sydney; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital	Levine, AC (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.	adam_levine@brown.edu	; Levine, Adam/F-1813-2016	Glavis-Bloom, Justin/0000-0002-4879-1572; Levine, Adam/0000-0003-3982-3824	National Institutes of Health Fogarty International Center; Thrasher Research Fund; Rhode Island Foundation; Brown University Department of Emergency Medicine; FOGARTY INTERNATIONAL CENTER [K01TW009208] Funding Source: NIH RePORTER	National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Thrasher Research Fund; Rhode Island Foundation; Brown University Department of Emergency Medicine; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Funding for this study was provided by the National Institutes of Health Fogarty International Center, the Thrasher Research Fund, the Rhode Island Foundation, and the Brown University Department of Emergency Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey B, 2010, ACAD EMERG MED, V17, P583, DOI 10.1111/j.1553-2712.2010.00767.x; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Churgay CA, 2012, AM FAM PHYSICIAN, V85, P1059; Colletti JE, 2010, J EMERG MED, V38, P686, DOI 10.1016/j.jemermed.2008.06.015; Duggan C, 1996, J PEDIATR GASTR NUTR, V22, P56, DOI 10.1097/00005176-199601000-00009; Fonseca BK, 2004, ARCH PEDIAT ADOL MED, V158, P483, DOI 10.1001/archpedi.158.5.483; Frifdman JN, 2004, J PEDIATR-US, V145, P201, DOI 10.1016/j.jpeds.2004.05.035; Goldman RD, 2008, PEDIATRICS, V122, P545, DOI 10.1542/peds.2007-3141; Gorelick MH, 1997, PEDIATRICS, V99, DOI 10.1542/peds.99.5.e6; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; King Caleb K, 2003, MMWR Recomm Rep, V52, P1; Kinlin LM, 2012, PEDIATRICS, V129, pE1211, DOI 10.1542/peds.2011-2985; Lamberti LM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-276; Levine AC, 2010, ACAD EMERG MED, V17, P1035, DOI 10.1111/j.1553-2712.2010.00830.x; Mo Health, 2012, RWAND DEM HLTH SURV; Organization WG, 2008, WGO PRACT GUID AC DI; Organization WH, 2005, TREATM DIARRH MAN PH; Organization WH, 2005, DEV DOCAAHA; Parkin PC, 2010, CLIN PEDIATR, V49, P235, DOI 10.1177/0009922809336670; Pringle K, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-58; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Steiner MJ, 2004, JAMA-J AM MED ASSOC, V291, P2746, DOI 10.1001/jama.291.22.2746; Trieu TV, 2013, PRESSE MED, V42, P60, DOI 10.1016/j.lpm.2012.10.012; Vega RM, 1997, PEDIATR EMERG CARE, V13, P179, DOI 10.1097/00006565-199706000-00001; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Woolley W, 2009, PEDIAT HLTH, V3, P191, DOI [10.2217/phe.09.10, DOI 10.2217/PHE.09.10]; World Health Organization, 2005, LIVRE POCHE SOINS HO	27	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82386	10.1371/journal.pone.0082386	http://dx.doi.org/10.1371/journal.pone.0082386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24349271	Green Published, Green Submitted, gold			2022-12-27	WOS:000327947800097
J	Cao, XL; Li, H; Yu, XL; Liang, P; Dong, BW; Fan, J; Li, M; Liu, FY				Cao, Xiao-lin; Li, Hua; Yu, Xiao-ling; Liang, Ping; Dong, Bao-wei; Fan, Jin; Li, Meng; Liu, Fang-yi			Predicting Early Intrahepatic Recurrence of Hepatocellular Carcinoma after Microwave Ablation Using SELDI-TOF Proteomic Signature	PLOS ONE			English	Article							MASS-SPECTROMETRY; PANCREATIC-CANCER; HEPATIC RESECTION; SERUM; DISCOVERY; PROTEIN; IDENTIFICATION; ULTRASOUND; BIOMARKERS; MS	Background/Aims: Despite great progress in the treatment of hepatocellular carcinoma (HCC) over the last-decade, intrahepatic recurrence is still the most frequent serious adverse event after all the treatments including microwave ablation. This study aimed to predict early recurrence of HCC after microwave ablation using serum proteomic signature. Methods: After curative microwave ablation of HCC, 86 patients were followed-up for 1 year. Serum samples were collected before microwave ablation. The mass spectra of proteins were generated using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS). Serum samples from 50 patients were randomly selected as a training set and for biomarkers discovery and model development. The remaining serum samples were categorized for validation of the algorithm. Results: According to preablation serum protein profiling obtained from the 50 HCC samples in the training set, nine significant differentially-expressed proteins were detected in the serum samples between recurrent and non-recurrent patients. Decision classification tree combined with three candidate proteins with m/z values of 7787, 6858 and 6646 was produced using Biomarker Patterns Software with sensitivity of 85.7% and specificity of 88.9% in the training set. When the SELDI marker pattern was tested with the blinded testing set, it yielded a sensitivity of 80.0%, a specificity of 88.5% and a positive predictive value of 86.1%. Conclusions: Differentially-expressed protein peaks in preablation serum screened by SELDI are associated with prognosis of HCC. The decision classification tree is a potential tool in predicting early intrahepatic recurrence in HCC patients after microwave ablation.	[Cao, Xiao-lin; Li, Hua; Yu, Xiao-ling; Liang, Ping; Dong, Bao-wei; Fan, Jin; Li, Meng; Liu, Fang-yi] Peoples Liberat Army, Gen Hosp, Dept Intervent Ultrasound, Beijing, Peoples R China; [Cao, Xiao-lin] Peoples Liberat Army, Gen Hosp, Dept Ultrasound, Southern Bldg Clin Div, Beijing, Peoples R China; [Li, Hua] Chinese Peoples Liberat Army, Hosp 306, Dept Ultrasound, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Yu, XL (corresponding author), Peoples Liberat Army, Gen Hosp, Dept Intervent Ultrasound, Beijing, Peoples R China.	dyuxl301@aliyun.com; liangping301@hotmail.com			National Scientific Foundation Committee of China [30825010, 81071210]	National Scientific Foundation Committee of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Scientific Foundation Committee of China (grant numbers 30825010, 81071210). The URL of the funder's website is http://www.nsfc.gov.cn/Portal0/default152.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albitar M, 2006, CANCER, V106, P1587, DOI 10.1002/cncr.21770; Aramaki M, 2004, HEPATO-GASTROENTEROL, V51, P1784; Buhimschi CS, 2007, PLOS MED, V4, P84, DOI 10.1371/journal.pmed.0040018; Catala V, 2007, EUR RADIOL, V17, P1066, DOI 10.1007/s00330-006-0444-6; Chignard N, 2004, GASTROENTEROLOGY, V127, pS120, DOI 10.1053/j.gastro.2004.09.025; Gilbert Kate, 2004, Methods Mol Biol, V264, P259; Hashimoto K, 2005, CANCER-AM CANCER SOC, V103, P1856, DOI 10.1002/cncr.20976; He QY, 2008, J CELL BIOCHEM, V103, P740, DOI 10.1002/jcb.21443; Imura S, 2012, SURG TODAY, V42, P35, DOI 10.1007/s00595-011-0006-7; Kuwata H, 1998, BIOCHEM BIOPH RES CO, V245, P764, DOI 10.1006/bbrc.1998.8466; Langbein S, 2006, TECHNOL CANCER RES T, V5, P67, DOI 10.1177/153303460600500109; Liang P, 2007, ONCOLOGY-BASEL, V72, P124, DOI 10.1159/000111718; Liang P, 2012, GUT, V61, P1100, DOI 10.1136/gutjnl-2011-300975; Liotta LA, 2003, NATURE, V425, P905, DOI 10.1038/425905a; Liu FY, 2011, INT J HYPERTHER, V27, P555, DOI 10.3109/02656736.2011.564262; Navaglia F, 2009, CLIN CHEM LAB MED, V47, P713, DOI 10.1515/CCLM.2009.158; Okuda K, 2000, J HEPATOL, V32, P225, DOI 10.1016/S0168-8278(00)80428-6; Ostroff RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046091; Paradis V, 2005, HEPATOLOGY, V41, P40, DOI 10.1002/hep.20505; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Purohit S, 2006, PROTEOMICS, V6, P6405, DOI 10.1002/pmic.200600420; Schwegler EE, 2005, HEPATOLOGY, V41, P634, DOI 10.1002/hep.20577; Semmes OJ, 2006, J CELL BIOCHEM, V98, P496, DOI 10.1002/jcb.20855; Solbiati L, 2004, EUR RADIOL, V14, pP34, DOI 10.1007/s10406-004-0089-y; Steel LF, 2001, DIS MARKERS, V17, P179, DOI 10.1155/2001/963023; Taguchi A, 2011, CANCER CELL, V20, P289, DOI 10.1016/j.ccr.2011.08.007; Tsunedomi R, 2008, CLIN CANCER RES, V14, P1025, DOI 10.1158/1078-0432.CCR-07-1116; Vascotto C, 2006, PROTEOMICS, V6, P3455, DOI 10.1002/pmic.200500770; Veltri A, 2012, RADIOL MED, V117, P378, DOI 10.1007/s11547-011-0745-y; Wang Y, 2008, EUR J RADIOL, V67, P357, DOI 10.1016/j.ejrad.2007.07.015; Wang ZL, 2008, J GASTROINTEST SURG, V12, P327, DOI 10.1007/s11605-007-0310-0; Ward DG, 2006, BRIT J CANCER, V94, P287, DOI 10.1038/sj.bjc.6602923; Wulfkuhle JD, 2003, NAT REV CANCER, V3, P267, DOI 10.1038/nrc1043; Xue AQ, 2012, PANCREATOLOGY, V12, P124, DOI 10.1016/j.pan.2012.02.009; Yamashiki N, 2007, J GASTROEN HEPATOL, V22, P2155, DOI 10.1111/j.1440-1746.2006.04732.x; Zeindl-Eberhart E, 2004, HEPATOLOGY, V39, P540, DOI 10.1002/hep.20060	38	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82448	10.1371/journal.pone.0082448	http://dx.doi.org/10.1371/journal.pone.0082448			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349287	Green Submitted, Green Published, gold			2022-12-27	WOS:000328734200044
J	Gurusamy, KS; Wilson, E; Koretz, RL; Allen, VB; Davidson, BR; Burroughs, AK; Gluud, C				Gurusamy, Kurinchi S.; Wilson, Edward; Koretz, Ronald L.; Allen, Victoria B.; Davidson, Brian R.; Burroughs, Andrew K.; Gluud, Christian			Is Sustained Virological Response a Marker of Treatment Efficacy in Patients with Chronic Hepatitis C Viral Infection with No Response or Relapse to Previous Antiviral Intervention?	PLOS ONE			English	Article							NATURAL-HISTORY; INTERFERON THERAPY; HEPATOCELLULAR-CARCINOMA; SPONTANEOUS CLEARANCE; VIRUS-INFECTION; RISK; COHORT; TRANSMISSION; EPIDEMIOLOGY; PREDICTION	Background: Randomised clinical trials (RCTs) of antiviral interventions in patients with chronic hepatitis C virus (HCV) infection use sustained virological response (SVR) as the main outcome. There is sparse information on long-term mortality from RCTs. Methods: We created a decision tree model based on a Cochrane systematic review on interferon retreatment for patients who did not respond to initial therapy or who relapsed following SVR. Extrapolating data to 20 years, we modelled the outcome from three scenarios: (1) observed medium-term (5 year) annual mortality rates continue to the long term (20 years); (2) long-term annual mortality in retreatment responders falls to that of the general population while retreatment non-responders continue at the medium-term mortality; (3) long-term annual mortality in retreatment non-responders is the same as control group non-responders (i.e., the increased treatment-related medium mortality "wears off"). Results: The mean differences in life expectancy over 20 years with interferon versus control in the first, second, and third scenarios were -0.34 years (95% confidence interval (CI) -0.71 to 0.03), -0.23 years (95% CI -0.69 to 0.24), and -0.01 (95% CI -0.3 to 0.27), respectively. The life expectancy was always lower in the interferon group than in the control group in scenario 1. In scenario 3, the interferon group had a longer life expectancy than the control group only when more than 7% in the interferon group achieved SVR. Conclusions: SVR may be a good prognostic marker but does not seem to be a valid surrogate marker for assessing HCV treatment efficacy of interferon retreatment. The SVR threshold at which retreatment increases life expectancy may be different for different drugs depending upon the adverse event profile and treatment efficacy. This has to be determined for each drug by RCTs and appropriate modelling before SVR can be accepted as a surrogate marker.	[Gurusamy, Kurinchi S.; Allen, Victoria B.; Davidson, Brian R.] UCL, Dept Surg, London, England; [Wilson, Edward] Univ E Anglia, Hlth Econ Grp, Norwich NR4 7TJ, Norfolk, England; [Wilson, Edward] Univ Cambridge, Cambridge Ctr Hlth Serv Res, Cambridge, England; [Koretz, Ronald L.] Cochrane Hepato Biliary Grp, Granada Hills, CA USA; [Burroughs, Andrew K.] Royal Free Hosp, Sheila Sherlock Liver Ctr, London NW3 2QG, England; [Burroughs, Andrew K.] Royal Free Hosp, Inst Liver & Digest Hlth, London NW3 2QG, England; [Burroughs, Andrew K.] UCL, London, England; [Gluud, Christian] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Cochrane Hepatobiliary Grp,Copenhagen Trial Unit, Copenhagen, Denmark	University of London; University College London; University of East Anglia; University of Cambridge; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Rigshospitalet; University of Copenhagen	Gurusamy, KS (corresponding author), UCL, Dept Surg, London, England.	kurinchi2k@hotmail.com	Gluud, Christian/AAY-1027-2021; Gluud, Christian/HGB-3191-2022; Wilson, Ed/P-4310-2019; Burroughs, Andrew K/C-5645-2009	Gluud, Christian/0000-0002-8861-0799; Wilson, Ed/0000-0002-8369-1577; Burroughs, Andrew K/0000-0001-6527-457X; Gurusamy, Kurinchi/0000-0002-0313-9134				Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Beinhardt S, 2012, GASTROENTEROLOGY, V142, P78, DOI 10.1053/j.gastro.2011.09.039; Beltrami EM, 2000, CLIN MICROBIOL REV, V13, P385, DOI 10.1128/CMR.13.3.385-407.2000; Brok J, 2010, COCHRANE DB SYST REV; Bucher HC, 1999, JAMA-J AM MED ASSOC, V282, P771, DOI 10.1001/jama.282.8.771; Buxton MJ, 1997, HEALTH ECON, V6, P217, DOI 10.1002/(SICI)1099-1050(199705)6:3<217::AID-HEC267>3.0.CO;2-W; Chou R, 2013, ANN INTERN MED, V158, P114, DOI 10.7326/0003-4819-158-2-201301150-00576; Fergusson DA, 2008, NEW ENGL J MED, V358, P2319, DOI 10.1056/NEJMoa0802395; Gluud C, 2007, J HEPATOL, V46, P734, DOI 10.1016/j.jhep.2007.01.003; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; HM Treasury, 2003, GREEN BOOK APPR EV C; Imai Y, 2010, J VIRAL HEPATITIS, V17, P185, DOI 10.1111/j.1365-2893.2009.01163.x; Imazeki F, 2003, HEPATOLOGY, V38, P493, DOI 10.1053/jhep.2003.50329; Jadad AR, 1998, JAMA-J AM MED ASSOC, V280, P278, DOI 10.1001/jama.280.3.278; Jafari S, 2010, INT J INFECT DIS, V14, pE928, DOI 10.1016/j.ijid.2010.03.019; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Keus F, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-90; Kleinman SH, 2009, TRANSFUSION, V49, P2454, DOI 10.1111/j.1537-2995.2009.02322.x; Kong Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052158; KORETZ RL, 2013, COCHRANE DB SYST REV, V1, P3617; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lehmann M, 2004, J MED VIROL, V73, P387, DOI 10.1002/jmv.20103; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Maruoka D, 2012, J GASTROEN HEPATOL, V27, P291, DOI 10.1111/j.1440-1746.2011.06871.x; *MHRA, 2007, APR TRAS SUSP UK MAR; Myers RP, 2002, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000370; Ng V, 2011, CLIN GASTROENTEROL H, V9, P923, DOI 10.1016/j.cgh.2011.05.028; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Office of National Statistics, 2011, INT LIF TABL 2008 20; Pineda JA, 2010, CLIN INFECT DIS, V51, P788, DOI 10.1086/656235; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Rodger AJ, 2000, HEPATOLOGY, V32, P582, DOI 10.1053/jhep.2000.9714; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Sangiovanni A, 2006, HEPATOLOGY, V43, P1303, DOI 10.1002/hep.21176; Seeff LB, 2009, LIVER INT, V29, P89, DOI 10.1111/j.1478-3231.2008.01927.x; Syriopoulou V, 2005, SCAND J INFECT DIS, V37, P350, DOI 10.1080/00365540510032105; Tanaka H, 2000, INT J CANCER, V87, P741, DOI 10.1002/1097-0215(20000901)87:5&lt;741::AID-IJC18&gt;3.0.CO;2-B; Tohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808; Tohra SK, 2011, DIGEST DIS SCI, V56, P2449, DOI 10.1007/s10620-011-1770-3; *US FDA, 2011, FDA APPR INC HEP C; Wawrzynowicz-Syczewska M, 2004, INFECTION, V32, P138, DOI 10.1007/s15010-004-3062-8; Wiese M, 2005, J HEPATOL, V43, P590, DOI 10.1016/j.jhep.2005.04.007; Xia X, 2008, PUBLIC HEALTH, V122, P990, DOI 10.1016/j.puhe.2008.01.014; Yudkin JS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7995	44	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83313	10.1371/journal.pone.0083313	http://dx.doi.org/10.1371/journal.pone.0083313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349487	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000328731800111
J	Li, L; Yang, BY; Yu, SF; Zhang, XL; Lao, SH; Wu, CY				Li, Li; Yang, Binyan; Yu, Sifei; Zhang, Xianlan; Lao, Suihua; Wu, Changyou			Human CD8(+) T Cells from TB Pleurisy Respond to Four Immunodominant Epitopes in Mtb CFP10 Restricted by HLA-B Alleles	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; LYMPHOCYTE RESPONSES; TUBERCULOSIS; ANTIGENS; IDENTIFICATION; CD4(+); ESAT-6; METAANALYSIS; SPECIFICITY; INFECTION	CD8(+) T cells are essential for host defense to Mycobacterium tuberculosis (Mtb) infection and identification of CD8(+) T cell epitopes from Mtb is of importance for the development of effective peptide-based diagnostics and vaccines. We previously demonstrated that the secreted 10-KDa culture filtrate protein (CFP10) from Mtb is a potent CD8(+) T cell antigen but the repertoire and dominance pattern of human CD8 epitopes for CFP10 remained poorly characterized. In the present study, we undertook to define immunodominant CD8 epitopes involved in CFP10 using a panel of CFP10-derived 13-15 amino acid (aa) peptides overlapping by 11 aa. Four peptides in CFP10 were observed to induce significant CD8(+) T cell responses and we further determined the size of the epitopes involved in each individual peptide tested. Four 9 aa CD8 epitopes were finally identified and deleting a single amino acid from the N or C terminus of either peptide markedly reduced IFN-gamma production, suggesting that they are minimum of CD8 epitopes. In the individuals tested, each epitope represented a single immunodominant response in CD8(+) T cells. The epitope-specific CD8(+) T cells displayed effector or effector memory phenotypes and could upregulate the expression of CD107a/b upon antigen stimulation. In addition, we found that epitope-specific CD8(+) T cells shared biased usage of T cell receptor (TCR) variable region of beta chain (V beta) 12, 9, 7.2 or V beta 4 chains. As judged from HLA-typing results and using bioinformatics technology for prediction of MHC binding affinity, we found that the epitope-specific CD8(+) T cells are all restricted by HLA-B alleles. Our findings suggest that the four epitopes in CFP10 recognized by CD8(+) T cells might be of importance for the development of Mtb peptide-based vaccines and for improved diagnosis of TB in humans.	[Li, Li; Yang, Binyan; Yu, Sifei; Wu, Changyou] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control Res, Inst Immunol,Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Xianlan; Lao, Suihua] Chest Hosp Guangzhou, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Wu, CY (corresponding author), Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control Res, Inst Immunol,Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China.	changyou_wu@yahoo.com			introduction of innovative R&D team program of Guangdong Province [2009010058]; National Natural Science Foundation of China [31100632]; Foundation of Guangzhou Pearl River Science New Star [2011J2200078]; Natural Science Foundation of Guangdong Province [S2011040004322, S2012010009159]; Graduate Education Innovation Training Project of Guangdong Province [sybzzxm201108]	introduction of innovative R&D team program of Guangdong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Guangzhou Pearl River Science New Star; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Graduate Education Innovation Training Project of Guangdong Province	This work was funded by the introduction of innovative R&D team program of Guangdong Province (No. 2009010058), the National Natural Science Foundation of China (31100632), the Foundation of Guangzhou Pearl River Science New Star (2011J2200078), Natural Science Foundation of Guangdong Province (S2011040004322, S2012010009159) and Graduate Education Innovation Training Project of Guangdong Province(sybzzxm201108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend SM, 2000, INFECT IMMUN, V68, P3314, DOI 10.1128/IAI.68.6.3314-3321.2000; Berthet FX, 1998, MICROBIOL-UK, V144, P3195, DOI 10.1099/00221287-144-11-3195; Billeskov R, 2007, J IMMUNOL, V179, P3973, DOI 10.4049/jimmunol.179.6.3973; Brewer TF, 2000, CLIN INFECT DIS, V31, pS64, DOI 10.1086/314072; Caccamo N, 2002, J INFECT DIS, V186, P991, DOI 10.1086/344174; Canaday DH, 2001, J IMMUNOL, V167, P2734, DOI 10.4049/jimmunol.167.5.2734; Charo J, 2001, EUR J IMMUNOL, V31, P3602, DOI 10.1002/1521-4141(200112)31:12<3602::AID-IMMU3602>3.0.CO;2-L; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Douek DC, 2002, J IMMUNOL, V168, P3099, DOI 10.4049/jimmunol.168.6.3099; Geluk A, 2000, J IMMUNOL, V165, P6463, DOI 10.4049/jimmunol.165.11.6463; Heinzel AS, 2002, J EXP MED, V196, P1473, DOI 10.1084/jem.20020609; Jacobsen M, 2007, J IMMUNOL, V179, P1331, DOI 10.4049/jimmunol.179.2.1331; KAUFMANN SHE, 1994, IMMUNOBIOLOGY, V191, P509, DOI 10.1016/S0171-2985(11)80457-2; Klein MR, 2002, INFECT IMMUN, V70, P981, DOI 10.1128/IAI.70.2.981-984.2002; Klein MR, 2001, J INFECT DIS, V183, P928, DOI 10.1086/319267; Klenerman P, 1998, NATURE, V394, P482, DOI 10.1038/28860; KOCHI A, 1991, TUBERCLE, V72, P1, DOI 10.1016/0041-3879(91)90017-M; Lalvani A, 2001, J INFECT DIS, V183, P469, DOI 10.1086/318081; Lalvani T, 1998, P NATL ACAD SCI USA, V95, P270, DOI 10.1073/pnas.95.1.270; Lazarevic V, 2002, AM J RESP CRIT CARE, V166, P1116, DOI 10.1164/rccm.2204027; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; Lewinsohn DM, 2001, J IMMUNOL, V166, P439, DOI 10.4049/jimmunol.166.1.439; Mohagheghpour N, 1998, J IMMUNOL, V161, P2400; Orme IM, 1996, CURR TOP MICROBIOL, V215, P181; Pantaleo G, 1997, P NATL ACAD SCI USA, V94, P254, DOI 10.1073/pnas.94.1.254; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Qiao D, 2011, INFECT IMMUN, V79, P3358, DOI 10.1128/IAI.00014-11; Reed S, 2005, MICROBES INFECT, V7, P922, DOI 10.1016/j.micinf.2005.03.011; Renshaw PS, 2002, J BIOL CHEM, V277, P21598, DOI 10.1074/jbc.M201625200; Shams H, 2004, J IMMUNOL, V173, P1966, DOI 10.4049/jimmunol.173.3.1966; Skjot RLV, 2001, SCAND J INFECT DIS, V33, P643, DOI 10.1080/00365540110026971; Smith SM, 2000, J IMMUNOL, V165, P7088, DOI 10.4049/jimmunol.165.12.7088; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Tan JS, 1997, J IMMUNOL, V159, P290; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Weichold FF, 2007, GENES IMMUN, V8, P334, DOI 10.1038/sj.gene.6364392; WILSON RK, 1988, IMMUNOL REV, V101, P149, DOI 10.1111/j.1600-065X.1988.tb00736.x; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799	38	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82196	10.1371/journal.pone.0082196	http://dx.doi.org/10.1371/journal.pone.0082196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349220	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800047
J	Tian, Y; Tao, TZ; Zhu, JL; Zou, Y; Wang, JF; Li, JB; Bo, LL; Deng, XM				Tian, Ye; Tao, Tianzhu; Zhu, Jiali; Zou, Yun; Wang, Jiafeng; Li, Jinbao; Bo, Lulong; Deng, Xiaoming			Soluble Tumor Necrosis Factor Related Apoptosis Inducing Ligand Level as a Predictor of Severity of Sepsis and the Risk of Mortality in Septic Patients	PLOS ONE			English	Article							TRAIL; EXPRESSION; IMMUNOSUPPRESSION; APO2L/TRAIL; SURVIVAL; IMPROVES; DISEASE; KIDNEY; DEATH; CELLS	Background: Tumor necrosis factor related apoptosis inducing ligand (TRAIL) as a member of the TNF gene superfamily induces apoptosis primarily in tumor cells. TRAIL also plays an important role in the modulation of inflammatory responses, especially in the process of immune paralysis. The aim of the present study was to examine soluble TRAIL (sTRAIL) levels in septic patients in an attempt to explore the association between sTRAIL level and the risk of mortality. Methods: Plasma sTRAIL levels were detected by ELISA in 50 septic patients and 20 healthy volunteers. HLA-DR expression in monocytes was detected by flow cytometry. Selective biochemical parameters were recorded, and patients were monitored in a 28-day period for mortality. Results: The mean plasma sTRAIL level in septic patients was significantly lower than that in healthy controls (16.9 +/- 8.3 vs. 68.3 +/- 8.6 pg/ml, P<0.01), and was significantly higher in 28-day survivors than those in non-survivors (19.4 +/- 9.8 vs. 13.9 +/- 4.7 pg/ml, P<0.05). Univariate analysis indicated that plasma sTRAIL level was positively correlated with monocyte and lymphocyte counts and HLA-DR expression level (r = 0.5, P<0.01; r = 0.3, P<0.05; r = 0.43, P<0.01, respectively). STRAIL level was negatively correlated with APACHE II score, BUN and age (r = -0.48, P<0.01; r = -0.29, P<0.05; r = -0.45, P<0.01, respectively). Multiple linear regression analysis indicated that the predictor of plasma soluble TRAIL level was HLA-DR expression (P<0.01). Conclusion: Low plasma sTRAIL levels were associated with immune paralysis and a high risk of mortality in patients with septic shock. sTRAIL may prove to be a potential biomarker of immune function and predict the survival of septic patients.	[Tian, Ye; Tao, Tianzhu; Zhu, Jiali; Zou, Yun; Wang, Jiafeng; Li, Jinbao; Bo, Lulong; Deng, Xiaoming] Second Mil Med Univ, Changhai Hosp, Dept Anesthesiol & Intens Care, Shanghai, Peoples R China; [Tian, Ye] Naval Gen Hosp, Dept Anesthesiol, Beijing, Peoples R China	Naval Medical University	Bo, LL (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Anesthesiol & Intens Care, Shanghai, Peoples R China.	nbastars@126.com; deng_x@yahoo.com	Deng, Xiaoming/E-2876-2010	Tao, Tianzhu/0000-0001-6853-1324; Wang, Jia-feng/0000-0002-1753-6499; Tian, Ye/0000-0002-2908-6122	National Natural Science Foundation of China [81272065, 81171788, 81201492]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the research grants from National Natural Science Foundation of China (Grant No. 81272065, No. 81171788 and No. 81201492). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anel A, 2011, RECENT PATENTS INFLA, V5, P184, DOI 10.2174/187221311797264883; [Anonymous], 2009, CHEST; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Cho YS, 2010, IMMUNOLOGY, V130, P504, DOI 10.1111/j.1365-2567.2010.03266.x; Cziupka K, 2010, CRIT CARE MED, V38, P2169, DOI 10.1097/CCM.0b013e3181eedaa8; Gonzalvez F, 2010, ONCOGENE, V29, P4752, DOI 10.1038/onc.2010.221; Gurung P, 2011, J IMMUNOL, V187, P2148, DOI 10.4049/jimmunol.1101180; Halaas O, 2000, SCAND J IMMUNOL, V51, P244; Herbeuval JP, 2005, BLOOD, V105, P2458, DOI 10.1182/blood-2004-08-3058; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Kasten KR, 2010, SHOCK, V34, P377, DOI 10.1097/SHK.0b013e3181dc0845; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liabeuf S, 2010, NEPHROL DIAL TRANSPL, V25, P2596, DOI 10.1093/ndt/gfq042; Lopez-Gomez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021766; Lyn-Kew K, 2008, CURR PHARM DESIGN, V14, P1870, DOI 10.2174/138161208784980545; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mori K, 2010, THROMB RES, V125, P322, DOI 10.1016/j.thromres.2009.11.024; Naved SA, 2011, JCPSP-J COLL PHYSICI, V21, P4, DOI 01.2011/JCPSP.0408; Renshaw SA, 2003, J IMMUNOL, V170, P1027, DOI 10.4049/jimmunol.170.2.1027; Shaker OG, 2010, ANGIOLOGY, V61, P756, DOI 10.1177/0003319710370961; Song CJ, 2004, TRANSPL P, V36, P1340, DOI 10.1016/j.transproceed.2004.05.005; Stary G, 2009, BLOOD, V114, P3854, DOI 10.1182/blood-2009-04-217927; Unsinger J, 2010, J IMMUNOL, V184, P6766, DOI 10.4049/jimmunol.0904054; Wu GS, 1999, CANCER RES, V59, P2770; Zhang Y, 2010, CRIT CARE, V14, DOI 10.1186/cc9354	26	13	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82204	10.1371/journal.pone.0082204	http://dx.doi.org/10.1371/journal.pone.0082204			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349222	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800048
J	Cilvik, SN; Wang, JI; Lavine, KJ; Uchida, K; Castro, A; Gierasch, CM; Weinheimer, CJ; House, SL; Kovacs, A; Nichols, CG; Ornitz, DM				Cilvik, Sarah N.; Wang, Joy I.; Lavine, Kory J.; Uchida, Keita; Castro, Angela; Gierasch, Carolyn M.; Weinheimer, Carla J.; House, Stacey L.; Kovacs, Attila; Nichols, Colin G.; Ornitz, David M.			Fibroblast Growth Factor Receptor 1 Signaling in Adult Cardiomyocytes Increases Contractility and Results in a Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; PROTEIN PHOSPHATASE; GENE-EXPRESSION; TROPONIN-I; VENTRICULAR MYOCYTES; MICE; CALCIUM; INHIBITOR; MUSCLE; HEART	Fibroblast growth factors (FGFs) and their receptors are highly conserved signaling molecules that have been implicated in postnatal cardiac remodeling. However, it is not known whether cardiomyocyte-expressed FGF receptors are necessary or sufficient for ventricular remodeling in the adult heart. To determine whether cardiomyocytes were competent to respond to an activated FGF receptor, and to determine if this signal would result in the development of hypertrophy, we engineered a doxycycline (DOX)-inducible, cardiomyocyte-specific, constitutively active FGF receptor mouse model (alpha MHC-rtTA, TRE-caFgfr1-myc). Echocardiographic and hemodynamic analysis indicated that acute expression of caFGFR1 rapidly and directly increased cardiac contractility, while chronic expression resulted in significant hypertrophy with preservation of systolic function. Subsequent histologic analysis showed increased cardiomyocyte cross-sectional area and regions of myocyte disarray and fibrosis, classic features of hypertrophic cardiomyopathy (HCM). Analysis of downstream pathways revealed a lack of clear activation of classical FGF-mediated signaling pathways, but did demonstrate a reduction in Serca2 expression and troponin I phosphorylation. Isolated ventricular myocytes showed enhanced contractility and reduced relaxation, an effect that was partially reversed by inhibition of actin-myosin interactions. We conclude that adult cardiomyocytes are competent to transduce FGF signaling and that FGF signaling is sufficient to promote increased cardiomyocyte contractility in vitro and in vivo through enhanced intrinsic actin-myosin interactions. Longterm, FGFR overexpression results in HCM with a dynamic outflow tract obstruction, and may serve as a unique model of HCM.	[Cilvik, Sarah N.; Wang, Joy I.; Castro, Angela; House, Stacey L.; Ornitz, David M.] Washington Univ, Dept Dev Biol, Sch Med, St Louis, MO 63130 USA; [Lavine, Kory J.; Gierasch, Carolyn M.; Weinheimer, Carla J.; Kovacs, Attila] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Uchida, Keita; Nichols, Colin G.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [House, Stacey L.] Washington Univ, Sch Med, Div Emergency Med, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Ornitz, DM (corresponding author), Washington Univ, Dept Dev Biol, Sch Med, St Louis, MO 63130 USA.	dornitz@wustl.edu	Cilvik, Sarah/AAO-6507-2021; Uchida, Keita/I-9099-2016	Cilvik, Sarah/0000-0003-4673-1186; Uchida, Keita/0000-0001-8458-9796; Ornitz, David/0000-0003-1592-7629	National Institutes of Health [HL105732, HL45742, P30 AR057235]; American Heart Association [0910110G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105732, R01HL045742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057235] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grant HL105732 (D. Ornitz), American Heart Association grant 0910110G (S. Cilvik), and National Institutes of Health grant HL45742 (C. Nichols). Transgenic mouse production was made possible through the Washington University Musculoskeletal Research Center (National Institutes of Health grant P30 AR057235). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ather S, 2013, BIOCHIM BIOPHYS ACTA; BACKX PH, 1994, J PHYSIOL-LONDON, V476, P487, DOI 10.1113/jphysiol.1994.sp020149; Barry SP, 2008, INT J BIOCHEM CELL B, V40, P2023, DOI 10.1016/j.biocel.2008.02.020; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Burkhoff D, 2005, AM J PHYSIOL-HEART C, V289, pH501, DOI 10.1152/ajpheart.00138.2005; Deshmukh PA, 2007, AM J PHYSIOL-HEART C, V292, pH792, DOI 10.1152/ajpheart.00225.2006; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Fifer MA, 2008, CIRCULATION, V117, P429, DOI 10.1161/CIRCULATIONAHA.107.694158; Flagg TP, 2009, CIRC RES, V104, P95, DOI 10.1161/CIRCRESAHA.108.186809; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Ho Carolyn Y, 2010, Heart Fail Clin, V6, P141, DOI 10.1016/j.hfc.2009.12.001; House Stacey L, 2010, Mol Cell Pharmacol, V2, P143; IZUMO S, 1988, P NATL ACAD SCI USA, V85, P339, DOI 10.1073/pnas.85.2.339; IZUMO S, 1987, J CLIN INVEST, V79, P970, DOI 10.1172/JCI112908; Jideama NM, 2006, INT J BIOL SCI, V2, P1; Kaye D, 1996, J CLIN INVEST, V97, P281, DOI 10.1172/JCI118414; Koitabashi N, 2012, NAT REV CARDIOL, V9, P147, DOI 10.1038/nrcardio.2011.172; Kolupaeva V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003447; Korf-Klingebiel M, 2011, CIRCULATION, V123, P504, DOI 10.1161/CIRCULATIONAHA.110.989665; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Li HL, 2010, P NATL ACAD SCI USA, V107, P13818, DOI 10.1073/pnas.1008397107; LOMPRE AM, 1991, INT REV CYTOL, V124, P137; Marian AJ, 2009, TEX HEART I J, V36, P194; Meguro T, 1999, CIRC RES, V84, P735, DOI 10.1161/01.RES.84.6.735; Naski MC, 1996, NAT GENET, V13, P233, DOI 10.1038/ng0696-233; Pellieux C, 2001, J CLIN INVEST, V108, P1843, DOI 10.1172/JCI200113627; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Saucerman JJ, 2006, ANN NY ACAD SCI, V1080, P348, DOI 10.1196/annals.1380.026; Scheinowitz M, 1998, INT J CARDIOL, V63, P217, DOI 10.1016/S0167-5273(97)00322-7; Schoenfeld JR, 1998, J MOL CELL CARDIOL, V30, P2269, DOI 10.1006/jmcc.1998.0787; Schultz JE, 1999, J CLIN INVEST, V104, P709, DOI 10.1172/JCI7315; SCHWARTZ K, 1986, CIRC RES, V59, P551, DOI 10.1161/01.RES.59.5.551; Semsarian C, 2002, J CLIN INVEST, V109, P1013, DOI 10.1172/JCI200214677; Teekakirikul P, 2010, J CLIN INVEST, V120, P3520, DOI 10.1172/JCI42028; Teranishi F, 2009, CANCER SCI, V100, P770, DOI 10.1111/j.1349-7006.2009.01084.x; Tidyman William E., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000902; Tsoutsman T, 2006, CLIN EXP PHARMACOL P, V33, P139, DOI 10.1111/j.1440-1681.2006.04340.x; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Valencik ML, 2001, TRANSGENIC RES, V10, P269, DOI 10.1023/A:1016601928465; Van den Bosch BJC, 2006, GENOMICS, V88, P480, DOI 10.1016/j.ygeno.2006.04.012; Virag JAI, 2007, AM J PATHOL, V171, P1431, DOI 10.2353/ajpath.2007.070003; Wang YC, 2012, J BIOL CHEM, V287, P2156, DOI 10.1074/jbc.M111.294306; Wijnker PJM, 2011, J MUSCLE RES CELL M, V32, P221, DOI 10.1007/s10974-011-9261-x; WINEGRAD S, 1984, CIRC RES, V55, P565, DOI 10.1161/01.RES.55.5.565; Yang F, 2008, BIOCHEM CELL BIOL, V86, P70, DOI [10.1139/O07-150, 10.1139/o07-150]; Yang GP, 2001, J MOL CELL CARDIOL, V33, P1505, DOI 10.1006/jmcc.2001.1413; Zhang HX, 2011, J MOL CELL CARDIOL, V50, P552, DOI 10.1016/j.yjmcc.2010.12.011; Zhang Z, 2009, DEV CELL, V16, P607, DOI 10.1016/j.devcel.2009.02.008; Zheng MZ, 2004, AM J PHYSIOL-HEART C, V286, pH424, DOI 10.1152/ajpheart.00110.2003	53	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82979	10.1371/journal.pone.0082979	http://dx.doi.org/10.1371/journal.pone.0082979			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349409	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300117
J	Clark, TG; Mallard, K; Coll, F; Preston, M; Assefa, S; Harris, D; Ogwang, S; Mumbowa, F; Kirenga, B; O'Sullivan, DM; Okwera, A; Eisenach, KD; Joloba, M; Bentley, SD; Ellner, JJ; Parkhill, J; Jones-Lopez, EC; McNerney, R				Clark, Taane G.; Mallard, Kim; Coll, Francesc; Preston, Mark; Assefa, Samuel; Harris, David; Ogwang, Sam; Mumbowa, Francis; Kirenga, Bruce; O'Sullivan, Denise M.; Okwera, Alphonse; Eisenach, Kathleen D.; Joloba, Moses; Bentley, Stephen D.; Ellner, Jerrold J.; Parkhill, Julian; Jones-Lopez, Edward C.; McNerney, Ruth			Elucidating Emergence and Transmission of Multidrug-Resistant Tuberculosis in Treatment Experienced Patients by Whole Genome Sequencing	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DRUG-RESISTANCE; GENETIC DIVERSITY; KATG MUTATIONS; PAIRED-END; EPIDEMIOLOGY; POLYMORPHISM; DATABASE; STRAINS; ALGORITHM	Background: Understanding the emergence and spread of multidrug-resistant tuberculosis (MDR-TB) is crucial for its control. MDR-TB in previously treated patients is generally attributed to the selection of drug resistant mutants during inadequate therapy rather than transmission of a resistant strain. Traditional genotyping methods are not sufficient to distinguish strains in populations with a high burden of tuberculosis and it has previously been difficult to assess the degree of transmission in these settings. We have used whole genome analysis to investigate M. tuberculosis strains isolated from treatment experienced patients with MDR-TB in Uganda over a period of four years. Methods and Findings: We used high throughput genome sequencing technology to investigate small polymorphisms and large deletions in 51 Mycobacterium tuberculosis samples from 41 treatment-experienced TB patients attending a TB referral and treatment clinic in Kampala. This was a convenience sample representing 69% of MDR-TB cases identified over the four year period. Low polymorphism was observed in longitudinal samples from individual patients (2-15 SNPs). Clusters of samples with less than 50 SNPs variation were examined. Three clusters comprising a total of 8 patients were found with almost identical genetic profiles, including mutations predictive for resistance to rifampicin and isoniazid, suggesting transmission of MDR-TB. Two patients with previous drug susceptible disease were found to have acquired MDR strains, one of which shared its genotype with an isolate from another patient in the cohort. Conclusions: Whole genome sequence analysis identified MDR-TB strains that were shared by more than one patient. The transmission of multidrug-resistant disease in this cohort of retreatment patients emphasises the importance of early detection and need for infection control. Consideration should be given to rapid testing for drug resistance in patients undergoing treatment to monitor the emergence of resistance and permit early intervention to avoid onward transmission.	[Clark, Taane G.; Mallard, Kim; Coll, Francesc; Assefa, Samuel; O'Sullivan, Denise M.; McNerney, Ruth] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England; [Clark, Taane G.; Preston, Mark] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Assefa, Samuel; Harris, David; Bentley, Stephen D.; Parkhill, Julian] Wellcome Trust Sanger Inst, Cambridge, England; [Ogwang, Sam; Mumbowa, Francis] Joint Clin Res Ctr, Kampala, Uganda; [Mumbowa, Francis; Joloba, Moses] Makerere Univ, Dept Med Microbiol, Coll Hlth Sci, Kampala, Uganda; [Kirenga, Bruce; Okwera, Alphonse] Mulago Hosp, Mulago Hosp TB Clin, Kampala, Uganda; [Eisenach, Kathleen D.] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Eisenach, Kathleen D.] Uganda Case Western Reserve Univ Res Collaborat, Kampala, Uganda; [Ellner, Jerrold J.; Jones-Lopez, Edward C.] Boston Med Ctr, Dept Med, Infect Dis Sect, Boston, MA USA; [Ellner, Jerrold J.; Jones-Lopez, Edward C.] Boston Univ, Sch Med, Boston, MA 02118 USA	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Wellcome Trust Sanger Institute; Joint Clinic Research Center - United Arab Emirates; Makerere University; Mulago National Referral Hospital; University of Arkansas System; University of Arkansas Medical Sciences; Case Western Reserve University; Boston Medical Center; Boston University	McNerney, R (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1, England.	Ruth.McNerney@lshtm.ac.uk	Coll, Francesc/V-1980-2019; Clark, Taane G./AAM-2570-2020; Parkhill, Julian/G-4703-2011; Preston, Mark D/P-1429-2015	Coll, Francesc/0000-0002-7882-2325; Clark, Taane G./0000-0001-8985-9265; Parkhill, Julian/0000-0002-7069-5958; Kirenga, Bruce/0000-0002-2023-2840; Preston, Mark D/0000-0002-6506-3104; Jones Lopez, Edward/0000-0001-6323-286X; Joloba, Moses/0000-0002-0334-9983	Wellcome Trust - Burroughs Wellcome Fund Infectious Diseases Initiative grant [063410/ABC/00/Z]; WT grant [098051]	Wellcome Trust - Burroughs Wellcome Fund Infectious Diseases Initiative grant; WT grant	This study was an adjunct to the Wellcome Trust - Burroughs Wellcome Fund Infectious Diseases Initiative grant 063410/ABC/00/Z and was partly funded by WT grant number 098051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2002, INT J TUBERC LUNG D, V6, P523; Ando H, 2010, ANTIMICROB AGENTS CH, V54, P1793, DOI 10.1128/AAC.01691-09; Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Brandis G, 2013, J ANTIMICROB CHEMOTH, V68, P2493, DOI 10.1093/jac/dkt224; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Cohen T, 2003, LANCET INFECT DIS, V3, P13, DOI 10.1016/S1473-3099(03)00483-3; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Coll F, 2012, BIOINFORMATICS, V28, P2991, DOI 10.1093/bioinformatics/bts544; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; de Vos M, 2013, ANTIMICROB AGENTS CH, V57, P827, DOI 10.1128/AAC.01541-12; DeBarber AE, 2000, P NATL ACAD SCI USA, V97, P9677, DOI 10.1073/pnas.97.17.9677; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Dorman SE, 2007, NAT MED, V13, P295, DOI 10.1038/nm0307-295; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Jones-Lopez EC, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000427; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kato-Maeda M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058235; Mallard K, 2010, J CLIN MICROBIOL, V48, P4512, DOI 10.1128/JCM.01683-10; Morlock GP, 2003, ANTIMICROB AGENTS CH, V47, P3799, DOI 10.1128/AAC.47.12.3799-3805.2003; Niemann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007407; Ormerod LP, 2005, BRIT MED BULL, V73-74, P17, DOI 10.1093/bmb/ldh047; Perez-Lago L, 2012, TUBERCULOSIS, V92, P232, DOI 10.1016/j.tube.2012.01.003; Pym AS, 2002, INFECT IMMUN, V70, P4955, DOI 10.1128/IAI.70.9.4955-4960.2002; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Rigouts L, 2013, J CLIN MICROBIOL; Robinson T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023204; Schurch AC, 2010, J CLIN MICROBIOL, V48, P3403, DOI 10.1128/JCM.00370-10; SIDDIQI SH, 1995, BACTEC 460 TB SYSTEM; Sola C, 2001, EMERG INFECT DIS, V7, P390; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Sreevatsan S, 1997, ANTIMICROB AGENTS CH, V41, P636, DOI 10.1128/AAC.41.3.636; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Temple B, 2008, CLIN INFECT DIS, V47, P1126, DOI 10.1086/592252; Traore Hamidou, 2007, Ann Clin Microbiol Antimicrob, V6, P1, DOI 10.1186/1476-0711-6-1; Van Deun A, 2013, J CLIN MICROBIOL; VANSOOLINGEN D, 1991, J CLIN MICROBIOL, V29, P2578, DOI 10.1128/JCM.29.11.2578-2586.1991; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Weir B. S., 1996, GENETIC DATA ANAL; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wong SY, 2011, ANTIMICROB AGENTS CH, V55, P2515, DOI 10.1128/AAC.01814-10; World Health Organization, 2011, GUID PROGR MAN DRUG; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320; Zignol M, 2012, B WORLD HEALTH ORGAN, V90, P111, DOI 10.2471/BLT.11.092585; Zumla A, 2012, J INFECT DIS, V205, pS228, DOI 10.1093/infdis/jir858	56	54	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83012	10.1371/journal.pone.0083012	http://dx.doi.org/10.1371/journal.pone.0083012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349420	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000328730300120
J	Broniatowski, DA; Paul, MJ; Dredze, M				Broniatowski, David A.; Paul, Michael J.; Dredze, Mark			National and Local Influenza Surveillance through Twitter: An Analysis of the 2012-2013 Influenza Epidemic	PLOS ONE			English	Article								Social media have been proposed as a data source for influenza surveillance because they have the potential to offer real-time access to millions of short, geographically localized messages containing information regarding personal well-being. However, accuracy of social media surveillance systems declines with media attention because media attention increases "chatter"-messages that are about influenza but that do not pertain to an actual infection masking signs of true influenza prevalence. This paper summarizes our recently developed influenza infection detection algorithm that automatically distinguishes relevant tweets from other chatter, and we describe our current influenza surveillance system which was actively deployed during the full 2012-2013 influenza season. Our objective was to analyze the performance of this system during the most recent 2012-2013 influenza season and to analyze the performance at multiple levels of geographic granularity, unlike past studies that focused on national or regional surveillance. Our system's influenza prevalence estimates were strongly correlated with surveillance data from the Centers for Disease Control and Prevention for the United States (r = 0.93, p < 0.001) as well as surveillance data from the Department of Health and Mental Hygiene of New York City (r = 0.88, p < 0.001). Our system detected the weekly change in direction (increasing or decreasing) of influenza prevalence with 85% accuracy, a nearly twofold increase over a simpler model, demonstrating the utility of explicitly distinguishing infection tweets from other chatter.	[Broniatowski, David A.] George Washington Univ, Dept Engn Management & Syst Engn, Washington, DC USA; [Broniatowski, David A.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Ctr Adv Modeling Social Behav & Hlth Sci, Baltimore, MD USA; [Paul, Michael J.; Dredze, Mark] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA; [Paul, Michael J.] Johns Hopkins Univ, Ctr Language & Speech Proc, Baltimore, MD USA; [Dredze, Mark] Johns Hopkins Univ, Human Language Technol Ctr Excellence, Baltimore, MD USA	George Washington University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Paul, MJ (corresponding author), Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21218 USA.	mpaul@cs.jhu.edu	Broniatowski, David/G-5586-2012	Broniatowski, David/0000-0002-3302-9497; Dredze, Mark/0000-0002-0422-2474	Office of the Director, National Institutes of Health [DP1OD003874]; National Science Foundation [DGE-0707427]; Open Access Promotion Fund of the Johns Hopkins University Libraries; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003874] Funding Source: NIH RePORTER	Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Open Access Promotion Fund of the Johns Hopkins University Libraries; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Dr. Broniatowski is supported in part by Pioneer Award Number DP1OD003874 awarded to J.M. Epstein by the Office of the Director, National Institutes of Health. Mr. Paul is supported in part by a National Science Foundation Graduate Research Fellowship under Grant No. DGE-0707427. Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NATURE, DOI DOI 10.1038/nature07634; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Burton SH, 2012, J MED INTERNET RES, V14, P366, DOI 10.2196/jmir.2121; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Copeland P., 2013, INT SOC NEGLECTED TR; Dredze M, 2013, P AAAI WORKSH EXP BO; Dugas AF, 2012, CLIN INFECT DIS, V54, P463, DOI 10.1093/cid/cir883; Lamb A., 2016, NAACL HLT 2016; Nsoesie Elaine, 2013, PLoS Curr, V5, DOI 10.1371/currents.outbreaks.bb1e879a23137022ea79a8c508b030bc; Paul M, 2011, TECHNICAL REPORT; Salathe M, 2013, NEW ENGL J MED, V369, P401, DOI 10.1056/NEJMp1307752; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; [No title captured]	16	269	273	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e83672	10.1371/journal.pone.0083672	http://dx.doi.org/10.1371/journal.pone.0083672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349542	gold, Green Submitted, Green Published			2022-12-27	WOS:000328705200134
J	Fitzsimons, HL; Schwartz, S; Given, FM; Scott, MJ				Fitzsimons, Helen L.; Schwartz, Silvia; Given, Fiona M.; Scott, Maxwell J.			The Histone Deacetylase HDAC4 Regulates Long-Term Memory in Drosophila	PLOS ONE			English	Article							CONTROLS CHONDROCYTE HYPERTROPHY; MUSHROOM BODY; SYNAPTIC PLASTICITY; NUCLEAR IMPORT; TRANSCRIPTION FACTOR; CONSOLIDATED MEMORY; MOLECULAR-BIOLOGY; MOUSE MODEL; KINASE-II; PROTEIN	A growing body of research indicates that pharmacological inhibition of histone deacetylases (HDACs) correlates with enhancement of long-term memory and current research is concentrated on determining the roles that individual HDACs play in cognitive function. Here, we investigate the role of HDAC4 in long-term memory formation in Drosophila. We show that overexpression of HDAC4 in the adult mushroom body, an important structure for memory formation, resulted in a specific impairment in long-term courtship memory, but had no affect on short-term memory. Overexpression of an HDAC4 catalytic mutant also abolished LTM, suggesting a mode of action independent of catalytic activity. We found that overexpression of HDAC4 resulted in a redistribution of the transcription factor MEF2 from a relatively uniform distribution through the nucleus into punctate nuclear bodies, where it colocalized with HDAC4. As MEF2 has also been implicated in regulation of long-term memory, these data suggest that the repressive effects of HDAC4 on long-term memory may be through interaction with MEF2. In the same genetic background, we also found that RNAi-mediated knockdown of HDAC4 impairs long-term memory, therefore we demonstrate that HDAC4 is not only a repressor of long-term memory, but also modulates normal memory formation.	[Fitzsimons, Helen L.; Schwartz, Silvia; Given, Fiona M.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Scott, Maxwell J.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA	Massey University; University of North Carolina; North Carolina State University	Fitzsimons, HL (corresponding author), Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand.	h.l.fitzsimons@massey.ac.nz	Scott, Maxwell J/J-1935-2015	Scott, Maxwell J/0000-0001-6536-4735; Fitzsimons, Helen/0000-0001-7825-3911; Schwartz, Silvia/0000-0003-1615-2378	Ministry of Business, Innovation and Employment; Sir Charles Hercus Health Research Fellowship of the Health Research Council of New Zealand; Massey University Research Fund	Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE)); Sir Charles Hercus Health Research Fellowship of the Health Research Council of New Zealand; Massey University Research Fund	This research was conducted during the tenure of a Postdoctoral Fellowship of the New Zealand Foundation for Research, Science and Technology (now known as the Ministry of Business, Innovation and Employment www.mbie.govt.nz) to HLF, a Sir Charles Hercus Health Research Fellowship of the Health Research Council of New Zealand (www.hrc.govt.nz) to HLF, and a Massey University Research Fund (www.massey.ac.nz) grant to HLF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalal DBG, 2010, J NEUROSCI, V30, P16699, DOI 10.1523/JNEUROSCI.1882-10.2010; Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Barrett RM, 2011, NEUROPSYCHOPHARMACOL, V36, P1545, DOI 10.1038/npp.2011.61; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Borghi S, 2001, J CELL SCI, V114, P4477; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Chan JKL, 2003, J BIOL CHEM, V278, P23515, DOI 10.1074/jbc.M301922200; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; Cohen TJ, 2009, FASEB J, V23, P99, DOI 10.1096/fj.08-115931; Cole CJ, 2012, NAT NEUROSCI, V15, P1255, DOI 10.1038/nn.3189; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Darcy MJ, 2010, J COMP NEUROL, V518, P722, DOI 10.1002/cne.22241; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Ejima A, 2005, CURR BIOL, V15, P194, DOI 10.1016/j.cub.2005.01.035; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Ficner R, 2009, CURR TOP MED CHEM, V9, P235, DOI 10.2174/156802609788085304; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fitzsimons HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029171; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Fontan-Lozano A, 2008, MOL CELL NEUROSCI, V39, P193, DOI 10.1016/j.mcn.2008.06.009; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Govindarajan N, 2011, J ALZHEIMERS DIS, V26, P187, DOI 10.3233/JAD-2011-110080; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Huang EY, 2000, GENE DEV, V14, P45; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Ishimoto H, 2009, P NATL ACAD SCI USA, V106, P6381, DOI 10.1073/pnas.0810213106; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Kao HY, 2002, J BIOL CHEM, V277, P187, DOI 10.1074/jbc.M108931200; Keene AC, 2006, CURR BIOL, V16, P1524, DOI 10.1016/j.cub.2006.06.022; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Kilgore M, 2010, NEUROPSYCHOPHARMACOL, V35, P870, DOI 10.1038/npp.2009.197; Kim MS, 2012, J NEUROSCI, V32, P10879, DOI 10.1523/JNEUROSCI.2089-12.2012; Knowles-Barley S, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq005; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Liu HD, 2008, J NEUROSCI RES, V86, P537, DOI 10.1002/jnr.21521; Lucchesi W, 2011, BRAIN RES BULL, V85, P2, DOI 10.1016/j.brainresbull.2010.10.009; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Mehren JE, 2004, J NEUROSCI, V24, P10584, DOI 10.1523/JNEUROSCI.3560-04.2004; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Nishino TG, 2008, BIOCHEM BIOPH RES CO, V377, P852, DOI 10.1016/j.bbrc.2008.10.079; Perazzona B, 2004, J NEUROSCI, V24, P8823, DOI 10.1523/JNEUROSCI.4542-03.2004; PINSKER HM, 1973, SCIENCE, V182, P1039, DOI 10.1126/science.182.4116.1039; Pitman JL, 2009, FLY, V3, P3, DOI 10.4161/fly.3.1.7726; Presente A, 2004, P NATL ACAD SCI USA, V101, P1764, DOI 10.1073/pnas.0308259100; Price V, 2013, J NEUROSCI RES, V91, P407, DOI 10.1002/jnr.23170; Redondo RL, 2010, J NEUROSCI, V30, P4981, DOI 10.1523/JNEUROSCI.3140-09.2010; Ricobaraza A, 2012, HIPPOCAMPUS, V22, P1040, DOI 10.1002/hipo.20883; Rodriguez AD, 2012, NAT METHODS, V9, P47, DOI [10.1038/NMETH.1800, 10.1038/nmeth.1800]; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Schlumm F, 2013, J BIOL CHEM, V288, P8074, DOI 10.1074/jbc.M112.432773; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Tubon TC, 2013, J NEUROSCI, V33, P7475, DOI 10.1523/JNEUROSCI.4387-12.2013; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wang AH, 1999, MOL CELL BIOL, V19, P7816; Wang AH, 2001, MOL CELL BIOL, V21, P5992, DOI 10.1128/MCB.21.17.5992-6005.2001; Wang WH, 2011, ANAT REC, V294, P1025, DOI 10.1002/ar.21389; YANG MY, 1995, NEURON, V15, P45; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Zeremski M, 2003, GENESIS, V35, P31, DOI 10.1002/gene.10159	80	54	56	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e83903	10.1371/journal.pone.0083903	http://dx.doi.org/10.1371/journal.pone.0083903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349558	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200137
J	Harvey, SAK; Dangi, A; Tandon, A; Gandhi, CR				Harvey, Stephen A. K.; Dangi, Anil; Tandon, Ashish; Gandhi, Chandrashekhar R.			The Transcriptomic Response of Rat Hepatic Stellate Cells to Endotoxin: Implications for Hepatic Inflammation and Immune Regulation	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; T-CELLS; KUPFFER CELLS; UP-REGULATION; INTERFERON-GAMMA; GENE-EXPRESSION; DOWN-REGULATION; ACTIVATED RAT; DNA-SYNTHESIS; LIVER	With their location in the perisinusoidal space of Disse, hepatic stellate cells (HSCs) communicate with all of the liver cell types both by physical association (cell body as well as cytosolic processes penetrating into sinusoids through the endothelial fenestrations) and by producing several cytokines and chemokines. Bacterial lipopolysaccharide (LPS), circulating levels of which are elevated in liver diseases and transplantation, stimulates HSCs to produce increased amounts of cytokines and chemokines. Although recent research provides strong evidence for the role of HSCs in hepatic inflammation and immune regulation, the number of HSC-elaborated inflammatory and immune regulatory molecules may be much greater then known at the present time. Here we report time-dependent changes in the gene expression profile of inflammatory and immune-regulatory molecules in LPS-stimulated rat HSCs, and their validation by biochemical analyses. LPS strongly up-regulated LPS-response elements (TLR2 and TLR7) but did not affect TLR4 and down-regulated TLR9. LPS also up-regulated genes in the MAPK, NF kappa B, STAT, SOCS, IRAK and interferon signaling pathways, numerous CC and CXC chemokines and IL17F. Interestingly, LPS modulated genes related to TGF beta and HSC activation in a manner that would limit their activation and fibrogenic activity. The data indicate that LPS-stimulated HSCs become a major cell type in regulating hepatic inflammatory and immunological responses by altering expression of numerous relevant genes, and thus play a prominent role in hepatic pathophysiology including liver diseases and transplantation.	[Harvey, Stephen A. K.] Univ Pittsburgh, Dept Opthalmol, Pittsburgh, PA USA; [Dangi, Anil; Tandon, Ashish; Gandhi, Chandrashekhar R.] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA; [Dangi, Anil; Gandhi, Chandrashekhar R.] Cincinnati VA Med Ctr, Cincinnati, OH USA; [Gandhi, Chandrashekhar R.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; Cincinnati Children's Hospital Medical Center	Gandhi, CR (corresponding author), Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA.	gandhicr@ucmail.uc.edu	Dangi, Anil/AAV-5261-2021	Dangi, Anil/0000-0003-1185-3079	National Institutes of Health [RO1-DK54411, PO1A1081678]; United States Department of Veterans Affairs Merit Review Award [1IO1BX001174]; Department of Surgery, University of Cincinnati; Children's Hospital Medical Center, Cincinnati; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054411] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs Merit Review Award(US Department of Veterans Affairs); Department of Surgery, University of Cincinnati; Children's Hospital Medical Center, Cincinnati; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	Funding came from National Institutes of Health RO1-DK54411, NIH PO1A1081678 and United States Department of Veterans Affairs Merit Review Award 1IO1BX001174, and Department of Surgery, University of Cincinnati and Children's Hospital Medical Center, Cincinnati. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Baker AK, 2009, MOL IMMUNOL, V46, P2249, DOI 10.1016/j.molimm.2009.04.011; Belz GT, 1998, P NATL ACAD SCI USA, V95, P13812, DOI 10.1073/pnas.95.23.13812; Brun P, 2005, AM J PHYSIOL-GASTR L, V289, pG571, DOI 10.1152/ajpgi.00537.2004; CALNE RY, 1969, NATURE, V223, P472, DOI 10.1038/223472a0; Chinnadurai R, 2010, HEPATOLOGY, V52, P2177, DOI 10.1002/hep.23953; Cismasiu VB, 2009, BIOCHEM J, V417, P457, DOI 10.1042/BJ20080925; Crispe IN, 2009, ANNU REV IMMUNOL, V27, P147, DOI 10.1146/annurev.immunol.021908.132629; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Dambach DM, 2002, HEPATOLOGY, V35, P1093, DOI 10.1053/jhep.2002.33162; Dangi A, 2012, J IMMUNOL, V188, P3667, DOI 10.4049/jimmunol.1102460; Dhupar R, 2011, SHOCK, V35, P293, DOI 10.1097/SHK.0b013e3181f6aab0; Dong H, 2002, BIOCHEM BIOPH RES CO, V298, P675, DOI 10.1016/S0006-291X(02)02528-7; Eksteen B, 2009, GASTROENTEROLOGY, V137, P320, DOI 10.1053/j.gastro.2009.02.046; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Feng S, 2012, JAMA-J AM MED ASSOC, V307, P283, DOI 10.1001/jama.2011.2014; Fielhaber JA, 2012, J IMMUNOL, V188, P4535, DOI 10.4049/jimmunol.1003655; Fitzner B, 2007, CELL SIGNAL, V19, P782, DOI 10.1016/j.cellsig.2006.10.002; Gandhi CR, 2011, MOL PATHOL LIB, V5, P53, DOI 10.1007/978-1-4419-7107-4_5; Gandhi CR, 2000, BRIT J PHARMACOL, V131, P319, DOI 10.1038/sj.bjp.0703577; Gorczynski RM, 2004, AM J REPROD IMMUNOL, V52, P147, DOI 10.1111/j.1600-0897.2004.00192.x; GUGENHEIM J, 1990, LANCET, V336, P519, DOI 10.1016/0140-6736(90)92082-S; Han YP, 2007, J BIOL CHEM, V282, P12928, DOI 10.1074/jbc.M700554200; Handy JA, 2011, BIOCHEM J, V440, P385, DOI 10.1042/BJ20102148; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Hogaboam CM, 2000, AM J PATHOL, V156, P1245, DOI 10.1016/S0002-9440(10)64995-4; Holt AP, 2009, GASTROENTEROLOGY, V136, P705, DOI 10.1053/j.gastro.2008.10.020; Ichikawa S, 2011, J IMMUNOL, V186, P5549, DOI 10.4049/jimmunol.1003917; Jiang GP, 2008, TRANSPLANTATION, V86, P1492, DOI 10.1097/TP.0b013e31818bfd13; Katsounas A, 2012, J VIRAL HEPATITIS, V19, P128, DOI 10.1111/j.1365-2893.2011.01503.x; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Klune JR, 2012, AM J PHYSIOL-GASTR L, V303, pG666, DOI 10.1152/ajpgi.00050.2012; KNOLLE P, 1995, J HEPATOL, V22, P226, DOI 10.1016/0168-8278(95)80433-1; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744; Leifeld L, 2003, J PATHOL, V199, P335, DOI 10.1002/path.1298; Lopez-Pelaez M, 2011, EUR J IMMUNOL, V41, P1733, DOI 10.1002/eji.201041101; Maiwald T, 2010, FEBS J, V277, P4741, DOI 10.1111/j.1742-4658.2010.07880.x; Matsukawa A, 2000, J IMMUNOL, V164, P2738, DOI 10.4049/jimmunol.164.5.2738; Mazariegos GV, 1997, TRANSPLANTATION, V63, P243, DOI 10.1097/00007890-199701270-00012; Mehal WZ, 2001, GASTROENTEROLOGY, V120, P250, DOI 10.1053/gast.2001.20947; Mencin A, 2009, GUT, V58, P704, DOI 10.1136/gut.2008.156307; Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049; Muta T, 2003, J ENDOTOXIN RES, V9, P187, DOI 10.1179/096805103125001612; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Park I, 2011, BIOCHEM J, V434, P171, DOI 10.1042/BJ20101473; Perugorria MJ, 2013, HEPATOLOGY, V57, P1238, DOI 10.1002/hep.26108; Prakash A, 2005, J BIOL CHEM, V280, P18651, DOI 10.1074/jbc.M501289200; QIAN SW, 1994, HEPATOLOGY, V19, P916, DOI 10.1002/hep.1840190418; Rao HY, 2010, J GASTROEN HEPATOL, V25, P1777, DOI 10.1111/j.1440-1746.2010.06264.x; Sanchez-Fueyo A, 2011, GASTROENTEROLOGY, V140, P51, DOI 10.1053/j.gastro.2010.10.059; Schaeffer V, 2011, J SURG RES, V171, P769, DOI 10.1016/j.jss.2010.05.035; Schildberg FA, 2011, HEPATOLOGY, V54, P262, DOI 10.1002/hep.24352; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2009, HEPATOLOGY, V50, P185, DOI 10.1002/hep.22952; Stafford MJ, 2006, FEBS LETT, V580, P4010, DOI 10.1016/j.febslet.2006.06.004; Starnes T, 2001, J IMMUNOL, V167, P4137, DOI 10.4049/jimmunol.167.8.4137; Stefanovic L, 2005, EXP BIOL MED, V230, P573, DOI 10.1177/153537020523000809; STEWART R, 2013, J HEPATOL IN PRESS; Sumpter TL, 2012, J IMMUNOL, V189, P3848, DOI 10.4049/jimmunol.1200819; Takatsuki M, 2001, TRANSPLANTATION, V72, P449, DOI 10.1097/00007890-200108150-00016; Tarantino G, 2013, J BIOL REG HOMEOS AG, V27, P233; Thirunavukkarasu C, 2005, J CELL PHYSIOL, V204, P654, DOI 10.1002/jcp.20366; Thirunavukkarasu C, 2006, HEPATOLOGY, V44, P389, DOI 10.1002/hep.21254; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; Tuyama AC, 2010, HEPATOLOGY, V52, P612, DOI 10.1002/hep.23679; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Ueki S, 2010, HEPATOLOGY, V51, P1692, DOI 10.1002/hep.23501; Uemura T, 2001, BRIT J PHARMACOL, V133, P1125, DOI 10.1038/sj.bjp.0704151; Valatas V, 2004, REGUL PEPTIDES, V120, P215, DOI 10.1016/j.regpep.2004.03.009; von Boehmer H, 2007, J EXP MED, V204, P1737, DOI 10.1084/jem.20071251; Wang CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026235; Wang SC, 1998, J BIOL CHEM, V273, P302, DOI 10.1074/jbc.273.1.302; Watanabe N, 2011, BIOCHEM BIOPH RES CO, V407, P135, DOI 10.1016/j.bbrc.2011.02.125; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; Xu Huan-Bin, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P282; Yamada H, 2005, J UROLOGY, V174, P1119, DOI 10.1097/01.ju.0000168619.25341.96; Yu MC, 2004, HEPATOLOGY, V40, P1312, DOI 10.1002/hep.20488; Zhong LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032195	85	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82159	10.1371/journal.pone.0082159	http://dx.doi.org/10.1371/journal.pone.0082159			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349206	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200065
J	Kim, CS; Oak, CY; Kim, HY; Kang, YU; Choi, JS; Bae, EH; Ma, SK; Kweon, SS; Kim, SW				Kim, Chang Seong; Oak, Chan Young; Kim, Ha Yeon; Kang, Yong Un; Choi, Joon Seok; Bae, Eun Hui; Ma, Seong Kwon; Kweon, Sun-Seog; Kim, Soo Wan			Incidence, Predictive Factors, and Clinical Outcomes of Acute Kidney Injury after Gastric Surgery for Gastric Cancer	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CORONARY-ARTERY-BYPASS; POSTOPERATIVE COMPLICATIONS; SERUM-ALBUMIN; RISK; MORTALITY; HYPOALBUMINEMIA; SURVIVAL; IMPACT; STAY	Background: Postoperative acute kidney injury (AKI), a serious surgical complication, is common after cardiac surgery; however, reports on AKI after noncardiac surgery are limited. We sought to determine the incidence and predictive factors of AKI after gastric surgery for gastric cancer and its effects on the clinical outcomes. Methods: We conducted a retrospective study of 4718 patients with normal renal function who underwent partial or total gastrectomy for gastric cancer between June 2002 and December 2011. Postoperative AKI was defined by serum creatinine change, as per the Kidney Disease Improving Global Outcomes guideline. Results: Of the 4718 patients, 679 (14.4%) developed AKI. Length of hospital stay, intensive care unit admission rates, and in-hospital mortality rate (3.5% versus 0.2%) were significantly higher in patients with AKI than in those without. AKI was also associated with requirement of renal replacement therapy. Multivariate analysis revealed that male gender; hypertension; chronic obstructive pulmonary disease; hypoalbuminemia (<4 g/dl); use of diuretics, vasopressors, and contrast agents; and packed red blood cell transfusion were independent predictors for AKI after gastric surgery. Postoperative AKI and vasopressor use entailed a high risk of 3-month mortality after multiple adjustments. Conclusions: AKI was common after gastric surgery for gastric cancer and associated with adverse outcomes. We identified several factors associated with postoperative AKI; recognition of these predictive factors may help reduce the incidence of AKI after gastric surgery. Furthermore, postoperative AKI in patients with gastric cancer is an important risk factor for short-term mortality.	[Kim, Chang Seong; Oak, Chan Young; Kim, Ha Yeon; Kang, Yong Un; Choi, Joon Seok; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan] Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea; [Kweon, Sun-Seog] Chonnam Natl Univ, Sch Med, Dept Prevent Med, Kwangju, South Korea; [Kweon, Sun-Seog] Chonnam Natl Univ, Hwasun Hosp, Jeonnam Reg Canc Ctr, Hwasun Gun, South Korea	Chonnam National University; Chonnam National University; Chonnam National University	Kim, SW (corresponding author), Chonnam Natl Univ, Sch Med, Dept Internal Med, Kwangju, South Korea.	skimw@chonnam.ac.kr	Kweon, Sun-Seog/AAZ-4732-2021	Kweon, Sun-Seog/0000-0003-2378-8550	Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0009743]; National Research Foundation of Korea (NRF) grant (MRC for Gene Regulation) [2011-0030132]; Korea government (MSIP)	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea (NRF) grant (MRC for Gene Regulation)(National Research Foundation of Korea); Korea government (MSIP)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0009743), and by the National Research Foundation of Korea (NRF) grant (MRC for Gene Regulation, 2011-0030132) funded by the Korea government (MSIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelha FJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7894; Arora P, 2008, CLIN J AM SOC NEPHRO, V3, P1266, DOI 10.2215/CJN.05271107; Bagur R, 2010, EUR HEART J, V31, P865, DOI 10.1093/eurheartj/ehp552; Cabezuelo JB, 2006, KIDNEY INT, V69, P1073, DOI 10.1038/sj.ki.5000216; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Comporti M, 2002, FREE RADICAL BIO MED, V32, P568, DOI 10.1016/S0891-5849(02)00759-1; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; de la Cruz KI, 2011, ANN THORAC SURG, V91, P671, DOI 10.1016/j.athoracsur.2010.09.004; De Vries B, 2004, TRANSPLANTATION, V77, P669, DOI 10.1097/01.TP.0000115002.28575.E7; Engelman DT, 1999, J THORAC CARDIOV SUR, V118, P866, DOI 10.1016/S0022-5223(99)70056-5; Flemming B, 2000, J AM SOC NEPHROL, V11, P18, DOI 10.1681/ASN.V11118; Haase M, 2012, NEPHROL DIAL TRANSPL, V27, P153, DOI 10.1093/ndt/gfr275; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Ichikawa D, 2004, HEPATO-GASTROENTEROL, V51, P613; Igleslas J, 1999, AM J PHYSIOL-RENAL, V277, pF711, DOI 10.1152/ajprenal.1999.277.5.F711; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; KAUFMANN MA, 1995, J PHARMACOL EXP THER, V273, P855; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; Kheterpal S, 2007, ANESTHESIOLOGY, V107, P892, DOI 10.1097/01.anes.0000290588.29668.38; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Lee EH, 2012, INTENS CARE MED, V38, P1478, DOI 10.1007/s00134-012-2599-8; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mizuno T, 2012, ONCOLOGY-BASEL, V82, P354, DOI 10.1159/000338664; Reddy V G, 2002, J Postgrad Med, V48, P64; RICH MW, 1989, AM J CARDIOL, V63, P714, DOI 10.1016/0002-9149(89)90257-9; Sah BK, 2009, EUR J CANCER CARE, V18, P202, DOI 10.1111/j.1365-2354.2008.01036.x; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Thakar CV, 2007, CLIN J AM SOC NEPHRO, V2, P426, DOI 10.2215/CJN.03961106; Thakar CV, 2013, ADV CHRONIC KIDNEY D, V20, P67, DOI 10.1053/j.ackd.2012.10.003; Thakar CV, 2009, CRIT CARE MED, V37, P2552, DOI 10.1097/CCM.0b013e3181a5906f; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; VISTE A, 1988, ANN SURG, V207, P7, DOI 10.1097/00000658-198801000-00003; WHO Scientific Group on Nutritional Anaemias & World Health Organization, 1968, WHO TECH REP SER, V405, P5	34	46	46	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82289	10.1371/journal.pone.0082289	http://dx.doi.org/10.1371/journal.pone.0082289			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349249	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200074
J	Li, Y; Zhang, X; Sun, YX; Feng, Q; Li, GL; Wang, M; Cui, XX; Kang, L; Jiang, YL				Li, Yi; Zhang, Xu; Sun, Yanxiao; Feng, Qiang; Li, Guanglei; Wang, Meng; Cui, Xinxing; Kang, Li; Jiang, Yunliang			Folate Deficiency during Early-Mid Pregnancy Affects the Skeletal Muscle Transcriptome of Piglets from a Reciprocal Cross	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; MATERNAL NUTRIENT RESTRICTION; FOLIC-ACID; DNA METHYLATION; BIRTH-WEIGHT; INSULIN-RESISTANCE; BODY-COMPOSITION; FAT DEPOSITION; METABOLISM; NUTRITION	Folate deficiency (FD) during pregnancy can cause fetal intrauterine growth restriction in pigs, of which the skeletal dysplasia is a major manifestation. Factors influencing muscle development are very important in the formation of porcine meat quality trait. However, the effect of folate deficiency on skeletal muscle development and its molecular mechanisms are unknown. The objective of this study is to determine the effect of maternal folate deficiency on the skeletal muscle transcriptome of piglets from a reciprocal cross, in which full-sibling Landrace (LR) and full-sibling Chinese local breed Laiwu (LW) pigs were used for reciprocal cross matings, and sows were fed either a folate deficient or a normal diet during early-mid gestation. In addition, the difference in the responsiveness of the piglets to folate deficiency during early-mid pregnancy between reciprocal cross groups was investigated. Longissimus dorsi (LD) muscle samples were collected from newborn piglets and a 4 x 44K Agilent porcine oligo microarray was used for transcriptome analysis of porcine LD muscle. The results showed that folate deficiency during early-mid pregnancy affected piglet body weight, LD muscle fiber number and content of intramuscular triglyceride. The microarray results indicated that 3154 genes were differentially expressed between folate deficient and normal piglets from the LR male x LW female cross, and 3885 differentially expressed genes (DEGs) in the ones from the LW male x LR female cross. From functional analyses, sow folate deficiency affected almost all biological processes in the progeny. Lipid metabolism-related genes and associated metabolic pathways were regulated extensively by folate deficiency, especially in LR male x LW female cross piglets. Most of the genes that are regulated by folate deficiency in the LD muscle of piglets were different between LR male x LW female and LW male x LR female crosses, suggesting some epigenetic effects of FD exist in genes underlying myogenesis and intramuscular fat deposition in piglets.	[Li, Yi; Zhang, Xu; Li, Guanglei; Wang, Meng; Cui, Xinxing; Kang, Li; Jiang, Yunliang] Shandong Agr Univ, Coll Anim Sci, Lab Anim Mol Genet, Tai An, Shandong, Peoples R China; [Li, Yi; Feng, Qiang] Cent Hosp Taian, Tai An, Shandong, Peoples R China; [Li, Yi; Feng, Qiang] Taishan Med Univ, Taian Hosp, Tai An, Shandong, Peoples R China; [Sun, Yanxiao] Laiwu Bur Anim Husb & Vet Med, Laiwu, Peoples R China	Shandong Agricultural University; Shandong First Medical University & Shandong Academy of Medical Sciences	Jiang, YL (corresponding author), Shandong Agr Univ, Coll Anim Sci, Lab Anim Mol Genet, Tai An, Shandong, Peoples R China.	yljiang723@aliyun.com			National Natural Science Foundation of China [31200983]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31200983). Http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkow B, 2001, BRIT J NUTR, V85, P179, DOI 10.1079/BJN2000238; Bee G, 2004, J ANIM SCI, V82, P826; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Billington CJ, 2013, J NUTR, V143, P332, DOI 10.3945/jn.112.168906; Bonneau M, 2010, MEAT SCI, V84, P293, DOI 10.1016/j.meatsci.2009.03.013; Branum AM, 2013, J NUTR, V143, P486, DOI 10.3945/jn.112.169987; Cerisuelo A, 2009, J ANIM SCI, V87, P729, DOI 10.2527/jas.2007-0677; Cooney CA, 2002, J NUTR, V132, p2393S; Crider KS, 2012, ADV NUTR, V3, P21, DOI 10.3945/an.111.000992; D'Andrea M, 2011, ANIM GENET, V42, P501, DOI 10.1111/j.1365-2052.2010.02164.x; Damon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033763; de Koning DJ, 2000, P NATL ACAD SCI USA, V97, P7947, DOI 10.1073/pnas.140216397; DWYER CM, 1994, J ANIM SCI, V72, P911, DOI 10.2527/1994.724911x; EISEN EJ, 1981, J ANIM SCI, V53, P952, DOI 10.2527/jas1981.534952x; Fleming TP, 2012, ANIM REPROD SCI, V130, P193, DOI 10.1016/j.anireprosci.2012.01.015; Greenwood PL, 2000, J ANIM SCI, V78, P50; Grimaldi A, 2004, DEVELOPMENT, V131, P3249, DOI 10.1242/dev.01194; Guay F, 2002, J ANIM SCI, V80, P2134; Kumar KA, 2013, J NUTR BIOCHEM, V24, P25, DOI 10.1016/j.jnutbio.2012.01.004; Lane RH, 1998, PEDIATR RES, V43, P563, DOI 10.1203/00006450-199805000-00001; LINDEMANN MD, 1993, J ANIM SCI, V71, P239, DOI 10.2527/1993.711239x; MATTE JJ, 1989, J ANIM SCI, V67, P426; Mckay JA, 2008, BRIT J NUTR, V99, P550, DOI 10.1017/S0007114507819131; McKay JA, 2011, GENES NUTR, V6, P189, DOI 10.1007/s12263-010-0199-1; McNamara LB, 2011, ANIMAL, V5, P1195, DOI 10.1017/S1751731111000176; Merks JWM, 2012, ANIMAL, V6, P535, DOI 10.1017/S1751731111002266; Micke GC, 2011, MOL CELL ENDOCRINOL, V332, P234, DOI 10.1016/j.mce.2010.10.018; Moores CJ, 2011, ANN NY ACAD SCI, V1229, P76, DOI 10.1111/j.1749-6632.2011.06101.x; Nezer C, 1999, NAT GENET, V21, P155, DOI 10.1038/5935; Nissen PM, 2011, ANIMAL, V5, P1382, DOI 10.1017/S1751731111000401; Oliver M H, 2007, Soc Reprod Fertil Suppl, V64, P397; Oster M, 2012, PHYSIOL GENOMICS, V44, P811, DOI 10.1152/physiolgenomics.00050.2012; Pickell L, 2009, BIRTH DEFECTS RES A, V85, P531, DOI 10.1002/bdra.20575; Rattink AP, 2000, MAMM GENOME, V11, P656, DOI 10.1007/s003350010117; Rehfeldt C, 2006, J Anim Sci, V84 Suppl, pE113; Rehfeldt C, 2012, EUR J NUTR, V51, P151, DOI 10.1007/s00394-011-0201-8; Schenk S, 2005, AM J PHYSIOL-ENDOC M, V288, pE519, DOI 10.1152/ajpendo.00401.2004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Sram RJ, 2005, MUTAT RES-FUND MOL M, V591, P302, DOI 10.1016/j.mrfmmm.2005.04.015; Swayne BG, 2012, J NUTR, V142, P813, DOI 10.3945/jn.112.157750; Wang JJ, 2008, J NUTR, V138, P60, DOI 10.1093/jn/138.1.60; Watkins AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028745; Wells JCK, 2007, BIOL REV, V82, P143, DOI 10.1111/j.1469-185X.2006.00007.x; Wigmore PM, 2002, INT REV CYTOL, V216, P175; Xie T, 2008, ENDOCRINOLOGY, V149, P2443, DOI 10.1210/en.2007-1458; Zhang XM, 2008, J NUTR SCI VITAMINOL, V54, P353, DOI 10.3177/jnsv.54.353; Zhu MJ, 2006, J PHYSIOL-LONDON, V575, P241, DOI 10.1113/jphysiol.2006.112110; Zhu MJ, 2004, BIOL REPROD, V71, P1968, DOI 10.1095/biolreprod.104.034561	49	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82616	10.1371/journal.pone.0082616	http://dx.doi.org/10.1371/journal.pone.0082616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349320	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200085
J	Pastor-Idoate, S; Rodriguez-Hernandez, I; Rojas, J; Fernandez, I; Garcia-Gutierrez, MT; Ruiz-Moreno, JM; Rocha-Sousas, A; Ramkissoon, Y; Harsum, S; MacLaren, RE; Charteris, D; VanMeurs, JC; Gonzalez-Sarmiento, R; Pastor, JC				Pastor-Idoate, Salvador; Rodriguez-Hernandez, Irene; Rojas, Jimena; Fernandez, Itziar; Garcia-Gutierrez, Maria T.; Ruiz-Moreno, Jose M.; Rocha-Sousas, Amandio; Ramkissoon, Yashin; Harsum, Steven; MacLaren, Robert E.; Charteris, David; VanMeurs, Jan C.; Gonzalez-Sarmiento, Rogelio; Pastor, Jose. C.		Genetics PVR Study Grp	The T309G MDM2 Gene Polymorphism Is a Novel Risk Factor for Proliferative Vitreoretinopathy	PLOS ONE			English	Article							RETINAL-DETACHMENT; GROWTH-FACTORS; CELL-DEATH; APOPTOSIS; MODEL; MANAGEMENT; FAILURE; SURGERY; IMPACT; SMAD7	Proliferative vitreoretinopathy (PVR) is still the major cause of failure in retinal detachment (RD) surgery. It is believed that down-regulation in the p53 pathway could be an important key in PVR pathogenesis. The purpose was to evaluate the impact of T309G MDM2 polymorphism (rs2279744) in PVR. Distribution of T309G MDM2 genotypes among European subjects undergoing RD surgery was evaluated. Proportions of genotypes between subsamples from different countries were analyzed. Also, a genetic interaction between rs2279744 in MDM2 and rs1042522 in p53 gene was analyzed. Significant differences were observed comparing MDM2 genotype frequencies at position 309 of intron 1 between cases (GG: 21.6%, TG: 54.5%, TT: 23.8%) and controls (GG: 7.3%, TG: 43.9%, TT: 48.7%). The proportions of genotypes between sub-samples from different countries showed a significant difference. Distribution of GG genotype revealed differences in Spain (35.1-53.0)/(22.6-32.9), Portugal (39.0-74.4)/(21.4-38.9), Netherlands (40.6-66.3)/(25.3-38.8) and UK (37.5-62.4)/(23.3-34.2). The OR of G carriers in the global sample was 5.9 (95% CI: 3.2 to 11.2). The OR of G carriers from Spain and Portugal was 5.4 (95% CI: 2.2-12.7), whereas in the UK and the Netherlands was 7.3 (95% CI: 2.8-19.1). Results indicate that the G allele of rs2279744 is associated with a higher risk of developing PVR in patients undergoing a RD surgery. Further studies are necessary to understand the role of this SNP in the development of PVR.	[Pastor-Idoate, Salvador; Rojas, Jimena; Fernandez, Itziar; Garcia-Gutierrez, Maria T.; Pastor, Jose. C.] Univ Valladolid, IOBA Retina Grp, Inst Oftalmobiol, Valladolid, Spain; [Pastor-Idoate, Salvador; Rodriguez-Hernandez, Irene; Gonzalez-Sarmiento, Rogelio] Univ Salamanca, Dept Med, Unidad Med Mol, E-37008 Salamanca, Spain; [Rodriguez-Hernandez, Irene; Gonzalez-Sarmiento, Rogelio] Univ Salamanca, CSIC, SACYL, Inst Invest Biomed Salamanca IBSAL, E-37008 Salamanca, Spain; [Rodriguez-Hernandez, Irene; Gonzalez-Sarmiento, Rogelio] Univ Salamanca, CSIC, SACYL, IBMCC, E-37008 Salamanca, Spain; [Ruiz-Moreno, Jose M.] Univ Castilla La Mancha, Vissum, Albacete, Spain; [Rocha-Sousas, Amandio] Univ Porto, Dept Sense Organs, Sch Med, Hosp San Joao, P-4100 Oporto, Portugal; [Ramkissoon, Yashin; Harsum, Steven; MacLaren, Robert E.; Charteris, David] Moorfields Eye Hosp, NIHR, Biomed Res Ctr, London, England; [MacLaren, Robert E.] Univ Oxford, John Radcliffe Hosp Oxford, Nuffield Lab Ophthalmol, Oxford OX1 2JD, England; [VanMeurs, Jan C.] Univ Rotterdam, Erasmus Med Ctr, Rotterdam Eye Hosp, Rotterdam, Netherlands	Universidad de Valladolid; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Universidad de Castilla-La Mancha; Sao Joao Hospital; Universidade do Porto; University of London; King's College London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of Oxford; Erasmus University Rotterdam; Erasmus MC; Rotterdam Eye Hospital	Gonzalez-Sarmiento, R (corresponding author), Univ Salamanca, Dept Med, Unidad Med Mol, E-37008 Salamanca, Spain.	gonzalez@usal.es; pastor@ioba.med.uva.es	Gonzalez-Sarmiento, Rogelio/V-5526-2019; Fernández, Itziar/AAF-9590-2020; Ruiz-Moreno, José M/E-4644-2016; Navea, Amparo/D-4577-2009; Jimeno, J Carlos Pastor/AAP-1156-2020; Martin, Rosa Maria Coco/H-4511-2015; PASTOR-IDOATE, SALVADOR/G-2548-2016; ESTEBAN, MARIA CARMEN DESCO/J-2281-2016; Zamora, Lurdes/K-8365-2014; Recalde, Sergio/D-1815-2017	Gonzalez-Sarmiento, Rogelio/0000-0002-2726-6795; Fernández, Itziar/0000-0002-5077-4448; Navea, Amparo/0000-0002-9856-5370; Jimeno, J Carlos Pastor/0000-0001-5934-7306; Martin, Rosa Maria Coco/0000-0002-1811-1417; PASTOR-IDOATE, SALVADOR/0000-0002-6463-4227; ESTEBAN, MARIA CARMEN DESCO/0000-0002-9239-7847; Rodriguez-Hernandez, Irene/0000-0002-6487-452X; Garcia-Arumi, Jose/0000-0001-8827-1160; Mataix Boronat, Jorge/0000-0002-7018-3506; Sanabria, Maria Rosa/0000-0002-1818-9812; Zamora, Lurdes/0000-0003-1713-7110; Rocha-Sousa, Amandio/0000-0001-8374-0298; Recalde, Sergio/0000-0002-9328-9725; Boixadera, Anna/0000-0003-2000-9478; Ruiz-Moreno, Jose M/0000-0001-9636-0788; MacLaren, Robert/0000-0002-3096-4682	SAF [2007-66394]; FIS [PI10/00219]; Group of Excellence Grant from Junta de Castilla y Leson [GR15]	SAF; FIS(Instituto de Salud Carlos III); Group of Excellence Grant from Junta de Castilla y Leson	This work was supported by SAF 2007-66394, FIS PI10/00219 and Group of Excellence Grant (GR15) from Junta de Castilla y Leson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alhopuro P, 2005, J MED GENET, V42, P694, DOI 10.1136/jmg.2005.031260; [Anonymous], 2010, R LANG ENV STAT COMP; Arroyo JG, 2005, AM J OPHTHALMOL, V139, P605, DOI 10.1016/j.ajo.2004.11.046; Assmann G, 2010, RHEUMATOL INT, V30, P1273, DOI 10.1007/s00296-009-1136-8; Aylward GW, 2008, PROLIFERATIVE VITREO, P41; AZEN SP, 1992, ARCH OPHTHALMOL-CHIC, V110, P770; AZEN SP, 1992, ARCH OPHTHALMOL-CHIC, V110, P780; Banerjee S, 2007, INVEST OPHTH VIS SCI, V48, P2203, DOI 10.1167/iovs.06-1358; Bhattacharya S, 2011, INVEST OPHTH VIS SCI, V52, P3368, DOI 10.1167/iovs.10-6991; Bond GL, 2005, CANCER RES, V65, P5481, DOI 10.1158/0008-5472.CAN-05-0825; Bougeard G, 2006, J MED GENET, V43, P531, DOI 10.1136/jmg.2005.037952; Brennan RC, 2011, CANCER RES, V71, P4205, DOI 10.1158/0008-5472.CAN-11-0058; Campochiaro PA, 1996, PROG RETIN EYE RES, V15, P547, DOI 10.1016/1350-9462(96)00012-2; Charteris DG, 1998, BRIT J OPHTHALMOL, V82, P106, DOI 10.1136/bjo.82.2.106; Charteris DG, 2004, OPHTHALMOLOGY, V111, P2240, DOI 10.1016/j.ophtha.2004.05.036; COOK B, 1995, INVEST OPHTH VIS SCI, V36, P990; Crawford DC, 2005, ANNU REV MED, V56, P303, DOI 10.1146/annurev.med.56.082103.104540; de la Rua ER, 2008, BRIT J OPHTHALMOL, V92, P523, DOI 10.1136/bjo.2007.127688; de la Rua ER, 2005, CURR EYE RES, V30, P147, DOI 10.1080/02713680490904142; Dempfle A, 2008, EUR J HUM GENET, V16, P1164, DOI 10.1038/ejhg.2008.106; Di Vuolo V, 2011, INFECT AGENTS CANCER, V6, DOI 10.1186/1750-9378-6-13; El-Ghrably IA, 2001, BRIT J OPHTHALMOL, V85, P461, DOI 10.1136/bjo.85.4.461; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Harada C, 2006, PROG RETIN EYE RES, V25, P149, DOI 10.1016/j.preteyeres.2005.09.001; HILTON G, 1983, OPHTHALMOLOGY, V90, P121, DOI 10.1016/s0161-6420(83)34588-7; Hinton DR, 2002, EYE, V16, P422, DOI 10.1038/sj.eye.6700190; Iwakuma T, 2003, MOL CANCER RES, V1, P993; Lei HT, 2012, AM J PATHOL, V181, P866, DOI 10.1016/j.ajpath.2012.05.036; LEWIS H, 1991, AM J OPHTHALMOL, V111, P15, DOI 10.1016/S0002-9394(14)76890-4; LEWIS H, 1991, AM J OPHTHALMOL, V111, P8, DOI 10.1016/S0002-9394(14)76889-8; Liou G, 2002, MOL VIS, V8, P494; Lo ACY, 2011, OPHTHALMOLOGICA, V226, P10, DOI 10.1159/000328206; MACHEMER R, 1991, AM J OPHTHALMOL, V112, P159, DOI 10.1016/S0002-9394(14)76695-4; Michels R. G., 1990, RETINAL DETACHMENT; MIETZ H, 1995, BRIT J OPHTHALMOL, V79, P874, DOI 10.1136/bjo.79.10.874; MILLER B, 1986, ARCH OPHTHALMOL-CHIC, V104, P281, DOI 10.1001/archopht.1986.01050140139037; Moll UM, 2003, MOL CANCER RES, V1, P1001; Moysidis SN, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/815937; Mukherjee S, 2007, INVEST OPHTH VIS SCI, V48, P1892, DOI 10.1167/iovs.06-1095; Pastor JC, 2006, OPHTHALMIC RES, V38, P193, DOI 10.1159/000093070; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Pastor JC, 1998, SURV OPHTHALMOL, V43, P3, DOI 10.1016/S0039-6257(98)00023-X; Pastor-Idoate S, 2013, OPHTHALMOLOGY, V120, P623, DOI 10.1016/j.ophtha.2012.08.019; Patel NN, 2004, RETINA-J RET VIT DIS, V24, P883, DOI 10.1097/00006982-200412000-00007; Ricker LJAG, 2011, INVEST OPHTH VIS SCI, V52, P4256, DOI 10.1167/iovs.10-6892; Rojas J, 2013, INVEST OPHTH VIS SCI, V54, P1665, DOI 10.1167/iovs.12-10931; Rojas J, 2010, OPHTHALMOLOGY, V117, P2417, DOI 10.1016/j.ophtha.2010.03.059; Rosenbaum DM, 1998, INVEST OPHTH VIS SCI, V39, P2132; Saika S, 2004, LAB INVEST, V84, P1245, DOI 10.1038/labinvest.3700156; Saika S, 2007, ARCH OPHTHALMOL-CHIC, V125, P647, DOI 10.1001/archopht.125.5.647; Ruiz-Colmenares MRS, 2006, ACTA OPHTHALMOL SCAN, V84, P309, DOI 10.1111/j.1600-0420.2005.00600.x; Schiff WM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1161, DOI 10.1001/archopht.125.9.1161; Scott JD, 1989, PROLIFERATIVE VITREO, P150; Turgut B, 2012, RETINA-J RET VIT DIS, V32, P232, DOI 10.1097/IAE.0b013e31821e2207; WIEDEMANN P, 1992, SURV OPHTHALMOL, V36, P373, DOI 10.1016/0039-6257(92)90115-A; Yang P, 2004, INVEST OPHTH VIS SCI, V45, P2438, DOI 10.1167/iovs.03-0805; Yu J, 2012, INVEST OPHTH VIS SCI, V53, P8146, DOI 10.1167/iovs.12-10079; Zacks DN, 2006, INVEST OPHTH VIS SCI, V47, P1691, DOI 10.1167/iovs.05-1209; Zhang C, 2002, INVEST OPHTH VIS SCI, V43, P3059	60	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82283	10.1371/journal.pone.0082283	http://dx.doi.org/10.1371/journal.pone.0082283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349246	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200071
J	Vilgrain, I; Sidibe, A; Polena, H; Cand, F; Mannic, T; Arboleas, M; Boccard, S; Baudet, A; Gulino-Debrac, D; Bouillet, L; Quesada, JL; Mendoza, C; Lebas, JF; Pelletier, L; Berger, F				Vilgrain, Isabelle; Sidibe, Adama; Polena, Helena; Cand, Francine; Mannic, Tiphaine; Arboleas, Melanie; Boccard, Sandra; Baudet, Antoine; Gulino-Debrac, Danielle; Bouillet, Laurence; Quesada, Jean-Louis; Mendoza, Christophe; Lebas, Jean-Francois; Pelletier, Laurent; Berger, Francois			Evidence for Post-Translational Processing of Vascular Endothelial (VE)-Cadherin in Brain Tumors: Towards a Candidate Biomarker	PLOS ONE			English	Article							CADHERIN TYROSINE PHOSPHORYLATION; GROWTH-FACTOR; VE-CADHERIN; MOLECULAR-MECHANISMS; CELL-PROLIFERATION; BLOOD-VESSELS; IN-VIVO; ANGIOGENESIS; GLIOBLASTOMA; PERMEABILITY	Vessel abnormalities are among the most important features in malignant glioma. Vascular endothelial (VE)-cadherin is of major importance for vascular integrity. Upon cytokine challenge, VE-cadherin structural modifications have been described including tyrosine phosphorylation and cleavage. The goal of this study was to examine whether these events occurred in human glioma vessels. We demonstrated that VE-cadherin is highly expressed in human glioma tissue and tyrosine phosphorylated at site Y-685, a site previously found phosphorylated upon VEGF challenge, via Src activation. In vitro experiments showed that VEGF-induced VE-cadherin phosphorylation, preceded the cleavage of its extracellular adhesive domain (sVE, 90 kDa). Interestingly, metalloproteases (MMPs) secreted by glioma cell lines were responsible for sVE release. Because VEGF and MMPs are important components of tumor microenvironment, we hypothesized that VE-cadherin proteolysis might occur in human brain tumors. Analysis of glioma patient sera prior treatment confirmed the presence of sVE in bloodstream. Furthermore, sVE levels studied in a cohort of 53 glioma patients were significantly predictive of the overall survival at three years (HR 0.13 [0.04; 0.40] p <= 0.001), irrespective to histopathological grade of tumors. Altogether, these results suggest that VE-cadherin structural modifications should be examined as candidate biomarkers of tumor vessel abnormalities, with promising applications in oncology.	[Vilgrain, Isabelle; Sidibe, Adama; Polena, Helena; Cand, Francine; Mannic, Tiphaine; Arboleas, Melanie; Boccard, Sandra; Gulino-Debrac, Danielle; Bouillet, Laurence] INSERM, U1036, Grenoble, France; [Vilgrain, Isabelle; Sidibe, Adama; Polena, Helena; Cand, Francine; Mannic, Tiphaine; Arboleas, Melanie; Boccard, Sandra; Gulino-Debrac, Danielle; Bouillet, Laurence] UJF Grenoble 1, Grenoble, France; [Vilgrain, Isabelle; Sidibe, Adama; Polena, Helena; Cand, Francine; Mannic, Tiphaine; Arboleas, Melanie; Boccard, Sandra; Gulino-Debrac, Danielle; Bouillet, Laurence] CEA Grenoble, DSV IRTSV, F-38054 Grenoble, France; [Baudet, Antoine; Bouillet, Laurence] Grenoble Univ Hosp, Div Internal Med, Grenoble, France; [Quesada, Jean-Louis; Mendoza, Christophe] Grenoble Univ Hosp, Clin Invest Ctr, INSERM 003, Grenoble, France; [Lebas, Jean-Francois] Grenoble Univ Hosp, Div Radiol, Grenoble, France; [Pelletier, Laurent; Berger, Francois] INSERM, Grenoble Neurosci Inst Grenoble, Brain Nanomed U836, Grenoble, France; [Pelletier, Laurent; Berger, Francois] Univ Grenoble 1, Sch Med, F-38402 St Martin Dheres, France; [Pelletier, Laurent] Grenoble Univ Hosp, Biol & Pathol Inst, Grenoble, France; [Berger, Francois] Grenoble Univ Hosp, Div Oncol, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Franche-Comte; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Vilgrain, I (corresponding author), INSERM, U1036, Grenoble, France.	isabelle.vilgrain@cea.fr	SIDIBE, Adama/AAA-5679-2021	SIDIBE, Adama/0000-0003-2808-3744; VILGRAIN, Isabelle/0000-0002-5511-5871; Boccard-Binet, Sandra/0000-0001-5540-3809	French National Institute of Health and Medical Research INSERM [UMRS 1036, U836]; French Atomic Energy and Alternative Energies Commission (CEA); Life Science division (DSV) / Institute of life sciences research and technologies (iRTSV) / Endothelial cell junctions and Angiogenesis team/Grenoble University Hospital; Institut National du Cancer (INCa); French Association against cancer (ARC Foundation); Federation Nationale des Centres de Lutte contre le Cancer (GEFLUC Grenoble-Dauphine-Savoie); Courtin Arthritis Foundation; Association pour la Recherche contre le Cancer (ARC Foundation); INCa Institut National du Cancer (INCa) [07/3D1616/PL-96-031/NG-NC]	French National Institute of Health and Medical Research INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); French Atomic Energy and Alternative Energies Commission (CEA)(French Atomic Energy Commission); Life Science division (DSV) / Institute of life sciences research and technologies (iRTSV) / Endothelial cell junctions and Angiogenesis team/Grenoble University Hospital; Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); French Association against cancer (ARC Foundation); Federation Nationale des Centres de Lutte contre le Cancer (GEFLUC Grenoble-Dauphine-Savoie); Courtin Arthritis Foundation; Association pour la Recherche contre le Cancer (ARC Foundation); INCa Institut National du Cancer (INCa)	This work was supported by the French National Institute of Health and Medical Research INSERM (UMRS 1036, U836), the French Atomic Energy and Alternative Energies Commission (CEA), Life Science division (DSV) / Institute of life sciences research and technologies (iRTSV) / Endothelial cell junctions and Angiogenesis team/Grenoble University Hospital, Institut National du Cancer (INCa), French Association against cancer (ARC Foundation), Federation Nationale des Centres de Lutte contre le Cancer (GEFLUC Grenoble-Dauphine-Savoie). AS and TM received grants from Courtin Arthritis Foundation. HP was a recipient of a grant from Association pour la Recherche contre le Cancer (ARC Foundation). SB and MA received grants from INCa Institut National du Cancer (INCa#:07/3D1616/PL-96-031/NG-NC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ghazaleh R, 2001, BIOCHEM J, V360, P255, DOI 10.1042/0264-6021:3600255; [Anonymous], 2001, GROWTH FACTORS; [Anonymous], 2007, J NUTR; Baluk P, 2005, CURR OPIN GENET DEV, V15, P102, DOI 10.1016/j.gde.2004.12.005; Baumeister U, 2005, EMBO J, V24, P1686, DOI 10.1038/sj.emboj.7600647; Bouillet L, 2011, J ALLERGY CLIN IMMUN, V128, P232, DOI 10.1016/j.jaci.2011.02.017; Brasch J, 2011, J MOL BIOL, V408, P57, DOI 10.1016/j.jmb.2011.01.031; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Charles NA, 2011, GLIA, V59, P1169, DOI 10.1002/glia.21136; Chi AS, 2009, ONCOLOGIST, V14, P621, DOI 10.1634/theoncologist.2008-0272; Corada M, 2002, BLOOD, V100, P905, DOI 10.1182/blood.V100.3.905; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Ducray F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-234; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Ebos JML, 2008, CANCER RES, V68, P521, DOI 10.1158/0008-5472.CAN-07-3217; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Esser S, 1998, J CELL SCI, V111, P1853; Farias-Eisner G, 2012, BRIT J NEUROSURG, V26, P189, DOI 10.3109/02688697.2011.629698; Feng HZ, 2011, J CLIN INVEST, V121, P4670, DOI 10.1172/JCI58559; Gerstner ER, 2008, CURR OPIN NEUROL, V21, P728, DOI 10.1097/WCO.0b013e328318402a; Greenfield JP, 2009, NEUROSURGERY, V64, P819, DOI 10.1227/01.NEU.0000343742.06625.DB; Haas TL, 1999, TRENDS CARDIOVAS MED, V9, P70, DOI 10.1016/S1050-1738(99)00014-6; Hermant B, 2003, J BIOL CHEM, V278, P14002, DOI 10.1074/jbc.M300351200; Hormigo A, 2007, CANCER CELL, V11, P6, DOI 10.1016/j.ccr.2006.12.008; Hudry-Clergeon H, 2005, FASEB J, V19, P512, DOI 10.1096/fj.04-2202com; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jiang Z, 2011, J NEURORADIOLOGY, V38, P53, DOI 10.1016/j.neurad.2010.03.004; Kargiotis O, 2006, J NEURO-ONCOL, V78, P281, DOI 10.1007/s11060-005-9097-6; Lambeng N, 2005, CIRC RES, V96, P384, DOI 10.1161/01.RES.0000156652.99586.9f; LI VW, 1994, LANCET, V344, P82, DOI 10.1016/S0140-6736(94)91280-7; LONG DM, 1970, J NEUROSURG, V32, P127, DOI 10.3171/jns.1970.32.2.0127; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Nagy JA, 2006, LAB INVEST, V86, P767, DOI 10.1038/labinvest.3700436; Pedraza LG, 2004, ONCOGENE, V23, P4754, DOI 10.1038/sj.onc.1207635; Petricoin EF, 2006, NAT REV CANCER, V6, P961, DOI 10.1038/nrc2011; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Sawlani RN, 2010, RADIOLOGY, V255, P622, DOI 10.1148/radiol.10091341; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Sidibe A, 2012, ARTHRITIS RHEUM-US, V64, P77, DOI 10.1002/art.33336; Sitohy B, 2011, CANCER RES, V71, P7021, DOI 10.1158/0008-5472.CAN-11-1693; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tabatabai G, 2010, ACTA NEUROPATHOL, V120, P585, DOI 10.1007/s00401-010-0750-6; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Wrensch M, 2002, NEURO-ONCOLOGY, V4, P278, DOI 10.1093/neuonc/4.4.278	51	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e80056	10.1371/journal.pone.0080056	http://dx.doi.org/10.1371/journal.pone.0080056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358106	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700002
J	Pan, Y; Wang, F; Qiu, Q; Ding, R; Zhao, BL; Zhou, H				Pan, Yang; Wang, Fang; Qiu, Qin; Ding, Ren; Zhao, Baolong; Zhou, Hua			Influence of the Angiotensin Converting Enzyme Insertion or Deletion Genetic Variant and Coronary Restenosis Risk: Evidence Based on 11,193 Subjects	PLOS ONE			English	Article							IN-STENT RESTENOSIS; SERIAL INTRAVASCULAR ULTRASOUND; PLACEBO-CONTROLLED TRIAL; ARTERY-DISEASE; BALLOON ANGIOPLASTY; MYOCARDIAL-INFARCTION; D ALLELE; CARDIOVASCULAR-DISEASE; NEOINTIMA FORMATION; DIABETIC-PATIENTS	The insertion/deletion (I/D) polymorphism of the gene encoding angiotensin converting enzyme is a controversial risk factor for restenosis after percutaneous transluminal coronary angioplasties (PTCA) in patients. Genetic association studies can be problematic to reproduce due to insufficient power, phenotypic heterogeneity, population stratification, small effect of the variant and even publication biases. To derive a more precise estimation of the relationship as well as to quantify the between-study heterogeneity and potential bias, a meta-analysis including 11,193 patients from 33 published cohort studies was performed. In a combined analysis, the summary per-allele odds ratio for restenosis was 1.31 (95% CI: 1.08-1.58, P = 0.006), and 1.22 (95% CI: 0.95-1.56, P = 0.12), for PTCA-stent and PTCA-balloon, respectively. In the subgroup analysis by ethnicity, significantly increased restenosis risks after PTCA-stent were found in Asians for the polymorphism; whereas no significant associations were found among Caucasians. As for restenosis risks after PTCA-balloon, no evidence of any gene-disease association was obtained in the stratified analyses according to ethnicity and study size. In conclusion, this meta-analysis demonstrated that the DD homozygous of ACE I/D polymorphism was significantly associated with elevated restenosis susceptibility after PTCA-stent among Asian populations.	[Pan, Yang; Qiu, Qin; Ding, Ren; Zhao, Baolong; Zhou, Hua] Baoshan Hosp Integrated Tradit Chinese & Western, Dept Cardiol, Shanghai, Peoples R China; [Wang, Fang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Cardiol, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Qiu, Q (corresponding author), Baoshan Hosp Integrated Tradit Chinese & Western, Dept Cardiol, Shanghai, Peoples R China.	qiuqin293@163.com						Agema WRP, 2004, EUR HEART J, V25, P1163, DOI 10.1016/j.ehj.2004.05.006; Agerholm-Larsen B, 2000, ARTERIOSCL THROM VAS, V20, P484, DOI 10.1161/01.ATV.20.2.484; Amant C, 1997, CIRCULATION, V96, P56; Andersen HR, 1996, CIRCULATION, V93, P1716; Arnett DK, 2007, CIRCULATION, V115, P2878, DOI 10.1161/CIRCULATIONAHA.107.183679; BALCON R, 1992, CIRCULATION, V86, P100; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BEOHAR N, 1995, J INVEST MED, V43, P275; BONITHONKOPP C, 1994, CIRCULATION, V89, P952, DOI 10.1161/01.CIR.89.3.952; CASTELLANO M, 1995, CIRCULATION, V91, P2721, DOI 10.1161/01.CIR.91.11.2721; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450; DANSER AHJ, 1995, CIRCULATION, V92, P1387, DOI 10.1161/01.CIR.92.6.1387; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DESMET W, 1994, CIRCULATION, V89, P385, DOI 10.1161/01.CIR.89.1.385; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; FARHY RD, 1993, CIRC RES, V72, P1202, DOI 10.1161/01.RES.72.6.1202; FAXON DP, 1995, J AM COLL CARDIOL, V25, P362, DOI 10.1016/0735-1097(94)00368-Z; Ferrari M, 2002, CARDIOLOGY, V97, P29, DOI 10.1159/000047416; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; [高璀乡 GAO Cuixiang], 2006, [南京医科大学学报. 自然科学版, Acta Universitatis Medicinalis Nanjing], V26, P351; Gensini F, 1999, Minerva Cardioangiol, V47, P516; Gomma AH, 2002, EUR HEART J, V23, P1955, DOI 10.1053/euhj.2002.3400; Guarda E, 1999, REV ESP CARDIOL, V52, P475, DOI 10.1016/S0300-8932(99)74954-7; Guneri S, 2005, INT HEART J, V46, P889, DOI 10.1536/ihj.46.889; Guo F, 2005, ZHONGGUO YOU SHENG Y, V13, P18; Gurlek A, 2000, J CARDIOVASC RISK, V7, P403; Hamon M, 1998, AM J CARDIOL, V81, P79, DOI 10.1016/S0002-9149(97)00852-7; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoffmann R, 1996, CIRCULATION, V94, P1247, DOI 10.1161/01.CIR.94.6.1247; Huang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069056; Jorgensen E, 2001, J AM COLL CARDIOL, V38, P1434, DOI 10.1016/S0735-1097(01)01580-7; KAKUTA T, 1994, CIRCULATION, V89, P2809, DOI 10.1161/01.CIR.89.6.2809; KAMITANI A, 1995, HYPERTENSION, V25, P950, DOI 10.1161/01.HYP.25.5.950; Kammerer CM, 2004, HYPERTENSION, V43, P466, DOI 10.1161/01.HYP.0000111830.36999.94; Kaski JC, 1996, AM J CARDIOL, V77, P875, DOI 10.1016/S0002-9149(97)89187-4; Koch W, 2000, CIRCULATION, V102, P197, DOI 10.1161/01.CIR.102.2.197; LAFONT A, 1995, CIRC RES, V76, P996, DOI 10.1161/01.RES.76.6.996; Langeveld B, 2005, J CARDIOVASC PHARM, V45, P88, DOI 10.1097/00005344-200501000-00015; Lee MS, 2004, J PATHOL, V203, P861, DOI 10.1002/path.1598; Lv D, 2012, ZHONGGUO FEN ZI XIN, V12, P76; Ma J, 1997, CANCER RES, V57, P1098; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mintz GS, 1996, AM J CARDIOL, V78, P18, DOI 10.1016/S0002-9149(96)00493-6; Mintz GS, 1996, CIRCULATION, V94, P35, DOI 10.1161/01.CIR.94.1.35; MORISHITA R, 1994, J CLIN INVEST, V94, P978, DOI 10.1172/JCI117464; NOBUYOSHI M, 1988, J AM COLL CARDIOL, V12, P616, DOI 10.1016/S0735-1097(88)80046-9; OHISHI M, 1993, NAT GENET, V5, P324, DOI 10.1038/ng1293-324; Oike Y, 1995, J CLIN INVEST, V96, P2975, DOI 10.1172/JCI118369; Okamura A, 1999, ANGIOLOGY, V50, P811, DOI 10.1177/000331979905001005; Okumura K, 2002, CIRC J, V66, P311, DOI 10.1253/circj.66.311; Passaro A, 2003, J INTERN MED, V254, P264, DOI 10.1046/j.1365-2796.2003.01184.x; Peters RJ, 1997, CIRCULATION, V95, P2254, DOI 10.1161/01.CIR.95.9.2254; POWELL JS, 1989, SCIENCE, V245, P186, DOI 10.1126/science.2526370; Prisco D, 2000, INT J CLIN LAB RES, V30, P179, DOI 10.1007/s005990070004; Qu Xiufen, 2002, Zhonghua Yi Xue Za Zhi, V82, P474; RAKUGI H, 1994, CIRCULATION, V90, P449, DOI 10.1161/01.CIR.90.1.449; RAKUGI H, 1994, J CLIN INVEST, V93, P339, DOI 10.1172/JCI116965; Ribichini F, 2003, AM J CARDIOL, V91, P154, DOI 10.1016/S0002-9149(02)03101-6; Ribichini F, 1998, CIRCULATION, V97, P147, DOI 10.1161/01.CIR.97.2.147; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Roiron C, 2006, HEART, V92, P641, DOI 10.1136/hrt.2005.061622; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ryu SK, 2002, YONSEI MED J, V43, P461, DOI 10.3349/ymj.2002.43.4.461; SAMANI NJ, 1995, LANCET, V345, P1013, DOI 10.1016/S0140-6736(95)90756-4; Sampietro ML, 2011, HUM MOL GENET, V20, P4748, DOI 10.1093/hmg/ddr389; Serruys PW, 1998, LANCET, V352, P673, DOI 10.1016/S0140-6736(97)11128-X; SERRUYS PW, 1988, CIRCULATION, V77, P361, DOI 10.1161/01.CIR.77.2.361; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; SIGWART U, 1987, NEW ENGL J MED, V316, P701, DOI 10.1056/NEJM198703193161201; Taniguchi I, 2001, JPN CIRC J, V65, P897, DOI 10.1253/jcj.65.897; Tantai J, 2013, TUMOR BIOL, DOI [10.1007/s13277-013-1094-3, DOI 10.1007/S13277-013-1094-3.PUBMED:23959479]; Tsukada K, 1997, JPN HEART J, V38, P799; Ujiie Y, 2006, INT HEART J, V47, P173, DOI 10.1536/ihj.47.173; VanBelle E, 1997, CIRCULATION, V96, P1454, DOI 10.1161/01.CIR.96.5.1454; VANBOCKXMEER FM, 1995, CIRCULATION, V92, P2066, DOI 10.1161/01.CIR.92.8.2066; VIOLARIS AG, 1995, CIRCULATION, V91, P2140, DOI 10.1161/01.CIR.91.8.2140; Volzke H, 2000, CLIN SCI, V99, P19; Wang H, 2005, ZHONGGUO LIN CHUANG, V9, P33; Wang SJ, 2005, ZHONGGUO LIN CHUANG, V12, P386; WEINTRAUB WS, 1993, J AM COLL CARDIOL, V21, P6, DOI 10.1016/0735-1097(93)90711-9; Wijpkema JS, 2006, PHARMACOGENET GENOM, V16, P331, DOI 10.1097/01.fpc.0000205001.07054.fa; Yoshida M, 1999, INT J CARDIOL, V70, P119, DOI 10.1016/S0167-5273(99)00064-9; Zee RYL, 2001, HYPERTENSION, V37, P851, DOI 10.1161/01.HYP.37.3.851; Zintzaras E, 2008, J CLIN EPIDEMIOL, V61, P634, DOI 10.1016/j.jclinepi.2007.12.011	85	7	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83415	10.1371/journal.pone.0083415	http://dx.doi.org/10.1371/journal.pone.0083415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349507	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200086
J	Puig, C; Calatayud, L; Marti, S; Tubau, F; Garcia-Vidal, C; Carratala, J; Linares, J; Ardanuy, C				Puig, Carmen; Calatayud, Laura; Marti, Sara; Tubau, Fe; Garcia-Vidal, Carolina; Carratala, Jordi; Linares, Josefina; Ardanuy, Carmen			Molecular Epidemiology of Nontypeable Haemophilus influenzae Causing Community-Acquired Pneumonia in Adults	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEIN-3; AMPICILLIN RESISTANCE GENES; AMINO-ACID SUBSTITUTIONS; BETA-LACTAM RESISTANCE; ANTIMICROBIAL SUSCEPTIBILITY; ANTIBIOTIC-RESISTANCE; INFECTIONS; DIVERSITY; PATHOGENS; STRAINS	Nontypeable Haemophilus influenzae (NTHi) is an opportunistic pathogen which causes a variety of respiratory infections. The objectives of the study were to determine its antimicrobial susceptibility, to characterize the beta-lactam resistance, and to establish a genetic characterization of NTHi isolates. Ninety-five NTHi isolates were analyzed by pulsed field gel electrophoresis (PFGE) and multi locus sequence typing (MLST). Antimicrobial susceptibility was determined by microdilution, and the ftsI gene (encoding penicillin-binding protein 3, PBP3) was PCR amplified and sequenced. Thirty (31.6%) isolates were non-susceptible to ampicillin (MIC >= 2 mg/L), with 10 of them producing beta-lactamase type TEM-1 as a resistance mechanism. After ftsI sequencing, 39 (41.1%) isolates showed amino acid substitutions in PBP3, with Asn526 -> R Lys being the most common (69.2%). Eighty-four patients were successfully treated with amoxicillin/clavulanic acid, ceftriaxone and levofloxacin. Eight patients died due either to aspiration or complication of their comorbidities. In conclusion, NTHi causing CAP in adults shows high genetic diversity and is associated with a high rate of reduced susceptibility to ampicillin due to alterations in PBP3. The analysis of treatment and outcomes demonstrated that NTHi strains with mutations in the ftsI gene could be successfully treated with ceftriaxone or fluoroquinolones.	[Puig, Carmen; Calatayud, Laura; Marti, Sara; Tubau, Fe; Linares, Josefina; Ardanuy, Carmen] Hosp Univ Bellvitge, Dept Microbiol, Barcelona, Spain; [Puig, Carmen; Calatayud, Laura; Marti, Sara; Tubau, Fe; Linares, Josefina; Ardanuy, Carmen] ISCIII, CIBER Enfermedades Resp CIBERes, Madrid, Spain; [Puig, Carmen; Calatayud, Laura; Marti, Sara; Linares, Josefina; Ardanuy, Carmen] IDIBELL, Epidemiol Bacterial Infect Grp, Barcelona, Spain; [Puig, Carmen; Linares, Josefina] Univ Barcelona, Dept Pathol & Expt Therapeut, Barcelona, Spain; [Garcia-Vidal, Carolina; Carratala, Jordi] Hosp Univ Bellvitge, Dept Infect Dis, Barcelona, Spain; [Garcia-Vidal, Carolina; Carratala, Jordi] ISCIII, Spanish Network Res Infect Dis REIPI, Madrid, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Instituto de Salud Carlos III	Ardanuy, C (corresponding author), Hosp Univ Bellvitge, Dept Microbiol, Barcelona, Spain.	c.ardanuy@bellvitgehospital.cat	Liñares, Josefina/N-9450-2014; Carratala, Jordi/AAC-2639-2020; Puig, Carmen/O-1257-2014; Ardanuy, Carmen/C-4463-2015; Marti, Sara/D-4823-2014; Carratalà, Jordi/B-8410-2011	Carratala, Jordi/0000-0003-3209-2563; Marti, Sara/0000-0002-0405-2305; Carratalà, Jordi/0000-0003-3209-2563; Ardanuy, Carmen/0000-0003-0225-607X; Garcia-Vidal, Carolina/0000-0002-8915-0683	Fondo de Investigaciones Sanitarias de la Seguridad Social [PI0901904]; CIBER de Enfermedades Respiratorias [CIBERES - CB06/06/0037]; Spanish Network for Research on Infectious Diseases (REIPI) [RD12/0015]; AGAUR-FI (Generalitat de Catalunya, Spain); FPU (Formacion de Profesorado Universitario, Ministerio de Educacion, Spain); Instituto de Salud Carlos III (ISCIII), Madrid, Spain [CD10/00298]	Fondo de Investigaciones Sanitarias de la Seguridad Social(Instituto de Salud Carlos III); CIBER de Enfermedades Respiratorias; Spanish Network for Research on Infectious Diseases (REIPI); AGAUR-FI (Generalitat de Catalunya, Spain)(Generalitat de Catalunya); FPU (Formacion de Profesorado Universitario, Ministerio de Educacion, Spain)(German Research Foundation (DFG)); Instituto de Salud Carlos III (ISCIII), Madrid, Spain(Instituto de Salud Carlos III)	This study was supported by a grant from the Fondo de Investigaciones Sanitarias de la Seguridad Social (PI0901904), by CIBER de Enfermedades Respiratorias (CIBERES - CB06/06/0037), run by the ISCIII (Instituto de Salud Carlos III), Madrid, Spain, and by Spanish Network for Research on Infectious Diseases (REIPI, RD12/0015), run by ISCIII, Madrid, Spain. CP was supported by grants from AGAUR-FI (Generalitat de Catalunya, Spain) and from FPU (Formacion de Profesorado Universitario, Ministerio de Educacion, Spain). SM was supported by a "Sara Borrell Postdoctoral Contract, CD10/00298'' from the Instituto de Salud Carlos III (ISCIII), Madrid, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2011, J CLIN MICROBIOL, V49, P3728, DOI 10.1128/JCM.05476-11; Barbosa AR, 2011, J ANTIMICROB CHEMOTH, V66, P788, DOI 10.1093/jac/dkq533; BELL SM, 1980, LANCET, V1, P279; Binks MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034083; Blosser-Middleton R, 2003, CLIN MICROBIOL INFEC, V9, P431, DOI 10.1046/j.1469-0691.2003.00543.x; Critchley IA, 2007, ANTIMICROB AGENTS CH, V51, P4382, DOI 10.1128/AAC.00971-07; Dabernat H, 2002, ANTIMICROB AGENTS CH, V46, P2208, DOI 10.1128/AAC.46.7.2208-2218.2002; De Schutter I, 2011, CLIN INFECT DIS, V52, P1437, DOI 10.1093/cid/cir235; Eldika N, 2006, CURR OPIN PULM MED, V12, P118, DOI 10.1097/01.mcp.0000208451.50231.8f; Erwin AL, 2007, TRENDS MICROBIOL, V15, P355, DOI 10.1016/j.tim.2007.06.004; FALLA TJ, 1994, J CLIN MICROBIOL, V32, P2382, DOI 10.1128/JCM.32.10.2382-2386.1994; Fluit AC, 2005, J ANTIMICROB CHEMOTH, V56, P133, DOI 10.1093/jac/dki167; Garcia-Cobos S, 2008, ANTIMICROB AGENTS CH, V52, P2760, DOI 10.1128/AAC.01674-07; Garcia-Cobos S, 2007, ANTIMICROB AGENTS CH, V51, P2564, DOI 10.1128/AAC.00354-07; Garcia-Vidal C, 2009, CLIN MICROBIOL INFEC, V15, P1033, DOI 10.1111/j.1469-0691.2009.02918.x; Gazagne L, 1998, J CLIN MICROBIOL, V36, P3629, DOI 10.1128/JCM.36.12.3629-3635.1998; Heilmann KP, 2005, ANTIMICROB AGENTS CH, V49, P2561, DOI 10.1128/aac.49.6.2561-2564.2005; Hotomi M, 2010, AURIS NASUS LARYNX, V37, P594, DOI 10.1016/j.anl.2010.02.005; Jansen WTM, 2006, J ANTIMICROB CHEMOTH, V58, P873, DOI 10.1093/jac/dkl310; Johansson N, 2010, CLIN INFECT DIS, V50, P202, DOI 10.1086/648678; KILIAN M, 1976, J GEN MICROBIOL, V93, P9, DOI 10.1099/00221287-93-1-9; Kim IS, 2007, ANTIMICROB AGENTS CH, V51, P453, DOI 10.1128/AAC.00960-06; Llor C, 2009, EUR J CLIN MICROBIOL, V28, P893, DOI 10.1007/s10096-009-0719-3; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Meats E, 2003, J CLIN MICROBIOL, V41, P1623, DOI 10.1128/JCM.41.4.1623-1636.2003; MENDELMAN PM, 1984, ANTIMICROB AGENTS CH, V26, P235, DOI 10.1128/AAC.26.2.235; MENDELMAN PM, 1987, INFECT IMMUN, V55, P2585, DOI 10.1128/IAI.55.11.2585-2589.1987; Morrissey I, 2008, J ANTIMICROB CHEMOTH, V62, pII97, DOI 10.1093/jac/dkn356; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, P43, DOI 10.1097/INF.0b013e318184dba2; PARR TR, 1984, ANTIMICROB AGENTS CH, V25, P747, DOI 10.1128/AAC.25.6.747; Perez-Trallero E, 2010, ANTIMICROB AGENTS CH, V54, P2953, DOI 10.1128/AAC.01548-09; Resman F, 2012, ANTIMICROB AGENTS CH, V56, P4408, DOI 10.1128/AAC.00415-12; Roson B, 2000, CLIN INFECT DIS, V31, P869, DOI 10.1086/318151; Saito Atsushi, 2006, Journal of Infection and Chemotherapy, V12, P63, DOI 10.1007/s10156-005-0425-8; Saito M, 1999, J CLIN MICROBIOL, V37, P2142, DOI 10.1128/JCM.37.7.2142-2147.1999; SCRIVER SR, 1994, ANTIMICROB AGENTS CH, V38, P1678, DOI 10.1128/AAC.38.7.1678; Shuel M, 2010, FEMS IMMUNOL MED MIC, V58, P277, DOI 10.1111/j.1574-695X.2009.00634.x; TENOVER FC, 1994, J CLIN MICROBIOL, V32, P2729, DOI 10.1128/JCM.32.11.2729-2737.1994; Tristram S, 2007, CLIN MICROBIOL REV, V20, P368, DOI 10.1128/CMR.00040-06; Ubukata K, 2001, ANTIMICROB AGENTS CH, V45, P1693, DOI 10.1128/AAC.45.6.1693-1699.2001; Viasus D, 2011, MEDICINE, V90, P110, DOI 10.1097/MD.0b013e318210504c; Wang H, 2011, INT J ANTIMICROB AG, V38, P376, DOI 10.1016/j.ijantimicag.2011.06.015; Wayne P., 2010, CLIN LAB STANDARDS I; Wayne P, 2006, M7A6 CLIN LAB STAND	44	31	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82515	10.1371/journal.pone.0082515	http://dx.doi.org/10.1371/journal.pone.0082515			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349303	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200048
J	Rosselli-Murai, LK; Almeida, LO; Zagni, C; Galindo-Moreno, P; Padial-Molina, M; Volk, SL; Murai, MJ; Rios, HF; Squarize, CH; Castilho, RM				Rosselli-Murai, Luciana K.; Almeida, Luciana O.; Zagni, Chiara; Galindo-Moreno, Pablo; Padial-Molina, Miguel; Volk, Sarah L.; Murai, Marcelo J.; Rios, Hector F.; Squarize, Cristiane H.; Castilho, Rogerio M.			Periostin Responds to Mechanical Stress and Tension by Activating the MTOR Signaling Pathway	PLOS ONE			English	Article							PERIODONTAL-LIGAMENT; CELL-GROWTH; EXTRACELLULAR-MATRIX; BINDING PARTNER; EXPRESSION; IDENTIFICATION; PROTEIN; RAPTOR; SKIN; TOR	Current knowledge about Periostin biology has expanded from its recognized functions in embryogenesis and bone metabolism to its roles in tissue repair and remodeling and its clinical implications in cancer. Emerging evidence suggests that Periostin plays a critical role in the mechanism of wound healing; however, the paracrine effect of Periostin in epithelial cell biology is still poorly understood. We found that epithelial cells are capable of producing endogenous Periostin that, unlike mesenchymal cell, cannot be secreted. Epithelial cells responded to Periostin paracrine stimuli by enhancing cellular migration and proliferation and by activating the mTOR signaling pathway. Interestingly, biomechanical stimulation of epithelial cells, which simulates tension forces that occur during initial steps of tissue healing, induced Periostin production and mTOR activation. The molecular association of Periostin and mTOR signaling was further dissected by administering rapamycin, a selective pharmacological inhibitor of mTOR, and by disruption of Raptor and Rictor scaffold proteins implicated in the regulation of mTORC1 and mTORC2 complex assembly. Both strategies resulted in ablation of Periostin-induced mitogenic and migratory activity. These results indicate that Periostin-induced epithelial migration and proliferation requires mTOR signaling. Collectively, our findings identify Periostin as a mechanical stress responsive molecule that is primarily secreted by fibroblasts during wound healing and expressed endogenously in epithelial cells resulting in the control of cellular physiology through a mechanism mediated by the mTOR signaling cascade.	[Rosselli-Murai, Luciana K.; Almeida, Luciana O.; Zagni, Chiara; Squarize, Cristiane H.; Castilho, Rogerio M.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Lab Epithelial Biol, Ann Arbor, MI 48109 USA; [Galindo-Moreno, Pablo; Padial-Molina, Miguel] Univ Granada, Sch Dent, Dept Oral Surg & Implant Dent, Granada, Spain; [Murai, Marcelo J.] Univ Michigan, Ctr Comprehens Canc, Div Hematol & Oncol, Ann Arbor, MI 48109 USA; [Padial-Molina, Miguel; Volk, Sarah L.; Rios, Hector F.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Granada; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Castilho, RM (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Lab Epithelial Biol, Ann Arbor, MI 48109 USA.	rcastilh@umich.edu	de Almeida, Luciana Oliveira/O-1013-2014; Padial-Molina, Miguel/L-9882-2013; Zagni, Chiara/AHH-9927-2022; Galindo-Moreno, Pablo/F-5567-2015; Almeida, Luciana O/G-8452-2012; de Almeida, Luciana Oliveira/AAF-1662-2020; Castilho, Rogerio M/E-4987-2010	de Almeida, Luciana Oliveira/0000-0002-5342-0434; Padial-Molina, Miguel/0000-0001-6222-1341; Galindo-Moreno, Pablo/0000-0002-6614-6470; Almeida, Luciana O/0000-0002-5342-0434; de Almeida, Luciana Oliveira/0000-0002-5342-0434; Castilho, Rogerio M/0000-0001-5358-612X; Zagni, Chiara/0000-0003-1220-4281; Squarize, Cristiane/0000-0002-6782-3429	National Institutes of Health (NIH/NCI) [P50-CA97248]; NATIONAL CANCER INSTITUTE [P50CA097248] Funding Source: NIH RePORTER	National Institutes of Health (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Institutes of Health (NIH/NCI) P50-CA97248 (University of Michigan Head and Neck SPORE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2002, CELL, V111, P9, DOI 10.1016/S0092-8674(02)01009-7; Arima M, 2012, INVEST OPHTH VIS SCI, V53, P6495, DOI 10.1167/iovs.12-9684; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; Ben QW, 2009, INT J ONCOL, V34, P821, DOI 10.3892/ijo_00000208; Bonnet N, 2009, J BIOL CHEM, V284, P35939, DOI 10.1074/jbc.M109.060335; Castilho RM, 2013, ORAL DIS, V19, P551, DOI 10.1111/odi.12070; Castilho RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010503; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Ehrenreiter K, 2005, J CELL BIOL, V168, P955, DOI 10.1083/jcb.200409162; Elias PM, 2005, EXP DERMATOL, V14, P719, DOI 10.1111/j.1600-0625.2005.00363.x; Elliott CG, 2012, J CELL SCI, V125, P121, DOI 10.1242/jcs.087841; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Fuchs E, 2008, COLD SH Q B, V73, P333, DOI 10.1101/sqb.2008.73.032; Gillan L, 2002, CANCER RES, V62, P5358; Goetsch SC, 2003, PHYSIOL GENOMICS, V14, P261, DOI 10.1152/physiolgenomics.00056.2003; Goranov AI, 2013, CURR BIOL, V23, P1269, DOI 10.1016/j.cub.2013.05.035; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hamilton DW, 2008, J CELL COMMUN SIGNAL, V2, P9, DOI 10.1007/s12079-008-0023-5; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jackson-Boeters L, 2009, J CELL COMMUN SIGNAL, V3, P125, DOI 10.1007/s12079-009-0057-3; Jimenez C, 2000, J CELL BIOL, V151, P249, DOI 10.1083/jcb.151.2.249; Kahan BD, 2000, LANCET, V356, P194, DOI 10.1016/S0140-6736(00)02480-6; Kaposztas Z, 2008, TRANSPL P, V40, P1744, DOI [10.1016/j.transproceed.2007.11.072, 10.1016/j.transproceed.2008.10.019]; Kim BY, 2009, J BIOL CHEM, V284, P19580, DOI 10.1074/jbc.M109.013607; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Knight RJ, 2007, CLIN TRANSPLANT, V21, P460, DOI 10.1111/j.1399-0012.2007.00668.x; Kruzynska-Frejtag A, 2001, MECH DEVELOP, V103, P183, DOI 10.1016/S0925-4773(01)00356-2; Kudo A, 2011, CELL MOL LIFE SCI, V68, P3201, DOI 10.1007/s00018-011-0784-5; Kudo Y, 2006, CANCER RES, V66, P6928, DOI 10.1158/0008-5472.CAN-05-4540; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lindner V, 2005, ARTERIOSCL THROM VAS, V25, P77, DOI 10.1161/01.ATV.0000149141.81230.c6; Moore SF, 2011, J BIOL CHEM, V286, P24553, DOI 10.1074/jbc.M110.202341; Naik PK, 2012, AM J PHYSIOL-LUNG C, V303, pL1046, DOI 10.1152/ajplung.00139.2012; Nakamura S, 2005, BIOCHEM BIOPH RES CO, V338, P1197, DOI 10.1016/j.bbrc.2005.10.076; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Ontsuka K, 2012, EXP DERMATOL, V21, P331, DOI 10.1111/j.1600-0625.2012.01454.x; Padial-Molina M, 2012, J DENT RES, V91, P1078, DOI 10.1177/0022034512459655; Padial-Molina M, 2013, J PERIODONTOL, V84, P694, DOI 10.1902/jop.2012.120078; Peltzer N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068123; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sasaki H, 2003, BREAST CANCER RES TR, V77, P245, DOI 10.1023/A:1021899904332; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Squarize CH, 2006, NEOPLASIA, V8, P733, DOI 10.1593/neo.06274; Squarize CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010643; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Tilman G, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-80; Tischler V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-273; Verreault M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059597; Watt FM, 2011, COLD SPRING HARB PER, V3; Wilde J, 2003, CELL TISSUE RES, V312, P345, DOI 10.1007/s00441-002-0664-2; WOODLEY DT, 1993, DERMATOL CLIN, V11, P641, DOI 10.1016/S0733-8635(18)30217-1; Yang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041994; Yoshiba N, 2007, CELL TISSUE RES, V330, P133, DOI 10.1007/s00441-007-0439-x; Zhou HM, 2010, J CELL COMMUN SIGNAL, V4, P99, DOI 10.1007/s12079-010-0090-2	62	40	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83580	10.1371/journal.pone.0083580	http://dx.doi.org/10.1371/journal.pone.0083580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349533	gold, Green Submitted, Green Published			2022-12-27	WOS:000328734200096
J	Weippert, M; Behrens, K; Rieger, A; Stoll, R; Kreuzfeld, S				Weippert, Matthias; Behrens, Kristin; Rieger, Annika; Stoll, Regina; Kreuzfeld, Steffi			Heart Rate Variability and Blood Pressure during Dynamic and Static Exercise at Similar Heart Rate Levels	PLOS ONE			English	Article							MYOCARDIAL OXYGEN-CONSUMPTION; RESPIRATORY SINUS ARRHYTHMIA; PHYSIOLOGICAL TIME-SERIES; CARDIAC VAGAL TONE; MUSCLE METABOREFLEX; ISOMETRIC-EXERCISE; CENTRAL COMMAND; CARDIOVASCULAR-RESPONSES; APPROXIMATE ENTROPY; SPECTRAL-ANALYSIS	Aim was to elucidate autonomic responses to dynamic and static (isometric) exercise of the lower limbs eliciting the same moderate heart rate (HR) response. Method: 23 males performed two kinds of voluntary exercise in a supine position at similar heart rates: static exercise (SE) of the lower limbs (static leg press) and dynamic exercise (DE) of the lower limbs (cycling). Subjective effort, systolic (SBP) and diastolic blood pressure (DBP), mean arterial pressure (MAP), rate pressure product (RPP) and the time between consecutive heart beats (RR-intervals) were measured. Time-domain (SDNN, RMSSD), frequency-domain (power in the low and high frequency band (LFP, HFP)) and geometric measures (SD1, SD2) as well as non-linear measures of regularity (approximate entropy (ApEn), sample entropy (SampEn) and correlation dimension D2) were calculated. Results: Although HR was similar during both exercise conditions (88 +/- 10 bpm), subjective effort, SBP, DBP, MAP and RPP were significantly enhanced during SE. HRV indicators representing overall variability (SDNN, SD 2) and vagal modulated variability (RMSSD, HFP, SD 1) were increased. LFP, thought to be modulated by both autonomic branches, tended to be higher during SE. ApEn and SampEn were decreased whereas D2 was enhanced during SE. It can be concluded that autonomic control processes during SE and DE were qualitatively different despite similar heart rate levels. The differences were reflected by blood pressure and HRV indices. HRV-measures indicated a stronger vagal cardiac activity during SE, while blood pressure response indicated a stronger sympathetic efferent activity to the vessels. The elevated vagal cardiac activity during SE might be a response mechanism, compensating a possible co-activation of sympathetic cardiac efferents, as HR and LF/HF was similar and LFP tended to be higher. However, this conclusion must be drawn cautiously as there is no HRV-marker reflecting "pure" sympathetic cardiac activity.	[Weippert, Matthias; Behrens, Kristin; Stoll, Regina; Kreuzfeld, Steffi] Univ Rostock, Sch Med, Inst Prevent Med, D-18055 Rostock, Mecklenburg Vor, Germany; [Weippert, Matthias; Rieger, Annika] Univ Rostock, Ctr Life Sci Automat, D-18055 Rostock, Mecklenburg Vor, Germany	University of Rostock; University of Rostock	Weippert, M (corresponding author), Univ Rostock, Sch Med, Inst Prevent Med, D-18055 Rostock, Mecklenburg Vor, Germany.	matthias.weippert@uni-rostock.de	Weippert, Matthias/AAE-4048-2021	Weippert, Matthias/0000-0003-2323-0047; Stoll, Regina/0000-0003-2800-5252; Kreuzfeld, Steffi/0000-0003-0785-5928	German Federal Ministry of Education and Research [03Z1KN11]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Part of this work was funded by the German Federal Ministry of Education and Research (http://www.bmbf.de/), Grant Number: 03Z1KN11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ABBOUD FM, 1979, AM J CARDIOL, V44, P903, DOI 10.1016/0002-9149(79)90221-2; Alam M, 1938, J PHYSIOL-LONDON, V92, P167, DOI 10.1113/jphysiol.1938.sp003592; Augustyniak RA, 2001, AM J PHYSIOL-HEART C, V280, pH1645, DOI 10.1152/ajpheart.2001.280.4.H1645; Backs RW, 1995, INT J AVIAT PSYCHOL, V5, P25, DOI 10.1207/s15327108ijap0501_3; Baguley T, 2004, APPL ERGON, V35, P73, DOI 10.1016/j.apergo.2004.01.002; Behnia S, 2008, CHINESE J PHYS, V46, P394; BERNTSON GG, 1991, PSYCHOL REV, V98, P459, DOI 10.1037/0033-295X.98.4.459; Blain G, 2009, AM J PHYSIOL-HEART C, V296, pH1651, DOI 10.1152/ajpheart.00881.2008; Bogaert C, 2001, AUTON NEUROSCI-BASIC, V90, P142, DOI 10.1016/S1566-0702(01)00280-6; Boon MY, 2008, J VISION, V8, DOI 10.1167/8.1.6; Botoeva N, 2012, J EARTH SCI ENG, P576; Bradshaw DI, 2005, RES Q EXERCISE SPORT, V76, P426; Camm AJ, 1996, CIRCULATION, V93, P1043; Smirmaul BDC, 2012, BRIT J SPORT MED, V46, P308, DOI 10.1136/bjsm.2010.071407; Carrington CA, 2001, CLIN SCI, V100, P643, DOI 10.1042/CS20000270; CASADEI B, 1995, ACTA PHYSIOL SCAND, V153, P125, DOI 10.1111/j.1748-1716.1995.tb09843.x; Casadei B, 1996, J APPL PHYSIOL, V81, P556, DOI 10.1152/jappl.1996.81.2.556; Casadei B, 2001, EXP PHYSIOL, V86, P817, DOI 10.1111/j.1469-445X.2001.tb00050.x; CHAPMAN JH, 1988, EUR J APPL PHYSIOL, V58, P152, DOI 10.1007/BF00636619; Crisafulli A, 2003, MED SCI SPORT EXER, V35, P221, DOI 10.1249/01.MSS.0000048639.02548.24; DeBeck LD, 2010, AM J PHYSIOL-REG I, V299, pR80, DOI 10.1152/ajpregu.00246.2009; Eckberg DL, 1997, CIRCULATION, V96, P3224, DOI 10.1161/01.CIR.96.9.3224; Elstad M, 2009, ACTA PHYSIOL, V195, P289, DOI 10.1111/j.1748-1716.2008.01887.x; Fisher JP, 2006, J PHYSIOL-LONDON, V572, P869, DOI 10.1113/jphysiol.2005.103028; Fojt O, 1998, IEEE ENG MED BIOL, V17, P96, DOI 10.1109/51.664037; GOBEL FL, 1978, CIRCULATION, V57, P549, DOI 10.1161/01.CIR.57.3.549; Gonzalez-Camarena R, 2000, MED SCI SPORT EXER, V32, P1719, DOI 10.1097/00005768-200010000-00010; GOODWIN GM, 1972, J PHYSIOL-LONDON, V226, P173, DOI 10.1113/jphysiol.1972.sp009979; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; Grossman P, 2007, BIOL PSYCHOL, V74, P263, DOI 10.1016/j.biopsycho.2005.11.014; Guzzetti S, 1996, CARDIOVASC RES, V31, P441; Hartwich D, 2011, J PHYSIOL-LONDON, V589, P6157, DOI 10.1113/jphysiol.2011.219964; HUIKURI HV, 1990, AM J CARDIOL, V65, P391, DOI 10.1016/0002-9149(90)90308-N; Ichinose M, 2011, AM J PHYSIOL-HEART C, V301, pH609, DOI 10.1152/ajpheart.00076.2011; Iellamo F, 1997, AM J PHYSIOL-HEART C, V272, pH1157, DOI 10.1152/ajpheart.1997.272.3.H1157; Iellamo F, 1997, EUR J APPL PHYSIOL O, V75, P89, DOI 10.1007/s004210050131; Iellamo F, 2001, AUTON NEUROSCI-BASIC, V90, P66, DOI 10.1016/S1566-0702(01)00269-7; Iellamo F, 1999, J APPL PHYSIOL, V86, P174, DOI 10.1152/jappl.1999.86.1.174; Iellamo F, 1999, CIRCULATION, V100, P27, DOI 10.1161/01.CIR.100.1.27; Julien C, 2006, J APPL PHYSIOL, V101, P684, DOI 10.1152/japplphysiol.00562.2006; Kingsley M, 2005, INT J SPORTS MED, V26, P39, DOI 10.1055/s-2004-817878; Korpelainen JT, 1997, STROKE, V28, P2150, DOI 10.1161/01.STR.28.11.2150; Kuwahara K, 2011, J PHYSIOL ANTHROPOL, V30, P223, DOI 10.2114/jpa2.30.223; LAIRD WP, 1979, CIRCULATION, V59, P651, DOI 10.1161/01.CIR.59.4.651; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Lake DE, 2011, AM J PHYSIOL-HEART C, V300, pH319, DOI 10.1152/ajpheart.00561.2010; Leicht AS, 2008, EUR J APPL PHYSIOL, V102, P195, DOI 10.1007/s00421-007-0574-9; LEWIS SF, 1985, J APPL PHYSIOL, V58, P146, DOI 10.1152/jappl.1985.58.1.146; Liang N, 2011, J APPL PHYSIOL, V110, P670, DOI 10.1152/japplphysiol.00740.2010; LIND AR, 1967, CAN MED ASSOC J, V96, P706; LIND AR, 1970, CIRCULATION, V41, P173, DOI 10.1161/01.CIR.41.2.173; LINDQUIST VA, 1973, AM HEART J, V85, P227, DOI 10.1016/0002-8703(73)90464-X; Louhevaara V, 2000, EUR J APPL PHYSIOL, V82, P340, DOI 10.1007/s004210000200; Lunt HC, 2011, PHYSIOL MEAS, V32, P1133, DOI 10.1088/0967-3334/32/8/009; Makikallio TH, 1996, J AM COLL CARDIOL, V28, P1005, DOI 10.1016/S0735-1097(96)00243-4; Makikallio Timo H, 2002, Card Electrophysiol Rev, V6, P250, DOI 10.1023/A:1016381025759; MARK AL, 1985, CIRC RES, V57, P461, DOI 10.1161/01.RES.57.3.461; Matsukawa K, 2012, EXP PHYSIOL, V97, P20, DOI 10.1113/expphysiol.2011.057661; MITCHELL JH, 1980, J PHYSIOL-LONDON, V309, P45, DOI 10.1113/jphysiol.1980.sp013492; MITCHELL JH, 1985, AM J CARDIOL, V55, pD34, DOI 10.1016/0002-9149(85)91053-7; NELSON RR, 1974, CIRCULATION, V50, P1179, DOI 10.1161/01.CIR.50.6.1179; NISHIYASU T, 1994, J APPL PHYSIOL, V77, P2778, DOI 10.1152/jappl.1994.77.6.2778; Nobrega ACL, 1997, J APPL PHYSIOL, V83, P712, DOI 10.1152/jappl.1997.83.3.712; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Penttila J., 2003, Autonomic & Autacoid Pharmacology, V23, P173, DOI 10.1046/j.1474-8673.2003.00293.x; Penttila J, 2001, CLIN PHYSIOL, V21, P365, DOI 10.1046/j.1365-2281.2001.00337.x; Perini R, 2003, EUR J APPL PHYSIOL, V90, P317, DOI 10.1007/s00421-003-0953-9; Perkiomaki J.S., 2000, ANN NONINVAS ELECTRO, V5, P179, DOI [10.1111/j.1542-474x.2000.tb00384.x, DOI 10.1111/J.1542-474X.2000.TB00384.X]; PIEPOLI M, 1995, AM J PHYSIOL-HEART C, V269, pH1428, DOI 10.1152/ajpheart.1995.269.4.H1428; PINCUS SM, 1992, OBSTET GYNECOL, V79, P249; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Ponikowski P, 1997, CIRCULATION, V96, P2586, DOI 10.1161/01.CIR.96.8.2586; Princi T, 2004, TECH PAPERS ISA, V449, P311; Raab C, 2006, BIOMED TECH, V51, P229, DOI 10.1515/BMT.2006.043; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rickards CA, 2010, J CLIN MONIT COMPUT, V24, P61, DOI 10.1007/s10877-009-9210-z; ROHMERT W., 1960, INTERNATL ZEITSCHR ANGEW PHYSIOL, V18, P123; ROWELL LB, 1990, J APPL PHYSIOL, V69, P407, DOI 10.1152/jappl.1990.69.2.407; Saboul D, 2013, EUR J SPORT SCI, V13, P534, DOI 10.1080/17461391.2013.767947; SAITO M, 1991, JPN J PHYSIOL, V41, P143, DOI 10.2170/jjphysiol.41.143; Schneider R, 2013, HEART RATE VARIABILITY (HRV) SIGNAL ANALYSIS: CLINICAL APPLICATIONS, P87; Tulppo MP, 2001, AM J PHYSIOL-HEART C, V280, pH1081, DOI 10.1152/ajpheart.2001.280.3.H1081; Tulppo MP, 2001, CLIN PHYSIOL, V21, P515, DOI 10.1046/j.1365-2281.2001.00344.x; Tulppo MP, 1996, AM J PHYSIOL-HEART C, V271, pH244, DOI 10.1152/ajpheart.1996.271.1.H244; TUTTLE WW, 1957, J APPL PHYSIOL, V10, P294, DOI 10.1152/jappl.1957.10.2.294; Vikman S, 1999, CIRCULATION, V100, P2079, DOI 10.1161/01.CIR.100.20.2079; Weber F, 1999, KIDNEY BLOOD PRESS R, V22, P166, DOI 10.1159/000025924; Weippert M, 2010, EUR J APPL PHYSIOL, V109, P779, DOI 10.1007/s00421-010-1415-9; WILLIAMS CA, 1985, EUR J APPL PHYSIOL, V54, P156, DOI 10.1007/BF02335923; Yeragani VK, 2005, DEPRESS ANXIETY, V21, P130, DOI 10.1002/da.20061	90	41	44	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83690	10.1371/journal.pone.0083690	http://dx.doi.org/10.1371/journal.pone.0083690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349546	gold, Green Published, Green Submitted			2022-12-27	WOS:000328734200100
J	Kleiman, LB; Krebs, AM; Kim, SY; Hong, TS; Haigis, KM				Kleiman, Laura B.; Krebs, Angela M.; Kim, Stephen Y.; Hong, Theodore S.; Haigis, Kevin M.			Comparative Analysis of Radiosensitizers for K-RAS Mutant Rectal Cancers	PLOS ONE			English	Article							CHECKPOINT KINASE 1; GROWTH-FACTOR RECEPTOR; MEDIATES RADIORESISTANCE; RADIATION-RESISTANCE; SELECTIVE INHIBITOR; LOCAL RECURRENCE; HUMAN CHK1; IN-VITRO; PHOSPHORYLATION; ABROGATION	Approximately 40% of rectal cancers harbor activating K-RAS mutations, and these mutations are associated with poor clinical response to chemoradiotherapy. We aimed to identify small molecule inhibitors (SMIs) that synergize with ionizing radiation (IR) ("radiosensitizers") that could be incorporated into current treatment strategies for locally advanced rectal cancers (LARCs) expressing mutant K-RAS. We first optimized a high-throughput assay for measuring individual and combined effects of SMIs and IR that produces similar results to the gold standard colony formation assay. Using this screening platform and K-RAS mutant rectal cancer cell lines, we tested SMIs targeting diverse signaling pathways for radiosensitizing activity and then evaluated our top hits in follow-up experiments. The two most potent radiosensitizers were the Chk1/2 inhibitor AZD7762 and the PI3K/mTOR inhibitor BEZ235. The chemotherapeutic agent 5-fluorouracil (5-FU), which is used to treat LARC, synergized with AZD7762 and enhanced radiosensitization by AZD7762. This study is the first to compare different SMIs in combination with IR for the treatment of K-RAS mutant rectal cancer, and our findings suggest that Chk1/2 inhibitors should be evaluated in new clinical trials for LARC.	[Kleiman, Laura B.; Krebs, Angela M.; Kim, Stephen Y.; Haigis, Kevin M.] Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA 02129 USA; [Kleiman, Laura B.; Krebs, Angela M.; Kim, Stephen Y.; Haigis, Kevin M.] Massachusetts Gen Hosp, Ctr Syst Biol, Charlestown, MA USA; [Krebs, Angela M.] Univ Freiburg, Inst Mol Med & Cell Res, Freiburg, Germany; [Hong, Theodore S.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Freiburg; Harvard University; Massachusetts General Hospital	Haigis, KM (corresponding author), Massachusetts Gen Hosp, Mol Pathol Unit, Ctr Canc Res, Charlestown, MA 02129 USA.	KHAIGIS@PARTNERS.ORG			American Cancer Society [MGO-114877, PF-11-260-01]; pilot project grant from the Proton Beam Federal Share program	American Cancer Society(American Cancer Society); pilot project grant from the Proton Beam Federal Share program	This work was funded by the American Cancer Society (MGO-114877 to K.M.H. and PF-11-260-01 to L.B.K.) and by a pilot project grant from the Proton Beam Federal Share program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM IJ, 1994, LANCET, V344, P707, DOI 10.1016/S0140-6736(94)92206-3; Aklilu M, 2011, NAT REV CLIN ONCOL, V8, P649, DOI 10.1038/nrclinonc.2011.118; Anderson VE, 2011, CANCER RES, V71, P463, DOI 10.1158/0008-5472.CAN-10-1252; Azad A, 2011, MOL CANCER RES, V9, P1696, DOI 10.1158/1541-7786.MCR-11-0312; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Bernhard EJ, 2000, CANCER RES, V60, P6597; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Brunner TB, 2005, CANCER RES, V65, P8433, DOI 10.1158/0008-5472.CAN-05-0158; Carlessi L, 2007, MOL CANCER THER, V6, P935, DOI 10.1158/1535-7163.MCT-06-0567; Carlessi L, 2010, BBA-MOL CELL RES, V1803, P1213, DOI 10.1016/j.bbamcr.2010.06.002; Castedo M, 2004, ONCOGENE, V23, P4353, DOI 10.1038/sj.onc.1207573; Cengel KA, 2007, NEOPLASIA, V9, P341, DOI 10.1593/neo.06823; Chen T, 2012, DRUG DISCOV TODAY, V17, P194, DOI 10.1016/j.drudis.2011.12.009; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Debucquoy A, 2010, CLIN CANCER RES, V16, P2709, DOI 10.1158/1078-0432.CCR-09-1622; Elshaikh M, 2006, ANNU REV MED, V57, P19, DOI 10.1146/annurev.med.57.121304.131431; Eng C, 2010, ONCOLOGIST, V15, P73, DOI 10.1634/theoncologist.2009-0167; Eriksson D, 2010, TUMOR BIOL, V31, P363, DOI 10.1007/s13277-010-0042-8; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fokas E, 2012, CANCER RES, V72, P239, DOI 10.1158/0008-5472.CAN-11-2263; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Garcia-Aguilar J, 2011, ANN SURG, V254, P486, DOI 10.1097/SLA.0b013e31822b8cfa; Grana TM, 2002, CANCER RES, V62, P4142; Gupta AK, 2001, CANCER RES, V61, P4278; Hong TS, 2012, CANCER DISCOV, V2, P117, DOI 10.1158/2159-8290.CD-11-0315; Jobson AG, 2009, J PHARMACOL EXP THER, V331, P816, DOI 10.1124/jpet.109.154997; Konstantinidou G, 2009, CANCER RES, V69, P7644, DOI 10.1158/0008-5472.CAN-09-0823; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Ma CX, 2011, TRENDS MOL MED, V17, P88, DOI 10.1016/j.molmed.2010.10.009; Ma ZK, 2012, MOL MED REP, V6, P897, DOI 10.3892/mmr.2012.999; Manfredi S, 2006, BRIT J SURG, V93, P1115, DOI 10.1002/bjs.5349; Maugeri-Sacca M, 2013, CANCER TREAT REV, V39, P525, DOI 10.1016/j.ctrv.2012.10.007; McKenna WG, 2003, ONCOGENE, V22, P5866, DOI 10.1038/sj.onc.1206699; McNeely S, 2010, CELL CYCLE, V9, P995, DOI 10.4161/cc.9.5.10935; Minjgee M, 2011, INT J RADIAT ONCOL, V81, P1506, DOI 10.1016/j.ijrobp.2011.05.057; Mitchell JB, 2010, CLIN CANCER RES, V16, P2076, DOI 10.1158/1078-0432.CCR-09-3277; Morgan MA, 2006, CELL CYCLE, V5, P1983, DOI 10.4161/cc.5.17.3184; Morgan MA, 2010, CANCER RES, V70, P4972, DOI 10.1158/0008-5472.CAN-09-3573; Mukherjee B, 2012, NEOPLASIA, V14, P34, DOI 10.1593/neo.111512; Niida H, 2005, J BIOL CHEM, V280, P39246, DOI 10.1074/jbc.M505009200; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Parsels LA, 2011, CLIN CANCER RES, V17, P3706, DOI 10.1158/1078-0432.CCR-10-3082; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Rodel C, 2005, J CLIN ONCOL, V23, P8688, DOI 10.1200/JCO.2005.02.1329; Santiskulvong C, 2011, CLIN CANCER RES, V17, P2373, DOI 10.1158/1078-0432.CCR-10-2289; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Vance SM, 2011, CELL CYCLE, V10, P4321, DOI 10.4161/cc.10.24.18661; Vitale I, 2011, NAT REV MOL CELL BIO, V12, P384, DOI 10.1038/nrm3115; Xiao Z, 2005, ONCOGENE, V24, P1403, DOI 10.1038/sj.onc.1208309; Xiao Z, 2006, MOL CANCER THER, V5, P1935, DOI 10.1158/1535-7163.MCT-06-0077; Yang H, 2011, BIOCHEM BIOPH RES CO, V406, P53, DOI 10.1016/j.bbrc.2011.01.106; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019	55	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82982	10.1371/journal.pone.0082982	http://dx.doi.org/10.1371/journal.pone.0082982			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349411	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800086
J	Liu, XP; Zhang, WJ; Cao, JS; Shen, HT; Zeng, XH; Yu, ZQ; Zhao, X				Liu, Xiuping; Zhang, Wanjun; Cao, Jiansheng; Shen, Huitao; Zeng, Xinhua; Yu, Zhiqiang; Zhao, Xin			Carbon Storages in Plantation Ecosystems in Sand Source Areas of North Beijing, China	PLOS ONE			English	Article							MAJOR FOREST TYPES; GARHWAL HIMALAYA; SOIL CARBON; SEQUESTRATION; AFFORESTATION; BIOMASS; REGION; VEGETATION; ACCUMULATION; GRASSLAND	Afforestation is a mitigation option to reduce the increased atmospheric carbon dioxide levels as well as the predicted high possibility of climate change. In this paper, vegetation survey data, statistical database, National Forest Resource Inventory database, and allometric equations were used to estimate carbon density (carbon mass per hectare) and carbon storage, and identify the size and spatial distribution of forest carbon sinks in plantation ecosystems in sand source areas of north Beijing, China. From 2001 to the end of 2010, the forest areas increased more than 2.3 million ha, and total carbon storage in forest ecosystems was 173.02 Tg C, of which 82.80 percent was contained in soil in the top 0-100 cm layer. Younger forests have a large potential for enhancing carbon sequestration in terrestrial ecosystems than older ones. Regarding future afforestation efforts, it will be more effective to increase forest area and vegetation carbon density through selection of appropriate tree species and stand structure according to local climate and soil conditions, and application of proper forest management including land-shaping, artificial tending and fencing plantations. It would be also important to protect the organic carbon in surface soils during forest management.	[Liu, Xiuping; Zhang, Wanjun; Cao, Jiansheng; Shen, Huitao; Zeng, Xinhua; Zhao, Xin] Chinese Acad Sci, Inst Genet & Dev Biol, Hebei Key Lab Agr Water Saving, Key Lab Agr Water Resources,Ctr Agr Resources Res, Shijiazhuang, Peoples R China; [Yu, Zhiqiang] Arizona State Univ, Biodesign Inst, Ctr BioEnerget, Tempe, AZ USA	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Arizona State University; Arizona State University-Tempe	Zhang, WJ (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Hebei Key Lab Agr Water Saving, Key Lab Agr Water Resources,Ctr Agr Resources Res, Shijiazhuang, Peoples R China.	zhangwj@sjziam.ac.cn			National Natural Science Foundation of China [31000251]; Chinese Academy of Sciences [XDA05060600]; Project of Efficient Utilization of Agricultural Resources [KSCX2-EW-J-5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Project of Efficient Utilization of Agricultural Resources	This work was funded by the National Natural Science Foundation of China (31000251), "Strategic Priority Research Program'' of the Chinese Academy of Sciences (XDA05060600), and Project of Efficient Utilization of Agricultural Resources (KSCX2-EW-J-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredsson H, 1998, FOREST ECOL MANAG, V112, P245, DOI 10.1016/S0378-1127(98)00346-6; Bai Xue-shuang, 2008, Shengtaixue Zazhi, V27, P1647; Batjes NH, 2014, EUR J SOIL SCI, V65, P10, DOI 10.1111/ejss.12114_2; Birdsey R.A., 1995, RM271 USDA FOR SERV, P56; Brown S., 1996, Unasylva (English ed.), V47, P3; Brown S., 1996, Commonwealth Forestry Review, V75, P80; Brown S, 2004, EXPLORATION CA UNPUB; Brown SL, 1999, FOREST ECOL MANAG, V123, P81, DOI 10.1016/S0378-1127(99)00017-1; Cairns MA, 1997, MITIG ADAPT STRAT GL, V1, P363; Cao SX, 2008, ENVIRON SCI TECHNOL, V42, P1826, DOI 10.1021/es0870597; Cao SX, 2011, AMBIO, V40, P828, DOI 10.1007/s13280-011-0150-8; Cao SX, 2011, CRIT REV ENV SCI TEC, V41, P317, DOI 10.1080/10643380902800034; Cao SX, 2011, EARTH-SCI REV, V104, P240, DOI 10.1016/j.earscirev.2010.11.002; Chang RY, 2011, ENVIRON MANAGE, V48, P1158, DOI 10.1007/s00267-011-9682-8; Chen XG, 2009, FOREST ECOL MANAG, V258, P199, DOI 10.1016/j.foreco.2008.07.010; Committee of Chinese Ecological Research Network, 2007, PROT STAND BIOL OBS; Corlett RT, 1999, FOREST ECOL MANAG, V116, P93, DOI 10.1016/S0378-1127(98)00443-5; Davis MR, 2002, AUST J SOIL RES, V40, P675, DOI 10.1071/SR01074; DETWILER RP, 1986, BIOGEOCHEMISTRY, V2, P67, DOI 10.1007/BF02186966; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; du Toit JT, 2004, TRENDS ECOL EVOL, V19, P12, DOI 10.1016/j.tree.2003.09.018; Editorial Committee of Flora Reipublicae Popularis Sinicae, 1959, FLORA REIPUBLICAE PO; Fan SY, 2001, AMBIO, V30, P384; Fang JY, 2007, SCI CHINA SER D, V50, P92, DOI 10.1007/s11430-007-2031-3; Fang JY, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002253; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; [冯瑞芳 FENG RuiFang], 2006, [生态学报, Acta Ecologica Sinica], V26, P3870; Feng Z. W., 1999, BIOMASS PRODUCTIVITY; Gaston GG, 1997, PHOTOGRAMM ENG REM S, V63, P51; Grunzweig JM, 2003, GLOBAL CHANGE BIOL, V9, P791, DOI 10.1046/j.1365-2486.2003.00612.x; Huang CD, 2008, THESIS SICHUAN AGR U THESIS SICHUAN AGR U; Huang Cong-de, 2008, Yingyong Shengtai Xuebao, V19, P1644; KOLCHUGINA TP, 1993, WATER AIR SOIL POLL, V70, P207, DOI 10.1007/BF01104998; Laclau P, 2003, FOREST ECOL MANAG, V180, P317, DOI 10.1016/S0378-1127(02)00580-7; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Li HaiKui, 2011, Scientia Silvae Sinicae, V47, P7; Li X, 2010, SCAND J FOREST RES, V25, P554, DOI 10.1080/02827581.2010.524892; Li X, 2011, J PLANT BIOL, V54, P33, DOI 10.1007/s12374-010-9140-9; Lin QS, 2009, CHINESE AGR SCI B, V25, P220; Liu JG, 2008, P NATL ACAD SCI USA, V105, P9477, DOI 10.1073/pnas.0706436105; [刘迎春 LIU Yingchun], 2011, [生态学报, Acta Ecologica Sinica], V31, P4277; Marin-Spiotta E, 2013, GLOBAL ECOL BIOGEOGR, V22, P105, DOI 10.1111/j.1466-8238.2012.00788.x; Meng L, 2010, THESIS NW A F U; Negi JDS, 2003, CURR SCI INDIA, V85, P1528; Norberg J, 2001, P NATL ACAD SCI USA, V98, P11376, DOI 10.1073/pnas.171315998; Nosetto MD, 2006, J ARID ENVIRON, V67, P142, DOI 10.1016/j.jaridenv.2005.12.008; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Ren Y, 2011, PLANT SOIL, V345, P125, DOI 10.1007/s11104-011-0766-2; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Sharma CM, 2011, J BIOSCIENCES, V36, P701, DOI 10.1007/s12038-011-9103-4; Sharma CM, 2010, FOREST ECOL MANAG, V260, P2170, DOI 10.1016/j.foreco.2010.09.014; Soil Survey Staff USDA, 1999, AGR HDB, V436; State Soil Survey Service of China, 1998, CHIN SOIL; Wang Xiaoke, 2001, Yingyong Shengtai Xuebao, V12, P13; Wang YF, 2011, ENVIRON SCI TECHNOL, V45, P1759, DOI 10.1021/es200042s; Watson RT, 2000, LAND USE LAND USE CH; Wolf S, 2011, GLOBAL CHANGE BIOL, V17, P2763, DOI 10.1111/j.1365-2486.2011.02460.x; Wu JJ, 2012, NAT HAZARDS, V62, P31, DOI 10.1007/s11069-011-0039-7; Yang H, 2004, GEOFORUM, V35, P507, DOI 10.1016/j.geoforum.2003.10.002; [张国斌 ZHANG GuoBin], 2008, [生态学报, Acta Ecologica Sinica], V28, P3176; Zhao M, 2006, CLIMATIC CHANGE, V74, P175, DOI 10.1007/s10584-006-6775-0; Zheng H, 2008, FOREST ECOL MANAG, V255, P1113, DOI 10.1016/j.foreco.2007.10.015; Zhou Y.R., 2000, CHIN J PLANT ECOL, V24, P518; Zinn YL, 2002, FOREST ECOL MANAG, V166, P285, DOI 10.1016/S0378-1127(01)00682-X	64	11	13	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82208	10.1371/journal.pone.0082208	http://dx.doi.org/10.1371/journal.pone.0082208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349223	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800049
J	Peng, WC; de Lau, W; Madoori, PK; Forneris, F; Granneman, JCM; Clevers, H; Gros, P				Peng, Weng Chuan; de Lau, Wim; Madoori, Pramod K.; Forneris, Federico; Granneman, Joke C. M.; Clevers, Hans; Gros, Piet			Structures of Wnt-Antagonist ZNRF3 and Its Complex with R-Spondin 1 and Implications for Signaling	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; WNT/BETA-CATENIN; TUMOR-SUPPRESSOR; STEM-CELLS; R-SPONDIN-4 RSPO4; GENE; LGR5; RNF43; ENDOCYTOSIS; RECOGNITION	Zinc RING finger 3 (ZNRF3) and its homolog RING finger 43 (RNF43) antagonize Wnt signaling in adult stem cells by ubiquitinating Frizzled receptors (FZD), which leads to endocytosis of the Wnt receptor. Conversely, binding of ZNRF3/RNF43 to LGR4-6 - R-spondin blocks Frizzled ubiquitination and enhances Wnt signaling. Here, we present crystal structures of the ZNRF3 ectodomain and its complex with R-spondin 1 (RSPO1). ZNRF3 binds RSPO1 and LGR5-RSPO1 with micromolar affinity via RSPO1 furin-like 1 (Fu1) domain. Anonychia-related mutations in RSPO4 support the importance of the observed interface. The ZNRF3-RSPO1 structure resembles that of LGR5-RSPO1-RNF43, though Fu2 of RSPO1 is variably oriented. The ZNRF3-binding site overlaps with trans-interactions observed in 2:2 LGR5-RSPO1 complexes, thus binding of ZNRF3/RNF43 would disrupt such an arrangement. Sequence conservation suggests a single ligand-binding site on ZNRF3, consistent with the proposed competing binding role of ZNRF3/RNF43 in Wnt signaling.	[Peng, Weng Chuan; Madoori, Pramod K.; Forneris, Federico; Granneman, Joke C. M.; Gros, Piet] Univ Utrecht, Dept Chem, Bijvoet Ctr Biomol Res, Fac Sci, NL-3584 CH Utrecht, Netherlands; [de Lau, Wim; Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Utrecht, Netherlands; [de Lau, Wim; Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands	Utrecht University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center	Gros, P (corresponding author), Univ Utrecht, Dept Chem, Bijvoet Ctr Biomol Res, Fac Sci, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	p.gros@uu.nl	Forneris, Federico/B-1145-2011; Gros, Piet/I-5569-2016; Forneris, Federico/AAL-5361-2020; Gros, Piet/AAD-6452-2019; Peng, Weng Chuan/Z-3618-2019	Forneris, Federico/0000-0002-7818-1804; Gros, Piet/0000-0002-7782-2585; Forneris, Federico/0000-0002-7818-1804; Gros, Piet/0000-0002-7782-2585; 	Netherlands Organization for Scientific Research (NWO-CW) [700.57.010]; European Research Council [233229]; European Community's Seventh Framework Programme under BioStruct-X [283570]	Netherlands Organization for Scientific Research (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); European Community's Seventh Framework Programme under BioStruct-X	Financial support was provided by the Netherlands Organization for Scientific Research (NWO-CW grant no. 700.57.010), the European Research Council (grant no. 233229), and the European Community's Seventh Framework Programme (FP7/2007-2013) under BioStruct-X (grant no. 283570). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL REP, V2, P540, DOI 10.1016/j.celrep.2012.08.018; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bergmann C, 2006, AM J HUM GENET, V79, P1105, DOI 10.1086/509789; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen PH, 2013, GENE DEV, V27, P1345, DOI 10.1101/gad.219915.113; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; de Lau WBM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-242; Deng C, 2013, J CELL SCI, V126, P2060, DOI 10.1242/jcs.123471; Durocher Y, 2000, ANAL BIOCHEM, V284, P316, DOI 10.1006/abio.2000.4698; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fafilek B, 2013, GASTROENTEROLOGY, V144, P381, DOI 10.1053/j.gastro.2012.10.048; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huch M, 2013, NATURE, V494, P247, DOI 10.1038/nature11826; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jiang XM, 2013, P NATL ACAD SCI USA, V110, P12649, DOI 10.1073/pnas.1307218110; Jin XL, 2011, FEBS J, V278, P78, DOI 10.1111/j.1742-4658.2010.07925.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Khan TN, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-120; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwon MS, 2013, MOL CELLS, V36, P267, DOI 10.1007/s10059-013-0173-z; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Luo XM, 2001, TRENDS BIOCHEM SCI, V26, P147, DOI 10.1016/S0968-0004(00)01768-0; Mahon P, 2000, PROTEIN SCI, V9, P1930, DOI 10.1110/ps.9.10.1930; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Peng WC, 2013, CELL REP, V3, P1885, DOI 10.1016/j.celrep.2013.06.009; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Ruffner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040976; Ryland GL, 2013, J PATHOL, V229, P469, DOI 10.1002/path.4134; SchrOdinger L., 2013, PYMOL MOL GRAPH SYST; Wang DL, 2013, GENE DEV, V27, P1339, DOI 10.1101/gad.219360.113; Wasif N, 2013, PEDIATR DERMATOL, V30, P139, DOI 10.1111/j.1525-1470.2011.01587.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu K, 2013, STRUCTURE, V21, P1683, DOI 10.1016/j.str.2013.07.001; Zhou YH, 2013, J MOL HISTOL, V44, P555, DOI 10.1007/s10735-013-9504-9	49	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83110	10.1371/journal.pone.0083110	http://dx.doi.org/10.1371/journal.pone.0083110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349440	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800094
J	Shiramatsu, TI; Kanzaki, R; Takahashi, H				Shiramatsu, Tomoyo Isoguchi; Kanzaki, Ryohei; Takahashi, Hirokazu			Cortical Mapping of Mismatch Negativity with Deviance Detection Property in Rat	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; PRIMARY AUDITORY-CORTEX; STIMULUS-SPECIFIC ADAPTATION; EVOKED-POTENTIALS; SENSORY MEMORY; HUMAN BRAIN; FREQUENCY DISCRIMINATION; ANESTHETIZED RATS; ACOUSTIC CHANGE; PITCH CHANGES	Mismatch Negativity (MMN) is an N-methyl-D-aspartic acid (NMDA)-mediated, negative deflection in human auditory evoked potentials in response to a cognitively discriminable change. MMN-like responses have been extensively investigated in animal models, but the existence of MMN equivalent is still controversial. In this study, we aimed to investigate how closely the putative MMN (MMNp) in rats exhibited the comparable properties of human MMN. We used a surface microelectrode array with a grid of 10x7 recording sites within an area of 4.5x3.0 mm to densely map evoked potentials in the auditory cortex of anesthetized rats under the oddball paradigm. Firstly, like human MMN, deviant stimuli elicited negative deflections in auditory evoked potentials following the positive middle-latency response, termed P1. Secondly, MMNp exhibited deviance-detecting property, which could not be explained by simple stimulus specific adaptation (SSA). Thirdly, this MMNp occurred focally in the auditory cortex, including both the core and belt regions, while P1 activation focus was obtained in the core region, indicating that both P1 and MMNp are generated in the auditory cortex, yet the sources of these signals do not completely overlap. Fourthly, MMNp significantly decreased after the application of AP5 (D-(-)-2-amino5- phosphonopentanoic acid), an antagonist at NMDA receptors. In stark contrast, AP5 affected neither P1 amplitude nor SSA of P1. These results provide compelling evidence that the MMNp we have examined in rats is functionally comparable to human MMN. The present work will stimulate translational research into MMN, which may help bridge the gap between electroencephalography (EEG)/magnetoencephalography (MEG) studies in humans and electrophysiological studies in animals.	[Shiramatsu, Tomoyo Isoguchi; Kanzaki, Ryohei; Takahashi, Hirokazu] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Mechano Informat, Tokyo, Japan; [Shiramatsu, Tomoyo Isoguchi; Kanzaki, Ryohei; Takahashi, Hirokazu] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Shiramatsu, Tomoyo Isoguchi] Japan Soc Promot Sci, Tokyo, Japan; [Takahashi, Hirokazu] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Saitama, Japan	University of Tokyo; University of Tokyo; Japan Society for the Promotion of Science; Japan Science & Technology Agency (JST)	Takahashi, H (corresponding author), Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Mechano Informat, Tokyo, Japan.	takahashi@i.u-tokyo.ac.jp			SCOPE [121803022]; KAKENHI [23135507, 24650252]; Grants-in-Aid for Scientific Research [11J07876] Funding Source: KAKEN	SCOPE; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by SCOPE (121803022) and KAKENHI (23135507, 24650252). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO K, 1995, EAR HEARING, V16, P38, DOI 10.1097/00003446-199502000-00004; Alho K, 1996, PSYCHOPHYSIOLOGY, V33, P369, DOI 10.1111/j.1469-8986.1996.tb01061.x; Amenedo E, 2000, EUR J NEUROSCI, V12, P2570, DOI 10.1046/j.1460-9568.2000.00114.x; ARNAULT P, 1990, J COMP NEUROL, V302, P110, DOI 10.1002/cne.903020109; Astikainen P, 2006, NEUROREPORT, V17, P1561, DOI 10.1097/01.wnr.0000233097.13032.7d; Astikainen P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024208; Atienza M, 2004, J COGNITIVE NEUROSCI, V16, P53, DOI 10.1162/089892904322755557; Baldeweg T, 2004, SCHIZOPHR RES, V69, P203, DOI 10.1016/j.schres.2003.09.009; Bramon E, 2004, SCHIZOPHR RES, V67, P1, DOI 10.1016/S0920-9964(03)00132-4; Brockhaus-Dumke A, 2005, SCHIZOPHR RES, V73, P297, DOI 10.1016/j.schres.2004.05.016; CSEPE V, 1992, ELECTROEN CLIN NEURO, V84, P538, DOI 10.1016/0168-5597(92)90043-B; CSEPE V, 1987, ELECTROEN CLIN NEURO, V66, P571, DOI 10.1016/0013-4694(87)90103-9; Deouell LY, 1998, PSYCHOPHYSIOLOGY, V35, P745, DOI 10.1111/1469-8986.3560745; Doron NN, 2002, J COMP NEUROL, V453, P345, DOI 10.1002/cne.10412; Ehrlichman RS, 2008, J COGNITIVE NEUROSCI, V20, P1403, DOI 10.1162/jocn.2008.20097; Eriksson J, 2005, BIOSYSTEMS, V79, P207, DOI 10.1016/j.biosystems.2004.09.017; Farley BJ, 2010, J NEUROSCI, V30, P16475, DOI 10.1523/JNEUROSCI.2793-10.2010; Fischer C, 1999, CLIN NEUROPHYSIOL, V110, P1601, DOI 10.1016/S1388-2457(99)00131-5; Fishman YI, 2012, J NEUROSCI, V32, P15747, DOI 10.1523/JNEUROSCI.2835-12.2012; FrodlBauch T, 1997, BRAIN TOPOGR, V10, P3, DOI 10.1023/A:1022214905452; FULLERTON BC, 1987, ELECTROEN CLIN NEURO, V66, P547, DOI 10.1016/0013-4694(87)90102-7; Funamizu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063655; GIARD MH, 1995, J COGNITIVE NEUROSCI, V7, P133, DOI 10.1162/jocn.1995.7.2.133; HARI R, 1984, NEUROSCI LETT, V50, P127, DOI 10.1016/0304-3940(84)90474-9; HERBERT H, 1991, J COMP NEUROL, V304, P103, DOI 10.1002/cne.903040108; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; Jacobsen T, 2003, CLIN NEUROPHYSIOL, V114, P1133, DOI 10.1016/S1388-2457(03)00043-9; Javitt DC, 1996, P NATL ACAD SCI USA, V93, P11962, DOI 10.1073/pnas.93.21.11962; JAVITT DC, 1992, ELECTROEN CLIN NEURO, V83, P87, DOI 10.1016/0013-4694(92)90137-7; Jung F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063203; Kaas JH, 1999, CURR OPIN NEUROBIOL, V9, P164, DOI 10.1016/S0959-4388(99)80022-1; Kane NM, 1996, INTENS CARE MED, V22, P39, DOI 10.1007/BF01728329; Kathmann N, 1999, CLIN NEUROPHYSIOL, V110, P317, DOI 10.1016/S1388-2457(98)00011-X; Kimura A, 2007, EUR J NEUROSCI, V25, P2819, DOI 10.1111/j.1460-9568.2007.05519.x; KING C, 1995, HEARING RES, V85, P45, DOI 10.1016/0378-5955(95)00028-3; KRAUS N, 1994, J ACOUST SOC AM, V96, P2758, DOI 10.1121/1.411282; KRAUS N, 1994, J NEUROPHYSIOL, V72, P1270, DOI 10.1152/jn.1994.72.3.1270; KRAUS N, 1995, J COGNITIVE NEUROSCI, V7, P25, DOI 10.1162/jocn.1995.7.1.25; Kujala A, 2003, NEUROREPORT, V14, P1683, DOI 10.1097/00001756-200309150-00005; Lazar R, 2003, HEARING RES, V181, P51, DOI 10.1016/S0378-5955(03)00166-7; Lee CC, 2008, J COMP NEUROL, V507, P1901, DOI 10.1002/cne.21614; Lee CC, 2008, J COMP NEUROL, V507, P1879, DOI 10.1002/cne.21611; Lee CC, 2008, J COMP NEUROL, V507, P1920, DOI 10.1002/cne.21613; Light GA, 2005, AM J PSYCHIAT, V162, P1741, DOI 10.1176/appi.ajp.162.9.1741; Lopez L, 2003, ANN NY ACAD SCI, V999, P124, DOI 10.1196/annals.1284.013; Luaute J, 2005, ARCH PHYS MED REHAB, V86, P917, DOI 10.1016/j.apmr.2004.08.011; Malmierca MS, 2003, INT REV NEUROBIOL, V56, P147, DOI 10.1016/S0074-7742(03)56005-6; Menning H, 2002, LEARN MEMORY, V9, P253, DOI 10.1101/lm.49402; Menning H, 2000, NEUROREPORT, V11, P817, DOI 10.1097/00001756-200003200-00032; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; NAATANEN R, 1982, BIOL PSYCHOL, V14, P53, DOI 10.1016/0301-0511(82)90017-5; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; NAATANEN R, 1993, PSYCHOPHYSIOLOGY, V30, P436, DOI 10.1111/j.1469-8986.1993.tb02067.x; Naatanen R, 1993, LEARN MEMORY, V4, P503; Nakamura T, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00367; Nelken I, 2008, FRONT NEUROSCI-SWITZ, V2, P107, DOI 10.3389/neuro.01.009.2008; Norena A, 2002, HEARING RES, V166, P202, DOI 10.1016/S0378-5955(02)00329-5; PAAVILAINEN P, 1991, ELECTROEN CLIN NEURO, V78, P466, DOI 10.1016/0013-4694(91)90064-B; Pincze Z, 2002, COGNITIVE BRAIN RES, V13, P249, DOI 10.1016/S0926-6410(01)00105-7; Pincze Z, 2001, CLIN NEUROPHYSIOL, V112, P778, DOI 10.1016/S1388-2457(01)00509-0; Pulvermuller F, 2003, NEUROIMAGE, V20, P159, DOI 10.1016/S1053-8119(03)00261-1; Roger C, 2009, PSYCHOPHYSIOLOGY, V46, P1028, DOI 10.1111/j.1469-8986.2009.00840.x; ROGER M, 1989, J COMP NEUROL, V287, P339, DOI 10.1002/cne.902870306; Rojas MJ, 2006, AM J PHYSIOL-REG I, V291, pR189, DOI 10.1152/ajpregu.00409.2005; Romanski L, 2006, CEREB CORTEX, V3, P515; Rosburg T, 2003, COGNITIVE BRAIN RES, V16, P83, DOI 10.1016/S0926-6410(02)00222-7; Rutkowski RG, 2005, P NATL ACAD SCI USA, V102, P13664, DOI 10.1073/pnas.0506838102; Rutkowski RG, 2003, HEARING RES, V181, P116, DOI 10.1016/S0378-5955(03)00182-5; Ruusuvirta T, 1998, NEUROSCI LETT, V248, P45, DOI 10.1016/S0304-3940(98)00330-9; Ruusuvirta T, 2007, CEREB CORTEX, V17, P2777, DOI 10.1093/cercor/bhm005; Ruusuvirta T, 2007, EUR J NEUROSCI, V26, P701, DOI 10.1111/j.1460-9568.2007.05687.x; Sacco T, 2010, SCIENCE, V329, P649, DOI 10.1126/science.1183165; SAMS M, 1985, ELECTROEN CLIN NEURO, V62, P437, DOI 10.1016/0168-5597(85)90054-1; Schall U, 2003, NEUROIMAGE, V20, P729, DOI 10.1016/S1053-8119(03)00398-7; Scherg M, 1989, J Cogn Neurosci, V1, P336, DOI 10.1162/jocn.1989.1.4.336; SHELLEY AM, 1991, BIOL PSYCHIAT, V30, P1059, DOI 10.1016/0006-3223(91)90126-7; Stevens MC, 2005, NEUROIMAGE, V26, P782, DOI 10.1016/j.neuroimage.2005.02.044; Taaseh N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023369; Takahashi H, 2005, HEARING RES, V210, P9, DOI 10.1016/j.heares.2005.05.014; Takahashi H, 2011, NEUROSCIENCE, V199, P243, DOI 10.1016/j.neuroscience.2011.09.046; Tervaniemi M, 2001, LEARN MEMORY, V8, P295, DOI 10.1101/lm.39501; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; TIITINEN H, 1993, PSYCHOPHYSIOLOGY, V30, P537, DOI 10.1111/j.1469-8986.1993.tb02078.x; Tikhonravov D, 2010, NEUROSCIENCE, V167, P1175, DOI 10.1016/j.neuroscience.2010.03.014; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Umbricht D, 2005, CLIN NEUROPHYSIOL, V116, P353, DOI 10.1016/j.clinph.2004.08.015; Umbricht D, 2002, BIOL PSYCHIAT, V51, P400, DOI 10.1016/S0006-3223(01)01242-2; Wijnen VJM, 2007, CLIN NEUROPHYSIOL, V118, P597, DOI 10.1016/j.clinph.2006.11.020; Winer JA, 2006, HEARING RES, V212, P1, DOI 10.1016/j.heares.2005.06.014	91	47	47	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82663	10.1371/journal.pone.0082663	http://dx.doi.org/10.1371/journal.pone.0082663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EU	24349330	gold, Green Submitted, Green Published			2022-12-27	WOS:000328731800072
J	Sperber, J; Lipcsey, M; Larsson, A; Larsson, A; Sjolin, J; Castegren, M				Sperber, Jesper; Lipcsey, Miklos; Larsson, Anders; Larsson, Anders; Sjolin, Jan; Castegren, Markus			Lung Protective Ventilation Induces Immunotolerance and Nitric Oxide Metabolites in Porcine Experimental Postoperative Sepsis	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; MECHANICAL VENTILATION; TIDAL VOLUMES; ENDOTOXIN TOLERANCE; EXPERIMENTAL-MODEL; ORGAN DYSFUNCTION; INJURY; RESPONSES	Low tidal volume ventilation is beneficial in patients with severe pulmonary dysfunction and would, in theory, reduce postoperative complications if implemented during routine surgery. The study aimed to investigate whether low tidal volume ventilation and high positive end-expiratory pressure (PEEP) in a large animal model of postoperative sepsis would attenuate the systemic inflammatory response and organ dysfunction. Thirty healthy pigs were randomized to three groups: Group Prot-7h, i.e. protective ventilation for 7 h, was ventilated with a tidal volume of 6 mL x kg(-1) for 7 h; group Prot-5h, i.e. protective ventilation for 5 h, was ventilated with a tidal volume of 10 mL x kg(-1) for 2 h, after which the group was ventilated with a tidal volume of 6 mL x kg(-1); and a control group that was ventilated with a tidal volume of 10 mL x kg(-1) for 7 h. In groups Prot-7h and Prot-5h PEEP was 5 cmH(2)O for 2 h and 10 cmH(2)O for 5 h. In the control group PEEP was 5 cmH(2)O for the entire experiment. After surgery for 2 h, postoperative sepsis was simulated with an endotoxin infusion for 5 h. Low tidal volume ventilation combined with higher PEEP led to lower levels of interleukin 6 and 10 in plasma, higher PaO2/FiO(2), better preserved functional residual capacity and lower plasma troponin I as compared with animals ventilated with a medium high tidal volume and lower PEEP. The beneficial effects of protective ventilation were seen despite greater reductions in cardiac index and oxygen delivery index. In the immediate postoperative phase low V-T ventilation with higher PEEP was associated with reduced ex vivo plasma capacity to produce TNF-alpha upon endotoxin stimulation and higher nitrite levels in urine. These findings might represent mechanistic explanations for the attenuation of systemic inflammation and inflammatory-induced organ dysfunction.	[Sperber, Jesper; Castegren, Markus] Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden; [Sperber, Jesper; Sjolin, Jan; Castegren, Markus] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Lipcsey, Miklos; Larsson, Anders] Uppsala Univ, Dept Surg Sci Anaesthesiol & Intens Care, Uppsala, Sweden; [Larsson, Anders] Uppsala Univ, Dept Med Sci Biochem Struct & Funct, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University	Sperber, J (corresponding author), Uppsala Univ, Ctr Clin Res Sormland, Uppsala, Sweden.	jesper.sperber@dll.se	Castegren, Markus/AAF-2620-2019; Lipcsey, Miklos/K-4308-2012	Lipcsey, Miklos/0000-0002-1976-4129; Castegren, Markus/0000-0002-9292-0298; Sperber, Jesper/0000-0001-8731-6953	Sormland County Council; Swedish Heart and Lung foundation; Family Olinder-Nielsen's Foundation; Uppsala University Hospital	Sormland County Council; Swedish Heart and Lung foundation(Swedish Heart-Lung Foundation); Family Olinder-Nielsen's Foundation; Uppsala University Hospital	"The R&D funds of the Sormland County Council and Uppsala University Hospital, the Swedish Heart and Lung foundation as well as the Family Olinder-Nielsen's Foundation contributed with financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERSTEN AD, 2003, OHS INTENSIVE CARE M, P1113; Blum JM, 2013, ANESTHESIOLOGY, V118, P19, DOI 10.1097/ALN.0b013e3182794975; Bregeon F, 2005, ANESTHESIOLOGY, V102, P331; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; BUNNELL JB, 1981, ANN BIOMED ENG, V9, P645, DOI 10.1007/BF02364777; Buttenschoen K, 2008, LANGENBECK ARCH SURG, V393, P473, DOI 10.1007/s00423-008-0317-3; Carlsson M, 2009, CRIT CARE MED, V37, P1031, DOI 10.1097/CCM.0b013e31819b5683; Castegren M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053221; Castegren M, 2012, SHOCK, V37, P501, DOI 10.1097/SHK.0b013e318249bb0d; Cavaillon JM, 2003, J ENDOTOXIN RES, V9, P101, DOI 10.1179/096805103125001487; Cormio M, 1999, J NEUROSURG, V90, P9, DOI 10.3171/jns.1999.90.1.0009; Costa ELV, 2013, CRIT CARE, V17, DOI 10.1186/cc12556; Determann RM, 2010, CRIT CARE, V14, DOI 10.1186/cc8230; Dias MB, 2005, J APPL PHYSIOL, V98, P1322, DOI 10.1152/japplphysiol.01243.2004; Feihl F, 2009, INTENS CARE MED, V35, P198, DOI 10.1007/s00134-008-1298-y; Fu Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002526; Gajic O, 2004, CRIT CARE MED, V32, P1817, DOI 10.1097/01.CCM.0000133019.52531.30; Imai Y, 2003, JAMA-J AM MED ASSOC, V289, P2104, DOI 10.1001/jama.289.16.2104; Jaecklin T, 2010, INTENS CARE MED, V36, P750, DOI 10.1007/s00134-010-1850-4; LARSSON A, 1987, ANESTHESIOLOGY, V67, P543, DOI 10.1097/00000542-198710000-00016; Lipcsey M, 2006, J ENDOTOXIN RES, V12, P99, DOI 10.1179/096805106X89053; Lipcsey M, 2008, SHOCK, V29, P173, DOI 10.1097/SHK.0b013e318067dfbc; Lipcsey M, 2009, CRIT CARE MED, V37, P2782, DOI 10.1097/CCM.0b013e3181a988f8; Moriondo A, 2011, ACTA PHYSIOL, V203, P331, DOI 10.1111/j.1748-1716.2011.02317.x; O'Mahony DS, 2006, CRIT CARE, V10, DOI 10.1186/cc5050; Poli-De-Figueiredo LF, 2008, SHOCK, V30, P53, DOI 10.1097/SHK.0b013e318181a343; Putensen C, 2007, ANESTHESIOLOGY, V106, P1085, DOI 10.1097/01.anes.0000265424.07486.8c; Quilez ME, 2012, CURR OPIN CRIT CARE, V18, P23, DOI 10.1097/MCC.0b013e32834ef3ea; Schmidhammer R, 2006, SHOCK, V25, P389, DOI 10.1097/01.shk.0000209529.43367.00; Schultz MJ, 2007, ANESTHESIOLOGY, V106, P1226, DOI 10.1097/01.anes.0000267607.25011.e8; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; Treschan TA, 2012, BRIT J ANAESTH, V109, P263, DOI 10.1093/bja/aes140; Vobruba V, 2013, EXP LUNG RES, V39, P1, DOI 10.3109/01902148.2012.737404; Wang HH, 2011, J CELL PHYSIOL, V226, P2244, DOI 10.1002/jcp.22560; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009	36	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83182	10.1371/journal.pone.0083182	http://dx.doi.org/10.1371/journal.pone.0083182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349457	gold, Green Submitted, Green Published			2022-12-27	WOS:000328731800101
J	Tseng, IL; Yang, YF; Yu, CW; Li, WH; Liao, VHC				Tseng, I-Ling; Yang, Ying-Fei; Yu, Chan-Wei; Li, Wen-Hsuan; Liao, Vivian Hsiu-Chuan			Phthalates Induce Neurotoxicity Affecting Locomotor and Thermotactic Behaviors and AFD Neurons through Oxidative Stress in Caenorhabditis elegans	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; NEUROBEHAVIORAL TOXICITY; DEVELOPMENTAL TOXICITY; THERMOSENSORY NEURONS; OLFACTORY NEURON; BISPHENOL-A; EXPOSURE; TEMPERATURE; EXPRESSION; DISORDER	Background: Phthalate esters are ubiquitous environmental contaminants and numerous organisms are thus exposed to various levels of phthalates in their natural habitat. Considering the critical, but limited, research on human neurobehavioral outcomes in association with phthalates exposure, we used the nematode Caenorhabditis elegans as an in vivo model to evaluate phthalates-induced neurotoxicity and the possible associated mechanisms. Principal Findings: Exposure to phthalates (DEHP, DBP, and DIBP) at the examined concentrations induced behavioral defects, including changes in body bending, head thrashing, reversal frequency, and thermotaxis in C. elegans. Moreover, phthalates (DEHP, DBP, and DIBP) exposure caused toxicity, affecting the relative sizes of cell body fluorescent puncta, and relative intensities of cell bodies in AFD neurons. The mRNA levels of the majority of the genes (TTX-1, TAX-2, TAX-4, and CEH-14) that are required for the differentiation and function of AFD neurons were decreased upon DEHP exposure. Furthermore, phthalates (DEHP, DBP, and DIBP) exposure at the examined concentrations produced elevated intracellular reactive oxygen species (ROS) in C. elegans. Finally, pretreatment with the antioxidant ascorbic acid significantly lowered the intracellular ROS level, ameliorated the locomotor and thermotactic behavior defects, and protected the damage of AFD neurons by DEHP exposure. Conclusions: Our study suggests that oxidative stress plays a critical role in the phthalate esters-induced neurotoxic effects in C. elegans.	[Tseng, I-Ling; Yang, Ying-Fei; Yu, Chan-Wei; Li, Wen-Hsuan; Liao, Vivian Hsiu-Chuan] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan	National Taiwan University	Liao, VHC (corresponding author), Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10764, Taiwan.	vivianliao@ntu.edu.tw	Yu, Chan-Wei/H-4885-2016	Yu, Chan-Wei/0000-0001-6903-0871; Liao, Vivian/0000-0002-4676-9953; Yang, Ying Fei/0000-0003-0304-1628	National Science Council of Taiwan [NSC 101-2628-E-002 -032-MY3, NSC 101-2313-B-002-041-MY3]; National Taiwan University	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University)	This work was financially supported in part by grants (NSC 101-2628-E-002-032-MY3 and NSC 101-2313-B-002-041-MY3) from the National Science Council of Taiwan to V. H.-C. Liao and the Career Development Projects from National Taiwan University to V. H.-C. Liao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2006, MED J AUSTRALIA, V185, P414, DOI 10.5694/j.1326-5377.2006.tb00634.x; Aliev G, 2002, BRAIN PATHOL, V12, P21; Beverly M, 2011, J NEUROSCI, V31, P11718, DOI 10.1523/JNEUROSCI.1098-11.2011; Biemann R, 2012, BIOCHEM BIOPH RES CO, V417, P747, DOI 10.1016/j.bbrc.2011.12.028; Biron D, 2008, P NATL ACAD SCI USA, V105, P11002, DOI 10.1073/pnas.0805004105; BRENNER S, 1974, GENETICS, V77, P71; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Cassata G, 2000, NEURON, V25, P587, DOI 10.1016/S0896-6273(00)81062-4; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHIBA CM, 1990, J NEUROBIOL, V21, P543, DOI 10.1002/neu.480210403; Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376; Choi SM, 2004, J TOXICOL ENV HEAL B, V7, P1, DOI 10.1080/10937400490253229; CROLL N A, 1975, P71, DOI 10.1016/S0065-308X(08)60319-X; DeRosa C, 1998, J TOXICOL ENV HEAL B, V1, P3, DOI 10.1080/10937409809524541; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470; Erkekoglu P, 2010, FREE RADICAL BIO MED, V49, P559, DOI 10.1016/j.freeradbiomed.2010.04.038; Foster PMD, 2005, CRIT REV TOXICOL, V35, P713, DOI 10.1080/10408440591007395; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; Hartwig K, 2009, GENES NUTR, V4, P59, DOI 10.1007/s12263-009-0113-x; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hobert Oliver, 2005, WormBook, P1; Hoshi H, 2009, B ENVIRON CONTAM TOX, V83, P62, DOI 10.1007/s00128-009-9729-1; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Ishido M, 2004, J NEUROCHEM, V91, P69, DOI 10.1111/j.1471-4159.2004.02696.x; Kim BN, 2009, BIOL PSYCHIAT, V66, P958, DOI 10.1016/j.biopsych.2009.07.034; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kuhara A, 2008, SCIENCE, V320, P803, DOI 10.1126/science.1148922; Kumsta C, 2011, ANTIOXID REDOX SIGN, V14, P1023, DOI 10.1089/ars.2010.3203; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Li WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062387; Li YF, 2009, J APPL TOXICOL, V29, P603, DOI 10.1002/jat.1447; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; Markey CM, 2002, J STEROID BIOCHEM, V83, P235, DOI 10.1016/S0960-0760(02)00272-8; Miodovnik A, 2011, NEUROTOXICOLOGY, V32, P261, DOI 10.1016/j.neuro.2010.12.009; Mori I, 2007, CURR OPIN NEUROBIOL, V17, P712, DOI 10.1016/j.conb.2007.11.010; Murakami S, 2005, NEUROBIOL AGING, V26, P899, DOI 10.1016/j.neurobiolaging.2004.08.007; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Rusyn I, 2001, MOL PHARMACOL, V59, P744, DOI 10.1124/mol.59.4.744; Satterlee JS, 2001, NEURON, V31, P943, DOI 10.1016/S0896-6273(01)00431-7; Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Smith JV, 2003, J ALZHEIMERS DIS, V5, P287, DOI 10.3233/JAD-2003-5404; Sulston J., 1998, NEMATODE CAENORHABDI, P587; Tanaka T, 2005, FOOD CHEM TOXICOL, V43, P581, DOI 10.1016/j.fct.2005.01.001; Tanaka T, 2002, FOOD CHEM TOXICOL, V40, P1499, DOI 10.1016/S0278-6915(02)00073-X; Testa C, 2012, ASN NEURO, V4, P223, DOI 10.1042/AN20120015; Tsalik EL, 2003, J NEUROBIOL, V56, P178, DOI 10.1002/neu.10245; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Xing XJ, 2009, ENVIRON TOXICOL PHAR, V28, P104, DOI 10.1016/j.etap.2009.03.006; Xu X, 2007, NEUROSCI RES, V58, P149, DOI 10.1016/j.neures.2007.02.011; Ye HY, 2008, NEUROBIOL LEARN MEM, V90, P10, DOI 10.1016/j.nlm.2007.12.001; Yolton K, 2011, NEUROTOXICOL TERATOL, V33, P558, DOI 10.1016/j.ntt.2011.08.003; Zhang YQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031849, 10.1371/journal.pone.0030262]; Zhao BB, 2003, J NEUROSCI, V23, P5319	55	49	56	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82657	10.1371/journal.pone.0082657	http://dx.doi.org/10.1371/journal.pone.0082657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349328	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800070
J	Wang, L; Liu, SF; Zhuang, ZM; Guo, L; Meng, ZN; Lin, HR				Wang, Le; Liu, Shufang; Zhuang, Zhimeng; Guo, Liang; Meng, Zining; Lin, Haoran			Population Genetic Studies Revealed Local Adaptation in a High Gene-Flow Marine Fish, the Small Yellow Croaker (Larimichthys polyactis)	PLOS ONE			English	Article							COD GADUS-MORHUA; ATLANTIC COD; ADAPTIVE DIVERGENCE; HEMOGLOBIN POLYMORPHISM; IDENTIFYING FOOTPRINTS; ENVIRONMENTAL-FACTORS; COMPUTER-PROGRAM; NORTH-SEA; SELECTION; DIFFERENTIATION	The genetic differentiation of many marine fish species is low. Yet local adaptation may be common in marine fish species as the vast and changing marine environment provides more chances for natural selection. Here, we used anonymous as well as known protein gene linked microsatellites and mitochondrial DNA to detect the population structure of the small yellow croaker (Larimichthys polyactis) in the Northwest Pacific marginal seas. Among these loci, we detected at least two microsatellites, anonymous H16 and HSP27 to be clearly under diversifying selection in outlier tests. Sequence cloning and analysis revealed that H16 was located in the intron of BAHCC1 gene. Landscape genetic analysis showed that H16 mutations were significantly associated with temperature, which further supported the diversifying selection at this locus. These marker types presented different patterns of population structure: (i) mitochondrial DNA phylogeny showed no evidence of genetic divergence and demonstrated only one glacial linage; (ii) population differentiation using putatively neutral microsatellites presented a pattern of high gene flow in the L. polyactis. In addition, several genetic barriers were identified; (iii) the population differentiation pattern revealed by loci under diversifying selection was rather different from that revealed by putatively neutral loci. The results above suggest local adaptation in the small yellow croaker. In summary, population genetic studies based on different marker types disentangle the effects of demographic history, migration, genetic drift and local adaptation on population structure and also provide valuable new insights for the design of management strategies in L. polyactis.	[Wang, Le; Guo, Liang; Meng, Zining; Lin, Haoran] Sun Yat Sen Univ, Sch Life Sci, Inst Aquat Econ Anim, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Le; Guo, Liang; Meng, Zining; Lin, Haoran] Sun Yat Sen Univ, Sch Life Sci, Guangdong Prov Key Lab Aquat Econ Anim, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Shufang; Zhuang, Zhimeng] Chinese Acad Fishery Sci, Yellow Sea Fisheries Res Inst, Qingdao, Shandong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS	Meng, ZN (corresponding author), Sun Yat Sen Univ, Sch Life Sci, Inst Aquat Econ Anim, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	mengzn@mail.sysu.edu.cn	lin, haoran/GXH-3030-2022		National High Technology R & D Program 863 of China [2009AA09Z401]; National Natural Science Foundation of China [40776097, 31061160187]	National High Technology R & D Program 863 of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High Technology R & D Program 863 of China (2009AA09Z401) and the National Natural Science Foundation of China (grant 40776097 & 31061160187). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CM, 2010, MOL ECOL RESOUR, V10, P576, DOI 10.1111/j.1755-0998.2010.02851.x; Andre C, 2011, HEREDITY, V106, P270, DOI 10.1038/hdy.2010.71; [Anonymous], 1979, ACTA OCEANOGRAPHICA; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; [鲍献文 Bao Xianwen], 2002, [海洋学报, Acta Oceanologica Sinica], V24, P125; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bekkevold D, 2005, EVOLUTION, V59, P2656; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Canino MF, 2010, MOL ECOL, V19, P4339, DOI 10.1111/j.1365-294X.2010.04815.x; CANTATORE P, 1994, J MOL EVOL, V39, P589, DOI 10.1007/BF00160404; Conover DO, 2006, J FISH BIOL, V69, P21, DOI 10.1111/j.1095-8649.2006.01274.x; Cornuet JM, 1996, GENETICS, V144, P2001; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; Deane EE, 2004, AM J PHYSIOL-REG I, V287, pR1054, DOI 10.1152/ajpregu.00347.2004; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; FROESE R, 2005, FAO FISHERY STAT; Fu YX, 1997, GENETICS, V147, P915; Gaggiotti OE, 2009, EVOLUTION, V63, P2939, DOI 10.1111/j.1558-5646.2009.00779.x; Goudet J, 1999, PCA GEN VERS 1 2; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; Graves John E., 1996, P335; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Han ZQ, 2009, AFR J AGR RES, V4, P605; Hansen MM, 2010, MOL ECOL, V19, P1787, DOI 10.1111/j.1365-294X.2010.04615.x; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hemmer-Hansen J, 2007, HEREDITY, V99, P592, DOI 10.1038/sj.hdy.6801055; Hewitt Godfrey M., 2004, Frontiers in Zoology, V1, P1, DOI 10.1186/1742-9994-1-4; HOAR WS, 1953, BIOL REV, V28, P437, DOI 10.1111/j.1469-185X.1953.tb01387.x; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Ikeda I., 1964, SEIKAI REG FISH RESO, V31, P1; Iwama GK, 1998, REV FISH BIOL FISHER, V8, P35, DOI 10.1023/A:1008812500650; Jin XS, 1996, FISH RES, V26, P337, DOI 10.1016/0165-7836(95)00422-X; Jin XS, 2004, ESTUAR COAST SHELF S, V59, P163, DOI 10.1016/j.ecss.2003.08.005; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Knowles LL, 2001, MOL ECOL, V10, P691, DOI 10.1046/j.1365-294x.2001.01206.x; Lambeck K, 2002, NATURE, V419, P199, DOI 10.1038/nature01089; Larmuseau MHD, 2010, MOL ECOL, V19, P2256, DOI 10.1111/j.1365-294X.2010.04643.x; Larsen PF, 2007, MOL ECOL, V16, P4674, DOI 10.1111/j.1365-294X.2007.03530.x; Larsson LC, 2007, MOL ECOL, V16, P1135, DOI 10.1111/j.1365-294X.2006.03217.x; Li N.S., 2000, GEOLOGY MARGINAL SEA; Lin LS, 2009, AFR J BIOTECHNOL, V8, P2700; Lin Long-shan, 2008, Marine Fisheries, V30, P126; Lin XZ., 1964, P MAR FISH RES; Liu J, 1999, MARINE GEOLOGY QUATE, V1, P1; Liu JX, 2007, MOL ECOL, V16, P275, DOI 10.1111/j.1365-294X.2006.03140.x; Liu X., 1962, RES SMALL YELLOW CRO, P35; Liu Y, 2007, J FISHERIES SCI CHIN, V14, P7; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Luo Y. L., 1963, STUDY CLASSIFICATION; Makinen HS, 2008, MOL ECOL, V17, P3565, DOI 10.1111/j.1365-294X.2008.03714.x; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Meng Zi-Ning, 2003, Shengwu Duoyangxing, V11, P197; Nielsen EE, 2003, MOL ECOL, V12, P1497, DOI 10.1046/j.1365-294X.2003.01819.x; Nielsen EE, 2006, MOL ECOL, V15, P3219, DOI 10.1111/j.1365-294X.2006.03025.x; Nielsen EE, 2009, MOL ECOL, V18, P3128, DOI 10.1111/j.1365-294X.2009.04272.x; Nishikawa M, 2008, INT J PHARM, V354, P23, DOI 10.1016/j.ijpharm.2007.09.030; Palumbi SR, 2003, ECOL APPL, V13, pS146; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pogson GH, 2003, MOL ECOL, V12, P63, DOI 10.1046/j.1365-294X.2003.01713.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rice KJ, 2003, FRONT ECOL ENVIRON, V1, P469, DOI 10.1890/1540-9295(2003)001[0469:MMRITF]2.0.CO;2; Riginos C, 2001, P ROY SOC B-BIOL SCI, V268, P1931, DOI 10.1098/rspb.2001.1748; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rokas A, 2003, MOL ECOL, V12, P2153, DOI 10.1046/j.1365-294X.2003.01894.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rooker JR, 2008, SCIENCE, V322, P742, DOI 10.1126/science.1161473; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruzzante DE, 2006, P ROY SOC B-BIOL SCI, V273, P1459, DOI 10.1098/rspb.2005.3463; Ruzzante DE, 1998, MOL ECOL, V7, P1663, DOI 10.1046/j.1365-294x.1998.00497.x; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; SICK K, 1965, HEREDITAS-GENETISK A, V54, P19, DOI 10.1111/j.1601-5223.1965.tb02004.x; SICK K, 1965, HEREDITAS-GENETISK A, V54, P49; Sims DW, 2004, J ANIM ECOL, V73, P333, DOI 10.1111/j.0021-8790.2004.00810.x; Sims DW, 2001, P ROY SOC B-BIOL SCI, V268, P2607, DOI 10.1098/rspb.2001.1847; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Sykes GE, 2009, T AM FISH SOC, V138, P1252, DOI 10.1577/T08-180.1; TAJIMA F, 1989, GENETICS, V123, P585; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vasemagi A, 2005, MOL ECOL, V14, P3623, DOI 10.1111/j.1365-294X.2005.02690.x; Verissimo A, 2010, MOL ECOL, V19, P1651, DOI 10.1111/j.1365-294X.2010.04598.x; Wang CH, 2008, MOL ECOL, V17, P3515, DOI 10.1111/j.1365-294X.2008.03850.x; WANG PX, 1994, CATENA, V23, P341; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; White TA, 2010, MOL ECOL, V19, P216, DOI 10.1111/j.1365-294X.2009.04446.x; Xiao YS, 2009, ENVIRON BIOL FISH, V85, P303, DOI 10.1007/s10641-009-9497-0; Zane L, 2007, HEREDITY, V99, P565, DOI 10.1038/sj.hdy.6801062	97	39	44	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83493	10.1371/journal.pone.0083493	http://dx.doi.org/10.1371/journal.pone.0083493			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349521	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800122
J	Hung, TJ; Tomiya, N; Chang, TH; Cheng, WC; Kuo, PH; Ng, SK; Lien, PC; Lee, YC; Chang, MDT				Hung, Ta-Jen; Tomiya, Noboru; Chang, Tse-Hao; Cheng, Wen-Chi; Kuo, Ping-Hsueh; Ng, Sim-Kun; Lien, Pei-Chun; Lee, Yuan-Chuan; Chang, Margaret Dah-Tsyr			Functional Characterization of ECP-Heparin Interaction: A Novel Molecular Model	PLOS ONE			English	Article							EOSINOPHIL CATIONIC PROTEIN; CRYSTAL-STRUCTURE; RNASE 3; NEUROTOXIN; SULFATE; RIBONUCLEASE; BINDING; FGF-1; GLYCOSAMINOGLYCANS; EVOLUTION	Human eosinophil cationic protein (ECP) and eosinophil derived neurotoxin (EDN) are two ribonuclease A (RNaseA) family members secreted by activated eosinophils. They share conserved catalytic triad and similar three dimensional structures. ECP and EDN are heparin binding proteins with diverse biological functions. We predicted a novel molecular model for ECP binding of heparin hexasaccharide (Hep6), [GlcNS(6S)-IdoA(2S)](3), and residues Gln(40), His(64) and Arg(105) were indicated as major contributions for the interaction. Interestingly, Gln(40) and His(64) on ECP formed a clamp-like structure to stabilize Hep6 in our model, which was not observed in the corresponding residues on EDN. To validate our prediction, mutant ECPs including ECP Q40A, H64A, R105A, and double mutant ECP Q40A/H64A were generated, and their binding affinity for heparins were measured by isothermal titration calorimetry (ITC). Weaker binding of ECP Q40A/H64A of all heparin variants suggested that Gln(40)-His(64) clamp contributed to ECP-heparin interaction significantly. Our in silico and in vitro data together demonstrate that ECP uses not only major heparin binding region but also use other surrounding residues to interact with heparin. Such correlation in sequence, structure, and function is a unique feature of only higher primate ECP, but not EDN.	[Hung, Ta-Jen; Chang, Tse-Hao; Cheng, Wen-Chi; Kuo, Ping-Hsueh; Ng, Sim-Kun; Lien, Pei-Chun; Lee, Yuan-Chuan; Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Tomiya, Noboru; Lee, Yuan-Chuan] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan	National Tsing Hua University; Johns Hopkins University; National Tsing Hua University	Chang, MDT (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	dtchang@life.nthu.edu.tw			National Science Council, Taiwan [NSC101-2622-B-007-001-CC1, NSC102-2622-B-007-001-CC1, NSC102-2325-B-007-002-]; Initiative Research Cooperation among Top Universities between UK and Taiwan [NSC99-2911-I-007-035]; Graduate Students Study Abroad Program of National Science Council of Taiwan [NSC100-2917-I-007-008]; Shen's Culture & Education Foundation (Apex Biotechnology Corporation, Taiwan)	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Initiative Research Cooperation among Top Universities between UK and Taiwan; Graduate Students Study Abroad Program of National Science Council of Taiwan; Shen's Culture & Education Foundation (Apex Biotechnology Corporation, Taiwan)	This work was supported by National Science Council, Taiwan (grant numbers NSC101-2622-B-007-001-CC1, NSC102-2622-B-007-001-CC1 and NSC102-2325-B-007-002-). Margaret Dah-Tsyr Chang and Ta-Jen Hung were supported by Initiative Research Cooperation among Top Universities between UK and Taiwan (grant number NSC99-2911-I-007-035). Ta-Jen Hung was supported by Graduate Students Study Abroad Program of National Science Council of Taiwan (grant number NSC100-2917-I-007-008). Ping-Hsueh Kuo and Sim-Kun Ng were supported by Shen's Culture & Education Foundation (Apex Biotechnology Corporation, Taiwan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN SJ, 1985, AM J TROP MED HYG, V34, P735, DOI 10.4269/ajtmh.1985.34.735; Ahl IM, 2009, BIOCHEMISTRY-US, V48, P9932, DOI 10.1021/bi900981k; Baranauskiene L, 2009, INT J MOL SCI, V10, P2752, DOI 10.3390/ijms10062752; Boix E, 1999, BIOCHEMISTRY-US, V38, P16794, DOI 10.1021/bi9919145; Boix E, 1999, J BIOL CHEM, V274, P15605, DOI 10.1074/jbc.274.22.15605; Boix E, 2012, J STRUCT BIOL, V179, P1, DOI 10.1016/j.jsb.2012.04.023; BROIDE DH, 1991, J ALLERGY CLIN IMMUN, V88, P637, DOI 10.1016/0091-6749(91)90158-K; Brown A, 2013, BIOPHYS J, V104, P1720, DOI 10.1016/j.bpj.2013.02.051; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chang HT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-38; DEWS I, 1989, J HUM HYPERTENS, V3, P35; Domachowske JB, 1998, J INFECT DIS, V177, P1458, DOI 10.1086/515322; Domachowske JB, 1998, NUCLEIC ACIDS RES, V26, P3358, DOI 10.1093/nar/26.14.3358; DURACK DT, 1979, P NATL ACAD SCI USA, V76, P1443, DOI 10.1073/pnas.76.3.1443; Fan TC, 2008, J BIOL CHEM, V283, P25468, DOI 10.1074/jbc.M803516200; Fan TC, 2007, TRAFFIC, V8, P1778, DOI 10.1111/j.1600-0854.2007.00650.x; Fang SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057318; Garcia-Mayoral MF, 2013, ACS CHEM BIOL, V8, P144, DOI 10.1021/cb300386v; Garcia-Mayoral MF, 2010, BIOPHYS J, V98, P2702, DOI 10.1016/j.bpj.2010.02.039; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; GLEICH GJ, 1986, P NATL ACAD SCI USA, V83, P3146, DOI 10.1073/pnas.83.10.3146; Gohlke H, 2002, ANGEW CHEM INT EDIT, V41, P2645; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Hung TJ, 2013, INT J MOL SCI, V14, P19067, DOI 10.3390/ijms140919067; Irie M, 1997, YAKUGAKU ZASSHI, V117, P561, DOI 10.1248/yakushi1947.117.9_561; Ishihara M, 1997, J BIOCHEM-TOKYO, V121, P345; Koh GCH, 2007, RESP MED, V101, P696, DOI 10.1016/j.rmed.2006.08.012; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laurents DV, 2009, BIOPOLYMERS, V91, P1018, DOI 10.1002/bip.21152; Lee JC, 2004, J AM CHEM SOC, V126, P476, DOI 10.1021/ja038244h; LEHRER RI, 1989, J IMMUNOL, V142, P4428; Leonidas DD, 2001, J BIOL CHEM, V276, P15009, DOI 10.1074/jbc.M010585200; Lien PC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/170398; Maeda T, 2002, EUR J BIOCHEM, V269, P307, DOI 10.1046/j.0014-2956.2001.02653.x; Mallorqui-Fernandez G, 2000, J MOL BIOL, V300, P1297, DOI 10.1006/jmbi.2000.3939; MIYAMOTO MM, 1988, P NATL ACAD SCI USA, V85, P7627, DOI 10.1073/pnas.85.20.7627; Mohan CG, 2002, BIOCHEMISTRY-US, V41, P12100, DOI 10.1021/bi0264521; Niccoli G, 2010, ATHEROSCLEROSIS, V211, P606, DOI 10.1016/j.atherosclerosis.2010.02.038; PETERSON CGB, 1988, EUR J HAEMATOL, V40, P415; Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h; ROSENBERG HF, 1995, J BIOL CHEM, V270, P21539, DOI 10.1074/jbc.270.37.21539; ROSENBERG HF, 1989, P NATL ACAD SCI USA, V86, P4460, DOI 10.1073/pnas.86.12.4460; ROSENBERG HF, 1995, NAT GENET, V10, P219, DOI 10.1038/ng0695-219; SILBERSTEIN DS, 1995, CRIT REV ONCOL HEMAT, V19, P47, DOI 10.1016/1040-8428(94)00127-F; SORRENTINO S, 1994, ARCH BIOCHEM BIOPHYS, V312, P340, DOI 10.1006/abbi.1994.1318; Sorrentino S, 2010, FEBS LETT, V584, P2194, DOI 10.1016/j.febslet.2010.04.018; SPRY CJF, 1989, SPRINGER SEMIN IMMUN, V11, P471; Swaminathan GJ, 2002, BIOCHEMISTRY-US, V41, P3341, DOI 10.1021/bi015911f; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; Torrent M, 2011, J MOL RECOGNIT, V24, P90, DOI 10.1002/jmr.1027; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u	54	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82585	10.1371/journal.pone.0082585	http://dx.doi.org/10.1371/journal.pone.0082585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349317	Green Submitted, gold, Green Published			2022-12-27	WOS:000328730300100
J	Rodel, MO; Brede, C; Hirschfeld, M; Schmitt, T; Favreau, P; Stocklin, R; Wunder, C; Mebs, D				Roedel, Mark-Oliver; Brede, Christian; Hirschfeld, Mareike; Schmitt, Thomas; Favreau, Philippe; Stoecklin, Reto; Wunder, Cora; Mebs, Dietrich			Chemical Camouflage - A Frog's Strategy to Co-Exist with Aggressive Ants	PLOS ONE			English	Article							AMPHIBIAN SKIN; ANTIMICROBIAL PEPTIDES; PALTOTHYREUS-TARSATUS; DENDROBATES-PUMILIO; ANURANS; HYMENOPTERA; SECRETIONS; MICROHYLIDAE; ALKALOIDS; EVOLUTION	Whereas interspecific associations receive considerable attention in evolutionary, behavioural and ecological literature, the proximate bases for these associations are usually unknown. This in particular applies to associations between vertebrates with invertebrates. The West-African savanna frog Phrynomantis microps lives in the underground nest of ponerine ants (Paltothyreus tarsatus). The ants usually react highly aggressively when disturbed by fiercely stinging, but the frog is not attacked and lives unharmed among the ants. Herein we examined the proximate mechanisms for this unusual association. Experiments with termites and mealworms covered with the skin secretion of the frog revealed that specific chemical compounds seem to prevent the ants from stinging. By HPLC-fractionation of an aqueous solution of the frogs' skin secretion, two peptides of 1,029 and 1,143 Da were isolated and found to inhibit the aggressive behaviour of the ants. By de novo sequencing using tandem mass spectrometry, the amino acid sequence of both peptides consisting of a chain of 9 and 11 residues, respectively, was elucidated. Both peptides were synthesized and tested, and exhibited the same inhibitory properties as the original frog secretions. These novel peptides most likely act as an appeasement allomone and may serve as models for taming insect aggression.	[Roedel, Mark-Oliver; Hirschfeld, Mareike] Leibniz Inst Res Evolut & Biodivers, Museum Nat Kunde Berlin, Berlin, Germany; [Roedel, Mark-Oliver; Brede, Christian; Hirschfeld, Mareike; Schmitt, Thomas] Bioctr Univ, Theodor Boveri Inst, Dept Anim Ecol & Trop Biol Zool 3, Wurzburg, Germany; [Favreau, Philippe; Stoecklin, Reto] Atheris Labs, Bernex, Switzerland; [Wunder, Cora; Mebs, Dietrich] Goethe Univ Frankfurt, Inst Legal Med, D-60054 Frankfurt, Germany; [Brede, Christian] Zentrum Expt Mol Med, Med Klin & Poliklin 2, Wurzburg, Germany; [Schmitt, Thomas] Tech Univ Darmstadt, Ecol Networks, Darmstadt, Germany	Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Wurzburg; Goethe University Frankfurt; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; Technical University of Darmstadt	Rodel, MO (corresponding author), Leibniz Inst Res Evolut & Biodivers, Museum Nat Kunde Berlin, Berlin, Germany.	mo.roedel@mfn-berlin.de	Schmitt, Thomas/H-3033-2013	Petersen, Mareike/0000-0001-8666-1931	German Ministry of Education and Science (BMB+F) [01LC0617J]	German Ministry of Education and Science (BMB+F)(Federal Ministry of Education & Research (BMBF))	This study was part of the BIOLOG-program of the German Ministry of Education and Science (BMB+F, http://www.bmbf.de/; Project BIOTA-West III, amphibian projects, 01LC0617J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino T, 2002, CHEMOECOLOGY, V12, P83, DOI 10.1007/s00049-002-8330-4; Bagneres AG, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P282, DOI 10.1017/CBO9780511711909.015; Barthalmus George T., 1994, P382; Becker JH, 2004, CORAL REEFS, V23, P515, DOI 10.1007/s00338-004-0429-3; BEVINS CL, 1990, ANNU REV BIOCHEM, V59, P395, DOI 10.1146/annurev.bi.59.070190.002143; Blair W. F., 1936, Copeia Ann Arbor, V1936, P115, DOI 10.2307/1436661; BRAUN U, 1994, BIOTROPICA, V26, P308, DOI 10.2307/2388852; Bronstein JL, 2006, NEW PHYTOL, V172, P412, DOI 10.1111/j.1469-8137.2006.01864.x; Clarke BT, 1997, BIOL REV, V72, P365, DOI 10.1017/S0006323197005045; COCROFT RB, 1989, BIOTROPICA, V21, P2, DOI 10.2307/2388434; Conlon JM, 2011, CELL MOL LIFE SCI, V68, P2303, DOI 10.1007/s00018-011-0720-8; Conlon JM, 2009, ANN NY ACAD SCI, V1163, P75, DOI 10.1111/j.1749-6632.2008.03618.x; Daly JW, 2002, P NATL ACAD SCI USA, V99, P13996, DOI 10.1073/pnas.222551599; DALY JW, 1987, TOXICON, V25, P1023, DOI 10.1016/0041-0101(87)90265-0; DEJEAN A, 1993, J ETHOL, V11, P43, DOI 10.1007/BF02350005; DEJEAN A, 1992, Alytes (Paris), V10, P31; Dundee Harold A., 2012, Tulane Studies in Zoology and Botany, V32, P31; Edwards DP, 2009, NATURWISSENSCHAFTEN, V96, P1137, DOI 10.1007/s00114-009-0559-0; Endler A, 2006, BEHAV ECOL SOCIOBIOL, V59, P490, DOI 10.1007/s00265-005-0073-0; Erickson DM, 2012, ANN ENTOMOL SOC AM, V105, P447, DOI 10.1603/AN11176; Erspamer Vittorio, 1994, P178; FRITZ G, 1981, BIOTROPICA, V13, P158, DOI 10.2307/2387719; Hirschfeld M, 2011, J TROP ECOL, V27, P601, DOI 10.1017/S0266467411000320; Holldobler B., 1990, pi; HOWARD RW, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P179; HUNT RH, 1980, NAT HIST, V89, P49; JAEGER RG, 1971, COPEIA, P160; Jones EI, 2012, ANN NY ACAD SCI, V1256, P66, DOI 10.1111/j.1749-6632.2012.06552.x; Karunarathna S. D. M. S., 2009, TAPROBANICA, V1, P16; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Lhomme P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043053; Martin SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2717, DOI 10.1098/rspb.2007.0795; Mebs D, 2010, SALAMANDRA, V46, P11; Nascimento ACC, 2003, PROTEIN PEPTIDE LETT, V10, P227, DOI 10.2174/0929866033478933; Nash D. R., 2008, SOCIOBIOLOGY COMMUNI, P55, DOI DOI 10.1093/ACPROF:OSO/9780199216840.003.0004; Ostlund-Nilsson S, 2005, BIOL LETTERS, V1, P454, DOI 10.1098/rsbl.2005.0363; Pickersgill M, 1997, HERPTILE, V22, P141; Poulin R, 2012, EVOL ECOL, V26, P1169, DOI 10.1007/s10682-011-9544-0; Ricciardi F, 2010, ENVIRON BIOL FISH, V87, P333, DOI 10.1007/s10641-010-9606-0; Rinaldi AC, 2002, CURR OPIN CHEM BIOL, V6, P799, DOI 10.1016/S1367-5931(02)00401-5; Rodel M-O, 2000, HERPETOFAUNA W AFRIC, VI; Rodel MO, 1999, BIOTROPICA, V31, P178; Rollins-Smith LA, 2009, BBA-BIOMEMBRANES, V1788, P1593, DOI 10.1016/j.bbamem.2009.03.008; Saporito RA, 2012, CHEMOECOLOGY, V22, P159, DOI 10.1007/s00049-011-0088-0; Schlueter Andreas, 2009, Herpetology Notes, V2, P101; Schuter A, 1996, AMPHIBIA-REPTILIA, V2, P117; Siliwal M, 2008, ZOOS PRINT, V23, P13; Simmaco M, 1998, BIOPOLYMERS, V47, P435, DOI 10.1002/(SICI)1097-0282(1998)47:6<435::AID-BIP3>3.3.CO;2-#; SZELISTOWSKI WA, 1985, BIOTROPICA, V17, P345, DOI 10.2307/2388601; Toledo LF, 2007, J ZOOL, V271, P170, DOI 10.1111/j.1469-7998.2006.00195.x; Toledo LF, 2011, ETHOL ECOL EVOL, V23, P1, DOI 10.1080/03949370.2010.534321; VANDERMEER RK, 1989, J CHEM ECOL, V15, P2247, DOI 10.1007/BF01014113; Weldon P. J., 2006, INSECT REPELLENTS PR, P47; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x	55	12	12	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81950	10.1371/journal.pone.0081950	http://dx.doi.org/10.1371/journal.pone.0081950			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349157	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300061
J	Bennett, AM; Pereira, D; Murray, DL				Bennett, Amanda M.; Pereira, David; Murray, Dennis L.			Investment into Defensive Traits by Anuran Prey (Lithobates pipiens) Is Mediated by the Starvation-Predation Risk Trade-Off	PLOS ONE			English	Article							FROG TADPOLES; PHENOTYPIC PLASTICITY; INDUCIBLE DEFENSES; LARVAL ANURANS; CHEMICAL CUES; BODY-SIZE; BEHAVIORAL-RESPONSES; DYNAMIC-MODELS; LIFE-HISTORIES; METAMORPHOSIS	Prey can invest in a variety of defensive traits when balancing risk of predation against that of starvation. What remains unknown is the relative costs of different defensive traits and how prey reconcile investment into these traits when energetically limited. We tested the simple allocation model of prey defense, which predicts an additive effect of increasing predation risk and resource availability, resulting in the full deployment of defensive traits under conditions of high risk and resource saturation. We collected morphometric, developmental, and behavioural data in an experiment using dragonfly larvae (predator) and Northern leopard frog tadpoles (prey) subject to variable levels of food availability and predation risk. Larvae exposed to food restriction showed limited response to predation risk; larvae at food saturation altered behaviour, development, and growth in response to predation risk. Responses to risk varied through time, suggesting ontogeny may affect the deployment of particular defensive traits. The observed negative correlation between body size and activity level for food-restricted prey - and the absence of a similar response among adequately-fed prey - suggests that a trade-off exists between behavioural and growth responses when energy budgets are limited. Our research is the first to demonstrate how investment into these defensive traits is mediated along gradients of both predation risk and resource availability over time. The interactions we demonstrate between resource availability and risk level on deployment of inducible defenses provide evidence that both internal condition and extrinsic risk factors play a critical role in the production of inducible defenses over time.	[Bennett, Amanda M.; Pereira, David; Murray, Dennis L.] Trent Univ, Peterborough, ON K9J 7B8, Canada	Trent University	Bennett, AM (corresponding author), Trent Univ, Peterborough, ON K9J 7B8, Canada.	amandabennett2@trentu.ca	Bennett, Amanda/O-5117-2019		NSERC Discovery grants program (Canada)	NSERC Discovery grants program (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by the NSERC Discovery grants program (Canada) to Dr. Dennis Murray (www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allran JW, 2000, ENVIRON TOXICOL CHEM, V19, P2850, DOI [10.1002/etc.5620191133, 10.1897/1551-5028(2000)019&lt;2850:EOAANO&gt;2.0.CO;2]; Altwegg R, 2003, EVOLUTION, V57, P872; Anholt BR, 2000, ECOLOGY, V81, P3509, DOI 10.2307/177510; ANHOLT BR, 1995, ECOLOGY, V76, P2230, DOI 10.2307/1941696; Anholt BR, 1996, HERPETOLOGICA, V52, P301; Armitage P., 1980, STAT METHODS MED RES; Babbitt KJ, 1998, OECOLOGIA, V114, P258, DOI 10.1007/s004420050444; BARRY MJ, 1994, OECOLOGIA, V97, P278, DOI 10.1007/BF00323161; Bates M, 2011, LME4 LINEAR MIXED EF; Beck CW, 2000, FUNCT ECOL, V14, P32, DOI 10.1046/j.1365-2435.2000.00386.x; Brookes JI, 2007, J EVOLUTION BIOL, V20, P1015, DOI 10.1111/j.1420-9101.2007.01299.x; Cook, 1984, INTRO CANADIAN AMPHI; Cooper WE, 2007, CAN J ZOOL, V85, P99, DOI 10.1139/Z06-200; Cooper WE, 2003, BEHAV ECOL SOCIOBIOL, V54, P179, DOI 10.1007/s00265-003-0619-y; Cowlishaw G, 1997, ANIM BEHAV, V53, P667, DOI 10.1006/anbe.1996.0298; Danner BJ, 2003, J INSECT BEHAV, V16, P453, DOI 10.1023/A:1027337405495; Downes S, 2001, ECOLOGY, V82, P2870, DOI 10.2307/2679967; Eklov P, 2000, OECOLOGIA, V123, P192, DOI 10.1007/s004420051005; Ferland-Raymond B, 2008, CAN J ZOOL, V86, P1329, DOI 10.1139/Z08-117; FROOM B, 1982, AMPHIBIANS CANADA; Glennemeier KA, 2002, J EXP ZOOL, V292, P32, DOI 10.1002/jez.1140; Gosner K. L., 1960, Herpetologica, V16, P183; Hammill E, 2008, J EVOLUTION BIOL, V21, P705, DOI 10.1111/j.1420-9101.2008.01520.x; HARVELL CD, 1990, Q REV BIOL, V65, P323, DOI 10.1086/416841; Higginson AD, 2010, ECOLOGY, V91, P2756, DOI 10.1890/08-2269.1; Higginson AD, 2009, FUNCT ECOL, V23, P1103, DOI 10.1111/j.1365-2435.2009.01598.x; Hossie TJ, 2012, J ZOOL, V288, P275, DOI 10.1111/j.1469-7998.2012.00955.x; Hossie TJ, 2010, ECOSCIENCE, V17, P100, DOI 10.2980/17-1-3312; Hossie TJ, 2010, OECOLOGIA, V163, P395, DOI 10.1007/s00442-010-1568-6; HOUSTON A, 1988, NATURE, V332, P29, DOI 10.1038/332029a0; Ireland DH, 2007, OECOLOGIA, V152, P162, DOI 10.1007/s00442-006-0637-3; JOHNSSON JI, 1993, ANIM BEHAV, V45, P1219, DOI 10.1006/anbe.1993.1143; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; KOHLER SL, 1989, ECOLOGY, V70, P1811, DOI 10.2307/1938114; Koprivnikar J, 2010, ECOL APPL, V20, P2263, DOI 10.1890/09-1558.1; Kuznetsova A, 2012, MIXMOD ANAL MIXED MO; Laurila A, 2002, EVOLUTION, V56, P617; Laurila A, 1998, OIKOS, V83, P307, DOI 10.2307/3546842; Laurila A, 1999, J ANIM ECOL, V68, P1123, DOI 10.1046/j.1365-2656.1999.00354.x; LIMA SL, 1985, ANIM BEHAV, V33, P155, DOI 10.1016/S0003-3472(85)80129-9; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Mathis A, 2003, ETHOLOGY, V109, P159, DOI 10.1046/j.1439-0310.2003.00849.x; MCNAMARA JM, 1987, ECOLOGY, V68, P1515, DOI 10.2307/1939235; Nilsson PA, 2000, OIKOS, V88, P539, DOI 10.1034/j.1600-0706.2000.880310.x; Peacor SD, 2006, HYDROBIOLOGIA, V573, P39, DOI 10.1007/s10750-006-0256-3; Petranka J, 1998, BEHAV ECOL SOCIOBIOL, V42, P263, DOI 10.1007/s002650050438; PETRANKA JW, 1987, ANIM BEHAV, V35, P420, DOI 10.1016/S0003-3472(87)80266-X; Pettersson LB, 1999, OECOLOGIA, V121, P12, DOI 10.1007/s004420050901; Puttlitz MH, 1999, ETHOLOGY, V105, P449, DOI 10.1046/j.1439-0310.1999.00416.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Relyea RA, 2005, J EVOLUTION BIOL, V18, P856, DOI 10.1111/j.1420-9101.2005.00882.x; Relyea RA, 2004, ECOL LETT, V7, P869, DOI 10.1111/j.1461-0248.2004.00645.x; Relyea RA, 2003, ECOLOGY, V84, P1840, DOI 10.1890/0012-9658(2003)084[1840:PCAPGT]2.0.CO;2; Relyea RA, 2002, ECOL MONOGR, V72, P77, DOI 10.1890/0012-9615(2002)072[0077:LPDIPP]2.0.CO;2; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Relyea RA, 2000, ECOLOGY, V81, P2278, DOI 10.1890/0012-9658(2000)081[2278:TMIEIL]2.0.CO;2; Rochette R, 1996, ANIM BEHAV, V52, P783, DOI 10.1006/anbe.1996.0223; Schmitz OJ, 1998, AM NAT, V151, P327, DOI 10.1086/286122; Schoeppner NM, 2005, ECOL LETT, V8, P505, DOI 10.1111/j.1461-0248.2005.00744.x; SEMLITSCH RD, 1990, CAN J ZOOL, V68, P1027, DOI 10.1139/z90-149; SINCLAIR ARE, 1995, ECOLOGY, V76, P882, DOI 10.2307/1939353; SKELLY DK, 1992, ECOLOGY, V73, P704, DOI 10.2307/1940779; STAUFFER HP, 1993, ANIM BEHAV, V46, P355, DOI 10.1006/anbe.1993.1197; Steiner UK, 2007, OECOLOGIA, V152, P201, DOI 10.1007/s00442-006-0645-3; Steiner UK, 2007, AM NAT, V169, P118, DOI 10.1086/509939; Stoks R, 1999, BEHAV ECOL SOCIOBIOL, V47, P70, DOI 10.1007/s002650050651; Teplitsky C, 2007, ECOLOGY, V88, P1641, DOI 10.1890/06-1703.1; TRAVIS J, 1985, OIKOS, V45, P59, DOI 10.2307/3565222; Van Buskirk J, 2000, ECOLOGY, V81, P2813, DOI 10.1890/0012-9658(2000)081[2813:TCOAID]2.0.CO;2; Van Buskirk J, 2002, ECOLOGY, V83, P1580, DOI 10.2307/3071977; Van Buskirk J, 2002, EVOLUTION, V56, P361; Venesky MD, 2010, COPEIA, P481, DOI 10.1643/CG-09-093; Watkins TB, 2006, COPEIA, P478, DOI 10.1643/0045-8511(2006)2006[478:GAPRIG]2.0.CO;2; WERNER EE, 1993, AM NAT, V142, P242, DOI 10.1086/285537; WERNER EE, 1992, COPEIA, P26, DOI 10.2307/1446532; Winkler JD, 2012, FUNCT ECOL, V26, P513, DOI 10.1111/j.1365-2435.2012.01965.x	76	27	27	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82344	10.1371/journal.pone.0082344	http://dx.doi.org/10.1371/journal.pone.0082344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349259	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200078
J	Chen, JF; Liu, H; Ni, HF; Lv, LL; Zhang, MH; Zhang, AH; Tang, RN; Chen, PS; Liu, BC				Chen, Jun-Feng; Liu, Hong; Ni, Hai-Feng; Lv, Lin-Li; Zhang, Ming-Hui; Zhang, Ai-Hua; Tang, Ri-Ning; Chen, Ping-Sheng; Liu, Bi-Cheng			Improved Mitochondrial Function Underlies the Protective Effect of Pirfenidone against Tubulointerstitial Fibrosis in 5/6 Nephrectomized Rats	PLOS ONE			English	Article							INTERSTITIAL FIBROSIS; OXIDATIVE STRESS; APOPTOSIS; INJURY; PROGRESSION; CATALASE; DISEASE; FTY720	Dysfunctional mitochondria participate in the progression of chronic kidney disease (CKD). Pirfenidone is a newly identified anti-fibrotic drug. However, its mechanism remains unclear. Mitochondrial dysfunction is an early event that occurs prior to the onset of renal fibrosis. In this context, we investigated the protective effect of pirfenidone on mitochondria and its relevance to apoptosis and oxidative stress in renal proximal tubular cells. A remnant kidney rat model was established. Human renal proximal tubular epithelial cells (HK2) using rotenone, a mitochondrial respiratory chain complex. inhibitor were further investigated in vitro to examine the mitochondrial protective effect of pirfenidone. Pirfenidone protected mitochondrial structures and functions by stabilizing the mitochondrial membrane potential, maintaining ATP production and improving the mitochondrial DNA (mtDNA) copy number. Pirfenidone decreased tubular cell apoptosis by inhibiting the mitochondrial apoptotic signaling pathway. Pirfenidone also reduced oxidative stress by enhancing manganese superoxide dismutase (Mn-SOD) and inhibiting intracellular reactive oxygen species (ROS) generation, which suggested that the anti-oxidant effects occurred at least partially via the mitochondrial pathway. Pirfenidone may be effective prior to the onset of renal fibrosis because this drug exerts its anti-fibrotic effect by protection of mitochondria in renal proximal tubular cells.	[Chen, Jun-Feng; Liu, Hong; Ni, Hai-Feng; Lv, Lin-Li; Zhang, Ming-Hui; Tang, Ri-Ning; Liu, Bi-Cheng] Southeast Univ, Sch Med, Zhong Da Hosp, Inst Nephrol, Nanjing, Jiangsu, Peoples R China; [Zhang, Ai-Hua] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Nephrol, Nanjing, Jiangsu, Peoples R China; [Zhang, Ai-Hua] Nanjing Med Univ, Inst Pediat, Nanjing, Jiangsu, Peoples R China; [Chen, Ping-Sheng] Southeast Univ, Sch Med, Dept Pathol, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Nanjing Medical University; Nanjing Medical University; Southeast University - China	Liu, BC (corresponding author), Southeast Univ, Sch Med, Zhong Da Hosp, Inst Nephrol, Nanjing, Jiangsu, Peoples R China.	liubc64@163.com			National Natural Scientific Foundation [81130010]; National Key Basic Research Project ("973") [2012CB517700]; National Scientific Foundation of Jiangsu Province [BK201106]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); National Key Basic Research Project ("973")(National Basic Research Program of China); National Scientific Foundation of Jiangsu Province	This study was supported by grants from the Key Project of the National Natural Scientific Foundation (No.81130010), the National Key Basic Research Project ("973") (No.2012CB517700), and the National Scientific Foundation of Jiangsu Province (No.BK201106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Armendariz-Borunda J, 2006, GUT, V55, P1663, DOI 10.1136/gut.2006.107136; Barnes JL, 2011, CONTRIB NEPHROL, V169, P73, DOI 10.1159/000313946; Brezniceanu ML, 2008, DIABETES, V57, P451, DOI 10.2337/db07-0013; Casalena G, 2012, SEMIN NEPHROL, V32, P295, DOI 10.1016/j.semnephrol.2012.04.009; Chen JF, 2013, AM J PHYSIOL-RENAL, V304, pF676, DOI 10.1152/ajprenal.00507.2012; Corcoran JB, 2013, BBA-MOL CELL RES, V1833, P1969, DOI 10.1016/j.bbamcr.2013.03.027; Covington MD, 2012, KIDNEY INT, V81, P391, DOI 10.1038/ki.2011.356; de Cavanagh EMV, 2007, AM J NEPHROL, V27, P545, DOI 10.1159/000107757; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF4, DOI 10.1152/ajprenal.00045.2005; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; FLAMENG W, 1980, J THORAC CARDIOV SUR, V79, P413; Granata S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-388; Grgic I, 2012, KIDNEY INT, V82, P172, DOI 10.1038/ki.2012.20; Hewitson TD, 2001, J NEPHROL, V14, P453; Hodgkins KS, 2012, PEDIATR NEPHROL, V27, P901, DOI 10.1007/s00467-011-1992-9; Hwang I, 2012, DIABETES, V61, P728, DOI 10.2337/db11-0584; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kramer S, 2009, AM J PHYSIOL-RENAL, V297, pF218, DOI 10.1152/ajprenal.90617.2008; Lambert AJ, 2009, METHODS MOL BIOL, V554, P165, DOI 10.1007/978-1-59745-521-3_11; Li XN, 2010, J AM SOC NEPHROL, V21, P1115, DOI 10.1681/ASN.2009070760; Macias-Barragan J, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-16; Manoli I, 2013, P NATL ACAD SCI USA, V110, P13552, DOI 10.1073/pnas.1302764110; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Okamura DM, 2011, AM J PHYSIOL-RENAL, V300, pF245, DOI 10.1152/ajprenal.00326.2010; Schaier M, 2009, AM J PHYSIOL-RENAL, V297, pF769, DOI 10.1152/ajprenal.90530.2008; Sharma K, 2011, J AM SOC NEPHROL, V22, P1144, DOI 10.1681/ASN.2010101049; Shihab FS, 2005, TRANSPLANTATION, V79, P419, DOI 10.1097/01.TP.0000151721.99418.48; Small DM, 2012, NEPHROLOGY, V17, P311, DOI 10.1111/j.1440-1797.2012.01572.x; Szeto HH, 2011, J AM SOC NEPHROL, V22, P1041, DOI 10.1681/ASN.2010080808; Takakuta K, 2010, EUR J PHARMACOL, V629, P118, DOI 10.1016/j.ejphar.2009.12.011; Walker JE, 2005, MULT SCLER J, V11, P149, DOI 10.1191/1352458505ms1134oa; Yuan YG, 2012, FREE RADICAL BIO MED, V53, P30, DOI 10.1016/j.freeradbiomed.2012.03.015	33	48	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e83593	10.1371/journal.pone.0083593	http://dx.doi.org/10.1371/journal.pone.0083593			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349535	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200131
J	Elo, LL; Schwikowski, B				Elo, Laura L.; Schwikowski, Benno			Analysis of Time-Resolved Gene Expression Measurements across Individuals	PLOS ONE			English	Article							COEXPRESSION NETWORK ANALYSIS; REVEALS; DIFFERENTIATION; INTERFERON; GATA-3	Genetic and environmental determinants of altered cellular function, disease state, and drug response are increasingly studied using time-resolved transcriptomic profiles. While it is widely acknowledged that the rate of biological processes may vary between individuals, data analysis approaches that go beyond evaluating differential expression of single genes have so far not taken this variability into account. To this end, we introduce here a robust multi-gene data analysis approach and evaluate it in a biomarker discovery scenario across four publicly available datasets. In our evaluation, existing methods perform surprisingly poorly on time-resolved data; only the approach taking the variability into account yields reproducible and biologically plausible results. Our results indicate the need to capture gene expression between potentially heterogeneous individuals at multiple time points, and highlight the importance of robust data analysis in the presence of heterogeneous gene expression responses.	[Elo, Laura L.] Univ Turku, Dept Math & Stat, Turku, Finland; [Elo, Laura L.] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Elo, Laura L.] Abo Akad Univ, Turku, Finland; [Schwikowski, Benno] Inst Pasteur, Dept Genomes & Genet, Syst Biol Lab, Paris, France	University of Turku; University of Turku; Abo Akademi University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Elo, LL (corresponding author), Univ Turku, Dept Math & Stat, Turku, Finland.	laliel@utu.fi; benno@pasteur.fr	Elo, Laura/A-9449-2015	Elo, Laura/0000-0001-5648-4532; Schwikowski, Benno/0000-0001-5127-5619	Academy of Finland [127575, 218591]; JDRF [2-2013-32]; NIH [P41 GM103504]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103504] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); JDRF(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the Academy of Finland (grants 127575, 218591), JDRF grant 2-2013-32, and NIH grant P41 GM103504. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addinall SG, 2008, GENETICS, V180, P2251, DOI 10.1534/genetics.108.092577; Addinall SG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001362; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bar-Joseph Z, 2012, NAT REV GENET, V13, P552, DOI 10.1038/nrg3244; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Calfee CS, 2011, CRIT CARE MED, V39, P711, DOI 10.1097/CCM.0b013e318207ec3c; Childs KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022196; Elo LL, 2010, IMMUNITY, V32, P852, DOI 10.1016/j.immuni.2010.06.011; Elo LL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni193; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Frossi B, 2007, J IMMUNOL, V178, P2549, DOI 10.4049/jimmunol.178.4.2549; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Gillespie Colin S, 2010, BMC Res Notes, V3, P81, DOI 10.1186/1756-0500-3-81; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Greenall A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r146; Hawkins RD, 2013, IMMUNITY, V38, P1271, DOI 10.1016/j.immuni.2013.05.011; Holloway AJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-511; Hossain MB, 2008, IMMUNOLOGY, V125, P377, DOI 10.1111/j.1365-2567.2008.02854.x; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Hudson NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007249; Knosp CA, 2011, J EXP MED, V208, P1523, DOI 10.1084/jem.20101167; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee DS, 2009, CIRC-HEART FAIL, V2, P387, DOI 10.1161/CIRCHEARTFAILURE.109.898429; Lin TH, 2008, BIOINFORMATICS, V24, pI147, DOI 10.1093/bioinformatics/btn152; Liu BH, 2010, BIOINFORMATICS, V26, P2637, DOI 10.1093/bioinformatics/btq471; Liu Q, 2010, BIOINFORMATICS, V26, P770, DOI 10.1093/bioinformatics/btq022; Mason MJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-327; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Pappas DJ, 2009, PHYSIOL GENOMICS, V38, P362, DOI 10.1152/physiolgenomics.00058.2009; Rahman N, 1968, THEORETICAL COURSE S; Remondini D, 2005, P NATL ACAD SCI USA, V102, P6902, DOI 10.1073/pnas.0502081102; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stritesky GL, 2011, IMMUNITY, V34, P39, DOI 10.1016/j.immuni.2010.12.013; Subramanian J, 2010, NAT REV CLIN ONCOL, V7, P327, DOI 10.1038/nrclinonc.2010.60; Taube SE, 2009, JNCI-J NATL CANCER I, V101, P1453, DOI 10.1093/jnci/djp334; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Taylor MW, 2007, J VIROL, V81, P3391, DOI 10.1128/JVI.02640-06; Tesson BM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-497; Trost DC, 2010, PATHODYNAMICS IMPROV; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	49	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82340	10.1371/journal.pone.0082340	http://dx.doi.org/10.1371/journal.pone.0082340			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349258	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200077
J	Moya-Anegon, F; Herrero-Solana, V				Moya-Anegon, Felix; Herrero-Solana, Victor			Worldwide Topology of the Scientific Subject Profile: A Macro Approach in the Country Level	PLOS ONE			English	Article							PUBLICATION PATTERNS; SCIENCE; INDICATORS; COLLABORATION	Background: Models for the production of knowledge and systems of innovation and science are key elements for characterizing a country in view of its scientific thematic profile. With regard to scientific output and publication in journals of international visibility, the countries of the world may be classified into three main groups according to their thematic bias. Methodology/Principal Findings: This paper aims to classify the countries of the world in several broad groups, described in terms of behavioural models that attempt to sum up the characteristics of their systems of knowledge and innovation. We perceive three clusters in our analysis: 1) the biomedical cluster, 2) the basic science & engineering cluster, and 3) the agricultural cluster. The countries are conceptually associated with the clusters via Principal Component Analysis (PCA), and a Multidimensional Scaling (MDS) map with all the countries is presented. Conclusions/Significance: As we have seen, insofar as scientific output and publication in journals of international visibility is concerned, the countries of the world may be classified into three main groups according to their thematic profile. These groups can be described in terms of behavioral models that attempt to sum up the characteristics of their systems of knowledge and innovation.	[Moya-Anegon, Felix] CSIC CCHS IPP, SCImago Grp, Madrid, Spain; [Herrero-Solana, Victor] Univ Granada, SCImago UGR, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Politicas y Bienes Publicos (IPP); University of Granada	Herrero-Solana, V (corresponding author), Univ Granada, SCImago UGR, Granada, Spain.	victorhs@ugr.es	Herrero-Solana, Victor/B-4541-2008; de Moya Anegón, Félix/V-3678-2019; de Moya Anegón, Félix/C-4004-2009	Herrero-Solana, Victor/0000-0003-1142-5074; de Moya Anegón, Félix/0000-0002-0255-8628; de Moya Anegón, Félix/0000-0002-0255-8628				Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Al Dwairi K, 2007, INVESTIG BIBLIOTECOL, V21, P185; Archambault E, 2005, ISSI 2005: PROCEEDINGS OF THE 10TH INTERNATIONAL CONFERENCE OF THE INTERNATIONAL SOCIETY FOR SCIENTOMETRICS AND INFORMETRICS, VOLS 1 AND 2, P149; BASALLA G, 1967, SCIENCE, V156, P611, DOI 10.1126/science.156.3775.611; BOHME G, 1973, Z SOZIOL, V2, P128; Bornmann L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013327; BRAUN T, 2000, WEB KNOWLEDGE FESTSC; De Moya-Anegon F, 1999, SCIENTOMETRICS, V46, P299, DOI 10.1007/BF02464780; De Moya-Anegon F, 2007, SCIENTOMETRICS, V73, P53, DOI 10.1007/s11192-007-1681-4; Ding Y, 1999, J INF SCI, V25, P67, DOI 10.1177/016555159902500107; Dore JC, 1996, J AM SOC INFORM SCI, V47, P588, DOI 10.1002/(SICI)1097-4571(199608)47:8<588::AID-ASI3>3.0.CO;2-P; ELALAMI J, 1992, SCIENTOMETRICS, V23, P249; Etzkowitz H., 2008, 3 HELIX U IND GOVT I; Etzkowitz H., 1999, SCI PUBL POLICY, V26, P138, DOI DOI 10.1093/SPP/26.2.138; FUNTOWICZ SO, 1993, FUTURES, V25, P739, DOI 10.1016/0016-3287(93)90022-L; GIBBONS M., 1994, NEW PRODUCTION KNOWL; Glanzel W, 2001, SCIENTOMETRICS, V51, P69, DOI 10.1023/A:1010512628145; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; Kozlowski J, 1999, SCIENTOMETRICS, V45, P137, DOI 10.1007/BF02458473; Leydesdorff L, 2005, SCIENTOMETRICS, V63, P617, DOI 10.1007/s11192-005-0231-1; MIQUEL JF, 1995, SCIENTOMETRICS, V33, P149, DOI 10.1007/BF02020566; MOYAANEGON F, 2013, ZENODO, DOI DOI 10.5281/ZEN0D0.7544; Narvaez-Berthelemot N, 2002, SCIENTOMETRICS, V54, P229, DOI 10.1023/A:1016033528117; Okubo Y, 1998, SCIENTOMETRICS, V41, P273, DOI 10.1007/BF02459045; OKUBO Y, 1992, SCIENTOMETRICS, V25, P321, DOI 10.1007/BF02028090; Osareh F, 1997, SCIENTOMETRICS, V39, P253, DOI 10.1007/BF02458529; Schaffer Wolf., 1983, FINALIZATION SCI SOC; SCHUBERT A, 1989, SCIENTOMETRICS, V16, P3, DOI 10.1007/BF02093234; Vinkler P, 2008, SCIENTOMETRICS, V74, P237, DOI 10.1007/s11192-008-0215-z; Ziman J, 2000, SCI WARS MISSING DIS, P135	30	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e83222	10.1371/journal.pone.0083222	http://dx.doi.org/10.1371/journal.pone.0083222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VD	24349467	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200127
J	Valentino, R; D'Esposito, V; Passaretti, F; Liotti, A; Cabaro, S; Longo, M; Perruolo, G; Oriente, F; Beguinot, F; Formisano, P				Valentino, Rossella; D'Esposito, Vittoria; Passaretti, Federica; Liotti, Antonietta; Cabaro, Serena; Longo, Michele; Perruolo, Giuseppe; Oriente, Francesco; Beguinot, Francesco; Formisano, Pietro			Bisphenol-A Impairs Insulin Action and Up-Regulates Inflammatory Pathways in Human Subcutaneous Adipocytes and 3T3-L1 Cells	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; BODY-MASS INDEX; METABOLIC SYNDROME; ENVIRONMENTAL CONTAMINANTS; ENDOCRINE DISRUPTORS; SERUM CONCENTRATIONS; WIDESPREAD EXPOSURE; PERINATAL EXPOSURE; ABDOMINAL OBESITY; ADIPOSE-TISSUE	Current evidence indicates that chemical pollutants may interfere with the homeostatic control of nutrient metabolism, thereby contributing to the increased prevalence of metabolic disorders. Bisphenol-A (BPA) is a lipophilic compound contained in plastic which is considered a candidate for impairing energy and glucose metabolism. We have investigated the impact of low doses of BPA on adipocyte metabolic functions. Human adipocytes derived from subcutaneous adipose tissue and differentiated 3T3-L1 cells were incubated with BPA, in order to evaluate the effect on glucose utilization, insulin sensitivity and cytokine secretion. Treatment with 1nM BPA significantly inhibited insulin-stimulated glucose utilization, without grossly interfering with adipocyte differentiation. Accordingly, mRNA levels of the adipogenic markers PPAR gamma and GLUT4 were unchanged upon BPA exposure. BPA treatment also impaired insulin-activated receptor phosphorylation and signaling. Moreover, adipocyte incubation with BPA was accompanied by increased release of IL-6 and IFN-gamma, as assessed by multiplex ELISA assays, and by activation of JNK, STAT3 and NFkB pathways. Treatment of the cells with the JNK inhibitor SP600125 almost fully reverted BPA effect on insulin signaling and glucose utilization. In conclusion, low doses of BPA interfere with inflammatory/insulin signaling pathways, leading to impairment of adipose cell function.	[Valentino, Rossella; Perruolo, Giuseppe; Beguinot, Francesco; Formisano, Pietro] CNR, IEOS, I-80125 Naples, Italy; [D'Esposito, Vittoria; Passaretti, Federica; Liotti, Antonietta; Cabaro, Serena; Longo, Michele; Oriente, Francesco; Beguinot, Francesco; Formisano, Pietro] Univ Naples Federico II, Dipartimento Sci Med Traslazionali, Naples, Italy; [Passaretti, Federica; Liotti, Antonietta] Univ Salerno, Dipartimento Sci Farmaceut, I-84100 Salerno, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Salerno	Formisano, P (corresponding author), CNR, IEOS, I-80125 Naples, Italy.	fpietro@unina.it	Cabaro, Serena/K-7697-2016; LONGO, Michele/AAB-9188-2019; D'Esposito, Vittoria/K-7633-2016; Formisano, Pietro/J-4237-2018; giuseppe, perruolo/AAW-3869-2021; Longo, Michele/AAB-5972-2020; Liotti, Antonietta/AAU-5456-2020; ORIENTE, Francesco/J-6652-2018	LONGO, Michele/0000-0003-4798-0504; D'Esposito, Vittoria/0000-0002-3675-8062; Liotti, Antonietta/0000-0001-9433-3428; Cabaro, Serena/0000-0002-9946-4475; Formisano, Pietro/0000-0001-7020-6870; Perruolo, Giuseppe/0000-0003-0479-8729; ORIENTE, Francesco/0000-0003-4375-4526	EC FP6 PREPOBEDIA [201681]; Associazione Italiana per la Ricerca sul Cancro - AIRC [IG 12136]; European Foundation for the Study of Diabetes (EFSD Diabetes and Cancer Programme); MIUR - PRIN [prot.2010MCLBCZ_003]; MIUR - FIRB MERIT [RBNE08NKH7_011]	EC FP6 PREPOBEDIA; Associazione Italiana per la Ricerca sul Cancro - AIRC; European Foundation for the Study of Diabetes (EFSD Diabetes and Cancer Programme); MIUR - PRIN; MIUR - FIRB MERIT	The manuscript was supported in part by EC FP6 PREPOBEDIA (201681); Associazione Italiana per la Ricerca sul Cancro - AIRC (IG 12136); European Foundation for the Study of Diabetes (EFSD Diabetes and Cancer Programme 2011); MIUR - PRIN (prot.2010MCLBCZ_003); MIUR - FIRB MERIT (RBNE08NKH7_011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Ben-Jonathan N, 2009, MOL CELL ENDOCRINOL, V304, P49, DOI 10.1016/j.mce.2009.02.022; Bernal AJ, 2010, BIRTH DEFECTS RES A, V88, P938, DOI 10.1002/bdra.20685; Botta G, 2010, HUM GENE THER, V21, P1067, DOI 10.1089/hum.2009.181; Calippe B, 2010, J IMMUNOL, V185, P1169, DOI 10.4049/jimmunol.0902383; Carpenter David O., 2008, Reviews on Environmental Health, V23, P59; Caruso M, 1997, J BIOL CHEM, V272, P7290, DOI 10.1074/jbc.272.11.7290; Carwile JL, 2011, ENVIRON RES, V111, P825, DOI 10.1016/j.envres.2011.05.014; D'Esposito V, 2012, DIABETOLOGIA, V55, P2811, DOI 10.1007/s00125-012-2629-7; Elobeid MA, 2008, CURR OPIN ENDOCRINOL, V15, P403, DOI 10.1097/MED.0b013e32830ce95c; Everett CJ, 2011, J ENVIRON MONITOR, V13, P241, DOI 10.1039/c0em00400f; Golub MS, 2010, BIRTH DEFECTS RES B, V89, P441, DOI 10.1002/bdrb.20275; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Grun F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI 10.1007/s11154-007-9049-x; Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Hursting SD, 2012, ANN NY ACAD SCI, V1271, P82, DOI 10.1111/j.1749-6632.2012.06737.x; Hyun E, 2011, CRIT REV IMMUNOL, V31, P307, DOI 10.1615/CritRevImmunol.v31.i4.30; Isakson P, 2009, DIABETES, V58, P1550, DOI 10.2337/db08-1770; Kidani T, 2010, J ATHEROSCLER THROMB, V17, P834, DOI 10.5551/jat.4051; Lee DH, 2007, DIABETES CARE, V30, P1596, DOI 10.2337/dc07-0072; Lee DH, 2007, DIABETES CARE, V30, P622, DOI 10.2337/dc06-2190; Makaji E, 2011, INT J TOXICOL, V30, P410, DOI 10.1177/1091581811405544; Miao MH, 2011, REPROD TOXICOL, V32, P64, DOI 10.1016/j.reprotox.2011.03.002; Mullerova D, 2007, PHYSIOL RES, V56, P375, DOI 10.33549/physiolres.931022; Muncke J, 2009, SCI TOTAL ENVIRON, V407, P4549, DOI 10.1016/j.scitotenv.2009.05.006; Neel BA, 2011, DIABETES, V60, P1838, DOI 10.2337/db11-0153; Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x; Newbold RR, 2005, BIRTH DEFECTS RES A, V73, P478, DOI 10.1002/bdra.20147; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Ritchie SA, 2007, NUTR METAB CARDIOVAS, V17, P319, DOI 10.1016/j.numecd.2006.07.005; Rogers JA, 2013, MOL IMMUNOL, V53, P421, DOI 10.1016/j.molimm.2012.09.013; Ropero AB, 2008, INT J ANDROL, V31, P194, DOI 10.1111/j.1365-2605.2007.00832.x; Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002; Rubin BS, 2009, MOL CELL ENDOCRINOL, V304, P55, DOI 10.1016/j.mce.2009.02.023; Russell CD, 1998, AM J PHYSIOL-ENDOC M, V275, pE507, DOI 10.1152/ajpendo.1998.275.3.E507; Ryan KK, 2010, ENDOCRINOLOGY, V151, P2603, DOI 10.1210/en.2009-1218; Sakurai K, 2004, BRIT J PHARMACOL, V141, P209, DOI 10.1038/sj.bjp.0705520; Sargis RM, 2010, OBESITY, V18, P1283, DOI 10.1038/oby.2009.419; Shankar A, 2011, J CLIN ENDOCR METAB, V96, P3822, DOI 10.1210/jc.2011-1682; Shapiro H, 2011, THESCIENTIFICWORLDJO, V11, P2509, DOI 10.1100/2011/397971; Silver MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026868; Siracusa MC, 2008, J IMMUNOL, V180, P1423, DOI 10.4049/jimmunol.180.3.1423; Somm E, 2009, ENVIRON HEALTH PERSP, V117, P1549, DOI 10.1289/ehp.11342; Szymanski A, 2006, ACTA CHROMATOGR, V17, P161; Tarantino G, 2013, CLIN ENDOCRINOL, V78, P447, DOI 10.1111/j.1365-2265.2012.04500.x; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Valentino R, 2006, DIABETOLOGIA, V49, P3058, DOI 10.1007/s00125-006-0455-5; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vandenberg LN, 2012, CIENC SAUDE COLETIVA, V17, P407, DOI 10.1590/S1413-81232012000200015; vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713; Wabitsch M, 1996, DIABETES, V45, P1435, DOI 10.2337/diabetes.45.10.1435; Wadia PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063902; Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528	57	79	80	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82099	10.1371/journal.pone.0082099	http://dx.doi.org/10.1371/journal.pone.0082099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349194	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200063
J	Loubaki, L; Hadj-Salem, I; Fakhfakh, R; Jacques, E; Plante, S; Boisvert, M; Aoudjit, F; Chakir, J				Loubaki, Lionel; Hadj-Salem, Ikhlass; Fakhfakh, Raouia; Jacques, Eric; Plante, Sophie; Boisvert, Marc; Aoudjit, Fawzi; Chakir, Jamila			Co-Culture of Human Bronchial Fibroblasts and CD4+T Cells Increases Th17 Cytokine Signature	PLOS ONE			English	Article							HELPER T-CELLS; AUTOIMMUNE INFLAMMATION; SYNOVIAL FIBROBLASTS; PULMONARY-FIBROSIS; ASTHMATIC SUBJECTS; UP-REGULATION; T(H)17 CELLS; TGF-BETA; IN-VIVO; DIFFERENTIATION	Background: Airway inflammation is an important characteristic of asthma and has been associated with airway remodelling and bronchial hyperreactivity. The mucosal microenvironment composed of structural cells and highly specialised extracellular matrix is able to amplify and promote inflammation. This microenvironment leads to the development and maintenance of a specific adaptive response characterized by Th2 and Th17. Bronchial fibroblasts produce multiple mediators that may play a role in maintaining and amplifying this response in asthma. Objective: To investigate the role of bronchial fibroblasts obtained from asthmatic subjects and healthy controls in regulating Th17 response by creating a local micro-environment that promotes this response in the airways. Methods: Human bronchial fibroblasts and CD4(+)T cells were isolated from atopic asthmatics and non-atopic healthy controls. CD4(+)T were co-cultured with bronchial fibroblasts of asthmatic subjects and healthy controls. RORc gene expression was detected by qPCR. Phosphorylated STAT-3 and ROR gamma t were evaluated by western blots. Th17 phenotype was measured by flow cytometry. IL-22, IL17, IL-6 TGF-beta and IL1-beta were assessed by qPCR and ELISA. Results: Co-culture of CD4(+)T cells with bronchial fibroblasts significantly stimulated RORc expression and induced a significant increase in Th17 cells as characterized by the percentage of IL-17(+)/CCR6(+) staining in asthmatic conditions. IL-17 and IL-22 were increased in both normal and asthmatic conditions with a significantly higher amount in asthmatics compared to controls. IL-6, IL-1 beta, TGF-beta and IL-23 were significantly elevated in fibroblasts from asthmatic subjects upon co-culture with CD4(+)T cells. IL-23 stimulates IL-6 and IL-1 beta expression by bronchial fibroblasts. Conclusion: Interaction between bronchial fibroblasts and T cells seems to promote specifically Th17 cells profile in asthma. These results suggest that cellular interaction particularly between T cells and fibroblasts may play a pivotal role in the regulation of the inflammatory response in asthma.	[Loubaki, Lionel; Hadj-Salem, Ikhlass; Fakhfakh, Raouia; Jacques, Eric; Plante, Sophie; Chakir, Jamila] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada; [Boisvert, Marc; Aoudjit, Fawzi] Univ Laval, Ctr Rech Rhumatol & Immunol, Quebec City, PQ, Canada	Laval University; Laval University	Chakir, J (corresponding author), Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	jamila.chakir@med.ulaval.ca		Plante, Sophie/0000-0003-1069-239X; fakhfakh, raouia/0000-0001-5379-0622	Canadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research Council of Canada (NSERC); Respiratory Health Network of the Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Respiratory Health Network of the Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This study was supported by the Canadian Institutes of Health Research (CIHR) and by the Natural Sciences and Engineering Research Council of Canada (NSERC). R.F. was a recipient of a fellowship from the Respiratory Health Network of the Fonds de la Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Brouty-Boye D, 2000, EUR J IMMUNOL, V30, P914, DOI 10.1002/1521-4141(200003)30:3<914::AID-IMMU914>3.0.CO;2-D; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Chakir J, 1996, LAB INVEST, V75, P735; Chakir J, 2001, J ALLERGY CLIN IMMUN, V107, P36, DOI 10.1067/mai.2001.111929; Chizzolini C, 2008, BLOOD, V112, P3696, DOI 10.1182/blood-2008-05-155408; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Darveau ME, 2008, J ALLERGY CLIN IMMUN, V121, P692, DOI 10.1016/j.jaci.2007.11.023; Dube J, 1998, LAB INVEST, V78, P297; Egan PJ, 2008, ARTHRITIS RHEUM-US, V58, P3720, DOI 10.1002/art.24075; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; GARDNER RM, 1988, J OCCUP ENVIRON MED, V30, P272; Hamilton L M, 2001, Monaldi Arch Chest Dis, V56, P48; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; Hashimoto T, 2005, INT ARCH ALLERGY IMM, V137, P51, DOI 10.1159/000085432; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kim KW, 2007, ARTHRITIS RHEUM-US, V56, P1076, DOI 10.1002/art.22439; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; Loubaki L, 2010, MOL IMMUNOL, V47, P2112, DOI 10.1016/j.molimm.2010.03.011; Matsunaga K, 2006, J ALLERGY CLIN IMMUN, V118, P84, DOI 10.1016/j.jaci.2006.04.020; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; McGeachy MJ, 2009, NAT IMMUNOL, V10, P314, DOI 10.1038/ni.1698; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Pap T, 2000, ARTHRITIS RES, V2, P361, DOI 10.1186/ar113; Parsonage G, 2003, THROMB HAEMOSTASIS, V90, P688, DOI 10.1160/TH03-04-0208; Plante S, 2006, J ALLERGY CLIN IMMUN, V117, P1321, DOI 10.1016/j.jaci.2005.12.1349; Schirmer C, 2010, BLOOD, V116, P1715, DOI 10.1182/blood-2010-01-263509; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Smith RS, 1997, AM J PATHOL, V151, P317; Vancheri C, 2001, AM J RESP CELL MOL, V25, P592, DOI 10.1165/ajrcmb.25.5.4609; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Wilson RH, 2009, AM J RESP CRIT CARE, V180, P720, DOI 10.1164/rccm.200904-0573OC; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhang K, 1996, BIOL SIGNAL, V5, P232; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	43	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81983	10.1371/journal.pone.0081983	http://dx.doi.org/10.1371/journal.pone.0081983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349168	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100077
J	Collins, DA; Hoskins, A; Bowman, J; Jones, J; Stemberger, NA; Richmond, PC; Leach, AJ; Lehmann, D				Collins, Deirdre A.; Hoskins, Anke; Bowman, Jacinta; Jones, Jade; Stemberger, Natalie A.; Richmond, Peter C.; Leach, Amanda J.; Lehmann, Deborah			High Nasopharyngeal Carriage of Non-Vaccine Serotypes in Western Australian Aboriginal People Following 10 Years of Pneumococcal Conjugate Vaccination	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; OTITIS-MEDIA; NONABORIGINAL CHILDREN; POPULATION; 6A; EPIDEMIOLOGY; DISEASE; 6C	Background: Invasive pneumococcal disease (IPD) continues to occur at high rates among Australian Aboriginal people. The seven-valent pneumococcal conjugate vaccine (7vPCV) was given in a 2-4-6-month schedule from 2001, with a 23-valent pneumococcal polysaccharide vaccine (23vPPV) booster at 18 months, and replaced with 13vPCV in July 2011. Since carriage surveillance can supplement IPD surveillance, we have monitored pneumococcal carriage in western Australia (WA) since 2008 to assess the impact of the 10-year 7vPCV program. Methods: We collected 1,500 nasopharyngeal specimens from Aboriginal people living in varied regions of WA from August 2008 until June 2011. Specimens were cultured on selective media. Pneumococcal isolates were serotyped by the quellung reaction. Results: Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis were carried by 71.9%, 63.2% and 63.3% respectively of children <5 years of age, and 34.6%, 22.4% and 27.2% of people >= 5 years. Of 43 pneumococcal serotypes identified, the most common were 19A, 16F and 6C in children <5 years, and 15B, 34 and 22F in older people. 7vPCV serotypes accounted for 14.5% of all serotypeable isolates, 13vPCV for 32.4% and 23vPPV for 49.9%, with little variation across all age groups. Serotypes 1 and 12F were rarely identified, despite causing recent IPD outbreaks in WA. Complete penicillin resistance (MIC >= 2 mu g/ml) was found in 1.6% of serotype 19A (5.2%), 19F (4.9%) and 16F (3.2%) isolates and reduced penicillin susceptibility (MIC >= 0.125 mu g/ml) in 24.9% of isolates, particularly 19F (92.7%), 19A (41.3%), 16F (29.0%). Multi-resistance to cotrimoxazole, tetracycline and erythromycin was found in 83.0% of 23F isolates. Among non-serotypeable isolates 76.0% had reduced susceptibility and 4.0% showed complete resistance to penicillin. Conclusions: Ten years after introduction of 7vPCV for Aboriginal Australian children, 7vPCV serotypes account for a small proportion of carried pneumococci. A large proportion of circulating serotypes are not covered by any currently licensed vaccine.	[Collins, Deirdre A.; Hoskins, Anke; Lehmann, Deborah] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Bowman, Jacinta; Jones, Jade; Stemberger, Natalie A.] PathWest Lab Med WA, Div Microbiol & Infect Dis, Perth, WA, Australia; [Stemberger, Natalie A.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Richmond, Peter C.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Leach, Amanda J.] Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT 0909, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Charles Darwin University; Menzies School of Health Research	Collins, DA (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia.	dcollins@ichr.uwa.edu.au	Richmond, Peter C/G-3379-2012; Collins, Deirdre A/D-4705-2017	Richmond, Peter C/0000-0001-7562-7228; Collins, Deirdre A/0000-0001-6754-9290	Western Australia Department of Health through the Collaboration for Applied Research and Evaluation; National Health and Medical Research Council [545232]	Western Australia Department of Health through the Collaboration for Applied Research and Evaluation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this study was provided by Western Australia Department of Health through the Collaboration for Applied Research and Evaluation and National Health and Medical Research Council Project Grant #545232. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030787; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P129; Australian Bureau of Statistics, 2011, 2011 CENS POP HOUS; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Cooper D, 2011, VACCINE, V29, P7207, DOI 10.1016/j.vaccine.2011.06.056; Giele C, 2012, 7 INT S PNEUM PNEUM, P2012; Jacoby P, 2011, PEDIATR INFECT DIS J, V30, P480, DOI 10.1097/INF.0b013e318217dc6e; Leach AJ, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-121; Leach AJ, 2008, J CLIN MICROBIOL, V46, P2081, DOI 10.1128/JCM.00048-08; Lehmann D, 2008, PAEDIATR PERINAT EP, V22, P60, DOI 10.1111/j.1365-3016.2007.00891.x; Lehmann D, 2010, CLIN INFECT DIS, V50, P1477, DOI 10.1086/652440; Lehmann D, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-32; Mackenzie GA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-304; Marsh RL, 2007, VACCINE, V25, P2434, DOI 10.1016/j.vaccine.2006.09.016; Menzies Robert, 2008, Commun Dis Intell Q Rep, V32 Suppl, pS2; Pai R, 2005, J INFECT DIS, V192, P1988, DOI 10.1086/498043; Park IH, 2008, J INFECT DIS, V198, P1818, DOI 10.1086/593339; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Rivera-Olivero IA, 2007, CLIN INFECT DIS, V45, P1427, DOI 10.1086/522984; Roca A, 2012, CLIN INFECT DIS, V55, P816, DOI 10.1093/cid/cis554; Rudolph K, 2013, DIAGN MICR INFEC DIS, V75, P271, DOI 10.1016/j.diagmicrobio.2012.11.021; Scott JR, 2012, J INFECT DIS, V205, P280, DOI 10.1093/infdis/jir730; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Spijkerman J, 2011, EMERG INFECT DIS, V17, P584, DOI 10.3201/eid1704.101115; Tocheva AS, 2011, VACCINE, V29, P4400, DOI 10.1016/j.vaccine.2011.04.004; Vakevainen M, 2001, J INFECT DIS, V184, P789, DOI 10.1086/322984; Watson K, 2006, PEDIATR INFECT DIS J, V25, P782, DOI 10.1097/01.inf.0000232705.49634.68; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8; Weinberger DM, 2011, EPIDEMIOLOGY, V22, P199, DOI 10.1097/EDE.0b013e3182087634; Wiertsema SP, 2011, VACCINE, V29, P5163, DOI 10.1016/j.vaccine.2011.05.035	30	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82280	10.1371/journal.pone.0082280	http://dx.doi.org/10.1371/journal.pone.0082280			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24349245	Green Submitted, gold, Green Published			2022-12-27	WOS:000327947800090
J	Stride, MC; Polkinghorne, A; Powell, MD; Nowak, BF				Stride, Megan C.; Polkinghorne, Adam; Powell, Mark D.; Nowak, Barbara F.			"Candidatus Similichlamydia laticola", a Novel Chlamydia-like Agent of epitheliocystis in Seven Consecutive Cohorts of Farmed Australian Barramundi, Lates calcarifer (Bloch)	PLOS ONE			English	Article							SALMO-SALAR L.; ATLANTIC SALMON; CLAVOCHLAMYDIA-SALMONICOLA; MOLECULAR CHARACTERIZATION; ORDER CHLAMYDIALES; BIDYANUS-BIDYANUS; STRIPED TRUMPETER; SILVER PERCH; PARILICHLAMYDIACEAE; IDENTIFICATION	Six consecutively hatched cohorts and one cohort of pre-hatch eggs of farmed barramundi (Lates calcarifer) from south Australia were examined for Chlamydia-like organisms associated with epitheliocystis. To identify and characterise the bacteria, 59 gill samples and three pre-hatch egg samples were processed for histology, in situ hybridisation and 16S rRNA amplification, sequencing and comprehensive phylogenetic analysis. Cases of epitheliocystis were observed microscopically and characterised by membrane-enclosed basophilic cysts filled with a granular material that caused hypertrophy of the epithelial cells. In situ hybridisation with a Chlamydiales-specific probe lead to specific labelling of the epitheliocystis inclusions within the gill epithelium. Two distinct but closely related 16S rRNA chlamydial sequences were amplified from gill DNA across the seven cohorts, including from pre-hatch eggs. These genotype sequences were found to be novel, sharing 97.1-97.5% similarity to the next closest 16S rRNA sequence, Ca. Similichlamydia latridicola, from Australian striped trumpeter. Comprehensive phylogenetic analysis of these genotype sequences against representative members of the Chlamydiales order and against other epitheliocystis agents revealed these Chlamydia-like organisms to be novel and taxonomically placed them within the recently proposed genus Ca. Similichlamydia. Following Fredricks and Relman's molecular postulates and based on these observations, we propose the epitheliocystis agents of barramundi to be known as "Candidatus Similichlamydia laticola" (sp. nov.).	[Stride, Megan C.; Nowak, Barbara F.] Univ Tasmania, Natl Ctr Marine Conservat & Resource Sustainabil, Launceston, Tas 7250, Australia; [Polkinghorne, Adam] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia; [Powell, Mark D.] Norwegian Inst Water Res, Trondheim, Norway	University of Tasmania; Queensland University of Technology (QUT)	Stride, MC (corresponding author), Univ Tasmania, Natl Ctr Marine Conservat & Resource Sustainabil, Launceston, Tas 7250, Australia.	mcstride@amc.edu.au	Nowak, Barbara/J-7261-2014	Nowak, Barbara/0000-0002-0347-643X; Stride, Megan/0000-0001-5523-8903; Polkinghorne, Adam/0000-0002-6803-9222; Polkinghorne, Adam/0000-0002-6567-2962	University of Tasmania	University of Tasmania	The project was internally funded by University of Tasmania. The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	ANDERSON IG, 1992, AUST VET J, V69, P226, DOI 10.1111/j.1751-0813.1992.tb09930.x; Draghi A, 2004, J CLIN MICROBIOL, V42, P5286, DOI 10.1128/JCM.42.11.5286-5297.2004; Draghi A, 2007, DIS AQUAT ORGAN, V76, P27, DOI 10.3354/dao076027; Draghi II A, 2006, THESIS U CONNECTICUT, P204; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; FAO Cultured Aquatic Species Information Programme, 2006, CULT AQ SPEC INF PRO; Frances J, 1997, J FISH DIS, V20, P453, DOI 10.1046/j.1365-2761.1997.00326.x; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Karlsen M, 2008, ENVIRON MICROBIOL, V10, P208, DOI 10.1111/j.1462-2920.2007.01445.x; Kumar G, 2013, VET REC, V172, DOI 10.1136/vr.101193; Lai CC, 2013, AQUACULTURE, V388, P99, DOI 10.1016/j.aquaculture.2013.01.020; LEWIS EJ, 1992, J FISH DIS, V15, P267, DOI 10.1111/j.1365-2761.1992.tb00663.x; Meijer A, 2006, APPL ENVIRON MICROB, V72, P284, DOI 10.1128/AEM.72.1.284-290.2006; Meijer A, 1999, ARTERIOSCL THROM VAS, V19, P2680, DOI 10.1161/01.ATV.19.11.2680; Miller M.A., 2010, P GAT COMP ENV WORKS; Miller M. A., 2010, CIPRES PORTALS; Mitchell SO, 2010, J FISH DIS, V33, P665, DOI 10.1111/j.1365-2761.2010.01171.x; Nowak BF, 2006, J FISH DIS, V29, P573, DOI 10.1111/j.1365-2761.2006.00747.x; Nowak BF, 2004, J FISH DIS, V27, P709, DOI 10.1111/j.1365-2761.2004.00593.x; Nowak BF, 1999, J FISH DIS, V22, P73, DOI 10.1046/j.1365-2761.1999.00140.x; Polinski M, 2013, FISH SHELLFISH IMMUN, V34, P1147, DOI 10.1016/j.fsi.2013.01.026; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Skirtun M, 2012, AUSTR FISHERIES STAT; Stride MC, 2013, APPL ENVIRON MICROB, V79, P4914, DOI 10.1128/AEM.00746-13; Stride MC, 2013, APPL ENVIRON MICROB, V79, P1590, DOI 10.1128/AEM.02899-12; Syasina I, 2004, B EUR ASSOC FISH PAT, V24, P260; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Venizelos A, 1996, J WORLD AQUACULT SOC, V27, P223, DOI 10.1111/j.1749-7345.1996.tb00274.x	29	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82889	10.1371/journal.pone.0082889	http://dx.doi.org/10.1371/journal.pone.0082889			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24349386	Green Published, gold, Green Submitted			2022-12-27	WOS:000327947800104
J	Laviola, L; Orlando, MR; Incalza, MA; Caccioppoli, C; Melchiorre, M; Leonardini, A; Cignarelli, A; Tortosa, F; Labarbuta, R; Martemucci, S; Pacelli, C; Cocco, T; Perrini, S; Natalicchio, A; Giorgino, F				Laviola, Luigi; Orlando, Maura Roberta; Incalza, Maria Angela; Caccioppoli, Cristina; Melchiorre, Mariangela; Leonardini, Anna; Cignarelli, Angelo; Tortosa, Federica; Labarbuta, Rossella; Martemucci, Sabina; Pacelli, Consiglia; Cocco, Tiziana; Perrini, Sebastio; Natalicchio, Annalisa; Giorgino, Francesco			TNF alpha Signals via p66(Shc) to Induce E-Selectin, Promote Leukocyte Transmigration and Enhance Permeability in Human Endothelial Cells	PLOS ONE			English	Article							CADHERIN-CATENIN COMPLEX; BLOOD MONONUCLEAR-CELLS; LIFE-SPAN DETERMINANT; NECROSIS-FACTOR-ALPHA; P38 MAP KINASE; OXIDATIVE STRESS; GENE-EXPRESSION; BETA-CATENIN; KAPPA-B; PROTEIN	Endothelial cells participate in inflammatory events leading to atherogenesis by regulating endothelial cell permeability via the expression of VE-Cadherin and beta-catenin and leukocyte recruitment via the expression of E-Selectins and other adhesion molecules. The protein p66(Shc) acts as a sensor/inducer of oxidative stress and may promote vascular dysfunction. The objective of this study was to investigate the role of p66(Shc) in tumor necrosis factor TNF alpha-induced E-Selectin expression and function in human umbilical vein endothelial cells (HUVEC). Exposure of HUVEC to 50 ng/ml TNF alpha resulted in increased leukocyte transmigration through the endothelial monolayer and E-Selectin expression, in association with augmented phosphorylation of both p66(Shc) on Ser(36) and the stress kinase c-Jun NH2-terminal protein kinase (JNK)-1/2, and higher intracellular reactive oxygen species (ROS) levels. Overexpression of p66(Shc) in HUVEC resulted in enhanced p66(Shc) phosphorylation on Ser(36), increased ROS and E-Selectin levels, and amplified endothelial cell permeability and leukocyte transmigration through the HUVEC monolayer. Conversely, overexpression of a phosphorylation-defective p66(Shc) protein, in which Ser(36) was replaced by Ala, did not augment ROS and E-Selectin levels, nor modify cell permeability or leukocyte transmigration beyond those found in wild-type cells. Moreover, siRNA-mediated silencing of p66(Shc) resulted in marked reduction of E-Selectin expression and leukocyte transmigration. In conclusion, p66(Shc) acts as a novel intermediate in the TNF alpha pathway mediating endothelial dysfunction, and its action requires JNK-dependent phosphorylation of p66(Shc) on Ser(36).	[Laviola, Luigi; Orlando, Maura Roberta; Incalza, Maria Angela; Caccioppoli, Cristina; Melchiorre, Mariangela; Leonardini, Anna; Cignarelli, Angelo; Tortosa, Federica; Labarbuta, Rossella; Martemucci, Sabina; Perrini, Sebastio; Natalicchio, Annalisa; Giorgino, Francesco] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Sect Internal Med Endocrinol Androl & Metab Dis, Bari, Italy; [Pacelli, Consiglia; Cocco, Tiziana] Univ Bari Aldo Moro, Dept Med Biochem Biol & Phys, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Giorgino, F (corresponding author), Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Sect Internal Med Endocrinol Androl & Metab Dis, Bari, Italy.	francesco.giorgino@uniba.it	Laviola, Luigi/AAC-2237-2022; Cocco, Tiziana/AAG-9064-2020; Cignarelli, Angelo/I-6353-2013; Pacelli, Consiglia/J-9032-2016; Giorgino, Francesco/K-7262-2016	Cignarelli, Angelo/0000-0001-6477-9031; Pacelli, Consiglia/0000-0003-4915-5823; Giorgino, Francesco/0000-0001-7372-2678; Cocco, Tiziana Maria/0000-0001-7171-3460; Perrini, Sebastio/0000-0002-2728-7721	Ministero dell'Universita e Ricerca (MIUR, Italy); COST Action of the European Science Foundation [BM0602]	Ministero dell'Universita e Ricerca (MIUR, Italy)(Ministry of Education, Universities and Research (MIUR)); COST Action of the European Science Foundation	This work was supported in part by grants from the Ministero dell'Universita e Ricerca (MIUR, Italy) and the COST Action BM0602 of the European Science Foundation to F. Giorgino. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammendola R, 2002, ARCH BIOCHEM BIOPHYS, V397, P253, DOI 10.1006/abbi.2001.2641; Arany I, 2008, J BIOL CHEM, V283, P6110, DOI 10.1074/jbc.M708799200; Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Cattelino A, 2003, J CELL BIOL, V162, P1111, DOI 10.1083/jcb.200212157; Cominacini L, 1997, DIABETOLOGIA, V40, P584, DOI 10.1007/s001250050719; Corda S, 2001, AM J RESP CELL MOL, V24, P762, DOI 10.1165/ajrcmb.24.6.4228; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Dejana E, 2012, CURR OPIN HEMATOL, V19, P218, DOI 10.1097/MOH.0b013e3283523e1c; Denk A, 2001, J BIOL CHEM, V276, P28451, DOI 10.1074/jbc.M102698200; Dewi BE, 2008, J GEN VIROL, V89, P642, DOI 10.1099/vir.0.83356-0; Dong ZM, 1998, J CLIN INVEST, V102, P145, DOI 10.1172/JCI3001; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; Francia P, 2009, J MOL MED, V87, P885, DOI 10.1007/s00109-009-0499-3; Gooding JM, 2004, BIOESSAYS, V26, P497, DOI 10.1002/bies.20033; Guo JF, 2009, CIRC RES, V104, P660, DOI 10.1161/CIRCRESAHA.108.186288; Gustin JA, 2004, AM J PHYSIOL-CELL PH, V286, pC547, DOI 10.1152/ajpcell.00332.2002; Hoefen RJ, 2002, VASC PHARMACOL, V38, P271, DOI 10.1016/S1537-1891(02)00251-3; Kelly M, 2007, J ALLERGY CLIN IMMUN, V120, P3, DOI 10.1016/j.jaci.2007.05.017; Kisielow M, 2002, BIOCHEM J, V363, P1, DOI 10.1042/0264-6021:3630001; Koch OR, 2008, LAB INVEST, V88, P750, DOI 10.1038/labinvest.2008.44; Kuldo JM, 2005, AM J PHYSIOL-CELL PH, V289, pC1229, DOI 10.1152/ajpcell.00620.2004; Kumar A, 2009, FASEB J, V23, P4344, DOI 10.1096/fj.09-138743; Le S, 2001, J BIOL CHEM, V276, P48332, DOI 10.1074/jbc.M106612200; Li MX, 2007, HEART VESSELS, V22, P423, DOI 10.1007/s00380-007-0994-9; Liu ZJ, 2011, ANN SURG, V254, P450, DOI 10.1097/SLA.0b013e31822a72dc; Martin-Padura I, 2008, ENDOTHELIUM-J ENDOTH, V15, P276, DOI 10.1080/10623320802487791; Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Mochizuki N, 2009, CIRC J, V73, P2183, DOI 10.1253/circj.CJ-09-0666; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Natalicchio A, 2009, AM J PHYSIOL-ENDOC M, V296, pE228, DOI 10.1152/ajpendo.90347.2008; Nemoto S, 2006, J BIOL CHEM, V281, P10555, DOI 10.1074/jbc.M511626200; Noda Y, 2010, CLIN CARDIOL, V33, P548, DOI 10.1002/clc.20761; Nwariaku FE, 2004, BLOOD, V104, P3214, DOI 10.1182/blood-2004-05-1868; Nwariaku FE, 2002, SHOCK, V18, P82, DOI 10.1097/00024382-200207000-00015; Oshikawa J, 2012, AM J PHYSIOL-HEART C, V302, pH724, DOI 10.1152/ajpheart.00739.2011; Pagnin E, 2005, J CLIN ENDOCR METAB, V90, P1130, DOI 10.1210/jc.2004-1283; Pinton P, 2008, CELL CYCLE, V7, P304, DOI 10.4161/cc.7.3.5360; Pober JS, 1998, PATHOL BIOL, V46, P159; Rankin James A, 2004, AACN Clin Issues, V15, P3, DOI 10.1097/00044067-200401000-00002; Read MA, 1997, J BIOL CHEM, V272, P2753, DOI 10.1074/jbc.272.5.2753; ROTHLEIN R, 1988, J IMMUNOL, V141, P1665; Sawant DA, 2011, MICROCIRCULATION, V18, P46, DOI 10.1111/j.1549-8719.2010.00067.x; Seifalian AM, 2010, CURR VASC PHARMACOL, V8, P155, DOI 10.2174/157016110790886956; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; Shi Y, 2011, ARTERIOSCL THROM VAS, V31, P2090, DOI 10.1161/ATVBAHA.111.229260; Skrha J, 2004, EUR J PHARMACOL, V493, P183, DOI 10.1016/j.ejphar.2004.04.025; Stielow C, 2006, BIOCHEM BIOPH RES CO, V344, P200, DOI 10.1016/j.bbrc.2006.03.114; TOZEREN A, 1995, INT J CANCER, V60, P426; Usui T, 2010, J PHARMACOL SCI, V113, P182, DOI 10.1254/jphs.10033FP; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Walker T, 2011, EUR J CARDIO-THORAC, V40, P1241, DOI 10.1016/j.ejcts.2011.01.076; Wan R, 2013, J CELL PHYSIOL, V228, P1295, DOI 10.1002/jcp.24286; Wind S, 2010, BRIT J PHARMACOL, V161, P885, DOI 10.1111/j.1476-5381.2010.00920.x; Xu YH, 2010, INT IMMUNOPHARMACOL, V10, P1552, DOI 10.1016/j.intimp.2010.09.006; Yoshida M, 2000, ANN NY ACAD SCI, V902, P307; Zhang HR, 2009, CLIN SCI, V116, P219, DOI 10.1042/CS20080196	60	25	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81930	10.1371/journal.pone.0081930	http://dx.doi.org/10.1371/journal.pone.0081930			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24349153	gold, Green Submitted, Green Published			2022-12-27	WOS:000327944500106
J	Macleod, J; Tang, L; Hobbs, FDR; Wharton, B; Holder, R; Hussain, S; Nichols, L; Stewart, P; Clark, P; Luzio, S; Holly, J; Smith, GD				Macleod, John; Tang, Lie; Hobbs, F. D. Richard; Wharton, Brian; Holder, Roger; Hussain, Shakir; Nichols, Linda; Stewart, Paul; Clark, Penny; Luzio, Steve; Holly, Jeff; Smith, George Davey			Effects of Nutritional Supplementation during Pregnancy on Early Adult Disease Risk: Follow Up of Offspring of Participants in a Randomised Controlled Trial Investigating Effects of Supplementation on Infant Birth Weight	PLOS ONE			English	Article							PROTEIN-ENERGY SUPPLEMENTATION; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; GROWTH-FACTORS; ASIAN MOTHERS; CHILDHOOD; CANCER; BIRMINGHAM; EXPOSURE; SORRENTO	Background: Observational evidence suggests that improving fetal growth may improve adult health. Experimental evidence from nutritional supplementation trials undertaken amongst pregnant women in the less developed world does not show strong or consistent effects on adult disease risk and no trials from the more developed world have previously been reported. Objective: To test the hypothesis that nutritional supplementation during pregnancy influences offspring disease risk in adulthood Design: Clinical assessment of a range of established diseases risk markers in young adult offspring of 283 South Asian mothers who participated in two trials of nutritional supplementation during pregnancy (protein/energy/vitamins; energy/vitamins or vitamins only) at Sorrento Maternity Hospital in Birmingham UK either unselected or selected on the basis of nutritional status. Results: 236 (83%) offspring were traced and 118 (50%) of these were assessed in clinic. Protein/energy/vitamins supplementation amongst undernourished mothers was associated with increased infant birthweight. Nutritional supplementation showed no strong association with any one of a comprehensive range of markers of adult disease risk and no consistent pattern of association with risk across markers in offspring of either unselected or undernourished mothers. Conclusions: We found no evidence that nutritional supplements given to pregnant women are an important influence on adult disease risk however our study lacked power to estimate small effects. Our findings do not provide support for a policy of nutritional supplementation for pregnant women as an effective means to improve adult health in more developed societies.	[Macleod, John; Smith, George Davey] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Macleod, John; Tang, Lie; Holder, Roger; Hussain, Shakir; Nichols, Linda] Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham, W Midlands, England; [Hobbs, F. D. Richard] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Wharton, Brian] Univ London, Inst Child Hlth, London WC1N 1EH, England; [Wharton, Brian] Univ Birmingham, Inst Child Hlth, London, England; [Wharton, Brian] Univ London, Inst Child Hlth, Birmingham, W Midlands, England; [Wharton, Brian] Univ Birmingham, Inst Child Hlth, Birmingham B15 2TT, W Midlands, England; [Stewart, Paul] Univ Birmingham, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England; [Clark, Penny] Univ Hosp Birmingham, Dept Clin Biochem, Birmingham, W Midlands, England; [Luzio, Steve] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Holly, Jeff] Univ Bristol, Sch Clin Sci, Bristol, Avon, England	University of Bristol; University of Birmingham; University of Oxford; University of London; University College London; University of Birmingham; University of London; University College London; University of London; University of Birmingham; University of Birmingham; University of Birmingham; Swansea University; University of Bristol	Macleod, J (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	john.macleod@bristol.ac.uk	Luzio, Stephen/AAD-8038-2020; Davey Smith, George/A-7407-2013	Luzio, Stephen/0000-0002-7206-6530; Davey Smith, George/0000-0002-1407-8314; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475; hobbs, richard/0000-0001-7976-7172; Macleod, John/0000-0001-8202-1144	Wellcome Trust [GR057124MA]; Medical Research Council [MC_UU_12013/1] Funding Source: researchfish; MRC [MC_UU_12013/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a grant from the Wellcome Trust (www.wellcome.ac.uk) GR057124MA (Investigators JM, GDS, FDRH, BW, PS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoore JN, 2005, BLOOD PRESS MONIT, V10, P51, DOI 10.1097/00126097-200502000-00009; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Barker DJP, 1998, MOTHERS BABIES HLTH; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Ben-Shlomo Y, 2005, CANCER EPIDEM BIOMAR, V14, P1336, DOI 10.1158/1055-9965.EPI-04-0908; Bhopal R, 2002, BRIT MED J, V324, P625, DOI 10.1136/bmj.324.7338.625; Burdge GC, 2009, BRIT J NUTR, V101, P619, DOI 10.1017/S0007114508145883; Draper N, 2005, J ENDOCRINOL, V186, P251, DOI 10.1677/joe.1.06019; Hawkesworth S, 2009, INT J EPIDEMIOL, V38, P119, DOI 10.1093/ije/dyn156; Kinra S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a605; Kramer MS, 2000, AM J EPIDEMIOL, V152, P605, DOI 10.1093/aje/152.7.605; LANGLEY SC, 1994, CLIN SCI, V86, P217, DOI 10.1042/cs0860217; Law CM, 1996, J HYPERTENS, V14, P935; Lawlor DA, 2005, CIRCULATION, V112, P1414, DOI 10.1161/CIRCULATIONAHA.104.528356; LEON DA, 2000, FETAL ORIGINS CARDIO, P23; Martin RM, 2007, EUR J CLIN NUTR, V61, P1281, DOI 10.1038/sj.ejcn.1602616; Martin RM, 2005, CLIN ENDOCRINOL, V62, P728, DOI 10.1111/j.1365-2265.2005.02287.x; McKeigue PM, 1998, DIABETOLOGIA, V41, P1133, DOI 10.1007/s001250051042; PANETH N, 1995, BRIT MED J, V310, P411, DOI 10.1136/bmj.310.6977.411; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Rubin DB, 2004, MULTIPLE IMPUTATION; Seckl JR, 2004, ANN NY ACAD SCI, V1032, P63, DOI 10.1196/annals.1314.006; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; StataCorp L, 2007, STAT DAT AN STAT SOF; Stein AD, 2006, AM J EPIDEMIOL, V164, P1160, DOI 10.1093/aje/kwj328; SWENNE I, 1987, DIABETES, V36, P454, DOI 10.2337/diabetes.36.4.454; Tang LP, 2004, NUTR B, V29, P310, DOI 10.1111/j.1467-3010.2004.00449.x; VIEGAS OAC, 1982, BRIT MED J, V285, P589, DOI 10.1136/bmj.285.6342.589; VIEGAS OAC, 1982, BMJ-BRIT MED J, V285, P592, DOI 10.1136/bmj.285.6342.592; Wallace IR, 2013, CLIN ENDOCRINOL, V78, P321, DOI 10.1111/cen.12086; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Webb AL, 2005, INT J EPIDEMIOL, V34, P898, DOI 10.1093/ije/dyi097; Yajnik CS, 2008, REV ENDOCR METAB DIS, V9, P203, DOI 10.1007/s11154-008-9087-z; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472	37	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83371	10.1371/journal.pone.0083371	http://dx.doi.org/10.1371/journal.pone.0083371			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349496	Green Submitted, gold, Green Published			2022-12-27	WOS:000328734200081
J	Yang, ZX; Su, JW; Peng, XR; Wu, NP				Yang, Zongxing; Su, Junwei; Peng, Xiaorong; Wu, Nanping			A Decline in HIV and Syphilis Epidemics in Chinese Female Sex Workers (2000-2011): A Systematic Review and Meta-Analysis	PLOS ONE			English	Article								Background: Female sex workers (FSWs) play an important role in transmitting HIV and syphilis from high-risk groups to the general population. However, the trends in HIV and syphilis epidemics in Chinese FSWs in the period after 2000 are unclear to date. Methods: The Preferred Reporting Items for Systematic Reviews and Meta-Analyses Statement was followed. Seven databases were searched for published peer-reviewed articles. The incidence of HIV and syphilis in FSWs in different time periods, provinces and workplaces in China were separately pooled by meta-analysis. Correlation analysis was conducted between HIV and syphilis incidence and study time, respectively. Results: After 1,662 articles were screened, 190 published papers were included in the final analysis. Estimated HIV prevalence was 0.284% (95% CI: 0.080-0.488%) in the period 2000-2002, 0.211% (95% CI: 0.149-0.273%) in 2003-2005, 0.242% (95% CI: 0.190-0.294%) in 2006-2008 and 0.041% (95% CI: 0.024-0.058%) in 2009-2011. The corresponding syphilis prevalence was 9.669% (95% CI: 7.810-11.529%), 4.970% (95% CI: 4.384-5.556%), 4.404% (95% CI: 4.032-4.775%) and 3.169% (95% CI: 2.738-3.600%), respectively. Spearman rank correlation coefficients were 20.165 (p = 0.002) between HIV prevalence and study time, and 20.209 (p = 0.000) between syphilis prevalence and study time. The combined HIV prevalence was 0.318% (95% CI: 0.156-0.479%) in medium and high-tier workplaces and 0.393% (95% CI: 0.176-0.610%) in low-tier workplaces. The corresponding syphilis prevalence was 3.216% (95% CI: 2.192-4.240%) and 13.817% (95% CI: 10.589-17.044%), respectively. Conclusions: Our data suggested a decline in HIV and syphilis epidemics in FSWs in China on a national level during the study period (2000-2011). FSWs in low-tier workplaces should be given more attention in the future to ensure they are included in prevention programs for HIV and sexually transmitted diseases.	[Yang, Zongxing; Su, Junwei; Peng, Xiaorong; Wu, Nanping] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Affiliated Hosp 1, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wu, NP (corresponding author), Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Affiliated Hosp 1, Sch Med, Hangzhou 310003, Zhejiang, Peoples R China.	flwnp2013@163.com			National Major Scientific and Technological Special Project by China Ministry of Science and Technology [2013ZX10004904-001]	National Major Scientific and Technological Special Project by China Ministry of Science and Technology	This work was supported by National Major Scientific and Technological Special Project by China Ministry of Science and Technology (2013ZX10004904-001 to NPW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baral S, 2012, LANCET INFECT DIS; China MoHo UNAIDS WHO, 2011, REP EP SIT AIDS CHIN; Fu ShengGao, 2010, Disease Surveillance, V25, P850; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gong XD, 2012, REP EP SIT SYPH GON; Li Y, 2012, AIDS BEHAV, V16, P943, DOI 10.1007/s10461-011-0102-0; Liang BH, 2008, MODERN PREVENTIVE ME, V35; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lin CC, 2006, SEX TRANSM DIS, V33, P726, DOI 10.1097/01.olq.0000222703.12018.58; Pan GL, 2012, ZHEJIANG PREVENTIVE, V24; Poon AN, 2011, AIDS CARE, V23, P5, DOI 10.1080/09540121.2011.554519; Sheng L, 2008, CHINESE MED J-PEKING, V121, P1230, DOI 10.1097/00029330-200807010-00016; UNAIDS, 2010, UNAIDS REP GLOB AIDS; [王岚 Wang Lan], 2011, [中华流行病学杂志, Chinese Journal of Epidemiology], V32, P20; Wang Lan, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P1009; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; Xien Gui, 2008, P143, DOI 10.1007/978-0-387-75722-3_9	17	22	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82451	10.1371/journal.pone.0082451	http://dx.doi.org/10.1371/journal.pone.0082451			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349288	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200045
J	Montibus, M; Ducos, C; Bonnin-Verdal, MN; Bormann, J; Ponts, N; Richard-Forget, F; Barreau, C				Montibus, Mathilde; Ducos, Christine; Bonnin-Verdal, Marie-Noelle; Bormann, Jorg; Ponts, Nadia; Richard-Forget, Florence; Barreau, Christian			The bZIP Transcription Factor Fgap1 Mediates Oxidative Stress Response and Trichothecene Biosynthesis But Not Virulence in Fusarium graminearum	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; LIQUID CULTURES; NUCLEAR EXPORT; HEAD BLIGHT; MAP KINASE; GENE; RESISTANCE; H2O2; TRANSFORMATION; CONSTRUCTION	Redox sensing is of primary importance for fungi to cope with oxidant compounds found in their environment. Plant pathogens are particularly subject to the oxidative burst during the primary steps of infection. In the budding yeast Saccharomyces cerevisiae, it is the transcription factor Yap1 that mediates the response to oxidative stress via activation of genes coding for detoxification enzymes. In the cereal pathogen Fusarium graminearum, Fgap1 a homologue of Yap1 was identified and its role was investigated. During infection, this pathogen produces mycotoxins belonging to the trichothecenes family that accumulate in the grains. The global regulation of toxin biosynthesis is not completely understood. However, it is now clearly established that an oxidative stress activates the production of toxins by F. graminearum. The involvement of Fgap1 in this activation was investigated. A deleted mutant and a strain expressing a truncated constitutive form of Fgap1 were constructed. None of the mutants was affected in pathogenicity. The deleted mutant showed higher level of trichothecenes production associated with overexpression of Tri genes. Moreover activation of toxin accumulation in response to oxidative stress was no longer observed. Regarding the mutant with the truncated constitutive form of Fgap1, toxin production was strongly reduced. Expression of oxidative stress response genes was not activated in the deleted mutant and expression of the gene encoding the mitochondrial superoxide dismutase MnSOD1 was up-regulated in the mutant with the truncated constitutive form of Fgap1. Our results demonstrate that Fgap1 plays a key role in the link between oxidative stress response and F. graminearum secondary metabolism.	[Montibus, Mathilde; Ducos, Christine; Bonnin-Verdal, Marie-Noelle; Ponts, Nadia; Richard-Forget, Florence; Barreau, Christian] INRA, Unite Rech MycSA 1264, Villenave Dornon, France; [Bormann, Jorg] Univ Hamburg, Bioctr Klein Flottbek, Dept Mol Phytopathol & Genet, Hamburg, Germany; [Barreau, Christian] CNRS, Unite Rech MycSA 1264, Villenave Dornon, France	INRAE; University of Hamburg; Centre National de la Recherche Scientifique (CNRS)	Montibus, M (corresponding author), INRA, Unite Rech MycSA 1264, Villenave Dornon, France.	mathilde.montibus@gmail.com		Bormann, Jorg/0000-0002-3493-2450	INRA; Conseil Regional d'Aquitaine	INRA; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	M. Montibus PhD fellowship is funded conjointly by the INRA and the Conseil Regional d'Aquitaine. This work is part of the ANR DON and Co project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarco AM, 1999, J BACTERIOL, V181, P700, DOI 10.1128/JB.181.3.700-708.1999; Alexander NJ, 2009, TOXIN REV, V28, P198, DOI 10.1080/15569540903092142; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; CAPPELLINI RA, 1965, MYCOLOGIA, V57, P962, DOI 10.2307/3756895; CARROLL AM, 1994, FUNGAL GENET NEWSLET, V41, P22, DOI DOI 10.4148/1941-4765.1367; Champeil A, 2004, PLANT SCI, V166, P1389, DOI 10.1016/j.plantsci.2004.02.004; Collopy PD, 2010, METHODS MOL BIOL, V638, P33, DOI 10.1007/978-1-60761-611-5_3; DESJARDINS AE, 1993, MICROBIOL REV, V57, P595, DOI 10.1128/MMBR.57.3.595-604.1993; Florent M, 2009, ANTIMICROB AGENTS CH, V53, P2982, DOI 10.1128/AAC.00880-08; Gardiner DM, 2009, FUNGAL GENET BIOL, V46, P604, DOI 10.1016/j.fgb.2009.04.004; Giles SS, 2006, EUKARYOT CELL, V5, P1447, DOI 10.1128/EC.00098-06; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Guo M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001302; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Ilgen P, 2009, MOL PLANT MICROBE IN, V22, P899, DOI 10.1094/MPMI-22-8-0899; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; JAVERZAT JP, 1993, NUCLEIC ACIDS RES, V21, P497, DOI 10.1093/nar/21.3.497; Jenczmionka NJ, 2005, CURR GENET, V47, P29, DOI 10.1007/s00294-004-0547-z; Kazan K, 2012, MOL PLANT PATHOL, V13, P399, DOI 10.1111/j.1364-3703.2011.00762.x; Kiel JAKW, 2005, FUNGAL GENET BIOL, V42, P154, DOI 10.1016/j.fgb.2004.10.010; Kimura M, 2007, BIOSCI BIOTECH BIOCH, V71, P2105, DOI 10.1271/bbb.70183; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Lev S, 2005, EUKARYOT CELL, V4, P443, DOI 10.1128/EC.4.2.443-454.2005; Maggio-Hall LA, 2005, MOL PLANT MICROBE IN, V18, P783, DOI 10.1094/MPMI-18-0783; MAREK ET, 1989, CURR GENET, V15, P421, DOI 10.1007/BF00376799; McCormick SP, 2011, TOXINS, V3, P802, DOI 10.3390/toxins3070802; Merhej J, 2011, APPL MICROBIOL BIOT, V91, P519, DOI 10.1007/s00253-011-3397-x; MONTIBUS M, 2013, CRIT REV MICROBIOL, P41414; Moye-Rowley WS, 2003, EUKARYOT CELL, V2, P381, DOI 10.1128/EC.2.3.381-389.2003; NAGAO K, 1995, J BACTERIOL, V177, P1536, DOI 10.1128/jb.177.6.1536-1543.1995; NGUYEN TV, 2013, MOL PLANT MICROBE IN; Osiewacz HD, 2011, BIOCHEM SOC T, V39, P1488, DOI 10.1042/BST0391488; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ponts N, 2006, FEMS MICROBIOL LETT, V258, P102, DOI 10.1111/j.1574-6968.2006.00200.x; PONTS N, 2003, ASPECTS APPL BIOL, V68; Ponts N, 2007, FEBS LETT, V581, P443, DOI 10.1016/j.febslet.2007.01.003; Ponts N, 2009, FEMS MICROBIOL LETT, V293, P255, DOI 10.1111/j.1574-6968.2009.01521.x; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; PUNT PJ, 1990, GENE, V93, P101, DOI 10.1016/0378-1119(90)90142-E; Qiao JJ, 2010, MYCOPATHOLOGIA, V170, P155, DOI 10.1007/s11046-010-9309-2; Reverberi M, 2008, EUKARYOT CELL, V7, P988, DOI 10.1128/EC.00228-07; Reverberi M, 2012, APPL MICROBIOL BIOT, V95, P1293, DOI 10.1007/s00253-012-3985-4; Rocha O, 2005, FOOD ADDIT CONTAM A, V22, P369, DOI 10.1080/02652030500058403; Rodrigues-Pousada CA, 2004, FEBS LETT, V567, P80, DOI 10.1016/j.febslet.2004.03.119; Rodrigues-Pousada C, 2010, YEAST, V27, P245, DOI 10.1002/yea.1752; Seong KY, 2009, MOL MICROBIOL, V72, P354, DOI 10.1111/j.1365-2958.2009.06649.x; Shetty NP, 2008, EUR J PLANT PATHOL, V121, P267, DOI 10.1007/s10658-008-9302-5; Temme N, 2009, MOL PLANT MICROBE IN, V22, P987, DOI 10.1094/MPMI-22-8-0987; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453; Vivancos AP, 2006, MOL GENET GENOMICS, V276, P495, DOI 10.1007/s00438-006-0175-z; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416; Yang F, 2011, PLANT PHYSIOL BIOCH, V49, P1362, DOI 10.1016/j.plaphy.2011.07.004; Yang SL, 2009, PHYSIOL MOL PLANT P, V74, P100, DOI 10.1016/j.pmpp.2009.09.007; Zhou WC, 2005, GENOME, V48, P770, DOI 10.1139/g05-041	57	62	66	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83377	10.1371/journal.pone.0083377	http://dx.doi.org/10.1371/journal.pone.0083377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349499	gold, Green Submitted, Green Published			2022-12-27	WOS:000328731800116
J	Therrien, M; Rouleau, GA; Dion, PA; Parker, JA				Therrien, Martine; Rouleau, Guy A.; Dion, Patrick A.; Parker, J. Alex			Deletion of C9ORF72 Results in Motor Neuron Degeneration and Stress Sensitivity in C-elegans	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; WIDESPREAD PROTEIN DAMAGE; RNA-PROCESSING PROTEIN; HEXANUCLEOTIDE REPEAT; GGGGCC REPEAT; MUTATIONS; ALS; NEURODEGENERATION; EXPANSION; GENE	An expansion of the hexanucleotide GGGGCC repeat in the first intron of C9ORF72 gene was recently linked to amyotrophic lateral sclerosis. It is not known if the mutation results in a gain of function, a loss of function or if, perhaps both mechanisms are linked to pathogenesis. We generated a genetic model of ALS to explore the biological consequences of a null mutation of the Caenorhabditis elegans C9ORF72 orthologue, F18A1.6, also called alfa-1. alfa-1 mutants displayed age-dependent motility defects leading to paralysis and the specific degeneration of GABAergic motor neurons. alfa-1 mutants showed differential susceptibility to environmental stress where osmotic stress provoked neurodegeneration. Finally, we observed that the motor defects caused by loss of alfa-1 were additive with the toxicity caused by mutant TDP-43 proteins, but not by the mutant FUS proteins. These data suggest that a loss of alfa-1/C9ORF72 expression may contribute to motor neuron degeneration in a pathway associated with other known ALS genes.	[Therrien, Martine; Parker, J. Alex] CRCHUM, Montreal, PQ, Canada; [Therrien, Martine; Dion, Patrick A.; Parker, J. Alex] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ, Canada; [Rouleau, Guy A.; Dion, Patrick A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Parker, J. Alex] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University; Universite de Montreal	Parker, JA (corresponding author), CRCHUM, Montreal, PQ, Canada.	ja.parker@umontreal.ca	Parker, Alex/F-4953-2014	Parker, Alex/0000-0002-3333-2445; Therrien, Martine/0000-0003-3150-4052	RMGA scholarship; CHUM Foundation; Muscular Dystrophy Association (USA); ALS Canada	RMGA scholarship; CHUM Foundation; Muscular Dystrophy Association (USA)(Muscular Dystrophy Association); ALS Canada	M.T. was supported by a RMGA scholarship. J.A.P. is a CIHR New Investigator. This research was supported by the CHUM Foundation, ALS Canada, and the Muscular Dystrophy Association (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Burkewitz K, 2011, AM J PHYSIOL-CELL PH, V301, pC566, DOI 10.1152/ajpcell.00030.2011; Chaineau M, 2013, TRAFFIC, V14, P1109, DOI 10.1111/tra.12096; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Ciura S, 2013, ANN NEUROL, V74, P180, DOI 10.1002/ana.23946; Cruts M, 2013, TRENDS NEUROSCI, V36, P450, DOI 10.1016/j.tins.2013.04.010; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Diaper DC, 2013, HUM MOL GENET, V22, P1539, DOI 10.1093/hmg/ddt005; Foerster BR, 2013, JAMA NEUROL, V70, P1, DOI [10.1001/jamaneurol.2013.234, DOI 10.1001/JAMANEUR0L.2013.234.PUBMED:23797905]; Hoppe T, 2011, AM J PHYSIOL-CELL PH, V301, pC555, DOI 10.1152/ajpcell.00206.2011; Ihara R, 2013, HUM MOL GENET, V22, P4474, DOI 10.1093/hmg/ddt296; Jorgensen Erik M, 2005, WormBook, P1; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002214; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Levine TP, 2013, BIOINFORMATICS, V29, P499, DOI 10.1093/bioinformatics/bts725; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sama RRK, 2013, J CELL PHYSIOL, V228, P2222, DOI 10.1002/jcp.24395; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stiernagle Theresa, 2006, WormBook, P1; Turner MR, 2013, LANCET NEUROL, V12, P310, DOI 10.1016/S1474-4422(13)70036-X; Vaccaro A, 2013, NEUROBIOL DIS, V55, P64, DOI 10.1016/j.nbd.2013.03.015; Vaccaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042117; Vaccaro A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002806; Vaccaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031321; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vashlishan AB, 2008, NEURON, V58, P346, DOI 10.1016/j.neuron.2008.02.019; Wang JW, 2011, J CLIN INVEST, V121, P4118, DOI 10.1172/JCI57883; Xi ZR, 2013, AM J HUM GENET, V92, P981, DOI 10.1016/j.ajhg.2013.04.017; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Zhang Dapeng, 2012, Frontiers in Genetics, V3, P283, DOI 10.3389/fgene.2012.00283; Zhang T, 2012, J BIOL CHEM, V287, P8371, DOI 10.1074/jbc.M111.311977	38	132	133	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83450	10.1371/journal.pone.0083450	http://dx.doi.org/10.1371/journal.pone.0083450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349511	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800119
J	Wang, L; Yang, YF				Wang, Lin; Yang, Yufang			Integrating the Meaning of Person Names into Discourse Context: An Event-Related Potential Study	PLOS ONE			English	Article							LANGUAGE COMPREHENSION; BRAIN POTENTIALS; ERP; N400; SENTENCES; PROPER	The meaning of person names is determined by their associated information. This study used event related potentials to investigate the time course of integrating the newly constructed meaning of person names into discourse context. The meaning of person names was built by two-sentence descriptions of the names. Then we manipulated the congruence of person names relative to discourse context in a way that the meaning of person names either matched or did not match the previous context. ERPs elicited by the names were compared between the congruent and the incongruent conditions. We found that the incongruent names elicited a larger N400 as well as a larger P600 compared to the congruent names. The results suggest that the meaning of unknown names can be effectively constructed from short linguistic descriptions and that the established meaning can be rapidly retrieved and integrated into contexts.	[Wang, Lin; Yang, Yufang] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Wang, L (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	wangl@psych.ac.cn		Wang, Lin/0000-0001-6911-0660	Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences [Y1CX312005]	Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences [grant number: Y1CX312005]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggio G, 2011, LANG COGNITIVE PROC, V26, P1338, DOI 10.1080/01690965.2010.542671; Borovsky A, 2010, COGNITION, V116, P289, DOI 10.1016/j.cognition.2010.05.004; Dien J, 2009, BIOL PSYCHOL, V80, P10, DOI 10.1016/j.biopsycho.2008.04.013; Frege G, 1892, SENSE MEANING; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; HAGOORT P, 1993, LANG COGNITIVE PROC, V8, P439, DOI 10.1080/01690969308407585; Hagoort P., 2009, COGNITIVE NEUROSCIEN, P819; Kolk H, 2007, BRAIN LANG, V100, P257, DOI 10.1016/j.bandl.2006.07.006; Kripke SA, 1981, NAMING NECESSITY; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lau E, 2009, BRAIN LANG, V111, P161, DOI 10.1016/j.bandl.2009.08.007; Luck S.J., 2005, INTRO EVENT RELATED; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mestres-Misse A, 2007, CEREB CORTEX, V17, P1858, DOI 10.1093/cercor/bhl094; Mv Elk, 2008, J PHYSIOL-PARIS, V102, P95; Nieuwand MS, 2005, COGNITIVE BRAIN RES, V24, P691, DOI 10.1016/j.cogbrainres.2005.04.003; Ozyurek A, 2007, J COGNITIVE NEUROSCI, V19, P605, DOI 10.1162/jocn.2007.19.4.605; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Proverbio AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007126; Proverbio AM, 2001, NEUROPSYCHOLOGIA, V39, P815, DOI 10.1016/S0028-3932(01)00003-3; Russell B., 1905, MIND, V14, P479, DOI [10.1093/mind/XIV.4.479, 10.2307/j.ctv2nrzgz1.4]; Sanford AJ, 2011, J COGNITIVE NEUROSCI, V23, P514, DOI 10.1162/jocn.2009.21370; Sciarone B., 1967, STUD LINGUISTICA, V21, P73, DOI DOI 10.1111/J.1467-9582.1967.TB00550.X; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; VALENTINE T, 1995, Q J EXP PSYCHOL-A, V48, P513, DOI 10.1080/14640749508401404; VALENTINE T, 1991, EUROPEAN J COGNITIVE, V3, P147, DOI DOI 10.1080/09541449108406224; van Berkum JJA, 1999, J COGNITIVE NEUROSCI, V11, P657, DOI 10.1162/089892999563724; van Berkum JJA, 2003, COGNITIVE BRAIN RES, V17, P701, DOI 10.1016/S0926-6410(03)00196-4; van den Brink D, 2001, J COGNITIVE NEUROSCI, V13, P967, DOI 10.1162/089892901753165872; Van Petten C, 2012, INT J PSYCHOPHYSIOL, V83, P176, DOI 10.1016/j.ijpsycho.2011.09.015; Vissers CTWM, 2007, BIOL PSYCHOL, V75, P8, DOI 10.1016/j.biopsycho.2006.10.004; Wang L, 2013, BRAIN LANG, V125, P118, DOI 10.1016/j.bandl.2013.01.006; Wang L, 2009, BRAIN RES, V1282, P50, DOI 10.1016/j.brainres.2009.05.069	36	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83206	10.1371/journal.pone.0083206	http://dx.doi.org/10.1371/journal.pone.0083206			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EU	24349462	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800103
J	Di Nardo, G; Breitner, M; Sadeghi, SJ; Castrignano, S; Mei, G; Di Venere, A; Nicolai, E; Allegra, P; Gilardi, G				Di Nardo, Giovanna; Breitner, Maximilian; Sadeghi, Sheila J.; Castrignano, Silvia; Mei, Giampiero; Di Venere, Almerinda; Nicolai, Eleonora; Allegra, Paola; Gilardi, Gianfranco			Dynamics and Flexibility of Human Aromatase Probed by FTIR and Time Resolved Fluorescence Spectroscopy	PLOS ONE			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; MAMMALIAN CYTOCHROME P4502B4; HYDROGEN-DEUTERIUM EXCHANGE; AMP RECEPTOR PROTEIN; ESCHERICHIA-COLI; STRUCTURAL BASIS; LIGAND-BINDING; MOLECULAR-DYNAMICS; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE	Human aromatase (CYP19A1) is a steroidogenic cytochrome P450 converting androgens into estrogens. No ligand-free crystal structure of the enzyme is available to date. The crystal structure in complex with the substrate androstenedione and the steroidal inhibitor exemestane shows a very compact conformation of the enzyme, leaving unanswered questions on the conformational changes that must occur to allow access of the ligand to the active site. As H/D exchange kinetics followed by FTIR spectroscopy can provide information on the conformational changes in proteins where solvent accessibility is affected, here the amide I region was used to measure the exchange rates of the different elements of the secondary structure for aromatase in the ligand-free form and in the presence of the substrate androstenedione and the inhibitor anastrozole. Biphasic exponential functions were found to fit the H/D exchange data collected as a function of time. Two exchange rates were assigned to two populations of protons present in different flexible regions of the protein. The addition of the substrate androstenedione and the inhibitor anastrozole lowers the H/D exchange rates of the alpha-helices of the enzyme when compared to the ligand-free form. Furthermore, the presence of the inhibitor anastrozole lowers exchange rate constant (k(1)) for beta-sheets from 0.22 +/- 0.06 min(-1) for the inhibitor-bound enzyme to 0.12 +/- 0.02 min(-1) for the free protein. Dynamics effects localised in helix F were studied by time resolved fluorescence. The data demonstrate that the fluorescence lifetime component associated to Trp224 emission undergoes a shift toward longer lifetimes (from approximate to 5.0 to approximate to 5.5 ns) when the substrate or the inhibitor are present, suggesting slower dynamics in the presence of ligands. Together the results are consistent with different degrees of flexibility of the access channel and therefore different conformations adopted by the enzyme in the free, substrate-and inhibitor-bound forms.	[Di Nardo, Giovanna; Breitner, Maximilian; Sadeghi, Sheila J.; Castrignano, Silvia; Allegra, Paola; Gilardi, Gianfranco] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy; [Mei, Giampiero; Di Venere, Almerinda; Nicolai, Eleonora] Univ Roma Tor Vergata, Dept Expt Med & Surg, Rome, Italy	University of Turin; University of Rome Tor Vergata	Gilardi, G (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.	gianfranco.gilardi@unito.it	Gilardi, Gianfranco/M-3748-2019; Gilardi, Gianfranco/B-4523-2010; Nicolai, Eleonora/AAR-4554-2020	Gilardi, Gianfranco/0000-0002-6559-276X; Gilardi, Gianfranco/0000-0002-6559-276X; Nicolai, Eleonora/0000-0003-1415-9808; SADEGHI, JILA/0000-0003-4951-1242; Di Nardo, Giovanna/0000-0002-4169-2635; Di Venere, Almerinda/0000-0002-9493-0270	Italian Ministry of University (MIUR) [RBFR12FI27_004]	Italian Ministry of University (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was funded by the Italian Ministry of University (MIUR), call FIRB-2012 grant nr. RBFR12FI27_004. The role of the funder was to provide support for blue sky research in terms of consumable, travel and postdoc salary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzenbacher P, 2001, J INORG BIOCHEM, V87, P209, DOI 10.1016/S0162-0134(01)00389-0; Anzenbacherova E, 2000, EUR J BIOCHEM, V267, P2916, DOI 10.1046/j.1432-1327.2000.01305.x; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Berka K, 2012, J INORG BIOCHEM, V110, P46, DOI 10.1016/j.jinorgbio.2012.02.010; Cojocaru V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002152; Contzen J, 1998, BIOCHEMISTRY-US, V37, P4317, DOI 10.1021/bi9731706; DEJONGH HHJ, 1995, BIOCHEMISTRY-US, V34, P172, DOI 10.1021/bi00001a021; Di Nardo G, 2013, BIOTECHNOL APPL BIOC, V60, P92, DOI 10.1002/bab.1088; Dong AC, 2002, BIOCHEMISTRY-US, V41, P6660, DOI 10.1021/bi020036z; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Ferrero VEV, 2012, DALTON T, V41, P2018, DOI 10.1039/c1dt11437a; Ghosh D, 2012, J MED CHEM, V55, P8464, DOI 10.1021/jm300930n; Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614; GILARDI G, 1994, BIOCHEMISTRY-US, V33, P1425, DOI 10.1021/bi00172a020; Girvan HM, 2007, J BIOL CHEM, V282, P564, DOI 10.1074/jbc.M607949200; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; Hamuro Y, 2008, J INORG BIOCHEM, V102, P364, DOI 10.1016/j.jinorgbio.2007.10.001; Hays AMA, 2004, J MOL BIOL, V344, P455, DOI 10.1016/j.jmb.2004.09.046; Hong YY, 2007, MOL ENDOCRINOL, V21, P401, DOI 10.1210/me.2006-0281; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Jiang WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032565; Jung C, 2000, J MOL RECOGNIT, V13, P325, DOI 10.1002/1099-1352(200011/12)13:6<325::AID-JMR507>3.0.CO;2-C; Jung C, 2008, ANAL BIOANAL CHEM, V392, P1031, DOI 10.1007/s00216-008-2216-4; Kagawa N, 2004, STEROIDS, V69, P235, DOI 10.1016/j.steroids.2004.01.002; Kagawa N, 2011, METHODS MOL BIOL, V705, P109, DOI 10.1007/978-1-61737-967-3_7; KIM KS, 1993, BIOCHEMISTRY-US, V32, P9600, DOI 10.1021/bi00088a012; KOLEY AP, 1995, J BIOL CHEM, V270, P5014, DOI 10.1074/jbc.270.10.5014; Kumar S, 2007, MOL PHARMACOL, V72, P1191, DOI 10.1124/mol.107.039693; Kumar S, 2006, PROTEIN ENG DES SEL, V19, P547, DOI 10.1093/protein/gzl042; Lampe JN, 2010, J BIOL CHEM, V285, P9594, DOI 10.1074/jbc.M109.087593; Lampe JN, 2008, J AM CHEM SOC, V130, P16168, DOI 10.1021/ja8071463; LEPHART ED, 1991, METHOD ENZYMOL, V206, P477; Li HY, 1997, NAT STRUCT BIOL, V4, P140, DOI 10.1038/nsb0297-140; Li JQ, 2002, BIOCHEMISTRY-US, V41, P14771, DOI 10.1021/bi026383q; Liao WL, 2009, BIOCHEMISTRY-US, V48, P4150, DOI 10.1021/bi900168m; Lo J, 2013, BIOCHEMISTRY-US, V52, P5821, DOI 10.1021/bi400669h; Maurelli S, 2011, CHEM COMMUN, V47, P10737, DOI 10.1039/c1cc13872c; Muralidhara BK, 2006, J BIOL CHEM, V281, P8051, DOI 10.1074/jbc.M509696200; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Poulos TL, 2003, P NATL ACAD SCI USA, V100, P13121, DOI 10.1073/pnas.2336095100; RAVICHANDRAN KG, 1993, SCIENCE, V261, P731, DOI 10.1126/science.8342039; Ravindranathan KP, 2006, J AM CHEM SOC, V128, P5786, DOI 10.1021/ja058465i; Roberts AG, 2006, BIOCHEMISTRY-US, V45, P1673, DOI 10.1021/bi0518895; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Scott EE, 2003, P NATL ACAD SCI USA, V100, P13196, DOI 10.1073/pnas.2133986100; Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Sohl CD, 2010, J BIOL CHEM, V285, P17734, DOI 10.1074/jbc.M110.123711; THOMPSON EA, 1974, J BIOL CHEM, V249, P5364; THOMPSON EA, 1974, J BIOL CHEM, V249, P5373; Tripathi S, 2013, SCIENCE, V340, P1227, DOI 10.1126/science.1235797; Wilderman PR, 2010, J BIOL CHEM, V285, P38602, DOI 10.1074/jbc.M110.180646; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yu SN, 2006, BIOCHEMISTRY-US, V45, P15318, DOI 10.1021/bi061701x; Zhang FM, 2002, BIOCHEM PHARMACOL, V64, P1317, DOI 10.1016/S0006-2952(02)01361-8	57	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82118	10.1371/journal.pone.0082118	http://dx.doi.org/10.1371/journal.pone.0082118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349198	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300074
J	Thielsen, KD; Moser, JM; Schmitt-John, T; Jensen, MS; Jensen, K; Holm, MM				Thielsen, Karina D.; Moser, Jakob M.; Schmitt-John, Thomas; Jensen, Morten S.; Jensen, Kimmo; Holm, Mai Marie			The Wobbler Mouse Model of Amyotrophic Lateral Sclerosis (ALS) Displays Hippocampal Hyperexcitability, and Reduced Number of Interneurons, but No Presynaptic Vesicle Release Impairments	PLOS ONE			English	Article							MOTOR-NEURON DISEASE; CERVICAL-SPINAL CORD; CORTICAL HYPEREXCITABILITY; AXONAL-TRANSPORT; ACID; DEGENERATION; GLUTAMATE; MUTATION; TDP-43; MOTONEURONS	Amyotrophic lateral sclerosis (ALS) is the most common adult-onset motor neuron disease. It is a fatal degenerative disease, best recognized for its debilitating neuromuscular effects. ALS however also induces cognitive impairments in as many as 50% of affected individuals. Moreover, many ALS patients demonstrate cortical hyperexcitability, which has been shown to precede the onset of clinical symptoms. The wobbler mouse is a model of ALS, and like ALS patients the wobbler mouse displays cortical hyperexcitability. Here we investigated if the neocortical aberrations of the wobbler mouse also occur in the hippocampus. Consequently, we performed extracellular field excitatory postsynaptic potential recordings in the CA1 region of the hippocampus on acute brain slices from symptomatic (P45-P60) and presymptomatic (P17-P21) wobbler mice. Significant increased excitation of hippocampal synapses was revealed by leftward shifted input/output-curves in both symptomatic and presymptomatic wobbler mice, and substantiated by population spike occurrence analyses, demonstrating that the increased synaptic excitation precedes the onset of visible phenotypic symptoms in the mouse. Synaptic facilitation tested by paired-pulse facilitation and trains in wobbler and control mice showed no differences, suggesting the absence of presynaptic defects. Immunohistochemical staining revealed that symptomatic wobbler mice have a lower number of parvalbumin positive interneurons when compared to controls and presymptomatic mice. This study reveals that the wobbler mouse model of ALS exhibits hippocampal hyperexcitability. We suggest that the hyperexcitability could be caused by increased excitatory synaptic transmission and a concomitant reduced inhibition due to a decreased number of parvalbumin positive interneurons. Thus we substantiate that wobbler brain impairments are not confined to the motor cortex, but extend to the hippocampus. Importantly, we have revealed more details of the early pathophysiology in asymptomatic animals, and studies like the present may facilitate the development of novel treatment strategies for earlier intervention in ALS patients in the future.	[Thielsen, Karina D.; Jensen, Morten S.; Jensen, Kimmo; Holm, Mai Marie] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Thielsen, Karina D.; Moser, Jakob M.; Schmitt-John, Thomas] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark	Aarhus University; Aarhus University	Holm, MM (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	mmh@fi.au.dk		Jensen, Kimmo/0000-0001-8895-6194; Jensen, Morten Skovgaard/0000-0002-3984-496X; Holm, Mai/0000-0001-7347-8724	Lundbeck Foundation; Danish Council for Independent Research	Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	The Lundbeck Foundation and the Danish Council for Independent Research are acknowledged for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral DaL P, 2007, HIPPOCAMPUS BOOK, P37; ANDERSEN P, 1971, EXP BRAIN RES, V13, P222; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Anderson P., 2007, HIPPOCAMPUS BOOK, P9; ANDERSON VER, 1995, J NEUROL SCI, V129, P75, DOI 10.1016/0022-510X(95)00069-E; Bastone A, 2009, J PROTEOME RES, V8, P5229, DOI 10.1021/pr900569d; Bigini P, 2001, NEUROREPORT, V12, P1815, DOI 10.1097/00001756-200107030-00011; BLONDET B, 1995, NEUROSCI LETT, V183, P179, DOI 10.1016/0304-3940(94)11145-9; Boillee S, 2003, MOL NEUROBIOL, V28, P65, DOI 10.1385/MN:28:1:65; Bonanno G, 2009, NEUROCHEM INT, V55, P302, DOI 10.1016/j.neuint.2009.03.013; Bonifacino JS, 2011, TRENDS CELL BIOL, V21, P159, DOI 10.1016/j.tcb.2010.11.003; CAMBIER D, 1995, J NEUROCHEM, V65, P1199; Caramia MD, 2000, NEUROLOGY, V54, P58, DOI 10.1212/WNL.54.1.58; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; Conibear E, 2000, MOL BIOL CELL, V11, P305, DOI 10.1091/mbc.11.1.305; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; DeAndrade MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035518; Dennis JS, 2009, NEUROSCIENCE, V158, P745, DOI 10.1016/j.neuroscience.2008.10.030; Diana V, 2010, EXP NEUROL, V225, P163, DOI 10.1016/j.expneurol.2010.06.008; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DUCHEN LW, 1968, J NEUROL NEUROSUR PS, V31, P535, DOI 10.1136/jnnp.31.6.535; Ferraiuolo L, 2011, NAT REV NEUROL, V7, P616, DOI 10.1038/nrneurol.2011.152; Foerster BR, 2012, NEUROLOGY, V78, P1596, DOI 10.1212/WNL.0b013e3182563b57; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Giordana MT, 2010, BRAIN PATHOL, V20, P351, DOI 10.1111/j.1750-3639.2009.00284.x; Inglefield JR, 1997, HIPPOCAMPUS, V7, P511, DOI 10.1002/(SICI)1098-1063(1997)7:5<511::AID-HIPO7>3.3.CO;2-V; Jiang MH, 2001, J COMP NEUROL, V439, P176, DOI 10.1002/cne.1341; Johnston D, 1994, FDN CELLULAR NEUROPH; Karlsson P, 2013, INT J MOL SCI, V14, P10908, DOI 10.3390/ijms140610908; KATO S, 1994, J NEUROL SCI, V126, P62, DOI 10.1016/0022-510X(94)90095-7; KRIEGER C, 1991, BRAIN RES, V551, P142, DOI 10.1016/0006-8993(91)90925-L; Kullmann DM, 2011, CURR OPIN NEUROBIOL, V21, P709, DOI 10.1016/j.conb.2011.05.006; Kuo JJ, 2005, J PHYSIOL-LONDON, V563, P843, DOI 10.1113/jphysiol.2004.074138; Kuo JJ, 2004, J NEUROPHYSIOL, V91, P571, DOI 10.1152/jn.00665.2003; Lai C, 2006, J NEUROSCI, V26, P11798, DOI 10.1523/JNEUROSCI.2084-06.2006; Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094, DOI 10.1212/01.WNL.0000055861.95202.8D; Maekawa S, 2004, BRAIN, V127, P1237, DOI 10.1093/brain/awh132; Martin E, 2013, NEUROBIOL DIS, V54, P116, DOI 10.1016/j.nbd.2013.02.011; Meyer M, 2013, J NEUROENDOCRINOL, V25, P235, DOI 10.1111/jne.12004; Miller RG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub3; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; MITSUMOTO H, 1990, MUSCLE NERVE, V13, P121, DOI 10.1002/mus.880130206; MITSUMOTO H, 1993, MUSCLE NERVE, V16, P542, DOI 10.1002/mus.880160517; MITSUMOTO H, 1986, ANN NEUROL, V19, P36, DOI 10.1002/ana.410190108; Moser JM, 2013, MOL GENET GENOMICS, V288, P207, DOI 10.1007/s00438-013-0741-0; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nieto-Gonzalez JL, 2011, CEREB CORTEX, V21, P625, DOI 10.1093/cercor/bhq134; NIHEI K, 1993, ACTA NEUROPATHOL, V86, P55, DOI 10.1007/BF00454899; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Perez-Victoria FJ, 2010, MOL BIOL CELL, V21, P3386, DOI 10.1091/mbc.E10-05-0392; Perez-Victoria FJ, 2010, P NATL ACAD SCI USA, V107, P12860, DOI 10.1073/pnas.1004756107; Pieri M, 2009, EXP NEUROL, V215, P368, DOI 10.1016/j.expneurol.2008.11.002; Pioro EP, 1998, NEUROREPORT, V9, P3041, DOI 10.1097/00001756-199809140-00023; Ringholz GM, 2005, NEUROLOGY, V65, P586, DOI 10.1212/01.wnl.0000172911.39167.b6; ROTHSTEIN JD, 1990, ANN NEUROL, V28, P18, DOI 10.1002/ana.410280106; Santoro B, 2004, NEUROBIOL DIS, V17, P349, DOI 10.1016/j.nbd.2004.07.003; Schmitt-John T, 2005, NAT GENET, V37, P1213, DOI 10.1038/ng1661; SHAW PJ, 1995, NEURODEGENERATION, V4, P209, DOI 10.1006/neur.1995.0026; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Takeda T, 2009, ACTA NEUROPATHOL, V117, P35, DOI 10.1007/s00401-008-0447-2; Van den Bosch L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/348765; Vucic S, 2008, BRAIN, V131, P1540, DOI 10.1093/brain/awn071; Vucic S, 2006, BRAIN, V129, P2436, DOI 10.1093/brain/awl172; Vucic S, 2009, EXP NEUROL, V220, P177, DOI 10.1016/j.expneurol.2009.08.017; WIGHTMAN G, 1992, NEUROSCI LETT, V139, P269, DOI 10.1016/0304-3940(92)90569-S; Woo NH, 2006, NEUROSCIENTIST, V12, P43, DOI 10.1177/1073858405284360; Wood-Allum C, 2010, CLIN MED, V10, P252, DOI 10.7861/clinmedicine.10-3-252; Wu XY, 2012, J NEUROSCI, V32, P331, DOI 10.1523/JNEUROSCI.3189-11.2012; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	72	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82767	10.1371/journal.pone.0082767	http://dx.doi.org/10.1371/journal.pone.0082767			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349357	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300106
J	van Breugel, M; Hall, JS; Craven, D; Bailon, M; Hernandez, A; Abbene, M; van Breugel, P				van Breugel, Michiel; Hall, Jefferson S.; Craven, Dylan; Bailon, Mario; Hernandez, Andres; Abbene, Michele; van Breugel, Paulo			Succession of Ephemeral Secondary Forests and Their Limited Role for the Conservation of Floristic Diversity in a Human-Modified Tropical Landscape	PLOS ONE			English	Article							ATLANTIC FOREST; SEED DISPERSAL; BIODIVERSITY CONSERVATION; SIMILARITY INDEXES; FUNCTIONAL TRAITS; SPECIES-RICHNESS; RAIN-FORESTS; TRADE-OFF; TREE; DYNAMICS	Both local- and landscape-scale processes drive succession of secondary forests in human-modified tropical landscapes. Nonetheless, until recently successional changes in composition and diversity have been predominantly studied at the patch level. Here, we used a unique dataset with 45 randomly selected sites across a mixed-use tropical landscape in central Panama to study forest succession simultaneously on local and landscape scales and across both life stages (seedling, sapling, juvenile and adult trees) and life forms (shrubs, trees, lianas, and palms). To understand the potential of these secondary forests to conserve tree species diversity, we also evaluated the diversity of species that can persist as viable metapopulations in a dynamic patchwork of short-lived successional forests, using different assumptions about the average relative size at reproductive maturity. We found a deterministic shift in the diversity and composition of the local plant communities as well as the metacommunity, driven by variation in the rate at which species recruited into and disappeared from the secondary forests across the landscape. Our results indicate that dispersal limitation and the successional niche operate simultaneously and shape successional dynamics of the metacommunity of these early secondary forests. A high diversity of plant species across the metacommunity of early secondary forests shows a potential for restoration of diverse forests through natural succession, when trees and fragments of older forests are maintained in the agricultural matrix and land is abandoned or set aside for a long period of time. On the other hand, during the first 32 years the number of species with mature-sized individuals was a relatively small and strongly biased sub-sample of the total species pool. This implies that ephemeral secondary forests have a limited role in the long-term conservation of tree species diversity in human-modified tropical landscapes.	[van Breugel, Michiel; Hall, Jefferson S.; Craven, Dylan; Bailon, Mario; Hernandez, Andres] Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Ciudad De Panama, Panama; [Craven, Dylan; Abbene, Michele] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [van Breugel, Paulo] Univ Copenhagen, Fac Life Sci, Forest & Landscape Ctr, Frederiksberg C, Denmark	Smithsonian Institution; Smithsonian Tropical Research Institute; Yale University; University of Copenhagen	van Breugel, M (corresponding author), Smithsonian Trop Res Inst, Ctr Trop Forest Sci, Ciudad De Panama, Panama.	mvbreugel@gmail.com	Craven, Dylan/K-2717-2012; HERNANDEZ-GARCIA, ANDRES/B-9051-2014; van Breugel, Michiel/A-8453-2017	Craven, Dylan/0000-0003-3940-833X; HERNANDEZ-GARCIA, ANDRES/0000-0002-5343-5513; van Breugel, Paulo/0000-0001-9579-0831; van Breugel, Michiel/0000-0003-2778-7803	HSBC climate partnership; Smithsonian Tropical Research Institute; Panama Canal Authority; Frank Levinson Family Foundation; Motta Family Foundation	HSBC climate partnership; Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Panama Canal Authority; Frank Levinson Family Foundation; Motta Family Foundation	Funding for the Agua Salud Project came from the HSBC climate partnership, the Smithsonian Tropical Research Institute, the Panama Canal Authority, the Frank Levinson Family Foundation and the Motta Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZBUYLLA ER, 1992, J ECOL, V80, P275, DOI 10.2307/2261011; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Asner GP, 2009, CONSERV BIOL, V23, P1386, DOI 10.1111/j.1523-1739.2009.01333.x; Barlow J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009609; Bazzaz, 1996, PLANTS CHANGING ENV; Bossuyt B, 2006, LANDSCAPE ECOL, V21, P1195, DOI 10.1007/s10980-006-0016-9; Brook BW, 2006, BIOTROPICA, V38, P302, DOI 10.1111/j.1744-7429.2006.00141.x; Calcagno V, 2006, ECOL LETT, V9, P897, DOI 10.1111/j.1461-0248.2006.00930.x; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Chao A, 2012, ECOLOGY, V93, P2037, DOI 10.1890/11-1817.1; Chazdon R.L., 2008, INTROPICAL FORESTCOM, P384; Chazdon RL, 2007, PHILOS T R SOC B, V362, P273, DOI 10.1098/rstb.2006.1990; Chazdon RL, 2011, ECOLOGY, V92, P1332, DOI 10.1890/10-1345.1; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; Condit R, 2013, P NATL ACAD SCI US; Cramer JM, 2007, BIOL CONSERV, V137, P415, DOI 10.1016/j.biocon.2007.02.019; Croat T.B., 1978, FLORA BARRO COLORADO; da Silva JMC, 2000, NATURE, V404, P72, DOI 10.1038/35003563; de Melo FPL, 2006, BIOL CONSERV, V132, P50, DOI 10.1016/j.biocon.2006.03.015; Dent DH, 2013, J VEG SCI, V24, P530, DOI 10.1111/j.1654-1103.2012.01482.x; Dias PC, 1996, TRENDS ECOL EVOL, V11, P326, DOI 10.1016/0169-5347(96)10037-9; Dullinger S, 2013, P NATL ACAD SCI; Etter A, 2005, FOREST ECOL MANAG, V208, P249, DOI 10.1016/j.foreco.2004.12.008; Finegan B, 1996, TRENDS ECOL EVOL, V11, P119, DOI 10.1016/0169-5347(96)81090-1; Finegan Bryan, 2004, P153; Food and Agricultural Organization, 2011, STAT WORLDS FOR; Foster BL, 2000, PLANT ECOL, V146, P1, DOI 10.1023/A:1009895103017; Gardner TA, 2007, BIOTROPICA, V39, P25, DOI 10.1111/j.1744-7429.2006.00228.x; Gerwing JJ, 2006, BIOTROPICA, V38, P256, DOI 10.1111/j.1744-7429.2006.00134.x; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Gomez-Pompa A, 1981, FOREST SUCCESSION CO, P246, DOI DOI 10.1007/978-1-4612-5950-3_16; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grime J.P., 2002, PLANT STRATEGIES VEG; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Harrison RD, 2013, ECOL LETT; Harvey CA, 2008, CONSERV BIOL, V22, P8, DOI 10.1111/j.1523-1739.2007.00863.x; Hassler SK, 2011, FOREST ECOL MANAG, V261, P1634, DOI 10.1016/j.foreco.2010.06.031; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Holl KD, 2011, FOREST ECOL MANAG, V261, P1558, DOI 10.1016/j.foreco.2010.07.004; Holl KD, 1999, BIOTROPICA, V31, P229, DOI 10.1111/j.1744-7429.1999.tb00135.x; HURTT GC, 1995, J THEOR BIOL, V176, P1, DOI 10.1006/jtbi.1995.0170; International Tropical Timber Organization, 2002, ITTO GUID REST MAN R; Jayakumar S., 2011, P INT ACAD ECOLOGY E, V1, P151; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Laurance WF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001017; Laurance WF, 2007, TRENDS ECOL EVOL, V22, P65, DOI 10.1016/j.tree.2006.09.014; Lawrence D, 2004, ECOL APPL, V14, P1855, DOI 10.1890/03-5321; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leigh EG, 1999, TROPICAL FOREST ECOL; Lugo AE, 2004, FOREST ECOL MANAG, V190, P145, DOI 10.1016/j.foreco.2003.09.012; Magurran A.E, 2004, MEASURING BIOL DIVER; Mayfield MM, 2006, J ECOL, V94, P522, DOI 10.1111/j.1365-2745.2006.01108.x; McCune B, 2002, ANAL ECOLOGICAL COMM; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; Melo FPL, 2013, TRENDS ECOL EVOL, P1; Metzger JP, 2002, LANDSCAPE ECOL, V17, P419, DOI 10.1023/A:1021250306481; Moran EF, 1996, ECOL ECON, V18, P41, DOI 10.1016/0921-8009(96)00034-1; Muller-Landau HC, 2010, P NATL ACAD SCI USA, V107, P4242, DOI 10.1073/pnas.0911637107; Neeff T, 2006, ECOSYSTEMS, V9, P609, DOI 10.1007/s10021-006-0001-9; Neumann-Cosel L, 2010, FOR ECOL MANAGE; Neumann-Cosel L, 2011, FOREST ECOL MANAG, V261, P1625, DOI 10.1016/j.foreco.2010.07.023; Norden N, 2009, ECOL LETT, V12, P385, DOI 10.1111/j.1461-0248.2009.01292.x; Ogden FL, 2013, WATER RECOU IN PRESS; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Oksanen J., 2011, MULTIVARIATE ANAL EC; Oliveira MA, 2008, FOREST ECOL MANAG, V256, P1910, DOI 10.1016/j.foreco.2008.07.014; Lopez-Martinez JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073660; Perz Stephen G., 2005, Environment Development and Sustainability, V7, P23, DOI 10.1007/s10668-003-6977-9; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Grau HR, 2008, ECOL SOC, V13; Ruiz J, 2005, BIOTROPICA, V37, P520, DOI 10.1111/j.1744-7429.2005.00070.x; Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018; Schnitzer SA, 2006, BIOTROPICA, V38, P581, DOI 10.1111/j.1744-7429.2006.00187.x; Tabarelli M, 2010, BIOL CONSERV, V143, P2328, DOI 10.1016/j.biocon.2010.02.005; Thomas SC, 1996, EVOL ECOL, V10, P517, DOI 10.1007/BF01237882; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Turner BL, 2011, BIOGEOCHEMISTRY, V103, P297, DOI 10.1007/s10533-010-9466-x; van Breugel M, 2007, BIOTROPICA, V39, P610, DOI 10.1111/j.1744-7429.2007.00316.x; van Breugel M, 2006, J TROP ECOL, V22, P663, DOI 10.1017/S0266467406003452; van Breugel M, 2012, PLANT ECOL, V213, P25, DOI 10.1007/s11258-011-0003-3; van Breugel M, 2011, FOREST ECOL MANAG, V262, P1648, DOI 10.1016/j.foreco.2011.07.018; Vellend M, 2006, ECOLOGY, V87, P542, DOI 10.1890/05-1182; Venables WN., 2002, MODERN APPL STAT S, V4; Walker LR, 2010, J ECOL, V98, P725, DOI 10.1111/j.1365-2745.2010.01664.x; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WOLDA H, 1981, OECOLOGIA, V50, P296, DOI 10.1007/BF00344966; Wright SJ, 2006, BIOTROPICA, V38, P287, DOI 10.1111/j.1744-7429.2006.00154.x; Wright SJ, 2005, J TROP ECOL, V21, P307, DOI 10.1017/S0266467405002294; Wunderle JM, 1997, FOREST ECOL MANAG, V99, P223, DOI 10.1016/S0378-1127(97)00208-9	94	76	76	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82433	10.1371/journal.pone.0082433	http://dx.doi.org/10.1371/journal.pone.0082433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349283	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300093
J	Weng, CH; Hu, CC; Lin, JL; Lin-Tan, DT; Hsu, CW; Yen, TH				Weng, Cheng-Hao; Hu, Ching-Chih; Lin, Ja-Liang; Lin-Tan, Dan-Tzu; Hsu, Ching-Wei; Yen, Tzung-Hai			Predictors of Acute Respiratory Distress Syndrome in Patients with Paraquat Intoxication	PLOS ONE			English	Article							PULSE THERAPY; HEPATOPULMONARY SYNDROME; SCORING SYSTEM; CLINICAL-TRIAL; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MODERATE	Introduction: Paraquat poisoning is characterized by acute lung injury, pulmonary fibrosis, respiratory failure, and multi-organ failure, resulting in a high rate of mortality and morbidity. The objectives of this study were to identify predictors of acute respiratory distress syndrome (ARDS) in cases of paraquat poisoning and determine the association between these parameters. Materials and Methods: In total, 187 patients were referred for management of intentional paraquat ingestion between 2000 and 2010. Demographic, clinical, and laboratory data were recorded. Sequential organ failure assessment (SOFA) and Acute Kidney Injury Network (AKIN) scores were collected, and predictors of ARDS were analyzed. Results: The overall mortality rate for the entire population was 54% (101/187). Furthermore, the mortality rate was higher in the ARDS patients than in the non-ARDS patients (80% vs. 43.80%, P<0.001). Additionally, the ARDS patients not only had higher AKIN(48-h) scores (P<0.009), SOFA(48-h) scores (P<0.001), and time to ARDS/nadir PaO2 (P=0.008) but also suffered from lower nadir PaO2 (P<0.001), nadir AaDO(2) (P<0.001), and nadir eGFR (P=0.001) compared to those in the non-ARDS patients. Moreover, pneumomediastinum episodes were more frequent in the ARDS patients than in the non-ARDS patients (P<0.001). A multivariate Cox regression model revealed that blood paraquat concentrations (P<0.001), SOFA(48-h) scores (P=0.001), and steroid and cyclophosphamide pulse therapies (P=0.024) were significant predictors of ARDS. The cumulative survival rates differed significantly (P<0.001) between patients with SOFA48-h scores <3 and SOFA(48-h) scores >= 3, with a sensitivity of 95.8%, specificity of 58.4%, and overall correctness of 67.6%. Finally, the area under the receiver operating characteristic (AUROC) analysis showed that SOFA(48-h) scores (P<0.001) had a better discriminatory power than blood paraquat concentrations (P=0.01) for predicting ARDS. Conclusions: The analytical results indicate that SOFA(48-h) scores, blood paraquat concentrations, and steroid and cyclophosphamide pulse therapies are significantly associated with ARDS complications after paraquat intoxication.	[Weng, Cheng-Hao; Lin, Ja-Liang; Lin-Tan, Dan-Tzu; Hsu, Ching-Wei; Yen, Tzung-Hai] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Nephrol, Tao Yuan, Taiwan; [Weng, Cheng-Hao; Hu, Ching-Chih; Lin, Ja-Liang; Lin-Tan, Dan-Tzu; Hsu, Ching-Wei; Yen, Tzung-Hai] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Hu, Ching-Chih] Chang Gung Mem Hosp, Dept Hepatogastroenterol, Keelung, Taiwan; [Hu, Ching-Chih] Chang Gung Mem Hosp, Liver Res Unit, Keelung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Yen, TH (corresponding author), Chang Gung Mem Hosp, Linkou Med Ctr, Dept Nephrol, Tao Yuan, Taiwan.	m19570@adm.cgmh.org.tw	Yen, Tzung-Hai/AAQ-4525-2020	Yen, Tzung-Hai/0000-0002-0907-1505	Chang Gung Memorial Hospital [CMRPG391161, CMRG3C0771]; National Science Council of Taiwan [NSC 102-2314-B-182 -044]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	Cheng-Hao Weng was funded by research grants from the Chang Gung Memorial Hospital (CMRPG391161). Tzung-Hai Yen was funded by research grants from the Chang Gung Memorial Hospital (CMRG3C0771) and National Science Council of Taiwan (NSC 102-2314-B-182 -044-). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashford NA, 2002, INT J OCCUP ENV HEAL, V8, P156; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Chang MW, 2008, AM J MED SCI, V335, P451, DOI 10.1097/MAJ.0b013e318157cb6d; Daisley H, 1999, VET HUM TOXICOL, V41, P23; Doi K, 2011, CLIN EXP NEPHROL, V15, P464, DOI 10.1007/s10157-011-0459-4; Hsieh YW, 2013, PEDIATR EMERG CARE, V29, P487, DOI 10.1097/PEC.0b013e31828a347e; Hsu CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048397; Hsu HH, 2003, J TOXICOL-CLIN TOXIC, V41, P89, DOI 10.1081/CLT-120018278; Huang NC, 2006, CLIN TOXICOL, V44, P99, DOI 10.1080/15563650500514251; IM JG, 1991, AM J ROENTGENOL, V157, P697, DOI 10.2214/ajr.157.4.1892020; Kramer AA, 1999, KIDNEY INT, V55, P2362, DOI 10.1046/j.1523-1755.1999.00460.x; Lee K, 2011, INT J TUBERC LUNG D, V15, P1099, DOI 10.5588/ijtld.10.0557; Li LR, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008084.pub3; Lin CY, 2010, SHOCK, V34, P352, DOI 10.1097/SHK.0b013e3181d8e61d; Lin JL, 2011, INTENS CARE MED, V37, P1006, DOI 10.1007/s00134-010-2127-7; Lin JL, 1995, ARCH ENVIRON HEALTH, V50, P432, DOI 10.1080/00039896.1995.9935979; Lin JL, 1999, AM J RESP CRIT CARE, V159, P357, DOI 10.1164/ajrccm.159.2.9803089; Lin JL, 2006, CRIT CARE MED, V34, P368, DOI 10.1097/01.CCM.0000195013.47004.A8; Lin JL, 1996, THORAX, V51, P661, DOI 10.1136/thx.51.7.661; Lin NC, 2003, J TOXICOL-CLIN TOXIC, V41, P877, DOI 10.1081/CLT-120025356; Liu KD, 2007, CRIT CARE MED, V35, P2755, DOI 10.1097/01.CCM.0000291649.72238.6D; Liu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036576; Macklin C, 1939, ARCH INTERN MED, V64, P14; Min YG, 2011, CLIN TOXICOL, V49, P840, DOI 10.3109/15563650.2011.619137; Narvaez-Rivera RM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-15; Park BH, 2011, SHOCK, V36, P109, DOI 10.1097/SHK.0b013e31821d8f2d; Rios FG, 2011, CRIT CARE, V15, DOI 10.1186/cc10369; Riscili BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018166; Rodriguez-Roisin R, 2008, NEW ENGL J MED, V358, P2378, DOI 10.1056/NEJMra0707185; Tsai TY, 2011, HUM EXP TOXICOL, V30, P71, DOI 10.1177/0960327110368419; VALE JA, 1987, HUM TOXICOL, V6, P41, DOI 10.1177/096032718700600107; Weng CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051743; Yang CJ, 2012, LIVER INT, V32, P1400, DOI 10.1111/j.1478-3231.2012.02829.x; Yen TH, 2010, AM J EMERG MED, V28, P728, DOI 10.1016/j.ajem.2009.06.001; Zhang JL, 2012, NAT REV GASTRO HEPAT, V9, P539, DOI 10.1038/nrgastro.2012.123	35	28	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82695	10.1371/journal.pone.0082695	http://dx.doi.org/10.1371/journal.pone.0082695			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349340	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300103
J	Young, KM; Gray, CM; Bekker, LG				Young, Katherine M.; Gray, Clive M.; Bekker, Linda-Gail			Is Obesity a Risk Factor for Vaccine Non-Responsiveness?	PLOS ONE			English	Article							HEPATITIS-B-VACCINE; GUT MICROBIOME; HIV-1 VACCINE; IMMUNOGENICITY; EFFICACY; INFECTION	Understanding the link between vaccine immunogenicity and efficacy is currently a major focus in HIV research. Consequently, recent developments in the HIV-1 vaccine field have led to a closer look at immune responses to known efficacious vaccines. We undertook a study to explore clinical predictors of vaccine efficacy following recombinant hepatitis B (rHBV) vaccination in a cohort of HIV-uninfected, hepatitis B virus naive women living in a peri-urban setting in Cape Town. Our aim was to define host biological risk factors associated with lack of vaccine uptake. We found a significant association (p=0.009) between body mass index (BMI) and lack of vaccine-specific IgG titre (<10mIU/mL). Obese individuals (BMI >= 30kg/m(2)) were significantly more likely to be non-responders following 2 rHBV vaccine doses (Adjusted Odds Ratio of 8.75; p=0.043). There was no observed association between vaccine responses and age, method of contraception or time from vaccination to antibody measurement. These data suggest that obesity-associated factors interfere with vaccine immunogenicity and possible efficacy.	[Young, Katherine M.; Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Gray, Clive M.] Inst Infect Dis & Mol Med & Clin Lab Sci, Div Immunol, Cape Town, South Africa; [Gray, Clive M.] Univ Cape Town, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town	Young, KM (corresponding author), Univ Cape Town, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa.	young.katherinem@gmail.com	Bekker, Linda-Gail/AAZ-8929-2020	Gray, Clive/0000-0002-9293-901X; BEKKER, LINDA-GAIL/0000-0002-0755-4386	HIV Vaccine Trials Network [UM1 A1068614]; National Institutes of Allergy and Infectious Disease, US National Institutes of Health; Fogarty International Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069519] Funding Source: NIH RePORTER	HIV Vaccine Trials Network; National Institutes of Allergy and Infectious Disease, US National Institutes of Health; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the HIV Vaccine Trials Network (UM1 A1068614) SHAPe Program supported by the National Institutes of Allergy and Infectious Disease, US National Institutes of Health; and the Fogarty International Center (http://www.hvtn.org/science/awards.html). The funders had no role in the study design, data collection and analysis or decision to publish, and played only a minor role in preparation of the manuscript. An early draft of the manuscript was reviewed by members of the HIV Vaccine Trials Network (HVTN) Protocol Committee. Suggestions from the committee were taken into consideration in finalization of the manuscript.	Adkins JC, 1998, BIODRUGS, V10, P137, DOI 10.2165/00063030-199810020-00005; Averhoff F, 1998, AM J PREV MED, V15, P1, DOI 10.1016/S0749-3797(98)00003-8; Beasley LE, 2009, OBESITY, V17, P1062, DOI 10.1038/oby.2008.627; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Estevez ZC, 2007, BIOLOGICALS, V35, P115, DOI 10.1016/j.biologicals.2006.06.001; de Wouters T, 2012, DIGEST DIS, V30, P33, DOI 10.1159/000342595; Department of Health Medical Research Council, 2007, ORCMACRO S AFR DEM H; Eliakim A, 2006, AUTOIMMUNITY, V39, P137, DOI 10.1080/08916930600597326; GOEDECKE JH, 2005, OBESITY S AFRICA CHR, P65; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Hullar MAJ, 2012, NESTLE NUTR WORKS SE, V73, P67, DOI 10.1159/000341288; Mast Eric E., 2005, Morbidity and Mortality Weekly Report, V54, P1; Middleman AB, 2010, PEDIATRICS, V125, pE508, DOI 10.1542/peds.2009-1592; Park HS, 2005, DIABETES RES CLIN PR, V69, P29, DOI 10.1016/j.diabres.2004.11.007; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sheridan PA, 2012, INT J OBESITY, V36, P1072, DOI 10.1038/ijo.2011.208; Sweeney TE, 2013, JAMA SURG, V148, P563, DOI 10.1001/jamasurg.2013.5; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; WOOD RC, 1991, JAMA-J AM MED ASSOC, V270, P2935; Ziccardi P, 2002, CIRCULATION, V105, P804, DOI 10.1161/hc0702.104279	20	41	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82779	10.1371/journal.pone.0082779	http://dx.doi.org/10.1371/journal.pone.0082779			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349359	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300107
J	Hettler, A; Werner, S; Eick, S; Laufer, S; Weise, F				Hettler, Alice; Werner, Simon; Eick, Stefan; Laufer, Stefan; Weise, Frank			A New In Vitro Model to Study Cellular Responses after Thermomechanical Damage in Monolayer Cultures	PLOS ONE			English	Article							SHOCK-PROTEIN 27; ENDOTHELIAL-CELLS; EXPRESSION; ADHESION; APOPTOSIS; KINETICS; ACTIVATION; MECHANISM; MIGRATION; NECROSIS	Although electrosurgical instruments are widely used in surgery to cut tissue layers or to achieve hemostasis by coagulation (electrocautery), only little information is available concerning the inflammatory or immune response towards the debris generated. Given the elevated local temperatures required for successful electrocautery, the remaining debris is likely to contain a plethora of compounds entirely novel to the intracorporal setting. A very common in vitro method to study cell migration after mechanical damage is the scratch assay, however, there is no established model for thermomechanical damage to characterise cellular reactions. In this study, we established a new in vitro model to investigate exposure to high temperature in a carefully controlled cell culture system. Heatable thermostat-controlled aluminium stamps were developed to induce local damage in primary human umbilical vein endothelial cells (HUVEC). The thermomechanical damage invoked is reproducibly locally confined, therefore allowing studies, under the same experimental conditions, of cells affected to various degrees as well as of unaffected cells. We show that the unaffected cells surrounding the thermomechanical damage zone are able to migrate into the damaged area, resulting in a complete closure of the 'wound' within 48 h. Initial studies have shown that there are significant morphological and biological differences in endothelial cells after thermomechanical damage compared to the mechanical damage inflicted by using the unheated stamp as a control. Accordingly, after thermomechanical damage, cell death as well as cell protection programs were activated. Mononuclear cells adhered in the area adjacent to thermomechanical damage, but not to the zone of mechanical damage. Therefore, our model can help to understand the differences in wound healing during the early phase of regeneration after thermomechanical vs. mechanical damage. Furthermore, this model lends itself to study the response of other cells, thus broadening the range of thermal injuries that can be analysed.	[Hettler, Alice; Weise, Frank] Univ Tubingen, Nat & Med Sci Inst, Dept Mol Biol, Reutlingen, Germany; [Werner, Simon] Univ Tubingen, Dept Biomicroelectromech Syst Sensors, Nat & Med Sci Inst, Reutlingen, Germany; [Eick, Stefan] Aesculap AG, Tuttlingen, Germany; [Laufer, Stefan] Univ Tubingen, Dept Pharmaceut Chem, Inst Pharmaceut Sci, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; B Braun Melsungen; Eberhard Karls University of Tubingen	Weise, F (corresponding author), Univ Tubingen, Nat & Med Sci Inst, Dept Mol Biol, Reutlingen, Germany.	weise@nmi.de		Laufer, Stefan/0000-0001-6952-1486	Aesculap AG	Aesculap AG	This study was partly funded by Aesculap AG. The funders had no role in study design, data collection and analysis. No additional external funding was received for this study.	CARLOS TM, 1994, BLOOD, V84, P2068; Chai JK, 2009, BURNS, V35, P1158, DOI 10.1016/j.burns.2009.02.010; Cines DB, 1998, BLOOD, V91, P3527; Di Lorenzo N, 2012, SURG ENDOSC, V26, P2917, DOI 10.1007/s00464-012-2285-5; Haddad JJ, 2002, BIOCHEM PHARMACOL, V63, P305, DOI 10.1016/S0006-2952(01)00870-X; HARLAN JM, 1985, BLOOD, V65, P513; Heniford BT, 2001, SURG ENDOSC-ULTRAS, V15, P799, DOI 10.1007/s004640080025; Hoenig DM, 1996, J ENDOUROL, V10, P431, DOI 10.1089/end.1996.10.431; Hurst BS, 2005, FERTIL STERIL, V83, P1, DOI 10.1016/j.fertnstert.2004.09.011; Janssen PF, 2012, SURG ENDOSC, V26, P2892, DOI 10.1007/s00464-012-2276-6; Keese CR, 2004, P NATL ACAD SCI USA, V101, P1554, DOI 10.1073/pnas.0307588100; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Leppa S, 1997, ANN MED, V29, P73, DOI 10.3109/07853899708998745; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Litta P, 2010, FERTIL STERIL, V94, P1882, DOI 10.1016/j.fertnstert.2009.08.049; MARUI N, 1993, J CLIN INVEST, V92, P1866, DOI 10.1172/JCI116778; Mills JC, 1999, J CELL BIOL, V146, P703, DOI 10.1083/jcb.146.4.703; Mo SJ, 2007, J ETHNOPHARMACOL, V109, P78, DOI 10.1016/j.jep.2006.07.006; Moloney TC, 2012, PROTEIN SCI, V21, P904, DOI 10.1002/pro.2077; Moore PL, 1990, J CELL BIOL, V111, P58; Mustafi SB, 2009, CELL STRESS CHAPERON, V14, P579, DOI 10.1007/s12192-009-0109-x; POBER JS, 1986, J IMMUNOL, V136, P1680; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Proskuryakov SY, 2002, BIOCHEMISTRY-MOSCOW+, V67, P387, DOI 10.1023/A:1015289521275; Richter S, 2006, J LAPAROENDOSC ADV S, V16, P149, DOI 10.1089/lap.2006.16.149; RUSSELL SW, 1972, AM J PATHOL, V69, P103; Rylander MN, 2005, J BIOMECH ENG-T ASME, V127, P751, DOI 10.1115/1.1993661; SASAKI DT, 1987, CYTOMETRY, V8, P413, DOI 10.1002/cyto.990080411; Schwacha MG, 2010, J SURG RES, V158, P112, DOI 10.1016/j.jss.2008.07.034; SELLAK H, 1994, BLOOD, V83, P2669; Sobral Christiane S, 2007, J Burns Wounds, V7, pe6; Sumpio BE, 2002, INT J BIOCHEM CELL B, V34, P1508, DOI 10.1016/S1357-2725(02)00075-4; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; van Wetering S, 2002, J CELL SCI, V115, P1837; Vidyasagar A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-7; Wallwiener C, 2007, FERTIL STERIL, V88, P206, DOI 10.1016/j.fertnstert.2006.11.204; Wallwiener CW, 2008, J MINIM INVAS GYN, V15, P605, DOI 10.1016/j.jmig.2008.05.003; Wang SH, 2003, J BIOMECH ENG-T ASME, V125, P794, DOI 10.1115/1.1632522; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Weigand K, 2012, HPB SURG, V2012, DOI [10.1155/2012/176723, DOI 10.1155/2012/176723]; Xu L, 2006, ONCOGENE, V25, P2987, DOI 10.1038/sj.onc.1209337	43	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82635	10.1371/journal.pone.0082635	http://dx.doi.org/10.1371/journal.pone.0082635			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349324	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200086
J	Petersson, EV; Nahar, N; Dahlin, P; Broberg, A; Troger, R; Dutta, PC; Jonsson, L; Sitbon, F				Petersson, Erik V.; Nahar, Nurun; Dahlin, Paul; Broberg, Anders; Troger, Rikard; Dutta, Paresh C.; Jonsson, Lisbeth; Sitbon, Folke			Conversion of Exogenous Cholesterol into Glycoalkaloids in Potato Shoots, Using Two Methods for Sterol Solubilisation	PLOS ONE			English	Article							BIOSYNTHESIS; PLANTS; ALKALOIDS; ACCUMULATION; SAFETY	Steroidal glycoalkaloids (SGA) are toxic secondary metabolites naturally occurring in the potato, as well as in certain other Solanaceous plant species, such as tomato, eggplant and pepper. To investigate the steroidal origin of SGA biosynthesis, cut potato shoots were fed cholesterol labelled with deuterium (D) in the sterol ring structure (D-5- or D-6-labelled), or side chain (D-7-labelled), and analysed after three or five weeks. The labelled cholesterol and presence of D-labelled SGA were analysed by GC-MS and LC-MS/MS, respectively. When feeding D-labelled cholesterol solubilised in Tween-80, labelled cholesterol in free form became present in both leaves and stems, although the major part was recovered as steryl esters. Minor amounts of D-labelled SGA (alpha-solanine and alpha-chaconine) were identified in cholesterol-treated shoots, but not in blank controls, or in shoots fed D-6-27-hydroxycholesterol. Solubilising the labelled cholesterol in methyl-beta-cyclodextrin instead of Tween-80 increased the levels of labelled SGA up to 100-fold, and about 1 mole% of the labelled cholesterol was recovered as labelled SGA in potato leaves. Both side chain and ring structure D labels were retained in SGA, showing that the entire cholesterol molecule is converted to SGA. However, feeding side chain D-7-labelled cholesterol resulted in D-5-labelled SGA, indicating that two hydrogen atoms were released during formation of the SGA nitrogen-containing ring system. Feeding with D-7-sitosterol did not produce any labelled SGA, indicating that cholesterol is a specific SGA precursor. In conclusion, we have demonstrated a superior performance of methyl-beta-cyclodextrin for delivery of cholesterol in plant tissue feeding experiments, and given firm evidence for cholesterol as a specific sterol precursor of SGA in potato.	[Petersson, Erik V.; Nahar, Nurun; Sitbon, Folke] Swedish Univ Agr Sci, Uppsala BioCtr, Dept Plant Biol & Forest Genet, Uppsala, Sweden; [Petersson, Erik V.; Nahar, Nurun; Sitbon, Folke] Linnean Ctr Plant Biol, Uppsala, Sweden; [Dahlin, Paul; Jonsson, Lisbeth] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Broberg, Anders] Swedish Univ Agr Sci, Uppsala BioCtr, Dept Chem, Uppsala, Sweden; [Troger, Rikard] Natl Food Agcy, Dept Sci, Chem Div 1, Uppsala, Sweden; [Dutta, Paresh C.] Swedish Univ Agr Sci, Uppsala BioCtr, Dept Food Sci, Uppsala, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Stockholm University; Swedish University of Agricultural Sciences; Swedish National Food Agency; Swedish University of Agricultural Sciences	Petersson, EV (corresponding author), Swedish Univ Agr Sci, Uppsala BioCtr, Dept Plant Biol & Forest Genet, Uppsala, Sweden.	erik.petersson@slv.se	Westerberg, Erik/O-5319-2014	Westerberg, Erik/0000-0003-3491-9501; Troger, Rikard/0000-0001-9911-7783	Swedish Research Council Formas [229-2004-1576]; Swedish Farmers' Foundation for Agricultural Research [H0942171]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Farmers' Foundation for Agricultural Research	This work was supported by The Swedish Research Council Formas Grant No. 229-2004-1576 and The Swedish Farmers' Foundation for Agricultural Research, Grant No. H0942171. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Arnqvist L, 2003, PLANT PHYSIOL, V131, P1792, DOI 10.1104/pp.102.018788; Behmer ST, 2011, FUNCT ECOL, V25, P484, DOI 10.1111/j.1365-2435.2010.01810.x; Benveniste P, 2004, ANNU REV PLANT BIOL, V55, P429, DOI 10.1146/annurev.arplant.55.031903.141616; BERGENSTRAHLE A, 1992, J PLANT PHYSIOL, V140, P269, DOI 10.1016/S0176-1617(11)81078-3; BERGENSTRAHLE A, 1993, PHYSIOL PLANTARUM, V89, P301, DOI [10.1034/j.1399-3054.1993.890209.x, 10.1111/j.1399-3054.1993.tb00158.x]; Bergenstrahle A, 1996, PHYTOCHEMISTRY, V41, P155, DOI 10.1016/0031-9422(95)00554-4; Beste L, 2011, PLANT PHYSIOL, V157, P426, DOI 10.1104/pp.110.171199; BOMER A, 1924, Z UNTERS NAHR GENUSS, V47, P97; Chakraborty S, 2009, J COLLOID INTERF SCI, V335, P242, DOI 10.1016/j.jcis.2009.03.047; Friedman M, 1997, CRIT REV PLANT SCI, V16, P55, DOI 10.1080/713608144; Ginzberg I, 2009, POTATO RES, V52, P1, DOI 10.1007/s11540-008-9103-4; GONDET L, 1994, PLANT PHYSIOL, V105, P509, DOI 10.1104/pp.105.2.509; HEFTMANN E, 1974, PHYTOCHEMISTRY, V13, P1801, DOI 10.1016/0031-9422(74)85093-4; HEFTMANN E, 1983, PHYTOCHEMISTRY, V22, P1843, DOI 10.1016/0031-9422(83)80001-6; Itkin M, 2013, SCIENCE, V341, P175, DOI 10.1126/science.1240230; Itkin M, 2011, PLANT CELL, V23, P4507, DOI 10.1105/tpc.111.088732; ITOH T, 1977, STEROIDS, V30, P425, DOI 10.1016/0039-128X(77)90033-2; ITOH T, 1977, PHYTOCHEMISTRY, V16, P140, DOI 10.1016/0031-9422(77)83038-0; JOHNSON DF, 1963, SCIENCE, V140, P198, DOI 10.1126/science.140.3563.198; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Korpan YI, 2004, TRENDS BIOTECHNOL, V22, P147, DOI 10.1016/j.tibtech.2004.01.009; Mccue KF, 2007, PHYTOCHEMISTRY, V68, P327, DOI 10.1016/j.phytochem.2006.10.025; Mccue KF, 2006, PHYTOCHEMISTRY, V67, P1590, DOI 10.1016/j.phytochem.2005.09.037; McCue KF, 2005, PLANT SCI, V168, P267, DOI 10.1016/j.plantsci.2004.08.006; Ohyama K, 2013, PHYTOCHEMISTRY, V89, P26, DOI 10.1016/j.phytochem.2013.01.010; Petersson EV, 2013, J AGR FOOD CHEM, V61, P5893, DOI 10.1021/jf400318p; SCHALLER H, 1995, PLANT PHYSIOL, V109, P761, DOI 10.1104/pp.109.3.761; SCHMITT P, 1981, PHYTOCHEMISTRY, V20, P197, DOI 10.1016/0031-9422(81)85092-3; Silvestro D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056429; SINDEN SL, 1984, AM POTATO J, V61, P141, DOI 10.1007/BF02854035; Stella VJ, 2008, TOXICOL PATHOL, V36, P30, DOI 10.1177/0192623307310945; TSCHESCH.R, 1967, Z NATURFORSCH PT B, VB 22, P791; TSCHESCHE R, 1976, PHYTOCHEMISTRY, V15, P1387, DOI 10.1016/S0031-9422(00)97122-X; Valkonen JPT, 1996, CRIT REV PLANT SCI, V15, P1, DOI 10.1080/713608127	34	15	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82955	10.1371/journal.pone.0082955	http://dx.doi.org/10.1371/journal.pone.0082955			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349406	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200118
J	Kramer, RSS; Jones, AL; Sharma, D				Kramer, Robin S. S.; Jones, Alex L.; Sharma, Dinkar			Sequential Effects in Judgements of Attractiveness: The Influences of Face Race and Sex	PLOS ONE			English	Article							OWN-RACE; SOCIAL CATEGORIZATION; SERIAL POSITION; BIAS; GENDER; MECHANISMS; ASSIMILATION; PERCEPTION; ORDER	In perceptual decision-making, a person's response on a given trial is influenced by their response on the immediately preceding trial. This sequential effect was initially demonstrated in psychophysical tasks, but has now been found in more complex, real-world judgements. The similarity of the current and previous stimuli determines the nature of the effect, with more similar items producing assimilation in judgements, while less similarity can cause a contrast effect. Previous research found assimilation in ratings of facial attractiveness, and here, we investigated whether this effect is influenced by the social categories of the faces presented. Over three experiments, participants rated the attractiveness of own-(White) and other-race (Chinese) faces of both sexes that appeared successively. Through blocking trials by race (Experiment 1), sex (Experiment 2), or both dimensions (Experiment 3), we could examine how sequential judgements were altered by the salience of different social categories in face sequences. For sequences that varied in sex alone, own-race faces showed significantly less opposite-sex assimilation (male and female faces perceived as dissimilar), while other-race faces showed equal assimilation for opposite-and same-sex sequences (male and female faces were not differentiated). For sequences that varied in race alone, categorisation by race resulted in no opposite-race assimilation for either sex of face (White and Chinese faces perceived as dissimilar). For sequences that varied in both race and sex, same-category assimilation was significantly greater than opposite-category. Our results suggest that the race of a face represents a superordinate category relative to sex. These findings demonstrate the importance of social categories when considering sequential judgements of faces, and also highlight a novel approach for investigating how multiple social dimensions interact during decision-making.	[Kramer, Robin S. S.; Sharma, Dinkar] Univ Kent, Keynes Coll, Sch Psychol, Canterbury CT2 7NZ, Kent, England; [Jones, Alex L.] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales	University of Kent; Bangor University	Kramer, RSS (corresponding author), Univ Kent, Keynes Coll, Sch Psychol, Canterbury CT2 7NZ, Kent, England.	remarknibor@gmail.com	Sharma, Dinkar/N-8978-2016; Jones, Alex L./J-2779-2019; Sharma, Dinkar/N-8937-2019	Sharma, Dinkar/0000-0002-0082-1285; Jones, Alex L./0000-0003-3600-3644; Sharma, Dinkar/0000-0002-0082-1285; Kramer, Robin/0000-0001-8339-8832	Leverhulme Trust [F/00236/AB]	Leverhulme Trust(Leverhulme Trust)	This work was supported by Grant F/00236/AB from the Leverhulme Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attali Y, 2011, EDUC PSYCHOL MEAS, V71, P68, DOI 10.1177/0013164410387344; Bernstein MJ, 2007, PSYCHOL SCI, V18, P706, DOI 10.1111/j.1467-9280.2007.01964.x; Bodenhausen GV, 1998, ADV SOC COG, V11, P1; Cassidy KD, 2011, J EXP SOC PSYCHOL, V47, P811, DOI 10.1016/j.jesp.2011.02.017; Damisch L, 2006, J EXP PSYCHOL-APPL, V12, P166, DOI 10.1037/1076-898X.12.3.166; de Bruin WB, 2005, ACTA PSYCHOL, V118, P245, DOI 10.1016/j.actpsy.2004.08.005; Freeman JB, 2013, SOC COGN IN PRESS; GENTNER D, 1994, PSYCHOL SCI, V5, P152, DOI 10.1111/j.1467-9280.1994.tb00652.x; GERNSBACHER MA, 1991, J EXP PSYCHOL LEARN, V17, P245, DOI 10.1037/0278-7393.17.2.245; GLANZER M, 1966, J VERB LEARN VERB BE, V5, P351, DOI 10.1016/S0022-5371(66)80044-0; HOLLAND MK, 1968, PERCEPT PSYCHOPHYS, V3, P409, DOI 10.3758/BF03205747; Hugenberg K, 2008, SOC PERSONAL PSYCHOL, V2, P1052, DOI 10.1111/j.1751-9004.2008.00090.x; Ito TA, 2005, COGN AFFECT BEHAV NE, V5, P21, DOI 10.3758/CABN.5.1.21; Ito TA, 2003, J PERS SOC PSYCHOL, V85, P616, DOI 10.1037/0022-3514.85.4.616; JESTEADT W, 1977, J EXP PSYCHOL HUMAN, V3, P92, DOI 10.1037/0096-1523.3.1.92; Johnson KL, 2012, J PERS SOC PSYCHOL, V102, P116, DOI 10.1037/a0025335; Kelly DJ, 2005, DEVELOPMENTAL SCI, V8, pF31, DOI 10.1111/j.1467-7687.2005.0434a.x; Kondo A, 2012, PERCEPTION, V41, P43, DOI 10.1068/p7116; Kondo A, 2013, ATTEN PERCEPT PSYCHO, V75, P1347, DOI 10.3758/s13414-013-0533-y; Levin DT, 1996, J EXP PSYCHOL LEARN, V22, P1364, DOI 10.1037/0278-7393.22.6.1364; Levin DT, 2000, J EXP PSYCHOL GEN, V129, P559, DOI 10.1037//0096-3445.129.4.559; Mantonakis A, 2009, PSYCHOL SCI, V20, P1309, DOI 10.1111/j.1467-9280.2009.02453.x; Matthews WJ, 2009, JUDGM DECIS MAK, V4, P64; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Miller JM, 1998, PUBLIC OPIN QUART, V62, P291, DOI 10.1086/297848; Mussweiler T, 2004, J PERS SOC PSYCHOL, V87, P832, DOI 10.1037/0022-3514.87.6.832; Mussweiler T, 2003, PSYCHOL REV, V110, P472, DOI 10.1037/0033-295X.110.3.472; OToole AJ, 1996, PERCEPTION, V25, P669, DOI 10.1068/p250669; Page L, 2010, J ECON BEHAV ORGAN, V73, P186, DOI 10.1016/j.jebo.2009.08.012; Quinn PC, 2008, J NEUROPSYCHOL, V2, P15, DOI 10.1348/174866407X231029; Reber R, 1998, PSYCHOL SCI, V9, P45, DOI 10.1111/1467-9280.00008; Rhodes G, 2009, PERCEPTION, V38, P232, DOI 10.1068/p6110; Stroessner SJ, 1996, SOC COGNITION, V14, P247, DOI 10.1521/soco.1996.14.3.247; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Walker PM, 2003, PERCEPTION, V32, P1117, DOI 10.1068/p5098; Wright DB, 2003, APPL COGNITIVE PSYCH, V17, P365, DOI 10.1002/acp.898; Wright DB, 2003, ACTA PSYCHOL, V114, P101, DOI 10.1016/S0001-6918(03)00052-0; ZARATE MA, 1990, SOC COGNITION, V8, P161, DOI 10.1521/soco.1990.8.2.161; ZARATE MA, 1995, SOC COGNITION, V13, P145, DOI 10.1521/soco.1995.13.2.145	39	17	17	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e82226	10.1371/journal.pone.0082226	http://dx.doi.org/10.1371/journal.pone.0082226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	265IN	24349226	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000327944500127
J	Li, M; Yang, YJ; Yang, Y; Yin, J; Zhang, J; Feng, YX; Shao, B				Li, Ming; Yang, Yunjia; Yang, Yi; Yin, Jie; Zhang, Jing; Feng, Yixing; Shao, Bing			Biotransformation of Bisphenol AF to Its Major Glucuronide Metabolite Reduces Estrogenic Activity	PLOS ONE			English	Article							LIVER S9 FRACTION; CELL-LINE MCF-7; BREAST-CANCER; RAT-LIVER; UDP-GLUCURONOSYLTRANSFERASES; RECEPTOR-ALPHA; IN-VITRO; BETA; PROLIFERATION; EXTRAPOLATION	Bisphenol AF (BPAF), an endocrine disrupting chemical, can induce estrogenic activity through binding to estrogen receptor (ER). However, the metabolism of BPAF in vivo and the estrogenic activity of its metabolites remain unknown. In the present study, we identified four metabolites including BPAF diglucuronide, BPAF glucuronide (BPAF-G), BPAF glucuronide dehydrated and BPAF sulfate in the urine of Sprague-Dawley (SD) rats. BPAF-G was further characterized by nuclear magnetic resonance (NMR). After treatment with a single dose of BPAF, BPAF was metabolized rapidly to BPAF-G, as detected in the plasma of SD rats. Biotransformation of BPAF to BPAF-G was confirmed with human liver microsomes (HLM), and V-max of glucuronidation for HLM was 11.6 nmol/min/mg. We also found that BPAF glucuronidation could be mediated through several human recombinant UDP-glucuronosyltransferases (UGTs) including UGT1A1, UGT1A3, UGT1A8, UGT1A9, UGT2B4, UGT2B7, UGT2B15 and UGT2B17, among which UGT2B7 showed the highest efficiency of glucuronidation. To explain the biological function of BPAF biotransformation, the estrogenic activities of BPAF and BPAF-G were evaluated in ER-positive breast cancer T47D and MCF7 cells. BPAF significantly stimulates ER-regulated gene expression and cell proliferation at the dose of 100 nM and 1 mu M in breast cancer cells. However, BPAF-G did not show any induction of estrogenic activity at the same dosages, implying that formation of BPAF-G is a potential host defense mechanism against BPAF. Based on our study, biotransformation of BPAF to BPAF-G can eliminate BPAF-induced estrogenic activity, which is therefore considered as reducing the potential threat to human beings.	[Li, Ming; Yang, Yunjia; Yang, Yi; Yin, Jie; Zhang, Jing; Feng, Yixing; Shao, Bing] Beijing Ctr Dis Control & Prevent, Beijing Key Lab Diagnost & Traceabil Technol Food, Beijing, Peoples R China; [Yang, Yunjia; Shao, Bing] Capital Med Univ, Sch Publ Hlth & Family Med, Beijing, Peoples R China	Capital Medical University	Shao, B (corresponding author), Beijing Ctr Dis Control & Prevent, Beijing Key Lab Diagnost & Traceabil Technol Food, Beijing, Peoples R China.	shaobingch@sina.com	shao, bing/L-8793-2019; Yang, Yunjia/AFS-0275-2022	Yang, Yunjia/0000-0002-0538-6235; Yang, Yi/0000-0003-1160-3627	National Natural Science Foundation of China [41273132, 21207008]; Beijing Municipal Senior Technical Training Plan for the Health System	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Senior Technical Training Plan for the Health System	This work was supported by National Natural Science Foundation of China (grant number 41273132 and 21207008, http://www.nsfc.gov.cn/Portal0/default166.htm) and the Beijing Municipal Senior Technical Training Plan for the Health System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Arewang CJ, 2007, CARBOHYD RES, V342, P970, DOI 10.1016/j.carres.2007.01.014; Ben-Jonathan N, 1998, TRENDS ENDOCRIN MET, V9, P124, DOI 10.1016/S1043-2760(98)00029-0; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Dairkee SH, 2008, CANCER RES, V68, P2076, DOI 10.1158/0008-5472.CAN-07-6526; Davis DL, 2007, ENVIRON HEALTH PERSP, V115, P941, DOI 10.1289/ehp.9540; Deschenes J, 2007, J BIOL CHEM, V282, P17335, DOI 10.1074/jbc.C700030200; Diel P, 2002, J STEROID BIOCHEM, V80, P61, DOI 10.1016/S0960-0760(01)00173-X; Doerge DR, 2011, TOXICOL APPL PHARM, V255, P261, DOI 10.1016/j.taap.2011.07.009; Doerge DR, 2010, TOXICOL APPL PHARM, V248, P1, DOI 10.1016/j.taap.2010.07.009; Elsby R, 2001, J PHARMACOL EXP THER, V297, P103; Feng YX, 2012, TOXICOL LETT, V211, P201, DOI 10.1016/j.toxlet.2012.03.802; Fisher JW, 2011, TOXICOL APPL PHARM, V257, P122, DOI 10.1016/j.taap.2011.08.026; Hayasaka T, 2011, TETRAHEDRON, V67, P2215, DOI 10.1016/j.tet.2011.01.087; Kang JH, 2006, TOXICOLOGY, V217, P81, DOI 10.1016/j.tox.2005.10.001; Keri RA, 2007, REPROD TOXICOL, V24, P240, DOI 10.1016/j.reprotox.2007.06.008; King CD, 1999, ARCH BIOCHEM BIOPHYS, V365, P156, DOI 10.1006/abbi.1999.1155; Kitamura S, 2005, TOXICOL SCI, V84, P249, DOI 10.1093/toxsci/kfi074; LaFleur AD, 2011, ANAL CHIM ACTA, V696, P6, DOI 10.1016/j.aca.2011.03.054; Lee S, 2013, NEUROTOX RES, V23, P249, DOI 10.1007/s12640-012-9353-4; Li Y, 2013, ENVIRON HEALTH PERSP, V121, P459, DOI 10.1289/ehp.1205951; Li Y, 2012, ENVIRON HEALTH PERSP, V120, P1029, DOI 10.1289/ehp.1104689; Lozada KW, 2011, BIOL REPROD, V85, P490, DOI 10.1095/biolreprod.110.090431; Matsushima A, 2010, ENVIRON HEALTH PERSP, V118, P1267, DOI 10.1289/ehp.0901819; Mercado-Feliciano M, 2008, ENVIRON HEALTH PERSP, V116, P1315, DOI 10.1289/ehp.11343; Nadal A, 2009, MOL CELL ENDOCRINOL, V304, P63, DOI 10.1016/j.mce.2009.02.016; Niwa T, 2001, BIOL PHARM BULL, V24, P1064, DOI 10.1248/bpb.24.1064; Ohno S, 2009, DRUG METAB DISPOS, V37, P32, DOI 10.1124/dmd.108.023598; Olsen CM, 2003, PHARMACOL TOXICOL, V92, P180, DOI 10.1034/j.1600-0773.2003.920408.x; Pottenger LH, 2000, TOXICOL SCI, V54, P3, DOI 10.1093/toxsci/54.1.3; Ritter JK, 2000, CHEM-BIOL INTERACT, V129, P171, DOI 10.1016/S0009-2797(00)00198-8; Safe SH, 1997, NEW ENGL J MED, V337, P1303, DOI 10.1056/NEJM199710303371809; Schmidt J, 2013, TOXICOL IN VITRO, V27, P1267, DOI 10.1016/j.tiv.2013.02.016; Sneitz N, 2011, J STEROID BIOCHEM, V127, P282, DOI 10.1016/j.jsbmb.2011.08.008; Song SJ, 2012, ENVIRON SCI TECHNOL, V46, P13136, DOI 10.1021/es303960k; Soto AM, 2008, BASIC CLIN PHARMACOL, V102, P125, DOI 10.1111/j.1742-7843.2007.00165.x; Sui YP, 2012, ENVIRON HEALTH PERSP, V120, P399, DOI 10.1289/ehp.1104426; Tang L, 2010, MOL PHARMACEUT, V7, P664, DOI 10.1021/mp900223c; Upmeier A, 2000, ARCH TOXICOL, V74, P431, DOI 10.1007/s002040000144; Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021; Yokota H, 1999, BIOCHEM J, V340, P405, DOI 10.1042/0264-6021:3400405; Yoshihara S, 2004, TOXICOL SCI, V78, P50, DOI 10.1093/toxsci/kfh047; Yoshihara S, 2001, TOXICOL SCI, V62, P221, DOI 10.1093/toxsci/62.2.221	43	31	31	10	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83170	10.1371/journal.pone.0083170	http://dx.doi.org/10.1371/journal.pone.0083170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349450	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200064
J	Zhou, Y; Bian, XQ; Fang, L; He, WC; Dai, CS; Yang, JW				Zhou, Yang; Bian, Xueqin; Fang, Li; He, Weichun; Dai, Chunsun; Yang, Junwei			Aristolochic Acid Causes Albuminuria by Promoting Mitochondrial DNA Damage and Dysfunction in Podocyte	PLOS ONE			English	Article							CHINESE HERBS; INTERSTITIAL FIBROSIS; UROTHELIAL CANCER; RENAL FIBROSIS; NEPHROPATHY; NEPHROTOXICITY; ETIOLOGY; RATS	Aristolochic acid nephropathy, initially found in patients intaking of slimming herbs containing aristolochic acid (AA), was previously considered as a progressive renal interstitial fibrosis and urothelial malignancy. However, the presence of albuminuria in some patients with AAN suggests that AA may also damage the glomerular filtration barrier. In this study, mice AAN model was generated by daily administration of aristolochic acid I sodium salt intraperitoneally at a dose of 6 mg/kg body weight for 3 days. All of the mice developed heavy albuminuria at day 3 and 7 after receiving AA. In the mice received AA, morphologic change of glomeruli was minor under light microscopy but podocyte foot-process effacement was evident under electron microscopy. In mitochondria isolated from kidney, prominent mitochondrial DNA (mtDNA) damage was accompanied with marked decrease of mtDNA copy number and mitochondrial protein expression level. Similar to those in vivo results, AA treatment impaired the filtration barrier function of cultured podocytes. AA promoted mtDNA damage, decreased mtDNA copy number and mitochondrial protein expression in cultured podocytes. In addition, AA treatment also decreased ATP content, oxygen consumption rate and mitochondrial membrane potential as well as increased cellular reactive oxygen species in cultured podocytes. This study highlighted that AA could induce podocyte damage and albuminuria, which may be mediated by promoting mtDNA damage and mitochondrial dysfunction in podocytes.	[Zhou, Yang; Bian, Xueqin; Fang, Li; He, Weichun; Dai, Chunsun; Yang, Junwei] Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Yang, JW (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Ctr Kidney Dis, Nanjing, Jiangsu, Peoples R China.	jwyang@njmu.edu.cn			Ministry of Science and Technology, China [2011CB504005]; Outstanding Medical Academic Leader Program of Jiangsu Province; Foundation from Department of science and technology of Jiangsu Province	Ministry of Science and Technology, China(Ministry of Science and Technology, China); Outstanding Medical Academic Leader Program of Jiangsu Province; Foundation from Department of science and technology of Jiangsu Province	This work was supported by "973" Science Program of the Ministry of Science and Technology, China (2011CB504005), Outstanding Medical Academic Leader Program of Jiangsu Province and Foundation from Department of science and technology of Jiangsu Province to J.W. Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt VM, 2002, MUTAGENESIS, V17, P265, DOI 10.1093/mutage/17.4.265; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Bu X, 2011, AM J PHYSIOL-RENAL, V301, pF784, DOI 10.1152/ajprenal.00210.2011; COSYNS JP, 1994, LANCET, V344, P188, DOI 10.1016/S0140-6736(94)92786-3; Debelle FD, 2004, KIDNEY INT, V66, P1815, DOI 10.1111/j.1523-1755.2004.00905.x; Debelle FD, 2002, J AM SOC NEPHROL, V13, P431, DOI 10.1681/ASN.V132431; Debelle FD, 2008, KIDNEY INT, V74, P158, DOI 10.1038/ki.2008.129; DEPIERREUX M, 1994, AM J KIDNEY DIS, V24, P172, DOI 10.1016/S0272-6386(12)80178-8; Gold LS, 2003, NEW ENGL J MED, V349, P1576, DOI 10.1056/NEJM200310163491619; Grollman AP, 2007, P NATL ACAD SCI USA, V104, P12129, DOI 10.1073/pnas.0701248104; Hashimoto K, 1999, J ETHNOPHARMACOL, V64, P185, DOI 10.1016/S0378-8741(98)00123-8; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Malik AN, 2013, MITOCHONDRION, V13, P481, DOI 10.1016/j.mito.2012.10.011; MENGS U, 1993, ARCH TOXICOL, V67, P307, DOI 10.1007/BF01973700; Natoli TA, 2002, J AM SOC NEPHROL, V13, P2058, DOI 10.1097/01.ASN.0000022420.48110.4B; Nortier JL, 2000, NEW ENGL J MED, V342, P1686, DOI 10.1056/NEJM200006083422301; Okada H, 2003, NEPHROL DIAL TRANSPL, V18, P2515, DOI 10.1093/ndt/gfg440; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Sato N, 2004, J PHARM PHARMACOL, V56, P221, DOI 10.1211/0022357023051; Schumacher VA, 2011, J AM SOC NEPHROL, V22, P1286, DOI 10.1681/ASN.2010080860; Stefanovic V, 2006, AM J NEPHROL, V26, P1, DOI 10.1159/000090705; Stiborova M, 2005, INT J CANCER, V113, P189, DOI 10.1002/ijc.20564; Stiborova M, 2001, CHEM RES TOXICOL, V14, P1128, DOI 10.1021/tx010059z; Tryggvason K, 2001, CURR OPIN NEPHROL HY, V10, P543, DOI 10.1097/00041552-200107000-00009; VANHAELEN M, 1994, LANCET, V343, P174, DOI 10.1016/S0140-6736(94)90964-4; Vanherweghem JL, 1997, LANCET, V349, P1399, DOI 10.1016/S0140-6736(05)63243-6; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	28	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83408	10.1371/journal.pone.0083408	http://dx.doi.org/10.1371/journal.pone.0083408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349506	gold, Green Published, Green Submitted			2022-12-27	WOS:000328734200085
J	He, MM; Wu, WJ; Wang, F; Wang, ZQ; Zhang, DS; Luo, HY; Qiu, MZ; Wang, FH; Ren, C; Zeng, ZL; Xu, RH				He, Ming-ming; Wu, Wen-jing; Wang, Feng; Wang, Zhi-qiang; Zhang, Dong-sheng; Luo, Hui-yan; Qiu, Miao-zhen; Wang, Feng-hua; Ren, Chao; Zeng, Zhao-lei; Xu, Rui-hua			S-1-Based Chemotherapy versus Capecitabine-Based Chemotherapy as First-Line Treatment for Advanced Gastric Carcinoma: A Meta-Analysis	PLOS ONE			English	Article							PHASE-II TRIAL; S-1 PLUS CISPLATIN; COMBINATION CHEMOTHERAPY; ELDERLY-PATIENTS; ORAL FLUOROPYRIMIDINES; CANCER; OXALIPLATIN; THERAPY; EFFICACY; FLUOROURACIL	Background: Although both oral fluoropyrimidines were reported effective and safe, doubts exist about whether S-1 or capecitabine is more advantageous in advanced gastric carcinoma (AGC). Herein, we performed a meta-analysis to comprehensively compare the efficacy and safety of S-1-based chemotherapy versus capecitabine-based chemotherapy as first-line treatment for AGC. Methods: PubMed/Medline, EmBase, Cochrane library, and China National Knowledge Infrastructure databases were searched for articles comparing S-1-based chemotherapy to capecitabine-based chemotherapy for AGC. Primary outcomes were overall response rate (ORR), time to progression (TTP), overall survival (OS), progression-free probability, and survival probability. Secondary outcomes were toxicities. Fixed-effects model were used and all the results were confirmed by random-effects model. Results: Five randomized controlled trials and five cohort studies with 821 patients were included. We found equivalent ORR (38.3% vs. 39.1%, odds ratio [OR] 0.92, 95% confidence interval [CI] 0.69-1.24, P = 0.59), TTP (harzad ratio [HR] 0.98, 95% CI 0.82-1.16, P = 0.79), OS (HR 0.99, 95% CI 0.87-1.13, P = 0.91), progression-free probability (3-month OR 1.02, 95% CI 0.62-1.68, P = 0.94; 6-month OR 1.34, 95% CI 0.88-2.04, P = 0.18) and survival probability (0.5-year OR 0.90, 95% CI 0.61-1.31, P = 0.57; 1-year OR 0.97, 95% CI 0.70-1.33, P = 0.84; 2-year OR 1.15, 95% CI 0.61-2.17, P = 0.66). Equivalent grade 3 to 4 hematological and non-hematological toxicities were found except hand-foot syndrome was less prominent in S-1-based chemotherapy (0.3% vs. 5.9%, OR 0.19, 95% CI 0.06-0.56, P = 0.003). There're no significant heterogeneity and publication bias. Cumulative analysis found stable time-dependent trend. Consistent results stratified by study design, age, regimen, cycle, country were observed. Conclusion: S-1-based chemotherapy was associated with non-inferior antitumor efficacy and better safety profile, compared with capecitabine-based therapy. We recommended S-1 and capecitabine can be used interchangeably for AGC, at least in Asia.	[Xu, Rui-hua] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China; Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Xu, RH (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China.	xurh@sysucc.org.cn	xu, rui/GRX-5734-2022; Xu, Rui-Hua/AAW-4766-2021; 骆, 卉妍/GWR-3383-2022	Xu, Rui-Hua/0000-0001-9771-8534; 骆, 卉妍/0000-0001-6312-9299	National High Technology Research and Development Program of China (863 Program), China [2012AA02A506]; Science and Technology Department of Guangdong Province, China [2012B031800088]; Medical Scientific Research Foundation of Guangdong Province, China [C2011019]	National High Technology Research and Development Program of China (863 Program), China(National High Technology Research and Development Program of China); Science and Technology Department of Guangdong Province, China; Medical Scientific Research Foundation of Guangdong Province, China	This study was supported by National High Technology Research and Development Program of China (863 Program), China (No. 2012AA02A506), the Science and Technology Department of Guangdong Province, China (No. 2012B031800088), and Medical Scientific Research Foundation of Guangdong Province, China (No. C2011019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 2010, J CLIN ONCOL, V28, P1547, DOI 10.1200/JCO.2009.25.4706; [巴楠 Ba Nan], 2012, [中国全科医学, Chinese General Practice], V15, P672; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bittoni A, 2010, EUR REV MED PHARMACO, V14, P309; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Boku N, 2008, INT J CLIN ONCOL, V13, P483, DOI 10.1007/s10147-008-0847-2; Cascinu S, 2008, LANCET ONCOL, V9, P188, DOI 10.1016/S1470-2045(08)70042-1; Cassidy J, 2011, ANN ONCOL, V22, P2604, DOI 10.1093/annonc/mdr031; Cassidy J, 2002, ANN ONCOL, V13, P566, DOI 10.1093/annonc/mdf089; Cervantes A, 2013, CANCER TREAT REV, V39, P60, DOI 10.1016/j.ctrv.2012.09.007; Chen XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060320; Chirila C, 2012, INT J COLORECTAL DIS, V27, P623, DOI 10.1007/s00384-011-1349-7; Choi KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050041; CHUGAI BYL, 2009, J CLIN ONCOL S15, V27, P4535; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; GAO W, 2012, PRACT GERIATR, V26, P501; Huang JH, 2011, MED ONCOL, V28, P1004, DOI 10.1007/s12032-010-9594-0; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jeung HC, 2007, ONCOLOGIST, V12, P543, DOI 10.1634/theoncologist.12-5-543; Jin M, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.4533; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kim GM, 2012, EUR J CANCER, V48, P518, DOI 10.1016/j.ejca.2011.12.017; Kim YT, 2011, MAR GEORESOUR GEOTEC, V29, P1, DOI 10.1080/1064119X.2010.514237; Kobayakawa M, 2011, ONCOTARGETS THER, V4, P193, DOI 10.2147/OTT.S19059; Koizumi W, 2010, ANN ONCOL, V21, P1001, DOI 10.1093/annonc/mdp464; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-2045(08)70035-4; Kunisaki C, 2013, ANTICANCER RES, V33, P697; Kunisaki C, 2011, CANCER CHEMOTH PHARM, V67, P1363, DOI 10.1007/s00280-010-1433-7; Lee JL, 2008, BRIT J CANCER, V99, P584, DOI 10.1038/sj.bjc.6604536; Liao MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068453; Lim DH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-583; Lordick F, 2011, MEMO-MAG EUR MED ONC, V4, P71, DOI 10.1007/s12254-011-0267-2; LU HF, 2012, MED HERALD, V9, P61; Lu M, 2011, CHINESE J CANCER RES, V23, P288, DOI 10.1007/s11670-011-0288-8; Luo HY, 2011, AM J CLIN ONCOL-CANC, V34, P555, DOI 10.1097/COC.0b013e3181f47ac1; Mochiki E, 2012, BRIT J CANCER, V107, P31, DOI 10.1038/bjc.2012.222; Oh SY, 2012, INVEST NEW DRUG, V30, P350, DOI 10.1007/s10637-010-9507-2; Ohtsu A, 2003, J CLIN ONCOL, V21, P54, DOI 10.1200/JCO.2003.04.130; Okines AFC, 2009, ANN ONCOL, V20, P1529, DOI 10.1093/annonc/mdp047; Park YH, 2006, BRIT J CANCER, V94, P959, DOI 10.1038/sj.bjc.6603046; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Pieters A, 2008, ACTA GASTRO-ENT BELG, V71, P361; Ryu MH, 2009, EXPERT REV ANTICANC, V9, P1745, DOI [10.1586/era.09.149, 10.1586/ERA.09.149]; Sawada N, 2007, ONCOL REP, V18, P775; Seol YM, 2009, JPN J CLIN ONCOL, V39, P43, DOI 10.1093/jjco/hyn119; Shitara K, 2013, INT J CLIN ONCOL, V18, P539, DOI 10.1007/s10147-012-0416-6; Stuck AE, 1998, BRIT MED J, V316, P469, DOI 10.1136/bmj.316.7129.469; Takashima Atsuo, 2009, Gastrointest Cancer Res, V3, P239; Takiuchi H, 2005, JPN J CLIN ONCOL, V35, P520, DOI 10.1093/jjco/hyi148; Thuss-Patience PC, 2011, BRIT J CANCER, V105, P505, DOI 10.1038/bjc.2011.278; Tsai James Y, 2003, Curr Oncol Rep, V5, P210, DOI 10.1007/s11912-003-0112-9; Tsuburaya A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-307; Van Cutsem E, 2008, EUR J CANCER, V44, P182, DOI 10.1016/j.ejca.2007.11.001; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Wagner AD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004064.pub3; Wells G, 2006, NEWCASTLE OTTAWA SCA; Wu HL, 2011, ASIAN PAC J CANCER P, V12, P3341; Wu YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066252; Xiang XJ, 2012, CHEMOTHERAPY, V58, P1, DOI 10.1159/000335585; XIONG HL, 2013, J MOD ONCOL, V21, P581; Yun J, 2010, EUR J CANCER, V46, P885, DOI 10.1016/j.ejca.2009.12.015; 闫树宁, 2012, [中国老年学杂志, Chinese Journal of Gerontology], V32, P2382	62	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82798	10.1371/journal.pone.0082798	http://dx.doi.org/10.1371/journal.pone.0082798			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349363	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800079
J	Iurilli, G; Olcese, U; Medini, P				Iurilli, Giuliano; Olcese, Umberto; Medini, Paolo			Preserved Excitatory-Inhibitory Balance of Cortical Synaptic Inputs following Deprived Eye Stimulation after a Saturating Period of Monocular Deprivation in Rats	PLOS ONE			English	Article							OCULAR DOMINANCE PLASTICITY; PRIMARY VISUAL-CORTEX; EXPERIENCE-DEPENDENT PLASTICITY; WHISKER MAP PLASTICITY; RECEPTIVE-FIELDS; BARREL CORTEX; FEEDFORWARD INHIBITION; IN-VIVO; INTRACORTICAL INHIBITION; DIRECTION SELECTIVITY	Monocular deprivation (MD) during development leads to a dramatic loss of responsiveness through the deprived eye in primary visual cortical neurons, and to degraded spatial vision (amblyopia) in all species tested so far, including rodents. Such loss of responsiveness is accompanied since the beginning by a decreased excitatory drive from the thalamo-cortical inputs. However, in the thalamorecipient layer 4, inhibitory interneurons are initially unaffected by MD and their synapses onto pyramidal cells potentiate. It remains controversial whether ocular dominance plasticity similarly or differentially affects the excitatory and inhibitory synaptic conductances driven by visual stimulation of the deprived eye and impinging onto visual cortical pyramids, after a saturating period of MD. To address this issue, we isolated visually-driven excitatory and inhibitory conductances by in vivo whole-cell recordings from layer 4 regular-spiking neurons in the primary visual cortex (V1) of juvenile rats. We found that a saturating period of MD comparably reduced visually-driven excitatory and inhibitory conductances driven by visual stimulation of the deprived eye. Also, the excitatory and inhibitory conductances underlying the synaptic responses driven by the ipsilateral, left open eye were similarly potentiated compared to controls. Multiunit recordings in layer 4 followed by spike sorting indicated that the suprathreshold loss of responsiveness and the MD-driven ocular preference shifts were similar for narrow spiking, putative inhibitory neurons and broad spiking, putative excitatory neurons. Thus, by the time the plastic response has reached a plateau, inhibitory circuits adjust to preserve the normal balance between excitation and inhibition in the cortical network of the main thalamorecipient layer.	[Iurilli, Giuliano; Olcese, Umberto; Medini, Paolo] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy	Istituto Italiano di Tecnologia - IIT	Medini, P (corresponding author), Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy.	paolo.medini@molbiol.umu.se	Medini, Paolo/R-7504-2018; Medini, Paolo/GWC-1936-2022	Olcese, Umberto/0000-0001-6968-2503; Iurilli, Giuliano/0000-0001-9037-2489	San Paolo Neuroscience program, Italy	San Paolo Neuroscience program, Italy	Grant Support was obtained through San Paolo Neuroscience program, Italy to Paolo Medini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; ALREJA M, 1994, BRAIN RES, V639, P320, DOI 10.1016/0006-8993(94)91746-9; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; ANDRADE R, 1991, EUR J PHARMACOL, V199, P259, DOI 10.1016/0014-2999(91)90467-5; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Bruno RM, 2002, J NEUROSCI, V22, P10966; BURCHFIEL JL, 1981, BRAIN RES, V206, P479, DOI 10.1016/0006-8993(81)90551-5; Caleo M, 1999, NEUROSCIENCE, V91, P1017, DOI 10.1016/S0306-4522(98)00682-4; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; DUFFY FH, 1976, NATURE, V260, P256, DOI 10.1038/260256a0; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Foeller E, 2005, J NEUROPHYSIOL, V94, P4387, DOI 10.1152/jn.00553.2005; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Gordon JA, 1996, J NEUROSCI, V16, P3274; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Harauzov A, 2010, J NEUROSCI, V30, P361, DOI 10.1523/JNEUROSCI.2233-09.2010; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; House DRC, 2011, NEURON, V72, P819, DOI 10.1016/j.neuron.2011.09.008; Iurilli G, 2011, CEREB CORTEX; Kameyama K, 2010, J NEUROSCI, V30, P1551, DOI 10.1523/JNEUROSCI.5025-09.2010; Khibnik LA, 2010, NEURON, V66, P493, DOI 10.1016/j.neuron.2010.04.012; Kiorpes L, 1998, J NEUROSCI, V18, P6411; Kiorpes L, 2006, STRABISMUS, V14, P3, DOI 10.1080/09273970500536193; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Ludwig KA, 2009, J NEUROPHYSIOL, V101, P1679, DOI 10.1152/jn.90989.2008; Ma WP, 2013, J NEUROSCI, V33, P11276, DOI 10.1523/JNEUROSCI.5598-12.2013; Maffei A, 2010, J NEUROSCI, V30, P3304, DOI 10.1523/JNEUROSCI.5340-09.2010; Mainardi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004342; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Medini P, 2011, NEUROSCIENCE, V190, P112, DOI 10.1016/j.neuroscience.2011.05.026; Medini P, 2011, J NEUROSCI, V31, P17134, DOI 10.1523/JNEUROSCI.2951-11.2011; Monier C, 2008, J NEUROSCI METH, V169, P323, DOI 10.1016/j.jneumeth.2007.11.008; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; MOWER GD, 1989, DEV BRAIN RES, V45, P211, DOI 10.1016/0165-3806(89)90040-0; Mrsic-Flogel TD, 2007, NEURON, V54, P961, DOI 10.1016/j.neuron.2007.05.028; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Porter JT, 2001, J NEUROSCI, V21, P2699, DOI 10.1523/JNEUROSCI.21-08-02699.2001; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Prusky GT, 2000, EUR J NEUROSCI, V12, P3781, DOI 10.1046/j.1460-9568.2000.00236.x; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Schuett S, 2002, J NEUROSCI, V22, P6549; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SILLITO AM, 1981, NATURE, V291, P318, DOI 10.1038/291318a0; Sun QQ, 2009, J NEUROPHYSIOL, V102, P2955, DOI 10.1152/jn.00562.2009; Sun QQ, 2006, J NEUROSCI, V26, P1219, DOI 10.1523/JNEUROSCI.4727-04.2006; Talbot MJ, 1996, J NEUROPHYSIOL, V76, P2120, DOI 10.1152/jn.1996.76.3.2120; THURLOW GA, 1988, J COMP NEUROL, V274, P595, DOI 10.1002/cne.902740408; Tolias AS, 2007, J NEUROPHYSIOL, V98, P3780, DOI 10.1152/jn.00260.2007; Tsiola A, 2003, J COMP NEUROL, V461, P415, DOI 10.1002/cne.10628; Ueda N, 2000, NEURAL COMPUT, V12, P2109, DOI 10.1162/089976600300015088; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; WIGSTROM H, 1986, J PHYSIOL-PARIS, V81, P228; Wilent WB, 2005, J NEUROSCI, V25, P2983, DOI 10.1523/JNEUROSCI.4906-04.2005; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485	66	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82044	10.1371/journal.pone.0082044	http://dx.doi.org/10.1371/journal.pone.0082044			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349181	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800034
J	Steinbeck, MJ; Chernets, N; Zhang, J; Kurpad, DS; Fridman, G; Fridman, A; Freeman, TA				Steinbeck, Marla J.; Chernets, Natalie; Zhang, Jun; Kurpad, Deepa S.; Fridman, Gregory; Fridman, Alexander; Freeman, Theresa A.			Skeletal Cell Differentiation Is Enhanced by Atmospheric Dielectric Barrier Discharge Plasma Treatment	PLOS ONE			English	Article							KINASE 1 ASK1; SIGNAL-REGULATING KINASE-1; MESENCHYMAL STEM-CELLS; HYDROGEN-PEROXIDE; NITRIC-OXIDE; CHONDROCYTE DIFFERENTIATION; MITOCHONDRIAL BIOGENESIS; SUPEROXIDE ANION; MAP KINASE; PATHWAY	Enhancing chondrogenic and osteogenic differentiation is of paramount importance in providing effective regenerative therapies and improving the rate of fracture healing. This study investigated the potential of non-thermal atmospheric dielectric barrier discharge plasma (NT-plasma) to enhance chondrocyte and osteoblast proliferation and differentiation. Although the exact mechanism by which NT-plasma interacts with cells is undefined, it is known that during treatment the atmosphere is ionized generating extracellular reactive oxygen and nitrogen species (ROS and RNS) and an electric field. Appropriate NT-plasma conditions were determined using lactate-dehydrogenase release, flow cytometric live/dead assay, flow cytometric cell cycle analysis, and Western blots to evaluate DNA damage and mitochondrial integrity. We observed that specific NT-plasma conditions were required to prevent cell death, and that loss of pre-osteoblastic cell viability was dependent on intracellular ROS and RNS production. To further investigate the involvement of intracellular ROS, fluorescent intracellular dyes Mitosox (superoxide) and dihydrorhodamine (peroxide) were used to assess onset and duration after NT-plasma treatment. Both intracellular superoxide and peroxide were found to increase immediately post NT-plasma treatment. These increases were sustained for one hour but returned to control levels by 24 hr. Using the same treatment conditions, osteogenic differentiation by NT-plasma was assessed and compared to peroxide or osteogenic media containing beta-glycerolphosphate. Although both NT-plasma and peroxide induced differentiation-specific gene expression, neither was as effective as the osteogenic media. However, treatment of cells with NT-plasma after 24 hr in osteogenic or chondrogenic media significantly enhanced differentiation as compared to differentiation media alone. The results of this study show that NT-plasma can selectively initiate and amplify ROS signaling to enhance differentiation, and suggest this technology could be used to enhance bone fusion and improve healing after skeletal injury.	[Steinbeck, Marla J.; Fridman, Gregory] Drexel Univ, Dept Biomed Engn, Philadelphia, PA 19104 USA; [Chernets, Natalie] Drexel Univ, Dept Elect Engn, Philadelphia, PA 19104 USA; [Zhang, Jun] Jilin Univ, Hosp 2, Dept Orthopaed, Changchun, Jilin, Peoples R China; [Zhang, Jun; Kurpad, Deepa S.; Freeman, Theresa A.] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Fridman, Alexander] Drexel Univ, Dept Mech Engn & Mech, Philadelphia, PA 19104 USA	Drexel University; Drexel University; University of Pennsylvania; Jilin University; Jefferson University; Drexel University	Freeman, TA (corresponding author), Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA.	Theresa.freeman@jefferson.edu		Fridman, Gregory/0000-0003-4006-4722; Freeman, Theresa/0000-0002-5959-5884	NIH [1 R01 EB 013011 - 01, 5R03 DE020840-03]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB013011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE020840] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NIH Grants 1 R01 EB 013011 - 01 (Freeman and Fridman) and 5R03 DE020840-03 (Freeman). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2009, IMMUNOPHARM IMMUNOT, V31, P388, DOI 10.1080/08923970802709197; Akterin S, 2006, CELL DEATH DIFFER, V13, P1454, DOI 10.1038/sj.cdd.4401818; Arjunan KP, 2011, J R SOC INTERFACE; Boota A, 1996, AM J PHYSIOL-LUNG C, V271, pL932, DOI 10.1152/ajplung.1996.271.6.L932; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; Castagna R, 2009, TOXICOL IN VITRO, V23, P365, DOI 10.1016/j.tiv.2008.12.016; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Choe Y, 2011, J CELL BIOCHEM, DOI [10.1002/jcb.24017, DOI 10.1002/JCB.24017.[]; Coulombe S, 2006, PURE APPL CHEM, V78, P1147, DOI 10.1351/pac200678061147; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Faigle R, 2004, MOL CELL BIOL, V24, P280, DOI 10.1128/MCB.24.1.280-293.2004; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Fridman A, 2005, J PHYS D APPL PHYS, V38, pR1, DOI 10.1088/0022-3727/38/2/R01; FRIDMAN A, 2004, PLASMA PHYS ENG, P853; Fridman G, 2008, PLASMA PROCESS POLYM, V5, P503, DOI 10.1002/ppap.200700154; Fridman G, 2007, PLASMA PROCESS POLYM, V4, P370, DOI 10.1002/ppap.200600217; Fridman G, 2006, PLASMA CHEM PLASMA P, V26, P425, DOI 10.1007/s11090-006-9024-4; Ge C, 2011, J BONE MINER RES, DOI [10.1002/jbmr.561, DOI 10.1002/JBMR.561.[]; Geiszt M, 2004, J BIOL CHEM, V279, P51715, DOI 10.1074/jbc.R400024200; GLOVER J L, 1982, Lasers in Surgery and Medicine, V2, P101; Gow AJ, 2001, J CELL PHYSIOL, V187, P277, DOI 10.1002/jcp.1085; Hancock JT, 1997, BRIT J BIOMED SCI, V54, P38; Hou YY, 2012, FREE RADICAL BIO MED, V52, P462, DOI 10.1016/j.freeradbiomed.2011.10.453; Hsieh CC, 2006, FASEB J, V20, P259, DOI 10.1096/fj.05-4376com; Ji AR, 2010, EXP MOL MED, V42, P175, DOI 10.3858/emm.2010.42.3.018; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Kamiya N, 2002, J BONE MINER RES, V17, P1832, DOI 10.1359/jbmr.2002.17.10.1832; Kashiwase K, 2005, BIOCHEM BIOPH RES CO, V327, P136, DOI 10.1016/j.bbrc.2004.12.002; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kushibiki T, 2010, J PHOTOCH PHOTOBIO B, V98, P211, DOI 10.1016/j.jphotobiol.2010.01.008; Laroussi M, 2005, PLASMA PROCESS POLYM, V2, P391, DOI 10.1002/ppap.200400078; Leduc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115021; Li J, 2010, CELL PROLIFERAT, V43, P333, DOI 10.1111/j.1365-2184.2010.00682.x; Lin IC, 2008, PLAST RECONSTR SURG, V121, P1554, DOI 10.1097/PRS.0b013e31816c3bd7; Linnane AW, 2007, BIOGERONTOLOGY, V8, P445, DOI 10.1007/s10522-007-9096-4; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Mandal CC, 2011, BIOCHEM J, V433, P393, DOI 10.1042/BJ20100357; Matsuzawa A, 2008, BBA-GEN SUBJECTS, V1780, P1325, DOI 10.1016/j.bbagen.2007.12.011; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Motohashi H, 2010, BLOOD, V115, P677, DOI 10.1182/blood-2009-05-223107; Mungrue IN, 2003, ACTA PHYSIOL SCAND, V179, P123, DOI 10.1046/j.1365-201X.2003.01182.x; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nicco C, 2005, BIOMED PHARMACOTHER, V59, P169, DOI 10.1016/j.biopha.2005.03.009; Parasassi T, 2010, THESCIENTIFICWORLDJO, V10, P1192, DOI 10.1100/tsw.2010.104; Pervaiz S, 2007, INT J BIOCHEM CELL B, V39, P1297, DOI 10.1016/j.biocel.2007.04.007; Tran P, 2012, J BIOL CHEM, V287, P11602, DOI 10.1074/jbc.M112.351601; Rigoulet M, 2011, ANTIOXID REDOX SIGN, V14, P459, DOI 10.1089/ars.2010.3363; Rosser J, 2012, METHODS MOL BIOL, V816, P67, DOI 10.1007/978-1-61779-415-5_6; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Sayama K, 2001, J BIOL CHEM, V276, P999, DOI 10.1074/jbc.M003425200; Shao JS, 2007, ANN NY ACAD SCI, V1117, P40, DOI 10.1196/annals.1402.075; Shekhter AB, 2005, NITRIC OXIDE-BIOL CH, V12, P210, DOI 10.1016/j.niox.2005.03.004; Stanton LA, 2003, DEV BIOL, V263, P165, DOI 10.1016/S0012-1606(03)00321-X; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Steinbeck MJ, 1998, J CELL PHYSIOL, V176, P574, DOI 10.1002/(SICI)1097-4652(199809)176:3<574::AID-JCP14>3.0.CO;2-#; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Suy S, 1998, J BIOL CHEM, V273, P17871, DOI 10.1074/jbc.273.28.17871; Takeda K, 2008, ANNU REV PHARMACOL, V48, P199, DOI 10.1146/annurev.pharmtox.48.113006.094606; Teixeira CC, 2005, BONE, V37, P37, DOI 10.1016/j.bone.2005.03.010; Terkhorn SP, 2007, J CELL PHYSIOL, V210, P257, DOI 10.1002/jcp.20873; Vandamme M, 2010, PLASMA PROCESS POLYM, V7, P264, DOI 10.1002/ppap.200900080; Vargo JJ, 2004, GASTROINTEST ENDOSC, V59, P81, DOI 10.1016/S0016-5107(03)02296-X; Weng CC, 2009, INT J RADIAT BIOL, V85, P362, DOI 10.1080/09553000902781105; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wu AS, 2013, J SURG RES, V179, pE1, DOI 10.1016/j.jss.2012.02.039; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; zur Nieden NI, 2007, J BIOTECHNOL, V129, P421, DOI 10.1016/j.jbiotec.2007.01.006	70	47	47	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82143	10.1371/journal.pone.0082143	http://dx.doi.org/10.1371/journal.pone.0082143			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349203	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800040
J	Wang, LW; Qu, AP; Yuan, JP; Chen, C; Sun, SR; Hu, MB; Liu, J; Li, Y				Wang, Lin-Wei; Qu, Ai-Ping; Yuan, Jing-Ping; Chen, Chuang; Sun, Sheng-Rong; Hu, Ming-Bai; Liu, Juan; Li, Yan			Computer-Based Image Studies on Tumor Nests Mathematical Features of Breast Cancer and Their Clinical Prognostic Value	PLOS ONE			English	Article							SURGICAL-MANAGEMENT; DUCTAL CARCINOMA; UNITED-STATES; GRADE; REVEALS	Background: The expending and invasive features of tumor nests could reflect the malignant biological behaviors of breast invasive ductal carcinoma. Useful information on cancer invasiveness hidden within tumor nests could be extracted and analyzed by computer image processing and big data analysis. Methods: Tissue microarrays from invasive ductal carcinoma (n = 202) were first stained with cytokeratin by immunohistochemical method to clearly demarcate the tumor nests. Then an expert-aided computer analysis system was developed to study the mathematical and geometrical features of the tumor nests. Computer recognition system and imaging analysis software extracted tumor nests information, and mathematical features of tumor nests were calculated. The relationship between tumor nests mathematical parameters and patients' 5-year disease free survival was studied. Results: There were 8 mathematical parameters extracted by expert-aided computer analysis system. Three mathematical parameters (number, circularity and total perimeter) with area under curve >0.5 and 4 mathematical parameters (average area, average perimeter, total area/total perimeter, average (area/perimeter)) with area under curve <0.5 in ROC analysis were combined into integrated parameter 1 and integrated parameter 2, respectively. Multivariate analysis showed that integrated parameter 1 (P = 0.040) was independent prognostic factor of patients' 5-year disease free survival. The hazard risk ratio of integrated parameter 1 was 1.454 (HR 95% CI [1.017-2.078]), higher than that of N stage (HR 1.396, 95% CI [1.125-1.733]) and hormone receptor status (HR 0.575, 95% CI [0.353-0.936]), but lower than that of histological grading (HR 3.370, 95% CI [1.125-5.364]) and T stage (HR 1.610, 95% CI [1.026-2.527]). Conclusions: This study indicated integrated parameter 1 of mathematical features (number, circularity and total perimeter) of tumor nests could be a useful parameter to predict the prognosis of early stage breast invasive ductal carcinoma.	[Wang, Lin-Wei; Yuan, Jing-Ping; Hu, Ming-Bai; Li, Yan] Wuhan Univ, Zhongnan Hosp, Dept Oncol, Hubei Key Lab Tumor Biol Behav, Wuhan 430072, Hubei Province, Peoples R China; [Wang, Lin-Wei; Yuan, Jing-Ping; Hu, Ming-Bai; Li, Yan] Hubei Canc Clin Study Ctr, Wuhan, Hubei Province, Peoples R China; [Qu, Ai-Ping; Liu, Juan] Wuhan Univ, Sch Comp, Wuhan 430072, Hubei Province, Peoples R China; [Chen, Chuang; Sun, Sheng-Rong] Wuhan Univ, Renmin Hosp, Dept Breast & Thyroid Surg, Wuhan 430072, Hubei Province, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Liu, J (corresponding author), Wuhan Univ, Sch Comp, Wuhan 430072, Hubei Province, Peoples R China.	liujuan@whu.edu.cn; liyansd2@163.com			National Natural Science Foundation of China [81230031/H18]; Fundamental Research Funds for the Central Universities [303274007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the Key Project of the National Natural Science Foundation of China (81230031/H18), and the Fundamental Research Funds for the Central Universities (303274007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allred DC, 2008, CLIN CANCER RES, V14, P370, DOI 10.1158/1078-0432.CCR-07-1127; Altunbay D, 2010, IEEE T BIO-MED ENG, V57, P665, DOI 10.1109/TBME.2009.2033804; Basavanhally Ajay, 2013, IEEE Trans Biomed Eng, V60, P2089, DOI 10.1109/TBME.2013.2245129; Beck AH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002564; Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; Chen C, 2011, BIOMATERIALS, V32, P7592, DOI 10.1016/j.biomaterials.2011.06.029; Chen C, 2010, BIOMATERIALS, V31, P8818, DOI 10.1016/j.biomaterials.2010.07.091; Chen C, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/9/095101; Chen C, 2009, BIOMATERIALS, V30, P2912, DOI 10.1016/j.biomaterials.2009.02.010; Cheng WY, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005974; Cuzick J, 2011, J CLIN ONCOL, V29, P4273, DOI 10.1200/JCO.2010.31.2835; Damasco C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014737; Di Cataldo S, 2012, COMPUT BIOL MED, V42, P1012, DOI 10.1016/j.compbiomed.2012.08.004; Dundar MM, 2011, IEEE T BIO-MED ENG, V58, P1977, DOI 10.1109/TBME.2011.2110648; ELSTON CW, 1982, BRIT J CANCER, V45, P655, DOI 10.1038/bjc.1982.106; Fan L, 2009, BREAST CANCER RES TR, V117, P409, DOI 10.1007/s10549-008-0303-z; Ginsburg GS, 2009, TRANSL RES, V154, P277, DOI 10.1016/j.trsl.2009.09.005; Greaves P, 2013, J CLIN ONCOL, V31, P256, DOI 10.1200/JCO.2011.39.9881; Gurcan Metin N, 2009, IEEE Rev Biomed Eng, V2, P147, DOI 10.1109/RBME.2009.2034865; Hou NQ, 2013, BREAST CANCER RES TR, V138, P633, DOI 10.1007/s10549-013-2434-0; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson RH, 2013, JAMA-J AM MED ASSOC, V309, P800, DOI 10.1001/jama.2013.776; Kong J, 2009, PATTERN RECOGN, V42, P1080, DOI 10.1016/j.patcog.2008.10.035; Liu XL, 2011, BIOCHEM BIOPH RES CO, V409, P577, DOI 10.1016/j.bbrc.2011.05.052; McLaughlin SA, 2013, SURG CLIN N AM, V93, P411, DOI 10.1016/j.suc.2012.12.006; Ozdemir E, 2012, IEEE T BIO-MED ENG, V59, P281, DOI 10.1109/TBME.2011.2173934; Park YH, 2011, ANN ONCOL, V22, P1554, DOI 10.1093/annonc/mdq617; Peng CW, 2012, BIOMATERIALS, V33, P5742, DOI 10.1016/j.biomaterials.2012.04.034; Peng CW, 2011, BIOMATERIALS, V32, P2907, DOI 10.1016/j.biomaterials.2010.12.053; Peng CW, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-101; Rizki A, 2004, CANCER CELL, V6, P1, DOI 10.1016/j.ccr.2004.06.019; Roylance R, 1999, CANCER RES, V59, P1433; Sertel O, 2009, J SIGNAL PROCESS SYS, V55, P169, DOI 10.1007/s11265-008-0201-y; Tabesh A, 2007, IEEE T MED IMAGING, V26, P1366, DOI 10.1109/TMI.2007.898536; Tambasco M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-140; Tawfik O, 2007, VIRCHOWS ARCH, V450, P627, DOI 10.1007/s00428-007-0400-0; van de Vijver M., 2012, WHO CLASSIFICATION T; Velcheti V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061427; Wittekind C, 2009, TNM CLASSIFICATION M; Yuan YY, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004330; Zhang BN, 2013, BREAST, V22, P676, DOI 10.1016/j.breast.2013.01.004	41	21	23	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82314	10.1371/journal.pone.0082314	http://dx.doi.org/10.1371/journal.pone.0082314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349253	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800056
J	Xing, QT; Chen, FZ; Song, XG; Chen, DG				Xing QuanTai; Chen FengZhe; Song XiuGuang; Chen DongGe			A Study of Cytological Changes in the Bone Marrow of Patients with Severe Fever with Thrombocytopenia Syndrome	PLOS ONE			English	Article							REAL-TIME PCR	Background: Peripheral blood leucopenia and thrombocytopenia are the main manifestations in severe fever with thrombocytopenia syndrome (SFTS) patients. However, the underlying causes are poorly understood. Therefore, we aimed to investigate cytology of bone marrow samples collected from SFTS patients. Methods: 10 SFTS patients were identified by typical clinical manifestations, detection of peripheral blood leucopenia and thrombocytopenia, and nucleic acid-based detection of the newly identified bunyavirus. SFTS patients, along with 10 participants with acute aplastic anemia and 10 healthy volunteers were enrolled in this study after written informed consent to undergo bone marrow cytological examination. Results: We observed similar bone marrow properties in SFTS patients and healthy volunteers, significantly different from the characteristics observed in acute aplastic anemia patients. Conclusion: Similarities between bone marrow samples collected from SFTS patients and healthy volunteers suggest that peripheral blood leucopenia and thrombocytopenia do not result from bone marrow cell plasticity.	[Xing QuanTai; Chen FengZhe] Shandong Univ, Dept Infect Dis, Qilu Hosp, Jinan 250100, Peoples R China; [Song XiuGuang] Infect Dis Hosp Jinan, Jinan, Peoples R China; [Chen DongGe] Shandong Univ, Dept Blood Lab, Qilu Hosp, Jinan 250100, Peoples R China	Shandong University; Shandong University	Xing, QT (corresponding author), Shandong Univ, Dept Infect Dis, Qilu Hosp, Jinan 250100, Peoples R China.	xqt1230629@sina.com			Scientific development fund of Shan-dong Public Health Bureau [2011HZ 047]; National Natural Science Foundation of China [81102171]	Scientific development fund of Shan-dong Public Health Bureau; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Source of support: Scientific development fund of Shan-dong Public Health Bureau (Grant No. 2011HZ 047), and National Natural Science Foundation of China (Grant No. 81102171). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cui Ning, 2012, Zhonghua Nei Ke Za Zhi, V51, P755; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Gai ZT, 2012, J INFECT DIS, V206, P1095, DOI 10.1093/infdis/jis472; Hygiene Ministry of the P.R.C, 2010, GUID PREV CUR SFTS 2; Kim YK, 2007, J INFECTION, V54, P381, DOI 10.1016/j.jinf.2006.07.006; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095	7	1	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83020	10.1371/journal.pone.0083020	http://dx.doi.org/10.1371/journal.pone.0083020			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349423	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800091
J	Zhao, MR; Huang, CY; Chen, Q; Wu, XL; Qu, JB; Zhang, JX				Zhao, Mengran; Huang, Chenyang; Chen, Qiang; Wu, Xiangli; Qu, Jibin; Zhang, Jinxia			Genetic Variability and Population Structure of the Mushroom Pleurotus eryngii var. tuoliensis	PLOS ONE			English	Article							TRICHOLOMA-MATSUTAKE; SPATIAL-DISTRIBUTION; DIVERSITY; POLYMORPHISM; COMPLEX; MARKERS; RAPD; DC.; INDIVIDUALS; PROTEIN	The genetic diversity of 123 wild strains of Pleurotus eryngii var. tuoliensis, which were collected from nine geographical locations in Yumin, Tuoli, and Qinghe counties in the Xinjiang Autonomous Region of China, was analysed using two molecular marker systems (inter-simple sequence repeat and start codon targeted). At the variety level, the percentage of polymorphic loci and Nei's gene diversity index for P. eryngii var. tuoliensis was 96.32% and 0.238, respectively. At the population level, Nei's gene diversity index ranged from 0.149 to 0.218 with an average of 0.186, and Shannon's information index ranged from 0.213 to 0.339 with an average of 0.284. These results revealed the abundant genetic variability in the wild resources of P. eryngii var. tuoliensis. Nei's gene diversity analysis indicated that the genetic variance was mainly found within individual geographical populations, and the analysis of molecular variance revealed low but significant genetic differentiation among local and regional populations. The limited gene flow (Nm = 1.794) was inferred as a major reason for the extent of genetic differentiation of P. eryngii var. tuoliensis. The results of Mantel tests showed that the genetic distance among geographical populations of P. eryngii var. tuoliensis was positively correlated with the geographical distance and the longitudinal distances (r(Go) = 0.789 and r(Ln) = 0.873, respectively), which indicates that geographical isolation is an important factor for the observed genetic differentiation. Nine geographical populations of P. eryngii var. tuoliensis were divided into three groups according to their geographical origins, which revealed that the genetic diversity was closely related to the geographical distribution of this wild fungus.	[Zhao, Mengran; Huang, Chenyang; Chen, Qiang; Wu, Xiangli; Qu, Jibin; Zhang, Jinxia] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Microbial Resources, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs	Zhang, JX (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Microbial Resources, Beijing 100193, Peoples R China.	zhangjinxia@caas.cn	Huang, Chenyang/A-4189-2013; chen, qiang/HGU-5418-2022	Huang, Chenyang/0000-0002-1956-6229; Zhang, Jinxia/0000-0002-5232-8222	China Agriculture Research System [CARS-24]; Ministry of Agriculture of the People's Republic of China	China Agriculture Research System; Ministry of Agriculture of the People's Republic of China(Ministry of Agriculture & Rural Affairs)	This work was supported by China Agriculture Research System (CARS-24), Ministry of Agriculture of the People's Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas MK, 2010, SCI HORTIC-AMSTERDAM, V124, P254, DOI 10.1016/j.scienta.2009.12.013; BoisselierDubayle MC, 1996, MYCOL RES, V100, P753, DOI 10.1016/S0953-7562(96)80210-3; Cao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073174; Chen ZC, 1991, ARID ZONE RES, V2, P94; Collard BCY, 2009, PLANT MOL BIOL REP, V27, P86, DOI 10.1007/s11105-008-0060-5; Cozzolino S, 2003, MOL ECOL, V12, P2783, DOI 10.1046/j.1365-294X.2003.01958.x; Soldati MC, 2013, BIOCHEM SYST ECOL, V47, P45, DOI 10.1016/j.bse.2012.10.011; De Gioia T, 2005, MYCOL RES, V109, P71, DOI 10.1017/S0953756204001637; Du P, 2011, INT J MED MUSHROOMS, V13, P289, DOI 10.1615/IntJMedMushr.v13.i3.90; Franzen I, 2007, MOL ECOL, V16, P3326, DOI 10.1111/j.1365-294X.2007.03394.x; Gascon C, 2000, P NATL ACAD SCI USA, V97, P13672, DOI 10.1073/pnas.230136397; George S, 2009, AM J BOT, V96, P2022, DOI 10.3732/ajb.0800368; Gorji AM, 2011, AM J POTATO RES, V88, P226, DOI 10.1007/s12230-011-9187-2; Guo DL, 2012, MOL BIOL REP, V39, P5307, DOI 10.1007/s11033-011-1329-6; Guo LQ, 2007, FOOD CHEM, V100, P643, DOI 10.1016/j.foodchem.2005.09.087; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; HAMRICK JL, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P75; Heinzelmann R, 2012, FUNGAL BIOL-UK, V116, P985, DOI 10.1016/j.funbio.2012.07.002; [黄晨阳 Huang Chenyang], 2011, [植物遗传资源学报, Journal of Plant Genetic Resources], V12, P825; Huang N. L., 1996, CULTIVATION 18 SPECI, P17; HUSS MJ, 1993, MYCOL RES, V97, P1119, DOI 10.1016/S0953-7562(09)80513-3; James TY, 1999, EVOLUTION, V53, P1665, DOI [10.1111/j.1558-5646.1999.tb04552.x, 10.2307/2640430]; Kauserud H, 2003, MYCOL RES, V107, P155, DOI 10.1017/S0953756203007214; Kawa G, 2008, MYCOSCIENCE, V49, P75, DOI 10.1007/s10267-007-0392-2; KAY E, 1992, MYCOLOGIA, V84, P173, DOI 10.2307/3760248; Lewinsohn D, 2001, MYCOL RES, V105, P941, DOI 10.1016/S0953-7562(08)61950-4; Lewinsohn D., 2005, INT J MED MUSHROOMS, V7, P429, DOI [10.1615/IntJMedMushr.v7.i3.700., DOI 10.1615/INTJMEDMUSHR.V7.I3.700]; Luo C, 2012, GENET RESOUR CROP EV, V59, P1505, DOI 10.1007/s10722-011-9779-1; Luo C, 2011, BIOCHEM SYST ECOL, V39, P676, DOI 10.1016/j.bse.2011.05.023; Luo C, 2010, BIOCHEM SYST ECOL, V38, P1176, DOI 10.1016/j.bse.2010.11.004; Lv H, 2009, PHYTOMEDICINE, V16, P198, DOI 10.1016/j.phymed.2008.07.004; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Ma DL, 2010, AFR J BIOTECHNOL, V9, P6244; Mao XL, 2001, MACROFUNGI CHINA, P64; Mou C., 1987, ACTA MYCOL SIN, V6, P153; Nevo E, 1998, J EXP ZOOL, V282, P95, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2&lt;95::AID-JEZ12&gt;3.0.CO;2-F; NEVO E, 1988, BIOL J LINN SOC, V35, P229, DOI 10.1111/j.1095-8312.1988.tb00468.x; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Raina SN, 2001, GENOME, V44, P763, DOI 10.1139/gen-44-5-763; Ravash R, 2010, MYCOL PROG, V9, P181, DOI 10.1007/s11557-009-0624-2; Estrada AER, 2010, FUNGAL BIOL-UK, V114, P421, DOI 10.1016/j.funbio.2010.03.003; Rohlf FJ, 2000, NTSYS PC NUMERICAL T; Singh YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049972; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SMITH ML, 1992, NATURE, V356, P428, DOI 10.1038/356428a0; Stewart CN, 1996, J EVOLUTION BIOL, V9, P153, DOI 10.1046/j.1420-9101.1996.9020153.x; Urbanelli S, 2003, HEREDITY, V90, P253, DOI 10.1038/sj.hdy.6800239; Urbanelli S, 2002, BIOL J LINN SOC, V75, P125, DOI 10.1046/j.1095-8312.2002.00009.x; Wang HZ, 2009, GENETICA, V136, P391, DOI 10.1007/s10709-008-9340-0; Wang XG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051667, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0036274, 10.1371/journal.pone.0048069, 10.1371/journal.pone.0032405]; Xiao Y, 2010, WORLD J MICROB BIOT, V26, P527, DOI 10.1007/s11274-009-0202-4; Xiong FQ, 2011, MOL BIOL REP, V38, P3487, DOI 10.1007/s11033-010-0459-6; [熊发前 Xiong Faqian], 2009, [分子植物育种, Molecular Plant Breeding], V7, P635; Xu JP, 2008, MOL ECOL, V17, P1238, DOI 10.1111/j.1365-294X.2007.03665.x; Xu J, 2006, CURR ISSUES MOL BIOL, V8, P75; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157; ZERVAKIS G, 1994, MYCOL RES, V98, P329, DOI 10.1016/S0953-7562(09)80461-9; Zervakis GI, 2001, MICROBIOL-SGM, V147, P3183, DOI 10.1099/00221287-147-11-3183; Zhang JX, 2006, APPL MICROBIOL BIOT, V71, P304, DOI 10.1007/s00253-005-0139-y	60	22	27	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83253	10.1371/journal.pone.0083253	http://dx.doi.org/10.1371/journal.pone.0083253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349475	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800107
J	Fatima, A; Shao, KF; Dittmann, S; Xu, GX; Gupta, MK; Linke, M; Zechner, U; Nguemo, F; Milting, H; Farr, M; Hescheler, J; Saric, T				Fatima, Azra; Shao Kaifeng; Dittmann, Sven; Xu, Guoxing; Gupta, Manoj K.; Linke, Matthias; Zechner, Ulrich; Nguemo, Filomain; Milting, Hendrik; Farr, Martin; Hescheler, Juergen; Saric, Tomo			The Disease-Specific Phenotype in Cardiomyocytes Derived from Induced Pluripotent Stem Cells of Two Long QT Syndrome Type 3 Patients	PLOS ONE			English	Article							BRUGADA-SYNDROME; SCN5A MUTATIONS; VENTRICULAR-TACHYCARDIA; SPLICE VARIANT; IN-VITRO; PREVALENCE; ARRHYTHMIA; EXPRESSION; SPECTRUM; MODEL	Long QT syndromes (LQTS) are heritable diseases characterized by prolongation of the QT interval on an electrocardiogram, which often leads to syncope and sudden cardiac death. Here we report the generation of induced pluripotent stems (iPS) cells from two patients with LQTS type 3 carrying a different point mutation in a sodium channel Na(v)1.5 (p.V240M and p.R535Q) and functional characterization of cardiomyocytes (CM) derived from them. The iPS cells exhibited all characteristic properties of pluripotent stem cells, maintained the disease-specific mutation and readily differentiated to CM. The duration of action potentials at 50% and 90% repolarization was longer in LQTS-3 CM as compared to control CM but this difference did not reach statistical significance due to high variations among cells. Sodium current recordings demonstrated longer time to peak and longer time to 90% of inactivation of the Na+ channel in the LQTS-3 CM. This hints at a defective Na+ channel caused by deficiency in open-state inactivation of the Na+ channel that is characteristic of LQTS-3. These analyses suggest that the effect of channel mutation in the diseased CM is demonstrated in vitro and that the iPS cell-derived CM can serve as a model system for studying the pathophysiology of LQTS-3, toxicity testing and design of novel therapeutics. However, further improvements in the model are still required to reduce cell-to-cell and cell line-to-cell line variability.	[Fatima, Azra; Shao Kaifeng; Xu, Guoxing; Gupta, Manoj K.; Nguemo, Filomain; Hescheler, Juergen; Saric, Tomo] Univ Cologne, Med Ctr, Inst Neurophysiol, D-50931 Cologne, Germany; [Dittmann, Sven; Milting, Hendrik; Farr, Martin] Ruhr Univ Bochum, Univ Hosp, Heart & Diabet Ctr NRW, Bad Oeynhausen, Germany; [Dittmann, Sven; Milting, Hendrik; Farr, Martin] Erich & Hanna Klessmann Inst Cardiovasc Res & Dev, Bad Oeynhausen, Germany; [Linke, Matthias; Zechner, Ulrich] Johannes Gutenberg Univ Mainz, Inst Human Genet, D-55122 Mainz, Germany	University of Cologne; Ruhr University Bochum; Ruhr University Bochum; Johannes Gutenberg University of Mainz	Hescheler, J (corresponding author), Univ Cologne, Med Ctr, Inst Neurophysiol, D-50931 Cologne, Germany.	j.hescheler@uni-koeln.de; tomo.saric@uni-koeln.de	Zechner, Ulrich/G-2116-2010; Saric, Tomo/B-3415-2015; Shao, Kaifeng/T-3547-2018	Saric, Tomo/0000-0001-8344-1095; Shao, Kaifeng/0000-0003-2066-9054; Dittmann, Sven/0000-0001-5829-3676; Nguemo, Filomain/0000-0002-2236-6797	Bundesministerium fur Bildung und Forschung/BMBF [01GN0824]; Koln Fortune Program; Maria-Pesch Stiftung; German Research Foundation/DFG [ZE 442/4-1]	Bundesministerium fur Bildung und Forschung/BMBF(Federal Ministry of Education & Research (BMBF)); Koln Fortune Program; Maria-Pesch Stiftung; German Research Foundation/DFG(German Research Foundation (DFG))	This work was supported by the Bundesministerium fur Bildung und Forschung/BMBF to TS and JH (project No. 01GN0824), Koln Fortune Program (to TS), Maria-Pesch Stiftung (to TS) and German Research Foundation/DFG (to UZ, grant ZE 442/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin AS, 2011, EUROPACE, V13, P968, DOI 10.1093/europace/eur011; Baroudi G, 2000, FEBS LETT, V487, P224, DOI 10.1016/S0014-5793(00)02360-7; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Cheng JD, 2010, CTS-CLIN TRANSL SCI, V3, P287, DOI 10.1111/j.1752-8062.2010.00249.x; Crotti L, 2012, J AM COLL CARDIOL, V60, P1410, DOI 10.1016/j.jacc.2012.04.037; Davis RP, 2012, CIRCULATION, V125, P3079, DOI 10.1161/CIRCULATIONAHA.111.066092; Fatima A, 2011, CELL PHYSIOL BIOCHEM, V28, P579, DOI 10.1159/000335753; Hedley PL, 2009, HUM MUTAT, V30, P1256, DOI 10.1002/humu.21066; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Kapplinger JD, 2010, HEART RHYTHM, V7, P33, DOI 10.1016/j.hrthm.2009.09.069; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Keller DI, 2005, CARDIOVASC RES, V67, P510, DOI 10.1016/j.cardiores.2005.03.024; Knollmann BC, 2013, CIRC RES, V112, P969, DOI 10.1161/CIRCRESAHA.112.300567; Lahti AL, 2012, DIS MODEL MECH, V5, P220, DOI 10.1242/dmm.008409; Makielski JC, 2003, CIRC RES, V93, P821, DOI 10.1161/01.RES.0000096652.14509.96; Malan D, 2011, CIRC RES, V109, P841, DOI 10.1161/CIRCRESAHA.111.243139; Matsa E, 2011, EUR HEART J, V32, P952, DOI 10.1093/eurheartj/ehr073; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; MOSS AJ, 1985, CIRCULATION, V71, P17, DOI 10.1161/01.CIR.71.1.17; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Napolitano C, 2003, CLIN CHEM LAB MED, V41, P439, DOI 10.1515/CCLM.2003.066; NAPOLITANO C, 1994, DRUGS, V47, P51, DOI 10.2165/00003495-199447010-00004; Nuyens D, 2001, NAT MED, V7, P1021, DOI 10.1038/nm0901-1021; Papadatos GA, 2002, P NATL ACAD SCI USA, V99, P6210, DOI 10.1073/pnas.082121299; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Refsgaard L, 2012, EUR J HUM GENET, V20, P905, DOI 10.1038/ejhg.2012.23; Remme CA, 2008, TRENDS CARDIOVAS MED, V18, P78, DOI 10.1016/j.tcm.2008.01.002; Smits JPP, 2002, J AM COLL CARDIOL, V40, P350, DOI 10.1016/S0735-1097(02)01962-9; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Terrenoire C, 2013, J GEN PHYSIOL, V141, P61, DOI 10.1085/jgp.201210899; Tost J, 2003, BIOTECHNIQUES, V35, P152, DOI 10.2144/03351md02; Viswanathan PC, 2003, J CLIN INVEST, V111, P341, DOI 10.1172/JCI200316879; Wehrens XHT, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9136; Ye B, 2003, PHYSIOL GENOMICS, V12, P187, DOI 10.1152/physiolgenomics.00117.2002; Zhang XH, 2013, CELL CALCIUM, V54, P57, DOI 10.1016/j.ceca.2013.04.004; Zimmer T, 2008, PROG BIOPHYS MOL BIO, V98, P120, DOI 10.1016/j.pbiomolbio.2008.10.005	36	66	68	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83005	10.1371/journal.pone.0083005	http://dx.doi.org/10.1371/journal.pone.0083005			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349418	gold, Green Submitted, Green Published			2022-12-27	WOS:000328730300118
J	Benbrook, CM; Butler, G; Latif, MA; Leifert, C; Davis, DR				Benbrook, Charles M.; Butler, Gillian; Latif, Maged A.; Leifert, Carlo; Davis, Donald R.			Organic Production Enhances Milk Nutritional Quality by Shifting Fatty Acid Composition: A United States-Wide, 18-Month Study	PLOS ONE			English	Article							ALPHA-LINOLENIC ACID; CARDIOVASCULAR-DISEASE; DAIRY CONSUMPTION; RISK-FACTORS; RETAIL MILK; CHAIN; N-3; OMEGA-3-FATTY-ACIDS; CONVERSION; DIET	Over the last century, intakes of omega-6 (omega-6) fatty acids in Western diets have dramatically increased, while omega-3 (omega-3) intakes have fallen. Resulting omega-6/omega-3 intake ratios have risen to nutritionally undesirable levels, generally 10 to 15, compared to a possible optimal ratio near 2.3. We report results of the first large-scale, nationwide study of fatty acids in U. S. organic and conventional milk. Averaged over 12 months, organic milk contained 25% less omega-6 fatty acids and 62% more omega-3 fatty acids than conventional milk, yielding a 2.5-fold higher omega-6/omega-3 ratio in conventional compared to organic milk (5.77 vs. 2.28). All individual omega-3 fatty acid concentrations were higher in organic milk-alpha-linolenic acid (by 60%), eicosapentaenoic acid (32%), and docosapentaenoic acid (19%)-as was the concentration of conjugated linoleic acid (18%). We report mostly moderate regional and seasonal variability in milk fatty acid profiles. Hypothetical diets of adult women were modeled to assess milk fatty-acid-driven differences in overall dietary omega-6/omega-3 ratios. Diets varied according to three choices: high instead of moderate dairy consumption; organic vs. conventional dairy products; and reduced vs. typical consumption of omega-6 fatty acids. The three choices together would decrease the omega-6/omega-3 ratio among adult women by similar to 80% of the total decrease needed to reach a target ratio of 2.3, with relative impact "switch to low omega-6 foods''. "switch to organic dairy products" approximate to "increase consumption of conventional dairy products." Based on recommended servings of dairy products and seafoods, dairy products supply far more a-linolenic acid than seafoods, about one-third as much eicosapentaenoic acid, and slightly more docosapentaenoic acid, but negligible docosahexaenoic acid. We conclude that consumers have viable options to reduce average omega-6/omega-3 intake ratios, thereby reducing or eliminating probable risk factors for a wide range of developmental and chronic health problems.	[Benbrook, Charles M.; Davis, Donald R.] Washington State Univ, Ctr Sustaining Agr & Nat Resources, Pullman, WA 99164 USA; [Butler, Gillian; Leifert, Carlo] Newcastle Univ, Sch Agr Food & Rural Dev, Northumberland Ne, England; [Latif, Maged A.] Organ Valley CROPP Cooperat Organ Prairie, Lafarge, WI USA	Washington State University; Newcastle University - UK; Lafarge	Benbrook, CM (corresponding author), Washington State Univ, Ctr Sustaining Agr & Nat Resources, Pullman, WA 99164 USA.	cbenbrook@wsu.edu	Benbrook, Charles/L-6589-2019; Davis, Donald R./B-8531-2009	Davis, Donald R./0000-0001-8343-1268; Leifert, Carlo/0000-0002-2974-3612; Butler, Gillian/0000-0003-0561-2797	Center for Sustaining Agriculture and Natural Resources at Washington State University; CROPP Cooperative, La Farge, Wisconsin; Newcastle University, Northumberland NE, United Kingdom	Center for Sustaining Agriculture and Natural Resources at Washington State University; CROPP Cooperative, La Farge, Wisconsin; Newcastle University, Northumberland NE, United Kingdom	Support for CMB and DRD came from the "Measure to Manage Program - Farm and Food Diagnostics for Sustainability and Health," Center for Sustaining Agriculture and Natural Resources at Washington State University. Support for MAL and milk sample testing came from CROPP Cooperative, La Farge, Wisconsin (http://www.farmers.coop/). Support for CL and GB came from Newcastle University, Northumberland NE, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ailhaud G, 2004, Obes Rev, V5, P21, DOI 10.1111/j.1467-789X.2004.00121.x; Ailhaud G, 2007, GENES NUTR, V2, P39, DOI 10.1007/s12263-007-0017-6; Amminger GP, 2010, ARCH GEN PSYCHIAT, V67, P146, DOI 10.1001/archgenpsychiatry.2009.192; AOAC (Association of Official Analytical Chemists), 1999, OFFICIAL METHODS ANA, V16; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Bonthuis M, 2010, EUR J CLIN NUTR, V64, P569, DOI 10.1038/ejcn.2010.45; Brenna JT, 2002, CURR OPIN CLIN NUTR, V5, P127, DOI 10.1097/00075197-200203000-00002; Brostow DP, 2011, AM J CLIN NUTR, V94, P520, DOI 10.3945/ajcn.110.009357; Burdge GC, 2005, EUR J LIPID SCI TECH, V107, P426, DOI 10.1002/ejlt.200501145; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Butler G, 2011, NJAS-WAGEN J LIFE SC, V58, P97, DOI 10.1016/j.njas.2011.04.002; Butler G, 2011, J DAIRY SCI, V94, P24, DOI 10.3168/jds.2010-3331; Butler G, 2008, J SCI FOOD AGR, V88, P1431, DOI 10.1002/jsfa.3235; Butler LJ, 2002, AM J ALTERNATIVE AGR, V17, P83, DOI 10.1079/AJAA200211/AJA200211; Chardigny JM, 2008, AM J CLIN NUTR, V87, P558, DOI 10.1093/ajcn/87.3.558; Childs CE, 2008, P NUTR SOC, V67, P19, DOI 10.1017/S0029665108005983; Couvreur S, 2006, J DAIRY SCI, V89, P1956, DOI 10.3168/jds.S0022-0302(06)72263-9; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; Djousse L, 2011, AM J CLIN NUTR, V94, P527, DOI 10.3945/ajcn.111.013334; Donahue SMA, 2011, AM J CLIN NUTR, V93, P780, DOI 10.3945/ajcn.110.005801; Elwood PC, 2010, LIPIDS, V45, P925, DOI 10.1007/s11745-010-3412-5; EMKEN EA, 1994, BBA-LIPID LIPID MET, V1213, P277, DOI 10.1016/0005-2760(94)00054-9; Forkman J, 2009, COMMUN STAT-THEOR M, V38, P233, DOI 10.1080/03610920802187448; Gebauer SK, 2006, AM J CLIN NUTR, V83, p1526S, DOI 10.1093/ajcn/83.6.1526S; Gebauer SK, 2011, ADV NUTR, V2, P332, DOI 10.3945/an.111.000521; German JB, 2009, EUR J NUTR, V48, P191, DOI 10.1007/s00394-009-0002-5; Gibson RA, 2011, MATERN CHILD NUTR, V7, P17, DOI 10.1111/j.1740-8709.2011.00299.x; Glasser F, 2007, J DAIRY SCI, V90, P2302, DOI 10.3168/jds.2006-870; Haug A, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-25; Hibbeln JR, 2006, AM J CLIN NUTR, V83, p1483S, DOI 10.1093/ajcn/83.6.1483S; Kris-Etherton PM, 2000, AM J CLIN NUTR, V71, p179S, DOI 10.1093/ajcn/71.1.179S; Krogh LM, 2010, J DAIRY SCI, V73, P2863; Kummeling I, 2008, BRIT J NUTR, V99, P598, DOI 10.1017/S0007114507815844; Lacroix E, 2012, AM J CLIN NUTR, V95, P318, DOI 10.3945/ajcn.111.023408; Larsson SC, 2005, AM J CLIN NUTR, V82, P894, DOI 10.1093/ajcn/82.4.894; Li GM, 2005, J LIPID RES, V46, P2134, DOI 10.1194/jlr.M500064-JLR200; Lock AL, 2004, LIPIDS, V39, P1197, DOI 10.1007/s11745-004-1348-6; Ludwig DS, 2013, JAMA PEDIAT, DOI [10.1001/jamapediatrics.2013.2408, DOI 10.1001/JAMAPEDIATRICS.2013.2408.ACCESSED]; Massiera F, 2010, J LIPID RES, V51, P2352, DOI 10.1194/jlr.M006866; Masters C, 1996, MOL CELL BIOCHEM, V165, P83, DOI 10.1007/BF00229469; Mathews KH, 2009, FDS09D01 USDA EC RES; McBride W. D., 2009, CHARACTERISTICS COST; McCullough BD, 2008, COMPUT STAT DATA AN, V52, P4570, DOI 10.1016/j.csda.2008.03.004; Meyer BJ, 2003, LIPIDS, V38, P391, DOI 10.1007/s11745-003-1074-0; Molkentin J, 2009, J AGR FOOD CHEM, V57, P785, DOI 10.1021/jf8022029; Moon RJ, 2013, J CLIN ENDOCR METAB, V98, P299, DOI 10.1210/jc.2012-2482; Mozaffarian D, 2010, ANN INTERN MED, V153, P790, DOI 10.7326/0003-4819-153-12-201012210-00005; O'Donnell AM, 2010, J DAIRY SCI, V93, P1918, DOI 10.3168/jds.2009-2799; Palupi E, 2012, J SCI FOOD AGR, V92, P2774, DOI 10.1002/jsfa.5639; Pawlosky R, 2003, BRIT J NUTR, V90, P993, DOI 10.1079/BJN2003985; Rice BH, 2013, NUTR REV, V71, P209, DOI 10.1111/nure.12007; Rinehart L., 2011, PASTURE ORGANIC RUMI; Rist L, 2007, BRIT J NUTR, V97, P735, DOI 10.1017/S0007114507433074; Rosell M, 2006, AM J CLIN NUTR, V84, P1481, DOI 10.1093/ajcn/84.6.1481; Russo GL, 2009, BIOCHEM PHARMACOL, V77, P937, DOI 10.1016/j.bcp.2008.10.020; Ruxton CHS, 2005, NUTR RES REV, V18, P113, DOI 10.1079/NRR200497; Ryan AS, 2010, PROSTAG LEUKOTR ESS, V82, P305, DOI 10.1016/j.plefa.2010.02.007; Rymer C., 2003, Nutrition Abstracts and Reviews. Series B, Livestock Feeds and Feeding, V73, p9R; Safarinejad MR, 2010, CLIN NUTR, V29, P100, DOI 10.1016/j.clnu.2009.07.008; Schuchardt JP, 2010, EUR J PEDIATR, V169, P149, DOI 10.1007/s00431-009-1035-8; Simopoulos AP, 2006, BIOMED PHARMACOTHER, V60, P502, DOI 10.1016/j.biopha.2006.07.080; Slots T, 2009, J DAIRY SCI, V92, P2057, DOI 10.3168/jds.2008-1392; Smit LA, 2010, AM J CLIN NUTR, V92, P34, DOI 10.3945/ajcn.2010.29524; Stancliffe RA, 2011, AM J CLIN NUTR, V94, P422, DOI 10.3945/ajcn.111.013342; Stergiadis S, 2012, J AGR FOOD CHEM, V60, P7270, DOI 10.1021/jf301053b; Studer M, 2005, ARCH INTERN MED, V165, P725, DOI 10.1001/archinte.165.7.725; The Role of Conjugated Linoleic Acid in Human Health, 2004, AM J CLIN NUTR, V79, p1131S; U.S. Department of Agriculture, 2012, NAT NUTR DAT STAND R; U.S. Department of Agriculture, 2008, DAIR 2007 2; U.S. Department of Agriculture and U.S. Department of Health and Human Services, 2020, DIET GUID AM 2020 20; Wang L, 2003, AM J CLIN NUTR, V78, P91; Williams CM, 2006, P NUTR SOC, V65, P42, DOI 10.1079/PNS2005473; Wood JT, 2010, J LIPID RES, V51, P1416, DOI 10.1194/jlr.M002436; Woods VB, 2009, LIVEST SCI, V126, P1, DOI 10.1016/j.livsci.2009.07.002; Yamagishi K, 2008, J AM COLL CARDIOL, V52, P988, DOI 10.1016/j.jacc.2008.06.018; Yehuda S, 2011, EUR J CLIN NUTR, V65, P1167, DOI 10.1038/ejcn.2011.80	77	87	90	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82429	10.1371/journal.pone.0082429	http://dx.doi.org/10.1371/journal.pone.0082429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349282	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200080
J	Travers, A; Arkoun, B; Safsaf, A; Milazzo, JP; Absyte, A; Bironneau, A; Perdrix, A; Sibert, L; Mace, B; Cauliez, B; Rives, N				Travers, Albanne; Arkoun, Brahim; Safsaf, Athmane; Milazzo, Jean-Pierre; Absyte, Anne; Bironneau, Amandine; Perdrix, Anne; Sibert, Louis; Mace, Bertrand; Cauliez, Bruno; Rives, Nathalie			Effects of Vitamin A on In Vitro Maturation of Pre-Pubertal Mouse Spermatogonial Stem Cells	PLOS ONE			English	Article							RETINOIC ACID; TESTICULAR TISSUE; FERTILITY PRESERVATION; 3-DIMENSIONAL CULTURE; ORGANOTYPIC CULTURE; MEIOTIC DIFFERENTIATION; ORGAN-CULTURE; GERM-CELLS; SPERMATOGENESIS; RAT	Testicular tissue cryopreservation is the only potential option for fertility preservation in pre-pubertal boys exposed to gonadotoxic treatment. Completion of spermatogenesis after in vitro maturation is one of the future uses of harvested testicular tissue. The purpose of the current study was to evaluate the effects of vitamin A on in vitro maturation of fresh and frozen-thawed mouse pre-pubertal spermatogonial stem cells in an organ culture system. Pre-pubertal CD1 mouse fresh testes were cultured for 7 (D7), 9 (D9) and 11 (D11) days using an organ culture system. Basal medium was supplemented with different concentrations of retinol (Re) or retinoic acid (RA) alone or in combination. Seminiferous tubule morphology (tubule diameter, intra-tubular cell type), intra-tubular cell death and proliferation (PCNA antibody) and testosterone level were assessed at D7, D9 and D11. Pre-pubertal mouse testicular tissue were frozen after a soaking temperature performed at -7 degrees C, -8 degrees C or -9 degrees C and after thawing, were cultured for 9 days, using the culture medium preserving the best fresh tissue functionality. Retinoic acid at 10(-6)M and retinol at 3.3.10(-7)M, as well as retinol 10-6M are favourable for seminiferous tubule growth, maintenance of intra-tubular cell proliferation and germ cell differentiation of fresh pre-pubertal mouse spermatogonia. Structural and functional integrity of frozen-thawed testicular tissue appeared to be well-preserved after soaking temperature at -8 degrees C, after 9 days of organotypic culture using 10(-6)M retinol. RA and Re can control in vitro germ cell proliferation and differentiation. Re at a concentration of 10(-6)M maintains intra-tubular cell proliferation and the ability of spermatogonia to initiate spermatogenesis in fresh and frozen pre-pubertal mouse testicular tissue using a soaking temperature at -8 degrees C. Our data suggested a possible human application for in vitro maturation of cryopreserved pre-pubertal testicular tissue.	[Travers, Albanne; Arkoun, Brahim; Safsaf, Athmane; Milazzo, Jean-Pierre; Absyte, Anne; Bironneau, Amandine; Perdrix, Anne; Mace, Bertrand; Rives, Nathalie] Univ Rouen, Inst Biomed Res, Rouen Univ Hosp, EA Gametogenesis & Gamete Qual 4308,Reprod Biol L, Rouen, France; [Sibert, Louis] Univ Rouen, Inst Biomed Res, Rouen Univ Hosp, EA Gametogenesis & Gamete Qual 4308,Dept Urol, Rouen, France; [Cauliez, Bruno] Univ Rouen, Inst Biomed Res, Rouen Univ Hosp, Biochem Lab, Rouen, France	CHU de Rouen; Universite de Rouen Normandie; CHU de Rouen; Universite de Rouen Normandie; CHU de Rouen; Universite de Rouen Normandie	Rives, N (corresponding author), Univ Rouen, Inst Biomed Res, Rouen Univ Hosp, EA Gametogenesis & Gamete Qual 4308,Reprod Biol L, Rouen, France.	nathalie.rives@chu-rouen.fr			Conseil Regional de Haute-Normandie; Rouen University	Conseil Regional de Haute-Normandie(Region Normandie); Rouen University	Albanne Travers's work was supported by grant from Conseil Regional de Haute-Normandie. Rouen University (www.univ-rouen.fr) has provided funding for reagents and consommables. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bowles J, 2007, DEVELOPMENT, V134, P3401, DOI 10.1242/dev.001107; Chung SSW, 2010, MICROSC RES TECHNIQ, V73, P583, DOI 10.1002/jemt.20797; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Curaba M, 2011, FERTIL STERIL, V95, P1229, DOI 10.1016/j.fertnstert.2010.04.062; Dann CT, 2008, STEM CELLS, V26, P2928, DOI 10.1634/stemcells.2008-0134; Dohle GR, 2010, INT J UROL, V17, P327, DOI 10.1111/j.1442-2042.2010.02484.x; Dong WZ, 2010, ANIM REPROD SCI, V118, P103, DOI 10.1016/j.anireprosci.2009.06.018; Gaemers IC, 1998, ENDOCRINOLOGY, V139, P4269, DOI 10.1210/en.139.10.4269; Gaemers IC, 1996, ENDOCRINOLOGY, V137, P479, DOI 10.1210/en.137.2.479; Ghyselinck NB, 2006, DEV DYNAM, V235, P1608, DOI 10.1002/dvdy.20795; Ginsberg JP, 2010, HUM REPROD, V25, P37, DOI 10.1093/humrep/dep371; Gohbara A, 2010, BIOL REPROD, V83, P261, DOI 10.1095/biolreprod.110.083899; Habeler W, 2009, ORGANOGENESIS, V5, P62, DOI 10.4161/org.5.2.9091; Hogarth CA, 2010, J CLIN INVEST, V120, P956, DOI 10.1172/JCI41303; Hou M, 2007, HUM REPROD, V22, P1899, DOI 10.1093/humrep/dem085; Hue D, 1998, BIOL REPROD, V59, P379, DOI 10.1095/biolreprod59.2.379; Jahnukainen K, 2006, PEDIATR RES, V59, p40R, DOI 10.1203/01.pdr.0000205153.18494.3b; Keros V, 2005, HUM REPROD, V20, P1676, DOI 10.1093/humrep/deh797; Keros V, 2007, HUM REPROD, V22, P1384, DOI 10.1093/humrep/del508; Kvist K, 2006, HUM REPROD, V21, P484, DOI 10.1093/humrep/dei331; Lambrot R, 2006, J CLIN ENDOCR METAB, V91, P2696, DOI 10.1210/jc.2005-2113; Lee JH, 2007, FERTIL STERIL, V87, P824, DOI 10.1016/j.fertnstert.2006.09.015; Lee JH, 2006, BIOMATERIALS, V27, P2845, DOI 10.1016/j.biomaterials.2005.12.028; Livera G, 2000, BIOL REPROD, V62, P1303, DOI 10.1095/biolreprod62.5.1303; Livera G, 2006, CELL TISSUE RES, V324, P507, DOI 10.1007/s00441-006-0167-7; Livera G, 2004, BIOL REPROD, V70, P1814, DOI 10.1095/biolreprod.103.021451; Livera G, 2002, REPRODUCTION, V124, P173, DOI 10.1530/rep.0.1240173; LIVERA G, 2007, ANDROLOGIE, V17, P25, DOI DOI 10.1007/BF03041153; Menon S, 2009, HUM REPROD, V24, P37, DOI 10.1093/humrep/den361; Milazzo JP, 2008, HUM REPROD, V23, P17, DOI 10.1093/humrep/dem355; Milazzo JP, 2010, J ANDROL, V31, P617, DOI 10.2164/jandrol.109.009324; MORALES C, 1987, ENDOCRINOLOGY, V121, P432, DOI 10.1210/endo-121-1-432; Nayernia K, 2006, LAB INVEST, V86, P654, DOI 10.1038/labinvest.3700429; Ogawa T, 2005, INT J HEMATOL, V82, P381, DOI 10.1532/IJH97.05088; Parks JE, 2003, THERIOGENOLOGY, V59, P73, DOI 10.1016/S0093-691X(02)01275-X; Patience C, 1998, CURR OPIN IMMUNOL, V10, P539, DOI 10.1016/S0952-7915(98)80220-3; Rouiller-Fabre V, 2003, ANDROLOGIA, V35, P79, DOI 10.1046/j.1439-0272.2003.00540.x; Roulet V, 2006, HUM REPROD, V21, P1564, DOI 10.1093/humrep/del018; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Schrader M, 2001, REPROD TOXICOL, V15, P611, DOI 10.1016/S0890-6238(01)00182-4; Snyder EM, 2011, BIOL REPROD, V84, P886, DOI 10.1095/biolreprod.110.089755; Soderlund MB, 2005, AM J CLIN NUTR, V81, P633; Staub C, 2001, J ANDROL, V22, P911; Stukenborg JB, 2008, J ANDROL, V29, P312, DOI 10.2164/jandrol.107.002857; Stukenborg JB, 2009, MOL HUM REPROD, V15, P521, DOI 10.1093/molehr/gap052; Tanaka H, 1997, INT J ANDROL, V20, P361; Toda S, 2009, ORGANOGENESIS, V5, P50, DOI 10.4161/org.5.2.8347; Tournaye H, 2004, HUM REPROD UPDATE, V10, P525, DOI 10.1093/humupd/dmh038; Trautmann E, 2008, CELL CYCLE, V7, P656, DOI 10.4161/cc.7.5.5482; Travers A, 2011, THERIOGENOLOGY, V76, P981, DOI 10.1016/j.theriogenology.2011.04.025; Tucci P, 2008, J BIOENERG BIOMEMBR, V40, P111, DOI 10.1007/s10863-008-9132-3; VANPELT AMM, 1991, ENDOCRINOLOGY, V128, P697, DOI 10.1210/endo-128-2-697; VANPELT AMM, 1990, BIOL REPROD, V43, P363, DOI 10.1095/biolreprod43.3.363; Verhoeven G, 2010, PHILOS T R SOC B, V365, P1537, DOI 10.1098/rstb.2009.0117; Vernet N, 2006, ENDOCRINOLOGY, V147, P96, DOI 10.1210/en.2005-0953; Woods EJ, 2004, CRYOBIOLOGY, V48, P146, DOI 10.1016/j.cryobiol.2004.03.002; Wyns C, 2011, HUM REPROD, V26, P737, DOI 10.1093/humrep/deq387; Wyns C, 2010, HUM REPROD UPDATE, V16, P312, DOI 10.1093/humupd/dmp054; Yang RW, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-264; Zhang Lei, 2011, Spermatogenesis, V1, P186; Zhou Q, 2008, BIOL REPROD, V78, P537, DOI 10.1095/biolreprod.107.064337	62	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82819	10.1371/journal.pone.0082819	http://dx.doi.org/10.1371/journal.pone.0082819			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349372	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200105
J	Albanus, RD; Dalmolin, RJS; Castro, MAA; Pasquali, MAD; Ramos, VD; Gelain, DP; Moreira, JCF				Albanus, Ricardo D'Oliveira; Siqueira Dalmolin, Rodrigo Juliani; Alves Castro, Mauro Antonio; de Bittencourt Pasquali, Matheus Augusto; Ramos, Vitor de Miranda; Gelain, Daniel Pens; Fonseca Moreira, Jose Claudio			Reverse Engineering the Neuroblastoma Regulatory Network Uncovers MAX as One of the Master Regulators of Tumor Progression	PLOS ONE			English	Article							OPEN-ACCESS DATABASE; C-MYC; GENE-EXPRESSION; MICROARRAY DATA; MYC/MAX/MAD NETWORK; CELL-PROLIFERATION; PROGNOSIS; TRANSCRIPTION; SURVIVAL; DIFFERENTIATION	Neuroblastoma is the most common extracranial tumor and a major cause of infant cancer mortality worldwide. Despite its importance, little is known about its molecular mechanisms. A striking feature of this tumor is its clinical heterogeneity. Possible outcomes range from aggressive invasion to other tissues, causing patient death, to spontaneous disease regression or differentiation into benign ganglioneuromas. Several efforts have been made in order to find tumor progression markers. In this work, we have reconstructed the neuroblastoma regulatory network using an information-theoretic approach in order to find genes involved in tumor progression and that could be used as outcome predictors or as therapeutic targets. We have queried the reconstructed neuroblastoma regulatory network using an aggressive neuroblastoma metastasis gene signature in order to find its master regulators (MRs). MRs expression profiles were then investigated in other neuroblastoma datasets so as to detect possible clinical significance. Our analysis pointed MAX as one of the MRs of neuroblastoma progression. We have found that higher MAX expression correlated with favorable patient outcomes. We have also found that MAX expression and protein levels were increased during neuroblastoma SH-SY5Y cells differentiation. We propose that MAX is involved in neuroblastoma progression, possibly increasing cell differentiation by means of regulating the availability of MYC:MAX heterodimers. This mechanism is consistent with the results found in our SH-SY5Y differentiation protocol, suggesting that MAX has a more central role in these cells differentiation than previously reported. Overexpression of MAX has been identified as anti-tumorigenic in other works, but, to our knowledge, this is the first time that the link between the expression of this gene and malignancy was verified under physiological conditions.	[Albanus, Ricardo D'Oliveira; Siqueira Dalmolin, Rodrigo Juliani; Alves Castro, Mauro Antonio; de Bittencourt Pasquali, Matheus Augusto; Ramos, Vitor de Miranda; Gelain, Daniel Pens; Fonseca Moreira, Jose Claudio] Univ Fed Rio Grande do Sul, Dept Bioquim, Nucleo Bioinformat, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul	Albanus, RD (corresponding author), Univ Fed Rio Grande do Sul, Dept Bioquim, Nucleo Bioinformat, Porto Alegre, RS, Brazil.	ricardo.albanus@ufrgs.br	RAMOS, VITOR/W-1811-2019; Gelain, Daniel Pens/I-5144-2013; Castro, Mauro A. A./A-5467-2008; de Bittencourt Pasquali, Matheus Augusto/B-7334-2015; Albanus, Ricardo D'Oliveira/AAQ-2431-2021; moreira, jose claudio/AAO-6400-2021; Dalmolin, Rodrigo J/L-3718-2013	RAMOS, VITOR/0000-0001-7004-0823; Gelain, Daniel Pens/0000-0001-5254-0509; Castro, Mauro A. A./0000-0003-4942-8131; de Bittencourt Pasquali, Matheus Augusto/0000-0001-8077-6818; Dalmolin, Rodrigo J/0000-0002-1688-6155; D'Oliveira Albanus, Ricardo/0000-0003-3651-0136	CNPq; CAPES; FAPERGS	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	This paper was funded by CNPq (http://www.cnpq.br/), CAPES (http://www.capes.gov.br/) and FAPERGS (http://www.fapergs.rs.gov.br/) funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asgharzadeh S, 2006, JNCI-J NATL CANCER I, V98, P1193, DOI 10.1093/jnci/djj330; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; AYER DE, 1993, GENE DEV, V7, P2110, DOI 10.1101/gad.7.11.2110; Babu M. Madan, 2009, V541, P163, DOI 10.1007/978-1-59745-243-4_8; Bagatell R, 2009, J CLIN ONCOL, V27, P365, DOI 10.1200/JCO.2008.17.9184; Banerjee A, 2006, BIOCHEMISTRY-US, V45, P2333, DOI 10.1021/bi0522551; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Benard J, 2008, MOL ONCOL, V2, P261, DOI 10.1016/j.molonc.2008.07.002; Bhatnagar SN, 2012, INDIAN J PEDIATR, V79, P787, DOI 10.1007/s12098-012-0748-2; Bouchard C, 2001, GENE DEV, V15, P2042, DOI 10.1101/gad.907901; Burnichon N, 2012, CLIN CANCER RES, V18, P2828, DOI 10.1158/1078-0432.CCR-12-0160; Canelles M, 1997, ONCOGENE, V14, P1315, DOI 10.1038/sj.onc.1200948; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Castro MAA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-4-r29; Chen DT, 2010, BREAST CANCER RES TR, V119, P335, DOI 10.1007/s10549-009-0344-y; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; DANGIO GJ, 1971, LANCET, V1, P1046; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Fletcher MNC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3464; Follis AV, 2009, BIOORG MED CHEM LETT, V19, P807, DOI 10.1016/j.bmcl.2008.12.025; Galan SR, 2013, CLIN ENDOCRINOL, V78, P165, DOI 10.1111/cen.12071; Garaventa A, 2009, EUR J CANCER, V45, P2835, DOI 10.1016/j.ejca.2009.06.010; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; GU W, 1993, P NATL ACAD SCI USA, V90, P2935, DOI 10.1073/pnas.90.7.2935; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; Hong SL, 2000, GENE DEV, V14, P17; Howman-Giles R, 2007, SEMIN NUCL MED, V37, P286, DOI 10.1053/j.semnuclmed.2007.02.009; Hurlin PJ, 2004, INT REV CYTOL, V238, P183, DOI 10.1016/S0074-7696(04)38004-6; Hurlin PJ, 1997, GENE DEV, V11, P44, DOI 10.1101/gad.11.1.44; KIRMANI S, 2008, HEREDITARY PARAGANGL; Kristiansson E, 2009, MOL BIOL EVOL, V26, P1299, DOI 10.1093/molbev/msp040; Kushner BH, 1996, J CLIN ONCOL, V14, P2174, DOI 10.1200/JCO.1996.14.7.2174; Ledent Valerie, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-6-RESEARCH0030; Li QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-474; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lin H, 2002, MODELING SURVIVAL DA, V44, P85; LINDEMAN GJ, 1995, ONCOGENE, V10, P1013; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Maris JM, 1999, J CLIN ONCOL, V17, P2264, DOI 10.1200/JCO.1999.17.7.2264; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; McMahon SB, 2000, MOL CELL BIOL, V20, P556, DOI 10.1128/MCB.20.2.556-562.2000; Mehra S, 2004, METAB ENG, V6, P326, DOI 10.1016/j.ymben.2004.05.002; Mills SE, 2002, MODERN PATHOL, V15, P264, DOI 10.1038/modpathol.3880522; Modak S, 2010, CANCER TREAT REV, V36, P307, DOI 10.1016/j.ctrv.2010.02.006; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Monclair T, 2009, J CLIN ONCOL, V27, P298, DOI 10.1200/JCO.2008.16.6876; Montagne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032172; Morandi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029922; Nishida Yuichiro, 2008, BMC Res Notes, V1, P95, DOI 10.1186/1756-0500-1-95; O'Hagan RC, 2000, NAT GENET, V24, P113, DOI 10.1038/72761; Oberthuer A, 2010, PHARMACOGENOMICS J, V10, P258, DOI 10.1038/tpj.2010.53; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Parise IZS, 2006, J PEDIAT HEMATOL ONC, V28, P82, DOI 10.1097/01.mph.0000199601.35010.52; Park J, 2001, GENE DEV, V15, P1619, DOI 10.1101/gad.900101; Peverali FA, 1996, ONCOGENE, V12, P457; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Pulverer B, 2000, J CELL PHYSIOL, V183, P399, DOI 10.1002/(SICI)1097-4652(200006)183:3<399::AID-JCP13>3.3.CO;2-Z; Rottmann S, 2006, CURR TOP MICROBIOL, V302, P63; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schmidt ML, 2005, J CLIN ONCOL, V23, P6474, DOI 10.1200/JCO.2005.05.183; Schmidt ML, 2000, J CLIN ONCOL, V18, P1260, DOI 10.1200/JCO.2000.18.6.1260; Schwab M, 2003, LANCET ONCOL, V4, P472, DOI 10.1016/S1470-2045(03)01166-5; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spix C, 2006, EUR J CANCER, V42, P2081, DOI 10.1016/j.ejca.2006.05.008; Tonini GP, 1997, J CLIN ONCOL, V15, P85, DOI 10.1200/JCO.1997.15.1.85; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Wang HB, 2007, MOL CANCER THER, V6, P2399, DOI 10.1158/1535-7163.MCT-07-0005; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618; Welander J, 2011, ENDOCR-RELAT CANCER, V18, pR253, DOI 10.1530/ERC-11-0170; Westermann F, 2002, CANCER LETT, V184, P127, DOI 10.1016/S0304-3835(02)00199-4; Yap CS, 2011, CELL CYCLE, V10, P2184, DOI 10.4161/cc.10.13.16249; Zhang HM, 2012, NUCLEIC ACIDS RES, V40, pD144, DOI 10.1093/nar/gkr965	77	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82457	10.1371/journal.pone.0082457	http://dx.doi.org/10.1371/journal.pone.0082457			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349289	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100111
J	Kuypers, E; Jellema, RK; Ophelders, DRMG; Dudink, J; Nikiforou, M; Wolfs, TGAM; Nitsos, I; Pillow, JJ; Polglasem, GR; Kemp, MW; Saito, M; Newnham, JP; Jobe, AH; Kallapur, SG; Kramer, BW				Kuypers, Elke; Jellema, Reint K.; Ophelders, Daan R. M. G.; Dudink, Jeroen; Nikiforou, Maria; Wolfs, Tim G. A. M.; Nitsos, Ilias; Pillow, J. Jane; Polglasem, Graeme R.; Kemp, Matthew W.; Saito, Masatoshi; Newnham, John P.; Jobe, Alan H.; Kallapur, Suhas G.; Kramer, Boris W.			Effects of Intra-Amniotic Lipopolysaccharide and Maternal Betamethasone on Brain Inflammation in Fetal Sheep	PLOS ONE			English	Article							ANTENATAL GLUCOCORTICOID TREATMENT; INNATE IMMUNE-SYSTEM; WHITE-MATTER INJURY; INTRAUTERINE INFECTION; CEREBRAL-PALSY; INDUCED CHORIOAMNIONITIS; LUNG MATURATION; RISK-FACTOR; PRETERM; EXPOSURE	Rationale: Chorioamnionitis and antenatal glucocorticoids are common exposures for preterm infants and can affect the fetal brain, contributing to cognitive and motor deficits in preterm infants. The effects of antenatal glucocorticoids on the brain in the setting of chorioamnionitis are unknown. We hypothesized that antenatal glucocorticoids would modulate inflammation in the brain and prevent hippocampal and white matter injury after intra-amniotic lipopolysaccharide (LPS) exposure. Methods: Time-mated ewes received saline (control), an intra-amniotic injection of 10 mg LPS at 106d GA or 113d GA, maternal intra-muscular betamethasone (0.5 mg/kg maternal weight) alone at 113d GA, betamethasone at 106d GA before LPS or betamethasone at 113d GA after LPS. Animals were delivered at 120d GA (term=150d). Brain structure volumes were measured on T2-weighted MRI images. The subcortical white matter (SCWM), periventricular white matter (PVWM) and hippocampus were analyzed for microglia, astrocytes, apoptosis, proliferation, myelin and pre-synaptic vesicles. Results: LPS and/or betamethasone exposure at different time-points during gestation did not alter brain structure volumes on MRI. Betamethasone alone did not alter any of the measurements. Intra-amniotic LPS at 106d or 113d GA induced inflammation as indicated by increased microglial and astrocyte recruitment which was paralleled by increased apoptosis and hypomyelination in the SCWM and decreased synaptophysin density in the hippocampus. Betamethasone before the LPS exposure at 113d GA prevented microglial activation and the decrease in synaptophysin. Betamethasone after LPS exposure increased microglial infiltration and apoptosis. Conclusion: Intra-uterine LPS exposure for 7d or 14d before delivery induced inflammation and injury in the fetal white matter and hippocampus. Antenatal glucocorticoids aggravated the inflammatory changes in the brain caused by pre-existing intra-amniotic inflammation. Antenatal glucocorticoids prior to LPS reduced the effects of intra-uterine inflammation on the brain. The timing of glucocorticoid administration in the setting of chorioamnionitis can alter outcomes for the fetal brain.	[Kuypers, Elke; Jellema, Reint K.; Ophelders, Daan R. M. G.; Nikiforou, Maria; Wolfs, Tim G. A. M.; Kramer, Boris W.] Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Dept Pediat, Maastricht, Netherlands; [Dudink, Jeroen] Erasmus Med Ctr Sophia, Dept Pediat, Rotterdam, Netherlands; [Nitsos, Ilias; Polglasem, Graeme R.; Kemp, Matthew W.; Saito, Masatoshi; Newnham, John P.; Jobe, Alan H.; Kallapur, Suhas G.] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA 6009, Australia; [Nitsos, Ilias; Polglasem, Graeme R.] Monash Inst Med Res, Ritchie Ctr, Melbourne, Australia; [Pillow, J. Jane] Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia; [Jobe, Alan H.; Kallapur, Suhas G.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA	Maastricht University; Erasmus University Rotterdam; Erasmus MC; University of Western Australia; University of Western Australia; Cincinnati Children's Hospital Medical Center	Kramer, BW (corresponding author), Maastricht Univ, Med Ctr, Sch Mental Hlth & Neurosci, Dept Pediat, Maastricht, Netherlands.	b.kramer@mumc.nl	Kramer, Boris/AAO-3183-2021; Pillow, Jane/A-3335-2009; Jellema, Reint/AAW-1214-2020	Pillow, Jane/0000-0002-6500-0138; Jellema, Reint/0000-0002-6918-0930; Wolfs, Tim/0000-0003-4417-4144; Dudink, Jeroen/0000-0003-0446-3646; Ophelders, Daan/0000-0001-7410-5102; Polglase, Graeme/0000-0002-8906-614X; Newnham, John/0000-0001-9983-7457	NIH [HD-57869]; National Institutes of Health (NIH), USA; National Health and Medical Research Council of Australia,; Women and Infants Research Foundation; Western Australia, Veni from the Dutch Scientific Research Organization and the Research School for Oncology and Developmental Biology (GROW), Maastricht University [BWK 016.096.141]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057869] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH), USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia,; Women and Infants Research Foundation; Western Australia, Veni from the Dutch Scientific Research Organization and the Research School for Oncology and Developmental Biology (GROW), Maastricht University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by NIH HD-57869 (SGK) from the National Institutes of Health (NIH), USA, the National Health and Medical Research Council of Australia, the Women and Infants Research Foundation, Western Australia, Veni BWK 016.096.141 from the Dutch Scientific Research Organization and the Research School for Oncology and Developmental Biology (GROW), Maastricht University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonow-Schlorke I, 2001, NEUROSCI LETT, V297, P147, DOI 10.1016/S0304-3940(00)01605-0; Antonow-Schlorke I, 2007, AM J OBSTET GYNECOL, V196, P553, DOI 10.1016/j.ajog.2006.10.898; Back SA, 2001, J NEUROSCI, V21, P1302; Back SA, 2006, J CHILD NEUROL, V21, P582, DOI 10.1177/08830738060210070101; Back SA, 2012, NEUROTHERAPEUTICS, V9, P359, DOI 10.1007/s13311-012-0108-y; BALLARD PL, 1995, AM J OBSTET GYNECOL, V173, P254, DOI 10.1016/0002-9378(95)90210-4; Bashiri A, 2006, J PERINAT MED, V34, P5, DOI 10.1515/JPM.2006.001; Baud O, 1999, NEW ENGL J MED, V341, P1190, DOI 10.1056/NEJM199910143411604; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Been JV, 2011, BJOG-INT J OBSTET GY, V118, P113, DOI 10.1111/j.1471-0528.2010.02751.x; Been JV, 2013, J PEDIATR-US, V162, P236, DOI 10.1016/j.jpeds.2012.07.012; Buka SL, 2001, ARCH GEN PSYCHIAT, V58, P1032, DOI 10.1001/archpsyc.58.11.1032; Burd I, 2011, REPROD SCI, V18, P900, DOI 10.1177/1933719111398498; Busillo JM, 2013, TRENDS ENDOCRIN MET, V24, P109, DOI 10.1016/j.tem.2012.11.005; Busillo JM, 2011, J BIOL CHEM, V286, P38703, DOI 10.1074/jbc.M111.275370; Chau V, 2009, ANN NEUROL, V66, P155, DOI 10.1002/ana.21713; Chinenov Y, 2007, MOL CELL ENDOCRINOL, V275, P30, DOI 10.1016/j.mce.2007.04.014; Collins JJP, 2012, AM J PHYSIOL-LUNG C, V303, pL778, DOI 10.1152/ajplung.00280.2011; Dammann O, 1997, PEDIATR RES, V42, P1, DOI 10.1203/00006450-199707000-00001; Dean JM, 2011, ANN NEUROL, V70, P846, DOI 10.1002/ana.22480; Dunlop S A, 1997, J Matern Fetal Med, V6, P309; French NP, 1999, AM J OBSTET GYNECOL, V180, P114, DOI 10.1016/S0002-9378(99)70160-2; Gantert M, 2010, J PERINATOL, V30, pS21, DOI 10.1038/jp.2010.96; Gantert M., 2012, FRONT BIOSCI, V4, P2845; Gavilanes AWD, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.003; Gavilanes Antonio Wenceslao Danilo, 2010, Front Biosci (Schol Ed), V2, P432; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Grether JK, 2003, ARCH PEDIAT ADOL MED, V157, P26, DOI 10.1001/archpedi.157.1.26; Hagberg H, 2012, ANN NEUROL, V71, P444, DOI 10.1002/ana.22620; Hartling L, 2012, ARCH DIS CHILD-FETAL, V97, pF8, DOI 10.1136/adc.2010.210187; Hendson L, 2011, J PEDIATR-US, V158, P397, DOI 10.1016/j.jpeds.2010.09.010; Jellema RK, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-13; Jobe AH, 1998, PEDIATRICS, V102, P1116, DOI 10.1542/peds.102.5.1116; Kallapur SG, 2001, AM J PHYSIOL-LUNG C, V280, pL527, DOI 10.1152/ajplung.2001.280.3.L527; Kallapur SG, 2003, AM J PHYSIOL-LUNG C, V284, pL633, DOI 10.1152/ajplung.00344.2002; Kaukola T, 2006, PEDIATR RES, V59, P478, DOI 10.1203/01.pdr.0000182596.66175.ee; Keogh MJ, 2012, AM J PHYSIOL-REG I, V303, pR270, DOI 10.1152/ajpregu.00216.2012; Kramer BW, 2007, AM J PHYSIOL-LUNG C, V293, pL345, DOI 10.1152/ajplung.00003.2007; Kuypers E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038257; Kuypers E, 2012, AM J PHYSIOL-LUNG C, V302, pL380, DOI 10.1152/ajplung.00338.2011; Liden J, 1997, J BIOL CHEM, V272, P21467, DOI 10.1074/jbc.272.34.21467; Limperopoulos C, 2008, PEDIATRICS, V121, P758, DOI 10.1542/peds.2007-2158; Malaeb S, 2009, J CHILD NEUROL, V24, P1119, DOI 10.1177/0883073809338066; Malaeb SN, 2009, J NEUROSCI RES, V87, P179, DOI 10.1002/jnr.21825; MCINTOSH GH, 1979, NEUROPATH APPL NEURO, V5, P103, DOI 10.1111/j.1365-2990.1979.tb00664.x; Modi N, 2001, PEDIATR RES, V50, P581, DOI 10.1203/00006450-200111000-00008; Nitsos I, 2006, J SOC GYNECOL INVEST, V13, P239, DOI 10.1016/j.jsgi.2006.02.011; Noorlandler CW, 2008, DEV NEUROBIOL, V68, P237, DOI 10.1002/dneu.20583; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Rebello CM, 1996, J APPL PHYSIOL, V80, P1674, DOI 10.1152/jappl.1996.80.5.1674; Redline Raymond W, 2004, Semin Neonatol, V9, P265, DOI 10.1016/j.siny.2003.09.005; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Roelfsema V, 2004, J CEREBR BLOOD F MET, V24, P877, DOI 10.1097/01.WCB.0000123904.17746.92; Shatrov JG, 2010, OBSTET GYNECOL, V116, P387, DOI 10.1097/AOG.0b013e3181e90046; Tijsseling D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033369; UNO H, 1990, DEV BRAIN RES, V53, P157, DOI 10.1016/0165-3806(90)90002-G; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; Wolfs TGAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005837; Yawno T, 2009, NEUROSCIENCE, V163, P838, DOI 10.1016/j.neuroscience.2009.07.009; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P797, DOI 10.1016/S0002-9378(97)70271-0	60	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2013	8	12							e81644	10.1371/journal.pone.0081644	http://dx.doi.org/10.1371/journal.pone.0081644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GT	24358119	Green Submitted, Green Published, gold			2022-12-27	WOS:000328737700001
J	van der Sluijs, MTW; Schroer-Joosten, DPH; Fid-Fourkour, A; Vrijenhoek, MP; Debyser, I; Moulin, V; Moormann, RJM; de Smit, AJ				van der Sluijs, Mirjam T. W.; Schroer-Joosten, Dianne P. H.; Fid-Fourkour, Aicha; Vrijenhoek, Mieke P.; Debyser, Isolde; Moulin, Veronique; Moormann, Rob J. M.; de Smit, Abraham J.			Transplacental Transmission of Bluetongue Virus Serotype 1 and Serotype 8 in Sheep: Virological and Pathological Findings	PLOS ONE			English	Article							INDUCED CONGENITAL ENCEPHALOPATHIES; INFECTION; CATTLE; VACCINE; EWES; REASSORTMENT; ORBIVIRUS; RESPONSES; SEQUENCE; STRAINS	The Bluetongue virus serotype 8 (BTV-8) strain, which emerged in Europe in 2006, had an unusually high ability to cause foetal infection in pregnant ruminants. Other serotypes of BTV had already been present in Europe for more than a decade, but transplacental transmission of these strains had never been demonstrated. To determine whether transplacental transmission is a unique feature of BTV-8 we compared the incidence and pathological consequences of transplacental transmission of BTV-8 to that of BTV-1. Nine pregnant ewes were infected with either BTV-8 or BTV-1. The BTV strains used for the infection were field strains isolated on embryonated chicken eggs and passaged twice on mammalian cells. Blood samples were taken to monitor the viraemia in the ewes. Four weeks after the infection, the foetuses were examined for pathological changes and for the presence of BTV. BTV-8 could be demonstrated in 12 foetuses (43%) from 5 ewes (56%). %). BTV-1 was detected in 14 foetuses (82%) from 6 ewes (67%). Pathological changes were mainly found in the central nervous system. In the BTV-8 group, lympho-histiocytic infiltrates, gliosis and slight vacuolation of the neuropil were found. BTV-1infection induced a severe necrotizing encephalopathy and severe meningitis, with macroscopic hydranencephaly or porencephaly in 8 foetuses. In our experimental setting, using low passaged virus strains, BTV-1 was able to induce transplacental transmission to a higher incidence compared to BTV-8, causing more severe pathology.	[van der Sluijs, Mirjam T. W.; Schroer-Joosten, Dianne P. H.; Fid-Fourkour, Aicha; Moulin, Veronique; de Smit, Abraham J.] MSD Anim Hlth, Res & Dev, Boxmeer, Netherlands; [Vrijenhoek, Mieke P.] MSD Anim Hlth, Anim Serv & Pathol, Boxmeer, Netherlands; [Debyser, Isolde] Consultancy Vet & Toxicol Pathol, CoVeToP, Enghien, Belgium; [Moormann, Rob J. M.] Univ Wageningen & Res Ctr, Anim Sci Grp, Cent Vet Inst, Lelystad, Netherlands; [Moormann, Rob J. M.] Univ Utrecht, Fac Vet Med, Div Virol, Dept Infect Dis & Immunol, Utrecht, Netherlands	Merck & Company; Intervet International B.V.; Merck & Company; Intervet International B.V.; Animal Sciences Group of Wageningen UR; Wageningen University & Research; Utrecht University	van der Sluijs, MTW (corresponding author), MSD Anim Hlth, Res & Dev, Boxmeer, Netherlands.	mirjam.vandersluijs@merck.com			MSDAH	MSDAH	This research was financed by MSDAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON CK, 1969, AM J VET RES, V30, P987; Backx A, 2009, VET MICROBIOL, V138, P235, DOI 10.1016/j.vetmic.2009.04.003; Batten CA, 2012, VET MICROBI IN PRESS; Bonneau KR, 2001, J VIROL, V75, P8298, DOI 10.1128/JVI.75.17.8298-8305.2001; Dal Pozzo F, 2009, VET J, V182, P142, DOI 10.1016/j.tvjl.2009.05.004; Darpel KE, 2007, VET REC, V161, P253, DOI 10.1136/vr.161.8.253; Darpel KE, 2009, EMERG INFECT DIS, V15, P2025, DOI 10.3201/eid1512.090788; EUR. FOOD SAFETY AUTH, 2008, SOL EL ONE BILL PEOP, P1; European Commission, 2013, HLTH CONS AN BLUET; FLANAGAN M, 1982, AUST VET J, V59, P18, DOI 10.1111/j.1751-0813.1982.tb02704.x; Flanagan M, 1995, AUST VET J, V72, P455, DOI 10.1111/j.1751-0813.1995.tb03488.x; GIBBS EPJ, 1979, RES VET SCI, V27, P118, DOI 10.1016/S0034-5288(18)32870-4; GOULD AR, 1987, VIRUS RES, V7, P169, DOI 10.1016/0168-1702(87)90078-5; GOULD AR, 1990, VIRUS RES, V17, P31, DOI 10.1016/0168-1702(90)90078-P; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; JOCHIM MM, 1974, AM J VET RES, V35, P517; Kirkland P D, 2004, Vet Ital, V40, P448; LUEDKE AJ, 1977, AM J VET RES, V38, P1687; Maan NS, 2012, J VIROL, V86, P5967, DOI 10.1128/JVI.00536-12; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; MACLACHLAN NJ, 1985, VET PATHOL, V22, P415, DOI 10.1177/030098588502200418; MacLachlan NJ, 2000, ANIM REPROD SCI, V60, P643, DOI 10.1016/S0378-4320(00)00105-6; Menzies FD, 2008, VET REC, V163, P203, DOI 10.1136/vr.163.7.203; OSBURN BI, 1971, LAB INVEST, V25, P197; OSBURN BI, 1971, LAB INVEST, V25, P206; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; RICHARDS WP, 1967, SCIENCE, V156, P530, DOI 10.1126/science.156.3774.530; RICHARDSON C, 1985, AM J VET RES, V46, P1912; ROEDER PL, 1991, VET REC, V128, P301, DOI 10.1136/vr.128.13.301; Roy P, 2008, CELL BIOCHEM BIOPHYS, V50, P143, DOI 10.1007/s12013-008-9009-4; Saegerman C, 2011, VET J, V187, P72, DOI 10.1016/j.tvjl.2009.11.012; Santman-Berends IMGA, 2010, THERIOGENOLOGY, V74, P1377, DOI 10.1016/j.theriogenology.2010.06.008; Savini G, 2012, TRANSBOUND IN PRESS; Savini G, 2008, COMP IMMUNOL MICROB, V31, P101, DOI 10.1016/j.cimid.2007.07.006; SCHULTZ GORDON, 1955, JOUR AMER VET MED ASSOC, V127, P224; Shaw AE, 2007, J VIROL METHODS, V145, P115, DOI 10.1016/j.jviromet.2007.05.014; Shaw AE, 2013, J VIROL, V87, P543, DOI 10.1128/JVI.02266-12; van der Sluijs M, 2011, VET MICROBIOL, V149, P113, DOI 10.1016/j.vetmic.2010.11.002; van der Sluijs MTW, 2012, VACCINE, V30, P647, DOI 10.1016/j.vaccine.2011.10.106; WALDVOGEL AS, 1987, VET PATHOL, V24, P404, DOI 10.1177/030098588702400507	41	21	21	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81429	10.1371/journal.pone.0081429	http://dx.doi.org/10.1371/journal.pone.0081429			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358112	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700008
J	Anderson, RA; Qin, BL; Canini, F; Poulet, L; Roussel, AM				Anderson, Richard A.; Qin, Bolin; Canini, Frederic; Poulet, Laurent; Roussel, Anne Marie			Cinnamon Counteracts the Negative Effects of a High Fat/High Fructose Diet on Behavior, Brain Insulin Signaling and Alzheimer-Associated Changes	PLOS ONE			English	Article							GROWTH-FACTOR EXPRESSION; AMYLOID-BETA; MEMORY; DISEASE; EXTRACT; RESISTANCE; DEFICITS; GLYCOGEN; GLUCOSE; HEMOGLOBIN	Insulin resistance leads to memory impairment. Cinnamon (CN) improves peripheral insulin resistance but its effects in the brain are not known. Changes in behavior, insulin signaling and Alzheimer-associated mRNA expression in the brain were measured in male Wistar rats fed a high fat/high fructose (HF/HFr) diet to induce insulin resistance, with or without CN, for 12 weeks. There was a decrease in insulin sensitivity associated with the HF/HFr diet that was reversed by CN. The CN fed rats were more active in a Y maze test than rats fed the control and HF/HFr diets. The HF/HFr diet fed rats showed greater anxiety in an elevated plus maze test that was lessened by feeding CN. The HF/HFr diet also led to a down regulation of the mRNA coding for GLUT1 and GLUT3 that was reversed by CN in the hippocampus and cortex. There were increases in Insr, Irs1 and Irs2 mRNA in the hippocampus and cortex due to the HF/HFr diet that were not reversed by CN. Increased peripheral insulin sensitivity was also associated with increased glycogen synthase in both hippocampus and cortex in the control and HF/HFr diet animals fed CN. The HF/HFr diet induced increases in mRNA associated with Alzheimers including PTEN, Tau and amyloid precursor protein (App) were also alleviated by CN. In conclusion, these data suggest that the negative effects of a HF/HFr diet on behavior, brain insulin signaling and Alzheimer-associated changes were alleviated by CN suggesting that neuroprotective effects of CN are associated with improved whole body insulin sensitivity and related changes in the brain.	[Anderson, Richard A.; Qin, Bolin] ARS, Diet Genom & Immunol Lab, Beltsville Human Nutr Res Ctr, USDA, Beltsville, MD USA; [Qin, Bolin] Integr Nutraceut Int, Springhill, TN USA; [Canini, Frederic; Poulet, Laurent] Army Inst Res Biol, Grenoble, France; [Poulet, Laurent; Roussel, Anne Marie] Univ Grenoble 1, Natl Inst Hlth, Grenoble, France; [Canini, Frederic] Ecole Val de Grace, Paris, France	United States Department of Agriculture (USDA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Anderson, RA (corresponding author), ARS, Diet Genom & Immunol Lab, Beltsville Human Nutr Res Ctr, USDA, Beltsville, MD USA.	Richard.anderson@ars.usda.gov		Poulet, Laurent/0000-0003-2795-4122	USDA/ARS/USA [CRADA:58-3K95-7-1184]; French National Agency for Research [PNRA 007]	USDA/ARS/USA(United States Department of Agriculture (USDA)USDA Agricultural Research Service); French National Agency for Research(French National Research Agency (ANR))	The work was funded by USDA/ARS/USA CRADA:58-3K95-7-1184 and French National Agency for Research (PNRA 007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akilen R, 2010, DIABETIC MED, V27, P1159, DOI 10.1111/j.1464-5491.2010.03079.x; Anderson RA, 2004, J AGR FOOD CHEM, V52, P65, DOI 10.1021/jf034916b; Benedict C, 2012, DIABETES CARE, V35, P488, DOI 10.2337/dc11-2075; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Bruehl H, 2010, J CLIN EXP NEUROPSYC, V32, P487, DOI 10.1080/13803390903224928; Buwalda B, 2001, PHYSIOL BEHAV, V73, P371, DOI 10.1016/S0031-9384(01)00493-0; Cao Heping, 2007, J Inflamm (Lond), V4, P1, DOI 10.1186/1476-9255-4-1; Cao HP, 2007, ARCH BIOCHEM BIOPHYS, V459, P214, DOI 10.1016/j.abb.2006.12.034; Cao HP, 2010, PHYTOMEDICINE, V17, P1027, DOI 10.1016/j.phymed.2010.03.023; Convit A, 2005, NEUROBIOL AGING, V26, pS31, DOI 10.1016/j.neurobiolaging.2005.09.018; Couturier K, 2010, ARCH BIOCHEM BIOPHYS, V501, P158, DOI 10.1016/j.abb.2010.05.032; Couturier K, 2011, METABOLISM, V60, P1590, DOI 10.1016/j.metabol.2011.03.016; Craft S, 2003, PSYCHONEUROENDOCRINO, V28, P809, DOI 10.1016/S0306-4530(02)00087-2; Crawford P, 2009, J AM BOARD FAM MED, V22, P507, DOI 10.3122/jabfm.2009.05.080093; CRUZ APM, 1994, PHARMACOL BIOCHEM BE, V49, P171, DOI 10.1016/0091-3057(94)90472-3; Cruz NF, 2002, J CEREBR BLOOD F MET, V22, P1476, DOI 10.1097/01.WCB.0000034362.37277.C0; de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45; de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101; Dellu F, 1997, NEUROBIOL LEARN MEM, V67, P112, DOI 10.1006/nlme.1997.3746; Frisardi V, 2010, J ALZHEIMERS DIS, V21, P57, DOI 10.3233/JAD-2010-100015; Frydman-Marom A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016564; Gibbs ME, 2012, NEUROCHEM RES, V37, P2456, DOI 10.1007/s11064-012-0805-2; Gonzales MM, 2010, OBESITY, V18, P2131, DOI 10.1038/oby.2010.183; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Gupta A, 2011, NEUROPHARMACOLOGY, V60, P910, DOI 10.1016/j.neuropharm.2011.01.033; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Irvine EE, 2011, LEARN MEMORY, V18, P375, DOI 10.1101/lm.2111311; Jarvill-Taylor KJ, 2001, J AM COLL NUTR, V20, P327, DOI 10.1080/07315724.2001.10719053; Jiao LH, 2013, FOOD CHEM TOXICOL, V56, P398, DOI 10.1016/j.fct.2013.02.049; Khan A, 2003, DIABETES CARE, V26, P3215, DOI 10.2337/diacare.26.12.3215; Killday KB, 2011, J NAT PROD, V74, P1833, DOI 10.1021/np1007944; Killick R, 2009, BIOCHEM BIOPH RES CO, V386, P257, DOI 10.1016/j.bbrc.2009.06.032; Kim B, 2012, TRENDS ENDOCRIN MET, V23, P133, DOI 10.1016/j.tem.2011.12.004; Kosari S, 2012, BEHAV BRAIN RES, V235, P98, DOI 10.1016/j.bbr.2012.07.017; Legendre A, 2006, AM J PHYSIOL-REG I, V291, pR1288, DOI 10.1152/ajpregu.00234.2006; Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13; Lu JM, 2010, CARCINOGENESIS, V31, P481, DOI 10.1093/carcin/bgp292; Lu T, 2012, NUTR RES, V32, P408, DOI 10.1016/j.nutres.2012.05.003; Lu ZL, 2011, PHYTOMEDICINE, V18, P298, DOI 10.1016/j.phymed.2010.08.008; Park CR, 2000, PHYSIOL BEHAV, V68, P509, DOI 10.1016/S0031-9384(99)00220-6; Park CR, 2001, NEUROSCI BIOBEHAV R, V25, P311, DOI 10.1016/S0149-7634(01)00016-1; Parra MA, 2009, BRAIN, V132, P1057, DOI 10.1093/brain/awp036; Peterson DW, 2009, J ALZHEIMERS DIS, V17, P585, DOI 10.3233/JAD-2009-1083; Prasad A, 1996, PHYSIOL BEHAV, V60, P1039, DOI 10.1016/0031-9384(96)00135-7; Preuss HG, 2006, J AM COLL NUTR, V25, P144, DOI 10.1080/07315724.2006.10719525; Qin B, 2010, HORM METAB RES, V42, P187, DOI 10.1055/s-0029-1242746; Qin Bolin, 2010, J Diabetes Sci Technol, V4, P685; Qutub AA, 2005, BRAIN RES REV, V49, P595, DOI 10.1016/j.brainresrev.2005.03.002; Reger MA, 2008, J ALZHEIMERS DIS, V13, P323, DOI 10.3233/jad-2008-13309; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Ryu BR, 1999, J NEUROBIOL, V39, P536, DOI 10.1002/(SICI)1097-4695(19990615)39:4<536::AID-NEU7>3.0.CO;2-J; Schioth HB, 2012, MOL NEUROBIOL, V46, P4, DOI 10.1007/s12035-011-8229-6; Soulis G, 2007, BEHAV NEUROSCI, V121, P483, DOI 10.1037/0735-7044.121.3.483; Souza CG, 2007, LIFE SCI, V81, P198, DOI 10.1016/j.lfs.2007.05.001; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; Stuart CA, 2011, BRAIN RES, V1384, P15, DOI 10.1016/j.brainres.2011.02.014; Takashima Akihiko, 2012, Front Mol Neurosci, V5, P47, DOI 10.3389/fnmol.2012.00047; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Wang JG, 2007, FERTIL STERIL, V88, P240, DOI 10.1016/j.fertnstert.2006.11.082; White CL, 2009, NEUROBIOL DIS, V35, P3, DOI 10.1016/j.nbd.2009.04.002; Woods SC, 2003, CURR PHARM DESIGN, V9, P795, DOI 10.2174/1381612033455323; Ziegenfuss TN, 2006, J INT SOC SPORT NUTR, V3, DOI 10.1186/1550-2783-3-2-45	63	44	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83243	10.1371/journal.pone.0083243	http://dx.doi.org/10.1371/journal.pone.0083243			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349472	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200070
J	Hallak, JA; Jassim, S; Khanolkar, V; Jain, S				Hallak, Joelle A.; Jassim, Sarmad; Khanolkar, Vishakha; Jain, Sandeep			Symptom Burden of Patients with Dry Eye Disease: A Four Domain Analysis	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; QUALITY-OF-LIFE; ASSOCIATION; DEPRESSION; SIGNS	Purpose: To determine which sensory (symptom persistence and intensity) and reactive (activity and affective interference) domains of symptom analysis are essential for assessing symptom burden in dry eye disease (DED) patients. Methods: A symptom domain tool was developed to investigate all four symptom domains in DED. In a cross-sectional pilot study, we administered the symptom burden tool and the Ocular Surface Disease Index (OSDI) questionnaire to 48 DED patients. Total and domain scores from the symptom burden tool and the OSDI were normalized to achieve comparability. Spearman correlation coefficients were calculated to measure the relationship between domains and subscales. Agreement between the symptom burden tool and OSDI was assessed by Bland-Altman plot. Assigned treatments were compared by symptom burden to determine whether treatment aggressiveness is linked to symptom intensity. Results: There was high agreement between the symptom burden tool and the OSDI. Symptom persistence had a stronger correlation with affective interference (r = 0.62 for the symptom burden tool and r = 0.73 for the OSDI) than activity interference (r = 0.58 for the symptom burden tool and r = 0.60 for the OSDI). Symptom intensity correlated weakly with affective interference (r = 0.38) and activity interference (r = 0.37) in the symptom burden tool (OSDI does not have a subscale for intensity). In patients with equal persistence of symptoms, those having high symptom intensity were receiving more aggressive treatment (66.7%) than those with lower symptom intensity (33.3%). Conclusions: Persistence of symptoms correlates better with affective interference than activity interference. Intensity of symptoms may be important for treatment decisions.	[Hallak, Joelle A.; Jassim, Sarmad; Khanolkar, Vishakha; Jain, Sandeep] Univ Illinois, Dept Ophthalmol & Visual Sci, Coll Med, Corneal Neurobiol Lab, Chicago, IL 60607 USA; [Hallak, Joelle A.] Univ Illinois, Sch Publ Hlth, Dept Epidemiol & Biostat, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Hallak, JA (corresponding author), Univ Illinois, Dept Ophthalmol & Visual Sci, Coll Med, Corneal Neurobiol Lab, Chicago, IL 60607 USA.	joelle@uic.edu			National Eye Institute (NEI) [EY018874, EY01792]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [K08EY018874, P30EY001792] Funding Source: NIH RePORTER	National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Eye Institute (NEI) Grant EY018874 (SJ), NEI core grant EY01792, and Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abetz L, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-111; Calonge M, 2001, SURV OPHTHALMOL, V45, pS227, DOI 10.1016/S0039-6257(00)00205-8; Cleeland Charles S, 2007, J Natl Cancer Inst Monogr, P16; Dogru M, 2011, EXPERT OPIN PHARMACO, V12, P325, DOI 10.1517/14656566.2010.518612; Fernandez CA, 2013, INVEST OPHTH VIS SCI, V54, P3666, DOI 10.1167/iovs.13-11635; Galor A, 2012, AM J OPHTHALMOL, V154, P340, DOI 10.1016/j.ajo.2012.02.009; Johnson ME, 2009, OCUL SURF, V7, P199, DOI 10.1016/S1542-0124(12)70187-8; Lemp Michael A., 1995, CLAO Journal, V21, P221; Li MY, 2012, INVEST OPHTH VIS SCI, V53, P5722, DOI 10.1167/iovs.11-9094; Li MY, 2011, CURR EYE RES, V36, P1, DOI 10.3109/02713683.2010.519850; mdanderson website Cleeland CS, 2010, MD ANDERSON SYMPTOM; Mertzanis P, 2005, INVEST OPHTH VIS SCI, V46, P46, DOI 10.1167/iovs.03-0915; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060; Mizuno Y, 2010, JPN J OPHTHALMOL, V54, P259, DOI 10.1007/s10384-010-0812-2; Nichols KK, 2004, CORNEA, V23, P762, DOI 10.1097/01.ico.0000133997.07144.9e; Schaumberg DA, 2007, OCUL SURF, V5, P50, DOI 10.1016/S1542-0124(12)70053-8; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Smith JA, 2007, OCUL SURF, V5, P93; Vitale Susan, 2004, Health Qual Life Outcomes, V2, P44, DOI 10.1186/1477-7525-2-44; Walt JG, 1997, DRUG INF J; Wlodarczyk J, 2009, OPHTHAL EPIDEMIOL, V16, P22, DOI 10.1080/09286580802521309	21	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82805	10.1371/journal.pone.0082805	http://dx.doi.org/10.1371/journal.pone.0082805			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349365	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200056
J	Jasper, JR; Habicht, C; Moffitt, S; Brenner, R; Marsh, J; Lewis, B; Fox, EC; Grauvogel, Z; Olive, SDR; Grant, WS				Jasper, James R.; Habicht, Christopher; Moffitt, Steve; Brenner, Rich; Marsh, Jennifer; Lewis, Bert; Fox, Elisabeth Creelman; Grauvogel, Zac; Olive, Serena D. Rogers; Grant, W. Stewart			Source-Sink Estimates of Genetic Introgression Show Influence of Hatchery Strays on Wild Chum Salmon Populations in Prince William Sound, Alaska	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISM MARKERS; MICROSATELLITE DNA ANALYSIS; BROWN TROUT POPULATIONS; STEELHEAD TROUT; STOCKING; SOFTWARE; BROODSTOCK; EVOLUTION; SELECTION; FITNESS	The extent to which stray, hatchery-reared salmon affect wild populations is much debated. Although experiments show that artificial breeding and culture influence the genetics of hatchery salmon, little is known about the interaction between hatchery and wild salmon in a natural setting. Here, we estimated historical and contemporary genetic population structures of chum salmon (Oncorhynchus keta) in Prince William Sound (PWS), Alaska, with 135 single nucleotide polymorphism (SNP) markers. Historical population structure was inferred from the analysis of DNA from fish scales, which had been archived since the late 1960's for several populations in PWS. Parallel analyses with microsatellites and a test based on Hardy-Weinberg proportions showed that about 50% of the fish-scale DNA was cross-contaminated with DNA from other fish. These samples were removed from the analysis. We used a novel application of the classical source-sink model to compare SNP allele frequencies in these archived fish-scales (1964-1982) with frequencies in contemporary samples (2008-2010) and found a temporal shift toward hatchery allele frequencies in some wild populations. Other populations showed markedly less introgression, despite moderate amounts of hatchery straying. The extent of introgression may reflect similarities in spawning time and life-history traits between hatchery and wild fish, or the degree that hybrids return to a natal spawning area. The source-sink model is a powerful means of detecting low levels of introgression over several generations.	[Jasper, James R.; Habicht, Christopher; Lewis, Bert; Fox, Elisabeth Creelman; Grauvogel, Zac; Olive, Serena D. Rogers; Grant, W. Stewart] Alaska Dept Fish & Game, Commercial Fisheries Div, Anchorage, AK 99518 USA; [Moffitt, Steve; Brenner, Rich] Alaska Dept Fish & Game, Commercial Fisheries Div, Cordova, AK USA; [Marsh, Jennifer] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Juneau, AK USA	Alaska Department of Fish & Game; Alaska Department of Fish & Game; University of Alaska System; University of Alaska Fairbanks	Jasper, JR (corresponding author), Alaska Dept Fish & Game, Commercial Fisheries Div, 333 Raspberry Rd, Anchorage, AK 99518 USA.	jim.jasper@alaska.gov; william.grant@alaska.gov		Marsh, Jennifer/0000-0003-0996-9558	Alaska Sustainable Salmon Fund Project [45863]; Alaska Department of Fish and Game	Alaska Sustainable Salmon Fund Project; Alaska Department of Fish and Game	This research was funded by the Alaska Sustainable Salmon Fund Project 45863 and the Alaska Department of Fish and Game. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EC, 2002, GENETICS, V160, P1217; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Araki H, 2007, CONSERV BIOL, V21, P181, DOI 10.1111/j.1523-1739.2006.00564.x; Banks MA, 1999, J HERED, V90, P281, DOI 10.1093/jhered/90.2.281; Botz J, 2012, 1206 AL DEP FISH GAM; Brenner RE, 2012, ENVIRON BIOL FISH, V94, P179, DOI 10.1007/s10641-012-9975-7; Buchholz WG, 2001, ANIM GENET, V32, P162, DOI 10.1046/j.1365-2052.2001.0723b.x; Dann TH, 2009, ALASKA DEP FIS UNPUB; Debevec E.M., 1997, 5J9717 AL DEP FISH G; Elfstrom CM, 2007, MOL ECOL NOTES, V7, P1211, DOI 10.1111/j.1471-8286.2007.01835.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Ford MJ, 2006, CAN J FISH AQUAT SCI, V63, P2343, DOI 10.1139/F06-119; Ford MJ, 2002, CONSERV BIOL, V16, P815, DOI 10.1046/j.1523-1739.2002.00257.x; Fraser DJ, 2011, HEREDITY, V106, P404, DOI 10.1038/hdy.2010.167; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 2006, HIERFSTAT ESTIMATION; Gow JL, 2011, EVOL APPL, V4, P763, DOI 10.1111/j.1752-4571.2011.00198.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hansen MM, 2006, J APPL ECOL, V43, P669, DOI 10.1111/j.1365-2664.2006.01185.x; Hansen MM, 2009, BIOL LETTERS, V5, P656, DOI 10.1098/rsbl.2009.0214; Hansen MM, 2009, MOL ECOL, V18, P2549, DOI 10.1111/j.1365-294X.2009.04198.x; Hansen MM, 2000, MOL ECOL, V9, P583, DOI 10.1046/j.1365-294x.2000.00898.x; Hansen MM, 2002, MOL ECOL, V11, P1003, DOI 10.1046/j.1365-294X.2002.01495.x; Hendry AP, 2000, SCIENCE, V290, P516, DOI 10.1126/science.290.5491.516; Iwamoto EM, 2012, MOL ECOL, V21, P1567, DOI 10.1111/j.1365-294X.2011.05419.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kostow KE, 2004, CAN J FISH AQUAT SCI, V61, P577, DOI [10.1139/f04-019, 10.1139/F04-019]; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Marie AD, 2011, CONSERV GENET, V12, P1215, DOI 10.1007/s10592-011-0224-y; Marie AD, 2010, MOL ECOL, V19, P2025, DOI 10.1111/j.1365-294X.2010.04628.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Perrier C, 2013, EVOL APPL, V6, P218, DOI 10.1111/j.1752-4571.2012.00280.x; Petrou EL, MOL ECOLOGY IN PRESS; Pritchard JK, 2000, GENETICS, V155, P945; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Rand PS, 2012, ENVIRON BIOL FISH, V94, P1, DOI 10.1007/s10641-012-9987-3; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; RYMAN N, 1991, CONSERV BIOL, V5, P325, DOI 10.1111/j.1523-1739.1991.tb00144.x; Seamons TR, 2012, EVOL APPL, V5, P705, DOI 10.1111/j.1752-4571.2012.00247.x; Seeb JE, 2011, MOL ECOL RESOUR, V11, P335, DOI 10.1111/j.1755-0998.2010.02936.x; Seeb LW, 1997, 5J9718 AL DEP FISH G; Small MP, 1998, MOL ECOL, V7, P141, DOI 10.1046/j.1365-294x.1998.00324.x; Smith CT, 2005, MOL ECOL, V14, P4193, DOI 10.1111/j.1365-294X.2005.02731.x; Smith CT, 2005, MOL ECOL NOTES, V5, P259, DOI 10.1111/j.1471-8286.2005.00903.x; Smith CT, 1998, MOL ECOL, V7, P1614; Smith MJ, 2011, MOL ECOL RESOUR, V11, P268, DOI 10.1111/j.1755-0998.2010.02965.x; Vercessi L, 2012, 1204 AL DEP FISH GAM	50	15	15	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e81916	10.1371/journal.pone.0081916	http://dx.doi.org/10.1371/journal.pone.0081916			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349150	gold, Green Published, Green Submitted			2022-12-27	WOS:000328734200018
J	Kendall, EA; Theron, D; Franke, MF; van Helden, P; Victor, TC; Murray, MB; Warren, RM; Jacobson, KR				Kendall, Emily A.; Theron, Danie; Franke, Molly F.; van Helden, Paul; Victor, Thomas C.; Murray, Megan B.; Warren, Robin M.; Jacobson, Karen R.			Alcohol, Hospital Discharge, and Socioeconomic Risk Factors for Default from Multidrug Resistant Tuberculosis Treatment in Rural South Africa: A Retrospective Cohort Study	PLOS ONE			English	Article							TREATMENT OUTCOMES; TREATMENT FAILURE; RETREATMENT	Background: Default from multidrug-resistant tuberculosis (MDR-TB) treatment remains a major barrier to cure and epidemic control. We sought to identify patient risk factors for default from MDR-TB treatment and high-risk time periods for default in relation to hospitalization and transition to outpatient care. Methods: We retrospectively analyzed a cohort of 225 patients who initiated MDR-TB treatment between 2007 through 2010 at a rural TB hospital in the Western Cape Province, South Africa. Results: Fifty percent of patients were cured or completed treatment, 27% defaulted, 14% died, 4% failed treatment, and 5% transferred out. Recent alcohol use was common (63% of patients). In multivariable proportional hazards regression, older age (hazard ratio [HR]= 0.97 [95% confidence interval 0.94-0.99] per year of greater age), formal housing (HR=0.38 [0.19-0.78]), and steady employment (HR= 0.41 [0.19-0.90]) were associated with decreased risk of default, while recent alcohol use (HR= 2.1 [1.1-4.0]), recent drug use (HR= 2.0 [1.0-3.6]), and Coloured (mixed ancestry) ethnicity (HR= 2.3 [1.1-5.0]) were associated with increased risk of default (P< 0.05). Defaults occurred throughout the first 18 months of the two-year treatment course but were especially frequent among alcohol users after discharge from the initial four-to-five-month in-hospital phase of treatment, with the highest default rates occurring among alcohol users within two months of discharge. Default rates during the first two months after discharge were also elevated for patients who received care from mobile clinics. Conclusions: Among patients who were not cured or did not complete MDR-TB treatment, the majority defaulted from treatment. Younger, economically-unstable patients and alcohol and drug users were particularly at risk. For alcohol users as well as mobile-clinic patients, the early outpatient treatment phase is a high-risk period for default that could be targeted in efforts to increase treatment completion rates.	[Kendall, Emily A.] Johns Hopkins Univ Hosp, Sch Med, Div Infect Dis, Baltimore, MD 21287 USA; [Theron, Danie] Brewelskloof Hosp, Worcester, South Africa; [Franke, Molly F.; Murray, Megan B.] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [van Helden, Paul; Victor, Thomas C.; Warren, Robin M.; Jacobson, Karen R.] Univ Stellenbosch, Div Mol Biol & Human Genet, Fac Med & Hlth Sci, ZA-7505 Tygerberg, South Africa; [Murray, Megan B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Jacobson, Karen R.] Boston Univ, Sch Med, Infect Dis Sect, Boston, MA 02118 USA	Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Harvard Medical School; Stellenbosch University; Harvard University; Harvard T.H. Chan School of Public Health; Boston University	Kendall, EA (corresponding author), Johns Hopkins Univ Hosp, Sch Med, Div Infect Dis, Baltimore, MD 21287 USA.	ekendal2@jhmi.edu	Franke, Molly/AAK-7559-2020; Jacobson, Karen/AAX-9461-2021	Franke, Molly/0000-0002-4890-5728; Kendall, Emily/0000-0002-0083-422X; Jacobson, Karen/0000-0003-4239-3685; Warren, Robin/0000-0001-5741-7358	Partners Center of Expertise Travel Grant; Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene Postdoctoral Fellowship in Tropical Infectious Diseases; National Institutes of Health/Fogarty International Center [1K01 TW009213]; FOGARTY INTERNATIONAL CENTER [K01TW009213] Funding Source: NIH RePORTER	Partners Center of Expertise Travel Grant; Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene Postdoctoral Fellowship in Tropical Infectious Diseases; National Institutes of Health/Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by a Partners Center of Expertise Travel Grant (E. A. K., http://www.partners.org/Graduate-Medical-Education/CentersOf-Expertise/Global-And-Humanitarian-Health/Funding-And-Resources/Global-Travel-Grants. aspx); the Burroughs Wellcome Fund/American Society of Tropical Medicine and Hygiene Postdoctoral Fellowship in Tropical Infectious Diseases (K. R. J., http://www.astmh.org/ASTMH_Sponsored_Fellowships/3506.htm); and the National Institutes of Health/Fogarty International Center (1K01 TW009213 to K. R. J., www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2009, CAPE WINELANDS OVERB; Andrews JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015735; [Anonymous], 2012, GLOB TUB REP 2012; [Anonymous], 2010, MAN DRUG RES TUB POL; Brasil Pedro Emmanuel Alvarenga Americano do, 2008, Cad. Saúde Pública, V24, ps485, DOI 10.1590/S0102-311X2008001600003; Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413; Dooley KE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-140; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Geneva: World Health Organization, 2013, MULT RES TUB 2013 UP; Holtz TH, 2006, INT J TUBERC LUNG D, V10, P649; Jenkins HE, 2013, INT J TUBERC LUNG D, V17, P373, DOI 10.5588/ijtld.12.0464; Jha UM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008873; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Kliiman K, 2010, INT J TUBERC LUNG D, V14, P454; Korenromp EL, 2009, INT J TUBERC LUNG D, V13, P283; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Lemanski C, 2009, HABITAT INT, V33, P472, DOI 10.1016/j.habitatint.2009.03.002; London L, 2000, DRUG ALCOHOL DEPEN, V59, P199, DOI 10.1016/S0376-8716(99)00120-9; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Nathanson E, 2006, EMERG INFECT DIS, V12, P1389, DOI 10.3201/eid1209.051618; Ojo OA, 2010, SAMJ S AFR MED J, V100, P180, DOI 10.7196/SAMJ.3767; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Rehm J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-450; Schafer JL, 2010, ANAL INCOMPLETE MULT; Shean KP, 2008, INT J TUBERC LUNG D, V12, P1182; Shin S, 2013, ADDICTION, V108, P1387, DOI 10.1111/add.12148; Shin SS, 2010, AM J RESP CRIT CARE, V182, P426, DOI 10.1164/rccm.200911-1768OC; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Van der Walt M, 2009, NATL STUDY IDENTIFY; World Health Organization, 2011, WHO PROGRESS REPORT	31	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83480	10.1371/journal.pone.0083480	http://dx.doi.org/10.1371/journal.pone.0083480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349518	Green Published, gold			2022-12-27	WOS:000328734200092
J	Yuzefovych, LV; LeDoux, SP; Wilson, GL; Rachek, LI				Yuzefovych, Larysa V.; LeDoux, Susan P.; Wilson, Glenn L.; Rachek, Lyudmila I.			Mitochondrial DNA Damage via Augmented Oxidative Stress Regulates Endoplasmic Reticulum Stress and Autophagy: Crosstalk, Links and Signaling	PLOS ONE			English	Article							SKELETAL-MUSCLE CELLS; INSULIN-RESISTANCE; ER STRESS; DYSFUNCTION; PALMITATE; APOPTOSIS; PREVENTS; KINASE	Saturated free fatty acids (FFAs) have been implicated in the increase of oxidative stress, mitochondrial dysfunction, endoplasmic reticulum (ER) stress, autophagy, and insulin resistance (IR) observed in skeletal muscle. Previously, we have shown that palmitate-induced mitochondrial DNA (mtDNA) damage triggers mitochondrial dysfunction, mitochondrial reactive oxygen species (mtROS) production, apoptosis and IR in L6 myotubes. The present study showed that mitochondrial overexpression of human 8-oxoguanine DNA glycosylase/AP lyase (hOGG1) decreased palmitate-induced carbonylation of proteins in mitochondria. Additionally, we found that protection of mtDNA from palmitate-induced damage significantly diminished markers of both ER stress and autophagy in L6 myotubes. Moreover, we observed that the addition of ROS scavenger, N-acetylcystein (NAC), to palmitate diminished both ER stress and autophagy markers mimicking the effect of mitochondrial overexpression of hOGG1. This is the first study to show that mtDNA damage is upstream of palmitate-induced ER stress and autophagy in skeletal muscle cells.	[Yuzefovych, Larysa V.; LeDoux, Susan P.; Wilson, Glenn L.; Rachek, Lyudmila I.] Univ S Alabama, Coll Med, Dept Cell Biol & Neurosci, Mobile, AL USA	University of South Alabama	Rachek, LI (corresponding author), Univ S Alabama, Coll Med, Dept Cell Biol & Neurosci, Mobile, AL USA.	Hlrachek@jaguar1.usouthal.edu			National Institutes of Health [DK073808]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health Grants DK073808 (L. I. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; Deldicque L, 2011, EUR J APPL PHYSIOL, V111, P1553, DOI 10.1007/s00421-010-1783-1; Deldicque L, 2010, AM J PHYSIOL-ENDOC M, V299, pE695, DOI 10.1152/ajpendo.00038.2010; Hoehn KL, 2009, P NATL ACAD SCI USA, V106, P17787, DOI 10.1073/pnas.0902380106; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hwang SL, 2010, BIOCHEM BIOPH RES CO, V396, P967, DOI 10.1016/j.bbrc.2010.05.034; Kaneto H, 2005, J MOL MED, V83, P429, DOI 10.1007/s00109-005-0640-x; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Koh EH, 2007, DIABETES, V56, P2973, DOI 10.2337/db07-0510; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Mitsuhashi S, 2011, HUM MOL GENET, V20, P3841, DOI 10.1093/hmg/ddr305; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Peter A, 2009, DIABETES, V58, P1757, DOI 10.2337/db09-0188; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rachek LI, 2007, ENDOCRINOLOGY, V148, P293, DOI 10.1210/en.2006-0998; Xu WM, 2004, NAT CELL BIOL, V6, P1129, DOI 10.1038/ncb1188; Yuzefovych L, 2010, AM J PHYSIOL-ENDOC M, V299, pE1096, DOI 10.1152/ajpendo.00238.2010; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Yuzefovych LV, 2012, ENDOCRINOLOGY, V153, P92, DOI 10.1210/en.2011-1442	22	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83349	10.1371/journal.pone.0083349	http://dx.doi.org/10.1371/journal.pone.0083349			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349491	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200078
J	Li, LS; Liu, SS; Li, LH; Fan, WT; Huang, DG; Zhou, HW				Li, Lishuang; Liu, Shanshan; Li, Lihua; Fan, Wenting; Huang, Degen; Zhou, Huiwei			A Multistage Gene Normalization System Integrating Multiple Effective Methods	PLOS ONE			English	Article							PERFORMANCE	Gene/protein recognition and normalization is an important preliminary step for many biological text mining tasks. In this paper, we present a multistage gene normalization system which consists of four major subtasks: pre-processing, dictionary matching, ambiguity resolution and filtering. For the first subtask, we apply the gene mention tagger developed in our earlier work, which achieves an F-score of 88.42% on the BioCreative II GM testing set. In the stage of dictionary matching, the exact matching and approximate matching between gene names and the EntrezGene lexicon have been combined. For the ambiguity resolution subtask, we propose a semantic similarity disambiguation method based on Munkres' Assignment Algorithm. At the last step, a filter based on Wikipedia has been built to remove the false positives. Experimental results show that the presented system can achieve an F-score of 90.1%, outperforming most of the state-of-the-art systems.	[Li, Lishuang; Liu, Shanshan; Fan, Wenting; Huang, Degen; Zhou, Huiwei] Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Liaoning, Peoples R China; [Li, Lihua] Hebei Normal Univ Sci & Technol, Sch Mathmat & Informat Sci & Technol, Qinhuangdao, Hebei, Peoples R China	Dalian University of Technology; Hebei Normal University of Science & Technology	Li, LS (corresponding author), Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Liaoning, Peoples R China.	lilishuang314@163.com			National Natural Science Foundation of China [61173101, 61173100, 61272375]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by grants from the National Natural Science Foundation of China (NO. 61173101, NO. 61173100 and NO. 61272375) (http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gonzalez G, 2007, P 2 BIOCREATIVE CHAL, P227; Grover C, 2007, MADR SPAIN P BIOCREA, P273; Hakenberg J., 2007, P 2 BIOCREATIVE CHAL, P141; Hakenberg J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S14; Hu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043558, 10.1371/journal.pone.0031970]; Huang ML, 2011, BIOINFORMATICS, V27, P1032, DOI 10.1093/bioinformatics/btr042; Lau W, 2007, MADR SPAIN P 2 BIOCR, P165; Li LS, 2012, J BIOMED INFORM, V45, P156, DOI 10.1016/j.jbi.2011.10.004; Liu H, 2007, MADR SPAIN P 2 BIOCR, P135; Morgan AA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S3; Neves ML, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-157; Smith L, 2008, GENOME BIOL, V9, DOI [10.1186/gb-2008-9-s2-s2, 10.1186/gb-2008-9-S2-S2]; Wermter J, 2009, BIOINFORMATICS, V25, P815, DOI 10.1093/bioinformatics/btp071; Xia N, 2011, EXPERT SYST APPL, V38, P7994, DOI 10.1016/j.eswa.2010.12.106	14	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81956	10.1371/journal.pone.0081956	http://dx.doi.org/10.1371/journal.pone.0081956			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349160	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800030
J	Napolitano, F; Izzo, MT; Di Giuseppe, G; Angelillo, IF				Napolitano, Francesco; Izzo, Maria Teresa; Di Giuseppe, Gabriella; Angelillo, Italo F.		Collaborative Working Grp	Frequency of Inappropriate Medication Prescription in Hospitalized Elderly Patients in Italy	PLOS ONE			English	Article							ADVERSE DRUG EVENTS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ACUTELY ILL POPULATION; OLDER-ADULTS; BEERS CRITERIA; PRIMARY-CARE; AVIAN INFLUENZA; RISK-FACTORS; PREVALENCE; AMIODARONE	Background: Older people often need comprehensive treatment, including many medications, and polypharmacy is common. The aims of this cross-sectional investigation were to examine the potentially inappropriate medication during the hospitalization and to identify the factors that may influence such inappropriateness among elderly in Italy. Methods: A sample of 605 individuals aged 65 years and older admitted in non-academic public acute care hospitals was randomly selected. Prescription of inappropriate medications were evaluated during the period from the day of admission to a randomly preselected day (index day). Beers Criteria were used to evaluate appropriateness. Results: At least one potentially inappropriate medication prescription from the day of hospital admission to the index day has been observed in 188 patients (31.1%), and respectively 84.1% and 15.9% of them had received one or two inappropriate medications. A total of 15 medications was prescribed inappropriately to these 188 patients, for 215 times with a total of 1143 doses. The multivariate logistic regression analysis revealed that the significant predictors for having at least one potentially inappropriate medication prescription during the hospitalization were: patients having an elementary education level, a lower pre-admission performance-based measure of basic activities of daily living, having received an inappropriate drug before the hospitalization, a hospital stay in the general and in the specialties surgical wards, a longer length of hospital stay from the admission to the index day, and having received a higher number of drugs from the day of the hospital admission to the index day. The most prevalent inappropriate medications administered were ketorolac (27.4%), amiodarone (19.1%), and clonidine (11.2%). Conclusions: This study supports the need for clinical guidelines implementation to assist physicians in choosing the most appropriate drugs for the elderly and for effective education of all physicians.	[Napolitano, Francesco; Izzo, Maria Teresa; Di Giuseppe, Gabriella; Angelillo, Italo F.; Collaborative Working Grp] Univ Naples 2, Dept Expt Med, Naples, Italy	Universita della Campania Vanvitelli	Napolitano, F (corresponding author), Univ Naples 2, Dept Expt Med, Naples, Italy.	italof.angelillo@unina2.it	Angelillo, Italo Francesco/AAK-1301-2021	Angelillo, Italo Francesco/0000-0003-1213-6602; DI GIUSEPPE, Gabriella/0000-0003-4466-6683; Napolitano, Francesco/0000-0003-4694-2418	Italian Ministry of University and Research [MIUR/PRIN2008-H8YFRE]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by the following Research Grant: Programs of Scientific Research of Relevant National Interest by the Italian Ministry of University and Research (MIUR/PRIN2008-H8YFRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate R, 2008, AM J INFECT CONTROL, V36, P39, DOI 10.1016/j.ajic.2007.01.006; Abbate R, 2006, EMERG INFECT DIS, V12, P1762, DOI 10.3201/eid1211.060671; Abd Wahab MS, 2012, INT J CLIN PHARM-NET, V34, P855, DOI 10.1007/s11096-012-9681-8; Akazawa M, 2010, AM J GERIATR PHARMAC, V8, P146, DOI 10.1016/j.amjopharm.2010.03.005; Berdot Sarah, 2009, BMC Geriatr, V9, P30, DOI 10.1186/1471-2318-9-30; Bregnhoj L, 2007, PHARM WORLD SCI, V29, P109, DOI 10.1007/s11096-007-9108-0; Brekke M, 2008, SCAND J PRIM HEALTH, V26, P80, DOI 10.1080/02813430802002875; Buck MD, 2009, AM J GERIATR PHARMAC, V7, P84, DOI 10.1016/j.amjopharm.2009.03.001; Chang CH, 2011, PHARMACOEPIDEM DR S, V20, P763, DOI 10.1002/pds.2140; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen LL, 2012, INT J CLIN PHARM-NET, V34, P596, DOI 10.1007/s11096-012-9651-1; Chen YC, 2009, PHARMACOEPIDEM DR S, V18, P53, DOI 10.1002/pds.1684; Colloca G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046669; Dedhiya SD, 2010, AM J GERIATR PHARMAC, V8, P562, DOI 10.1016/S1543-5946(10)80005-4; Di Giuseppe G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-36; Ernawati DK, 2008, BRIT J CLIN PHARMACO, V66, P82, DOI 10.1111/j.1365-2125.2008.03177.x; Fick DM, 2003, ARCH INTERN MED, V163, P2716, DOI 10.1001/archinte.163.22.2716; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Finlayson E, 2011, J AM GERIATR SOC, V59, P2139, DOI 10.1111/j.1532-5415.2011.03567.x; Fu AZ, 2007, MED CARE, V45, P472, DOI 10.1097/01.mlr.0000254571.05722.34; Gallagher P, 2011, EUR J CLIN PHARMACOL, V67, P1175, DOI 10.1007/s00228-011-1061-0; Gallagher PF, 2008, AGE AGEING, V37, P96, DOI 10.1093/ageing/afm116; Gnjidic D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-115; Hamilton H, 2011, ARCH INTERN MED, V171, P1013, DOI 10.1001/archinternmed.2011.215; Harugeri A, 2010, J POSTGRAD MED, V56, P186, DOI 10.4103/0022-3859.68642; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; Kim MH, 2011, CLIN THER, V33, P1668, DOI 10.1016/j.clinthera.2011.10.005; Lai HY, 2009, CLIN THER, V31, P1859, DOI 10.1016/j.clinthera.2009.08.023; Lanas A, 2006, GUT, V55, P1731, DOI 10.1136/gut.2005.080754; Lehnert T, 2011, MED CARE RES REV, V68, P387, DOI 10.1177/1077558711399580; Lin HY, 2008, DRUG AGING, V25, P49, DOI 10.2165/00002512-200825010-00006; Lund BC, 2010, ANN PHARMACOTHER, V44, P957, DOI 10.1345/aph.1M657; Maio V, 2010, J CLIN PHARM THER, V35, P219, DOI 10.1111/j.1365-2710.2009.01094.x; Marcum ZA, 2012, AM J GERIATR PHARMAC, V10, P151, DOI 10.1016/j.amjopharm.2012.03.002; Meurer WJ, 2010, ACAD EMERG MED, V17, P231, DOI [10.1111/j.1553-2712.2010.00667.x, 10.1111/j.1553-2712.2010.00717.x]; Vishwas H, 2012, GERIATR GERONTOL INT, V12, P506, DOI 10.1111/j.1447-0594.2011.00806.x; O'Mahony D, 2008, AGE AGEING, V37, P138, DOI 10.1093/ageing/Afm189; Oliveira MG, 2012, INT J CLIN PHARM-NET, V34, P626, DOI 10.1007/s11096-012-9656-9; Onder G, 2005, EUR J CLIN PHARMACOL, V61, P453, DOI 10.1007/s00228-005-0928-3; Opondo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043617; Passman RS, 2012, AM J MED, V125, P447, DOI 10.1016/j.amjmed.2011.09.020; Pelullo CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042856; Radosevic N, 2008, PHARMACOEPIDEM DR S, V17, P733, DOI 10.1002/pds.1531; Rothberg MB, 2008, J HOSP MED, V3, P91, DOI 10.1002/jhm.290; Ruggiero C, 2009, DRUG AGING, V26, P15, DOI 10.2165/11534630-000000000-00000; Ryan C, 2009, BRIT J CLIN PHARMACO, V68, P936, DOI 10.1111/j.1365-2125.2009.03531.x; Sacerdote C, 2012, INT J EPIDEMIOL, V41, P1162, DOI 10.1093/ije/dys091; Sakuma M, 2011, PHARMACOEPIDEM DR S, V20, P386, DOI 10.1002/pds.2110; Munoz-Torrero JFS, 2010, EUR J CLIN PHARMACOL, V66, P1257, DOI 10.1007/s00228-010-0866-6; Schafer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014060; Serebruany VL, 2005, AM J CARDIOL, V95, P1218, DOI 10.1016/j.amjcard.2005.01.049; Sessa A, 2010, EUR J PUBLIC HEALTH, V20, P631, DOI 10.1093/eurpub/ckp204; Shiyanbola OO, 2010, AM J GERIATR PHARMAC, V8, P245, DOI 10.1016/j.amjopharm.2010.06.002; Song YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068599; Stata Corporation, 2007, STAT REF MAN REL 10	55	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82359	10.1371/journal.pone.0082359	http://dx.doi.org/10.1371/journal.pone.0082359			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EU	24349262	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800058
J	Wu, ZQ; Gudur, MSR; Deng, CX				Wu, Ziqi; Gudur, Madhu S. R.; Deng, Cheri X.			Transmural Ultrasound Imaging of Thermal Lesion and Action Potential Changes in Perfused Canine Cardiac Wedge Preparations by High Intensity Focused Ultrasound Ablation	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; ATRIAL-FIBRILLATION; CATHETER ABLATION; IN-VITRO; CONDUCTION; SIZE; MYOCARDIUM	Intra-procedural imaging is important for guiding cardiac arrhythmia ablation. It is difficult to obtain intra-procedural correlation of thermal lesion formation with action potential (AP) changes in the transmural plane during ablation. This study tested parametric ultrasound imaging for transmural imaging of lesion and AP changes in high intensity focused ultrasound (HIFU) ablation using coronary perfused canine ventricular wedge preparations (n = 13). The preparations were paced from epi/endocardial surfaces and subjected to HIFU application (3.5 MHz, 11 Hz pulse-repetition-frequency, 70% duty cycle, duration 4 s, 3500 W/cm(2)), during which simultaneous optical mapping (1 kframes/s) using di-4-ANEPPS and ultrasound imaging (30 MHz) of the same transmural surface of the wedge were performed. Spatiotemporally correlated AP measurements and ultrasound imaging allowed quantification of the reduction of AP amplitude (APA), shortening of AP duration at 50% repolarization, AP triangulation, decrease of optical AP rise, and change of conduction velocity along tissue depth direction within and surrounding HIFU lesions. The threshold of irreversible change in APA correlating to lesions was determined to be 43 +/- 1% with a receiver operating characteristic (ROC) area under curve (AUC) of 0.96 +/- 0.01 (n = 13). Ultrasound imaging parameters such as integrated backscatter, Rayleigh (alpha) and log-normal (sigma) parameters, cumulative extrema of sigma were tested, with the cumulative extrema of sigma performing the best in detecting lesion (ROC AUC 0.89 +/- 0.01, n = 13) and change of APA (ROC AUC 0.79 +/- 0.03, n = 13). In conclusion, characteristic tissue and AP changes in HIFU ablation were identified and spatiotemporally correlated using optical mapping and ultrasound imaging. Parametric ultrasound imaging using cumulative extrema of sigma can detect HIFU lesion and APA reduction.	[Wu, Ziqi; Gudur, Madhu S. R.; Deng, Cheri X.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Deng, CX (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	cxdeng@umich.edu	Wu, Ziqi/J-1431-2019	Wu, Ziqi/0000-0001-7654-2496	NIH [R01 EB008999]; University of Michigan; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB008999] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by funding from NIH R01 EB008999 and the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter WT, 2001, BIOPHYS J, V80, P516, DOI 10.1016/S0006-3495(01)76034-1; Cappato R, 2005, CIRCULATION, V111, P1100, DOI 10.1161/01.CIR.0000157153.30978.67; Chorro FJ, 1998, PACE, V21, P659, DOI 10.1111/j.1540-8159.1998.tb00121.x; CLIFFORD L, 1993, ULTRASOUND MED BIOL, V19, P487, DOI 10.1016/0301-5629(93)90124-7; Deng CRX, 2005, ANN BIOMED ENG, V33, P1352, DOI 10.1007/s10439-005-6806-4; Eyerly SA, 2012, HEART RHYTHM, V9, P1855, DOI 10.1016/j.hrthm.2012.07.003; Eyerly SA, 2010, J CARDIOVASC ELECTR, V21, P557, DOI 10.1111/j.1540-8167.2009.01664.x; Fedorov VV, 2007, HEART RHYTHM, V4, P619, DOI 10.1016/j.hrthm.2006.12.047; FISHBEIN MC, 1981, AM HEART J, V101, P593, DOI 10.1016/0002-8703(81)90226-X; Fleming CP, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3459134; GE YZ, 1995, PACE, V18, P323, DOI 10.1111/j.1540-8159.1995.tb02523.x; Glukhov AV, 2010, CIRC RES, V106, P981, DOI 10.1161/CIRCRESAHA.109.204891; Gudur MSR, 2012, IEEE T ULTRASON FERR, V59, P1687, DOI 10.1109/TUFFC.2012.2374; Hao XH, 2002, IEEE T ULTRASON FERR, V49, P1530, DOI 10.1109/TUFFC.2002.1049735; Kobza R, 2004, HEART RHYTHM, V1, P676, DOI 10.1016/j.hrthm.2004.08.009; Kolios MC, 2002, ULTRASOUND MED BIOL, V28, P589, DOI 10.1016/S0301-5629(02)00492-1; Kumon RE, 2012, ULTRASOUND MED BIOL, V38, P626, DOI 10.1016/j.ultrasmedbio.2012.01.004; LANGBERG JJ, 1992, CIRCULATION, V86, P1469, DOI 10.1161/01.CIR.86.5.1469; Lardo AC, 2000, CIRCULATION, V102, P698, DOI 10.1161/01.CIR.102.6.698; Laughner JI, 2012, AM J PHYSIOL-HEART C, V303, pH753, DOI 10.1152/ajpheart.00404.2012; Libbus I, 2004, AM J PHYSIOL-HEART C, V286, pH1901, DOI 10.1152/ajpheart.00581.2003; Marrouche NF, 2003, CIRCULATION, V107, P2710, DOI 10.1161/01.CIR.0000070541.83326.15; Melby SJ, 2008, HEART RHYTHM, V5, P1296, DOI 10.1016/j.hrthm.2008.06.009; Miyagi Y, 2009, J CARDIAC SURG, V24, P34, DOI 10.1111/j.1540-8191.2008.00747.x; Morady F, 1999, NEW ENGL J MED, V340, P534, DOI 10.1056/NEJM199902183400707; NATH S, 1994, J CARDIOVASC ELECTR, V5, P838, DOI 10.1111/j.1540-8167.1994.tb01122.x; Ouyang FF, 2005, CIRCULATION, V111, P127, DOI 10.1161/01.CIR.0000151289.73085.36; Pappone C, 2000, CIRCULATION, V102, P2619; Parsons JE, 2006, J ACOUST SOC AM, V119, P1432, DOI 10.1121/1.2166708; Perez FJ, 2006, CIRCULATION, V113, P1723, DOI 10.1161/CIRCULATIONAHA.105.596593; Reddy VY, 2009, CIRCULATION, V120, P12, DOI 10.1161/CIRCULATIONAHA.108.840587; Saha RK, 2011, IEEE T ULTRASON FERR, V58, P2118, DOI 10.1109/TUFFC.2011.2061; Vaseghi M, 2005, HEART RHYTHM, V2, P914, DOI 10.1016/j.hrthm.2005.06.007; Voss F, 2009, HEART RHYTHM, V6, P1028, DOI 10.1016/j.hrthm.2009.03.028; Wood MA, 2002, J CARDIOVASC ELECTR, V13, P56, DOI 10.1046/j.1540-8167.2002.00056.x; Wright M, 2011, HEART RHYTHM, V8, P304, DOI 10.1016/j.hrthm.2010.10.039; Wu CC, 1999, J CARDIOVASC ELECTR, V10, P1252, DOI 10.1111/j.1540-8167.1999.tb00303.x; Yokoyama K, 2008, CIRC-ARRHYTHMIA ELEC, V1, P354, DOI 10.1161/CIRCEP.108.803650	38	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82689	10.1371/journal.pone.0082689	http://dx.doi.org/10.1371/journal.pone.0082689			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349337	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800073
J	Barlow, FK; Hornsey, MJ; Thai, M; Sengupta, NK; Sibley, CG				Barlow, Fiona Kate; Hornsey, Matthew J.; Thai, Michael; Sengupta, Nikhil K.; Sibley, Chris G.			The Wallpaper Effect: The Contact Hypothesis Fails for Minority Group Members Who Live in Areas with a High Proportion of Majority Group Members	PLOS ONE			English	Article							CROSS-GROUP FRIENDSHIPS; INTERGROUP CONTACT; RACIAL-DISCRIMINATION; INTERRACIAL CONTACT; PREJUDICE-REDUCTION; GROUP THREAT; ATTITUDES; WHITE; RACE; REJECTION	We aim to provide one explanation for why the link between contact and prejudice is consistently less strong for minority group members than it is for majority group members. Specifically, we propose a "wallpaper effect" such that contact works to increase minority group members' positivity towards majority groups when they live in areas densely populated with other minority group members. Conversely, we suggest that when minority group members live in neighborhoods patterned with majority group faces (as is so often the case), contact will be less transformative. We test this assumption using a large sample of both New Zealander minority (Maori; N = 925) and majority (European; N = 3805) group members. In line with predictions, Maori who lived in minority dense neighborhoods showed the traditional association between contact and increased warmth towards New Zealander Europeans. This relationship, however, was weak or non-existent when they lived in primarily European neighborhoods. Contact effects in majority group members were unaffected by neighborhood composition. The interaction held when controlling for, and was not explained by: gender, income, experiences of harm, cognitions of race-based rejection, or realistic threat. We provide the first evidence to suggest that when it comes to minority group members' intergroup attitudes, contact with majority group members may be a relatively ineffective predictor unless the "wallpaper" of their lives is minority-dense.	[Barlow, Fiona Kate; Hornsey, Matthew J.; Thai, Michael] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Sengupta, Nikhil K.; Sibley, Chris G.] Univ Auckland, Dept Psychol, Auckland, New Zealand	University of Queensland; University of Auckland	Barlow, FK (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	f.barlow@psy.uq.edu.au	Sibley, Chris G/D-2974-2009; Thai, Michael/L-4207-2019	Sibley, Chris G/0000-0002-4064-8800; Barlow, Fiona Kate/0000-0001-9533-1256; , Michael/0000-0002-8000-9413; Hornsey, Matthew/0000-0003-1275-3977	Australian Research Council [DE120102068, DP1093654]; University of Auckland FRDF [3624435/9853]; ECREA [3626075]	Australian Research Council(Australian Research Council); University of Auckland FRDF; ECREA	The research contained within this paper was in part supported by the first author's Australian Research Council Discovery Early Career Research Award (DE120102068), and Australian Research Council grants awarded to the second author (DP1093654). Collection of the New Zealand Attitudes and Values Study 2009 (NZAVS-09) data analyzed in this paper was funded by University of Auckland FRDF (#3624435/9853) and ECREA (#3626075) grants awarded to the fifth author. Parts of this manuscript were prepared while the fifth author was on sabbatical visiting the University of Queensland. In each case, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allport G. W., 1954, NATURE PREJUDICE; Ayers JW, 2009, SOC SCI QUART, V90, P593, DOI 10.1111/j.1540-6237.2009.00633.x; Barlow FK, 2012, PERS SOC PSYCHOL B, V38, P1629, DOI 10.1177/0146167212457953; Barlow FK, 2012, BRIT J SOC PSYCHOL, V51, P167, DOI 10.1111/j.2044-8309.2011.02040.x; Barlow FK, 2010, EUR J SOC PSYCHOL, V40, P805, DOI 10.1002/ejsp.651; Barlow FK, 2009, BRIT J SOC PSYCHOL, V48, P389, DOI 10.1348/014466608X387089; Binder J, 2009, J PERS SOC PSYCHOL, V96, P843, DOI 10.1037/a0013470; Bobo L, 1998, AM BEHAV SCI, V41, P985, DOI 10.1177/0002764298041007009; Briggs XD, 2007, CITY COMMUNITY, V6, P263; Brown R, 1999, EUR J SOC PSYCHOL, V29, P741, DOI 10.1002/(SICI)1099-0992(199908/09)29:5/6<741::AID-EJSP972>3.0.CO;2-8; Brown R, 2005, ADV EXP SOC PSYCHOL, V37, P255, DOI 10.1016/S0065-2601(05)37005-5; Cernat V, 2010, J COMMUNITY APPL SOC, V20, P15, DOI 10.1002/casp.1001; Chauhan P, 2010, J COMMUNITY PSYCHOL, V38, P532, DOI 10.1002/jcop.20377; Costarelli S, 2006, J SOC PSYCHOL, V146, P5, DOI 10.3200/SOCP.146.1.5-13; Crystal DS, 2008, BRIT J DEV PSYCHOL, V26, P51, DOI 10.1348/026151007X198910; Davies K, 2011, PERS SOC PSYCHOL REV, V15, P332, DOI 10.1177/1088868311411103; Dixon J, 2012, BEHAV BRAIN SCI, V35, P411, DOI 10.1017/S0140525X11002214; Dixon J, 2010, J SOC ISSUES, V66, P401, DOI 10.1111/j.1540-4560.2010.01652.x; Dixon J, 2010, CURR DIR PSYCHOL SCI, V19, P76, DOI 10.1177/0963721410363366; Hamm JV, 2001, YOUTH SOC, V33, P62, DOI 10.1177/0044118X01033001003; Hewstone M., 2005, SOCIAL PSYCHOL INCLU, P265, DOI 10.4324; Hunt MO, 2007, SOC PSYCHOL QUART, V70, P272, DOI 10.1177/019027250707000306; KIRCHLER E, 1995, J COMMUNITY APPL SOC, V5, P59, DOI 10.1002/casp.2450050105; Paolini S, 2004, PERS SOC PSYCHOL B, V30, P770, DOI 10.1177/0146167203262848; Pettigrew TF, 2008, EUR J SOC PSYCHOL, V38, P922, DOI 10.1002/ejsp.504; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Quillian L, 1996, AM J SOCIOL, V102, P816, DOI 10.1086/230998; QUILLIAN L, 1995, AM SOCIOL REV, V60, P586, DOI 10.2307/2096296; Sengupta NK, 2013, PERS SOC PSYCHOL B, V39, P1391, DOI 10.1177/0146167213497593; Sengupta NK, 2012, INT J INTERCULT REL, V36, P506, DOI 10.1016/j.ijintrel.2011.12.011; Sibley CG, 2004, NEW ZEAL J PSYCHOL, V33, P88; Sibley CG, 2009, AUST J PSYCHOL, V61, P119, DOI 10.1080/00049530802239300; Swart H, 2011, J PERS SOC PSYCHOL, V101, P1221, DOI 10.1037/a0024450; Tausch N, 2011, GROUP PROCESS INTERG, V14, P239, DOI 10.1177/1368430210390534; Taylor MC, 1998, AM SOCIOL REV, V63, P512, DOI 10.2307/2657265; Tropp LR, 2007, SOC PSYCHOL QUART, V70, P70, DOI 10.1177/019027250707000108; Tropp LR, 2006, J APPL SOC PSYCHOL, V36, P769, DOI 10.1111/j.0021-9029.2006.00031.x; Tropp LR, 2005, PSYCHOL SCI, V16, P951, DOI 10.1111/j.1467-9280.2005.01643.x; Wagner U, 2003, GROUP PROCESS INTERG, V6, P22, DOI 10.1177/1368430203006001010; WAGNER U, 1989, HUM RELAT, V42, P561, DOI 10.1177/001872678904200701; Wagner U, 2006, SOC PSYCHOL QUART, V69, P380, DOI 10.1177/019027250606900406; Wright S.C., 2009, INTERGROUP MISUNDERS, P291, DOI [10.4324/9780203848814, DOI 10.4324/9780203848814]	42	28	28	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82228	10.1371/journal.pone.0082228	http://dx.doi.org/10.1371/journal.pone.0082228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349227	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300086
J	Comte, A; Christen, P; Davidson, S; Pophillat, M; Lorquin, J; Auria, R; Simon, G; Casalot, L				Comte, Alexia; Christen, Pierre; Davidson, Sylvain; Pophillat, Matthieu; Lorquin, Jean; Auria, Richard; Simon, Gwenola; Casalot, Laurence			Biochemical, Transcriptional and Translational Evidences of the Phenol-meta-Degradation Pathway by the Hyperthermophilic Sulfolobus solfataricus 98/2	PLOS ONE			English	Article							KINETIC-PARAMETERS; BACILLUS-STEAROTHERMOPHILUS; THERMOSTABLE ENZYMES; CONTINUOUS CULTURES; PSEUDOMONAS-PUTIDA; SP A2; STRAIN; BIODEGRADATION; INDUCTION; CATECHOL	Phenol is a widespread pollutant and a model molecule to study the biodegradation of monoaromatic compounds. After a first oxidation step leading to catechol in mesophilic and thermophilic microorganisms, two main routes have been identified depending on the cleavage of the aromatic ring: ortho involving a catechol 1,2 dioxygenase (C12D) and meta involving a catechol 2,3 dioxygenase (C23D). Our work aimed at elucidating the phenol-degradation pathway in the hyperthermophilic archaea Sulfolobus solfataricus 98/2. For this purpose, the strain was cultivated in a fermentor under different substrate and oxygenation conditions. Indeed, reducing dissolved-oxygen concentration allowed slowing down phenol catabolism (specific growth and phenol-consumption rates dropped 55% and 39%, respectively) and thus, evidencing intermediate accumulations in the broth. HPLC/Diode Array Detector and LC-MS analyses on culture samples at low dissolved-oxygen concentration (DOC = 0.06 mg.L-1) suggested, apart for catechol, the presence of 2-hydroxymuconic acid, 4-oxalocrotonate and 4-hydroxy-2-oxovalerate, three intermediates of the meta route. RT-PCR analysis on oxygenase-coding genes of S. solfataricus 98/2 showed that the gene coding for the C23D was expressed only on phenol. In 2D-DIGE/MALDI-TOF analysis, the C23D was found and identified only on phenol. This set of results allowed us concluding that S. solfataricus 98/2 degrade phenol through the meta route.	[Comte, Alexia; Christen, Pierre; Davidson, Sylvain; Lorquin, Jean; Auria, Richard; Simon, Gwenola; Casalot, Laurence] Aix Marseille Univ, CNRS, INSU, IRD,MIO,UM 110, Marseille, France; [Comte, Alexia; Christen, Pierre; Davidson, Sylvain; Lorquin, Jean; Auria, Richard; Simon, Gwenola; Casalot, Laurence] Univ Sud Toulon Var, CNRS, INSU, IRD,MIO,UM 110, La Garde, France; [Pophillat, Matthieu] Aix Marseille Univ, CNRS, Inst J Paoli I Calmettes, CRCM,UMR7258, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Christen, P (corresponding author), Aix Marseille Univ, CNRS, INSU, IRD,MIO,UM 110, Marseille, France.	pierre.christen@univ-amu.fr	Casalot, Laurie/B-7536-2013; Casalot, Laurie/ABB-7062-2021	Casalot, Laurie/0000-0002-4191-6889; Casalot, Laurie/0000-0002-4191-6889	CIFRE fellowship (Kemesys/ANRT)	CIFRE fellowship (Kemesys/ANRT)	Alexia Comte was the recipient of a CIFRE fellowship (Kemesys/ANRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS D, 1988, J GEN MICROBIOL, V134, P3179; Agarry SE, 2008, INT J ENVIRON POLLUT, V32, P12, DOI 10.1504/IJEP.2008.016895; Ali S, 1998, ENZYME MICROB TECH, V23, P462, DOI 10.1016/S0141-0229(98)00072-6; [Anonymous], 2012, IJESAT; Banerjee A, 2010, BIORESOURCE TECHNOL, V101, P5501, DOI 10.1016/j.biortech.2010.02.018; Bertoldo C, 2004, ENG LIFE SCI, V4, P521, DOI 10.1002/elsc.200402155; Bouzas TD, 2006, PROTEIN PEPTIDE LETT, V13, P645, DOI 10.2174/092986606777790548; Busca G, 2008, J HAZARD MATER, V160, P265, DOI 10.1016/j.jhazmat.2008.03.045; BUSWELL JA, 1975, J GEN MICROBIOL, V87, P377, DOI 10.1099/00221287-87-2-377; Cao B, 2008, APPL MICROBIOL BIOT, V81, P99, DOI 10.1007/s00253-008-1728-3; Chae JC, 2007, BIOCHEM BIOPH RES CO, V357, P815, DOI 10.1016/j.bbrc.2007.04.027; Christen P, 2012, BIOCHEM ENG J, V62, P56, DOI 10.1016/j.bej.2011.12.012; Christen P, 2011, BIODEGRADATION, V22, P475, DOI 10.1007/s10532-010-9420-6; Contreras EM, 2008, J HAZARD MATER, V158, P366, DOI 10.1016/j.jhazmat.2008.01.082; Feitkenhauer H, 2003, J BIOTECHNOL, V103, P129, DOI 10.1016/S0168-1656(03)00105-6; Feitkenhauer H, 2001, APPL MICROBIOL BIOT, V57, P744; Haki GD, 2003, BIORESOURCE TECHNOL, V89, P17, DOI 10.1016/S0960-8524(03)00033-6; HAMZAH RY, 1994, APPL MICROBIOL BIOT, V41, P250, DOI 10.1007/BF00186968; Izzo V, 2005, RES MICROBIOL, V156, P677, DOI 10.1016/j.resmic.2005.04.001; Kapley A, 2001, WORLD J MICROB BIOT, V17, P801, DOI 10.1023/A:1013526001972; Leonard D, 1998, MICROBIOL-UK, V144, P241, DOI 10.1099/00221287-144-1-241; Leonard D, 1999, BIOTECHNOL BIOENG, V65, P407; Liebgott PP, 2007, FEMS MICROBIOL LETT, V276, P26, DOI 10.1111/j.1574-6968.2007.00896.x; Loh KC, 2002, ENZYME MICROB TECH, V30, P620, DOI 10.1016/S0141-0229(02)00016-9; Lucas S, 2009, SULFOLOBUS SOLFATARI; Mutzel A, 1996, APPL MICROBIOL BIOT, V46, P593, DOI 10.1007/s002530050866; Niehaus F, 1999, APPL MICROBIOL BIOT, V51, P711, DOI 10.1007/s002530051456; Nikakhtari H, 2005, CAN J CHEM ENG, V83, P493; Omokoko B, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-197; Powlowski Justin, 1994, Biodegradation, V5, P219, DOI 10.1007/BF00696461; ROLFSMEIER M, 1995, J BACTERIOL, V177, P482, DOI 10.1128/jb.177.2.482-485.1995; Seker S, 1997, APPL MICROBIOL BIOT, V47, P610; Simon G, 2009, FEMS MICROBIOL LETT, V299, P255, DOI 10.1111/j.1574-6968.2009.01759.x; Stetter KO, 2013, BIOCHEM SOC T, V41, P416, DOI 10.1042/BST20120284; Tao Y, 2004, APPL ENVIRON MICROB, V70, P3814, DOI 10.1128/AEM.70.7.3814-3820.2004; Tsirogianni I, 2004, BBA-PROTEINS PROTEOM, V1700, P117, DOI 10.1016/j.bbapap.2004.04.003; Turner P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-9; Ulas T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043401; VANSCHIE PM, 2000, BIOREMEDIAT J, V4, P1, DOI DOI 10.1080/10588330008951128; Viggor S, 2008, BIODEGRADATION, V19, P759, DOI 10.1007/s10532-008-9180-8	40	12	12	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82397	10.1371/journal.pone.0082397	http://dx.doi.org/10.1371/journal.pone.0082397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349276	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300091
J	Falkstedt, D; Sorjonen, K; Hemmingsson, T; Deary, IJ; Melin, B				Falkstedt, Daniel; Sorjonen, Kimmo; Hemmingsson, Tomas; Deary, Ian J.; Melin, Bo			Psychosocial Functioning and Intelligence Both Partly Explain Socioeconomic Inequalities in Premature Death. A Population-Based Male Cohort Study	PLOS ONE			English	Article							ALL-CAUSE-MORTALITY; COGNITIVE-ABILITY; HEALTH INEQUALITIES; SOCIAL-CLASS; MIDDLE-AGE; PERSONALITY; IQ; POSITION; RISK; ASSOCIATION	Objective: The possible contributions of psychosocial functioning and intelligence differences to socioeconomic status (SES)-related inequalities in premature death were investigated. None of the previous studies focusing on inequalities in mortality has included measures of both psychosocial functioning and intelligence. Methods: The study was based on a cohort of 49 321 men born 1949-1951 from the general community in Sweden. Data on psychosocial functioning and intelligence from military conscription at similar to 18 years of age were linked with register data on education, occupational class, and income at 35-39 years of age. Psychosocial functioning was rated by psychologists as a summary measure of differences in level of activity, power of initiative, independence, and emotional stability. Intelligence was measured through a multidimensional test. Causes of death between 40 and 57 years of age were followed in registers. Results: The estimated inequalities in all-cause mortality by education and occupational class were attenuated with 32% (95% confidence interval: 20-45%) and 41% (29-52%) after adjustments for individual psychological differences; both psychosocial functioning and intelligence contributed to account for the inequalities. The inequalities in cardiovascular and injury mortality were attenuated by as much as 51% (24-76%) and 52% (35-68%) after the same adjustments, and the inequalities in alcohol-related mortality were attenuated by up to 33% (8-59%). Less of the inequalities were accounted for when those were measured by level of income, with which intelligence had a weaker correlation. The small SES-related inequalities in cancer mortality were not attenuated by adjustment for intelligence. Conclusions: Differences in psychosocial functioning and intelligence might both contribute to the explanation of observed SES-related inequalities in premature death, but the magnitude of their contributions likely varies with measure of socioeconomic status and cause of death. Both psychosocial functioning and intelligence should be considered in future studies.	[Falkstedt, Daniel] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Falkstedt, Daniel; Sorjonen, Kimmo; Melin, Bo] Karolinska Inst, Dept Clin Neurosci, Div Psychol, Stockholm, Sweden; [Hemmingsson, Tomas] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Hemmingsson, Tomas] Stockholm Univ, Ctr Social Res Alcohol & Drugs, S-10691 Stockholm, Sweden; [Deary, Ian J.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Stockholm University; University of Edinburgh	Falkstedt, D (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	daniel.falkstedt@ki.se	Deary, Ian J/C-6297-2009	Deary, Ian J/0000-0002-1733-263X; Falkstedt, Daniel/0000-0003-4441-7003; Hemmingsson, Tomas/0000-0001-6156-3964; Melin, Bo Arthur/0000-0002-8008-2215	Swedish Research Council [2007-0992]; Swedish Council for Working Life and Social Research [2011-0634]; BBSRC; EPSRC; ESRC; MRC [G0700704/84698]; Medical Research Council [G0700704, MR/K026992/1] Funding Source: researchfish; MRC [G0700704] Funding Source: UKRI	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Swedish Research Council (http://www.vr.se/), project no. 2007-0992, and the Swedish Council for Working Life and Social Research (http://www.fas.se/), project no. 2011-0634. The funder had no role in the study design, in the collection, analysis, and interpretation of data, in the writing of the paper, or in the decision to submit the paper for publication. The researchers were independent from the funders and sponsors of the study. IJD is a member of The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Life Long Health and Wellbeing Initiative. Funding from the BBSRC, EPSRC, ESRC and MRC is gratefully acknowledged (G0700704/84698).	[Anonymous], 2003, PERSONALITY TRAITS; Batty GD, 2009, EUR HEART J, V30, P1903, DOI 10.1093/eurheartj/ehp254; Batty GD, 2009, AM J EPIDEMIOL, V169, P606, DOI 10.1093/aje/kwn381; Batty GD, 2006, BMJ-BRIT MED J, V332, P580, DOI 10.1136/bmj.38723.660637.AE; Borghans L, 2011, PERS INDIV DIFFER, V51, P315, DOI 10.1016/j.paid.2011.03.029; Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190; Canty A, 2012, BOOT BOOTSTRAP R S P; Chapman BP, 2010, AM J EPIDEMIOL, V171, P83, DOI 10.1093/aje/kwp323; Costa PT, 1997, J PERS ASSESS, V68, P86, DOI 10.1207/s15327752jpa6801_7; Deary Ian J, 2010, Psychol Sci Public Interest, V11, P53, DOI 10.1177/1529100610387081; Gallacher J, 2008, INT J EPIDEMIOL, V37, P602, DOI 10.1093/ije/dyn062; Galobardes B, 2007, BRIT MED BULL, V81-82, P21, DOI 10.1093/bmb/ldm001; Gottfredson LS, 2004, CURR DIR PSYCHOL SCI, V13, P1, DOI 10.1111/j.0963-7214.2004.01301001.x; Gottfredson LS, 2004, J PERS SOC PSYCHOL, V86, P174, DOI 10.1037/0022-3514.86.1.174; Hart CL, 2003, PSYCHOSOM MED, V65, P877, DOI 10.1097/01.PSY.0000088584.82822.86; Hayes LJ, 2002, J EPIDEMIOL COMMUN H, V56, P762, DOI 10.1136/jech.56.10.762; Heckman JJ, 2007, P NATL ACAD SCI USA, V104, P13250, DOI 10.1073/pnas.0701362104; Hemmingsson T, 2006, INT J EPIDEMIOL, V35, P665, DOI 10.1093/ije/dyi321; Hemmingsson T, 2009, J EPIDEMIOL COMMUN H, V63, P697, DOI 10.1136/jech.2008.079160; Jokela M, 2009, PSYCHOSOM MED, V71, P322, DOI 10.1097/PSY.0b013e31819b69f6; Just C, 2011, PERS INDIV DIFFER, V50, P765, DOI 10.1016/j.paid.2011.01.008; Krueger RF, 2000, J PERS, V68, P967, DOI 10.1111/1467-6494.00123; Lager A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5282; Lilieblad B, 1977, C5501107 FOA ARM FOR; Lindqvist E, 2011, AM ECON J-APPL ECON, V3, P101, DOI 10.1257/app.3.1.101; Mackenbach JP, 2012, SOC SCI MED, V75, P761, DOI 10.1016/j.socscimed.2012.02.031; Mackenbach JP, 2005, J EPIDEMIOL COMMUN H, V59, P268, DOI 10.1136/jech.2004.026807; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Nabi H, 2008, INT J EPIDEMIOL, V37, P591, DOI 10.1093/ije/dyn021; Ozer DJ, 2006, ANNU REV PSYCHOL, V57, P401, DOI 10.1146/annurev.psych.57.102904.190127; Pulkki L, 2003, INT J EPIDEMIOL, V32, P968, DOI 10.1093/ije/dyg097; Roberts BW, 2007, PERSPECT PSYCHOL SCI, V2, P313, DOI 10.1111/j.1745-6916.2007.00047.x; Singh-Manoux A, 2005, AM J EPIDEMIOL, V161, P831, DOI 10.1093/aje/kwi109; Smith TW, 2006, CURR DIR PSYCHOL SCI, V15, P227, DOI 10.1111/j.1467-8721.2006.00441.x; Sorjonen K, 2012, INTELLIGENCE, V40, P269, DOI 10.1016/j.intell.2012.02.009; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; Weiss A, 2009, PSYCHOSOM MED, V71, P385, DOI 10.1097/PSY.0b013e318198de78	37	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82031	10.1371/journal.pone.0082031	http://dx.doi.org/10.1371/journal.pone.0082031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349174	Green Published, gold			2022-12-27	WOS:000328730300070
J	Spoelstra, J; Schiff, SL; Brown, SJ				Spoelstra, John; Schiff, Sherry L.; Brown, Susan J.			Artificial Sweeteners in a Large Canadian River Reflect Human Consumption in the Watershed	PLOS ONE			English	Article							SURFACE WATERS; WASTE-WATER; MASS-SPECTROMETRY; ACESULFAME-K; SUCRALOSE; GROUNDWATER; SAMPLES; ASPARTAME	Artificial sweeteners have been widely incorporated in human food products for aid in weight loss regimes, dental health protection and dietary control of diabetes. Some of these widely used compounds can pass non-degraded through wastewater treatment systems and are subsequently discharged to groundwater and surface waters. Measurements of artificial sweeteners in rivers used for drinking water production are scarce. In order to determine the riverine concentrations of artificial sweeteners and their usefulness as a tracer of wastewater at the scale of an entire watershed, we analyzed samples from 23 sites along the entire length of the Grand River, a large river in Southern Ontario, Canada, that is impacted by agricultural activities and urban centres. Municipal water from household taps was also sampled from several cities within the Grand River Watershed. Cyclamate, saccharin, sucralose, and acesulfame were found in elevated concentrations despite high rates of biological activity, large daily cycles in dissolved oxygen and shallow river depth. The maximum concentrations that we measured for sucralose (21 mu g/L), cyclamate (0.88 mu g/L), and saccharin (7.2 mu g/L) are the highest reported concentrations of these compounds in surface waters to date anywhere in the world. Acesulfame persists at concentrations that are up to several orders of magnitude above the detection limit over a distance of 300 km and it behaves conservatively in the river, recording the wastewater contribution from the cumulative population in the basin. Acesulfame is a reliable wastewater effluent tracer in rivers. Furthermore, it can be used to assess rates of nutrient assimilation, track wastewater plume dilution, separate human and animal waste contributions and determine the relative persistence of emerging contaminants in impacted watersheds where multiple sources confound the usefulness of other tracers. The effects of artificial sweeteners on aquatic biota in rivers and in the downstream Great Lakes are largely unknown.	[Spoelstra, John; Brown, Susan J.] Environm Canada, Water Sci & Technol Directorate, Burlington, ON L7R 4A6, Canada; [Spoelstra, John; Schiff, Sherry L.] Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada	Environment & Climate Change Canada; University of Waterloo	Spoelstra, J (corresponding author), Environm Canada, Water Sci & Technol Directorate, Burlington, ON L7R 4A6, Canada.	John.Spoelstra@ec.gc.ca		Brown, Susan/0000-0003-2482-0743	Natural Sciences and Engineering Research Council (NSERC) Strategic Project [STPGP 336807-06]	Natural Sciences and Engineering Research Council (NSERC) Strategic Project	Research on the Grand River was funded by an Natural Sciences and Engineering Research Council (NSERC) Strategic Project (STPGP 336807-06; www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brorstrom-Lunden E., 2008, B1769 IVL SWED ENV R; Buerge IJ, 2011, ENVIRON SCI TECHNOL, V45, P615, DOI 10.1021/es1031272; Buerge IJ, 2009, ENVIRON SCI TECHNOL, V43, P4381, DOI 10.1021/es900126x; Engelhardt I, 2011, J HYDROL, V400, P255, DOI 10.1016/j.jhydrol.2011.01.033; Ferrer I, 2010, J CHROMATOGR A, V1217, P4127, DOI 10.1016/j.chroma.2010.02.020; Grand River Conservation Authority, 2012, GRAND RIV CONS AUTH; Hjorth M, 2011, GREENLAND CHEM ECOL, V26, P385; Huggett DB, 2011, FOOD CHEM TOXICOL, V49, P2575, DOI 10.1016/j.fct.2011.06.073; Huvaere K, 2012, FOOD ADDIT CONTAM A, V29, P54, DOI 10.1080/19440049.2011.627572; LABARE MP, 1994, APPL MICROBIOL BIOT, V42, P173, DOI [10.1007/s002530050234, 10.1007/BF00170242]; LABARE MP, 1993, ENVIRON TOXICOL CHEM, V12, P797, DOI 10.1002/etc.5620120502; Leclercq C, 1999, FOOD ADDIT CONTAM, V16, P99, DOI 10.1080/026520399284145; Leth T, 2008, FOOD ADDIT CONTAM A, V25, P662, DOI 10.1080/02652030701765749; Lillicrap A, 2011, ENVIRON TOXICOL CHEM, V30, P673, DOI 10.1002/etc.433; Lino CM, 2008, FOOD ADDIT CONTAM A, V25, P1291, DOI 10.1080/02652030802195309; Loos R, 2009, J CHROMATOGR A, V1216, P1126, DOI 10.1016/j.chroma.2008.12.048; Mawhinney DB, 2011, ENVIRON SCI TECHNOL, V45, P8716, DOI 10.1021/es202404c; Minten J, 2011, INT J ENVIRON AN CH, V91, P357, DOI 10.1080/03067310903582333; Muller CE, 2011, ENVIRON POLLUT, V159, P1419, DOI 10.1016/j.envpol.2010.12.035; Oppenheimer J, 2011, WATER RES, V45, P4019, DOI 10.1016/j.watres.2011.05.014; Robertson WD, 2013, J HYDROL, V477, P43, DOI 10.1016/j.jhydrol.2012.10.048; Rosamond MS, 2012, NAT GEOSCI, V5, P715, DOI [10.1038/ngeo1556, 10.1038/NGEO1556]; Scheurer M, 2010, WATER RES, V44, P3573, DOI 10.1016/j.watres.2010.04.005; Scheurer M, 2009, ANAL BIOANAL CHEM, V394, P1585, DOI 10.1007/s00216-009-2881-y; Soh L, 2011, ENVIRON SCI TECHNOL, V45, P1363, DOI 10.1021/es102719d; The Corporation of the City of Brantford, 2013, CIT BRANTF WAT SYST; Van Stempvoort DR, 2013, SCI TOTAL ENVIRON, V461, P348, DOI 10.1016/j.scitotenv.2013.05.001; Van Stempvoort DR, 2011, GROUND WATER MONIT R, V31, P95, DOI 10.1111/j.1745-6592.2011.01353.x; Van Stempvoort DR, 2011, J HYDROL, V401, P126, DOI 10.1016/j.jhydrol.2011.02.013; Wiklund AKE, 2012, CHEMOSPHERE, V86, P50, DOI 10.1016/j.chemosphere.2011.08.049; Wolf L, 2012, SCI TOTAL ENVIRON, V430, P8, DOI 10.1016/j.scitotenv.2012.04.059	31	52	54	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82706	10.1371/journal.pone.0082706	http://dx.doi.org/10.1371/journal.pone.0082706			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349342	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300104
J	Terwagne, M; Mirabella, A; Lemaire, J; Deschamps, C; De Bolle, X; Letesson, JJ				Terwagne, Matthieu; Mirabella, Aurelie; Lemaire, Julien; Deschamps, Chantal; De Bolle, Xavier; Letesson, Jean-Jacques			Quorum Sensing and Self-Quorum Quenching in the Intracellular Pathogen Brucellamelitensis	PLOS ONE			English	Article							HOMOSERINE LACTONE ACYLASE; PSEUDOMONAS-AERUGINOSA PAO1; BRUCELLA-MELITENSIS 16M; IV SECRETION SYSTEM; AGROBACTERIUM-TUMEFACIENS; CEPHALOSPORIN ACYLASE; GENE-EXPRESSION; LUXR HOMOLOG; ENDOPLASMIC-RETICULUM; PENICILLIN ACYLASE	Brucella quorum sensing has been described as an important regulatory system controlling crucial virulence determinants such as the VirB type IV secretion system and the flagellar genes. However, the basis of quorum sensing, namely the production of autoinducers in Brucella has been questioned. Here, we report data obtained from the use of a genetic tool allowing the in situ detection of long-chain N-acyl-homoserine lactones (AHL) activity at single bacterium level in Brucella melitensis. These data are consistent with an intrinsic production of AHL by B. melitensis in low concentration both during in vitro growth and macrophage infection. Moreover, we identified a protein, named AibP, which is homologous to the AHL-acylases of various bacterial species. In vitro and during infection, expression of aibP coincided with a decrease in endogenous AHL activity within B. melitensis, suggesting that AibP could efficiently impair AHL accumulation. Furthermore, we showed that deletion of aibP in B. melitensis resulted in enhanced virB genes expression and VirB8 production as well as in a reduced flagellar genes expression and production of FlgE (hook protein) and FliC (flagellin) in vitro. Altogether, these results suggest that AHL-dependent quorum sensing and AHL-quorum quenching coexist in Brucella, at least to regulate its virulence.	[Terwagne, Matthieu; Mirabella, Aurelie; Lemaire, Julien; Deschamps, Chantal; De Bolle, Xavier; Letesson, Jean-Jacques] Univ Namur, Dept Biol, URBM, Namur, Belgium	University of Namur	Letesson, JJ (corresponding author), Univ Namur, Dept Biol, URBM, Namur, Belgium.	jean-jacques.letesson@fundp.ac.be	Jean-Jacques, LETESSON/AHB-6921-2022	LETESSON, Jean-Jacques/0000-0002-5838-0224; De Bolle, Xavier/0000-0002-3845-3043	ARC Convention from the French community of Belgium [08/13-015]; Interuniversity Attraction Poles Programme; FRIA (Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture); Aspirant du FNRS	ARC Convention from the French community of Belgium; Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); FRIA (Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture)(Fonds de la Recherche Scientifique - FNRS); Aspirant du FNRS(Fonds de la Recherche Scientifique - FNRS)	Part of this work was funded by an ARC Convention from the French community of Belgium (no. 08/13-015) and by the Interuniversity Attraction Poles Programme initiated by the Belgian Science Policy Office (http://www.belspo.be/belspo/iap/index_en.stm). AM, JL and CD were recipients of a specialization grant from FRIA (Fonds pour la Formation a la Recherche dans l'Industrie et l'Agriculture). MT has a PhD grant as "Aspirant du FNRS" (http://www.fnrs.be/fr/financer-les-chercheurs/introduction.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmer BMM, 2004, MOL MICROBIOL, V52, P933, DOI 10.1111/j.1365-2958.2004.04054.x; Arocena GM, 2010, J BACTERIOL, V192, P3434, DOI 10.1128/JB.00232-10; Ausubel FM, 1991, CURRENT PROTOCOLS MO; Barbier T, 2011, FEBS LETT, V585, P2929, DOI 10.1016/j.febslet.2011.08.011; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Boyer M, 2009, FEMS MICROBIOL ECOL, V70, P1, DOI 10.1111/j.1574-6941.2009.00745.x; Brachmann AO, 2013, NAT CHEM BIOL; Carnes EC, 2010, NAT CHEM BIOL, V6, P41, DOI [10.1038/NCHEMBIO.264, 10.1038/nchembio.264]; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; Chen CN, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-89; Danino VE, 2003, MOL MICROBIOL, V50, P511, DOI 10.1046/j.1365-2958.2003.03699.x; Delrue RM, 2005, CELL MICROBIOL, V7, P1151, DOI 10.1111/j.1462-5822.2005.00543.x; Dong YH, 2001, NATURE, V411, P813, DOI 10.1038/35081101; Dong YH, 2007, PHILOS T R SOC B, V362, P1201, DOI 10.1098/rstb.2007.2045; Dozot M, 2006, CELL MICROBIOL, V8, P1791, DOI 10.1111/j.1462-5822.2006.00749.x; DUGGLEBY HJ, 1995, NATURE, V373, P264, DOI 10.1038/373264a0; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; Ferluga S, 2007, MOL PLANT PATHOL, V8, P529, DOI [10.1111/j.1364-3703.2007.00415.x, 10.1111/J.1364-3703.2007.00415.X]; Ferooz J, 2011, MICROBIOL-SGM, V157, P1253, DOI 10.1099/mic.0.044867-0; Fretin D, 2005, CELL MICROBIOL, V7, P687, DOI 10.1111/j.1462-5822.2005.00502.x; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Godefroid M, 2010, FEMS IMMUNOL MED MIC, V59, P364, DOI 10.1111/j.1574-695X.2010.00689.x; Godfroid J, 2011, PREV VET MED; HASTINGS JW, 1977, ANNU REV MICROBIOL, V31, P549, DOI 10.1146/annurev.mi.31.100177.003001; Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87; Hoang HH, 2004, J BACTERIOL, V186, P5460, DOI 10.1128/JB.186.16.5460-5472.2004; Huang JJ, 2006, APPL ENVIRON MICROB, V72, P1190, DOI 10.1128/AEM.72.2.1190-1197.2006; Huang JJ, 2003, APPL ENVIRON MICROB, V69, P5941, DOI 10.1128/AEM.69.10.5941-5949.2003; Jubier-Maurin V, 2001, J BACTERIOL, V183, P426, DOI 10.1128/JB.183.2.426-434.2001; Khan SR, 2009, J BACTERIOL, V191, P1320, DOI 10.1128/JB.01304-08; Kim S, 2001, J BIOL CHEM, V276, P48376, DOI 10.1074/jbc.M109603200; Kim Y, 2000, STRUCTURE, V8, P1059, DOI 10.1016/S0969-2126(00)00505-0; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lamont IL, 2003, MICROBIOL-SGM, V149, P833, DOI 10.1099/mic.0.26085-0; Leadbetter JR, 2000, J BACTERIOL, V182, P6921, DOI 10.1128/JB.182.24.6921-6926.2000; Lee JH, 2006, MOL MICROBIOL, V59, P602, DOI 10.1111/j.1365-2958.2005.04960.x; Leonard S, 2007, J BACTERIOL, V189, P131, DOI 10.1128/JB.00712-06; Li Y, 1999, EUR J BIOCHEM, V262, P713, DOI 10.1046/j.1432-1327.1999.00417.x; Lin YH, 2003, MOL MICROBIOL, V47, P849, DOI 10.1046/j.1365-2958.2003.03351.x; McVey CE, 2001, J MOL BIOL, V313, P139, DOI 10.1006/jmbi.2001.5043; Mei GY, 2010, APPL ENVIRON MICROB, V76, P4933, DOI 10.1128/AEM.00477-10; Mirabella A, 2012, MICROBIOL-SGM, V158, P2642, DOI 10.1099/mic.0.060863-0; Moreno E, 2002, P NATL ACAD SCI USA, V99, P1, DOI 10.1073/pnas.022622699; Morohoshi T, 2008, BIOSCI BIOTECH BIOCH, V72, P1887, DOI 10.1271/bbb.80139; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; Patankar AV, 2009, FEMS MICROBIOL REV, V33, P739, DOI 10.1111/j.1574-6976.2009.00163.x; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; PEARSON JP, 1995, P NATL ACAD SCI USA, V92, P1490, DOI 10.1073/pnas.92.5.1490; Petersen E, 2011, J BACTERIOL; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Platt TG, 2010, TRENDS MICROBIOL, V18, P383, DOI 10.1016/j.tim.2010.05.003; Qazi SNA, 2001, INFECT IMMUN, V69, P7074, DOI 10.1128/IAI.69.11.7074-7082.2001; Rarnbow-Larsen AA, 2008, J BACTERIOL, V190, P3274, DOI 10.1128/JB.01915-07; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Roche DM, 2004, MICROBIOL-SGM, V150, P2023, DOI 10.1099/mic.0.26977-0; Romero M, 2008, FEMS MICROBIOL LETT, V280, P73, DOI 10.1111/j.1574-6968.2007.01046.x; Roop RM, 2009, MED MICROBIOL IMMUN, V198, P221, DOI 10.1007/s00430-009-0123-8; Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003; Shepherd RW, 2009, APPL ENVIRON MICROB, V75, P45, DOI 10.1128/AEM.01723-08; Sieira R, 2000, J BACTERIOL, V182, P4849, DOI 10.1128/JB.182.17.4849-4855.2000; Sieira R, 2004, MOL MICROBIOL, V54, P808, DOI 10.1111/j.1365-2958.2004.04316.x; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sio CF, 2006, INFECT IMMUN, V74, P1673, DOI 10.1128/IAI.74.3.1673-1682.2006; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Tait K, 2009, ENVIRON MICROBIOL, V11, P1792, DOI 10.1111/j.1462-2920.2009.01904.x; Taminiau B, 2002, INFECT IMMUN, V70, P3004, DOI 10.1128/IAI.70.6.3004-3011.2002; Terwagne M, 2013, CELL MICROBIOL, V15, P942, DOI 10.1111/cmi.12088; Terwagne M, 2012, BRUCELLA: MOLECULAR MICROBIOLOGY AND GENOMICS, P163; Uroz S, 2008, APPL ENVIRON MICROB, V74, P1357, DOI 10.1128/AEM.02014-07; Uroz S, 2009, CHEMBIOCHEM, V10, P205, DOI 10.1002/cbic.200800521; Uzureau S, 2007, J BACTERIOL, V189, P6035, DOI 10.1128/JB.00265-07; Uzureau S, 2010, J PROTEOME RES, V9, P3200, DOI 10.1021/pr100068p; Weeks JN, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-167; White CE, 2009, J BACTERIOL, V191, P1123, DOI 10.1128/JB.01681-08; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699; Zygmunt MS, 2006, MICROBES INFECT, V8, P2849, DOI 10.1016/j.micinf.2006.09.002	79	22	25	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82514	10.1371/journal.pone.0082514	http://dx.doi.org/10.1371/journal.pone.0082514			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349302	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300095
J	Otero, C; Linke, M; Sanchez, P; Gonzalez, A; Schaap, IAT				Otero, Carolina; Linke, Max; Sanchez, Paula; Gonzalez, Alfonso; Schaap, Iwan A. T.			Propranolol Restricts the Mobility of Single EGF-Receptors on the Cell Surface before Their Internalization	PLOS ONE			English	Article							FC-EPSILON-RI; PLASMA-MEMBRANE; LIVING CELLS; ACTIVATION; FLUORESCENCE; DIMERIZATION; DOMAIN; ENDOCYTOSIS; MICROSCOPY; DIFFUSION	The epidermal growth factor receptor is involved in morphogenesis, proliferation and cell migration. Its up-regulation during tumorigenesis makes this receptor an interesting therapeutic target. In the absence of the ligand, the inhibition of phosphatidic acid phosphohydrolase activity by propranolol treatment leads to internalization of empty/inactive receptors. The molecular events involved in this endocytosis remain unknown. Here, we quantified the effects of propranolol on the mobility of single quantum-dot labelled receptors before the actual internalization took place. The single receptors showed a clear stop-and-go motion; their diffusive tracks were continuously interrupted by sub-second stalling events, presumably caused by transient clustering. In the presence of propranolol we found that: i) the diffusion rate reduced by 22 %, which indicates an increase in drag of the receptor. Atomic force microscopy measurements did not show an increase of the effective membrane tension, such that clustering of the receptor remains the likely mechanism for its reduced mobility. ii) The receptor got frequently stalled for longer periods of multiple seconds, which may signal the first step of the internalization process.	[Otero, Carolina] Univ Andres Bello, CIMIS, Santiago, Chile; [Otero, Carolina] Ctr Desarrollo Nanociencia & Nanotecnol, Santiago, Chile; [Linke, Max; Sanchez, Paula; Schaap, Iwan A. T.] Univ Gottingen, Fac Phys, Phys Inst 3, D-37073 Gottingen, Germany; [Gonzalez, Alfonso] Pontificia Univ Catolica Chile, Fac Med, Dept Inmunol Clin & Reumatol, Santiago, Chile; [Gonzalez, Alfonso] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Envejecimiento & Regenerac, Dept Biol Celular & Mol, Santiago, Chile; [Sanchez, Paula; Schaap, Iwan A. T.] Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, Gottingen, Germany	Universidad Andres Bello; University of Gottingen; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Otero, C (corresponding author), Univ Andres Bello, CIMIS, Santiago, Chile.	maria.otero@unab.cl	Schaap, Iwan A. T./L-3177-2013	Schaap, Iwan A. T./0000-0001-6665-5104; Otero, Carolina/0000-0002-8608-9813	FONDECYT [3095010, 1100747]; BASAL [FB0807]; CONICYT [PFB12/2007]; FONDEF [D09I1104]; Cluster of Excellence; "DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain";  [MIFAB-FCHBC-MF105]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); BASAL(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDEF; Cluster of Excellence; "DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain"(German Research Foundation (DFG)); 	The authors CO & AG acknowledge the financial support of FONDECYT Postdoctoral Fellowship #3095010, BASAL Grant #FB0807, CONICYT #PFB12/2007, Fondecyt #1100747, FONDEF #D09I1104 and Program MIFAB-FCHBC-MF105. IATS & PS were funded through the Cluster of Excellence and "DFG Research Center Nanoscale Microscopy and Molecular Physiology of the Brain". The instrument development was supported by the DFG-SFB860. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulrob A, 2010, J BIOL CHEM, V285, P3145, DOI 10.1074/jbc.M109.073338; Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Ariotti N, 2010, MOL CELL BIOL, V30, P3795, DOI 10.1128/MCB.01615-09; Asp L, 2009, MOL BIOL CELL, V20, P780, DOI 10.1091/mbc.E08-03-0256; Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759; Chang JC, 2011, METHODS MOL BIOL, V726, P51, DOI 10.1007/978-1-61779-052-2_4; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Crank J., 1975, MATH DIFFUSION; Di Fiore PP, 2009, MOL ONCOL, V3, P273, DOI 10.1016/j.molonc.2009.06.002; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006; Funfschilling U, 2012, J NEUROSCI, V32, P7632, DOI 10.1523/JNEUROSCI.1352-11.2012; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Grange M, 2000, J BIOL CHEM, V275, P33379, DOI 10.1074/jbc.M006329200; Ichinose J, 2004, BIOCHEM BIOPH RES CO, V324, P1143, DOI 10.1016/j.bbrc.2004.09.173; Jovanovic OA, 2006, MOL BIOL CELL, V17, P327, DOI 10.1091/mbc.E05-06-0523; Knight JD, 2009, BIOPHYS J, V96, P566, DOI 10.1016/j.bpj.2008.10.020; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Marcus WD, 2002, ANN BIOMED ENG, V30, P1273, DOI 10.1114/1.1528614; Matsuoka S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002862; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; NIRMAL M, 1994, PHYS REV B, V50, P2293, DOI 10.1103/PhysRevB.50.2293; Norambuena A, 2010, MOL BIOL CELL, V21, P2916, DOI 10.1091/mbc.E10-02-0167; Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192; Patwardhan A, 1997, J MICROSC-OXFORD, V186, P246, DOI 10.1046/j.1365-2818.1997.1970761.x; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Ritchie K, 2003, MOL MEMBR BIOL, V20, P13, DOI 10.1080/0968768021000055698; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Sheetz MP, 1996, TRENDS CELL BIOL, V6, P85, DOI 10.1016/0962-8924(96)80993-7; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Spendier K, 2012, FEBS LETT, V586, P416, DOI 10.1016/j.febslet.2012.01.013; THOMPSON NL, 1981, BIOPHYS J, V33, P435, DOI 10.1016/S0006-3495(81)84905-3; Turkcan S, 2010, BIOPHYS J, V102, P2288; Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1; WIER ML, 1986, J CELL BIOL, V103, P215, DOI 10.1083/jcb.103.1.215	38	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e83086	10.1371/journal.pone.0083086	http://dx.doi.org/10.1371/journal.pone.0083086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349439	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200124
J	Song, LQ; Liu, DP; Wu, CG; Wu, SZ; Yang, JL; Ren, FP; Li, Y				Song, Liqiang; Liu, Dapeng; Wu, Changgui; Wu, Shouzhen; Yang, Junlan; Ren, Fangping; Li, Yan			Antibody to mCLCA3 Suppresses Symptoms in a Mouse Model of Asthma	PLOS ONE			English	Article							ACTIVATED CHLORIDE CHANNEL; MUCUS OVERPRODUCTION; T-LYMPHOCYTES; APOPTOSIS; GOB-5; EXPRESSION; PATHOGENESIS; INFLAMMATION; PROTEIN; CLONING	Background: Asthma is a complex and heterogeneous chronic inflammatory disorder that is associated with mucous cell metaplasia and mucus hypersecretion. Functional genomic analysis indicates that mucous cell metaplasia and mucus hypersecretion depend on members of the calcium-activated chloride channel (CLCA) gene family. It has been reported that the inhibition of CLCAs could relieve the symptoms of asthma. Thus, the mCLCA3 antibody may be a promising strategy to treat allergic diseases such as asthma. Methods: We constructed asthmatic mouse models of OVA-induced chronic airway inflammatory disorder to study the function of the mCLCA3 antibody. Airway inflammation was measured by HE staining; goblet cell hyperplasia and mucus hypersecretion were detected by PAS staining; muc5ac, IL-13, IFN-gamma levels in bronchoalveolar lavage fluid (BALF) were examined by ELISA; Goblet cell apoptosis was measured by TUNEL assay and alcian blue staining; mCLCA3, Bcl-2 and Bax expression were detected by RT-PCR, Western blotting and immunohistochemical analysis. Results: In our study, mice treated with mCLCA3 antibody developed fewer pathological changes compared with control mice and asthmatic mice, including a remarkable reduction in airway inflammation, the number of goblet cells and mCLCA3 expression in lung tissue. The levels of muc5ac and IL-13 were significantly reduced in BALF. We also found that the rate of goblet cell apoptosis was increased after treatment with mCLCA3 antibody, which was accompanied by an increase in Bax levels and a decrease in Bcl-2 expression in goblet cells. Conclusions: Taken together, our results indicate that mCLCA3 antibody may have the potential as an effective pharmacotherapy for asthma.	[Song, Liqiang; Liu, Dapeng; Wu, Changgui; Yang, Junlan; Ren, Fangping] Fourth Mil Med Univ, Dept Pulm & Crit Care Med, Xijing Hosp, Xian 710032, Peoples R China; [Wu, Shouzhen] Fourth Mil Med Univ, Dept Pharm, Xian 710032, Peoples R China; [Li, Yan] Fourth Mil Med Univ, Dept Cardiovasc Med, Xijing Hosp, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Li, Y (corresponding author), Fourth Mil Med Univ, Dept Cardiovasc Med, Xijing Hosp, Xian 710032, Peoples R China.	liyanshaanxi@gmail.com		Li, Yan/0000-0003-0096-0813	National Natural Science Foundation of China [81070029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support was provided by National Natural Science Foundation of China (NO. 81070029). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Beilke LD, 2009, TOXICOL LETT, V188, P38, DOI 10.1016/j.toxlet.2009.03.005; Dhanabal M, 1999, J BIOL CHEM, V274, P11721, DOI 10.1074/jbc.274.17.11721; Duan W, 2004, J IMMUNOL, V172, P7053, DOI 10.4049/jimmunol.172.11.7053; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Gaspar KJ, 2000, PHYSIOL GENOMICS, V3, P101, DOI 10.1152/physiolgenomics.2000.3.2.101; Groneberg DA, 2002, HISTOPATHOLOGY, V40, P367, DOI 10.1046/j.1365-2559.2002.01378.x; Hauber HP, 2010, J CYST FIBROS, V9, P277, DOI 10.1016/j.jcf.2010.05.002; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hoshino M, 2002, AM J RESP CRIT CARE, V165, P1132, DOI 10.1164/ajrccm.165.8.2107068; IWASHITA J, 2013, REGULATION MUC5AC MU; Klein E, 2010, AM J PHYSIOL-LUNG C, V299, pL816, DOI 10.1152/ajplung.00188.2010; Kline JN, 1998, J IMMUNOL, V160, P2555; Knudson CM, 1997, NAT GENET, V16, P358, DOI 10.1038/ng0897-358; Komiya T, 1999, BIOCHEM BIOPH RES CO, V255, P347, DOI 10.1006/bbrc.1999.0168; Kondo M, 2002, AM J RESP CELL MOL, V27, P536, DOI 10.1165/rcmb.4682; Kuyper LM, 2003, AM J MED, V115, P6, DOI 10.1016/S0002-9343(03)00241-9; Larche M, 2003, J ALLERGY CLIN IMMUN, V111, P450, DOI 10.1067/mai.2003.169; Le Cras TD, 2011, AM J PHYSIOL-LUNG C, V300, pL414, DOI 10.1152/ajplung.00346.2010; Leverkoehne I, 2002, J HISTOCHEM CYTOCHEM, V50, P829, DOI 10.1177/002215540205000609; Marino R, 2011, J IMMUNOL, V186, P4433, DOI 10.4049/jimmunol.1001539; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Mushaben EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054426; Nakanishi A, 2001, P NATL ACAD SCI USA, V98, P5175, DOI 10.1073/pnas.081510898; Patel AC, 2009, ANNU REV PHYSIOL, V71, P425, DOI 10.1146/annurev.physiol.010908.163253; Pauli BU, 2000, CLIN EXP PHARMACOL P, V27, P901, DOI 10.1046/j.1440-1681.2000.03358.x; Robichaud A, 2005, AM J RESP CELL MOL, V33, P303, DOI 10.1165/rcmb.2004-0372OC; Royce SG, 2012, MOL CELL ENDOCRINOL, V351, P167, DOI 10.1016/j.mce.2012.01.007; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; Song LQ, 2013, INT ARCH ALLERGY IMM, V161, P243, DOI 10.1159/000345972; Toda M, 2002, J ALLERGY CLIN IMMUN, V109, P246, DOI 10.1067/mai.2002.121555; Vignola AM, 1999, J ALLERGY CLIN IMMUN, V103, P563, DOI 10.1016/S0091-6749(99)70225-3; Wong CK, 2001, CLIN EXP IMMUNOL, V125, P177, DOI 10.1046/j.1365-2249.2001.01602.x; Zhang XB, 2011, INVEST OPHTH VIS SCI, V52, P6279, DOI 10.1167/iovs.10-7081; Zhou YH, 2001, AM J RESP CELL MOL, V25, P486, DOI 10.1165/ajrcmb.25.4.4578	35	10	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82367	10.1371/journal.pone.0082367	http://dx.doi.org/10.1371/journal.pone.0082367			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349268	gold, Green Submitted, Green Published			2022-12-27	WOS:000328705200079
J	Tsai, YC; Tsai, JC; Chiu, YW; Kuo, HT; Chen, SC; Hwang, SJ; Chen, TH; Kuo, MC; Chen, HC				Tsai, Yi-Chun; Tsai, Jer-Chia; Chiu, Yi-Wen; Kuo, Hung-Tien; Chen, Szu-Chia; Hwang, Shang-Jyh; Chen, Tzu-Hui; Kuo, Mei-Chuan; Chen, Hung-Chun			Is Fluid Overload More Important than Diabetes in Renal Progression in Late Chronic Kidney Disease?	PLOS ONE			English	Article							BIOIMPEDANCE SPECTROSCOPY; HEMODIALYSIS-PATIENTS; FUNCTION DECLINE; VOLUME; MORTALITY; DIALYSIS; ULTRAFILTRATION; ASSOCIATIONS; PARAMETERS; MANAGEMENT	Fluid overload is one of the major presentations in patients with late stage chronic kidney disease (CKD). Diabetes is the leading cause of renal failure, and progression of diabetic nephropathy has been associated with changes in extracellular fluid volume. The aim of the study was to assess the association of fluid overload and diabetes in commencing dialysis and rapid renal function decline (the slope of estimated glomerular filtration rate (eGFR) less than -3 ml/min per 1.73 m(2)/y) in 472 patients with stages 4-5 CKD. Fluid status was determined by bioimpedance spectroscopy method, Body Composition Monitor. The study population was further classified into four groups according to the median of relative hydration status (Delta HS = fluid overload/extracellular water) and the presence or absence of diabetes. The median level of relative hydration status was 7%. Among all patients, 207(43.9 %) were diabetic. 71 (15.0%) subjects had commencing dialysis, and 187 (39.6%) subjects presented rapid renal function decline during a median 17.3-month follow-up. Patients with fluid overload had a significantly increased risk for commencing dialysis and renal function decline independent of the presence or absence of diabetes. No significantly increased risk for renal progression was found between diabetes and non-diabetes in late CKD without fluid overload. In conclusion, fluid overload has a higher predictive value of an elevated risk for renal progression than diabetes in late CKD.	[Tsai, Yi-Chun; Tsai, Jer-Chia; Chiu, Yi-Wen; Kuo, Hung-Tien; Hwang, Shang-Jyh; Kuo, Mei-Chuan; Chen, Hung-Chun] Kaohsiung Med Univ Hosp, Div Nephrol, Kaohsiung, Taiwan; [Chen, Tzu-Hui] Kaohsiung Med Univ Hosp, Dept Nursing, Kaohsiung, Taiwan; [Tsai, Jer-Chia; Chiu, Yi-Wen; Kuo, Hung-Tien; Chen, Szu-Chia; Hwang, Shang-Jyh; Kuo, Mei-Chuan; Chen, Hung-Chun] Kaohsiung Med Univ, Fac Renal Care, Kaohsiung, Taiwan; [Chen, Szu-Chia] Kaohsiung Municipal Hsiaokang Hosp, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Kuo, MC (corresponding author), Kaohsiung Med Univ Hosp, Div Nephrol, Kaohsiung, Taiwan.	mechku@cc.kmu.edu.tw	蘇, 河名/AAE-9843-2019	Kuo, Hung-Tien/0000-0002-9931-4354				BROWNLEE M, 1992, DIABETES CARE, V15, P1835, DOI 10.2337/diacare.15.12.1835; Chen SC, 2011, CLIN J AM SOC NEPHRO, V6, P2750, DOI 10.2215/CJN.04660511; Chen SC, 2011, CLIN J AM SOC NEPHRO, V6, P724, DOI 10.2215/CJN.07700910; Crepaldi C, 2009, CONTRIB NEPHROL, V163, P1, DOI 10.1159/000223772; Di Loreto V, 2004, ACTA DIABETOL, V41, P56, DOI 10.1007/s00592-004-0145-z; Essig M, 2008, NEPHROL DIAL TRANSPL, V23, P239, DOI 10.1093/ndt/gfm542; Forbes JM, 2007, EXP CLIN ENDOCR DIAB, V115, P69, DOI 10.1055/s-2007-949721; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Gan HB, 2005, INT UROL NEPHROL, V37, P575, DOI 10.1007/s11255-005-1202-4; Hur E, 2013, AM J KIDNEY DIS, V61, P957, DOI 10.1053/j.ajkd.2012.12.017; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Moissl UM, 2006, PHYSIOL MEAS, V27, P921, DOI 10.1088/0967-3334/27/9/012; Movilli E, 2007, NEPHROL DIAL TRANSPL, V22, P3547, DOI 10.1093/ndt/gfm466; Nakayama M, 2002, PERITON DIALYSIS INT, V22, P411; Ozkahya M, 2006, NEPHROL DIAL TRANSPL, V21, P3506, DOI 10.1093/ndt/gfl487; Paniagua R, 2010, NEPHROL DIAL TRANSPL, V25, P551, DOI 10.1093/ndt/gfp395; Saran R, 2006, KIDNEY INT, V69, P1222, DOI 10.1038/sj.ki.5000186; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shurraw S, 2011, ARCH INTERN MED, V171, P1920, DOI 10.1001/archinternmed.2011.537; Tsai YC, 2013, AM J KIDNEY DIS, DOI [10.1053/j.ajkd.2013.06.011, DOI 10.1053/J.AJKD.2013.06.011.PUBMED:23896483]; TUCKER BJ, 1991, KIDNEY INT, V39, P1176, DOI 10.1038/ki.1991.149; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; United States Renal Data System, 2011, USRDS 2011 ANN DAT R; Van Biesen W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017148; Vasavada N, 2003, KIDNEY INT, V64, P1772, DOI 10.1046/j.1523-1755.2003.00273.x; Wabel P, 2009, BLOOD PURIFICAT, V27, P75, DOI 10.1159/000167013; Wieskotten S, 2008, PHYSIOL MEAS, V29, P639, DOI 10.1088/0967-3334/29/5/009; WIZEMANN V, 1995, NEPHROL DIAL TRANSPL, V10, P2114; WIZEMANN V, 1995, ARTIF ORGANS, V19, P416, DOI 10.1111/j.1525-1594.1995.tb02352.x; Wizemann V, 2008, CONTRIB NEPHROL, V161, P115, DOI 10.1159/000130423; Wizemann V, 2009, NEPHROL DIAL TRANSPL, V24, P1574, DOI 10.1093/ndt/gfn707; WOLF BA, 1991, J CLIN INVEST, V87, P31, DOI 10.1172/JCI114988; Yokoyama Hisayo, 2003, J Atheroscler Thromb, V10, P253	33	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82566	10.1371/journal.pone.0082566	http://dx.doi.org/10.1371/journal.pone.0082566			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349311	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200083
J	De Vooght, V; Carlier, V; Devos, FC; Haenen, S; Verbeken, E; Nemery, B; Hoet, PHM; Vanoirbeek, JAJ				De Vooght, Vanessa; Carlier, Vincent; Devos, Fien C.; Haenen, Steven; Verbeken, Erik; Nemery, Benoit; Hoet, Peter H. M.; Vanoirbeek, Jeroen A. J.			B-lymphocytes as Key Players in Chemical-Induced Asthma	PLOS ONE			English	Article							IMMUNOLOGICAL DETERMINANTS; DERMAL SENSITIZATION; CELL SUBSETS; MURINE MODEL; MOUSE MODEL; EFFECTOR; RESPONSES; EXPOSURE; LONG; CD19	T-lymphocytes and B-lymphocytes are key players in allergic asthma, with B-lymphocytes producing antigen-specific immunoglobulins E (IgE). We used a mouse model of chemical-induced asthma and transferred B-lymphocytes from sensitized animals into naive wild type mice, B-lymphocyte knock-out (B-KO) mice or severe combined immunodeficiency (SCID) mice. On days 1 and 8, BALB/c mice were dermally sensitized with 0.3% toluene diisocyanate (TDI) (20 mu l/ear). On day 15, mice were euthanized and the auricular lymph nodes isolated. B-lymphocytes (CD19(+)) were separated from the whole cell suspension and 175,000 cells were injected in the tail vein of naive wild type, B-KO or SCID mice. Three days later, the mice received a single oropharyngeal challenge with 0.01% TDI (20 mu l) or vehicle (acetone/olive oil (AOO)) (controls). Airway reactivity to methacholine and total and differential cell counts in the bronchoalveolar lavage (BAL) fluid were measured 24 hours after challenge. B-lymphocytes of AOO or TDI-sensitized mice were characterized for the expression of surface markers and production of cytokines. We found that transfer of B-cells obtained from mice dermally sensitized to toluene diisocyanate (TDI) into nave wild type mice, B-KO mice or SCID mice led, within three days, to an acute asthma-like phenotype after an airway challenge with TDI. This response was specific and independent of IgE. These B-lymphocytes showed antigen presenting capacities (CD80/CD86 and CD40) and consisted of B effector (Be)2- (IL-4) and Be1-lymphocytes (IFN-gamma). The transferred B-lymphocytes were visualized near large airways, 24 hours after TDI challenge. Thus, B-lymphocytes can provoke an asthmatic response without the action of T-lymphocytes and without major involvement of IgE.	[De Vooght, Vanessa; Devos, Fien C.; Haenen, Steven; Nemery, Benoit; Hoet, Peter H. M.; Vanoirbeek, Jeroen A. J.] Lab Occupat & Environm Toxicol, Louvain, Belgium; [Carlier, Vincent] Ctr Mol & Vasc Biol, Louvain, Belgium; [Verbeken, Erik] Katholieke Univ Leuven, Louvain, Belgium	KU Leuven	Vanoirbeek, JAJ (corresponding author), Lab Occupat & Environm Toxicol, Louvain, Belgium.	jeroen.vanoirbeek@med.kuleuven.be	Hoet, Peter/H-9987-2013; Nemery, Benoit/N-3155-2019; Vanoirbeek, Jeroen/D-5183-2016	Hoet, Peter/0000-0002-0292-6603; Nemery, Benoit/0000-0003-0571-4689; Vanoirbeek, Jeroen/0000-0001-5508-3518	Interuniversity Attraction Pole Program, Belgian State, Belgian Science Policy [P7/30]	Interuniversity Attraction Pole Program, Belgian State, Belgian Science Policy(Belgian Federal Science Policy Office)	The project was supported by a grant of the Interuniversity Attraction Pole Program, Belgian State, Belgian Science Policy P7/30. V.D.V. and J.A.J.V. are post-doctoral fellows of the 'Fonds voor Wetenschappelijk Onderzoek Vlaanderen'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018; Bello D, 2007, ENVIRON HEALTH PERSP, V115, P328, DOI 10.1289/ehp.9557; Cannons JL, 2012, NAT IMMUNOL, V13, P630, DOI 10.1038/ni.2349; Carter RH, 2002, IMMUNOL RES, V26, P45, DOI 10.1385/IR:26:1-3:045; De Vooght V, 2011, TOXICOLOGY, V279, P85, DOI 10.1016/j.tox.2010.09.014; De Vooght V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012581; De Vooght V, 2010, THORAX, V65, P252, DOI 10.1136/thx.2009.121293; De Vooght V, 2009, TOXICOLOGY, V259, P84, DOI 10.1016/j.tox.2009.02.007; Doody GM, 1996, CURR OPIN IMMUNOL, V8, P378, DOI 10.1016/S0952-7915(96)80128-2; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Fairfax KA, 2008, SEMIN IMMUNOL, V20, P49, DOI 10.1016/j.smim.2007.12.002; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Herrick CA, 2003, J ALLERGY CLIN IMMUN, V111, P1087, DOI 10.1067/mai.2003.1413; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Kawikova I, 2004, IMMUNOLOGY, V113, P234, DOI 10.1111/j.1365-2567.2004.01936.x; KURTJONES EA, 1988, J IMMUNOL, V140, P3773; Lavaud F, 2013, ALLERGY, V68, P813, DOI 10.1111/all.12149; Lindell DM, 2008, PLOS ONE, V3, pe3129, DOI [10.1371/journal.pone.0003129, DOI 10.1371/J0URNAL.P0NE.0003129.PUBMED:18769622]; Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Malo JL, 2009, J ALLERGY CLIN IMMUN, V123, P545, DOI 10.1016/j.jaci.2008.09.010; Matheson JM, 2005, TOXICOL SCI, V84, P99, DOI 10.1093/toxsci/kfi051; Matheson JM, 2005, TOXICOL SCI, V84, P88, DOI 10.1093/toxsci/kfi050; Sastre J, 2003, EUR RESPIR J, V22, P364, DOI 10.1183/09031936.03.00045103; Tarkowski M, 2007, AM J PHYSIOL-LUNG C, V292, pL207, DOI 10.1152/ajplung.00157.2005; Vanoirbeek JAJ, 2004, TOXICOL SCI, V80, P310, DOI 10.1093/toxsci/kfh155; Vanoirbeek JAJ, 2008, J ALLERGY CLIN IMMUN, V121, P456, DOI 10.1016/j.jaci.2007.09.006; Vanoirbeek JAJ, 2006, J ALLERGY CLIN IMMUN, V117, P1090, DOI 10.1016/j.jaci.2006.01.027; Vanoirbeek JAJ, 2010, AM J RESP CELL MOL, V42, P96, DOI 10.1165/rcmb.2008-0487OC; Vanoirbeek JAJ, 2009, TOXICOL SCI, V109, P256, DOI 10.1093/toxsci/kfp065; Vanoirbeek JAJ, 2009, TOXICOLOGY, V257, P144, DOI 10.1016/j.tox.2008.12.020; Wenzel SE, 2012, NAT MED, V18, P716, DOI 10.1038/nm.2678; Wisnewski AV, 2001, CURR OPIN ALLERGY CL, V1, P169, DOI 10.1097/00130832-200104000-00009; Wojciechowski W, 2009, IMMUNITY, V30, P421, DOI 10.1016/j.immuni.2009.01.006	35	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83228	10.1371/journal.pone.0083228	http://dx.doi.org/10.1371/journal.pone.0083228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349469	gold, Green Submitted, Green Published			2022-12-27	WOS:000328734200068
J	Frenk, S; Ben-Moshe, T; Dror, I; Berkowitz, B; Minz, D				Frenk, Sammy; Ben-Moshe, Tal; Dror, Ishai; Berkowitz, Brian; Minz, Dror			Effect of Metal Oxide Nanoparticles on Microbial Community Structure and Function in Two Different Soil Types	PLOS ONE			English	Article							DAPHNIA-MAGNA; WASTE-WATER; TIO2; TOXICITY; BACTERIA; ZNO; BIOAVAILABILITY; STERILIZATION; NANOMATERIALS; SUSPENSIONS	Increased availability of nanoparticle-based products will, inevitably, expose the environment to these materials. Engineered nanoparticles (ENPs) may thus find their way into the soil environment via wastewater, dumpsters and other anthropogenic sources; metallic oxide nanoparticles comprise one group of ENPs that could potentially be hazardous for the environment. Because the soil bacterial community is a major service provider for the ecosystem and humankind, it is critical to study the effects of ENP exposure on soil bacteria. These effects were evaluated by measuring bacterial community activity, composition and size following exposure to copper oxide (CuO) and magnetite (Fe3O4) nanosized (<50 nm) particles. Two different soil types were examined: a sandy loam (Bet-Dagan) and a sandy clay loam (Yatir), under two ENP concentrations (1%, 0.1%). Results indicate that the bacterial community in Bet-Dagan soil was more susceptible to change due to exposure to these ENPs, relative to Yatir soil. More specifically, CuO had a strong effect on bacterial hydrolytic activity, oxidative potential, community composition and size in Bet-Dagan soil. Few effects were noted in the Yatir soil, although 1% CuO exposure did cause a significant decreased oxidative potential and changes to community composition. Fe3O4 changed the hydrolytic activity and bacterial community composition in Bet-Dagan soil but did not affect the Yatir soil bacterial community. Furthermore, in Bet-Dagan soil, abundance of bacteria annotated to OTUs from the Bacilli class decreased after addition of 0.1% CuO but increased with 1% CuO, while in Yatir soil their abundance was reduced with 1% CuO. Other important soil bacterial groups, including Rhizobiales and Sphingobacteriaceae, were negatively affected by CuO addition to soil. These results indicate that both ENPs are potentially harmful to soil environments. Furthermore, it is suggested that the clay fraction and organic matter in different soils interact with the ENPs and reduce their toxicity.	[Frenk, Sammy; Minz, Dror] Agr Res Org, Inst Soil Water & Environm Sci, IL-50250 Bet Dagan, Israel; [Ben-Moshe, Tal; Dror, Ishai; Berkowitz, Brian] Weizmann Inst Sci, Dept Environm Sci & Energy Res, IL-76100 Rehovot, Israel; [Frenk, Sammy] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Weizmann Institute of Science; Hebrew University of Jerusalem	Minz, D (corresponding author), Agr Res Org, Inst Soil Water & Environm Sci, IL-50250 Bet Dagan, Israel.	minz@agri.gov.il	; BERKOWITZ, BRIAN/K-1497-2012	Frenk, Carlos/0000-0002-2338-716X; Minz, Dror/0000-0001-6746-9151; BERKOWITZ, BRIAN/0000-0003-3078-1859				Adams LK, 2006, WATER RES, V40, P3527, DOI 10.1016/j.watres.2006.08.004; Akafia MM, 2011, APPL GEOCHEM, V26, pS154, DOI 10.1016/j.apgeochem.2011.03.091; Andreazza R, 2011, BRAZ J MICROBIOL, V42, P66, DOI 10.1590/S1517-83822011000100009; Ben-Moshe T, 2013, CHEMOSPHERE, V90, P640, DOI 10.1016/j.chemosphere.2012.09.018; Bharde A, 2005, J AM CHEM SOC, V127, P9326, DOI 10.1021/ja0508469; BOYLE JS, 1995, TRENDS GENET, V11, P8, DOI 10.1016/S0168-9525(00)88977-5; Brar SK, 2010, WASTE MANAGE, V30, P504, DOI 10.1016/j.wasman.2009.10.012; CASIDA L. E., 1964, SOIL SCI, V98, P371, DOI 10.1097/00010694-196412000-00004; Collins D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042663; Deng H, 2009, FEMS MICROBIOL ECOL, V70, P293, DOI 10.1111/j.1574-6941.2009.00741.x; Desai C, 2008, BIORESOURCE TECHNOL, V99, P6059, DOI 10.1016/j.biortech.2007.12.046; Doran JW, 2000, APPL SOIL ECOL, V15, P3, DOI 10.1016/S0929-1393(00)00067-6; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; EXCOFFIER L, 1992, GENETICS, V131, P479; Ge Y, 2012, APPL ENVIRON MICROB, V78, P6749, DOI 10.1128/AEM.00941-12; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gremion F, 2003, ENVIRON MICROBIOL, V5, P896, DOI 10.1046/j.1462-2920.2003.00484.x; Griffiths BS, 2004, MICROB ECOL, V47, P104, DOI 10.1007/s00248-002-2043-7; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Handy RD, 2008, ECOTOXICOLOGY, V17, P287, DOI 10.1007/s10646-008-0199-8; He SG, 2013, J INTELL MANUF, V24, P25, DOI 10.1007/s10845-011-0533-5; Heinlaan M, 2008, CHEMOSPHERE, V71, P1308, DOI 10.1016/j.chemosphere.2007.11.047; Hund-Rinke K, 2006, ENVIRON SCI POLLUT R, V13, P225, DOI 10.1065/espr2006.06.311; Inbar E, 2005, MICROB ECOL, V50, P73, DOI 10.1007/s00248-004-0111-x; Inglett KS, 2011, INT J SYST EVOL MICR, V61, P2626, DOI 10.1099/ijs.0.024554-0; Jiang C, 2009, J HAZARD MATER, V167, P1170, DOI 10.1016/j.jhazmat.2009.01.107; Kaegi R, 2008, ENVIRON POLLUT, V156, P233, DOI 10.1016/j.envpol.2008.08.004; Kiser MA, 2009, ENVIRON SCI TECHNOL, V43, P6757, DOI 10.1021/es901102n; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Kumar N, 2011, J HAZARD MATER, V190, P816, DOI 10.1016/j.jhazmat.2011.04.005; Lead JR, 2006, ENVIRON CHEM, V3, P159, DOI 10.1071/EN06025; Lin HR, 2010, SOIL BIOL BIOCHEM, V42, P1038, DOI 10.1016/j.soilbio.2010.02.023; Lovern SB, 2007, ENVIRON SCI TECHNOL, V41, P4465, DOI 10.1021/es062146p; Luechinger NA, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/44/445201; Musee N, 2011, ENVIRON INT, V37, P112, DOI 10.1016/j.envint.2010.08.005; Muyzer G., 1996, MOL MICROBIAL ECOLOG, P1; Obernosterer I, 2005, AQUAT MICROB ECOL, V39, P293, DOI 10.3354/ame039293; Oehlinger R, 1995, METHODS SOIL MICROBI, P95; Ofek M, 2009, APPL ENVIRON MICROB, V75, P6441, DOI 10.1128/AEM.00736-09; Peralta-Videa JR, 2011, J HAZARD MATER, V186, P1, DOI 10.1016/j.jhazmat.2010.11.020; Perugini P, 2002, INT J PHARMACEUT, V246, P37, DOI 10.1016/S0378-5173(02)00356-3; Pradhan A, 2011, MICROB ECOL, V62, P58, DOI 10.1007/s00248-011-9861-4; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Qafoku NP, 2010, ADV AGRON, V107, P33, DOI 10.1016/S0065-2113(10)07002-1; Reid BJ, 2000, ENVIRON POLLUT, V108, P103, DOI 10.1016/S0269-7491(99)00206-7; Rietmeijer FJM, 1997, J GEOPHYS RES-PLANET, V102, P6621, DOI 10.1029/96JE03989; Rousk J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034197; Sagee O, 2012, CHEMOSPHERE, V88, P670, DOI 10.1016/j.chemosphere.2012.03.055; SAKAGUCHI T, 1993, NATURE, V365, P47, DOI 10.1038/365047a0; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SCHNURER J, 1982, APPL ENVIRON MICROB, V43, P1256; Shah V, 2009, WATER AIR SOIL POLL, V197, P143, DOI 10.1007/s11270-008-9797-6; Solioz M, 2010, J BIOL INORG CHEM, V15, P3, DOI 10.1007/s00775-009-0588-3; Trevors JT, 1996, J MICROBIOL METH, V26, P53, DOI 10.1016/0167-7012(96)00843-3; Warheit DB, 2007, TOXICOL LETT, V171, P99, DOI 10.1016/j.toxlet.2007.04.008; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wilson MA, 2008, GEODERMA, V146, P291, DOI 10.1016/j.geoderma.2008.06.004; WOLF DC, 1989, J ENVIRON QUAL, V18, P39, DOI 10.2134/jeq1989.00472425001800010007x; Zhu XS, 2008, J ENVIRON SCI HEAL A, V43, P278, DOI 10.1080/10934520701792779	60	107	115	5	151	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e84441	10.1371/journal.pone.0084441	http://dx.doi.org/10.1371/journal.pone.0084441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349575	Green Submitted, gold, Green Published			2022-12-27	WOS:000328734200116
J	Shibata, Y; Inoue, S; Igarashi, A; Yamauchi, K; Abe, S; Aida, Y; Nunomiya, K; Sato, M; Nakano, H; Sato, K; Nemoto, T; Kimura, T; Watanabe, T; Konta, T; Daimon, M; Ueno, Y; Kato, T; Kayama, T; Kubota, I				Shibata, Yoko; Inoue, Sumito; Igarashi, Akira; Yamauchi, Keiko; Abe, Shuichi; Aida, Yasuko; Nunomiya, Keiko; Sato, Masamichi; Nakano, Hiroshi; Sato, Kento; Nemoto, Takako; Kimura, Tomomi; Watanabe, Tetsu; Konta, Tsuneo; Daimon, Makoto; Ueno, Yoshiyuki; Kato, Takeo; Kayama, Takamasa; Kubota, Isao			A Lower Level of Forced Expiratory Volume in 1 Second Is a Risk Factor for All-Cause and Cardiovascular Mortality in a Japanese Population: The Takahata Study	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION; CIGARETTE-SMOKING; HEALTH CHECK; COPD; PARTICIPANTS; INDIVIDUALS; FEV1/FEV6; DECLINE; SMOKERS	Chronic obstructive pulmonary disease is a known risk factor for cardiovascular death in Western countries. Because Japan has a low cardiovascular death rate, the association between a lower level of forced expiratory volume in 1 s (FEV1) and mortality in Japan's general population is unknown. To clarify this, we conducted a community-based longitudinal study. This study included 3253 subjects, who received spirometry from 2004 to 2006 in Takahata, with a 7-year follow-up. The causes of death were assessed on the basis of the death certificate. In 338 subjects, airflow obstruction was observed by spirometry. A total of 127 subjects died. Cardiovascular death was the second highest cause of death in this population. The pulmonary functions of the deceased subjects were significantly lower than those of the subjects who were alive at the end of follow-up. The relative risk of death by all causes, respiratory failure, lung cancer, and cardiovascular disease was significantly increased with airflow obstruction. The Kaplan-Meier analysis showed that all-cause and cardiovascular mortality significantly increased with a worsening severity of airflow obstruction. After adjusting for possible factors that could influence prognosis, a Cox proportional hazard model analysis revealed that a lower level of FEV1 was an independent risk factor for all-cause and cardiovascular mortality (per 10% increase; hazard ratio [HR], 0.89; 95% confidence interval [CI], 0.82-0.98; and HR, 0.72; 95% CI, 0.61-0.86, respectively). In conclusion, airflow obstruction is an independent risk factor for all-cause and cardiovascular death in the Japanese general population. Spirometry might be a useful test to evaluate the risk of cardiovascular death and detect the risk of respiratory death by lung cancer or respiratory failure in healthy Japanese individuals.	[Shibata, Yoko; Inoue, Sumito; Igarashi, Akira; Yamauchi, Keiko; Abe, Shuichi; Aida, Yasuko; Nunomiya, Keiko; Sato, Masamichi; Nakano, Hiroshi; Sato, Kento; Nemoto, Takako; Kimura, Tomomi; Watanabe, Tetsu; Konta, Tsuneo; Kubota, Isao] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan; [Daimon, Makoto; Ueno, Yoshiyuki; Kato, Takeo; Kayama, Takamasa] Yamagata Univ, Sch Med, Global Ctr Excellence Program Study Grp, Yamagata 99023, Japan	Yamagata University; Yamagata University	Shibata, Y (corresponding author), Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 99023, Japan.	shibata@med.id.yamagata-u.ac.jp	Daimon, Makoto/AAY-1289-2020; Ueno, Yoshiyuki/R-9242-2019; Konta, Tsuneo/AAO-9286-2021	Daimon, Makoto/0000-0002-3775-1719; Ueno, Yoshiyuki/0000-0001-5623-4250; 	Global COE program of the Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [24700963] Funding Source: KAKEN	Global COE program of the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-aid from the Global COE program of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Aida Y, 2011, INT J MED SCI, V8, P470, DOI 10.7150/ijms.8.470; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; *COMM PULM PHYS JA, 2004, GUID PULM FUNCT TEST, P56; Cosio MG, 2012, EUR RESPIR J, V39, P1298, DOI 10.1183/09031936.00135711; Daimon M, 2012, METABOLISM, V61, P504, DOI 10.1016/j.metabol.2011.08.004; de Torres JP, 2011, AM J RESP CRIT CARE, V184, P913, DOI 10.1164/rccm.201103-0430OC; Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x; *GOLD GLOB IN CHRO, OBSTR LUNG DIS GLOB; Hole DJ, 1996, BRIT MED J, V313, P711; Iwamoto H, 2009, AM J RESP CRIT CARE, V179, P35, DOI 10.1164/rccm.200804-560OC; Kishi H, 2011, INTERNAL MED, V50, P87, DOI 10.2169/internalmedicine.50.4276; KONTA T, 2013, CLIN EXP NEPHROL; LANGE P, 1990, J CLIN EPIDEMIOL, V43, P867, DOI 10.1016/0895-4356(90)90070-6; NAGAI A, 2013, EPIDEMIOLOGY SOCIE E; Nemoto T, 2011, INTERNAL MED, V50, P2547, DOI 10.2169/internalmedicine.50.5948; Nishimura M, 2012, AM J RESP CRIT CARE, V185, P44, DOI 10.1164/rccm.201106-0992OC; Nunomiya K, 2013, EUR RESPIR J, V42, P18, DOI 10.1183/09031936.00066212; Osaka D, 2010, INTERNAL MED, V49, P1489, DOI 10.2169/internalmedicine.49.3364; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Sato M, 2013, INT J MED SCI, V10, P1, DOI 10.7150/ijms.5003; Shibata Y, 2011, INT J MED SCI, V8, P514, DOI 10.7150/ijms.8.514; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Steyerberg E., 2009, CLIN PREDICTION MODE; SUWABE A, 2008, J JPN SOC INTERN MED, V97, P2927; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Wada H, 2010, RESPIROLOGY, V15, P1252, DOI 10.1111/j.1440-1843.2010.01854.x; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; WHO, 2007, WORLD HLTH STAT; YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P165, DOI 10.1007/BF01117450	33	35	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83725	10.1371/journal.pone.0083725	http://dx.doi.org/10.1371/journal.pone.0083725			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349548	Green Submitted, Green Published, gold			2022-12-27	WOS:000328734200101
J	Chang, TI; Oh, HJ; Kang, EW; Yoo, TH; Shin, SK; Kang, SW; Choi, KH; Han, DS; Han, SH				Chang, Tae Ik; Oh, Hyung Jung; Kang, Ea Wha; Yoo, Tae-Hyun; Shin, Sug Kyun; Kang, Shin-Wook; Choi, Kyu Hun; Han, Dae Suk; Han, Seung Hyeok			A Low Serum Bicarbonate Concentration as a Risk Factor for Mortality in Peritoneal Dialysis Patients	PLOS ONE			English	Article							CHRONIC METABOLIC-ACIDOSIS; HEMODIALYSIS-PATIENTS; ASSOCIATION; NUTRITION; DEATH	Background and Aim: Metabolic acidosis is common in patients with chronic kidney disease and is associated with increased mortality in hemodialysis patients. However, this relationship has not yet been determined in peritoneal dialysis (PD) patients. Methods: This prospective observational study included a total of 441 incident patients who started PD between January 2000 and December 2005. Using time-averaged serum bicarbonate (TA-Bic) levels, we aimed to investigate whether a low serum bicarbonate concentration can predict mortality in these patients. Results: Among the baseline parameters, serum bicarbonate level was positively associated with hemoglobin level and residual glomerular filtration rate (GFR), while it was negatively associated with albumin, C-reactive protein (CRP) levels, peritoneal Kt/V urea, and normalized protein catabolic rate (nPCR) in a multivariable linear regression analysis. During a median follow-up of 34.8 months, 149 deaths were recorded. After adjustment for age, diabetes, coronary artery disease, serum albumin, ferritin, CRP, residual GFR, peritoneal Kt/V urea, nPCR, and percentage of lean body mass, TA-Bic level was associated with a significantly decreased risk of mortality (HR per 1 mEq/L increase, 0.83; 95% CI, 0.76-0.91; p < 0.001). In addition, compared to patients with a TA-Bic level of 24-26 mEq/L, those with a TA-Bic level < 22 and between 22-24 mEq/L conferred a 13.10- and 2.13-fold increased risk of death, respectively. Conclusions: This study showed that a low serum bicarbonate concentration is an independent risk factor for mortality in PD patients. This relationship between low bicarbonate levels and adverse outcome could be related to enhanced inflammation and a more rapid loss of RRF associated with metabolic acidosis. Large randomized clinical trials to correct acidosis are warranted to confirm our findings.	[Chang, Tae Ik; Kang, Ea Wha; Shin, Sug Kyun] Ilsan Hosp, Dept Internal Med, NHIS Med Ctr, Goyangshi, Gyeonggi Do, South Korea; [Oh, Hyung Jung; Yoo, Tae-Hyun; Kang, Shin-Wook; Choi, Kyu Hun; Han, Dae Suk; Han, Seung Hyeok] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Severance Biomed Sci Inst, Seoul 120749, South Korea	NHIS Ilsan Hospital; Yonsei University; Yonsei University Health System; Yonsei University	Han, SH (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	hansh@yuhs.ac	Han, Seung Hyeok/K-4559-2018; Han, Seung Hyeok/W-8825-2019	Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Yoo, Tae-Hyun/0000-0002-9183-4507; Choi, Kyu Hun/0000-0003-0095-9011; Kang, Shin-Wook/0000-0002-5677-4756	Brain Korea 21 Project for Medical Science, Yonsei University; National Research Foundation of Korea (NRF); Korean government (MEST) [2011-0030711]; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A102065]	Brain Korea 21 Project for Medical Science, Yonsei University(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Brain Korea 21 Project for Medical Science, Yonsei University, by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2011-0030711), and by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, AM J KIDNEY DIS, V35, pS1, DOI DOI 10.1053/AJKD.2000.V35.AAJKD03517; Bailey JL, 2000, SEMIN DIALYSIS, V13, P227, DOI 10.1046/j.1525-139x.2000.00063.x; BALLMER PE, 1995, J CLIN INVEST, V95, P39, DOI 10.1172/JCI117668; Bommer J, 2004, AM J KIDNEY DIS, V44, P661, DOI 10.1053/j.ajkd.2004.06.008; Brener ZZ, 2010, AM J MED SCI, V339, P453, DOI 10.1097/MAJ.0b013e3181cf7d5b; Dumler F, 1996, ADV PERIT D, V12, P307; Eknoyan G, 2003, AM J KIDNEY DIS, V41, pS1, DOI 10.1016/S0272-6386(03)00111-2; Franch H A, 1998, J Am Soc Nephrol, V9, pS78; Goraya N, 2013, CURR OPIN NEPHROL HY, V22, P193, DOI 10.1097/MNH.0b013e32835dcbbe; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; Han SH, 2012, NAT REV NEPHROL, V8, P163, DOI 10.1038/nrneph.2012.12; Kalantar-Zadeh K, 2004, SEMIN DIALYSIS, V17, P455, DOI 10.1111/j.0894-0959.2004.17606.x; Kirschbaum B, 2000, AM J KIDNEY DIS, V35, P1068, DOI 10.1016/S0272-6386(00)70041-2; Kopple JD, 2005, KIDNEY INT, V67, pS21, DOI 10.1111/j.1523-1755.2005.09503.x; Kovesdy CP, 2009, NEPHROL DIAL TRANSPL, V24, P1232, DOI 10.1093/ndt/gfn633; Kraut JA, 2005, AM J KIDNEY DIS, V45, P978, DOI 10.1053/j.ajkd.2005.03.003; Kung S C, 2001, Adv Perit Dial, V17, P235; Lin SH, 2002, NEPHROL DIAL TRANSPL, V17, P2006, DOI 10.1093/ndt/17.11.2006; LOWRIE EG, 1990, AM J KIDNEY DIS, V15, P458, DOI 10.1016/S0272-6386(12)70364-5; Mactier R, 2009, CLIN PRACTICE GUIDEL; Mehrotra R, 2003, KIDNEY INT, V64, pS13, DOI 10.1046/j.1523-1755.2003.08802.x; Mitch WE, 2002, J AM SOC NEPHROL, V13, pS22; Mujais S, 2003, KIDNEY INT, V64, pS26, DOI 10.1046/j.1523-1755.2003.08803.x; NOLPH KD, 1993, PERITON DIALYSIS INT, V13, P178; Ori Y, 2013, BLOOD PURIFICAT, V35, P181, DOI 10.1159/000346689; Pickering WP, 2002, KIDNEY INT, V61, P1286, DOI 10.1046/j.1523-1755.2002.00276.x; Stein A, 1997, KIDNEY INT, V52, P1089, DOI 10.1038/ki.1997.433; Szeto CC, 2003, J AM SOC NEPHROL, V14, P2119, DOI 10.1097/01.ASN.0000080316.37254.7A; Uribarri J, 1999, AM J KIDNEY DIS, V34, P493, DOI 10.1016/S0272-6386(99)70077-6; Vashistha T, 2013, CLIN J AM SOC NEPHRO, V8, P254, DOI 10.2215/CJN.05780612; Vilar E, 2011, SEMIN DIALYSIS, V24, P487, DOI 10.1111/j.1525-139X.2011.00968.x; Vonesh EF, 2006, KIDNEY INT, V70, pS3, DOI 10.1038/sj.ki.5001910; Woodrow G, 2010, CLIN PRACTICE GUIDEL; Wu DY, 2006, CLIN J AM SOC NEPHRO, V1, P70, DOI 10.2215/CJN.00010505	34	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82912	10.1371/journal.pone.0082912	http://dx.doi.org/10.1371/journal.pone.0082912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349396	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800085
J	Lai, CC; Yeh, YH; Hsieh, WP; Kuo, CT; Wang, WC; Chu, CH; Hung, CL; Cheng, CY; Tsai, HY; Lee, JL; Tang, CY; Hsu, LA				Lai, Chun-Chi; Yeh, Yung-Hsin; Hsieh, Wen-Ping; Kuo, Chi-Tai; Wang, Wen-Ching; Chu, Chia-Han; Hung, Chiu-Lien; Cheng, Chia-Yang; Tsai, Hsin-Yi; Lee, Jia-Lin; Tang, Chuan-Yi; Hsu, Lung-An			Whole-Exome Sequencing to Identify a Novel LMNA Gene Mutation Associated with Inherited Cardiac Conduction Disease	PLOS ONE			English	Article							LAMIN A/C GENE; DILATED CARDIOMYOPATHY; FUNCTIONAL CONSEQUENCES; ATRIOVENTRICULAR-BLOCK; ATRIAL-FIBRILLATION; CRYSTAL-STRUCTURE; VARIANTS; DOMAIN; DIMER; 2B	Background: Inherited cardiac conduction diseases (CCD) are rare but are caused by mutations in a myriad of genes. Recently, whole-exome sequencing has successfully led to the identification of causal mutations for rare monogenic Mendelian diseases. Objective: To investigate the genetic background of a family affected by inherited CCD. Methods and Results: We used whole-exome sequencing to study a Chinese family with multiple family members affected by CCD. Using the pedigree information, we proposed a heterozygous missense mutation (c. G695T, Gly232Val) in the lamin A/C (LMNA) gene as a candidate mutation for susceptibility to CCD in this family. The mutation is novel and is expected to affect the conformation of the coiled-coil rod domain of LMNA according to a structural model prediction. Its pathogenicity in lamina instability was further verified by expressing the mutation in a cellular model. Conclusions: Our results suggest that whole-exome sequencing is a feasible approach to identifying the candidate genes underlying inherited conduction diseases.	[Lai, Chun-Chi; Cheng, Chia-Yang; Tang, Chuan-Yi] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan; [Yeh, Yung-Hsin; Kuo, Chi-Tai; Tsai, Hsin-Yi; Hsu, Lung-An] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Cardiovasc Div 1, Taoyuan, Taiwan; [Hsieh, Wen-Ping] Natl Tsing Hua Univ, Inst Stat, Hsinchu, Taiwan; [Wang, Wen-Ching; Hung, Chiu-Lien; Lee, Jia-Lin] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Wang, Wen-Ching; Hung, Chiu-Lien; Lee, Jia-Lin] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Wang, Wen-Ching; Chu, Chia-Han; Hung, Chiu-Lien; Cheng, Chia-Yang] Natl Tsing Hua Univ, Biomed Sci & Engn Ctr, Hsinchu, Taiwan	National Tsing Hua University; Chang Gung Memorial Hospital; Chang Gung University; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University	Hsu, LA (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Cardiovasc Div 1, Taoyuan, Taiwan.	hsula@adm.cgmh.org.tw	Chu, Chu/T-6038-2019; Wang, Wen-Ching/ABI-2253-2020; Yeh, Yung-Hsin/ABD-9351-2021	Hsu, Lung-An/0000-0002-0012-2804; Lee, Jia-Lin/0000-0002-6984-1313	Chang Gung Memorial Hospital [CMRPG 300121, CMRPG 3B0991]; National Science Council [NSC101-2325-B-007-001]; National Tsing Hua University; Ministry of Education, Taiwan, R.O.C.	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council(Ministry of Science and Technology, Taiwan); National Tsing Hua University; Ministry of Education, Taiwan, R.O.C.(Ministry of Education, Taiwan)	This study was supported by research grants from the Chang Gung Memorial Hospital (CMRPG 300121 and CMRPG 3B0991), the National Science Council (NSC101-2325-B-007-001), and the "Aim for the Top University Project" of the National Tsing Hua University and the Ministry of Education, Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbustini E, 2002, J AM COLL CARDIOL, V39, P981, DOI 10.1016/S0735-1097(02)01724-2; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bonne G, 2000, ANN NEUROL, V48, P170, DOI 10.1002/1531-8249(200008)48:2<170::AID-ANA6>3.0.CO;2-J; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Cattin ME, 2013, CURR OPIN CARDIOL, V28, P297, DOI 10.1097/HCO.0b013e32835f0c79; Charniot JC, 2003, HUM MUTAT, V21, P473, DOI 10.1002/humu.10170; Chernyatina AA, 2012, J STRUCT BIOL, V177, P46, DOI 10.1016/j.jsb.2011.11.014; Chernyatina AA, 2012, P NATL ACAD SCI USA, V109, P13620, DOI 10.1073/pnas.1206836109; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Holaska JM, 2008, CIRC RES, V103, P16, DOI 10.1161/CIRCRESAHA.108.172197; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Marsman RF, 2011, CIRC-CARDIOVASC GENE, V4, P280, DOI 10.1161/CIRCGENETICS.110.959221; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Norton N, 2011, AM J HUM GENET, V88, P273, DOI 10.1016/j.ajhg.2011.01.016; Pan H, 2009, HEART RHYTHM, V6, P707, DOI 10.1016/j.hrthm.2009.01.037; Park DS, 2011, CIRCULATION, V123, P904, DOI 10.1161/CIRCULATIONAHA.110.942284; Parry DAD, 2010, J STRUCT BIOL, V170, P364, DOI 10.1016/j.jsb.2009.12.006; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Rudenskaya GE, 2008, CLIN GENET, V74, P127, DOI 10.1111/j.1399-0004.2008.01045.x; Saj M, 2012, MOL DIAGN THER, V16, P99, DOI 10.2165/11597540-000000000-00000; Sebillon P, 2003, J MED GENET, V40, P560, DOI 10.1136/jmg.40.8.560; Smits JPP, 2005, EUROPACE, V7, P122, DOI 10.1016/j.eupc.2004.11.004; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stitziel NO, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-227; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093; Taylor MRG, 2003, J AM COLL CARDIOL, V41, P771, DOI 10.1016/S0735-1097(02)02954-6; van Berlo JH, 2005, J MOL MED, V83, P79, DOI 10.1007/s00109-004-0589-1; Vytopil M, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.12.e132; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Whitby FG, 2000, PROTEINS, V38, P49; Wolf CM, 2006, J CARDIOVASC ELECTR, V17, P446, DOI 10.1111/j.1540-8167.2006.00427.x	41	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83322	10.1371/journal.pone.0083322	http://dx.doi.org/10.1371/journal.pone.0083322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349489	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800112
J	Tanaka, K; Nakayama, M; Kanno, M; Kimura, H; Watanabe, K; Tani, Y; Kusano, Y; Suzuki, H; Hayashi, Y; Asahi, K; Sato, K; Miyata, T; Watanabe, T				Tanaka, Kenichi; Nakayama, Masaaki; Kanno, Makoto; Kimura, Hiroshi; Watanabe, Kimio; Tani, Yoshihiro; Kusano, Yuki; Suzuki, Hodaka; Hayashi, Yoshimitsu; Asahi, Koichi; Sato, Keiji; Miyata, Toshio; Watanabe, Tsuyoshi			Skin Autofluorescence Is Associated with the Progression of Chronic Kidney Disease: A Prospective Observational Study	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; STAGE RENAL-DISEASE; HEMODIALYSIS-PATIENTS; OXIDATIVE STRESS; AUTOXIDATION PRODUCTS; DIABETIC-NEPHROPATHY; COMPLICATIONS; ACCUMULATION; MORTALITY; RISK	Background: Advanced glycation end product (AGE) accumulation is thought to be a measure of cumulative metabolic stress that has been reported to independently predict cardiovascular disease in diabetes and renal failure. The aim of this study was to evaluate the association between AGE accumulation, measured as skin autofluorescence, and the progression of renal disease in pre-dialysis patients with chronic kidney disease (CKD). Methods: Skin autofluorescence was measured noninvasively with an autofluorescence reader at baseline in 449 pre-dialysis patients with CKD. The primary end point was defined as a doubling of serum creatinine and/or need for dialysis. Results: Thirty-three patients were lost to follow-up. Forty six patients reached the primary end point during the follow-up period (Median 39 months). Kaplan-Meier analysis showed a significantly higher risk of development of the primary end points in patients with skin autofluorescence levels above the optimal cut-off level of 2.31 arbitrary units, derived by receiver operator curve analysis. Cox regression analysis revealed that skin autofluorescence was an independent predictor of the primary end point, even after adjustment for age, gender, smoking history, diabetes, estimated glomerular filtration rate and proteinuria (adjusted hazard ratio 2.58, P = 0.004). Conclusions: Tissue accumulation of AGEs, measured as skin autofluorescence, is a strong and independent predictor of progression of CKD. Skin autofluorescence may be useful for risk stratification in this group of patients; further studies should clarify whether AGE accumulation could be one of the therapeutic targets to improve the prognosis of CKD.	[Tanaka, Kenichi; Nakayama, Masaaki; Kanno, Makoto; Kimura, Hiroshi; Watanabe, Kimio; Tani, Yoshihiro; Kusano, Yuki; Suzuki, Hodaka; Hayashi, Yoshimitsu; Watanabe, Tsuyoshi] Fukushima Med Univ, Dept Nephrol, Fukushima, Japan; [Tanaka, Kenichi; Nakayama, Masaaki; Kanno, Makoto; Kimura, Hiroshi; Watanabe, Kimio; Tani, Yoshihiro; Kusano, Yuki; Suzuki, Hodaka; Hayashi, Yoshimitsu; Watanabe, Tsuyoshi] Fukushima Med Univ, Dept Hypertens, Fukushima, Japan; [Asahi, Koichi] Fukushima Med Univ, Dept Chron Kidney Dis Initiat, Fukushima, Japan; [Sato, Keiji] Fujita Gen Hosp, Dept Nephrol, Kunimi, Japan; [Miyata, Toshio] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Sendai, Miyagi 980, Japan	Fukushima Medical University; Fukushima Medical University; Fukushima Medical University; Tohoku University	Tanaka, K (corresponding author), Fukushima Med Univ, Dept Nephrol, Fukushima, Japan.	kennichi@fmu.ac.jp	Miyata, Toshio/A-4872-2010					Aronson D, 2003, J HYPERTENS, V21, P3, DOI 10.1097/00004872-200301000-00002; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Coughlan MT, 2007, KIDNEY INT, V72, pS54, DOI 10.1038/sj.ki.5002387; Daroux M, 2010, DIABETES METAB, V36, P1, DOI 10.1016/j.diabet.2009.06.005; de Zeeuw D, 2004, KIDNEY INT, V65, P2309, DOI 10.1111/j.1523-1755.2004.00653.x; Forbes JM, 2003, FASEB J, V17, P1762, DOI 10.1096/fj.02-1102fje; Gerrits EG, 2008, DIABETES CARE, V31, P517, DOI 10.2337/dc07-1755; Gerrits EG, 2009, NEPHROL DIAL TRANSPL, V24, P710, DOI 10.1093/ndt/gfn634; Joshi D, 2009, J CARDIOVASC PHARM, V54, P72, DOI 10.1097/FJC.0b013e3181ac3a34; Keane WF, 2003, KIDNEY INT, V63, P1499, DOI 10.1046/j.1523-1755.2003.00885.x; Matsumoto T, 2007, RHEUMATOL INT, V28, P157, DOI 10.1007/s00296-007-0408-4; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McIntyre NJ, 2011, CLIN J AM SOC NEPHRO, V6, P2356, DOI 10.2215/CJN.02420311; Meerwaldt R, 2005, ANN NY ACAD SCI, V1043, P290, DOI 10.1196/annals.1333.036; Meerwaldt R, 2005, J AM SOC NEPHROL, V16, P3687, DOI 10.1681/ASN.2005020144; Meerwaldt R, 2004, DIABETOLOGIA, V47, P1324, DOI 10.1007/s00125-004-1451-2; Meerwaldt R, 2007, DIABETES CARE, V30, P107, DOI 10.2337/dc06-1391; Miyata T, 1999, INT J ARTIF ORGANS, V22, P195, DOI 10.1177/039139889902200402; Miyata T, 1996, J AM SOC NEPHROL, V7, P1198; Miyata T, 1997, KIDNEY INT, V51, P1170, DOI 10.1038/ki.1997.160; Miyata TR, 1998, KIDNEY INT, V54, P1290, DOI 10.1046/j.1523-1755.1998.00093.x; Mulder DJ, 2006, DIABETES TECHNOL THE, V8, P523, DOI 10.1089/dia.2006.8.523; Na RH, 2001, J INVEST DERMATOL, V116, P536, DOI 10.1046/j.1523-1747.2001.01285.x; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Ohnuki Y, 2009, INTERNAL MED, V48, P587, DOI 10.2169/internalmedicine.48.1390; Ramasamy R, 2005, GLYCOBIOLOGY, V15, p16R, DOI 10.1093/glycob/cwi053; Schwedler SB, 2002, KIDNEY INT, V62, P301, DOI 10.1046/j.1523-1755.2002.00423.x; Tanaka K, 2012, DIABETIC MED, V29, P492, DOI 10.1111/j.1464-5491.2011.03448.x; Tanaka K, 2011, NEPHROL DIAL TRANSPL, V26, P214, DOI 10.1093/ndt/gfq369; Tanaka K, 2010, THER APHER DIAL, V14, P334, DOI 10.1111/j.1744-9987.2009.00782.x; Tanji N, 2000, J AM SOC NEPHROL, V11, P1656, DOI 10.1681/ASN.V1191656; Ueno H, 2008, METABOLISM, V57, P1452, DOI 10.1016/j.metabol.2008.05.016; Ueno H, 2011, METABOLISM, V60, P453, DOI 10.1016/j.metabol.2010.04.001; Yue X, 2011, DIABETIC MED, V28, P818, DOI 10.1111/j.1464-5491.2010.03217.x; Zhou LL, 2012, KIDNEY INT, V82, P759, DOI 10.1038/ki.2012.184	35	29	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83799	10.1371/journal.pone.0083799	http://dx.doi.org/10.1371/journal.pone.0083799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349550	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800132
J	Burger, C; Nord, A; Nilsson, JA; Gilot-Fromont, E; Both, C				Burger, Claudia; Nord, Andreas; Nilsson, Jan-Ake; Gilot-Fromont, Emmanuelle; Both, Christiaan			Fitness Consequences of Northward Dispersal as Possible Adaptation to Climate Change, Using Experimental Translocation of a Migratory Passerine	PLOS ONE			English	Article							GENE FLOW; LIMITS; FAMILIARITY; EVOLUTION; PATTERNS; SWALLOWS; COSTS; FOOD	Climate change leads to rapid, differential changes in phenology across trophic levels, often resulting in temporal mismatches between predators and their prey. If a species cannot easily adjust its timing, it can adapt by choosing a new breeding location with a later phenology of its prey. In this study, we experimentally investigated whether long-distance dispersal to northern breeding grounds with a later phenology could be a feasible process to restore the match between timing of breeding and peak food abundance and thus improve reproductive success. Here, we report the successful translocation of pied flycatchers (Ficedula hypoleuca) to natural breeding sites 560 km to the Northeast. We expected translocated birds to have a fitness advantage with respect to environmental phenology, but to potentially pay costs through the lack of other locally adapted traits. Translocated individuals started egg laying 11 days earlier than northern control birds, which were translocated only within the northern site. The number of fledglings produced was somewhat lower in translocated birds, compared to northern controls, and fledglings were in lower body condition. Translocated individuals were performing not significantly different to control birds that remained at the original southern site. The lack of advantage of the translocated individuals most likely resulted from the exceptionally cold spring in which the experiment was carried out. Our results, however, suggest that pied flycatchers can successfully introduce their early breeding phenotype after dispersing to more northern areas, and thus that adaptation through dispersal is a viable option for populations that get locally maladapted through climate change.	[Burger, Claudia; Both, Christiaan] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands; [Nord, Andreas; Nilsson, Jan-Ake] Lund Univ, Sect Evolutionary Ecol, Dept Biol, Lund, Sweden; [Gilot-Fromont, Emmanuelle] Univ Lyon, VetAgro Sup, Marcy Letoile, France; [Gilot-Fromont, Emmanuelle] Univ Lyon, Univ Lyon Lab Biometrie & Biol Evolut UMR5558, Villeurbanne, France	University of Groningen; Lund University; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Burger, C (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands.	c.burger@rug.nl	Both, Christiaan/E-6459-2011	Both, Christiaan/0000-0001-7099-9831; Gilot-Fromont, Emmanuelle/0000-0003-0011-7519	VIDI grant from the Dutch Science Foundation (N. W. O.)	VIDI grant from the Dutch Science Foundation (N. W. O.)	This work was supported by a VIDI grant from the Dutch Science Foundation (N. W. O.) awarded to CB(Christiaan Both). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; Both C, 2005, GLOBAL CHANGE BIOL, V11, P1606, DOI 10.1111/j.1365-2486.2005.01038.x; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Both C, 2009, J ANIM ECOL, V78, P73, DOI 10.1111/j.1365-2656.2008.01458.x; Both C, 2012, J AVIAN BIOL, V43, P193, DOI 10.1111/j.1600-048X.2012.05721.x; Both C, 2010, P ROY SOC B-BIOL SCI, V277, P1259, DOI 10.1098/rspb.2009.1525; Both C, 2010, CURR BIOL, V20, P243, DOI 10.1016/j.cub.2009.11.074; Bowler DE, 2005, BIOL REV, V80, P205, DOI 10.1017/S1464793104006645; Brown CR, 2008, ANIM BEHAV, V76, P1201, DOI 10.1016/j.anbehav.2008.03.028; Brown CR, 2000, BEHAV ECOL SOCIOBIOL, V47, P339, DOI 10.1007/s002650050674; Burger C, 2012, J ANIM ECOL, V81, P926, DOI 10.1111/j.1365-2656.2012.01968.x; Burger C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018143; Coltman DW, 2005, NATURE, V433, P23, DOI 10.1038/433023a; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Doligez B, 2008, J ANIM ECOL, V77, P1199, DOI 10.1111/j.1365-2656.2008.01446.x; Dunn PO, 2011, ECOLOGY, V92, P450, DOI 10.1890/10-0478.1; Edelaar P, 2008, EVOLUTION, V62, P2462, DOI 10.1111/j.1558-5646.2008.00459.x; Eeva T, 2000, CAN J ZOOL, V78, P67, DOI 10.1139/cjz-78-1-67; Garant D, 2005, NATURE, V433, P60, DOI 10.1038/nature03051; Lehtonen PK, 2009, MOL ECOL, V18, P4463, DOI 10.1111/j.1365-294X.2009.04364.x; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Liedvogel M, 2012, J EVOLUTION BIOL, V25, P813, DOI 10.1111/j.1420-9101.2012.02480.x; Lundberg A, 1992, PIED FLYCATCHER; MARTIN TE, 1987, ANNU REV ECOL SYST, V18, P453, DOI 10.1146/annurev.ecolsys.18.1.453; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Nichols J., 2001, DISPERSAL; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PART T, 1995, ANIM BEHAV, V49, P1029, DOI 10.1006/anbe.1995.0132; Perfito N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034997; RDevelopmentCoreTeam, 2008, R LANG ENV STAT COMP; SILVERIN B, 1993, GEN COMP ENDOCR, V90, P14, DOI 10.1006/gcen.1993.1055; Smith KW, 2011, BIRD STUDY, V58, P506, DOI 10.1080/00063657.2011.616186; Tank AMGK, 2002, INT J CLIMATOL, V22, P1441, DOI 10.1002/joc.773; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; Thomas DW, 2001, SCIENCE, V291, P2598, DOI 10.1126/science.1057487; Visser ME, 2008, P ROY SOC B-BIOL SCI, V275, P649, DOI 10.1098/rspb.2007.0997; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Winkler DW, 2005, J ANIM ECOL, V74, P1080, DOI 10.1111/j.1365-2656.2005.01007.x	41	11	11	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83176	10.1371/journal.pone.0083176	http://dx.doi.org/10.1371/journal.pone.0083176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349454	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300137
J	Lewis, JR; Dhaliwal, SS; Zhu, K; Prince, RL				Lewis, Joshua R.; Dhaliwal, Satvinder S.; Zhu, Kun; Prince, Richard L.			A Predictive Model for Knee Joint Replacement in Older Women	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; TOTAL HIP; OSTEOARTHRITIS; OBESITY; OVERWEIGHT; AUSTRALIA; AUSDIAB; HEALTH	Knee replacement (KR) is expensive and invasive. To date no predictive algorithms have been developed to identify individuals at high risk of surgery. This study assessed whether patient self-reported risk factors predict 10-year KR in a population-based study of 1,462 women aged over 70 years recruited for the Calcium Intake Fracture Outcome Study (CAIFOS). Complete hospital records of prevalent (1980-1998) and incident (1998-2008) total knee replacement were available via the Western Australian Data Linkage System. Potential risk factors were assessed for predicative ability using a modeling approach based on a pre-planned selection of risk factors prior to model evaluation. There were 129 (8.8%) participants that underwent KR over the 10 year period. Baseline factors including; body mass index, knee pain, previous knee replacement and analgesia use for joint pain were all associated with increased risk, (P < 0.001). These factors in addition to age demonstrated good discrimination with a C-statistic of 0.79 +/- 0.02 as well as calibration determined by the Hosmer-Lemeshow Goodness-of-Fit test. For clinical recommendations, three categories of risk for 10-year knee replacement were selected; low < 5%; moderate 5 to < 10% and high >= 10% predicted risk. The actual risk of knee replacement was; low 16 / 741 (2.2%); moderate 32 / 330 (9.7%) and high 81 / 391 (20.7%), P < 0.001. Internal validation of this 5-variable model on 6-year knee replacements yielded a similar C-statistic of 0.81 +/- 0.02, comparable to the WOMAC weighted score; C-statistic 0.75 +/- 0.03, P = 0.064. In conclusion 5 easily obtained patient self-reported risk factors predict 10-year KR risk well in this population. This algorithm should be considered as the basis for a patient-based risk calculator to assist in the development of treatment regimens to reduce the necessity for surgery in high risk groups such as the elderly.	[Lewis, Joshua R.; Zhu, Kun; Prince, Richard L.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Lewis, Joshua R.; Zhu, Kun; Prince, Richard L.] Sir Charles Gairdner Hosp, Dept Endocrinol & Diabet, Perth, WA, Australia; [Dhaliwal, Satvinder S.] Curtin Univ, Sch Publ Hlth, Perth, WA 6845, Australia	University of Western Australia; University of Western Australia; Curtin University	Lewis, JR (corresponding author), Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia.	joshua.lewis@uwa.edu.au	lewis, josh/GZG-7164-2022; Zhu, Kun/L-2208-2013	Zhu, Kun/0000-0002-8723-7574	Healthway Health Promotion Foundation of Western Australia; Australasian Menopause Society; Australian National Health and Medical Research Council [254627, 303169, 572604]; Arthritis Australia Barbara Cameron Memorial Grant; Raine Medical Research Foundation Priming Grant	Healthway Health Promotion Foundation of Western Australia; Australasian Menopause Society; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Arthritis Australia Barbara Cameron Memorial Grant; Raine Medical Research Foundation Priming Grant	This study was supported by research grants from the Healthway Health Promotion Foundation of Western Australia, the Australasian Menopause Society, the Australian National Health and Medical Research Council (projects grants 254627, 303169 and 572604) and the Arthritis Australia Barbara Cameron Memorial Grant. The salary of Dr. Lewis is supported by a Raine Medical Research Foundation Priming Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Institute of Health and Welfare, 2008, ARTHR OST AUSTR 2008; Bellamy N, 2002, WOMAC USERS GUIDE 5; Britt H, 1997, Health Inf Manag, V27, P171; Bruce DG, 2002, J AM GERIATR SOC, V50, P84, DOI 10.1046/j.1532-5415.2002.50012.x; Cameron AJ, 2009, MED J AUSTRALIA, V191, P202, DOI 10.5694/j.1326-5377.2009.tb02753.x; Cameron AJ, 2003, MED J AUSTRALIA, V178, P427, DOI 10.5694/j.1326-5377.2003.tb05283.x; Chen J, 2003, J RHEUMATOL UNPUB; Conaghan PG, 2010, ANN RHEUM DIS, V69, P644, DOI 10.1136/ard.2008.099564; de Guia Nicole, 2006, Healthc Policy, V1, P36; Devine A, 2004, J BONE MINER RES, V19, P1634, DOI 10.1359/JBMR.040804; Dixon T, 2004, ANN RHEUM DIS, V63, P825, DOI 10.1136/ard.2003.012724; Donaldson MG, 2011, J BONE MINER RES, V26, P1767, DOI 10.1002/jbmr.371; Ensrud KE, 2009, ARCH INTERN MED, V169, P2087, DOI 10.1001/archinternmed.2009.404; FELSON DT, 1988, ANN INTERN MED, V109, P18, DOI 10.7326/0003-4819-109-1-18; Gossec L, 2005, ANN RHEUM DIS, V64, P1028, DOI 10.1136/ard.2004.029546; Grotle M, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-132; Holman CDJ, 2008, AUST HEALTH REV, V32, P766, DOI 10.1071/AH080766; Jenkins PJ, 2013, BONE JOINT J, V95B, P115, DOI 10.1302/0301-620X.95B1.29835; Kim S, 2008, ARTHRIT RHEUM-ARTHR, V59, P481, DOI 10.1002/art.23525; Labek G, 2011, J BONE JOINT SURG BR, V93B, P293, DOI 10.1302/0301-620X.93B3.25467; Lane NE, 2004, ARTHRITIS RHEUM-US, V50, P1477, DOI 10.1002/art.20213; Manninen P, 1996, INT J OBESITY, V20, P595; McArdle WD, 1991, ENERGY NUTR HUMAN PE; Pollock ML., 1978, HLTH FITNESS PHYS AC; Prince RL, 2006, ARCH INTERN MED, V166, P869, DOI 10.1001/archinte.166.8.869; Srikanth VK, 2005, OSTEOARTHR CARTILAGE, V13, P769, DOI 10.1016/j.joca.2005.04.014; Wang Y, 2009, DRUG FUTURE, V34, P11, DOI 10.1358/dof.2009.034.01.1324393; WHO (World Health Organization), 1977, MAN INT STAT CLASS D; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; World Health Organization, 2004, ICD 10 INT STAT CLAS, DOI 10/2016/en#/II; Zeni JA, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-86	31	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83665	10.1371/journal.pone.0083665	http://dx.doi.org/10.1371/journal.pone.0083665			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349541	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300151
J	Purwantini, E; Mukhopadhyay, B				Purwantini, Endang; Mukhopadhyay, Biswarup			Rv0132c of Mycobacterium tuberculosis Encodes a Coenzyme F-420-Dependent Hydroxymycolic Acid Dehydrogenase	PLOS ONE			English	Article							OXYGENATED MYCOLIC ACIDS; BOVIS BCG; CELL-WALL; METHYLENETETRAHYDROMETHANOPTERIN REDUCTASE; TREHALOSE 6,6'-DIMYCOLATE; CIS-CYCLOPROPANATION; METHOXYMYCOLIC ACID; DRUG CANDIDATE; CORD FACTOR; F-420	The ability of Mycobacterium tuberculosis to manipulate and evade human immune system is in part due to its extraordinarily complex cell wall. One of the key components of this cell wall is a family of lipids called mycolic acids. Oxygenation of mycolic acids generating methoxy-and ketomycolic acids enhances the pathogenic attributes of M. tuberculosis. Thus, the respective enzymes are of interest in the research on mycobacteria. The generation of methoxy-and ketomycolic acids proceeds through intermediary formation of hydroxymycolic acids. While the methyl transferase that generates methoxymycolic acids from hydroxymycolic acids is known, hydroxymycolic acids dehydrogenase that oxidizes hydroxymycolic acids to ketomycolic acids has been elusive. We found that hydroxymycolic acid dehydrogenase is encoded by the rv0132c gene and the enzyme utilizes F-420, a deazaflavin coenzyme, as electron carrier, and accordingly we called it F-420-dependent hydroxymycolic acid dehydrogenase. This is the first report on the involvement of F-420 in the synthesis of a mycobacterial cell envelope. Also, F-420-dependent hydroxymycolic acid dehydrogenase was inhibited by PA-824, and therefore, it is a previously unknown target for this new tuberculosis drug.	[Purwantini, Endang; Mukhopadhyay, Biswarup] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Purwantini, Endang; Mukhopadhyay, Biswarup] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA USA; [Mukhopadhyay, Biswarup] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Mukhopadhyay, Biswarup] Virginia Tech, Virginia Tech Caril Sch Med, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Mukhopadhyay, B (corresponding author), Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA.	biswarup@vt.edu		Mukhopadhyay, Biswarup/0000-0003-0736-0298	Virginia Bioinformatics Institute, Virginia Tech; National Institutes of Health [1R21AI100039]	Virginia Bioinformatics Institute, Virginia Tech; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by Virginia Bioinformatics Institute, Virginia Tech and grant 1R21AI100039 from the National Institutes of Health to BM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibaud L, 2010, J BIOL CHEM, V285, P21698, DOI 10.1074/jbc.M110.125724; Aufhammer SW, 2005, PROTEIN SCI, V14, P1840, DOI 10.1110/ps.041289805; Aufhammer SW, 2004, STRUCTURE, V12, P361, DOI 10.1016/j.str.2004.02.010; Barkan D, 2010, J BACTERIOL, V192, P3661, DOI 10.1128/JB.00312-10; Bashiri G, 2008, J BIOL CHEM, V283, P17531, DOI 10.1074/jbc.M801854200; Bashiri G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045003; Behr MA, 2000, J BACTERIOL, V182, P3394, DOI 10.1128/JB.182.12.3394-3399.2000; Besra GS, 1998, MYCOBACTERIA PROTOCO; Beukes M, 2010, CHEM PHYS LIPIDS, V163, P800, DOI 10.1016/j.chemphyslip.2010.09.006; Biro JC, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-15; Brennan PJ, 2007, CURR TOP MED CHEM, V7, P475, DOI 10.2174/156802607780059763; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Choi KP, 2002, J BACTERIOL, V184, P2420, DOI 10.1128/JB.184.9.2420-2428.2002; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Creighton T. E., 1993, PROTEINS STRUCTURE M; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; DANIELS L, 1985, SYST APPL MICROBIOL, V6, P12, DOI 10.1016/S0723-2020(85)80004-7; Dao DN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000081; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; Dinadayala P, 2003, J BIOL CHEM, V278, P7310, DOI 10.1074/jbc.M210501200; Dubnau E, 1998, MOL MICROBIOL, V29, P1526; Dubnau E, 1997, MOL MICROBIOL, V23, P313, DOI 10.1046/j.1365-2958.1997.2301589.x; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Fujita Y, 2005, MICROBIOL-SGM, V151, P2065, DOI 10.1099/mic.0.27790-0; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; GEORGE KM, 1995, J BIOL CHEM, V270, P27292, DOI 10.1074/jbc.270.45.27292; Ginsberg AM, 2010, DRUGS, V70, P2201, DOI 10.2165/11538170-000000000-00000; Glickman MS, 2001, J BIOL CHEM, V276, P2228, DOI 10.1074/jbc.C000652200; Graham DE, 2010, MOL MICROBIOL, V78, P533, DOI 10.1111/j.1365-2958.2010.07358.x; Guerra-Lopez D, 2007, MICROBIOL-SGM, V153, P2724, DOI 10.1099/mic.0.2006/009241-0; Hunter RL, 2006, AM J PATHOL, V168, P1249, DOI 10.2353/ajpath.2006.050848; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; Indrigo J, 2003, MICROBIOL-SGM, V149, P2049, DOI 10.1099/mic.0.26226-0; Khasnobis Shampa, 2002, Expert Opin Ther Targets, V6, P21, DOI 10.1517/14728222.6.1.21; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Laval F, 2008, J BIOL CHEM, V283, P1419, DOI 10.1074/jbc.M708859200; LEDERER E, 1975, MOL CELL BIOCHEM, V7, P87, DOI 10.1007/BF01792076; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; Manjunatha Ujjini, 2009, Commun Integr Biol, V2, P215; McDonough JA, 2005, J BACTERIOL, V187, P7667, DOI 10.1128/JB.187.22.7667-7679.2005; MINNIKIN DE, 1984, ARCH MICROBIOL, V139, P225, DOI 10.1007/BF00402005; Mukherjee T, 2011, FUTURE MED CHEM, V3, P1427, DOI [10.4155/FMC.11.90, 10.4155/fmc.11.90]; Mukhopadhyay B, 2000, BBA-GEN SUBJECTS, V1475, P191, DOI 10.1016/S0304-4165(00)00064-7; O Gaora P, 1998, METH MOL B, V101, P261; O'Toole R, 2010, ADV APPL MICROBIOL, V71, P75, DOI 10.1016/S0065-2164(10)71003-0; Purwantini E, 1996, J BACTERIOL, V178, P2861, DOI 10.1128/jb.178.10.2861-2866.1996; Purwantini E, 1998, J BACTERIOL, V180, P2212, DOI 10.1128/JB.180.8.2212-2219.1998; Purwantini E, 1997, FEMS MICROBIOL LETT, V146, P129, DOI 10.1016/S0378-1097(96)00465-X; Purwantini E, 2009, P NATL ACAD SCI USA, V106, P6333, DOI 10.1073/pnas.0812883106; Quemard A, 1997, EUR J BIOCHEM, V250, P758, DOI 10.1111/j.1432-1033.1997.00758.x; Rao V, 2006, J CLIN INVEST, V116, P1660, DOI 10.1172/JCI27335; Sambandan D, 2013, MBIO, V4, DOI 10.1128/mBio.00222-13; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shima S, 2000, J MOL BIOL, V300, P935, DOI 10.1006/jmbi.2000.3909; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Sutcliffe IC, 2002, MICROBIOL-SGM, V148, P2065, DOI 10.1099/00221287-148-7-2065; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Taylor MC, 2010, MOL MICROBIOL, V78, P561, DOI 10.1111/j.1365-2958.2010.07356.x; Vander Beken S, 2011, EUR J IMMUNOL, V41, P450, DOI 10.1002/eji.201040719; Varela C, 2012, CHEM BIOL, V19, P498, DOI 10.1016/j.chembiol.2012.03.006; Yagi T, 2003, J BIOL CHEM, V278, P26497, DOI 10.1074/jbc.M302216200; Yuan Y, 1998, MOL MICROBIOL, V29, P1449, DOI 10.1046/j.1365-2958.1998.01026.x; Yuan Y, 1996, P NATL ACAD SCI USA, V93, P12828, DOI 10.1073/pnas.93.23.12828; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	68	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81985	10.1371/journal.pone.0081985	http://dx.doi.org/10.1371/journal.pone.0081985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349169	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300067
J	Xue, B; Saunders, RMK				Xue, Bine; Saunders, Richard M. K.			Reassessing Morphological Homologies in the Early-Divergent Angiosperm Fenerivia (Annonaceae) Based on Floral Vascular Anatomy: Significance for Interpreting Putative Homeotic Mutations	PLOS ONE			English	Article							GENUS FENERIVIA; POLYALTHIA; EVOLUTION	Fenerivia species (Annonaceae) are characterized by a prominent flange immediately below the perianth, which has been interpreted as synapomorphic for the genus. The homology of this flange is controversial: previous studies of Fenerivia heteropetala (an aberrant species, with 12 perianth parts in three whorls) have suggested that the flange may represent a vestigial calyx resulting from a disruption to the homeotic control of organ identity during floral development. Comparative data on floral vasculature in Fenerivia capuronii are presented to elucidate the homology of the flange in other Fenerivia species (which possess nine perianth parts in three whorls, typical of most Annonaceae). The flange in F. capuronii differs from that in F. heteropetala as it is unvascularized. It is nevertheless suggested that the flange is likely to be homologous, and that a homeotic mutation in the F. heteropetala lineage resulted in the formation of a vestigial but vascularized calyx that fused with the otherwise unvascularized flange.	[Xue, Bine; Saunders, Richard M. K.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Saunders, RMK (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China.	saunders@hku.hk	Saunders, Richard M. K./A-7436-2008	Saunders, Richard M. K./0000-0002-8104-7761; Xue, Bine/0000-0002-4515-4316	Hong Kong Research Grants Council [HKU 775009M]; University of Hong Kong Research Committee	Hong Kong Research Grants Council(Hong Kong Research Grants Council); University of Hong Kong Research Committee(University of Hong Kong)	Financial support was provided by grants from the Hong Kong Research Grants Council (HKU 775009M) and the University of Hong Kong Research Committee, both awarded to RMKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardello Gabriel, 2007, P19, DOI 10.1007/978-1-4020-5937-7_2; Cavaco A., 1957, Bull. Jard. bot. Etat Brux., V27, P59, DOI 10.2307/3666980; Cavaco A, 1958, FLORE MADAGASCAR COM, P1; Chaowasku T, 2012, PHYTOTAXA, V69, P33, DOI 10.11646/phytotaxa.69.1.6; Chatrou LW, 2012, BOT J LINN SOC, V169, P5, DOI 10.1111/j.1095-8339.2012.01235.x; De Craene LPR, 2003, INT J PLANT SCI, V164, pS329, DOI 10.1086/377063; DECRAENE LPR, 1993, BOT J LINN SOC, V113, P285; DEROIN T, 1989, CR ACAD SCI III-VIE, V309, P647; Deroin T, 1989, COMPT REND HEBD SE 3, V3, P71; Deroin T, 1988, THESIS U PARIS ORSAY; Deroin Thierry, 1999, Systematics and Geography of Plants, V68, P213, DOI 10.2307/3668602; Deroin T, 2007, ADANSONIA, V29, P7; Diels L., 1925, NOTIZBLATT BOT GARTE, V9, P334, DOI [10.2307/3994385, DOI 10.2307/3994385]; Ghesquiere MJ, 1939, REV ZOOLOGIE BOT AFR, V32, P139; Mols JB, 2008, SYST BOT, V33, P490, DOI 10.1600/036364408785679752; Nepi Massimo, 2007, P129, DOI 10.1007/978-1-4020-5937-7_3; OBrien T.P., 1981, STUDY PLANT STRUCTUR, P357, DOI DOI 10.1111/1365-3040.EP11572627; Ozenda P, 1949, CONTRIBUTION ANGIOSP; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; Saunders RMK, 2012, BOT J LINN SOC, V169, P222, DOI 10.1111/j.1095-8339.2011.01208.x; Saunders RMK, 2011, TAXON, V60, P1407, DOI 10.1002/tax.601028; Saunders RMK, 2010, BIOL REV, V85, P571, DOI 10.1111/j.1469-185X.2009.00116.x; SCHATZ G E, 1990, Bulletin du Museum National d'Histoire Naturelle Section B Adansonia Botanique Phytochimie, V12, P113; Xue B, 2012, TAXON, V61, P1021, DOI 10.1002/tax.615009; Xue BN, 2011, SYST BIODIVERS, V9, P17, DOI 10.1080/14772000.2010.542497	25	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81923	10.1371/journal.pone.0081923	http://dx.doi.org/10.1371/journal.pone.0081923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349152	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300059
J	Chang, YL; Hung, SH; Ling, W; Lin, HC; Li, HC; Chung, SD				Chang, Yen-Liang; Hung, Shih-Han; Ling, Wells; Lin, Herng-Ching; Li, Hsien-Chang; Chung, Shiu-Dong			Association between Ischemic Stroke and Iron-Deficiency Anemia: A Population-Based Study	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; CHRONIC KIDNEY-DISEASE; RISK-FACTORS; THROMBOCYTOSIS; MORTALITY; OUTCOMES; IMPACT	Background: Very little is known about the relationship between non-sickle cell anemia and stroke. The purpose of this study is to evaluate the association of iron-deficiency anemia (IDA) with stroke based on a nationwide coverage database in Taiwan. Methods: The case-control study subjects were obtained from the Taiwanese Longitudinal Health Insurance Database 2000. We included 51,093 subjects with stroke as cases and randomly selected 153,279 controls (3 controls per case) in this study. Separate conditional logistic regression analyses were used to calculate the odds ratio (OR) for having been previously diagnosed with IDA between cases and controls. We further analyzed the association between stroke and IDA by stroke subtype. Results: Results showed that 3,685 study subjects (1.81%) had been diagnosed with IDA prior to the index date; of those subjects, 1,268 (2.48%) were cases and 2,417 (1.58%) were controls (p<0.001). Conditional logistic regression shows that the OR of having previously received an IDA diagnosis among cases was 1.49 (95% CI: 1.39+/-1.60; p<0.01) that of controls after adjusting for monthly income, geographic region, hypertension, diabetes, coronary heart disease, atrial fibrillation, heart failure, hyperlipidemia, tobacco use disorder, and alcohol abuse/alcohol dependency syndrome. Furthermore, the adjusted OR of prior IDA for cases with ischemic stroke was found to be 1.45 (95% CI: 1.34 similar to 1.58) compared to controls. However, we did not find any significant relationship between IDA and subarachnoid/intracerebral hemorrhage even adjusting for other confounding factors (OR=1.17, 95% CI=0.97 similar to 1.40). Conclusion: There is a significant association between prior IDA and ischemic stroke.	[Chang, Yen-Liang] Cathay Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei, Taiwan; [Chang, Yen-Liang] Fu Jen Catholic Univ, Sch Med, Taipei, Taiwan; [Hung, Shih-Han] Taipei Med Univ Hosp, Dept Otolaryngol, Taipei, Taiwan; [Ling, Wells] St Louis Univ, Dept Psychol, St Louis, MO 63103 USA; [Lin, Herng-Ching; Chung, Shiu-Dong] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Lin, Herng-Ching; Li, Hsien-Chang] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Chung, Shiu-Dong] Far Eastern Mem Hosp, Dept Surg, Div Urol, New Taipei City, Taiwan	Cathay General Hospital; Fu Jen Catholic University; Taipei Medical University; Taipei Medical University Hospital; Saint Louis University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Far Eastern Memorial Hospital	Chung, SD (corresponding author), Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan.	chungshiudong@gmail.com		Hung, Shih-Han/0000-0001-9591-5489				Abramson JL, 2003, KIDNEY INT, V64, P610, DOI 10.1046/j.1523-1755.2003.00109.x; Adams RJ, 1998, CONTROL CLIN TRIALS, V19, P110, DOI 10.1016/S0197-2456(97)00099-8; ALEXANDER MB, 1983, SOUTHERN MED J, V76, P662, DOI 10.1097/00007611-198305000-00035; Baptist EC, 2002, CLIN PEDIATR, V41, P533, DOI 10.1177/000992280204100714; Basak R, 2008, Mymensingh Med J, V17, P74; Besarab A, 2009, ONCOLOGIST, V14, P22, DOI 10.1634/theoncologist.2009-S1-22; Brill JR, 2000, AM FAM PHYSICIAN, V62, P2255; Carson JL, 1995, AM J SURG, V170, pS32, DOI 10.1016/S0002-9610(99)80056-7; Chaker S, 2010, REV MED INTERNE, V31, P631, DOI 10.1016/j.revmed.2010.01.012; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; CHUNG SD, 2013, BURNS; Chung SD, 2012, BJU INT, V110, pE1053, DOI 10.1111/j.1464-410X.2012.11210.x; Del Fabbro P, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-27; Driscoll MC, 2003, BLOOD, V101, P2401, DOI 10.1182/blood.V101.6.2401; Dubyk MD, 2012, CAN J NEUROL SCI, V39, P189, DOI 10.1017/S0317167100013214; GAGNON DR, 1994, AM HEART J, V127, P674, DOI 10.1016/0002-8703(94)90679-3; GROSS S, 1964, PEDIATRICS, V34, P315; Hao ZL, 2013, J CLIN NEUROSCI, V20, P37, DOI 10.1016/j.jocn.2012.05.020; Huan WY, 2009, J CLIN NEUROSCI, V16, P645, DOI 10.1016/j.jocn.2008.08.014; Kang JH, 2013, LARYNGOSCOPE, V123, P835, DOI 10.1002/lary.23829; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Karkouti K, 2008, TRANSFUSION, V48, P666, DOI 10.1111/j.1537-2995.2007.01590.x; Kelly-Hayes Margaret, 2003, J Stroke Cerebrovasc Dis, V12, P119, DOI 10.1016/S1052-3057(03)00042-9; Kuku I, 2009, PLATELETS, V20, P401, DOI 10.1080/09537100903137306; Kuriyan Mercy, 2005, Anesthesiol Clin North Am, V23, P315, DOI 10.1016/j.atc.2005.01.005; Lawler PR, 2013, AM HEART J, V165, P143, DOI 10.1016/j.ahj.2012.10.024; Maguire JL, 2007, PEDIATRICS, V120, P1053, DOI 10.1542/peds.2007-0502; Mehta PJ, 2012, CASE REP NEUROL MED, V2012, DOI 10.1155/2012/487080; Minino Arialdi M, 2011, Natl Vital Stat Rep, V59, P1; MOHR JP, 1992, NEW ENGL J MED, V326, P637, DOI 10.1056/NEJM199202273260911; Munot P, 2011, ARCH DIS CHILD, V96, P276, DOI 10.1136/adc.2010.189241; Musallam KM, 2013, ANEMIA, V2013, DOI 10.1155/2013/206829; Nicastro N, 2012, CASE REP MED, V2012, DOI 10.1155/2012/497814; Nikolsky E, 2004, J AM COLL CARDIOL, V44, P547, DOI 10.1016/j.jacc.2004.03.080; Park MJ, 2013, PLATELETS, V24, P348, DOI 10.3109/09537104.2012.699641; Pegelow CH, 1997, AM J MED, V102, P171; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Saxena K, 2005, CLIN PEDIATR, V44, P175, DOI 10.1177/000992280504400210; SAYER JM, 1993, GUT, V34, P1297, DOI 10.1136/gut.34.10.1297; Scoditti U, 1990, Riv Neurol, V60, P146; Sico JJ, 2013, J STROKE CEREBROVASC, V22, P271, DOI 10.1016/j.jstrokecerebrovasdis.2011.09.003; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Vlagopoulos PT, 2005, J AM SOC NEPHROL, V16, P3403, DOI 10.1681/ASN.2005030226; Williams B, 2008, AM J MED SCI, V336, P279, DOI 10.1097/MAJ.0b013e3181862556	46	56	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82952	10.1371/journal.pone.0082952	http://dx.doi.org/10.1371/journal.pone.0082952			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349404	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200117
J	Habte, D; Teklu, S; Melese, T; Magafu, MGMD				Habte, Dereje; Teklu, Sisay; Melese, Tadele; Magafu, Mgaywa G. M. D.			Correlates of Unintended Pregnancy in Ethiopia: Results From a National Survey	PLOS ONE			English	Article							UNWANTED PREGNANCIES; WOMEN; PREVALENCE; CHILDREN; AGE	Background: Unintended pregnancy has been a major reproductive health challenge in resource poor settings including Ethiopia. It has adverse consequences to the mother, child and the health sector's resources. Understanding the extent of unintended pregnancy and the factors associated is crucial to devise evidence based interventions. The analysis was aimed at assessing the unintended pregnancy prevalence rate among pregnant women and the factors predisposing to unintended pregnancy. Methods: This secondary data analysis was done on women's dataset from the 2011 Ethiopian Demographic and Health Survey (DHS). A total of 1267 pregnant women were included in the analysis. Multiple logistic regression analysis was performed using SPSS software to identify the factors associated with unintended pregnancy. Odds Ratio with 95% confidence interval (95% CI) was computed to assess the association of different factors with unintended pregnancy. Results: The overall prevalence of unintended pregnancy was found to be 24%: those who wanted it at a later time and not at all accounted for 17.1% and 6.9%, respectively. The unintended pregnancy rate ranged from 1.5% in Afar Regional State to 39.8% in Oromiya Regional State. Women who knew the timing of ovulation had a 45% reduced chance of unintended pregnancy (OR (95% CI): 0.55 (0.35, 0.85)). Ever use of family planning, presence of five or more born children, and two or more births in the past five years were associated with unintended pregnancy (OR (95% CI): 1.79 (1.31, 2.45), 2.36 (1.01, 5.49) and 2.00 (1.12, 3.58), respectively). Conclusions: A significant proportion of the current pregnancies were found to be unintended with significant variations among the different regions. Women already burdened with higher fertility were suffering from unintended pregnancy. Family planning programs need to concentrate on the highly affected regions and target women with higher fertility to reduce the level of unintended pregnancy at national level.	[Habte, Dereje; Magafu, Mgaywa G. M. D.] Univ Botswana, Sch Publ Hlth, Gaborone, Botswana; [Teklu, Sisay] Univ Addis Ababa, Dept Gynecol Obstet, Addis Ababa, Ethiopia; [Melese, Tadele] Univ Botswana, Sch Med, Gaborone, Botswana	University of Botswana; Addis Ababa University; University of Botswana	Habte, D (corresponding author), Univ Botswana, Sch Publ Hlth, Gaborone, Botswana.	dereje.habte@gmail.com		Melese, Tadele/0000-0001-8003-4005; Habte, Dereje/0000-0002-4720-4188	United States Agency for International Development (USAID); HIV/AIDS Prevention and Control Office (HAPCO), USAID; United Nations Population Fund (UNFPA); United Kingdom for International Development (DFID); United Nations Children's Fund (UNICEF); Centers for Disease Control and Prevention (CDC)	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); HIV/AIDS Prevention and Control Office (HAPCO), USAID; United Nations Population Fund (UNFPA); United Kingdom for International Development (DFID); United Nations Children's Fund (UNICEF); Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The 2011 Ethiopia Demographic and Health Survey (2011 EDHS) is part of the worldwide MEASURE DHS project which is funded by the United States Agency for International Development (USAID). The survey was implemented by the Ethiopian Central Statistical Agency (CSA). The funding for the EDHS was provided by the HIV/AIDS Prevention and Control Office (HAPCO), USAID, the United Nations Population Fund (UNFPA), the United Kingdom for International Development (DFID), the United Nations Children's Fund (UNICEF) and the Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assefa N, 2013, ACTA OBSTET GYN SCAN, V92, P642, DOI 10.1111/aogs.12097; Bowers D, 2019, MED STAT SCRATCH INT, V16; Central Statistical Agency, 2007, ETH POP HOUS CENS RE; Central Statistical Agency [Ethiopia] and ORC Macro [USA], 2011, ETH DEM HLTH SURV; Exavery A, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-35; Geda NR., 2011, J GEOGR REGIONAL PLA, V4, P417; Goto A, 2002, SOC SCI MED, V54, P1065, DOI 10.1016/S0277-9536(01)00081-8; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Hamdela B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039074; Henshaw SK, 1998, FAM PLANN PERSPECT, V30, P24, DOI 10.2307/2991522; Ikamari L, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-69; Joyce T, 2000, Matern Child Health J, V4, P171, DOI 10.1023/A:1009571313297; Kamal M, 2011, SALUD PUBLICA MEXICO, V53, P108, DOI 10.1590/S0036-36342011000200003; Kassa N, 2010, REPROD HLTH, V9, P1; Kaye DK, 2006, TROP MED INT HEALTH, V11, P90, DOI 10.1111/j.1365-3156.2005.01531.x; KUBICKA L, 1995, ACTA PSYCHIAT SCAND, V91, P361, DOI 10.1111/j.1600-0447.1995.tb09795.x; Magadi MA, 2003, SOC SCI MED, V56, P167, DOI 10.1016/S0277-9536(02)00018-7; Marston C, 2003, POP STUD-J DEMOG, V57, P77, DOI 10.1080/0032472032000061749; MYHRMAN A, 1988, ACTA PSYCHIAT SCAND, V77, P181, DOI 10.1111/j.1600-0447.1988.tb05098.x; Santelli J, 2003, PERSPECT SEX REPRO H, V35, P94, DOI 10.1111/j.1931-2393.2003.tb00111.x; Sedgh G, 2006, INT FAM PLAN PERSPEC, V32, P175, DOI 10.1363/3217506; Singh S, 2010, STUD FAMILY PLANN, V41, P241, DOI 10.1111/j.1728-4465.2010.00250.x; Tsui AO, 2010, EPIDEMIOL REV, V32, P152, DOI 10.1093/epirev/mxq012; Woldemicael G, 2010, HEALTH CARE WOMEN IN, V31, P599, DOI 10.1080/07399331003599555; Worku S, 2007, ETHIOP J HEALTH DEV, V20, P79; World Health Organization, 2009, WORLD HLTH REP 2005	26	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82987	10.1371/journal.pone.0082987	http://dx.doi.org/10.1371/journal.pone.0082987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VD	24349413	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200120
J	Ikeno, S; Haruyama, T				Ikeno, Shinya; Haruyama, Tetsuya			Boost Protein Expression through Co-Expression of LEA-Like Peptide in Escherichia coli	PLOS ONE			English	Article							EMBRYOGENESIS ABUNDANT PROTEIN; WATER-STRESS; DESICCATION; DEHYDRINS; PURIFICATION; AGGREGATION; TOLERANCE; NEMATODE; CARRIER; SURFACE	The boost protein expression has been done successfully by simple co-expression with a late embryogenesis abundant (LEA)-like peptide in Escherichia coli. Frequently, overexpression of a recombinant protein fails to provide an adequate yield. In the study, we developed a simple and efficient system for overexpressing transgenic proteins in bacteria by co-expression with an LEA-like peptide. The design of this peptide was based on part of the primary structure of an LEA protein that is known hydrophilic protein to suppress aggregation of other protein molecules. In our system, the expression of the target protein was increased remarkably by co-expression with an LEA-like peptide consisting of only 11 amino acid residues. This could provide a practical method for producing recombinant proteins efficiently.	[Ikeno, Shinya; Haruyama, Tetsuya] Kyushu Inst Technol, Dept Biol Funct & Engn, Kitakyushu, Fukuoka 804, Japan	Kyushu Institute of Technology	Haruyama, T (corresponding author), Kyushu Inst Technol, Dept Biol Funct & Engn, Kitakyushu Sci & Res Pk, Kitakyushu, Fukuoka 804, Japan.	haruyama@life.kyutech.ac.jp			Ministry of Education, Culture, Sports, Science and (MEXT) JAPAN [25820405]; Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP) from the Japan Science and Technology Agency (JST) [AS232Z00962E]; Grants-in-Aid for Scientific Research [25820405] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and (MEXT) JAPAN; Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP) from the Japan Science and Technology Agency (JST); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Part of these works were supported by the Grant-in-Aid for Yong Scientists (B) No. 25820405 (to SI) from The Ministry of Education, Culture, Sports, Science and (MEXT) JAPAN, the Adaptable & Seamless Technology Transfer Program through Target-driven R&D (A-STEP) No. AS232Z00962E (to SI) from the Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asakawa H, 2009, LANGMUIR, V25, P8841, DOI 10.1021/la900974n; Chakrabortee S, 2007, P NATL ACAD SCI USA, V104, P18073, DOI 10.1073/pnas.0706964104; CLOSE TJ, 1993, PLANT PHYSIOL, V101, P773, DOI 10.1104/pp.101.3.773; CLOSE TJ, 1989, PLANT MOL BIOL, V13, P95, DOI 10.1007/BF00027338; Close TJ, 1996, PHYSIOL PLANTARUM, V97, P795, DOI 10.1111/j.1399-3054.1996.tb00546.x; Dure L, 2001, PROTEIN PEPTIDE LETT, V8, P115, DOI 10.2174/0929866013409643; Gal TZ, 2004, FEBS LETT, V577, P21, DOI 10.1016/j.febslet.2004.09.049; Garay-Arroyo A, 2000, J BIOL CHEM, V275, P5668, DOI 10.1074/jbc.275.8.5668; Goyal K, 2005, FEBS LETT, V579, P4093, DOI 10.1016/j.febslet.2005.06.036; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Goyal K, 2003, J BIOL CHEM, V278, P12977, DOI 10.1074/jbc.M212007200; Hand SC, 2007, J EXP ZOOL PART A, V307A, P62, DOI 10.1002/jez.a.343; HIRAISHI A, 1992, LETT APPL MICROBIOL, V15, P210, DOI 10.1111/j.1472-765X.1992.tb00765.x; Ikeno S, 2004, SENSOR MATER, V16, P413; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; Kikawada T, 2006, BIOCHEM BIOPH RES CO, V348, P56, DOI 10.1016/j.bbrc.2006.07.003; LESLIE AGW, 1990, J MOL BIOL, V213, P167, DOI 10.1016/S0022-2836(05)80129-9; Lichty JJ, 2005, PROTEIN EXPRES PURIF, V41, P98, DOI 10.1016/j.pep.2005.01.019; Ma JKC, 2003, NAT REV GENET, V4, P794, DOI 10.1038/nrg1177; Menze MA, 2009, J BIOL CHEM, V284, P10714, DOI 10.1074/jbc.C900001200; Nishihara K, 2000, APPL ENVIRON MICROB, V66, P884, DOI 10.1128/AEM.66.3.884-889.2000; Paananen A, 2003, BIOCHEMISTRY-US, V42, P5253, DOI 10.1021/bi034031t; Maldonado LMTP, 2007, BIOMOL ENG, V24, P217, DOI 10.1016/j.bioeng.2006.10.001; Shimizu T, 2010, BIOCHEMISTRY-US, V49, P1093, DOI 10.1021/bi901745f; SHIPLEY JM, 1993, J BIOL CHEM, V268, P12193; Singh J, 2009, PROTEIN EXPRES PURIF, V67, P15, DOI 10.1016/j.pep.2009.04.003; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Wise MJ, 2004, TRENDS PLANT SCI, V9, P13, DOI 10.1016/j.tplants.2003.10.012; Wise MJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-52; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026	30	9	10	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82824	10.1371/journal.pone.0082824	http://dx.doi.org/10.1371/journal.pone.0082824			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349373	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800081
J	Murdock, DG; Bradford, Y; Schnetz-Boutaud, N; Mayo, P; Allen, MJ; D'Aoust, LN; Liang, XY; Mitchell, SL; Zuchner, S; Small, GW; Gilbert, JR; Pericak-Vance, MA; Haines, JL				Murdock, Deborah G.; Bradford, Yuki; Schnetz-Boutaud, Nathalie; Mayo, Ping; Allen, Melissa J.; D'Aoust, Laura N.; Liang, Xueying; Mitchell, Sabrina L.; Zuchner, Stephan; Small, Gary W.; Gilbert, John R.; Pericak-Vance, Margaret A.; Haines, Jonathan L.			KIAA1462, A Coronary Artery Disease Associated Gene, Is a Candidate Gene for Late Onset Alzheimer Disease in APOE Carriers	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPES; LINKAGE; LOCUS; RISK; CHROMOSOME-10; IDENTIFICATION; HETEROGENEITY; CONVERGENCE; PEDIGREES; ALLELE	Alzheimer disease (AD) is a devastating neurodegenerative disease affecting more than five million Americans. In this study, we have used updated genetic linkage data from chromosome 10 in combination with expression data from serial analysis of gene expression to choose a new set of thirteen candidate genes for genetic analysis in late onset Alzheimer disease (LOAD). Results in this study identify the KIAA1462 locus as a candidate locus for LOAD in APOE4 carriers. Two genes exist at this locus, KIAA1462, a gene associated with coronary artery disease, and "rokimi'', encoding an untranslated spliced RNA The genetic architecture at this locus suggests that the gene product important in this association is either "rokimi'', or a different isoform of KIAA1462 than the isoform that is important in cardiovascular disease. Expression data suggests that isoform f of KIAA1462 is a more attractive candidate for association with LOAD in APOE4 carriers than "rokimi'' which had no detectable expression in brain.	[Murdock, Deborah G.; Bradford, Yuki; Schnetz-Boutaud, Nathalie; Mayo, Ping; Allen, Melissa J.; D'Aoust, Laura N.; Liang, Xueying; Mitchell, Sabrina L.; Haines, Jonathan L.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Murdock, Deborah G.; Bradford, Yuki; Schnetz-Boutaud, Nathalie; Mayo, Ping; Allen, Melissa J.; D'Aoust, Laura N.; Liang, Xueying; Mitchell, Sabrina L.; Haines, Jonathan L.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Zuchner, Stephan; Gilbert, John R.; Pericak-Vance, Margaret A.] Univ Miami, Miller Sch Med, Miami Inst Human Genom, Miami, FL 33136 USA; [Small, Gary W.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA	Vanderbilt University; Vanderbilt University; University of Miami; University of California System; University of California Los Angeles	Haines, JL (corresponding author), Vanderbilt Univ, Ctr Human Genet Res, 221 Kirkland Hall, Nashville, TN 37235 USA.	jonathan.haines@case.edu	Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728; Mitchell, Sabrina/0000-0001-7930-2447	NIH [AG019757, AG021547, AG20135, AG21886]; Alzheimer Association [IIRG-00-2006]; Vanderbilt GCRC [MO1 RR-00095]; Harvard Brain Tissue Resource Center [R24MH068855]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, R01AG019757, R01AG020135, R01AG021547] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Vanderbilt GCRC; Harvard Brain Tissue Resource Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NIH grants AG019757, AG021547, AG20135, AG21886; Alzheimer Association (IIRG-00-2006); Vanderbilt GCRC (MO1 RR-00095); Harvard Brain Tissue Resource Center (R24MH068855). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2011, BIOCHEM BIOPH RES CO, V413, P224, DOI 10.1016/j.bbrc.2011.08.073; Alzheimer's Association, 2012, ALZH DIS FACTS FIG; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Bergem ALM, 1997, ARCH GEN PSYCHIAT, V54, P264; Bertram L, 2000, SCIENCE, V290, P2302, DOI 10.1126/science.290.5500.2302; Bertram L, 2012, PROG MOL BIOL TRANSL, V107, P79, DOI 10.1016/B978-0-12-385883-2.00008-4; Bhat A, 1999, HUM HERED, V49, P229, DOI 10.1159/000022879; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Casserly I, 2004, LANCET, V363, P1139, DOI 10.1016/S0140-6736(04)15900-X; Chapuis J, 2009, MOL PSYCHIATR, V14, P1004, DOI 10.1038/mp.2009.10; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Erdmann J, 2011, EUR HEART J, V32, P158, DOI 10.1093/eurheartj/ehq405; Eriksson UK, 2010, ALZ DIS ASSOC DIS, V24, P213, DOI 10.1097/WAD.0b013e3181d1b99b; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; Farrer LA, 2003, HUM MOL GENET, V12, P415, DOI 10.1093/hmg/ddg037; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hebert LE, 2001, ALZ DIS ASSOC DIS, V15, P169, DOI 10.1097/00002093-200110000-00002; HODGE SE, 1994, AM J MED GENET, V54, P318, DOI 10.1002/ajmg.1320540408; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; Li YJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-504; Liang XY, 2008, ANN HUM GENET, V72, P141, DOI 10.1111/j.1469-1809.2007.00394.x; Liang X, 2007, HUM MUTAT, V28, P1065, DOI 10.1002/humu.20567; Liang XY, 2009, HUM MUTAT, V30, P463, DOI 10.1002/humu.20953; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Martin ER, 2003, AM J HUM GENET, V73, P1016, DOI 10.1086/378779; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2003, GENET EPIDEMIOL, V25, P203, DOI 10.1002/gepi.10258; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Myers A, 2000, SCIENCE, V290, P2304, DOI 10.1126/science.290.5500.2304; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pericak-Vance MA, 2000, EXP GERONTOL, V35, P1343, DOI 10.1016/S0531-5565(00)00196-0; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogaev EI, 1997, GENOMICS, V40, P415, DOI 10.1006/geno.1996.4523; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Vina J, 2010, J ALZHEIMERS DIS, V20, pS527, DOI 10.3233/JAD-2010-100501; Xu PT, 2007, MOL CELL NEUROSCI, V36, P313, DOI 10.1016/j.mcn.2007.06.009; Zubenko GS, 1998, GENOMICS, V50, P121, DOI 10.1006/geno.1998.5306	45	8	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82194	10.1371/journal.pone.0082194	http://dx.doi.org/10.1371/journal.pone.0082194			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349219	Green Published, gold			2022-12-27	WOS:000328731800046
J	Axelsson, J; Rehman, JU; Akerstedt, T; Ekman, R; Miller, GE; Hoglund, CO; Lekander, M				Axelsson, John; Rehman, Javaid-ur; Akerstedt, Torbjorn; Ekman, Rolf; Miller, Gregory E.; Hoglund, Caroline Olgart; Lekander, Mats			Effects of Sustained Sleep Restriction on Mitogen-Stimulated Cytokines, Chemokines and T Helper 1/T Helper 2 Balance in Humans	PLOS ONE			English	Article							GROWTH-HORMONE; DEPRIVATION; DURATION; PROLACTIN; RESPONSES; CORTISOL; ASTHMA; CELLS; MECHANISMS; EXPRESSION	Background: Recent studies suggest that acute sleep deprivation disrupts cellular immune responses by shifting T helper (Th) cell activity towards a Th2 cytokine profile. Since little is known about more long-term effects, we investigated how five days of sleep restriction would affect pro-inflammatory, chemotactic, Th1- and Th2 cytokine secretion. Methods: Nine healthy males participated in an experimental sleep protocol with two baseline sleep-wake cycles (sleep 23.00 - 07.00 h) followed by 5 days with restricted sleep (03.00 - 07.00 h). On the second baseline day and on the fifth day with restricted sleep, samples were drawn every third hour for determination of cytokines/chemokines (tumor necrosis factor alpha (TNF-alpha), interleukin (IL) -1 beta, IL-2, IL-4 and monocyte chemoattractant protein-1 (MCP-1)) after in vitro stimulation of whole blood samples with the mitogen phytohemagglutinin (PHA). Also leukocyte numbers, mononuclear cells and cortisol were analysed. Results: 5-days of sleep restriction affected PHA-induced immune responses in several ways. There was a general decrease of IL-2 production (p<.05). A shift in Th1/Th2 cytokine balance was also evident, as determined by a decrease in IL2/IL4 ratio. No other main effects of restricted sleep were shown. Two significant interactions showed that restricted sleep resulted in increased TNF-alpha and MCP-1 in the late evening and early night hours (p's<.05). In addition, all variables varied across the 24 h day. Conclusions: 5-days of sleep restriction is characterized by a shift towards Th2 activity (i.e. lower 1L-2/IL-4 ratio) which is similar to the effects of acute sleep deprivation and psychological stress. This may have implications for people suffering from conditions characterized by excessive Th2 activity like in allergic disease, such as asthma, for whom restricted sleep could have negative consequences.	[Axelsson, John; Rehman, Javaid-ur] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Axelsson, John; Hoglund, Caroline Olgart; Lekander, Mats] Karolinska Inst, Osher Ctr Integrat Med, Stockholm, Sweden; [Axelsson, John; Akerstedt, Torbjorn; Lekander, Mats] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Ekman, Rolf] Univ Gothenburg, Inst Neurosci & Physiol, Gothenburg, Sweden; [Miller, Gregory E.] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Hoglund, Caroline Olgart] Karolinska Inst, Dept Med Solna, Resp Med Unit, Stockholm, Sweden; [Hoglund, Caroline Olgart] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Hoglund, Caroline Olgart] Karolinska Univ Hosp, Stockholm, Sweden; [Hoglund, Caroline Olgart] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Hoglund, Caroline Olgart; Lekander, Mats] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Stockholm University; University of Gothenburg; University of British Columbia; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Axelsson, J (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	john.axelsson@ki.se	Axelsson, John/AAH-5998-2019	Axelsson, John/0000-0003-3932-7310	Swedish Tercentary Fund [J2001-0462:1, J2001-0462:3]; Swedish Working Life Fund [2002-0461]; Swedish Society for Medical Research; Swedish Sleep Research Society; Swedish Heart Lung Foundation; Swedish Asthma and Allergy Association; Swedish Sleep Research Society in Sweden	Swedish Tercentary Fund; Swedish Working Life Fund; Swedish Society for Medical Research; Swedish Sleep Research Society; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Asthma and Allergy Association; Swedish Sleep Research Society in Sweden	This study was supported by the Swedish Tercentary Fund (J2001-0462:1, J2001-0462:3, http://www.rj.se/English), the Swedish Working Life Fund (2002-0461, http://www.forte.se/), The Swedish Society for Medical Research (http://www.ssmf.se/in-english), the Swedish Sleep Research Society (http://www.swedishsleepresearch.com/), the Swedish Heart Lung Foundation (http://www.hjart-lungfonden.se/Om-Hjart-lungfonden/About-HLF/), and the Swedish Asthma and Allergy Association (http://www.astmaoallergiforbundet.se/). The "Swedish Sleep Research Society" is a non-profit organisation with the purpose to support sleep research in Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBAS AK, 1991, IMMUNOL REV, V123, P5, DOI 10.1111/j.1600-065X.1991.tb00603.x; Akerstedt T, 2009, SLEEP, V32, P217, DOI 10.1093/sleep/32.2.217; Bollinger T, 2010, IMMUNOLOGY, V131, P488, DOI 10.1111/j.1365-2567.2010.03320.x; Born J, 1997, J IMMUNOL, V158, P4454; Brandenberger G, 2000, LANCET, V356, P1408, DOI 10.1016/S0140-6736(00)02847-6; Bryant PA, 2004, NAT REV IMMUNOL, V4, P457, DOI 10.1038/nri1369; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cohen S, 2009, ARCH INTERN MED, V169, P62, DOI 10.1001/archinternmed.2008.505; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Dimitrov S, 2004, BRAIN BEHAV IMMUN, V18, P341, DOI 10.1016/j.bbi.2003.08.004; Dimitrov S, 2004, BRAIN BEHAV IMMUN, V18, P368, DOI 10.1016/j.bbi.2003.09.014; DINGES DF, 1995, ADV NEUROIMMUNOL, V5, P97, DOI 10.1016/0960-5428(95)00002-J; Everson CA, 2005, AM J PHYSIOL-REG I, V288, pR374, DOI 10.1152/ajpregu.00565.2004; FIGUERAS J, 1995, CIRCULATION, V92, P1737, DOI 10.1161/01.CIR.92.7.1737; FitzGerald SP, 2005, CLIN CHEM, V51, P1165, DOI 10.1373/clinchem.2005.049429; FONDELL E, 2011, BRAIN BEHAV IMMUN; Frey DJ, 2007, BRAIN BEHAV IMMUN, V21, P1050, DOI 10.1016/j.bbi.2007.04.003; Giron-Gonzalez JA, 2000, EUR J ENDOCRINOL, V143, P31, DOI 10.1530/eje.0.1430031; Heiser P, 2000, EUR ARCH PSY CLIN N, V250, P16, DOI 10.1007/PL00007534; HETZEL MR, 1977, THORAX, V32, P418, DOI 10.1136/thx.32.4.418; Hoglund CO, 2006, CLIN EXP ALLERGY, V36, P982, DOI 10.1111/j.1365-2222.2006.02529.x; Irwin M, 1996, FASEB J, V10, P643, DOI 10.1096/fasebj.10.5.8621064; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Kronholm E, 2008, J SLEEP RES, V17, P54, DOI 10.1111/j.1365-2869.2008.00627.x; Lai H, 2010, J AEROSOL MED PULM D, V23, P219, DOI 10.1089/jamp.2009.0802; Lange T, 2006, ARCH INTERN MED, V166, P1695, DOI 10.1001/archinte.166.16.1695; Lungato L, 2012, BBA-GEN SUBJECTS, V1820, P1997, DOI 10.1016/j.bbagen.2012.09.010; Mauad T, 2008, CURR OPIN PULM MED, V14, P31, DOI 10.1097/MCP.0b013e3282f19846; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; MOLDOFSKY H, 1989, FASEB J, V3, P1972, DOI 10.1096/fasebj.3.8.2785942; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; Mullington JM, 2010, BEST PRACT RES CL EN, V24, P775, DOI 10.1016/j.beem.2010.08.014; MURPHY WJ, 1993, J EXP MED, V178, P231, DOI 10.1084/jem.178.1.231; Ozturk L, 1999, Sleep Res Online, V2, P107; PALMBLAD J, 1979, PSYCHOSOM MED, V41, P273, DOI 10.1097/00006842-197906000-00001; Patel SR, 2009, SLEEP, V32, P200, DOI 10.1093/sleep/32.2.200; PELLEGRINI I, 1992, MOL ENDOCRINOL, V6, P1023, DOI 10.1210/me.6.7.1023; Petrovsky N, 1998, Int Rev Immunol, V16, P635, DOI 10.3109/08830189809043012; Ranjbaran Z, 2007, INFLAMM RES, V56, P51, DOI 10.1007/s00011-006-6067-1; Redwine L, 2003, PSYCHOSOM MED, V65, P75, DOI 10.1097/01.PSY.0000038943.33335.D2; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sakami S, 2002, NEUROIMMUNOMODULAT, V10, P337, DOI 10.1159/000071474; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Spiegel K, 1999, LANCET, V354, P1435, DOI 10.1016/S0140-6736(99)01376-8; Spiegel K, 2002, JAMA-J AM MED ASSOC, V288, P1471, DOI 10.1001/jama.288.12.1471-a; Spiegel K, 2004, J CLIN ENDOCR METAB, V89, P5762, DOI 10.1210/jc.2004-1003; UTHGENANNT D, 1995, PSYCHOSOM MED, V57, P97, DOI 10.1097/00006842-199503000-00001; van Leeuwen WMA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004589; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Weil ZM, 2009, EXP NEUROL, V218, P129, DOI 10.1016/j.expneurol.2009.04.018; WEITZMAN ED, 1983, J CLIN ENDOCR METAB, V56, P352, DOI 10.1210/jcem-56-2-352; Zielinski MR, 2012, BRAIN BEHAV IMMUN, V26, P672, DOI 10.1016/j.bbi.2012.03.002	53	48	49	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82291	10.1371/journal.pone.0082291	http://dx.doi.org/10.1371/journal.pone.0082291			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349251	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300087
J	Mohamed, HG; Idris, SB; Ahmed, MF; Boe, OE; Mustafa, K; Ibrahim, SO; Astrom, AN				Mohamed, Hasaan G.; Idris, Shaza B.; Ahmed, Mutaz F.; Boe, Olav E.; Mustafa, Kamal; Ibrahim, Salah O.; Astrom, Anne N.			Association between Oral Health Status and Type 2 Diabetes Mellitus among Sudanese Adults: A Matched Case-Control Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; PERIODONTAL-DISEASE; METABOLIC-CONTROL; DENTAL-CARIES; POPULATION; XEROSTOMIA	Aim: The purpose of this study was to compare the clinical and subjective oral health indicators of type 2 diabetic patients (T2DM) with age and gender matched non-diabetic controls. A second aim was to identify clinical and subjective oral health indicators that discriminate between well-controlled and poorly controlled T2DM patients as well as between patients with long and short duration of the disease. Methods: A total of 457 individuals participated in the study (154 T2DM cases and 303 non-diabetic controls). The T2DM group was sub-divided according to metabolic control [(well-controlled: glycosylated haemoglobin test 8%), (poorly controlled: glycosylated haemoglobin test. 8%)] and according to duration of T2DM [(long duration: >10 years), (short duration: 10 years)]. Participants were interviewed using a structured questionnaire including socio-demographics, lifestyle and oral health related quality of life factors. The clinical examination comprised full mouth probing depths, plaque index, tooth mobility index, furcation involvement and coronal and root surface caries. Results: The T2DM patients presented with more probing depths 4mm, furcation involvement, tooth mobility, missing teeth, and oral impacts on daily performance (OIDP). The corresponding adjusted odds ratios and their 95% confidence intervals were 4.07 (1.74-9.49), 2.96 (1.36-6.45), 5.90 (2.26-15.39), 0.23 (0.08-0.63) and 3.46 (1.61-7.42), respectively. Moreover, the odds ratio was 2.60 (1.21-5.55) for the poorly controlled T2DM patients to have high levels of mobility index and 2.94 (1.24-6.94) for those with long duration of T2DM to have high decayed, missed and filled teeth (DMFT) values. Conclusion: This study revealed that chronic periodontitis, tooth mobility, furcation involvement and OIDP were more prevalent among T2DM patients compared to their non-diabetic controls.	[Mohamed, Hasaan G.; Idris, Shaza B.; Boe, Olav E.; Mustafa, Kamal; Ibrahim, Salah O.; Astrom, Anne N.] Univ Bergen, Fac Med & Dent, Dept Clin Dent, Bergen, Norway; [Mohamed, Hasaan G.] Univ Khartoum, Fac Dent, Dept Oral Rehabil, Khartoum, Sudan; [Ahmed, Mutaz F.] Hamad Med Corp, Endodont Restorat Dent, Doha, Qatar	University of Bergen; University of Khartoum; Hamad Medical Corporation	Mohamed, HG (corresponding author), Univ Bergen, Fac Med & Dent, Dept Clin Dent, Bergen, Norway.	hasaan.mohamed@student.uib.no	Mustafa, Kamal/ABD-4458-2020		Norwegian State Educational Loan Fund (Quota Programme)	Norwegian State Educational Loan Fund (Quota Programme)	This study was supported by the Norwegian State Educational Loan Fund (Quota Programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelgadir A, 2006, DIABETES RES CLIN PR, V74, P90, DOI 10.1016/j.diabres.2006.03.003; Adulyanon S, 1997, MEASURING ORAL HLTH, P152; Albandar JM, 2002, J CLIN PERIODONTOL, V29, P823, DOI 10.1034/j.1600-051X.2002.290906.x; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Ali WM, 2011, THESIS U BERGEN; Allen EM, 2008, J ORAL REHABIL, V35, P218, DOI 10.1111/j.1365-2842.2007.01760.x; Allen P.F., 2003, HEALTH QUAL LIFE OUT, V1, P40, DOI [10.1186/1477-7525-1-40, DOI 10.1186/1477-7525-1-40]; Alpagot T, 2001, J PERIODONTAL RES, V36, P169, DOI 10.1034/j.1600-0765.2001.360305.x; [Anonymous], 2011, DIABETES; Arrieta-Blanco Juan Jose, 2003, Med Oral, V8, P97; Astrom Anne Nordrehaug, 2003, BMC Oral Health, V3, P5, DOI 10.1186/1472-6831-3-5; Bjelland S, 2002, AUST DENT J, V47, P202, DOI 10.1111/j.1834-7819.2002.tb00329.x; Borgnakke WS, 2013, J CLIN PERIODONTOL, V40, pS135, DOI [10.1111/jcpe.12080, 10.1902/jop.2013.1340013]; Borrell LN, 2007, J PERIODONTAL RES, V42, P559, DOI 10.1111/j.1600-0765.2007.00983.x; Campus G, 2005, J PERIODONTOL, V76, P418, DOI 10.1902/jop.2005.76.3.418; COHEN LK, 1976, INT J HEALTH SERV, V6, P681, DOI 10.2190/LE7A-UGBW-J3NR-Q992; Collin HL, 1998, ORAL SURG ORAL MED O, V85, P680, DOI 10.1016/S1079-2104(98)90035-X; Costa PP, 2010, J PERIODONTOL, V81, P384, DOI 10.1902/jop.2009.090510; HAMP S-E, 1975, Journal of Clinical Periodontology, V2, P126, DOI 10.1111/j.1600-051X.1975.tb01734.x; Hintao J, 2007, COMMUNITY DENT ORAL, V35, P302, DOI 10.1111/j.1600-0528.2007.00325.x; Hintao J, 2007, ORAL MICROBIOL IMMUN, V22, P175, DOI 10.1111/j.1399-302X.2007.00341.x; Hodge PJ, 2012, J CLIN PERIODONTOL, V39, P20, DOI 10.1111/j.1600-051X.2011.01791.x; Jawed M, 2012, EXP DIABETES RES, DOI 10.1155/2012/947304; Jawed M, 2011, J DIABETES COMPLICAT, V25, P183, DOI 10.1016/j.jdiacomp.2010.07.001; Khader Y. S., 2008, Eastern Mediterranean Health Journal, V14, P654; Lalla Evanthia, 2012, Dent Clin North Am, V56, P819, DOI 10.1016/j.cden.2012.07.008; Lalla E, 2011, NAT REV ENDOCRINOL, V7, P738, DOI 10.1038/nrendo.2011.106; Lamster IB, 2008, J AM DENT ASSOC, V139, p19S, DOI 10.14219/jada.archive.2008.0363; Leroy R, 2010, BMC ORAL HEALTH, V10, DOI 10.1186/1472-6831-10-8; Leung WK, 2008, ORAL HLTH PREV DENT, V6, P105; Lim LP, 2007, J CLIN PERIODONTOL, V34, P118, DOI 10.1111/j.1600-051X.2006.01032.x; Lin B P, 1999, Spec Care Dentist, V19, P8, DOI 10.1111/j.1754-4505.1999.tb01361.x; Locker D, 1988, Community Dent Health, V5, P3; LOE H, 1993, DIABETES CARE, V16, P329, DOI 10.2337/diacare.16.1.329; Masalu JR, 2003, COMMUNITY DENT ORAL, V31, P7, DOI 10.1034/j.1600-0528.2003.00011.x; Mealey BL, 2007, PERIODONTOL 2000, V44, P127, DOI 10.1111/j.1600-0757.2006.00193.x; Miller SC, 1938, TXB PERIODONTIA; Moore PA, 1999, J PERIODONTOL, V70, P409, DOI 10.1902/jop.1999.70.4.409; Moore PA, 2001, ORAL SURG ORAL MED O, V92, P281, DOI 10.1067/moe.2001.117815; Morita I, 2012, J DENT RES, V91, P161, DOI 10.1177/0022034511431583; Nasir Elwalid Fadul, 2009, BMC Oral Health, V9, P30, DOI 10.1186/1472-6831-9-30; Nassar H, 2007, PERIODONTOL 2000, V43, P233, DOI 10.1111/j.1600-0757.2006.00168.x; Nurelhuda NM, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-152; Preshaw PM, 2010, J CLIN PERIODONTOL, V37, P165, DOI 10.1111/j.1600-051X.2009.01519.x; Ribeiro FV, 2011, J PERIODONTOL, V82, P1187, DOI 10.1902/jop.2011.100643; Busato IMS, 2012, COMMUNITY DENT ORAL, V40, P62, DOI 10.1111/j.1600-0528.2011.00635.x; Sandberg GE, 2000, DIABETES RES CLIN PR, V50, P27, DOI 10.1016/S0168-8227(00)00159-5; Santos VR, 2012, ARCH ORAL BIOL, V57, P293, DOI 10.1016/j.archoralbio.2011.08.003; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; SILNESS J, 1964, Acta Odontol Scand, V22, P121, DOI 10.3109/00016356408993968; Suliman NM, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-19; Susanto H, 2012, CLIN ORAL INVEST, V16, P1237, DOI 10.1007/s00784-011-0621-0; Susanto H, 2011, J PERIODONTOL, V82, P550, DOI 10.1902/jop.2010.100285; Takeda M, 2006, J PERIODONTOL, V77, P15, DOI 10.1902/jop.2006.77.1.15; Tanwir F, 2009, ACTA ODONTOL SCAND, V67, P129, DOI 10.1080/00016350802208406; Taylor G W, 2001, Ann Periodontol, V6, P99, DOI 10.1902/annals.2001.6.1.99; Tsai C, 2002, COMMUNITY DENT ORAL, V30, P182, DOI 10.1034/j.1600-0528.2002.300304.x; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; World Health Organization, 1980, INT CLASS IMP DIS HA; World Health Organization, 1997, OR HLTH SURV BAS MET, V4th; Zielinski Marzenna B, 2002, Spec Care Dentist, V22, P94, DOI 10.1111/j.1754-4505.2002.tb01169.x	63	29	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82158	10.1371/journal.pone.0082158	http://dx.doi.org/10.1371/journal.pone.0082158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349205	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300078
J	Peng, YM; Luo, GX; Zhou, JY; Wang, XJ; Hu, J; Cui, YY; Li, XC; Tan, JL; Yang, SS; Zhan, RX; Yang, JJ; He, WF; Wu, J				Peng, Yanmeng; Luo, Gaoxing; Zhou, Junyi; Wang, Xiaojuan; Hu, Jie; Cui, Yanyan; Li, Xian C.; Tan, Jianglin; Yang, Sisi; Zhan, Rixing; Yang, Junjie; He, Weifeng; Wu, Jun			CD86 Is an Activation Receptor for NK Cell Cytotoxicity against Tumor Cells	PLOS ONE			English	Article							COSTIMULATION MODULATOR ABATACEPT; NATURAL-KILLER-CELLS; RHEUMATOID-ARTHRITIS; PHASE IIB; IMMUNOSUPPRESSION; RESPONSES; CANCER; B7-2	CTLA4Ig has been successfully used in the clinic for suppression of T cell activation. However, patients treated with CTLA4Ig experienced reduced incidence of tumors than predicted, but the underlying mechanism remains unknown. In this paper, we showed that brief administration of CTLA4Ig significantly reduced tumor metastasis and prolonged the survival of host mice bearing B16 melanoma. Depletion of NK cells prior to CTLA4Ig administration eliminated the CTLA4Ig-mediated anti-tumor activity. CTLA4Ig enhanced NK cell cytotoxicity to tumor cells via up-regulation of NK cell effecter molecules CD107a and perforin in vivo. In addition, we demonstrated that, upon activation, NK cells could significantly increase the expression of CD86 both in vitro and in vivo, and ligation of CD86 with CTLA4Ig significantly increased the ability of NK cells to kill tumor cells. Furthermore, a human NK cell line that expressed high level of CD86 was directly activated by CTLA4Ig so that killing of tumor targets was enhanced; this enhanced killing could be inhibited by blocking CD86. Our findings uncover a novel function of CTLA4Ig in tumor immunity and suggest that CD86 on NK cells is an activating receptor and closely involved in the CTLA4Ig-mediated anti-tumor response.	[Peng, Yanmeng; Luo, Gaoxing; Zhou, Junyi; Wang, Xiaojuan; Hu, Jie; Cui, Yanyan; Tan, Jianglin; Yang, Sisi; Zhan, Rixing; Yang, Junjie; He, Weifeng; Wu, Jun] Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China; [Peng, Yanmeng; Luo, Gaoxing; Zhou, Junyi; Wang, Xiaojuan; Hu, Jie; Cui, Yanyan; Tan, Jianglin; Yang, Sisi; Zhan, Rixing; Yang, Junjie; He, Weifeng; Wu, Jun] Chongqing Key Lab Dis, Chongqing, Peoples R China; [Li, Xian C.] Houston Methodist Hosp, Transplant Immunol Program, Immunobiol Res Ctr, Houston, TX USA	Army Medical University; The Methodist Hospital System; The Methodist Hospital - Houston	He, WF (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Burn Res, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China.	heweifeng7412@aliyun.com; editorinchief@burninchina.com	Gaoxing, LUO/AAE-4505-2020	LUO, Gaoxing/0000-0003-4764-3209; Li, Xian Chang/0000-0002-5981-2762	National Science and Technology Major Project of China [2010ZX09401-306-4-5]; Key Project of Military Plan [BWS11J039-4]; "863" project [2012AA020504]; State Key Laboratory Funding [SKLZZ201012]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080779] Funding Source: NIH RePORTER	National Science and Technology Major Project of China; Key Project of Military Plan; "863" project; State Key Laboratory Funding; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from National Science and Technology Major Project of China (2010ZX09401-306-4-5), Key Project of Military Plan (BWS11J039-4), "863" project (2012AA020504) and the State Key Laboratory Funding (SKLZZ201012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison C, 2005, Issues Emerg Health Technol, P1; Dantal J, 1998, LANCET, V351, P623, DOI 10.1016/S0140-6736(97)08496-1; Dumont FJ, 2004, CURR OPIN MOL THER, V6, P318; FINCK BK, 1994, SCIENCE, V265, P1225, DOI 10.1126/science.7520604; Gorczynski R M, 1994, Transpl Int, V7 Suppl 1, pS599; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Hanna J, 2005, MOL IMMUNOL, V42, P425, DOI 10.1016/j.molimm.2004.07.022; Hervey PS, 2006, BIODRUGS, V20, P53, DOI 10.2165/00063030-200620010-00004; Hunter CA, 1997, J IMMUNOL, V158, P2285; Kremer JM, 2005, ARTHRITIS RHEUM, V52, P2263, DOI 10.1002/art.21201; Larsen CP, 2005, AM J TRANSPLANT, V5, P443, DOI 10.1111/j.1600-6143.2005.00749.x; Martin-Fontecha A, 1999, J IMMUNOL, V162, P5910; Maxwell LJ, 2010, J RHEUMATOL, V37, P234, DOI 10.3899/jrheum.091066; Qureshi OS, 2012, J BIOL CHEM, V287, P9429, DOI 10.1074/jbc.M111.304329; Smyth MJ, 2006, J IMMUNOL, V176, P1582, DOI 10.4049/jimmunol.176.3.1582; Suvas S, 2002, J BIOL CHEM, V277, P7766, DOI 10.1074/jbc.M105902200; Tremblay F, 2002, ANN SURG ONCOL, V9, P785, DOI 10.1245/ASO.2001.06.030; TRINCHIERI G, 1993, NAT IMMUN, V12, P218; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Webb LMC, 1996, EUR J IMMUNOL, V26, P2320, DOI 10.1002/eji.1830261008; Westhovens R, 2009, J RHEUMATOL, V36, P736, DOI 10.3899/jrheum.080813; Wilson JL, 1999, J IMMUNOL, V163, P4207; Zingoni A, 2004, J IMMUNOL, V173, P3716, DOI 10.4049/jimmunol.173.6.3716	23	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83913	10.1371/journal.pone.0083913	http://dx.doi.org/10.1371/journal.pone.0083913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349559	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300153
J	Sun, Q; Mao, SS; Li, HQ; Zen, K; Zhang, CY; Li, L				Sun, Qi; Mao, Susu; Li, Hanqin; Zen, Ke; Zhang, Chen-Yu; Li, Liang			Role of miR-17 Family in the Negative Feedback Loop of Bone Morphogenetic Protein Signaling in Neuron	PLOS ONE			English	Article							STEM-CELLS; DIFFERENTIATION; EXPRESSION; CLUSTER; APOPTOSIS; PATHWAY; TRANSDUCTION; RECEPTORS; MICRORNAS; MECHANISM	Bone morphogenetic protein (BMP) signaling is active in many tissues including the central nervous system, in which it regulates cell proliferation, differentiation and maturation. The modulation of BMP pathway is crucial since abnormality of BMP signaling may cause cellular malfunction such as apoptosis. There are evidences indicating that miR-17 family is involved in the BMP signaling. In the present study, we demonstrated that BMP2 stimulation directly increased the transcription of miR-17-92 and miR-106b-25 cluster via Smad activation, which leads to the up-regulation of mature miR-17/20a/93. In addition, we provided evidence that BMP2 activation repressed BMPRII expression through modulating miR-17 family in primary neurons. Furthermore, we proved that such negative regulation protected neurons from apoptosis induced by abnormal BMP signaling. Taken together, these results suggest a regulatory pathway of BMP-miR-17 family-BMPRII, which consist a negative feedback loop that balances BMP signaling and maintains cell homeostasis in neurons.	[Sun, Qi; Mao, Susu; Li, Hanqin; Zen, Ke; Zhang, Chen-Yu; Li, Liang] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Zen, Ke] Univ Calif Berkeley, Sch Publ Hlth, Dept Virol, Berkeley, CA 94720 USA	Nanjing University; University of California System; University of California Berkeley	Zen, K (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	kzen@nju.edu.cn; cyzhang@nju.eud.cn; lijing@sibs.ac.cn			National Natural Science Foundation of China [31000478, 31100777, 31271378]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (31000478, 31100777 and 31271378). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 1997, COLD SPRING HARB SYM, V62, P493; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beveridge NJ, 2009, CELL SIGNAL, V21, P1837, DOI 10.1016/j.cellsig.2009.07.019; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Chen H, 2010, NEUROL RES, V32, P603, DOI 10.1179/174313209X455691; Clement JH, 2000, J CANCER RES CLIN, V126, P271, DOI 10.1007/s004320050342; Foshay KM, 2009, DEV BIOL, V326, P431, DOI 10.1016/j.ydbio.2008.11.016; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hyzy SL, 2012, J CELL BIOCHEM, V113, P3236, DOI 10.1002/jcb.24201; Kang H, 2012, J BIOL CHEM, V287, P38656, DOI 10.1074/jbc.M112.390898; Kondo M, 2007, FEBS J, V274, P2960, DOI 10.1111/j.1742-4658.2007.05838.x; Lesuisse C, 2002, J NEUROBIOL, V51, P9, DOI 10.1002/neu.10037; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Miyazono K, 2010, J BIOCHEM, V147, P35, DOI 10.1093/jb/mvp148; Nielsen-Preiss SM, 2003, J CELL BIOCHEM, V90, P964, DOI 10.1002/jcb.10709; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Pi WF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035283; Pospisil V, 2011, EMBO J, V30, P4450, DOI 10.1038/emboj.2011.317; Rainger J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002114; Sato T, 2010, J COMP NEUROL, V518, P4513, DOI 10.1002/cne.22469; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Sun Q, 2013, PROTEIN CELL, V4, P197, DOI 10.1007/s13238-013-2119-9; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Tournay O, 1996, MOL CELL BIOL, V16, P2418; Trompeter HI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016138; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wagner TU, 2007, FEBS J, V274, P2968, DOI 10.1111/j.1742-4658.2007.05839.x; Wang J, 2010, DEV CELL, V19, P903, DOI 10.1016/j.devcel.2010.10.022; Weng LP, 2001, HUM MOL GENET, V10, P237, DOI 10.1093/hmg/10.3.237; Yanagisawa M, 2001, FEBS LETT, V489, P139, DOI 10.1016/S0014-5793(01)02095-6; Yang DH, 2012, J CELL SCI, V125, P1673, DOI 10.1242/jcs.086421	35	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83067	10.1371/journal.pone.0083067	http://dx.doi.org/10.1371/journal.pone.0083067			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349434	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300130
J	Zhao, CJ; Zhang, FF; Chu, YZ; Liu, Y; Cao, B; Chen, MJ; Yu, YS; Liao, K; Zhang, LY; Sun, ZY; Hu, BJ; Lei, JE; Hu, ZD; Zhang, XB; Wang, H				Zhao, Chunjiang; Zhang, Feifei; Chu, Yunzhuo; Liu, Yong; Cao, Bin; Chen, Minjun; Yu, Yunsong; Liao, Kang; Zhang, Liyan; Sun, Ziyong; Hu, Bijie; Lei, Jin'e; Hu, Zhidong; Zhang, Xiaobing; Wang, Hui			Phenotypic and Genotypic Characteristic of Invasive Pneumococcal Isolates from Both Children and Adult Patients from a Multicenter Surveillance in China 2005-2011	PLOS ONE			English	Article							PNEUMONIAE SEROTYPE 19A; STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; UNITED-STATES; DISEASE; EPIDEMIOLOGY; IMPACT; RISK	Streptococcus pneumoniae is an important pathogen in both children and the elderly, but previous studies in China have provided limited information about invasive pneumococcal disease (IPD). A total of 240 IPD S. pneumoniae strains (from 105 children and 135 adults) were collected from 12 cities in China in 2005-2011. Their phenotypes and genetic characteristics were analyzed. Streptococcus pneumoniae remained highly resistant to macrolides, tetracycline, and cotrimoxazole each year. Serotypes were assigned to the 240 isolates, and 19A (22.1%), 19F (21.7%), 14 (7.5%), 3 (7.1%), and 23F (5.4%) were the most prevalent, accounting for 63.8% of all strains. Serogroup 19 strains were significantly more common among children than among adults (58.7% vs 32.4%, respectively; P < 0.001). Serotypes 19F and 19A demonstrated higher resistance to beta-lactams and cephalosporins than the other serotypes. The coverage of PCV13 was superior to that calculated for PCV7 and PCV10 (77.9% vs 40.8% and 47.1%, respectively), and coverage was higher in children than in adults (85.6% vs 72.1%, respectively; P = 0.012). A multilocus sequence typing analysis revealed great diversity, with nine clonal complexes and 83 singletons among all the strains. Specifically, CC271 was more common in children, whereas singletons were more prevalent in adults. Among the serogroup 19 strains, 84.7% were ST271, ST320, or ST236, belonging to CC271. The homogeneous genetic background of 19F and 19A, together with the high resistance of these strains, suggests that clonal spread is responsible for the high prevalence of serogroup 19 in IPD. This is the first large study to investigate IPD strains in both children and adults in China.	[Zhao, Chunjiang; Zhang, Feifei; Wang, Hui] Peking Univ, Peoples Hosp, Dept Clin Lab, Beijing 100871, Peoples R China; [Chu, Yunzhuo] China Med Univ, Hosp 1, Dept Clin Lab, Shenyang, Liaoning, Peoples R China; [Liu, Yong] China Med Univ, Shengjing Hosp, Dept Clin Lab, Shenyang, Liaoning, Peoples R China; [Cao, Bin] Capital Med Univ, Beijing Chao Yang Hosp, Dept Infect Dis & Clin Microbiol, Beijing, Peoples R China; [Chen, Minjun] Beijing Union Med Coll Hosp, Dept Clin Lab, Beijing, Peoples R China; [Yu, Yunsong] Hangzhou Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China; [Liao, Kang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Clin Lab, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Liyan] Guangdong Gen Hosp, Dept Clin Lab, Guangzhou, Guangdong, Peoples R China; [Sun, Ziyong] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Hu, Bijie] Fudan Univ, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Lei, Jin'e] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Clin Lab, Xian 710049, Shaanxi, Peoples R China; [Hu, Zhidong] Tianjin Med Univ, Gen Hosp, Dept Clin Lab, Tianjin, Peoples R China; [Zhang, Xiaobing] Southwest Hosp, Dept Clin Lab, Chongqing, Peoples R China	Peking University; China Medical University; China Medical University; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Zhejiang University; Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Huazhong University of Science & Technology; Fudan University; Xi'an Jiaotong University; Tianjin Medical University; Army Medical University	Wang, H (corresponding author), Peking Univ, Peoples Hosp, Dept Clin Lab, Beijing 100871, Peoples R China.	whuibj@gmail.com	Zhang, Li/GWM-7501-2022	Wang, Hui/0000-0001-9220-0357	GPRS project of Sanofi-Aventis, Pharmaceuticals Co., Ltd.	GPRS project of Sanofi-Aventis, Pharmaceuticals Co., Ltd.	This study was partially supported by GPRS project of Sanofi-Aventis, Pharmaceuticals Co., Ltd., for collection of Streptococcus pneumoniae strains and no additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrich WC, 2007, CLIN INFECT DIS, V44, P1569, DOI 10.1086/518149; Ardanuy C, 2009, CLIN INFECT DIS, V48, P57, DOI 10.1086/594125; Chen Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027333; Choi EH, 2008, EMERG INFECT DIS, V14, P275, DOI 10.3201/eid1402.070807; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V32; CLSI, 2013, PERFORMANCE STANDARD; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Huang SS, 2005, PEDIATRICS, V116, pE408, DOI 10.1542/peds.2004-2338; Jauneikaite E, 2012, VACCINE, V30, P3503, DOI 10.1016/j.vaccine.2012.03.066; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Liu CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054254; Liu YD, 2008, DIAGN MICR INFEC DIS, V61, P256, DOI 10.1016/j.diagmicrobio.2008.02.004; Lynch JP, 2009, SEMIN RESP CRIT CARE, V30, P189, DOI 10.1055/s-0029-1202938; Messina AF, 2007, PEDIATR INFECT DIS J, V26, P461, DOI 10.1097/INF.0b013e31805cdbeb; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Nyasulu P, 2011, PEDIATR INFECT DIS J, V30, P1075, DOI 10.1097/INF.0b013e31822cca05; Pelton SI, 2007, PEDIATR INFECT DIS J, V26, P468, DOI 10.1097/INF.0b013e31803df9ca; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; World Health Organization, 2007, WKLY EPIDEMIOL REC, V82, P93; Xue L, 2010, CLIN INFECT DIS, V50, P741, DOI 10.1086/650534; Yao KH, 2011, VACCINE, V29, P2296, DOI 10.1016/j.vaccine.2011.01.027; Zhou L, 2011, VACCINE, V29, P7704, DOI 10.1016/j.vaccine.2011.07.137	23	29	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82361	10.1371/journal.pone.0082361	http://dx.doi.org/10.1371/journal.pone.0082361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349263	gold, Green Submitted, Green Published			2022-12-27	WOS:000328730300089
J	Grey, JNC; Kent, VT; Hill, RA				Grey, Julia N. Chase; Kent, Vivien T.; Hill, Russell A.			Evidence of a High Density Population of Harvested Leopards in a Montane Environment	PLOS ONE			English	Article							CAPTURE-RECAPTURE MODELS; PANTHERA-PARDUS; CAMERA-TRAPS; SOUTH-AFRICA; HOME-RANGE; JAGUAR DENSITIES; LARGE CARNIVORES; TIGER DENSITIES; NATURE-RESERVE; RAIN-FOREST	Populations of large carnivores can persist in mountainous environments following extensive land use change and the conversion of suitable habitat for agriculture and human habitation in lower lying areas of their range. The significance of these populations is poorly understood, however, and little attention has focussed on why certain mountainous areas can hold high densities of large carnivores and what the conservation implications of such populations might be. Here we use the leopard (Panthera pardus) population in the western Soutpansberg Mountains, South Africa, as a model system and show that montane habitats can support high numbers of leopards. Spatially explicit capture-recapture (SECR) analysis recorded the highest density of leopards reported outside of state-protected areas in sub-Saharan Africa. This density represents a temporally high local abundance of leopards and we explore the explanations for this alongside some of the potential conservation implications.	[Grey, Julia N. Chase; Kent, Vivien T.; Hill, Russell A.] Univ Durham, Dept Anthropol, Durham, England; [Grey, Julia N. Chase; Hill, Russell A.] Lajuma Res Ctr, Primate & Predator Project, Louis Trichardt, Makhado, South Africa	Durham University	Grey, JNC (corresponding author), Univ Durham, Dept Anthropol, Durham, England.	j.n.chase-grey@durham.ac.uk	Hill, Russell/D-9113-2013	Hill, Russell/0000-0002-7601-5802	ESRC-NERC interdisciplinary studentship; British Fund for Women Graduates; John Simpson Memorial Fund, Hilde and Bede College, Durham University	ESRC-NERC interdisciplinary studentship; British Fund for Women Graduates; John Simpson Memorial Fund, Hilde and Bede College, Durham University	JCG was funded by an ESRC-NERC interdisciplinary studentship and additional funding was provided by the British Fund for Women Graduates and the John Simpson Memorial Fund, Hilde and Bede College, Durham University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, AFRICAN LEOPARD ECOL; Balme GA, 2010, ANIM CONSERV, V13, P315, DOI 10.1111/j.1469-1795.2009.00342.x; Balme GA, 2013, MAMMAL REV, V43, P221, DOI 10.1111/j.1365-2907.2012.00219.x; Balme Guy A., 2010, P341; Balme GA, 2009, BIOL CONSERV, V142, P2681, DOI 10.1016/j.biocon.2009.06.020; Balme GA, 2009, J WILDLIFE MANAGE, V73, P433, DOI 10.2193/2007-368; Balme GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035209; Bothma J. du P., 1984, Koedoe, V27, P259; Carbone C, 2001, ANIM CONSERV, V4, P75, DOI 10.1017/S1367943001001081; Carbone C, 2002, SCIENCE, V295, P2273, DOI 10.1126/science.1067994; Cavallo J, 1993, STUDY LEOPARD BEHAV, P33; Chase Grey JN, 2011, THESIS DURHAM U UK; Cooley HS, 2009, ANIM CONSERV, V12, P321, DOI 10.1111/j.1469-1795.2009.00256.x; Efford MG, 2009, ENVIRON ECOL STAT SE, V3, P255, DOI 10.1007/978-0-387-78151-8_11; Efford MG, 2009, ECOLOGY, V90, P2676, DOI 10.1890/08-1735.1; Foster RJ, 2012, J WILDLIFE MANAGE, V76, P224, DOI 10.1002/jwmg.275; Gaigher I. G., 2003, 1 SYNTHESIS ENV BIOL; Gavashelishvili A, 2008, J APPL ECOL, V45, P579, DOI 10.1111/j.1365-2664.2007.01432.x; Gerdel K, 2008, THESIS U TUBINGEN GE; Gopalaswamy A.M., 2011, SPACECAP PROGRAM EST; Grassman Lon I., 1999, Natural History Bulletin of the Siam Society, V47, P77; Hahn N., 2006, THESIS U PRETORIA S; Hamilton PH, 1976, THESIS U NAIROBI KEN; Hatten JR, 2005, J WILDLIFE MANAGE, V69, P1024, DOI 10.2193/0022-541X(2005)069[1024:ASMOPJ]2.0.CO;2; Hayward MW, 2006, J ZOOL, V270, P298, DOI 10.1111/j.1469-7998.2006.00139.x; Henschel P, 2011, J ZOOL, V285, P11, DOI 10.1111/j.1469-7998.2011.00826.x; Henschel P., 2008, IUCN RED LIST THREAT; Henschel P, 2003, LEOPARDS AFRICAN RAI; Herschel P, 2008, THESIS U GOTTINGEN G; Hunter L., 2003, ECOL J, V5, P24; Hunter L, 1999, ENV WILDL, V7, P32; Jackson RM, 2006, WILDLIFE SOC B, V34, P772, DOI 10.2193/0091-7648(2006)34[772:ESLPAU]2.0.CO;2; Jenny D, 1996, J ZOOL, V240, P427, DOI 10.1111/j.1469-7998.1996.tb05296.x; Kabanda TA, 2003, 1 SYNTHESIS ENV BIOL; Karanth K.U., 2002, MONITORING TIGERS TH, DOI [10.1111/j.1523-1739.2003.01769.x, DOI 10.1111/J.1523-1739.2003.01769.X]; Karanth KU, 2006, ECOLOGY, V87, P2925, DOI 10.1890/0012-9658(2006)87[2925:ATPDUP]2.0.CO;2; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 2004, ANIM CONSERV, V7, P285, DOI 10.1017/S1367943004001477; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karanth KU, 1998, ECOLOGY, V79, P2852; Kawanishi K, 2004, BIOL CONSERV, V120, P329, DOI 10.1016/j.biocon.2004.03.005; Kent VT, 2013, ORYX, V47, P431, DOI 10.1017/S0030605312001007; Lindsey PA, 2005, BIOL CONSERV, V125, P113, DOI 10.1016/j.biocon.2005.03.015; MacKenzie John, 1988, EMPIRE NATURE HUNTIN; Maputla NW, 2013, AFR J ECOL; Martins Q.E., 2010, THESIS U BRISTOL UK; Mizutani F, 1999, AFR J ECOL, V37, P211, DOI 10.1046/j.1365-2028.1999.00171.x; Mizutani F, 1998, J ZOOL, V244, P269, DOI 10.1111/j.1469-7998.1998.tb00031.x; Mostert Theo H.C., 2008, Koedoe, V50, P32; Noss AJ, 2012, ANIM CONSERV, V15, P527, DOI 10.1111/j.1469-1795.2012.00545.x; Novaro AJ, 2005, J APPL ECOL, V42, P910, DOI 10.1111/j.1365-2664.2005.01067.x; O'Brien TG, 2003, ANIM CONSERV, V6, P131, DOI 10.1017/S1367943003003172; Ogada MO, 2003, CONSERV BIOL, V17, P1521, DOI 10.1111/j.1523-1739.2003.00061.x; Owen C., 2006, THESIS U KWAZULU NAT; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; R Development Core Team, 2012, R LANG ENV STAT COMP; Ray JC, 2005, 24 WCS; Riley SJ, 2001, ENVIRON MANAGE, V28, P317, DOI 10.1007/s0026702503; Robinson HS, 2008, ECOL APPL, V18, P1028, DOI 10.1890/07-0352.1; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2011, J WILDLIFE MANAGE, V75, P604, DOI 10.1002/jwmg.79; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Ruth TK, 2011, J WILDLIFE MANAGE, V75, P1381, DOI 10.1002/jwmg.190; Schaller G. B., 1972, SERENGETI LION; Soisalo MK, 2006, BIOL CONSERV, V129, P487, DOI 10.1016/j.biocon.2005.11.023; Sollmann R, 2011, BIOL CONSERV, V144, P1017, DOI 10.1016/j.biocon.2010.12.011; Spalton JA, 2006, ORYX, V40, P287, DOI 10.1017/S0030605306000743; Stander PE, 1997, J ZOOL, V242, P343; Stein AB, 2011, AFR J ECOL, V49, P383, DOI 10.1111/j.1365-2028.2011.01267.x; Swanepoel L, 2009, THESIS U PRETORIA S; Swanepoel LH, 2013, ANIM CONSERV, V16, P41, DOI 10.1111/j.1469-1795.2012.00566.x; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Tobler MW, 2013, BIOL CONSERV, V159, P375, DOI 10.1016/j.biocon.2012.12.012; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Tobler MW, 2009, J TROP ECOL, V25, P261, DOI 10.1017/S0266467409005896; UNESCO, 2009, UNESCO MAB BIOSPH RE; Uphyrkina O, 2001, MOL ECOL, V10, P2617, DOI 10.1046/j.0962-1083.2001.01350.x; Wang SW, 2009, BIOL CONSERV, V142, P606, DOI 10.1016/j.biocon.2008.11.023; Weaver JL, 1996, CONSERV BIOL, V10, P964, DOI 10.1046/j.1523-1739.1996.10040964.x; Wegge P, 2004, ANIM CONSERV, V7, P251, DOI 10.1017/S1367943004001441; Willems EP, 2009, BEHAV ECOL, V20, P985, DOI 10.1093/beheco/arp087; Willems EP, 2009, ECOLOGY, V90, P546, DOI 10.1890/08-0765.1	83	38	38	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82832	10.1371/journal.pone.0082832	http://dx.doi.org/10.1371/journal.pone.0082832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349375	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000328705200106
J	Kosenko, A; Hoshi, N				Kosenko, Anastasia; Hoshi, Naoto			A Change in Configuration of the Calmodulin-KCNQ Channel Complex Underlies Ca2+-Dependent Modulation of KCNQ Channel Activity	PLOS ONE			English	Article							RECEPTOR-MEDIATED INHIBITION; POTASSIUM CHANNEL; K+ CHANNELS; BINDING; DOMAINS; PIP2	All subtypes of KCNQ channel subunits (KCNQ1-5) require calmodulin as a co-factor for functional channels. It has been demonstrated that calmodulin plays a critical role in KCNQ channel trafficking as well as calcium-mediated current modulation. However, how calcium-bound calmodulin suppresses the M-current is not well understood. In this study, we investigated the molecular mechanism of KCNQ2 current suppression mediated by calcium-bound calmodulin. We show that calcium induced slow calmodulin dissociation from the KCNQ2 channel subunit. In contrast, in homomeric KCNQ3 channels, calcium facilitated calmodulin binding. We demonstrate that this difference in calmodulin binding was due to the unique cysteine residue in the KCNQ2 subunit at aa 527 in Helix B, which corresponds to an arginine residue in other KCNQ subunits including KCNQ3. In addition, a KCNQ2 channel associated protein AKAP79/150 (79 for human, 150 for rodent orthologs) also preferentially bound calcium-bound calmodulin. Therefore, the KCNQ2 channel complex was able to retain calcium-bound calmodulin either through the AKPA79/150 or KCNQ3 subunit. Functionally, increasing intracellular calcium by ionomycin suppressed currents generated by KCNQ2, KCNQ2(C527R) or heteromeric KCNQ2/KCNQ3 channels to an equivalent extent. This suggests that a change in the binding configuration, rather than dissociation of calmodulin, is responsible for KCNQ current suppression. Furthermore, we demonstrate that KCNQ current suppression was accompanied by reduced KCNQ affinity toward phosphatidylinositol 4,5-bisphosphate (PIP2) when assessed by a voltage-sensitive phosphatase, Ci-VSP. These results suggest that a rise in intracellular calcium induces a change in the configuration of CaM-KCNQ binding, which leads to the reduction of KCNQ affinity for PIP2 and subsequent current suppression.	[Kosenko, Anastasia; Hoshi, Naoto] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Hoshi, N (corresponding author), Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA.	nhoshi@uci.edu			National Institutes of Health [NS067288]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health grant, NS067288 to NH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Bal M, 2008, J PHYSIOL-LONDON, V586, P2307, DOI 10.1113/jphysiol.2008.152777; Bal M, 2010, J NEUROSCI, V30, P2311, DOI 10.1523/JNEUROSCI.5175-09.2010; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Dell'Acqua ML, 1998, EMBO J, V17, P2246, DOI 10.1093/emboj/17.8.2246; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Faux MC, 1997, J BIOL CHEM, V272, P17038, DOI 10.1074/jbc.272.27.17038; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kosenko A, 2012, EMBO J, V31, P3147, DOI 10.1038/emboj.2012.156; Lawrence JJ, 2006, J NEUROSCI, V26, P12325, DOI 10.1523/JNEUROSCI.3521-06.2006; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Park HY, 2008, P NATL ACAD SCI USA, V105, P542, DOI 10.1073/pnas.0710810105; Shahidullah M, 2005, P NATL ACAD SCI USA, V102, P16454, DOI 10.1073/pnas.0503966102; Smith IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026338; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Varnai P, 2002, J BIOL CHEM, V277, P27412, DOI 10.1074/jbc.M109672200; Villalba-Galea CA, 2009, J GEN PHYSIOL, V134, P5, DOI 10.1085/jgp.200910215; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Xu Q, 2013, J MOL BIOL, V425, P378, DOI 10.1016/j.jmb.2012.11.023; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	29	41	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82290	10.1371/journal.pone.0082290	http://dx.doi.org/10.1371/journal.pone.0082290			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349250	gold, Green Published			2022-12-27	WOS:000328705200075
J	Li, MC; Li, SQ; Yu, LZ; Wu, JL; She, TH; Gan, YP; Hu, ZW; Liao, WL; Xia, HL				Li, Mincai; Li, Suqin; Yu, Liangzhu; Wu, Jiliang; She, Tonghui; Gan, Yaping; Hu, Zhenwu; Liao, Wenli; Xia, Hongli			Bone Mesenchymal Stem Cells Contributed to the Neointimal Formation after Arterial Injury	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PROGENITOR CELLS; ENDOTHELIAL-CELL; VASCULAR REPAIR; IN-VITRO; REGENERATION ENHANCEMENT; TRANSPLANTATION; REENDOTHELIALIZATION; ANGIOGENESIS; CULTURE	Objectives: Recent findings suggest that in response to repair-to-injury bone marrow mesenchymal stem cells (BMSCs) participate in the process of angiogenesis. It is unclear what role BMSCs play in the structure of the vessel wall. In present study, we aimed to determine whether BMSCs had the capacity of endothelial cells (ECs). Methods: BMSCs were separated and cultured. FACS and RT-PCR analysis confirmed the gene expression phenotype. The capacity of migration and adhesion and the ultrastructure of BMSCs were examined. The effect of BMSCs transplantation on the vascular repair was investigated in a murine carotid artery-injured model. Results: BMSCs could express some markers and form the tube-like structure. The migration and adhesion capacity of BMSCs increased significantly after stimulated. In addition, BMSCs had the intact cell junction. In vivo the local transfer of BMSCs differentiated into neo-endothelial cells in the injury model for carotid artery and contributed to the vascular remodeling. Conclusion: These results showed that BMSCs could contribute to neointimal formation for vascular lesion and might be associated with the differentiation into ECs, which indicated the important therapeutic implications for vascular diseases.	[Li, Mincai; Li, Suqin; Wu, Jiliang] HuBei Univ Sci & Technol, Hubei Prov Key Lab Cardiovasc Cerebrovasc & Metab, Xianning, Peoples R China; [Li, Mincai; Li, Suqin; Yu, Liangzhu; She, Tonghui; Gan, Yaping; Hu, Zhenwu; Liao, Wenli] HuBei Univ Sci & Technol, Sch Med, Xianning, Peoples R China; [Xia, Hongli] Cent Hosp Xianning, Dept Abdominal Surg, Xianning, Peoples R China	Hubei University of Science & Technology; Hubei University of Science & Technology	Yu, LZ (corresponding author), HuBei Univ Sci & Technol, Sch Med, Xianning, Peoples R China.	ylz7210281034@163.com; xywjl@163.com	Stefanadis, Christodoulos/ABH-2232-2020; yu, liangzhu/AAE-1941-2019	Stefanadis, Christodoulos/0000-0001-5974-6454; 	National Natural Science Foundation of China [81270355]; Hubei Province Educational Department [Q20122805]; Hubei University of Science and Technology [BK1002, ZX1125, PY1107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Province Educational Department; Hubei University of Science and Technology	This work was supported by the grant from the National Natural Science Foundation of China (no. 81270355) and the grants from the Fund of Hubei Province Educational Department (Q20122805) and the Fund of Hubei University of Science and Technology (BK1002, ZX1125, and PY1107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Briasoulis A, 2010, CARDIOVASC THER; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; Deng WW, 2004, STEM CELLS, V22, P1279, DOI 10.1634/stemcells.2004-0032; Eggermann J, 2003, CARDIOVASC RES, V58, P478, DOI 10.1016/S0008-6363(03)00252-9; Fischer-Rasokat U, 2009, CIRC-HEART FAIL, V2, P417, DOI 10.1161/CIRCHEARTFAILURE.109.855023; Galbusera M, 1997, BLOOD, V90, P1558, DOI 10.1182/blood.V90.4.1558.1558_1558_1564; Gulati R, 2003, CIRCULATION, V108, P1520, DOI 10.1161/01.CIR.0000089084.48655.49; Hegner B, 2005, J HYPERTENS, V23, P1191, DOI 10.1097/01.hjh.0000170382.31085.5d; Hoffmann B, 2005, J VIROL METHODS, V130, P36, DOI 10.1016/j.jviromet.2005.05.030; Houwerzijl EJ, 2004, BLOOD, V103, P500, DOI 10.1182/blood-2003-01-0275; Hristov M, 2008, BIOL CHEM, V389, P837, DOI 10.1515/BC.2008.093; Hutter R, 2004, CIRCULATION, V110, P2430, DOI 10.1161/01.CIR.0000145120.37891.8A; Ionescu L, 2012, AM J PHYSIOL-LUNG C, V303, pL967, DOI 10.1152/ajplung.00144.2011; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Jackson DE, 2000, TISSUE ANTIGENS, V56, P105, DOI 10.1034/j.1399-0039.2000.560201.x; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013; Kroll H, 2000, BLOOD, V96, P1409, DOI 10.1182/blood.V96.4.1409.h8001409_1409_1414; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Leistner DM, 2011, CLIN RES CARDIOL, V100, P925, DOI 10.1007/s00392-011-0327-y; Li HX, 2010, AM J PHYSIOL-HEART C, V299, pH1772, DOI 10.1152/ajpheart.00557.2010; Li MC, 2010, CELL REPROGRAM, V12, P405, DOI 10.1089/cell.2009.0088; Li MC, 2010, EXP MOL PATHOL, V88, P250, DOI 10.1016/j.yexmp.2009.12.001; Li Y, 2011, LIFE SCI, V88, P130, DOI 10.1016/j.lfs.2010.10.030; Mehes G, 2001, AM J PATHOL, V159, P17, DOI 10.1016/S0002-9440(10)61667-7; Meyer GP, 2009, EUR HEART J, V30, P2978, DOI 10.1093/eurheartj/ehp374; Novotny NM, 2008, CYTOKINE, V43, P215, DOI 10.1016/j.cyto.2008.05.015; Pawelczyk E, 2008, STEM CELLS, V26, P1366, DOI 10.1634/stemcells.2007-0707; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Real Carla, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P185, DOI 10.2174/187152908785849071; Sata M, 2003, TRENDS CARDIOVAS MED, V13, P249, DOI 10.1016/S1050-1738(03)00106-3; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Wakitani S, 2011, J TISSUE ENG REGEN M, V5, P146, DOI 10.1002/term.299; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Zacharaki D, 2013, J MOL NEUROSCI, V51, P282, DOI 10.1007/s12031-013-9992-9	39	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82743	10.1371/journal.pone.0082743	http://dx.doi.org/10.1371/journal.pone.0082743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349351	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200096
J	Dong, F; Long, RY; Chen, H; Li, XH; Yang, QL				Dong, Feng; Long, Ruyin; Chen, Hong; Li, Xiaohui; Yang, Qingliang			Factors Affecting Regional Per-Capita Carbon Emissions in China Based on an LMDI Factor Decomposition Model	PLOS ONE			English	Article							INPUT-OUTPUT-ANALYSIS; DIOXIDE EMISSIONS; CO2 EMISSIONS; ENVIRONMENTAL EFFICIENCY; ENERGY INTENSITY; DRIVERS; TRADE; OECD	China is considered to be the main carbon producer in the world. The per-capita carbon emissions indicator is an important measure of the regional carbon emissions situation. This study used the LMDI factor decomposition model-panel co-integration test two-step method to analyze the factors that affect per-capita carbon emissions. The main results are as follows. (1) During 1997, Eastern China, Central China, and Western China ranked first, second, and third in the per-capita carbon emissions, while in 2009 the pecking order changed to Eastern China, Western China, and Central China. (2) According to the LMDI decomposition results, the key driver boosting the per-capita carbon emissions in the three economic regions of China between 1997 and 2009 was economic development, and the energy efficiency was much greater than the energy structure after considering their effect on restraining increased per-capita carbon emissions. (3) Based on the decomposition, the factors that affected per-capita carbon emissions in the panel co-integration test showed that Central China had the best energy structure elasticity in its regional per-capita carbon emissions. Thus, Central China was ranked first for energy efficiency elasticity, while Western China was ranked first for economic development elasticity.	[Dong, Feng; Long, Ruyin; Chen, Hong; Yang, Qingliang] China Univ Min & Technol, Sch Management, Xuzhou, Jiangsu, Peoples R China; [Li, Xiaohui] Yantai Univ, Sch Foreign Languages, Yantai, Shandong, Peoples R China	China University of Mining & Technology; Yantai University	Dong, F (corresponding author), China Univ Min & Technol, Sch Management, Xuzhou, Jiangsu, Peoples R China.	dongfeng2008@126.com	Yang, Qingliang/GRY-1981-2022	Dong, Feng/0000-0002-5177-6453; Chen, Hong/0000-0002-2035-6851; Gong, Likun/0000-0001-8821-641X	National Natural Science Foundation in China [41101569, 71273258]; China Postdoctoral Science Foundation [2011M500965]; Jiangsu Funds of Social Science [11EYC023]; Doctoral Discipline New Teachers Fund [20110095120002]; Fundamental Research Funds for the Central Universities [2013W01]; Talent Introduction Funds of China University of Mining and Technology (CUMT); Sail Plan Funds for Young Teachers of CUMT; High Level Thesis Foundation of the College of Management, CUMT; National Social Science Foundation in China [12ZD062]	National Natural Science Foundation in China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Funds of Social Science; Doctoral Discipline New Teachers Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Talent Introduction Funds of China University of Mining and Technology (CUMT); Sail Plan Funds for Young Teachers of CUMT; High Level Thesis Foundation of the College of Management, CUMT; National Social Science Foundation in China	This work is supported by National Natural Science Foundation in China (41101569 and 71273258), China Postdoctoral Science Foundation funded project (2011M500965), Jiangsu Funds of Social Science (11EYC023), Doctoral Discipline New Teachers Fund (20110095120002), the Fundamental Research Funds for the Central Universities (2013W01), the Talent Introduction Funds of China University of Mining and Technology (CUMT), the Sail Plan Funds for Young Teachers of CUMT, and the High Level Thesis Foundation of the College of Management, CUMT. The Major Program of the National Social Science Foundation in China (12&ZD062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang BW, 2010, ENERG ECON, V32, P1209, DOI 10.1016/j.eneco.2010.03.011; Ang BW, 2004, ENERG POLICY, V32, P1131, DOI 10.1016/S0301-4215(03)00076-4; Ang BW, 1998, ENERGY, V23, P489, DOI 10.1016/S0360-5442(98)00016-4; Ang BW, 1999, ENERG POLICY, V27, P943, DOI 10.1016/S0301-4215(99)00084-1; Balezentis A, 2011, ENERG POLICY, V39, P7322, DOI 10.1016/j.enpol.2011.08.055; Bei-bei T.L.-x.Z., 2011, CHINA POPULATION RES; Chuzhi H., 2008, CHINA POPUL RESOUR E, V18, P38, DOI DOI 10.1016/S1872-583X(09)60006-1; CNBSa ( China's National Bureau of Statistics, 2007, CHIN EN STAT YB 1997; CNBSa ( China's National Bureau of Statistics), 2008, CHIN EN STAT YB 1997; CNBSa ( China's National Bureau of Statistics), 2000, CHIN EN STAT YB 1997; CNBSa ( China's National Bureau of Statistics), 2010, CHIN EN STAT YB 1997; CNBSa ( China's National Bureau of Statistics), 2005, CHIN EN STAT YB 1997; CNBSa ( China's National Bureau of Statistics), 2006, CHIN EN STAT YB 1997; CNBSa ( China's National Bureau of Statistics), 2011, CHIN EN STAT YB 1997; CNBSa ( China's National Bureau of Statistics, 2003, CHIN EN STAT YB 1997; CNBSa (China's National Bureau of Statistics), 2000, CHIN EN STAT YB 1997; CNBSb (China's National Bureau of Statistics), 1999, CHIN STAT YB 1998 20; Dong J, 2010, FUT INF TECHN MAN EN, V1, P246; Du HB, 2011, ENERG POLICY, V39, P5980, DOI 10.1016/j.enpol.2011.06.060; Fan Y, 2007, ECOL ECON, V62, P683, DOI 10.1016/j.ecolecon.2006.08.016; Feng KS, 2012, J IND ECOL, V16, P600, DOI 10.1111/j.1530-9290.2012.00494.x; Harris RDF, 1999, J ECONOMETRICS, V91, P201, DOI 10.1016/S0304-4076(98)00076-1; IPCC, 2006, IPCC GUIDELINES NATL, VII; Jorgenson AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057107; Lanne M, 2004, ENERG J, V25, P41; Lee CC, 2008, ENERGY, V33, P1468, DOI 10.1016/j.energy.2008.05.002; Lin BQ, 2011, ENERG POLICY, V39, P5137, DOI 10.1016/j.enpol.2011.05.050; Lozano S, 2008, ECOL ECON, V66, P687, DOI 10.1016/j.ecolecon.2007.11.003; Ma C, 2008, ENERG ECON, V30, P1037, DOI 10.1016/j.eneco.2007.05.005; Mielnik O, 1999, ENERG POLICY, V27, P307, DOI 10.1016/S0301-4215(99)00018-X; Pedroni P, 1999, OXFORD B ECON STAT, V61, P653, DOI 10.1111/1468-0084.61.s1.14; Shanthini R, 2010, INT J OIL GAS COAL T, V3, P182, DOI 10.1504/IJOGCT.2010.033564; Sheinbaum C, 2010, ENERG ECON, V32, P1337, DOI 10.1016/j.eneco.2010.02.011; Su B, 2012, ECON SYST RES, V24, P299, DOI 10.1080/09535314.2012.677997; Su B, 2012, ENERG ECON, V34, P177, DOI 10.1016/j.eneco.2011.10.009; Su B, 2010, ECOL ECON, V70, P10, DOI 10.1016/j.ecolecon.2010.08.016; Sun JW, 1998, ENERGY, V23, P835, DOI 10.1016/S0360-5442(98)00031-0; Sun JW, 2005, ENERG POLICY, V33, P975, DOI 10.1016/j.enpol.2003.10.023; Tunc GI, 2009, ENERG POLICY, V37, P4689, DOI 10.1016/j.enpol.2009.06.019; [王倩倩 WANG Qian-qian], 2009, [自然资源学报, Journal of Natural Resources], V24, P833; Wang QW, 2012, APPL ENERG, V90, P161, DOI 10.1016/j.apenergy.2011.02.022; Wang YF, 2013, ENERG POLICY, V58, P312, DOI 10.1016/j.enpol.2013.03.022; [徐国泉 XU Guoquan], 2006, [中国人口·资源与环境, China Population·Resources and Environment], V16, P158; Zaim O, 2000, J ENVIRON MANAGE, V58, P95, DOI 10.1006/jema.1999.0312; Zhang M, 2009, ENERG POLICY, V37, P767, DOI 10.1016/j.enpol.2008.11.025; Zhang ZQ, 2008, J GEOGR SCI, V18, P387, DOI 10.1007/s11442-008-0387-8; Zhou P, 2006, ECOL ECON, V60, P111, DOI 10.1016/j.ecolecon.2005.12.001; Zhou P, 2010, ENERG ECON, V32, P194, DOI 10.1016/j.eneco.2009.10.003; Zofio JL, 2001, RESOUR ENERGY ECON, V23, P63, DOI 10.1016/S0928-7655(00)00030-0	49	15	15	7	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e80888	10.1371/journal.pone.0080888	http://dx.doi.org/10.1371/journal.pone.0080888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24353753	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566700021
J	Kuang, YQ; Yan, J; Li, Y; Huang, XH; Wang, Y; Yu, GL; Yan, XG; Lin, P; Qin, B; Lin, P				Kuang, Yi-Qun; Yan, Jin; Li, Yan; Huang, Xuhe; Wang, Ye; Yu, Guolong; Yan, Xinge; Lin, Ping; Qin, Bing; Lin, Peng			Molecular Epidemiologic Characterization of a Clustering HCV Infection Caused by Inappropriate Medical Care in Heyuan City of Guangdong, China	PLOS ONE			English	Article							HEPATITIS-C VIRUS; NONSEXUAL TRANSMISSION; GENOTYPE DISTRIBUTION; GENETIC HISTORY; BLOOD-DONORS; SEROPREVALENCE; PREVALENCE; ENDOSCOPY; EVOLUTION; MODE	Background: From November 2011 to January 2012, a number of clustering cases of HCV infection were reported in Zijin County, Heyuan City, Guangdong, China. Most patients in the clustering cases suspected that they could be infected due to inappropriate medical care in the clinic located at the Xiangshui road. However, the molecular epidemiology of the clustering cases remains unknown. Methodology: The residents, living at Xiangshui Road, with HCV antibody positive reported from 2011 and 2012 were recruited. A survey of the HCV infected individuals from the clustering cases was conducted. Each participant underwent a questionnaire defining demographic characteristics and health care history. HCV serological test and viral load test were performed to confirm the infection status. Molecular phylogenetic analysis and Bayesian coalescence analysis were conducted to further confirm the HCV subtype distribution and to reconstruct the associated demographic history and time-scaled phylogeny among the clustering cases. Principal Findings: The molecular phylogenetic analysis revealed that only two HCV subtypes, 2a and 6a, were found among the clustering cases. There was no close HCV subtype evolutionary relation was observed among patients from the same family. The 6a cluster showed higher viral loads than the 2a cluster. In addition, the Bayesian skyline plot analysis showed that both the HCV 2a and 6a subtype infections among the Heyuan cases experienced an "expansion-diminishment-expansion" featured dissemination. The 2a clustering infection occurred in 2004, and the 6a clustering cases originated in 2006. Conclusions: The molecular epidemiological characters imply that the inappropriate medical practices were possibly associated with the clustering HCV cases in Heyuan City during 2011, 2012. Latent HCV subtypes 2a and 6a infection may cause the prevalence and become a new public health issue in Guangdong, China.	[Kuang, Yi-Qun; Huang, Xuhe] Guangdong Prov Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Kuang, Yi-Qun; Yan, Jin; Li, Yan; Huang, Xuhe; Wang, Ye; Yu, Guolong; Yan, Xinge; Lin, Ping; Qin, Bing; Lin, Peng] Guangdong Prov Ctr Dis Control & Prevent, Inst HIV AIDS Control & Prevent, Guangzhou, Guangdong, Peoples R China; [Qin, Bing] Guangdong Prov Ctr Dis Control & Prevent, Guangdong Inst Biol Prod & Drugs, Guangzhou, Guangdong, Peoples R China	Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention	Yan, J (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Inst HIV AIDS Control & Prevent, Guangzhou, Guangdong, Peoples R China.	yanjin212@163.com	Kuang, Yi-Qun/AAW-4884-2021	Kuang, Yi-Qun/0000-0002-1452-4388	Medical Research Foundation of Guangdong province [B2012073]; Science and Technology Planning Project of Guangdong Province, China [2012B031800267]	Medical Research Foundation of Guangdong province; Science and Technology Planning Project of Guangdong Province, China	This work was supported in part by a grant from Medical Research Foundation of Guangdong province (No. B2012073) and a grant from Science and Technology Planning Project of Guangdong Province, China (2012B031800267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman Z, 2000, J VIRAL HEPATITIS, V7, P93; [Anonymous], 2004, WORK WHO W PAC REG R, P141; Center for Disease Control and Prevention of Guangdong Province, 2012, HIV AIDS EP ANN REP; Chen Yuan-Ding, 2002, Hepatobiliary Pancreat Dis Int, V1, P194; Du H, 2012, J CLIN VIROL, V54, P207, DOI 10.1016/j.jcv.2012.04.017; Fu Y, 2011, J VIRAL HEPATITIS, V18, P42, DOI 10.1111/j.1365-2893.2010.01280.x; Fu YS, 2010, TRANSFUSION, V50, P1505, DOI 10.1111/j.1537-2995.2010.02616.x; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; Gray RR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-131; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Holodniy M, 2012, INFECT CONT HOSP EP, V33, P649, DOI 10.1086/666345; Hong Guo-hu, 2011, Zhonghua Gan Zang Bing Za Zhi, V19, P502, DOI 10.3760/cma.j.issn.1007-3418.2011.07.009; Hsu E, 1996, SOC SCI MED, V42, P421, DOI 10.1016/0277-9536(95)00106-9; Idrees M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-5; Kuiken C, 2008, NUCLEIC ACIDS RES, V36, pD512, DOI 10.1093/nar/gkm962; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Li Y, 2012, AIDS BEHAV, V16, P943, DOI 10.1007/s10461-011-0102-0; Liu PP, 2008, AIDS RES HUM RETROV, V24, P1, DOI 10.1089/aid.2007.0144; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008467; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Lu L, 2013, J VIROL IN PRESS; Luo Y, 2005, IMMUNIZATION PLAN CH, V11, P89; Mikhail NN, 2007, GASTROINTEST ENDOSC, V65, P584, DOI 10.1016/j.gie.2006.07.033; Nakamura I, 2011, HEPATOL RES, V41, P838, DOI 10.1111/j.1872-034X.2011.00843.x; Nakano T, 2006, J GEN VIROL, V87, P73, DOI 10.1099/vir.0.81360-0; Naoumov NV, 1997, J HEPATOL, V27, P331, DOI 10.1016/S0168-8278(97)80179-1; Orlando R, 2007, INFECTION, V35, P465, DOI 10.1007/s15010-007-6188-7; Plancoulaine S, 2008, GUT, V57, P1268, DOI 10.1136/gut.2007.140681; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Shan H, 2002, LANCET, V360, P1770, DOI 10.1016/S0140-6736(02)11669-2; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; TIBBS CJ, 1995, J VIRAL HEPATITIS, V2, P113, DOI 10.1111/j.1365-2893.1995.tb00016.x; Tohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808; Xia XS, 2008, J MED VIROL, V80, P1142, DOI 10.1002/jmv.21204; Yan ZH, 2012, HEPAT MON, V12, P196, DOI [10.5812/hepatmon.857, 10.5812/hepatmon.5123]; Yuan MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064698; Zhang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016817; Zhang XL, 2011, DIGEST LIVER DIS, V43, P305, DOI 10.1016/j.dld.2010.12.010; Zhao Lu, 2012, Yichuan, V34, P666, DOI 10.3724/SP.J.1005.2012.00666; Zhou XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024889; Zhou YQ, 2009, J CLIN VIROL, V46, P230, DOI 10.1016/j.jcv.2009.08.003	42	5	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82304	10.1371/journal.pone.0082304	http://dx.doi.org/10.1371/journal.pone.0082304			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24349252	Green Published, gold, Green Submitted			2022-12-27	WOS:000327947800091
J	Ebrahimi, M; Ahmadzadeh, F; Mostafavi, H; Mehrabian, AR; Abdoli, A; Mahini, AS				Ebrahimi, Mehregan; Ahmadzadeh, Faraham; Mostafavi, Hossein; Mehrabian, Aahmad Reza; Abdoli, Asghar; Mahini, Abdolrasoul Salman			The Ecological Associations of Surface-Dwelling Lizards in Qom Province in the Northwest of Central Plateau of Iran	PLOS ONE			English	Article							ELEVATIONAL GRADIENT; DIVERSITY; HABITAT; SEX	We used pitfall trapping to investigate the effects of elevation, plant density and soil structure on species diversity and the impact of these habitat factors on lizard habitat selectivity in the Qom Province in the Central Plateau of Iran. From a total of 12 1-ha plots, we captured 363 individuals of 15 species of lizards (six species of Lacertidae, five species of Agamidae, two species of Gekkonidae, one species of Varanidae and one species of Scincidae). A generalized linear model (GLM) determined that elevation was the most important factor impacting species diversity. The highest species diversity was at the intermediate elevation (1289 m). Abundance of 6 out of 15 species showed strong relationships with some habitat factors. These relationships were demonstrated by habitat selectivity index (Ivlev's index). Our result supports other surveys that showed that elevation plays an important role in determining lizard species diversity.	[Ebrahimi, Mehregan] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Ahmadzadeh, Faraham; Mostafavi, Hossein; Abdoli, Asghar] Shehid Beheshti Univ, Dept Biodivers & Ecosyst Management, ESRI, Tehran, Iran; [Ahmadzadeh, Faraham] Zool Forsch Museum Alexander Koenig, Bonn, Germany; [Mehrabian, Aahmad Reza] Shahid Beheshti Univ, Fac Biol Sci, Dept Bot, Tehran, Iran; [Mahini, Abdolrasoul Salman] Gorgan Univ Agr Sci & Nat Resources, Dept Environm Sci, Gorgan, Iran	Flinders University South Australia; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Shahid Beheshti University	Ebrahimi, M (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	mehregan.ebrahimi@gmail.com	Ebrahimi, Mehregan/H-3614-2013; Ahmadzadeh, Faraham/AAB-1283-2021	Ebrahimi, Mehregan/0000-0002-7140-047X; Ahmadzadeh, Faraham/0000-0001-7152-8484; Abdoli, Asghar/0000-0003-1229-933X; Ebrahimi, Mehregan/0000-0003-1897-9694	Department of Environment of Qom Province [127-9112]; Environmental Sciences Research Institute (ESRI) in Shehid Beheshti University [127-9112]	Department of Environment of Qom Province; Environmental Sciences Research Institute (ESRI) in Shehid Beheshti University	We wish to thank the Department of Environment of Qom Province and Environmental Sciences Research Institute (ESRI) in Shehid Beheshti University for providing an opportunity for our study, within the framework of the project of aquatic and terrestrial habitats of Qom Province (127-9112). Game wardens of Department of Environment of Qom Province especially Mr Naser. Prof. M. Bull and Prof S. C. Anderson for their great advice. Dr A. L. Fenner, Dr S. T. Leu and Mrs. J. Schofield for their suggestions and editing. Prof. H. Liaghati, Prof. Kiabi, Mr. M. Zohary, Mr. Alikhani and Mr. Kakai are thanked for their efforts to ensure that the vehicles and other materials used in this demanding field work were available, and also we would like to thank the volunteer students (Hadi Heidary, Meisam Habibi) for establishing the plots.	Anderson SC, 1999, LIZARDS IRAN; Baker R, 1978, GLIM SYSTEM RELEASE; Braun-Blanquet J., 1964, PFLANZENSOZIOLOGIE G; BROWN R. B., 2003, SOIL TEXTURE; Brown WS, 2007, COPEIA, P656; CODY ML, 1968, AM NAT, V102, P107, DOI 10.1086/282531; COLWELL RK, 2000, ESTIMATES STAT ESTIM; Day PR, 1954, CLAYS CLAY MINER, V3, P557, DOI [10.1346/CCMN.1954.0030144, DOI 10.1346/CCMN.1954.0030144]; Fischer J, 2005, DIVERS DISTRIB, V11, P225, DOI 10.1111/j.1366-9516.2005.00139.x; Gaston Kevin J., 2004, BIODIVERSITY INTRO; Heatwole H, 1982, ECOLOGY; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Hofer U, 1999, ECOLOGY, V80, P976, DOI 10.2307/177031; Huey RB, 1983, LIZARD ECOLOGY STUDI; Kasangaki A, 2003, AFR J ECOL, V41, P115, DOI 10.1046/j.1365-2028.2003.00383.x; Kelly MG, 2001, WATER RES, V35, P2784, DOI 10.1016/S0043-1354(00)00554-6; Li JS, 2003, GLOBAL ECOL BIOGEOGR, V12, P449, DOI 10.1046/j.1466-822X.2003.00052.x; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; McCain CM, 2010, GLOBAL ECOL BIOGEOGR, V19, P541, DOI 10.1111/j.1466-8238.2010.00528.x; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; Meik JM, 2008, J ARID ENVIRON, V72, P1193, DOI 10.1016/j.jaridenv.2008.01.003; Miyanishi K, 2006, RHEUMATOLOGY, V45, P855, DOI 10.1093/rheumatology/kel013; Perry G, 2002, ECOLOGY, V83, P1870, DOI 10.2307/3071771; R Development Core Team, 2005, R LANG ENV STAT COMP; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Sanders NJ, 2003, GLOBAL ECOL BIOGEOGR, V12, P93, DOI 10.1046/j.1466-822X.2003.00324.x; Shenbrot G, 1997, J ZOOL, V241, P429, DOI 10.1111/j.1469-7998.1997.tb04835.x; Shenbrot GI, 1991, GEN M SOC HEP EUR BU, P82; Shenbrot GI, 1988, EKOLOGIYA, V5, P50; Sindaco R, 2008, REPTILES W PALEARCTI, V1; Smith KA, 1991, SOIL ANAL PHYS METHO, P690; Stamps JA, 1983, LIZARD ECOLOGY, P169; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Towns DR, 1996, NEW ZEAL J ECOL, V20, P191; Tuomisto H, 2010, OECOLOGIA, V164, P853, DOI 10.1007/s00442-010-1812-0; Vitt LJ., 1994, LIZARD ECOLOGY HIST	36	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83890	10.1371/journal.pone.0083890	http://dx.doi.org/10.1371/journal.pone.0083890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349557	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200105
J	Seto, S; Sugaya, K; Tsujimura, K; Nagata, T; Horii, T; Koide, Y				Seto, Shintaro; Sugaya, Keiko; Tsujimura, Kunio; Nagata, Toshi; Horii, Toshinobu; Koide, Yukio			Rab39a Interacts with Phosphatidylinositol 3-Kinase and Negatively Regulates Autophagy Induced by Lipopolysaccharide Stimulation in Macrophages	PLOS ONE			English	Article							TOLL-LIKE-RECEPTORS; BECLIN 1; MYCOBACTERIUM-TUBERCULOSIS; PHAGOSOMES; PROTEINS; RUBICON; GTPASES; MATURATION; IMMUNITY; 3-METHYLADENINE	Rab39a has pleiotropic functions in phagosome maturation, inflammatory activation and neuritogenesis. Here, we characterized Rab39a function in membrane trafficking of phagocytosis and autophagy induction in macrophages. Rab39a localized to the periphery of LAMP2-positive vesicles and showed the similar kinetics on the phagosome to that of LAMP1. The depletion of Rab39a did not influence the localization of LAMP2 to the phagosome, but it augments the autophagosome formation and LC3 processing by lipopolysaccharide (LPS) stimulation. The augmentation of autophagosome formation in Rab39a-knockdown macrophages was suppressed by Atg5 depletion or an inhibitor for phosphatidylinostol 3-kinase (PI3K). Immunoprecipitation analysis revealed that Rab39a interacts with PI3K and that the amino acid residues from 34th to 41st in Rab39a were indispensable for this interaction. These results suggest that Rab39a negatively regulates the LPS-induced autophagy in macrophages.	[Seto, Shintaro; Tsujimura, Kunio; Horii, Toshinobu; Koide, Yukio] Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka 4313192, Japan; [Sugaya, Keiko; Nagata, Toshi] Hamamatsu Univ Sch Med, Dept Hlth Sci, Hamamatsu, Shizuoka 4313192, Japan; [Koide, Yukio] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 4313192, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Seto, S (corresponding author), Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka 4313192, Japan.	s-seto@hama-med.ac.jp	Nagata, Toshi/J-2407-2014	Nagata, Toshi/0000-0001-7912-4468; Sugaya, Kiminobu/0000-0002-2788-5457	Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare of Japan; United States-Japan Cooperative Medical Science Committee	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); United States-Japan Cooperative Medical Science Committee	This work was supported in part by Grants-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science; the Health and Labour Science Research Grants for Research into Emerging and Reemerging Infectious Diseases from the Ministry of Health, Labour and Welfare of Japan; and the United States-Japan Cooperative Medical Science Committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Becker CE, 2009, J BIOL CHEM, V284, P34531, DOI 10.1074/jbc.M109.046102; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Chua CEL, 2011, CELL MOL LIFE SCI, V68, P3349, DOI 10.1007/s00018-011-0748-9; Copetti T, 2009, MOL CELL BIOL, V29, P2594, DOI 10.1128/MCB.01396-08; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Fairn GD, 2012, TRENDS IMMUNOL, V33, P397, DOI 10.1016/j.it.2012.03.003; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Funderburk SF, 2010, TRENDS CELL BIOL, V20, P355, DOI 10.1016/j.tcb.2010.03.002; Giannandrea M, 2010, AM J HUM GENET, V86, P185, DOI 10.1016/j.ajhg.2010.01.011; Harris J, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00083; Hirota Y, 2013, AUTOPHAGY DOUBLE EDG, P47; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Into T, 2012, CELL SIGNAL, V24, P1150, DOI 10.1016/j.cellsig.2012.01.020; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mori Y, 2013, BIOCHEM BIOPH RES CO, V435, P113, DOI 10.1016/j.bbrc.2013.04.051; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Seto S, 2012, CELL MICROBIOL, V14, P710, DOI 10.1111/j.1462-5822.2012.01754.x; Seto S, 2011, TRAFFIC, V12, P407, DOI 10.1111/j.1600-0854.2011.01165.x; Seto S, 2010, MICROBIOL IMMUNOL, V54, P170, DOI 10.1111/j.1348-0421.2010.00199.x; Seto S, 2009, BIOCHEM BIOPH RES CO, V387, P272, DOI 10.1016/j.bbrc.2009.06.152; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Sugaya K, 2011, BIOCHEM BIOPH RES CO, V410, P371, DOI 10.1016/j.bbrc.2011.06.023; Sun QM, 2010, P NATL ACAD SCI USA, V107, P19338, DOI 10.1073/pnas.1010554107; Sun QM, 2008, P NATL ACAD SCI USA, V105, P19211, DOI 10.1073/pnas.0810452105; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Tabata K, 2010, MOL BIOL CELL, V21, P4162, DOI 10.1091/mbc.E10-06-0495; Takenaka M, 2013, GENES CELLS, V18, P203, DOI 10.1111/gtc.12028; Wang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032086; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	48	30	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83324	10.1371/journal.pone.0083324	http://dx.doi.org/10.1371/journal.pone.0083324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349490	gold, Green Published			2022-12-27	WOS:000328734200077
J	Zhang, JF; Zhang, ZQ; Zhang, DY; Zhu, JB; Zhang, TT; Wang, CQ				Zhang, Junfeng; Zhang, Zongqi; Zhang, David Y.; Zhu, Jianbing; Zhang, Tiantian; Wang, Changqian			microRNA 126 Inhibits the Transition of Endothelial Progenitor Cells to Mesenchymal Cells via the PIK3R2-PI3K/Akt Signalling Pathway	PLOS ONE			English	Article							STEM-CELLS; EXPRESSION; MIR-126; SMAD; DIFFERENTIATION; MOBILIZATION; FOXO	Aims: Endothelial progenitor cells (EPCs) are capable of proliferating and differentiating into mature endothelial cells, and they have been considered as potential candidates for coronary heart disease therapy. However, the transition of EPCs to mesenchymal cells is not fully understood. This study aimed to explore the role of microRNA 126 (miR-126) in the endothelial-to-mesenchymal transition (EndMT) induced by transforming growth factor beta 1 (TGF beta 1). Methods and Results: EndMT of rat bone marrow-derived EPCs was induced by TGF beta 1 (5 ng/mL) for 7 days. miR-126 expression was depressed in the process of EPC EndMT. The luciferase reporter assay showed that the PI3K regulatory subunit p85 beta (PIK3R2) was a direct target of miR-126 in EPCs. Overexpression of miR-126 by a lentiviral vector (lenti-miR-126) was found to downregulate the mRNA expression of mesenchymal cell markers (alpha-SMA, sm22-a, and myocardin) and to maintain the mRNA expression of progenitor cell markers (CD34, CD133). In the cellular process of EndMT, there was an increase in the protein expression of PIK3R2 and the nuclear transcription factors FoxO3 and Smad4; PI3K and phosphor-Akt expression decreased, a change that was reversed markedly by overexpression of miR-126. Furthermore, knockdown of PIK3R2 gene expression level showed reversed morphological changes of the EPCs treated with TGF beta 1, thereby giving the evidence that PIK3R2 is the target gene of miR-126 during EndMT process. Conclusions: These results show that miR-126 targets PIK3R2 to inhibit EPC EndMT and that this process involves regulation of the PI3K/Akt signalling pathway. miR-126 has the potential to be used as a biomarker for the early diagnosis of intimal hyperplasia in cardiovascular disease and can even be a therapeutic tool for treating cardiovascular diseases mediated by the EndMT process.	[Zhang, Junfeng; Wang, Changqian] Shanghai Jiao Tong Univ, Dept Cardiol, Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China; [Zhang, Zongqi; Zhu, Jianbing; Zhang, Tiantian] Shanghai Jiao Tong Univ, Dept Cardiol, Peoples Hosp 3, Sch Med, Shanghai 200030, Peoples R China; [Zhang, David Y.] Univ Chicago, Pritzker Sch Med, Dept Med, Cardiol Sect, Chicago, IL 60637 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Chicago	Wang, CQ (corresponding author), Shanghai Jiao Tong Univ, Dept Cardiol, Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China.	changqianwang@hotmail.com	Zhang, Zongqi/AAQ-1471-2020		Shanghai Municipal Natural Science Foundation [12ZR1417400]; Innovation Program of Shanghai Municipal Education Commission [12YZ045]; Doctoral Fund of Ministry of Education of China [20110073120096]; Science and Technology Foundation from Shanghai Jiao-Tong University School of Medicine [11XJ21031]	Shanghai Municipal Natural Science Foundation; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Science and Technology Foundation from Shanghai Jiao-Tong University School of Medicine	This work was supported by the Shanghai Municipal Natural Science Foundation [12ZR1417400 to JF Zhang]; and Innovation Program of Shanghai Municipal Education Commission [12YZ045 to ZQ Zhang]. It was further supported by the Doctoral Fund of Ministry of Education of China [20110073120096 to ZQ Zhang] and Science and Technology Foundation from Shanghai Jiao-Tong University School of Medicine[11XJ21031 to ZQ Zhang]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2007, AM J PHYSIOL-CELL PH, V292, pC188, DOI 10.1152/ajpcell.00542.2005; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chen JJ, 2011, CARDIOL J, V18, P675, DOI 10.5603/CJ.2011.0032; Cheng BB, 2012, J CELL BIOCHEM, V113, P3663, DOI 10.1002/jcb.24239; Czech MP, 2003, P NATL ACAD SCI USA, V100, P11198, DOI 10.1073/pnas.2135308100; Diez M, 2010, CARDIOVASC RES, V88, P502, DOI 10.1093/cvr/cvq236; Durrans A, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-4; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Ghosh AK, 2012, CELL SIGNAL, V24, P1031, DOI 10.1016/j.cellsig.2011.12.024; Gomis RR, 2006, P NATL ACAD SCI USA, V103, P12747, DOI 10.1073/pnas.0605333103; Imamura H, 2010, ATHEROSCLEROSIS, V211, P114, DOI 10.1016/j.atherosclerosis.2010.02.040; Jakob P, 2012, CARDIOVASC RES, V93, P614, DOI 10.1093/cvr/cvr311; Kim EK, 2007, EXP MOL MED, V39, P149, DOI 10.1038/emm.2007.17; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Kumarswamy R, 2012, ARTERIOSCL THROM VAS, V32, P361, DOI 10.1161/ATVBAHA.111.234286; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Meng S, 2012, J MOL CELL CARDIOL, V53, P64, DOI 10.1016/j.yjmcc.2012.04.003; Meng S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068611; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Miyata T, 2005, J CELL PHYSIOL, V204, P948, DOI 10.1002/jcp.20362; Mogi M, 2008, HYPERTENS RES, V31, P153, DOI 10.1291/hypres.31.153; Moonen JRAJ, 2010, CARDIOVASC RES, V86, P506, DOI 10.1093/cvr/cvq012; Peinado VI, 2006, AM J RESP CELL MOL, V34, P257, DOI 10.1165/rcmb.2005-0255OC; Rotmans JI, 2005, CIRCULATION, V112, P12, DOI 10.1161/CIRCULATIONAHA.104.504407; Salvucci O, 2012, HAEMATOL-HEMATOL J, V97, P818, DOI 10.3324/haematol.2011.056945; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Toya SP, 2012, IMMUNOBIOLOGY, V217, P569, DOI 10.1016/j.imbio.2011.03.006; Ueki K, 2003, J BIOL CHEM, V278, P48453, DOI 10.1074/jbc.M305602200; van Solingen C, 2011, CARDIOVASC RES, V92, P449, DOI 10.1093/cvr/cvr227; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Yan T, 2013, J CELL BIOCHEM, V114, P2148, DOI 10.1002/jcb.24563; Zhang Y, 2013, NAT CELL BIOL, V15, P284, DOI 10.1038/ncb2690; Zhu N, 2011, MOL CELL BIOCHEM, V351, P157, DOI 10.1007/s11010-011-0723-7; Zou J, 2011, CIRC RES, V108, P201, DOI 10.1161/CIRCRESAHA.110.225045	34	46	47	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83294	10.1371/journal.pone.0083294	http://dx.doi.org/10.1371/journal.pone.0083294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349482	gold, Green Submitted, Green Published			2022-12-27	WOS:000328734200073
J	Bohr, I; Read, JCA				Bohr, Iwo; Read, Jenny C. A.			Stereoacuity with Frisby and Revised FD2 Stereo Tests	PLOS ONE			English	Article							DISTANCE STEREOACUITY; VISUAL-ACUITY; AGE; CHILDREN; RANDOT; NORMS; BLUR	We compared near stereoacuity, measured with the Frisby test, and distance stereoacuity, measured with the revised Frisby-Davis (FD2) test, enabling a comparison with the original version of the FD2. In the revised version of the FD2 test, a white background is used instead of a backlit background. We also examined the effect of age, gender and visual problems. We used the Frisby test at distances ranging from 30-80 cm and FD2 at 6 m. The best possible score was 20 seconds of arc (arcsec) on the Frisby and 5 arcsec on the FD2; participants who could not perform a test despite demonstrating understanding of it were classed as stereonegative. We examined both the whole population recruited, and a subpopulation screened so as to exclude visual problems. We analysed our results in three age-groups: "visually developing" (36 children aged 5-10 years); "visually mature" (300 participants aged 11-49 years) and "older" (29 participants aged 50-82). In the whole population, the median stereoacuity on the Frisby test was 25, 20 and 85 arcsec in the three age-groups. In the sub-population with no visual problems, median Frisby stereoacuity was similar at 20, 20 and 80 arcsec respectively. On the FD2, the medians were 10, 10, 20 arcsec for the whole population and 7.5, 10 and 12.5 for the sub-population. Children were more likely than adults to be stereonegative on the FD2, although none of the children were stereonegative on the Frisby. The two tests showed fair agreement when used to classify people into three categories of stereovision. Poor stereovision was often associated with binocular problems such as tropia, but with many exceptions. In line with previous studies, we found improvements in measured stereoacuity in childhood and declines in late adulthood. The new FD2 test gives comparable values to the original FD2.	[Bohr, Iwo; Read, Jenny C. A.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK	Bohr, I (corresponding author), Newcastle Univ, Inst Neurosci, Henry Welcome Bldg Neuroecol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	iwo.bohr@newcastle.ac.uk	Bohr, Iwo/E-9339-2017; Read, Jenny/A-7493-2013	Read, Jenny/0000-0002-9029-5185	British Sky Broadcasting Limited (BSkyB); Royal Society [UF041260]	British Sky Broadcasting Limited (BSkyB); Royal Society(Royal Society of London)	The work was funded by British Sky Broadcasting Limited (BSkyB, http://corporate.sky.com/). The design of the study was discussed with BSkyB before funding was agreed. A copy of this manuscript was given to the funder before submission. They did not request any changes. JCAR was funded by Royal Society University Research Fellowship UF041260.	Adams WE, 2005, BRIT J OPHTHALMOL, V89, P1438, DOI 10.1136/bjo.2005.071761; Adams WE, 2008, J AAPOS, V12, P141, DOI 10.1016/j.jaapos.2007.09.015; Adams WE, 2009, OPHTHALMOLOGY, V116, P281, DOI 10.1016/j.ophtha.2008.09.012; BIRCH EE, 1982, VISION RES, V22, P507, DOI 10.1016/0042-6989(82)90108-0; Braddick O, 1983, Hum Neurobiol, V2, P65; BROWN B, 1993, OPHTHAL PHYSL OPT, V13, P138, DOI 10.1111/j.1475-1313.1993.tb00442.x; Buck D, 2007, BRIT J OPHTHALMOL, V91, P215, DOI 10.1136/bjo.2006.097790; Ciner EB, 1996, OPTOMETRY VISION SCI, V73, P43, DOI 10.1097/00006324-199601000-00007; CINER EB, 1991, OPTOMETRY VISION SCI, V68, P533, DOI 10.1097/00006324-199107000-00004; COOPER J, 1979, J AM OPTOM ASSOC, V50, P807; Costa MF, 2010, OPHTHAL PHYSL OPT, V30, P660, DOI 10.1111/j.1475-1313.2010.00750.x; FOX R, 1986, INVEST OPHTH VIS SCI, V27, P598; Frisby JP, 1996, EYE, V10, P286, DOI 10.1038/eye.1996.60; Garnham L, 2006, BRIT J OPHTHALMOL, V90, P91, DOI 10.1136/bjo.2005.077719; Hatt SR, 2007, BRIT J OPHTHALMOL, V91, P219, DOI 10.1136/bjo.2006.099465; HELD R, 1980, P NATL ACAD SCI-BIOL, V77, P5572, DOI 10.1073/pnas.77.9.5572; Holmes JM, 2005, AM J OPHTHALMOL, V139, P193, DOI 10.1016/j.ajo.2004.07.008; Holmes JM, 2007, OPHTHALMOLOGY, V114, P1215, DOI 10.1016/j.ophtha.2006.06.066; Hong SW, 2008, BRIT J OPHTHALMOL, V92, P1186, DOI 10.1136/bjo.2008.138362; Laird PW, 2008, J AAPOS, V12, P370, DOI 10.1016/j.jaapos.2008.01.013; Laird PW, 2007, J AAPOS, V11, P362, DOI 10.1016/j.jaapos.2007.01.116; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leat SJ, 2001, J PEDIAT OPHTH STRAB, V38, P284; Lee Se-Youp, 2005, Korean J Ophthalmol, V19, P136; Odell NV, 2009, J AAPOS, V13, P136, DOI 10.1016/j.jaapos.2008.09.005; Oduntan Alabi O, 1998, Clin Exp Optom, V81, P193; Ohlsson J, 2001, J AAPOS, V5, P316, DOI 10.1067/mpa.2001.118669; Rahi JS, 2009, OPHTHALMOLOGY, V116, P270, DOI 10.1016/j.ophtha.2008.09.018; ROMANO PE, 1975, AM J OPHTHALMOL, V79, P966, DOI 10.1016/0002-9394(75)90679-0; Rosner J, 1984, J Am Optom Assoc, V55, P505; Saxena R, 2011, BRIT J OPHTHALMOL, V95, P1098, DOI 10.1136/bjo.2010.182139; SCHMID M, 1986, EUR J PEDIATR, V145, P475, DOI 10.1007/BF02429046; Schneck ME, 2000, OPTOMETRY VISION SCI, V77, P531, DOI 10.1097/00006324-200010000-00007; Serrano-Pedraza I, 2011, INVEST OPHTH VIS SCI, V52, P2352, DOI 10.1167/iovs.10-6144; Sharma P, 2008, INDIAN J OPHTHALMOL, V56, P121, DOI 10.4103/0301-4738.39116; SIMONS K, 1981, ARCH OPHTHALMOL-CHIC, V99, P439; Smith J, 1988, PERCEPTION, V17, P365; Takai Y, 2005, JPN J OPHTHALMOL, V49, P1, DOI 10.1007/s10384-004-0141-4; Taroyan NA, 2004, DOC OPHTHALMOL, V108, P185, DOI 10.1007/s10633-004-4061-x; Wattam-Bell J, 2009, J VISION, V9, DOI 10.1167/9.6.9; WRIGHT LA, 1992, EYE, V6, P473, DOI 10.1038/eye.1992.100; Young BJ, 2009, J OPHTHALMOL, V2009, DOI 10.1155/2009/343827; Zaroff CM, 2003, INVEST OPHTH VIS SCI, V44, P891, DOI 10.1167/iovs.02-0361	43	41	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82999	10.1371/journal.pone.0082999	http://dx.doi.org/10.1371/journal.pone.0082999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349416	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800090
J	Chui, TTT; Lee, WC				Chui, Tina Tsz-Ting; Lee, Wen-Chung			A Regression-Based Method for Estimating Risks and Relative Risks in Case-Base Studies	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; COHORT; DESIGN; RATIO	Both the absolute risk and the relative risk (RR) have a crucial role to play in epidemiology. RR is often approximated by odds ratio (OR) under the rare-disease assumption in conventional case-control study; however, such a study design does not provide an estimate for absolute risk. The case-base study is an alternative approach which readily produces RR estimation without resorting to the rare-disease assumption. However, previous researchers only considered one single dichotomous exposure and did not elaborate how absolute risks can be estimated in a case-base study. In this paper, the authors propose a logistic model for the case-base study. The model is flexible enough to admit multiple exposures in any measurement scale-binary, categorical or continuous. It can be easily fitted using common statistical packages. With one additional step of simple calculations of the model parameters, one readily obtains relative and absolute risk estimates as well as their confidence intervals. Monte-Carlo simulations show that the proposed method can produce unbiased estimates and adequate-coverage confidence intervals, for ORs, RRs and absolute risks. The case-base study with all its desirable properties and its methods of analysis fully developed in this paper may become a mainstay in epidemiology.	[Chui, Tina Tsz-Ting; Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Lee, Wen-Chung] Natl Taiwan Univ, Coll Publ Hlth, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University	Lee, WC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	wenchung@ntu.edu.tw		Lee, Wen-Chung/0000-0003-3171-7672	National Science Council, Taiwan [NSC 102-2628-B-002-036-MY3]; National Taiwan University, Taiwan [NTU-CESRP-102R7622-8]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University, Taiwan(National Taiwan University)	This paper is partly supported by grants from National Science Council, Taiwan (NSC 102-2628-B-002-036-MY3) and National Taiwan University, Taiwan (NTU-CESRP-102R7622-8). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Breslow NE, 2009, AM J EPIDEMIOL, V169, P1398, DOI 10.1093/aje/kwp055; Carter RE, 2005, BIOSTATISTICS, V6, P39, DOI 10.1093/biostatistics/kxh016; Diaz-Quijano FA, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-14; KUPPER LL, 1975, J AM STAT ASSOC, V70, P524, DOI 10.2307/2285927; Lumley T, 2006, U WASHINGTON BIOSTAT, V293; Marschner IC, 2012, BIOSTATISTICS, V13, P179, DOI 10.1093/biostatistics/kxr030; Marti H, 2011, STAT MED, V30, P1595, DOI 10.1002/sim.4130; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; MIETTINEN O, 1982, SCAND J WORK ENV HEA, V8, P7; PRENTICE RL, 1986, BIOMETRIKA, V73, P1; SATO T, 1994, ENVIRON HEALTH PERSP, V102, P53, DOI 10.1289/ehp.94102s853; SATO T, 1992, BIOMETRICS, V48, P1215, DOI 10.2307/2532713; Scheike TH, 2004, SCAND J STAT, V31, P283, DOI 10.1111/j.1467-9469.2004.02-064.x; SELF SG, 1988, ANN STAT, V16, P64, DOI 10.1214/aos/1176350691; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	17	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83275	10.1371/journal.pone.0083275	http://dx.doi.org/10.1371/journal.pone.0083275			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349478	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800109
J	Dai, XQ; Ouyang, Z; Li, YS; Wang, HM				Dai, Xiaoqin; Ouyang, Zhu; Li, Yunsheng; Wang, Huimin			Variation in Yield Gap Induced by Nitrogen, Phosphorus and Potassium Fertilizer in North China Plain	PLOS ONE			English	Article							LONG-TERM FERTILIZATION; SOIL ORGANIC-CARBON; CROPPING SYSTEMS; INORGANIC FERTILIZERS; MANURE APPLICATION; GRAIN-YIELD; MAIZE; NUTRIENT; EFFICIENCY	A field experiment was conducted under a wheat-maize rotation system from 1990 to 2006 in North China Plain (NCP) to determine the effects of N, P and K on yield and yield gap. There were five treatments: NPK, PK, NK, NP and a control. Average wheat and maize yields were the highest in the NPK treatment, followed by those in the NP plots among all treatments. For wheat and maize yield, a significant increasing trend over time was found in the NPK-treated plots and a decreasing trend in the NK-treated plots. In the absence of N or P, wheat and maize yields were significantly lower than those in the NPK treatment. For both crops, the increasing rate of the yield gap was the highest in the P omission plots, i.e., 189.1 kg ha(-1) yr(-1) for wheat and 560.6 kg ha(-1) yr(-1) for maize. The cumulative omission of P fertilizer induced a deficit in the soil available N and extractable P concentrations for maize. The P fertilizer was more pivotal in long-term wheat and maize growth and soil fertility conservation in NCP, although the N fertilizer input was important for both crops growth. The crop response to K fertilizers was much lower than that to N or P fertilizers, but for maize, the cumulative omission of K fertilizer decreased the yield by 26% and increased the yield gap at a rate of 322.7 kg ha(-1) yr(-1). The soil indigenous K supply was not sufficiently high to meet maize K requirement over a long period. The proper application of K fertilizers is necessary for maize production in the region. Thus, the appropriate application of N and P fertilizers for the growth of both crops, while regularly combining K fertilizers for maize growth, is absolutely necessary for sustainable crop production in the NCP.	[Dai, Xiaoqin; Ouyang, Zhu; Li, Yunsheng; Wang, Huimin] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Dai, XQ (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.	daixq@igsnrr.ac.cn; liys@igsnrr.ac.cn	wang, huimin/HDM-8421-2022		Strategic Science Plan of Institute of Geographic Sciences and Natural Resources Research [2012ZD004]; Ministry of Science and Technology of China [2013BAD05B03]	Strategic Science Plan of Institute of Geographic Sciences and Natural Resources Research; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This study was financially supported by the Strategic Science Plan of Institute of Geographic Sciences and Natural Resources Research (2012ZD004) and National Science and Technology Support Projects of Ministry of Science and Technology of China (2013BAD05B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajwa MI, 1994, POTASH REV, P67; Berzsenyi Z, 2000, EUR J AGRON, V13, P225, DOI 10.1016/S1161-0301(00)00076-9; Bi LD, 2009, AGR ECOSYST ENVIRON, V129, P534, DOI 10.1016/j.agee.2008.11.007; Blake L, 2000, NUTR CYCL AGROECOSYS, V56, P263, DOI 10.1023/A:1009841603931; Cai ZC, 2006, GEODERMA, V136, P708, DOI 10.1016/j.geoderma.2006.05.008; China Statistics Bureau, 2001, CHIN STAT BUR ANN AG, P112; Fan TL, 2005, AGR ECOSYST ENVIRON, V106, P313, DOI 10.1016/j.agee.2004.09.003; Glendining MJ, 1996, J AGR SCI, V127, P347, DOI 10.1017/S0021859600078527; Gong W, 2009, PLANT SOIL, V314, P67, DOI 10.1007/s11104-008-9705-2; Jiang D, 2006, PEDOSPHERE, V16, P25, DOI 10.1016/S1002-0160(06)60022-2; Liu XJ, 2006, AGR ECOSYST ENVIRON, V113, P370, DOI 10.1016/j.agee.2005.11.002; Lu R.K., 1998, SOIL PLANT NUTRIENTS, P102; Manna MC, 2005, FIELD CROP RES, V93, P264, DOI 10.1016/j.fcr.2004.10.006; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Mussgnug F, 2006, FIELD CROP RES, V98, P127, DOI 10.1016/j.fcr.2005.12.012; Olsen S., 1954, ESTIMATION AVAILABLE; Page AL, 1982, METHODS SOIL ANAL 2, P539; Shen J, 2004, FIELD CROP RES, V86, P225, DOI 10.1016/j.fcr.2003.08.013; Tan DeShui, 2007, Scientia Agricultura Sinica, V40, P133, DOI 10.1016/S1671-2927(07)60035-2; Tang X, 2008, FIELD CROP RES, V108, P231, DOI 10.1016/j.fcr.2008.05.007; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Wang YC, 2010, NUTR CYCL AGROECOSYS, V86, P105, DOI 10.1007/s10705-009-9276-5; Yan XY, 2010, PLANT SOIL, V331, P471, DOI 10.1007/s11104-009-0268-7; Yu Q, 2006, AGR SYST, V89, P457, DOI 10.1016/j.agsy.2005.10.009; Zhang H, 2009, J AGR SCI-CAMBRIDGE, V147, P31, DOI 10.1017/S0021859608008265; Zhang Y, 2008, ATMOS ENVIRON, V42, P1436, DOI 10.1016/j.atmosenv.2007.11.002; Zhong WH, 2007, APPL SOIL ECOL, V36, P84, DOI 10.1016/j.apsoil.2006.12.001	27	26	26	7	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82147	10.1371/journal.pone.0082147	http://dx.doi.org/10.1371/journal.pone.0082147			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349204	Green Submitted, gold, Green Published			2022-12-27	WOS:000328731800041
J	Lam, SKW; Ma, XL; Sing, TL; Shilton, BH; Brandl, CJ; Davey, MJ				Lam, Simon K. W.; Ma, Xiaoli; Sing, Tina L.; Shilton, Brian H.; Brandl, Christopher J.; Davey, Megan J.			The PS1 Hairpin of Mcm3 Is Essential for Viability and for DNA Unwinding In Vitro	PLOS ONE			English	Article							S-PHASE; PHOSPHORYLATION SITES; ATP HYDROLYSIS; MECHANISM; REPLICATION; HELICASE; YEAST; COMPLEX; PROTEINS; KINASE	The pre-sensor 1 (PS1) hairpin is found in ring-shaped helicases of the AAA+ family (ATPases associated with a variety of cellular activities) of proteins and is implicated in DNA translocation during DNA unwinding of archaeal mini-chromosome maintenance (MCM) and superfamily 3 viral replicative helicases. To determine whether the PS1 hairpin is required for the function of the eukaryotic replicative helicase, Mcm2-7 (also comprised of AAA+ proteins), we mutated the conserved lysine residue in the putative PS1 hairpin motif in each of the Saccharomyces cerevisiae Mcm2-7 subunits to alanine. Interestingly, only the PS1 hairpin of Mcm3 was essential for viability. While mutation of the PS1 hairpin in the remaining MCM subunits resulted in minimal phenotypes, with the exception of Mcm7 which showed slow growth under all conditions examined, the viable alleles were synthetic lethal with each other. Reconstituted Mcm2-7 containing Mcm3 with the PS1 mutation (Mcm3(K499A)) had severely decreased helicase activity. The lack of helicase activity provides a probable explanation for the inviability of the mcm3(K499A) strain. The ATPase activity of Mcm2-73(K499A) was similar to the wild type complex, but its interaction with single-stranded DNA in an electrophoretic mobility shift assay and its associations in cells were subtly altered. Together, these findings indicate that the PS1 hairpins in the Mcm2-7 subunits have important and distinct functions, most evident by the essential nature of the Mcm3 PS1 hairpin in DNA unwinding.	[Lam, Simon K. W.; Ma, Xiaoli; Sing, Tina L.; Shilton, Brian H.; Brandl, Christopher J.; Davey, Megan J.] Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada	Western University (University of Western Ontario)	Brandl, CJ (corresponding author), Univ Western Ontario, Dept Biochem, Schulich Sch Med & Dent, London, ON, Canada.	cbrandl@uwo.ca	Shilton, Brian H/A-6667-2011	Sing, Tina/0000-0002-2166-969X	Canadian Institutes of Health Research [MOP 68926]; Schulich School of Medicine Dentistry; CIHR [MOP 10845]; Schulich Graduate Scholarship; Biochemistry Summer Undergraduate Research Program	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Schulich School of Medicine Dentistry; CIHR(Canadian Institutes of Health Research (CIHR)); Schulich Graduate Scholarship; Biochemistry Summer Undergraduate Research Program	This work was supported by funding from the Canadian Institutes of Health Research (MOP 68926) and Gap Funding from The Schulich School of Medicine & Dentistry to Megan Davey. CJB's work was supported by CIHR grant MOP 10845. SKWL received funding from The Schulich Graduate Scholarship and TLS from the Biochemistry Summer Undergraduate Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae B, 2009, STRUCTURE, V17, P211, DOI 10.1016/j.str.2008.11.010; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Brewster AS, 2010, CRIT REV BIOCHEM MOL, V45, P243, DOI 10.3109/10409238.2010.484836; Brewster AS, 2008, P NATL ACAD SCI USA, V105, P20191, DOI 10.1073/pnas.0808037105; Brown GW, 1998, J BIOL CHEM, V273, P22083, DOI 10.1074/jbc.273.34.22083; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Charych DH, 2008, J CELL BIOCHEM, V104, P1075, DOI 10.1002/jcb.21698; Chivian D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl480; Chuang LC, 2009, MOL CELL, V35, P206, DOI 10.1016/j.molcel.2009.06.014; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Fernandez-Cid A, 2013, MOL CELL, V50, P577, DOI 10.1016/j.molcel.2013.03.026; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Forsburg SL, 1997, GENETICS, V147, P1025; Frigola J, 2013, NATURE, V495, P339, DOI 10.1038/nature11920; Gai' DH, 2004, CELL, V119, P47, DOI 10.1016/j.cell.2004.09.017; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Hoke SM, CURR GENET, V56, P447; Kaplan DL, 2003, J BIOL CHEM, V278, P49171, DOI 10.1074/jbc.M308074200; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; MAINE GT, 1984, GENETICS, V106, P365; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; Mutiu AI, 2007, GENETICS, V177, P151, DOI 10.1534/genetics.107.074476; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; Saleh A, 1997, J BIOL CHEM, V272, P5571, DOI 10.1074/jbc.272.9.5571; SCHERER S, 1979, P NATL ACAD SCI USA, V76, P4951, DOI 10.1073/pnas.76.10.4951; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Stead BE, NUCL ACIDS RES, V39, P6998; Stead BE, 2009, J MOL BIOL, V391, P301, DOI 10.1016/j.jmb.2009.06.038; Tsuji T, 2006, MOL BIOL CELL, V17, P4459, DOI 10.1091/mbc.E06-03-0241; Tye BK, 2000, J BIOL CHEM, V275, P34833, DOI 10.1074/jbc.R000018200; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Winzeler EA, 1997, CURR OPIN GENET DEV, V7, P771, DOI 10.1016/S0959-437X(97)80039-1	50	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82177	10.1371/journal.pone.0082177	http://dx.doi.org/10.1371/journal.pone.0082177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349215	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300082
J	Prabhakaran, PM; De, J; Sheeba, V				Prabhakaran, Priya M.; De, Joydeep; Sheeba, Vasu			Natural Conditions Override Differences in Emergence Rhythm among Closely Related Drosophilids	PLOS ONE			English	Article							ADULT EMERGENCE; FRUIT-FLIES; MELANOGASTER	Previous studies on adult emergence rhythm of Drosophila melanogaster (DM) done under semi-natural conditions have shown that emergence is correlated to daily changes in temperature, humidity and light at dawn. Recently we showed that under laboratory conditions D. ananassae (DA), a closely related species of DM exhibits patterns in its activity/rest rhythm distinct from the latter. Here, we report the results of a study aimed at examining whether this difference in activity/rest rhythm among species extends to other circadian behaviours such as the adult emergence rhythm under a more natural environment with multiple cyclic time cues. We monitored the adult emergence rhythm of recently wild-caught DM and DA populations in parallel with those of a related species D. malerkotliana (DK), both in the laboratory and under semi-natural conditions. We find that although DM, DK and DA showed marked difference from one another under laboratory conditions, such differences were not detectable in the emergence behaviour of these three species under semi-natural conditions, and that they respond very similarly to seasonal changes in the environment. The results suggest that seasonal changes in temperature and humidity contribute largely to the variation in adult emergence waveform in terms of gate width, phase and amplitude of the peak and day-to-day variance in the timing of the emergence peak. In all three species, seasons with cooler and wetter conditions make the rhythm less tightly gated, with low amplitude peak and high day-to-day variation in timing of the peak of emergence. We show that in nature the emergence rhythm of DM, DK and DA is strongly influenced by environmental factors such that in a given season all of them exhibit similar time course and waveform and that with the changing season, they all modify their emergence patterns in a similar manner.	[Prabhakaran, Priya M.; De, Joydeep; Sheeba, Vasu] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Behav Neurogenet Lab, Bangalore 560012, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Sheeba, V (corresponding author), Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Evolutionary & Organismal Biol Unit, Behav Neurogenet Lab, Bangalore 560012, Karnataka, India.	sheeba@jncasr.ac.in		Vasu, Sheeba/0000-0003-2924-7130	JNCASR; Department of Science and Technology, India (DST); Council of Scientific and Industrial Research	JNCASR; Department of Science and Technology, India (DST)(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by funding from JNCASR, Ramanujan Fellowship from the Department of Science and Technology, India (DST) to VS, and Council of Scientific and Industrial Research fellowship to PMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahn JH, 2009, GENETICS, V181, P965, DOI 10.1534/genetics.108.099069; Bhutani S, 2009, THESIS U LEICESTER L; Crosby MA, 2007, NUCLEIC ACIDS RES, V35, pD486, DOI 10.1093/nar/gkl827; De J, 2013, P NATL ACAD SCI USA, V110, P8984, DOI 10.1073/pnas.1220960110; De J, 2012, J BIOL RHYTHM, V27, P280, DOI 10.1177/0748730412448360; Hermann C, 2013, J COMP NEUROL, V521, P367, DOI 10.1002/cne.23178; Kannan NN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050379; Kumar S, 2007, J EXP BIOL, V210, P906, DOI 10.1242/jeb.001354; Menegazzi P, 2012, J BIOL RHYTHM, V27, P433, DOI 10.1177/0748730412463181; Mukherjee N, 2012, J EXP BIOL, V215, P2960, DOI 10.1242/jeb.071290; PITTENDRIGH CS, 1954, P NATL ACAD SCI USA, V40, P1018, DOI 10.1073/pnas.40.10.1018; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Prabhakaran PM, 2013, J EXP BIOL; Prabhakaran PM, 2012, J BIOL RHYTHM, V27, P365, DOI 10.1177/0748730412458661; Saunders DS, 2002, INSECT CLOCKS, V4, P44; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Vaze KM, 2012, NATURWISSENSCHAFTEN, V99, P967, DOI 10.1007/s00114-012-0978-1; Zhang SD, 2011, MOL PHYLOGENET EVOL, V60, P21, DOI [10.1016/j.ympev.2011.04.008, 10.1016/j.ympev.2011.09.018]	18	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83048	10.1371/journal.pone.0083048	http://dx.doi.org/10.1371/journal.pone.0083048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349430	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300127
J	Franchini, DM; Incorvaia, E; Rangam, G; Coker, HA; Petersen-Mahrt, SK				Franchini, Don-Marc; Incorvaia, Elisabetta; Rangam, Gopinath; Coker, Heather A.; Petersen-Mahrt, Svend K.			Simultaneous In Vitro Characterisation of DNA Deaminase Function and Associated DNA Repair Pathways	PLOS ONE			English	Article							CLASS-SWITCH RECOMBINATION; SOMATIC HYPERMUTATION; IMMUNOGLOBULIN GENES; MISMATCH REPAIR; AID; REPLICATION; URACIL; PCNA; SPECIFICITY; INSTABILITY	During immunoglobulin (Ig) diversification, activation-induced deaminase (AID) initiates somatic hypermutation and class switch recombination by catalysing the conversion of cytosine to uracil. The synergy between AID and DNA repair pathways is fundamental for the introduction of mutations, however the molecular and biochemical mechanisms underlying this process are not fully elucidated. We describe a novel method to efficiently decipher the composition and activity of DNA repair pathways that are activated by AID-induced lesions. The in vitro resolution (IVR) assay combines AID based deamination and DNA repair activities from a cellular milieu in a single assay, thus avoiding synthetically created DNA-lesions or genetic-based readouts. Recombinant GAL4-AID fusion protein is targeted to a plasmid containing GAL4 binding sites, allowing for controlled cytosine deamination within a substrate plasmid. Subsequently, the Xenopus laevis egg extract provides a source of DNA repair proteins and functional repair pathways. Our results demonstrated that DNA repair pathways which are in vitro activated by AID-induced lesions are reminiscent of those found during AID-induced in vivo Ig diversification. The comparative ease of manipulation of this in vitro systems provides a new approach to dissect the complex DNA repair pathways acting on defined physiologically lesions, can be adapted to use with other DNA damaging proteins (e. g. APOBECs), and provide a means to develop and characterise pharmacological agents to inhibit these potentially oncogenic processes.	[Franchini, Don-Marc; Incorvaia, Elisabetta; Rangam, Gopinath; Petersen-Mahrt, Svend K.] IFOM Fdn Inst FIRC Oncol Mol, DNA Editing Immun & Epigenet, Milan, Italy; [Franchini, Don-Marc; Rangam, Gopinath; Coker, Heather A.; Petersen-Mahrt, Svend K.] London Res Inst, DNA Editing Lab, Clare Hall Labs, S Mimms, Herts, England	IFOM - FIRC Institute of Molecular Oncology	Petersen-Mahrt, SK (corresponding author), IFOM Fdn Inst FIRC Oncol Mol, DNA Editing Immun & Epigenet, Milan, Italy.	svend.petersen-mahrt@ifom.eu	Franchini, Don Marc/A-5203-2015; Rangam, Gopinath/J-8832-2019	Franchini, Don Marc/0000-0002-2562-5643; Rangam, Gopinath/0000-0001-5081-5804; Coker, Heather/0000-0001-9570-944X	IFOM-FIRC; LRI-CRUK; AICR (Associazione Italiana per la Ricerca sul Cancro) [13149]; Fondo per la promozione di Accordi Istituzionali (FINLOMBARDA SPA Ente Gestore di Regione Lombardia, Italia)	IFOM-FIRC; LRI-CRUK; AICR (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Fondo per la promozione di Accordi Istituzionali (FINLOMBARDA SPA Ente Gestore di Regione Lombardia, Italia)	E.I. was supported by IFOM-FIRC fellowships. D. M. F. and G. R. was supported by IFOM-FIRC and LRI-CRUK fellowships. H. C. was supported by an LRI-CRUK fellowship. S. K. P. M. was supported by IFOM-FIRC, AICR (Associazione Italiana per la Ricerca sul Cancro, n. 13149), Fondo per la promozione di Accordi Istituzionali (FINLOMBARDA SPA Ente Gestore di Regione Lombardia, Italia) and LRI-CRUK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besmer E, 2006, MOL CELL BIOL, V26, P4378, DOI 10.1128/MCB.02375-05; Carbone A, 2012, ACTA BIOCHIM POL, V59, P275; Chelico L, 2009, PHILOS T R SOC B, V364, P583, DOI 10.1098/rstb.2008.0195; Coker HA, 2007, DNA REPAIR, V6, P235, DOI 10.1016/j.dnarep.2006.10.001; Coker HA, 2006, METHOD ENZYMOL, V408, P156, DOI 10.1016/S0076-6879(06)08010-4; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Di Noia JM, 2006, EMBO J, V25, P585, DOI 10.1038/sj.emboj.7600939; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gaillard PHL, 1996, CELL, V86, P887, DOI 10.1016/S0092-8674(00)80164-6; Garner E, 2009, DNA REPAIR, V8, P1025, DOI 10.1016/j.dnarep.2009.04.015; Jacobs AL, 2012, CHROMOSOMA, V121, P1, DOI 10.1007/s00412-011-0347-4; Jacobs H, 1998, J EXP MED, V187, P1735, DOI 10.1084/jem.187.11.1735; KARRAN P, 1981, BIOCHEMISTRY-US, V20, P6092, DOI 10.1021/bi00524a027; Langerak P, 2007, J EXP MED, V204, P1989, DOI 10.1084/jem.20070902; Li ZQ, 2004, J EXP MED, V200, P47, DOI 10.1084/jem.20040355; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Martomo SA, 2004, J EXP MED, V200, P61, DOI 10.1084/jem.20040691; MATTOCCIA E, 1976, P NATL ACAD SCI USA, V73, P4551, DOI 10.1073/pnas.73.12.4551; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Pena-Diaz J, 2012, MOL CELL, V47, P669, DOI 10.1016/j.molcel.2012.07.006; Petersen-Mahrt S, 2005, IMMUNOL REV, V203, P80, DOI 10.1111/j.0105-2896.2005.00232.x; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pham P, 2008, J BIOL CHEM, V283, P31754, DOI 10.1074/jbc.M805524200; Punchihewa C, 2012, J BIOL CHEM, V287, P14289, DOI 10.1074/jbc.M112.353201; Rada C, 1998, IMMUNITY, V9, P135, DOI 10.1016/S1074-7613(00)80595-6; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Rangam G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043279; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Roa S, 2008, P NATL ACAD SCI USA, V105, P16248, DOI 10.1073/pnas.0808182105; Schanz S, 2009, P NATL ACAD SCI USA, V106, P5593, DOI 10.1073/pnas.0901726106; Schmitz KM, 2012, SEMIN IMMUNOL, V24, P241, DOI 10.1016/j.smim.2012.07.001; Shen HM, 2004, P NATL ACAD SCI USA, V101, P12997, DOI 10.1073/pnas.0404974101; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; Willmann KL, 2012, J EXP MED, V209, P2099, DOI 10.1084/jem.20112145; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067	43	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82097	10.1371/journal.pone.0082097	http://dx.doi.org/10.1371/journal.pone.0082097			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349193	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200062
J	Sharma, M; Fomda, BA; Mazta, S; Sehgal, R; Singh, BB; Malla, N				Sharma, Monika; Fomda, Bashir Ahmad; Mazta, Saligram; Sehgal, Rakesh; Singh, Balbir Bagicha; Malla, Nancy			Genetic Diversity and Population Genetic Structure Analysis of Echinococcus granulosus sensu stricto Complex Based on Mitochondrial DNA Signature	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; CYSTIC ECHINOCOCCOSIS; SEQUENCE ALIGNMENT; IDENTIFICATION; EPIDEMIOLOGY; NEUTRALITY; PHYLOGENY; POSITION; TESTS; G3	The genetic diversity and population genetics of the Echinococcus granulosus sensu stricto complex were investigated based on sequencing of mitochondrial DNA (mtDNA). Total 81 isolates of hydatid cyst collected from ungulate animals from different geographical areas of North India were identified by sequencing of cytochrome c oxidase subunit1 (coxi) gene. Three genotypes belonging to E. granulosus sensu stricto complex were identified (G1, G2 and G3 genotypes). Further the nucleotide sequences (retrieved from GenBank) for the coxi gene from seven populations of E. granulosus sensu stricto complex covering 6 continents, were compared with sequences of isolates analysed in this study. Molecular diversity indices represent overall high mitochondrial DNA diversity for these populations, but low nucleotide diversity between haplotypes. The neutrality tests were used to analyze signatures of historical demographic events. The Tajima's D test and Fu's FS test showed negative value, indicating deviations from neutrality and both suggested recent population expansion for the populations. Pairwise fixation index was significant for pairwise comparison of different populations (except between South America and East Asia, Middle East and Europe, South America and Europe, Africa and Australia), indicating genetic differentiation among populations. Based on the findings of the present study and those from earlier studies, we hypothesize that demographic expansion occurred in E. granulosus after the introduction of founder haplotype particular by anthropogenic movements.	[Sharma, Monika; Sehgal, Rakesh; Malla, Nancy] Post Grad Inst Med Educ & Res, Dept Parasitol, Chandigarh, India; [Fomda, Bashir Ahmad] Sherikashmir Inst Med Sci, Dept Microbiol, Kashmir, Jammu & Kashmir, India; [Mazta, Saligram] Indira Gandhi Med Coll, Dept Community Med, Shimla, Himachal Prades, India; [Singh, Balbir Bagicha] Guru Angad Dev Vet & Anim Sci Univ, Sch Publ Hlth & Zoonoses, Ludhiana, Punjab, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Sher-i-Kashmir Institute of Medical Sciences; Indira Gandhi Medical College & Hospital Shimla; Guru Angad Dev Veterinary & Animal Sciences University (GADVASU)	Malla, N (corresponding author), Post Grad Inst Med Educ & Res, Dept Parasitol, Chandigarh, India.	drmallanancy@gmail.com	Singh, BB/W-1071-2019	Singh, BB/0000-0002-6823-6146	Department or Science and Technology, New Delhi [SR/S0/HS/0031/2010]	Department or Science and Technology, New Delhi	This work was supported by the grant from the Department or Science and Technology, New Delhi (Grant no SR/S0/HS/0031/2010). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Badaraco JL, 2008, EXP PARASITOL, V119, P453, DOI 10.1016/j.exppara.2008.02.004; Bart JM, 2006, PARASITOLOGY, V133, P571, DOI 10.1017/S0031182006000734; Beyhan YE, 2011, VET PARASITOL, V181, P174, DOI 10.1016/j.vetpar.2011.04.038; BOWLES J, 1992, MOL BIOCHEM PARASIT, V54, P165, DOI 10.1016/0166-6851(92)90109-W; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Busi M, 2007, VET PARASITOL, V150, P75, DOI 10.1016/j.vetpar.2007.09.003; Casulli A, 2012, INFECT GENET EVOL, V12, P377, DOI 10.1016/j.meegid.2011.12.014; Chessa B, 2009, SCIENCE, V324, P532, DOI 10.1126/science.1170587; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; de la Rue ML, 2011, VET PARASITOL, V177, P97, DOI 10.1016/j.vetpar.2010.11.018; Eckert J, 2001, WHO/OIE MANUAL ON ECHINOCOCCOSIS IN HUMANS AND ANIMALS: A PUBLIC HEALTH PROBLEM OF GLOBAL CONCERN, P72; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YX, 1997, GENETICS, V147, P915; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huttner M, 2008, INT J PARASITOL, V38, P861, DOI 10.1016/j.ijpara.2007.10.013; Latif AA, 2010, VET PARASITOL, V170, P44, DOI 10.1016/j.vetpar.2010.02.003; Lavikainen A, 2003, PARASITOLOGY, V127, P207, DOI 10.1017/S0031182003003780; McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; Moro P, 2009, INT J INFECT DIS, V13, P125, DOI 10.1016/j.ijid.2008.03.037; Nakao M, 2007, PARASITOLOGY, V134, P713, DOI 10.1017/S0031182006001934; Nakao M, 2010, INT J PARASITOL, V40, P379, DOI 10.1016/j.ijpara.2009.09.006; Pednekar RP, 2009, VET PARASITOL, V165, P58, DOI 10.1016/j.vetpar.2009.06.021; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Scott JC, 1997, PARASITOLOGY, V114, P37, DOI 10.1017/S0031182096008062; Sharma M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002262; Singh BB, 2012, VET PARASITOL, V186, P503, DOI 10.1016/j.vetpar.2011.11.064; TAJIMA F, 1989, GENETICS, V123, P585; TEMPLETON AR, 1992, GENETICS, V132, P619; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thompson RCA, 2008, EXP PARASITOL, V119, P439, DOI 10.1016/j.exppara.2008.04.016; Tibayrenc M, 2009, METHODS MOL BIOL, V551, P1, DOI 10.1007/978-1-60327-999-4_1; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yanagida T, 2012, PARASITOL INT, V61, P599, DOI 10.1016/j.parint.2012.05.014; Zhang LH, 1998, AM J TROP MED HYG, V59, P171, DOI 10.4269/ajtmh.1998.59.171	37	39	45	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82904	10.1371/journal.pone.0082904	http://dx.doi.org/10.1371/journal.pone.0082904			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349394	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200114
J	Zhang, L; Pan, CW; Yang, B; Xiao, Y; Yu, BP				Zhang, Li; Pan, Chenwei; Yang, Bin; Xiao, Yong; Yu, Baoping			Enhanced Expression of Cystathionine beta-Synthase and Cystathionine gamma-Lyase During Acute Cholecystitis-Induced Gallbladder Inflammation	PLOS ONE			English	Article							ENDOGENOUS HYDROGEN-SULFIDE; SMOOTH-MUSCLE; ACALCULOUS CHOLECYSTITIS; OXIDATIVE STRESS; LUNG INJURY; GUINEA-PIG; CONTRACTILITY; MEDIATOR; MICE; NEUROMODULATOR	Background: Hydrogen sulfide (H2S) has recently been shown to play an important role in the digestive system, but the role of endogenous H2S produced locally in the gallbladder is unknown. The aim of this study was to investigate whether gallbladder possesses the enzymatic machinery to synthesize H2S, and whether H2S synthesis is changed in gallbladder inflammation during acute acalculous cholecystitis (AC). Methods: Adult male guinea pigs underwent either a sham operation or common bile duct ligation (CBDL). One, two, or three days after CBDL, the animals were sacrificed separately. Hematoxylin and eosin-stained slides of gallbladder samples were scored for inflammation. H2S production rate in gallbladder tissue from each group was determined; immunohistochemistry and western blotting were used to determine expression levels of the H2S-producing enzymes cystathionine beta-synthase (CBS) and cystathionine gamma-lyase (CSE) in gallbladder. Results: There was a progressive inflammatory response after CBDL. Immunohistochemistry analysis showed that CBS and CSE were expressed in the gallbladder epithelium, muscular layer, and blood vessels and that the expression increased progressively with increasing inflammation following CBDL. The expression of CBS protein as well as the H2S-production rate was significantly increased in the animals that underwent CBDL, compared to those that underwent the sham operation. Conclusions: Both CBS and CSE are expressed in gallbladder tissues. The expression of these enzymes, as well as H2S synthesis, was up-regulated in the context of inflammation during AC.	[Zhang, Li; Pan, Chenwei; Yang, Bin; Xiao, Yong; Yu, Baoping] Wuhan Univ, Dept Gastroenterol, Renmin Hosp, Wuhan 430072, Peoples R China; [Pan, Chenwei] Wenzhou Med Univ, Affiliated Hosp 2, Dept Infect Dis, Wenzhou, Peoples R China	Wuhan University; Wenzhou Medical University	Yu, BP (corresponding author), Wuhan Univ, Dept Gastroenterol, Renmin Hosp, Wuhan 430072, Peoples R China.	yubp62@126.com			National Natural Science Foundation of China [81170351]; Fundamental Research Funds for the Central Universities [2012302020213]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China (No. 81170351) and the Fundamental Research Funds for the Central Universities (No.2012302020213). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia M, 2005, FASEB J, V19, P623, DOI 10.1096/fj.04-3023fje; Bhatia M, 2005, BRIT J PHARMACOL, V145, P141, DOI 10.1038/sj.bjp.0706186; Cui J, 2013, EXP THER MED, V5, P689, DOI 10.3892/etm.2012.870; Gomez-Pinilla PJ, 2010, J PHYSIOL BIOCHEM, V66, P161, DOI 10.1007/s13105-010-0021-y; Han YF, 2011, EUR J PHARMACOL, V673, P85, DOI 10.1016/j.ejphar.2011.10.018; Li HZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041614; Li L, 2006, CURR OPIN PHARMACOL, V6, P125, DOI 10.1016/j.coph.2005.10.007; Li L, 2005, FASEB J, V19, P1196, DOI 10.1096/fj.04-3583fje; Linden DR, 2008, J NEUROCHEM, V106, P1577, DOI 10.1111/j.1471-4159.2008.05502.x; Linden DR, 2013, ANTIOXID RE IN PRESS; Lowicka E, 2007, PHARMACOL REP, V59, P4; Martin GR, 2010, DIGEST LIVER DIS, V42, P103, DOI 10.1016/j.dld.2009.05.016; Nagao M, 2011, J GASTROINTEST SURG, V15, P12, DOI 10.1007/s11605-010-1306-8; Parkman HP, 1999, DIGEST DIS SCI, V44, P2235, DOI 10.1023/A:1026600603121; Parkman HP, 2001, J SURG RES, V96, P135, DOI 10.1006/jsre.2001.6082; Parkman HP, 2000, J SURG RES, V88, P186, DOI 10.1006/jsre.1999.5788; Renga Barbara, 2011, Inflammation & Allergy Drug Targets, V10, P85; Schicho R, 2006, GASTROENTEROLOGY, V131, P1542, DOI 10.1053/j.gastro.2006.08.035; Soylu S, 2009, J SURG RES, V155, P70, DOI 10.1016/j.jss.2008.08.002; Tamizhselvi R, 2011, PANCREAS, V40, P444, DOI 10.1097/MPA.0b013e31820720e6; Teague B, 2002, BRIT J PHARMACOL, V137, P139, DOI 10.1038/sj.bjp.0704858; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wang R, 2010, ANTIOXID REDOX SIGN, V12, P1061, DOI 10.1089/ars.2009.2938; Wang YF, 2009, ARTERIOSCL THROM VAS, V29, P173, DOI 10.1161/ATVBAHA.108.179333; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Yonezawa D, 2007, TOXICOLOGY, V241, P11, DOI 10.1016/j.tox.2007.07.020; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhang HL, 2007, J IMMUNOL, V179, P4153, DOI 10.4049/jimmunol.179.6.4153; Zhang HL, 2007, AM J PHYSIOL-LUNG C, V292, pL960, DOI 10.1152/ajplung.00388.2006; Zhao P, 2009, EUR J PHARMACOL, V616, P223, DOI 10.1016/j.ejphar.2009.05.014	30	8	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82711	10.1371/journal.pone.0082711	http://dx.doi.org/10.1371/journal.pone.0082711			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349344	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200093
J	Canu, E; Agosta, F; Galantucci, S; Chio, A; Riva, N; Silani, V; Falini, A; Comi, G; Filippi, M				Canu, Elisa; Agosta, Federica; Galantucci, Sebastiano; Chio, Adriano; Riva, Nilo; Silani, Vincenzo; Falini, Andrea; Comi, Giancarlo; Filippi, Massimo			Extramotor Damage Is Associated with Cognition in Primary Lateral Sclerosis Patients	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; DIAGNOSTIC-CRITERIA; NORMATIVE DATA; RATING-SCALE; ALSFRS-R; IMPAIRMENT; POPULATION; CONSENSUS; DISEASE	Objectives: This is a cross-sectional study aimed at investigating cognitive performances in patients with primary lateral sclerosis (PLS) and using diffusion tensor (DT) magnetic resonance imaging (MRI) to determine the topographical distribution of microstructural white matter (WM) damage in patients with or without cognitive deficits. Methods: DT MRI scans were obtained from 21 PLS patients and 35 age-and sex-matched healthy controls. All PLS patients underwent a comprehensive neuropsychological battery. Tract-based-spatial-statistics (TBSS) was used to perform a whole-brain voxel-wise analysis of fractional anisotropy (FA), axial, radial (radD) and mean diffusivity (MD). Results: Ten PLS patients had abnormal scores in at least one neuropsychological test (PLS with cognitive deficits, PLS-cd). Compared with healthy controls and cognitively unimpaired PLS patients (PLS-cu), PLS-cd cases showed decreased FA and increased MD and radD in the corticospinal tract (CST), corpus callosum, brainstem, anterior limb of internal capsule, superior and inferior longitudinal fasciculi, fornix, thalamic radiations, and parietal lobes, bilaterally. Compared with healthy controls, PLS-cd patients showed further decreased FA and increased radD in the cerebellar WM, bilaterally. Compared with controls, PLS-cu patients showed decreased FA in the mid-body of corpus callosum. In PLS, executive and language test scores correlated with WM damage. Conclusions: This is the first study evaluating the relationship between cognitive performance and WM tract damage in PLS patients. PLS can be associated with a multi-domain cognitive impairment. WM damage to interhemispheric, limbic and major associative WM tracts seem to be the structural correlate of cognitive abnormalities in these patients.	[Canu, Elisa; Agosta, Federica; Galantucci, Sebastiano; Filippi, Massimo] Univ Vita Salute San Raffaele, Neuroimaging Res Unit, Inst Expt Neurol, Div Neurosci,San Raffaele Sci Inst, Milan, Italy; [Riva, Nilo; Comi, Giancarlo; Filippi, Massimo] Univ Vita Salute San Raffaele, Dept Neurol, Inst Expt Neurol, Div Neurosci,San Raffaele Sci Inst, Milan, Italy; [Falini, Andrea] Univ Vita Salute San Raffaele, Dept Neuroradiol, CERMAC, San Raffaele Sci Inst, Milan, Italy; [Chio, Adriano] Univ Turin, Rita Levi Montalcini Dept Neurosci, Turin, Italy; [Silani, Vincenzo] Univ Milan, Dept Neurol, Milan, Italy; [Silani, Vincenzo] Univ Milan, Lab Neurosci, IRCCS Ist Auxol Italiano, Dept Pathophysiol & Tranplantat,Dino Ferrari Ctr, Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Turin; University of Milan; IRCCS Istituto Auxologico Italiano; University of Milan	Filippi, M (corresponding author), Univ Vita Salute San Raffaele, Neuroimaging Res Unit, Inst Expt Neurol, Div Neurosci,San Raffaele Sci Inst, Milan, Italy.	filippi.massimo@hsr.it	Silani, Vincenzo/P-4421-2017; Chio, Adriano/K-3425-2016; Filippi, Massimo/K-1755-2018; Galantucci, Sebastiano/K-3379-2018; riva, nilo/J-7187-2012; Canu, Elisa/K-1423-2016; Agosta, Federica/J-9908-2016	Silani, Vincenzo/0000-0002-7698-3854; Chio, Adriano/0000-0001-9579-5341; Filippi, Massimo/0000-0002-5485-0479; Galantucci, Sebastiano/0000-0002-2583-607X; riva, nilo/0000-0002-0513-9517; Canu, Elisa/0000-0001-5804-3378; falini, andrea/0000-0002-1461-8755; Agosta, Federica/0000-0003-3121-4979	Italian Ministry of Health [RF-2010-2313220]; European Community [259867]	Italian Ministry of Health(Ministry of Health, Italy); European Community(European Commission)	This work was supported by the Italian Ministry of Health, grant number #RF-2010-2313220; and by the European Community's Health Seventh Framework Programme (FP7/2007-2013), grant number #259867. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams S, 2000, NEUROPSYCHOLOGIA, V38, P734, DOI 10.1016/S0028-3932(99)00146-3; Agosta F, 2013, HUM BRAIN M IN PRESS; Alberici A, 2007, NEUROL SCI, V28, P80, DOI 10.1007/s10072-007-0791-3; Basso A, 1987, Funct Neurol, V2, P189; Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; CASELLI RJ, 1995, NEUROLOGY, V45, P2005, DOI 10.1212/WNL.45.11.2005; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Ciccarelli O, 2009, HUM BRAIN MAPP, V30, P615, DOI 10.1002/hbm.20527; Della Sala S, 2003, NEUROL SCI, V24, P10, DOI 10.1007/s100720300015; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gunning-Dixon FM, 2000, NEUROPSYCHOLOGY, V14, P224, DOI 10.1037//0894-4105.14.2.224; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Iwata NK, 2011, BRAIN, V134, P2642, DOI 10.1093/brain/awr178; Kimura F, 2006, NEUROLOGY, V66, P265, DOI 10.1212/01.wnl.0000194316.91908.8a; Kosaka T, 2012, NEUROPATHOLOGY, V32, P373, DOI 10.1111/j.1440-1789.2011.01271.x; Koziol LF, 2013, CEREBELLUM IN PRESS; Kuipers-Upmeijer J, 2001, J NEUROL NEUROSUR PS, V71, P615, DOI 10.1136/jnnp.71.5.615; Laiacona M, 2000, NEUROL SCI, V21, P279, DOI 10.1007/s100720070065; Le Forestier N, 2001, BRAIN, V124, P1989, DOI 10.1093/brain/124.10.1989; Lucchelli F, 2005, NEUROCASE, V11, P234, DOI 10.1080/13554790590944889; Miceli G., 1994, BATTERIA LANALISI DE; Murphy MJ, 2008, AMYOTROPH LATERAL SC, V9, P359, DOI 10.1080/17482960802411740; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; NOVELLI G, 1986, Archivio di Psicologia Neurologia e Psichiatria, V47, P477; ORSINI A, 1987, ITAL J NEUROL SCI, V8, P539; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Piquard A, 2006, AMYOTROPH LATERAL SC, V7, P150, DOI 10.1080/17482960600680371; Prell T, 2013, AMYOTROPH LATERAL SC; PRINGLE CE, 1992, BRAIN, V115, P495, DOI 10.1093/brain/115.2.495; Sarro L, 2011, AM J NEURORADIOL, V32, P1866, DOI 10.3174/ajnr.A2658; Smith CD, 2002, NEUROLOGY, V58, P647, DOI 10.1212/WNL.58.4.647; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; Tsermentseli S, 2012, CORTEX, V48, P166, DOI 10.1016/j.cortex.2011.02.004; Turner MR, 2012, BIOMARK MED, V6, P319, DOI [10.2217/BMM.12.26, 10.2217/bmm.12.26]; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Unrath A, 2010, HUM BRAIN MAPP, V31, P1727, DOI 10.1002/hbm.20971; van der Graaff MM, 2011, BRAIN, V134, P1211, DOI 10.1093/brain/awr016; Weigl E, 1927, Z PSYCHOL, V103, P245; Wilson SM, 2011, NEURON, V72, P397, DOI 10.1016/j.neuron.2011.09.014; Yoshida M, 2004, NEUROPATHOLOGY, V24, P87, DOI 10.1111/j.1440-1789.2003.00544.x; Zago S, 2008, BEHAV NEUROL, V19, P169, DOI 10.1155/2008/825042	42	30	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82017	10.1371/journal.pone.0082017	http://dx.doi.org/10.1371/journal.pone.0082017			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349172	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100079
J	Tsepilov, YA; Ried, JS; Strauch, K; Grallert, H; van Duijn, CM; Axenovich, TI; Aulchenko, YS				Tsepilov, Yakov A.; Ried, Janina S.; Strauch, Konstantin; Grallert, Harald; van Duijn, Cornelia M.; Axenovich, Tatiana I.; Aulchenko, Yurii S.			Development and Application of Genomic Control Methods for Genome-Wide Association Studies Using Non-Additive Models	PLOS ONE			English	Article							POPULATION STRATIFICATION; DISEASE; LOCI; RELATEDNESS; TESTS	Genome-wide association studies (GWAS) comprise a powerful tool for mapping genes of complex traits. However, an inflation of the test statistic can occur because of population substructure or cryptic relatedness, which could cause spurious associations. If information on a large number of genetic markers is available, adjusting the analysis results by using the method of genomic control (GC) is possible. GC was originally proposed to correct the Cochran-Armitage additive trend test. For non-additive models, correction has been shown to depend on allele frequencies. Therefore, usage of GC is limited to situations where allele frequencies of null markers and candidate markers are matched. In this work, we extended the capabilities of the GC method for non-additive models, which allows us to use null markers with arbitrary allele frequencies for GC. Analytical expressions for the inflation of a test statistic describing its dependency on allele frequency and several population parameters were obtained for recessive, dominant, and over-dominant models of inheritance. We proposed a method to estimate these required population parameters. Furthermore, we suggested a GC method based on approximation of the correction coefficient by a polynomial of allele frequency and described procedures to correct the genotypic (two degrees of freedom) test for cases when the model of inheritance is unknown. Statistical properties of the described methods were investigated using simulated and real data. We demonstrated that all considered methods were effective in controlling type 1 error in the presence of genetic substructure. The proposed GC methods can be applied to statistical tests for GWAS with various models of inheritance. All methods developed and tested in this work were implemented using R language as a part of the GenABEL package.	[Tsepilov, Yakov A.; Axenovich, Tatiana I.; Aulchenko, Yurii S.] Inst Cytol & Genet SD RAS, Novosibirsk, Russia; [Tsepilov, Yakov A.; Axenovich, Tatiana I.; Aulchenko, Yurii S.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Ried, Janina S.; Strauch, Konstantin] German Res Ctr Environm Hlth, Inst Genet Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Strauch, Konstantin] Univ Munich, Inst Med Informat Biometry & Epidemiol, Chair Genet Epidemiol, Munich, Germany; [Grallert, Harald] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Neuherberg, Germany; [van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Aulchenko, Yurii S.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Novosibirsk State University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Erasmus University Rotterdam; Erasmus MC; University of Edinburgh	Aulchenko, YS (corresponding author), Inst Cytol & Genet SD RAS, Novosibirsk, Russia.	yurii.aulchenko@gmail.com	Axenovich, Tatiana I/AAD-2595-2022; Grallert, Harald/B-3424-2013; Tsepilov, Yakov A./D-6997-2018; Aulchenko, Yurii/M-8270-2013	Axenovich, Tatiana I/0000-0002-4318-4458; Tsepilov, Yakov A./0000-0002-4931-6052; Aulchenko, Yurii/0000-0002-7899-1575; Van Duijn, Cornelia/0000-0002-2374-9204	Helmholtz Zentrum Munchen, German Research Center for Environmental Health; German Federal Ministry of Education and Research (BMBF); State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ; Helmholtz Association; RFBR (Russian Foundation for Basic Research) [11-04-00098, 12-04-91322]; European Union [305280]	Helmholtz Zentrum Munchen, German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ; Helmholtz Association(Helmholtz Association); RFBR (Russian Foundation for Basic Research)(Russian Foundation for Basic Research (RFBR)); European Union(European Commission)	The KORA study was initiated and financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. KORA research was supported within the Munich Center of Health Sciences (MC-Health), Ludwig-Maximilians-Universitat, as part of LMUinnovativ. Research leading to these results has received funding from a grant of the Helmholtz Association and the RFBR (Russian Foundation for Basic Research, grants No. 11-04-00098 and 12-04-91322) in the context of a Helmholtz-Russia Joint Research Group as well as from the European Union's Seventh Framework Programme (FP7-Health-F5-2012) under grant agreement No. 305280 (MIMOmics).	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; Bittles AH, 2001, CLIN GENET, V60, P89, DOI 10.1034/j.1399-0004.2001.600201.x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Dadd T, 2010, HUM HERED, V69, P285, DOI 10.1159/000302720; de Bakker PIW, 2012, HUM MOL GENET, V21, pR29, DOI 10.1093/hmg/dds384; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Gorroochurn P, 2006, GENET EPIDEMIOL, V30, P277, DOI 10.1002/gepi.20143; Kobayashi D, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-34; Kolz M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000504; Liu F, 2009, J ALZHEIMERS DIS, V18, P51, DOI 10.3233/JAD-2009-1137; Liu J, 2013, MOVEMENT DISORD, V28, P1892, DOI 10.1002/mds.25599; McLaren PJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003515; Oliehoek PA, 2006, GENETICS, V173, P483, DOI 10.1534/genetics.105.049940; Pritchard JK, 2000, GENETICS, V155, P945; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Yan T, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-78; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zang Y, 2007, HUM HERED, V63, P187, DOI 10.1159/000099831; Zheng G, 2006, AM J HUM GENET, V78, P350, DOI 10.1086/500054; Zheng G, 2005, BIOMETRICS, V61, P186, DOI 10.1111/j.0006-341X.2005.t01-1-.x	26	11	11	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81431	10.1371/journal.pone.0081431	http://dx.doi.org/10.1371/journal.pone.0081431			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358113	Green Published, gold			2022-12-27	WOS:000328735700009
J	Brauer, CJ; Unmack, PJ; Hammer, MP; Adams, M; Beheregaray, LB				Brauer, Chris J.; Unmack, Peter J.; Hammer, Michael P.; Adams, Mark; Beheregaray, Luciano B.			Catchment-Scale Conservation Units Identified for the Threatened Yarra Pygmy Perch (Nannoperca obscura) in Highly Modified River Systems	PLOS ONE			English	Article							FRESH-WATER FISH; SPATIAL AUTOCORRELATION ANALYSIS; SOUTH-EASTERN AUSTRALIA; POPULATION-STRUCTURE; GENE FLOW; TELEOSTEI PERCICHTHYIDAE; BIOLOGICAL CONSERVATION; MICROSATELLITE MARKERS; EVOLUTIONARY PROCESSES; MULTILOCUS GENOTYPES	Habitat fragmentation caused by human activities alters metapopulation dynamics and decreases biological connectivity through reduced migration and gene flow, leading to lowered levels of population genetic diversity and to local extinctions. The threatened Yarra pygmy perch, Nannoperca obscura, is a poor disperser found in small, isolated populations in wetlands and streams of southeastern Australia. Modifications to natural flow regimes in anthropogenically-impacted river systems have recently reduced the amount of habitat for this species and likely further limited its opportunity to disperse. We employed highly resolving microsatellite DNA markers to assess genetic variation, population structure and the spatial scale that dispersal takes place across the distribution of this freshwater fish and used this information to identify conservation units for management. The levels of genetic variation found for N. obscura are amongst the lowest reported for a fish species (mean heterozygosity of 0.318 and mean allelic richness of 1.92). We identified very strong population genetic structure, nil to little evidence of recent migration among demes and a minimum of 11 units for conservation management, hierarchically nested within four major genetic lineages. A combination of spatial analytical methods revealed hierarchical genetic structure corresponding with catchment boundaries and also demonstrated significant isolation by riverine distance. Our findings have implications for the national recovery plan of this species by demonstrating that N. obscura populations should be managed at a catchment level and highlighting the need to restore habitat and avoid further alteration of the natural hydrology.	[Brauer, Chris J.; Beheregaray, Luciano B.] Flinders Univ S Australia, Sch Biol Sci, Mol Ecol Lab, Adelaide, SA 5001, Australia; [Unmack, Peter J.] Univ Canberra, Inst Appl Ecol, Canberra, ACT 2601, Australia; [Unmack, Peter J.] Univ Canberra, Collaborat Res Network Murray Darling Basin Futur, Canberra, ACT 2601, Australia; [Hammer, Michael P.; Adams, Mark] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Hammer, Michael P.] Fishes Museum & Art Gallery Northern Terr, Darwin, NT, Australia; [Hammer, Michael P.; Adams, Mark] S Australian Museum, Evolutionary Biol Unit, Adelaide, SA 5000, Australia	Flinders University South Australia; University of Canberra; University of Canberra; University of Adelaide	Beheregaray, LB (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Mol Ecol Lab, Adelaide, SA 5001, Australia.	luciano.beheregaray@flinders.edu.au	Beheregaray, Luciano B/A-8621-2008; Unmack, Peter J./AAU-3023-2020; Beheregaray, Luciano/AAY-6384-2021	Beheregaray, Luciano B/0000-0003-0944-3003; Unmack, Peter J./0000-0003-1175-1152; Beheregaray, Luciano/0000-0003-0944-3003; Brauer, Chris/0000-0003-2968-5915; Hammer, Michael/0000-0002-0981-4647	Australian Research Council [LP100200409]; AJ & IM Naylon Honours scholarship; Australian Government's Collaborative Research Networks (CRN) Program; Cooperative Research Centre for Freshwater Ecology; Australian Postgraduate Award	Australian Research Council(Australian Research Council); AJ & IM Naylon Honours scholarship; Australian Government's Collaborative Research Networks (CRN) Program(Australian Government); Cooperative Research Centre for Freshwater Ecology(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Postgraduate Award(Australian Government)	Financial support for this study was provided by the Australian Research Council (LP100200409 to LB Beheregaray, J Harris & M Adams). Support was provided to CJB by the AJ & IM Naylon Honours scholarship. PJU was supported as a Murray-Darling Basin futures research fellow through the Australian Government's Collaborative Research Networks (CRN) Program. MPH was provided support by the Cooperative Research Centre for Freshwater Ecology and an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Anderson CD, 2010, MOL ECOL, V19, P3565, DOI 10.1111/j.1365-294X.2010.04757.x; Beheregaray LB, 2004, MOL ECOL NOTES, V4, P330, DOI 10.1111/j.1471-8286.2004.00686.x; Carvalho DC, 2011, CONSERV GENET RESOUR, V3, P601, DOI 10.1007/s12686-011-9413-8; Coleman RA, 2010, CONSERV GENET, V11, P1911, DOI 10.1007/s10592-010-0082-z; Cook BD, 2007, BIOL CONSERV, V138, P60, DOI 10.1016/j.biocon.2007.04.002; Cook BD, 2011, FRESHWATER BIOL, V56, P812, DOI 10.1111/j.1365-2427.2010.02527.x; Cooke GM, 2012, J EVOLUTION BIOL, V25, P1305, DOI 10.1111/j.1420-9101.2012.02514.x; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Diniz JAF, 2002, CONSERV BIOL, V16, P924, DOI 10.1046/j.1523-1739.2002.00295.x; Drummond CS, 2007, MOL ECOL, V16, P753, DOI 10.1111/j.1365-294X.2006.03186.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Faulks LK, 2011, EVOL APPL, V4, P589, DOI 10.1111/j.1752-4571.2011.00183.x; Faulks LK, 2010, MOL ECOL, V19, P4723, DOI 10.1111/j.1365-294X.2010.04848.x; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; Fischer J, 2000, BIOL CONSERV, V96, P1, DOI 10.1016/S0006-3207(00)00048-3; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; FOEN, 2011, LIST NAT PRIOR SPEC; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R, 2010, BIOL CONSERV, V143, P1919, DOI 10.1016/j.biocon.2010.05.011; Frankham R, 2010, CONSERV GENET, V11, P661, DOI 10.1007/s10592-009-0010-2; Gilbert KJ, 2012, MOL ECOL, V21, P4925, DOI 10.1111/j.1365-294X.2012.05754.x; Groce MC, 2012, T AM FISH SOC, V141, P825, DOI 10.1080/00028487.2012.680382; Hammer, 2010, NATL RECOVERY PLAN Y; Hammer M, 2009, ACTION PLAN S AUSTR; Hammer MP, 2013, MAR FRESHWATER RES, V64, P807, DOI 10.1071/MF12258; Hammer MP, 2010, CONSERV GENET, V11, P213, DOI 10.1007/s10592-009-0024-9; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Heath D, 2010, EVOL APPL, V3, P77, DOI 10.1111/j.1752-4571.2009.00100.x; Huey JA, 2008, FRESHWATER BIOL, V53, P1393, DOI 10.1111/j.1365-2427.2008.01971.x; Huey JA, 2006, BIOL J LINN SOC, V87, P457, DOI 10.1111/j.1095-8312.2006.00590.x; Huff DD, 2011, MOL ECOL, V20, P4246, DOI 10.1111/j.1365-294X.2011.05271.x; Hughes J, 1999, HEREDITY, V83, P5, DOI 10.1038/sj.hdy.6885390; Hughes JM, 2013, FRESHWATER BIOL, V58, P951, DOI 10.1111/fwb.12099; Hughes JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040546; Hughes JM, 2009, BIOSCIENCE, V59, P573, DOI 10.1525/bio.2009.59.7.8; IPCC, 2001, CLIMATE CHANGE 2001, DOI DOI 10.1017/CBO9781107415379; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kingsford RT, 2011, MAR FRESHWATER RES, V62, P255, DOI 10.1071/MF09315; Kuiter RH, 1996, FRESHWATER FISHES S; Lande R, 1998, RES POPUL ECOL, V40, P259, DOI 10.1007/BF02763457; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Lintermans M, 2013, ECOLOGY OF AUSTRALIAN FRESHWATER FISHES, P283; Lowe WH, 2010, MOL ECOL, V19, P3038, DOI 10.1111/j.1365-294X.2010.04688.x; Luque S, 2012, LANDSCAPE ECOL, V27, P153, DOI 10.1007/s10980-011-9700-5; Marie AD, 2012, CAN J FISH AQUAT SCI, V69, P884, DOI 10.1139/F2012-027; McGlashan DJ, 2002, MAR FRESHWATER RES, V53, P897, DOI 10.1071/MF01107; MEFFE G K, 1988, Conservation Biology, V2, P157, DOI 10.1111/j.1523-1739.1988.tb00167.x; Meirmans PG, 2012, MOL ECOL, V21, P2839, DOI 10.1111/j.1365-294X.2012.05578.x; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Murray-Darling Basin Authority, 2010, GUID PROP BAS PLAN O; Palmer MA, 2008, FRONT ECOL ENVIRON, V6, P81, DOI 10.1890/060148; Peakall R, 2003, EVOLUTION, V57, P1182, DOI 10.1111/j.0014-3820.2003.tb00327.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Primmer CR, 2006, MOL ECOL, V15, P653, DOI 10.1111/j.1365-294X.2005.02844.x; Pritchard JK, 2000, GENETICS, V155, P945; Rambaut A, 2009, TRACER V1 5; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rourke ML, 2010, MAR FRESHWATER RES, V61, P918, DOI 10.1071/MF10037; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saddlier S, 2013, MAR FRESHWATER RES, V64, P874, DOI 10.1071/MF12260; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Segelbacher G, 2010, CONSERV GENET, V11, P375, DOI 10.1007/s10592-009-0044-5; SLATKIN M, 1995, GENETICS, V139, P457; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Stein JL, 2002, LANDSCAPE URBAN PLAN, V60, P1, DOI 10.1016/S0169-2046(02)00048-8; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Taffs K.H., 2001, AUSTR GEOGRAPHICAL S, V39, P279, DOI DOI 10.1111/1467-8470.00147; Unmack PJ, 2013, MOL ECOL, V22, P1683, DOI 10.1111/mec.12204; Unmack PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038433; Unmack PJ, 2001, J BIOGEOGR, V28, P1053, DOI 10.1046/j.1365-2699.2001.00615.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Victorian Government Department of Sustainability and Environment, 2013, ADV LIST THREATN VER; Wear RJ, 2006, IMPACT DRAIN DISCHAR; Wedderburn SD, 2012, HYDROBIOLOGIA, V691, P35, DOI 10.1007/s10750-011-0993-9; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177	91	28	28	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82953	10.1371/journal.pone.0082953	http://dx.doi.org/10.1371/journal.pone.0082953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349405	Green Published, gold			2022-12-27	WOS:000328734200061
J	Davies, KD; Mahale, S; Astling, DP; Aisner, DL; Le, AT; Hinz, TK; Vaishnavi, A; Bunn, PA; Heasley, LE; Tan, AC; Camidge, DR; Varella-Garcia, M; Doebele, RC				Davies, Kurtis D.; Mahale, Sakshi; Astling, David P.; Aisner, Dara L.; Le, Anh T.; Hinz, Trista K.; Vaishnavi, Aria; Bunn, Paul A., Jr.; Heasley, Lynn E.; Tan, Aik-Choon; Camidge, D. Ross; Varella-Garcia, Marileila; Doebele, Robert C.			Resistance to ROS1 Inhibition Mediated by EGFR Pathway Activation in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; ACQUIRED-RESISTANCE; CRIZOTINIB RESISTANCE; T790M MUTATIONS; GEFITINIB; MECHANISM; GENE; ZD1839; IRESSA	The targeting of oncogenic 'driver' kinases with small molecule inhibitors has proven to be a highly effective therapeutic strategy in selected non-small cell lung cancer (NSCLC) patients. However, acquired resistance to targeted therapies invariably arises and is a major limitation to patient care. ROS1 fusion proteins are a recently described class of oncogenic driver, and NSCLC patients that express these fusions generally respond well to ROS1-targeted therapy. In this study, we sought to determine mechanisms of acquired resistance to ROS1 inhibition. To accomplish this, we analyzed tumor samples from a patient who initially responded to the ROS1 inhibitor crizotinib but eventually developed acquired resistance. In addition, we generated a ROS1 inhibition-resistant derivative of the initially sensitive NSCLC cell line HCC78. Previously described mechanisms of acquired resistance to tyrosine kinase inhibitors including target kinase-domain mutation, target copy number gain, epithelial-mesenchymal transition, and conversion to small cell lung cancer histology were found to not underlie resistance in the patient sample or resistant cell line. However, we did observe a switch in the control of growth and survival signaling pathways from ROS1 to EGFR in the resistant cell line. As a result of this switch, ROS1 inhibition-resistant HCC78 cells became sensitive to EGFR inhibition, an effect that was enhanced by co-treatment with a ROS1 inhibitor. Our results suggest that co-inhibition of ROS1 and EGFR may be an effective strategy to combat resistance to targeted therapy in some ROS1 fusion-positive NSCLC patients.	[Davies, Kurtis D.; Mahale, Sakshi; Astling, David P.; Le, Anh T.; Vaishnavi, Aria; Bunn, Paul A., Jr.; Tan, Aik-Choon; Camidge, D. Ross; Varella-Garcia, Marileila; Doebele, Robert C.] Univ Colorado, Div Med Oncol, Dept Med, Aurora, CO USA; [Aisner, Dara L.] Univ Colorado, Dept Pathol, Aurora, CO USA; [Hinz, Trista K.; Heasley, Lynn E.] Univ Colorado, Dept Craniofacial Biol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Doebele, RC (corresponding author), Univ Colorado, Div Med Oncol, Dept Med, Anschutz Med Campus, Aurora, CO USA.	robert.doebele@ucdenver.edu	Tan, Aik Choon/A-3135-2011; Doebele, Robert C./I-8230-2019; Camidge, David Ross/AAG-9144-2019	Tan, Aik Choon/0000-0003-2955-8369; Doebele, Robert C./0000-0001-6728-6857; Astling, David/0000-0001-8179-0304	Cancer League of Colorado; Boettcher Foundation Webb-Waring Biomedical Research Award; University of Colorado Lung Cancer SPORE grant [P50CA058187]; NATIONAL CANCER INSTITUTE [P30CA046934, K12CA086913, P50CA058187] Funding Source: NIH RePORTER	Cancer League of Colorado; Boettcher Foundation Webb-Waring Biomedical Research Award; University of Colorado Lung Cancer SPORE grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by research funding from the Cancer League of Colorado to K. D. Davies, the Boettcher Foundation Webb-Waring Biomedical Research Award to R. C. Doebele, and the University of Colorado Lung Cancer SPORE grant (P50CA058187) to M. Varella-Garcia and R. C. Doebele. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Awad MM, 2013, NEW ENGL J MED, V368, P2395, DOI 10.1056/NEJMoa1215530; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Camidge DR, 2012, NAT REV CLIN ONCOL, V9, P268, DOI 10.1038/nrclinonc.2012.43; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Cortot AB, 2013, CANCER RES, V73, P834, DOI 10.1158/0008-5472.CAN-12-2066; Davies KD, 2013, CLIN CANCER RES, V19, P4040, DOI 10.1158/1078-0432.CCR-12-2851; Davies KD, 2012, CLIN CANCER RES, V18, P4570, DOI 10.1158/1078-0432.CCR-12-0550; Doebele RC, 2012, CLIN CANCER RES, V18, P1472, DOI 10.1158/1078-0432.CCR-11-2906; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Ercan D, 2012, CANCER DISCOV, V2, P934, DOI 10.1158/2159-8290.CD-12-0103; Hammerman PS, 2009, CLIN CANCER RES, V15, P7502, DOI 10.1158/1078-0432.CCR-09-0189; Helfrich BA, 2006, CLIN CANCER RES, V12, P7117, DOI 10.1158/1078-0432.CCR-06-0760; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Katayama R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003316; Katayama R, 2011, P NATL ACAD SCI USA, V108, P7535, DOI 10.1073/pnas.1019559108; Kim S, 2013, J THORAC ONCOL, V8, P415, DOI 10.1097/JTO.0b013e318283dcc0; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Koivunen JP, 2008, CLIN CANCER RES, V14, P4275, DOI 10.1158/1078-0432.CCR-08-0168; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ohashi K, 2013, J CLIN ONCOL, V31, P1070, DOI 10.1200/JCO.2012.43.3912; Ohashi K, 2012, P NATL ACAD SCI USA, V109, pE2127, DOI 10.1073/pnas.1203530109; Oie HK, 1996, J CELL BIOCHEM, P24; Ono M, 2004, MOL CANCER THER, V3, P465; OU SHI, 2013, J CLIN ONCOL S, V31; Oxnard GR, 2013, J CLIN ONCOL, V31, P1097, DOI 10.1200/JCO.2012.42.9829; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Phelps RM, 1996, J CELL BIOCHEM, P32; Ronson M, 2002, J CLIN ONCOL, V20, P2240, DOI 10.1200/JCO.2002.10.112; Sasaki T, 2011, CANCER RES, V71, P6051, DOI 10.1158/0008-5472.CAN-11-1340; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Virmani AK, 1998, GENE CHROMOSOME CANC, V21, P308, DOI 10.1002/(SICI)1098-2264(199804)21:4<308::AID-GCC4>3.0.CO;2-2; Voena C, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.7; Ware KE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.4; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Yamada T, 2012, CLIN CANCER RES, V18, P3592, DOI 10.1158/1078-0432.CCR-11-2972; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	43	86	111	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82236	10.1371/journal.pone.0082236	http://dx.doi.org/10.1371/journal.pone.0082236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349229	Green Submitted, Green Published, gold			2022-12-27	WOS:000328734200029
J	Hak, L; Houdijk, H; Beek, PJ; van Dieen, JH				Hak, Laura; Houdijk, Han; Beek, Peter J.; van Dieen, Jaap H.			Steps to Take to Enhance Gait Stability: The Effect of Stride Frequency, Stride Length, and Walking Speed on Local Dynamic Stability and Margins of Stability	PLOS ONE			English	Article							VARIABILITY; BALANCE; SENSITIVITY; STRATEGIES; WIDTH	The purpose of the current study was to investigate whether adaptations of stride length, stride frequency, and walking speed, independently influence local dynamic stability and the size of the medio-lateral and backward margins of stability during walking. Nine healthy subjects walked 25 trials on a treadmill at different combinations of stride frequency, stride length, and consequently at different walking speeds. Visual feedback about the required and the actual combination of stride frequency and stride length was given during the trials. Generalized Estimating Equations were used to investigate the independent contribution of stride length, stride frequency, and walking speed on the measures of gait stability. Increasing stride frequency was found to enhance medio-lateral margins of stability. Backward margins of stability became larger as stride length decreased or walking speed increased. For local dynamic stability no significant effects of stride frequency, stride length or walking speed were found. We conclude that adaptations in stride frequency, stride length and/or walking speed can result in an increase of the medio-lateral and backward margins of stability, while these adaptations do not seem to affect local dynamic stability. Gait training focusing on the observed stepping strategies to enhance margins of stability might be a useful contribution to programs aimed at fall prevention.	[Hak, Laura; Houdijk, Han; Beek, Peter J.; van Dieen, Jaap H.] Vrije Univ Amsterdam, Res Inst MOVE, Fac Human Movement Sci, Amsterdam, Netherlands; [Houdijk, Han] Heliomare Rehabil Ctr, Wijk Aan Zee, Netherlands	Vrije Universiteit Amsterdam	van Dieen, JH (corresponding author), Vrije Univ Amsterdam, Res Inst MOVE, Fac Human Movement Sci, Amsterdam, Netherlands.	j.van.dieen@vu.nl	Houdijk, Han/GXV-2986-2022; van Dieen, Jaap/B-3937-2013	Houdijk, Han/0000-0002-7069-1973; van Dieen, Jaap/0000-0002-7719-5585; Beek, Peter/0000-0002-0917-8548	Motek Medical	Motek Medical	The contribution of Laura Hak is partly sponsored by Motek Medical (www.motekmedical.com). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri FA, 2013, GAIT POSTURE, V37, P542, DOI 10.1016/j.gaitpost.2012.09.015; Bertram JEA, 2005, J EXP BIOL, V208, P979, DOI 10.1242/jeb.01498; Bertram JEA, 2001, J THEOR BIOL, V209, P445, DOI 10.1006/jtbi.2001.2279; Brady RA, 2009, GAIT POSTURE, V29, P645, DOI 10.1016/j.gaitpost.2009.01.010; Bruijn SM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0999; Bruijn SM, 2009, J BIOMECH, V42, P1506, DOI 10.1016/j.jbiomech.2009.03.047; Bruijn SM, 2009, J NEUROSCI METH, V178, P327, DOI 10.1016/j.jneumeth.2008.12.015; Curtze C, 2011, GAIT POSTURE, V33, P292, DOI 10.1016/j.gaitpost.2010.11.023; Dingwell JB, 2006, J BIOMECH, V39, P444, DOI 10.1016/j.jbiomech.2004.12.014; Dingwell JB, 2000, J BIOMECH, V33, P1269, DOI 10.1016/S0021-9290(00)00092-0; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; Espy DD, 2010, GAIT POSTURE, V32, P378, DOI 10.1016/j.gaitpost.2010.06.013; Espy DD, 2010, J BIOMECH, V43, P2548, DOI 10.1016/j.jbiomech.2010.05.015; Hak L, 2013, ARCH PHYS MED REHAB, V94, P2186, DOI 10.1016/j.apmr.2013.07.020; Hak L, 2013, J BIOMECH, V46, P905, DOI 10.1016/j.jbiomech.2012.12.017; Hak L, 2012, GAIT POSTURE, V36, P260, DOI 10.1016/j.gaitpost.2012.03.005; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hof AL, 2008, HUM MOVEMENT SCI, V27, P112, DOI 10.1016/j.humov.2007.08.003; Hof AL, 2007, GAIT POSTURE, V25, P250, DOI 10.1016/j.gaitpost.2006.04.013; Kang HG, 2008, J BIOMECH, V41, P2899, DOI 10.1016/j.jbiomech.2008.08.002; Krasovsky T, 2013, J NEUROPHYSIOL, V109, P77, DOI 10.1152/jn.00552.2012; Kuo AD, 2001, J BIOMECH ENG-T ASME, V123, P264, DOI 10.1115/1.1372322; Lamoth CC, 2010, MED ENG PHYS, V32, P1009, DOI 10.1016/j.medengphy.2010.07.001; McAndrew PM, 2011, J BIOMECH, V44, P644, DOI 10.1016/j.jbiomech.2010.11.007; McAndrew PM, 2010, J BIOMECH, V43, P1470, DOI 10.1016/j.jbiomech.2010.02.003; MEES AI, 1993, PHYSICA D, V68, P427, DOI 10.1016/0167-2789(93)90135-N; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Paysant J, 2006, J REHABIL RES DEV, V43, P153, DOI 10.1682/JRRD.2005.02.0043; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Suptitz F, 2013, HUM MOV SCI; Sutherland D, 1997, GAIT POSTURE, V6, P163, DOI 10.1016/S0966-6362(97)00029-5; Toebes MJP, 2012, GAIT POSTURE, V36, P527, DOI 10.1016/j.gaitpost.2012.05.016; van Schooten KS, 2013, J BIOMECH, V46, P137, DOI 10.1016/j.jbiomech.2012.10.032; van Schooten KS, 2011, GAIT POSTURE, V33, P656, DOI 10.1016/j.gaitpost.2011.02.017; VONSCHROEDER HP, 1995, J REHABIL RES DEV, V32, P25; Weerdesteyn V, 2008, J REHABIL RES DEV, V45, P1195, DOI 10.1682/JRRD.2007.09.0145; Young PMM, 2012, GAIT POSTURE, V36, P219, DOI 10.1016/j.gaitpost.2012.02.020; Young PMM, 2012, J BIOMECH, V45, P1053, DOI 10.1016/j.jbiomech.2011.12.027; Young PMM, 2012, GAIT POSTURE, V35, P472, DOI 10.1016/j.gaitpost.2011.11.010	40	116	116	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82842	10.1371/journal.pone.0082842	http://dx.doi.org/10.1371/journal.pone.0082842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276FP	24349379	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200057
J	Lopez, XM; D'Andrea, E; Barbot, P; Bridoux, AS; Rorive, S; Salmon, I; Debeir, O; Decaestecker, C				Lopez, Xavier Moles; D'Andrea, Etienne; Barbot, Paul; Bridoux, Anne-Sophie; Rorive, Sandrine; Salmon, Isabelle; Debeir, Olivier; Decaestecker, Christine			An Automated Blur Detection Method for Histological Whole Slide Imaging	PLOS ONE			English	Article							SELECTION; EXPRESSION; CARCINOMA; PROFILES	Whole slide scanners are novel devices that enable high-resolution imaging of an entire histological slide. Furthermore, the imaging is achieved in only a few minutes, which enables image rendering of large-scale studies involving multiple immunohistochemistry biomarkers. Although whole slide imaging has improved considerably, locally poor focusing causes blurred regions of the image. These artifacts may strongly affect the quality of subsequent analyses, making a slide review process mandatory. This tedious and time-consuming task requires the scanner operator to carefully assess the virtual slide and to manually select new focus points. We propose a statistical learning method that provides early image quality feedback and automatically identifies regions of the image that require additional focus points.	[Lopez, Xavier Moles; D'Andrea, Etienne; Debeir, Olivier; Decaestecker, Christine] Univ Libre Bruxelles, Labs Image Signal Proc & Acoust LISA, Brussels, Belgium; [Lopez, Xavier Moles; D'Andrea, Etienne; Barbot, Paul; Bridoux, Anne-Sophie; Rorive, Sandrine; Salmon, Isabelle; Decaestecker, Christine] Univ Libre Bruxelles, DIAPath Ctr Microscopy & Mol Imaging, Gosselies, Belgium; [Rorive, Sandrine; Salmon, Isabelle] Univ Libre Bruxelles, Dept Pathol, Erasme Hosp, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles	Decaestecker, C (corresponding author), Univ Libre Bruxelles, Labs Image Signal Proc & Acoust LISA, Brussels, Belgium.	cdecaes@ulb.ac.be		Decaestecker, Christine/0000-0002-5495-1931	Televie program of the "Fonds National de la Recherche Scientifique'' (FNRS, Brussels, Belgium); Fonds Yvonne Boel (Brussels, Belgium); European Regional Development Fund; Walloon Region; CWality program of the Walloon Region	Televie program of the "Fonds National de la Recherche Scientifique'' (FNRS, Brussels, Belgium)(Fonds de la Recherche Scientifique - FNRS); Fonds Yvonne Boel (Brussels, Belgium); European Regional Development Fund(European Commission); Walloon Region; CWality program of the Walloon Region	X.M.L. is supported by the Televie program of the "Fonds National de la Recherche Scientifique'' (FNRS, Brussels, Belgium) and Fonds Yvonne Boel (Brussels, Belgium). The CMMI is supported by the European Regional Development Fund and the Walloon Region. E.D. is supported by the CWality program of the Walloon Region. A.-S.B. is a student from the University of Mons (UMONS, Belgium) and contributed to this work during an internship at the DIAPath unit of the CMMI. C.D. is a Senior Research Associate with the FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista Pinky A, 2010, J Pathol Inform, V1, P25, DOI 10.4103/2153-3539.73320; Breiman L., 1984, CLASSIFICATION REGRE; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Dougherty ER, 2003, SPIE TUTORIAL TEXTS; Eskicioglu AM, 1995, IEEE T COMMUN, V43, P2959, DOI 10.1109/26.477498; Ferzli R, 2009, IEEE T IMAGE PROCESS, V18, P717, DOI 10.1109/TIP.2008.2011760; Hashimoto Noriaki, 2012, J Pathol Inform, V3, P9, DOI 10.4103/2153-3539.93891; Wei H, 2007, PATTERN RECOGN LETT, V28, P493, DOI 10.1016/j.patrec.2006.09.005; Jones E., 2011, SCIPY OPEN SOURCE SC; KROTKOV E, 1987, INT J COMPUT VISION, V1, P223, DOI 10.1007/BF00127822; Lahrmann B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061441; Latinne P, 2002, PATTERN ANAL APPL, V5, P201, DOI 10.1007/s100440200018; Laurinavicius A, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-27; Le Mercier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045475; Loh WY, 1997, STAT SINICA, V7, P815; Maree R., 2013, DECISION FORESTCOM, P125, DOI DOI 10.1007/978-1-4471-4929-3_10; Mathieu A, 2005, MODERN PATHOL, V18, P1264, DOI 10.1038/modpathol.3800416; Newcombe RG, 2006, STAT MED, V25, P543, DOI 10.1002/sim.2323; Oliphant T, 2011, NUMBA; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pedregosa F., 2012, SCIKIT LEARN MACHINE; Remmelink M, 2011, HISTOPATHOLOGY, V58, P543, DOI 10.1111/j.1365-2559.2011.03776.x; Rorive S, 2010, MODERN PATHOL, V23, P1418, DOI 10.1038/modpathol.2010.136; Shih YS, 1997, QUEST CLASSIFICATION; Sun Y, 2004, MICROSC RES TECHNIQ, V65, P139, DOI 10.1002/jemt.20118; Theodoridis S, 2009, PATTERN RECOGNITION, 4RTH EDITION, P1; van der Walt S, 2011, SCIKIT IMAGE IMAGE P; Verset L, 2013, BRIT J CANCER, V109, P114, DOI 10.1038/bjc.2013.290; Walkowski S, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S14; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang Z, 2002, IEEE SIGNAL PROC LET, V9, P81, DOI 10.1109/97.995823; YEO TTE, 1993, IMAGE VISION COMPUT, V11, P629, DOI 10.1016/0262-8856(93)90059-P; Zerbe N, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S16	34	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82710	10.1371/journal.pone.0082710	http://dx.doi.org/10.1371/journal.pone.0082710			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349343	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200051
J	Mao, Y; Niu, SF; Xu, X; Wang, J; Su, YQ; Wu, Y; Zhong, SP				Mao, Yong; Niu, Sufang; Xu, Xin; Wang, Jun; Su, Yongquan; Wu, Yang; Zhong, Shengping			The Effect of an Adding Histidine on Biological Activity and Stability of Pc-pis from Pseudosciaena crocea	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; CRYPTOCARYON-IRRITANS; HYDROPHOBIC INTERACTIONS; EPINEPHELUS-COIOIDES; AEROMONAS-HYDROPHILA; MEMBRANE INTERFACES; MAST-CELLS; PISCIDIN; ANALOGS; FISH	Pc-pis is a novel piscidin-like antimicrobial polypeptide that was identified in Pseudosciaena crocea. Although active against most bacteria tested, Pc-pis was inactive against Aeromonas hydrophila and Pseudomonas aeruginosa. The Pc-pis analogue Pc-pis-His was designed by adding a histidine residue at the carboxyl terminal. Pc-pis-His demonstrated a more broad-spectrum and stronger antimicrobial activity against a representative set of microorganisms and more potent antiparasitic activity against Cryptocaryon irritans trophonts than Pc-pis. The stability assay revealed that Pc-pis-His was active against Staphylococcus aureus not only in acidic (pH 5.5-7.3) and relatively low concentration monovalent cation (0-160 mM NaCl) environments but also in alkaline (pH 7.5-9.5), divalent cation (1.25-160 mM MgCl2 and 1.25-40 mM CaCl2) and high concentration monovalent cation (320-2560 mM NaCl) environments, which indicates that the added histidine residue conferred better salt-, acid- and alkali-tolerance to Pc-pis-His. Pc-pis-His also possessed the desired heat-tolerance, which was reflected by the antimicrobial activity of the peptide after being boiled for 10-60 minutes. Hemolytic activity analysis revealed that Pc-pis-His at concentrations up to 6 mu M exhibited no hemolysis against human erythrocytes, with 6 mu M being a concentration that is highly active against most of the microorganisms tested, although the hemolytic activity of Pc-pis-His was enhanced compared to Pc-pis. These results provide a unique, reasonable basis for designing novel piscidins with potent, broad-spectrum and stable antimicrobial activity and new insight into the future development of piscidins as potential therapeutic agents against microbial and external protozoan parasite infections.	[Mao, Yong; Niu, Sufang; Xu, Xin; Wang, Jun; Su, Yongquan; Wu, Yang; Zhong, Shengping] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Fujian, Peoples R China	Xiamen University	Mao, Y (corresponding author), Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Fujian, Peoples R China.	maoyong@xmu.edu.cn			State 863 Project of China [2012AA10A403]; National Natural Science Foundation of China [41176115, 31372504]	State 863 Project of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded through the State 863 Project of China (Grant No. 2012AA10A403) and National Natural Science Foundation of China (Grant No. 41176115 and 31372504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buonocore F, 2012, FISH SHELLFISH IMMUN, V33, P1183, DOI 10.1016/j.fsi.2012.09.005; Campagna S, 2007, BIOCHEMISTRY-US, V46, P1771, DOI 10.1021/bi0620297; Chekmenev EY, 2006, BBA-BIOMEMBRANES, V1758, P1359, DOI 10.1016/j.bbamem.2006.03.034; Colorni A, 2008, J FISH DIS, V31, P423, DOI 10.1111/j.1365-2761.2008.00922.x; Dathe M, 1996, BIOCHEMISTRY-US, V35, P12612, DOI 10.1021/bi960835f; de Latour FA, 2010, BIOCHEM BIOPH RES CO, V396, P825, DOI 10.1016/j.bbrc.2010.04.158; Dezfuli BS, 2010, FISH SHELLFISH IMMUN, V28, P476, DOI 10.1016/j.fsi.2009.12.012; Diggles BK, 1997, J EUKARYOT MICROBIOL, V44, P25, DOI 10.1111/j.1550-7408.1997.tb05686.x; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Fernandes JMO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009501; Kim JK, 2010, BBA-BIOMEMBRANES, V1798, P1913, DOI 10.1016/j.bbamem.2010.06.026; Lauth X, 2002, J BIOL CHEM, V277, P5030, DOI 10.1074/jbc.M109173200; Lee K, 2004, BIOCHEM BIOPH RES CO, V323, P712, DOI 10.1016/j.bbrc.2004.08.144; Lee KH, 2006, BIOCHEM J, V394, P105, DOI 10.1042/BJ20051574; Lee SA, 2007, BIOCHEMISTRY-US, V46, P3653, DOI 10.1021/bi062233u; Liu CQ, 1997, STRUCTURAL MOL BIOL, P181; Lokanathan Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-76; Mason AJ, 2007, BIOPHYS J, V93, P4289, DOI 10.1529/biophysj.107.116681; Niu SF, 2013, FISH SHELLFISH IMMUN, V35, P513, DOI 10.1016/j.fsi.2013.05.007; Noga EJ, 2009, COMP BIOCHEM PHYS B, V152, P299, DOI 10.1016/j.cbpb.2008.12.018; Park NG, 2011, BIOCHEMISTRY-US, V50, P3288, DOI 10.1021/bi101395j; Rekdal O, 2012, J BIOL CHEM, V287, P233, DOI 10.1074/jbc.M111.279281; Ruangsri J, 2012, FISH SHELLFISH IMMUN, V32, P396, DOI 10.1016/j.fsi.2011.11.022; Salger SA, 2011, FISH SHELLFISH IMMUN, V30, P420, DOI 10.1016/j.fsi.2010.10.009; Silphaduang U, 2001, NATURE, V414, P268, DOI 10.1038/35104690; Torcato IM, 2013, BBA-BIOMEMBRANES, V1828, P944, DOI 10.1016/j.bbamem.2012.12.002; Vial HJ, 2003, MOL BIOCHEM PARASIT, V126, P143, DOI 10.1016/S0166-6851(02)00281-5; Wang JY, 2002, BIOCHEMISTRY-US, P123; Wang N, 2013, FISH SHELLFISH IMMUN, V34, P74, DOI 10.1016/j.fsi.2012.10.003; White SH, 1998, BBA-REV BIOMEMBRANES, V1376, P339, DOI 10.1016/S0304-4157(98)00021-5; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Wiradharma N, 2013, MACROMOL RAPID COMM, V34, P74, DOI 10.1002/marc.201200534; Wu L, 2012, MICROB PATHOGENESIS, V53, P183, DOI 10.1016/j.micpath.2012.07.007; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; Yambot AV, 2006, AQUACULTURE, V260, P1, DOI 10.1016/j.aquaculture.2006.05.055; Yambot AV, 2003, DIS AQUAT ORGAN, V54, P147, DOI 10.3354/dao054147; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yin ZX, 2006, AQUACULTURE, V253, P204, DOI 10.1016/j.aquaculture.2005.10.002; Zhai ZH, 2000, CELL BIOL	39	15	17	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83268	10.1371/journal.pone.0083268	http://dx.doi.org/10.1371/journal.pone.0083268			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349477	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200072
J	Mross, K; Richly, H; Fischer, R; Scharr, D; Buchert, M; Stern, A; Gille, H; Audoly, LP; Scheulen, ME				Mross, Klaus; Richly, Heike; Fischer, Richard; Scharr, Dirk; Buechert, Martin; Stern, Angelika; Gille, Hendrik; Audoly, Laurent P.; Scheulen, Max E.			First-in-Human Phase I Study of PRS-050 (Angiocal), an Anticalin Targeting and Antagonizing VEGF-A, in Patients with Advanced Solid Tumors	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; RENAL-CELL CARCINOMA; COLORECTAL-CANCER PATIENTS; TYROSINE KINASE INHIBITOR; BINDING-PROTEINS; NITRIC-OXIDE; MATRIX METALLOPROTEINASES; SIGNALING PATHWAY; ANGIOGENIC SWITCH; INTERFERON-ALPHA	Background: To report the nonrandomized first-in-human phase I trial of PRS-050, a novel, rationally engineered Anticalin based on human tear lipocalin that targets and antagonizes vascular endothelial growth factor A (VEGF-A). Methods: Patients with advanced solid tumors received PRS-050 at 0.1 mg/kg to 10 mg/kg by IV in successive dosing cohorts according to the 3+3 escalation scheme. The primary end point was safety. Results: Twenty-six patients were enrolled; 25 were evaluable. Two patients experienced dose-limiting toxicity, comprising grade (G) 3 hypertension and G3 pyrexia, respectively. The maximum tolerated dose was not reached. Most commonly reported treatment-emergent adverse events (AEs) included chills (52%; G3, 4%), fatigue (52%; G3, 4%), hypertension (44%; G3, 16%), and nausea (40%, all G1/2). No anti-PRS-050 antibodies following multiple administration of the drug were detected. PRS-050 showed dose-proportional pharmacokinetics (PK), with a terminal half-life of approximately 6 days. Free VEGF-A was detectable at baseline in 9/25 patients, becoming rapidly undetectable after PRS-050 infusion for up to 3 weeks. VEGF-A/PRS-050 complex was detectable for up to 3 weeks at all dose levels, including in patients without detectable baseline-free VEGF-A. We also detected a significant reduction in circulating matrix metalloproteinase 2, suggesting this end point could be a pharmacodynamic (PD) marker of the drug's activity. Conclusions: PRS-050, a novel Anticalin with high affinity for VEGF-A, was well-tolerated when administered at the highest dose tested, 10 mg/kg. Based on target engagement and PK/PD data, the recommended phase II dose is 5 mg/kg every 2 weeks administered as a 120-minute infusion.	[Mross, Klaus; Scharr, Dirk] Univ Freiburg, Klin Tumorbiol, D-79106 Freiburg, Germany; [Richly, Heike; Scheulen, Max E.] Univ Duisburg Essen, Dept Med Oncol, West German Canc Ctr, Univ Hosp, Essen, Germany; [Fischer, Richard] Univ Med Ctr, Dept Gastroenterol, Freiburg, Germany; [Buechert, Martin] Univ Med Ctr, Magnet Resonance Dev & Applicat Ctr, Freiburg, Germany; [Stern, Angelika] Stern Consult, Basel, Switzerland; [Gille, Hendrik; Audoly, Laurent P.] Pieris AG, Freising Weihenstephan, Germany	University of Freiburg; University of Duisburg Essen; University of Freiburg; University of Freiburg	Mross, K (corresponding author), Univ Freiburg, Klin Tumorbiol, Hugstetter Str 55, D-79106 Freiburg, Germany.	mross@tumorbio.uni-freiburg.de	Buechert, Martin/B-3107-2011	Buechert, Martin/0000-0001-5844-8711	Pieris AG	Pieris AG	This study was sponsored by Pieris AG, the employer of HG and LPA. AS is affiliated to Stern Consult. There is a pending patent (PCT/EP2012/072406) relating to this study: "Novel uses of VEGF antagonists", inventors HG and LPA. KM and MES have received a travel grant from Pieris AG, and AS and MES have consulted for Pieris AG. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Belotti D, 2003, CANCER RES, V63, P5224; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Breustedt DA, 2006, BBA-PROTEINS PROTEOM, V1764, P161, DOI 10.1016/j.bbapap.2005.12.006; Breustedt DA, 2005, J BIOL CHEM, V280, P484, DOI 10.1074/jbc.M410466200; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Collen A, 2003, BLOOD, V101, P1810, DOI 10.1182/blood-2002-05-1593; Dartt DA, 2011, OCUL SURF, V9, P126, DOI 10.1016/S1542-0124(11)70022-2; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Drevs J, 2005, ANN ONCOL, V16, P558, DOI 10.1093/annonc/mdi118; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gebauer M, 2012, METHOD ENZYMOL, V503, P157, DOI 10.1016/B978-0-12-396962-0.00007-0; George S, 2012, ANN ONCOL, V23, P3180, DOI 10.1093/annonc/mds179; Gerber HP, 2007, P NATL ACAD SCI USA, V104, P3478, DOI 10.1073/pnas.0611492104; Gille H, 2011, AM ASS CANC RES AACR; Gille H, 2008, AM ASS CANC RES AACR; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; Heinzerling John H, 2006, Curr Surg, V63, P334, DOI 10.1016/j.cursur.2006.06.002; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Holmes DIR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-209; Hu JW, 2012, EXP THER MED, V4, P1045, DOI 10.3892/etm.2012.702; Hua H, 2011, CELL MOL LIFE SCI, V68, P3853, DOI 10.1007/s00018-011-0763-x; Itoh T, 1998, CANCER RES, V58, P1048; Jones Suzanne F, 2011, Clin Adv Hematol Oncol, V9, P845; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Langenberg MHG, 2011, ANN ONCOL, V22, P2508, DOI 10.1093/annonc/mdq767; Launay-Vacher V, 2009, ANTI-CANCER DRUG, V20, P81, DOI 10.1097/CAD.0b013e3283161012; Meyer T, 2009, J THROMB HAEMOST, V7, P171, DOI 10.1111/j.1538-7836.2008.03212.x; MILLAUER B, 1994, NATURE, V367, P576, DOI 10.1038/367576a0; Mirjolet JF, 2009, AM ASS CANC RES AACR; Mordenti J, 1999, TOXICOL PATHOL, V27, P14, DOI 10.1177/019262339902700104; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Mross K, 2005, EUR J CANCER, V41, P1291, DOI 10.1016/j.ejca.2005.03.005; Mross K, 2012, CLIN CANCER RES, V18, P2658, DOI 10.1158/1078-0432.CCR-11-1900; Mross K, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-16; Mross K, 2009, VASC CELL, V1, DOI 10.1186/2040-2384-1-5; Nalluri SR, 2008, JAMA-J AM MED ASSOC, V300, P2277, DOI 10.1001/jama.2008.656; Osterlund P, 2011, BRIT J CANCER, V104, P599, DOI 10.1038/bjc.2011.2; Olwill SA, 2013, MOL CANCER THER, V12, P2459, DOI 10.1158/1535-7163.MCT-13-0318; Patel TV, 2008, JNCI-J NATL CANCER I, V100, P282, DOI 10.1093/jnci/djm311; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; Rini BI, 2011, JNCI-J NATL CANCER I, V103, P763, DOI 10.1093/jnci/djr128; Rini BI, 2008, J CLIN ONCOL, V26, P5422, DOI 10.1200/JCO.2008.16.9847; Robinson ES, 2010, SEMIN NEPHROL, V30, P591, DOI 10.1016/j.semnephrol.2010.09.007; Roodhart JM, 2008, CURR CLIN PHARMACOL, V3, P132, DOI 10.2174/157488408784293705; Rooprai HK, 2000, BRIT J CANCER, V82, P52, DOI 10.1054/bjoc.1999.0876; Rudge JS, 2007, P NATL ACAD SCI USA, V104, P18363, DOI 10.1073/pnas.0708865104; Scheffler K, 2003, MAGNET RESON MED, V49, P781, DOI 10.1002/mrm.10421; Schlehuber S, 2005, DRUG DISCOV TODAY, V10, P23, DOI 10.1016/S1359-6446(04)03294-5; Schonfeld D, 2009, P NATL ACAD SCI USA, V106, P8198, DOI 10.1073/pnas.0813399106; Shen BQ, 1999, J BIOL CHEM, V274, P33057, DOI 10.1074/jbc.274.46.33057; Skerra A, 2000, BBA-PROTEIN STRUCT M, V1482, P337, DOI 10.1016/S0167-4838(00)00145-X; Skerra A, 2007, CURR OPIN MOL THER, V9, P336; Song X, 2012, CURR CLIN PHARMACOL, V7, P56, DOI 10.2174/157488412799218806; Tahover E, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0327-4; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; Wei W, 2004, J CARDIOVASC PHARM, V44, P615, DOI 10.1097/00005344-200411000-00016; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491	61	37	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83232	10.1371/journal.pone.0083232	http://dx.doi.org/10.1371/journal.pone.0083232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349470	gold, Green Published, Green Submitted			2022-12-27	WOS:000328734200069
J	Diab, A; Jenq, RR; Rizzuto, GA; Cohen, AD; Huggins, DW; Merghoub, T; Engelhorn, ME; Guevara-Patino, JA; Suh, D; Hubbard-Lucey, VM; Kochman, AA; Chen, SZ; Zhong, H; Wolchok, JD; van den Brink, MRM; Houghton, AN; Perales, MA				Diab, Adi; Jenq, Robert R.; Rizzuto, Gabrielle A.; Cohen, Adam D.; Huggins, Deonka W.; Merghoub, Taha; Engelhorn, Manuel E.; Guevara-Patino, Jose A.; Suh, David; Hubbard-Lucey, Vanessa M.; Kochman, Adam A.; Chen, Suzie; Zhong, Hong; Wolchok, Jedd D.; van den Brink, Marcel R. M.; Houghton, Alan N.; Perales, Miguel-Angel			Enhanced Responses to Tumor Immunization Following Total Body Irradiation Are Time-Dependent	PLOS ONE			English	Article							CD8(+) T-CELLS; DNA IMMUNIZATION; LANGERHANS CELLS; CANCER IMMUNITY; DENDRITIC CELLS; TRANSGENIC MICE; STEADY-STATE; SELF-ANTIGEN; RADIATION; PROLIFERATION	The development of successful cancer vaccines is contingent on the ability to induce effective and persistent antitumor immunity against self-antigens that do not typically elicit immune responses. In this study, we examine the effects of a non-myeloablative dose of total body irradiation on the ability of tumor-naive mice to respond to DNA vaccines against melanoma. We demonstrate that irradiation followed by lymphocyte infusion results in a dramatic increase in responsiveness to tumor vaccination, with augmentation of T cell responses to tumor antigens and tumor eradication. In irradiated mice, infused CD8(+) T cells expand in an environment that is relatively depleted in regulatory T cells, and this correlates with improved CD8(+) T cell functionality. We also observe an increase in the frequency of dendritic cells displaying an activated phenotype within lymphoid organs in the first 24 hours after irradiation. Intriguingly, both the relative decrease in regulatory T cells and increase in activated dendritic cells correspond with a brief window of augmented responsiveness to immunization. After this 24 hour window, the numbers of dendritic cells decline, as does the ability of mice to respond to immunizations. When immunizations are initiated within the period of augmented dendritic cell activation, mice develop anti-tumor responses that show increased durability as well as magnitude, and this approach leads to improved survival in experiments with mice bearing established tumors as well as in a spontaneous melanoma model. We conclude that irradiation can produce potent immune adjuvant effects independent of its ability to induce tumor ablation, and that the timing of immunization and lymphocyte infusion in the irradiated host are crucial for generating optimal anti-tumor immunity. Clinical strategies using these approaches must therefore optimize such parameters, as the correct timing of infusion and vaccination may mean the difference between an ineffective treatment and successful tumor eradication.	[Diab, Adi; Rizzuto, Gabrielle A.; Cohen, Adam D.; Huggins, Deonka W.; Merghoub, Taha; Engelhorn, Manuel E.; Guevara-Patino, Jose A.; Zhong, Hong; Wolchok, Jedd D.; Houghton, Alan N.] Mem Sloan Kettering Canc Ctr, Dept Med, Swim Amer Lab Tumor Immunol, New York, NY 10021 USA; [Jenq, Robert R.; van den Brink, Marcel R. M.; Perales, Miguel-Angel] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplantat Serv, New York, NY 10021 USA; [Rizzuto, Gabrielle A.; Huggins, Deonka W.; Merghoub, Taha; Engelhorn, Manuel E.; Guevara-Patino, Jose A.; Suh, David; Hubbard-Lucey, Vanessa M.; Kochman, Adam A.; Zhong, Hong; Wolchok, Jedd D.; van den Brink, Marcel R. M.; Houghton, Alan N.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10021 USA; [Jenq, Robert R.; Rizzuto, Gabrielle A.; Cohen, Adam D.; Wolchok, Jedd D.; van den Brink, Marcel R. M.; Houghton, Alan N.; Perales, Miguel-Angel] Weill Cornell Med Coll, New York, NY USA; [Chen, Suzie] Rutgers State Univ, Ernest Mario Sch Pharm, Susan Lehman Cullman Lab Canc Res, New Brunswick, NJ 08903 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Rutgers State University New Brunswick	Perales, MA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplantat Serv, 1275 York Ave, New York, NY 10021 USA.	peralesm@mskcc.org	van den Brink, Marcel R. M./HGB-9434-2022; Guevara, Jose/AAD-6707-2020; Merghoub, Taha/ABD-8362-2021; Rizzuto, Gabrielle/GWR-2224-2022	Cohen, Adam/0000-0003-0939-3843; Rizzuto, Gabrielle/0000-0003-3052-0253; PERALES, MIGUEL-ANGEL/0000-0002-5910-4571; Jenq, Robert/0000-0002-5434-439X	National Institutes of Health [K08-CA10260, PO1-CA33049, CA59350, CA58621, CA47179, T32-CA009512, GM07739, RO1-HL069929, RO1-CA107096, RO1-AI080455, R01-HL095075]; US Department of Defense: USAMRAA Award [W81XWH-09-1-0294]; Radiation Effects Research Foundation (RERF-NIAID); Swim Across America; Ryan Gibson Foundation; Elsa U. Pardee Foundation; Byrne Foundation; Emerald Foundation; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Commonwealth Foundation for Cancer Research; Bobby Zucker Memorial Fund; Lymphoma Foundation; ASCO Young Investigator Award; Clinical Scholars Biomedical Research Training Program; Charles A. Dana Foundation; Cancer Research Institute; Damon Runyon-Lilly Clinical Investigator Award; Damon Runyon foundation; NATIONAL CANCER INSTITUTE [P01CA047179, T32CA009512, P01CA059350, R01CA107096, P01CA033049, P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069929, R01HL095075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense: USAMRAA Award; Radiation Effects Research Foundation (RERF-NIAID); Swim Across America; Ryan Gibson Foundation; Elsa U. Pardee Foundation; Byrne Foundation; Emerald Foundation; Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center; Commonwealth Foundation for Cancer Research; Bobby Zucker Memorial Fund; Lymphoma Foundation; ASCO Young Investigator Award; Clinical Scholars Biomedical Research Training Program; Charles A. Dana Foundation; Cancer Research Institute; Damon Runyon-Lilly Clinical Investigator Award; Damon Runyon foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health award numbers K08-CA10260 (MAP), PO1-CA33049 (MAP, MvdB, ANH), CA59350, CA58621, and CA47179 (ANH), T32-CA009512 (ADC), GM07739 (GAR), RO1-HL069929, RO1-CA107096, RO1-AI080455 and R01-HL095075 (MvdB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Support was also received from the US Department of Defense: USAMRAA Award W81XWH-09-1-0294 (MvdB), the Radiation Effects Research Foundation (RERF-NIAID) (MvdB), Swim Across America (MAP, AD, ADC, DWH, MEE, JDW, ANH, JAGP), the Ryan Gibson Foundation (MvdB), the Elsa U. Pardee Foundation (MvdB), the Byrne Foundation (MAP, MvdB), the Emerald Foundation (MvdB), and The Experimental Therapeutics Center of Memorial Sloan-Kettering Cancer Center funded by Mr. William H. Goodwin and Mrs. Alice Goodwin (MAP, MvdB, ANH, MEE), the Commonwealth Foundation for Cancer Research (MvdB), The Bobby Zucker Memorial Fund (MvdB), The Lymphoma Foundation (MAP, MvdB, ANH, MEE), an ASCO Young Investigator Award (ADC), the Clinical Scholars Biomedical Research Training Program and the Charles A. Dana Foundation (ADC), a Cancer Research Institute pre-doctoral fellowship (GAR), a Damon Runyon-Lilly Clinical Investigator Award (JDW), a Fellowship award from the Cancer Research Institute (MEE). ANH has Damon Runyon/Eli Lilly mentorship support. With regards to the the Damon Runyon-Lilly Clinical Investigator Award and mentorship support, funds came directly from the Damon Runyon foundation and not from Eli-Lilly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Baccala R, 2005, TRENDS IMMUNOL, V26, P5, DOI 10.1016/j.it.2004.11.006; Bowne WB, 1999, J EXP MED, V190, P1717, DOI 10.1084/jem.190.11.1717; Chakraborty M, 2004, CANCER RES, V64, P4328, DOI 10.1158/0008-5472.CAN-04-0073; Cozzo C, 2003, J IMMUNOL, V171, P5678, DOI 10.4049/jimmunol.171.11.5678; Cummings RJ, 2009, RADIAT RES, V171, P687, DOI 10.1667/RR1600.1; Demaria S, 2005, CLIN CANCER RES, V11, P728; Dewan MZ, 2009, CLIN CANCER RES, V15, P5379, DOI 10.1158/1078-0432.CCR-09-0265; Dummer W, 2002, J CLIN INVEST, V110, P185, DOI 10.1172/JCI200215175; Dyall R, 1998, J EXP MED, V188, P1553, DOI 10.1084/jem.188.9.1553; Engelhorn ME, 2008, MOL THER, V16, P773, DOI 10.1038/mt.2008.8; Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480; Gattinoni L, 2005, J EXP MED, V202, P907, DOI 10.1084/jem.20050732; Ginsberg BA, 2010, CLIN CANCER RES, V16, P4057, DOI 10.1158/1078-0432.CCR-10-1093; Gold JS, 2003, J IMMUNOL, V170, P5188, DOI 10.4049/jimmunol.170.10.5188; Guevara-Patino JA, 2006, J CLIN INVEST, V116, P1382, DOI 10.1172/JCI25591; Hawkins WG, 2000, SURGERY, V128, P273, DOI 10.1067/msy.2000.107421; He YK, 2006, IMMUNITY, V24, P643, DOI 10.1016/j.immuni.2006.03.014; HELLSTROM KE, 1978, J EXP MED, V148, P799, DOI 10.1084/jem.148.3.799; Hung CF, 2001, J IMMUNOL, V166, P5733, DOI 10.4049/jimmunol.166.9.5733; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Klebanoff CA, 2011, IMMUNOL REV, V239, P27, DOI 10.1111/j.1600-065X.2010.00979.x; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; Lee YJ, 2009, BLOOD, V114, P589, DOI 10.1182/blood-2009-02-206870; Lucas PJ, 2006, BLOOD, V108, P2789, DOI 10.1182/blood-2006-05-025676; Ma J, 2003, EUR J IMMUNOL, V33, P2123, DOI 10.1002/eji.200324034; Mayerova D, 2004, IMMUNITY, V21, P391, DOI 10.1016/j.immuni.2004.07.019; Min B, 2004, P NATL ACAD SCI USA, V101, P3874, DOI 10.1073/pnas.0400606101; Okunieff P, 2006, SEMIN RADIAT ONCOL, V16, P65, DOI 10.1016/j.semradonc.2005.12.001; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Perales MA, 2002, CYTOKINES CELL MOL T, V7, P125, DOI 10.1080/13684730310000923; Perales MA, 2002, SEMIN CANCER BIOL, V12, P63, DOI 10.1006/scbi.2001.0397; Perales MA, 2006, J IMMUNOL, V177, P4159, DOI 10.4049/jimmunol.177.6.4159; Postow MA, 2012, NEW ENGL J MED, V366, P925, DOI 10.1056/NEJMoa1112824; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Rapoport AP, 2005, NAT MED, V11, P1230, DOI 10.1038/nm1310; Ross HM, 1997, CLIN CANCER RES, V3, P2191; Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102; Schiffner S, 2012, EXP DERMATOL, V21, P786, DOI 10.1111/j.1600-0625.2012.01560.x; Schmaltz C, 2001, BLOOD, V97, P2886, DOI 10.1182/blood.V97.9.2886; Schuster SJ, 2011, J CLIN ONCOL, V29, P2787, DOI 10.1200/JCO.2010.33.3005; Schwartzentruber DJ, 2011, NEW ENGL J MED, V364, P2119, DOI 10.1056/NEJMoa1012863; Scott JE, 2007, J ALLERGY CLIN IMMUN, V120, P1382, DOI 10.1016/j.jaci.2007.08.004; Shiao SL, 2010, J MAMMARY GLAND BIOL, V15, P411, DOI 10.1007/s10911-010-9194-9; Shibaki A, 2004, J INVEST DERMATOL, V123, P109, DOI 10.1111/j.0022-202X.2004.22701.x; Stoitzner P, 2005, J INVEST DERMATOL, V125, P116, DOI 10.1111/j.0022-202X.2005.23757.x; Verbrugge I, 2012, CANCER RES, V72, P3163, DOI 10.1158/0008-5472.CAN-12-0210; Wang LX, 2005, CANCER RES, V65, P9547, DOI 10.1158/0008-5472.CAN-05-1175; Weber LW, 1998, J CLIN INVEST, V102, P1258, DOI 10.1172/JCI4004; Whitmire JK, 2000, PHILOS T R SOC B, V355, P373, DOI 10.1098/rstb.2000.0577; Xiao ZY, 2006, INT J RADIAT ONCOL, V65, P882, DOI 10.1016/j.ijrobp.2006.01.031; Zaft T, 2005, J IMMUNOL, V175, P6428, DOI 10.4049/jimmunol.175.10.6428	53	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82496	10.1371/journal.pone.0082496	http://dx.doi.org/10.1371/journal.pone.0082496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349298	gold, Green Submitted, Green Published			2022-12-27	WOS:000328731800065
J	Jiang, YZ; Liu, YR; Yu, KD; Zuo, WJ; Shao, ZM				Jiang, Yi-Zhou; Liu, Yi-Rong; Yu, Ke-Da; Zuo, Wen-Jia; Shao, Zhi-Ming			Immediate Postmastectomy Breast Reconstruction Showed Limited Advantage in Patient Survival after Stratifying by Family Income	PLOS ONE			English	Article							SKIN-SPARING MASTECTOMY; POSTMENOPAUSAL WOMEN; ADJUVANT TREATMENT; CANCER; TAMOXIFEN; CARCINOMA; TRIAL	Background: Postmastectomy breast reconstruction is widely used in breast cancer patients for its aesthetic effect. Although several studies have casted suspicion upon the oncological safety of immediate breast reconstruction after mastectomy, the potential impact of different reconstruction methods on patient survival remains unclear. Patients and Methods: We identified 35,126 female patients diagnosed with breast cancer from January 1, 1998 to December 31, 2002 in the Surveillance, Epidemiology, and End Results database. Breast cancer-specific survival (BCSS) and overall survival (OS) were compared among patients who underwent mastectomy with or without immediate breast reconstruction (autologous reconstruction or implant reconstruction) using Cox proportional hazard regression models. Results: In multivariate analysis unadjusted for family income, patients undergoing immediate postmastectomy reconstruction exhibited improved BCSS [pooled reconstruction (any types of reconstruction): hazard ratio (HR) = 0.87, 95% confidence interval (CI) 0.80-0.95, P = 0.001] and OS (pooled reconstruction: HR = 0.70, 95% CI 0.65-0.75, P<0.001) compared to patients who underwent mastectomy alone. However, after stratifying by family income, patients receiving reconstruction showed limited advantage in BCSS and OS compared with those undergoing mastectomy alone. When comparing between the two reconstruction methods, no significant differences were observed in either BCSS (implant versus autologous reconstruction: HR = 1.11, 95% CI 0.90-1.35, P = 0.330) or OS (implant versus autologous reconstruction: HR = 1.07, 95% 0.90-1.28, P = 0.424). Conclusions: Compared to mastectomy alone, immediate postmastectomy reconstruction had limited advantage in survival after adjusting for confounding factor of family income. Our findings, if validated in other large databases, may help to illustrate the actual effect of immediate postmastectomy reconstruction on patient survival.	[Yu, Ke-Da] Fudan Univ, Dept Breast Surg, Ctr Canc, Shanghai Med Coll, Shanghai 200433, Peoples R China; Fudan Univ, Shanghai Med Coll, Inst Canc, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Yu, KD (corresponding author), Fudan Univ, Dept Breast Surg, Ctr Canc, Shanghai Med Coll, Shanghai 200433, Peoples R China.	yukeda@163.com; zhiminqshao@yahoo.com		Liu, Yirong/0000-0003-4019-6901	National Natural Science Foundation of China [81001169]; Shanghai United Developing Technology Project of Municipal Hospitals [SHDC12010116]; Shanghai Key Laboratory of Breast Cancer [12DZ2260100]; Zhuo-Xue Project of Fudan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai United Developing Technology Project of Municipal Hospitals; Shanghai Key Laboratory of Breast Cancer; Zhuo-Xue Project of Fudan University	This research was supported by grants from the National Natural Science Foundation of China (81001169), the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010116), the Shanghai Key Laboratory of Breast Cancer (12DZ2260100), and the Zhuo-Xue Project of Fudan University (For KDY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal J, 2012, BREAST J, V18, P226, DOI 10.1111/j.1524-4741.2012.01235.x; Agarwal S, 2010, BREAST J, V16, P503, DOI 10.1111/j.1524-4741.2010.00958.x; American Cancer Society, 2011, GLOB CANC FACTS FIG; Bezuhly M, 2009, CANCER, V115, P4648, DOI 10.1002/cncr.24511; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; Cordeiro PG, 2008, NEW ENGL J MED, V359, P1590, DOI 10.1056/NEJMct0802899; Downes KJ, 2005, CANCER-AM CANCER SOC, V103, P906, DOI 10.1002/cncr.20851; Gouy S, 2005, ANN SURG ONCOL, V12, P161, DOI 10.1245/ASO.2005.04.003; Holmich LR, 2008, ANN PLAS SURG, V61, P11, DOI 10.1097/SAP.0b013e31814fba15; Howell A, 2005, LANCET, V365, P60, DOI 10.1016/s0140-6736(04)17666-6; Iyengar P, 2005, J CLIN INVEST, V115, P1163, DOI 10.1172/JCI200523424; Manabe Y, 2003, J PATHOL, V201, P221, DOI 10.1002/path.1430; Medina-Franco H, 2002, ANN SURG, V235, P814, DOI 10.1097/00000658-200206000-00008; Petit JY, 2013, ANN ONCOL, V24, P1479, DOI 10.1093/annonc/mds660; Sandelin K, 2004, BREAST, V13, P210, DOI 10.1016/j.breast.2003.10.010; Shambaugh EM WM, 1998, SEER PROGRAM CODE MA; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747	18	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82807	10.1371/journal.pone.0082807	http://dx.doi.org/10.1371/journal.pone.0082807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349366	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800080
J	Ke, TY; Liao, WY; Wu, HY				Ke, Ting-Yung; Liao, Wei-Yu; Wu, Hung-Yi			A Leaderless Genome Identified during Persistent Bovine Coronavirus Infection Is Associated with Attenuation of Gene Expression	PLOS ONE			English	Article							MOUSE HEPATITIS-VIRUS; DEFECTIVE INTERFERING RNA; CIS-ACTING ELEMENT; PENAEUS-MONODON PRAWNS; MOUTH-DISEASE VIRUS; MESSENGER-RNA; UNTRANSLATED REGION; SEQUENCE-ANALYSIS; MINUS-STRAND; STEM-LOOP	The establishment of persistent viral infection is often associated with the selection of one or more mutant viruses. For example, it has been found that an intraleader open reading frame (ORF) in genomic and subgenomic mRNA (sgmRNA) molecules is selected during bovine coronavirus (BCoV) persistence which leads to translation attenuation of the downstream ORF. Here, we report the unexpected identification of leaderless genomes, in addition to leader-containing genomes, in a cell culture persistently infected with BCoV. The discovery was made by using a head-to-tail ligation method that examines genomic 59-terminal sequences at different times postinfection. Functional analyses of the leaderless genomic RNA in a BCoV defective interfering (DI) RNA revealed that (1) the leaderless genome was able to serve as a template for the synthesis of negative-strand genome, although it cannot perform replicative positive-strand genomic RNA synthesis, and (2) the leaderless genome retained its function in translation and transcription, although the efficiency of these processes was impaired. Therefore, this previously unidentified leaderless genome is associated with the attenuation of genome expression. Whether the leaderless genome contributes to the establishment of persistent infection remains to be determined.	[Ke, Ting-Yung; Liao, Wei-Yu; Wu, Hung-Yi] Natl Chung Hsing Univ, Coll Vet Med, Inst Pathobiol, Taichung 40227, Taiwan	National Chung Hsing University	Wu, HY (corresponding author), Natl Chung Hsing Univ, Coll Vet Med, Inst Pathobiol, Taichung 40227, Taiwan.	hwu2@dragon.nchu.edu.tw		Wu, Hung-Yi/0000-0002-1260-6259	National Science Council (NSC) of Republic of China [99-2313-B-005-024]	National Science Council (NSC) of Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grant 99-2313-B-005-024 from the National Science Council (NSC) of Republic of China (http://web1.nsc.gov.tw/mp.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED R, 1991, J VIROL, V65, P4242, DOI 10.1128/JVI.65.8.4242-4247.1991; AHMED R, 1981, CELL, V25, P325, DOI 10.1016/0092-8674(81)90050-7; BARIC RS, 1990, VIROLOGY, V177, P646, DOI 10.1016/0042-6822(90)90530-5; BORZAKIAN S, 1992, VIROLOGY, V186, P398, DOI 10.1016/0042-6822(92)90005-A; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; Brown CG, 2007, J VIROL, V81, P7716, DOI 10.1128/JVI.00549-07; BROWN EA, 1991, J VIROL, V65, P5828, DOI 10.1128/JVI.65.11.5828-5838.1991; Cavanagh D, 1997, ARCH VIROL, V142, P629; Chang RY, 1996, J VIROL, V70, P2720, DOI 10.1128/JVI.70.5.2720-2729.1996; CHANG RY, 1994, J VIROL, V68, P8223, DOI 10.1128/JVI.68.12.8223-8231.1994; CHEN W, 1995, J VIROL, V69, P7529, DOI 10.1128/JVI.69.12.7529-7540.1995; Chen ZW, 2010, VET RES, V41, DOI 10.1051/vetres/2009053; Cowley JA, 2000, J GEN VIROL, V81, P1473, DOI 10.1099/0022-1317-81-6-1473; Cowley JA, 2002, J GEN VIROL, V83, P927, DOI 10.1099/0022-1317-83-4-927; DELATORRE JC, 1988, J VIROL, V62, P2050, DOI 10.1128/JVI.62.6.2050-2058.1988; DENBOON JA, 1991, J VIROL, V65, P2910, DOI 10.1128/JVI.65.6.2910-2920.1991; DERMODY TS, 1993, J VIROL, V67, P2055, DOI 10.1128/JVI.67.4.2055-2063.1993; Frolov I, 2001, RNA, V7, P1638, DOI 10.1017/S135583820101010X; FU KS, 1994, J VIROL, V68, P7458, DOI 10.1128/JVI.68.11.7458-7466.1994; Gonzaalez JM, 2003, ARCH VIROL, V148, P2207, DOI 10.1007/s00705-003-0162-1; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4847, DOI 10.1093/nar/17.12.4847; Gustin KM, 2009, J VIROL, V83, P6087, DOI 10.1128/JVI.00160-09; HERNANDEZ AMM, 1994, P NATL ACAD SCI USA, V91, P3705; HOFMANN MA, 1990, J VIROL, V64, P4108, DOI 10.1128/JVI.64.9.4108-4114.1990; HOFMANN MA, 1993, P NATL ACAD SCI USA, V90, P11733, DOI 10.1073/pnas.90.24.11733; HUANG DD, 1987, AVIAN DIS, V31, P438, DOI 10.2307/1590721; Hunziker IP, 2007, VIROLOGY, V360, P120, DOI 10.1016/j.virol.2006.09.041; JANG SK, 1989, J VIROL, V63, P1651, DOI 10.1128/JVI.63.4.1651-1660.1989; KING B, 1982, J VIROL, V42, P700, DOI 10.1128/JVI.42.2.700-707.1982; Krishnan R, 1996, VIROLOGY, V218, P400, DOI 10.1006/viro.1996.0210; Kulasegaran-Shylini R, 2009, VIROLOGY, V387, P211, DOI 10.1016/j.virol.2009.02.027; LAI MMC, 1983, J VIROL, V46, P1027, DOI 10.1128/JVI.46.3.1027-1033.1983; LAI MMC, 1992, CURR TOP MICROBIOL, V176, P21; LAI MMC, 1984, P NATL ACAD SCI-BIOL, V81, P3626, DOI 10.1073/pnas.81.12.3626; LAI MMC, 1990, ANNU REV MICROBIOL, V44, P303, DOI 10.1146/annurev.mi.44.100190.001511; LAI MMC, 1982, J VIROL, V41, P557, DOI 10.1128/JVI.41.2.557-565.1982; LAPPS W, 1987, VIROLOGY, V157, P47, DOI 10.1016/0042-6822(87)90312-6; LIAO CL, 1994, J VIROL, V68, P4727, DOI 10.1128/JVI.68.8.4727-4737.1994; LIN YJ, 1994, J VIROL, V68, P8131, DOI 10.1128/JVI.68.12.8131-8140.1994; MAKINO S, 1989, J VIROL, V63, P5285, DOI 10.1128/JVI.63.12.5285-5292.1989; MARTINEZSALAS E, 1993, J VIROL, V67, P3748; Masters PS, 2006, ADV EXP MED BIOL, V581, P163; Ozdarendeli A, 2001, J VIROL, V75, P7362, DOI 10.1128/JVI.75.16.7362-7374.2001; Pasternak AO, 2006, J GEN VIROL, V87, P1403, DOI 10.1099/vir.0.81611-0; Pasternak AO, 2003, J VIROL, V77, P1175, DOI 10.1128/JVI.77.2.1175-1183.2003; Pasternak AO, 2001, EMBO J, V20, P7220, DOI 10.1093/emboj/20.24.7220; Raman S, 2005, J VIROL, V79, P12434, DOI 10.1128/JVI.79.19.12434-12446.2005; Raman S, 2003, J VIROL, V77, P6720, DOI 10.1128/JVI.77.12.6720-6730.2003; ROHLL JB, 1994, J VIROL, V68, P4384, DOI 10.1128/JVI.68.7.4384-4391.1994; Sawicki SG, 2005, CURR TOP MICROBIOL, V287, P31, DOI 10.1007/3-540-26765-4_2; SAWICKI SG, 1990, J VIROL, V64, P1050, DOI 10.1128/JVI.64.3.1050-1056.1990; Schlichter UHA, 1996, NAT BIOTECHNOL, V14, P1202, DOI 10.1038/nbt1096-1202a; Senanayake SD, 1999, J VIROL, V73, P8003, DOI 10.1128/JVI.73.10.8003-8009.1999; SETHNA PB, 1989, P NATL ACAD SCI USA, V86, P5626, DOI 10.1073/pnas.86.14.5626; Smits SL, 2005, J VIROL, V79, P8275, DOI 10.1128/JVI.79.13.8275-8281.2005; SNIJDER EJ, 1990, J VIROL, V64, P331, DOI 10.1128/JVI.64.1.331-338.1990; SNIJDER EJ, 1993, J GEN VIROL, V74, P2305, DOI 10.1099/0022-1317-74-11-2305; SNIJDER EJ, 1990, NUCLEIC ACIDS RES, V18, P4535, DOI 10.1093/nar/18.15.4535; SPAAN WJM, 1982, J VIROL, V42, P432, DOI 10.1128/JVI.42.2.432-439.1982; STEIN SB, 1992, J VIROL, V66, P4508, DOI 10.1128/JVI.66.7.4508-4517.1992; Szymkowiak C, 2003, J VIROL METHODS, V107, P15, DOI 10.1016/S0166-0934(02)00184-2; TAHARA SM, 1994, VIROLOGY, V202, P621, DOI 10.1006/viro.1994.1383; TOMPKINS WA, 1974, J NATL CANCER I, V52, P1101, DOI 10.1093/jnci/52.4.1101; van Vliet ALW, 2002, EMBO J, V21, P6571, DOI 10.1093/emboj/cdf635; Wang YC, 2000, J VIROL, V74, P10571, DOI 10.1128/JVI.74.22.10571-10580.2000; Williams GD, 1999, J VIROL, V73, P8349, DOI 10.1128/JVI.73.10.8349-8355.1999; Wu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070548; Wu HY, 2010, P NATL ACAD SCI USA, V107, P12257, DOI 10.1073/pnas.1000378107; Wu HY, 2006, J VIROL, V80, P2183, DOI 10.1128/JVI.80.5.2183-2193.2006	69	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82176	10.1371/journal.pone.0082176	http://dx.doi.org/10.1371/journal.pone.0082176			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349214	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800044
J	Liu, CS; Xu, HY; Lam, SH; Gong, ZY				Liu, Chunsheng; Xu, Hongyan; Lam, Siew Hong; Gong, Zhiyuan			Selection of Reliable Biomarkers from PCR Array Analyses Using Relative Distance Computational Model: Methodology and Proof-of-Concept Study	PLOS ONE			English	Article							IN-VITRO; OXIDATIVE STRESS; RAINBOW-TROUT; DNA-DAMAGE; FISH BILE; EXPRESSION; RESPONSES; CELLS; ASSOCIATIONS; METABOLITES	It is increasingly evident about the difficulty to monitor chemical exposure through biomarkers as almost all the biomarkers so far proposed are not specific for any individual chemical. In this proof-of-concept study, adult male zebrafish (Danio rerio) were exposed to 5 or 25 mu g/L 17 beta-estradiol (E2), 100 mu g/L lindane, 5 nM 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or 15 mg/L arsenic for 96 h, and the expression profiles of 59 genes involved in 7 pathways plus 2 well characterized biomarker genes, vtg1 (vitellogenin1) and cyp1a1 (cytochrome P450 1A1), were examined. Relative distance (RD) computational model was developed to screen favorable genes and generate appropriate gene sets for the differentiation of chemicals/concentrations selected. Our results demonstrated that the known biomarker genes were not always good candidates for the differentiation of pair of chemicals/concentrations, and other genes had higher potentials in some cases. Furthermore, the differentiation of 5 chemicals/concentrations examined were attainable using expression data of various gene sets, and the best combination was the set consisting of 50 genes; however, as few as two genes (e.g. vtg1 and hspa5 [heat shock protein 5]) were sufficient to differentiate the five chemical/concentration groups in the present test. These observations suggest that multi-parameter arrays should be more reliable for biomonitoring of chemical exposure than traditional biomarkers, and the RD computational model provides an effective tool for the selection of parameters and generation of parameter sets.	[Liu, Chunsheng; Xu, Hongyan; Lam, Siew Hong; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Liu, CS (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	liuchunshengidid@126.com; dbsgzy@nus.edu.sg	LIU, Chunsheng/M-3369-2014; Lam, Siew Hong/H-8483-2012; Gong, Zhiyuan/H-8794-2012	Gong, Zhiyuan/0000-0002-9660-5260	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme [R-154-000-328-272]	Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme	This work was supported by the Singapore National Research Foundation under its Environmental & Water Technologies Strategic Research Programme and administered by the Environment & Water Industry Programme Office (EWI) of the PUB, grant number R-154-000-328-272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin RP, 2002, TOXICOLOGY, V181, P555, DOI 10.1016/S0300-483X(02)00481-X; Ankley GT, 2008, AQUAT TOXICOL, V88, P69, DOI 10.1016/j.aquatox.2008.03.005; ARIESE F, 1993, AQUAT TOXICOL, V26, P273, DOI 10.1016/0166-445X(93)90034-X; Bartosiewicz M, 2001, ENVIRON HEALTH PERSP, V109, P71, DOI 10.2307/3434924; Caino MC, 2007, MOL PHARMACOL, V71, P744, DOI 10.1124/mol.106.032078; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Cuesta A, 2008, FISH SHELLFISH IMMUN, V25, P682, DOI 10.1016/j.fsi.2008.02.006; DIGIULIO RT, 1989, ENVIRON TOXICOL CHEM, V8, P1103, DOI 10.1002/etc.5620081203; FLOURIOT G, 1995, J MOL ENDOCRINOL, V15, P143, DOI 10.1677/jme.0.0150143; Franco R, 2009, MUTAT RES-GEN TOX EN, V674, P3, DOI 10.1016/j.mrgentox.2008.11.012; Garcia-Reyero N, 2009, ENVIRON SCI TECHNOL, V43, P4188, DOI 10.1021/es803702a; Gupta SC, 2010, LIFE SCI, V86, P377, DOI 10.1016/j.lfs.2009.12.015; Hamadeh HK, 2002, TOXICOL SCI, V67, P219, DOI 10.1093/toxsci/67.2.219; Handzel Z T, 2000, Rev Environ Health, V15, P325; HARADA M, 1995, CRIT REV TOXICOL, V25, P1, DOI 10.3109/10408449509089885; Harley KG, 2010, ENVIRON HEALTH PERSP, V118, P699, DOI 10.1289/ehp.0901450; Hartwig A, 2002, TOXICOL LETT, V127, P47, DOI 10.1016/S0378-4274(01)00482-9; Hook SE, 2006, AQUAT TOXICOL, V77, P372, DOI 10.1016/j.aquatox.2006.01.007; Khalaf H, 2009, SCI TOTAL ENVIRON, V407, P1452, DOI 10.1016/j.scitotenv.2008.10.016; Lackner R., 1998, FISH ECOTOXICOLOGY, P203, DOI DOI 10.1007/978-3-0348-8853-0_6; Lam SH, 2006, PHYSIOL GENOMICS, V27, P351, DOI 10.1152/physiolgenomics.00201.2005; Lam SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000121; Lee SM, 2006, CHEMOSPHERE, V65, P1074, DOI 10.1016/j.chemosphere.2006.02.042; Lucarelli F, 2003, ANAL LETT, V36, P1887, DOI 10.1081/AL-120023620; Mattingly C, 2011, DEV DYNAM, V222, P645; Meeker JD, 2013, ENV HLTH PERSPECT, V118, P318; Murata M, 2004, BIOCHEMISTRY-US, V43, P2569, DOI 10.1021/bi035613d; Nelson JW, 2010, ENVIRON HEALTH PERSP, V118, P197, DOI 10.1289/ehp.0901165; Osborn HL, 2013, AQUAT TOXICOL, V138, P12, DOI 10.1016/j.aquatox.2013.04.002; Pomati F, 2006, ENVIRON SCI TECHNOL, V40, P2442, DOI 10.1021/es051715a; Roberts RA, 1997, FUND APPL TOXICOL, V38, P107, DOI 10.1006/faat.1997.2331; Schnurstein A, 2001, ECOTOX ENVIRON SAFE, V49, P187, DOI 10.1006/eesa.2001.2050; SIMIC MG, 1991, J ENVIRON SCI HEAL C, V9, P113, DOI 10.1080/10590509109373404; Soto AM, 2010, NAT REV ENDOCRINOL, V6, P364, DOI 10.1038/nrendo.2010.87; Stapleton HM, 2011, ENVIRON HEALTH PERSP, V119, P1454, DOI 10.1289/ehp.1003235; Thomas M, 1996, WATER RES, V30, P3083, DOI 10.1016/S0043-1354(96)00190-X; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Vested A, 2013, ENVIRON HEALTH PERSP, V121, P453, DOI 10.1289/ehp.1205118; VINDIMIAN E, 1991, AQUAT TOXICOL, V21, P255, DOI 10.1016/0166-445X(91)90076-L; Wu JP, 2009, TOXICOL SCI, V107, P385, DOI 10.1093/toxsci/kfn239; Xu HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068737; Xu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006097; Yamaguchi A, 2005, AQUAT TOXICOL, V72, P239, DOI 10.1016/j.aquatox.2004.12.011; Zeng ZQ, 2005, ENVIRON SCI TECHNOL, V39, P9001, DOI 10.1021/es050728l; Zheng WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053562	45	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83954	10.1371/journal.pone.0083954	http://dx.doi.org/10.1371/journal.pone.0083954			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349563	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800135
J	Reiter, U; Reiter, G; Kovacs, G; Stalder, AF; Gulsun, MA; Greiser, A; Olschewski, H; Fuchsjager, M				Reiter, Ursula; Reiter, Gert; Kovacs, Gabor; Stalder, Aurelien F.; Gulsun, Mehmet A.; Greiser, Andreas; Olschewski, Horst; Fuchsjaeger, Michael			Evaluation of Elevated Mean Pulmonary Arterial Pressure Based on Magnetic Resonance 4D Velocity Mapping: Comparison of Visualization Techniques	PLOS ONE			English	Article							BLOOD-FLOW PATTERNS; PHASE-CONTRAST MR; TASK-FORCE; HYPERTENSION; STREAMLINES	Purpose: Three-dimensional (3D) magnetic resonance phase contrast imaging (PC-MRI) allows non-invasive diagnosis of pulmonary hypertension (PH) and estimation of elevated mean pulmonary arterial pressure (mPAP) based on vortical motion of blood in the main pulmonary artery. The purpose of the present study was to compare the presence and duration of PH-associated vortices derived from different flow visualization techniques with special respect to their performance for non-invasive assessment of elevated mPAP and diagnosis of PH. Methods: Fifty patients with suspected PH (23 patients with and 27 without PH) were investigated by right heart catheterization and time-resolved PC-MRI of the main pulmonary artery. PC-MRI data were visualized with dedicated prototype software, providing 3D vector, multi-planar reformatted (MPR) 2D vector, streamline, and particle trace representation of flow patterns. Persistence of PH-associated vortical blood flow (t(vortex)) was evaluated with all visualization techniques. Dependencies of t(vortex) on visualization techniques were analyzed by means of correlation and receiver operating characteristic (ROC) curve analysis. Results: t(vortex) values from 3D vector visualization correlated strongly with those from other visualization techniques (r = 0.98, 0.98 and 0.97 for MPR, streamline and particle trace visualization, respectively). Areas under ROC curves for diagnosis of PH based on t(vortex) did not differ significantly and were 0.998 for 3D vector, MPR vector and particle trace visualization and 0.999 for streamline visualization. Correlations between elevated mPAP and t(vortex) in patients with PH were r = 0.96, 0.93, 0.95 and 0.92 for 3D vector, MPR vector, streamline and particle trace visualization, respectively. Corresponding standard deviations from the linear regression lines ranged between 3 and 4 mmHg. Conclusion: 3D vector, MPR vector, streamline as well as particle trace visualization of time-resolved 3D PC-MRI data of the main pulmonary artery can be employed for accurate vortex-based diagnosis of PH and estimation of elevated mPAP.	[Reiter, Ursula; Fuchsjaeger, Michael] Med Univ Graz, Dept Radiol, Div Gen Radiol, Graz, Austria; [Reiter, Gert] Siemens AG, Healthcare Sect, Graz, Austria; [Kovacs, Gabor; Olschewski, Horst] Med Univ Graz, Dept Internal Med, Div Pulmol, Graz, Austria; [Kovacs, Gabor; Olschewski, Horst] LBI Lung Vasc Res, Graz, Austria; [Stalder, Aurelien F.; Greiser, Andreas] Siemens AG, Healthcare Sect, Erlangen, Germany; [Gulsun, Mehmet A.] Siemens Corp Res, Baltimore, MD USA	Medical University of Graz; Siemens AG; Medical University of Graz; Siemens AG; Siemens Germany; Siemens AG	Reiter, U (corresponding author), Med Univ Graz, Dept Radiol, Div Gen Radiol, Graz, Austria.	ursula.reiter@klinikum-graz.at	Stalder, Aurelien F/A-7071-2010; Olschewski, Horst/L-3547-2019; Reiter, Ursula/P-7259-2016	Stalder, Aurelien F/0000-0002-0590-2746; Olschewski, Horst/0000-0002-2834-7466; Fuchsjager, Michael/0000-0002-5175-780X	Styrian government [ABT08-16.R-8/2013-9]	Styrian government	The project was supported by a grant of the Styrian government (grant number ABT08-16.R-8/2013-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachler P, 2013, MAGN RESON IMAGING, V31, P178, DOI 10.1016/j.mri.2012.06.036; Bernstein MA, 1998, MAGN RESON MED, V39, P300, DOI 10.1002/mrm.1910390218; Bogren HG, 2010, RADIOLOGY, V257, P895, DOI 10.1148/radiol.101298; Bradlow WM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-6; Buonocore MH, 1998, MAGN RESON MED, V40, P210, DOI 10.1002/mrm.1910400207; Francois CJ, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-16; Frydrychowicz A, 2012, EUR RADIOL, V22, P1122, DOI 10.1007/s00330-011-2353-6; Frydrychowicz A, 2011, INVEST RADIOL, V46, P317, DOI 10.1097/RLI.0b013e3182034fc2; Galie N, 2004, EUR HEART J, V25, P2243, DOI 10.1016/j.ehj.2004.09.014; Gulsun MA, 2012, NOVEL 4D FLOW TOOL C, P1176; Hope MD, 2010, RADIOLOGY, V255, P53, DOI 10.1148/radiol.09091437; Krishnan H, 2012, IEEE T VIS COMPUT GR, V18, P966, DOI 10.1109/TVCG.2011.80; Markl M, 2004, J COMPUT ASSIST TOMO, V28, P459, DOI 10.1097/00004728-200407000-00005; Markl M, 2012, J MAGN RESON IMAGING, V36, P1015, DOI 10.1002/jmri.23632; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; McLoughlin T, 2013, COMPUT GRAPH FORUM, V29, P1807; MOHIADDIN RH, 1994, J COMPUT ASSIST TOMO, V18, P383, DOI 10.1097/00004728-199405000-00008; NAPEL S, 1992, JMRI-J MAGN RESON IM, V2, P143, DOI 10.1002/jmri.1880020206; Oertel H, 2004, PRANDTLS ESSENTIALS, P50; PELC N J, 1991, Magnetic Resonance Quarterly, V7, P229; Post FH, 2002, EUROGRAPHICS 2002 ST, P69; Reiter G, 2007, J CARDIOVASC MAGN R, V9, P237; Reiter G, 2008, CIRC-CARDIOVASC IMAG, V1, P23, DOI 10.1161/CIRCIMAGING.108.780247; Sundareswaran KS, 2012, J THORAC CARDIOV SUR, V143, P1108, DOI 10.1016/j.jtcvs.2011.09.067; Wigstrom L, 1999, MAGNET RESON MED, V41, P793, DOI 10.1002/(SICI)1522-2594(199904)41:4<793::AID-MRM19>3.0.CO;2-2; Ye XH, 2005, IEEE VISUALIZATION 2005, PROCEEDINGS, P471	26	47	49	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82212	10.1371/journal.pone.0082212	http://dx.doi.org/10.1371/journal.pone.0082212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349224	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800050
J	Rose, JH; Calipari, ES; Mathews, TA; Jones, SR				Rose, Jamie H.; Calipari, Erin S.; Mathews, Tiffany A.; Jones, Sara R.			Greater Ethanol-Induced Locomotor Activation in DBA/2J versus C57BL/6J Mice Is Not Predicted by Presynaptic Striatal Dopamine Dynamics	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; INBRED STRAINS; PLACE PREFERENCE; IN-VIVO; COCAINE; NEURONS; MOUSE; RATS; TRANSPORTERS; AMPHETAMINE	A large body of research has aimed to determine the neurochemical factors driving differential sensitivity to ethanol between individuals in an attempt to find predictors of ethanol abuse vulnerability. Here we find that the locomotor activating effects of ethanol are markedly greater in DBA/2J compared to C57BL/6J mice, although it is unclear as to what neurochemical differences between strains mediate this behavior. Dopamine elevations in the nucleus accumbens and caudate-putamen regulate locomotor behavior for most drugs, including ethanol; thus, we aimed to determine if differences in these regions predict strain differences in ethanol-induced locomotor activity. Previous studies suggest that ethanol interacts with the dopamine transporter, potentially mediating its locomotor activating effects; however, we found that ethanol had no effects on dopamine uptake in either strain. Ex vivo voltammetry allows for the determination of ethanol effects on presynaptic dopamine terminals, independent of drug-induced changes in firing rates of afferent inputs from either dopamine neurons or other neurotransmitter systems. However, differences in striatal dopamine dynamics did not predict the locomotor-activating effects of ethanol, since the inhibitory effects of ethanol on dopamine release were similar between strains. There were differences in presynaptic dopamine function between strains, with faster dopamine clearance in the caudate-putamen of DBA/2J mice; however, it is unclear how this difference relates to locomotor behavior. Because of the role of the dopamine system in reinforcement and reward learning, differences in dopamine signaling between the strains could have implications for addiction-related behaviors that extend beyond ethanol effects in the striatum.	[Rose, Jamie H.; Calipari, Erin S.; Jones, Sara R.] Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27101 USA; [Mathews, Tiffany A.] Wayne State Univ, Dept Chem, Detroit, MI 48202 USA	Wake Forest University; Wayne State University	Jones, SR (corresponding author), Wake Forest Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27101 USA.	srjones@wakehealth.edu	Jones, Sara R/K-4816-2014	Jones, Sara R/0000-0002-3424-7576; Calipari, Erin/0000-0003-4723-0623	National Institute of Health, National Institute on Drug Abuse (NIDA) [F31 DA031533, T32 DA007246]; National Institute of Health, National Institute of Alcohol Abuse and Alcoholism (NIAAA) [T32 AA07565, P01 AA021099, U01 AA014091]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P01AA017056, T32AA007565, U01AA014091, P01AA021099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030161, T32DA007246, F31DA031533] Funding Source: NIH RePORTER	National Institute of Health, National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Health, National Institute of Alcohol Abuse and Alcoholism (NIAAA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors are thankful for fundering from the National Institute of Health, National Institute on Drug Abuse (NIDA) and National Institute of Alcohol Abuse and Alcoholism (NIAAA). NIDA grant numbers: F31 DA031533 (ESC), T32 DA007246 (ESC), NIAAA grant numbers: T32 AA07565 (JHR), P01 AA021099 (SRJ) and U01 AA014091 (SRJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias C, 2010, DEV PSYCHOBIOL, V52, P13, DOI 10.1002/dev.20407; Baumann MH, 2008, PHARMACOL BIOCHEM BE, V90, P208, DOI 10.1016/j.pbb.2008.02.018; Brodie MS, 1999, ALCOHOL CLIN EXP RES, V23, P1848, DOI 10.1111/j.1530-0277.1999.tb04082.x; Cabib S, 2002, BEHAV BRAIN RES, V130, P103, DOI 10.1016/S0166-4328(01)00422-3; CASTELLANO C, 1976, PSYCHOPHARMACOLOGY, V49, P29; Colelli V, 2010, GENES BRAIN BEHAV, V9, P703, DOI 10.1111/j.1601-183X.2010.00604.x; CUNNINGHAM CL, 1992, PSYCHOPHARMACOLOGY, V107, P385, DOI 10.1007/BF02245166; Ferris MJ, 2013, EUR J NEUROSCI, V38, P2628, DOI 10.1111/ejn.12266; GESSA GL, 1985, BRAIN RES, V348, P201, DOI 10.1016/0006-8993(85)90381-6; Ginsburg BC, 2008, EUR J PHARMACOL, V578, P228, DOI 10.1016/j.ejphar.2007.09.017; Gremel CM, 2006, ALCOHOL CLIN EXP RES, V30, P783, DOI 10.1111/j.1530-0277.2006.00091.x; Grimm JW, 1997, PHYSIOL BEHAV, V61, P755, DOI 10.1016/S0031-9384(96)00532-X; KAKIHANA R, 1979, BEHAV NEURAL BIOL, V26, P97, DOI 10.1016/S0163-1047(79)92933-9; Kapasova Z, 2008, ALCOHOL CLIN EXP RES, V32, P617, DOI 10.1111/j.1530-0277.2008.00620.x; Linsenbardt DN, 2009, ALCOHOL CLIN EXP RES, V33, P464, DOI 10.1111/j.1530-0277.2008.00857.x; LISTER RG, 1987, ALCOHOL, V4, P17, DOI 10.1016/0741-8329(87)90054-1; Mantsch JR, 2001, PSYCHOPHARMACOLOGY, V157, P31, DOI 10.1007/s002130100744; Mayfield RD, 2001, J NEUROCHEM, V79, P1070, DOI 10.1046/j.1471-4159.2001.00656.x; McDaid J, 2008, J NEUROPHYSIOL, V100, P1202, DOI 10.1152/jn.00994.2007; Meyer PJ, 2009, GENES BRAIN BEHAV, V8, P346, DOI 10.1111/j.1601-183X.2009.00481.x; Orsini C, 2004, PSYCHOPHARMACOLOGY, V172, P264, DOI 10.1007/s00213-003-1647-z; PHILLIPS TJ, 1994, BEHAV NEUROSCI, V108, P789, DOI 10.1037/0735-7044.108.4.789; Riddle EL, 2005, AAPS J, V7, pE847, DOI 10.1208/aapsj070481; Riherd DN, 2008, ALCOHOL, V42, P499, DOI 10.1016/j.alcohol.2008.04.009; Robinson DL, 2005, ALCOHOL CLIN EXP RES, V29, P746, DOI 10.1097/01.ALC.0000164362.21484.14; Sulzer D, 2011, NEURON, V69, P628, DOI 10.1016/j.neuron.2011.02.010; Yoneyama N, 2008, ALCOHOL, V42, P149, DOI 10.1016/j.alcohol.2007.12.006; Yorgason JT, 2011, J NEUROSCI METH, V202, P158, DOI 10.1016/j.jneumeth.2011.03.001; Zocchi A, 1998, NEUROSCIENCE, V82, P521	29	21	23	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83852	10.1371/journal.pone.0083852	http://dx.doi.org/10.1371/journal.pone.0083852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349553	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800133
J	Thomassen, YE; van 't Oever, AG; van Oijen, MGCT; Wijffels, RH; van der Pol, LA; Bakker, WAM				Thomassen, Yvonne E.; van 't Oever, Aart G.; van Oijen, Monique G. C. T.; Wijffels, Rene H.; van der Pol, Leo A.; Bakker, Wilfried A. M.			Next Generation Inactivated Polio Vaccine Manufacturing to Support Post Polio-Eradication Biosafety Goals	PLOS ONE			English	Article							TECHNOLOGY-TRANSFER; SABIN STRAINS; ANTIGEN; IPV; IMMUNOGENICITY; GROWTH; SAFETY; CELLS	Worldwide efforts to eradicate polio caused a tipping point in polio vaccination strategies. A switch from the oral polio vaccine, which can cause circulating and virulent vaccine derived polioviruses, to inactivated polio vaccines (IPV) is scheduled. Moreover, a manufacturing process, using attenuated virus strains instead of wild-type polioviruses, is demanded to enhance worldwide production of IPV, especially in low-and middle income countries. Therefore, development of an IPV from attenuated (Sabin) poliovirus strains (sIPV) was pursued. Starting from the current IPV production process based on wild type Salk strains, adaptations, such as lower virus cultivation temperature, were implemented. sIPV was produced at industrial scale followed by formulation of both plain and aluminium adjuvanted sIPV. The final products met the quality criteria, were immunogenic in rats, showed no toxicity in rabbits and could be released for testing in the clinic. Concluding, sIPV was developed to manufacturing scale. The technology can be transferred worldwide to support post polio-eradication biosafety goals.	[Thomassen, Yvonne E.; van 't Oever, Aart G.; van Oijen, Monique G. C. T.; van der Pol, Leo A.; Bakker, Wilfried A. M.] Inst Translat Vaccinol Intravacc, Bilthoven, Netherlands; [Wijffels, Rene H.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	Thomassen, YE (corresponding author), Inst Translat Vaccinol Intravacc, Bilthoven, Netherlands.	yvonne.thomassen@intravacc.nl	Thomassen, Yvonne/A-8691-2019; Bakker, Wilfried/AAZ-8673-2020	Thomassen, Yvonne/0000-0002-8570-5987; Bakker, Wilfried/0000-0001-8731-6689; Wijffels, Rene/0000-0001-7630-4295	WHO [APW HQ/07/039621]; WHO's polio research committee through the Bill and Melinda Gates foundation	WHO(World Health Organization); WHO's polio research committee through the Bill and Melinda Gates foundation	The sIPV proof of principle study was financed by WHO (www.who.int) grant APW HQ/07/039621. Initial process development and the production of clinical lots were funded by WHO's polio research committee through a grant from the Bill and Melinda Gates foundation (www.gatesfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, EUROPEAN PHARMACOPOE, V7th; Aylward B, 2011, VACCINE, V29, pD80, DOI 10.1016/j.vaccine.2011.10.005; Bakker WAM, 2011, VACCINE, V29, P7188, DOI 10.1016/j.vaccine.2011.05.079; DUCHENE M, 1990, Viral Immunology, V3, P243, DOI 10.1089/vim.1990.3.243; Kersten G, 1999, VACCINE, V17, P2059, DOI 10.1016/S0264-410X(98)00409-5; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Kreeftenberg H, 2006, BIOLOGICALS, V34, P155, DOI 10.1016/j.biologicals.2006.02.011; Liao GY, 2012, J INFECT DIS, V205, P237, DOI 10.1093/infdis/jir723; SABIN A. B., 1973, Journal of Biology, V1, P115, DOI 10.1016/0092-1157(73)90048-6; Salk D, 1984, Vaccine, V2, P59, DOI 10.1016/S0264-410X(98)90035-4; Tanimoto T, 2012, LANCET, V380, P1647, DOI 10.1016/S0140-6736(12)61948-5; ten Have R, 2012, BIOLOGICALS, V40, P84, DOI 10.1016/j.biologicals.2011.11.004; Thomassen YE, 2013, BIOTECHNOL BIOENG, V110, P1354, DOI 10.1002/bit.24798; Thomassen YE, 2012, PROCESS BIOCHEM, V47, P288, DOI 10.1016/j.procbio.2011.11.006; Thomassen YE, 2010, BIOTECHNOL BIOENG, V107, P96, DOI 10.1002/bit.22788; van Alken WG, 2004, WHO TECH REP SER, V926, P1; van Wezel A.L., 1985, P265; van Wezel A L, 1979, Dev Biol Stand, V42, P65; van Wezel A L, 1971, Prog Immunobiol Stand, V5, P187; van Wezel A L, 1978, Dev Biol Stand, V41, P159; VANHEMERT P, 1969, BIOTECHNOL BIOENG, V11, P875, DOI 10.1002/bit.260110513; VANNOORT RBJC, 1992, VACCINE, V10, P909, DOI 10.1016/0264-410X(92)90323-C; VANSTEENIS G, 1981, DEV BIOL STAND, V47, P119; VANWEZEL AI, 1984, REV INFECT DIS, V6, pS335; VANWEZEL AL, 1967, NATURE, V216, P64, DOI 10.1038/216064a0; Verdijk P, 2013, VACCINE, V31, P5531, DOI 10.1016/j.vaccine.2013.09.021; Westdijk J, 2013, VACCINE, V31, P1298, DOI 10.1016/j.vaccine.2012.12.076; Westdijk J, 2011, VACCINE, V29, P3390, DOI 10.1016/j.vaccine.2011.02.085; *WHO, 2012, REC ASS QUAL SAF EFF; World Health Organization, 2013, WKLY EPIDEMIOL REC, V88, P1; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	43	33	39	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83374	10.1371/journal.pone.0083374	http://dx.doi.org/10.1371/journal.pone.0083374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349497	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800114
J	Zhang, CS; Zhu, CT; Ling, Y; Zhou, XF; Dong, CL; Luo, JD; Liu, YP				Zhang, Changsong; Zhu, Changtai; Ling, Yang; Zhou, Xifa; Dong, Chunlei; Luo, Judong; Liu, Yongping			The Clinical Value of Huangqi Injection in the Treatment of Leucopenia: A Meta-Analysis of Clinical Controlled Trials	PLOS ONE			English	Article							CHEMOTHERAPY-INDUCED LEUKOPENIA; CELL LUNG-CANCER	Background: Huangqi injection is derived from Astragalus membranaceus root. In China, recent reports of Huangqi injection for the treatment of leucopenia have emerged. However, a systematic review of these reports has not been performed. Thus, we conducted a meta-analysis of clinical controlled trials to assess the clinical value of Huangqi injection in the treatment of leucopenia. Methods: We searched the Chinese Biomedical Literature Database (CBM), Wanfang Database, China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals Full-text Database (VIP), as well as PubMed and EMBASE to collect the data about trials of Huangqi injection for treating leucopenia. A meta-analysis was performed using RevMan 5.2 software. Results: A total of 13 studies involving 841 patients were included in this study. The overall study quality was lower according to the Jadad scale. The meta-analysis showed that experimentally treated patients experienced greater therapeutic efficacy and lower white blood cell counts than control groups treated with Western medicine (P < 0.05). No publication bias was evident, according to Egger's test. Conclusions: The validity of this meta-analysis was limited by the overall poor quality of the included studies. Huangqi injection may have potential clinical value in the treatment of leucopenia, but confirmation with rigorously well-designed multi-center trials is needed.	[Zhang, Changsong; Zhu, Changtai; Ling, Yang; Liu, Yongping] Soochow Univ, Dept Oncol, Changzhou Tumor Hosp, Changzhou, Peoples R China; [Zhu, Changtai; Dong, Chunlei] Soochow Univ, Dept Lab Med, Changzhou Tumor Hosp, Changzhou, Peoples R China; [Zhou, Xifa; Luo, Judong] Soochow Univ, Dept Radiat Oncol, Changzhou Tumor Hosp, Changzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Zhang, CS (corresponding author), Soochow Univ, Dept Oncol, Changzhou Tumor Hosp, Changzhou, Peoples R China.	hbzcs@126.com; zct101@163.com; lingyang11566@163.com	zhu, changtai/W-6581-2019; Zhu, Changtai/V-1583-2017	zhu, changtai/0000-0002-5250-1937; Zhu, Changtai/0000-0002-5250-1937	Natural Science Foundation of China [81071799, 81372212]; Science and Technology Bureau of Changzhou Municipality [CJ2012202]; Natural Science Foundation of Jiangsu [BK2011251]; Jiangsu Provincial Special Program of Medical Science [BL2013012]; Health Talents Project for Jiangsu [LJ201157, RC2011038, BRA2011038]; "831" Health Talents Project of Changzho Municipality	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Bureau of Changzhou Municipality; Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); Jiangsu Provincial Special Program of Medical Science; Health Talents Project for Jiangsu; "831" Health Talents Project of Changzho Municipality	This project was supported by the Natural Science Foundation of China (81071799, 81372212), the Science and Technology Bureau of Changzhou Municipality (CJ2012202), the Natural Science Foundation of Jiangsu (BK2011251), Jiangsu Provincial Special Program of Medical Science (BL2013012), the Health Talents Project for Jiangsu (LJ201157; RC2011038; BRA2011038), and the "831" Health Talents Project of Changzho Municipality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Ponce JL, 2013, ORAL ONCOL, V49, P249, DOI 10.1016/j.oraloncology.2012.09.008; Bao XN., 1999, ZHONG YI YAO LI YU L, V15, P39; Bruserud O, 1998, CANCER IMMUNOL IMMUN, V46, P221, DOI 10.1007/s002620050481; Cai Xiao-yan, 2006, Zhongguo Zhong Xi Yi Jie He Za Zhi, V26, P443; Dai Y, 1999, ZHEJIANG ZHONG YI ZA, V34, P42; Dong J, 2010, ZHONG YI YAO DAO BAO, V16, P87; Fan JH, 2007, HAINAN YI XUE YUAN X, V13, P233; Feng CL, 2000, SHI YONG ZHONG YI NE, V2, P23; Fu SF, 2009, YAO WU PING JIA YAN, V32, P54; Fu SF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019604; Gao P, 2000, CHANGCHUN ZHONG YI X, V4, P24; Hayashi K, 2011, YAKUGAKU ZASSHI, V131, P139, DOI 10.1248/yakushi.131.139; Hooper C, 2012, AUST VET J, V90, P24, DOI 10.1111/j.1751-0813.2011.00877.x; Huang CS, 2012, ASIAN PAC J CANCER P, V13, P4481, DOI 10.7314/APJCP.2012.13.9.4481; Jadad AR, 1996, J CLIN EPIDEMIOL, V49, P235, DOI 10.1016/0895-4356(95)00062-3; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Li MX, 2011, J ETHNOPHARMACOL, V133, P412, DOI 10.1016/j.jep.2010.10.012; Li QZ, 1997, SHANGHAI YI YAO, V18, P21; Liu BJ, 2000, LIAONING YAO WU YU L, V3, P13; Liu Z Q, 2001, Zhongguo Zhong Xi Yi Jie He Za Zhi, V21, P274; Luo WW, 2000, ZHONGHUA SHEN ZANG B, V16, P189; McCulloch M, 2006, J CLIN ONCOL, V24, P419, DOI 10.1200/JCO.2005.03.6392; Mo GW, 2005, GUANGZHOU ZHONG YI Y, V22, P13; Mo WX, 2009, NE KE, V4, P64; Moher D, 1996, INT J TECHNOL ASSESS, V12, P195, DOI 10.1017/S0266462300009570; Qin HZ, 2011, YI XUE XIN XI, V24, P151; Qu W, 2000, TIANJIN YAO XUE, V4, P71; Shafi MS, 2009, JCPSP-J COLL PHYSICI, V19, P346, DOI 06.2009/JCPSP.346349; [是俊凤 Shi Junfeng], 2002, [上海第二医科大学学报, Acta Universitatis Medicinalis Secondae Shanghai], V22, P245; Su Li, 2007, Zhong Xi Yi Jie He Xue Bao, V5, P272; Tang JC, 2007, SHI YONG YI XUE ZA Z, V23, P280; Wang HJ, 2007, LANZHOU DA XUE XUE B, V33, P76; Wang HJ, 2007, SICHUAN ZHONG YI, V25, P20; Wroblova K, 2012, DIGEST DIS SCI, V57, P2394, DOI 10.1007/s10620-012-2163-y; Wu T, 2005, COCHRANE DB SYST REV, V25; Xiao AQ, 2007, TAISHAN YI XUE YUAN, V28, P706; Xiao L, 2012, ZHONGGUO ZHI YE YAO, V9, P25; Xu L, 2008, CONTEMP CLIN TRIALS, V29, P727, DOI 10.1016/j.cct.2008.05.003; Yang DS, 2001, XIAN DAI ZHONG XI YI, V10, P812; Zhang MJ, 1999, LIN CHUANG XUE YE XU, V12, P28; Zhang YS, 2000, SHI ZHEN GUO YI GUO, V11, P935; Zhou WB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037249; Zhu XL, 2001, ZHONGGUO ZHONG XI YI, V8, P284; Zou Yu-he, 2003, Zhongguo Zhong Xi Yi Jie He Za Zhi, V23, P733	44	7	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83123	10.1371/journal.pone.0083123	http://dx.doi.org/10.1371/journal.pone.0083123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349444	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800096
J	Dorea, FC; McEwen, BJ; McNab, WB; Sanchez, J; Revie, CW				Dorea, Fernanda C.; McEwen, Beverly J.; McNab, W. Bruce; Sanchez, Javier; Revie, Crawford W.			Syndromic Surveillance Using Veterinary Laboratory Data: Algorithm Combination and Customization of Alerts	PLOS ONE			English	Article							OUTBREAK DETECTION; CHALLENGES; SYSTEMS	Background: Syndromic surveillance research has focused on two main themes: the search for data sources that can provide early disease detection; and the development of efficient algorithms that can detect potential outbreak signals. Methods: This work combines three algorithms that have demonstrated solid performance in detecting simulated outbreak signals of varying shapes in time series of laboratory submissions counts. These are: the Shewhart control charts designed to detect sudden spikes in counts; the EWMA control charts developed to detect slow increasing outbreaks; and the Holt-Winters exponential smoothing, which can explicitly account for temporal effects in the data stream monitored. A scoring system to detect and report alarms using these algorithms in a complementary way is proposed. Results: The use of multiple algorithms in parallel resulted in increased system sensitivity. Specificity was decreased in simulated data, but the number of false alarms per year when the approach was applied to real data was considered manageable (between 1 and 3 per year for each of ten syndromic groups monitored). The automated implementation of this approach, including a method for on-line filtering of potential outbreak signals is described. Conclusion: The developed system provides high sensitivity for detection of potential outbreak signals while also providing robustness and flexibility in establishing what signals constitute an alarm. This flexibility allows an analyst to customize the system for different syndromes.	[Dorea, Fernanda C.; Sanchez, Javier; Revie, Crawford W.] Univ Prince Edward Isl, Dept Hlth Management, Charlottetown, PE C1A 4P3, Canada; [McEwen, Beverly J.] Univ Guelph, Hlth Anim Lab, Guelph, ON N1G 2W1, Canada; [McNab, W. Bruce] Ontario Minist Agr Food & Rural Affairs, Anim Hlth & Welf Branch, Guelph, ON, Canada	University of Prince Edward Island; University of Guelph	Dorea, FC (corresponding author), Natl Vet Inst SVA, Swedish Zoonosis Ctr, Uppsala, Sweden.	dorea.meyer@gmail.com	sanchez, javier/AAA-4179-2022; Revie, Crawford/B-5002-2011	Revie, Crawford/0000-0002-5018-0340; Dorea, Fernanda/0000-0001-8638-8525	OMAFRA-UG Agreement through the Animal Health Strategic Investment fund (AHSI)	OMAFRA-UG Agreement through the Animal Health Strategic Investment fund (AHSI)	This project was supported by the OMAFRA-UG Agreement through the Animal Health Strategic Investment fund (AHSI) managed by the Animal Health Laboratory of the University of Guelph. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bravata DM, 2004, ANN INTERN MED, V140, P910, DOI 10.7326/0003-4819-140-11-200406010-00013; Buckeridge David L, 2005, MMWR Suppl, V54, P109; Buckeridge DL, 2005, J BIOMED INFORM, V38, P99, DOI 10.1016/j.jbi.2004.11.007; Buckeridge DL, 2007, J BIOMEDICAL INFORM, V40; Burkom HS, 2007, STAT MED, V26, P4202, DOI 10.1002/sim.2835; Centers for Disease Control and Prevention (CDC), ANN BIBL SYNDR SURV; Doherr MG, 2001, PHILOS T R SOC B, V356, P1097, DOI 10.1098/rstb.2001.0898; Dohoo I., 2009, VET EPIDEMIOLOGIC RE; Dorea FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057334; Dorea FC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0114; Dorea FC, 2013, PREV VET MED, V109, P219, DOI 10.1016/j.prevetmed.2012.10.010; Dorea FC, 2011, PREV VET MED, V101, P1, DOI 10.1016/j.prevetmed.2011.05.004; Elbert Y, 2009, STAT MED, V28, P3226, DOI 10.1002/sim.3708; Fricker RD, 2008, STAT MED, V27, P3407, DOI 10.1002/sim.3197; Hutwagner LC, 2005, STAT MED, V24, P543, DOI 10.1002/sim.2034; Lombardo Joseph S, 2004, MMWR Suppl, V53, P159; Lotze T., 2008, ADV DIS SURVEILL, V6, P1; Mandl Kenneth D, 2004, MMWR Suppl, V53, P130; O'Sullivan T, 2012, PREV VET MED, V106, P275, DOI 10.1016/j.prevetmed.2012.03.005; R Core Team, 2012, R LANG ENV STAT COMP; Reis BY, 2003, P NATL ACAD SCI USA, V100, P1961, DOI 10.1073/pnas.0335026100; Shmueli G, 2010, TECHNOMETRICS, V52, P39, DOI 10.1198/TECH.2010.06134; van den Wjingaard C.C., 2011, EUROSURVEILLANCE, V16; Wang L, 2005, ARTIF INTELL MED, V34, P269, DOI 10.1016/j.artmed.2004.11.002; Widdowson MA, 2003, EMERG INFECT DIS, V9, P1046; Yahav I, 2007, LECT NOTES COMPUT SC, V4506, P91	26	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82183	10.1371/journal.pone.0082183	http://dx.doi.org/10.1371/journal.pone.0082183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349216	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000328730300083
J	Kim, JR; Moon, YJ; Kwon, KS; Bae, JS; Wagle, S; Kim, KM; Park, HS; Lee, H; Moon, WS; Chung, MJ; Kang, MJ; Jang, KY				Kim, Jung Ryul; Moon, Young Jae; Kwon, Keun Sang; Bae, Jun Sang; Wagle, Sajeev; Kim, Kyoung Min; Park, Ho Sung; Lee, Ho; Moon, Woo Sung; Chung, Myoung Ja; Kang, Myoung Jae; Jang, Kyu Yun			Tumor Infiltrating PD1-Positive Lymphocytes and the Expression of PD-L1 Predict Poor Prognosis of Soft Tissue Sarcomas	PLOS ONE			English	Article							REGULATORY T-CELLS; PROGRAMMED DEATH-1 LIGAND-1; B7-H1 PD-L1; POSTOPERATIVE RECURRENCE; CLINICAL-SIGNIFICANCE; UP-REGULATION; CARCINOMA; BLOCKADE; OVEREXPRESSION; AGGRESSIVENESS	Recently, the possibility of PD1 pathway-targeted therapy has been extensively studied in various human malignant tumors. However, no previous study has investigated their potential application for soft-tissue sarcomas (STS). In this study, we evaluated the clinical impact of intra-tumoral infiltration of PD1-positive lymphocytes and PD-L1 expression in tumor cells in 105 cases of STS. Intra-tumoral infiltration of PD1-positive lymphocytes and PD-L1 expression were seen in 65% and 58% of STS, respectively. Both PD1-positivity and PD-L1 expression were significantly associated with advanced clinicopathological parameters such as higher clinical stage, presence of distant metastasis, higher histological grade, poor differentiation of tumor, and tumor necrosis. Moreover, both PD1-positivity and PD-L1 positivity were independent prognostic indicators of overall survival (OS) and event-free survival (EFS) of STS by multivariate analysis. In addition, the combined pattern of PD1- and PD-L1-positivity was also an independent prognostic indicator for OS and EFS by multivariate analysis. The patents with a PD1(+)/PD-L1(+) pattern had the shortest survival time. In conclusion, this study is the first to demonstrate that the infiltration of PD1 positive lymphocytes and PD-L1 expression in STS cells could be used as novel prognostic indicators for STS. Moreover, the evaluation of PD1- and PD-L1-positivity in STS is also available as possible criteria for selection of patients suitable for PD1-based immunotherapy.	[Kim, Jung Ryul; Moon, Young Jae] Chonbuk Natl Univ, Sch Med, Dept Orthopaed Surg, Res Inst Clin Med, Jeonju, South Korea; [Kim, Jung Ryul; Moon, Young Jae; Kwon, Keun Sang; Bae, Jun Sang; Wagle, Sajeev; Kim, Kyoung Min; Park, Ho Sung; Lee, Ho; Moon, Woo Sung; Chung, Myoung Ja; Kang, Myoung Jae; Jang, Kyu Yun] Res Inst Endocrine Sci, Jeonju, South Korea; [Kwon, Keun Sang] Chonbuk Natl Univ, Sch Med, Dept Prevent Med, Res Inst Clin Med, Jeonju, South Korea; [Bae, Jun Sang; Wagle, Sajeev; Kim, Kyoung Min; Park, Ho Sung; Moon, Woo Sung; Chung, Myoung Ja; Kang, Myoung Jae; Jang, Kyu Yun] Chonbuk Natl Univ, Sch Med, Dept Pathol, Res Inst Clin Med, Jeonju, South Korea; [Lee, Ho] Chonbuk Natl Univ, Sch Med, Dept Forens Med, Res Inst Clin Med, Jeonju, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University	Jang, KY (corresponding author), Chonbuk Natl Univ, Sch Med, Dept Pathol, Res Inst Clin Med, Jeonju, South Korea.	kyjang@chonbuk.ac.kr	Wagle, Sajeev/N-1524-2013	Wagle, Sajeev/0000-0001-9762-0262	National Research Foundation of Korea (NRF) grant; Korea government (MEST) [2011-0028928]; Korea government [2011-0028928]	National Research Foundation of Korea (NRF) grant(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea government(Korean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-0028928). National Research Foundation of Korea (NRF) grant funded by the Korea government (No. 2011-0028928). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blank C, 2006, INT J CANCER, V119, P317, DOI 10.1002/ijc.21775; Clark MA, 2005, NEW ENGL J MED, V353, P701, DOI 10.1056/NEJMra041866; Constantinidou A, 2013, EXPERT REV ANTICANC, V13, P211, DOI [10.1586/ERA.12.161, 10.1586/era.12.161]; Dong HD, 1999, NAT MED, V5, P1365; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Edge S, 2010, AJCC CANC STAGING HD; Fletcher C., 2013, IARC WHO CLASSIFICAT, V5; French JD, 2012, J CLIN ENDOCR METAB, V97, pE934, DOI 10.1210/jc.2011-3428; Gao Q, 2009, CLIN CANCER RES, V15, P971, DOI 10.1158/1078-0432.CCR-08-1608; Ghebeh H, 2006, NEOPLASIA, V8, P190, DOI 10.1593/neo.05733; Hams E, 2011, J IMMUNOL, V186, P5648, DOI 10.4049/jimmunol.1003161; Iwai Y, 2005, INT IMMUNOL, V17, P133, DOI 10.1093/intimm/dxh194; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Kang MJ, 2013, TRANSL ONCOL, V6, P282, DOI 10.1593/tlo.13256; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; McDermott DF, 2011, J CLIN ONCOL, V29, DOI 10.1200/jco.2011.29.7_suppl.331; Nakanishi J, 2007, CANCER IMMUNOL IMMUN, V56, P1173, DOI 10.1007/s00262-006-0266-z; Nishimura H, 2001, TRENDS IMMUNOL, V22, P265, DOI 10.1016/S1471-4906(01)01888-9; Nomi T, 2007, CLIN CANCER RES, V13, P2151, DOI 10.1158/1078-0432.CCR-06-2746; Ohigashi Y, 2005, CLIN CANCER RES, V11, P2947, DOI 10.1158/1078-0432.CCR-04-1469; Okudaira K, 2009, INT J ONCOL, V35, P741, DOI 10.3892/ijo_00000387; Park HJ, 2012, CELL IMMUNOL, V278, P76, DOI 10.1016/j.cellimm.2012.07.001; Raimondi G, 2006, J IMMUNOL, V176, P2808, DOI 10.4049/jimmunol.176.5.2808; Richendollar BG, 2011, HUM PATHOL, V42, P552, DOI 10.1016/j.humpath.2010.08.015; Selenko-Gebauer N, 2003, J IMMUNOL, V170, P3637, DOI 10.4049/jimmunol.170.7.3637; Shi F, 2011, INT J CANCER, V128, P887, DOI 10.1002/ijc.25397; Sznol M, 2013, CLIN CANCER RES, V19, P1021, DOI 10.1158/1078-0432.CCR-12-2063; Thompson RH, 2007, CLIN CANCER RES, V13, P1757, DOI 10.1158/1078-0432.CCR-06-2599; Thompson RH, 2005, CANCER, V104, P2084, DOI 10.1002/cncr.21470; Thompson RH, 2004, P NATL ACAD SCI USA, V101, P17174, DOI 10.1073/pnas.0406351101; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wu CP, 2006, ACTA HISTOCHEM, V108, P19, DOI 10.1016/j.acthis.2006.01.003	32	104	110	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82870	10.1371/journal.pone.0082870	http://dx.doi.org/10.1371/journal.pone.0082870			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349382	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300111
J	Westwood, JH; Groen, SC; Du, ZY; Murphy, AM; Anggoro, DT; Tungadi, T; Luang-In, V; Lewsey, MG; Rossiter, JT; Powell, G; Smith, AG; Carr, JP				Westwood, Jack H.; Groen, Simon C.; Du, Zhiyou; Murphy, Alex M.; Anggoro, Damar Tri; Tungadi, Trisna; Luang-In, Vijitra; Lewsey, Mathew G.; Rossiter, John T.; Powell, Glen; Smith, Alison G.; Carr, John P.			A Trio of Viral Proteins Tunes Aphid-Plant Interactions inArabidopsis thaliana	PLOS ONE			English	Article							CUCUMBER-MOSAIC-VIRUS; GREEN PEACH APHID; REPLICASE-MEDIATED RESISTANCE; ARABIDOPSIS-THALIANA; SALICYLIC-ACID; MYZUS-PERSICAE; 2B PROTEIN; GENE; TRANSMISSION; EXPRESSION	Background: Virus-induced deterrence to aphid feeding is believed to promote plant virus transmission by encouraging migration of virus-bearing insects away from infected plants. We investigated the effects of infection by an aphid-transmitted virus, cucumber mosaic virus (CMV), on the interaction of Arabidopsis thaliana, one of the natural hosts for CMV, with Myzus persicae (common names: 'peach-potato aphid', 'green peach aphid'). Methodology/Principal Findings: Infection of Arabidopsis (ecotype Col-0) with CMV strain Fny (Fny-CMV) induced biosynthesis of the aphid feeding-deterrent 4-methoxy-indol-3-yl-methylglucosinolate (4MI3M). 4MI3M inhibited phloem ingestion by aphids and consequently discouraged aphid settling. The CMV 2b protein is a suppressor of antiviral RNA silencing, which has previously been implicated in altering plant-aphid interactions. Its presence in infected hosts enhances the accumulation of CMV and the other four viral proteins. Another viral gene product, the 2a protein (an RNA-dependent RNA polymerase), triggers defensive signaling, leading to increased 4MI3M accumulation. The 2b protein can inhibit ARGONAUTE1 (AGO1), a host factor that both positively-regulates 4MI3M biosynthesis and negatively-regulates accumulation of substance(s) toxic to aphids. However, the 1a replicase protein moderated 2b-mediated inhibition of AGO1, ensuring that aphids were deterred from feeding but not poisoned. The LS strain of CMV did not induce feeding deterrence in Arabidopsis ecotype Col-0. Conclusions/Significance: Inhibition of AGO1 by the 2b protein could act as a booby trap since this will trigger antibiosis against aphids. However, for Fny-CMV the interplay of three viral proteins (1a, 2a and 2b) appears to balance the need of the virus to inhibit antiviral silencing, while inducing a mild resistance (antixenosis) that is thought to promote transmission. The strain-specific effects of CMV on Arabidopsis-aphid interactions, and differences between the effects of Fny-CMV on this plant and those seen previously in tobacco (inhibition of resistance to aphids) may have important epidemiological consequences.	[Westwood, Jack H.; Groen, Simon C.; Du, Zhiyou; Murphy, Alex M.; Anggoro, Damar Tri; Tungadi, Trisna; Lewsey, Mathew G.; Smith, Alison G.; Carr, John P.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Luang-In, Vijitra; Rossiter, John T.; Powell, Glen] Univ London Imperial Coll Sci Technol & Med, London, England	University of Cambridge; Imperial College London	Westwood, JH (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	jpc1005@hermes.cam.ac.uk	Rossiter, John/AAF-8247-2021; Murphy, Alex/AAU-4861-2020; DU, ZHIYOU/M-7675-2014; Tungadi, Trisna/HDM-6302-2022; Luang-In, Vijitra/P-1297-2019; Groen, Simon/G-2443-2012; Carr, John/H-5646-2016; Tungadi, Trisna/AAT-8578-2021; Lewsey, Mathew G/AAE-8530-2019; Carr, John Peter/N-7707-2019	Murphy, Alex/0000-0002-2226-8759; Luang-In, Vijitra/0000-0002-5009-5058; Carr, John/0000-0002-5028-2160; Carr, John Peter/0000-0002-5028-2160; Tungadi, Trisna/0000-0001-6304-1844; Lewsey, Mathew/0000-0002-2631-4337; Smith, Alison Gail/0000-0001-6511-5704	U.K. Biotechnology and Biological Research Council (BBSRC) [BB/D008204/1, BB/D014376/1, BB/J011762/1]; Leverhulme Trust [F/09 741/F, RPG-2012-667]; Cambridge University Isaac Newton Trust; Cambridge European Trust; BBSRC [BB/J011762/1, BB/D008204/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J011762/1, BB/D008204/1] Funding Source: researchfish	U.K. Biotechnology and Biological Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leverhulme Trust(Leverhulme Trust); Cambridge University Isaac Newton Trust; Cambridge European Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work was funded by grants from the U.K. Biotechnology and Biological Research Council (BBSRC) (BB/D008204/1, BB/D014376/1, BB/J011762/1), The Leverhulme Trust (F/09 741/F, RPG-2012-667), and Cambridge University Isaac Newton Trust. ZD was a EU Marie Curie Fellow (PIIF-GA-2009-236443). SCG was BBSRC-funded with additional support from the Cambridge European Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON TW, 1952, ANN MATH STAT, V23, P193, DOI 10.1214/aoms/1177729437; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Asaoka R, 2010, MOL PLANT MICROBE IN, V23, P332, DOI 10.1094/MPMI-23-3-0332; BANIK MT, 1983, PHYTOPATHOLOGY, V73, P362; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Blanc S, 2011, CURR OPIN MICROBIOL, V14, P483, DOI 10.1016/j.mib.2011.07.008; Boquel S, 2011, EUR J PLANT PATHOL, V129, P507, DOI 10.1007/s10658-010-9732-8; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Canto T, 1997, VIROLOGY, V237, P237, DOI 10.1006/viro.1997.8804; Canto T, 1998, VIROLOGY, V250, P325, DOI 10.1006/viro.1998.9333; Canto T, 2006, J VIROL, V80, P9064, DOI 10.1128/JVI.00953-06; CARR JP, 1994, VIROLOGY, V199, P439, DOI 10.1006/viro.1994.1142; Chou YM, 1998, J QUAL TECHNOL, V30, P133; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Csorba T, 2009, ADV VIRUS RES, V75, P35, DOI 10.1016/S0065-3527(09)07502-2; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dawkins R., 1982, pi; De Vos M, 2007, PLANT SIGNAL BEHAV, V2, P527, DOI 10.4161/psb.2.6.4663; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; DEVONSHIRE AL, 1979, NATURE, V280, P140, DOI 10.1038/280140a0; Gilliland A, 2003, PLANT PHYSIOL, V132, P1518, DOI 10.1104/pp.102.017640; GLAZEBROOK J, 1994, P NATL ACAD SCI USA, V91, P8955, DOI 10.1073/pnas.91.19.8955; Gonzalez I, 2012, RNA, V18, P771, DOI 10.1261/rna.031260.111; Gonzalez I, 2010, MOL PLANT MICROBE IN, V23, P294, DOI 10.1094/MPMI-23-3-0294; Handford MG, 2006, NATURAL RESISTANCE MECHANISMS OF PLANTS TO VIRUSES, P315, DOI 10.1007/1-4020-3780-5_14; Harvey JJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014639; HAYES RJ, 1990, CELL, V63, P363, DOI 10.1016/0092-8674(90)90169-F; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Hunter LJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066530; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; JEFFERSON RA, 1987, EMBO J, V6, P3901; JOHNSON NJ, 1978, J AM STAT ASSOC, V73, P536, DOI 10.2307/2286597; Kettles GJ, 2013, NEW PHYTOL, V198, P1178, DOI 10.1111/nph.12218; Kim JH, 2007, PLANT J, V49, P1008, DOI 10.1111/j.1365-313X.2006.03019.x; Lanet E, 2009, PLANT CELL, V21, P1762, DOI 10.1105/tpc.108.063412; LEATHER SR, 1984, ENTOMOL EXP APPL, V35, P137, DOI 10.1007/BF00217532; Lewsey M, 2007, PLANT J, V50, P240, DOI 10.1111/j.1365-313X.2007.03042.x; Lewsey MG, 2010, MOL PLANT MICROBE IN, V23, P835, DOI 10.1094/MPMI-23-7-0835; Lewsey MG, 2009, J GEN VIROL, V90, P3010, DOI 10.1099/vir.0.014555-0; Li Y, 2010, PLANT PHYSIOL, V152, P2222, DOI 10.1104/pp.109.151803; Lu BB, 2011, J BIOSCIENCES, V36, P123, DOI 10.1007/s12038-011-9016-2; Mauck K, 2012, FUNCT ECOL, V26, P1162, DOI 10.1111/j.1365-2435.2012.02026.x; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Ng J, 1999, PLANT PATHOL, V48, P388, DOI 10.1046/j.1365-3059.1999.00348.x; Ng JCK, 2004, MOL PLANT PATHOL, V5, P505, DOI [10.1111/j.1364-3703.2004.00240.x, 10.1111/J.1364-3703.2004.00240.X]; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Pagan I, 2010, PHILOS T R SOC B, V365, P1983, DOI 10.1098/rstb.2010.0062; Palukaitis P, 2003, ADV VIRUS RES, V62, P241, DOI 10.1016/S0065-3527(03)62005-1; PALUKAITIS P, 1992, ADV VIRUS RES, V41, P281, DOI 10.1016/B978-0-12-394314-9.00013-0; Pfalz M, 2009, PLANT CELL, V21, P985, DOI 10.1105/tpc.108.063115; Powell G, 2005, J GEN VIROL, V86, P469, DOI 10.1099/vir.0.80632-0; PROVVIDENTI R, 1980, HORTSCIENCE, V15, P528; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; RIZZO TM, 1990, MOL GEN GENET, V222, P249, DOI 10.1007/BF00633825; Robert-Seilaniantz A, 2011, PLANT J, V67, P218, DOI 10.1111/j.1365-313X.2011.04591.x; ROOSSINCK MJ, 1990, MOL PLANT MICROBE IN, V3, P188, DOI 10.1094/MPMI-3-188; ROSSITER JT, 1990, PHYTOCHEMISTRY, V29, P2509, DOI 10.1016/0031-9422(90)85177-H; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ryabov EV, 2001, VIROLOGY, V286, P363, DOI 10.1006/viro.2001.0982; Sarria E, 2009, COMPUT ELECTRON AGR, V67, P35, DOI 10.1016/j.compag.2009.02.006; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Sisterson MS, 2008, J ECON ENTOMOL, V101, P1, DOI 10.1603/0022-0493(2008)101[1:EOIPFH]2.0.CO;2; Soards AJ, 2002, MOL PLANT MICROBE IN, V15, P647, DOI 10.1094/MPMI.2002.15.7.647; Stewart SA, 2009, MOL PLANT MICROBE IN, V22, P1645, DOI 10.1094/MPMI-22-12-1645; Surplus SL, 1998, PLANT CELL ENVIRON, V21, P685, DOI 10.1046/j.1365-3040.1998.00325.x; Suzuki M, 2003, J GEN VIROL, V84, P1931, DOI 10.1099/vir.0.19070-0; TJALLINGII WF, 1993, PHYSIOL ENTOMOL, V18, P317, DOI 10.1111/j.1365-3032.1993.tb00604.x; TJALLINGII WF, 1978, ENTOMOL EXP APPL, V24, P721, DOI 10.1007/BF02385128; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Westwood JH, 2013, MOL PLANT PATHOL, V14, P158, DOI 10.1111/j.1364-3703.2012.00840.x; Westwood JH, 2010, ADV VIRUS RES, V76, P179, DOI 10.1016/S0065-3527(10)76005-X; Whitham SA, 2003, PLANT J, V33, P271, DOI 10.1046/j.1365-313X.2003.01625.x; Xu P, 2008, NEW PHYTOL, V180, P911, DOI 10.1111/j.1469-8137.2008.02627.x; Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169; ZAITLIN M, 1994, VIROLOGY, V201, P200, DOI 10.1006/viro.1994.1286; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; ZHANG L, 1994, J GEN VIROL, V75, P3185, DOI 10.1099/0022-1317-75-11-3185; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Ziebell H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00187; Ziebell H, 2009, J GEN VIROL, V90, P2288, DOI 10.1099/vir.0.012070-0	85	54	54	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83066	10.1371/journal.pone.0083066	http://dx.doi.org/10.1371/journal.pone.0083066			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349433	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300129
J	Gabriel, BM; Pugh, J; Pruneta-Deloche, V; Moulin, P; Ratkevicius, A; Gray, SR				Gabriel, Brendan Morris; Pugh, Jamie; Pruneta-Deloche, Valerie; Moulin, Philippe; Ratkevicius, Aivaras; Gray, Stuart Robert			The Effect of High Intensity Interval Exercise on Postprandial Triacylglycerol and Leukocyte Activation - Monitored for 48h Post Exercise	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE ACTIVITY; B SCAVENGER RECEPTOR; MODERATE EXERCISE; LIPID-METABOLISM; SKELETAL-MUSCLE; SPRINT INTERVAL; ENDOTHELIAL DYSFUNCTION; PHYSICAL-ACTIVITY; VITAMIN-C; FAT MEAL	Postprandial phenomenon are thought to contribute to atherogenesis alongside activation of the immune system. A single bout of high intensity interval exercise attenuates postprandial triacylglycerol (TG), although the longevity and mechanisms underlying this observation are unknown. The aims of this study were to determine whether this attenuation in postprandial TG remained 2 days after high intensity interval exercise, to monitor markers of leukocyte activation and investigate the underlying mechanisms. Eight young men each completed two three day trials. On day 1: subjects rested (Control) or performed 5 x 30 s maximal sprints (high intensity interval exercise). On day 2 and 3 subjects consumed high fat meals for breakfast and 3 h later for lunch. Blood samples were taken at various times and analysed for TG, glucose and TG-rich lipoprotein (TRL)-bound LPL-dependent TRL-TG hydrolysis (LTTH). Flow cytometry was used to evaluate granulocyte, monocyte and lymphocyte CD11b and CD36 expression. On day 2 after high intensity interval exercise TG area under the curve was lower (P<0.05) (7.46 +/- 1.53 mmol/l/7h) compared to the control trial (9.47 +/- 3.04 mmol/l/7h) with no differences during day 3 of the trial. LTTH activity was higher (P<0.05) after high intensity interval exercise, at 2 hours of day 2, compared to control. Granulocyte, monocyte and lymphocyte CD11b expression increased with time over day 2 and 3 of the study (P<0.0001). Lymphocyte and monocyte CD36 expression decreased with time over day 2 and 3 (P<0.05). There were no differences between trials in CD11b and CD36 expression on any leukocytes. A single session of high intensity interval exercise attenuated postprandial TG on day 2 of the study, with this effect abolished by day 3. The reduction in postprandial TG was associated with an increase in LTTH. High intensity interval exercise had no effect on postprandial responses of CD11b or CD36.	[Gabriel, Brendan Morris; Ratkevicius, Aivaras; Gray, Stuart Robert] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland; [Pruneta-Deloche, Valerie; Moulin, Philippe] Univ Lyon, Hop Louis Pradel, Dept Endocrinol, Lyon, France; [Pugh, Jamie] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England	University of Aberdeen; CHU Lyon; Loughborough University	Gray, SR (corresponding author), Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland.	s.r.gray@abdn.ac.uk	Gabriel, Brendan/AAH-2625-2019; Gray, Stuart R/L-2489-2017	Gabriel, Brendan/0000-0001-6878-8779; Gray, Stuart R/0000-0001-8969-9636	Saltire Energy Studentship	Saltire Energy Studentship	BG was supported by a Saltire Energy Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Al-Shayji IAR, 2012, AM J PHYSIOL-ENDOC M, V302, pE349, DOI 10.1152/ajpendo.00498.2011; Alipour A, 2008, ARTERIOSCL THROM VAS, V28, P792, DOI 10.1161/ATVBAHA.107.159749; Anderson RA, 2006, DIABETIC MED, V23, P258, DOI 10.1111/j.1464-5491.2005.01767.x; Babraj JA, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-3; Bae JH, 2001, ATHEROSCLEROSIS, V155, P517, DOI 10.1016/S0021-9150(00)00601-8; Bartlett JD, 2011, J SPORT SCI, V29, P547, DOI 10.1080/02640414.2010.545427; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; CRIQUI MH, 1993, NEW ENGL J MED, V328, P1220, DOI 10.1056/NEJM199304293281702; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Evans M, 2003, EUR J CLIN INVEST, V33, P231, DOI 10.1046/j.1365-2362.2003.01120.x; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Ferguson MA, 1998, J APPL PHYSIOL, V85, P1169, DOI 10.1152/jappl.1998.85.3.1169; Freese EC, 2011, J APPL PHYSIOL, V111, P1584, DOI 10.1152/japplphysiol.00416.2011; FUSTER V, 2010, M CHALLENGES DEV COU, P6; Gabriel B, 2012, CLIN SCI, V123, P313, DOI 10.1042/CS20110600; Gaenzer H, 2001, CARDIOVASC RES, V52, P509, DOI 10.1016/S0008-6363(01)00427-8; Giannotti G, 2007, HERZ, V32, P568, DOI 10.1007/s00059-007-3073-1; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gill JMR, 2003, J NUTR BIOCHEM, V14, P122, DOI 10.1016/S0955-2863(02)00275-9; Gill JMR, 2003, EUR J APPL PHYSIOL, V89, P184, DOI 10.1007/s00421-002-0788-9; Gill JMR, 2001, CLIN SCI, V100, P517, DOI 10.1042/CS20000258; Gill JMR, 2001, EUR J CLIN INVEST, V31, P201, DOI 10.1046/j.1365-2362.2001.00799.x; Gower RM, 2011, ARTERIOSCL THROM VAS, V31, P160, DOI 10.1161/ATVBAHA.110.215434; Hamilton MT, 1998, AM J PHYSIOL-ENDOC M, V275, pE1016, DOI 10.1152/ajpendo.1998.275.6.E1016; Han DH, 2009, AM J PHYSIOL-ENDOC M, V297, pE236, DOI 10.1152/ajpendo.00244.2009; Han JH, 2000, J BIOL CHEM, V275, P1241, DOI 10.1074/jbc.275.2.1241; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hardman AE, 1998, J APPL PHYSIOL, V84, P1895, DOI 10.1152/jappl.1998.84.6.1895; Herd SL, 2000, J APPL PHYSIOL, V89, P2049, DOI 10.1152/jappl.2000.89.5.2049; Herd SL, 2001, METABOLISM, V50, P756, DOI 10.1053/meta.2001.24199; Herd SL, 1998, BRIT J NUTR, V80, P57, DOI 10.1017/S0007114598001779; KANNEL WB, 1971, ANN INTERN MED, V74, P1, DOI 10.7326/0003-4819-74-1-1; KANTOR MA, 1984, METABOLISM, V33, P454, DOI 10.1016/0026-0495(84)90147-1; Klop B, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/947417; Magkos F, 2006, AM J PHYSIOL-ENDOC M, V290, pE355, DOI 10.1152/ajpendo.00259.2005; Miyashita M, 2008, AM J CLIN NUTR, V88, P1225, DOI 10.3945/ajcn.2008.26493; Miyashita M, 2008, BRIT J NUTR, V99, P1076, DOI 10.1017/S0007114507853438; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Peddie MC, 2012, PROG LIPID RES, V51, P11, DOI 10.1016/j.plipres.2011.11.002; Pruneta-Deloche V, 2004, J LIPID RES, V45, P859, DOI 10.1194/jlr.M300435-JLR200; Rakobowchuk M, 2008, AM J PHYSIOL-REG I, V295, pR236, DOI 10.1152/ajpregu.00069.2008; SADY SP, 1986, JAMA-J AM MED ASSOC, V256, P2552, DOI 10.1001/jama.256.18.2552; Silverstein RL, 2000, CURR OPIN LIPIDOL, V11, P483, DOI 10.1097/00041433-200010000-00006; Smith J C, 1991, Br J Sports Med, V25, P196; Strohacker K, 2012, APPL PHYSIOL NUTR ME, V37, P530, DOI [10.1139/h2012-034, 10.1139/H2012-034]; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Van Berkel TJC, 2000, ANN NY ACAD SCI, V902, P113; Yiannis TE, 2007, METABOLISM, V56, P1037, DOI 10.1016/j.metabol.2007.03.012; Zamora C, 2012, CYTOKINE, V60, P257, DOI 10.1016/j.cyto.2012.06.020; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473	50	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82669	10.1371/journal.pone.0082669	http://dx.doi.org/10.1371/journal.pone.0082669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349333	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000328705200090
J	Liepelt-Scarfone, I; Berger, MF; Prakash, D; Csoti, I; Graber, S; Maetzler, W; Berg, D				Liepelt-Scarfone, Inga; Berger, Monika Fruhmann; Prakash, Deborah; Csoti, Ilona; Graeber, Susanne; Maetzler, Walter; Berg, Daniela			Clinical Characteristics with an Impact on ADL Functions of PD Patients with Cognitive Impairment Indicative of Dementia	PLOS ONE			English	Article							PARKINSONS-DISEASE DEMENTIA; QUALITY-OF-LIFE; INSTRUMENTAL ACTIVITIES; DIAGNOSTIC-CRITERIA; DISABILITY; DEFICITS; DECLINE; BURDEN; INDIVIDUALS; PROGRESSION	Background: Dementia in Parkinson's disease (PD) is defined as cognitive decline severe enough to affect activities of daily living function (ADL). The aim of our exploratory study was to compare two groups of PD patients. Both groups had cognitive deficits severe enough to justify diagnosis of dementia, but they differed according to caregivers' rating on ADL dysfunction. Parameters which differed between the two groups were interpreted to affect the caregivers' perception of ADL dysfunction in PD patients with cognitive impairment indicative of Parkinson's disease dementia. Methodology/Principal Findings: Thirty of 131 Parkinson's disease patients fulfilled the Movement Disorders Society Task Force - recommended, cognitive Level-I-criteria for dementia. According to standardized caregiver ratings, volunteers were grouped into 18 patients with (ADL-) and 12 without instrumental activities of daily living dysfunction (ADL+). Caregiver activities of daily living function ratings closely correlated with self-estimates of patients and those of physician (p<0.001). ADL-patients performed worse on tests assessing visual-construction (p<0.05) and attention (p=0.03) than ADL+ patients. Moreover, the postural instability and gait disorder subtype was more frequent in ADL-patients (p=0.009). ADL-patients tended to have more communication problems (p=0.05), more anxiety (p=0.05) and showed a tendency to be treated more often with neuroleptics (p=0.049) than ADL+. Conclusions/Significance: Results indicate that worse attention, visual-construction abilities, the postural instability and gait disorder subtype, communication problems, medication and presence of anxiety are related to activities of daily living dysfunctions in Parkinson's disease patients with cognitive decline indicative of dementia. Our data suggests that not only cognitive factors but also non-cognitive factors seem to be linked to the diagnosis of Parkinson's disease dementia associated with significant impact on instrumental activities of daily living function. Further studies with larger sample sizes are needed to verify our results.	[Liepelt-Scarfone, Inga; Berger, Monika Fruhmann; Prakash, Deborah; Graeber, Susanne; Maetzler, Walter; Berg, Daniela] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Liepelt-Scarfone, Inga; Berger, Monika Fruhmann; Prakash, Deborah; Graeber, Susanne; Maetzler, Walter; Berg, Daniela] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat, Tubingen, Germany; [Csoti, Ilona] Gertrudis Hosp, Dept Neurol, Leun Biskirchen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Liepelt-Scarfone, I (corresponding author), German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany.	Inga.Liepelt@dzne.de	Maetzler, Walter/A-6796-2011; Maetzler, Walter/AAE-5831-2020; Berg, Daniela/A-8728-2019	Maetzler, Walter/0000-0002-5945-4694; Maetzler, Walter/0000-0002-5945-4694; Berg, Daniela/0000-0001-5796-5442				Aarsland D, 2004, ARCH NEUROL-CHICAGO, V61, P1906, DOI 10.1001/archneur.61.12.1906; Aarsland D, 2012, NAT REV NEUROL, V8, P35, DOI 10.1038/nrneurol.2011.189; Alves G, 2005, NEUROLOGY, V65, P1436, DOI 10.1212/01.wnl.0000183359.50822.f2; Alves G, 2006, MOVEMENT DISORD, V21, P1123, DOI 10.1002/mds.20897; Azuma T, 2003, INT J GERIATR PSYCH, V18, P1043, DOI 10.1002/gps.1015; Barton B, 2012, MOVEMENT DISORD, V27, P248, DOI 10.1002/mds.24059; Bronnick K, 2006, J NEUROL NEUROSUR PS, V77, P1136, DOI 10.1136/jnnp.2006.093146; Cahn DA, 1998, ARCH CLIN NEUROPSYCH, V13, P575, DOI 10.1016/S0887-6177(98)00024-9; Christ JBM, 2013, PARKINSONISM RELAT D, V19, P371, DOI 10.1016/j.parkreldis.2012.11.004; Colman KSF, 2009, CORTEX, V45, P930, DOI 10.1016/j.cortex.2008.12.010; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Di Battista ME, 2011, J NEURAL TRANSM, V118, P1609, DOI 10.1007/s00702-011-0638-1; Dubois B, 2007, MOVEMENT DISORD, V22, P2314, DOI 10.1002/mds.21844; Dujardin K, 2010, MOVEMENT DISORD, V25, P2769, DOI 10.1002/mds.23391; Dymek MP, 2001, NEUROLOGY, V56, P17, DOI 10.1212/WNL.56.1.17; Emre M, 2007, MOVEMENT DISORD, V22, P1689, DOI 10.1002/mds.21507; Esselink RAJ, 2004, NEUROLOGY, V62, P201, DOI 10.1212/01.WNL.0000103235.12621.C3; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forsaa EB, 2010, NEUROLOGY, V75, P1270, DOI 10.1212/WNL.0b013e3181f61311; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Goldman JG, 2012, MOVEMENT DISORD, V27, P1129, DOI 10.1002/mds.25062; Grosset K, 2004, MOVEMENT DISORD, V19, P1370, DOI 10.1002/mds.20210; Haerting C, 2000, WECHSLER GEDACHTNIST; Hariz GM, 2011, ACTA NEUROL SCAND, V123, P20, DOI 10.1111/j.1600-0404.2010.01344.x; Hautzinger M., 1995, BECKS DEPRESSIONS IN; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Ho AK, 1998, BEHAV NEUROL, V11, P131, DOI 10.1155/1999/327643; Hobson JP, 2001, CLIN REHABIL, V15, P241, DOI 10.1191/026921501666767060; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Holroyd S, 2005, NEUROLOGY, V64, P2134, DOI 10.1212/01.WNL.0000165958.12724.0D; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Jankovic J, 2001, ARCH NEUROL-CHICAGO, V58, P1611, DOI 10.1001/archneur.58.10.1611; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; Kalbe E, 2008, PARKINSONISM RELAT D, V14, P93, DOI 10.1016/j.parkreldis.2007.06.008; Liepelt I., 2007, Z NEUROPSYCHOL, V18, P193, DOI DOI 10.1024/1016-264X.18.3.193; Liepelt-Scarfone I, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/540843; Marson D, 2001, NEUROLOGIST, V7, P317, DOI 10.1097/00127893-200111000-00001; Martinez-Martin P, 2008, MOVEMENT DISORD, V23, P1673, DOI 10.1002/mds.22106; Martinez-Martin R, 2011, PARKINSONISM RELAT D, V17, P621, DOI 10.1016/j.parkreldis.2011.05.017; Memory Clinic. NPZ, 2005, CONS EST REG ALZH DI; Miller N, 2008, CLIN REHABIL, V22, P14, DOI 10.1177/0269215507079096; Oswald W.D., 1999, NURNBERGER ALTERS IN, V4th; Poletti M, 2012, J NEUROL SCI, V317, P97, DOI 10.1016/j.jns.2012.02.022; Rasovska H, 2011, J NEUROL SCI, V310, P279, DOI 10.1016/j.jns.2011.07.048; Razani J, 2007, J AM GERIATR SOC, V55, P1415, DOI 10.1111/j.1532-5415.2007.01307.x; Riedel O, 2010, J NEUROL, V257, P1073, DOI 10.1007/s00415-010-5465-z; Roland KP, 2010, MOVEMENT DISORD, V25, P189, DOI 10.1002/mds.22939; Rosenthal E, 2010, MOVEMENT DISORD, V25, P1170, DOI 10.1002/mds.23073; Schwab J., 1969, PROJECTION TECHNIQUE; STARKSTEIN SE, 1992, J NEUROL NEUROSUR PS, V55, P377, DOI 10.1136/jnnp.55.5.377; Stepkina D A, 2010, Neurosci Behav Physiol, V40, P61, DOI 10.1007/s11055-009-9223-6; Stoffers D, 2007, BRAIN, V130, P1847, DOI 10.1093/brain/awm034; Tucha O, 2004, TOWER LONDON; Warrington EK, 1992, THESIS THAMES VALLEY; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; Zhao YJ, 2008, EUR J NEUROL, V15, P737, DOI 10.1111/j.1468-1331.2008.02178.x; Zimmermann P., 2002, TESTBATTERIE AUFMERK	58	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82902	10.1371/journal.pone.0082902	http://dx.doi.org/10.1371/journal.pone.0082902			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VD	24349393	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200113
J	Zhou, R; Yang, ZL; Tang, XR; Tan, Y; Wu, XF; Liu, F				Zhou, Rong; Yang, Zailiang; Tang, Xurong; Tan, Yan; Wu, Xiaofeng; Liu, Feng			Propofol Protects Against Focal Cerebral Ischemia via Inhibition of Microglia-Mediated Proinflammatory Cytokines in a Rat Model of Experimental Stroke	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; ACTIVATION; NEUROPROTECTION; INJURY; NEURODEGENERATION; PROLIFERATION; INTERLEUKIN-1; TRANSLATION; DYSFUNCTION; EXPRESSION	Ischemic stroke induces microglial activation and release of proinflammatory cytokines, contributing to the expansion of brain injury and poor clinical outcome. Propofol has been shown to ameliorate neuronal injury in a number of experimental studies, but the precise mechanisms involved in its neuroprotective effects remain unclear. We tested the hypothesis that propofol confers neuroprotection against focal ischemia by inhibiting microglia-mediated inflammatory response in a rat model of ischemic stroke. Sprague-Dawley rats were subjected to middle cerebral artery occlusion (MCAO) for 2 h followed by 24 h of reperfusion. Propofol (50 mg/kg/h) or vehicle was infused intravenously at the onset of reperfusion for 30 minutes. In vehicle-treated rats, MCAO resulted in significant cerebral infarction, higher neurological deficit scores and decreased time on the rotarod compared with sham-operated rats. Propofol treatment reduced infarct volume and improved the neurological functions. In addition, molecular studies demonstrated that mRNA expression of microglial marker Cd68 and Emr1 was significantly increased, and mRNA and protein expressions of proinflammatory cytokines tumor necrosis factor-alpha, interleukin-1 beta and interleukin-6 were augmented in the peri-infarct cortical regions of vehicle-treated rats 24 h after MCAO. Immunohistochemical study revealed that number of total microglia and proportion of activated microglia in the peri-infarct cortical regions were markedly elevated. All of these findings were ameliorated in propofol-treated rats. Furthermore, vehicle-treated rats had higher plasma levels of interleukin-6 and C-reactive protein 24 h after MCAO, which were decreased after treatment with propofol. These results suggest that propofol protects against focal cerebral ischemia via inhibition of microglia-mediated proinflammatory cytokines. Propofol may be a promising therapeutic agent for the treatment of ischemic stroke and other neurodegenerative diseases associated with microglial activation.	[Zhou, Rong; Tang, Xurong] Chongqing Med Univ, Childrens Hosp, Dept Operating Room, Chongqing, Peoples R China; [Zhou, Rong; Liu, Feng] Chongqing Med Univ, Childrens Hosp, Key Lab Child Dev & Disorders, Minist Educ, Chongqing, Peoples R China; [Yang, Zailiang] Acad Mil Med Sci, Affiliated Hosp, Hematopoiet Stem Cell Transplantat & Gene Therapy, Beijing, Peoples R China; [Yang, Zailiang] Third Mil Med Univ, Daping Hosp, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China; [Yang, Zailiang; Tan, Yan; Wu, Xiaofeng] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Chongqing, Peoples R China; [Liu, Feng] Chongqing Med Univ, Childrens Hosp, Dept Anesthesiol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Academy of Military Medical Sciences - China; Army Medical University; Army Medical University; Chongqing Medical University	Liu, F (corresponding author), Chongqing Med Univ, Childrens Hosp, Key Lab Child Dev & Disorders, Minist Educ, Chongqing, Peoples R China.	liuf-cmu@hotmail.com			Chongqing Medical University Research Foundation	Chongqing Medical University Research Foundation	The work was supported by Chongqing Medical University Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An K, 2008, ANAESTHESIA, V63, P1187, DOI 10.1111/j.1365-2044.2008.05627.x; Arrick DM, 2012, J APPL PHYSIOL, V113, P1121, DOI 10.1152/japplphysiol.00437.2012; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Barreto George, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P164; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Chen HI, 2008, CRIT CARE MED, V36, P1214, DOI 10.1097/CCM.0b013e31816a0607; Chen YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040165; Corcoran TB, 2004, J CARDIOTHOR VASC AN, V18, P592, DOI 10.1053/j.jvca.2004.07.018; DiNapoli VA, 2010, NEUROSCIENCE, V170, P633, DOI 10.1016/j.neuroscience.2010.07.011; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Emsley HCA, 2003, J NEUROIMMUNOL, V139, P93, DOI 10.1016/S0165-5728(03)00134-6; Ferrarese C, 1999, J CEREBR BLOOD F MET, V19, P1004, DOI 10.1097/00004647-199909000-00008; Gui B, 2012, INFLAMMATION, V35, P1632, DOI 10.1007/s10753-012-9478-x; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Li DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073334; Liang C, 2013, J NEUROSURG ANESTH, V25, P311, DOI 10.1097/ANA.0b013e31828c6af5; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Marik PE, 2005, PHARMACOTHERAPY, V25, p28S, DOI 10.1592/phco.2005.25.5_Part_2.28S; Mizoguchi K, 2002, PHARMACOL BIOCHEM BE, V71, P79, DOI 10.1016/S0091-3057(01)00636-0; Patzer A, 2008, EUR J NEUROSCI, V28, P1786, DOI 10.1111/j.1460-9568.2008.06478.x; Rana I, 2010, BRAIN RES, V1326, P96, DOI 10.1016/j.brainres.2010.02.028; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rothwell N, 1997, J CLIN INVEST, V100, P2648, DOI 10.1172/JCI119808; Schellinger PD, 2004, CURR OPIN NEUROL, V17, P69, DOI 10.1097/00019052-200402000-00012; Smith CJ, 2013, J NEUROIMMUNE PHARM, V8, P867, DOI 10.1007/s11481-013-9469-1; Stolp HB, 2009, NEUROPATH APPL NEURO, V35, P132, DOI 10.1111/j.1365-2990.2008.01005.x; Taniguchi T, 2000, CRIT CARE MED, V28, P1101, DOI 10.1097/00003246-200004000-00032; Taniguchi T, 2002, CRIT CARE MED, V30, P904, DOI 10.1097/00003246-200204000-00032; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Vila N, 2000, STROKE, V31, P2325, DOI 10.1161/01.STR.31.10.2325; Wang HY, 2011, J NEUROCHEM, V119, P210, DOI 10.1111/j.1471-4159.2011.07400.x; Wang XK, 2005, EXPERT OPIN INV DRUG, V14, P393, DOI 10.1517/13543784.14.4.393; Wang YY, 2013, MOL CELL ENDOCRINOL, V367, P50, DOI 10.1016/j.mce.2012.12.016; Wei ZL, 2011, STROKE, V42, P2589, DOI 10.1161/STROKEAHA.111.614834; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676; Yang SC, 2013, J IMMUNOL, V190, P6511, DOI 10.4049/jimmunol.1202215; Ye XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052887; Yilmaz G, 2008, NEUROL RES, V30, P783, DOI 10.1179/174313208X341085; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Yu GX, 2011, SURGERY, V150, P887, DOI 10.1016/j.surg.2011.04.002; Zhao XC, 2013, NEUROCHEM RES, V38, P530, DOI 10.1007/s11064-012-0945-4; Zhao Y, 2005, EUR J NEUROSCI, V22, P278, DOI 10.1111/j.1460-9568.2005.04200.x; Zhou HT, 2012, MOL MED REP, V5, P842, DOI 10.3892/mmr.2011.719	45	45	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82729	10.1371/journal.pone.0082729	http://dx.doi.org/10.1371/journal.pone.0082729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349350	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200095
J	Yanik, M; Alzubi, J; Lahaye, T; Cathomen, T; Pingoud, A; Wende, W				Yanik, Mert; Alzubi, Jamal; Lahaye, Thomas; Cathomen, Toni; Pingoud, Alfred; Wende, Wolfgang			TALE-Pvull Fusion Proteins - Novel Tools for Gene Targeting	PLOS ONE			English	Article							ZINC-FINGER NUCLEASES; DNA-BINDING SPECIFICITY; RESTRICTION-ENDONUCLEASE; PVUII ENDONUCLEASE; CRYSTAL-STRUCTURE; GENOME; FOKI; EFFECTORS; SITE; TOXICITY	Zinc finger nucleases (ZFNs) consist of zinc fingers as DNA-binding module and the non-specific DNA-cleavage domain of the restriction endonuclease FokI as DNA-cleavage module. This architecture is also used by TALE nucleases (TALENs), in which the DNA-binding modules of the ZFNs have been replaced by DNA-binding domains based on transcription activator like effector (TALE) proteins. Both TALENs and ZFNs are programmable nucleases which rely on the dimerization of FokI to induce double-strand DNA cleavage at the target site after recognition of the target DNA by the respective DNA-binding module. TALENs seem to have an advantage over ZFNs, as the assembly of TALE proteins is easier than that of ZFNs. Here, we present evidence that variant TALENs can be produced by replacing the catalytic domain of FokI with the restriction endonuclease PvuII. These fusion proteins recognize only the composite recognition site consisting of the target site of the TALE protein and the PvuII recognition sequence (addressed site), but not isolated TALE or PvuII recognition sites (unaddressed sites), even at high excess of protein over DNA and long incubation times. In vitro, their preference for an addressed over an unaddressed site is > 34,000-fold. Moreover, TALE-PvuII fusion proteins are active in cellula with minimal cytotoxicity.	[Yanik, Mert; Pingoud, Alfred; Wende, Wolfgang] Univ Giessen, Inst Biochem, D-35390 Giessen, Germany; [Alzubi, Jamal; Cathomen, Toni] Univ Med Ctr Freiburg, Inst Cell & Gene Therapy, Freiburg, Germany; [Alzubi, Jamal; Cathomen, Toni] Univ Med Ctr Freiburg, Ctr Chron Immunodeficiency, Freiburg, Germany; [Lahaye, Thomas] Univ Tubingen, ZMBP Gen Genet, Tubingen, Germany	Justus Liebig University Giessen; University of Freiburg; University of Freiburg; Eberhard Karls University of Tubingen	Wende, W (corresponding author), Univ Giessen, Inst Biochem, D-35390 Giessen, Germany.	wolfgang.wende@chemie.bio.uni-giessen.de	Cathomen, Toni/ABG-8410-2021; Cathomen, Toni/GZL-2702-2022; Wende, Wolfgang/F-6127-2014	Cathomen, Toni/0000-0002-7757-4630; Cathomen, Toni/0000-0002-7757-4630; Wende, Wolfgang/0000-0001-6577-9535; Alzubi, Jamal/0000-0003-4284-2006	Deutsche Forschungsgemeinschaft [International Research Training Group GRK 1384]; Deutsche Forschungsgemeinschaft [Excellence Cluster ECCPS]; Bundesministerium fur Bildung und Forschung [ReGene - 01GN1003D]	Deutsche Forschungsgemeinschaft [International Research Training Group GRK 1384]; Deutsche Forschungsgemeinschaft [Excellence Cluster ECCPS](German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by the Deutsche Forschungsgemeinschaft [International Research Training Group GRK 1384 to WW and Excellence Cluster ECCPS to AP] and the Bundesministerium fur Bildung und Forschung [ReGene - 01GN1003D to TC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwin S, 2005, MOL THER, V12, P610, DOI 10.1016/j.ymthe.2005.06.094; [Anonymous], 2011, NAT BIOTECHNOL, V29, P681, DOI 10.1038/nbt.1935; ATHANASIADIS A, 1994, NAT STRUCT BIOL, V1, P469, DOI 10.1038/nsb0794-469; Beurdeley M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2782; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; BONAS U, 1989, MOL GEN GENET, V218, P127, DOI 10.1007/BF00330575; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Camenisch TD, 2008, MINI-REV MED CHEM, V8, P669, DOI 10.2174/138955708784567458; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Carroll D, 2011, CURR GENE THER, V11, P2, DOI 10.2174/156652311794520076; Catto LE, 2006, NUCLEIC ACIDS RES, V34, P1711, DOI 10.1093/nar/gkl076; CHENG XD, 1994, EMBO J, V13, P3927, DOI 10.1002/j.1460-2075.1994.tb06708.x; Chiang WC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011837; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Clark KJ, 2011, ZEBRAFISH, V8, P147, DOI 10.1089/zeb.2011.9993; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cornu TI, 2008, MOL THER, V16, P352, DOI 10.1038/sj.mt.6300357; Eisenschmidt K, 2005, NUCLEIC ACIDS RES, V33, P7039, DOI 10.1093/nar/gki1009; Fonfara I, 2012, NUCLEIC ACIDS RES, V40, P847, DOI 10.1093/nar/gkr788; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gabsalilow L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt080; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Galetto R, 2009, EXPERT OPIN BIOL TH, V9, P1289, DOI 10.1517/14712590903213669; Geel TM, 2009, EXP CELL RES, V315, P2487, DOI 10.1016/j.yexcr.2009.06.011; Handel EM, 2011, CURR GENE THER, V11, P28, DOI 10.2174/156652311794520120; Halford SE, 2011, BIOCHEM SOC T, V39, P584, DOI 10.1042/BST0390584; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KACZOROWSKI T, 1989, GENE, V80, P209, DOI 10.1016/0378-1119(89)90285-0; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kleinstiver BP, 2012, P NATL ACAD SCI USA, V109, P8061, DOI 10.1073/pnas.1117984109; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Mak ANS, 2013, CURR OPIN STRUC BIOL, V23, P93, DOI 10.1016/j.sbi.2012.11.001; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marcaida MJ, 2010, CELL MOL LIFE SCI, V67, P727, DOI 10.1007/s00018-009-0188-y; McMahon MA, 2012, NAT METHODS, V9, P28, DOI 10.1038/nmeth.1811; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mussolino C, 2013, NAT BIOTECHNOL, V31, P208, DOI 10.1038/nbt.2527; Mussolino C, 2011, NUCLEIC ACIDS RES, V39, P9283, DOI 10.1093/nar/gkr597; OELGESCHLAGER T, 1990, GENE, V89, P19, DOI 10.1016/0378-1119(90)90201-2; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Pauwels K, 2013, N BIOTECHNOL, DOI [10.1016/j.nbt.2013.1007.1001, DOI 10.1016/J.NBT.2013.1007.1001]; Perez-Pinera P, 2012, CURR OPIN CHEM BIOL, V16, P268, DOI 10.1016/j.cbpa.2012.06.007; Pernstich C, 2012, NUCLEIC ACIDS RES, V40, P1203, DOI 10.1093/nar/gkr809; Pingoud A, 2001, NUCLEIC ACIDS RES, V29, P3705, DOI 10.1093/nar/29.18.3705; Pingoud A, 2007, NAT BIOTECHNOL, V25, P743, DOI 10.1038/nbt0707-743; Pingoud A, 2011, CHEMBIOCHEM, V12, P1495, DOI 10.1002/cbic.201100055; Rahman SH, 2011, HUM GENE THER, V22, P925, DOI 10.1089/hum.2011.087; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Romer P, 2007, SCIENCE, V318, P645, DOI 10.1126/science.1144958; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Rusling DA, 2012, NUCLEIC ACIDS RES, V40, P4977, DOI 10.1093/nar/gks183; Schierling B, 2012, NUCLEIC ACIDS RES, V40, P2623, DOI 10.1093/nar/gkr1112; Scholze H, 2011, CURR OPIN MICROBIOL, V14, P47, DOI 10.1016/j.mib.2010.12.001; Silanskas A, 2011, BIOCHEMISTRY-US, V50, P2800, DOI 10.1021/bi2000609; Silva G, 2011, CURR GENE THER, V11, P11, DOI 10.2174/156652311794520111; Simoncsits A, 2001, J MOL BIOL, V309, P89, DOI 10.1006/jmbi.2001.4651; Sollu C, 2010, NUCLEIC ACIDS RES, V38, P8269, DOI 10.1093/nar/gkq720; Stoddard BL, 2008, PROGR GENE THERAPY, P135; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; SUGISAKI H, 1981, GENE, V16, P73; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; SZYBALSKI W, 1991, GENE, V100, P13, DOI 10.1016/0378-1119(91)90345-C; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; van der Oost J, 2013, SCIENCE, V339, P768, DOI 10.1126/science.1234726; Vanamee ES, 2001, J MOL BIOL, V309, P69, DOI 10.1006/jmbi.2001.4635; Wang Z, 2012, ASIA PACIFIC SIGNAL, P1; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zhu Z, 2009, [No title captured], Patent No. [US 2009/0029376 A1, 20090029376]	77	17	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82539	10.1371/journal.pone.0082539	http://dx.doi.org/10.1371/journal.pone.0082539			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349308	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100117
J	Du, GX; Stinski, MF				Du, Guixin; Stinski, Mark F.			Interaction Network of Proteins Associated with Human Cytomegalovirus IE2-p86 Protein during Infection: A Proteomic Analysis	PLOS ONE			English	Article							POLYMERASE PROCESSIVITY FACTOR; TRANSCRIPTION FACTOR TFIIB; TYPE-1 TAT TRANSACTIVATOR; CELLULAR-PROTEIN; DNA-REPLICATION; IE86 PROTEIN; IMMEDIATE-EARLY-2 PROTEIN; STATISTICAL-MODEL; MASS-SPECTROMETRY; TARGET SEQUENCE	Human cytomegalovirus protein IE2-p86 exerts its functions through interaction with other viral and cellular proteins. To further delineate its protein interaction network, we generated a recombinant virus expressing SG-tagged IE2-p86 and used tandem affinity purification coupled with mass spectrometry. A total of 9 viral proteins and 75 cellular proteins were found to associate with IE2-p86 protein during the first 48 hours of infection. The protein profile at 8, 24, and 48 h post infection revealed that UL84 tightly associated with IE2-p86, and more viral and cellular proteins came into association with IE2-p86 with the progression of virus infection. A computational analysis of the protein-protein interaction network indicated that all of the 9 viral proteins and most of the cellular proteins identified in the study are interconnected to varying degrees. Of the cellular proteins that were confirmed to associate with IE2-p86 by immunoprecipitation, C1QBP was further shown to be upregulated by HCMV infection and colocalized with IE2-p86, UL84 and UL44 in the virus replication compartment of the nucleus. The IE2-p86 interactome network demonstrated the temporal development of stable and abundant protein complexes that associate with IE2-p86 and provided a framework to benefit future studies of various protein complexes during HCMV infection.	[Du, Guixin; Stinski, Mark F.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Stinski, MF (corresponding author), Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA.	mark-stinski@uiowa.edu			National Institutes of Health [AI-13562]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI013562, R21AI013562] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant AI-13562 from the National Institutes of Health (to M.F.S). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair R, 2002, J GEN VIROL, V83, P1315, DOI 10.1099/0022-1317-83-6-1315; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Beyer AR, 2013, J VIROL, V87, P1069, DOI 10.1128/JVI.02463-12; Brokstad KA, 2001, BIOCHEM BIOPH RES CO, V281, P1161, DOI 10.1006/bbrc.2001.4473; Bryant HE, 2000, J VIROL, V74, P11322, DOI 10.1128/JVI.74.23.11322-11328.2000; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; CASWELL R, 1993, J GEN VIROL, V74, P2691, DOI 10.1099/0022-1317-74-12-2691; Chen CY, 2000, GENE DEV, V14, P1236; CHERRINGTON JM, 1991, J VIROL, V65, P887, DOI 10.1128/JVI.65.2.887-896.1991; Du GX, 2011, J VIROL, V85, P804, DOI 10.1128/JVI.01173-10; Dunn W, 2003, P NATL ACAD SCI USA, V100, P14223, DOI 10.1073/pnas.2334032100; Dziurzynski K, 2012, NEURO-ONCOLOGY, V14, P246, DOI 10.1093/neuonc/nor227; Fatima G, 2012, J GEN VIROL, V93, P706, DOI 10.1099/vir.0.035691-0; Fogal V, 2008, CANCER RES, V68, P7210, DOI 10.1158/0008-5472.CAN-07-6752; Gao Y, 2008, J VIROL, V82, P96, DOI 10.1128/JVI.01559-07; Gao Y, 2010, J VIROL, V84, P8484, DOI 10.1128/JVI.00738-10; Gao Y, 2009, J VIROL, V83, P2393, DOI 10.1128/JVI.02339-08; Gebert S, 1997, J VIROL, V71, P7048, DOI 10.1128/JVI.71.9.7048-7060.1997; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; Greaves RF, 1998, J VIROL, V72, P366, DOI 10.1128/JVI.72.1.366-379.1998; HERMISTON TW, 1990, J VIROL, V64, P3532, DOI 10.1128/JVI.64.7.3532-3536.1990; Hertel L, 2004, J VIROL, V78, P11988, DOI 10.1128/JVI.78.21.11988-12011.2004; Huang LJ, 2008, INVEST OPHTH VIS SCI, V49, P5243, DOI 10.1167/iovs.07-1625; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Isomura H, 2005, J VIROL, V79, P9597, DOI 10.1128/JVI.79.15.9597-9607.2005; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim YE, 2010, J VIROL, V84, P8409, DOI 10.1128/JVI.00189-10; Krosky PM, 2003, J VIROL, V77, P7720, DOI 10.1128/JVI.77.14.7720-7727.2003; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Majumdar M, 2002, BIOCHEM BIOPH RES CO, V291, P829, DOI 10.1006/bbrc.2002.6491; Marchini A, 2001, J VIROL, V75, P1870, DOI 10.1128/JVI.75.4.1870-1878.2001; Marschall M, 2003, VIROLOGY, V311, P60, DOI 10.1016/S0042-6822(03)00147-8; Matthews DA, 1998, J GEN VIROL, V79, P1677, DOI 10.1099/0022-1317-79-7-1677; Michaelis M, 2009, NEOPLASIA, V11, P1, DOI 10.1593/neo.81178; Mitchell DP, 2009, J VIROL, V83, P10187, DOI 10.1128/JVI.00396-09; Mocarski ES, 2007, FIELDS VIROLOGY LIPP; Moorman NJ, 2008, CELL HOST MICROBE, V3, P253, DOI 10.1016/j.chom.2008.03.002; Murphy EA, 2000, J VIROL, V74, P7108, DOI 10.1128/JVI.74.15.7108-7118.2000; Muta T, 1997, J BIOL CHEM, V272, P24363, DOI 10.1074/jbc.272.39.24363; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Pari GS, 2008, CURR TOP MICROBIOL, V325, P153; Penfold MET, 1997, VIROLOGY, V239, P46, DOI 10.1006/viro.1997.8848; Petrik DT, 2007, J VIROL, V81, P5807, DOI 10.1128/JVI.02437-06; Pichlmair A, 2012, NATURE, V487, P486, DOI 10.1038/nature11289; PIZZORNO MC, 1990, J VIROL, V64, P6154, DOI 10.1128/JVI.64.12.6154-6165.1990; Raffetseder U, 2003, J BIOL CHEM, V278, P18241, DOI 10.1074/jbc.M212518200; Salsman J, 2012, J VIROL, V86, P806, DOI 10.1128/JVI.05442-11; Savaryn JP, 2013, J VIROL, V87, P2463, DOI 10.1128/JVI.01926-12; Song YJ, 2005, J VIROL, V79, P2597, DOI 10.1128/JVI.79.4.2597-2603.2005; Song YJ, 2002, P NATL ACAD SCI USA, V99, P2836, DOI 10.1073/pnas.052010099; Sourvinos G, 2007, J VIROL, V81, P10123, DOI 10.1128/JVI.01009-07; SPECTOR DJ, 1994, J VIROL, V68, P7549, DOI 10.1128/JVI.68.11.7549-7553.1994; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; Stinski MF, 2008, CURR TOP MICROBIOL, V325, P133; Strang BL, 2012, MBIO, V3, DOI 10.1128/mBio.00301-11; Strang BL, 2010, J GEN VIROL, V91, P2167, DOI 10.1099/vir.0.022640-0; Strang BL, 2010, J VIROL, V84, P1771, DOI 10.1128/JVI.01510-09; Streblow DN, 2008, CURR TOP MICROBIOL, V325, P397; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; TANAKA S, 1975, J VIROL, V15, P297, DOI 10.1128/JVI.15.2.297-304.1975; Tavalai N, 2008, J VIROL, V82, P126, DOI 10.1128/JVI.01685-07; Taylor RT, 2006, J VIROL, V80, P920, DOI 10.1128/JVI.80.2.920-928.2006; Taylor TJ, 2004, J VIROL, V78, P5856, DOI 10.1128/JVI.78.11.5856-5866.2004; Terhune SS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000965; To A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017796; Trinkle-Mulcahy L, 2008, J CELL BIOL, V183, P223, DOI 10.1083/jcb.200805092; Van Scoy S, 2000, VIROLOGY, V275, P145, DOI 10.1006/viro.2000.0508; Wang YL, 1997, VIROLOGY, V236, P18, DOI 10.1006/viro.1997.8739; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Yoshikawa H, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006148; Yu D, 2003, P NATL ACAD SCI USA, V100, P12396, DOI 10.1073/pnas.1635160100; YU L, 1995, J VIROL, V69, P3007, DOI 10.1128/JVI.69.5.3007-3016.1995; YU L, 1995, J VIROL, V69, P3017, DOI 10.1128/JVI.69.5.3017-3023.1995; Zhang MY, 2011, PROTEOMICS, V11, P4632, DOI 10.1002/pmic.201100339	74	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81583	10.1371/journal.pone.0081583	http://dx.doi.org/10.1371/journal.pone.0081583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358118	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700014
J	Liu, Y; Yang, XS; Utheim, TP; Guo, CY; Xiao, MC; Liu, Y; Yin, ZQ; Ma, J				Liu, Yong; Yang, Xuesen; Utheim, Tor Paaaske; Guo, Chenying; Xiao, Mingchun; Liu, Yan; Yin, Zhengqin; Ma, Jie			Correlation of Cytokine Levels and Microglial Cell Infiltration during Retinal Degeneration in RCS Rats	PLOS ONE			English	Article							POSTNATAL-DEVELOPMENT; NERVOUS-SYSTEM; DYSTROPHY; PHAGOCYTOSIS; MIGRATION; LIGHT; INFLAMMATION; ACTIVATION; DETACHMENT; RECEPTORS	Microglial cells, which are immunocompetent cells, are involved in all diseases of the central nervous system. During their activation in various diseases, a variety of soluble factors are released. In the present study, the correlation between cytokine levels and microglial cell migration in the course of retinal degeneration of Royal College of Surgeons (RCS) rats was evaluated. MFG-E8 and CD11b were used to confirm the microglial cells. In the retina of RCS rats, the mRNA expression of seven genes (MFG-E8 and its integrins alpha upsilon and beta 5, CD11b and the cytokines TNF-alpha, IL-1 beta, and MCP-1) formed almost similar bimodal peak distributions, which were centred at P7 and P45 to P60. In contrast, in rdy rats, which comprised the control group, a unimodal peak distribution centred at P14 was observed. The gene expression accompanied the activation and migration of microglial cells from the inner to the outer layer of the retina during the process of degeneration. Principal component analysis and discriminant function analysis revealed that the expression of these seven genes, especially TNF-alpha and CD11b, positively correlated with retinal degeneration and microglial activity during retinal degeneration in RCS rats, but not in the control rats. Furthermore, linear regression analysis demonstrated a significant correlation between the expression of these genes and the activation of microglial cells in the dystrophic retina. Our findings suggest that the suppression of microglial cells and the blockade of their cytotoxic effects may constitute a novel therapeutic strategy for treating photoreceptor death in various retinal disorders.	[Liu, Yong; Yin, Zhengqin] Third Mil Med Univ, Key Lab Visual Damage & Repair Chongqing, Southwest Eye Hosp, Southwest Hosp, Chongqing, Peoples R China; [Yang, Xuesen; Liu, Yan] Third Mil Med Univ, Inst Trop Med, Chongqing, Peoples R China; [Utheim, Tor Paaaske; Guo, Chenying; Ma, Jie] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Schepens Eye Res Inst,Dept Ophthalmol, Boston, MA USA; [Utheim, Tor Paaaske] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Xiao, Mingchun] Southwest Univ, Coll Life Sci, Chongqing, Peoples R China	Army Medical University; Army Medical University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute; University of Oslo; Southwest University - China	Liu, Y (corresponding author), Third Mil Med Univ, Key Lab Visual Damage & Repair Chongqing, Southwest Eye Hosp, Southwest Hosp, Chongqing, Peoples R China.	liu_yong2012@yahoo.com			National Basic Research Program of China (973 Program) [2013CB967002]; National Natural Science Foundation of China [81130017, 30700931, 30970672]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the the National Basic Research Program of China (973 Program, 2013CB967002) and National Natural Science Foundation of China (numbers 81130017, 30700931 and 30970672). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIRRE GD, 1975, J AM VET MED ASSOC, V166, P157; Benbrook DM, 2008, GENE REGUL SYST BIO, V2, P21; CALEY DW, 1972, AM J ANAT, V133, P179, DOI 10.1002/aja.1001330205; Coulson EJ, 2000, J BIOL CHEM, V275, P30537, DOI 10.1074/jbc.M005214200; Dalgin Gul S, 2005, Genome Inform, V16, P245; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; ESSNER E, 1979, INVEST OPHTH VIS SCI, V18, P11; Feng W, 2002, J BIOL CHEM, V277, P17016, DOI 10.1074/jbc.M107876200; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Huang DR, 2000, IMMUNOL REV, V177, P52, DOI 10.1034/j.1600-065X.2000.17709.x; Hughes EH, 2003, INVEST OPHTH VIS SCI, V44, P2229, DOI 10.1167/iovs.02-0824; Inoue K, 2002, GLIA, V40, P156, DOI 10.1002/glia.10150; Jarvis JN, 2004, ARTHRITIS RES THER, V6, pR15, DOI 10.1186/ar1018; Jones GE, 2000, J LEUKOCYTE BIOL, V68, P593; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kohno H, 2013, J BIOL CHEM, V288, P15326, DOI 10.1074/jbc.M112.448712; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kwan W, 2012, J CLIN INVEST, V122, P4737, DOI 10.1172/JCI64484; LAVAIL MM, 1981, INVEST OPHTH VIS SCI, V20, P671; LAVAIL MM, 1975, EXP EYE RES, V21, P167, DOI 10.1016/0014-4835(75)90080-9; Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055754; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Nakazawa T, 2011, INVEST OPHTH VIS SCI, V52, P1384, DOI 10.1167/iovs.10-6509; Nandrot EF, 2007, P NATL ACAD SCI USA, V104, P12005, DOI 10.1073/pnas.0704756104; OSTEEN WK, 1974, AM J ANAT, V139, P503, DOI 10.1002/aja.1001390404; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Rogue RS, 1999, BRAIN RES, V836, P110, DOI 10.1016/S0006-8993(99)01625-X; Roque RS, 1996, INVEST OPHTH VIS SCI, V37, P196; Santos AM, 2008, J COMP NEUROL, V506, P224, DOI 10.1002/cne.21538; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuetz E, 2004, CURR DRUG TARGETS, V5, P619, DOI 10.2174/1389450043345164; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; THANOS S, 1993, INT J DEV NEUROSCI, V11, P671, DOI 10.1016/0736-5748(93)90054-H; TSO MOM, 1994, INVEST OPHTH VIS SCI, V35, P2693; Vollrath D, 2001, P NATL ACAD SCI USA, V98, P12584, DOI 10.1073/pnas.221364198	38	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82061	10.1371/journal.pone.0082061	http://dx.doi.org/10.1371/journal.pone.0082061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349184	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200023
J	Terkawi, MA; Ratthanophart, J; Salama, A; AbouLaila, M; Asada, M; Ueno, A; Alhasan, H; Guswanto, A; Masatani, T; Yokoyama, N; Nishikawa, Y; Xuan, XN; Igarashi, I				Terkawi, Mohamad Alaa; Ratthanophart, Jadsada; Salama, Akram; AbouLaila, Mahmoud; Asada, Masahito; Ueno, Akio; Alhasan, Hend; Guswanto, Azirwan; Masatani, Tatsunori; Yokoyama, Naoaki; Nishikawa, Yoshifumi; Xuan, Xuenan; Igarashi, Ikuo			Molecular Characterization of a New Babesia bovis Thrombospondin-Related Anonymous Protein (BbTRAP2)	PLOS ONE			English	Article							HOST-CELL INVASION; ERYTHROCYTE INVASION; PLASMODIUM-FALCIPARUM; MICRONEME PROTEINS; PARASITES; GIBSONI; TRAP; VACCINES; BINDING; SURFACE	A gene encoding a Babesia bovis protein that shares significant degree of similarity to other apicomplexan thrombospondin-related anonymous proteins (TRAPs) was found in the genomic database and designated as BbTRAP2. Recombinant protein containing a conserved region of BbTRAP2 was produced in E. coli. A high antigenicity of recombinant BbTRAP2 (rBbTRAP2) was observed with field B. bovis-infected bovine sera collected from geographically different regions of the world. Moreover, antiserum against rBbTRAP2 specifically reacted with the authentic protein by Western blot analysis and an indirect fluorescent antibody test. Three bands corresponding to 104-, 76-, and 44-kDa proteins were identified in the parasite lysates and two bands of 76- and 44-kDa proteins were detected in the supernatant of cultivated parasites, indicating that BbTRAP2 was proteolytically processed and shed into the culture. Apical and surface localizations of BbTRAP2 were observed in the intracellular and extracellular parasites, respectively, by confocal laser microscopic examination. Moreover, native BbTRAP2 was precipitated by bovine erythrocytes, suggesting its role in the attachment to erythrocytes. Furthermore, the specific antibody to rBbTRAP2 inhibited the growth of B. bovis in a concentration-dependent manner. Consistently, pre-incubation of the free merozoites with the antibody to rBbTRAP2 resulted in an inhibition of the parasite invasion into host erythrocytes. Interestingly, the antibody to rBbTRAP2 was the most inhibitive for the parasite's growth as compared to those of a set of antisera produced against different recombinant proteins, including merozoite surface antigen 2c (BbMSA-2c), rhoptry-associated protein 1 C-terminal (BbRAP-1CT), and spherical body protein 1 (BbSBP-1). These results suggest that BbTRAP2 might be a potential candidate for development of a subunit vaccine against B. bovis infection.	[Terkawi, Mohamad Alaa; Ratthanophart, Jadsada; Salama, Akram; Asada, Masahito; Ueno, Akio; Alhasan, Hend; Guswanto, Azirwan; Masatani, Tatsunori; Yokoyama, Naoaki; Nishikawa, Yoshifumi; Xuan, Xuenan; Igarashi, Ikuo] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan; [AbouLaila, Mahmoud] Sadat City Univ, Dept Parasitol, Fac Vet Med, Minoufiya, Egypt; [Salama, Akram] Sadat City Univ, Dept Anim Med & Infect Dis, Fac Vet Med, Minoufiya, Egypt	Obihiro University of Agriculture & Veterinary Medicine; Egyptian Knowledge Bank (EKB); University of Sadat City; Egyptian Knowledge Bank (EKB); University of Sadat City	Igarashi, I (corresponding author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan.	igarcpmi@obihiro.ac.jp	Ueno, Akio/AAR-3709-2021; AbouLaila, Mahmoud/P-4239-2016	Ueno, Akio/0000-0001-6332-2232; AbouLaila, Mahmoud/0000-0003-1535-3696; Guswanto, Azirwan/0000-0002-4721-2487; Asada, Masahito/0000-0003-0042-6856; Salama, Akram/0000-0002-8047-8965	Global COE Program from the Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Society for Promotion of Science (JSPS)	Global COE Program from the Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a grant from the Global COE Program from the Japanese Ministry of Education, Culture, Sports, Science and Technology and by Grants-in-Aid for Scientific Research from the Japan Society for Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouLaila M, 2010, VET PARASITOL, V167, P19, DOI 10.1016/j.vetpar.2009.09.049; Asada M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035227; Bargieri DY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3552; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006; Bock R, 2004, PARASITOLOGY, V129, pS247, DOI 10.1017/S0031182004005190; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Brown WC, 2006, PARASITE IMMUNOL, V28, P315, DOI 10.1111/j.1365-3024.2006.00849.x; Carruthers VB, 2005, MOL MICROBIOL, V55, P1617, DOI 10.1111/j.1365-2958.2005.04483.x; Carruthers Vern B., 2008, V47, P33; Ejigiri I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002725; FISH L, 2008, VACCINE, V6, P29; Franssen FFJ, 2003, MICROBES INFECT, V5, P365, DOI 10.1016/S1286-4579(03)00041-8; Gaffar FR, 2004, MOL BIOCHEM PARASIT, V136, P25, DOI 10.1016/j.molbiopara.2004.02.006; Goo YK, 2008, EXP PARASITOL, V118, P555, DOI 10.1016/j.exppara.2007.11.010; Goo YK, 2013, EXP PARASITOL, V135, P42, DOI 10.1016/j.exppara.2013.06.002; Kuttler K.L., 1988, P1; Montero E, 2007, MOL BIOCHEM PARASIT, V153, P80, DOI 10.1016/j.molbiopara.2007.01.014; Morahan BJ, 2009, TRENDS PARASITOL, V25, P77, DOI 10.1016/j.pt.2008.11.004; Morgan RE, 2007, CURR DRUG TARGETS, V8, P61, DOI 10.2174/138945007779315678; Naitza S, 1998, PARASITOL TODAY, V14, P479, DOI 10.1016/S0169-4758(98)01346-5; Opitz C, 2002, EMBO J, V21, P1577, DOI 10.1093/emboj/21.7.1577; PATARROYO JH, 1995, VET PARASITOL, V59, P189, DOI 10.1016/0304-4017(94)00756-3; ROBSON KJH, 1995, EMBO J, V14, P3883, DOI 10.1002/j.1460-2075.1995.tb00060.x; Salama AA, 2013, EXP PARASITOL, V135, P623, DOI 10.1016/j.exppara.2013.09.017; Shkap V, 2000, ANN NY ACAD SCI, V916, P154, DOI 10.1111/j.1749-6632.2000.tb05286.x; Shkap V, 2007, TRENDS PARASITOL, V23, P420, DOI 10.1016/j.pt.2007.07.003; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Soldati-Favre D, 2008, PARASITE, V15, P197, DOI 10.1051/parasite/2008153197; Terkawi MA, 2007, PARASITOL RES, V102, P35, DOI 10.1007/s00436-007-0718-1; Terkawi MA, 2011, MOL BIOCHEM PARASIT, V178, P40, DOI 10.1016/j.molbiopara.2011.02.006; Terkawi MA, 2011, CLIN VACCINE IMMUNOL, V18, P337, DOI 10.1128/CVI.00388-10; Thompson J, 2004, MOL BIOCHEM PARASIT, V134, P225, DOI 10.1016/j.molbiopara.2003.12.003; Uchime O, 2012, EUKARYOT CELL, V11, P615, DOI 10.1128/EC.00039-12; Uilenberg G, 2006, VET PARASITOL, V138, P3, DOI 10.1016/j.vetpar.2006.01.035; WAAL DT, 2006, VET PARASITOL, V138, P88, DOI DOI 10.1016/J.VETPAR.2006.01.042.PUBMED:16504404; WALTISBUHL DJ, 1987, PARASITOL RES, V73, P319, DOI 10.1007/BF00531085; Wilkowsky SE, 2003, MOL BIOCHEM PARASIT, V127, P133, DOI 10.1016/S0166-6851(02)00329-8; Yokoyama N, 2002, INFECT IMMUN, V70, P5822, DOI 10.1128/IAI.70.10.5822-5826.2002; Yokoyama N, 2006, VET PARASITOL, V138, P22, DOI 10.1016/j.vetpar.2006.01.037; Zhou JL, 2006, MOL BIOCHEM PARASIT, V148, P190, DOI 10.1016/j.molbiopara.2006.03.015	41	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83305	10.1371/journal.pone.0083305	http://dx.doi.org/10.1371/journal.pone.0083305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349483	gold, Green Published, Green Submitted			2022-12-27	WOS:000328734200074
J	Urbanczyk, H; Urbanczyk, Y; Hayashi, T; Ogura, Y				Urbanczyk, Henryk; Urbanczyk, Yoshiko; Hayashi, Tetsuya; Ogura, Yoshitoshi			Diversification of Two Lineages of Symbiotic photobacterium	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; SIPHAMIA-VERSICOLOR; BIOLUMINESCENT SYMBIOSIS; SPECIES DEFINITION; GENOME SEQUENCE; LEIOGNATHI; FISH; MANDAPAMENSIS; PROKARYOTES; BACTERIA	Understanding of processes driving bacterial speciation requires examination of closely related, recently diversified lineages. To gain an insight into diversification of bacteria, we conducted comparative genomic analysis of two lineages of bioluminescent symbionts, Photobacterium leiognathi and 'P. mandapamensis'. The two lineages are evolutionary and ecologically closely related. Based on the methods used in bacterial taxonomy for classification of new species (DNA-DNA hybridization and ANI), genetic relatedness of the two lineages is at a cut-off point for species delineation. In this study, we obtained the whole genome sequence of a representative P. leiognathi strain lrivu.4.1, and compared it to the whole genome sequence of 'P. mandapamensis' svers.1.1. Results of the comparative genomic analysis suggest that P. leiognathi has a more plastic genome and acquired genes horizontally more frequently than 'P. mandapamensis'. We predict that different rates of recombination and gene acquisition contributed to diversification of the two lineages. Analysis of lineage-specific sequences in 25 strains of P. leiognathi and 'P. mandapamensis' found no evidence that bioluminescent symbioses with specific host animals have played a role in diversification of the two lineages.	[Urbanczyk, Henryk; Urbanczyk, Yoshiko] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki, Japan; [Hayashi, Tetsuya; Ogura, Yoshitoshi] Miyazaki Univ, Div Bioenvironm Sci, Frontier Sci Res Ctr, Miyazaki, Japan; [Hayashi, Tetsuya; Ogura, Yoshitoshi] Miyazaki Univ, Fac Med, Div Microbiol, Dept Infect Dis, Miyazaki, Japan	University of Miyazaki; University of Miyazaki; University of Miyazaki	Urbanczyk, H (corresponding author), Miyazaki Univ, Interdisciplinary Res Org, Miyazaki, Japan.	henryk@med.miyazaki-u.ac.jp	Hayashi, Tetsuya/ABA-1074-2020		Japanese Ministry of Education, Culture, Sports, Science and Technology; University of Miyazaki	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); University of Miyazaki	This work was financially supported by the Program to Disseminate Tenure Tracking System from the Japanese Ministry of Education, Culture, Sports, Science and Technology and by a grant for Scientific Research on Priority Areas from the University of Miyazaki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ast JC, 2004, ARCH MICROBIOL, V181, P352, DOI 10.1007/s00203-004-0663-7; Ast JC, 2007, J BACTERIOL, V189, P6148, DOI 10.1128/JB.00672-07; Beijerinck M.W., 1889, ARCH NEERL SCI EXACT, V23, P401; BOISVERT H, 1967, ANN I PASTEUR PARIS, V112, P520; Chakrabarty P, 2011, J MORPHOL, V272, P704, DOI 10.1002/jmor.10941; Cohan FM, 2007, CURR BIOL, V17, pR373, DOI 10.1016/j.cub.2007.03.032; Dunlap PV, 2012, J FISH BIOL, V81, P1340, DOI 10.1111/j.1095-8649.2012.03415.x; Dunlap PV, 2007, CLADISTICS, V23, P507, DOI 10.1111/j.1096-0031.2007.00157.x; Dunlap PV, 2008, APPL ENVIRON MICROB, V74, P7471, DOI 10.1128/AEM.01619-08; DUNLAP PV, 1987, ANN NY ACAD SCI, V503, P269, DOI 10.1111/j.1749-6632.1987.tb40614.x; DUNLAP PV, 1985, ARCH MICROBIOL, V141, P44, DOI 10.1007/BF00446738; Dunlap PV., 2013, PROKARYOTES, P495, DOI [10.1007/978-3-642-30141-4_75, DOI 10.1007/978-3-642-30141-4_75]; Dunlap PV., 2009, ENCY MICROBIOLOGY, P45, DOI [10.1016/B978-012373944-5.00066-3, DOI 10.1016/B978-012373944-5.00066-3]; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; HAYGOOD MG, 1993, CRIT REV MICROBIOL, V19, P191, DOI 10.3109/10408419309113529; HENDRIE MS, 1970, J GEN MICROBIOL, V64, P151, DOI 10.1099/00221287-64-2-151; Kaeding AJ, 2007, APPL ENVIRON MICROB, V73, P3173, DOI 10.1128/AEM.02212-06; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Madison DR, 2005, MACCLADE 4 ANAL PHYL; Mandel MJ, 2009, NATURE, V458, P215, DOI 10.1038/nature07660; Persson OP, 2007, ENVIRON MICROBIOL, V11, P1348; REICHELT JL, 1975, INT J SYST BACTERIOL, V25, P208, DOI 10.1099/00207713-25-2-208; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Shapiro BJ, 2012, SCIENCE, V336, P48, DOI 10.1126/science.1218198; Sugawara H, 2009, 20 INT C GEN INF; Suzuki K, 2001, IDENTIFICATION MANUA, P34; Urbanczyk H, 2008, J BACTERIOL, V190, P3494, DOI 10.1128/JB.00101-08; Urbanczyk H, 2012, FEMS MICROBIOL ECOL, V81, P355, DOI 10.1111/j.1574-6941.2012.01353.x; Urbanczyk H, 2011, J BACTERIOL, V193, P3144, DOI 10.1128/JB.00370-11; Urbanczyk H, 2011, FEMS MICROBIOL REV, V35, P324, DOI 10.1111/j.1574-6976.2010.00250.x; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; Visick KL, 2009, MOL MICROBIOL, V74, P782, DOI 10.1111/j.1365-2958.2009.06899.x; Wada M, 2006, FEMS MICROBIOL LETT, V260, P186, DOI 10.1111/j.1574-6968.2006.00322.x; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444	38	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82917	10.1371/journal.pone.0082917	http://dx.doi.org/10.1371/journal.pone.0082917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349398	gold, Green Submitted, Green Published			2022-12-27	WOS:000328734200059
J	Basile, CE; Fournier, P; Hutchins, S; Hebert, S				Basile, Charles-Edouard; Fournier, Philippe; Hutchins, Sean; Hebert, Sylvie			Psychoacoustic Assessment to Improve Tinnitus Diagnosis	PLOS ONE			English	Article							RESIDUAL INHIBITION FUNCTIONS; HEARING-LOSS; AFFECTIVE DIMENSIONS; LOUDNESS; PAIN; HANDICAP; PITCH; QUESTIONNAIRE; ANNOYANCE; SPECTRUM	The diagnosis of tinnitus relies on self-report. Psychoacoustic measurements of tinnitus pitch and loudness are essential for assessing claims and discriminating true from false ones. For this reason, the quantification of tinnitus remains a challenging research goal. We aimed to: (1) assess the precision of a new tinnitus likeness rating procedure with a continuous-pitch presentation method, controlling for music training, and (2) test whether tinnitus psychoacoustic measurements have the sensitivity and specificity required to detect people faking tinnitus. Musicians and non-musicians with tinnitus, as well as simulated malingerers without tinnitus, were tested. Most were retested several weeks later. Tinnitus pitch matching was first assessed using the likeness rating method: pure tones from 0.25 to 16 kHz were presented randomly to participants, who had to rate the likeness of each tone to their tinnitus, and to adjust its level from 0 to 100 dB SPL. Tinnitus pitch matching was then assessed with a continuous-pitch method: participants had to match the pitch of their tinnitus to an external tone by moving their finger across a touch-sensitive strip, which generated a continuous pure tone from 0.5 to 20 kHz in 1-Hz steps. The predominant tinnitus pitch was consistent across both methods for both musicians and non-musicians, although musicians displayed better external tone pitch matching abilities. Simulated malingerers rated loudness much higher than did the other groups with a high degree of specificity (94.4%) and were unreliable in loudness (not pitch) matching from one session to the other. Retest data showed similar pitch matching responses for both methods for all participants. In conclusion, tinnitus pitch and loudness reliably correspond to the tinnitus percept, and psychoacoustic loudness matches are sensitive and specific to the presence of tinnitus.	[Basile, Charles-Edouard; Fournier, Philippe; Hebert, Sylvie] Univ Montreal, Sch Speech Pathol & Audiol, Montreal, PQ, Canada; [Basile, Charles-Edouard; Fournier, Philippe; Hutchins, Sean; Hebert, Sylvie] Univ Montreal, Int Lab Res Brain Mus & Sound BRAMS, Montreal, PQ, Canada; [Basile, Charles-Edouard; Fournier, Philippe; Hebert, Sylvie] CRIUGM, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Hebert, S (corresponding author), Univ Montreal, Sch Speech Pathol & Audiol, Montreal, PQ, Canada.	Sylvie.hebert@umontreal.ca	Campailla, Jasmin/AAK-2420-2021	Fournier, Philippe/0000-0003-2423-3434	Caroline-Durand Foundation; Institut de recherche Robert-Sauve en Sante et en Securite du Travail du Quebec (IRSST); Fonds de Recherche Sante du Quebec (FRQS)	Caroline-Durand Foundation; Institut de recherche Robert-Sauve en Sante et en Securite du Travail du Quebec (IRSST); Fonds de Recherche Sante du Quebec (FRQS)	This research was partly supported by a grant from the Caroline-Durand Foundation to S. Hebert and a studentship from Institut de recherche Robert-Sauve en Sante et en Securite du Travail du Quebec (IRSST) and Fonds de Recherche Sante du Quebec (FRQS) to P.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 2003, AURIS NASUS LARYNX, V30, P129, DOI 10.1016/S0385-8146(03)00008-7; Balkenhol T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053180; BURNS EM, 1984, AUDIOLOGY, V23, P426; Cima RFF, 2012, LANCET, V379, P1951, DOI 10.1016/S0140-6736(12)60469-3; de Azevedo AA, 2009, OTOL NEUROTOL, V30, P676, DOI 10.1097/MAO.0b013e3181ab8fd5; El Refaie A, 2004, INT J AUDIOL, V43, P410; Fournier P, 2013, HEARING RES, V295, P16, DOI 10.1016/j.heares.2012.05.011; HALLAM RS, 1985, ACTA OTO-LARYNGOL, V99, P501, DOI 10.3109/00016488509182253; Heijneman KM, 2013, NOISE HEALTH, V15, P101, DOI 10.4103/1463-1741.110290; Henry JA, 2006, ACTA OTO-LARYNGOL, V126, P34, DOI 10.1080/03655230600895291; Henry J A, 1999, J Am Acad Audiol, V10, P502; Henry J A, 2000, Am J Audiol, V9, P36, DOI 10.1044/1059-0889(2000/002); Henry JA, 2004, J REHABIL RES DEV, V41, P871, DOI 10.1682/JRRD.2003.10.0158; Henry JA, 2001, J REHABIL RES DEV, V38, P557; Henry JA, 2013, J REHABIL RES DEV, V50, P573, DOI 10.1682/JRRD.2012.05.0090; Henry JA, 2009, J REHABIL RES DEV, V46, P619, DOI 10.1682/JRRD.2008.11.0157; Hesser H, 2011, CLIN PSYCHOL REV, V31, P545, DOI 10.1016/j.cpr.2010.12.006; Hiller W, 2007, AUDIOL NEURO-OTOL, V12, P391, DOI 10.1159/000106482; Hiller W, 2006, ARCH OTOLARYNGOL, V132, P1323, DOI 10.1001/archotol.132.12.1323; Holgers K-M, 2003, AUDIOLOGICAL MED, V2, P101; Hutchins S, 2012, MUSIC PERCEPTION; Hutchins S, 2012, J EXP PSYCHOL GEN, V141, P76, DOI 10.1037/a0025064; Hutchins SM, 2012, J EXPT PSYCHOL GEN; Jacobson G P, 2000, J Am Acad Audiol, V11, P156; JOHNSON RM, 1993, ARCH OTOLARYNGOL, V119, P842; Karatas E, 2012, EUR ARCH OTO-RHINO-L, V269, P441, DOI 10.1007/s00405-011-1655-2; KAY F, 2008, NZ AUDILOGICAL SOC B, V18, P27; Konig O, 2006, HEARING RES, V221, P59, DOI 10.1016/j.heares.2006.07.007; KUK FK, 1990, EAR HEARING, V11, P434, DOI 10.1097/00003446-199012000-00005; Kunz M, 2012, PAIN, V153, P350, DOI 10.1016/j.pain.2011.10.027; Langguth B, 2007, PROG BRAIN RES, V166, P525, DOI 10.1016/S0079-6123(07)66050-6; Maes IHL, 2013, EAR HEARING, V34, P508, DOI 10.1097/AUD.0b013e31827d113a; Martines Francesco, 2010, Int J Otolaryngol, V2010, P265861, DOI 10.1155/2010/265861; Meric C, 1997, J OTOLARYNGOL, V26, P167; Mitchell C R, 1993, J Am Acad Audiol, V4, P139; Moffat G, 2009, HEARING RES, V254, P82, DOI 10.1016/j.heares.2009.04.016; Moore BCJ, 2010, HEARING RES, V261, P51, DOI 10.1016/j.heares.2010.01.003; Nageris BI, 2010, AM J OTOLARYNG, V31, P181, DOI 10.1016/j.amjoto.2008.12.007; NEWMAN CW, 1994, AUDIOLOGY, V33, P47; Norena A, 2002, AUDIOL NEURO-OTOL, V7, P358, DOI 10.1159/000066156; Pan T, 2009, INT J AUDIOL, V48, P277, DOI 10.1080/14992020802581974; PENNER MJ, 1992, EAR HEARING, V13, P410, DOI 10.1097/00003446-199212000-00007; PENNER MJ, 1994, EAR HEARING, V15, P416, DOI 10.1097/00003446-199412000-00002; PENNER MJ, 1992, J SPEECH HEAR RES, V35, P694, DOI 10.1044/jshr.3503.694; Rainville P, 2005, PAIN, V118, P306, DOI 10.1016/j.pain.2005.08.022; Rainville P, 1999, PAIN, V82, P159, DOI 10.1016/S0304-3959(99)00048-2; Roberts LE, 2008, JARO-J ASSOC RES OTO, V9, P417, DOI 10.1007/s10162-008-0136-9; Roberts LE, 2006, ACTA OTO-LARYNGOL, V126, P27, DOI 10.1080/03655230600895358; Roberts LE, 2013, NEUROSCI BIOBEHAV R; Savastano M, 2008, EUR ARCH OTO-RHINO-L, V265, P1295, DOI 10.1007/s00405-008-0630-z; Schecklmann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034878; Schlauch RS, 2009, HDB CLIN AUDIOLOGY, V6, P30; Sereda M, 2011, INT J AUDIOL, V50, P303, DOI 10.3109/14992027.2010.551221; Shekhawat GS, 2013, EUROPEAN ARCH OTO RH; TYLER RS, 1983, J SPEECH HEAR RES, V26, P59, DOI 10.1044/jshr.2601.59; Tyler RS, 1983, METHODS BRIT J AUDIO, V17, P101; Vernon JA, 2003, OTOLARYNG CLIN N AM, V36, P293, DOI 10.1016/S0030-6665(02)00162-7; Villemure C, 2002, PAIN, V95, P195, DOI 10.1016/S0304-3959(02)00007-6; Villemure C, 2009, J NEUROSCI, V29, P705, DOI 10.1523/JNEUROSCI.3822-08.2009; Ward LM, 2009, AM J AUDIOL, V18, P119, DOI 10.1044/1059-0889(2009/07-0033); Weisz N, 2006, HEARING RES, V222, P108, DOI 10.1016/j.heares.2006.09.003; Zhou X, 2011, HEARING RES, V277, P107, DOI 10.1016/j.heares.2011.02.006	62	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82995	10.1371/journal.pone.0082995	http://dx.doi.org/10.1371/journal.pone.0082995			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EU	24349414	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800088
J	Larose, J; Boulay, P; Sigal, RJ; Wright, HE; Kenny, GP				Larose, Joanie; Boulay, Pierre; Sigal, Ronald J.; Wright, Heather E.; Kenny, Glen P.			Age-Related Decrements in Heat Dissipation during Physical Activity Occur as Early as the Age of 40	PLOS ONE			English	Article							THERMOREGULATORY RESPONSES; DRY-HEAT; EXERCISE; MEN; EXPOSURE; WORK	Older adults typically experience greater levels of thermal strain during physical efforts in the heat compared to young individuals. While this may be related to an age-dependent reduction in whole-body sweating, no study has clearly delineated at what age this occurs. In the present study, we report direct measurements of human heat dissipation during physical activity in the heat in males ranging in age from 20-70 years. Eighty-five males performed four 15-min bouts of cycling separated by 15-min rest periods, in a calorimeter regulated to 35 degrees C and 20% relative humidity. Direct calorimetry was used to measure total heat loss (whole-body evaporative heat loss and dry heat exchange). We also used indirect calorimetry as a continuous measure of metabolic heat production. Body heat storage was calculated as the temporal summation of heat production and total heat loss over the experimental session. Whole-body sweat rate (WBSR) was calculated from measurements of evaporative heat loss. Males were divided into five age categories for the analysis of WBSR and body heat storage: 20-31 years (n = 18), 40-44 years (n = 15), 45-49 years (n = 15), 50-55 years (n = 21) and 56-70 years (n = 16). Relative to young males, WBSR was reduced in males aged 56-70 during each exercise (all P<0.05), in males aged 50-55 during the second (P = 0.031) and third exercises (P = 0.028) and in males aged 45-49 during the final exercise bout (P = 0.046). Although not significantly different, 40-44 years old males also had a lower rate of heat loss compared to younger males. Over the sum of two hours, the change in body heat content was greater in males 40-70 years compared to young males (all P<0.05). Our findings suggest that middle-aged and older adults have impairments in heat dissipation when doing physical activity in the heat, thus possibly increasing their risk of heat-related illness under such conditions.	[Larose, Joanie; Wright, Heather E.; Kenny, Glen P.] Univ Ottawa, Human & Environm Physiol Res Unit, Sch Human Kinet, Ottawa, ON, Canada; [Boulay, Pierre] Univ Sherbrooke, Fac Phys Educ & Sports, Sherbrooke, PQ J1K 2R1, Canada; [Sigal, Ronald J.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Sigal, Ronald J.] Univ Calgary, Fac Med, Dept Med, Calgary, AB, Canada; [Sigal, Ronald J.] Univ Calgary, Fac Med, Dept Cardiac Sci, Calgary, AB, Canada; [Sigal, Ronald J.] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Sigal, Ronald J.] Univ Calgary, Dept Med, Fac Kinesiol, Calgary, AB, Canada; [Sigal, Ronald J.] Univ Calgary, Dept Cardiac Sci, Fac Kinesiol, Calgary, AB, Canada; [Sigal, Ronald J.] Univ Calgary, Dept Community Hlth Sci, Fac Kinesiol, Calgary, AB, Canada	University of Ottawa; University of Sherbrooke; University of Ottawa; Ottawa Hospital Research Institute; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Kenny, GP (corresponding author), Univ Ottawa, Human & Environm Physiol Res Unit, Sch Human Kinet, Ottawa, ON, Canada.	gkenny@uottawa.ca	Sigal, Ron/AAK-7627-2020; Sigal, Ronald/AAU-6081-2020	Wright Beatty, Heather/0000-0002-1450-1186	Workplace Safety and Insurance Board of Ontario [10001]; Canadian Institutes of Health Research [286363]; Canada Foundation for Innovation; Alberta Innovates-Health Solutions	Workplace Safety and Insurance Board of Ontario; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Innovates-Health Solutions	This project was supported by a research grant provided by the Workplace Safety and Insurance Board of Ontario (grant #10001), the Canadian Institutes of Health Research (grant #286363), and Leaders Opportunity Fund from the Canada Foundation for Innovation (funds held by Dr. Kenny). Dr. Sigal was supported by a Health Senior Scholar award from Alberta Innovates-Health Solutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG CG, 1993, J APPL PHYSIOL, V75, P2162, DOI 10.1152/jappl.1993.75.5.2162; Chodzko-Zajko WJ, 2009, MED SCI SPORT EXER, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; DAVIES CTM, 1979, EUR J APPL PHYSIOL O, V42, P71, DOI 10.1007/BF00421907; Viveiros JD, 2012, INT J SPORTS MED, V33, P211, DOI 10.1055/s-0031-1295444; Du Bois D, 1989, Nutrition, V5, P303; Dufour A, 2007, EUR J APPL PHYSIOL, V100, P19, DOI 10.1007/s00421-007-0396-9; HAVENITH G, 1995, EUR J APPL PHYSIOL O, V70, P88, DOI 10.1007/BF00601814; HELLON RF, 1956, J PHYSIOL-LONDON, V133, P118, DOI 10.1113/jphysiol.1956.sp005570; Inbar O, 2004, EXP PHYSIOL, V89, P691, DOI 10.1113/expphysiol.2004.027979; Jay O., 2007, J HUM ENV SYST, V10, P19, DOI DOI 10.1618/JHES.10.19; Jay O, 2007, J APPL PHYSIOL, V103, P443, DOI 10.1152/japplphysiol.00117.2007; Jay O, 2007, AM J PHYSIOL-REG I, V292, pR167, DOI 10.1152/ajpregu.00338.2006; KENNEY WL, 1988, EUR J APPL PHYSIOL O, V57, P120, DOI 10.1007/BF00691250; Kenny GP, 2010, CAN MED ASSOC J, V182, P1053, DOI 10.1503/cmaj.081050; Kenny GP, 2010, EUR J APPL PHYSIOL, V109, P81, DOI 10.1007/s00421-009-1266-4; LIND AR, 1970, J APPL PHYSIOL, V28, P50; Minson CT, 1998, J APPL PHYSIOL, V84, P1323, DOI 10.1152/jappl.1998.84.4.1323; PANDOLF KB, 1988, J APPL PHYSIOL, V65, P65, DOI 10.1152/jappl.1988.65.1.65; Reardon FD, 2006, MED BIOL ENG COMPUT, V44, P721, DOI 10.1007/s11517-006-0086-5; SAGAWA S, 1988, J GERONTOL, V43, pM1, DOI 10.1093/geronj/43.1.M1; Siri W E, 1993, Nutrition, V9, P480; TANKERSLEY CG, 1991, J APPL PHYSIOL, V71, P236, DOI 10.1152/jappl.1991.71.1.236; WAGNER JA, 1972, J APPL PHYSIOL, V33, P616, DOI 10.1152/jappl.1972.33.5.616; Worfolk JB, 2000, GERIATR NURS, V21, P70, DOI 10.1067/mgn.2000.107131	24	63	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83148	10.1371/journal.pone.0083148	http://dx.doi.org/10.1371/journal.pone.0083148			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349447	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800099
J	Johnson, DH; Sutherland, D; Acosta, EP; Erdem, H; Richardson, D; Haas, DW				Johnson, Daniel H.; Sutherland, Deborah; Acosta, Edward P.; Erdem, Husamettin; Richardson, Danielle; Haas, David W.			Genetic and Non-Genetic Determinants of Raltegravir Penetration into Cerebrospinal Fluid: A Single Arm Pharmacokinetic Study	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; STEADY-STATE PHARMACOKINETICS; P-GLYCOPROTEIN EXPRESSION; MDR1 GENE; MULTIDRUG-RESISTANCE; C3435T POLYMORPHISM; ABCB1 GENE; ASSOCIATION; EPILEPSY; PHARMACOGENETICS	Background: Antiretroviral drugs vary in their central nervous system penetration, with better penetration possibly conferring neurocognitive benefit during human immunodeficiency virus (HIV) therapy. The efflux transporter gene ABCB1 is expressed in the blood-brain barrier, and an ABCB1 variant (3435C -> T) has been reported to affect ABCB1 expression. The integrase inhibitor raltegravir is a substrate for ABCB1. We examined whether ABCB1 3435C -> T affects raltegravir disposition into cerebrospinal fluid (CSF), and explored associations with polymorphisms in other membrane transporter genes expressed in the blood-brain barrier. Methods: Forty healthy, HIV-negative adults of European descent (20 homozygous for ABCB1 3435 C/C, 20 homozygous for 3435 T/T, each group divided equally between males and females) were given raltegravir 400 mg twice daily for 7 days. With the final dose, plasma was collected for pharmacokinetic analysis at 9 timepoints over 12 hours, and CSF collected 4 hours post dose. Results: The 4-hour CSF concentration correlated more strongly with 2-hour (r(2)=0.76, P=1.12x10(-11)) than 4-hour (r(2)=0.47, P=6.89x10(-6)) single timepoint plasma concentration, and correlated strongly with partial plasma area-under-the-curve values (AUC(0-4h) r(2)=0.86, P=5.15x10(-16)). There was no significant association between ABCB1 3435C -> T and ratios of CSF-to-plasma AUC or concentration (p>0.05 for each comparison). In exploratory analyses, CSF-to-plasma ratios were not associated with 276 polymorphisms across 16 membrane transporter genes. Conclusions: Among HIV-negative adults, CSF raltegravir concentrations do not differ by ABCB1 3435C -> T genotype but strongly correlate with plasma exposure.	[Johnson, Daniel H.; Sutherland, Deborah; Erdem, Husamettin; Haas, David W.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Haas, David W.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; [Haas, David W.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Richardson, Danielle; Haas, David W.] Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Nashville, TN 37212 USA; [Acosta, Edward P.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Alabama System; University of Alabama Birmingham	Haas, DW (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA.	david.w.haas@vanderbilt.edu			Merck; Vanderbilt CTSA grant from NCRR/NIH [UL1 RR024975]; NIAID/NIH [RO1 AI077505]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077505] Funding Source: NIH RePORTER	Merck(Merck & Company); Vanderbilt CTSA grant from NCRR/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was primarily supported by a research grant from Merck (www.merck.com) to Vanderbilt University Medical Center (DWH, Principal Investigator). This work was also supported in part by the Vanderbilt CTSA grant UL1 RR024975 from NCRR/NIH (www.nih.gov), and by RO1 AI077505 from NIAID/NIH (DWH) (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHONEN A, 1978, ACTA NEUROL SCAND, V58, P358; Asano Takeshi, 2003, Pharmacogenetics, V13, P675, DOI 10.1097/00008571-200311000-00003; Basic S, 2008, SEIZURE-EUR J EPILEP, V17, P524, DOI 10.1016/j.seizure.2008.01.003; Chinn LW, 2007, CLIN PHARMACOL THER, V81, P265, DOI 10.1038/sj.clpt.6100052; Cianfriglia M, 2009, INTERACTION HIV INTE; Coller JK, 2006, CLIN PHARMACOL THER, V80, P682, DOI 10.1016/j.clpt.2006.09.011; Croteau D, 2010, ANTIMICROB AGENTS CH, V54, P5156, DOI 10.1128/AAC.00507-10; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Deeken JF, 2007, CLIN CANCER RES, V13, P1663, DOI 10.1158/1078-0432.CCR-06-2854; Dey S, 2003, EXPERT OPIN BIOL TH, V3, P23, DOI 10.1517/14712598.3.1.23; Drescher S, 2002, BRIT J CLIN PHARMACO, V53, P526, DOI 10.1046/j.1365-2125.2002.01591.x; Educational Testing Service, 2012, GUID DOC PSYCH DIS A; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; GOUDSMIT J, 1986, LANCET, V2, P177; Haas DW, 2000, CLIN PHARMACOL THER, V68, P367, DOI 10.1067/mcp.2000.109391; Haas DW, 2005, J INFECT DIS, V192, P1931, DOI 10.1086/497610; Haas DW, 2003, JAIDS-J ACQ IMM DEF, V34, P295, DOI 10.1097/00126334-200311010-00006; Haas DW, 2003, ANTIMICROB AGENTS CH, V47, P2131, DOI 10.1128/AAC.47.7.2131-2137.2003; Haerian BS, 2010, SEIZURE-EUR J EPILEP, V19, P339, DOI 10.1016/j.seizure.2010.05.004; Haldar T, 2012, ANN HUM GENET, V76, P237, DOI 10.1111/j.1469-1809.2012.00708.x; Hermann DM, 2006, ANN NEUROL, V60, P489, DOI 10.1002/ana.21012; Hitzl M, 2001, PHARMACOGENETICS, V11, P293, DOI 10.1097/00008571-200106000-00003; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Hung CC, 2007, PHARMACOGENOMICS, V8, P1151, DOI 10.2217/14622416.8.9.1151; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kim RB, 1998, J CLIN INVEST, V101, P289, DOI 10.1172/JCI1269; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Kwan P, 2007, EPILEPSY BEHAV, V11, P112, DOI 10.1016/j.yebeh.2007.04.013; Lanktree MB, 2009, J LIPID RES, V50, P1487, DOI 10.1194/jlr.P900008-JLR200; Lee CGL, 1998, BIOCHEMISTRY-US, V37, P3594, DOI 10.1021/bi972709x; Letendre S, 2008, ARCH NEUROL-CHICAGO, V65, P65, DOI 10.1001/archneurol.2007.31; Long MC, 2008, J CHROMATOGR B, V867, P165, DOI 10.1016/j.jchromb.2008.03.022; Mai I, 2004, BRIT J CLIN PHARMACO, V58, P548, DOI 10.1111/j.1365-2125.2004.02182.x; Marzolini C, 2004, CLIN PHARMACOL THER, V75, P13, DOI 10.1016/j.clpt.2003.09.012; Moss DM, 2011, ANTIMICROB AGENTS CH, V55, P879, DOI 10.1128/AAC.00623-10; Nichols WC, 2009, NEUROLOGY, V72, P310, DOI 10.1212/01.wnl.0000327823.81237.d1; Nies AT, 2007, CANCER LETT, V254, P11, DOI 10.1016/j.canlet.2006.12.023; Novoa SR, 2006, CLIN INFECT DIS, V42, P291, DOI 10.1086/499056; Owen A, 2005, BRIT J CLIN PHARMACO, V59, P365, DOI 10.1111/j.1365-2125.2005.02229.x; Pauli-Magnus C, 2003, CLIN PHARMACOL THER, V74, P487, DOI 10.1016/S0009-9236(03)00234-0; R Core Team, 2011, R LANG ENV STAT COMP; RESNICK L, 1988, NEUROLOGY, V38, P9, DOI 10.1212/WNL.38.1.9; Saccone SF, 2011, NUCLEIC ACIDS RES, V39, pD901, DOI 10.1093/nar/gkq1054; Sauer G, 2002, CANCER LETT, V185, P79, DOI 10.1016/S0304-3835(02)00232-X; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986; Smurzynski M, 2011, AIDS, V25, P357, DOI 10.1097/QAD.0b013e32834171f8; Takane H, 2004, J PHARMACOL EXP THER, V311, P1179, DOI 10.1124/jpet.104.069724; Urquhart BL, 2009, EUR J CLIN PHARMACOL, V65, P1063, DOI 10.1007/s00228-009-0714-8; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Yilmaz A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006877; Zhu D, 2004, ANTIVIR THER, V9, P929	54	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82672	10.1371/journal.pone.0082672	http://dx.doi.org/10.1371/journal.pone.0082672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349334	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300102
J	Liu, YJ; Li, HY; Feng, J; Cui, XY; Huang, W; Li, YD; Su, FX; Liu, Q; Zhu, JJ; Lv, XB; Chen, JN; Huang, D; Yu, FY				Liu, Yujie; Li, Haiyan; Feng, Juan; Cui, Xiuying; Huang, Wei; Li, Yudong; Su, Fengxi; Liu, Qiang; Zhu, Jiujun; Lv, Xiaobin; Chen, Jianing; Huang, Di; Yu, Fengyan			Lin28 Induces Epithelial-to-Mesenchymal Transition and Stemness via Downregulation of Let-7a in Breast Cancer Cells	PLOS ONE			English	Article							MICRORNA EXPRESSION; SELF-RENEWAL; INVASION; MIR-200; TRANSFORMATION; PLURIPOTENCY; METFORMIN; ZCCHC11; BINDING; EMT	The RNA-binding protein Lin28 is known to promote malignancy by inhibiting the biogenesis of let-7, which functions as a tumor suppressor. However, the role of the Lin28/let-7 axis in the epithelial-to-mesenchymal transition (EMT) and stemness in breast cancer has not been clearly expatiated. In our previous study, we demonstrated that let-7 regulates self-renewal and tumorigenicity of breast cancer stem cells. In the present study, we demonstrated that Lin28 was highly expressed in mesenchymal (M) type cells (MDA-MB-231 and SK-3rd), but it was barely detectable in epithelial (E) type cells (MCF-7 and BT-474). Lin28 remarkably induced the EMT, increased a higher mammosphere formation rate and ALDH activity and subsequently promoted colony formation, as well as adhesion and migration in breast cancer cells. Furthermore, we demonstrated that Lin28 induced EMT in breast cancer cells via downregulation of let-7a. Strikingly, Lin28 overexpression was found in breast cancers that had undergone metastasis and was strongly predictive of poor prognoses in breast cancers. Given that Lin28 induced the EMT via let-7a and promoted breast cancer metastasis, Lin28 may be a therapeutic target for the eradication of breast cancer metastasis.	[Liu, Yujie; Li, Haiyan; Feng, Juan; Huang, Wei; Li, Yudong; Su, Fengxi; Liu, Qiang; Zhu, Jiujun; Chen, Jianing; Huang, Di; Yu, Fengyan] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Breast Surg, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yujie; Li, Haiyan; Feng, Juan; Cui, Xiuying; Huang, Wei; Li, Yudong; Su, Fengxi; Liu, Qiang; Zhu, Jiujun; Lv, Xiaobin; Chen, Jianing; Huang, Di; Yu, Fengyan] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Key Lab Malignant Tumor Gene Regulat & Target The, Guangdong Higher Educ Inst, Guangzhou 510275, Guangdong, Peoples R China; [Li, Haiyan] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Breast & Thyroid Surg, Guangzhou 510275, Guangdong, Peoples R China; [Feng, Juan] Hubei Univ Med, Dept Xiangyang Hosp, Xiangyang, Peoples R China; [Lv, Xiaobin] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Med Res Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Hubei University of Medicine; Sun Yat Sen University	Yu, FY (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Breast Surg, Guangzhou 510275, Guangdong, Peoples R China.	fengyanyu_summer@163.com	Lv, Xiao-Bin/T-7607-2019; Liu, Qiang/HHZ-3181-2022; Li, Yudong/GSN-4036-2022; li, yu/HGL-9518-2022; li, Yu/HCI-9086-2022	Liu, Qiang/0000-0002-5451-4862; Li, Haiyan/0000-0002-5541-3035	Guangdong Natural Science Funds for Distinguished Young Scholar [S20120011199]; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China [121042]; Program for New Century Excellent Talents in University of Ministry of Education of China [NCET-09-0816]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD) [81000-3149001]; Foundation for the Young Teachers in the Higher Education Institutions of China [20110171120082]; Natural Science Foundation of China [81172524, 81072178, 81272894, 81102022]; Science Foundation of Guangdong Province [S2012030006287]; Translational medicine public platform of Guangdong Province [4202037]	Guangdong Natural Science Funds for Distinguished Young Scholar; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China(Fok Ying Tung Education Foundation); Program for New Century Excellent Talents in University of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD)(Foundation for the Author of National Excellent Doctoral Dissertation of China); Foundation for the Young Teachers in the Higher Education Institutions of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Translational medicine public platform of Guangdong Province	This work was supported by grants from Guangdong Natural Science Funds for Distinguished Young Scholar (S20120011199), Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China (121042), Program for New Century Excellent Talents in University of Ministry of Education of China (NCET-09-0816), Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD, 81000-3149001), Foundation for the Young Teachers in the Higher Education Institutions of China (20110171120082), Natural Science Foundation of China (81172524, 81072178, 81272894, 81102022), Science Foundation of Guangdong Province (S2012030006287) and Translational medicine public platform of Guangdong Province(4202037). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Braeutigam C, 2013, RNA BINDING PROTEIN; Burger PE, 2009, STEM CELLS, V27, P2220, DOI 10.1002/stem.135; Cai WY, 2013, J CELL SCI, V126, P2877, DOI 10.1242/jcs.123810; Chang CJ, 2011, ONCOL REP, V26, P1003, DOI 10.3892/or.2011.1360; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Feng C, 2012, CELL CYCLE, V11, P2486, DOI 10.4161/cc.20893; Graziano F, 2010, PHARMACOGENOMICS J, V10, P458, DOI 10.1038/tpj.2010.9; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo L, 2013, ONCOGENE, V32, P5272, DOI 10.1038/onc.2012.573; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; King CE, 2011, ONCOGENE, V30, P4185, DOI 10.1038/onc.2011.131; Li YW, 2009, CANCER RES, V69, P6704, DOI 10.1158/0008-5472.CAN-09-1298; Lv KZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040008; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McCarty MF, 2012, MED HYPOTHESES, V78, P262, DOI 10.1016/j.mehy.2011.10.041; McCoy EL, 2009, J CLIN INVEST, V119, P2663, DOI 10.1172/JCI37691; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Qian PX, 2011, CANCER RES, V71, P6463, DOI 10.1158/0008-5472.CAN-11-1322; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Sakurai M, 2012, J STEROID BIOCHEM, V131, P101, DOI 10.1016/j.jsbmb.2011.10.007; Shapiro IM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002218; Thornton JE, 2012, RNA, V18, P1875, DOI 10.1261/rna.034538.112; Valacca C, 2010, J CELL BIOL, V191, P87, DOI 10.1083/jcb.201001073; van der Pluijm G, 2011, BONE, V48, P37, DOI 10.1016/j.bone.2010.07.023; Vazquez-Martin A, 2010, CELL CYCLE, V9, P3807, DOI 10.4161/cc.9.18.13131; Venables JP, 2013, MOL CELL BIOL, V33, P396, DOI 10.1128/MCB.01174-12; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang QZ, 2009, CURR CANCER DRUG TAR, V9, P572, DOI 10.2174/156800909788486731; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	43	60	64	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83083	10.1371/journal.pone.0083083	http://dx.doi.org/10.1371/journal.pone.0083083			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349438	gold, Green Submitted, Green Published			2022-12-27	WOS:000328730300132
J	Zheng, YY; Zhu, JH; Zhou, MR; Cui, L; Yao, WM; Liu, YY				Zheng, Yayuan; Zhu, Jianhong; Zhou, Manru; Cui, Liao; Yao, Weimin; Liu, Yuyu			Meta-Analysis of Long-Term Vitamin D Supplementation on Overall Mortality	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HIGH-DOSE CHOLECALCIFEROL; PLACEBO-CONTROLLED TRIAL; BONE-MINERAL DENSITY; DOUBLE-BLIND; ELDERLY-WOMEN; OLDER-PEOPLE; D DEFICIENCY; 25-HYDROXYVITAMIN D; COLORECTAL-CANCER	Introduction: It has been suggested that vitamin D is effective to prevent mortality. However, there is no consistent conclusion that the effects of vitamin D supplementation on all-cause mortality are associated with duration of treatment. We conducted a meta-analysis regarding this issue in an effort to provide a more robust answer. Methods: A comprehensive search in a number of databases, including MEDLINE, Embase and The Cochrane Central Register of Controlled Trials, was conducted for collecting randomized controlled trials (RCTs) on vitamin D supplementation preventing mortality. Two investigators independently screened the literature according to the inclusive and exclusive criteria and the relative data were extracted. Data analysis was performed by using Review Manager 5.0 software. Results: Data from forty-two RCT s were included. Vitamin D therapy significantly decreased all-cause mortality with a duration of follow-up longer than 3 years with a RR (95% CI) of 0.94 (0.90-0.98). No benefit was seen in a shorter follow-up periods with a RR (95% CI) of 1.04 (0.97-1.12). Results remain robust after sensitivity analysis. The following subgroups of long-term follow-up had significantly fewer deaths: female only, participants with a mean age younger than 80, daily dose of 800 IU or less, participants with vitamin D insufficiency (baseline 25-hydroxyvitamin D level less than 50 nmol/L) and cholecalciferol therapy. In addition, the combination of vitamin D and calcium significantly reduced mortality and vitamin D alone also had a trend to decrease mortality in a longer time follow up. Conclusions: The data suggest that supplementation of vitamin D is effective in preventing overall mortality in a long-term treatment, whereas it is not significantly effective in a treatment duration shorter than 3 years. Future studies are needed to identify the efficacy of vitamin D on specific mortality, such as cancer and cardiovascular disease mortality in a long-term treatment duration.	[Zheng, Yayuan; Zhu, Jianhong; Zhou, Manru; Cui, Liao; Liu, Yuyu] Guangdong Med Coll, Dept Pharmacol, Zhanjiang, Peoples R China; [Yao, Weimin] Guangdong Med Coll, Inst Resp Dis, Zhanjiang, Peoples R China	Guangdong Medical University; Guangdong Medical University	Yao, WM (corresponding author), Guangdong Med Coll, Inst Resp Dis, Zhanjiang, Peoples R China.	616286464@qq.com; liuyuyu77@yeah.net			National Natural Science Foundation of China [81102450]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the grants from National Natural Science Foundation of China (81102450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2009, INT J CANCER, V124, P250, DOI 10.1002/ijc.23904; Aloia JF, 2005, ARCH INTERN MED, V165, P1618, DOI 10.1001/archinte.165.14.1618; Alvarez JA, 2012, AM J CLIN NUTR, V96, P672, DOI 10.3945/ajcn.112.040642; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; Artaza JN, 2009, CLIN J AM SOC NEPHRO, V4, P1515, DOI 10.2215/CJN.02260409; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Avenell Alison, 2004, Clin Trials, V1, P490, DOI 10.1191/1740774504cn053oa; Avenell A, 2012, J CLIN ENDOCR METAB, V97, P614, DOI 10.1210/jc.2011-1309; Baeksgaard L, 1998, OSTEOPOROSIS INT, V8, P255, DOI 10.1007/s001980050062; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bischoff-Ferrari H A, 2009, BMJ, V339, pb3692, DOI 10.1136/bmj.b3692; Bischoff-Ferrari HA, 2012, NEW ENGL J MED, V367, P40, DOI 10.1056/NEJMoa1109617; BJELAKOVIC G, 2011, COCHRANE DB SYST REV, V7; Bjoerkman M, 2008, AGE AGEING, V37, P25, DOI 10.1093/ageing/afm141; Bolland MJ, 2011, AM J CLIN NUTR, V94, P1144, DOI 10.3945/ajcn.111.015032; Bolton-Smith C, 2007, J BONE MINER RES, V22, P509, DOI [10.1359/jbmr.070116, 10.1359/JBMR.070116]; Bouillon R, 2006, J STEROID BIOCHEM, V102, P156, DOI 10.1016/j.jsbmb.2006.09.014; Brazier M, 2005, CLIN THER, V27, P1885, DOI 10.1016/j.clinthera.2005.12.010; Broe KE, 2007, J AM GERIATR SOC, V55, P234, DOI 10.1111/j.1532-5415.2007.01048.x; Burleigh E, 2007, AGE AGEING, V36, P507, DOI 10.1093/ageing/afm087; Cashman KD, 2012, FOOD NUTR RES, V56, DOI 10.3402/fnr.v56i0.5383; Chapuy MC, 2002, OSTEOPOROSIS INT, V13, P257, DOI 10.1007/s001980200023; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Chel V, 2008, OSTEOPOROSIS INT, V19, P663, DOI 10.1007/s00198-007-0465-2; Chen PZ, 2010, BREAST CANCER RES TR, V121, P469, DOI 10.1007/s10549-009-0593-9; Chung Mei, 2009, Evid Rep Technol Assess (Full Rep), P1; Cooper L, 2003, AM J CLIN NUTR, V77, P1324, DOI 10.1093/ajcn/77.5.1324; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Flicker L, 2005, J AM GERIATR SOC, V53, P1881, DOI 10.1111/j.1532-5415.2005.00468.x; Gepner AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036617; Gilbert R, 2011, CANCER CAUSE CONTROL, V22, P319, DOI 10.1007/s10552-010-9706-3; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Harwood RH, 2004, AGE AGEING, V33, P45, DOI 10.1093/ageing/afh002; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Hsia J, 2007, CIRCULATION, V115, P846, DOI 10.1161/CIRCULATIONAHA.106.673491; Kalyani RR, 2010, J AM GERIATR SOC, V58, P1299, DOI 10.1111/j.1532-5415.2010.02949.x; Kilkkinen A, 2008, CANCER EPIDEM BIOMAR, V17, P3274, DOI 10.1158/1055-9965.EPI-08-0199; Komulainen M, 1999, J CLIN ENDOCR METAB, V84, P546, DOI 10.1210/jc.84.2.546; Krieg MA, 1999, OSTEOPOROSIS INT, V9, P483, DOI 10.1007/s001980050174; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Larsen ER, 2004, J BONE MINER RES, V19, P370, DOI 10.1359/JBMR.0301240; Latham NK, 2003, J AM GERIATR SOC, V51, P291, DOI 10.1046/j.1532-5415.2003.51101.x; Lavie CJ, 2011, J AM COLL CARDIOL, V58, P1547, DOI 10.1016/j.jacc.2011.07.008; Law M, 2006, AGE AGEING, V35, P482, DOI 10.1093/ageing/afj080; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Lehouck A, 2012, ANN INTERN MED, V156, P105, DOI 10.7326/0003-4819-156-2-201201170-00004; Lips P, 1996, ANN INTERN MED, V124, P400, DOI 10.7326/0003-4819-124-4-199602150-00003; Lips P, 2010, AM J CLIN NUTR, V91, P985, DOI 10.3945/ajcn.2009.28113; Lyons RA, 2007, OSTEOPOROSIS INT, V18, P811, DOI 10.1007/s00198-006-0309-5; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; Margolis KL, 2008, HYPERTENSION, V52, P847, DOI 10.1161/HYPERTENSIONAHA.108.114991; Mathieu C, 2005, DIABETOLOGIA, V48, P1247, DOI 10.1007/s00125-005-1802-7; Meier C, 2004, J BONE MINER RES, V19, P1221, DOI 10.1359/JBMR.040511; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Meyer HE, 2002, J BONE MINER RES, V17, P709, DOI 10.1359/jbmr.2002.17.4.709; Michaelsson K, 2010, AM J CLIN NUTR, V92, P841, DOI 10.3945/ajcn.2010.29749; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; OOMS ME, 1995, J CLIN ENDOCR METAB, V80, P1052, DOI 10.1210/jc.80.4.1052; Porthouse J, 2005, BMJ-BRIT MED J, V330, P1003, DOI 10.1136/bmj.330.7498.1003; Prince RL, 2008, ARCH INTERN MED, V168, P103, DOI 10.1001/archinternmed.2007.31; Punthakee Z, 2012, DIABETOLOGIA, V55, P36, DOI 10.1007/s00125-011-2357-4; Ravani P, 2009, KIDNEY INT, V75, P88, DOI 10.1038/ki.2008.501; Rejnmark L, 2012, J CLIN ENDOCR METAB, V97, P2670, DOI 10.1210/jc.2011-3328; Rovner AJ, 2008, PEDIATRICS, V122, P907, DOI 10.1542/peds.2008-1743; Salovaara K, 2010, J BONE MINER RES, V25, P1487, DOI 10.1002/jbmr.48; Sanders KM, 2010, JAMA-J AM MED ASSOC, V303, P1815, DOI 10.1001/jama.2010.594; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; Sugden JA, 2008, DIABETIC MED, V25, P320, DOI 10.1111/j.1464-5491.2007.02360.x; Thacher TD, 2011, MAYO CLIN PROC, V86, P50, DOI 10.4065/mcp.2010.0567; Touvier M, 2011, CANCER EPIDEM BIOMAR, V20, P1003, DOI 10.1158/1055-9965.EPI-10-1141; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469, DOI 10.1136/bmj.326.7387.469; Uusi-Rasi K, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.21082; van den Bergh Joop P W, 2011, Curr Osteoporos Rep, V9, P36, DOI 10.1007/s11914-010-0041-0; Wahl D A, 2012, Arch Osteoporos, V7, P155, DOI 10.1007/s11657-012-0093-0; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wasse H, 2012, AM J CLIN NUTR, V95, P522, DOI 10.3945/ajcn.111.025502; Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC; Witham MD, 2010, CIRC-HEART FAIL, V3, P195, DOI 10.1161/CIRCHEARTFAILURE.109.907899; Zhu K, 2008, J CLIN ENDOCR METAB, V93, P743, DOI 10.1210/jc.2007-1466	82	60	67	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82109	10.1371/journal.pone.0082109	http://dx.doi.org/10.1371/journal.pone.0082109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24349197	Green Published, Green Submitted, gold			2022-12-27	WOS:000327947800084
J	Errafiy, R; Aguado, C; Ghislat, G; Esteve, JM; Gil, A; Loutfi, M; Knecht, E				Errafiy, Rajaa; Aguado, Carmen; Ghislat, Ghita; Esteve, Juan M.; Gil, Anabel; Loutfi, Mohammed; Knecht, Erwin			PTEN Increases Autophagy and Inhibits the Ubiquitin-Proteasome Pathway in Glioma Cells Independently of its Lipid Phosphatase Activity	PLOS ONE			English	Article							RAPAMYCIN-INDUCED AUTOPHAGY; TUMOR-SUPPRESSOR; NEGATIVE REGULATION; CANCER; FIBROBLASTS; DEGRADATION; LYSOSOMES; VACUOLES; DISEASE; TARGET	Two major mechanisms of intracellular protein degradation, autophagy and the ubiquitin-proteasome pathway, operate in mammalian cells. PTEN, which is frequently mutated in glioblastomas, is a tumor suppressor gene that encodes a dual specificity phosphatase that antagonizes the phosphatidylinositol 3-kinase class I/AKT/mTOR pathway, which is a key regulator of autophagy. Here, we investigated in U87MG human glioma cells the role of PTEN in the regulation of autophagy and the ubiquitin-proteasome pathway, because both are functionally linked and are relevant in cancer progression. Since U87MG glioma cells lack a functional PTEN, we used stable clones that express, under the control of a tetracycline-inducible system (Tet-on), wild-type PTEN and two of its mutants, G129E-PTEN and C124S-PTEN, which, respectively, lack the lipid phosphatase activity only and both the lipid and the protein phosphatase activities of this protein. Expression of PTEN in U87MG glioma cells decreased proteasome activity and also reduced protein ubiquitination. On the contrary, expression of PTEN increased the autophagic flux and the lysosomal mass. Interestingly, and although PTEN negatively regulates the phosphatidylinositol 3-kinase class I/AKT/mTOR signaling pathway by its lipid phosphatase activity, both effects in U87MG cells were independent of this activity. These results suggest a new mTOR-independent signaling pathway by which PTEN can regulate in opposite directions the main mechanisms of intracellular protein degradation.	[Errafiy, Rajaa; Aguado, Carmen; Ghislat, Ghita; Esteve, Juan M.; Gil, Anabel; Knecht, Erwin] Ctr Invest Principe Felipe, Lab Biol Celular, Valencia, Spain; [Aguado, Carmen; Knecht, Erwin] Ctr Invest Biomed Red Enfermedades, Raras Valencia, Spain; [Errafiy, Rajaa; Loutfi, Mohammed] Fac Sci, Lab Biochim & Biol Mol, Casablanca, Morocco	Prince Felipe Research Center; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hassan II University of Casablanca	Knecht, E (corresponding author), Ctr Invest Principe Felipe, Lab Biol Celular, Valencia, Spain.	knecht@cipf.es	Knecht, Erwin/A-9366-2014; Knecht, Erwin/K-2432-2014; Ghislat, Ghita/ABA-4769-2020; Aguado, Carmen/K-4354-2014	Knecht, Erwin/0000-0002-7208-3832; Aguado, Carmen/0000-0002-3113-4269	Ministerio de Educacion y Ciencia [BFU2011-22630]; Generalitat Valenciana [PROMETEO/2012/061]; Program Santiago Grisol a "Formacion de Personal Investigador Extranjero en Centros de Investigacion de la Comunitat Valenciana" [GRISOLIA/2008/072]	Ministerio de Educacion y Ciencia(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Program Santiago Grisol a "Formacion de Personal Investigador Extranjero en Centros de Investigacion de la Comunitat Valenciana"	This work was supported by the Ministerio de Educacion y Ciencia (Grant BFU2011-22630) and Generalitat Valenciana (PROMETEO/2012/061). RE was supported by the Program Santiago Grisol a "Formacion de Personal Investigador Extranjero en Centros de Investigacion de la Comunitat Valenciana" (Grant GRISOLIA/2008/072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado C, 2010, HUM MOL GENET, V19, P2867, DOI 10.1093/hmg/ddq190; Ahn Y, 2008, BIOCHEM J, V412, P331, DOI 10.1042/BJ20071403; Arico S, 2001, J BIOL CHEM, V276, P35243, DOI 10.1074/jbc.C100319200; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Bonneau D, 2000, HUM MUTAT, V16, P109, DOI 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Choi KS, 2012, EXP MOL MED, V44, P109, DOI 10.3858/emm.2012.44.2.033; Ciechanover A, 2012, BBA-PROTEINS PROTEOM, V1824, P3, DOI 10.1016/j.bbapap.2011.03.007; CUERVO AM, 1995, EUR J BIOCHEM, V227, P792, DOI 10.1111/j.1432-1033.1995.tb20203.x; de Llano JJM, 2000, ANAL CHEM, V72, P2406, DOI 10.1021/ac991287p; Devoy A, 2005, ESSAYS BIOCHEM, V41, P187, DOI 10.1042/EB0410187; Driscoll JJ, 2012, CANCER LETT, V325, P147, DOI 10.1016/j.canlet.2012.06.016; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; Esteban I, 2007, FEBS LETT, V581, P3415, DOI 10.1016/j.febslet.2007.06.043; Esteve JM, 2010, EXP CELL RES, V316, P2618, DOI 10.1016/j.yexcr.2010.06.019; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Moruno-Manchon JF, 2013, BIOCHEM J, V449, P497, DOI 10.1042/BJ20121122; Fu LL, 2013, INT J BIOCHEM CELL B, V45, P921, DOI 10.1016/j.biocel.2013.02.007; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Ghislat G, 2012, J CELL SCI, V125, P92, DOI 10.1242/jcs.086728; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Iwamaru A, 2007, ONCOGENE, V26, P1840, DOI 10.1038/sj.onc.1209992; Keniry M, 2008, ONCOGENE, V27, P5477, DOI 10.1038/onc.2008.248; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kisselev AF, 2005, METHOD ENZYMOL, V398, P364, DOI 10.1016/S0076-6879(05)98030-0; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; KNECHT E, 1984, EXP CELL RES, V154, P224, DOI 10.1016/0014-4827(84)90682-7; Knecht E, 2009, CELL MOL LIFE SCI, V66, P2427, DOI 10.1007/s00018-009-0030-6; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; Koul D, 2008, CANCER BIOL THER, V7, P1321, DOI 10.4161/cbt.7.9.6954; Lamark T, 2010, CURR OPIN CELL BIOL, V22, P192, DOI 10.1016/j.ceb.2009.11.002; Leslie NR, 2009, ADV ENZYME REGUL, V49, P190, DOI 10.1016/j.advenzreg.2008.12.002; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Morselli E, 2009, BBA-MOL CELL RES, V1793, P1524, DOI 10.1016/j.bbamcr.2009.01.006; Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Ueno T, 2008, AUTOPHAGY, V4, P692, DOI 10.4161/auto.6085; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Weng LP, 2001, HUM MOL GENET, V10, P251, DOI 10.1093/hmg/10.3.251; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wong E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a006734; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	50	45	48	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83318	10.1371/journal.pone.0083318	http://dx.doi.org/10.1371/journal.pone.0083318			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349488	Green Submitted, Green Published, gold			2022-12-27	WOS:000328734200076
J	Haberman, RP; Colantuoni, C; Koh, MT; Gallagher, M				Haberman, Rebecca P.; Colantuoni, Carlo; Koh, Ming Teng; Gallagher, Michela			Behaviorally Activated mRNA Expression Profiles Produce Signatures of Learning and Enhanced Inhibition in Aged Rats with Preserved Memory	PLOS ONE			English	Article							LONG-TERM POTENTIATION; GENE-EXPRESSION; CONSOLIDATION; HIPPOCAMPUS; IMPAIRMENT; MECHANISMS; DECLINE; BRAIN; ARC	Aging is often associated with cognitive decline, but many elderly individuals maintain a high level of function throughout life. Here we studied outbred rats, which also exhibit individual differences across a spectrum of outcomes that includes both preserved and impaired spatial memory. Previous work in this model identified the CA3 subfield of the hippocampus as a region critically affected by age and integral to differing cognitive outcomes. Earlier microarray profiling revealed distinct gene expression profiles in the CA3 region, under basal conditions, for aged rats with intact memory and those with impairment. Because prominent age-related deficits within the CA3 occur during neural encoding of new information, here we used microarray analysis to gain a broad perspective of the aged CA3 transcriptome under activated conditions. Behaviorally-induced CA3 expression profiles differentiated aged rats with intact memory from those with impaired memory. In the activated profile, we observed substantial numbers of genes (greater than 1000) exhibiting increased expression in aged unimpaired rats relative to aged impaired, including many involved in synaptic plasticity and memory mechanisms. This unimpaired aged profile also overlapped significantly with a learning induced gene profile previously acquired in young adults. Alongside the increased transcripts common to both young learning and aged rats with preserved memory, many transcripts behaviorally-activated in the current study had previously been identified as repressed in the aged unimpaired phenotype in basal expression. A further distinct feature of the activated profile of aged rats with intact memory is the increased expression of an ensemble of genes involved in inhibitory synapse function, which could control the phenotype of neural hyperexcitability found in the CA3 region of aged impaired rats. These data support the conclusion that aged subjects with preserved	[Haberman, Rebecca P.; Koh, Ming Teng; Gallagher, Michela] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA; [Colantuoni, Carlo] Johns Hopkins Sch Med, Lieber Inst Brain Dev, Baltimore, MD USA; [Colantuoni, Carlo] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Haberman, RP (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA.	rahabs@jhu.edu		Gallagher, Michela/0000-0002-9585-6500; Colantuoni, Carlo/0000-0001-6818-6380	National Institute on Aging/National Institutes of Health [P01AG09973]; NATIONAL INSTITUTE ON AGING [P01AG009973] Funding Source: NIH RePORTER	National Institute on Aging/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute on Aging/National Institutes of Health Grant P01AG09973. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albert MS, 2011, NEUROBIOL AGING, V32, pS58, DOI 10.1016/j.neurobiolaging.2011.09.010; Bakker A, 2012, NEURON, V74, P467, DOI 10.1016/j.neuron.2012.03.023; Boric K, 2008, J NEUROSCI, V28, P8034, DOI 10.1523/JNEUROSCI.2036-08.2008; Brown JT, 2003, EPILEPSY RES, V57, P121, DOI 10.1016/j.eplepsyres.2003.10.013; Cavallaro S, 2002, P NATL ACAD SCI USA, V99, P16279, DOI 10.1073/pnas.242597199; Chalifoux JR, 2011, CURR OPIN NEUROBIOL, V21, P339, DOI 10.1016/j.conb.2011.02.004; den Dunnen WFA, 2008, NEUROBIOL AGING, V29, P1127, DOI 10.1016/j.neurobiolaging.2008.04.010; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; GALLAGHER M, 1989, NEUROBIOL AGING, V10, P691, DOI 10.1016/0197-4580(89)90006-7; Gallagher M, 2006, AGE, V28, P221, DOI 10.1007/s11357-006-9017-5; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Haberman RP, 2008, P NATL ACAD SCI USA, V105, P10601, DOI 10.1073/pnas.0804292105; Haberman RP, 2011, NEUROBIOL AGING, V32, P1678, DOI 10.1016/j.neurobiolaging.2009.10.005; Hines RM, 2012, CURR OPIN NEUROBIOL, V22, P552, DOI 10.1016/j.conb.2011.10.007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Igaz LM, 2002, J NEUROSCI, V22, P6781; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kim D, 2009, CELL, V137, P997, DOI 10.1016/j.cell.2009.05.042; Koh MT, 2013, NEUROPHARMACOLOGY, V64, P145, DOI 10.1016/j.neuropharm.2012.06.023; Koh MT, 2010, NEUROPSYCHOPHARMACOL, V35, P1016, DOI 10.1038/npp.2009.207; Lee HK, 2005, NAT NEUROSCI, V8, P1657, DOI 10.1038/nn1586; Loebrich S, 2006, EMBO J, V25, P987, DOI 10.1038/sj.emboj.7600995; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Maei HR, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.004.2009; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; Parihar MS, 2010, J ALZHEIMERS DIS, V22, P741, DOI 10.3233/JAD-2010-101020; Robitsek RJ, 2008, J NEUROSCI, V28, P8945, DOI 10.1523/JNEUROSCI.1893-08.2008; SANCHEZ PE, 2012, P NATL ACAD SCI US; Sarto-Jackson I, 2012, J BIOL CHEM, V287, P14201, DOI 10.1074/jbc.M111.293175; Smith TD, 2000, J NEUROSCI, V20, P6587, DOI 10.1523/JNEUROSCI.20-17-06587.2000; Tucker AM, 2011, CURR ALZHEIMER RES, V8, P354; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wilson IA, 2005, J NEUROSCI, V25, P6877, DOI 10.1523/JNEUROSCI.1744-05.2005; Wilson IA, 2003, NEUROBIOL AGING, V24, P297, DOI 10.1016/S0197-4580(02)00080-5; Wilson IA, 2006, TRENDS NEUROSCI, V29, P662, DOI 10.1016/j.tins.2006.10.002; Yang S, 2013, J NEUROSCI, V33, P12670, DOI 10.1523/JNEUROSCI.1086-13.2013; Yassa MA, 2011, P NATL ACAD SCI USA, V108, P8873, DOI 10.1073/pnas.1101567108; Yassa MA, 2011, HIPPOCAMPUS, V21, P968, DOI 10.1002/hipo.20808; Yassa MA, 2010, NEUROIMAGE, V51, P1242, DOI 10.1016/j.neuroimage.2010.03.040	41	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83674	10.1371/journal.pone.0083674	http://dx.doi.org/10.1371/journal.pone.0083674			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349543	Green Submitted, gold, Green Published			2022-12-27	WOS:000328734200097
J	Rosenzweig, I; Kempton, MJ; Crum, WR; Glasser, M; Milosevic, M; Beniczky, S; Corfield, DR; Williams, SC; Morrell, MJ				Rosenzweig, Ivana; Kempton, Matthew J.; Crum, William R.; Glasser, Martin; Milosevic, Milan; Beniczky, Sandor; Corfield, Douglas R.; Williams, Steven C.; Morrell, Mary J.			Hippocampal Hypertrophy and Sleep Apnea: A Role for the Ischemic Preconditioning?	PLOS ONE			English	Article							BRAIN STRUCTURAL-CHANGES; INTERMITTENT HYPOXIA; NEUROCOGNITIVE FUNCTION; AUTOMATIC SEGMENTATION; ADULT NEUROGENESIS; CEREBELLAR ATROPHY; STROKE; RATS; MORPHOLOGY; DISORDER	The full impact of multisystem disease such as obstructive sleep apnoea (OSA) on regions of the central nervous system is debated, as the subsequent neurocognitive sequelae are unclear. Several preclinical studies suggest that its purported major culprits, intermittent hypoxia and sleep fragmentation, can differentially affect adult hippocampal neurogenesis. Although the prospective biphasic nature of chronic intermittent hypoxia in animal models of OSA has been acknowledged, so far the evidence for increased 'compensatory' neurogenesis in humans is uncertain. In a cross-sectional study of 32 patients with mixed severity OSA and 32 non-apnoeic matched controls inferential analysis showed bilateral enlargement of hippocampi in the OSA group. Conversely, a trend for smaller thalami in the OSA group was noted. Furthermore, aberrant connectivity between the hippocampus and the cerebellum in the OSA group was also suggested by the correlation analysis. The role for the ischemia/hypoxia preconditioning in the neuropathology of OSA is herein indicated, with possible further reaching clinical implications.	[Rosenzweig, Ivana; Kempton, Matthew J.; Crum, William R.; Williams, Steven C.] Kings Coll London, Dept Neuroimaging, Inst Psychiat, London WC2R 2LS, England; [Rosenzweig, Ivana; Beniczky, Sandor] Danish Epilepsy Ctr, Dianalund, Denmark; [Glasser, Martin; Morrell, Mary J.] Univ London Imperial Coll Sci Technol & Med, Acad Unit Sleep & Breathing, Natl Heart & Lung Inst, London, England; [Glasser, Martin; Morrell, Mary J.] Royal Brompton & Harefield NHS Fdn Trust, NIHR Resp Dis Biomed Res Unit, London, England; [Glasser, Martin; Morrell, Mary J.] Univ London Imperial Coll Sci Technol & Med, London, England; [Milosevic, Milan] Univ Zagreb, Sch Med, Dept Environm & Occupat Hlth, Andrija Stampar Sch Publ Hlth, Zagreb 41001, Croatia; [Beniczky, Sandor] Aarhus Univ Hosp, Dept Clin Neurophysiol, DK-8000 Aarhus, Denmark; [Corfield, Douglas R.] Univ Manchester, Manchester Med Sch, Manchester, Lancs, England	University of London; King's College London; Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London; University of Zagreb; Aarhus University; University of Manchester	Rosenzweig, I (corresponding author), Kings Coll London, Dept Neuroimaging, Inst Psychiat, London WC2R 2LS, England.	i.rosenzweig@camprot.com	Crum, William R/C-4891-2008; Kempton, Matthew/F-8683-2011; Williams, Steve C/D-6979-2011	Crum, William R/0000-0001-9369-2197; Williams, Steve C/0000-0003-4299-1941; Kempton, Matthew/0000-0003-3541-9947; Beniczky, Sandor/0000-0002-6035-6581; opoku, anita/0000-0001-7243-8157; Milosevic, Milan/0000-0001-9008-7645	National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London; Maudsley NHS Foundation Trust; King's College London; King's College London Centre of Excellence in Medical Engineering; Wellcome Trust; EPSRC [WT 088641/Z/09/Z]; MRC [MR/J008915/1]; NIHR Respiratory Biomedical Research Unit at the Royal Brompton; Harefield NHS Foundation Trust, Imperial College London; Medical Research Council [MR/J008915/1] Funding Source: researchfish; National Institute for Health Research [08/56/02] Funding Source: researchfish	National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; King's College London; King's College London Centre of Excellence in Medical Engineering; Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Respiratory Biomedical Research Unit at the Royal Brompton; Harefield NHS Foundation Trust, Imperial College London; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The author W.R. Crum receives salary support from the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the author and not necessarily those of the NHS, the NIHR or the Department of Health. W.R. Crum also acknowledges support from the King's College London Centre of Excellence in Medical Engineering funded by the Wellcome Trust and EPSRC (WT 088641/Z/09/Z). M.J. Kempton is funded by an MRC Fellowship (grant number MR/J008915/1). The project was supported by the NIHR Respiratory Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust, Imperial College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggleton JP, 2010, EUR J NEUROSCI, V31, P2292, DOI 10.1111/j.1460-9568.2010.07251.x; Ayalon L, 2010, AM J RESP CRIT CARE, V182, P413, DOI 10.1164/rccm.200912-1805OC; BALFORS EM, 1994, AM J RESP CRIT CARE, V150, P1587, DOI 10.1164/ajrccm.150.6.7952619; Bonnici HM, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00290; Canessa N, 2011, JAMA-J AM MED ASSOC, V306, P654, DOI 10.1001/jama.2011.1124; Canessa N, 2011, AM J RESP CRIT CARE, V183, P1419, DOI 10.1164/rccm.201005-0693OC; Cerasa A, 2009, AM J NEURORADIOL, V30, P1240, DOI 10.3174/ajnr.A1544; Comi AM, 2003, J CHILD NEUROL, V18, P509, DOI 10.1177/08830738030180080701; DeVisser A, 2011, NEUROBIOL DIS, V44, P161, DOI 10.1016/j.nbd.2011.06.005; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Doring TM, 2011, J MAGN RESON IMAGING, V33, P565, DOI 10.1002/jmri.22473; Durgan DJ, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000091; Eleore L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023538; Ferriero DM, 2005, EPILEPSIA, V46, P45, DOI 10.1111/j.1528-1167.2005.00302.x; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; Goldbart AD, 2006, BRAIN RES, V1090, P190, DOI 10.1016/j.brainres.2006.03.046; Gozal D, 2003, J NEUROCHEM, V86, P1545, DOI 10.1046/j.1471-4159.2003.01973.x; Gozal D, 2003, EUR J NEUROSCI, V18, P2335, DOI 10.1046/j.1460-9568.2003.02947.x; Gozal D, 2013, J PHYSIOL-LONDON, V591, P387, DOI 10.1113/jphysiol.2012.246017; Gozal D, 2013, J PHYSIOL-LONDON, V591, P379, DOI 10.1113/jphysiol.2012.241216; Gronenschild EHBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038234; Haddad GG, 2009, BRAIN HYPOXIA ISCHEM, Vxi; Hajak G, 1996, CHEST, V110, P670, DOI 10.1378/chest.110.3.670; Hoffmann LC, 2009, P NATL ACAD SCI USA, V106, P21371, DOI 10.1073/pnas.0908403106; Joo EY, 2007, SLEEP, V30, P1515, DOI 10.1093/sleep/30.11.1515; Joo EY, 2010, SLEEP, V33, P235, DOI 10.1093/sleep/33.2.235; Jung ME, 2008, J APPL PHYSIOL, V105, P510, DOI 10.1152/japplphysiol.90317.2008; Kumar R, 2012, J NEUROSCI RES, V90, P2043, DOI 10.1002/jnr.23083; Kushida CA, 2012, SLEEP, V35, P1593, DOI 10.5665/sleep.2226; Lavie L, 2006, MED HYPOTHESES, V66, P1069, DOI 10.1016/j.mehy.2005.10.033; Li YP, 2012, NEUROMOL MED, V14, P168, DOI 10.1007/s12017-011-8165-7; Lichtenwalner RJ, 2006, J CEREBR BLOOD F MET, V26, P1, DOI 10.1038/sj.jcbfm.9600170; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Macey PM, 2008, SLEEP, V31, P967; Macey PM, 2002, AM J RESP CRIT CARE, V166, P1382, DOI 10.1164/rccm.200201-050OC; McDonald CR, 2008, EPILEPSY RES, V79, P130, DOI 10.1016/j.eplepsyres.2008.01.006; McKenna JT, 2004, J COMP NEUROL, V480, P115, DOI 10.1002/cne.20342; Meadows GE, 2005, STROKE, V36, P2367, DOI 10.1161/01.STR.0000185923.49484.0f; Morrell MJ, 2010, THORAX, V65, P908, DOI 10.1136/thx.2009.126730; Morrell MJ, 2011, AM J RESP CRIT CARE, V183, P1292, DOI 10.1164/rccm.201103-0562ED; Morrell MJ, 2003, SLEEP MED, V4, P451, DOI 10.1016/S1389-9457(03)00159-X; Munoz R, 2006, STROKE, V37, P2317, DOI 10.1161/01.STR.0000236560.15735.0f; Nanduri J, 2008, RESP PHYSIOL NEUROBI, V164, P277, DOI 10.1016/j.resp.2008.07.006; NEWMAN PP, 1979, J PHYSIOL-LONDON, V287, P405, DOI 10.1113/jphysiol.1979.sp012667; O'Donoghue FJ, 2012, SLEEP, V35, P41, DOI 10.5665/sleep.1582; O'Donoghue FJ, 2005, AM J RESP CRIT CARE, V171, P1185, DOI 10.1164/rccm.200406-738OC; Papadakis M, 2013, NAT MED, V19, P351, DOI 10.1038/nm.3097; Pengas G, 2009, J NEUROIMAGING, V19, P37, DOI 10.1111/j.1552-6569.2008.00246.x; Plessen KJ, 2006, ARCH GEN PSYCHIAT, V63, P795, DOI 10.1001/archpsyc.63.7.795; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Rosenzweig I, 2013, J PHYSIOL-LONDON, V591, P389, DOI 10.1113/jphysiol.2012.246157; Rosenzweig I, 2013, J PHYSIOL-LONDON, V591, P383, DOI 10.1113/jphysiol.2012.241224; Rosenzweig I, 2012, NEUROSCI BIOBEHAV R, V36, P1848, DOI 10.1016/j.neubiorev.2012.05.006; Ross HH, 2012, EXP NEUROL, V235, P238, DOI 10.1016/j.expneurol.2012.01.027; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schonwald SV, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-89; Seki T, 2011, NEUROGENESIS ADULT B; Sforza Emilia, 2012, Front Neurol, V3, P87, DOI 10.3389/fneur.2012.00087; Sica AL, 2000, BRAIN RES, V883, P224, DOI 10.1016/S0006-8993(00)02800-6; Somers VK, 2008, CIRCULATION, V118, P1080, DOI 10.1161/CIRCULATIONAHA.107.189375; Tae WS, 2008, NEURORADIOLOGY, V50, P569, DOI 10.1007/s00234-008-0383-9; Torelli F, 2011, NEUROIMAGE, V54, P787, DOI 10.1016/j.neuroimage.2010.09.065; Tsai YW, 2013, J CEREBR BLOOD F MET, V33, P764, DOI 10.1038/jcbfm.2013.15; Tsai YW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024001; Twigg GL, 2010, AM J RESP CRIT CARE, V182, P98, DOI 10.1164/rccm.200901-0065OC; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Webb EA, 2012, BRAIN, V135, P216, DOI 10.1093/brain/awr305; Aviles-Reyes RX, 2010, J NEUROCHEM, V112, P854, DOI 10.1111/j.1471-4159.2009.06535.x; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Yaouhi K, 2009, J SLEEP RES, V18, P36, DOI 10.1111/j.1365-2869.2008.00705.x; Zhu XH, 2010, J NEUROSCI, V30, P12653, DOI 10.1523/JNEUROSCI.6414-09.2010	72	44	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83173	10.1371/journal.pone.0083173	http://dx.doi.org/10.1371/journal.pone.0083173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349453	Green Published, gold			2022-12-27	WOS:000328734200065
J	Webb, JT; Ferguson, MA; Nielsen, JA; Anderson, JS				Webb, J. Taylor; Ferguson, Michael A.; Nielsen, Jared A.; Anderson, Jeffrey S.			BOLD Granger Causality Reflects Vascular Anatomy	PLOS ONE			English	Article							INTRINSIC FUNCTIONAL CONNECTIVITY; HUMAN CONNECTOME PROJECT; CEREBRAL-CORTEX; DEFAULT MODE; FMRI; NETWORKS; FLUCTUATIONS; SIGNAL; ORGANIZATION; DYNAMICS	A number of studies have tried to exploit subtle phase differences in BOLD time series to resolve the order of sequential activation of brain regions, or more generally the ability of signal in one region to predict subsequent signal in another region. More recently, such lag-based measures have been applied to investigate directed functional connectivity, although this application has been controversial. We attempted to use large publicly available datasets (FCON 1000, ADHD 200, Human Connectome Project) to determine whether consistent spatial patterns of Granger Causality are observed in typical fMRI data. For BOLD datasets from 1,240 typically developing subjects ages 7-40, we measured Granger causality between time series for every pair of 7,266 spherical ROIs covering the gray matter and 264 seed ROIs at hubs of the brain's functional network architecture. Granger causality estimates were strongly reproducible for connections in a test and replication sample (n=620 subjects for each group), as well as in data from a single subject scanned repeatedly, both during resting and passive video viewing. The same effect was even stronger in high temporal resolution fMRI data from the Human Connectome Project, and was observed independently in data collected during performance of 7 task paradigms. The spatial distribution of Granger causality reflected vascular anatomy with a progression from Granger causality sources, in Circle of Willis arterial inflow distributions, to sinks, near large venous vascular structures such as dural venous sinuses and at the periphery of the brain. Attempts to resolve BOLD phase differences with Granger causality should consider the possibility of reproducible vascular confounds, a problem that is independent of the known regional variability of the hemodynamic response.	[Webb, J. Taylor; Ferguson, Michael A.; Anderson, Jeffrey S.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Nielsen, Jared A.; Anderson, Jeffrey S.] Univ Utah, Program Neurosci, Salt Lake City, UT USA; [Anderson, Jeffrey S.] Univ Utah, Inst Brain, Salt Lake City, UT USA; [Anderson, Jeffrey S.] Univ Utah, Div Neuroradiol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Anderson, JS (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.	andersonjeffs@gmail.com		Nielsen, Jared/0000-0002-2717-193X; Anderson, Jeffrey/0000-0002-9669-3846	National Institutes of Health [K08 MH092697]; the1000 Functional Connectomes Project; International Neuroimaging Data-sharing Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH092697] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); the1000 Functional Connectomes Project; International Neuroimaging Data-sharing Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The project described was supported by National Institutes of Health grant number K08 MH092697 and by the Ben B. and Iris M. Margolis Foundation. Funding sources for data contributed by the1000 Functional Connectomes Project (http://fcon_1000.projects.nitrc.org/) and the ADHD 200 project from the International Neuroimaging Data-sharing Initiative (http://fcon_1000.projects.nitrc.org/indi/adhd200/) are listed on the corresponding web sites. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna C, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00062; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Anderson JS, 2008, AM J NEURORADIOL, V29, P1722, DOI 10.3174/ajnr.A1220; Anderson JS, 2011, AM J NEURORADIOL, V32, P548, DOI 10.3174/ajnr.A2330; Anderson JS, 2011, BRAIN CONNECT, V1, P147, DOI 10.1089/brain.2011.0007; Anderson JS, 2011, BRAIN, V134, P3739, DOI 10.1093/brain/awr263; Anderson JS, 2011, HUM BRAIN MAPP, V32, P919, DOI 10.1002/hbm.21079; Barnett L, 2011, J NEUROSCI METH, V201, P404, DOI 10.1016/j.jneumeth.2011.08.010; Birn RM, 2001, NEUROIMAGE, V14, P817, DOI 10.1006/nimg.2001.0873; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Chang C, 2008, NEUROIMAGE, V43, P90, DOI 10.1016/j.neuroimage.2008.06.030; Chang C, 2009, NEUROIMAGE, V44, P857, DOI 10.1016/j.neuroimage.2008.09.029; Christova P, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046025; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; Deshpande G, 2010, NEUROIMAGE, V52, P884, DOI 10.1016/j.neuroimage.2009.11.060; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Friston KJ, 2013, CURR OPIN NEUROBIOL, V23, P172, DOI 10.1016/j.conb.2012.11.010; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Ji GJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063183; KWIATKOWSKI D, 1992, J ECONOMETRICS, V54, P159, DOI 10.1016/0304-4076(92)90104-Y; Luo Q, 2013, NEUROIMAGE, V79, P241, DOI 10.1016/j.neuroimage.2013.04.091; Madjar C, 2012, NEUROIMAGE, V61, P41, DOI 10.1016/j.neuroimage.2012.02.080; Marcus DS, 2013, NEUROIMAGE, V80, P202, DOI 10.1016/j.neuroimage.2013.05.077; Menon RS, 2012, NEUROIMAGE, V62, P1068, DOI 10.1016/j.neuroimage.2012.01.011; Milham MP, 2012, NEURON, V73, P214, DOI 10.1016/j.neuron.2011.11.004; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Schippers MB, 2011, NEUROIMAGE, V57, P22, DOI 10.1016/j.neuroimage.2011.02.008; Seth AK, 2013, NEUROIMAGE, V65, P540, DOI 10.1016/j.neuroimage.2012.09.049; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Singh M, 2002, IEEE T NUCL SCI, V49, P2284, DOI 10.1109/TNS.2002.803774; Smith SM, 2012, NEUROIMAGE, V59, P1228, DOI 10.1016/j.neuroimage.2011.08.015; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Stephan KE, 2012, NEUROIMAGE, V62, P856, DOI 10.1016/j.neuroimage.2012.01.034; Valdes-Sosa PA, 2011, NEUROIMAGE, V58, P339, DOI 10.1016/j.neuroimage.2011.03.058; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Wen XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067428; Wen XT, 2012, NEUROIMAGE, V60, P1587, DOI 10.1016/j.neuroimage.2012.01.079; Wen XT, 2012, J NEUROSCI, V32, P1284, DOI 10.1523/JNEUROSCI.2817-11.2012; Wiener N., 1956, MODERN MATH ENG, P165; Wu GR, 2013, BRAIN CONNECT, V3, P294, DOI 10.1089/brain.2013.0142; Yan H, 2013, J INT NEUROPSYCH SOC, V19, P400, DOI 10.1017/S1355617712001580; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011	62	36	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e84279	10.1371/journal.pone.0084279	http://dx.doi.org/10.1371/journal.pone.0084279			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349569	Green Submitted, gold, Green Published			2022-12-27	WOS:000328734200110
J	Duggan, AT; Whitten, M; Wiebe, V; Crawford, M; Butthof, A; Spitsyn, V; Makarov, S; Novgorodov, I; Osakovsky, V; Pakendorf, B				Duggan, Ana T.; Whitten, Mark; Wiebe, Victor; Crawford, Michael; Butthof, Anne; Spitsyn, Victor; Makarov, Sergey; Novgorodov, Innokentiy; Osakovsky, Vladimir; Pakendorf, Brigitte			Investigating the Prehistory of Tungusic Peoples of Siberia and the Amur-Ussuri Region with Complete mtDNA Genome Sequences and Y-chromosomal Markers	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; HAPLOGROUP-N; POPULATIONS; DIVERSITY; ORIGINS; AFFINITIES; LINEAGES; PATTERNS; HISTORY; EVEN	Evenks and Evens, Tungusic-speaking reindeer herders and hunter-gatherers, are spread over a wide area of northern Asia, whereas their linguistic relatives the Udegey, sedentary fishermen and hunter-gatherers, are settled to the south of the lower Amur River. The prehistory and relationships of these Tungusic peoples are as yet poorly investigated, especially with respect to their interactions with neighbouring populations. In this study, we analyse over 500 complete mtDNA genome sequences from nine different Evenk and even subgroups as well as their geographic neighbours from Siberia and their linguistic relatives the Udegey from the Amur-Ussuri region in order to investigate the prehistory of the Tungusic populations. These data are supplemented with analyses of Y-chromosomal haplogroups and STR haplotypes in the Evenks, Evens, and neighbouring Siberian populations. We demonstrate that whereas the North Tungusic Evenks and Evens show evidence of shared ancestry both in the maternal and in the paternal line, this signal has been attenuated by genetic drift and differential gene flow with neighbouring populations, with isolation by distance further shaping the maternal genepool of the Evens. The Udegey, in contrast, appear quite divergent from their linguistic relatives in the maternal line, with a mtDNA haplogroup composition characteristic of populations of the Amur-Ussuri region. Nevertheless, they show affinities with the Evenks, indicating that they might be the result of admixture between local Amur-Ussuri populations and Tungusic populations from the north.	[Duggan, Ana T.; Wiebe, Victor] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Whitten, Mark; Butthof, Anne; Pakendorf, Brigitte] Max Planck Inst Evolutionary Anthropol, MPRG Comparat Populat Linguist, Leipzig, Germany; [Crawford, Michael] Univ Kansas, Dept Anthropol, Lawrence, KS 66045 USA; [Spitsyn, Victor; Makarov, Sergey] Russian Acad Med Sci, Med Genet Res Ctr, Moscow, Russia; [Novgorodov, Innokentiy] North Eastern Fed Univ, Inst Foreign Philol & Reg Studies, Yakutsk, Russia; [Osakovsky, Vladimir] North Eastern Fed Univ, Inst Hlth, Yakutsk, Russia	Max Planck Society; Max Planck Society; University of Kansas; Research Centre for Medical Genetics; Russian Academy of Medical Sciences; North-Eastern Federal University in Yakutsk; North-Eastern Federal University in Yakutsk	Duggan, AT (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany.	ana_duggan@eva.mpg.de; Brigitte.Pakendorf@cnrs.fr	Osakovskij, Vladimir L./A-7843-2014; Duggan, Ana T./G-8839-2016; Novgorodov, Innokentiy/F-2871-2016; Spitsyn, Viktor/O-8137-2015	Osakovskij, Vladimir L./0000-0001-9529-2488; Novgorodov, Innokentiy/0000-0002-9378-0987; Duggan, Ana/0000-0002-2582-2954; Spitsyn, Viktor/0000-0002-4354-2905	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	This research was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEKSEEV AN, 1996, DREVNJAJA JAKUTIJA Z; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barbieri C, 2012, MOL BIOL EVOL, V29, P1213, DOI 10.1093/molbev/msr291; BLACK LT, 1988, CROSSROADS CONTINENT, P24; Bosch E, 2006, ANN HUM GENET, V70, P459, DOI 10.1111/j.1469-1809.2005.00251.x; BURYKIN AA, 2004, JAZYK MALOCISLENNOGO, V373; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Filippo C, 2011, MOL BIOL EVOL, V28, P1255, DOI 10.1093/molbev/msq312; Derbeneva OA, 2002, AM J HUM GENET, V70, P1009, DOI 10.1086/339524; Derenko M, 2006, HUM GENET, V118, P591, DOI 10.1007/s00439-005-0076-y; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Derenko M, 2007, J HUM GENET, V52, P763, DOI 10.1007/s10038-007-0179-5; Derenko M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015214; Derenko MV, 2003, ANN HUM GENET, V67, P391, DOI 10.1046/j.1469-1809.2003.00035.x; Derenko MV, 2000, HUM BIOL, V72, P945; DOLGIKH BO, 1960, RODOVOY PLEMENNOY SO; Dray S., 2007, R NEWS, V7, P47; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fedorova SA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-127; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Forster P, 1996, AM J HUM GENET, V59, P935; Goedbloed M, 2009, INT J LEGAL MED, V123, P471, DOI 10.1007/s00414-009-0342-y; GOGOLEV AI, 1993, JAKUTY PROBLEMY ETHO; Gurvich I.S., 1980, ETHNOGENESIS PEOPLES, P152; Hijmans RJ, 2012, GEOSPHERE SPHERICAL; Janhunen Juha Antero, 1996, MANCHURIA ETHNIC HIS; Jin HJ, 2010, AM J PHYS ANTHROPOL, V142, P303, DOI 10.1002/ajpa.21232; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karafet TM, 2002, HUM BIOL, V74, P761, DOI 10.1353/hub.2003.0006; Kloss-Brandstatter A, 2011, HUM MUTAT, V32, P25, DOI 10.1002/humu.21382; KOCESKOV NV, 1997, ISTORIJA KULTURA EVE; Lell JT, 2002, AM J HUM GENET, V70, P192, DOI 10.1086/338457; Macaulay VA, 1997, AM J HUM GENET, V61, P983; Malyarchuk B, 2010, ANN HUM GENET, V74, P539, DOI 10.1111/j.1469-1809.2010.00601.x; Malyarchuk BA, 2012, J HUM GENET, V57, P685, DOI 10.1038/jhg.2012.93; Nasidze I, 2005, AM J PHYS ANTHROPOL, V128, P846, DOI 10.1002/ajpa.20159; Paabo S, 1996, AM J HUM GENET, V59, P493; Pakendorf B, 2007, AM J PHYS ANTHROPOL, V133, P1013, DOI 10.1002/ajpa.20590; Pakendorf B, 2006, HUM GENET, V120, P334, DOI 10.1007/s00439-006-0213-2; Pakendorf B, 2009, J LANG CONTACT, V2, P85, DOI 10.1163/000000009792497724; ROMANOVA AV, 1962, OCERKI TOKKINSKOGO T; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; Rubicz R. C., 2007, THESIS U KANSAS; Rubicz R, 2010, AM J PHYS ANTHROPOL, V143, P62, DOI 10.1002/ajpa.21290; Sato T, 2007, J HUM GENET, V52, P618, DOI 10.1007/s10038-007-0164-z; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; SMOLJAK AV, 2001, NARODY NIZNEGO AMURA; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; SPEVAKOVSKY AB, 1994, ENCY WORLD CULTURES, P115; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; StatSoft_ Inc, 2011, STATISTICA; Sukernik RI, 2012, AM J PHYS ANTHROPOL, V148, P123, DOI 10.1002/ajpa.22050; TAKSAMI CM, 2007, NIVXI ETNICESKAJA KU; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VASILEVIC GM, 1969, EVENKI ISTORIKO ETNO; VASILEVIC GM, 1948, OCERKI DIALEKTOV EVE; Volodko NV, 2008, AM J HUM GENET, V82, P1084, DOI 10.1016/j.ajhg.2008.03.019; WURM SA, 1996, ATLAS LANGUAGES INTE, P969; Zlojutro M, 2009, AM J PHYS ANTHROPOL, V139, P474, DOI 10.1002/ajpa.21003	63	25	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83570	10.1371/journal.pone.0083570	http://dx.doi.org/10.1371/journal.pone.0083570			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349531	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800128
J	Kusano, H; Akiba, J; Ogasawara, S; Sanada, S; Yasumoto, M; Nakayama, M; Ueda, K; Ueda, K; Kurita, T; Todoroki, K; Umeno, Y; Nakashima, O; Yano, H				Kusano, Hironori; Akiba, Jun; Ogasawara, Sachiko; Sanada, Sakiko; Yasumoto, Makiko; Nakayama, Masamichi; Ueda, Keiko; Ueda, Kosuke; Kurita, Takashi; Todoroki, Keita; Umeno, Yumi; Nakashima, Osamu; Yano, Hirohisa			Pegylated Interferon-alpha 2a Inhibits Proliferation of Human Liver Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; PEGINTERFERON ALPHA-2B; PLUS RIBAVIRIN; LONG-TERM; THERAPY; LINE; GROWTH; ESTABLISHMENT; RECURRENCE	Purpose: We investigated the effects of pegylated interferon-alpha 2a (PEG-IFN-alpha 2a) on the growth of human liver cancer cells. Methods: The effect of PEG-IFN-alpha 2a on the proliferation of 13 liver cancer cell lines was investigated in vitro. Cells were cultured with medium containing 0-4,194 ng/mL of PEG-IFN-alpha 2a, and after 1, 2, 3, or 4 days of culture, morphologic observation and growth assay were performed. After hepatocellular carcinoma (HCC) cells (HAK-1B and KIM-1) were transplanted into nude mice, various doses of PEG-IFN-alpha 2a were subcutaneously administered to the mice once a week for 2 weeks, and tumor volume, weight, and histology were examined. Results: PEG-IFN-alpha 2a inhibited the growth of 8 and 11 cell lines in a time-and dose-dependent manner, respectively, although the 50% growth inhibitory concentrations of 7 measurable cell lines on Day 4 were relatively high and ranged from 253 ng/mL to 4,431 ng/mL. Various levels of apoptosis induction were confirmed in 8 cell lines. PEG-IFN-alpha 2a induced a dose-dependent decrease in tumor volume and weight, and a significant increase of apoptotic cells in the tumor. Subcutaneous administration of clinical dose for chronic hepatitis C (3 mu g/kg, 0.06 mu g/ mouse) was effective and induced about 30-50% reduction in the tumor volume and weight as compared with the control. Conclusions: Although in vitro anti-proliferative effects of PEG-IFN-alpha 2a were relatively weak, PEG-IFN-alpha 2a induced strong anti-tumor effects on HCC cells in vivo. The data suggest potential clinical application of PEG-IFN-alpha 2a for the prevention and treatment of HCC.	[Kusano, Hironori; Akiba, Jun; Ogasawara, Sachiko; Sanada, Sakiko; Yasumoto, Makiko; Nakayama, Masamichi; Ueda, Keiko; Ueda, Kosuke; Kurita, Takashi; Todoroki, Keita; Umeno, Yumi; Yano, Hirohisa] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan; [Nakashima, Osamu] Kurume Univ Hosp, Dept Clin Lab Med, Kurume, Fukuoka, Japan	Kurume University; Kurume University	Kusano, H (corresponding author), Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 830, Japan.	kusano_hironori@kurume-u.ac.jp		Kusano, Hironori/0000-0002-9911-2007	Sarah Cousins Memorial Fund, Boston, Massachusetts; Ministry of Health, Labor and Welfare of Japan	Sarah Cousins Memorial Fund, Boston, Massachusetts; Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by the Sarah Cousins Memorial Fund, Boston, Massachusetts, and by a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailon P, 2001, BIOCONJUGATE CHEM, V12, P195, DOI 10.1021/bc000082g; Bruix J, 2011, GASTROENTEROLOGY, V140, P1990, DOI 10.1053/j.gastro.2011.03.010; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Dinney CPN, 1998, CANCER RES, V58, P808; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; GILLESPIE D, 1982, TEX REP BIOL MED, V41, P37; Haramaki M, 1997, Hum Cell, V10, P183; Hisaka T, 2004, J HEPATOL, V41, P782, DOI 10.1016/j.jhep.2004.07.012; Hlatky L, 2002, JNCI-J NATL CANCER I, V94, P883; Jonasch E, 2001, ONCOLOGIST, V6, P34, DOI 10.1634/theoncologist.6-1-34; Kojiro S, 2006, J GASTROEN HEPATOL, V21, P129, DOI 10.1111/j.1440-1746.2005.04154.x; LAI CL, 1993, HEPATOLOGY, V17, P389; Lok AS, 2011, GASTROENTEROLOGY, V140, P840, DOI 10.1053/j.gastro.2010.11.050; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Miyake Y, 2010, INT J CANCER, V127, P989, DOI 10.1002/ijc.25090; Miyake Y, 2009, J GASTROENTEROL, V44, P470, DOI 10.1007/s00535-009-0024-z; MURAKAMI T, 1987, HEPATOLOGY, V7, P551, DOI 10.1002/hep.1840070322; Murakami T., 1984, ACTA HEPATOL JPN, V25, P532, DOI DOI 10.2957/KANZ0.25.532; Murakami T, 1988, JPN J CANC RES, V292; Nagano H, 2007, CANCER-AM CANCER SOC, V110, P2493, DOI 10.1002/cncr.23033; Nishiguchi S, 2005, INTERVIROLOGY, V48, P71, DOI 10.1159/000082098; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; Qu LS, 2010, J SURG ONCOL, V102, P796, DOI 10.1002/jso.21741; Sakaguchi Y, 2005, INTERVIROLOGY, V48, P64, DOI 10.1159/000082097; Takemoto Y, 2004, CLIN CANCER RES, V10, P7418, DOI 10.1158/1078-0432.CCR-04-0279; Theise ND, 2010, WHO CLASSIFICATION T, P225; Utsunomiya I, 1999, INT J ONCOL, V15, P669; YANO H, 1986, IN VITRO CELL DEV B, V22, P637; YANO H, 1993, HEPATOLOGY, V18, P320, DOI 10.1016/0270-9139(93)90015-F; Yano H, 1999, HEPATOLOGY, V29, P1708, DOI 10.1002/hep.510290624; YANO H, 1988, ACTA PATHOL JAPON, V38, P953; Yano H, 1996, J HEPATOL, V24, P413, DOI 10.1016/S0168-8278(96)80161-9; Yano H, 2006, LIVER INT, V26, P964, DOI 10.1111/j.1478-3231.2006.01321.x	33	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83195	10.1371/journal.pone.0083195	http://dx.doi.org/10.1371/journal.pone.0083195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349459	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800102
J	Luo, WR; Yao, KT				Luo, Weiren; Yao, Kaitai			Molecular Characterization and Clinical Implications of Spindle Cells in Nasopharyngeal Carcinoma: A Novel Molecule-Morphology Model of Tumor Progression Proposed	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EPSTEIN-BARR-VIRUS; ALDEHYDE DEHYDROGENASE 1; CANCER STEM-CELLS; N-CADHERIN EXPRESSION; TISSUE MICROARRAYS; MARKER; HETEROGENEITY; PREDICTOR; INFECTION	Up to now, the precise molecular and morphological changes underlying the invasive and metastatic properties of nasopharyngeal carcinoma (NPC) remain largely unresolved. We speculate that neoplastic spindle cells, which are prominently found in the invasive tumor front and the surrounding stroma, might be responsible for the aggressive patterns. Expression profiling of various biomarkers relevant to cancer stem cells (CSCs) and epithelial-mesenchymal transition (EMT) was performed by tissue microarray-based immunohistochemistry in NPC samples. The expression of EBER and LMP1 was detected by in situ hybridization and immunohistochemistry, respectively. We found that overexpression of CSCs-related markers (ALDH1, Nanog and ABCG2) and up-regulation of EMT markers (Fibronectin, MMP-2, Periostin, SPARC, Snail and Slug), together with E-to N-cadherin switching, occurred preferentially in tumors containing a large proportion of spindle-shaped malignant cells. Furthermore, CSCs-like properties were highly present in spindle cells compared with non-spindle cells of tumors, and correlated strongly with EMT features. In addition, EBV-related factors EBER and LMP1 were highly expressed and correlated strongly with CSCs and EMT characteristics in neoplastic spindle cells. Importantly, high proportion of spindle cells (>= 20%) correlated significantly with various aggressive aspects including lymph node metastasis (P = 0.031) and local recurrence (P = 0.014). Patients with high proportion of spindle cells had poor survival (P = 0.004), though it was not an independent value. In conclusion, we demonstrate that spindle cells could be valuable morphological indicators of tumor progression and unfavorable prognosis of NPC. An integrated molecule-morphology model of NPC firstly constructed may shed significant light on the metastatic cascade and clinical relevance of patients.	[Luo, Weiren; Yao, Kaitai] Southern Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Luo, WR (corresponding author), Southern Med Univ, Canc Res Inst, Guangzhou, Guangdong, Peoples R China.	luoweiren@hotmail.com; yao.kaitai@hotmail.com	Luo, Weiren/AAI-8364-2020	Luo, Weiren/0000-0002-2762-6332	National Natural Science Foundation of China (NSFC)-Guangdong Joint Fund [u0732006]; National Natural Science Foundation of China [81202125]; National 863 High Technology Research and Development program of China [2006AA02A404]; National 973 Basic Research Program of China [2010CB529400]	National Natural Science Foundation of China (NSFC)-Guangdong Joint Fund(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 High Technology Research and Development program of China(National High Technology Research and Development Program of China); National 973 Basic Research Program of China(National Basic Research Program of China)	This work was supported by funding from National Natural Science Foundation of China (NSFC)-Guangdong Joint Fund [u0732006], National Natural Science Foundation of China [81202125], National 863 High Technology Research and Development program of China [2006AA02A404] and National 973 Basic Research Program of China [2010CB529400]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Camp RL, 2008, J CLIN ONCOL, V26, P5630, DOI 10.1200/JCO.2008.17.3567; Chan ATC, 2002, ANN ONCOL, V13, P1007, DOI 10.1093/annonc/mdf179; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Chen MH, 1992, J CLIN EXP PATHOL, V8, P179; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Harn HJ, 1998, HISTOPATHOLOGY, V33, P117, DOI 10.1046/j.1365-2559.1998.00470.x; Hassan KA, 2009, CLIN CANCER RES, V15, P6386, DOI 10.1158/1078-0432.CCR-09-1105; Horikawa T, 2011, BRIT J CANCER, V104, P1160, DOI 10.1038/bjc.2011.38; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kondo S, 2011, J VIROL, V85, P11255, DOI 10.1128/JVI.00188-11; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li J, 2008, CLIN CANCER RES, V14, P6996, DOI 10.1158/1078-0432.CCR-08-0754; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Li XJ, 2012, CARCINOGENESIS, V33, P1302, DOI 10.1093/carcin/bgs181; LIANG P C, 1962, Chin Med J, V81, P629; Liu ZY, 2011, J CLIN PATHOL, V64, P325, DOI 10.1136/jcp.2010.083956; Luo WR, 2012, HISTOPATHOLOGY, V61, P1072, DOI 10.1111/j.1365-2559.2012.04350.x; Luo WR, 2012, HISTOPATHOLOGY, V61, P113, DOI 10.1111/j.1365-2559.2012.04205.x; Luo Wei-ren, 2010, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V45, P941; Luo WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056324; Luo WR, 2012, INT J CANCER, V131, P1863, DOI 10.1002/ijc.27467; Luo WR, 2013, VIRCHOWS ARCH, DOI [10.1007/s00428-013-1508-z, DOI 10.1007/S00428-013-1508-Z.PUBMED:24248285]; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Niedobitek G, 2000, J CLIN PATHOL-MOL PA, V53, P248, DOI 10.1136/mp.53.5.248; NIEDOBITEK G, 1993, J PATHOL, V170, P457, DOI 10.1002/path.1711700409; NIEDOBITEK G, 1991, J PATHOL, V165, P17, DOI 10.1002/path.1711650105; Park SY, 2010, CLIN CANCER RES, V16, P876, DOI 10.1158/1078-0432.CCR-09-1532; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Razak ARA, 2010, EUR J CANCER, V46, P1967, DOI 10.1016/j.ejca.2010.04.004; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; SENBA M, 1994, LANCET, V343, P1104, DOI 10.1016/S0140-6736(94)90217-8; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson Lester, 2006, Ear Nose Throat J, V85, P74; Vallejos CS, 2010, CLIN BREAST CANCER, V10, P294, DOI 10.3816/CBC.2010.n.038; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wu AB, 2013, CANCER LETT, V330, P181, DOI 10.1016/j.canlet.2012.11.046; Xia HP, 2010, J BIOL CHEM, V285, P36995, DOI 10.1074/jbc.M110.133744; Zhang L, 2011, ANN SURG ONCOL, V18, P233, DOI 10.1245/s10434-010-1292-9	56	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83135	10.1371/journal.pone.0083135	http://dx.doi.org/10.1371/journal.pone.0083135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349446	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800098
J	Monceau, K; Cezilly, F; Moreau, J; Motreuil, S; Wattier, R				Monceau, Karine; Cezilly, Frank; Moreau, Jerome; Motreuil, Sebastien; Wattier, Remi			Colonisation and Diversification of the Zenaida Dove (Zenaida aurita) in the Antilles: Phylogeography, Contemporary Gene Flow and Morphological Divergence	PLOS ONE			English	Article							BANANAQUIT COEREBA-FLAVEOLA; MITOCHONDRIAL-DNA; F-ST; POPULATION BOTTLENECKS; PHENOTYPIC DIVERGENCE; STATISTICAL TESTS; PASSER-DOMESTICUS; TAXON CYCLE; P-ST; DIFFERENTIATION	Caribbean avifaunal biogeography has been mainly studied based on mitochondrial DNA. Here, we investigated both past and recent island differentiation and micro-evolutionary changes in the Zenaida Dove (Zenaida aurita) based on combined information from one mitochondrial (Cytochrome c Oxydase subunit I, COI) and 13 microsatellite markers and four morphological characters. This Caribbean endemic and abundant species has a large distribution, and two subspecies are supposed to occur: Z. a. zenaida in the Greater Antilles (GA) and Z. a. aurita in the Lesser Antilles (LA). Doves were sampled on two GA islands (Puerto Rico and the British Virgin Islands) and six LA islands (Saint Barthelemy, Guadeloupe, Les Saintes, Martinique, Saint Lucia and Barbados). Eleven COI haplotypes were observed that could be assembled in two distinct lineages, with six specific to GA, four to LA, the remaining one occurring in all islands. However, the level of divergence between those two lineages was too moderate to fully corroborate the existence of two subspecies. Colonisation of the studied islands appeared to be a recent process. However, both phenotypic and microsatellite data suggest that differentiation is already under way between all of them, partly associated with the existence of limited gene flow. No isolation by distance was observed. Differentiation for morphological traits was more pronounced than for neutral markers. These results suggest that despite recent colonisation, genetic drift and/or restricted gene flow are promoting differentiation for neutral markers. Variation in selective pressures between islands may explain the observed phenotypic differentiation.	[Monceau, Karine; Cezilly, Frank; Moreau, Jerome; Motreuil, Sebastien; Wattier, Remi] Univ Bourgogne, UMR CNRS Biogeosci 6282, Equipe Ecol Evolut, Dijon, France; [Cezilly, Frank] Inst Univ France, Paris, France	Universite de Bourgogne; Institut Universitaire de France	Wattier, R (corresponding author), Univ Bourgogne, UMR CNRS Biogeosci 6282, Equipe Ecol Evolut, Dijon, France.	remi.wattier@u-bourgogne.fr	Wattier, Remi/ABC-3410-2021; moreau, jerome/A-3496-2013	Monceau, Karine/0000-0003-3786-1835	Ministere de la Recherche et de l'Enseignement Superieur; Agence Nationale pour la Recherche; Conseil regional de Bourgogne; National Science Foundation [DEB-0542390]	Ministere de la Recherche et de l'Enseignement Superieur; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Conseil regional de Bourgogne(Region Bourgogne-Franche-Comte); National Science Foundation(National Science Foundation (NSF))	KM was supported by a doctoral grant from the Ministere de la Recherche et de l'Enseignement Superieur. Financial support was provided by the Agence Nationale pour la Recherche (programme blanc Monogamix), and the Conseil regional de Bourgogne. Fieldwork in the British Virgin Islands was supported by National Science Foundation grant DEB-0542390. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALL RM, 1992, AUK, V109, P626; Baptista L. F., 1997, HDB BIRDS WORLD, V4, P60; Barbanera F, 2011, J ZOOL, V285, P56, DOI 10.1111/j.1469-7998.2011.00813.x; Bellemain E, 2008, TRENDS ECOL EVOL, V23, P536, DOI 10.1016/j.tree.2008.08.002; Bellemain E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-240; Benjamini Y, 2001, ANN STAT, V29, P1165; Brommer JE, 2011, J EVOLUTION BIOL, V24, P1160, DOI 10.1111/j.1420-9101.2011.02268.x; Illera JC, 2012, QUATERNARY SCI REV, V50, P14, DOI 10.1016/j.quascirev.2012.07.013; Cezilly F, 2012, IBIS, V154, P161, DOI 10.1111/j.1474-919X.2011.01173.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chui CKS, 2009, J BIOGEOGR, V36, P1945, DOI 10.1111/j.1365-2699.2009.02132.x; Clegg SM, 2002, EVOLUTION, V56, P2090; Clegg SM, 2010, PHILOS T R SOC B, V365, P1077, DOI 10.1098/rstb.2009.0281; Cornuet JM, 1999, GENETICS, V153, P1989; Cornuet JM, 1996, GENETICS, V144, P2001; Crawley M.J., 2007, R BOOK; Darwin C.R., 1859, ORIGIN SPECIES MEANS; Davalos LM, 2007, J BIOGEOGR, V34, P364, DOI 10.1111/j.1365-2699.2006.01610.x; De Neve L, 2010, CAN J ZOOL, V88, P1021, DOI 10.1139/Z10-067; Dechaume-Moncharmont FX, 2011, AUK, V128, P78, DOI 10.1525/auk.2011.10129; DEGNAN SM, 1992, AUK, V109, P800, DOI 10.2307/4088154; Dietzen C, 2006, J ORNITHOL, V147, P485, DOI 10.1007/s10336-005-0044-2; Edelaar P, 2011, MOL ECOL, V20, P4830, DOI 10.1111/j.1365-294X.2011.05333.x; Edelaar P, 2011, MOL ECOL, V20, P1805, DOI 10.1111/j.1365-294X.2011.05051.x; Emerson BC, 2002, MOL ECOL, V11, P951, DOI 10.1046/j.1365-294X.2002.01507.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fahey AL, 2012, EVOL BIOL, V39, P400, DOI 10.1007/s11692-012-9164-9; Filardi CE, 2005, NATURE, V438, P216, DOI 10.1038/nature04057; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R, 1997, HEREDITY, V78, P311, DOI 10.1038/hdy.1997.46; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Fu YX, 1997, GENETICS, V147, P915; Goudet J, 1996, GENETICS, V144, P1933; Goudet J., 2002, FSTAT PROGRAM ESTIMA; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hille SM, 2003, MOL ECOL, V12, P2145, DOI 10.1046/j.1365-294X.2003.01891.x; Hoeck PEA, 2010, PHILOS T R SOC B, V365, P1127, DOI 10.1098/rstb.2009.0311; Hunt JS, 2001, AUK, V118, P35, DOI 10.1642/0004-8038(2001)118[0035:MSABOA]2.0.CO;2; Illera JC, 2007, MOL ECOL, V16, P4599, DOI 10.1111/j.1365-294X.2007.03543.x; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Johnson KP, 2011, J BIOGEOGR, V38, P1069, DOI 10.1111/j.1365-2699.2011.02501.x; Johnson KP, 2000, CONDOR, V102, P864, DOI 10.1650/0010-5422(2000)102[0864:AMPOTD]2.0.CO;2; Juan C, 2000, TRENDS ECOL EVOL, V15, P104, DOI 10.1016/S0169-5347(99)01776-0; Kekkonen J, 2012, IBIS, V154, P846, DOI 10.1111/j.1474-919X.2012.01252.x; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kirchman JJ, 2007, MOL PHYLOGENET EVOL, V43, P14, DOI 10.1016/j.ympev.2006.12.013; Latta SC, 2012, J FIELD ORNITHOL, V83, P107, DOI 10.1111/j.1557-9263.2012.00361.x; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; Lehtonen PK, 2009, MOL ECOL, V18, P4463, DOI 10.1111/j.1365-294X.2009.04364.x; Leinonen T, 2008, J EVOLUTION BIOL, V21, P1, DOI 10.1111/j.1420-9101.2007.01445.x; Lin J, 2008, J FISH BIOL, V73, P1993, DOI 10.1111/j.1095-8649.2008.02014.x; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Lovette IJ, 1999, CONSERV BIOL, V13, P1088, DOI 10.1046/j.1523-1739.1999.98300.x; Lovette IJ, 1998, AUK, V115, P890, DOI 10.2307/4089508; Lovette Irby J., 1999, Biological Invasions, V1, P33, DOI 10.1023/A:1010090414598; Luikart G, 1998, MOL ECOL, V7, P963, DOI 10.1046/j.1365-294x.1998.00414.x; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; Macdonald R, 2000, EARTH-SCI REV, V49, P1, DOI 10.1016/S0012-8252(99)00069-0; Markland HM, 2005, IBIS, V147, P764, DOI 10.1111/j.1474-919x.2005.00464.x; Monceau K, 2013, J HERED, V104, P47, DOI 10.1093/jhered/ess073; Monceau K, 2011, AUK, V128, P15, DOI 10.1525/auk.2010.09247; Monceau K, 2009, CONSERV GENET, V10, P1577, DOI 10.1007/s10592-008-9798-4; Moreno-Rueda G, 2003, J ORNITHOL, V144, P438, DOI 10.1007/BF02465506; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Phillimore AB, 2006, P R SOC B, V273, P1049, DOI 10.1098/rspb.2005.3425; Phillimore AB, 2007, EVOLUTION, V61, P942, DOI 10.1111/j.1558-5646.2007.00068.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; PITMAN WC, 1993, BIOLOGICAL RELATIONSHIPS BETWEEN AFRICA AND SOUTH AMERICA, P15; Pritchard JK, 2000, GENETICS, V155, P945; Pruett CL, 2000, CONDOR, V102, P871, DOI 10.1650/0010-5422(2000)102[0871:MDAMVO]2.0.CO;2; Pujol B, 2008, MOL ECOL, V17, P4782, DOI 10.1111/j.1365-294X.2008.03958.x; Quinard A, 2012, ANIM BEHAV, V83, P47, DOI 10.1016/j.anbehav.2011.09.032; R Development Core Team, 2008, R LANG ENV STAT COMP; Raeymaekers JAM, 2007, MOL ECOL, V16, P891, DOI 10.1111/j.1365-294X.2006.03190.x; Raffaele H, 1998, BIRDS W INDIES; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RICKLEFS RE, 1978, AM NAT, V112, P875, DOI 10.1086/283329; Ricklefs RE, 1999, OSTRICH, V70, P49, DOI 10.1080/00306525.1999.9639749; Ricklefs RE, 2001, SCIENCE, V294, P1522, DOI 10.1126/science.1065005; Ricklefs R, 2008, PHILOS T R SOC B, V363, P2393, DOI 10.1098/rstb.2007.2068; Ricklefs RE, 2007, AM NAT, V169, P285, DOI 10.1086/510730; Ricklefs RE, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P388; Rivera-Milan FF, 1999, J WILDLIFE MANAGE, V63, P232, DOI 10.2307/3802505; Rivera-Milan FF, 2000, CONDOR, V102, P385, DOI 10.1650/0010-5422(2000)102[0385:DOZDIP]2.0.CO;2; Romagosa Christina M., 1999, North American Birds, V53, P348; Rosenberg NA, 2007, EVOLUTION, V61, P317, DOI 10.1111/j.1558-5646.2007.00023.x; Saether BE, 2005, NATURE, V436, P99, DOI 10.1038/nature03666; Santiago-Alarcon D, 2007, CONDOR, V109, P132, DOI 10.1650/0010-5422(2007)109[132:SSDAME]2.0.CO;2; Santiago-Alarcon D, 2006, WILSON J ORNITHOL, V118, P194, DOI 10.1676/05-010.1; Schneider S, 1999, GENETICS, V152, P1079; SEUTIN G, 1993, AUK, V110, P117; SEUTIN G, 1994, EVOLUTION, V48, P1041, DOI 10.1111/j.1558-5646.1994.tb05292.x; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Sonsthagen SA, 2012, BIOL CONSERV, V146, P116, DOI 10.1016/j.biocon.2011.11.031; Speed R, 1994, CARIBBEAN GEOLOGY IN, P179; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Thorpe RS, 2008, MOL ECOL, V17, P1489, DOI 10.1111/j.1365-294X.2007.03686.x; Thorpe RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000929; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VanderWerf EA, 2010, CONSERV GENET, V11, P1283, DOI 10.1007/s10592-009-9958-1; Veech JA, 2011, J BIOGEOGR, V38, P69, DOI 10.1111/j.1365-2699.2010.02397.x; Wallace A. R., 1880; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wiley James W., 1991, Ornitologia Neotropical, V2, P49; Wojcieszek JM, 2012, EVOLUTION, V66, P1138, DOI 10.1111/j.1558-5646.2011.01509.x; Wright S, 1931, GENETICS, V16, P0097; Young DL, 1997, MOL ECOL, V6, P877, DOI 10.1046/j.1365-294X.1997.00253.x	117	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82189	10.1371/journal.pone.0082189	http://dx.doi.org/10.1371/journal.pone.0082189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349217	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800045
J	Willmer, M; Berglind, D; Sorensen, TIA; Naslund, E; Tynelius, P; Rasmussen, F				Willmer, Mikaela; Berglind, Daniel; Sorensen, Thorkild I. A.; Naeslund, Erik; Tynelius, Per; Rasmussen, Finn			Surgically Induced Interpregnancy Weight Loss and Prevalence of Overweight and Obesity in Offspring	PLOS ONE			English	Article							MATERNAL OBESITY; BARIATRIC SURGERY; FETAL; PREGNANCY; CHILDREN; PERCEPTIONS; CHILDHOOD; GAIN	Introduction: According to the fetal overnutrition hypothesis, obesity in pregnancy predisposes the offspring to obesity. Previous studies have suggested that after biliopancreatic surgery for obesity, the offspring is less likely to be obese. This study aims to further compare the BMI development of children born before and after maternal surgical weight loss. Method: Women with at least one child born before and one child born after bariatric surgery were identified by record-linkage. Information about maternal BMI was extracted from medical records, as was information about the children's BMI from birth to 10 years of age. We retrieved BMI data at four years of age for 340 children, born to 223 women (164 children born before surgery (BS), 176 children born after surgery (AS)). We evaluated prevalence of overweight/obesity and mean BMI in children born BS and AS at the ages of four, six and ten using GEE regression models. For 71 families, where we had complete data on mother and both children, we used a fixed-effects regression model to explore the association between differences in maternal BMI in w10 of the pre- and post-operative pregnancies with siblings' BMI differences at age four. Results: In no age group did we see a significantly reduced prevalence of overweight/obesity AS. For 10-year-old girls, the AS group had significantly higher rates of obesity. There was no association between differences in maternal BMI in early pregnancy and differences in siblings' BMI at four years of age (beta = -0.01, CI 95% = -0.11; 0.09). Conclusions: We have been unable to demonstrate any effect of bariatric surgery on weight development in offspring. It seems unlikely that restrictive bariatric surgery conveys a protective effect in offspring with regards to obesity.	[Willmer, Mikaela; Berglind, Daniel; Tynelius, Per; Rasmussen, Finn] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Sorensen, Thorkild I. A.] Bispebjerg & Frederiksberg Univ Hosp, Inst Prevent Med, Copenhagen, The Capital Reg, Denmark; [Naeslund, Erik] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Surg, Stockholm, Sweden; [Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Basic Metab Res, DK-1168 Copenhagen, Denmark	Karolinska Institutet; University of Copenhagen; Bispebjerg Hospital; Danderyds Hospital; Karolinska Institutet; Novo Nordisk Foundation; University of Copenhagen	Rasmussen, F (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	Finn.Rasmussen@ki.se		Rasmussen, Finn/0000-0001-7915-7809; Tynelius, Per/0000-0001-8155-7406	Stockholm County Council; Karolinska Institutet	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	Financial support for this project was provided through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abodeely A, 2008, SURG OBES RELAT DIS, V4, P464, DOI 10.1016/j.soard.2007.08.018; Anderson JW, 2001, AM J CLIN NUTR, V74, P579; [Anonymous], 2013, SCAND OB RES ANN REP; Barisione M, 2012, SURG OBES RELAT DIS, V8, P387, DOI 10.1016/j.soard.2011.09.016; Barker DJP, 2007, OBES REV, V8, P45, DOI 10.1111/j.1467-789X.2007.00317.x; Bergstrom E, 2009, ACTA PAEDIATR, V98, P1956, DOI 10.1111/j.1651-2227.2009.01490.x; Boney CM, 2005, PEDIATRICS, V115, pE290, DOI 10.1542/peds.2004-1808; Brownell KD, 2010, BEHAV RES THER, V48, P717, DOI 10.1016/j.brat.2010.05.018; Carnell S, 2005, INT J OBESITY, V29, P353, DOI 10.1038/sj.ijo.0802889; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Cnattingius S, 2011, INT J OBES LOND; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dhariwal Laura, 2012, Surg Obes Relat Dis, V8, P391, DOI 10.1016/j.soard.2011.12.003; Eckstein KC, 2006, PEDIATRICS, V117, P681, DOI 10.1542/peds.2005-0910; Edholm D, 2012, SURG OBES RELAT DIS; Falken Y, 2011, J CLIN ENDOCR METAB, V96, P2227, DOI 10.1210/jc.2010-2876; Ferraro ZM, 2012, J MATERN-FETAL NEO M, V25, P538, DOI 10.3109/14767058.2011.638953; Gasser T., 2004, METHODS HUMAN GROWTH, P179, DOI DOI 10.1017/CBO9780511542411.008; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Jacobson P, 2007, AM J EPIDEMIOL, V165, P101, DOI 10.1093/aje/kwj342; Kominiarek MA, 2010, OBSTET GYN CLIN N AM, V37, P305, DOI 10.1016/j.ogc.2010.02.010; Kral JG, 2006, PEDIATRICS, V118, pE1644, DOI 10.1542/peds.2006-1379; Lawlor DA, 2007, AM J EPIDEMIOL, V165, P418, DOI 10.1093/aje/kwk030; Magdaleno R, 2012, ARCH GYNECOL OBSTET, V285, P559, DOI 10.1007/s00404-011-2187-0; Marild S, 2004, ACTA PAEDIATR, V93, P1588, DOI 10.1080/08035250410018265; Nader PR, 2006, PEDIATRICS, V118, pE594, DOI 10.1542/peds.2005-2801; Neovius M, 2006, OBES REV, V7, P1, DOI 10.1111/j.1467-789x.2006.00190.x; Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69; Poston L, 2012, BEST PRACT RES CL EN, V26, P627, DOI 10.1016/j.beem.2012.03.010; Ramsay JE, 2006, BMJ-BRIT MED J, V333, P1159, DOI 10.1136/bmj.39049.439444.DE1; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; Rao RS, 2012, OBES REV, V13, P316, DOI 10.1111/j.1467-789X.2011.00955.x; Shankaran S, 2011, J PERINATOL, V31, P711, DOI 10.1038/jp.2011.14; Simmons R, 2008, SEMIN PERINATOL, V32, P371, DOI 10.1053/j.semperi.2008.08.004; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Smith J, 2009, J CLIN ENDOCR METAB, V94, P4275, DOI 10.1210/jc.2009-0709; Speakman JR, 2007, AM J CLIN NUTR, V86, P316, DOI 10.1093/ajcn/86.2.316; Vidmar S, 2004, STATA J, V4, P50, DOI 10.1177/1536867X0100400104; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; WHO, 2012, OB OV WHO; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S	41	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82247	10.1371/journal.pone.0082247	http://dx.doi.org/10.1371/journal.pone.0082247			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349234	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800054
J	Munoz-Hernandez, MD; Garcia-Hernandez, JJ; Morales-Sandoval, M				Diego Munoz-Hernandez, Mario; Juan Garcia-Hernandez, Jose; Morales-Sandoval, Miguel			A Collusion-Resistant Fingerprinting System for Restricted Distribution of Digital Documents	PLOS ONE			English	Article							INFORMATION SECURITY; TEXT WATERMARKING; IDENTIFICATION; CAPACITY; MARKING; LINE	Digital fingerprinting is a technique that consists of inserting the ID of an authorized user in the digital content that he requests. This technique has been mainly used to trace back pirate copies of multimedia content such as images, audio, and video. This study proposes the use of state-of-the-art digital fingerprinting techniques in the context of restricted distribution of digital documents. In particular, the system proposed by Kuribayashi for multimedia content is investigated. Extensive simulations show the robustness of the proposed system against average collusion attack. Perceptual transparency of the fingerprinted documents is also studied. Moreover, by using an efficient Fast Fourier Transform core and standard computer machines it is shown that the proposed system is suitable for real-world scenarios.	[Diego Munoz-Hernandez, Mario; Juan Garcia-Hernandez, Jose; Morales-Sandoval, Miguel] CINVESTAV IPN, Lab Tecnol Informac, Tamaulipas, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Munoz-Hernandez, MD (corresponding author), CINVESTAV IPN, Lab Tecnol Informac, Tamaulipas, Mexico.	mhernandez@tamps.cinvestav.mx	Morales-Sandoval, Miguel/CAG-1219-2022; Morales-Sandoval, Miguel/E-8851-2019; Garcia-Hernandez, Jose Juan/E-8633-2010	Morales-Sandoval, Miguel/0000-0003-1702-8467; Morales-Sandoval, Miguel/0000-0003-1702-8467; Garcia-Hernandez, Jose Juan/0000-0002-1249-5413	CONACyT [CB-2010-1-50910]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The work was supported by CONACyT (www.conacyt.gob.mx) under grant CB-2010-1-50910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adobe, 2010, MAK CAS PDF A AD ACR; Alattar AM, 2004, P SOC PHOTO-OPT INS, V5306, P685, DOI 10.1117/12.527147; Berghel H, 2012, COMPUTER, V45, P70, DOI 10.1109/MC.2012.105; Brassil J., 1994, C INF SCI SYST CISS, P482; Brassil JT, 1995, IEEE J SEL AREA COMM, P1278; Choo HG, 2004, LECT NOTES COMPUT SC, V2939, P593; Chotikakamthorn N, 1998, APCCAS '98 - IEEE ASIA-PACIFIC CONFERENCE ON CIRCUITS AND SYSTEMS, P419, DOI 10.1109/APCCAS.1998.743799; Coles-Kemp L, 2010, ADV INFORM SECUR, V49, P45, DOI 10.1007/978-1-4419-7133-3_3; Cox IJ, 1997, IEEE T IMAGE PROCESS, V6, P1673, DOI 10.1109/83.650120; Cox IJ, 1996, INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, PROCEEDINGS - VOL III, P243, DOI 10.1109/ICIP.1996.560429; de Madrid A, 2013, BIBLIOTECA DIGITAL A; Distler T, 2013, IQA; Frigo M, 2005, P IEEE, V93, P216, DOI 10.1109/JPROC.2004.840301; GAFF BM, 2012, COMPUTER, V45, P9; Gupta R, 2008, CONTRACT LIFECYCLE M; He B, 2009, 2009 WRI WORLD C COM, V7, P290; Hore Alain, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P2366, DOI 10.1109/ICPR.2010.579; Huang D, 2001, IEEE T CIRC SYST VID, V11, P1237, DOI 10.1109/76.974678; Ismail Avcibas B.S., 1999, STAT ANAL IMAGE QUAL; Jalil Z, 2009, 2009 INTERNATIONAL CONFERENCE ON INFORMATION AND MULTIMEDIA TECHNOLOGY, PROCEEDINGS, P230, DOI 10.1109/ICIMT.2009.11; Garcia-Hernandez JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065985; Kessler GC, 2012, COMPUTER, V45, P59, DOI 10.1109/MC.2011.262; Kim YW, 2003, PROC INT CONF DOC, P775; Kuribayashi M, 2011, EURASIP J INFORM SEC, V2011, P16; Lefebvre F, 2001, 2001 IEEE FOURTH WORKSHOP ON MULTIMEDIA SIGNAL PROCESSING, P511, DOI 10.1109/MMSP.2001.962784; Low SH, 1998, IEEE T COMMUN, V46, P372, DOI 10.1109/26.662643; Low SH, 2000, IEEE SIGNAL PROC LET, V7, P345, DOI 10.1109/97.883364; LOW SH, 1995, IEEE INFOCOM SER, P853, DOI 10.1109/INFCOM.1995.515956; Qadir MA, 2005, CAR C SECUR, P101, DOI 10.1109/CCST.2005.1594854; Schiere Richard, 2011, CHINA AFRICA EMERGIN, P1; Villars SFRL, 2006, INFORM LIFECYCLE MAN; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang ZJ, 2004, EURASIP J APPL SIG P, V2004, P2153, DOI 10.1155/S1110865704312151; Yawai W., 2012, Proceedings of the 2012 8th International Conference on Computing Technology and Information Management (NCM and ICNIT), P427; Yuan-Liang Tang, 2010, Proceedings 2010 First International Conference on Pervasive Computing, Signal Processing and Applications (PCSPA 2010), P357, DOI 10.1109/PCSPA.2010.93; Zhou XD, 2009, INT J ORAL SCI, V1, P1	36	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81976	10.1371/journal.pone.0081976	http://dx.doi.org/10.1371/journal.pone.0081976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349165	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300065
J	Guo, H; Dai, LM; Huang, YM; Liao, Q; Bai, Y				Guo, Hong; Dai, Limeng; Huang, Yanming; Liao, Qiong; Bai, Yun			A Large Novel Deletion Downstream ofPAX6 Gene in a Chinese Family with Ocular Coloboma	PLOS ONE			English	Article							PAX6 GENE; ANIRIDIA; EXPRESSION; REGION	Purpose: The paired box gene 6 (PAX6) is an essential transcription factor for eye formation. Genetic alterations in PAX6 can lead to various ocular malformations including aniridia. The purpose of this study was to identify genetic defects as the underlying cause of familial ocular coloboma in a large Chinese family. Methods: After linkage analysis was carried out in this family, all exons of PAX6 in the proband were sequenced by the Sanger sequencing technique. Then the genome of the proband was evaluated by a microarray-based comparative genomic hybridization (aCGH). Quantitative real-time PCR was applied to verify the abnormal aCGH findings. Results: All patients presented bilateral partial coloboma of iris, severe congenital nystagmus, hyperpresbyopia and congenital posterior polar cataracts. Two-point linkage analysis in the autosomal dominant family showed loss of heterozygosity at the D11S914 locus. There was no pathogenic mutation in the exons of PAX6. The aCGH analysis revealed a 681 kb heterozygous deletion on chromosome 11p13. Quantitative real-time PCR verified the deletion in the patients and further confirmed this deletion cosegregation with the ocular coloboma phenotype in the family. Conclusions: The 681 kb large deletion of chromosome 11p13 downstream of PAX6 is the genetic cause of the familial ocular coloboma in this large Chinese family. aCGH should be applied if there is a negative result for the mutation detection of PAX6 in patients with ocular coloboma.	[Guo, Hong; Dai, Limeng; Bai, Yun] Third Mil Med Univ, Dept Med Genet, Chongqing, Peoples R China; [Huang, Yanming; Liao, Qiong] Third Mil Med Univ, Xinqiao Hosp, Dept Ophthalmol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Liao, Q (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Ophthalmol, Chongqing, Peoples R China.	liaoq375@gmail.com; geneticsby@gmail.com	guo, hong/C-2985-2012		National Natural Science Foundation of China [81100068, 81171678]; Natural Science Foundation Project of CQ CSTC [cstc2011jjA10080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC)	This work was supported by the National Natural Science Foundation of China (No. 81100068 and 81171678) and Natural Science Foundation Project of CQ CSTC (No. cstc2011jjA10080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayrakli F, 2009, J CLIN NEUROSCI, V16, P1610, DOI 10.1016/j.jocn.2009.03.022; Cheng F, 2011, MOL VIS, V17, P448; D'Elia AV, 2007, MOL VIS, V13, P1245; Davis LK, 2008, HUM GENET, V123, P371, DOI 10.1007/s00439-008-0484-x; Georgala PA, 2011, DEV NEUROBIOL, V71, P690, DOI 10.1002/dneu.20895; Gregory-Evans CY, 2004, J MED GENET, V41, P881, DOI 10.1136/jmg.2004.025494; Griffin C, 2002, MECH DEVELOP, V112, P89, DOI 10.1016/S0925-4773(01)00646-3; Hurles ME, 2008, TRENDS GENET, V24, P238, DOI 10.1016/j.tig.2008.03.001; Kleinjan DA, 2001, HUM MOL GENET, V10, P2049, DOI 10.1093/hmg/10.19.2049; Kleinjan DA, 2006, DEV BIOL, V299, P563, DOI 10.1016/j.ydbio.2006.08.060; Kokotas H, 2010, CLIN GENET, V77, P409, DOI 10.1111/j.1399-0004.2010.01372.x; Lauderdale J, 2000, P NATL ACAD SCI USA, V97, P13755, DOI 10.1073/pnas.240398797; McBride DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028616; Slavotinek AM, 2011, MOL GENET METAB, V104, P448, DOI 10.1016/j.ymgme.2011.09.029; Wawrocka A, 2012, OPHTHALMIC GENET, V33, P44, DOI 10.3109/13816810.2011.615076; Zhang XH, 2011, MOL VIS, V17, P548	16	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83073	10.1371/journal.pone.0083073	http://dx.doi.org/10.1371/journal.pone.0083073			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349436	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300131
J	van Voorhis, M; Knopp, S; Julliard, W; Fechner, JH; Zhang, XJ; Schauer, JJ; Mezrich, JD				van Voorhis, Michael; Knopp, Samantha; Julliard, Walker; Fechner, John H.; Zhang, Xiaoji; Schauer, James J.; Mezrich, Joshua D.			Exposure to Atmospheric Particulate Matter Enhances Th17 Polarization through the Aryl Hydrocarbon Receptor	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; AIR-POLLUTION; OBLITERATIVE BRONCHIOLITIS; RESPIRATORY SYMPTOMS; CULTURE-MEDIUM; AH RECEPTOR; ACTIVATION; ASTHMA; CELLS; IL-17	Lung diseases, including asthma, COPD, and other autoimmune lung pathologies are aggravated by exposure to particulate matter (PM) found in air pollution. IL-17 has been shown to exacerbate airway disease in animal models. As PM is known to contain aryl hydrocarbon receptor (AHR) ligands and the AHR has recently been shown to play a role in differentiation of Th17 T cells, the aim of this study was to determine whether exposure to PM could impact Th17 polarization in an AHR-dependent manner. This study used both cell culture techniques and in vivo exposure in mice to examine the response of T cells to PM. Initially experiments were conducted with urban dust particles from a standard reference material, and ultimately repeated with freshly collected samples of diesel exhaust and cigarette smoke. The readout for the assays was increased T cell differentiation as indicated by increased generation of IL-17A in culture, and increased populations of IL-17 producing cells by intracellular flow cytometry. The data illustrate that Th17 polarization was significantly enhanced by addition of urban dust in a dose dependent fashion in cultures of wild-type but not AHR(-/-) mice. The data further suggest that polycyclic aromatic hydrocarbons played a primary role in this enhancement. There was both an increase of Th17 cell differentiation, and also an increase in the amount of IL-17 secreted by the cells. In summary, this paper identifies a novel mechanism whereby PM can directly act on the AHR in T cells, leading to enhanced Th17 differentiation. Further understanding of the molecular mechanisms responsible for pathologic Th17 differentiation and autoimmunity seen after exposure to pollution will allow direct targeting of proteins involved in AHR activation and function for treatment of PM exposures.	[van Voorhis, Michael; Knopp, Samantha; Julliard, Walker; Fechner, John H.; Zhang, Xiaoji; Mezrich, Joshua D.] Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Div Transplantat Surg, Madison, WI USA; [Schauer, James J.] Univ Wisconsin, Dept Civil & Environm Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mezrich, JD (corresponding author), Univ Wisconsin, Dept Surg, Sch Med & Publ Hlth, Div Transplantat Surg, Madison, WI USA.	mezrich@surgery.wisc.edu	Fechner, John/C-5962-2016	Fechner, John/0000-0002-8220-7237; Schauer, James/0000-0002-5405-1511	American Lung Association [G-233319-N]; Clinical and Translational Science Award program of National Institutes of Health/National Center for Advancing Translational Sciences [UL1TROOO427]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025012] Funding Source: NIH RePORTER	American Lung Association; Clinical and Translational Science Award program of National Institutes of Health/National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The work was funded by the following: American Lung Association Grant G-233319-N, http://www.lung.org/; and Clinical and Translational Science Award program of National Institutes of Health/National Center for Advancing Translational Sciences, grant UL1TROOO427, http://www.ncats.nih.gov/research/cts/ctsa/ctsa.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbami Lara J, 2011, Natl Health Stat Report, P1; Brackbill RM, 2009, JAMA-J AM MED ASSOC, V302, P502, DOI 10.1001/jama.2009.1121; Burlingham WJ, 2007, J CLIN INVEST, V117, P3498, DOI 10.1172/JCI28031; Cazzola M, 2012, EXPERT REV RESP MED, V6, P135, DOI [10.1586/ERS.12.7, 10.1586/ers.12.7]; Chen K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020333; Chen TM, 2007, AM J MED SCI, V333, P230, DOI 10.1097/MAJ.0b013e31803b8c91; De Sario M, 2013, EUR RESPIR J, V42, P826, DOI 10.1183/09031936.00074712; Deiuliis JA, 2012, AM J PHYSIOL-LUNG C, V302, pL399, DOI 10.1152/ajplung.00261.2011; Fan L, 2011, AM J TRANSPLANT, V11, P911, DOI 10.1111/j.1600-6143.2011.03482.x; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Ivanov S, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-44; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Kish L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062220; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Kumar P, 2013, J CANCER, V4, P57, DOI 10.7150/jca.5048; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li N, 2010, AM J PHYSIOL-LUNG C, V299, pL374, DOI 10.1152/ajplung.00115.2010; Lighty JS, 2000, J AIR WASTE MANAGE, V50, P1565, DOI 10.1080/10473289.2000.10464197; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Mentese S, 2012, J AIR WASTE MANAGE, V62, P1380, DOI 10.1080/10962247.2012.714717; Miller RL, 2010, PEDIATR ALLERGY IMMU, V21, P260, DOI 10.1111/j.1399-3038.2009.00980.x; Miller RL, 2004, CHEST, V126, P1071, DOI 10.1378/chest.126.4.1071; Nawrot TS, 2011, THORAX, V66, P748, DOI 10.1136/thx.2010.155192; Nukaya M, 2009, P NATL ACAD SCI USA, V106, P4923, DOI 10.1073/pnas.0809613106; Oberg M, 2005, TOXICOL SCI, V85, P935, DOI 10.1093/toxsci/kfi154; Okuda T, 2009, ENERG FUEL, V23, P4974, DOI 10.1021/ef900370v; Park SS, 2005, CHEMOSPHERE, V59, P217, DOI 10.1016/j.chemosphere.2004.11.001; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Ringuet J, 2012, SCI TOTAL ENVIRON, V437, P297, DOI 10.1016/j.scitotenv.2012.07.072; Roca M, 2013, EUR J CLIN INVEST, V43, P510, DOI 10.1111/eci.12064; Rylance J, 2013, AM J PHYSL LUNG CELL; Saunders V, 2010, ENVIRON HEALTH PERSP, V118, P640, DOI 10.1289/ehp.0901461; Schauer JJ, 1999, ENVIRON SCI TECHNOL, V33, P1578, DOI 10.1021/es980081n; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Sekine H, 2009, MOL CELL BIOL, V29, P6391, DOI 10.1128/MCB.00337-09; Sheesley RJ, 2007, AEROSOL SCI TECH, V41, P981, DOI 10.1080/02786820701644277; Sibilano R, 2012, J IMMUNOL, V189, P120, DOI 10.4049/jimmunol.1200009; Silverpil E, 2012, EXPERT REV RESP MED, V6, P173, DOI [10.1586/ERS.12.12, 10.1586/ers.12.12]; Steenhof M, 2013, OCCUP ENVIRON MED, V70, P341, DOI 10.1136/oemed-2012-100993; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Vattanasit U, 2014, INT J HYG ENVIR HEAL, V217, P23, DOI 10.1016/j.ijheh.2013.03.002; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Veldhoen M, 2009, J EXP MED, V206, P43, DOI 10.1084/jem.20081438; Verleden SE, 2012, AM J TRANSPLANT, V12, P1831, DOI 10.1111/j.1600-6143.2012.04134.x; Wincent E, 2012, P NATL ACAD SCI USA, V109, P4479, DOI 10.1073/pnas.1118467109	50	93	96	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82545	10.1371/journal.pone.0082545	http://dx.doi.org/10.1371/journal.pone.0082545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349309	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300096
J	Tomas, BA; Pell, C; Cavanillas, AB; Solvas, JG; Pool, R; Roura, M				Abarca Tomas, Bruno; Pell, Christopher; Bueno Cavanillas, Aurora; Guillen Solvas, Jose; Pool, Robert; Roura, Maria			Tuberculosis in Migrant Populations. A Systematic Review of the Qualitative Literature	PLOS ONE			English	Review							FOREIGN-BORN; PULMONARY TUBERCULOSIS; COST-EFFECTIVENESS; TB CONTROL; IMMIGRANTS; PREVENTION; COUNTRIES; BARRIERS; PERCEPTIONS; MIGRATION	Background: The re-emergence of tuberculosis (TB) in low-incidence countries and its disproportionate burden on immigrants is a public health concern posing specific social and ethical challenges. This review explores perceptions, knowledge, attitudes and treatment adherence behaviour relating to TB and their social implications as reported in the qualitative literature. Methods: Systematic review in four electronic databases. Findings from thirty selected studies extracted, tabulated, compared and synthesized. Findings: TB was attributed to many non-exclusive causes including air-born transmission of bacteria, genetics, malnutrition, excessive work, irresponsible lifestyles, casual contact with infected persons or objects; and exposure to low temperatures, dirt, stress and witchcraft. Perceived as curable but potentially lethal and highly contagious, there was confusion around a condition surrounded by fears. A range of economic, legislative, cultural, social and health system barriers could delay treatment seeking. Fears of deportation and having contacts traced could prevent individuals from seeking medical assistance. Once on treatment, family support and "the personal touch" of health providers emerged as key factors facilitating adherence. The concept of latent infection was difficult to comprehend and while TB screening was often seen as a socially responsible act, it could be perceived as discriminatory. Immigration and the infectiousness of TB mutually reinforced each another exacerbating stigma. This was further aggravated by indirect costs such as losing a job, being evicted by a landlord or not being able to attend school. Conclusions: Understanding immigrants' views of TB and the obstacles that they face when accessing the health system and adhering to a treatment programme-taking into consideration their previous experiences at countries of origin as well as the social, economic and legislative context in which they live at host countries-has an important role and should be considered in the design, evaluation and adaptation of programmes.	[Abarca Tomas, Bruno; Bueno Cavanillas, Aurora; Guillen Solvas, Jose] Univ Granada, Dept Prevent Med & Publ Hlth, Granada, Spain; [Pell, Christopher; Pool, Robert; Roura, Maria] Univ Barcelona, Ctr Int Hlth Res CRESIB, Hosp Clin, Barcelona, Spain; [Pell, Christopher; Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands; [Bueno Cavanillas, Aurora; Guillen Solvas, Jose] San Cecilio Univ Hosp, Serv Prevent Med, Granada, Spain; [Bueno Cavanillas, Aurora; Guillen Solvas, Jose] CIBERESP, Consorcio Invest Biomed Red Epidemiol & Salud Pub, Madrid, Spain	University of Granada; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Amsterdam; Hospital Universitario San Cecilio; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Tomas, BA (corresponding author), Univ Granada, Dept Prevent Med & Publ Hlth, Granada, Spain.	brunoat@correo.ugr.es	Roura, Maria/K-6668-2014; Bueno-Cavanillas, Aurora/O-1513-2015	Roura, Maria/0000-0001-9556-1940; Bueno-Cavanillas, Aurora/0000-0002-0649-3016; Pell, Christopher/0000-0001-9405-5851	EC within the 7th Framework Programme under the COHEMI project [FP7-GA-26149]; Spanish Ministry of Economy and Competitiveness (MINECO)	EC within the 7th Framework Programme under the COHEMI project; Spanish Ministry of Economy and Competitiveness (MINECO)	This work has been funded by the EC within the 7th Framework Programme under the COHEMI project - grant agreement no. FP7-GA-26149 as well as the "Ramon y Cajal" fellowship program of the Spanish Ministry of Economy and Competitiveness (MINECO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achkar JM, 2008, CLIN INFECT DIS, V47, P1277, DOI 10.1086/592572; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; AhChing L P, 2001, Pac Health Dialog, V8, P15; Ailinger RL, 1997, QUAL HEALTH RES, V7, P521, DOI 10.1177/104973239700700406; Al-Maniri A, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-210; [Anonymous], 2011, GLOB TUB CONTR 2011; Atkins S, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-21; Barniol J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-197; Bender A, 2010, HEALTH PLACE, V16, P1069, DOI 10.1016/j.healthplace.2010.06.007; Bhugra D, 2004, ACTA PSYCHIAT SCAND, V109, P243, DOI 10.1046/j.0001-690X.2003.00246.x; Blasco T, 2010, CALIDAD VIDA PERCIBI; Borrell S, 2010, CLIN MICROBIOL INFEC, V16, P568, DOI 10.1111/j.1469-0691.2009.02886.x; Brewin P, 2006, J PUBLIC HEALTH-UK, V28, P253, DOI 10.1093/pubmed/fdl031; Broekmans JF, 2002, EUR RESPIR J, V19, P765, DOI 10.1183/09031936.02.00261402; Coker R, 2006, EUR RESPIR J, V27, P801, DOI 10.1183/09031936.06.00104305; Coker R, 2004, BRIT MED J, V328, P298, DOI 10.1136/bmj.328.7435.298; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Coreil Jeannine, 2004, J Immigr Health, V6, P63, DOI 10.1023/B:JOIH.0000019166.80968.70; Dasgupta K, 2005, EUR RESPIR J, V25, P1107, DOI 10.1183/09031936.05.00074004; European Centre for Disease Prevention and Control (ECDC), 2009, MIGR HLTH BACKGR NOT; Gibson N, 2005, SOC SCI MED, V61, P931, DOI 10.1016/j.socscimed.2004.10.026; Gilbert RL, 2009, INT J TUBERC LUNG D, V13, P645; HARDIE RM, 1993, BRIT MED J, V307, P1539, DOI 10.1136/bmj.307.6918.1539; Hemingway P., 2009, HAYWARD MED COMMUNIC, V2, P1; Ho MJ, 2004, SOC SCI MED, V59, P753, DOI 10.1016/j.socscimed.2003.11.033; Ho MJ, 2003, MED ANTHROPOL Q, V17, P442, DOI 10.1525/maq.2003.17.4.442; Houston HR, 2002, ETHNIC HEALTH, V7, P255, DOI 10.1080/1355785022000060718; Huffman SA, 2012, SOC SCI MED, V74, P864, DOI 10.1016/j.socscimed.2011.07.019; Ito KL, 1999, MED ANTHROPOL Q, V13, P338, DOI 10.1525/maq.1999.13.3.338; Johnson A, 2006, BELIEFS BARRIERS REL; Joseph HA, 2008, J IMMIGR MINOR HEALT, V10, P177, DOI 10.1007/s10903-007-9067-5; Kirwan DE, 2009, TROP MED INT HEALTH, V14, P1442, DOI 10.1111/j.1365-3156.2009.02405.x; Klinkenberg E, 2009, EUR RESPIR J, V34, P1180, DOI 10.1183/09031936.00038009; Kulane A, 2010, HEALTH POLICY, V97, P26, DOI 10.1016/j.healthpol.2010.02.014; Littleton J, 2008, AUST NZ J PUBL HEAL, V32, P142, DOI 10.1111/j.1753-6405.2008.00191.x; Long Q, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-202; MacPherson DW, 2006, PUBLIC HEALTH, V120, P712, DOI 10.1016/j.puhe.2006.05.002; Maguire H, 2002, THORAX, V57, P617, DOI 10.1136/thorax.57.7.617; McEwen Marylyn M, 2005, J Transcult Nurs, V16, P347, DOI 10.1177/1043659605278943; McEwen Marylyn Morris, 2007, Res Theory Nurs Pract, V21, P185, DOI 10.1891/088971807781503729; Moore-Gillon J, 2010, THORAX, V65, P663, DOI 10.1136/thx.2009.132373; New Zealand Ministry. of Health, 2010, GUID TUB CONTR NZ 20; Ng Shiu R, 2008, RAL E RES ANTHR LING, P218; Nnoaham KE, 2006, INT J TUBERC LUNG D, V10, P1013; Ponticiello A, 2005, EUR J EPIDEMIOL, V20, P729, DOI 10.1007/s10654-005-0615-9; PORTER JDH, 1994, ANNU REV PUBL HEALTH, V15, P303; Poss JE, 1998, SOC SCI MED, V47, P195, DOI 10.1016/S0277-9536(98)00062-8; Sagbakken M, 2010, SCAND J PUBLIC HEALT, V38, P283, DOI 10.1177/1403494809357101; Schneider DL, 2007, AM J PREV MED, V33, P9, DOI 10.1016/j.amepre.2007.02.044; Schwartzman K, 2000, AM J RESP CRIT CARE, V161, P780, DOI 10.1164/ajrccm.161.3.9902005; Sterne JAC, 1998, INT J TUBERC LUNG D, V2, P200; Tardin A, 2009, TROP MED INT HEALTH, V14, P995, DOI 10.1111/j.1365-3156.2009.02325.x; Valin N, 2005, INT J TUBERC LUNG D, V9, P528; Van der Oest C, 2005, NZ MED J, V118, P1216; Wang WB, 2007, EUR J PUBLIC HEALTH, V17, P419, DOI 10.1093/eurpub/ckm029; Wei XL, 2009, TROP MED INT HEALTH, V14, P754, DOI 10.1111/j.1365-3156.2009.02286.x; WHO, 2005, ADDR POV TB CONTR OP; Wieland ML, 2012, J IMMIGR MINOR HEALT, V14, P14, DOI 10.1007/s10903-010-9391-z; Wyss LL, 2007, ONLINE J ISSUES NURS, V12, P7; Yamada S, 1999, Fam Med, V31, P477; Zuber PLF, 1997, JAMA-J AM MED ASSOC, V278, P304, DOI 10.1001/jama.278.4.304	61	102	102	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82440	10.1371/journal.pone.0082440	http://dx.doi.org/10.1371/journal.pone.0082440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273WD	24349284	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100108
J	Chufan, EE; Kapoor, K; Sim, HM; Singh, S; Talele, TT; Durell, SR; Ambudkar, SV				Chufan, Eduardo E.; Kapoor, Khyati; Sim, Hong-May; Singh, Satyakam; Talele, Tanaji T.; Durell, Stewart R.; Ambudkar, Suresh V.			Multiple Transport-Active Binding Sites Are Available for a Single Substrate on Human P-Glycoprotein (ABCB1)	PLOS ONE			English	Article							DRUG-BINDING; MULTIDRUG-RESISTANCE; CATALYTIC CYCLE; ATP HYDROLYSIS; FUNCTIONAL-CHARACTERIZATION; EXPRESSION SYSTEM; MAMMALIAN-CELLS; MOLECULAR-BASIS; RESIDUES; REVEALS	P-glycoprotein (Pgp, ABCB1) is an ATP-Binding Cassette (ABC) transporter that is associated with the development of multidrug resistance in cancer cells. Pgp transports a variety of chemically dissimilar amphipathic compounds using the energy from ATP hydrolysis. In the present study, to elucidate the binding sites on Pgp for substrates and modulators, we employed site-directed mutagenesis, cell-and membrane-based assays, molecular modeling and docking. We generated single, double and triple mutants with substitutions of the Y307, F343, Q725, F728, F978 and V982 residues at the proposed drug-binding site with cys in a cysless Pgp, and expressed them in insect and mammalian cells using a baculovirus expression system. All the mutant proteins were expressed at the cell surface to the same extent as the cysless wild-type Pgp. With substitution of three residues of the pocket (Y307, Q725 and V982) with cysteine in a cysless Pgp, QZ59S-SSS, cyclosporine A, tariquidar, valinomycin and FSBA lose the ability to inhibit the labeling of Pgp with a transport substrate, [I-125]-Iodoarylazidoprazosin, indicating these drugs cannot bind at their primary binding sites. However, the drugs can modulate the ATP hydrolysis of the mutant Pgps, demonstrating that they bind at secondary sites. In addition, the transport of six fluorescent substrates in HeLa cells expressing triple mutant (Y307C/Q725C/V982C) Pgp is also not significantly altered, showing that substrates bound at secondary sites are still transported. The homology modeling of human Pgp and substrate and modulator docking studies support the biochemical and transport data. In aggregate, our results demonstrate that a large flexible pocket in the Pgp transmembrane domains is able to bind chemically diverse compounds. When residues of the primary drug-binding site are mutated, substrates and modulators bind to secondary sites on the transporter and more than one transport-active binding site is available for each substrate.	[Chufan, Eduardo E.; Kapoor, Khyati; Sim, Hong-May; Durell, Stewart R.; Ambudkar, Suresh V.] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Singh, Satyakam; Talele, Tanaji T.] St Johns Univ, Dept Pharmaceut Sci, Coll Pharm & Hlth Sci, Queens, NY USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Saint John's University	Ambudkar, SV (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	ambudkar@helix.nih.gov	Ambudkar, Suresh V/L-1317-2016		National Institutes of Health, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZICBC011075] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawi MK, 2011, ESSAYS BIOCHEM, V50, P63, DOI [10.1042/BSE0500063, 10.1042/bse0500063]; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambudkar SV, 2006, EUR J PHARM SCI, V27, P392, DOI 10.1016/j.ejps.2005.10.010; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504; Blatter XL, 2010, BIOPHYS J, V99, P3589, DOI 10.1016/j.bpj.2010.10.033; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chakraborty S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049313; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Dolghih E, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002083; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GREENBERGER LM, 1990, J BIOL CHEM, V265, P4394; Gribar JJ, 2000, J MEMBRANE BIOL, V173, P203, DOI 10.1007/s002320001020; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; HAMADA H, 1986, P NATL ACAD SCI USA, V83, P7785, DOI 10.1073/pnas.83.20.7785; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kannan P, 2011, ACS CHEM NEUROSCI, V2, P82, DOI 10.1021/cn100078a; Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200; Klepsch F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002036; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Loo TW, 2008, ARCH BIOCHEM BIOPHYS, V476, P51, DOI 10.1016/j.abb.2008.02.025; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2012, J BIOL CHEM, V287, P26806, DOI 10.1074/jbc.M112.376202; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 2003, J BIOL CHEM, V278, P39706, DOI 10.1074/jbc.M308559200; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2003, J BIOL CHEM, V278, P50136, DOI 10.1074/jbc.M310448200; Loo TW, 2003, J BIOL CHEM, V278, P20449, DOI 10.1074/jbc.C300154200; Loo TW, 1997, J BIOL CHEM, V272, P31945, DOI 10.1074/jbc.272.51.31945; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Loo TW, 2002, J BIOL CHEM, V277, P44332, DOI 10.1074/jbc.M208433200; Loo TW, 2001, J BIOL CHEM, V276, P36877, DOI 10.1074/jbc.C100467200; Loo TW, 2001, J BIOL CHEM, V276, P14972, DOI 10.1074/jbc.M100407200; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P14020, DOI 10.1021/bi0511179; Marcoux J, 2013, P NATL ACAD SCI USA, V110, P9704, DOI 10.1073/pnas.1303888110; Martin C, 2000, MOL PHARMACOL, V58, P624, DOI 10.1124/mol.58.3.624; Martin C, 1999, BRIT J PHARMACOL, V128, P403, DOI 10.1038/sj.bjp.0702807; Ohnuma S, 2011, BIOCHEMISTRY-US, V50, P3724, DOI 10.1021/bi200073f; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; Ramachandra M, 1996, MOL BIOL CELL, V7, P1485, DOI 10.1091/mbc.7.10.1485; Safa Ahmad R., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P1, DOI 10.2174/1568011043482142; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Sauna ZE, 2002, BIOCHEMISTRY-US, V41, P13989, DOI 10.1021/bi026626e; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Shapiro AB, 1999, EUR J BIOCHEM, V259, P841, DOI 10.1046/j.1432-1327.1999.00098.x; Sharom FJ, 2011, ESSAYS BIOCHEM, V50, P161, DOI [10.1042/BSE0500161, 10.1042/bse0500161]; Shukla S, 2012, DRUG METAB DISPOS, V40, P304, DOI 10.1124/dmd.111.042721; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tao HC, 2011, CHEMBIOCHEM, V12, P868, DOI 10.1002/cbic.201100048; Taylor AM, 2001, BRIT J PHARMACOL, V134, P1609, DOI 10.1038/sj.bjp.0704400; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110	57	71	71	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82463	10.1371/journal.pone.0082463	http://dx.doi.org/10.1371/journal.pone.0082463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349290	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100113
J	Beedessee, G; Watanabe, H; Ogura, T; Nemoto, S; Yahagi, T; Nakagawa, S; Nakamura, K; Takai, K; Koonjul, M; Marie, DEP				Beedessee, Girish; Watanabe, Hiromi; Ogura, Tomomi; Nemoto, Suguru; Yahagi, Takuya; Nakagawa, Satoshi; Nakamura, Kentaro; Takai, Ken; Koonjul, Meera; Marie, Daniel E. P.			High Connectivity of Animal Populations in Deep-Sea Hydrothermal Vent Fields in the Central Indian Ridge Relevant to Its Geological Setting	PLOS ONE			English	Article							BIOGEOGRAPHY; DISPERSAL; EVOLUTION; SHRIMP; COMMUNITIES; GASTROPODS; GENETICS; LARVAE	Dispersal ability plays a key role in the maintenance of species in spatially and temporally discrete niches of deep-sea hydrothermal vent environments. On the basis of population genetic analyses in the eastern Pacific vent fields, dispersal of animals in the mid-oceanic ridge systems generally appears to be constrained by geographical barriers such as trenches, transform faults, and microplates. Four hydrothermal vent fields (the Kairei and Edmond fields near the Rodriguez Triple Junction, and the Dodo and Solitaire fields in the Central Indian Ridge) have been discovered in the mid-oceanic ridge system of the Indian Ocean. In the present study, we monitored the dispersal of four representative animals, Austinograea rodriguezensis, Rimicaris kairei, Alviniconcha and the scaly-foot gastropods, among these vent fields by using indirect methods, i.e., phylogenetic and population genetic analyses. For all four investigated species, we estimated potentially high connectivity, i.e., no genetic difference among the populations present in vent fields located several thousands of kilometers apart; however, the direction of migration appeared to differ among the species, probably because of different dispersal strategies. Comparison of the intermediate-spreading Central Indian Ridge with the fast-spreading East Pacific Rise and slow-spreading Mid-Atlantic Ridge revealed the presence of relatively high connectivity in the intermediate- and slow-spreading ridge systems. We propose that geological background, such as spreading rate which determines distance among vent fields, is related to the larval dispersal and population establishment of vent-endemic animal species, and may play an important role in controlling connectivity among populations within a biogeographical province.	[Beedessee, Girish; Marie, Daniel E. P.] Mauritius Oceanog Inst, Quatre Bornes, Mauritius; [Watanabe, Hiromi; Ogura, Tomomi; Takai, Ken] Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, Yokosuka, Kanagawa 2370061, Japan; [Ogura, Tomomi] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technoloy, Minato Ku, Tokyo, Japan; [Nemoto, Suguru] Enoshima Aquarium, Fujisawa, Kanagawa, Japan; [Yahagi, Takuya] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba, Japan; [Nakagawa, Satoshi] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido, Japan; [Nakamura, Kentaro; Takai, Ken] Japan Agcy Marine Earth Sci & Technol, Precambrian Ecosyst Lab, Yokosuka, Kanagawa 2370061, Japan; [Koonjul, Meera] Minist Fisheries, Albion Fisheries Res Ctr, Petite Riviere, Mauritius	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Tokyo University of Marine Science & Technology; University of Tokyo; Hokkaido University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Watanabe, H (corresponding author), Japan Agcy Marine Earth Sci & Technol, Inst Biogeosci, 2-15 Natsushimacho, Yokosuka, Kanagawa 2370061, Japan.	hwatanabe@jamstec.go.jp	Beedessee, Girish/B-7248-2015; Beedessee, Girish/AAC-1703-2021	Beedessee, Girish/0000-0003-4397-7471; Beedessee, Girish/0000-0003-4397-7471; Nakamura, Kentaro/0000-0001-9115-589X; Watanabe, Hiromi/0000-0001-5031-9018	Kakenhi (TAIGA project); Western Indian Ocean Marine Science Association (WIOMSA) for a MARG grant; InterRidge/ISA Endowment Fund	Kakenhi (TAIGA project); Western Indian Ocean Marine Science Association (WIOMSA) for a MARG grant; InterRidge/ISA Endowment Fund	Part of this study was supported by Kakenhi (TAIGA project). GB wishes to acknowledge the support of the Western Indian Ocean Marine Science Association (WIOMSA) for a MARG grant and the InterRidge/ISA Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachraty C, 2009, DEEP-SEA RES PT I, V56, P1371, DOI 10.1016/j.dsr.2009.01.009; Beerli Peter, 2009, V17, P42; Billiard S, 2005, EVOLUTION, V59, P13; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Epifanio CE, 1999, MAR ECOL PROG SER, V185, P147, DOI 10.3354/meps185147; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; GEBRUK AV, 1993, MAR ECOL PROG SER, V98, P247, DOI 10.3354/meps098247; German CR, 2010, P NATL ACAD SCI USA, V107, P14020, DOI 10.1073/pnas.1009205107; German CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023259; Hasegawa Takashi, 1996, Benthos Research, V51, P33; Hashimoto J, 2001, ZOOL SCI, V18, P717, DOI 10.2108/zsj.18.717; Herring PJ, 1998, DEEP-SEA RES PT I, V45, P2105, DOI 10.1016/S0967-0637(98)00050-8; HESSLER RR, 1991, DEEP-SEA RES, V38, P185, DOI 10.1016/0198-0149(91)90079-U; Hilario A, 2009, MAR ECOL PROG SER, V378, P153, DOI 10.3354/meps07858; Hurtado LA, 2004, MOL ECOL, V13, P2603, DOI 10.1111/j.1365-294X.2004.02287.x; Kim SL, 1998, DEEP-SEA RES PT II, V45, P423, DOI 10.1016/S0967-0645(97)00042-8; KIM SL, 1994, J GEOPHYS RES-OCEANS, V99, P12655, DOI 10.1029/94JC00644; Kojima S, 2001, BIOL BULL-US, V200, P298, DOI 10.2307/1543511; Koyama S, 2005, MAR BIOTECHNOL, V7, P272, DOI 10.1007/s10126-004-3050-0; LONSDALE P, 1977, DEEP-SEA RES, V24, P857, DOI 10.1016/0146-6291(77)90478-7; LUTZ RA, 1984, SCIENCE, V226, P1451, DOI 10.1126/science.226.4681.1451; LUTZ RA, 1994, NATURE, V371, P663, DOI 10.1038/371663a0; Mullineaux LS, 2005, MAR ECOL PROG SER, V293, P1, DOI 10.3354/meps293001; Nakamura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032965; OLIVIERI I, 1995, AM NAT, V146, P202, DOI 10.1086/285795; Pond DW, 2000, MAR ECOL PROG SER, V198, P171, DOI 10.3354/meps198171; Pradillon F, 2001, NATURE, V413, P698, DOI 10.1038/35099674; Ramirez-Llodra E, 2007, OCEANOGRAPHY, V20, P30, DOI 10.5670/oceanog.2007.78; Rogers AD, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001234; Suzuki Y, 2006, EARTH PLANET SC LETT, V242, P39, DOI 10.1016/j.epsl.2005.11.029; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tao CH, 2012, GEOLOGY, V40, P47, DOI 10.1130/G32389.1; Teixeira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038521; Thomson RE, 2003, NATURE, V424, P545, DOI 10.1038/nature01824; Townsend CR., 1996, ECOLOGY INDIVIDUALS, DOI [10.1002/9781444313765, DOI 10.1002/9781444313765]; Tunnicliffe V, 2003, ECOSY WORLD, V28, P81; Tunnicliffe V, 1996, NATURE, V379, P531, DOI 10.1038/379531a0; Tyler PA, 1999, J MAR BIOL ASSOC UK, V79, P193, DOI 10.1017/S0025315499000235; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; Van Dover CL, 2001, SCIENCE, V294, P818, DOI 10.1126/science.1064574; Van Dover CL, 2002, MAR BIOL, V141, P761, DOI 10.1007/s00227-002-0865-y; VANDOVER CL, 1990, TRENDS ECOL EVOL, V5, P242, DOI 10.1016/0169-5347(90)90063-J; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; WAREN A, 1993, ZOOL SCR, V22, P1, DOI 10.1111/j.1463-6409.1993.tb00342.x; Watabe H, 2002, ZOOL SCI, V19, P1167, DOI 10.2108/zsj.19.1167; Watanabe H, 2005, MAR ECOL PROG SER, V288, P233, DOI 10.3354/meps288233; Watanabe H, 2010, TOP GEOBIOL, V33, P379, DOI 10.1007/978-90-481-9572-5_12	49	38	41	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81570	10.1371/journal.pone.0081570	http://dx.doi.org/10.1371/journal.pone.0081570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358117	Green Published, gold, Green Submitted			2022-12-27	WOS:000328735700013
J	Kim, S; Kim, H; Ko, D; Yamaoka, Y; Otsuru, M; Kawai-Yamada, M; Ishikawa, T; Oh, HM; Nishida, I; Li-Beisson, Y; Lee, Y				Kim, Sangwoo; Kim, Hanul; Ko, Donghwi; Yamaoka, Yasuyo; Otsuru, Masumi; Kawai-Yamada, Maki; Ishikawa, Toshiki; Oh, Hee-Mock; Nishida, Ikuo; Li-Beisson, Yonghua; Lee, Youngsook			Rapid Induction of Lipid Droplets in Chlamydomonas reinhardtii and Chlorella vulgaris by Brefeldin A	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED-PROTEIN RESPONSE; PLANTS; CELLS; ER; BIOSYNTHESIS; ACCUMULATION; ARABIDOPSIS; DYNAMICS; BIOFUELS	Algal lipids are the focus of intensive research because they are potential sources of biodiesel. However, most algae produce neutral lipids only under stress conditions. Here, we report that treatment with Brefeldin A (BFA), a chemical inducer of ER stress, rapidly triggers lipid droplet (LD) formation in two different microalgal species, Chlamydomonas reinhardtii and Chlorella vulgaris. LD staining using Nile red revealed that BFA-treated algal cells exhibited many more fluorescent bodies than control cells. Lipid analyses based on thin layer chromatography and gas chromatography revealed that the additional lipids formed upon BFA treatment were mainly triacylglycerols (TAGs). The increase in TAG accumulation was accompanied by a decrease in the betaine lipid diacylglyceryl N,N,N-trimethylhomoserine (DGTS), a major component of the extraplastidic membrane lipids in Chlamydomonas, suggesting that at least some of the TAGs were assembled from the degradation products of membrane lipids. Interestingly, BFA induced TAG accumulation in the Chlamydomonas cells regardless of the presence or absence of an acetate or nitrogen source in the medium. This effect of BFA in Chlamydomonas cells seems to be due to BFA-induced ER stress, as supported by the induction of three homologs of ER stress marker genes by the drug. Together, these results suggest that ER stress rapidly triggers TAG accumulation in two green microalgae, C. reinhardtii and C. vulgaris. A further investigation of the link between ER stress and TAG synthesis may yield an efficient means of producing biofuel from algae.	[Kim, Sangwoo; Kim, Hanul; Yamaoka, Yasuyo; Lee, Youngsook] POSTECH, Div Mol Life Sci, Pohang, South Korea; [Ko, Donghwi; Lee, Youngsook] POSTECH, POSTECH UZH Global Res Lab, Div Integrat Biol & Biotechnol, Pohang, South Korea; [Otsuru, Masumi; Kawai-Yamada, Maki; Ishikawa, Toshiki; Nishida, Ikuo] Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Saitama 3388570, Japan; [Kawai-Yamada, Maki] Saitama Univ, Inst Environm Sci & Technol, Saitama 3388570, Japan; [Oh, Hee-Mock] Korea Res Inst Biosci & Biotechnol KRIBB, Environm Biotechnol Res Ctr, Taejon, South Korea; [Li-Beisson, Yonghua] Aix Marseille Univ, CEA, CNRS, Dept Plant Biol & Environm Microbiol, St Paul Les Durance, France	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Saitama University; Saitama University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lee, Y (corresponding author), POSTECH, Div Mol Life Sci, Pohang, South Korea.	ylee@postech.ac.kr	Nishida, Ikuo/E-3339-2010; Nishida, Ikuo/W-8007-2019; Lee, Youngsook/E-6578-2016; Ishikawa, Toshiki/F-6970-2018; Kawai-Yamada, Maki/B-2739-2012; Li-Beisson, Yonghua/C-7047-2011; Yamaoka, Yasuyo/W-1397-2019	Nishida, Ikuo/0000-0002-9669-4005; Lee, Youngsook/0000-0002-5808-9613; Ishikawa, Toshiki/0000-0001-8083-6542; Kawai-Yamada, Maki/0000-0002-8732-052X; Li-Beisson, Yonghua/0000-0003-1064-1816; Yamaoka, Yasuyo/0000-0002-0708-8872; Oh, Hee-Mock/0000-0002-2151-3687	Global Frontier Program of the Republic of Korea [2011-0031345]; Gyeongbuk Sea Grant Program; Ministry of Oceans and Fisheries, Korea; Ministry of Education, Culture, Sports, Science and Technology of Japan [21570034]; French ANR (DIESALG); Grants-in-Aid for Scientific Research [24570040, 26292190] Funding Source: KAKEN	Global Frontier Program of the Republic of Korea; Gyeongbuk Sea Grant Program; Ministry of Oceans and Fisheries, Korea; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); French ANR (DIESALG)(French National Research Agency (ANR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by grants from the Global Frontier Program (2011-0031345) of the Republic of Korea awarded to YL and HO, from Gyeongbuk Sea Grant Program funded by the Ministry of Oceans and Fisheries, Korea, from a Grant-in-Aid for Scientific Research (21570034) from the Ministry of Education, Culture, Sports, Science and Technology of Japan awarded to IN, and from the French ANR (DIESALG) awarded to YL-B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; EICHENBERGER W, 1993, PLANT PHYSIOL BIOCH, V31, P213; EICHENBERGER W, 1978, FEBS LETT, V88, P201, DOI 10.1016/0014-5793(78)80173-2; Fei WH, 2009, BIOCHEM J, V424, P61, DOI 10.1042/BJ20090785; Gaspar ML, 2008, J BIOL CHEM, V283, P25735, DOI 10.1074/jbc.M802685200; Gentile CL, 2011, ANTIOXID REDOX SIGN, V15, P505, DOI 10.1089/ars.2010.3790; GIROUD C, 1988, PLANT CELL PHYSIOL, V29, P587; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Grima EM, 2003, BIOTECHNOL ADV, V20, P491; Harris E.H, 2009, INTRO CHLAMYDOMONAS; Harwood JL, 2004, MEMBRANE LIPIDS ALGA, P53; Hayashi S, 2012, PLANT J, V69, P946, DOI 10.1111/j.1365-313X.2011.04844.x; Howell SH, 2013, ANNU REV PLANT BIOL, V64, P477, DOI 10.1146/annurev-arplant-050312-120053; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; KOHNO K, 1993, MOL CELL BIOL, V13, P877, DOI 10.1128/MCB.13.2.877; La Russa M, 2012, J BIOTECHNOL, V162, P13, DOI 10.1016/j.jbiotec.2012.04.006; Lee JH, 2008, CELL, V133, P829, DOI 10.1016/j.cell.2008.04.028; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Mano S, 2011, PLANT CELL PHYSIOL, V52, P244, DOI 10.1093/pcp/pcq184; Martinez IM, 2003, PLANT CELL, V15, P561, DOI 10.1105/tpc.007609; Merigout P, 2002, FEBS LETT, V518, P88, DOI 10.1016/S0014-5793(02)02651-0; Moellering ER, 2010, EUKARYOT CELL, V9, P97, DOI 10.1128/EC.00203-09; Moharikar S, 2006, J PHYCOL, V42, P423, DOI 10.1111/j.1529-8817.2006.00207.x; Nguyen HM, 2011, PROTEOMICS, V11, P4266, DOI 10.1002/pmic.201100114; Okamura K, 2000, BIOCHEM BIOPH RES CO, V279, P445, DOI 10.1006/bbrc.2000.3987; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Sambrook J, 1989, MOL CLONING; Schubert C, 2006, NAT BIOTECHNOL, V24, P777, DOI 10.1038/nbt0706-777; Scott SA, 2010, CURR OPIN BIOTECH, V21, P277, DOI 10.1016/j.copbio.2010.03.005; Shank KJ, 2001, PLANT PHYSIOL, V126, P267, DOI 10.1104/pp.126.1.267; Shao RG, 1996, EXP CELL RES, V227, P190, DOI 10.1006/excr.1996.0266; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; Song WY, 2004, PLANT PHYSIOL, V135, P1027, DOI 10.1104/pp.103.037739; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Welte MA, 2007, TRENDS CELL BIOL, V17, P363, DOI 10.1016/j.tcb.2007.06.004; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yohn C., 2012, US Patent, Patent No. [20,120,322,157, 20120322157]	39	50	52	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e81978	10.1371/journal.pone.0081978	http://dx.doi.org/10.1371/journal.pone.0081978			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349166	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200021
J	Zhou, LJ; Powell, CA; Li, WB; Irey, M; Duan, YP				Zhou, Lijuan; Powell, Charles A.; Li, Wenbin; Irey, Mike; Duan, Yongping			Prophage-Mediated Dynamics of 'Candidatus Liberibacter asiaticus' Populations, the Destructive Bacterial Pathogens of Citrus Huanglongbing	PLOS ONE			English	Article							GREENING DISEASE; DIVERSITY; BACTERIOPHAGES; GENOME; GENES; MYCOBACTERIOPHAGES; IDENTIFICATION; SEQUENCES; ABUNDANCE; REGIONS	Prophages are highly dynamic components in the bacterial genome and play an important role in intraspecies variations. There are at least two prophages in the chromosomes of Candidatus Liberibacter asiaticus' (Las) Floridian isolates. Las is both unculturable and the most prevalent species of Liberibacter pathogens that cause huanglongbing (HLB), a worldwide destructive disease of citrus. In this study, seven new prophage variants resulting from two hyper-variable regions were identified by screening clone libraries of infected citrus, periwinkle and psyllids. Among them, Types A and B share highly conserved sequences and localize within the two prophages, FP1 and FP2, respectively. Although Types B and C were abundant in all three libraries, Type A was much more abundant in the libraries from the Las-infected psyllids than from the Las-infected plants, and Type D was only identified in libraries from the infected host plants but not from the infected psyllids. Sequence analysis of these variants revealed that the variations may result from recombination and rearrangement events. Conventional PCR results using type-specific molecular markers indicated that A, B, C and D are the four most abundant types in Las-infected citrus and periwinkle. However, only three types, A, B and C are abundant in Las-infected psyllids. Typing results for Las-infected citrus field samples indicated that mixed populations of Las bacteria present in Floridian isolates, but only the Type D population was correlated with the blotchy mottle symptom. Extended cloning and sequencing of the Type D region revealed a third prophage/phage in the Las genome, which may derive from the recombination of FP1 and FP2. Dramatic variations in these prophage regions were also found among the global Las isolates. These results are the first to demonstrate the prophage/phage-mediated dynamics of Las populations in plant and insect hosts, and their correlation with insect transmission and disease development.	[Zhou, Lijuan; Duan, Yongping] ARS, Hort Res Lab, USDA, Ft Pierce, FL USA; [Zhou, Lijuan; Powell, Charles A.] Univ Florida, Indian River Res & Educ Ctr, Ft Pierce, FL USA; [Li, Wenbin] US Anim & Plant Hlth Inspect Serv, Ctr Plant Hlth Sci & Technol, USDA, Beltsville, MD USA; [Irey, Mike] US Sugar Corp, Southern Garden Citrus, Clewiston, FL USA	United States Department of Agriculture (USDA); State University System of Florida; University of Florida; United States Department of Agriculture (USDA)	Duan, YP (corresponding author), ARS, Hort Res Lab, USDA, Ft Pierce, FL USA.	yongping.duan@ars.usda.gov	Zhou, Li/GSE-4531-2022		Florida Citrus Research and Development Foundation [162, 310]; ARS [ARS-0423073] Funding Source: Federal RePORTER	Florida Citrus Research and Development Foundation; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding for this work was provided by the Florida Citrus Research and Development Foundation awards 162 and 310. http://citrusrdf.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida A, 2009, MAR DRUGS, V7, P268, DOI 10.3390/md7030268; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Bove JM, 2006, J PLANT PATHOL, V88, P7; Boyd EF, 2002, TRENDS MICROBIOL, V10, P521, DOI 10.1016/S0966-842X(02)02459-9; Bruce DS, 2005, 2 INT CITR CANK HUAN; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Canchaya C, 2003, CURR OPIN MICROBIOL, V6, P417, DOI 10.1016/S1369-5274(03)00086-9; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; CHAO A, 1993, BIOMETRIKA, V80, P193, DOI 10.2307/2336768; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Doddapaneni H., 2008, BMC RES NOTES, V1, P72, DOI [10.1186/1756-0500-1-72, DOI 10.1186/1756-0500-1-72]; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; GRANGE JM, 1975, TUBERCLE, V56, P227, DOI 10.1016/0041-3879(75)90056-2; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Hatfull GF, 2010, ANNU REV MICROBIOL, V64, P331, DOI 10.1146/annurev.micro.112408.134233; Hoffman MT, 2011, PHYTOPATHOLOGY, V101, pS73; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jagoueix S, 1997, INT J SYST BACTERIOL, V47, P224, DOI 10.1099/00207713-47-1-224; Jones JB, 2007, ANNU REV PHYTOPATHOL, V45, P245, DOI 10.1146/annurev.phyto.45.062806.094411; Kurahashi H, 2004, J BIOL CHEM, V279, P35377, DOI 10.1074/jbc.M400354200; Kutateladze M, 2010, TRENDS BIOTECHNOL, V28, P591, DOI 10.1016/j.tibtech.2010.08.001; Lang AS, 2007, TRENDS MICROBIOL, V15, P54, DOI 10.1016/j.tim.2006.12.001; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Liu R, 2011, PLANT DIS, V95, P431, DOI 10.1094/PDIS-04-10-0300; Lyle S., 2012, CITRUS DIS HUANGLONG; Michel B, 2000, TRENDS BIOCHEM SCI, V25, P173, DOI 10.1016/S0968-0004(00)01560-7; Morgan JK, 2012, MOL PROBE, V10, P1; Palmer KM, 2000, APPL ENVIRON MICROB, V66, P2445, DOI 10.1128/AEM.66.6.2445-2450.2000; Petrillo M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-170; Ravenschlag K, 1999, APPL ENVIRON MICROB, V65, P3982; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Salloum M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020256; Santelli CM, 2008, NATURE, V453, P653, DOI 10.1038/nature06899; Scortichini M, 2012, MOL PLANT PATHOL, V13, P631, DOI 10.1111/j.1364-3703.2012.00788.x; Siguier P, 2006, CURR OPIN MICROBIOL, V9, P526, DOI 10.1016/j.mib.2006.08.005; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Storz G, 2005, ANNU REV BIOCHEM, V74, P199, DOI 10.1146/annurev.biochem.74.082803.133136; Teixeira DD, 2005, INT J SYST EVOL MICR, V55, P1857, DOI 10.1099/ijs.0.63677-0; Tobes R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-62; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Varani AD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004059; Vogel J, 2007, CURR OPIN MICROBIOL, V10, P262, DOI 10.1016/j.mib.2007.06.001; Wang XF, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-18, 10.1186/1471-2105-13-113]; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Zhang SJ, 2011, MOL PLANT MICROBE IN, V24, P458, DOI 10.1094/MPMI-11-10-0256; Zhao XY, 1981, P INT SOC CITRICULTU, V1, P466; Zhou LJ, 2011, APPL ENVIRON MICROB, V77, P6663, DOI 10.1128/AEM.05111-11	52	22	25	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82248	10.1371/journal.pone.0082248	http://dx.doi.org/10.1371/journal.pone.0082248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349235	gold, Green Published, Green Submitted			2022-12-27	WOS:000328734200033
J	Wang, JX; Zhu, C; Cheng, T; Peng, XC; Zhang, W; Qin, H; Zhang, XL				Wang, Jiaxing; Zhu, Chen; Cheng, Tao; Peng, Xiaochun; Zhang, Wen; Qin, Hui; Zhang, Xianlong			A Systematic Review and Meta-Analysis of Antibiotic-Impregnated Bone Cement Use in Primary Total Hip or Knee Arthroplasty	PLOS ONE			English	Article							PROPHYLACTIC USE; EMERGING STANDARD; GENTAMICIN; INFECTION; REVISION; POLYMETHYLMETHACRYLATE	Background: Antibiotic-impregnated bone cement (AIBC) has been widely used for the treatment of infected revision arthroplasty, but its routine use in primary total joint arthroplasty (TJA) remains considerably controversial. With this meta-analysis of published randomized controlled trials, we intended to assess the antimicrobial efficacy and safety of AIBC for its prophylactic use in primary TJA. Methods: A literature search was performed in MEDLINE, Embase, CBMdisc and the Cochrane Library until June, 2013. The studies were divided into two sub-groups according to the type of the control group. Outcomes of interest included postoperative infection rates, radiographic outcomes and clinical joint score. Study quality was evaluated using the Jadad scale (five points). Results: In total, eight studies were included, with a sample size of 6,381 arthroplasties. The overall pooled data demonstrated that, compared with the control (plain cement or systemic antibiotic), AIBC did not reveal an advantage in decreasing the rate of superficial infection (relative risk [RR] = 1.47; 95% CI, 1.13-1.91; P=0.004), while there were significant differences in deep infection rate between the AIBC and control group (RR = 0.41; 95% CI, 0.17-0.97; P=0.04). For the analysis of gentamicin and cefuroxime subgroups, the gentamicin was superior to the cefuroxime in reducing deep infection rate (P=0.0005 versus P=0.10). However, no significant differences were found in their radiographic outcomes and clinical joint score. Conclusion: This meta-analysis had proven that the prophylactic use of AIBC could lower the deep infection rate in primary TJA, while AIBC did not show an improvement in reducing the superficial infection rate compared with the control. More sufficiently powered studies would be required to further evaluate the efficacy and safety of AIBC for primary TJA.	[Wang, Jiaxing; Zhu, Chen; Cheng, Tao; Peng, Xiaochun; Zhang, Wen; Qin, Hui; Zhang, Xianlong] Shanghai Jiao Tong Univ, Dept Orthopaed Surg, Shanghai Peoples Hosp 6, Sch Med, Shanghai 200030, Peoples R China; [Zhu, Chen] Anhui Med Univ, Dept Orthopaed Surg, Anhui Prov Hosp, Hefei, Peoples R China	Shanghai Jiao Tong University; Anhui Medical University	Zhang, XL (corresponding author), Shanghai Jiao Tong Univ, Dept Orthopaed Surg, Shanghai Peoples Hosp 6, Sch Med, Shanghai 200030, Peoples R China.	zxl40@vip.sina.com	zhang, xian/GYA-0290-2022					Adalberth G, 2002, ACTA ORTHOP SCAND, V73, P531, DOI 10.1080/000164702321022802; Arciola CR, 2002, BIOMATERIALS, V23, P1495, DOI 10.1016/S0142-9612(01)00275-7; Bohm E, 2012, ACTA ORTHOP, V83, P115, DOI 10.3109/17453674.2011.652885; Bourne RB, 2004, J ARTHROPLASTY, V19, P69, DOI 10.1016/j.arth.2004.03.005; BUCHHOLZ HW, 1970, CHIRURG, V41, P511; Chiu FY, 2002, J BONE JOINT SURG AM, V84A, P759, DOI 10.2106/00004623-200205000-00009; Cram P, 2012, JAMA-J AM MED ASSOC, V308, P1227, DOI 10.1001/2012.jama.11153; Cummins JS, 2009, J BONE JOINT SURG AM, V91A, P634, DOI 10.2106/JBJS.G.01029; Dunbar MJ, 2009, ORTHOPEDICS, DOI [10.3928/01477447-2009 90728-20, DOI 10.3928/01477447-2009]; ELSON RA, 1977, J BONE JOINT SURG BR, V59, P200, DOI 10.1302/0301-620X.59B2.873980; Espehaug B, 1997, J BONE JOINT SURG BR, V79B, P590, DOI 10.1302/0301-620X.79B4.7420; Hanssen AD, 2004, J ARTHROPLASTY, V19, P73, DOI 10.1016/j.arth.2004.04.006; HARRIS WH, 1976, J BONE JOINT SURG AM, V58, P612, DOI 10.2106/00004623-197658050-00005; HAVELIN LI, 1995, J BONE JOINT SURG AM, V77, P1543, DOI 10.2106/00004623-199510000-00009; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hinarejos P, 2013, J BONE JOINT SURG AM, V95A, P769, DOI 10.2106/JBJS.L.00901; HOLM NJ, 1976, ACTA ORTHOP SCAND, V47, P144, DOI 10.3109/17453677608989709; HOPE PG, 1989, J BONE JOINT SURG BR, V71, P851, DOI 10.1302/0301-620X.71B5.2584258; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jaeblon T, 2010, J AM ACAD ORTHOP SUR, V18, P297, DOI 10.5435/00124635-201005000-00006; Jiranek WA, 2006, J BONE JOINT SURG AM, V88A, P2487, DOI 10.2106/JBJS.E.01126; JOSEFSSON G, 1981, CLIN ORTHOP RELAT R, P194; JOSEFSSON G, 1993, CLIN ORTHOP RELAT R, P210; JOSEFSSON G, 1990, CLIN ORTHOP RELAT R, P173; Joseph Thomas N, 2003, J Am Acad Orthop Surg, V11, P38; Konig DP, 2001, LANGENBECK ARCH SURG, V386, P328, DOI 10.1007/s004230100229; Kuhn KD, 2000, BONE CEMENTS UP TO D, P36, DOI DOI 10.1007/978-3-642-59762-6; Kurtz S, 2006, T ORTHOP RES SOC, V31, P179; Kurtz SM, 2007, J BONE JOINT SURG AM, V89A, P144, DOI 10.2106/JBJS.G.00587; LAUTENSCHLAGER EP, 1976, J BIOMED MATER RES, V10, P929, DOI 10.1002/jbm.820100610; McLaren AC, 2004, CLIN ORTHOP RELAT R, P101, DOI 10.1097/01.blo.0000143554.56897.26; McQueen M M, 1990, J Arthroplasty, V5, P169, DOI 10.1016/S0883-5403(06)80236-6; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Neut D, 2001, J ANTIMICROB CHEMOTH, V47, P885, DOI 10.1093/jac/47.6.885; Parvizi J, 2008, ACTA ORTHOP, V79, P335, DOI 10.1080/17453670710015229; Pfarr B, 1979, Aktuelle Probl Chir Orthop, P207; Popat KC, 2007, SMALL, V3, P1878, DOI 10.1002/smll.200700412; Postak PD, 2003, P AM ACAD ORTHOP SUR, V4, P656; Randelli P, 2010, KNEE SURG SPORT TR A, V18, P181, DOI 10.1007/s00167-009-0921-y; Seldes RM, 2005, J BONE JOINT SURG AM, V87A, P268, DOI 10.2106/JBJS.C.00728; WAHLIG H, 1980, ACTA ORTHOP SCAND, V51, P49, DOI 10.3109/17453678008990768; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181	42	70	77	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82745	10.1371/journal.pone.0082745	http://dx.doi.org/10.1371/journal.pone.0082745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349353	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800076
J	Elwood, P; Galante, J; Pickering, J; Palmer, S; Bayer, A; Ben-Shlomo, Y; Longley, M; Gallacher, J				Elwood, Peter; Galante, Julieta; Pickering, Janet; Palmer, Stephen; Bayer, Antony; Ben-Shlomo, Yoav; Longley, Marcus; Gallacher, John			Healthy Lifestyles Reduce the Incidence of Chronic Diseases and Dementia: Evidence from the Caerphilly Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; EARLY OLD-AGE; COGNITIVE DECLINE; PHYSICAL-ACTIVITY; WHITEHALL II; PRIMARY PREVENTION; SOUTH WALES; RISK; MEN	Background: Healthy lifestyles based on non-smoking, an acceptable BMI, a high fruit and vegetable intake, regular physical activity, and low/moderate alcohol intake, are associated with reductions in the incidence of certain chronic diseases, but to date there is limited evidence on cognitive function and dementia. Methods: In 1979 healthy behaviours were recorded on 2,235 men aged 45-59 years in Caerphilly, UK. During the following 30 years incident diabetes, vascular disease, cancer and death were recorded, and in 2004 cognitive state was determined. Findings: Men who followed four or five of the behaviours had an odds ratio (OR) and confidence intervals (CI) for diabetes, corrected for age and social class, of 0.50 (95% CI: 0.19, 1.31; P for trend with increasing numbers of healthy behaviours <0.0005). For vascular disease the OR was 0.50 (95% CI: 0.30, 0.84; P for trend <0.0005), and there was a delay in vascular disease events of up to 12 years. Cancer incidence was not significantly related to lifestyle although there was a reduction associated with non-smoking (OR: 0.65; 95% CI: 0.54, 0.79). All-cause mortality was reduced in men following four or five behaviours (OR 0.40; 95% CI: 0.24, 0.67; P for trend <0.005). After further adjustment for NART, the OR for men following four or five healthy behaviours was 0.36 (95% CI: 0.12, 1.09; P for trend <0.001) for cognitive impairment, and 0.36 (95% CI: 0.07, 1.99; P for trend <0.02) for dementia. The adoption of a healthy lifestyle by men was low and appears not to have changed during the subsequent 30 years, with under 1% of men following all five of the behaviours and 5% reporting four or more in 1979 and in 2009. Interpretation: A healthy lifestyle is associated with increased disease-free survival and reduced cognitive impairment but the uptake remains low.	[Elwood, Peter; Galante, Julieta; Pickering, Janet; Palmer, Stephen; Bayer, Antony; Gallacher, John] Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales; [Ben-Shlomo, Yoav] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Longley, Marcus] Univ South Wales, Welsh Inst Hlth & Social Care, Pontypridd, M Glam, Wales	Cardiff University; University of Bristol; University of South Wales	Elwood, P (corresponding author), Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales.	ElwoodPC@cardiff.ac.uk	Ben-Shlomo, Yoav/ABD-2004-2021; Bayer, Antony/H-4376-2019; Bayer, Antony/H-4434-2019; Galante, Julieta/C-3151-2016	Ben-Shlomo, Yoav/0000-0001-6648-3007; Bayer, Antony/0000-0002-7514-248X; Galante, Julieta/0000-0002-4108-5341				Alexopoulos P, 2011, J ALZHEIMERS DIS, V26, P207, DOI 10.3233/JAD-2011-110356; [Anonymous], 2010, WELSH HLTH SURVEY 20; BERG L, 1988, PSYCHOPHARMACOL BULL, V24, P637; BRENNER H, 1993, EPIDEMIOLOGY, V4, P229, DOI 10.1097/00001648-199305000-00006; Buchman AS, 2012, NEUROLOGY, V78, P1323, DOI 10.1212/WNL.0b013e3182535d35; Chakravarty EF, 2012, AM J MED, V125, P190, DOI 10.1016/j.amjmed.2011.08.006; Chiuve SE, 2006, CIRCULATION, V114, P160, DOI 10.1161/CIRCULATIONAHA.106.621417; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Elwood P, 2010, J EPIDEMIOL COMMUN H, V64, P761, DOI 10.1136/jech.2009.087767; ELWOOD PC, 1984, J EPIDEMIOL COMMUN H, V38, P259, DOI 10.1136/jech.38.3.259; Elwood PC, 1999, J EPIDEMIOL COMMUN H, V53, P9, DOI 10.1136/jech.53.1.9; Fish M, 2008, NEUROEPIDEMIOLOGY, V30, P25, DOI 10.1159/000115439; Ford ES, 2011, AM J PUBLIC HEALTH, V101, P1922, DOI [10.2105/AJPH.2011.300167, 10.2105//AJPH.2011.300167]; Ford ES, 2009, ARCH INTERN MED, V169, P1355, DOI 10.1001/archinternmed.2009.237; Gelber RP, 2012, J AM GERIATR SOC, V60, P118, DOI 10.1111/j.1532-5415.2011.03768.x; Gow AJ, 2012, NEUROLOGY, V79, P1802, DOI 10.1212/WNL.0b013e3182703fd2; Hagger-Johnson G, 2013, BRIT J PSYCHIAT, V203, P120, DOI 10.1192/bjp.bp.112.122960; Hale J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-460; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Huppert FA, 2009, PERSPECT PSYCHOL SCI, V4, P208; Iwasa H, 2012, J PSYCHOSOM RES, V72, P159, DOI 10.1016/j.jpsychores.2011.10.002; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; Liu R, 2012, MED SCI SPORT EXER, V44, P253, DOI 10.1249/MSS.0b013e31822cf717; McCullough ML, 2011, CANCER EPIDEM BIOMAR, V20, P1089, DOI 10.1158/1055-9965.EPI-10-1173; Morgan GS, 2012, J ALZHEIMERS DIS, V31, P569, DOI 10.3233/JAD-2012-112171; Nelson HE, 2004, NATL ADULT READING T; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; Reeves MJ, 2005, ARCH INTERN MED, V165, P854, DOI 10.1001/archinte.165.8.854; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Ruscheweyh R, 2011, NEUROBIOL AGING, V32, P1304, DOI 10.1016/j.neurobiolaging.2009.08.001; Sabia S, 2009, AM J EPIDEMIOL, V170, P428, DOI 10.1093/aje/kwp161; Singh-Manoux A, 2012, NEUROLOGY, V79, P755, DOI 10.1212/WNL.0b013e3182661f63; Small GW, 2013, INT PSYCHOGERIATR, V25, P981, DOI 10.1017/S1041610213000082; Snowden M, 2011, J AM GERIATR SOC, V59, P704, DOI 10.1111/j.1532-5415.2011.03323.x; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Williams John W, 2010, Evid Rep Technol Assess (Full Rep), P1	42	98	98	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81877	10.1371/journal.pone.0081877	http://dx.doi.org/10.1371/journal.pone.0081877			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VD	24349147	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000328705200055
J	Park, D; Lee, Y; Bhupindersingh, G; Iyer, VR				Park, Daechan; Lee, Yaelim; Bhupindersingh, Gurvani; Iyer, Vishwanath R.			Widespread Misinterpretable ChIP-seq Bias in Yeast	PLOS ONE			English	Article							PROTEIN-DNA INTERACTIONS; MESSENGER-RNA LEVELS; SACCHAROMYCES-CEREVISIAE; HUMAN GENOME; TRANSCRIPTION FACTOR; EUKARYOTIC GENOME; CELL-CYCLE; CHROMATIN; ELEMENTS; REGIONS	Chromatin immunoprecipitation followed by sequencing (ChIP-seq) is widely used to detect genome-wide interactions between a protein of interest and DNA in vivo. Loci showing strong enrichment over adjacent background regions are typically considered to be sites of binding. Insufficient attention has been given to systematic artifacts inherent to the ChIP-seq procedure that might generate a misleading picture of protein binding to certain loci. We show here that unrelated transcription factors appear to consistently bind to the gene bodies of highly transcribed genes in yeast. Strikingly, several types of negative control experiments, including a protein that is not expected to bind chromatin, also showed similar patterns of strong binding within gene bodies. These false positive signals were evident across sequencing platforms and immunoprecipitation protocols, as well as in previously published datasets from other labs. We show that these false positive signals derive from high rates of transcription, and are inherent to the ChIP procedure, although they are exacerbated by sequencing library construction procedures. This expression bias is strong enough that a known transcriptional repressor like Tup1 can erroneously appear to be an activator. Another type of background bias stems from the inherent nucleosomal structure of chromatin, and can potentially make it seem like certain factors bind nucleosomes even when they don't. Our analysis suggests that a mock ChIP sample offers a better normalization control for the expression bias, whereas the ChIP input is more appropriate for the nucleosomal periodicity bias. While these controls alleviate the effect of the biases to some extent, they are unable to eliminate it completely. Caution is therefore warranted regarding the interpretation of data that seemingly show the association of various transcription and chromatin factors with highly transcribed genes in yeast.	[Park, Daechan; Lee, Yaelim; Bhupindersingh, Gurvani; Iyer, Vishwanath R.] Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Iyer, VR (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Inst Cellular & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA.	vishy.iyer@gmail.com		Park, Daechan/0000-0003-4991-5247	National Institutes of Health [CA095548]; NATIONAL CANCER INSTITUTE [R01CA095548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded in part by grants from the National Institutes of Health (CA095548) to VRI. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach RK, 2009, P NATL ACAD SCI USA, V106, P14926, DOI 10.1073/pnas.0905443106; Chadwick LH, 2012, EPIGENOMICS-UK, V4, P317, DOI [10.2217/epi.12.18, 10.2217/EPI.12.18]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fan XC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005029; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kidder BL, 2011, NAT IMMUNOL, V12, P918, DOI 10.1038/ni.2117; Lee BK, 2012, GENOME RES, V22, P9, DOI 10.1101/gr.127597.111; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Li XR, 1999, J BIOL CHEM, V274, P24220, DOI 10.1074/jbc.274.34.24220; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Preti M, 2010, MOL CELL, V38, P614, DOI 10.1016/j.molcel.2010.04.016; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rougemont J, 2012, METHODS MOL BIOL, V786, P263, DOI 10.1007/978-1-61779-292-2_16; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Shao Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r16; Shivaswamy S, 2008, MOL CELL BIOL, V28, P2221, DOI 10.1128/MCB.01659-07; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tippmann SC, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.23; van Dijk EL, 2011, NATURE, V475, P114, DOI 10.1038/nature10118; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Wilbanks EG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011471; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036; Zaret K., 2005, CURR PROTOC MOL BIOL, V21, P21, DOI 10.1002/0471142727.mb2101s69; Zentner GE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003317; Zhang LY, 2011, GENOME RES, V21, P875, DOI 10.1101/gr.117465.110; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu XF, 2006, MOL CELL, V22, P169, DOI 10.1016/j.molcel.2006.03.032	45	92	92	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e83506	10.1371/journal.pone.0083506	http://dx.doi.org/10.1371/journal.pone.0083506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349523	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200130
J	Bhattacharya, S; Maheshwari, A; Mollison, J				Bhattacharya, Siladitya; Maheshwari, Abha; Mollison, Jill			Factors Associated with Failed Treatment: an Analysis of 121,744 Women Embarking on Their First IVF Cycles	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; FOLLICLE-STIMULATING-HORMONE; ASSISTED REPRODUCTION; ONGOING PREGNANCY; PREDICTION MODEL; LIVE BIRTH; SUCCESS; AGE; CONCEPTION; STANDARD	Background: In-vitro fertilization (IVF) is the treatment of choice for unresolved infertility. It comprises a number of key steps, each of which has to be negotiated before the next is attempted, but the factors which are associated with failure at each stage have not been reported. Methods and Findings: We analyzed anonymised national data on women undergoing their first fresh autologous IVF and intracytoplasmic sperm injection (ICSI) cycle in the United Kingdom between 2000 and 2007 to predict factors associated with overall lack of livebirth as well as the chance of non-progress at different stages of an IVF cycle. A total of 121,744 women were included in this analysis. Multivariable models underlined the importance of increased female age and duration of infertility, lack of previous pregnancy, and a diagnosis of tubal or male factor infertility in predicting the risk of not having a live birth in an IVF treatment. At each stage, a woman's chance of proceeding to the next stage of IVF treatment is affected by increased age and duration of infertility. The intention to use intra-cytoplasmic sperm injection (ICSI) is associated with a decreased risk of treatment failure in women starting an IVF cycle (RR 0.93, 99% CI 0.92, 0.94) but this association is reversed at a later stage once fertilisation has been confirmed (RR=1.01, 99% CI 1.00, 1.03). Conclusions: Female age is a key predictor of failure to have a livebirth following IVF as well as the risk of poor performance at each stage of treatment. While increased duration of infertility is also associated with worse outcomes at every stage, its impact appears to be less influential. Women embarking on ICSI treatment for male factor infertility have a lower chance of treatment failure but this does not appear to be due to increased chances of implantation of ICSI embryos.	[Bhattacharya, Siladitya; Maheshwari, Abha; Mollison, Jill] Univ Aberdeen, Div Appl Hlth Sci, Aberdeen, Scotland	University of Aberdeen	Bhattacharya, S (corresponding author), Univ Aberdeen, Div Appl Hlth Sci, Aberdeen, Scotland.	s.bhattacharya@abdn.ac.uk		Bhattacharya, Siladitya/0000-0002-4588-356X; Mollison, Jill/0000-0002-5539-5615				Bancsi LFJMM, 2000, FERTIL STERIL, V73, P552, DOI 10.1016/S0015-0282(99)00552-X; *CAPR ESHR WORKSH, 2013, HUM REPROD UPDATE, V191, P354, DOI DOI 10.1093/HUMUPD/DMT007.PUBMED:23459992; Ebbesen SMS, 2009, HUM REPROD, V24, P2173, DOI 10.1093/humrep/dep185; Ferlitsch K, 2004, J ASSIST REPROD GEN, V21, P431, DOI 10.1007/s10815-004-8759-1; Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Hart R, 2001, HUM REPROD, V16, P2411, DOI 10.1093/humrep/16.11.2411; Hauzman E, 2004, FERTIL STERIL, V81, P66, DOI 10.1016/j.fertnstert.2003.05.007; Hunault CC, 2002, FERTIL STERIL, V77, P725, DOI 10.1016/S0015-0282(01)03243-5; JOHNSON N, 2010, COCHRANE DB SYST REV, V1, P87014; Lawlor DA, 2012, LANCET, V379, P521, DOI 10.1016/S0140-6736(11)61267-1; Maugey-Laulom B, 2002, EUR J OBSTET GYN R B, V104, P137, DOI 10.1016/S0301-2115(02)00102-1; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Min JK, 2004, HUM REPROD, V19, P3, DOI 10.1093/humrep/deh028; Nelson SM, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000386; Ottosen LDM, 2007, J ASSIST REPROD GEN, V24, P29, DOI 10.1007/s10815-006-9082-9; Sabatin L, 2008, REPROD BIOMED ONLINE, V17, P10, DOI 10.1016/S1472-6483(10)60287-8; Sharma V, 2002, FERTIL STERIL, V78, P40, DOI 10.1016/S0015-0282(02)03160-6; Stolwijk AM, 1997, FERTIL STERIL, V67, P702, DOI 10.1016/S0015-0282(97)81370-2; Strandell A, 2000, HUM REPROD, V15, P2520, DOI 10.1093/humrep/15.12.2520; Sunkara SK, 2011, HUM REPROD, V26, P1768, DOI 10.1093/humrep/der106; Syrop CH, 1999, HUM REPROD, V14, P1752, DOI 10.1093/humrep/14.7.1752; Templeton A, 1996, LANCET, V348, P1402, DOI 10.1016/S0140-6736(96)05291-9; van der Gaast MH, 2006, REPROD BIOMED ONLINE, V13, P476, DOI 10.1016/S1472-6483(10)60633-5; van Loendersloot LL, 2011, REPROD BIOMED ONLINE, V22, P597, DOI 10.1016/j.rbmo.2011.02.012; van Loendersloot LL, 2010, HUM REPROD UPDATE, V16, P577, DOI 10.1093/humupd/dmq015; Wang YA, 2008, HUM REPROD, V23, P1633, DOI 10.1093/humrep/den135; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	28	58	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82249	10.1371/journal.pone.0082249	http://dx.doi.org/10.1371/journal.pone.0082249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349236	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000328566100093
J	Martinez-Lobo, FJ; Hidalgo, A; Garcia, M; Arguello, H; Naharro, G; Carvajal, A; Rubio, P				Javier Martinez-Lobo, Francisco; Hidalgo, Alvaro; Garcia, Marta; Argueello, Hector; Naharro, German; Carvajal, Ana; Rubio, Pedro			First Identification of "Brachyspira hampsonii" in Wild European Waterfowl	PLOS ONE			English	Article							ANTIMICROBIAL SUSCEPTIBILITY; MOLECULAR CHARACTERIZATION; SERPULINA PILOSICOLI; LAYING HENS; HYODYSENTERIAE; PCR; DIFFERENTIATION; PREVALENCE; PIGS	Anseriformes deserve special attention in the epidemiology of Brachyspira spp. because diverse Anseriformes species have been described to act as highly efficient carriers of several Brachyspira spp. that can also infect livestock. The aim of this study was to investigate the prevalence and diversity of Brachyspira spp. in waterfowl that winter in Spain. Brachyspira spp. were isolated from 51 of the 205 faecal samples collected from graylag geese and mallards in the Villafafila Lagoons Nature Reserve (Northwestern Spain). The Brachyspira species identified through phenotyping, PCR and sequencing of the nox gene were B. pilosicoli (5.9%), B. alvinipulli (11.8%), "B. hampsonii" (19.6%), B. murdochii (23.5%) and B. innocens (39.2%). The most relevant finding of this study is the description of "B. hampsonii" in specimens from birds for the first time. Phylogenetic analysis of the nox gene sequences grouped all of the obtained "B. hampsonii" isolates into a cluster with Brachyspira strains previously identified by others as "B. hampsonii" and separated from other Brachyspira spp. isolates and reference strains. Additionally, this cluster was related to clades that grouped B. murdochii and B. innocens isolates. The identification of "B. hampsonii" was also achieved in 8 of the 10 isolates by sequencing the16S rRNA gene and tlyA gene. Regardless of the species identified, no antimicrobial resistance was observed in any of the enteropathogenic isolates recovered. This is the first description of "B. hampsonii" in European waterfowl, which might represent hosts that serve as natural reservoirs of this Brachyspira species. This finding indicates that this spirochete is not limited to North America, and its presence in wild birds in Europe poses a risk of transmission to livestock.	[Javier Martinez-Lobo, Francisco; Hidalgo, Alvaro; Garcia, Marta; Argueello, Hector; Naharro, German; Carvajal, Ana; Rubio, Pedro] Univ Leon, Fac Vet Med, Infect Dis & Epidemiol Unit, E-24071 Leon, Spain	Universidad de Leon	Martinez-Lobo, FJ (corresponding author), Univ Leon, Fac Vet Med, Infect Dis & Epidemiol Unit, E-24071 Leon, Spain.	fmarl@unileon.es	Carvajal, Ana/P-2351-2017; Arguello, Hector/L-2287-2017; Naharro, Germán/AAA-6572-2019	Carvajal, Ana/0000-0001-8961-636X; Arguello, Hector/0000-0001-8504-2717; Naharro, Germán/0000-0002-7391-4378; Martinez-Lobo, Francisco Javier/0000-0002-4419-5124; Rubio, Pedro/0000-0002-4267-5650	Ministerio de Economia y Competitividad [AGL 2010-18804]	Ministerio de Economia y Competitividad(Spanish Government)	This work was funded by "Ministerio de Economia y Competitividad" (project AGL 2010-18804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaraz P, 2012, J ANIM ECOL, V81, P1113, DOI 10.1111/j.1365-2656.2012.01972.x; Boye M, 2001, VET MICROBIOL, V81, P33, DOI 10.1016/S0378-1135(01)00328-5; Burrough ER, 2012, J VET DIAGN INVEST, V24, P1025, DOI 10.1177/1040638712457927; Carvajal A, 2006, VET REC, V158, P700, DOI 10.1136/vr.158.20.700; Chander Y, 2012, J VET DIAGN INVEST, V24, P903, DOI 10.1177/1040638712456975; Cheung PP, 2009, J CLIN VIROL, V46, P90, DOI 10.1016/j.jcv.2009.06.016; FELLSTROM C, 1995, RES VET SCI, V59, P1, DOI 10.1016/0034-5288(95)90021-7; Fossi M, 2004, J CLIN MICROBIOL, V42, P3153, DOI 10.1128/JCM.42.7.3153-3158.2004; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hampson DJ, 2006, EMERG INFECT DIS, V12, P869, DOI 10.3201/eid1205.051180; Hidalgo A, 2010, VET MICROBIOL, V146, P356, DOI 10.1016/j.vetmic.2010.05.016; Jansson DS, 2008, VET MICROBIOL, V130, P348, DOI 10.1016/j.vetmic.2008.02.010; Jansson DS, 2011, SYST APPL MICROBIOL, V34, P566, DOI 10.1016/j.syapm.2011.10.001; Jansson DS, 2011, AVIAN PATHOL, V40, P387, DOI 10.1080/03079457.2011.588197; Jansson Desiree S., 2001, Animal Health Research Reviews, V2, P93; Jansson DS, 2008, ANAEROBE, V14, P287, DOI 10.1016/j.anaerobe.2008.09.002; Jansson DS, 2004, J MED MICROBIOL, V53, P293, DOI 10.1099/jmm.0.05488-0; JENKINSON SR, 1981, VET REC, V109, P384, DOI 10.1136/vr.109.17.384; Jensen NS, 1996, VET MICROBIOL, V52, P259, DOI 10.1016/S0378-1135(96)00076-4; Jong E. de, 2013, Proceedings of the Joint Meeting of the 5th European Symposium of Porcine Health Management and  the 50th Anniversary Meeting of the Pig Veterinary Society of Great Britain, Edinburgh, UK, 22nd - 24th May 2013, P54; Kear J., 2005, DUCKS GEESE SWANS, V2; Kear J., 2005, DUCKS GEESE SWANS, V1; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Lebarbenchon Camille, 2008, J Mol Genet Med, V3, P121; Lillehaug A, 2005, ACTA VET SCAND, V46, P193, DOI 10.1186/1751-0147-46-4-193; Motro Y, 2009, VET MICROBIOL, V134, P340, DOI 10.1016/j.vetmic.2008.09.051; NEEF NA, 1994, INFECT IMMUN, V62, P2395, DOI 10.1128/IAI.62.6.2395-2403.1994; Nei M., 2000, MOL EVOLUTION PHYLOG; Nemes CS, 2006, AVIAN PATHOL, V35, P4, DOI 10.1080/03079450500465577; Oxberry SL, 1998, EPIDEMIOL INFECT, V121, P219, DOI 10.1017/S0950268898008863; Pringle M, 2012, ACTA VET SCAND, V54, DOI 10.1186/1751-0147-54-54; Rasback T, 2006, J MICROBIOL METH, V66, P347, DOI 10.1016/j.mimet.2005.12.008; Rasback T, 2007, ENVIRON MICROBIOL, V9, P983, DOI 10.1111/j.1462-2920.2006.01220.x; Rohde J, 2002, J CLIN MICROBIOL, V40, P2598, DOI 10.1128/JCM.40.7.2598-2600.2002; Rohde J, 2012, VET MICROBIOL, V158, P211, DOI 10.1016/j.vetmic.2012.02.008; Rubin JE, 2013, MICROB ECOL, V66, P813, DOI 10.1007/s00248-013-0273-5; Rubin JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057146; Swayne D. E., 1997, P267; SWAYNE DE, 2003, DIS POULTRY, P826; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trott DJ, 1996, INT J SYST BACTERIOL, V46, P206, DOI 10.1099/00207713-46-1-206	42	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82626	10.1371/journal.pone.0082626	http://dx.doi.org/10.1371/journal.pone.0082626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24349322	gold, Green Published, Green Submitted			2022-12-27	WOS:000327949300162
J	Bhattacharya, S; Ghosh, R; Maiti, S; Khan, GA; Sinha, AK				Bhattacharya, Suman; Ghosh, Rajeshwary; Maiti, Smarajit; Khan, Gausal Azam; Sinha, Asru K.			The Activation by Glucose of Liver Membrane Nitric Oxide Synthase in the Synthesis and Translocation of Glucose transporter-4 in the Production of Insulin in the Mice Hepatocytes	PLOS ONE			English	Article							STIMULATION; RECEPTORS; ADIPOCYTE; PROTEIN; MUSCLE; RATS	Introduction: Glucose has been reported to have an essential role in the synthesis and secretion of insulin in hepatocytes. As the efflux of glucose is facilitated from the liver cells into the circulation, the mechanism of transportation of glucose into the hepatocytes for the synthesis of insulin was investigated. Methods: Grated liver suspension (GLS) was prepared by grating intact liver from adult mice by using a grater. Nitric oxide (NO) was measured by methemoglobin method. Glucose transporter-4 (Glut-4) was measured by immunoblot technique using Glut-4 antibody. Results: Incubation of GLS with different amounts of glucose resulted in the uptake of glucose by the suspension with increased NO synthesis due to the stimulation of a glucose activated nitric oxide synthase that was present in the liver membrane. The inhibition of glucose induced NO synthesis resulted in the inhibition of glucose uptake. Glucose at 0.02M that maximally increased NO synthesis in the hepatocytes led to the translocation and increased synthesis of Glut-4 by 3.3 fold over the control that was inhibited by the inhibition of NO synthesis. The glucose induced NO synthesis was also found to result in the synthesis of insulin, in the presence of glucose due to the expression of both proinsulin genes I and II in the liver cells. Conclusion: It was concluded that glucose itself facilitated its own transportation in the liver cells both via Glut-4 and by the synthesis of NO which had an essential role for insulin synthesis in the presence of glucose in these cells.	[Bhattacharya, Suman; Ghosh, Rajeshwary; Khan, Gausal Azam; Sinha, Asru K.] Sinha Inst Med Sci & Technol, Dept Biochem, Kolkata, India; [Bhattacharya, Suman; Maiti, Smarajit] Vidyasagar Univ, Dept Biochem, Midnapore, India	Vidyasagar University	Sinha, AK (corresponding author), Sinha Inst Med Sci & Technol, Dept Biochem, Kolkata, India.	asruksinha@yahoo.com	Khan, Gausal A/B-9525-2009	Khan, Gausal A/0000-0002-0306-6641; Ghosh, Rajeshwary/0000-0001-6528-2940	Defence Research and Development Organisation (DRDO) [DLS/81/48222/LSRB-247/EPB/2012]	Defence Research and Development Organisation (DRDO)(Defence Research & Development Organisation (DRDO))	This work was financially supported by Defence Research and Development Organisation (DRDO No: DLS/81/48222/LSRB-247/EPB/2012, www.drdo.gov.in). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASPLUND K, 1969, DIABETOLOGIA, V5, P260, DOI 10.1007/BF01212095; Baelde HJ, 2001, J CLIN PATHOL, V54, P778, DOI 10.1136/jcp.54.10.778; Bank S, 2013, CLIN LAB IN PRESS; Bhattacharya S, 2013, INT J BIOME IN PRESS; Cherry J H, 1974, Methods Enzymol, V31, P583; Coligan J. E., 1992, CURRENT PROTOCOLIN I, V1; COX RD, 1982, J ANAL TOXICOL, V6, P148, DOI 10.1093/jat/6.3.148; ENGVALL E, 1972, J IMMUNOL, V109, P129; FEHLMANN M, 1982, P NATL ACAD SCI-BIOL, V79, P5921, DOI 10.1073/pnas.79.19.5921; Ghosh R., 2012, INT J BIOMED SCI, V3, P171; Ghosh Rajeshwary, 2012, Thrombosis, V2012, P987932, DOI 10.1155/2012/987932; Ghosh R, 2011, J THROMB THROMBOLYS, V31, P13, DOI 10.1007/s11239-010-0515-z; Ghosh R, 2010, ENDOCRINE, V38, P294, DOI 10.1007/s12020-010-9388-3; GREEN DPL, 1984, MED HYPOTHESES, V15, P47, DOI 10.1016/0306-9877(84)90007-0; GRODSKY GM, 1972, J CLIN INVEST, V51, P2047, DOI 10.1172/JCI107011; JARETT L, 1980, SCIENCE, V210, P1127, DOI 10.1126/science.7003710; KARL IE, 1990, DIABETES, V39, P1106, DOI 10.2337/diabetes.39.9.1106; Karmohapatra SK, 2007, AM J HEMATOL, V82, P986, DOI 10.1002/ajh.20955; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lira VA, 2007, AM J PHYSIOL-ENDOC M, V293, pE1062, DOI 10.1152/ajpendo.00045.2007; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; Meyer C, 2002, AM J PHYSIOL-ENDOC M, V282, pE419, DOI 10.1152/ajpendo.00032.2001; Neuberger A, 1988, NEW COMPREHENSIVE A, V18A, P124; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Petit JM, 2001, J HEPATOL, V35, P279, DOI 10.1016/S0168-8278(01)00143-X; ROSENZWEIG JL, 1980, P NATL ACAD SCI-BIOL, V77, P572, DOI 10.1073/pnas.77.1.572; SAKUMA I, 1988, P NATL ACAD SCI USA, V85, P8664, DOI 10.1073/pnas.85.22.8664; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Sinha AK, 1999, LIFE SCI, V65, P2687, DOI 10.1016/S0024-3205(99)00537-8; Tanaka T, 2003, EUR J ENDOCRINOL, V149, P61, DOI 10.1530/eje.0.1490061; VIRJI MAG, 1980, P NATL ACAD SCI-BIOL, V77, P875, DOI 10.1073/pnas.77.2.875; Yang LJ, 2002, P NATL ACAD SCI USA, V99, P8078, DOI 10.1073/pnas.122210699; Zhou J, 2001, EXP BIOL MED, V226, P312, DOI 10.1177/153537020122600408; ZIMMERMAN R, 1979, EUR J BIOCHEM, V99, P247, DOI 10.1111/j.1432-1033.1979.tb13251.x	34	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81935	10.1371/journal.pone.0081935	http://dx.doi.org/10.1371/journal.pone.0081935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24349154	Green Submitted, Green Published, gold			2022-12-27	WOS:000327947800070
J	Han, GF; Wang, ZM; Wang, JM; Yang, WX; Chen, J; Kang, JY; Zhang, S; Wang, AM; Lai, XN				Han, Gengfen; Wang, Ziming; Wang, Jianmin; Yang, Weixiao; Chen, Jing; Kang, Jianyi; Zhang, Sen; Wang, Aimin; Lai, Xinan			Characteristics and Mechanisms of Cardiopulmonary Injury Caused by Mine Blasts in Shoals: A Randomized Controlled Study in a Rabbit Model	PLOS ONE			English	Article							SECONDARY INJURY; CHEST; PNEUMOTHORAX; CONTUSION; ABDOMEN; TRAUMA; LUNGS	Background: Because the characteristics of blast waves in water are different from those in air and because kinetic energy is liberated by a pressure wave at the water-air interface, thoracic injuries from mine blasts in shoals may be serious. The aim of the present study was to investigate the characteristics and mechanisms of cardiopulmonary injury caused by mine blasts in shoals. Methods: To study the characteristics of cardiopulmonary injury, 56 animals were divided randomly into three experimental groups (12 animals in the sham group, 22 animals in the land group and 22 animals in the shoal group). To examine the biomechanics of injury, 20 animals were divided randomly into the land group and the shoal group. In the experimental model, the water surface was at the level of the rabbit's xiphoid process, and paper electric detonators (600 mg RDX) were used to simulate mines. Electrocardiography and echocardiography were conducted, and arterial blood gases, serum levels of cardiac troponin I and creatine kinase-MB and other physiologic parameters were measured over a 12-hour period after detonation. Pressures in the thorax and abdomen and the acceleration of the thorax were measured. Conclusion: The results indicate that severe cardiopulmonary injury and dysfunction occur following exposure to mine blasts in shoals. Therefore, the mechanisms of cardiopulmonary injury may result from shear waves that produce strain at the water-air interface. Another mechanism of injury includes the propagation of the shock wave from the planta to the thorax, which causes a much higher peak overpressure in the abdomen than in the thorax; as a result, the abdominal organs and diaphragm are thrust into the thorax, damaging the lungs and heart.	[Han, Gengfen; Wang, Ziming; Zhang, Sen; Wang, Aimin] Third Mil Med Univ, Daping Hosp, Dept Orthoped, Chongqing, Peoples R China; [Wang, Jianmin; Chen, Jing; Kang, Jianyi; Lai, Xinan] Third Mil Med Univ, Daping Hosp, Inst Surg Res, Chongqing, Peoples R China; [Yang, Weixiao] Third Mil Med Univ, Dept Ultrasound, Daping Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Wang, AM (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Orthoped, Chongqing, Peoples R China.	trauma3@163.com; laixinan4@163.com	wang, jian/GVS-0711-2022		planning scheme, PLA Army, China [AWS12J002]	planning scheme, PLA Army, China	This study was supported by a grant (AWS12J002) from the planning scheme, PLA Army, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aylward M, 1994, MINES SURF ZONE PROP; Barton E D, 1999, Curr Opin Pulm Med, V5, P269, DOI 10.1097/00063198-199907000-00016; Braunwald E., 1988, HEART DIS TXB CARDIO; BRUNE WH, 1957, ARCH SURG-CHICAGO, V75, P715; Carlsten A, 1995, ACTA PHYSL SCAND, V33, P243; CASEBY NG, 1976, INJURY, V8, P1, DOI 10.1016/0020-1383(76)90002-4; CLEMEDSON C. J., 1954, MILITARY SURGEON, V114, P424; COOPER GJ, 1991, J BIOMECH, V24, P273, DOI 10.1016/0021-9290(91)90346-O; COPPEL DL, 1976, BRIT J SURG, V63, P735, DOI 10.1002/bjs.1800631003; DANCEWICZ R, 1988, Zeitschrift fuer Experimentelle Chirurgie Transplantation und Kuenstliche Organe, V21, P91; Davis KA, 1999, J TRAUMA, V46, P824, DOI 10.1097/00005373-199905000-00010; Decker GH, 1961, DEP ARMY FIELD MANUA, P37; Fan Chong-Xi, 2011, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V23, P243; Gu J, 2011, ACTA ANAESTH SCAND, V55, P1272, DOI 10.1111/j.1399-6576.2011.02526.x; HULLER T, 1970, ARCH SURG-CHICAGO, V100, P24; Irwin RJ, 1997, J TRAUMA, V43, P650, DOI 10.1097/00005373-199710000-00015; Johnson G, 1996, J ACCID EMERG MED, V13, P173; Knoferl MW, 2003, SHOCK, V19, P519, DOI 10.1097/01.shk.0000070739.34700.f6; Madill JJ, 2010, J EMERG MED, V39, P194, DOI 10.1016/j.jemermed.2009.08.026; Melton SM, 1999, SHOCK, V11, P396; Moore T, 1944, BRIT MED J, V1944, P626, DOI 10.1136/bmj.2.4375.626; Oveland NP, 2013, CHEST, V143, P415, DOI 10.1378/chest.12-1445; Rukhliada N V, 1998, Vestn Khir Im I I Grek, V157, P79; Sandra IE, 2002, SHALLOW WATER MINES; TENNEY SM, 1963, NATURE, V197, P54, DOI 10.1038/197054a0; WEILERRAVELL D, 1975, ISRAEL J MED SCI, V11, P268; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Yang Zhi-huan, 2004, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V16, P226	28	2	2	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81310	10.1371/journal.pone.0081310	http://dx.doi.org/10.1371/journal.pone.0081310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358110	Green Published, gold			2022-12-27	WOS:000328735700006
J	Lacy, RC; Miller, PS; Nyhus, PJ; Pollak, JP; Raboy, BE; Zeigler, SL				Lacy, Robert C.; Miller, Philip S.; Nyhus, Philip J.; Pollak, J. P.; Raboy, Becky E.; Zeigler, Sara L.			Metamodels for Transdisciplinary Analysis of Wildlife Population Dynamics	PLOS ONE			English	Article							CANINUS OGILBY PHALANGERIDAE; SOUTH-EASTERN AUSTRALIA; DEMOGRAPHIC-MODELS; EXTINCTION RISK; SPECIES INTERACTIONS; SIMULATION-MODEL; CLIMATE-CHANGE; SENSITIVITY; VIABILITY; SCIENCE	Wildlife population models have been criticized for their narrow disciplinary perspective when analyzing complexity in coupled biological - physical - human systems. We describe a "metamodel" approach to species risk assessment when diverse threats act at different spatiotemporal scales, interact in non-linear ways, and are addressed by distinct disciplines. A metamodel links discrete, individual models that depict components of a complex system, governing the flow of information among models and the sequence of simulated events. Each model simulates processes specific to its disciplinary realm while being informed of changes in other metamodel components by accessing common descriptors of the system, populations, and individuals. Interactions among models are revealed as emergent properties of the system. We introduce a new metamodel platform, both to further explain key elements of the metamodel approach and as an example that we hope will facilitate the development of other platforms for implementing metamodels in population biology, species risk assessments, and conservation planning. We present two examples - one exploring the interactions of dispersal in metapopulations and the spread of infectious disease, the other examining predator-prey dynamics - to illustrate how metamodels can reveal complex processes and unexpected patterns when population dynamics are linked to additional extrinsic factors. Metamodels provide a flexible, extensible method for expanding population viability analyses beyond models of isolated population demographics into more complete representations of the external and intrinsic threats that must be understood and managed for species conservation.	[Lacy, Robert C.] Chicago Zool Soc, Brookfield, IL USA; [Miller, Philip S.] IUCN SSC Conservat Breeding Specialist Grp, Apple Valley, MN USA; [Nyhus, Philip J.] Colby Coll, Waterville, ME 04901 USA; [Pollak, J. P.] Cornell Univ, Ithaca, NY USA; [Raboy, Becky E.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Zeigler, Sara L.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA	Colby College; Cornell University; University of Toronto; Virginia Polytechnic Institute & State University	Lacy, RC (corresponding author), Chicago Zool Soc, Brookfield, IL USA.	rlacy@ix.netcom.com		Zeigler, Sara/0000-0002-5472-769X	NSF [DEB-0083615, DEB-1146198]; Division Of Environmental Biology [1146198] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research has been supported by NSF awards DEB-0083615 and DEB-1146198. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, 2009, RAMAS METAPOP VIABIL; Allendorf FW, 2002, POPULATION VIABILITY ANALYSIS, P50; Anderson BJ, 2009, P ROY SOC B-BIOL SCI, V276, P1415, DOI 10.1098/rspb.2008.1681; [Anonymous], 2008, ECOLOGY EXPT ANAL DI; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Bradshaw CJA, 2012, J APPL ECOL, V49, P268, DOI 10.1111/j.1365-2664.2011.02081.x; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Brook BW, 2009, BIOL LETTERS, V5, P723, DOI 10.1098/rsbl.2009.0480; Burgman M, 2012, RISK ANAL, V32, P1956, DOI 10.1111/j.1539-6924.2012.01871.x; Carroll R, 1996, ECOL APPL, V6, P1; Chapin FS, 2006, AM NAT, V168, pS36, DOI 10.1086/509047; Cornelis H, 2013, PLOS ONE, V7, DOI [10.1371/journal.pone.0022856, DOI 10.1371/J0URNAL.P0NE.0022856]; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; Cross PC, 2001, CONSERV BIOL, V15, P1335, DOI 10.1046/j.1523-1739.2001.00031.x; Dobson A.P., 1986, P345; Fahrig L, 2002, ECOL APPL, V12, P346, DOI 10.1890/1051-0761(2002)012[0346:EOHFOT]2.0.CO;2; Fieberg J, 2001, ECOL LETT, V4, P244, DOI 10.1046/j.1461-0248.2001.00202.x; Gerber LR, 2006, FRONT ECOL ENVIRON, V4, P419, DOI 10.1890/1540-9295(2006)4[419:IBDIDM]2.0.CO;2; Gross LJ, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P467; Hess G, 1996, ECOLOGY, V77, P1617, DOI 10.2307/2265556; Holling C.S., 1998, CE, V2, P4; Holling CS, 1996, ECOL APPL, V6, P733, DOI 10.2307/2269475; Hunter CM, 2010, ECOLOGY, V91, P2883, DOI 10.1890/09-1641.1; IUCN/SSC, 2008, STRAT PLANN SPEC CON; KANER S, 1996, FACILITATORS GUIDE P; Keet D. F., 2009, DIS RISK ASS WORKSH; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Korpimaki E, 2004, BIOSCIENCE, V54, P1071, DOI 10.1641/0006-3568(2004)054[1071:TPOPCA]2.0.CO;2; Krebs CJ, 2001, BIOSCIENCE, V51, P25, DOI 10.1641/0006-3568(2001)051[0025:WDTYCO]2.0.CO;2; Kurz WA, 2000, COMPUT ELECTRON AGR, V27, P227, DOI 10.1016/S0168-1699(00)00109-5; LACY RC, 1995, BIOL CONSERV, V73, P131, DOI 10.1016/0006-3207(95)91940-Y; Lacy RC, 2012, OUTBREAK VERSION 2 0; Lacy Robert C., 1996, Primate Conservation, V14-15, P27; Lacy Robert C., 2000, Ecological Bulletins, V48, P191; Lacy Robert C., 2000, Ecological Bulletins, V48, P39; Lawler JJ, 2002, ECOL APPL, V12, P663, DOI 10.2307/3060975; LINDENMAYER DB, 1995, BIOL CONSERV, V73, P119, DOI 10.1016/0006-3207(95)00049-A; Lindenmayer DB, 2003, ECOL LETT, V6, P41, DOI 10.1046/j.1461-0248.2003.00391.x; Lindenmayer DB, 2000, ECOL APPL, V10, P580, DOI 10.1890/1051-0761(2000)010[0580:TASMFP]2.0.CO;2; Liu JG, 2007, SCIENCE, V317, P1513, DOI 10.1126/science.1144004; McCarthy MA, 1996, ECOL MODEL, V86, P297, DOI 10.1016/0304-3800(95)00067-4; MCCARTHY MA, 1995, BIOL CONSERV, V73, P93, DOI 10.1016/0006-3207(95)00046-7; Melbourne BA, 2008, NATURE, V454, P100, DOI 10.1038/nature06922; Midgley GF, 2010, ECOGRAPHY, V33, P612, DOI 10.1111/j.1600-0587.2009.06000.x; Miller P. S., 2003, EXPT CONSILIENCE INT, P333; Miller P.S., 2003, EXPT CONSILIENCE INT, P41; Morgan M. S., 1999, MODELS MEDIATORS PER; Morris W. F., 2002, QUANTITATIVE CONSERV; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; Munns WR, 2006, ECOL SOC, V11; Nicolson CR, 2002, ECOSYSTEMS, V5, P376, DOI 10.1007/s10021-001-0081-5; Nyhus PJ, 2007, ECOL SOC, V12; Nyhus PJ, 2002, SOC NATUR RESOUR, V15, P923, DOI 10.1080/08941920290107657; Pollak J. P., 2013, SPATIAL MODEL ANIMAL; Pollak J.P., 2013, METAMODEL MANAGER VE; Pollak JP, 2013, VORTEX STOCHASTIC SI; Prowse TAA, 2013, J ANIM ECOL, V82, P355, DOI 10.1111/1365-2656.12029; Purves D, 2013, NATURE, V493, P295, DOI 10.1038/493295a; Quadling HS, 2002, S AFR J SCI, V98, P449; Raboy BE, 2013, METAMODEL MANAGER US; Redford KH, 2011, BIOSCIENCE, V61, P39, DOI 10.1525/bio.2011.61.1.9; Sabo JL, 2008, BIOL CONSERV, V141, P276, DOI 10.1016/j.biocon.2007.10.002; Scheller RM, 2007, LANDSCAPE ECOL, V22, P491, DOI 10.1007/s10980-006-9048-4; Scheller RM, 2007, ECOL MODEL, V201, P409, DOI 10.1016/j.ecolmodel.2006.10.009; SCHEMSKE DW, 1994, ECOLOGY, V75, P584, DOI 10.2307/1941718; SCHUMAKER NH, 2009, HEXSIM USERS GUIDE; Scott S., 1998, HUMAN DEMOGRAPHY DIS; Stephens PA, 2002, J ANIM ECOL, V71, P343, DOI 10.1046/j.1365-2656.2002.00605.x; Traill LW, 2010, J ANIM ECOL, V79, P937, DOI 10.1111/j.1365-2656.2010.01695.x; Vanclay Jerome K., 2003, SMALL SCALE FOREST E, V2, P117; VANDENBELT M, 2004, MEDIATED MODELING SY; Vucetich JA, 1999, CONSERV BIOL, V13, P1172, DOI 10.1046/j.1523-1739.1999.98366.x; Vucetich JA, 1997, CONSERV BIOL, V11, P957, DOI 10.1046/j.1523-1739.1997.95366.x; Wang H, 2009, MATH BIOSCI, V221, P1, DOI 10.1016/j.mbs.2009.06.004; Westley F., 2003, EXPT CONSILIENCE INT; Westley F. R., 2003, EXPT CONSILIENCE INT, P64; Whitman KL, 2007, CONSERV BIOL, V21, P591, DOI 10.1111/j.1523-1739.2007.00700.x; Willis KJ, 2009, SCIENCE, V326, P806, DOI 10.1126/science.1178838; Wondolleck J. M., 2000, MAKING COLLABORATION	79	23	24	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e84211	10.1371/journal.pone.0084211	http://dx.doi.org/10.1371/journal.pone.0084211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349567	Green Published, gold			2022-12-27	WOS:000328734200108
J	Sitek, KR; Mathalon, DH; Roach, BJ; Houde, JF; Niziolek, CA; Ford, JM				Sitek, Kevin R.; Mathalon, Daniel H.; Roach, Brian J.; Houde, John F.; Niziolek, Caroline A.; Ford, Judith M.			Auditory Cortex Processes Variation in Our Own Speech	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; COROLLARY DISCHARGE DYSFUNCTION; FEEDBACK-CONTROL; SENSORIMOTOR ADAPTATION; EVOKED-POTENTIALS; VOICE; PITCH; SCHIZOPHRENIA; RESPONSES; MANIPULATION	As we talk, we unconsciously adjust our speech to ensure it sounds the way we intend it to sound. However, because speech production involves complex motor planning and execution, no two utterances of the same sound will be exactly the same. Here, we show that auditory cortex is sensitive to natural variations in self-produced speech from utterance to utterance. We recorded event-related potentials (ERPs) from ninety-nine subjects while they uttered "ah'' and while they listened to those speech sounds played back. Subjects' utterances were sorted based on their formant deviations from the previous utterance. Typically, the N1 ERP component is suppressed during talking compared to listening. By comparing ERPs to the least and most variable utterances, we found that N1 was less suppressed to utterances that differed greatly from their preceding neighbors. In contrast, an utterance's difference from the median formant values did not affect N1. Trial-to-trial pitch (f0) deviation and pitch difference from the median similarly did not affect N1. We discuss mechanisms that may underlie the change in N1 suppression resulting from trial-to-trial formant change. Deviant utterances require additional auditory cortical processing, suggesting that speaking-induced suppression mechanisms are optimally tuned for a specific production.	[Sitek, Kevin R.; Mathalon, Daniel H.; Roach, Brian J.; Ford, Judith M.] San Francisco VA Med Ctr, Mental Hlth Serv, San Francisco, CA USA; [Mathalon, Daniel H.; Niziolek, Caroline A.; Ford, Judith M.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Houde, John F.; Niziolek, Caroline A.] Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sitek, KR (corresponding author), Harvard Univ, Program Speech & Hearing Biosci & Technol, Div Med Sci, Boston, MA 02115 USA.	sitek@fas.harvard.edu	Mathalon, Daniel H/AEE-5878-2022; Sitek, Kevin/ABD-3760-2020	Mathalon, Daniel H/0000-0001-6090-4974; Sitek, Kevin/0000-0002-2172-5786; Niziolek, Caroline/0000-0002-6085-1371; Roach, Brian/0000-0002-3264-1465	University of California, San Francisco's Resource Allocation Program; Department of Veterans Affairs; National Institute of Mental Health [MH-58262, MH-076989]; National Institute on Deafness and Other Communication Disorders [R01-DC010145]; National Science Foundation [BCS-0926196]; National Institutes of Health [NRSA 1F32DC011249]; National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI [UL1 TR000004]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076989, U01MH076989, R01MH058262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010145, T32DC000038] Funding Source: NIH RePORTER	University of California, San Francisco's Resource Allocation Program(University of California System); Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a grant from the University of California, San Francisco's Resource Allocation Program, the Department of Veterans Affairs (Merit Review, Research Career Scientist: JF), the National Institute of Mental Health (MH-58262: JF, BR, DM, KS; MH-076989: JF, BR, DM, KS), the National Institute on Deafness and Other Communication Disorders (R01-DC010145: JH, CN), the National Science Foundation (BCS-0926196: JH, CN), the National Institutes of Health (NRSA 1F32DC011249: CN), and the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant Number UL1 TR000004 (JF, DM). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behroozmand R, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-54; Cai SQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041830; Chang EF, 2013, P NATL ACAD SCI USA, V110, P2653, DOI 10.1073/pnas.1216827110; Chen CMA, 2011, J COGNITIVE NEUROSCI, V23, P2892, DOI 10.1162/jocn.2010.21589; Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457; CREUTZFELDT O, 1989, EXP BRAIN RES, V77, P476, DOI 10.1007/BF00249601; Curio G, 2000, HUM BRAIN MAPP, V9, P183, DOI 10.1002/(SICI)1097-0193(200004)9:4<183::AID-HBM1>3.0.CO;2-Z; Eliades SJ, 2005, CEREB CORTEX, V15, P1510, DOI 10.1093/cercor/bhi030; Eliades SJ, 2003, J NEUROPHYSIOL, V89, P2194, DOI 10.1152/jn.00627.2002; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Ford JM, 2001, AM J PSYCHIAT, V158, P2069, DOI 10.1176/appi.ajp.158.12.2069; Ford JM, 2012, INT J PSYCHOPHYSIOL, V83, P232, DOI 10.1016/j.ijpsycho.2011.09.004; Ford JM, 2010, NAT PROTOC, V5, P1160, DOI 10.1038/nprot.2010.67; Friston KJ, 2012, INT J PSYCHOPHYSIOL, V83, P248, DOI 10.1016/j.ijpsycho.2011.11.014; Godey B, 2001, CLIN NEUROPHYSIOL, V112, P1850, DOI 10.1016/S1388-2457(01)00636-8; Guenther FH, 2006, J COMMUN DISORD, V39, P350, DOI 10.1016/j.jcomdis.2006.06.013; Heinks-Maldonado TH, 2005, PSYCHOPHYSIOLOGY, V42, P180, DOI 10.1111/j.1469-8986.2005.00272.x; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; Houde JF, 2002, J COGNITIVE NEUROSCI, V14, P1125, DOI 10.1162/089892902760807140; Houde JF, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00082; Johnson K., 1997, ACOUSTIC AUDITORY PH; LANE H, 1970, J ACOUST SOC AM, V47, P618, DOI 10.1121/1.1911937; LANE H, 1971, J SPEECH HEAR RES, V14, P677, DOI 10.1044/jshr.1404.677; Larson CR, 2008, EXP BRAIN RES, V187, P613, DOI 10.1007/s00221-008-1330-z; Leonowicz Z, 2005, J NEUROSCI METH, V142, P17, DOI 10.1016/j.jneumeth.2004.07.008; Lombard E, 1911, ANN MALADIES OREILLE, P101; Mathalon DH, 2008, CLIN EEG NEUROSCI, V39, P82, DOI 10.1177/155005940803900212; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; NAATANEN R, 1982, BIOL PSYCHOL, V14, P53, DOI 10.1016/0301-0511(82)90017-5; Niziolek CA, 2013, J NEUROSCI, V33, P16110, DOI 10.1523/JNEUROSCI.2137-13.2013; Niziolek CA, 2013, J NEUROSCI, V33, P12090, DOI 10.1523/JNEUROSCI.1008-13.2013; NOLL AM, 1967, J ACOUST SOC AM, V41, P293, DOI 10.1121/1.1910339; O'Shaughnessy D, 1987, SPEECH COMMUNICATION; Pardo JS, 2006, J ACOUST SOC AM, V119, P2382, DOI 10.1121/1.2178720; Perez VB, 2011, SCHIZOPHR B, V38, P1216; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Poulet JFA, 2006, SCIENCE, V311, P518, DOI 10.1126/science.1120847; Purcell DW, 2006, J ACOUST SOC AM, V120, P966, DOI 10.1121/1.2217714; Purcell DW, 2006, J ACOUST SOC AM, V119, P2288, DOI 10.1121/1.2173514; SAMS M, 1985, ELECTROEN CLIN NEURO, V62, P437, DOI 10.1016/0168-5597(85)90054-1; Sancier ML, 1997, J PHONETICS, V25, P421, DOI 10.1006/jpho.1997.0051; Sober SJ, 2009, NAT NEUROSCI, V12, P927, DOI 10.1038/nn.2336; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Stevens SS, 1937, J ACOUST SOC AM, V8, P185, DOI 10.1121/1.1915893; SUGA N, 1974, SCIENCE, V183, P1211, DOI 10.1126/science.183.4130.1211; Tourville JA, 2008, NEUROIMAGE, V39, P1429, DOI 10.1016/j.neuroimage.2007.09.054; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; Villacorta VM, 2007, J ACOUST SOC AM, V122, P2306, DOI 10.1121/1.2773966; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503	51	31	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82925	10.1371/journal.pone.0082925	http://dx.doi.org/10.1371/journal.pone.0082925			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276FP	24349399	Green Submitted, Green Published, gold			2022-12-27	WOS:000328734200060
J	Chen, SY; Huang, CH; Wu, BD; Lian, XJ; Mei, XQ; Wan, JX				Chen, Shanying; Huang, Chunhong; Wu, Bide; Lian, Xuejian; Mei, Xuqiao; Wan, Jianxin			Cardiac Troponin I in Non-Acute Coronary Syndrome Patients with Chronic Kidney Disease	PLOS ONE			English	Article							VASCULAR CALCIFICATION; NONDIALYSIS PATIENTS; PROGNOSTIC VALUE; RENAL-FUNCTION; ASSOCIATION; MECHANISMS; INJURY; ASSAY	Objective: The aim of this study was to assess the results of troponin I (cTnI) in non-acute Coronary Syndrome (ACS) patients with chronic kidney disease (CKD). We also examined the risk factors for elevated cTnI in non-ACS patients with CKD and whether stage 5 CKD modifies the associations of elevated cTnI and the risk factors in non-ACS patients with CKD. Methods: A retrospective study was performed. Logistic regression models were used. Results: 293 non-ACS patients with CKD were included in the current study. 43.34% non-ACS patients with CKD have an elevated cTnI level and 5.12% have an elevated cTnT level in MI range. In CKD patients without ACS and heart failure, only 26.03% (38/146) patients have an elevated cTnT level. In adjusted analyses, age, diastolic blood pressure and congestive heart failure is associated with an elevated cTnI level in non-ACS patients with CKD. Congestive heart failure is associated with an elevated cTnI level in non-ACS patients with CKD (OR 2.30, 95% CI 1.08,4.88, P=0.03). Stage 5 CKD does not modify the association of congestive heart failure and an elevated cTnI level. Conclusion: 43.34% non-ACS patients with CKD and 26.03% CKD patients without ACS and congestive heart failure have an elevated cTnI level. Congestive heart failure is associated with an elevated cTnI level in non-ACS patients with CKD. Stage 5 CKD does not modify the association of congestive heart failure and an elevated cTnI level.	[Chen, Shanying; Huang, Chunhong; Wu, Bide; Lian, Xuejian] Fujian Med Univ, Dept Nephrol, Zhangzhou Affiliated Hosp, Fuzhou, Peoples R China; [Mei, Xuqiao] Fujian Med Univ, Clin Lab, Zhangzhou Affiliated Hosp, Fuzhou, Peoples R China; [Wan, Jianxin] Fujian Med Univ, Affiliated Hosp 1, Dept Nephrol, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Medical University	Wan, JX (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Dept Nephrol, Fuzhou, Peoples R China.	wanjx@263.net						Abbas NA, 2005, CLIN CHEM, V51, P2059, DOI 10.1373/clinchem.2005.055665; ADAMS JE, 1993, CIRCULATION, V88, P101, DOI 10.1161/01.CIR.88.1.101; Agarwal R, 2011, CLIN J AM SOC NEPHRO, V6, P528, DOI 10.2215/CJN.07770910; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Apple FS, 1997, AM J KIDNEY DIS, V29, P399, DOI 10.1016/S0272-6386(97)90201-8; Babuin L, 2005, CAN MED ASSOC J, V173, P1191, DOI 10.1503/cmaj/051291; Beciani M, 2003, NEPHROL DIAL TRANSPL, V18, P942, DOI 10.1093/ndt/gfg057; Bertinchant JP, 2000, CLIN CHIM ACTA, V298, P13, DOI 10.1016/S0009-8981(00)00223-0; Collinson PO, 1999, NEPHROL DIAL TRANSPL, V14, P1030, DOI 10.1093/ndt/14.4.1030; Conway B, 2005, NEPHROL DIAL TRANSPL, V20, P2759, DOI 10.1093/ndt/gfi125; Coudrey L, 1998, ARCH INTERN MED, V158, P1173, DOI 10.1001/archinte.158.11.1173; de Lemos JA, 2012, J AM COLL CARDIOL, V59, P490, DOI 10.1016/j.jacc.2011.10.874; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi C, 2012, CLIN CHEM, V58, P1342, DOI 10.1373/clinchem.2012.185322; Diris JHC, 2004, CIRCULATION, V109, P23, DOI 10.1161/01.CIR.0000109483.45211.8F; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Flisinski M, 2007, KARDIOL POL, V65, P1068; Giachelli CM, 2005, CIRC RES, V96, P717, DOI 10.1161/01.RES.0000161997.24797.c0; Hojs R, 2005, THER APHER DIAL, V9, P205, DOI 10.1111/j.1774-9987.2005.00254.x; Jaffe AS, 2011, J AM COLL CARDIOL, V58, P1819, DOI 10.1016/j.jacc.2011.08.026; KATUS HA, 1992, CLIN CHEM, V38, P386; Kumar N, 2011, NEPHROL DIAL TRANSPL, V26, P665, DOI 10.1093/ndt/gfq442; Lamb EJ, 2007, AM J KIDNEY DIS, V49, P507, DOI 10.1053/j.ajkd.2007.01.015; Lamb EJ, 2004, ANN CLIN BIOCHEM, V41, P1, DOI 10.1258/000456304322664645; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mishra RK, 2013, AM J KIDNEY DIS, V61, P701, DOI 10.1053/j.ajkd.2012.11.034; Mitch WE, 1998, AM J CLIN NUTR, V67, P359, DOI 10.1093/ajcn/67.3.359; Moe SM, 2008, J AM SOC NEPHROL, V19, P213, DOI 10.1681/ASN.2007080854; Newby LK, 2012, J AM COLL CARDIOL, V60, P2427, DOI 10.1016/j.jacc.2012.08.969; SOKOLOW M, 1949, AM HEART J, V37, P161, DOI 10.1016/0002-8703(49)90562-1; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Wang AYM, 2007, CLIN CHEM, V53, P882, DOI 10.1373/clinchem.2006.078378	32	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82752	10.1371/journal.pone.0082752	http://dx.doi.org/10.1371/journal.pone.0082752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349354	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800077
J	Mawatari, S; Uto, H; Ido, A; Nakashima, K; Suzuki, T; Kanmura, S; Kumagai, K; Oda, K; Tabu, K; Tamai, T; Moriuchi, A; Oketani, M; Shimada, Y; Sudoh, M; Shoji, I; Tsubouchi, H				Mawatari, Seiichi; Uto, Hirofumi; Ido, Akio; Nakashima, Kenji; Suzuki, Tetsuro; Kanmura, Shuji; Kumagai, Kotaro; Oda, Kohei; Tabu, Kazuaki; Tamai, Tsutomu; Moriuchi, Akihiro; Oketani, Makoto; Shimada, Yuko; Sudoh, Masayuki; Shoji, Ikuo; Tsubouchi, Hirohito			Hepatitis C Virus NS3/4A Protease Inhibits Complement Activation by Cleaving Complement Component 4	PLOS ONE			English	Article							IMMUNE-RESPONSES; IMMUNOLOGY; INFECTION; CARRIERS; EVASION; LYSIS; HOST	Background: It has been hypothesized that persistent hepatitis C virus (HCV) infection is mediated in part by viral proteins that abrogate the host immune response, including the complement system, but the precise mechanisms are not well understood. We investigated whether HCV proteins are involved in the fragmentation of complement component 4 (C4), composed of subunits C4 alpha, C4 beta, and C4 gamma, and the role of HCV proteins in complement activation. Methods: Human C4 was incubated with HCV nonstructural (NS) 3/4A protease, core, or NS5. Samples were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then subjected to peptide sequencing. The activity of the classical complement pathway was examined using an erythrocyte hemolysis assay. The cleavage pattern of C4 in NS3/4A-expressing and HCV-infected cells, respectively, was also examined. Results: HCV NS3/4A protease cleaved C4 gamma in a concentration-dependent manner, but viral core and NS5 did not. A specific inhibitor of NS3/4A protease reduced C4 gamma cleavage. NS3/4A protease-mediated cleavage of C4 inhibited classical pathway activation, which was abrogated by a NS3/4A protease inhibitor. In addition, co-transfection of cells with C4 and wild-type NS3/4A, but not a catalytic-site mutant of NS3/4A, produced cleaved C4 gamma fragments. Such C4 processing, with a concomitant reduction in levels of full-length C4 gamma, was also observed in HCV-infected cells expressing C4. Conclusions: C4 is a novel cellular substrate of the HCV NS3/4A protease. Understanding disturbances in the complement system mediated by NS3/4A protease may provide new insights into the mechanisms underlying persistent HCV infection.	[Mawatari, Seiichi; Uto, Hirofumi; Ido, Akio; Kanmura, Shuji; Kumagai, Kotaro; Oda, Kohei; Tabu, Kazuaki; Tamai, Tsutomu; Moriuchi, Akihiro; Oketani, Makoto] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Kagoshima 890, Japan; [Nakashima, Kenji; Suzuki, Tetsuro] Hamamatsu Univ, Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka 4312102, Japan; [Shimada, Yuko] Miyazaki Prefectural Ind Support Fdn, Miyazaki, Japan; [Sudoh, Masayuki] Chugai Pharmaceut Co Ltd, Kamakura Res Div, Kamakura, Kanagawa, Japan; [Shoji, Ikuo] Kobe Univ, Grad Sch Med, Div Microbiol, Kobe, Hyogo 657, Japan; [Tsubouchi, Hirohito] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept HGF Tissue Repair & Regenerat Med, Kagoshima 890, Japan	Kagoshima University; Hamamatsu University School of Medicine; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Kobe University; Kagoshima University	Uto, H (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human & Environm Sci, Kagoshima 890, Japan.	hirouto@m2.kufm.kagoshima-u.ac.jp	Shoji, Ikuo/Y-7079-2019	Shoji, Ikuo/0000-0002-0730-4379	Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Miyazaki Prefecture Collaboration of Regional Entities for the Advancement of Technological Excellence	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Miyazaki Prefecture Collaboration of Regional Entities for the Advancement of Technological Excellence	This study was supported by a Grant-in-Aid for Research on Hepatitis and BSE from the Ministry of Health, Labour and Welfare of Japan; a grant for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and a grant from the Miyazaki Prefecture Collaboration of Regional Entities for the Advancement of Technological Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amet T, 2012, HEPATOLOGY, V55, P354, DOI 10.1002/hep.24686; ANDOH A, 1993, J IMMUNOL, V151, P4239; Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750; Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545; Banerjee A, 2011, J VIROL, V85, P4157, DOI 10.1128/JVI.02449-10; Barnaba V, 2010, J HEPATOL, V53, P752, DOI 10.1016/j.jhep.2010.06.003; BARTENSCHLAGER R, 1995, J VIROL, V69, P198, DOI 10.1128/JVI.69.1.198-205.1995; Blom AM, 2004, SCAND J CLIN LAB INV, V64, P479, DOI 10.1080/00365510410002904; CHAN AC, 1983, J CLIN INVEST, V72, P1639, DOI 10.1172/JCI111123; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Imakiire K, 2012, MOL MED REP, V6, P259, DOI 10.3892/mmr.2012.924; Kapadia SB, 2002, IMMUNITY, V17, P143, DOI 10.1016/S1074-7613(02)00369-2; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Matsui C, 2012, J VIROL, V86, P12903, DOI 10.1128/JVI.01418-12; MATTSSON L, 1991, SCAND J GASTROENTERO, V26, P1257, DOI 10.3109/00365529108998622; Mazumdar B, 2012, J VIROL, V86, P2221, DOI 10.1128/JVI.06577-11; Mehlhop E, 2006, J EXP MED, V203, P1371, DOI 10.1084/jem.20052388; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Morikawa K, 2011, J VIRAL HEPATITIS, V18, P305, DOI 10.1111/j.1365-2893.2011.01451.x; Moulton EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000249; Murayama A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000885; Persico M, 2006, J VIRAL HEPATITIS, V13, P290, DOI 10.1111/j.1365-2893.2005.00667.x; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sullivan BL, 1996, J IMMUNOL, V157, P1791; Terajima M, 2011, J VIROL, V85, P13463, DOI 10.1128/JVI.05193-11; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406	27	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82094	10.1371/journal.pone.0082094	http://dx.doi.org/10.1371/journal.pone.0082094			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349192	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800038
J	Chandra, H; Yadav, E; Yadav, JS				Chandra, Harish; Yadav, Ekta; Yadav, Jagjit S.			Alveolar Macrophage Innate Response to Mycobacterium immunogenum, the Etiological Agent of Hypersensitivity Pneumonitis: Role of JNK and p38 MAPK Pathways	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; METALWORKING FLUIDS; LEGIONELLA-PNEUMOPHILA; HUMAN NEUTROPHILS; INFLAMMASOME; CELLS; TUBERCULOSIS; EXPRESSION	Mycobacterium immunogenum is an emerging pathogen of the immune-mediated lung disease hypersensitivity pneumonitis (HP) reported in machinists occupationally exposed to contaminated metal working fluid (MWF). However, the mechanism of its interaction with the host lung is unclear. Considering that alveolar macrophages play a central role in host defense in the exposed lung, understanding their interaction with the pathogen could provide initial insights into the underlying immunopathogenesis events and mechanisms. In the current study, M. immunogenum 700506, a predominant genotype isolated from HP-linked fluids, was shown to multiply intracellularly, induce proinflammatory mediators (TNF-alpha, IL-1 alpha, IL-1 beta, IL-6, GM-CSF, NO) and cause cytotoxicity/cell death in the cultured murine alveolar macrophage cell line MH-S in a dose-and time-dependent manner. The responses were detected as early as 3h post-infection. Comparison of this and four additional genotypes of M. immunogenum (MJY-3, MJY-4, MJY-12, MJY-14) using an effective dose-time combination (100 MOI for 24h) showed these macrophage responses in the following order (albeit with some variations for individual response indicators). Inflammatory: MJY-3 >= 700506 > MJY-4 >= MJY-14 >= MJY-12; Cytotoxic: 700506 >= MJY-3 > MJY-4 >= MJY-12 >= MJY-14. In general, 700506 and MJY-3 showed a more aggressive response than other genotypes. Chemical blocking of either p38 or JNK inhibited the induction of proinflammatory mediators (cytokines, NO) by 700506. However, the cellular responses showed a somewhat opposite effect. This is the first report on M. immunogenum interactions with alveolar macrophages and on the identification of JNK- and p38- mediated signaling and its role in mediating the proinflammatory responses during these interactions.	[Chandra, Harish; Yadav, Ekta; Yadav, Jagjit S.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Microbial Pathogenesis Lab, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Yadav, JS (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Microbial Pathogenesis Lab, Cincinnati, OH 45267 USA.	jagjit.yadav@uc.edu	Yadav, Jagjit S./AAN-8805-2020; chandra, Harish/GQB-5139-2022; Yadav, Ekta/ABC-7392-2020	Yadav, Jagjit S./0000-0001-5036-3609; 	National Institute of Occupational Safety and Health (NIOSH), the Centers for Disease Control and Prevention (CDC) [2R01OH007364]; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [R01OH007364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006096] Funding Source: NIH RePORTER	National Institute of Occupational Safety and Health (NIOSH), the Centers for Disease Control and Prevention (CDC); NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grant 2R01OH007364 (to JSY) from the National Institute of Occupational Safety and Health (NIOSH), the Centers for Disease Control and Prevention (CDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JL, 2001, PROGR MED CHEM, V38, P1, DOI 10.1016/S0079-6468(08)70091-2; Beckett W, 2005, ENVIRON HEALTH PERSP, V113, P767, DOI 10.1289/ehp.7727; BLANCHARD DK, 1989, J LEUKOCYTE BIOL, V45, P538, DOI 10.1002/jlb.45.6.538; BLANCHARD DK, 1987, INFECT IMMUN, V55, P433, DOI 10.1128/IAI.55.2.433-437.1987; Blumenthal A, 2005, INFECT IMMUN, V73, P3330, DOI 10.1128/IAI.73.6.3330-3341.2005; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Falkinham Joseph O, 2003, Can J Infect Dis, V14, P281; Gordon T, 2006, INHAL TOXICOL, V18, P449, DOI 10.1080/08958370600563904; Gudmundsson G, 1998, AM J RESP CELL MOL, V19, P812, DOI 10.1165/ajrcmb.19.5.3153; Hasan Z, 2003, TUBERCULOSIS, V83, P299, DOI 10.1016/S1472-9792(03)00003-9; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Khan IUH, 2005, FEMS MICROBIOL ECOL, V54, P329, DOI 10.1016/j.femsec.2005.04.009; Lacasse Y, 2012, CHEST, V142, P208, DOI 10.1378/chest.11-2479; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; Lee SB, 2005, INFECT IMMUN, V73, P6499, DOI 10.1128/IAI.73.10.6499-6507.2005; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Matsunaga K, 2001, AM J RESP CELL MOL, V24, P326, DOI 10.1165/ajrcmb.24.3.4359; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Perskvist N, 2002, J IMMUNOL, V168, P6358, DOI 10.4049/jimmunol.168.12.6358; Perskvist N, 2000, J IMMUNOL, V164, P959, DOI 10.4049/jimmunol.164.2.959; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3; Regan AD, 2009, VIROLOGY, V384, P135, DOI 10.1016/j.virol.2008.11.006; Ren T, 2006, PLOS PATHOG, V2, P175, DOI 10.1371/journal.ppat.0020018; Rosenman KD, 2009, CURR OPIN ALLERGY CL, V9, P97, DOI 10.1097/ACI.0b013e3283229f96; Sampaio EP, 2008, AM J RESP CELL MOL, V39, P431, DOI 10.1165/rcmb.2007-0413OC; Seimon TA, 2009, J CLIN INVEST, V119, P886, DOI 10.1172/JCI37262; Shelton BG, 1999, EMERG INFECT DIS, V5, P270, DOI 10.3201/eid0502.990213; Souza CD, 2007, AM J VET RES, V68, P625, DOI 10.2460/ajvr.68.6.625; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Suzuki T, 2007, PLOS PATHOG, V3, P1082, DOI 10.1371/journal.ppat.0030111; Svensson C, 2011, BIOCHEM BIOPH RES CO, V406, P488, DOI 10.1016/j.bbrc.2011.02.083; Thorne PS, 2006, AM J RESP CRIT CARE, V173, P759, DOI 10.1164/rccm.200405-627OC; Tillie-Leblond I, 2011, EUR RESPIR J, V37, P640, DOI 10.1183/09031936.00195009; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Trout Douglas, 2003, Appl Occup Environ Hyg, V18, P953; Wallace RJ, 2002, APPL ENVIRON MICROB, V68, P5580, DOI 10.1128/AEM.68.11.5580-5584.2002; Wen J, 2008, J HEALTH SCI, V54, P129, DOI 10.1248/jhs.54.129; Wilson RW, 2001, INT J SYST EVOL MICR, V51, P1751, DOI 10.1099/00207713-51-5-1751; Yadav Jagjit S, 2003, Appl Occup Environ Hyg, V18, P966; Yadav M, 2006, J IMMUNOL, V176, P5494, DOI 10.4049/jimmunol.176.9.5494; Zhang Y, 2005, J IMMUNOL, V174, P7939, DOI 10.4049/jimmunol.174.12.7939	45	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83172	10.1371/journal.pone.0083172	http://dx.doi.org/10.1371/journal.pone.0083172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349452	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300136
J	DeNardo, BD; Holloway, MP; Ji, QQ; Nguyen, KT; Cheng, Y; Valentine, MB; Salomon, A; Altura, RA				DeNardo, Bradley D.; Holloway, Michael P.; Ji, Qinqin; Nguyen, Kevin T.; Cheng, Yan; Valentine, Marcus B.; Salomon, Arthur; Altura, Rachel A.			Quantitative Phosphoproteomic Analysis Identifies Activation of the RET and IGF-1R/IR Signaling Pathways in Neuroblastoma	PLOS ONE			English	Article							GROWTH-FACTOR-I; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; SMALL-MOLECULE INHIBITOR; THERAPEUTIC TARGET; MASS-SPECTROMETRY; RETINOIC ACID; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; PEDIATRIC-PATIENTS; VANDETANIB ZD6474; MAMMALIAN TARGET	Neuroblastoma is an embryonal tumor of childhood with a heterogenous clinical presentation that reflects differences in activation of complex biological signaling pathways. Protein phosphorylation is a key component of cellular signal transduction and plays a critical role in processes that control cancer cell growth and survival. We used shotgun LC/MS to compare phosphorylation between a human MYCN amplified neuroblastoma cell line (NB10), modeling a resistant tumor, and a human neural precursor cell line (NPC), modeling a normal baseline neural crest cell. 2181 unique phosphorylation sites representing 1171 proteins and 2598 phosphopeptides were found. Protein kinases accounted for 6% of the proteome, with a predominance of tyrosine kinases, supporting their prominent role in oncogenic signaling pathways. Highly abundant receptor tyrosine kinase (RTK) phosphopeptides in the NB10 cell line relative to the NPC cell line included RET, insulin-like growth factor 1 receptor/insulin receptor (IGF-1R/IR), and fibroblast growth factor receptor 1 (FGFR1). Multiple phosphorylated peptides from downstream mediators of the PI3K/AKT/mTOR and RAS pathways were also highly abundant in NB10 relative to NPC. Our analysis highlights the importance of RET, IGF-1R/IR and FGFR1 as RTKs in neuroblastoma and suggests a methodology that can be used to identify potential novel biological therapeutic targets. Furthermore, application of this previously unexploited technology in the clinic opens the possibility of providing a new wide-scale molecular signature to assess disease progression and prognosis.	[DeNardo, Bradley D.; Holloway, Michael P.; Nguyen, Kevin T.; Cheng, Yan; Altura, Rachel A.] Brown Univ, Dept Pediat, Warren Albert Sch Med, Div Pediat Hematol Oncol, Providence, RI 02912 USA; [Ji, Qinqin] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Valentine, Marcus B.] St Jude Childrens Res Hosp, St Jude Comprehens Canc Ctr Cytogenet Shared Reso, Memphis, TN 38105 USA; [Salomon, Arthur] Brown Univ, Dept Mol & Cellular Biochem, Providence, RI 02912 USA	Brown University; Brown University; St Jude Children's Research Hospital; Brown University	Altura, RA (corresponding author), Brown Univ, Dept Pediat, Warren Albert Sch Med, Div Pediat Hematol Oncol, Providence, RI 02912 USA.	rachel_altura@brown.edu			Hyundai Hope on Wheels Foundation; National Institute Of General Medical Sciences of the National Institutes of Health [P20GM103421]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103421] Funding Source: NIH RePORTER	Hyundai Hope on Wheels Foundation; National Institute Of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Hyundai Hope on Wheels Foundation (RAA) and by the National Institute Of General Medical Sciences of the National Institutes of Health under Award Number P20GM103421 (RAA, MPH, YC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi N, 2012, MOL CANCER THER, V11, P2644, DOI 10.1158/1535-7163.MCT-12-0447; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Barrett D, 2012, PEDIATR DRUGS, V14, P299, DOI 10.2165/11594740-000000000-00000; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Baserga R, 2003, INT J CANCER, V107, P873, DOI 10.1002/ijc.11487; Beaudry P, 2008, MOL CANCER THER, V7, P418, DOI 10.1158/1535-7163.MCT-07-0568; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Belfiore A, 2007, CURR PHARM DESIGN, V13, P671, DOI 10.2174/138161207780249173; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; BORRELLO MG, 1993, INT J CANCER, V54, P540, DOI 10.1002/ijc.2910540404; Buck E, 2010, MOL CANCER THER, V9, P2652, DOI 10.1158/1535-7163.MCT-10-0318; Burris HA, 2013, CANCER CHEMOTH PHARM, V71, P829, DOI 10.1007/s00280-012-2043-3; Cao L, 2007, J IMMUNOL, V179, P5864, DOI 10.4049/jimmunol.179.9.5864; Carboni JM, 2009, MOL CANCER THER, V8, P3341, DOI 10.1158/1535-7163.MCT-09-0499; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Cerchia L, 2006, MOL CANCER RES, V4, P481, DOI 10.1158/1541-7786.MCR-06-0050; CHANTHERY YH, 2012, SCI TRANSL MED, V4, P18692; Chen QR, 2010, J PROTEOME RES, V9, P373, DOI 10.1021/pr900701v; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Choudhary C, 2010, NAT REV MOL CELL BIO, V11, P427, DOI 10.1038/nrm2900; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Cole KA, 2012, CLIN CANCER RES, V18, P2423, DOI 10.1158/1078-0432.CCR-11-1409; Cole KA, 2011, P NATL ACAD SCI USA, V108, P3336, DOI 10.1073/pnas.1012351108; Del Rosario AM, 2010, CURR OPIN GENET DEV, V20, P23, DOI 10.1016/j.gde.2009.12.005; Demirkan G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021729; Dephoure N, 2011, METHODS, V54, P379, DOI 10.1016/j.ymeth.2011.03.008; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; FORRESTER K, 1987, NATURE, V327, P298, DOI 10.1038/327298a0; Fox E, 2013, CLIN CANCER RES, V19, P4239, DOI 10.1158/1078-0432.CCR-13-0071; Fulda S, 2009, CURR CANCER DRUG TAR, V9, P729, DOI 10.2174/156800909789271521; Futami H, 2009, CANCER SCI, V100, P1034, DOI 10.1111/j.1349-7006.2009.01143.x; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172; Haapasalo A, 2001, BIOCHEM BIOPH RES CO, V280, P1352, DOI 10.1006/bbrc.2001.4296; Helou YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069641; Hishiki T, 1998, CANCER RES, V58, P2158; Ho R, 2002, CANCER RES, V62, P6462; Holzel M, 2010, CELL, V142, P218, DOI 10.1016/j.cell.2010.06.004; Hou XN, 2011, CANCER RES, V71, P7597, DOI 10.1158/0008-5472.CAN-11-1080; Houghton PJ, 2010, PEDIATR BLOOD CANCER, V54, P921, DOI 10.1002/pbc.22367; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; HUNG CM, 2012, COLD SPRING HARB PER, V4, P24837; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; IKEDA I, 1990, ONCOGENE, V5, P1291; IWAMOTO T, 1993, BRIT J CANCER, V67, P504, DOI 10.1038/bjc.1993.94; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jasty R, 2001, NEOPLASIA, V3, P304, DOI 10.1038/sj.neo.7900171; Johnsen JI, 2008, ONCOGENE, V27, P2910, DOI 10.1038/sj.onc.1210938; KATOH M, 2013, MED RES REV, DOI DOI 10.1002/MED.21288.PUBMED:23696246; Kim B, 2004, ONCOGENE, V23, P130, DOI 10.1038/sj.onc.1206924; Kim B, 2009, APOPTOSIS, V14, P665, DOI 10.1007/s10495-009-0331-0; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Lingohr MK, 2002, DIABETES, V51, P966, DOI 10.2337/diabetes.51.4.966; Liu BA, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-27; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Magrassi L, 2005, ONCOGENE, V24, P5198, DOI 10.1038/sj.onc.1208708; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Marshall GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002135; Marshall GM, 1997, CANCER RES, V57, P5399; Massoner P, 2010, BRIT J CANCER, V103, P1479, DOI 10.1038/sj.bjc.6605932; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Megison ML, 2013, CLIN EXP METASTAS, V30, P555, DOI 10.1007/s10585-012-9560-7; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Misawa A, 2000, CANCER RES, V60, P64; Modak S, 2010, CANCER TREAT REV, V36, P307, DOI 10.1016/j.ctrv.2010.02.006; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Morabito A, 2009, ONCOLOGIST, V14, P378, DOI 10.1634/theoncologist.2008-0261; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2013, LANCET ONCOL, V14, P472, DOI 10.1016/S1470-2045(13)70095-0; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; NAGAO M, 1990, JPN J CANCER RES, V81, P309, DOI 10.1111/j.1349-7006.1990.tb02566.x; Nguyen LB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002026; Nguyen V, 2009, MOL CELL PROTEOMICS, V8, P2418, DOI 10.1074/mcp.M800307-MCP200; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Oberthuer A, 2010, J CLIN ONCOL, V28, P3506, DOI 10.1200/JCO.2009.27.3367; Owonikoko TK, 2013, AM SOC CLIN ONCOL ED, V2013, P395, DOI DOI 10.1200/EDB00K_; Park JR, 2010, HEMATOL ONCOL CLIN N, V24, P65, DOI 10.1016/j.hoc.2009.11.011; Pelicci G, 2002, MOL CELL BIOL, V22, P7351, DOI 10.1128/MCB.22.20.7351-7363.2002; Pene F, 2002, ONCOGENE, V21, P6587, DOI 10.1038/sj.onc.1205923; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Perrinjaquet M, 2010, J BIOL CHEM, V285, P31867, DOI 10.1074/jbc.M110.144923; Phay JE, 2010, CLIN CANCER RES, V16, P5936, DOI 10.1158/1078-0432.CCR-09-0786; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Previs SF, 2000, J BIOL CHEM, V275, P38990, DOI 10.1074/jbc.M006490200; Ptacek J, 2006, TRENDS GENET, V22, P545, DOI 10.1016/j.tig.2006.08.005; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Radi M, 2011, BIOORG MED CHEM LETT, V21, P5928, DOI 10.1016/j.bmcl.2011.07.079; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Russell MR, 2013, CANCER RES, V73, P776, DOI 10.1158/0008-5472.CAN-12-2669; Salm F, 2013, ONCOGENE, V32, P3944, DOI 10.1038/onc.2012.416; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schramm A, 2005, CANCER LETT, V228, P143, DOI 10.1016/j.canlet.2005.02.051; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Spunt SL, 2011, J CLIN ONCOL, V29, P2933, DOI 10.1200/JCO.2010.33.4649; Steelman LS, 2004, LEUKEMIA, V18, P189, DOI 10.1038/sj.leu.2403241; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tanno B, 2006, CLIN CANCER RES, V12, P6772, DOI 10.1158/1078-0432.CCR-06-1479; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tian W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067929; Tonini GP, 2012, CANCER LETT, V326, P128, DOI 10.1016/j.canlet.2012.08.017; Trochet D, 2004, AM J HUM GENET, V74, P761, DOI 10.1086/383253; Vadas O, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002165; van Golen CM, 2006, CANCER RES, V66, P6570, DOI 10.1158/0008-5472.CAN-05-1448; Vermeulen J, 2009, LANCET ONCOL, V10, P663, DOI 10.1016/S1470-2045(09)70154-8; Vogt PK, 2011, CURR TOP MICROBIOL, V347, P79, DOI 10.1007/82_2010_80; Wang K, 2011, NATURE, V469, P216, DOI 10.1038/nature09609; Wick MJ, 2003, J BIOL CHEM, V278, P42913, DOI 10.1074/jbc.M304172200; Wojtalla A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047109; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yoshikawa D, 2009, BRIT J CANCER, V100, P1257, DOI 10.1038/sj.bjc.6604988; Yu KB, 2010, PROTEOMICS, V10, P2113, DOI 10.1002/pmic.200900159; Yu KB, 2009, PROTEOMICS, V9, P5350, DOI 10.1002/pmic.200900119; Zage PE, 2010, CANCER-AM CANCER SOC, V116, P2465, DOI 10.1002/cncr.25017	124	22	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82513	10.1371/journal.pone.0082513	http://dx.doi.org/10.1371/journal.pone.0082513			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349301	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300094
J	Fan, XB; Zhang, QN; Li, S; Lv, YF; Su, HQ; Jiang, HP; Hao, ZM				Fan, Xiaobao; Zhang, Qiannan; Li, Shuang; Lv, Yifei; Su, Houqiang; Jiang, Huiping; Hao, Zhiming			Attenuation of CCl4-Induced Hepatic Fibrosis in Mice by Vaccinating against TGF-beta 1	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LIVER FIBROSIS; CANCER VACCINE; LUNG-CANCER; II RECEPTOR; TNF-ALPHA; INHIBITION; IMMUNIZATION; ANGIOGENESIS; DYSFUNCTION	Transforming growth factor beta 1 (TGF-beta 1) is the pivotal pro-fibrogenic cytokine in hepatic fibrosis. Reducing the over-produced expression of TGF-beta 1 or blocking its signaling pathways is considered to be a promising therapeutic strategy for hepatic fibrosis. In this study, we evaluated the feasibility of attenuating hepatic fibrosis by vaccination against TGF-beta 1 with TGF-beta 1 kinoids. Two TGF-beta 1 kinoid vaccines were prepared by cross-linking TGF-beta 1-derived polypeptides (TGF-beta 1(25)-[41-65] and TGF-beta 1(30)-[83-112]) to keyhole limpet hemocyanin (KLH). Immunization with the two TGF-beta 1 kinoids efficiently elicited the production of high-levels of TGF-beta 1-specific antibodies against in BALB/c mice as tested by enzyme-linked immunosorbent assay (ELISA) and Western blotting. The antisera neutralized TGF-beta 1-induced growth-inhibition on mink lung epithelial cells (Mv1Lu) and attenuated TGF-beta 1-induced Smad2/3 phosphorylation, alpha-SMA, collagen type 1 alpha 2 (COL1A2), plasminogen activator inhibitor-1 (PAI-1) and tissue inhibitor of metalloproteinase-1 (TIMP-1) expression in the rat hepatic stellate cell (HSC) line, HSC-T6. Vaccination against TGF-beta 1 with the kinoids significantly suppressed CCl4-induced collagen deposition and the expression of alpha-SMA and desmin, attenuated hepatocyte apoptosis and accelerated hepatocyte proliferation in BALB/c mice. These results demonstrated that immunization with the TGF-beta 1 kinoids efficiently attenuated CCl4-induced hepatic fibrosis and liver injury. Our study suggests that vaccination against TGF-beta 1 might be developed into a feasible therapeutic approach for the treatment of chronic fibrotic liver diseases.	[Fan, Xiaobao; Zhang, Qiannan; Li, Shuang; Lv, Yifei; Su, Houqiang; Jiang, Huiping; Hao, Zhiming] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Gastroenterol, Xian 710049, Peoples R China	Xi'an Jiaotong University	Hao, ZM (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Dept Gastroenterol, Xian 710049, Peoples R China.	haozhm66@hotmail.com			National Foundation of Natural Sciences, China [30871144, 81070351]	National Foundation of Natural Sciences, China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Foundation of Natural Sciences, China (No. 30871144 and No. 81070351). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLARDINI G, 1988, VIRCHOWS ARCH B, V56, P45, DOI 10.1007/BF02890000; BORDER WA, 1990, NATURE, V346, P371, DOI 10.1038/346371a0; Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4; Cheng K, 2009, MOL PHARMACEUT, V6, P772, DOI 10.1021/mp9000469; Cheong HJ, 2006, VACCINE, V24, P2417, DOI 10.1016/j.vaccine.2005.11.064; Dalum I, 1999, NAT BIOTECHNOL, V17, P666, DOI 10.1038/10878; Dalum I, 1996, J IMMUNOL, V157, P4796; Delavallee L, 2008, ANN RHEUM DIS, V67, P1332, DOI 10.1136/ard.2007.079137; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; George J, 1999, P NATL ACAD SCI USA, V96, P12719, DOI 10.1073/pnas.96.22.12719; GIRI SN, 1993, THORAX, V48, P959, DOI 10.1136/thx.48.10.959; Gonzalez G, 2003, ANN ONCOL, V14, P461, DOI 10.1093/annonc/mdg102; Gonzalez G, 1998, ANN ONCOL, V9, P431, DOI 10.1023/A:1008261031034; Gonzalez G, 2007, HUM VACCINES, V3, P8, DOI 10.4161/hv.3.1.3537; Hao ZM, 2012, J PHARMACOL EXP THER, V342, P835, DOI 10.1124/jpet.112.194357; Holmgren L, 2006, P NATL ACAD SCI USA, V103, P9208, DOI 10.1073/pnas.0603110103; Huang SS, 1999, J BIOL CHEM, V274, P27754, DOI 10.1074/jbc.274.39.27754; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kanzler S, 1999, AM J PHYSIOL-GASTR L, V276, pG1059, DOI 10.1152/ajpgi.1999.276.4.G1059; Kinoshita K, 2007, GUT, V56, P706, DOI 10.1136/gut.2006.092460; Le Buanec H, 2006, P NATL ACAD SCI USA, V103, P19442, DOI 10.1073/pnas.0604827103; Ling H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054499; Nakamura T, 2000, HEPATOLOGY, V32, P247, DOI 10.1053/jhep.2000.9109; Vinageras EN, 2008, J CLIN ONCOL, V26, P1452, DOI 10.1200/JCO.2007.11.5980; OBERHAMMER F, 1993, HEPATOLOGY, V18, P1238; Okuno M, 2001, GASTROENTEROLOGY, V120, P1784, DOI 10.1053/gast.2001.24832; Qi Z, 1999, P NATL ACAD SCI USA, V96, P2345, DOI 10.1073/pnas.96.5.2345; Qian SW, 1996, J BIOL CHEM, V271, P30656, DOI 10.1074/jbc.271.48.30656; Rad FH, 2007, P NATL ACAD SCI USA, V104, P2837, DOI 10.1073/pnas.0611022104; Reddy GK, 1996, CLIN BIOCHEM, V29, P225, DOI 10.1016/0009-9120(96)00003-6; RUSSELL WE, 1988, P NATL ACAD SCI USA, V85, P5126, DOI 10.1073/pnas.85.14.5126; San-Martin A, 2010, AESTHET PLAST SURG, V34, P430, DOI 10.1007/s00266-010-9475-0; Spohn G, 2008, EUR J IMMUNOL, V38, P877, DOI 10.1002/eji.200737989; Thompson Alexander James, 2010, Curr Gastroenterol Rep, V12, P23, DOI 10.1007/s11894-009-0080-9; Tohyama S, 2008, GENE THER, V15, P1513, DOI 10.1038/gt.2008.112; Ueno H, 2000, HUM GENE THER, V11, P33, DOI 10.1089/10430340050016139; Yata Y, 2002, HEPATOLOGY, V35, P1022, DOI 10.1053/jhep.2002.32673; Zagury D, 2003, CYTOKINE GROWTH F R, V14, P123, DOI 10.1016/S1359-6101(03)00004-2; Zagury D, 1999, BIOMED PHARMACOTHER, V53, P90, DOI 10.1016/S0753-3322(99)80065-1; Zagury D, 2001, P NATL ACAD SCI USA, V98, P8024, DOI 10.1073/pnas.141224798	40	25	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82190	10.1371/journal.pone.0082190	http://dx.doi.org/10.1371/journal.pone.0082190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349218	gold, Green Submitted, Green Published			2022-12-27	WOS:000328730300084
J	Lopes, P; Nunes, T; Campos, D; Furlong, LI; Bauer-Mehren, A; Sanz, F; Carrascosa, MC; Mestres, J; Kors, J; Singh, B; van Mulligen, E; Van der Lei, J; Diallo, G; Avillach, P; Ahlberg, E; Boyer, S; Diaz, C; Oliveira, JL				Lopes, Pedro; Nunes, Tiago; Campos, David; Ines Furlong, Laura; Bauer-Mehren, Anna; Sanz, Ferran; Carmen Carrascosa, Maria; Mestres, Jordi; Kors, Jan; Singh, Bharat; van Mulligen, Erik; Van der Lei, Johan; Diallo, Gayo; Avillach, Paul; Ahlberg, Ernst; Boyer, Scott; Diaz, Carlos; Oliveira, Jose Luis			Gathering and Exploring Scientific Knowledge in Pharmacovigilance	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; HEALTH-CARE; SIGNAL-DETECTION; DESIGN; IDENTIFICATION; CHALLENGES; DATABASES; NETWORK; PROJECT; FOOD	Pharmacovigilance plays a key role in the healthcare domain through the assessment, monitoring and discovery of interactions amongst drugs and their effects in the human organism. However, technological advances in this field have been slowing down over the last decade due to miscellaneous legal, ethical and methodological constraints. Pharmaceutical companies started to realize that collaborative and integrative approaches boost current drug research and development processes. Hence, new strategies are required to connect researchers, datasets, biomedical knowledge and analysis algorithms, allowing them to fully exploit the true value behind state-of-the-art pharmacovigilance efforts. This manuscript introduces a new platform directed towards pharmacovigilance knowledge providers. This system, based on a service-oriented architecture, adopts a plugin-based approach to solve fundamental pharmacovigilance software challenges. With the wealth of collected clinical and pharmaceutical data, it is now possible to connect knowledge providers' analysis and exploration algorithms with real data. As a result, new strategies allow a faster identification of high-risk interactions between marketed drugs and adverse events, and enable the automated uncovering of scientific evidence behind them. With this architecture, the pharmacovigilance field has a new platform to coordinate large-scale drug evaluation efforts in a unique ecosystem, publicly available at http://bioinformatics.ua.pt/euadr/.	[Lopes, Pedro; Nunes, Tiago; Campos, David; Oliveira, Jose Luis] Univ Aveiro, DETI IEETA, P-3800 Aveiro, Portugal; [Ines Furlong, Laura; Bauer-Mehren, Anna; Sanz, Ferran; Carmen Carrascosa, Maria; Mestres, Jordi] IMIM Hosp Mar Res Inst, Res Programme Biomed Informat GRIB, Barcelona, Spain; [Ines Furlong, Laura; Bauer-Mehren, Anna; Sanz, Ferran; Carmen Carrascosa, Maria; Mestres, Jordi] Univ Pompeu Fabra, Barcelona, Spain; [Kors, Jan; Singh, Bharat; van Mulligen, Erik; Van der Lei, Johan] Erasmus MC, Rotterdam, Netherlands; [Diallo, Gayo; Avillach, Paul] Univ Bordeaux, LESIM ISPED, Bordeaux, France; [Avillach, Paul] Univ Aix Marseille, Fac Med, LERTIM, EA 3283, Marseille, France; [Ahlberg, Ernst; Boyer, Scott] AstraZeneca, Molndal, Sweden; [Diaz, Carlos] Synapse Res Management Partners, Barcelona, Spain	Universidade de Aveiro; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Pompeu Fabra University; Erasmus University Rotterdam; Erasmus MC; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Aix-Marseille Universite; AstraZeneca	Oliveira, JL (corresponding author), Univ Aveiro, DETI IEETA, P-3800 Aveiro, Portugal.	jlo@ua.pt	Sanz, Ferran/B-3852-2009; Mestres, Jordi/B-3673-2009; Oliveira, José Luis/A-2223-2012; Diallo, Gayo/T-2106-2019; Gasull, Martina/J-4076-2019; Furlong, Laura I./AAX-1376-2020; Campos, David/N-2461-2013	Sanz, Ferran/0000-0002-7534-7661; Mestres, Jordi/0000-0002-5202-4501; Oliveira, José Luis/0000-0002-6672-6176; Diallo, Gayo/0000-0002-9799-9484; Furlong, Laura I./0000-0002-9383-528X; van Mulligen, Erik/0000-0003-1377-9386; Campos, David/0000-0002-3448-2111	European Commission (EU-ADR) [ICT-215847]; FCT [PTDC/EIA-CCO/100541/2008]; Instituto de Salud Carlos III FEDER [CP10/00524]	European Commission (EU-ADR)(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Instituto de Salud Carlos III FEDER(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by the European Commission (EU-ADR, ICT-215847), FCT (PTDC/EIA-CCO/100541/2008), and Instituto de Salud Carlos III FEDER (CP10/00524). The Research Programme on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Requejo A, 1998, EUR J CLIN PHARMACOL, V54, P483, DOI 10.1007/s002280050498; Avillach P, 2012, J AM MED INFORM ASSN; Avillach P, 2009, STUD HEALTH TECHNOL, V150, P190, DOI 10.3233/978-1-60750-044-5-190; Baker A, 2011, LECT NOTES COMPUT SC, V6779, P99, DOI 10.1007/978-3-642-21716-6_11; Bauer-Mehren A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002457; Behrman RE, 2011, NEW ENGL J MED, V364, P498, DOI 10.1056/NEJMp1014427; Chan KA, 2005, PHARMACOEPIDEM DR S, V14, P597, DOI 10.1002/pds.1128; Cheung KH, 2008, J BIOMED INFORM, V41, P694, DOI 10.1016/j.jbi.2008.04.001; Coloma PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072148; Coloma PM, 2012, PHARMACOEPIDEM DR S, V21, P611, DOI 10.1002/pds.3197; Coloma PM, 2011, PHARMACOEPIDEM DR S, V20, P1, DOI 10.1002/pds.2053; Curtis LH, 2012, PHARMACOEPIDEM DR S, V21, P23, DOI 10.1002/pds.2336; De Bruin ML, 2002, BRIT J CLIN PHARMACO, V53, P370, DOI 10.1046/j.1365-2125.2002.01569.x; de Leon J, 2011, J CLIN PSYCHOPHARM, V31, P263, DOI 10.1097/JCP.0b013e318218f3e4; Dudley JT, 2010, NAT BIOTECHNOL, V28, P1181, DOI 10.1038/nbt1110-1181; Eland IA, 1999, BRIT J CLIN PHARMACO, V48, P623; Ema Ema, 2010, ANN REPORT; Fu Y, 2010, ACM T MANAGE INF SYS, V1, P1; Gini R, 2013, 29 INT C PHARM THER; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Harmark L, 2008, EUR J CLIN PHARMACOL, V64, P743, DOI 10.1007/s00228-008-0475-9; Hollingsworth D., 1995, WORKFLOW REFERENCE M; Jamil H, 2008, IEEE CONGRESS ON SERVICES 2008, PT I, PROCEEDINGS, P453, DOI 10.1109/SERVICES-1.2008.73; Koh Hian Chye, 2005, J Healthc Inf Manag, V19, P64; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Lopes P, 2012, J BIOMED SEMANT, V3, DOI 10.1186/2041-1480-3-11; Ludascher B, 2006, CONCURR COMP-PRACT E, V18, P1039, DOI 10.1002/cpe.994; MCCLURE DL, 2009, PHARM MED, V23, P127; Meyboom RHB, 2002, DRUG SAFETY, V25, P459, DOI 10.2165/00002018-200225060-00011; Nelson JC, 2012, PHARMACOEPIDEM DR S, V21, P62, DOI 10.1002/pds.2324; Oliveira JL, 2012, EU ADR WEB PLATFORM; Papay J, 2012, PHARMACOEPIDEM DR S, V21, P289, DOI 10.1002/pds.2276; Petkov S, 2005, ASPECTS WORKFLOW MAN, P20; Platt R, 2012, PHARMACOEPIDEM DR S, V21, P1, DOI 10.1002/pds.2343; Platt R, 2009, NEW ENGL J MED, V361, P645, DOI 10.1056/NEJMp0905338; Robb MA, 2012, PHARMACOEPIDEM DR S, V21, P9, DOI 10.1002/pds.2311; Ryan PB, 2012, STAT MED, V31, P4401, DOI 10.1002/sim.5620; Schuemie MJ, 2011, PHARMACOEPIDEM DR S, V20, P292, DOI 10.1002/pds.2051; Shibata A, 2011, P 14 INT C INF FUS, P1; Sommet A, 2012, PHARMACOEPIDEM DR S, V21, P285, DOI 10.1002/pds.2307; Staffa JA, 2012, CLIN PHARMACOL THER, V91, P555, DOI 10.1038/clpt.2011.289; Stahl M, 2003, DRUG SAFETY, V26, P721; Stang PE, 2010, ANN INTERN MED, V153, P600, DOI 10.7326/0003-4819-153-9-201011020-00010; Trifiro G, 2011, STUD HEALTH TECHNOL, V166, P25, DOI 10.3233/978-1-60750-740-6-25; Trifiro G, 2009, STUD HEALTH TECHNOL, V148, P43, DOI 10.3233/978-1-60750-043-8-43; Trifiro G, 2009, PHARMACOEPIDEM DR S, V18, P1176, DOI 10.1002/pds.1836; Trontell AE, 2005, JAMA-J AM MED ASSOC, V294, P1206, DOI 10.1001/jama.294.10.1206-a; Vilar S, 2011, J AM MED INFORM ASSN, V18, pI73, DOI 10.1136/amiajnl-2011-000417; Wang K, 2010, ENTERP INF SYST-UK, V4, P225, DOI 10.1080/17517575.2010.498525; Wilke RA, 2011, CLIN PHARMACOL THER, V89, P379, DOI 10.1038/clpt.2010.260; Wilson AM, 2004, BRIT J CLIN PHARMACO, V57, P127, DOI 10.1046/j.1365-2125.2003.01968.x; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Xu L, 2011, J PHARM SCI-US, V100, P38, DOI 10.1002/jps.22243; Yu SC, 2010, IEEE INFOCOM SER, DOI 10.1109/INFCOM.2010.5462174; Zadeh L.A., 1986, AI MAG, V7, P85, DOI DOI 10.1609/AIMAG.V7I2.542; Zhang R, 2010, P 2010 IEEE 3 INT C, P268, DOI DOI 10.1109/TCC.2019.2923222	56	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83016	10.1371/journal.pone.0083016	http://dx.doi.org/10.1371/journal.pone.0083016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349421	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300121
J	Koh, EYC; Ho, SCL; Mariati; Song, ZW; Bi, XZ; Bardor, M; Yang, YS				Koh, Esther Y. C.; Ho, Steven C. L.; Mariati; Song, Zhiwei; Bi, Xuezhi; Bardor, Muriel; Yang, Yuansheng			An Internal Ribosome Entry Site (IRES) Mutant Library for Tuning Expression Level of Multiple Genes in Mammalian Cells	PLOS ONE			English	Article							ENCEPHALOMYOCARDITIS VIRUS-RNA; GATEWAY CLONE DESIGN; TRANSLATIONAL EFFICIENCY; ANTIBODY-PRODUCTION; HETEROLOGOUS GENES; LIVING CELLS; HEAVY-CHAIN; INITIATION; LIGHT; GENERATION	A set of mutated Encephalomyocarditis virus (EMCV) internal ribosome entry site (IRES) elements with varying strengths is generated by mutating the translation initiation codons of 10th, 11th, and 12th AUG to non-AUG triplets. They are able to control the relative expression of multiple genes over a wide range in mammalian cells in both transient and stable transfections. The relative strength of each IRES mutant remains similar in different mammalian cell lines and is not gene specific. The expressed proteins have correct molecular weights. Optimization of light chain over heavy chain expression by these IRES mutants enhances monoclonal antibody expression level and quality in stable transfections. Uses of this set of IRES mutants can be extended to other applications such as synthetic biology, investigating interactions between proteins and its complexes, cell engineering, multi-subunit protein production, gene therapy, and reprogramming of somatic cells into stem cells.	[Koh, Esther Y. C.; Ho, Steven C. L.; Mariati; Song, Zhiwei; Bi, Xuezhi; Bardor, Muriel; Yang, Yuansheng] Agcy Sci Technol & Res, Bioproc Technol Inst, Singapore, Singapore; [Bardor, Muriel] Univ Rouen, Lab GlycoMEV Glycobiol & Matrice Extracellulaire, Mont St Aignan, France; [Yang, Yuansheng] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); Universite de Rouen Normandie; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Yang, YS (corresponding author), Agcy Sci Technol & Res, Bioproc Technol Inst, Singapore, Singapore.	yang_yuansheng@bti.a-star.edu.sg	Bi, Xuezhi/A-8532-2015	Bi, Xuezhi/0000-0001-6702-0805; Ho, Steven C.L./0000-0002-5582-9057	Biomedical Research Council/Science and Engineering Research Council of A*STAR (Agency for Science, Technology and Research), Singapore	Biomedical Research Council/Science and Engineering Research Council of A*STAR (Agency for Science, Technology and Research), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council/Science and Engineering Research Council of A*STAR (Agency for Science, Technology and Research), Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieniossek C, 2012, TRENDS BIOCHEM SCI, V37, P49, DOI 10.1016/j.tibs.2011.10.005; Bochkov YA, 2006, BIOTECHNIQUES, V41, P283, DOI 10.2144/000112243; BORMAN AM, 1995, NUCLEIC ACIDS RES, V23, P3656, DOI 10.1093/nar/23.18.3656; Borman AM, 1997, NUCLEIC ACIDS RES, V25, P925, DOI 10.1093/nar/25.5.925; Bouabe H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1119; Chan HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028885; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; DAVIES MV, 1992, J VIROL, V66, P1924, DOI 10.1128/JVI.66.4.1924-1932.1992; Davies SL, 2011, BIOTECHNOL PROGR, V27, P1689, DOI 10.1002/btpr.692; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; de Felipe P, 2010, BIOTECHNOL J, V5, P213, DOI 10.1002/biot.200900134; de Quinto SL, 1998, GENE, V217, P51; DUKE GM, 1992, J VIROL, V66, P1602, DOI 10.1128/JVI.66.3.1602-1609.1992; Eszterhas SK, 2002, MOL CELL BIOL, V22, P469, DOI 10.1128/MCB.22.2.469-479.2002; Fallot S, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp716; Fussenegger M, 1998, CYTOTECHNOLOGY, V28, P111, DOI 10.1023/A:1008037916674; Gonzalez R, 2002, J THEOR BIOL, V214, P529, DOI 10.1006/jtbi.2001.2478; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Hennecke M, 2001, NUCLEIC ACIDS RES, V29, P3327, DOI 10.1093/nar/29.16.3327; Ho SCL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063247; Ho SCL, 2013, J BIOTECHNOL, V165, P157, DOI 10.1016/j.jbiotec.2013.03.019; Ho SCL, 2012, J BIOTECHNOL, V157, P130, DOI 10.1016/j.jbiotec.2011.09.023; KAMINSKI A, 1990, EMBO J, V9, P3753, DOI 10.1002/j.1460-2075.1990.tb07588.x; KAMINSKI A, 1994, EMBO J, V13, P1673, DOI 10.1002/j.1460-2075.1994.tb06431.x; Kaminski A, 1998, RNA, V4, P626, DOI 10.1017/S1355838298971898; Kim JH, 2011, PLOS ONE, V6; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Kriz A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1120; Lee CJ, 2009, BIOTECHNOL BIOENG, V102, P1107, DOI 10.1002/bit.22126; Leitzgen K, 1997, J BIOL CHEM, V272, P3117, DOI 10.1074/jbc.272.5.3117; LENNY N, 1991, J BIOL CHEM, V266, P20532; Li JD, 2007, PROTEIN ENG DES SEL, V20, P491, DOI 10.1093/protein/gzm038; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Martinez-Salas E, 1999, CURR OPIN BIOTECH, V10, P458, DOI 10.1016/S0958-1669(99)00010-5; MEHDI H, 1990, GENE, V91, P173, DOI 10.1016/0378-1119(90)90085-6; MOUNTFORD PS, 1995, TRENDS GENET, V11, P179, DOI 10.1016/S0168-9525(00)89040-X; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; Rees S, 1996, BIOTECHNIQUES, V20, P102; Sasaki Y, 2008, J BIOTECHNOL, V136, P103, DOI 10.1016/j.jbiotec.2008.06.007; Schlatter S, 2005, BIOTECHNOL PROGR, V21, P122, DOI 10.1021/bp049780w; Tornoe J, 2002, GENE, V297, P21, DOI 10.1016/S0378-1119(02)00878-8; Trowitzsch S, 2011, BIOESSAYS, V33, P946, DOI 10.1002/bies.201100109; Yahata K, 2005, J BIOTECHNOL, V118, P123, DOI 10.1016/j.jbiotec.2005.02.020; Yang YS, 2009, BIOTECHNOL BIOENG, V102, P1152, DOI 10.1002/bit.22152	44	29	37	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82100	10.1371/journal.pone.0082100	http://dx.doi.org/10.1371/journal.pone.0082100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349195	Green Published, gold			2022-12-27	WOS:000328705200064
J	Abu Hanifah, R; Mohamed, MNA; Jaafar, Z; Mohsein, NAA; Jalaludin, MY; Majid, HA; Murray, L; Cantwell, M; Su, TT				Abu Hanifah, Redzal; Mohamed, Mohd Nahar Azmi; Jaafar, Zulkarnain; Mohsein, Nabilla Al-Sadat Abdul; Jalaludin, Muhammad Yazid; Majid, Hazreen Abdul; Murray, Liam; Cantwell, Marie; Su, Tin Tin			The Correlates of Body Composition with Heart Rate Recovery after Step Test: An Exploratory Study of Malaysian Adolescents	PLOS ONE			English	Article							TO-HEIGHT RATIO; BIOELECTRICAL-IMPEDANCE ANALYSIS; AUTONOMIC NERVOUS-SYSTEM; DISEASE RISK-FACTORS; WAIST CIRCUMFERENCE; CARDIOMETABOLIC RISK; CARDIOVASCULAR-DISEASE; SUBMAXIMAL EXERCISE; MAXIMAL EXERCISE; OBESE CHILDREN	Background: In adults, heart rate recovery is a predictor of mortality, while in adolescents it is associated with cardio-metabolic risk factors. The aim of this study was to examine the relationship between body composition measures and heart rate recovery (HRR) after step test in Malaysian secondary school students. Methods: In the Malaysian Health and Adolescents Longitudinal Research Team (MyHEART) study, 1071 healthy secondary school students, aged 13 years old, participated in the step test. Parameters for body composition measures were body mass index z-score, body fat percentage, waist circumference, and waist height ratio. The step test was conducted by using a modified Harvard step test. Heart rate recovery of 1 minute (HRR1min) and heart rate recovery of 2 minutes (HRR2min) were calculated by the difference between the peak pulse rate during exercise and the resting pulse rate at 1 and 2 minutes, respectively. Analysis was done separately based on gender. Pearson correlation analysis was used to determine the association between the HRR parameters with body composition measures, while multiple regression analysis was used to determine which body composition measures was the strongest predictor for HRR. Results: For both gender groups, all body composition measures were inversely correlated with HRR1min. In girls, all body composition measures were inversely correlated with HRR2min, while in boys all body composition measures, except BMI z-score, were associated with HRR2min. In multiple regression, only waist circumference was inversely associated with HRR2min (p=0.024) in boys, while in girls it was body fat percentage for HRR2min (p=0.008). Conclusion: There was an inverse association between body composition measurements and HRR among apparently healthy adolescents. Therefore, it is important to identify cardio-metabolic risk factors in adolescent as an early prevention of consequent adulthood morbidity. This reiterates the importance of healthy living which should start from young.	[Abu Hanifah, Redzal; Mohamed, Mohd Nahar Azmi; Jaafar, Zulkarnain] Univ Malaya, Fac Med, Sports Med Unit, Kuala Lumpur, Malaysia; [Mohsein, Nabilla Al-Sadat Abdul; Majid, Hazreen Abdul; Su, Tin Tin] Univ Malaya, Fac Med, Dept Social & Prevent Med, CePH, Kuala Lumpur, Malaysia; [Jalaludin, Muhammad Yazid] Univ Malaya, Fac Med, Dept Paediat, Kuala Lumpur, Malaysia; [Murray, Liam; Cantwell, Marie] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Publ Hlth, Belfast, Antrim, North Ireland	Universiti Malaya; Universiti Malaya; Universiti Malaya; Queens University Belfast	Abu Hanifah, R (corresponding author), Univ Malaya, Fac Med, Sports Med Unit, Kuala Lumpur, Malaysia.	docredzal@gmail.com	Jalaludin, Muhammad Yazid/B-9172-2010; Mohamed, Mohd Nahar Azmi/J-9930-2014; JAAFAR, ZULKARNAIN/C-1155-2010; SU, TIN TIN/B-9968-2010; Abdul Majid, Hazreen/B-8619-2010	Jalaludin, Muhammad Yazid/0000-0003-4513-8444; Mohamed, Mohd Nahar Azmi/0000-0002-8480-3788; JAAFAR, ZULKARNAIN/0000-0002-4331-788X; Abu Hanifah, Redzal/0000-0002-2246-2180; Su, Tin Tin/0000-0003-0387-6406; Abdul Majid, Hazreen/0000-0002-2718-8424	University of Malaya Research Grant [RG299-11HTM]; Vice Chancellor Research Grant [UMQUB3D-2011]; MRC [MR/K023241/1] Funding Source: UKRI; Medical Research Council [MR/K023241/1] Funding Source: researchfish	University of Malaya Research Grant; Vice Chancellor Research Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	1) University of Malaya Research Grant : RG299-11HTM; 2) Vice Chancellor Research Grant: UMQUB3D-2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aggoun Y, 2008, EUR HEART J, V29, P792, DOI 10.1093/eurheartj/ehm633; Agirbasli M, 2011, METAB SYNDR RELAT D, V9, P453, DOI 10.1089/met.2011.0018; Ali Kizilbash M, 2006, EUR HEART J, V27, P1592, DOI 10.1093/eurheartj/ehl043; ARAI Y, 1989, AM J PHYSIOL, V256, pH132, DOI 10.1152/ajpheart.1989.256.1.H132; Baum P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054546; Bluher S, 2013, J CLIN ENDOCR METAB, V98, P3384, DOI 10.1210/jc.2013-1389; Brambilla P, 2006, INT J OBESITY, V30, P23, DOI 10.1038/sj.ijo.0803163; Buchheit M, 2009, EXP PHYSIOL, V94, P795, DOI 10.1113/expphysiol.2009.048041; Buchheit M, 2007, AM J PHYSIOL-HEART C, V293, pH8, DOI 10.1152/ajpheart.00335.2007; Carnethon MR, 2005, MED SCI SPORT EXER, V37, P606, DOI 10.1249/01.MSS.0000158190.56061.32; Cheng YLJ, 2003, DIABETES CARE, V26, P2052, DOI 10.2337/diacare.26.7.2052; Cole CR, 2000, ANN INTERN MED, V132, P552, DOI 10.7326/0003-4819-132-7-200004040-00007; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Crisafulli A, 2003, EUR J APPL PHYSIOL, V89, P209, DOI 10.1007/s00421-003-0796-4; Dimkpa U, 2009, J EXE PHYSL, V12, P19; DROTT C, 1994, EUR J SURG, P65; Falcone C, 2005, CIRCULATION, V112, P1959, DOI 10.1161/CIRCULATIONAHA.105.545111; Faria FR, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/501638; Freedman DS, 2005, INT J OBESITY, V29, P1, DOI 10.1038/sj.ijo.0802735; Freedman DS, 2001, PEDIATRICS, V108, P712, DOI 10.1542/peds.108.3.712; Goulding A, 2010, INT J OBESITY, V34, P1188, DOI 10.1038/ijo.2009.278; Haas GM, 2011, WORLD J PEDIATR, V7, P16, DOI 10.1007/s12519-011-0241-4; Hirschler V, 2011, CLIN BIOCHEM, V44, P659, DOI 10.1016/j.clinbiochem.2011.02.004; Hunt S, 2001, NEW ENGL J MED, V345, P762, DOI 10.1056/NEJM200109063451011; Hydrie M. Z. I., 2004, Pakistan Journal of Nutrition, V3, P43; IMAI K, 1994, J AM COLL CARDIOL, V24, P1529, DOI 10.1016/0735-1097(94)90150-3; Johnson ST, 2010, J PEDIATR-US, V156, P247, DOI 10.1016/j.jpeds.2009.08.010; Kasmini K, 1997, Asia Pac J Clin Nutr, V6, P172; Kelishadi R, 2007, INT J CARDIOL, V117, P340, DOI 10.1016/j.ijcard.2006.06.012; Kim C, 2010, DIABETES RES CLIN PR, V88, P307, DOI 10.1016/j.diabres.2010.02.005; Kriemler S, 2009, EUR J CLIN NUTR, V63, P619, DOI 10.1038/ejcn.2008.19; Kuba VM, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-91; Laguna M, 2013, NUTR METAB CARDIOVAS, V23, P995, DOI 10.1016/j.numecd.2012.10.002; Lee JM, 2009, PEDIATR DIABETES, V10, P336, DOI 10.1111/j.1399-5448.2008.00474.x; Lin LY, 2008, DIABETES CARE, V31, P1015, DOI 10.2337/dc07-2299; Mahon AD, 2003, MED SCI SPORT EXER, V35, P2093, DOI 10.1249/01.MSS.0000099180.80952.83; Malavolti M, 2003, ANN HUM BIOL, V30, P380, DOI 10.1080/0301446031000095211; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; Medici G, 2005, EUR J CLIN NUTR, V59, P932, DOI 10.1038/sj.ejcn.1602165; Meng LH, 2011, BIOMED ENVIRON SCI, V24, P22, DOI 10.3967/0895-3988.2011.01.003; Mokha JS, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-73; Nishime EO, 2000, JAMA-J AM MED ASSOC, V284, P1392, DOI 10.1001/jama.284.11.1392; Ohtake PJ, 2005, CARDIOPULM PHYS THER, V16, P5; Ohuchi H, 2000, PEDIATR RES, V47, P329, DOI 10.1203/00006450-200003000-00008; PERINI R, 1989, EUR J APPL PHYSIOL, V58, P879, DOI 10.1007/BF02332222; Prado DM, 2010, INT J SPORTS MED, V31, P860, DOI 10.1055/s-0030-1267158; Ramachandran A, 2007, DIABETES CARE, V30, P1828, DOI 10.2337/dc06-2097; Rampal L, 2007, ASIA PAC J CLIN NUTR, V16, P561; ROTHSCHILD M, 1988, AM J CARDIOL, V62, P637, DOI 10.1016/0002-9149(88)90670-4; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Schwandt P, 2010, ATHEROSCLEROSIS, V211, P667, DOI 10.1016/j.atherosclerosis.2010.03.032; SCHWARTZ PJ, 1992, CIRCULATION, V85, P77; Sears CE, 1998, J APPL PHYSIOL, V84, P1596, DOI 10.1152/jappl.1998.84.5.1596; Shetler K, 2001, J AM COLL CARDIOL, V38, P1980, DOI 10.1016/S0735-1097(01)01652-7; Singh TP, 2007, PEDIATR CARDIOL, V28, P276, DOI 10.1007/s00246-006-0114-0; Singh TP, 2008, MED SCI SPORT EXER, V40, P601, DOI 10.1249/MSS.0b013e3181621ec4; Singh TP, 2007, J HEART LUNG TRANSPL, V26, P1306, DOI 10.1016/j.healun.2007.08.013; Singh TP, 2010, ARCH PEDIAT ADOL MED, V164, P479, DOI 10.1001/archpediatrics.2010.57; Staiano AE, 2012, INT J OBESITY, V36, P1261, DOI 10.1038/ijo.2012.95; The National Health and Morbidity Survey, 2006, NAT HLTH MORB SURV 2; Trevino RP, 2004, ARCH PEDIAT ADOL MED, V158, P911, DOI 10.1001/archpedi.158.9.911; Trevino RP, 1999, DIABETES CARE, V22, P202, DOI 10.2337/diacare.22.2.202; Velasquez-Mieyer P, 2005, DIABETES SPECTRUM, V18, P213, DOI DOI 10.2337/DIASPECT.18.4.213; Watanabe J, 2001, CIRCULATION, V104, P1911, DOI 10.1161/circ.104.16.1911; Wee BS, 2011, BMC PUBLIC HEALTH, V11, DOI DOI 10.1186/1471-2458-1111-1333; Wilks DC, 2014, EUR J PREV CARDIOL, V21, P876, DOI 10.1177/2047487312465691; Yakinci C, 2000, BRAIN DEV-JPN, V22, P151, DOI 10.1016/S0387-7604(00)00094-2; Zalilah M S, 2006, Med J Malaysia, V61, P48	68	11	11	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82893	10.1371/journal.pone.0082893	http://dx.doi.org/10.1371/journal.pone.0082893			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349388	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100131
J	Lee, J; Zee, BCY; Li, Q				Lee, Jack; Zee, Benny Chung Ying; Li, Qing			Detection of Neovascularization Based on Fractal and Texture Analysis with Interaction Effects in Diabetic Retinopathy	PLOS ONE			English	Article							RETINAL MICROVASCULAR ABNORMALITIES; METHODOLOGY; VESSELS; RISK; EYE	Diabetic retinopathy is a major cause of blindness. Proliferative diabetic retinopathy is a result of severe vascular complication and is visible as neovascularization of the retina. Automatic detection of such new vessels would be useful for the severity grading of diabetic retinopathy, and it is an important part of screening process to identify those who may require immediate treatment for their diabetic retinopathy. We proposed a novel new vessels detection method including statistical texture analysis (STA), high order spectrum analysis (HOS), fractal analysis (FA), and most importantly we have shown that by incorporating their associated interactions the accuracy of new vessels detection can be greatly improved. To assess its performance, the sensitivity, specificity and accuracy (AUC) are obtained. They are 96.3%, 99.1% and 98.5% (99.3%), respectively. It is found that the proposed method can improve the accuracy of new vessels detection significantly over previous methods. The algorithm can be automated and is valuable to detect relatively severe cases of diabetic retinopathy among diabetes patients.	[Lee, Jack; Zee, Benny Chung Ying; Li, Qing] Chinese Univ Hong Kong, Div Biostat, Jockey Club Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong	Zee, BCY (corresponding author), Chinese Univ Hong Kong, Div Biostat, Jockey Club Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China.	bzee@cuhk.edu.hk	Zee, Benny Chung Ying/G-5606-2017	Zee, Benny Chung Ying/0000-0002-7238-845X				Acharya UR, 2012, J MED SYST, V36, P2011, DOI 10.1007/s10916-011-9663-8; Acharya UR, 2008, J MED SYST, V32, P431; Agurto C, 2012, IEEE ENG MED BIO, P4946, DOI 10.1109/EMBC.2012.6347102; Akram MU, 2012, LECT NOTES COMPUT SC, V7325, P372, DOI 10.1007/978-3-642-31298-4_44; Anderson D. R., 2008, MODEL BASED INFERENC; Andjelkovic Jelena, 2008, WSEAS Transactions on Information Science and Applications, V5, P1561; Azemin MZC, 2011, IEEE T MED IMAGING, V30, P243, DOI 10.1109/TMI.2010.2076322; Azemin MZC, 2010, IEEE ENG MED BIO, P4308, DOI 10.1109/IEMBS.2010.5626209; Bailey R. R., 2002, MOMENTS IMAGE PROCES; Barton K, 2020, MUMIN MULTIMODEL INF; Bremananth R, 2009, 2009 INTERNATIONAL CONFERENCE ON ADVANCES IN RECENT TECHNOLOGIES IN COMMUNICATION AND COMPUTING (ARTCOM 2009), P615, DOI 10.1109/ARTCom.2009.10; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Che Azemin M. Z., 2010, 2010 IEEE International Conference on Imaging Systems and Techniques (IST 2010), P125, DOI 10.1109/IST.2010.5548470; DAXER A, 1992, LANCET, V339, P618, DOI 10.1016/0140-6736(92)90905-I; Daxer A, 1933, GRAEFES ARCH CLIN EX, V231, P681; Evertsz C.J.G., 1992, CHAOS FRACTALS; FAMILY F, 1989, PHYSICA D, V38, P98, DOI 10.1016/0167-2789(89)90178-4; Galloway M., 1975, COMPUTER GRAPHICS IM, V4, P172, DOI DOI 10.1016/S0146-664X(75)80008-6; Goatman KA, 2011, IEEE T MED IMAGING, V30, P972, DOI 10.1109/TMI.2010.2099236; Hassan SSA, 2012, J DIGIT IMAGING, V25, P437, DOI 10.1007/s10278-011-9418-6; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; HWANG H, 1995, IEEE T IMAGE PROCESS, V4, P499, DOI 10.1109/83.370679; Karthikeyen, 2012, IJART, V2, P55; KING G, 2001, POLITICAL ANAL, V0009; MacGillivray TJ, 2007, P ANN INT IEEE EMBS, P6456; MAINSTER MA, 1990, EYE, V4, P235, DOI 10.1038/eye.1990.33; Marcel D, 2003, SUPERVISED GENE CLUS; Masters B. R., 1990, NONINVASIVE DIAGNOST; Park B, 2002, COMPUT ELECTRON AGR, V33, P219, DOI 10.1016/S0168-1699(02)00010-8; Press W. H., 1990, NUMERICAL RECIPES C; Saranya KB, 2012, IEEE ADV TECHN HUM I, DOI [10.1109/ICCSP.2012.6208394, DOI 10.1109/ICCSP.2012.6208394]; Selesnick IW, 2005, IEEE SIGNAL PROC MAG, V22, P123, DOI 10.1109/MSP.2005.1550194; Silakari S., 2009, INT J COMPUTER SCI I, V4, P31; Stosic T, 2006, IEEE T MED IMAGING, V25, P1101, DOI 10.1109/TMI.2006.879316; Takerkart S, 2008, I S BIOMED IMAGING, P1457, DOI 10.1109/ISBI.2008.4541282; Tan JH, 2010, INFRARED PHYS TECHN, V53, P120, DOI 10.1016/j.infrared.2009.10.006; Tuceryan M., 1993, HDB PATTERN RECOGNIT; Turner MJ., 1998, FRACTAL GEOMETRY DIG; Venkata MD, 2011, VSRD INT J ELECT ELE, V1, P402; Wang JJ, 2003, HYPERTENSION, V42, P534, DOI 10.1161/01.HYP.0000090122.38230.41; WESZKA JS, 1976, PATTERN RECOGN, V8, P195, DOI 10.1016/0031-3203(76)90039-X; Wong T, 2007, LANCET, V369, P425, DOI 10.1016/S0140-6736(07)60198-6; Wong TY, 2004, OPHTHALMOLOGY, V111, P1183, DOI 10.1016/j.ophtha.2003.09.039; Wong TY, 2003, OPHTHALMOLOGY, V110, P658, DOI 10.1016/S0161-6420(02)01931-0; Zana F, 2001, IEEE T IMAGE PROCESS, V10, P1010, DOI 10.1109/83.931095	46	38	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e75699	10.1371/journal.pone.0075699	http://dx.doi.org/10.1371/journal.pone.0075699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358105	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700001
J	Gonzalez-Navarro, FF; Belanche-Munoz, LA; Silva-Colon, KA				Gonzalez-Navarro, Felix F.; Belanche-Munoz, Lluis A.; Silva-Colon, Karen A.			Effective Classification and Gene Expression Profiling for the Facioscapulohumeral Muscular Dystrophy	PLOS ONE			English	Article							SELECTION; CANCER	The Facioscapulohumeral Muscular Dystrophy (FSHD) is an autosomal dominant neuromuscular disorder whose incidence is estimated in about one in 400,000 to one in 20,000. No effective therapeutic strategies are known to halt progression or reverse muscle weakness and atrophy. It is known that the FSHD is caused by modifications located within a D4ZA repeat array in the chromosome 4q, while recent advances have linked these modifications to the DUX4 gene. Unfortunately, the complete mechanisms responsible for the molecular pathogenesis and progressive muscle weakness still remain unknown. Although there are many studies addressing cancer databases from a machine learning perspective, there is no such precedent in the analysis of the FSHD. This study aims to fill this gap by analyzing two specific FSHD databases. A feature selection algorithm is used as the main engine to select genes promoting the highest possible classification capacity. The combination of feature selection and classification aims at obtaining simple models (in terms of very low numbers of genes) capable of good generalization, that may be associated with the disease. We show that the reported method is highly efficient in finding genes to discern between healthy cases (not affected by the FSHD) and FSHD cases, allowing the discovery of very parsimonious models that yield negligible repeated cross-validation error. These models in turn give rise to very simple decision procedures in the form of a decision tree. Current biological evidence regarding these genes shows that they are linked to skeletal muscle processes concerning specific human conditions.	[Gonzalez-Navarro, Felix F.; Silva-Colon, Karen A.] Univ Autonoma Baja California, Inst Ingn, Mexicali 21100, Baja California, Mexico; [Belanche-Munoz, Lluis A.] Univ Politecn Cataluna, Fac Comp Sci, Barcelona, Spain	Universidad Autonoma de Baja California; Universitat Politecnica de Catalunya	Gonzalez-Navarro, FF (corresponding author), Univ Autonoma Baja California, Inst Ingn, Mexicali 21100, Baja California, Mexico.	fernando.gonzalez@uabc.edu.mx	Gonzalez-Navarro, Felix F./N-9985-2018	Gonzalez-Navarro, Felix F./0000-0002-9627-676X	Universidad Autonoma de Baja California; Universitat Politecnica de Catalunya	Universidad Autonoma de Baja California; Universitat Politecnica de Catalunya	The authors gratefully acknowledge funding from the Universidad Autonoma de Baja California and Universitat Politecnica de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell DA, 2000, MACH LEARN, V41, P175, DOI 10.1023/A:1007612503587; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Breiman L., 1984, CLASSIFICATION REGRE; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Duda R. O., 2001, PATTERN CLASSIFICATI; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Engel A, 2004, MYOLOGY, P1123; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Furlanello C, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-54; Gunn SR, 1997, TECHNICAL REPORT; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hall M, 2011, MYOGENESIS, P274; Hall MN, 2011, DEV BIOL, V357, P248, DOI 10.1016/j.ydbio.2011.06.032; Hofstra RMW, 2000, HUM MUTAT, V15, P418, DOI 10.1002/(SICI)1098-1004(200005)15:5<418::AID-HUMU3>3.0.CO;2-2; John G., 1994, P INT C MACH LEARN; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Liu H, 1998, FEATURE EXTRACTION C; Liu Huiqing, 2002, Genome Inform, V13, P51; Lukas L, 2004, ARTIF INTELL MED, V31, P73, DOI 10.1016/j.artmed.2004.01.001; Pistoni M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003186; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; Rahimov F, 2012, P NATL ACAD SCI USA, V109, P16234, DOI 10.1073/pnas.1209508109; Reunanen J., 2003, Journal of Machine Learning Research, V3, P1371, DOI 10.1162/153244303322753715; Ripley B. D., 1996, PATTERN RECOGNITION; Rose M, 2004, DRUG TREATMENT FACIO, P2; Scholkopf B., 2004, KERNEL METHODS COMPU; Tawil R, 1998, ANN NEUROL, V43, P279, DOI 10.1002/ana.410430303; Tawil R, 2008, NEUROTHERAPEUTICS, V5, P601, DOI 10.1016/j.nurt.2008.07.005; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tim R, 2001, J CLIN NEUROMUSCULAR, V3; van der Maarel SM, 2007, BBA-MOL BASIS DIS, V1772, P186, DOI 10.1016/j.bbadis.2006.05.009; van der Maarel SM, 2011, TRENDS MOL MED, V17, P252, DOI 10.1016/j.molmed.2011.01.001; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vapnik V., 1998, STAT LEARNING THEORY; Zhou X, 2006, BIOINFORMATICS, V22, P2507, DOI 10.1093/bioinformatics/btl438	36	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82071	10.1371/journal.pone.0082071	http://dx.doi.org/10.1371/journal.pone.0082071			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349187	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200024
J	Jugdaohsingh, R; Brown, A; Dietzel, M; Powell, JJ				Jugdaohsingh, Ravin; Brown, Andy; Dietzel, Martin; Powell, Jonathan J.			High-Aluminum-Affinity Silica Is a Nanoparticle That Seeds Secondary Aluminosilicate Formation	PLOS ONE			English	Article							BINDING; ACID; TRANSFERRIN; ABSORPTION; TOXICITY; SERUM; IONS	Despite the importance and abundance of aluminosilicates throughout our natural surroundings, their formation at neutral pH is, surprisingly, a matter of considerable debate. From our experiments in dilute aluminum and silica containing solutions (pH similar to 7) we previously identified a silica polymer with an extraordinarily high affinity for aluminium ions (high-aluminum-affinity silica polymer, HSP). Here, further characterization shows that HSP is a colloid of approximately 2.4 nm in diameter with a mean specific surface area of about 1,000 m(2) g(-1) and it competes effectively with transferrin for Al(III) binding. Aluminum binding to HSP strongly inhibited its decomposition whilst the reaction rate constant for the formation of the beta-silicomolybdic acid complex indicated a diameter between 3.6 and 4.1 nm for these aluminum-containing nanoparticles. Similarly, high resolution microscopic analysis of the air dried aluminum-containing silica colloid solution revealed 3.9 +/- 1.3 nm sized crystalline Al-rich silica nanoparticles (ASP) with an estimated Al: Si ratio of between 2 and 3 which is close to the range of secondary aluminosilicates such as imogolite. Thus the high-aluminum-affinity silica polymer is a nanoparticle that seeds early aluminosilicate formation through highly competitive binding of Al(III) ions. In niche environments, especially in vivo, this may serve as an alternative mechanism to polyhydroxy Al(III) species binding monomeric silica to form early phase, non-toxic aluminosilicates.	[Jugdaohsingh, Ravin; Powell, Jonathan J.] Elsie Widdowson Lab, MRC HNR, Cambridge, England; [Brown, Andy] Univ Leeds, Inst Mat Res, SPEME, Leeds, W Yorkshire, England; [Dietzel, Martin] Graz Univ Technol, Inst Appl Geosci, A-8010 Graz, Austria	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Leeds; Graz University of Technology	Jugdaohsingh, R (corresponding author), Elsie Widdowson Lab, MRC HNR, Cambridge, England.	ravin.jugdaohsingh@mrc-hnr.cam.ac.uk		Dietzel, Martin/0000-0003-2222-2459; Brown, Andy/0000-0001-9692-2154	Medical Research Council [MC_US_A090_0008, U1059]; EPSRC [EP/E059678/1] Funding Source: UKRI; MRC [MC_U105960399] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E059678/1] Funding Source: researchfish; Medical Research Council [MC_U105960399] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Medical Research Council (grant number MC_US_A090_0008/Unit Programme number U1059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anseau MR, 2005, INORG CHEM, V44, P8023, DOI 10.1021/ic050594c; Bellia JP, 1996, ANN CLIN LAB SCI, V26, P227; BIRCHALL JD, 1989, NATURE, V338, P146, DOI 10.1038/338146a0; Brown SH, 2010, ZEOLITES CATALYSIS H; Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361; COCHRAN M, 1984, FEBS LETT, V176, P129, DOI 10.1016/0014-5793(84)80926-6; COCHRAN M, 1987, LIFE SCI, V40, P2337, DOI 10.1016/0024-3205(87)90507-8; Desouky M, 2002, P NATL ACAD SCI USA, V99, P3394, DOI 10.1073/pnas.062478699; Dietzel M, 2000, GEOCHIM COSMOCHIM AC, V64, P3275, DOI 10.1016/S0016-7037(00)00426-9; DIETZEL M, 1992, APPL GEOCHEM, V7, P177, DOI 10.1016/0883-2927(92)90035-2; DOBBIE JW, 1982, SCOT MED J, V27, P10, DOI 10.1177/003693308202700104; Doucet FJ, 2001, GEOCHIM COSMOCHIM AC, V65, P2461, DOI 10.1016/S0016-7037(01)00571-3; EDWARDSON JA, 1993, LANCET, V342, P211, DOI 10.1016/0140-6736(93)92301-9; Exley C, 1999, J INORG BIOCHEM, V76, P133, DOI 10.1016/S0162-0134(99)00125-7; Exley C, 2012, COORDIN CHEM REV, V256, P82, DOI 10.1016/j.ccr.2011.06.022; FARMER VC, 1994, GEOCHIM COSMOCHIM AC, V58, P3331, DOI 10.1016/0016-7037(94)90088-4; FATEMI SJA, 1991, BIOCHEM J, V280, P527, DOI 10.1042/bj2800527; Flaten TP, 2001, BRAIN RES BULL, V55, P187, DOI 10.1016/S0361-9230(01)00459-2; Godoi RHM, 2008, ATMOS ENVIRON, V42, P7027, DOI 10.1016/j.atmosenv.2008.07.002; Hajimohammadi A, 2008, IND ENG CHEM RES, V47, P9396, DOI 10.1021/ie8006825; HANSEN PL, 1994, MICROSC MICROANAL M, V5, P173, DOI 10.1051/mmm:0199400503017300; Hondow N, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0977-3; ILER RK, 1982, ACS SYM SER, V194, P95; Iter RK, 1979, CHEM SILICA SOLUBILI; Jugdaohsingh R, 2000, AM J CLIN NUTR, V71, P944; Jugdaohsingh R, 1999, THESIS U LONDON; Jugdaohsingh R, 2008, METAL IONS BIOL MED, V10, P45; Klein C, 1993, ROCKS MINERALS DUSTY, P8; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Kroger N, 2000, P NATL ACAD SCI USA, V97, P14133, DOI 10.1073/pnas.260496497; Lomer MCE, 2002, P NUTR SOC, V61, P123, DOI 10.1079/PNS2001134; Parfitt RL, 2009, CLAY MINER, V44, P135, DOI 10.1180/claymin.2009.044.1.135; Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234; Swaddle TW, 2001, COORDIN CHEM REV, V219, P665, DOI 10.1016/S0010-8545(01)00362-9; Taylor PD, 1997, J AM CHEM SOC, V119, P8852, DOI 10.1021/ja964476n; Teien HC, 2006, SCI TOTAL ENVIRON, V358, P151, DOI 10.1016/j.scitotenv.2005.09.052; TOKUTAKE S, 1995, NEUROSCI LETT, V185, P99, DOI 10.1016/0304-3940(94)11234-A; Tokutake S, 1997, Ann N Y Acad Sci, V826, P510, DOI 10.1111/j.1749-6632.1997.tb48515.x; TRAPP GA, 1983, LIFE SCI, V33, P311, DOI 10.1016/S0024-3205(83)80002-2; VANHAERINGEN B, 1995, PROTEINS, V23, P233, DOI 10.1002/prot.340230212; White KN, 2008, ENVIRON SCI TECHNOL, V42, P2189, DOI 10.1021/es7028608; WILSON MA, 1986, CLAY MINER, V21, P879, DOI 10.1180/claymin.1986.021.5.03; Wonisch H, 2008, GEODERMA, V144, P435, DOI 10.1016/j.geoderma.2007.11.022; Yang XY, 2011, CHEM COMMUN, V47, P2763, DOI 10.1039/c0cc03734f	44	4	4	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e84397	10.1371/journal.pone.0084397	http://dx.doi.org/10.1371/journal.pone.0084397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349573	Green Published, gold			2022-12-27	WOS:000328734200114
J	Eichner, J; Topf, F; Drager, A; Wrzodek, C; Wanke, D; Zell, A				Eichner, Johannes; Topf, Florian; Draeger, Andreas; Wrzodek, Clemens; Wanke, Dierk; Zell, Andreas			TFpredict and SABINE: Sequence-Based Prediction of Structural and Functional Characteristics of Transcription Factors	PLOS ONE			English	Article							DNA-BINDING PROTEINS; SUPPORT VECTOR MACHINES; DATABASE; BIOINFORMATICS; IDENTIFICATION; EVOLUTIONARY; GENERATION; SIMILARITY; RESIDUES; BLAST	One of the key mechanisms of transcriptional control are the specific connections between transcription factors (TF) and cis-regulatory elements in gene promoters. The elucidation of these specific protein-DNA interactions is crucial to gain insights into the complex regulatory mechanisms and networks underlying the adaptation of organisms to dynamically changing environmental conditions. As experimental techniques for determining TF binding sites are expensive and mostly performed for selected TFs only, accurate computational approaches are needed to analyze transcriptional regulation in eukaryotes on a genome-wide level. We implemented a four-step classification workflow which for a given protein sequence (1) discriminates TFs from other proteins, (2) determines the structural superclass of TFs, (3) identifies the DNA-binding domains of TFs and (4) predicts their cis-acting DNA motif. While existing tools were extended and adapted for performing the latter two prediction steps, the first two steps are based on a novel numeric sequence representation which allows for combining existing knowledge from a BLAST scan with robust machine learning-based classification. By evaluation on a set of experimentally confirmed TFs and non-TFs, we demonstrate that our new protein sequence representation facilitates more reliable identification and structural classification of TFs than previously proposed sequence-derived features. The algorithms underlying our proposed methodology are implemented in the two complementary tools TFpredict and SABINE. The online and stand-alone versions of TFpredict and SABINE are freely available to academics at http://www.cogsys.cs.uni-tuebingen.de/software/TFpredict/ and http://www.cogsys.cs.uni-tuebingen.de/software/SABINE/.	[Eichner, Johannes; Topf, Florian; Draeger, Andreas; Wrzodek, Clemens; Zell, Andreas] Univ Tubingen, Ctr Bioinformat Tuebingen ZBIT, Tubingen, Germany; [Draeger, Andreas] Univ Calif San Diego, La Jolla, CA 92093 USA; [Wanke, Dierk] Univ Tubingen, Ctr Plant Physiol Tuebingen ZMBP, Tubingen, Germany	Eberhard Karls University of Tubingen; University of California System; University of California San Diego; Eberhard Karls University of Tubingen	Eichner, J (corresponding author), Univ Tubingen, Ctr Bioinformat Tuebingen ZBIT, Tubingen, Germany.	johannes.eichner@uni-tuebingen.de	Dräger, Andreas/F-5620-2015; Wanke, Dierk/AAA-8529-2019	Dräger, Andreas/0000-0002-1240-5553; Wrzodek, Clemens/0000-0003-4995-780X	Federal Ministry of Education and Research (BMBF), Germany [0315384C]; Virtual Liver Network [0315756]; Marie Curie International Outgoing Fellowship within the EU 7th Framework Program for Research and Technological Development (project AMBiCon) [332020]; German Research Foundation; Open Access Publishing Fund of Tuebingen	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); Virtual Liver Network; Marie Curie International Outgoing Fellowship within the EU 7th Framework Program for Research and Technological Development (project AMBiCon); German Research Foundation(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen	The Federal Ministry of Education and Research (BMBF), Germany funded this work in the MedSys project Spher4Sys, (grant number 0315384C), the Virtual Liver Network (grant number 0315756) and a Marie Curie International Outgoing Fellowship within the EU 7th Framework Program for Research and Technological Development (project AMBiCon, 332020) to AD. Further financial support was provided by the German Research Foundation and the Open Access Publishing Fund of Tuebingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2012, NUCL ACIDS RES; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Cai YD, 2004, BIOINFORMATICS, V20, P1292, DOI 10.1093/bioinformatics/bth085; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Charoensawan V, 2010, NUCLEIC ACIDS RES, V38, P7364, DOI 10.1093/nar/gkq617; Chou KC, 2004, BIOCHEM BIOPH RES CO, V321, P1007, DOI 10.1016/j.bbrc.2004.07.059; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Dietterich TG, 1995, SOLVING MULTICLASS L; Fang Y, 2008, AMINO ACIDS, V34, P103, DOI 10.1007/s00726-007-0568-2; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Guo AY, 2005, BIOINFORMATICS, V21, P2568, DOI 10.1093/bioinformatics/bti334; Heinemeyer T, 1999, NUCLEIC ACIDS RES, V27, P318, DOI 10.1093/nar/27.1.318; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hwang S, 2007, BIOINFORMATICS, V23, P634, DOI 10.1093/bioinformatics/btl672; Iida K, 2005, DNA RES, V12, P247, DOI 10.1093/dnares/dsi011; Jia PL, 2007, BIOCHEM BIOPH RES CO, V357, P366, DOI 10.1016/j.bbrc.2007.03.139; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kumar M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-463; Latchman DS, 2007, EUKARYOTIC TRANSCRIP, DOI DOI 10.1016/B978-012373983-4.50001-8; LESLIE C, 2002, P PSB, V7, P566; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Liao L, 2003, J COMPUT BIOL, V10, P857, DOI 10.1089/106652703322756113; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Morozov AV, 2005, NUCLEIC ACIDS RES, V33, P5781, DOI 10.1093/nar/gki875; Ouzounis CA, 1997, MOL B INT U, P1; Pape UJ, 2008, BIOINFORMATICS, V24, P350, DOI 10.1093/bioinformatics/btm610; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Prlic A, 2012, BIOINFORMATICS, V28, P2693, DOI 10.1093/bioinformatics/bts494; Saigo H, 2004, BIOINFORMATICS, V20, P1682, DOI 10.1093/bioinformatics/bth141; Schroder A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013876; Stegmaier Philip, 2004, Genome Inform, V15, P276; SUZUKI M, 1994, P NATL ACAD SCI USA, V91, P12357, DOI 10.1073/pnas.91.26.12357; Tan K, 2005, GENOME RES, V15, P312, DOI 10.1101/gr.3069205; Wilson D, 2008, NUCLEIC ACIDS RES, V36, pD88, DOI 10.1093/nar/gkm964; Zheng GY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-282	43	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82238	10.1371/journal.pone.0082238	http://dx.doi.org/10.1371/journal.pone.0082238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349230	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800053
J	Ribeiro, FF; Qin, JG				Ribeiro, Flavio F.; Qin, Jian G.			Modelling Size-Dependent Cannibalism in Barramundi Lates calcarifer: Cannibalistic Polyphenism and Its Implication to Aquaculture	PLOS ONE			English	Article							INTRACOHORT CANNIBALISM; PREY SIZE; SIBLING CANNIBALISM; ARCTIC CHARR; CAPTURE SUCCESS; DYNAMICS; FISH; POLYMORPHISM; PREDATION; SELECTION	This study quantified size-dependent cannibalism in barramundi Lates calcarifer through coupling a range of prey-predator pairs in a different range of fish sizes. Predictive models were developed using morphological traits with the alterative assumption of cannibalistic polyphenism. Predictive models were validated with the data from trials where cannibals were challenged with progressing increments of prey sizes. The experimental observations showed that cannibals of 25-131 mm total length could ingest the conspecific prey of 78-72% cannibal length. In the validation test, all predictive models underestimate the maximum ingestible prey size for cannibals of a similar size range. However, the model based on the maximal mouth width at opening closely matched the empirical observations, suggesting a certain degree of phenotypic plasticity of mouth size among cannibalistic individuals. Mouth size showed allometric growth comparing with body depth, resulting in a decreasing trend on the maximum size of ingestible prey as cannibals grow larger, which in parts explains why cannibalism in barramundi is frequently observed in the early developmental stage. Any barramundi has the potential to become a cannibal when the initial prey size was <50% of the cannibal body length, but fish could never become a cannibal when prey were >58% of their size, suggesting that 50% of size difference can be the threshold to initiate intracohort cannibalism in a barramundi population. Cannibalistic polyphenism was likely to occur in barramundi that had a cannibalistic history. An experienced cannibal would have a greater ability to stretch its mouth size to capture a much larger prey than the models predict. The awareness of cannibalistic polyphenism has important application in fish farming management to reduce cannibalism.	[Ribeiro, Flavio F.; Qin, Jian G.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia	Flinders University South Australia	Qin, JG (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	Jian.Qin@Flinders.edu.au	Ribeiro, Flavio F./H-1499-2014	Ribeiro, Flavio F./0000-0002-9865-9334; Qin, Jianguang/0000-0003-2448-8058	CAPES Brazil	CAPES Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This project was funded by CAPES Brazil for a PhD Scholarship to F Ribeiro (http://www.cambridgetrusts.org/partners/capes-brazil) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2003, EVOL ECOL RES, V5, P213; Baras E, 2000, J FISH BIOL, V57, P1001, DOI 10.1111/j.1095-8649.2000.tb02207.x; Baras E, 1999, J FISH BIOL, V54, P82, DOI 10.1006/jfbi.1998.0847; Baras E, 2002, AQUAC RES, V33, P461, DOI 10.1046/j.1365-2109.2002.00732.x; Baras E, 2010, AQUACULTURE, V305, P42, DOI 10.1016/j.aquaculture.2010.04.004; Baras E, 2012, AQUACULTURE IN PRESS; Baras E, 2011, AQUAT LIVING RESOUR, V24, P379, DOI 10.1051/alr/2011141; Closs GP, 2003, MANAGING INVASIVE FRESHWATER FISH IN NEW ZEALAND, P37; Crump Martha L., 1992, P256; DABROWSKI K, 1984, AQUACULTURE, V40, P41, DOI 10.1016/0044-8486(84)90214-X; Ellis T, 1997, MAR ECOL PROG SER, V149, P83, DOI 10.3354/meps149083; Gill AB, 2003, J FISH BIOL, V63, P105, DOI 10.1111/j.1095-8649.2003.00214.x; HECHT T, 1988, J ZOOL, V214, P21, DOI 10.1111/j.1469-7998.1988.tb04984.x; Hecht Thomas, 1993, Journal of the World Aquaculture Society, V24, P246, DOI 10.1111/j.1749-7345.1993.tb00014.x; HINDAR K, 1993, BIOL J LINN SOC, V48, P63, DOI 10.1111/j.1095-8312.1993.tb00877.x; Hoffman EA, 1999, ECOLOGY, V80, P1076, DOI 10.2307/177041; Hseu J-R, 2012, AQUACULTURE IN PRESS; Hseu JR, 2007, AQUAC RES, V38, P1056, DOI 10.1111/j.1365-2109.2007.01762.x; Hseu JR, 2004, FISHERIES SCI, V70, P482, DOI 10.1111/j.1444-2906.2004.00829.x; Hseu JR, 2003, AQUACULTURE, V218, P203, DOI 10.1016/S0044-8486(02)00315-0; Johnson JM, 1996, T AM FISH SOC, V125, P809, DOI 10.1577/1548-8659(1996)125<0809:MCOICI>2.3.CO;2; Jonsson B, 2001, J FISH BIOL, V58, P605, DOI 10.1006/jfbi.2000.1515; JUANES F, 1994, MAR ECOL PROG SER, V114, P59, DOI 10.3354/meps114059; Juanes F., 1994, THEORY APPL FISH FEE, P79; Kestemont P, 2003, AQUACULTURE, V227, P333, DOI 10.1016/S0044-8486(03)00513-1; Komiya T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017430; OTTERA H, 1993, J FISH BIOL, V43, P643; PARAZO MM, 1991, J APPL ICHTHYOL, V7, P1, DOI 10.1111/j.1439-0426.1991.tb00588.x; POLIS GA, 1981, ANNU REV ECOL SYST, V12, P225, DOI 10.1146/annurev.es.12.110181.001301; Qin JG, 2004, J WORLD AQUACULT SOC, V35, P113, DOI 10.1111/j.1749-7345.2004.tb01067.x; Qin JG, 1996, AQUACULTURE, V144, P313, DOI 10.1016/0044-8486(96)01299-9; Sakakura Y, 1996, J FISH BIOL, V48, P16, DOI 10.1111/j.1095-8649.1996.tb01415.x; Scharf FS, 1998, CAN J FISH AQUAT SCI, V55, P1695, DOI 10.1139/cjfas-55-7-1695; Schipp G, 2007, BARRAMUNDI FARMING H, P71; Smith C., 1991, Reviews in Fish Biology and Fisheries, V1, P41, DOI 10.1007/BF00042661; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; SOGARD SM, 1994, ENVIRON BIOL FISH, V39, P183, DOI 10.1007/BF00004936; Tachihara K., 1993, B NAGASAKI PREF I FI, V19, P1; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341	39	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82488	10.1371/journal.pone.0082488	http://dx.doi.org/10.1371/journal.pone.0082488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349295	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800064
J	Wang, HL; Zhao, XK; Lin, ML; Dahlgren, RA; Chen, W; Zhou, JP; Xu, CY; Jin, CL; Xu, Y; Wang, XD; Ding, L; Bao, QY				Wang Huili; Zhao Xiaokai; Lin Meili; Dahlgren, Randy A.; Chen Wei; Zhou Jaiopeng; Xu Chengyang; Jin Chunlei; Xu Yi; Wang Xuedong; Ding Li; Bao Qiyu			Proteomic Analysis and qRT-PCR Verification of Temperature Response to Arthrospira (Spirulina) platensis	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; STRESS; CYANOBACTERIUM; EXPRESSION; GENE; RNA; ACCLIMATION; TOLERANCE; HSPA; DNA	Arthrospira (Spirulina) platensis (ASP) is a representative filamentous, non-N-2-fixing cyanobacterium that has great potential to enhance the food supply and possesses several valuable physiological features. ASP tolerates high and low temperatures along with highly alkaline and salty environments, and can strongly resist oxidation and irradiation. Based on genomic sequencing of ASP, we compared the protein expression profiles of this organism under different temperature conditions (15 degrees C, 35 degrees C and 45 degrees C) using 2-DE and peptide mass fingerprinting techniques. A total of 122 proteins having a significant differential expression response to temperature were retrieved. Of the positively expressed proteins, the homologies of 116 ASP proteins were found in Arthrospira (81 proteins in Arthrospira platensis str. Paraca and 35 in Arthrospira maxima CS-328). The other 6 proteins have high homology with other microorganisms. We classified the 122 differentially expressed positive proteins into 14 functions using the COG database, and characterized their respective KEGG metabolism pathways. The results demonstrated that these differentially expressed proteins are mainly involved in post-translational modification (protein turnover, chaperones), energy metabolism (photosynthesis, respiratory electron transport), translation (ribosomal structure and biogenesis) and carbohydrate transport and metabolism. Others proteins were related to amino acid transport and metabolism, cell envelope biogenesis, coenzyme metabolism and signal transduction mechanisms. Results implied that these proteins can perform predictable roles in rendering ASP resistance against low and high temperatures. Subsequently, we determined the transcription level of 38 genes in vivo in response to temperature and identified them by qRT-PCR. We found that the 26 differentially expressed proteins, representing 68.4% of the total target genes, maintained consistency between transcription and translation levels. The remaining 12 genes showed inconsistent protein expression with transcription level and accounted for 31.6% of the total target genes.	[Wang Huili; Zhao Xiaokai; Lin Meili; Chen Wei; Zhou Jaiopeng; Xu Chengyang; Jin Chunlei; Xu Yi; Ding Li; Bao Qiyu] Wenzhou Med Univ, Sch Life Sci, Zhejiang Prov Key Lab Med Genet, Inst Biomed Informat, Wenzhou, Peoples R China; [Dahlgren, Randy A.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Wang Xuedong] Wenzhou Med Univ, Sch Environm Sci & Publ Hlth, Wenzhou, Peoples R China	Wenzhou Medical University; University of California System; University of California Davis; Wenzhou Medical University	Wang, XD (corresponding author), Wenzhou Med Univ, Sch Environm Sci & Publ Hlth, Wenzhou, Peoples R China.	zjuwxd@163.com; baoqywzmc@aliyun.com	Wang, Xuedong/B-3279-2018; Wang, Huili/AAA-4941-2020; Bao, Qiyu/AAH-6113-2020	Wang, Huili/0000-0002-1359-9484; Bao, Qiyu/0000-0001-6523-8763	National Natural Science Foundation of China [31071115, 31270548]; Key Project of Environmental Protection Department of Zhejiang Province, China [2012B014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Environmental Protection Department of Zhejiang Province, China	This work was jointly funded by National Natural Science Foundation of China (31071115 and 31270548) and Key Project of Environmental Protection Department of Zhejiang Province, China (2012B014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto S, 2013, PHOTOSYNTH RES; Amiri RM, 2010, J INTEGR PLANT BIOL, V52, P289, DOI 10.1111/j.1744-7909.2010.00890.x; Apiradee H, 2000, BIOSCI BIOTECH BIOCH, V70, P1592; Apiradee H, 2009, PROTEOME SCI, V7, P35, DOI [10.1186/1477-5956-7-35, DOI 10.1186/1477-5956-7-35.PUBMED:19737410]; Balogi Z, 2008, J BIOL CHEM, V283, P22983, DOI 10.1074/jbc.M710400200; Barthel S, 2011, PLANT CELL PHYSIOL, V52, P1776, DOI 10.1093/pcp/pcr116; BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203; Bradbury LMT, 2012, P NATL ACAD SCI USA, V109, pE1888, DOI 10.1073/pnas.1206002109; Deshnium P, 2000, FEMS MICROBIOL LETT, V184, P207, DOI 10.1111/j.1574-6968.2000.tb09015.x; Dikanov SA, 2009, PHYS CHEM CHEM PHYS, V11, P6807, DOI 10.1039/b904597j; Ehling-Schulz M, 2002, MOL MICROBIOL, V46, P827, DOI 10.1046/j.1365-2958.2002.03209.x; Engel M, 2012, FEMS MICROBIOL ECOL, V79, P741, DOI 10.1111/j.1574-6941.2011.01255.x; Fang F, 2004, CURR MICROBIOL, V49, P192, DOI 10.1007/s00284-004-4340-5; Gao X, 2012, MOL MICROBIOL, V85, P907, DOI 10.1111/j.1365-2958.2012.08152.x; Giavalisco P, 2003, ELECTROPHORESIS, V24, P207, DOI 10.1002/elps.200390016; Giro M, 2011, FEBS OPEN BIO, V1, P7, DOI 10.1016/j.fob.2011.10.004; Grove H, 2009, ELECTROPHORESIS, V30, P1856, DOI 10.1002/elps.200800568; Hecker M, 1996, MOL MICROBIOL, V19, P417, DOI 10.1046/j.1365-2958.1996.396932.x; Hongsthong A, 2008, FEMS MICROBIOL LETT, V288, P92, DOI 10.1111/j.1574-6968.2008.01330.x; Kainkaryam RM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-299; Karp NA, 2009, PROTEOMICS, V9, P388, DOI 10.1002/pmic.200800485; Kirilovsky D, 2013, PHOTOCH PHOTOBIO SCI, V12, P1135, DOI 10.1039/c3pp25406b; Kojima K, 2005, BIOCHEM BIOPH RES CO, V331, P583, DOI 10.1016/j.bbrc.2005.04.009; Kojima K, 2002, BIOCHEM BIOPH RES CO, V297, P616, DOI 10.1016/S0006-291X(02)02256-8; Kulshreshtha A, 2008, CURR PHARM BIOTECHNO, V9, P400, DOI 10.2174/138920108785915111; Kurdrid P, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-39; Kurdrid P, 2010, J BIOSCI BIOENG, V109, P205, DOI 10.1016/j.jbiosc.2009.09.002; Kurreck J, 2009, ANGEW CHEM INT EDIT, V48, P1378, DOI 10.1002/anie.200802092; Li H, 2007, PHOTOSYNTH RES, V94, P59, DOI 10.1007/s11120-007-9214-9; Li WZ, 2012, MICROBIOL-SGM, V158, P2440, DOI 10.1099/mic.0.060038-0; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; Matsuda N, 2006, BIOSCI BIOTECH BIOCH, V70, P273, DOI 10.1271/bbb.70.273; Mikulski A, 2011, J CHEM ECOL, V37, P670, DOI 10.1007/s10886-011-9969-5; MOHANTY N, 1987, PHOTOSYNTH RES, V14, P259, DOI 10.1007/BF00032709; Morsy FM, 2008, PHOTOSYNTH RES, V95, P73, DOI 10.1007/s11120-007-9235-4; Ndong C, 2001, PLANT MOL BIOL, V45, P691, DOI 10.1023/A:1010684719225; Pinto F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034983; Prasad J, 2003, APPL ENVIRON MICROB, V69, P917, DOI 10.1128/AEM.69.2.917-925.2003; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Pronk TE, 2011, TOXICOL IN VITRO, V25, P1841, DOI 10.1016/j.tiv.2011.05.012; Pulz O, 2004, APPL MICROBIOL BIOT, V65, P635, DOI 10.1007/s00253-004-1647-x; Rhee JS, 2012, J MICROBIOL BIOTECHN, V22, P118, DOI 10.4014/jmb.1108.08001; Richaond A, 1986, MICROALGAE EC POTENT, P199; Rosana ARR, 2012, PLANT CELL PHYSIOL, V53, P646, DOI 10.1093/pcp/pcs020; Samuel P, 2013, MICROBIOL RES, V168, P615, DOI 10.1016/j.micres.2013.06.007; Schluchter WM, 2010, ADV EXP MED BIOL, V675, P211, DOI 10.1007/978-1-4419-1528-3_12; Sheng J, 2011, BIORESOURCE TECHNOL, V102, P11218, DOI 10.1016/j.biortech.2011.09.083; Szabados L, 2011, ADV BOT RES, V57, P105, DOI 10.1016/B978-0-12-387692-8.00004-7; WADA H, 1984, PLANT CELL PHYSIOL, V25, P907; Wu SX, 2011, J MICROBIOL BIOTECHN, V21, P830, DOI 10.4014/jmb.1101.10068; Zeng Xiaolin, 2012, Weishengwu Xuebao, V52, P594; Zhang L, 2011, J PROTEOMICS, V74, P1135, DOI 10.1016/j.jprot.2011.04.012; Zhang YM, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-52	53	9	10	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83485	10.1371/journal.pone.0083485	http://dx.doi.org/10.1371/journal.pone.0083485			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349519	Green Published, gold			2022-12-27	WOS:000328731800121
J	Angeloni, C; Turroni, S; Bianchi, L; Fabbri, D; Motori, E; Malaguti, M; Leoncini, E; Maraldi, T; Bini, L; Brigidi, P; Hrelia, S				Angeloni, Cristina; Turroni, Silvia; Bianchi, Laura; Fabbri, Daniele; Motori, Elisa; Malaguti, Marco; Leoncini, Emanuela; Maraldi, Tullia; Bini, Luca; Brigidi, Patrizia; Hrelia, Silvana			Novel Targets of Sulforaphane in Primary Cardiomyocytes Identified by Proteomic Analysis	PLOS ONE			English	Article							MIGRATION-INHIBITORY FACTOR; ISCHEMIA-REPERFUSION INJURY; PHASE-II ENZYMES; RAT CARDIOMYOCYTES; OXIDATIVE STRESS; GLYOXALASE-I; FACTOR MIF; VASCULAR COMPLICATIONS; CARDIOVASCULAR-DISEASE; PROTEIN-KINASE	Cardiovascular diseases represent the main cause of mortality in the industrialized world and the identification of effective preventive strategies is of fundamental importance. Sulforaphane, an isothiocyanate from cruciferous vegetables, has been shown to up-regulate phase II enzymes in cardiomyocytes and counteract oxidative stress-induced apoptosis. Aim of the present study was the identification and characterization of novel sulforaphane targets in cardiomyocytes applying a proteomic approach. Two-dimensional gel electrophoresis and mass spectrometry were used to generate protein profiles of primary neonatal rat cardiomyocytes treated and untreated with 5 mu M sulforaphane for 1-48 h. According to image analysis, 64 protein spots were found as differentially expressed and their functional correlations were investigated using the MetaCore program. We mainly focused on 3 proteins: macrophage migration inhibitory factor (MIF), CLP36 or Elfin, and glyoxalase 1, due to their possible involvement in cardioprotection. Validation of the time-dependent differential expression of these proteins was performed by western blotting. In particular, to gain insight into the cardioprotective role of the modulation of glyoxalase 1 by sulforaphane, further experiments were performed using methylglyoxal to mimic glycative stress. Sulforaphane was able to counteract methylglyoxal-induced apoptosis, ROS production, and glycative stress, likely through glyoxalase 1 up-regulation. In this study, we reported for the first time new molecular targets of sulforaphane, such as MIF, CLP36 and glyoxalase 1. In particular, we gave new insights into the anti-glycative role of sulforaphane in cardiomyocytes, confirming its pleiotropic behavior in counteracting cardiovascular diseases.	[Angeloni, Cristina; Fabbri, Daniele; Motori, Elisa; Malaguti, Marco; Leoncini, Emanuela; Hrelia, Silvana] Alma Mater Studiorum Univ Bologna, Dept Life Qual Studies, Bologna, Italy; [Turroni, Silvia; Brigidi, Patrizia] Alma Mater Studiorum Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Bianchi, Laura; Bini, Luca] Univ Siena, Dept Life Sci, Funct Prote Lab, I-53100 Siena, Italy; [Maraldi, Tullia] Univ Modena & Reggio Emilia, Dept Surg Med Dent & Morphol Sci Interest Transpl, Modena, Italy	University of Bologna; University of Bologna; University of Siena; Universita di Modena e Reggio Emilia	Hrelia, S (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Life Qual Studies, Bologna, Italy.	silvana.hrelia@unibo.it	Motori, Elisa/AAM-2028-2021; Hrelia, Silvana/P-2864-2015; Turroni, Silvia/J-7195-2016; Malaguti, Marco/K-5994-2015; Maraldi, Tullia/J-5264-2016	Hrelia, Silvana/0000-0001-7857-4512; Turroni, Silvia/0000-0003-2345-9482; Malaguti, Marco/0000-0003-0349-7772; Maraldi, Tullia/0000-0003-3331-2513; Bini, Luca/0000-0001-8951-2106; Brigidi, Patrizia/0000-0001-8375-6150; Bianchi, Laura/0000-0001-9219-1227	Italian Ministry of the Economic Development (project "Made in Italy-over 50"); Fondazione del Monte di Bologna e Ravenna (Italy); Italian Ministry of University and Scientific Research (FIRB project: "Italian Human ProteomeNet") [BRN07BMCT_013]	Italian Ministry of the Economic Development (project "Made in Italy-over 50"); Fondazione del Monte di Bologna e Ravenna (Italy); Italian Ministry of University and Scientific Research (FIRB project: "Italian Human ProteomeNet")	This work was supported by grants from the Italian Ministry of the Economic Development (project "Made in Italy-over 50") and Fondazione del Monte di Bologna e Ravenna (Italy) to SH; and by grants from the Italian Ministry of University and Scientific Research (FIRB project: "Italian Human ProteomeNet" - BRN07BMCT_013) to LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni C, 2011, AM J PHYSIOL-HEART C, V300, pH2196, DOI 10.1152/ajpheart.00934.2010; Angeloni C, 2009, J AGR FOOD CHEM, V57, P5615, DOI 10.1021/jf900549c; Beisswenger PJ, 2005, DIABETES, V54, P3274, DOI 10.2337/diabetes.54.11.3274; Bordoni A, 2005, J AGR FOOD CHEM, V53, P490, DOI 10.1021/jf049426d; Bourajjaj M, 2003, BIOCHEM SOC T, V31, P1400; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brouwers O, 2010, DIABETOLOGIA, V53, P989, DOI 10.1007/s00125-010-1677-0; Cao ZX, 2006, EXP BIOL MED, V231, P1353, DOI 10.1177/153537020623100809; Clarke JD, 2011, PHARMACOL RES, V64, P456, DOI 10.1016/j.phrs.2011.07.005; Cross JV, 2009, BIOCHEM J, V423, P315, DOI 10.1042/BJ20091170; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; Gasper AV, 2005, AM J CLIN NUTR, V82, P1283, DOI 10.1093/ajcn/82.6.1283; Guy PM, 1999, MOL BIOL CELL, V10, P1973, DOI 10.1091/mbc.10.6.1973; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P412, DOI 10.1016/0003-2697(88)90208-4; Hrelia S, 2002, BBA-BIOMEMBRANES, V1567, P150, DOI 10.1016/S0005-2736(02)00612-0; HRELIA S, 1992, BIOCHEM BIOPH RES CO, V183, P893, DOI 10.1016/0006-291X(92)90567-5; Hu R, 2004, J PHARMACOL EXP THER, V310, P263, DOI 10.1124/jpet.103.064261; Ichiyama H, 2004, CYTOKINE, V26, P187, DOI 10.1016/j.cyto.2004.02.007; Jian Z, 2009, CLIN CHIM ACTA, V405, P132, DOI 10.1016/j.cca.2009.04.016; Kalousova M, 2008, ANN NY ACAD SCI, V1126, P268, DOI 10.1196/annals.1433.012; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kleemann R, 1998, J MOL BIOL, V280, P85, DOI 10.1006/jmbi.1998.1864; Koga K, 2011, ANTIOXID REDOX SIGN, V14, P1191, DOI 10.1089/ars.2010.3163; Kotaka M, 1999, J CELL BIOCHEM, V72, P279, DOI 10.1002/(SICI)1097-4644(19990201)72:2<279::AID-JCB12>3.0.CO;2-7; Kotaka M, 2001, J CELL BIOCHEM, V83, P463, DOI 10.1002/jcb.1244; Kuhla B, 2005, ANN NY ACAD SCI, V1043, P211, DOI 10.1196/annals.1333.026; Kumagai T, 2009, AM J PHYSIOL-RENAL, V296, pF912, DOI 10.1152/ajprenal.90575.2008; Leoncini E, 2011, J FOOD SCI, V76, pH175, DOI 10.1111/j.1750-3841.2011.02311.x; Li SY, 2007, LIFE SCI, V80, P1051, DOI 10.1016/j.lfs.2006.11.035; Malaguti M, 2009, J APPL PHYSIOL, V107, P1028, DOI 10.1152/japplphysiol.00293.2009; Maraldi T, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt203; Marella M, 2007, J BIOL CHEM, V282, P24146, DOI 10.1074/jbc.M701819200; MCLELLAN AC, 1989, MECH AGEING DEV, V48, P63, DOI 10.1016/0047-6374(89)90026-2; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; Molavi B, 2004, CURR OPIN CARDIOL, V19, P488, DOI 10.1097/01.hco.0000133657.77024.bd; Mukherjee S, 2008, J AGR FOOD CHEM, V56, P609, DOI 10.1021/jf0728146; Murashima M, 2004, BIOFACTORS, V22, P271, DOI 10.1002/biof.5520220154; Nakagawa N, 2000, BIOCHEM BIOPH RES CO, V272, P505, DOI 10.1006/bbrc.2000.2787; Nguyen MT, 2003, J IMMUNOL, V170, P3337, DOI 10.4049/jimmunol.170.6.3337; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; Pagnotta E, 2006, J AGR FOOD CHEM, V54, P10159, DOI 10.1021/jf062859r; Resca E, 2013, PLACENTA, V34, P526, DOI 10.1016/j.placenta.2013.03.017; Sinha P, 2001, PROTEOMICS, V1, P835, DOI 10.1002/1615-9861(200107)1:7<835::AID-PROT835>3.3.CO;2-U; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Tarozzi A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/415078; Thiele M, 2005, ANTIOXID REDOX SIGN, V7, P1234, DOI 10.1089/ars.2005.7.1234; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Thornalley PJ, 2003, BIOCHEM SOC T, V31, P1343; Thorpe SR, 2003, AMINO ACIDS, V25, P275, DOI 10.1007/s00726-003-0017-9; Vallenius T, 2002, J CELL SCI, V115, P2067; Wang XL, 2010, AM J PHYSIOL-ENDOC M, V299, pE207, DOI 10.1152/ajpendo.00215.2010; White CN, 2008, AM J PHYSIOL-CELL PH, V294, pC572, DOI 10.1152/ajpcell.00242.2007; Yochum L, 1999, AM J EPIDEMIOL, V149, P943, DOI 10.1093/oxfordjournals.aje.a009738; Yu CM, 2003, J HISTOCHEM CYTOCHEM, V51, P625, DOI 10.1177/002215540305100508; Yutani C, 1999, PATHOL INT, V49, P273, DOI 10.1046/j.1440-1827.1999.00861.x; Zernecke A, 2008, CIRCULATION, V117, P1594, DOI 10.1161/CIRCULATIONAHA.107.729125; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; Zhang YS, 1998, CANCER RES, V58, P4632; Zheng M, 2010, J MOL CELL BIOL, V2, P96, DOI 10.1093/jmcb/mjp038	60	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83283	10.1371/journal.pone.0083283	http://dx.doi.org/10.1371/journal.pone.0083283			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349480	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300142
J	Hennus, MP; van Vught, AJ; Brabander, M; Brus, F; Jansen, NJ; Bont, LJ				Hennus, Marije P.; van Vught, Adrianus J.; Brabander, Mark; Brus, Frank; Jansen, Nicolaas J.; Bont, Louis J.			Mechanical Ventilation Drives Inflammation in Severe Viral Bronchiolitis	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; DISEASE SEVERITY; DISTRESS-SYNDROME; HOSPITALIZED INFANTS; LUNG INFLAMMATION; TRACT INFECTION; CHILDREN; CYTOKINES; LOAD; NASOPHARYNGEAL	Introduction: Respiratory insufficiency due to severe respiratory syncytial virus (RSV) infection is the most frequent cause of paediatric intensive care unit admission in infants during the winter season. Previous studies have shown increased levels of inflammatory mediators in airways of mechanically ventilated children compared to spontaneous breathing children with viral bronchiolitis. In this prospective observational multi-center study we aimed to investigate whether this increase was related to disease severity or caused by mechanical ventilation. Materials and Methods: Nasopharyngeal aspirates were collected <1 hour before intubation and 24 hours later in RSV bronchiolitis patients with respiratory failure (n = 18) and non-ventilated RSV bronchiolitis controls (n = 18). Concentrations of the following cytokines were measured: interleukin (IL)-1 alpha, IL-1 beta, IL-6, monocyte chemotactic protein (MCP)-1 and macrophage inflammatory protein (MIP)-1 alpha. Results: Baseline cytokine levels were comparable between ventilated and non-ventilated infants. After 24 hours of mechanical ventilation mean cytokine levels, except for MIP-1 alpha, were elevated compared to non-ventilated infected controls: IL-1 alpha (159 versus 4 pg/ml, p<0.01), IL-1 beta (1068 versus 99 pg/ml, p<0.01), IL-6 (2343 versus 958 pg/ml, p<0.05) and MCP-1 (174 versus 26 pg/ml, p<0.05). Conclusions: Using pre-and post-intubation observations, this study suggests that endotracheal intubation and subsequent mechanical ventilation cause a robust pulmonary inflammation in infants with RSV bronchiolitis.	[Hennus, Marije P.; van Vught, Adrianus J.; Brabander, Mark; Jansen, Nicolaas J.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Intens Care, Utrecht, Netherlands; [Brus, Frank] Locat Juliana Childrens Hosp, Dept Paediat, Haga Hosp, The Hague, Netherlands; [Bont, Louis J.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Infect Dis, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Haga Hospital; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Hennus, MP (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Intens Care, Utrecht, Netherlands.	m.p.hennus@umcutrecht.nl	Hennus, Marije/D-1643-2014	Hennus, Marije/0000-0003-1508-0456	Elisabeth von Freyburg Foundation (Catharijne Foundation)	Elisabeth von Freyburg Foundation (Catharijne Foundation)	This work was funded by a grant from the Elisabeth von Freyburg Foundation (Catharijne Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MBP, 1998, NEW ENGL J MED, V338, P347, DOI 10.1056/NEJM199802053380602; Behrendt CE, 1998, EUR J PEDIATR, V157, P215, DOI 10.1007/s004310050798; Belderbos ME, 2009, CLIN IMMUNOL, V133, P228, DOI 10.1016/j.clim.2009.07.003; Bem RA, 2009, AM J PHYSIOL-LUNG C, V296, pL46, DOI 10.1152/ajplung.00467.2007; Bennett BL, 2007, J INFECT DIS, V195, P1532, DOI 10.1086/515575; Bont L, 2001, J INFECT DIS, V184, P355, DOI 10.1086/322035; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Buckingham SC, 2000, PEDIATR INFECT DIS J, V19, P113, DOI 10.1097/00006454-200002000-00006; Chiumello D, 1999, AM J RESP CRIT CARE, V160, P109, DOI 10.1164/ajrccm.160.1.9803046; El Saleeby CM, 2011, J INFECT DIS, V204, P996, DOI 10.1093/infdis/jir494; Faber TE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034364; Fodha I, 2007, J MED VIROL, V79, P1951, DOI 10.1002/jmv.21026; Garcia C, 2012, PEDIATR INFECT DIS J, V31, P86, DOI 10.1097/INF.0b013e31822dc8c1; Garofalo RP, 2001, J INFECT DIS, V184, P393, DOI 10.1086/322788; Hennus MP, 2012, EUR RESPIR J, V40, P1508, DOI 10.1183/09031936.00177111; Hornsleth A, 2001, J CLIN VIROL, V21, P163, DOI 10.1016/S1386-6532(01)00159-7; Houben ML, 2010, J MED VIROL, V82, P1266, DOI 10.1002/jmv.21771; Joshi P, 1998, J ALLERGY CLIN IMMUN, V102, P618, DOI 10.1016/S0091-6749(98)70278-7; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; Plotz FB, 2002, INTENS CARE MED, V28, P486, DOI 10.1007/s00134-002-1216-7; Sheeran P, 1999, PEDIATR INFECT DIS J, V18, P115, DOI 10.1097/00006454-199902000-00007; Simoes EAF, 1999, LANCET, V354, P847, DOI 10.1016/S0140-6736(99)80040-3; Soilly AL, 2012, EPIDEMIOL INFECT, V140, P608, DOI 10.1017/S0950268811001208; Thorburn K, 2006, THORAX, V61, P611, DOI 10.1136/thx.2005.048397; Tremblay LN, 2006, INTENS CARE MED, V32, P24, DOI 10.1007/s00134-005-2817-8; Welliver TP, 2007, J INFECT DIS, V195, P1126, DOI 10.1086/512615; Wright M, 2011, PEDIATR PULM, V46, P324, DOI 10.1002/ppul.21377; Zosky GR, 2009, J APPL PHYSIOL, V107, P1472, DOI 10.1152/japplphysiol.00393.2009	30	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83035	10.1371/journal.pone.0083035	http://dx.doi.org/10.1371/journal.pone.0083035			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349427	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300125
J	Zelle, SG; Vidaurre, T; Abugattas, JE; Manrique, JE; Sarria, G; Jeronimo, J; Seinfeld, JN; Lauer, JA; Sepulveda, CR; Venegas, D; Baltussen, R				Zelle, Sten G.; Vidaurre, Tatiana; Abugattas, Julio E.; Manrique, Javier E.; Sarria, Gustavo; Jeronimo, Jose; Seinfeld, Janice N.; Lauer, Jeremy A.; Sepulveda, Cecilia R.; Venegas, Diego; Baltussen, Rob			Cost-Effectiveness Analysis of Breast Cancer Control Interventions in Peru	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; MILLENNIUM DEVELOPMENT GOALS; SUB-SAHARAN AFRICA; LATIN-AMERICA; HEALTH; STRATEGIES; MANAGEMENT; MASSES; MORTALITY; COUNTRIES	Objectives: In Peru, a country with constrained health resources, breast cancer control is characterized by late stage treatment and poor survival. To support breast cancer control in Peru, this study aims to determine the cost-effectiveness of different breast cancer control interventions relevant for the Peruvian context. Methods: We performed a cost-effectiveness analysis (CEA) according to WHO-CHOICE guidelines, from a healthcare perspective. Different screening, early detection, palliative, and treatment interventions were evaluated using mathematical modeling. Effectiveness estimates were based on observational studies, modeling, and on information from Instituto Nacional de Enfermedades Neoplasicas (INEN). Resource utilizations and unit costs were based on estimates from INEN and observational studies. Cost-effectiveness estimates are in 2012 United States dollars (US$) per disability adjusted life year (DALY) averted. Results: The current breast cancer program in Peru ($8,426 per DALY averted) could be improved through implementing triennial or biennial screening strategies. These strategies seem the most cost-effective in Peru, particularly when mobile mammography is applied (from $4,125 per DALY averted), or when both CBE screening and mammography screening are combined (from $4,239 per DALY averted). Triennially, these interventions costs between $63 million and $72 million per year. Late stage treatment, trastuzumab therapy and annual screening strategies are the least cost-effective. Conclusions: Our analysis suggests that breast cancer control in Peru should be oriented towards early detection through combining fixed and mobile mammography screening (age 45-69) triennially. However, a phased introduction of triennial CBE screening (age 40-69) with upfront FNA in non-urban settings, and both CBE (age 40-49) and fixed mammography screening (age 50-69) in urban settings, seems a more feasible option and is also cost-effective. The implementation of this intervention is only meaningful if awareness raising, diagnostic, referral, treatment and basic palliative services are simultaneously improved, and if financial and organizational barriers to these services are reduced.	[Zelle, Sten G.; Baltussen, Rob] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands; [Vidaurre, Tatiana; Abugattas, Julio E.; Sarria, Gustavo] INEN, Directorio Med INEN, Lima, Peru; [Manrique, Javier E.] INEN, Directorio Ejecut Promoc Salud Prevenc & Control, Lima, Peru; [Jeronimo, Jose] INEN, Dept Radioterapia, Lima, Peru; [Jeronimo, Jose] PATH, Programa Comunitario Salud Mamaria, Seattle, WA USA; [Seinfeld, Janice N.] Univ Pacifico, Ctr Invest, Lima, Peru; [Lauer, Jeremy A.] WHO, Costs Effectiveness Expenditure & Prior Setting, CH-1211 Geneva, Switzerland; [Sepulveda, Cecilia R.] WHO, Canc Control, Management Noncommunicable Dis, CH-1211 Geneva, Switzerland; [Venegas, Diego] Minist Salud MINSA, Direcc Gen Salud Personas, Lima, Peru	Radboud University Nijmegen; Universidad del Pacifico Peru; World Health Organization; World Health Organization	Zelle, SG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands.	Sten.Zelle@radboudumc.nl	Baltussen, R.M.P.M./L-4181-2015	Lauer, Jeremy A/0000-0003-0652-0691; venegas, diego/0000-0003-1704-888X	Susan G. Komen for the Cure	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation)	The overall project was funded by Susan G. Komen for the Cure (http://ww5.komen.org/Default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; Adjuvant! Online, 2012, DEC MAK TOOLS HLTH C; Anderson BO, 2006, BREAST J, V12, pS3, DOI 10.1111/j.1075-122X.2006.00199.x; [Anonymous], 2006, PLAN NAC FORT PREV C; Ariga R, 2002, AM J SURG, V184, P410, DOI 10.1016/S0002-9610(02)01014-0; Baltussen R, 2005, BMJ-BRIT MED J, V331, P1364, DOI 10.1136/bmj.38645.660093.68; Bland KI, 1998, CANCER-AM CANCER SOC, V83, P1262, DOI 10.1002/(SICI)1097-0142(19980915)83:6<1262::AID-CNCR28>3.0.CO;2-2; Bobo JK, 2000, J NATL CANCER I, V92, P971, DOI 10.1093/jnci/92.12.971; Bosetti C, 2005, ANN ONCOL, V16, P489, DOI 10.1093/annonc/mdi086; Broekx S, 2011, EUR J HEALTH ECON, V12, P311, DOI 10.1007/s10198-010-0237-3; Brown ML, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P569; Bukhari Mulazim Hussain, 2011, Patholog Res Int, V2011, P689521, DOI 10.4061/2011/689521; Cazap E, 2008, CANCER-AM CANCER SOC, V113, P2359, DOI 10.1002/cncr.23834; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Devi BCR, 2007, ANN ONCOL, V18, P1172, DOI 10.1093/annonc/mdm105; Duffy SW, 2005, BRIT J CANCER, V92, P597, DOI 10.1038/sj.bjc.6602345; Eberl MM, 2008, ANN FAM MED, V6, P528, DOI 10.1370/afm.905; Alcalde-Rabanal JE, 2011, SALUD PUBLICA MEXICO, V53, pS243; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; ENAHO, 2004, ACT MET TRAT BAS DAT; Flobbe K, 2001, INT J CANCER, V92, P616, DOI 10.1002/ijc.1235; Ginsberg GM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e614; Greene FL, 2006, AJCC CANC STAGING AT, Vix; Groot MT, 2006, BREAST J, V12, pS81, DOI 10.1111/j.1075-122X.2006.00206.x; Hortobagyi GN, 2002, SEMIN ONCOL, V29, P134, DOI 10.1053/sonc.2002.34066; Huicho L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-47; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Instituto Nacional de Enfermedades Neoplasicas (INEN), 2008, PERF EP 2008 2009; Instituto Nacional de Enfermedades Neoplasticas, 2011, PLAN ESTR I 2011 201; Instituto Nacional de Estadistica e Informatica Dirreccion Tecnica de Demografia (INEI), 2007, CENS NAC POBL 2007; Instituto Regional de Enfermedades Neoplasicas IREN Norte, 2011, REG HOSP CANC; Kerlikowske K, 2003, ANN INTERN MED, V139, P274, DOI 10.7326/0003-4819-139-4-200308190-00010; Kumar SK, 2007, J PAIN SYMPTOM MANAG, V33, P623, DOI 10.1016/j.jpainsymman.2007.02.005; Lauer Jeremy A, 2003, Cost Eff Resour Alloc, V1, P6, DOI 10.1186/1478-7547-1-6; Laxminarayan R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P35; Lozano-Ascencio R, 2009, SALUD PUBLICA MEXICO, V51, pS147, DOI 10.1590/S0036-36342009000800004; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Mittra I, 2010, INT J CANCER, V126, P976, DOI 10.1002/ijc.24840; Nagar S, 2012, AM J SURG, V204, P193, DOI 10.1016/j.amjsurg.2011.10.018; National Evaluation Team for Breast cancer screening in the Netherlands (NETB), 2009, 19902007 NETB; Nguansangiam S, 2009, ASIAN PAC J CANCER P, V10, P623; Okonkwo QL, 2008, JNCI-J NATL CANCER I, V100, P1290, DOI 10.1093/jnci/djn292; Ortegon M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e607; Purmonen TT, 2011, ACTA ONCOL, V50, P344, DOI 10.3109/0284186X.2011.553841; Radice D, 2003, PHARMACOECONOMICS, V21, P383, DOI 10.2165/00019053-200321060-00003; Salomon JA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e355; Schwartsmann G, 2001, J CLIN ONCOL, V19, p118S; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Thomas JO, 1999, CYTOPATHOLOGY, V10, P206, DOI 10.1046/j.1365-2303.1999.00187.x; Tsu VD, 2013, B WORLD HEALTH ORGAN, V91, P683, DOI 10.2471/BLT.12.116020; Vallejos CS, 2010, CLIN BREAST CANCER, V10, P294, DOI 10.3816/CBC.2010.n.038; Vimpeli SM, 2008, ACTA RADIOL, V49, P863, DOI 10.1080/02841850802235751; Walsh D, 2006, SUPPORT CARE CANCER, V14, P831, DOI 10.1007/s00520-005-0899-z; WHO Chronic Disease Department (CDC), 2012, BREAST CANC BURD POL; WHO Commission on Macroeconomics and Health, 2011, MACR HLTH INV HLTH E; WHO-CHOICE, CHOOS INT AR COST EF; Whyte S, 2011, VALUE HEALTH, V14, P465, DOI 10.1016/j.jval.2010.10.037; Wilson Luis, 2009, Rev. perú. med. exp. salud publica, V26, P207; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, CANC CONTR KNOWL ACT; Zelle SG, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-20; Zelle SG, 2012, TROP MED INT HEALTH, V17, P1031, DOI 10.1111/j.1365-3156.2012.03021.x; Zotov Vladimir, 2003, Breast J, V9 Suppl 2, pS75, DOI 10.1046/j.1524-4741.9.s2.7.x	63	32	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82575	10.1371/journal.pone.0082575	http://dx.doi.org/10.1371/journal.pone.0082575			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24349314	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400085
J	Dinkel, PJ; Willmes, K; Krinzinger, H; Konrad, K; Koten, JW				Dinkel, Philipp Johannes; Willmes, Klaus; Krinzinger, Helga; Konrad, Kerstin; Koten, Jan Willem, Jr.			Diagnosing Developmental Dyscalculia on the Basis of Reliable Single Case FMRI Methods: Promises and Limitations	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; CHILDREN; BRAIN; REPRESENTATIONS; ATTENTION; ORIGINS	FMRI-studies are mostly based on a group study approach, either analyzing one group or comparing multiple groups, or on approaches that correlate brain activation with clinically relevant criteria or behavioral measures. In this study we investigate the potential of fMRI-techniques focusing on individual differences in brain activation within a test-retest reliability context. We employ a single-case analysis approach, which contrasts dyscalculic children with a control group of typically developing children. In a second step, a support-vector machine analysis and cluster analysis techniques served to investigate similarities in multivariate brain activation patterns. Children were confronted with a non-symbolic number comparison and a non-symbolic exact calculation task during fMRI acquisition. Conventional second level group comparison analysis only showed small differences around the angular gyrus bilaterally and the left parieto-occipital sulcus. Analyses based on single-case statistical procedures revealed that developmental dyscalculia is characterized by individual differences predominantly in visual processing areas. Dyscalculic children seemed to compensate for relative under-activation in the primary visual cortex through an upregulation in higher visual areas. However, overlap in deviant activation was low for the dyscalculic children, indicating that developmental dyscalculia is a disorder characterized by heterogeneous brain activation differences. Using support vector machine analysis and cluster analysis, we tried to group dyscalculic and typically developing children according to brain activation. Fronto-parietal systems seem to qualify for a distinction between the two groups. However, this was only effective when reliable brain activations of both tasks were employed simultaneously. Results suggest that deficits in number representation in the visual-parietal cortex get compensated for through finger related aspects of number representation in fronto-parietal cortex. We conclude that dyscalculic children show large individual differences in brain activation patterns. Nonetheless, the majority of dyscalculic children can be differentiated from controls employing brain activation patterns when appropriate methods are used.	[Dinkel, Philipp Johannes; Willmes, Klaus] Rhein Westfal TH Aachen, Univ Hosp, Interdisciplinary Ctr Clin Res BIOMAT, D-52062 Aachen, Germany; [Willmes, Klaus; Koten, Jan Willem, Jr.] Rhein Westfal TH Aachen, Univ Hosp, Sect Neuropsychol, Dept Neurol, D-52062 Aachen, Germany; [Krinzinger, Helga; Konrad, Kerstin] Rhein Westfal TH Aachen, Univ Hosp, Sect Child Neuropsychol, Dept Child & Adolescent Psychiat, D-52062 Aachen, Germany; [Konrad, Kerstin] Forschungszentrum Julich, Inst Neurosci & Med INM 3, D-52425 Julich, Germany	RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Helmholtz Association; Research Center Julich	Dinkel, PJ (corresponding author), Rhein Westfal TH Aachen, Univ Hosp, Interdisciplinary Ctr Clin Res BIOMAT, D-52062 Aachen, Germany.	philipp.dinkel@rwth-aachen.de	Konrad, Kerstin/H-7747-2013; Willmes, Klaus F/A-1268-2014	Konrad, Kerstin/0000-0001-9039-2615; Willmes, Klaus F/0000-0002-9012-0553	Federal Ministry of Education and Research (BMBF) within the NIL 3 initiative [01GJ0808]	Federal Ministry of Education and Research (BMBF) within the NIL 3 initiative(Federal Ministry of Education & Research (BMBF))	Klaus Willmes and Kerstin Konrad were supported by the Federal Ministry of Education and Research (BMBF, http://www.bmbf.de) grant 01GJ0808 within the NIL 3 initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2006, NEUROIMAGE, V29, P1000, DOI 10.1016/j.neuroimage.2005.08.010; Ashkenazi S, 2012, DEV COGN NEUROS-NETH, V2, pS152, DOI 10.1016/j.dcn.2011.09.006; Bennett CM, 2010, ANN NY ACAD SCI, V1191, P133, DOI 10.1111/j.1749-6632.2010.05446.x; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Butterworth B, 2011, SCIENCE, V332, P1049, DOI 10.1126/science.1201536; Butterworth B, 2010, TRENDS COGN SCI, V14, P534, DOI 10.1016/j.tics.2010.09.007; Cicchetti DV, 2001, J CLIN EXP NEUROPSYC, V23, P695, DOI 10.1076/jcen.23.5.695.1249; CICCHETTI DV, 1981, AM J MENT DEF, V86, P127; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Davis N, 2009, NEUROPSYCHOLOGIA, V47, P2470, DOI 10.1016/j.neuropsychologia.2009.04.024; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Delazer M, 2005, NEUROIMAGE, V25, P838, DOI 10.1016/j.neuroimage.2004.12.009; Delazer M, 2003, COGNITIVE BRAIN RES, V18, P76, DOI 10.1016/j.cogbrainres.2003.09.005; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Eaton KP, 2008, NEUROIMAGE, V41, P311, DOI 10.1016/j.neuroimage.2008.02.033; Fair DA, 2012, P NATL ACAD SCI USA, V109, P6769, DOI 10.1073/pnas.1115365109; Fehr T, 2010, NEUROPSYCHOLOGIA, V48, P1407, DOI 10.1016/j.neuropsychologia.2010.01.007; Grabner RH, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00130; Grabner RH, 2009, NEUROPSYCHOLOGIA, V47, P604, DOI 10.1016/j.neuropsychologia.2008.10.013; Hucker HO, 2002, COLOURED PROGR MATRI; Issa NP, 2008, J NEUROPHYSIOL, V99, P2745, DOI 10.1152/jn.90211.2008; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Kaufmann L., 2009, TEDI MATH TEST ERFAS; Kaufmann L, 2011, DEV NEUROPSYCHOL, V36, P763, DOI 10.1080/87565641.2010.549884; Kaufmann L, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-35; Koolschijn PCMP, 2011, J NEUROSCI, V31, P4204, DOI 10.1523/JNEUROSCI.6415-10.2011; Kovas Y, 2007, MONOGR SOC RES CHILD, V72, P1; Kovas Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004587; Krinzinger H, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00373; Krinzinger H, 2011, DEV NEUROPSYCHOL, V36, P721, DOI 10.1080/87565641.2010.549882; Kucian Karin, 2006, Behav Brain Funct, V2, P31; Little DM, 2008, INVEST OPHTH VIS SCI, V49, P1728, DOI 10.1167/iovs.07-0372; Mussolin C, 2010, J COGNITIVE NEUROSCI, V22, P860, DOI 10.1162/jocn.2009.21237; Nigg JT, 2005, BRIT J DEV PSYCHOL, V23, P513, DOI 10.1348/026151005X55848; Price GR, 2007, CURR BIOL, V17, pR1042, DOI 10.1016/j.cub.2007.10.013; RICKEN G, 2011, EMPIRISCHE SONDERPAD, P256; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; von Aster MG, 2007, DEV MED CHILD NEUROL, V49, P868, DOI 10.1111/j.1469-8749.2007.00868.x	40	18	18	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e83722	10.1371/journal.pone.0083722	http://dx.doi.org/10.1371/journal.pone.0083722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349547	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200135
J	Tonazzi, A; Eberini, I; Indiveri, C				Tonazzi, Annamaria; Eberini, Ivano; Indiveri, Cesare			Molecular Mechanism of Inhibition of the Mitochondrial Carnitine/Acylcarnitine Transporter by Omeprazole Revealed by Proteoliposome Assay, Mutagenesis and Bioinformatics	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; RAT-LIVER MITOCHONDRIA; CARNITINE ACYLCARNITINE TRANSLOCASE; SUBSTRATE-BINDING SITE; PROTON PUMP INHIBITORS; CHEMICAL-MODIFICATION; CYSTEINE RESIDUES; CARRIER; IDENTIFICATION; PURIFICATION	The effect of omeprazole on the mitochondrial carnitine/acylcarnitine transporter has been studied in proteoliposomes. Externally added omeprazole inhibited the carnitine/carnitine antiport catalysed by the transporter. The inhibition was partially reversed by DTE indicating that it was caused by the covalent reaction of omeprazole with Cys residue(s). Inhibition of the C-less mutant transporter indicated also the occurrence of an alternative non-covalent mechanism. The IC50 of the inhibition of the WT and the C-less CACT by omeprazole were 5.4 mu M and 29 mu M, respectively. Inhibition kinetics showed non competitive inhibition of the WT and competitive inhibition of the C-less. The presence of carnitine or acylcarnitines during the incubation of the proteoliposomes with omeprazole increased the inhibition. Using site-directed Cys mutants it was demonstrated that C283 and C136 were essential for covalent inhibition. Molecular docking of omeprazole with CACT indicated the formation of both covalent interactions with C136 and C283 and non-covalent interactions in agreement with the experimental data.	[Tonazzi, Annamaria; Indiveri, Cesare] CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy; [Eberini, Ivano] Univ Milan, Lab Biochim & Biofis Computaz, Dipartimento Sci Farmacol & Biomol, Sez Biochim Biofis Fisiol & Immunopatol, Milan, Italy; [Indiveri, Cesare] Univ Calabria, Unit Biochem & Mol Biotechnol, Dept BEST Biol Ecol Sci Terra, Arcavacata Di Rende, Italy	Consiglio Nazionale delle Ricerche (CNR); University of Milan; University of Calabria	Indiveri, C (corresponding author), CNR, Inst Biomembranes & Bioenerget, I-70126 Bari, Italy.	indiveri@unical.it		Indiveri, Cesare/0000-0001-9818-6621	PON-ricerca e competitivita - MIUR (PON project) [01_00937]	PON-ricerca e competitivita - MIUR (PON project)	This work was supported by a grant from PON-ricerca e competitivita 2007-2013 - MIUR (PON project 01_00937: "Modelli sperimentali biotecnologici integrati per la produzione ed il monitoraggio di biomolecole di interesse per la salute dell'uomo".) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besancon M, 1997, J BIOL CHEM, V272, P22438, DOI 10.1074/jbc.272.36.22438; Eldesbrunner H, 1995, P 28 HAW INT C SYST; Galluccio M, 2007, PROTEIN EXPRES PURIF, V52, P175, DOI 10.1016/j.pep.2006.09.002; Ganapathy ME, 2000, J BIOL CHEM, V275, P1699, DOI 10.1074/jbc.275.3.1699; Giangregorio N, 2007, BBA-BIOENERGETICS, V1767, P1331, DOI 10.1016/j.bbabio.2007.08.010; Giangregorio N, 2010, BBA-BIOENERGETICS, V1797, P839, DOI 10.1016/j.bbabio.2010.03.017; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Inarrea P, 2011, FREE RADICAL BIO MED, V50, P1575, DOI 10.1016/j.freeradbiomed.2011.03.003; Indiveri C, 1998, BIOCHEM J, V333, P285, DOI 10.1042/bj3330285; Indiveri C, 1998, BIOCHEM BIOPH RES CO, V249, P589, DOI 10.1006/bbrc.1998.9197; INDIVERI C, 1991, BIOCHIM BIOPHYS ACTA, V1069, P110, DOI 10.1016/0005-2736(91)90110-T; INDIVERI C, 1990, BIOCHIM BIOPHYS ACTA, V1020, P81, DOI 10.1016/0005-2728(90)90096-M; Indiveri C, 2002, BIOCHEMISTRY-US, V41, P8649, DOI 10.1021/bi012183n; INDIVERI C, 1995, EUR J BIOCHEM, V228, P271; Indiveri C, 2010, CURR CHEM BIOL, V4, P108, DOI DOI 10.2174/187231310791170748; Indiveri C, 2011, MOL ASPECTS MED, V32, P223, DOI 10.1016/j.mam.2011.10.008; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Lambrecht N, 1998, J BIOL CHEM, V273, P13719, DOI 10.1074/jbc.273.22.13719; LORENTZON P, 1985, BIOCHIM BIOPHYS ACTA, V817, P25, DOI 10.1016/0005-2736(85)90064-1; Oppedisano F, 2008, J BIOCHEM MOL TOXIC, V22, P8, DOI 10.1002/jbt.20208; Palmieri F, 1995, METHOD ENZYMOL, V260, P349, DOI 10.1016/0076-6879(95)60150-3; PANDE SV, 1975, P NATL ACAD SCI USA, V72, P883, DOI 10.1073/pnas.72.3.883; Pochini L, 2004, BBA-BIOMEMBRANES, V1661, P78, DOI 10.1016/j.bbamem.2003.12.001; Pochini L, 2008, CHEM-BIOL INTERACT, V173, P187, DOI 10.1016/j.cbi.2008.03.003; Pochini L, 2009, CHEM-BIOL INTERACT, V179, P394, DOI 10.1016/j.cbi.2008.10.052; Shin JM, 2013, J NEUROGASTROENTEROL, V19, P25, DOI 10.5056/jnm.2013.19.1.25; Shin JM, 2004, J AM CHEM SOC, V126, P7800, DOI 10.1021/ja049607w; STANLEY CA, 1992, NEW ENGL J MED, V327, P19, DOI 10.1056/NEJM199207023270104; Szewczyk A, 2002, PHARMACOL REV, V54, P101, DOI 10.1124/pr.54.1.101; Tonazzi A, 2005, BBA-BIOMEMBRANES, V1718, P53, DOI 10.1016/j.bbamem.2005.10.007; Tonazzi A, 2005, J BIOL CHEM, V280, P19607, DOI 10.1074/jbc.M411181200; Tonazzi A, 2013, CHEM BIOL INTERACT; Tonazzi A, 2012, BBA-BIOENERGETICS, V1817, P697, DOI 10.1016/j.bbabio.2012.02.007; Tonazzi A, 2009, BBA-BIOENERGETICS, V1787, P1009, DOI 10.1016/j.bbabio.2009.02.026; WHA BI, 1985, J BIOL CHEM, V260, P4591; Zomorodi K, 1997, XENOBIOTICA, V27, P49, DOI 10.1080/004982597240758	36	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82286	10.1371/journal.pone.0082286	http://dx.doi.org/10.1371/journal.pone.0082286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349247	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200072
J	Aguilar-Jimenez, W; Zapata, W; Caruz, A; Rugeles, MT				Aguilar-Jimenez, Wbeimar; Zapata, Wildeman; Caruz, Antonio; Rugeles, Maria T.			High Transcript Levels of Vitamin D Receptor Are Correlated with Higher mRNA Expression of Human Beta Defensins and IL-10 in Mucosa of HIV-1-Exposed Seronegative Individuals	PLOS ONE			English	Article							COMMERCIAL SEX WORKERS; 1,25-DIHYDROXYVITAMIN D-3; ANTIMICROBIAL RESPONSE; HIV-1 INFECTION; CELLS; MONOCYTES; 1-ALPHA,25-DIHYDROXYVITAMIN-D3; MACROPHAGES; ACTIVATION; PROTECTION	Vitamin D (VitD) is an endogenous immunomodulator that could protect from HIV-1 infection reducing immune activation and inducing the expression of anti-HIV-1 peptides. To establish a correlation between VitD and natural resistance to HIV-1 infection, a case-control study using blood and mucosa samples of 58 HIV-1-exposed but seronegative (HESN) individuals, 43 HIV-1 seropositives (SPs) and 59 non-exposed healthy controls (HCs) was carried out. The VitD concentration in plasma was determined by ELISA, and mRNA relative units (RU) of VDR, IL-10, TGF-beta, TNF-alpha and IL-1 beta in peripheral blood mononuclear cells (PBMCs), oral and genital mucosa was quantified by qRT-PCR. mRNA levels of human beta-defensin (HBD) -2 and -3 were previously reported and used for correlations. Significantly higher levels of VitD were found in plasma as well as higher mRNA RU of VDR in PBMCs, and in genital mucosa from HESN compared to HCs. In addition, higher mRNA RU of TNF-alpha, IL-1 beta and IL-10, and lower mRNA RU of TGF-beta were found in PBMC from HESNs compared to HCs. We also observed higher IL-10 mRNA RU in genital mucosa of HESNs compared to HCs, and the mRNA levels of TNF-alpha in oral and genital mucosa of SPs were higher compared to HESNs. Furthermore, positive correlations between VDR and IL-10 mRNA RU in PBMCs and genital mucosa of HESNs were found. Finally, HBD-2 and HBD-3 mRNA RU were positively correlated with VDR mRNA expression in oral mucosa from HESNs. These results suggest that high levels of VitD and its receptor are associated with natural resistance to HIV-1 infection. Up-regulation of the anti-inflammatory IL-10, and the induction of anti-HIV-1 defensins in mucosa might be part of the mechanisms involved in this association. However, further studies are required to define causal associations.	[Aguilar-Jimenez, Wbeimar; Zapata, Wildeman; Rugeles, Maria T.] Univ Antioquia UdeA, Fac Med, Grp Inmunovirol, Medellin, Colombia; [Zapata, Wildeman] Univ Cooperat Colombia, Fac Med, Grp Infettare, Medellin, Colombia; [Caruz, Antonio] Univ Jaen, Fac Ciencias Expt, Dept Biol Expt, Unidad Inmunogenet, Jaen, Spain	Universidad de Antioquia; Universidad Cooperativa de Colombia; Universidad de Jaen	Rugeles, MT (corresponding author), Univ Antioquia UdeA, Fac Med, Grp Inmunovirol, Medellin, Colombia.	mtrugel@udea.edu.co	Zapata, Wildeman/C-1622-2018; Zapata, Wildeman/ABE-5082-2020; Caruz, Antonio/N-5557-2014	Zapata, Wildeman/0000-0002-7351-8738; Zapata, Wildeman/0000-0002-7351-8738; Caruz, Antonio/0000-0002-5788-7840; Rugeles, Maria T./0000-0001-7855-1409; Aguilar Jimenez, Wbeimar/0000-0002-0790-055X	COLCIENCIAS, Colombia [111549326091]; Universidad de Antioquia, Colombia [255]; Fondo de Investigaciones Sanitarias [PI021205]; Junta de Andalucia, Spain [PI-0335/2009]	COLCIENCIAS, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Universidad de Antioquia, Colombia; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Junta de Andalucia, Spain(Junta de Andalucia)	This work was supported by COLCIENCIAS (code 111549326091), Colombia; Universidad de Antioquia (Sostenibilidad 2013-2014 and CODI No255), Colombia; Fondo de Investigaciones Sanitarias (PI021205) and Junta de Andalucia (PI-0335/2009), Spain. WAJ is recipient of a doctoral scholarship from COLCIENCIAS, Colombia. The funders had no role in the design of the study, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AC, 2012, MULT SCLER J, V18, P1797, DOI 10.1177/1352458512442992; Biasin M, 2000, J INFECT DIS, V182, P1365, DOI 10.1086/315873; Briones TL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-244; Campbell GR, 2011, J BIOL CHEM, V286, P18890, DOI 10.1074/jbc.M110.206110; Cervero M, 2012, AIDS RES HUM RETROV, V28, P763, DOI [10.1089/AID.2011.0244, 10.1089/aid.2011.0244]; Chege D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043670; CONNOR RI, 1991, BIOCHEM BIOPH RES CO, V176, P852, DOI 10.1016/S0006-291X(05)80264-5; Dai XJ, 2010, J DERMATOL SCI, V60, P179, DOI 10.1016/j.jdermsci.2010.09.008; Fox J, 2010, ANTIVIR RES, V85, P276, DOI 10.1016/j.antiviral.2009.10.012; Gauzzi MC, 2005, J IMMUNOL, V174, P270, DOI 10.4049/jimmunol.174.1.270; Herzberg M C, 2006, Adv Dent Res, V19, P158; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; Korf H, 2012, IMMUNOBIOLOGY, V217, P1292, DOI 10.1016/j.imbio.2012.07.018; Lajoie J, 2012, MUCOSAL IMMUNOL, V5, P277, DOI 10.1038/mi.2012.7; LEMIRE JM, 1995, J NUTR, V125, pS1704, DOI 10.1093/jn/125.suppl_6.1704S; Liu PT, 2007, TRENDS MOL MED, V13, P117, DOI 10.1016/j.molmed.2007.01.006; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Matilainen JM, 2010, BBA-MOL CELL RES, V1803, P1276, DOI 10.1016/j.bbamcr.2010.07.009; Mazzoli S, 1997, NAT MED, V3, P1250, DOI 10.1038/nm1197-1250; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; McMahon L, 2011, INFECT IMMUN, V79, P2250, DOI 10.1128/IAI.00099-11; Milliken SVI, 2012, J ALLERGY CLIN IMMUN, V129, P1554, DOI 10.1016/j.jaci.2012.03.001; Nevado J, 2007, J MOL ENDOCRINOL, V38, P587, DOI 10.1677/JME-06-0065; Sanchez de la Torre M, 2008, J INFECT DIS, V197, P405, DOI 10.1086/525043; Schauber J, 2006, IMMUNOLOGY, V118, P509, DOI 10.1111/j.1365-2567.2006.02399.x; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; SKOLNIK PR, 1991, P NATL ACAD SCI USA, V88, P6632, DOI 10.1073/pnas.88.15.6632; Songok EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030048; Sun LL, 2005, J VIROL, V79, P14318, DOI 10.1128/JVI.79.22.14318-14329.2005; Taborda-Vanegas Natalia, 2011, Open Virol J, V5, P35, DOI 10.2174/1874357901105010035; Thota C, 2013, REPROD SCI, V20, P463, DOI 10.1177/1933719112459225; Torres C, 2010, CURR HIV RES, V8, P487, DOI 10.2174/157016210793499330; Tugizov SM, 2011, VIROLOGY, V409, P211, DOI 10.1016/j.virol.2010.10.004; Urry Z, 2012, EUR J IMMUNOL, V42, P2697, DOI 10.1002/eji.201242370; Van Den Bout-Van Den Beukel CJP, 2008, AIDS RES HUM RETROV, V24, P1375, DOI 10.1089/aid.2008.0058; van der Aar AMG, 2011, J ALLERGY CLIN IMMUN, V127, P1532, DOI 10.1016/j.jaci.2011.01.068; Walker NJ, 2002, SCIENCE, V296, P557, DOI 10.1126/science.296.5567.557; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; White JH, 2010, J STEROID BIOCHEM, V121, P234, DOI 10.1016/j.jsbmb.2010.03.034; Young JM, 2011, AIDS RES HUM RETROV, V27, P737, DOI [10.1089/aid.2010.0313, 10.1089/AID.2010.0313]; Zapata W, 2013, AIDS RES HU IN PRESS; Zapata W, 2008, CURR HIV RES, V6, P531, DOI 10.2174/157016208786501463	43	25	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82717	10.1371/journal.pone.0082717	http://dx.doi.org/10.1371/journal.pone.0082717			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349345	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100126
J	Wang, ZL; Wang, J; Yue, TL; Yuan, YH; Cai, R; Niu, C				Wang, Zhouli; Wang, Jun; Yue, Tianli; Yuan, Yahong; Cai, Rui; Niu, Chen			Immunomagnetic Separation Combined with Polymerase Chain Reaction for the Detection of Alicyclobacillus acidoterrestris in Apple Juice	PLOS ONE			English	Article							REAL-TIME PCR; RAPID DETECTION; ENZYMATIC AMPLIFICATION; SPP.; PRODUCTS; SAMPLES	A combination of immunomagnetic separation (IMS) and polymerase chain reaction (PCR) was used to detect Alicyclobacillus acidoterrestris (A. acidoterrestris) in apple juice. The optimum technological parameters of the IMS system were investigated. The results indicated that the immunocapture reactions could be finished in 60 min and the quantity of IMPs used for IMS was 2.5 mg/mL. Then the combined IMS-PCR procedure was assessed by detecting A. acidoterrestris in apple juice samples. The agarose gel electrophoresis results of 20 different strains showed that the IMS-PCR procedure presented high specificity to the A. acidoterrestris. The sensitivity of the IMS-PCR was 2x10(1) CFU/mL and the total detection time was 3 to 4 h. Of the 78 naturally contaminated apple juice samples examined, the sensitivity, specificity and accuracy of IMS-PCR compared with the standardized pour plate method were 90.9%, 97.0% and 96.2%, respectively. The results exhibited that the developed IMS-PCR method will be a valuable tool for detecting A. acidoterrestris and improving food quality in juice samples.	[Wang, Zhouli; Yue, Tianli; Yuan, Yahong; Cai, Rui; Niu, Chen] Northwest A&F Univ, Coll Food Sci & Engn, Yangling, Shaanxi, Peoples R China; [Wang, Jun] XuChang Univ, Coll Food Sci & Engn, Xuchang, Henan, Peoples R China	Northwest A&F University - China; Xuchang University	Yue, TL (corresponding author), Northwest A&F Univ, Coll Food Sci & Engn, Yangling, Shaanxi, Peoples R China.	yuetl305@nwsuaf.edu.cn	Cai, Rui/GRO-1869-2022; yue, tianli/AEY-3384-2022	yue, tianli/0000-0002-4768-5831	National Science & Technology Support Program [2012BAK17B06, 2012BAD31B01]; National Natural Science Foundation of China [31071550, 31171721]	National Science & Technology Support Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by National Science & Technology Support Program during the "12th Five-Year" (2012BAK17B06, 2012BAD31B01) and National Natural Science Foundation of China (31071550, 31171721). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira Yokota, 2007, ALICYCLOBACILLUS THE, P64; Concina I, 2010, FOOD RES INT, V43, P2108, DOI 10.1016/j.foodres.2010.07.012; Connor CJ, 2005, INT J FOOD MICROBIOL, V99, P229, DOI 10.1016/j.ijfoodmicro.2004.08.016; Danyluk MD, 2011, FOOD MICROBIOL, V28, P472, DOI 10.1016/j.fm.2010.10.008; Fu Z, 2005, INT J FOOD MICROBIOL, V99, P47, DOI 10.1016/j.ijfoodmicro.2004.07.013; Henczka M, 2013, J MICROBIOL METH, V92, P1, DOI 10.1016/j.mimet.2012.10.007; Jenikova Gabriela, 2000, International Microbiology, V3, P225; Liandris E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020026; Luo H, 2004, LETT APPL MICROBIOL, V39, P376, DOI 10.1111/j.1472-765X.2004.01596.x; Malkova K, 1998, FOOD AGR IMMUNOL, V10, P271, DOI 10.1080/09540109809354990; McCloskey ML, 2007, BIOCHEM GENET, V45, P761, DOI 10.1007/s10528-007-9114-x; Murray MB, 2007, INT J FOOD MICROBIOL, V115, P59, DOI 10.1016/j.ijfoodmicro.2006.10.025; Patel P, 2000, J RAPID METH AUT MIC, V8, P227, DOI 10.1111/j.1745-4581.2000.tb00326.x; Perez-Cacho PR, 2008, J AGR FOOD CHEM, V56, P9785, DOI 10.1021/jf801244j; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Siegmund B, 2007, J AGR FOOD CHEM, V55, P6692, DOI 10.1021/jf070524j; Smit Y, 2011, FOOD MICROBIOL, V28, P331, DOI 10.1016/j.fm.2010.11.008; Spanova A, 2003, J CHROMATOGR A, V1009, P215, DOI 10.1016/S0021-9673(03)00431-X; Wang Y, 2010, J FOOD PROTECT, V73, P390, DOI 10.4315/0362-028X-73.2.390; Wang ZL, 2013, FOOD RES INT, V54, P302, DOI 10.1016/j.foodres.2013.07.021; Wang ZL, 2013, INT J FOOD MICROBIOL, V166, P28, DOI 10.1016/j.ijfoodmicro.2013.06.015; Wang ZL, 2012, J FOOD SCI, V77, pM643, DOI 10.1111/j.1750-3841.2012.02961.x; Yamazaki K, 1996, LETT APPL MICROBIOL, V23, P350, DOI 10.1111/j.1472-765X.1996.tb00206.x; Yang H, 2007, INT J FOOD MICROBIOL, V118, P132, DOI 10.1016/j.ijfoodmicro.2007.06.019; Yang ZY, 2010, J AGR FOOD CHEM, V58, P7135, DOI 10.1021/jf1009654; Zhang JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067704; Zhao XJ, 2004, P NATL ACAD SCI USA, V101, P15027, DOI 10.1073/pnas.0404806101	28	22	24	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e82376	10.1371/journal.pone.0082376	http://dx.doi.org/10.1371/journal.pone.0082376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24349270	gold, Green Submitted, Green Published			2022-12-27	WOS:000327947800095
J	Bistinas, I; Oom, D; Sa, ACL; Harrison, SP; Prentice, IC; Pereira, JMC				Bistinas, Ioannis; Oom, Duarte; Sa, Ana C. L.; Harrison, Sandy P.; Prentice, I. Colin; Pereira, Jose M. C.			Relationships between Human Population Density and Burned Area at Continental and Global Scales	PLOS ONE			English	Article							CLIMATE-CHANGE; FIRE REGIMES; REGRESSION; BIOMASS; VEGETATION; DRIVERS; COVER	We explore the large spatial variation in the relationship between population density and burned area, using continental-scale Geographically Weighted Regression (GWR) based on 13 years of satellite-derived burned area maps from the global fire emissions database (GFED) and the human population density from the gridded population of the world (GPW 2005). Significant relationships are observed over 51.5% of the global land area, and the area affected varies from continent to continent: population density has a significant impact on fire over most of Asia and Africa but is important in explaining fire over < 22% of Europe and Australia. Increasing population density is associated with both increased and decreased in fire. The nature of the relationship depends on land-use: increasing population density is associated with increased burned are in rangelands but with decreased burned area in croplands. Overall, the relationship between population density and burned area is non-monotonic: burned area initially increases with population density and then decreases when population density exceeds a threshold. These thresholds vary regionally. Our study contributes to improved understanding of how human activities relate to burned area, and should contribute to a better estimate of atmospheric emissions from biomass burning.	[Bistinas, Ioannis; Oom, Duarte; Sa, Ana C. L.; Pereira, Jose M. C.] Univ Lisbon, Inst Super Agron, Ctr Estudos Florestais, P-1699 Lisbon, Portugal; [Harrison, Sandy P.; Prentice, I. Colin] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Harrison, Sandy P.] Univ Reading, Sch Human & Environm Sci, Reading, Berks, England; [Prentice, I. Colin] Imperial Coll, Grantham Inst Climate Change, Ascot, Berks, England; [Prentice, I. Colin] Imperial Coll, Dept Life Sci, Ascot, Berks, England	Universidade de Lisboa; Macquarie University; University of Reading; Imperial College London; Imperial College London	Prentice, IC (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	i.bistinas@gmail.com	Pereira, José/N-2829-2019; Oom, Duarte/B-5290-2008; bistinas, ioannis/D-7064-2013; Sá, Ana C.L./R-9148-2018; Pereira, Jose MC/I-1283-2014	Pereira, José/0000-0003-2583-3669; Oom, Duarte/0000-0002-9244-3487; Sá, Ana C.L./0000-0003-0827-7189; Pereira, Jose MC/0000-0003-2583-3669; Bistinas, Ioannis/0000-0002-4221-6817; Harrison, Sandy/0000-0001-5687-1903	Marie Curie Research Training Network GREENCYCLES [MRTN-CT-2004]	Marie Curie Research Training Network GREENCYCLES	This study was funded by the Marie Curie Research Training Network GREENCYCLES, contract number MRTN-CT-2004 (www.greencycles.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Aldersley A, 2011, SCI TOTAL ENVIRON, V409, P3472, DOI 10.1016/j.scitotenv.2011.05.032; Archibald S, 2012, P NATL ACAD SCI USA, V109, P847, DOI 10.1073/pnas.1118648109; Archibald S, 2009, GLOBAL CHANGE BIOL, V15, P613, DOI 10.1111/j.1365-2486.2008.01754.x; Barbosa PM, 1999, GLOBAL BIOGEOCHEM CY, V13, P933, DOI 10.1029/1999GB900042; Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Bond WJ, 1996, FIRE PLANTS; Brunsdon C, 1998, J ROY STAT SOC D-STA, V47, P431, DOI 10.1111/1467-9884.00145; Brunsdon C, 2011, ENVIRON PLANN B, V38, P216, DOI 10.1068/b36093; Byrne G, 2009, 10 INT C GEOC UNSW S; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Center for International Earth Science Information Network (CIESIN) Food and Agriculture Organization of the United Nations (FAO) and Centro Internacional de Agricultura Tropical (CIAT), 2005, GRIDD POP WORLD VERS; Chiu GS, 2003, THESIS U BRIT COLUMB; Ellis EC, 2008, FRONT ECOL ENVIRON, V6, P439, DOI 10.1890/070062; Ellis EC, 2010, GLOBAL ECOL BIOGEOGR, V19, P589, DOI 10.1111/j.1466-8238.2010.00540.x; Flannigan MD, 2000, SCI TOTAL ENVIRON, V262, P221, DOI 10.1016/S0048-9697(00)00524-6; Fotheringham A.S., 2002, GEOGRAPHICALLY WEIGH; Giglio L, 2010, BIOGEOSCIENCES, V7, P1171, DOI 10.5194/bg-7-1171-2010; Gralewicz NJ, 2012, INT J WILDLAND FIRE, V21, P230, DOI 10.1071/WF10095; Guyette RP, 2002, ECOSYSTEMS, V5, P472, DOI 10.1007/s10021-002-0115-7; Harrison SP, 2010, INT YEAR PLANET EART, P21, DOI 10.1007/978-90-481-8716-4_3; Johnson E.A., 1996, FIRE VEGETATION DYNA; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Krawchuk MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005102; Laris P, 2002, HUM ECOL, V30, P155, DOI 10.1023/A:1015685529180; Le Page Y, 2010, GLOBAL ECOL BIOGEOGR, V19, P575, DOI 10.1111/j.1466-8238.2010.00525.x; Leff B, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002108; Lenihan JM, 2008, CLIMATIC CHANGE, V87, pS215, DOI 10.1007/s10584-007-9362-0; Loboda TV, 2012, FRONT EARTH SCI-PRC, V6, P196, DOI 10.1007/s11707-012-0313-3; Marlon JR, 2008, NAT GEOSCI, V1, P697, DOI 10.1038/ngeo313; Oom D, 2013, INT J APPL EARTH OBS, V21, P326, DOI 10.1016/j.jag.2012.07.018; Openshaw S, 1981, QUANT GEOGR BR VIEW, P60, DOI DOI 10.1002/9781118526729.CH3; Page Le Y, 2010, J GEOPHYS RES, V115, P11; Prentice IC, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003906; Pyne S.J., 1996, INTRO WILDLAND FIRE, P769; Pyne SJ, 2009, PROG HUM GEOG, V33, P443, DOI 10.1177/0309132508101598; Ryan CM, 2011, ECOL APPL, V21, P48, DOI 10.1890/09-1489.1; Sa ACL, 2011, J GEOGR SYST, V13, P227, DOI 10.1007/s10109-010-0123-7; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; Scholze M, 2006, P NATL ACAD SCI USA, V103, P13116, DOI 10.1073/pnas.0601816103; Silva JMN, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016056; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Syphard AD, 2007, ECOL APPL, V17, P1388, DOI 10.1890/06-1128.1; Tansey K, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003598; Thonicke K, 2010, BIOGEOSCIENCES, V7, P1991, DOI 10.5194/bg-7-1991-2010; Toms JD, 2003, ECOLOGY, V84, P2034, DOI 10.1890/02-0472; Venevsky S, 2002, GLOBAL CHANGE BIOL, V8, P984, DOI 10.1046/j.1365-2486.2002.00528.x	49	57	57	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81188	10.1371/journal.pone.0081188	http://dx.doi.org/10.1371/journal.pone.0081188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GD	24358108	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000328735700004
J	Mike, A; Strammer, E; Aradi, M; Orsi, G; Perlaki, G; Hajnal, A; Sandor, J; Banati, M; Illes, E; Zaitsev, A; Herold, R; Guttmann, CRG; Illes, Z				Mike, Andrea; Strammer, Erzsebet; Aradi, Mihaly; Orsi, Gergely; Perlaki, Gabor; Hajnal, Andras; Sandor, Janos; Banati, Miklos; Illes, Eniko; Zaitsev, Alexander; Herold, Robert; Guttmann, Charles R. G.; Illes, Zsolt			Disconnection Mechanism and Regional Cortical Atrophy Contribute to Impaired Processing of Facial Expressions and Theory of Mind in Multiple Sclerosis: A Structural MRI Study	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; SURFACE-BASED ANALYSIS; WHITE-MATTER TRACTS; COGNITIVE IMPAIRMENT; SOCIAL COGNITION; ASPERGER-SYNDROME; CEREBRAL-CORTEX; NEURAL SYSTEMS; FACE PERCEPTION; NORMAL ADULTS	Successful socialization requires the ability of understanding of others' mental states. This ability called as mentalization (Theory of Mind) may become deficient and contribute to everyday life difficulties in multiple sclerosis. We aimed to explore the impact of brain pathology on mentalization performance in multiple sclerosis. Mentalization performance of 49 patients with multiple sclerosis was compared to 24 age-and gender matched healthy controls. T1- and T2-weighted three-dimensional brain MRI images were acquired at 3Tesla from patients with multiple sclerosis and 18 gender- and age matched healthy controls. We assessed overall brain cortical thickness in patients with multiple sclerosis and the scanned healthy controls, and measured the total and regional T1 and T2 white matter lesion volumes in patients with multiple sclerosis. Performances in tests of recognition of mental states and emotions from facial expressions and eye gazes correlated with both total T1-lesion load and regional T1-lesion load of association fiber tracts interconnecting cortical regions related to visual and emotion processing (genu and splenium of corpus callosum, right inferior longitudinal fasciculus, right inferior fronto-occipital fasciculus, uncinate fasciculus). Both of these tests showed correlations with specific cortical areas involved in emotion recognition from facial expressions (right and left fusiform face area, frontal eye filed), processing of emotions (right entorhinal cortex) and socially relevant information (left temporal pole). Thus, both disconnection mechanism due to white matter lesions and cortical thinning of specific brain areas may result in cognitive deficit in multiple sclerosis affecting emotion and mental state processing from facial expressions and contributing to everyday and social life difficulties of these patients.	[Mike, Andrea; Strammer, Erzsebet; Banati, Miklos; Illes, Eniko; Illes, Zsolt] Univ Pecs, Div Clin & Expt Neuroimmunol, Dept Neurol, Pecs, Hungary; [Aradi, Mihaly; Orsi, Gergely; Perlaki, Gabor] Univ Pecs, Diagnost Ctr Pecs, Pecs, Hungary; [Hajnal, Andras; Herold, Robert] Univ Pecs, Dept Psychiat & Psychotherapy, Pecs, Hungary; [Sandor, Janos] Univ Debrecen, Fac Publ Hlth, H-4012 Debrecen, Hungary; [Mike, Andrea; Zaitsev, Alexander; Guttmann, Charles R. G.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Imaging,Dept Radiol, Boston, MA 02115 USA; [Mike, Andrea; Zaitsev, Alexander; Guttmann, Charles R. G.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Imaging,Dept Neurol, Boston, MA 02115 USA; [Orsi, Gergely; Perlaki, Gabor; Illes, Zsolt] MTA PTE Clin Neurosci MR Res Grp, Pecs, Hungary; [Illes, Zsolt] Univ Southern Denmark, Odense Univ Hosp, Inst Clin Res, Dept Neurol, Odense, Denmark	University of Pecs; University of Pecs; University of Pecs; University of Debrecen; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Pecs; University of Southern Denmark; Odense University Hospital	Illes, Z (corresponding author), Univ Pecs, Div Clin & Expt Neuroimmunol, Dept Neurol, Pecs, Hungary.	zsolt.illes@aok.pte.hu	Guttmann, Charles RG/J-3093-2018; Herold, Robert/B-2318-2012	Guttmann, Charles/0000-0002-7006-9762; Illes, Zsolt/0000-0001-9655-0450	Multiple Sclerosis International Federation; European Economic Area/Norwegian Financial Mechanism HU [0114]; National Bureau of Research Development, HKTH INNODIAG; American Recovery and Reinvestment Act supplement (National Institute of Biomedical Imaging and Bioengineering) [P41 RR13218, P41 EB015898]; National Multiple Sclerosis Society [RG3574A1]; Hungarian National Research Fund [OTKA K77892]; Hungarian Neuroimaging Foundation; TAMOP - Tarsadalmi Megujulas Operativ Program (Social Renewal Operational Programme) [4.2.2.A-11]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013218] Funding Source: NIH RePORTER	Multiple Sclerosis International Federation; European Economic Area/Norwegian Financial Mechanism HU; National Bureau of Research Development, HKTH INNODIAG; American Recovery and Reinvestment Act supplement (National Institute of Biomedical Imaging and Bioengineering); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Neuroimaging Foundation; TAMOP - Tarsadalmi Megujulas Operativ Program (Social Renewal Operational Programme); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Andrea Mike was a recipient of the 2008 McDonald Fellowship from the Multiple Sclerosis International Federation. Mihaly Aradi, Gergely Orsi, and Gabor Perlaki were supported by the grants of European Economic Area/Norwegian Financial Mechanism HU 0114; and National Bureau of Research Development, HKTH INNODIAG. Alexander Zaitsev was supported by an American Recovery and Reinvestment Act supplement to NAC - Neuroimage Analysis Center (National Institutes of Health National Center for Research Resources P41 RR13218 which is now National Institute of Biomedical Imaging and Bioengineering P41 EB015898). Charles RG Guttmann was supported by the National Multiple Sclerosis Society (Grant RG3574A1). Zsolt Illes was supported by the Hungarian National Research Fund (OTKA K77892), the Hungarian Neuroimaging Foundation, and TAMOP - Tarsadalmi Megujulas Operativ Program (Social Renewal Operational Programme) 4.2.2.A-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Amato MP, 2004, NEUROLOGY, V63, P89, DOI 10.1212/01.WNL.0000129544.79539.D5; Atkinson AP, 2011, PHILOS T R SOC B, V366, P1726, DOI 10.1098/rstb.2010.0349; Banati M, 2010, EUR J NEUROL, V17, P426, DOI 10.1111/j.1468-1331.2009.02836.x; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; Bastiaansen JACJ, 2009, PHILOS T R SOC B, V364, P2391, DOI 10.1098/rstb.2009.0058; BEATTY WW, 1989, B PSYCHONOMIC SOC, V27, P361; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Duering M, 2011, BRAIN, V134, P2366, DOI 10.1093/brain/awr169; Filippi M, 2010, NEUROLOGY, V75, P2121, DOI 10.1212/WNL.0b013e318200d768; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Henry A, 2011, J INT NEUROPSYCH SOC, V17, P1122, DOI 10.1017/S1355617711001147; Henry JD, 2009, J INT NEUROPSYCH SOC, V15, P277, DOI 10.1017/S1355617709090195; Herold R, 2009, ACTA PSYCHIAT SCAND, V119, P199, DOI 10.1111/j.1600-0447.2008.01297.x; Jehna M, 2011, BRAIN IMAGING BEHAV, V5, P241, DOI 10.1007/s11682-011-9128-1; Jehna M, 2010, CLIN NEUROL NEUROSUR, V112, P482, DOI 10.1016/j.clineuro.2010.03.020; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Krause M, 2009, BEHAV BRAIN RES, V205, P280, DOI 10.1016/j.bbr.2009.08.009; Kuperberg GR, 2003, ARCH GEN PSYCHIAT, V60, P878, DOI 10.1001/archpsyc.60.9.878; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Kuzmanovic B, 2012, NEUROIMAGE, V60, P179, DOI 10.1016/j.neuroimage.2011.12.046; Langdon DW, 2011, CURR OPIN NEUROL, V24, P244, DOI 10.1097/WCO.0b013e328346a43b; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Naikar N, 1996, NEUROPSYCHOLOGIA, V34, P1041, DOI 10.1016/0028-3932(96)00019-X; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; Ouellet J, 2010, J INT NEUROPSYCH SOC, V16, P287, DOI 10.1017/S1355617709991329; Park HJ, 2008, HUM BRAIN MAPP, V29, P503, DOI 10.1002/hbm.20314; Philippi CL, 2009, J NEUROSCI, V29, P15089, DOI 10.1523/JNEUROSCI.0796-09.2009; Phillips LH, 2011, NEUROPSYCHOLOGY, V25, P131, DOI 10.1037/a0020752; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Prochnow D, 2011, J NEUROL, V258, P1683, DOI 10.1007/s00415-011-6002-4; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Schulte-Ruther M, 2011, SOC NEUROSCI-UK, V6, P1, DOI 10.1080/17470911003708032; Sepulcre J, 2009, ARCH NEUROL-CHICAGO, V66, P173, DOI 10.1001/archneurol.2008.562; Shamay-Tsoory SG, 2005, NEUROPSYCHOLOGY, V19, P288, DOI 10.1037/0894-4105.19.3.288; Skelly LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040371; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Spielberger C., 1983, MANUAL SATE TRAIT AN; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Summers MM, 2008, MULT SCLER J, V14, P197, DOI 10.1177/1352458507082353; Symington SH, 2010, SOC NEUROSCI-UK, V5, P296, DOI 10.1080/17470910903462419; van Walderveen MAA, 1998, NEUROLOGY, V50, P1282, DOI 10.1212/WNL.50.5.1282; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Williams JHG, 2008, AUTISM RES, V1, P73, DOI 10.1002/aur.15; Zaki J, 2010, J NEUROSCI, V30, P8481, DOI 10.1523/JNEUROSCI.0382-10.2010	62	63	64	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82422	10.1371/journal.pone.0082422	http://dx.doi.org/10.1371/journal.pone.0082422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349280	Green Published, gold, Green Accepted			2022-12-27	WOS:000328734200041
J	Setti-Perdigao, P; Serrano, MAR; Flausino, OA; Bolzani, VS; Guimaraes, MZP; Castro, NG				Setti-Perdigao, Pedro; Serrano, Maria A. R.; Flausino, Otavio A., Jr.; Bolzani, Vanderlan S.; Guimaraes, Marilia Z. P.; Castro, Newton G.			Erythrina mulungu Alkaloids Are Potent Inhibitors of Neuronal Nicotinic Receptor Currents in Mammalian Cells	PLOS ONE			English	Article							ANXIETY-RELATED RESPONSES; RAT HIPPOCAMPAL-NEURONS; WATER-ALCOHOL EXTRACT; ACETYLCHOLINE-RECEPTORS; HYDROALCOHOLIC EXTRACTS; PHARMACOLOGICAL ACTION; DORSAL HIPPOCAMPUS; BETA-ERYTHROIDINE; ANIMAL-MODELS; GENE FAMILY	Crude extracts and three isolated alkaloids from Erythrina mulungu plants have shown anxiolytic effects in different animal models. We investigated whether these alkaloids could affect nicotinic acetylcholine receptors and if they are selective for different central nervous system (CNS) subtypes. Screening experiments were performed using a single concentration of the alkaloid co-applied with acetylcholine in whole cell patch-clamp recordings in three different cell models: (i) PC12 cells natively expressing alpha 3* nicotinic acetylcholine receptors; (ii) cultured hippocampal neurons natively expressing alpha 7* nicotinic acetylcholine receptors; and (iii) HEK 293 cells heterologoulsy expressing alpha 4 beta 2 nicotinic acetylcholine receptors. For all three receptors, the percent inhibition of acetylcholine-activated currents by (+)-11a-hydroxyerysotrine was the lowest, whereas (+)-erythravine and (+)-11a-hydroxyerythravine inhibited the currents to a greater extent. For the latter two substances, we obtained concentration-response curves with a pre-application protocol for the alpha 7* and alpha 4 beta 2 nicotinic acetylcholine receptors. The IC50 obtained with (+)-erythravine and (+)-11a-hydroxyerythravine were 6 mu M and 5 mu M for the alpha 7* receptors, and 13 nM and 4 nM for the alpha 4 beta 2 receptors, respectively. Our data suggest that these Erythrina alkaloids may exert their behavioral effects through inhibition of CNS nicotinic acetylcholine receptors, particularly the alpha 4 beta 2 subtype.	[Setti-Perdigao, Pedro; Guimaraes, Marilia Z. P.; Castro, Newton G.] Univ Fed Rio de Janeiro, Lab Farmacol Mol, Inst Ciencias Biomed, Rio De Janeiro, Brazil; [Serrano, Maria A. R.; Flausino, Otavio A., Jr.; Bolzani, Vanderlan S.] Univ Estadual Paulista, Nucleo Bioensaios Biossintese & Ecofisiol Prod Na, Inst Quim, Araraquara, Brazil	Universidade Federal do Rio de Janeiro; Universidade Estadual Paulista	Castro, NG (corresponding author), Univ Fed Rio de Janeiro, Lab Farmacol Mol, Inst Ciencias Biomed, Rio De Janeiro, Brazil.	ngcastro@farmaco.ufrj.br	Castro, Newton G/C-3263-2009; Guimaraes, Marilia ZP/C-3255-2009; Bolzani, Vanderlan S/C-2111-2012; Castro, Newton/AGX-7014-2022; Bolzani, Vanderlan/C-2111-2012	Castro, Newton G/0000-0001-9570-7428; Guimaraes, Marilia ZP/0000-0001-6397-8506; Bolzani, Vanderlan S/0000-0003-0615-8776; Castro, Newton/0000-0001-9570-7428; Bolzani, Vanderlan/0000-0001-7019-5825	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq 478428/2007-3]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [FAPERJ E26/110.269/2010]; CAPES	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by unrestricted grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq 478428/2007-3), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ E26/110.269/2010) and a CAPES fellowship to PSP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; Bacher I, 2009, EXPERT OPIN PHARMACO, V10, P2709, DOI 10.1517/14656560903329102; Blumenthal EM, 1997, J NEUROSCI, V17, P6094; Booker TK, 2007, PHARMACOL BIOCHEM BE, V87, P146, DOI 10.1016/j.pbb.2007.04.011; BOULTER J, 1987, P NATL ACAD SCI USA, V84, P7763, DOI 10.1073/pnas.84.21.7763; Cheeta S, 2001, PHARMACOL BIOCHEM BE, V70, P491, DOI 10.1016/S0091-3057(01)00641-4; Daly JW, 2005, CELL MOL NEUROBIOL, V25, P513, DOI 10.1007/s10571-005-3968-4; DECKER MW, 1995, EUR J PHARMACOL, V280, P79, DOI 10.1016/0014-2999(95)00191-M; Faggion SA, 2011, EPILEPSY BEHAV, V20, P441, DOI 10.1016/j.yebeh.2010.12.037; File SE, 2002, PSYCHOPHARMACOLOGY, V164, P309, DOI 10.1007/s00213-002-1219-7; File SE, 1998, BEHAV NEUROSCI, V112, P1423, DOI 10.1037/0735-7044.112.6.1423; Flausino OA, 2007, BIOL PHARM BULL, V30, P375, DOI 10.1248/bpb.30.375; Flausino O, 2007, J NAT PROD, V70, P48, DOI 10.1021/np060254j; Folkers K, 1937, J AM CHEM SOC, V59, P1580, DOI 10.1021/ja01287a509; Giniatullin RA, 2000, MOL PHARMACOL, V58, P778, DOI 10.1124/mol.58.4.778; GOLDMAN D, 1987, CELL, V48, P965, DOI 10.1016/0092-8674(87)90705-7; Iturriaga-Vasquez P, 2010, MOL PHARMACOL, V78, P366, DOI 10.1124/mol.110.065490; Lehman AJ, 1937, J PHARMACOL EXP THER, V60, P69; Lippiello PM, 2008, CNS NEUROSCI THER, V14, P266, DOI 10.1111/j.1755-5949.2008.00054.x; Liu X, 2007, PSYCHOPHARMACOLOGY, V194, P463, DOI 10.1007/s00213-007-0863-3; Lorenzi, 2002, RVORES BRASILEIRAS M; Marks MJ, 1999, J PHARMACOL EXP THER, V289, P1090; McGranahan TM, 2011, J NEUROSCI, V31, P10891, DOI 10.1523/JNEUROSCI.0937-11.2011; Mineur YS, 2013, P NATL ACAD SCI USA, V110, P3573, DOI 10.1073/pnas.1219731110; Onusic GM, 2003, BIOL PHARM BULL, V26, P1538, DOI 10.1248/bpb.26.1538; Onusic GM, 2002, BRAZ J MED BIOL RES, V35, P473, DOI 10.1590/S0100-879X2002000400011; Ouagazzal AM, 1999, EUR J NEUROSCI, V11, P3957, DOI 10.1046/j.1460-9568.1999.00823.x; Ribeiro MD, 2006, BRAZ J MED BIOL RES, V39, P263, DOI 10.1590/S0100-879X2006000200013; Rodrigues V.E.G., 2001, PLANTAS MED DOMINIO; Rosa DS, 2012, EPILEPSY BEHAV, V23, P205, DOI 10.1016/j.yebeh.2012.01.003; Salas R, 2003, J NEUROSCI, V23, P6255; Santos HR, 2006, J PHARMACOL EXP THER, V319, P376, DOI 10.1124/jpet.106.106385; Seth P, 2002, PHARMACOL BIOCHEM BE, V71, P795, DOI 10.1016/S0091-3057(01)00715-8; Tekinay AB, 2009, P NATL ACAD SCI USA, V106, P4477, DOI 10.1073/pnas.0813109106; Tucci S, 2002, BEHAV PHARMACOL, V13, P615, DOI 10.1097/00008877-200212000-00002; Tucci S, 2003, BEHAV PHARMACOL, V14, P323, DOI 10.1097/01.fbp.0000081782.35927.c6; Tucci SA, 2003, NEUROPHARMACOLOGY, V44, P367, DOI 10.1016/S0028-3908(02)00391-X; Unna K, 1944, J PHARMACOL EXP THER, V80, P39; Unna K, 1944, J PHARMACOL EXP THER, V80, P53; Vasconcelos SMM, 2007, J ETHNOPHARMACOL, V110, P271, DOI 10.1016/j.jep.2006.09.023; Vasconcelos SMM, 2004, J PHARM PHARMACOL, V56, P389, DOI 10.1211/0022357022746; Vasconcelos SMM, 2003, BIOL PHARM BULL, V26, P946, DOI 10.1248/bpb.26.946; Watkins SS, 1999, PHARMACOL BIOCHEM BE, V62, P743, DOI 10.1016/S0091-3057(98)00226-3; Zarrindast MR, 2012, BRAIN RES, V1460, P25, DOI 10.1016/j.brainres.2012.04.036	44	25	25	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82726	10.1371/journal.pone.0082726	http://dx.doi.org/10.1371/journal.pone.0082726			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349349	Green Submitted, gold, Green Published			2022-12-27	WOS:000328734200053
J	Tang, WF; Qiu, H; Ding, H; Sun, B; Wang, LX; Yin, J; Gu, HY				Tang, Weifeng; Qiu, Hao; Ding, Hao; Sun, Bin; Wang, Lixin; Yin, Jun; Gu, Haiyong			Association between the STK15 F31I Polymorphism and Cancer Susceptibility: A Meta-Analysis Involving 43,626 Subjects	PLOS ONE			English	Article							AURORA-KINASE-A; PHE31ILE POLYMORPHISM; COLORECTAL-CANCER; FUNCTIONAL POLYMORPHISM; GENETIC POLYMORPHISMS; BLADDER-CANCER; LUNG-CANCER; RISK; AURKA; OVEREXPRESSION	The association between the Serine/threonine kinase 15 (STK15) F31I polymorphism (rs2273535) and cancer susceptibility remains controversial. To further investigate this potential relationship, we conducted a comprehensive meta-analysis of 27 published studies involving a total of 19,267 multiple cancer cases and 24,359 controls. Our results indicate statistical evidence of an association between the STK15 F31I polymorphism and the increased risk of overall cancer in four genetic models: AA vs. TA+TT, AA vs. TT, AA vs. TA, and A vs. T. In a stratified analysis by cancer type, there was an increased risk of breast cancer in four genetic models: AA vs. TA+TT, AA vs. TT, AA vs. TA, and A vs. T, as well as esophageal cancer in two genetic models: AA vs. TA+TT and AA vs. TA. In a stratified analysis by ethnicity, there was a significant increase in cancer risk among Asians, but not Caucasians, in four genetic models: AA vs. TA+TT, AA vs. TT, AA vs. TA and A vs. T. In addition, a stratified analysis by ethnicity in the breast cancer subgroup revealed a significant increase in cancer risk among Asians in two genetic models: AA vs. TA+TT and AA vs. TT, as well as among Caucasians in one genetic model: AA vs. TA. In summary, this meta-analysis demonstrates that the STK15 F31I polymorphism may be a risk factor for cancer.	[Tang, Weifeng; Sun, Bin; Yin, Jun; Gu, Haiyong] Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Peoples R China; [Qiu, Hao; Wang, Lixin] Southeast Univ, Sch Med, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Ding, Hao] Jiangsu Univ, Dept Resp Dis, Affiliated Peoples Hosp, Zhenjiang, Peoples R China	Jiangsu University; Southeast University - China; Jiangsu University	Yin, J (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Peoples R China.	yin912@126.com; haiyong_gu@hotmail.com	Qiu, Hao/HGU-4490-2022		Jiangsu University Clinical medicine science and technology development fund [JLY20120004]	Jiangsu University Clinical medicine science and technology development fund	This study was supported by Jiangsu University Clinical medicine science and technology development fund (JLY20120004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2010, BREAST CANCER RES TR, V120, P727, DOI 10.1007/s10549-009-0489-8; Akkiz H, 2010, J VIRAL HEPATITIS, V17, P668, DOI 10.1111/j.1365-2893.2009.01225.x; Andrew AS, 2006, CARCINOGENESIS, V27, P1030, DOI 10.1093/carcin/bgi284; Baba Y, 2009, NEOPLASIA, V11, P418, DOI 10.1593/neo.09154; Briassouli P, 2007, CANCER RES, V67, P1689, DOI 10.1158/0008-5472.CAN-06-2272; Chen JY, 2007, CLIN CANCER RES, V13, P3100, DOI 10.1158/1078-0432.CCR-06-2319; Chen JY, 2007, MOL CARCINOGEN, V46, P249, DOI 10.1002/mc.20283; Chen L, 2005, GENETIC POLYMORPHISM; Chen Xia-bin, 2009, Zhonghua Yufang Yixue Zazhi, V43, P559, DOI 10.3760/cma.j.issn.0253-9624.2009.07.006; Cox DG, 2006, CANCER CAUSE CONTROL, V17, P81, DOI 10.1007/s10552-005-0429-9; Dai Q, 2004, CANCER EPIDEM BIOMAR, V13, P2065; DiCioccio RA, 2004, CANCER EPIDEM BIOMAR, V13, P1589; Dogan I, 2008, DNA CELL BIOL, V27, P443, DOI 10.1089/dna.2007.0719; Egan KM, 2004, CARCINOGENESIS, V25, P2149, DOI 10.1093/carcin/bgh231; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Fletcher O, 2006, J NATL CANCER I, V98, P1014, DOI 10.1093/jnci/djj268; Gu J, 2007, CARCINOGENESIS, V28, P350, DOI 10.1093/carcin/bgl149; Hammerschmied CG, 2007, ONCOL REP, V17, P3; Hienonen T, 2006, INT J CANCER, V118, P505, DOI 10.1002/ijc.21344; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ihsan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029431; Ju H, 2006, CANCER LETT, V242, P273, DOI 10.1016/j.canlet.2005.11.015; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liu L, 2011, CARCINOGENESIS, V32, P336, DOI 10.1093/carcin/bgq264; Lo YL, 2005, INT J CANCER, V115, P276, DOI 10.1002/ijc.20855; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Miao XP, 2004, CANCER RES, V64, P2680, DOI 10.1158/0008-5472.CAN-04-0651; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Navaratne KS, 2010, WORLD NEUROSURG, V74, P144, DOI 10.1016/j.wneu.2010.04.003; Nickels S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003284; Ricketts C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006037; Ruan Y, 2011, J PATHOL, V225, P535, DOI 10.1002/path.2902; Shi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043412; Siegert S, 2013, HUM GENET, V132, P219, DOI 10.1007/s00439-012-1239-2; Song B, 2010, XIANDAI MINIAO WA IK, V15, P277; Sun T, 2004, CARCINOGENESIS, V25, P2225, DOI 10.1093/carcin/bgh244; Tchatchou S, 2007, CANCER LETT, V247, P266, DOI 10.1016/j.canlet.2006.05.002; Terry PD, 2006, INT J CANCER, V118, P3170, DOI 10.1002/ijc.21768; Touvier M., 2013, INT J CANC; Vidarsdottir L, 2007, CANCER LETT, V250, P206, DOI 10.1016/j.canlet.2006.10.003; Wang W, 2007, CLIN CANCER RES, V13, P5974, DOI 10.1158/1078-0432.CCR-07-0113; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Webb EL, 2006, BRIT J CANCER, V95, P1047, DOI 10.1038/sj.bjc.6603382; Yang SB, 2007, ONCOL REP, V17, P1083; Zhang Wen-jie, 2006, Zhonghua Zhongliu Zazhi, V28, P43; Zhao G, 2013, J CANC SURVIV; 桑永华, 2012, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V29, P1220	49	35	35	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82790	10.1371/journal.pone.0082790	http://dx.doi.org/10.1371/journal.pone.0082790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349361	Green Submitted, Green Published, gold			2022-12-27	WOS:000328734200054
J	Itoh, M; Kato, H; Suganami, T; Konuma, K; Marumoto, Y; Terai, S; Sakugawa, H; Kanai, S; Hamaguchi, M; Fukaishi, T; Aoe, S; Akiyoshi, K; Komohara, Y; Takeya, M; Sakaida, I; Ogawa, Y				Itoh, Michiko; Kato, Hideaki; Suganami, Takayoshi; Konuma, Kuniha; Marumoto, Yoshio; Terai, Shuji; Sakugawa, Hiroshi; Kanai, Sayaka; Hamaguchi, Miho; Fukaishi, Takahiro; Aoe, Seiichiro; Akiyoshi, Kazunari; Komohara, Yoshihiro; Takeya, Motohiro; Sakaida, Isao; Ogawa, Yoshihiro			Hepatic Crown-Like Structure: A Unique Histological Feature in Non-Alcoholic Steatohepatitis in Mice and Humans	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ADIPOSE-TISSUE; MOUSE MODEL; CELLS; FIBROSIS; OBESITY; INFLAMMATION; MACROPHAGES; PROGRESSION; ROLES	Although macrophages are thought to be crucial for the pathogenesis of chronic inflammatory diseases, how they are involved in disease progression from simple steatosis to non-alcoholic steatohepatitis (NASH) is poorly understood. Here we report the unique histological structure termed "hepatic crown-like structures (hCLS)" in the mouse model of human NASH; melanocortin-4 receptor deficient mice fed a Western diet. In hCLS, CD11c-positive macrophages aggregate to surround hepatocytes with large lipid droplets, which is similar to those described in obese adipose tissue. Histological analysis revealed that hCLS is closely associated with activated fibroblasts and collagen deposition. When treatment with clodronate liposomes effectively depletes macrophages scattered in the liver, with those in hCLS intact, hepatic expression of inflammatory and fibrogenic genes is unaffected, suggesting that hCLS is an important source of inflammation and fibrosis during the progression of NASH. Notably, the number of hCLS is positively correlated with the extent of liver fibrosis. We also observed increased number of hCLS in the liver of non-alcoholic fatty liver disease/NASH patients. Collectively, our data provide evidence that hCLS is involved in the development of hepatic inflammation and fibrosis, thereby suggesting its pathophysiologic role in disease progression from simple steatosis to NASH.	[Itoh, Michiko; Suganami, Takayoshi] Tokyo Med & Dent Univ, Dept Organ Network & Metab, Tokyo, Japan; [Kato, Hideaki; Konuma, Kuniha; Kanai, Sayaka; Hamaguchi, Miho; Fukaishi, Takahiro; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Tokyo, Japan; [Suganami, Takayoshi] Japan Sci & Technol Agcy, PRESTO, Tokyo, Japan; [Kato, Hideaki] Shionogi & Co Ltd, Med Res Labs, Osaka, Japan; [Marumoto, Yoshio; Terai, Shuji; Sakaida, Isao] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Yamaguchi, Japan; [Aoe, Seiichiro] Otsuma Womens Univ, Dept Home Econ, Tokyo, Japan; [Akiyoshi, Kazunari] Kyoto Univ, Dept Polymer Chem, Grad Sch Engn, Kyoto, Japan; [Komohara, Yoshihiro; Takeya, Motohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Cell Pathol, Kumamoto, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Shionogi & Company Limited; Yamaguchi University; Kyoto University; Kumamoto University	Suganami, T (corresponding author), Tokyo Med & Dent Univ, Dept Organ Network & Metab, Tokyo, Japan.	suganami.mem@tmd.ac.jp; ogawa.mem@tmd.ac.jp	SUGANAMI, Takayoshi/A-9475-2016	Ogawa, Yoshihiro/0000-0002-0834-2836	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labour and Welfare of Japan; Japan Science and Technology Agency, PRESTO; Takeda Science Foundation; Ono Medical Research Foundation; Japan Research Foundation for Clinical Pharmacology; Nestle Nutrition Council, Japan; Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation; Medical Research Institute, Tokyo Medical and Dental University	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency, PRESTO(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ono Medical Research Foundation; Japan Research Foundation for Clinical Pharmacology; Nestle Nutrition Council, Japan; Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation(Uehara Memorial Foundation); Medical Research Institute, Tokyo Medical and Dental University	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Ministry of Health, Labour and Welfare of Japan, and Japan Science and Technology Agency, PRESTO. This work was also supported by research grants from Takeda Science Foundation, Ono Medical Research Foundation, Japan Research Foundation for Clinical Pharmacology, Nestle Nutrition Council, Japan, Astellas Foundation for Research on Metabolic Disorders, The Uehara Memorial Foundation, and the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Asano T, 2009, J GASTROEN HEPATOL, V24, P1669, DOI 10.1111/j.1440-1746.2009.06039.x; Asanuma T, 2010, GUT, V59, P258, DOI 10.1136/gut.2009.176651; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Bremer AA, 2011, J CLIN ENDOCR METAB, V96, pE1782, DOI 10.1210/jc.2011-1577; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Caballero T, 2012, HISTOL HISTOPATHOL, V27, P459, DOI 10.14670/HH-27.459; Cassiman D, 2002, J HEPATOL, V36, P200, DOI 10.1016/S0168-8278(01)00260-4; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Fotiadu A, 2010, PATHOL INT, V60, P87, DOI 10.1111/j.1440-1827.2009.02489.x; Gautron L, 2010, J COMP NEUROL, V518, P6, DOI 10.1002/cne.22221; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ikejima K, 2002, GASTROENTEROLOGY, V122, P1399, DOI 10.1053/gast.2002.32995; Imajo K, 2012, CELL METAB, V16, P44, DOI 10.1016/j.cmet.2012.05.012; Ioannou GN, 2013, J LIPID RES, V54, P1326, DOI 10.1194/jlr.M034876; Itoh M, 2007, ARTERIOSCL THROM VAS, V27, P1918, DOI 10.1161/ATVBAHA.106.136853; Itoh M, 2011, AM J PATHOL, V179, P2454, DOI 10.1016/j.ajpath.2011.07.014; Iwamoto T, 2013, CELL TISSUE RES, V351, P487, DOI 10.1007/s00441-012-1528-z; Juluri R, 2011, J CLIN GASTROENTEROL, V45, P55, DOI 10.1097/MCG.0b013e3181dd1348; Kamada Y, 2003, GASTROENTEROLOGY, V125, P1796, DOI 10.1053/j.gastro.2003.08.029; Kleiner DE, 2006, SEMIN DIAGN PATHOL, V23, P161, DOI 10.1053/j.semdp.2006.11.003; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Ma KL, 2008, HEPATOLOGY, V48, P770, DOI 10.1002/hep.22423; Magness ST, 2004, HEPATOLOGY, V40, P1151, DOI 10.1002/hep.20427; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Ramadori G, 2001, EUR J GASTROEN HEPAT, V13, P777, DOI 10.1097/00042737-200107000-00004; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Rensen SS, 2009, AM J PATHOL, V175, P1473, DOI 10.2353/ajpath.2009.080999; Rivera CA, 2001, AM J PHYSIOL-GASTR L, V281, pG200, DOI 10.1152/ajpgi.2001.281.1.G200; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; Suganami T, 2012, ENDOCR J, V59, P849, DOI 10.1507/endocrj.EJ12-0271; Terai S, 2006, STEM CELLS, V24, P2292, DOI 10.1634/stemcells.2005-0542; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Tosello-Trampont AC, 2012, J BIOL CHEM, V287, P40161, DOI 10.1074/jbc.M112.417014; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Varela-Rey M, 2009, INT J BIOCHEM CELL B, V41, P969, DOI 10.1016/j.biocel.2008.10.027; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200	52	86	88	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82163	10.1371/journal.pone.0082163	http://dx.doi.org/10.1371/journal.pone.0082163			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349208	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300079
J	Lapierre, M; Howe, PDL; Cropper, SJ				Lapierre, Mark; Howe, Piers D. L.; Cropper, Simon J.			Transfer of Learning between Hemifields in Multiple Object Tracking: Memory Reduces Constraints of Attention	PLOS ONE			English	Article							SIGNAL-DETECTION-THEORY; VISUAL WORKING-MEMORY; CAPACITY	Many tasks involve tracking multiple moving objects, or stimuli. Some require that individuals adapt to changing or unfamiliar conditions to be able to track well. This study explores processes involved in such adaptation through an investigation of the interaction of attention and memory during tracking. Previous research has shown that during tracking, attention operates independently to some degree in the left and right visual hemifields, due to putative anatomical constraints. It has been suggested that the degree of independence is related to the relative dominance of processes of attention versus processes of memory. Here we show that when individuals are trained to track a unique pattern of movement in one hemifield, that learning can be transferred to the opposite hemifield, without any evidence of hemifield independence. However, learning is not influenced by an explicit strategy of memorisation of brief periods of recognisable movement. The findings lend support to a role for implicit memory in overcoming putative anatomical constraints on the dynamic, distributed spatial allocation of attention involved in tracking multiple objects.	[Lapierre, Mark; Howe, Piers D. L.; Cropper, Simon J.] Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3052, Australia	University of Melbourne	Lapierre, M (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Parkville, Vic 3052, Australia.	mark.lapierre@alumni.unimelb.edu.au		Cropper, Simon James/0000-0002-3574-6414; Howe, Piers/0000-0001-6171-1381; Lapierre, Mark/0000-0003-2621-5811				Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; Allen R, 2006, Q J EXP PSYCHOL, V59, P1101, DOI 10.1080/02724980543000097; Allen R, 2004, APPL COGNITIVE PSYCH, V18, P337, DOI 10.1002/acp.975; Alvarez GA, 2005, PSYCHOL SCI, V16, P637, DOI 10.1111/j.1467-9280.2005.01587.x; ASH DW, 1990, HUM FACTORS, V32, P139, DOI 10.1177/001872089003200202; BANKS WP, 1970, PSYCHOL BULL, V74, P81, DOI 10.1037/h0029531; Barker K, 2010, EXP PSYCHOL, V57, P208, DOI 10.1027/1618-3169/a000026; Battelli L, 2009, J COGNITIVE NEUROSCI, V21, P1946, DOI 10.1162/jocn.2008.21149; Bettencourt KC, 2009, J VISION, V9, DOI 10.1167/9.7.9; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Byers A, 2012, VISION RES, V74, P30, DOI 10.1016/j.visres.2012.07.008; Carlson TA, 2007, P NATL ACAD SCI USA, V104, P13496, DOI 10.1073/pnas.0702685104; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Chun MM, 1999, PSYCHOL SCI, V10, P360, DOI 10.1111/1467-9280.00168; Delvenne JF, 2012, COGNITION, V122, P258, DOI 10.1016/j.cognition.2011.10.015; Delvenne JF, 2005, COGNITION, V96, pB79, DOI 10.1016/j.cognition.2004.12.007; Fine I, 2002, J VISION, V2, P190, DOI 10.1167/2.2.5; Fiser J, 2001, PSYCHOL SCI, V12, P499, DOI 10.1111/1467-9280.00392; Fiser J, 2009, LEARN BEHAV, V37, P141, DOI 10.3758/LB.37.2.141; Fougnie D, 2006, PSYCHOL SCI, V17, P526, DOI 10.1111/j.1467-9280.2006.01739.x; GIBSON EJ, 1963, ANNU REV PSYCHOL, V14, P29, DOI 10.1146/annurev.ps.14.020163.000333; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Green CS, 2006, COGNITION, V101, P217, DOI 10.1016/j.cognition.2005.10.004; Green DM, 1966, SIGNAL DETECTION THE; Hudson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043796; Iordanescu L, 2009, J VISION, V9, DOI 10.1167/9.4.1; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Kellman PJ, 2009, PHYS LIFE REV, V6, P53, DOI 10.1016/j.plrev.2008.12.001; Kleiner M., 2007, WHATS NEW PSYCHTOOLB; Kunar MA, 2005, J VISION, V5, P412; Levin JR, 1994, PSYCHOL B, V115; Lu ZL, 2011, NEUROBIOL LEARN MEM, V95, P145, DOI 10.1016/j.nlm.2010.09.010; Ma WJ, 2009, J VISION, V9, DOI 10.1167/9.11.3; MACMILLAN NA, 1990, PSYCHOL BULL, V107, P401, DOI 10.1037/0033-2909.107.3.401; Makovski T, 2009, J EXP PSYCHOL HUMAN, V35, P1687, DOI 10.1037/a0016453; Makovski T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002228; McNicol D., 1972, PRIMER SIGNAL DETECT; Morey RD, 2008, TUTOR QUANT METHODS, V4, P61, DOI 10.20982/tqmp.04.2.p061; Ogawa H, 2009, VIS COGN, V17, P1244, DOI 10.1080/13506280802457176; Oksama L, 2004, VIS COGN, V11, P631, DOI 10.1080/13506280344000473; Oksama L, 2008, COGNITIVE PSYCHOL, V56, P237, DOI 10.1016/j.cogpsych.2007.03.001; Papenmeier F, 2012, ATTEN PERCEPT PSYCHO, V74, P397, DOI 10.3758/s13414-011-0242-3; Peck AC, 2000, HUM FACTORS, V42, P379, DOI 10.1518/001872000779698150; Perruchet P, 2006, TRENDS COGN SCI, V10, P233, DOI 10.1016/j.tics.2006.03.006; Pinto Y, 2010, J VISION, V10, DOI 10.1167/10.10.4; Proctor R. W., 1995, SKILL ACQUISITION HU; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Sagi D, 2011, VISION RES, V51, P1552, DOI 10.1016/j.visres.2010.10.019; Sasaki Y, 2012, WIRES COGN SCI, V3, P293, DOI 10.1002/wcs.1175; Scholl B.J., 2010, ENCY PERCEPTION, VVol. 2, P935; Scholl BJ, 2009, COMPUTATION, COGNITION, AND PYLYSHYN, P49; Seitz AR, 2009, VISION RES, V49, P2604, DOI 10.1016/j.visres.2009.08.003; Shim WM, 2008, PSYCHON B REV, V15, P390, DOI 10.3758/PBR.15.2.390; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; The MathWorks I, 2006, MATLAB; Turk-Browne NB, 2005, J EXP PSYCHOL GEN, V134, P552, DOI 10.1037/0096-3445.134.4.552; Turk-Browne NB, 2010, J NEUROSCI, V30, P11177, DOI 10.1523/JNEUROSCI.0858-10.2010; Turk-Browne NB, 2009, J EXP PSYCHOL HUMAN, V35, P195, DOI 10.1037/0096-1523.35.1.195; Vul E., 2009, ADV NEURAL INFORM PR, P1955; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828	64	1	1	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83872	10.1371/journal.pone.0083872	http://dx.doi.org/10.1371/journal.pone.0083872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349555	Green Published, gold			2022-12-27	WOS:000328730300152
J	Seo, EH; Lee, DY; Lee, JM; Park, JS; Sohn, BK; Choe, YM; Byun, MS; Choi, HJ; Woo, JI				Seo, Eun Hyun; Lee, Dong Young; Lee, Jong-Min; Park, Jun-Sung; Sohn, Bo Kyung; Choe, Young Min; Byun, Min Soo; Choi, Hyo Jung; Woo, Jong Inn			Influence ofAPOE Genotype on Whole-Brain Functional Networks in Cognitively Normal Elderly	PLOS ONE			English	Article							APOLIPOPROTEIN-E EPSILON-4; POSITRON-EMISSION-TOMOGRAPHY; GRAPH-THEORETICAL ANALYSIS; ALZHEIMERS-DISEASE; GENETIC RISK; TOPOLOGICAL PATTERNS; BLOOD-FLOW; ALLELE; MRI; ASSOCIATION	This study aimed to investigate the influence of apolipoprotein E (APOE) epsilon 4 allele on whole-brain functional networks in cognitively normal (CN) elderly by applying graph theoretical analysis to brain glucose metabolism. Eighty-six CN elderly [28 APOE epsilon 4 carriers (epsilon 4+) and 58 non-carriers (epsilon 4-)] underwent clinical evaluation and resting [F-18] fluorodeoxyglucose positron emission tomography scan. Whole-brain functional networks were constructed from correlations of the 90 regions of interest using the automated anatomical labeling template, and analyzed using graph theoretical approaches. The overall small-world property seen in epsilon 4- was preserved in epsilon 4+. However, both local clustering and path length were lower in epsilon 4+ compared to epsilon 4-. In terms of the hubs of functional networks, epsilon 4+ showed decreased centrality of the right hippocampus but increased centrality of several brain regions associated with the default mode network compared to epsilon 4-. Our results indicate that genetic vulnerability to Alzheimer's disease may alter whole-brain functional networks even before clinical symptoms appear.	[Seo, Eun Hyun; Lee, Dong Young; Sohn, Bo Kyung; Choe, Young Min; Byun, Min Soo; Choi, Hyo Jung; Woo, Jong Inn] Seoul Natl Univ Hosp, Dept Neuropsychiat, Seoul 110744, South Korea; [Lee, Dong Young; Sohn, Bo Kyung; Choe, Young Min; Byun, Min Soo; Choi, Hyo Jung; Woo, Jong Inn] Seoul Natl Univ, Coll Med, Dept Neuropsychiat, Seoul, South Korea; [Seo, Eun Hyun; Lee, Dong Young; Woo, Jong Inn] Seoul Natl Univ, Interdisciplinary Program Cognit Sci, Seoul, South Korea; [Lee, Jong-Min; Park, Jun-Sung] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Hanyang University	Lee, DY (corresponding author), Seoul Natl Univ Hosp, Dept Neuropsychiat, Seoul 110744, South Korea.	chwila@hanmail.net	Lee, Jeong Min/V-3429-2019; Byun, Min Soo/GLS-1324-2022	Lee, Jeong Min/0000-0003-0561-8777; 	Seoul National University Hospital [2012-0568]; Korea Healthcare Technology R & D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea [A092145]; KIST Open Research Program [2013-1520]; Korea government (MEST) [2011-0028333]	Seoul National University Hospital; Korea Healthcare Technology R & D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea; KIST Open Research Program; Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This study was supported by a grant from the Seoul National University Hospital (Grant No. 2012-0568), a grant from the Korea Healthcare Technology R & D Project, Ministry of Health, Welfare & Family Affairs, Republic of Korea (Grant No. A092145), a grant from KIST Open Research Program (Grant No. 2013-1520), and a grant from Korea government (MEST) (Grant No. 2011-0028333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bondi MW, 2005, NEUROLOGY, V64, P501, DOI 10.1212/01.WNL.0000150885.00929.7E; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Brown JA, 2011, P NATL ACAD SCI USA, V108, P20760, DOI 10.1073/pnas.1109038108; Buldu JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019584; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chen TF, 2009, PSYCHIAT RES-NEUROIM, V173, P15, DOI 10.1016/j.pscychresns.2008.09.002; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; Dukart J, 2010, NEUROIMAGE, V49, P1490, DOI 10.1016/j.neuroimage.2009.09.017; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Fleisher AS, 2009, NEUROIMAGE, V47, P1678, DOI 10.1016/j.neuroimage.2009.06.021; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Jhoo JH, 2010, PSYCHIAT RES-NEUROIM, V183, P237, DOI 10.1016/j.pscychresns.2010.03.006; JUEPTNER M, 1995, NEUROIMAGE, V2, P148, DOI 10.1006/nimg.1995.1017; Kim KW, 2002, INT J GERIATR PSYCH, V17, P635, DOI 10.1002/gps.664; Lee DY, 2004, J INT NEUROPSYCH SOC, V10, P72, DOI 10.1017/s1355617704101094; Lee J. H., 2002, J GERONTOL B-PSYCHOL, V57, P47, DOI DOI 10.1093/GER0NB/57.1.P47; Lemaitre H, 2005, NEUROIMAGE, V24, P1205, DOI 10.1016/j.neuroimage.2004.10.016; Lind J, 2006, NEUROSCI LETT, V396, P23, DOI 10.1016/j.neulet.2005.11.070; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mosconi L, 2013, NEUROBIOL AGING, V34, P22, DOI 10.1016/j.neurobiolaging.2012.03.002; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Pihlajamaki M, 2009, BEHAV NEUROL, V21, P77, DOI 10.3233/BEN-2009-0231; Power JD, 2010, NEURON, V67, P735, DOI 10.1016/j.neuron.2010.08.017; Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Reiman EM, 2001, P NATL ACAD SCI USA, V98, P3334, DOI 10.1073/pnas.061509598; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Seo EH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053922, 10.1371/journal.pone.0076875]; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; SOKOLOFF L, 1981, FED PROC, V40, P2311; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00005; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Supekar K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000100; Tuminello Elizabeth R, 2011, Int J Alzheimers Dis, V2011, P726197, DOI 10.4061/2011/726197; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Westlye ET, 2011, J NEUROSCI, V31, P7775, DOI 10.1523/JNEUROSCI.1230-11.2011; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Zhu WL, 2012, NEUROBIOL AGING, V33, P899, DOI 10.1016/j.neurobiolaging.2010.06.022	52	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83205	10.1371/journal.pone.0083205	http://dx.doi.org/10.1371/journal.pone.0083205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349461	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300139
J	Hovik, KT; Saunes, BK; Aarlien, AK; Egeland, J				Hovik, Kjell Tore; Saunes, Brit-Kari; Aarlien, Anne Kristine; Egeland, Jens			RCT of Working Memory Training in ADHD: Long-Term Near-Transfer Effects	PLOS ONE			English	Article							CHILDREN; BRAIN; DEFICITS; MODEL	Objective: The aim of the study is to evaluate the long-term near-transfer effects of computerized working memory (WM) training on standard WM tasks in children with Attention-Deficit/Hyperactivity Disorder (ADHD). Method: Sixty-seven children aged 10-12 years in Vestfold/Telemark counties (Norway) diagnosed with F90.0 Hyperkinetic disorder (ICD-10) were randomly assigned to training or control group. The training group participated in a 25-day training program at school, while the control group received treatment-as-usual Participants were tested one week before intervention, immediately after and eight months later. Based on a component analysis, six measures of WM were grouped into composites representing Visual, Auditory and Manipulation WM. Results: The training group had significant long-term differential gains compared to the control group on all outcome measures. Performance gains for the training group were significantly higher in the visual domain than in the auditory domain. The differential gain in Manipulation WM persisted after controlling for an increase in simple storage capacity. Conclusion: Systematic training resulted in a long-term positive gain in performance on similar tasks, indicating the viability of training interventions for children with ADHD. The results provide evidence for both domain-general and domain-specific models. Far-transfer effects were not investigated in this article.	[Hovik, Kjell Tore; Aarlien, Anne Kristine; Egeland, Jens] Vestfold Hosp Trust, Div Mental Hlth & Addict, Tonsberg, Norway; [Hovik, Kjell Tore; Egeland, Jens] Univ Oslo, Dept Psychol, Oslo, Norway; [Saunes, Brit-Kari] Telemark Hosp Trust, Div Child & Adolescent Psychiat, Skien, Norway	University of Oslo; Telemark Hospital Trust	Hovik, KT (corresponding author), Vestfold Hosp Trust, Div Mental Hlth & Addict, Tonsberg, Norway.	kjell.tore.hovik@sykehuset-innlandet.no			Centre for Child and Adolescent Mental Health, Eastern & Southern Norway; Norwegian Resource Center for ADHD, Tourette and Narcolepsy	Centre for Child and Adolescent Mental Health, Eastern & Southern Norway; Norwegian Resource Center for ADHD, Tourette and Narcolepsy	Funding from a grant from the Centre for Child and Adolescent Mental Health, Eastern & Southern Norway and a grant from The Norwegian Resource Center for ADHD, Tourette and Narcolepsy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aben B, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00301; Adolfsdottir S, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-9; Alloway TP, 2006, CHILD DEV, V77, P1698, DOI 10.1111/j.1467-8624.2006.00968.x; Baddeley AD, 2008, COGNITIVE NEUROSCIEN; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barkley RA, 2006, J AM ACAD CHILD PSY, V45, P192, DOI 10.1097/01.chi.0000189134.97436.e2; Barnett SM, 2002, PSYCHOL BULL, V128, P612, DOI 10.1037//0033-2909.128.4.612; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Bradley-Johnson S, 1998, PSYCHOL SCH, V35, P409; Carpenter PA, 2000, CURR OPIN NEUROBIOL, V10, P195, DOI 10.1016/S0959-4388(00)00074-X; Casey BJ, 2005, CURR OPIN NEUROBIOL, V15, P239, DOI 10.1016/j.conb.2005.03.012; Crowe SF, 2000, ASSESSMENT, V7, P113, DOI 10.1177/107319110000700202; Dahlin KIE, 2011, READ WRIT, V24, P479, DOI 10.1007/s11145-010-9238-y; DANEMAN M, 1987, ATTENTION PERFORM, P491; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Duff SC, 2008, SCAND J PSYCHOL, V40, P251; Egeland J, 2013, PLOS ONE, DOI [10.1371/journal.pone.0075660, DOI 10.1371/J0URNAL.P0NE.0075660]; Egeland J, 2006, NORD PSYCHOL, V58, P136, DOI 10.1027/1901-2276.58.2.136; Engle Randall W., 1999, MODELS WORKING MEMOR, P102; Gibson BS, 2011, CHILD NEUROPSYCHOL, V17, P546, DOI 10.1080/09297049.2010.551186; Grafman J., 2006, DISORDERS VOLITION, P347; Hale JB, 2002, J PSYCHOEDUC ASSESS, V20, P128, DOI 10.1177/073428290202000202; Holmes J, 2010, APPL COGNITIVE PSYCH, V24, P827, DOI 10.1002/acp.1589; Holmes J, 2009, DEVELOPMENTAL SCI, V12, pF9, DOI 10.1111/j.1467-7687.2009.00848.x; Klingberg T, 2002, J CLIN EXP NEUROPSYC, V24, P781, DOI 10.1076/jcen.24.6.781.8395; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Landro NI, 2001, NEUROREPORT, V12, P4047, DOI 10.1097/00001756-200112210-00038; Loe IM, 2007, J PEDIATR PSYCHOL, V32, P643, DOI 10.1093/jpepsy/jsl054; Logie RH, 2008, COGNITIVE NEUROSCIEN; Martinussen R, 2005, J AM ACAD CHILD PSY, V44, P377, DOI 10.1097/01.chi.0000153228.72591.73; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Mezzacappa E., 2010, SCH MENTAL HLTH, V2, P202, DOI DOI 10.1007/S12310-010-9030-9; Miyake A., 1999, MODELS WORKING MEMOR; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Ottem E, 2007, SKOLEPSYKOLOGI, V4, P13; Ottem E., 2005, SPRAK 6 16 SCREENING; Perry W, 2001, SCHIZOPHRENIA BULL, V27, P157, DOI 10.1093/oxfordjournals.schbul.a006854; Roid G.H., 1997, LEITER INT PERFORMAN; Sergeant J, 2000, NEUROSCIENCE BIOBEHA; Sergeant JA, 2005, BIOL PSYCHIAT, V57, P1248, DOI 10.1016/j.biopsych.2004.09.010; Shah P, 1996, J EXP PSYCHOL GEN, V125, P4, DOI 10.1037/0096-3445.125.1.4; Shipstead Z, 2012, PSYCHOL BULL, V138, P628, DOI 10.1037/a0027473; Shipstead Z, 2010, PSYCHOL BELG, V50, P245, DOI 10.5334/pb-50-3-4-245; Tehan G., 2007, WORKING MEMORY BEHAV, P153; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; Wechsler D., 2004, WISC 4 WECHSLER INTE, DOI 10.1037/t15174-000	46	42	44	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e80561	10.1371/journal.pone.0080561	http://dx.doi.org/10.1371/journal.pone.0080561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VD	24352414	Green Submitted, gold, Green Published			2022-12-27	WOS:000328705200007
J	Siering, U; Eikermann, M; Hausner, E; Hoffmann-Esser, W; Neugebauer, EA				Siering, Ulrich; Eikermann, Michaela; Hausner, Elke; Hoffmann-Esser, Wiebke; Neugebauer, Edmund A.			Appraisal Tools for Clinical Practice Guidelines: A Systematic Review	PLOS ONE			English	Review							INFECTIOUS-DISEASES SOCIETY; CORONARY-HEART-DISEASE; CONFLICT-OF-INTEREST; INTERNATIONAL GUIDELINES; METHODOLOGICAL QUALITY; MEDICAL LITERATURE; USERS GUIDES; AMERICAN-COLLEGE; RECOMMENDATIONS; CARE	Introduction: Clinical practice guidelines can improve healthcare processes and patient outcomes, but are often of low quality. Guideline appraisal tools aim to help potential guideline users in assessing guideline quality. We conducted a systematic review of publications describing guideline appraisal tools in order to identify and compare existing tools. Methods: Among others we searched MEDLINE, EMBASE and the Cochrane Database of Systematic Reviews from 1995 to May 2011 for relevant primary and secondary publications. We also handsearched the reference lists of relevant publications. On the basis of the available literature we firstly generated 34 items to be used in the comparison of appraisal tools and grouped them into thirteen quality dimensions. We then extracted formal characteristics as well as questions and statements of the appraisal tools and assigned them to the items. Results: We identified 40 different appraisal tools. They covered between three and thirteen of the thirteen possible quality dimensions and between three and 29 of the possible 34 items. The main focus of the appraisal tools were the quality dimensions "evaluation of evidence" (mentioned in 35 tools; 88%), "presentation of guideline content" (34 tools; 85%), "transferability" (33 tools; 83%), "independence" (32 tools; 80%), "scope" (30 tools; 75%), and "information retrieval" (29 tools; 73%). The quality dimensions "consideration of different perspectives" and "dissemination, implementation and evaluation of the guideline" were covered by only twenty (50%) and eighteen tools (45%) respectively. Conclusions: Most guideline appraisal tools assess whether the literature search and the evaluation, synthesis and presentation of the evidence in guidelines follow the principles of evidence-based medicine. Although conflicts of interest and norms and values of guideline developers, as well as patient involvement, affect the trustworthiness of guidelines, they are currently insufficiently considered. Greater focus should be placed on these issues in the further development of guideline appraisal tools.	[Siering, Ulrich; Hausner, Elke; Hoffmann-Esser, Wiebke] Inst Qual & Efficiency Hlth Care IQWiG, Cologne, Germany; [Eikermann, Michaela; Neugebauer, Edmund A.] Univ Witten Herdecke, Dept Med, Fac Hlth, Inst Res Operat Med IFOM, Cologne, Germany	Witten Herdecke University	Siering, U (corresponding author), Inst Qual & Efficiency Hlth Care IQWiG, Cologne, Germany.	ulrich.siering@iqwig.de						ADAPTE Collaborating, 2009, GUID AD RES TOOLK VE; Agency for Healthcare Research and Quality, 2011, NAT GUID CLEAR; AGREE Next Steps Consortium, 2009, APPR GUID RES EV 2 A; Alonso-Coello P, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2010.042077; Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; American College of Cardiology Foundation and American Heart Association, 2010, METH MAN POL ACCF AH; American Medical Association, 1990, ATTR GUID DEV PRACT; [Anonymous], 1995, GASTROENTEROLOGY, V108, P925; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften Arztliches Zentrum fur Qualitat in der Medizin, 2008, DTSCH INSTR METH LEI; Baumann MH, 2007, CHEST, V132, P1015, DOI 10.1378/chest.07-1271; Baxter NN, 2003, SEMIN COLON RECTAL S, V14, P19, DOI [10.1053/scrs.2003.127416, DOI 10.1053/SCRS.2003.127416]; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Boyd EA, 2000, JAMA-J AM MED ASSOC, V284, P2209, DOI 10.1001/jama.284.17.2209; Broedl UC, 2003, J GEN INTERN MED, V18, P190, DOI 10.1046/j.1525-1497.2003.20207.x; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Bundesarztekammer Kassenarztliche Bundesvereinigung, 1997, DTSCH ARZTEBL, V94, pA2154; Burgers JS, 2003, INT J TECHNOL ASSESS, V19, P148, DOI 10.1017/S026646230300014X; Burgers JS, 2002, DIABETES CARE, V25, P1933, DOI 10.2337/diacare.25.11.1933; Burls A, 2010, LANCET, V376, P1128, DOI 10.1016/S0140-6736(10)61034-3; Calder L, 1997, CAN MED ASSOC J, V156, pS1; Campbell EG, 2007, NEW ENGL J MED, V357, P1796, DOI 10.1056/NEJMp078141; Canadian Medical Association, 1994, GUID CAN CLIN PRACT; Chauhan SP, 2006, AM J OBSTET GYNECOL, V194, P1564, DOI 10.1016/j.ajog.2006.03.001; Chong C, 2009, J GEN INTERN MED, V24, P977, DOI 10.1007/s11606-009-0987-8; Chou R, 2008, PAIN MED, V9, P531, DOI 10.1111/j.1526-4637.2008.00422_2.x; Chou R, 2008, PAIN MED, V9, P518, DOI 10.1111/j.1526-4637.2008.00422_1.x; Cluzeau F, 1997, APPRAISAL INSTRUMENT; Cluzeau FA, 1999, INT J QUAL HEALTH C, V11, P21, DOI 10.1093/intqhc/11.1.21; Cook DJ, 1998, CRIT CARE MED, V26, P599, DOI 10.1097/00003246-199803000-00038; Cox L, 2011, CAN FAM PHYSICIAN, V57, pE263; Coyne DW, 2007, CLIN J AM SOC NEPHRO, V2, P3, DOI 10.2215/CJN.02170606; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Detsky AS, 2006, CAN MED ASSOC J, V175, P1033, DOI 10.1503/cmaj.061181; Deutsche Gesellschaft fur Unfallchirurgie, 2008, LEITL METH DGU; Eccles MP, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-60; Field MJ, 1992, GUID CLIN PRACT DEV; Field MJ, 1990, CLIN PRACTICE GUIDEL; Fields SD, 2000, GERIATRICS, V55, P59; Fortin M, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-74; Foy R, 2002, J CLIN EPIDEMIOL, V55, P717, DOI 10.1016/S0895-4356(02)00403-1; Fretheim A, 2002, J FAM PRACTICE, V51, P963; FRETHEIM A, 2006, HEALTH RES POLICY SY, V4, P15, DOI DOI 10.1186/1478-4505-4-15; Friedman SE, 2011, CLIN J AM SOC NEPHRO, V6, P1185, DOI 10.2215/CJN.09391010; Gardner B, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-48; Gillois P, 2006, STUD HEALTH TECHNOL, V124, P639; Graham ID, 2000, INT J TECHNOL ASSESS, V16, P1024, DOI 10.1017/S0266462300103095; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; GRILLI R, 1994, MED CARE, V32, P202, DOI 10.1097/00005650-199403000-00002; Grimshaw Jeremy, 2004, J Contin Educ Health Prof, V24 Suppl 1, pS31, DOI 10.1002/chp.1340240506; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Grol R, 2003, BRIT J CANCER, V89, pS4, DOI 10.1038/sj.bjc.6601077; Grol R, 1998, BRIT MED J, V317, P858, DOI 10.1136/bmj.317.7162.858; Gronseth GS., 2011, AM ACAD NEUROLOGY; Guyatt G, 2002, USERS GUIDES MED LIT, P175; GUYATT GH, 1995, JAMA-J AM MED ASSOC, V274, P1800, DOI 10.1001/jama.274.22.1800; HADORN DC, 1994, JOINT COMM J QUAL IM, V20, P539, DOI 10.1016/S1070-3241(16)30099-2; HAINES A, 1994, BMJ-BRIT MED J, V308, P1488, DOI 10.1136/bmj.308.6942.1488; Hakkennes S, 2008, QUAL SAF HEALTH CARE, V17, P296, DOI 10.1136/qshc.2007.023804; Hargrove P, 2008, LANG SPEECH HEAR SER, V39, P289, DOI 10.1044/0161-1461(2008/028); Hart RG, 2002, NEUROLOGY, V59, P977, DOI 10.1212/WNL.59.7.977; Hasenfeld R, 2003, QUAL SAF HEALTH CARE, V12, P428, DOI 10.1136/qhc.12.6.428; Hayward R S, 1993, Ann Intern Med, V118, P731; HAYWARD RSA, 1995, JAMA-J AM MED ASSOC, V274, P570, DOI 10.1001/jama.274.7.570; HAYWARD RSA, 1993, CAN MED ASSOC J, V148, P507; Hindley C, 2005, J ADV NURS, V52, P307, DOI 10.1111/j.1365-2648.2005.03593.x; Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen, ERPR METH BEW INT LI; Jacobs AK, 2004, J AM COLL CARDIOL, V44, P1736, DOI 10.1016/j.jacc.2004.08.040; Kashyap N, 2011, GLIA GUIDLINE IMPLEM; Kelly AM, 2008, RESP MED, V102, P1830, DOI 10.1016/j.rmed.2008.07.026; Khan AR, 2010, CLIN INFECT DIS, V51, P1147, DOI 10.1086/656735; Kravitz SR, 2010, ADV SKIN WOUND CARE, V23, P161, DOI 10.1097/01.ASW.0000363529.93253.dd; Kryworuchko J, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-49; Kulig M, 2003, EUR J HEART FAIL, V5, P327, DOI 10.1016/S1388-9842(03)00040-0; Kung J, 2012, ARCH INTERN MED, V172, P1628, DOI 10.1001/2013.jamainternmed.56; Kyoong A, 2006, INTERN MED J, V36, P506, DOI 10.1111/j.1445-5994.2006.01142.x; Lee DH, 2011, ARCH INTERN MED, V171, P18, DOI 10.1001/archinternmed.2010.482; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Liddle J, 1996, METHOD EVALUATION RE; Linskey Mark E, 2010, Clin Neurosurg, V57, P28; Manuel DG, 2006, BMJ-BRIT MED J, V332, P1419, DOI 10.1136/bmj.38849.487546.DE; Marshall JK, 2000, CAN J GASTROENTEROL, V14, P505, DOI 10.1155/2000/302785; McAlister FA, 2007, PLOS MED, V4, P1325, DOI 10.1371/journal.pmed.0040250; Medves J, 2010, INT J EVID-BASED HEA, V8, P79, DOI 10.1111/j.1744-1609.2010.00166.x; Moreira T, 2006, J CLIN EPIDEMIOL, V59, P1199, DOI 10.1016/j.jclinepi.2005.08.021; MOTTURPILSON C, 1995, INT J QUAL HEALTH C, V7, P31, DOI 10.1093/intqhc/7.1.31; Moyer VA, 2004, PEDIATRICS, V114, P1511, DOI 10.1542/peds.2004-1076; Mutasingwa DR, 2011, CAN FAM PHYSICIAN, V57, pE253; National Institute for Health and Clinical Excellence, 2009, GUID MAN; Nicholson D, 2002, EVIDENCE BASED REHAB, P193; Nonino F, 2004, NEUROL SCI, V25, P2, DOI 10.1007/s10072-004-0217-7; Nuckols TK, 2008, J GEN INTERN MED, V23, P37, DOI 10.1007/s11606-007-0440-9; Pagliari C, 2002, J EVAL CLIN PRACT, V8, P145, DOI 10.1046/j.1365-2753.2002.00333.x; Pagliari C, 2001, J EVAL CLIN PRACT, V7, P165, DOI 10.1046/j.1365-2753.2001.00272.x; Pentheroudakis G, 2008, ANN ONCOL, V19, P2067, DOI 10.1093/annonc/mdn418; Pinsky LE, 2000, EVIDENCE-BASED CLINICAL PRACTICE: CONCEPTS AND APPROACHES, P119; Platz T, 2009, NEUROL REHABIL, V15, P75; Qaseem A, 2012, ANN INTERN MED, V156, P525, DOI 10.7326/0003-4819-156-7-201204030-00009; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Raine R, 2004, LANCET, V364, P429, DOI 10.1016/S0140-6736(04)16766-4; Reed GM, 2002, AM PSYCHOL, V57, P1052, DOI 10.1037//0003-066X.57.12.1052; Rosenfeld RM, 2006, OTOLARYNGOL HEAD S S, V135, pS1, DOI [10.1016/j.otohns.2006.05.733, DOI 10.1016/J.OTOHNS.2006.05.733]; Rosumeck S, 2011, J DTSCH DERMATOL GES, V9, P297, DOI 10.1111/j.1610-0387.2011.07615.x; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Sanderlin BW, 2007, J AM OSTEOPATH ASSOC, V107, P321; Sanders GD, 2000, MED DECIS MAKING, V20, P145, DOI 10.1177/0272989X0002000201; Savoie I, 2000, J Health Serv Res Policy, V5, P76; Scottish Intercollegiate Guidelines Network, 2011, SIGN 50 GUID DEV HDB; Shaneyfelt TM, 2009, JAMA-J AM MED ASSOC, V301, P868, DOI 10.1001/jama.2009.225; Shaneyfelt TM, 1999, JAMA-J AM MED ASSOC, V281, P1900, DOI 10.1001/jama.281.20.1900; Sheehy AM, 2010, MAYO CLIN PROC, V85, P27, DOI 10.4065/mcp.2009.0289; Shekelle P, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-62; Shekelle PG, 2000, HEALTH SERV RES, V34, P1429; Shiffman RN, 2000, J AM MED INFORM ASSN, V7, P488, DOI 10.1136/jamia.2000.0070488; Shiffman RN, 2003, ANN INTERN MED, V139, P493, DOI 10.7326/0003-4819-139-6-200309160-00013; Sniderman AD, 2009, JAMA-J AM MED ASSOC, V301, P429, DOI 10.1001/jama.2009.15; Snowball R, 2005, EVIDENCE BASED PRACT, P127; Solberg L I, 2000, Jt Comm J Qual Improv, V26, P171; Sonnad S, 1993, MED DECIS MAKING, V13, P398; The AGREE Collaboration, 2001, APPR GUID RES EV; Thorson T, 1999, CHANGING; Turner T, 2008, IMPLEMENT SCI, V3, DOI 10.1186/1748-5908-3-45; Veale B, 1999, Aust Fam Physician, V28, P744; Vlayen J, 2005, INT J QUAL HEALTH C, V17, P235, DOI 10.1093/intqhc/mzi027; von Eckardstein A, 2005, Z Kardiol, V94, P52; Ward JE, 1996, MED J AUSTRALIA, V165, P574, DOI 10.5694/j.1326-5377.1996.tb138645.x; Warriner RA, 2011, PLAST RECONSTR SURG, V127, p144S, DOI 10.1097/PRS.0b013e31820023dc; Watine J, 2006, CLIN CHEM, V52, P65, DOI 10.1373/clinchem.2005.056952; Williams MJ, 2011, MED J AUSTRALIA, V195, P442, DOI 10.5694/mja10.11130; WILSON MC, 1995, JAMA-J AM MED ASSOC, V274, P1630, DOI 10.1001/jama.274.20.1630; WOOLF SH, 1995, AM FAM PHYSICIAN, V51, P1455; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; Woolf S, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-61; World Health Organization, 2003, GUID WHO GUID; Yu HR, 2010, PEDIATR NEONATOL, V51, P273, DOI 10.1016/S1875-9572(10)60053-8; Zuiderent-Jerak T, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6702	136	121	124	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82915	10.1371/journal.pone.0082915	http://dx.doi.org/10.1371/journal.pone.0082915			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VD	24349397	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200115
J	Peng, JY; Chen, YJ; Green, MD; Sabatinos, SA; Forsburg, SL; Hsu, CN				Peng, Jyh-Ying; Chen, Yen-Jen; Green, Marc D.; Sabatinos, Sarah A.; Forsburg, Susan L.; Hsu, Chun-Nan			PombeX: Robust Cell Segmentation for Fission Yeast Transillumination Images	PLOS ONE			English	Article							TRACKING; ONSET; SET	Schizosaccharomyces pombe shares many genes and proteins with humans and is a good model for chromosome behavior and DNA dynamics, which can be analyzed by visualizing the behavior of fluorescently tagged proteins in vivo. Performing a genome-wide screen for changes in such proteins requires developing methods that automate analysis of a large amount of images, the first step of which requires robust segmentation of the cell. We developed a segmentation system, PombeX, that can segment cells from transmitted illumination images with focus gradient and varying contrast. Corrections for focus gradient are applied to the image to aid in accurate detection of cell membrane and cytoplasm pixels, which is used to generate initial contours for cells. Gradient vector flow snake evolution is used to obtain the final cell contours. Finally, a machine learning-based validation of cell contours removes most incorrect or spurious contours. Quantitative evaluations show overall good segmentation performance on a large set of images, regardless of differences in image quality, lighting condition, focus condition and phenotypic profile. Comparisons with recent related methods for yeast cells show that PombeX outperforms current methods, both in terms of segmentation accuracy and computational speed.	[Peng, Jyh-Ying; Chen, Yen-Jen] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Peng, Jyh-Ying] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Peng, Jyh-Ying] Natl Yang Ming Univ, Ctr Syst & Synthet Biol, Taipei 112, Taiwan; [Green, Marc D.; Sabatinos, Sarah A.; Forsburg, Susan L.] Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA USA; [Hsu, Chun-Nan] Univ Calif San Diego, Dept Med, Div Biomed Informat, La Jolla, CA 92093 USA; [Hsu, Chun-Nan] Acad Sinica, Inst Informat Sci, Taipei, Taiwan; [Hsu, Chun-Nan] Univ So Calif, Inst Informat Sci, Marina Del Rey, CA 90292 USA	National Yang Ming Chiao Tung University; Taipei City Hospital; National Yang Ming Chiao Tung University; University of Southern California; University of California System; University of California San Diego; Academia Sinica - Taiwan; University of Southern California	Peng, JY (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.	jypeng@ym.edu.tw; chunnan@iis.sinica.edu.tw		Forsburg, Susan L/0000-0002-4895-8598	Taipei City Hospital [R98073, 99TPECH05, 100TPECH05, 102TPECH04]; National Institutes of Health [R01 GM059321]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059321] Funding Source: NIH RePORTER	Taipei City Hospital; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JYP is supported by Taipei City Hospital, grant no. R98073 (99TPECH05, 100TPECH05 and 102TPECH04). MDG, SAS and SLF are supported by National Institutes of Health grant R01 GM059321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bredies Kristian, 2012, COMPUTING VISUALIZAT, P1; Grallert B, 1996, GENE DEV, V10, P2644, DOI 10.1101/gad.10.20.2644; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kvarnstrom M, 2008, OPT EXPRESS, V16, P12943, DOI 10.1364/OE.16.012943; Mukherjee DP, 2004, IEEE T IMAGE PROCESS, V13, P562, DOI 10.1109/TIP.2003.819858; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ray N, 2002, IEEE T MED IMAGING, V21, P1222, DOI 10.1109/TMI.2002.806291; SAKA Y, 1993, CELL, V74, P383, DOI 10.1016/0092-8674(93)90428-S; Suzuki G, 2006, CURR GENET, V49, P237, DOI 10.1007/s00294-005-0051-0; Tscherepanow M, 2008, LECT NOTES ARTIF INT, V5108, P158, DOI 10.1007/978-3-540-70715-8_13; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Xu CY, 1998, IEEE T IMAGE PROCESS, V7, P359, DOI 10.1109/83.661186; Zimmer C, 2002, IEEE T MED IMAGING, V21, P1212, DOI 10.1109/TMI.2002.806292	15	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81434	10.1371/journal.pone.0081434	http://dx.doi.org/10.1371/journal.pone.0081434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24353754	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566700036
J	Cunningham, C; Srivastava, A; Collin, E; Grad, S; Alini, M; Pandit, A; Wall, JG				Cunningham, Claire; Srivastava, Akshay; Collin, Estelle; Grad, Sibylle; Alini, Mauro; Pandit, Abhay; Wall, J. Gerard			Isolation and Characterisation of a Recombinant Antibody Fragment That Binds NCAM1-Expressing Intervertebral Disc Cells	PLOS ONE			English	Article							HUMAN NUCLEUS PULPOSUS; DOMOIC ACID; PROTEIN; DEGENERATION; EXPRESSION; SINGLE; TISSUE; GENE; IMMOBILIZATION; REGENERATION	Degeneration of the intervertebral discs (IVD) is a leading cause of neck and low back pain. Degeneration begins in the central nucleus pulposus region, leading to loss of IVD osmotic properties. Regeneration approaches include administration of matrix-mimicking scaffolds, cells and/or therapeutic factors. Cell-targeting strategies are likely to improve delivery due to the low cell numbers in the IVD. Single-chain antibody fragments (scFvs) that bind IVD cells were isolated for potential delivery of therapeutics to degenerated IVD. The most cell-distal domain of neural cell adhesion molecule 1 (NCAM1) was cloned and expressed in Escherichia coli. Phage display technology was used to isolate a human scFv against the recombinant domain by panning a scFv library on the immobilised protein. The isolated scFv bound cultured rat astrocytes, as well as bovine nucleus pulposus and annulus fibrosus cells in immunocytochemical studies. The scFv also labelled cells in bovine spinal cord and six-month and two-year old bovine IVD sections by immunohistochemistry. Antibody fragments can provide cell-binding moieties at improved cost, time, yield and functionalisation potential over whole antibodies. The described scFv has potential application in delivery of therapeutics to NCAM1-expressing cells in degenerated IVD.	[Cunningham, Claire; Srivastava, Akshay; Wall, J. Gerard] Natl Univ Ireland, Network Excellence Funct Biomat NFB, Galway NUI Galway, Galway, Ireland; [Cunningham, Claire; Srivastava, Akshay; Collin, Estelle; Grad, Sibylle; Alini, Mauro; Pandit, Abhay; Wall, J. Gerard] NUI Galway, Galway, Ireland; [Grad, Sibylle; Alini, Mauro] AO Res Inst, Davos, Switzerland	Ollscoil na Gaillimhe-University of Galway	Wall, JG (corresponding author), Natl Univ Ireland, Network Excellence Funct Biomat NFB, Galway NUI Galway, Galway, Ireland.	gerard.wall@nuigalway.ie	Pandit, Abhay/B-6187-2008; Alini, Mauro/AAG-7961-2020	Pandit, Abhay/0000-0002-6292-4933; Srivastava, Akshay/0000-0001-5048-9420; Wall, Gerard/0000-0003-4603-4276	Science Foundation Ireland [07/SRC/B1163]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The work was supported by Science Foundation Ireland (www.sfi.ie) Grant No. 07/SRC/B1163 to the Network of Excellence for Functional Biomaterials at NUI Galway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Asgeirsdottir SA, 2010, J CONTROL RELEASE, V141, P241, DOI 10.1016/j.jconrel.2009.09.008; Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002; Burton AK, 2006, EUR SPINE J, V15, pS136, DOI 10.1007/s00586-006-1070-3; Chang Ki-Hwan, 2012, Immune Netw, V12, P155, DOI 10.4110/in.2012.12.4.155; Collin EC, 2011, BIOMATERIALS, V32, P2862, DOI 10.1016/j.biomaterials.2011.01.018; Freemont T J, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002885; Frobin W, 2001, EUR RADIOL, V11, P263, DOI 10.1007/s003300000556; Gaetani P, 2008, TISSUE ENG PT A, V14, P1415, DOI 10.1089/ten.tea.2007.0330; Gruber HE, 2011, EXP MOL PATHOL, V91, P534, DOI 10.1016/j.yexmp.2011.06.001; Guarino V, 2012, POLYMERS-BASEL, V4, P1590, DOI 10.3390/polym4031590; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guterl CC, 2013, EUR CELLS MATER, V25, P1; Halloran DO, 2008, BIOMATERIALS, V29, P438, DOI 10.1016/j.biomaterials.2007.10.009; Hong H, 2012, ACS NANO, V6, P2361, DOI 10.1021/nn204625e; Hortiguela MJ, 2013, MAR DRUGS, V11, P881, DOI 10.3390/md11030881; Hu X., 2012, BIOL INTERACTIONS SU, P90; Hu XJ, 2005, J BIOTECHNOL, V120, P38, DOI 10.1016/j.jbiotec.2005.05.018; Hu XJ, 2007, PROTEIN EXPRES PURIF, V52, P194, DOI 10.1016/j.pep.2006.08.009; Hu XJ, 2006, J PHYS CHEM B, V110, P18703, DOI 10.1021/jp062423e; Hu XJ, 2013, BIOMACROMOLECULES, V14, P153, DOI 10.1021/bm301518p; Illien-Junger S, 2010, SPINE, V35, P1744, DOI 10.1097/BRS.0b013e3181c48019; Jendeberg L, 1997, J IMMUNOL METHODS, V201, P25, DOI 10.1016/S0022-1759(96)00215-3; Kepler CK, 2011, J AM ACAD ORTHOP SUR, V19, P543, DOI 10.5435/00124635-201109000-00005; LYONS G, 1981, BIOCHIM BIOPHYS ACTA, V673, P443, DOI 10.1016/0304-4165(81)90476-1; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; MILLER JM, 1988, SYST BOT, V13, P173, DOI 10.1097/00007632-198802000-00008; Molloy PE, 1995, MOL BIOTECHNOL, V4, P239, DOI 10.1007/BF02779017; Newland B, 2013, ACS CHEM NEUROSCI, V4, P540, DOI 10.1021/cn4000023; O'Dwyer R, 2009, APPL BIOCHEM BIOTECH, V159, P178, DOI 10.1007/s12010-008-8379-9; Pansri P, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-6; Parolin M, 2010, Evid Based Spine Care J, V1, P67, DOI 10.1055/s-0028-1100919; Pattappa G, 2012, J ANAT, V221, P480, DOI 10.1111/j.1469-7580.2012.01521.x; Power KA, 2011, ARTHRITIS RHEUM-US, V63, P3876, DOI 10.1002/art.30607; Prasarn ML, 2012, J NEUROSURG-SPINE, V16, P172, DOI 10.3171/2011.10.SPINE11116; Richardson SM, 2008, BIOMATERIALS, V29, P85, DOI 10.1016/j.biomaterials.2007.09.018; Ronn LCB, 1998, EXP GERONTOL, V33, P853, DOI 10.1016/S0531-5565(98)00040-0; Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1; Rutges J, 2010, OSTEOARTHR CARTILAGE, V18, P416, DOI 10.1016/j.joca.2009.09.009; Sakai D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2226; Sakai D, 2009, SPINE, V34, P1448, DOI 10.1097/BRS.0b013e3181a55705; Spada S, 2002, EXTREMOPHILES, V6, P301, DOI 10.1007/s00792-001-0257-0; Strange DGT, 2012, J MECH BEHAV BIOMED, V11, P16, DOI 10.1016/j.jmbbm.2011.10.003; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Terpe K, 2003, APPL MICROBIOL BIOT, V60, P523, DOI 10.1007/s00253-002-1158-6; Thie Holger, 2009, V525, P309, DOI 10.1007/978-1-59745-554-1_16; Thomsen NK, 1996, NAT STRUCT BIOL, V3, P581, DOI 10.1038/nsb0796-581; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Yoon ST, 2003, SPINE, V28, P1773, DOI 10.1097/01.BRS.0000083204.44190.34; Zhang Y, 2007, SPINE, V32, P2515, DOI 10.1097/BRS.0b013e318158cc09	50	8	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83678	10.1371/journal.pone.0083678	http://dx.doi.org/10.1371/journal.pone.0083678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349544	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200098
J	White, RR; Sung, P; Vestal, CG; Benedetto, G; Cornelio, N; Richardson, C				White, Ryan R.; Sung, Patricia; Vestal, C. Greer; Benedetto, Gregory; Cornelio, Noelle; Richardson, Christine			Double-Strand Break Repair by Interchromosomal Recombination: An In Vivo Repair Mechanism Utilized by Multiple Somatic Tissues in Mammals	PLOS ONE			English	Article							DNA-TOPOISOMERASE-II; HOMOLOGOUS RECOMBINATION; CHROMOSOMAL TRANSLOCATIONS; CELL-CYCLE; V(D)J RECOMBINATION; INFANT LEUKEMIA; TRANSGENIC MICE; STEM-CELLS; GENOME; GENE	Homologous recombination (HR) is essential for accurate genome duplication and maintenance of genome stability. In eukaryotes, chromosomal double strand breaks (DSBs) are central to HR during specialized developmental programs of meiosis and antigen receptor gene rearrangements, and form at unusual DNA structures and stalled replication forks. DSBs also result from exposure to ionizing radiation, reactive oxygen species, some anti-cancer agents, or inhibitors of topoisomerase II. Literature predicts that repair of such breaks normally will occur by non-homologous end-joining (in G1), intrachromosomal HR (all phases), or sister chromatid HR (in S/G2). However, no in vivo model is in place to directly determine the potential for DSB repair in somatic cells of mammals to occur by HR between repeated sequences on heterologs (i.e., interchromosomal HR). To test this, we developed a mouse model with three transgenes-two nonfunctional green fluorescent protein (GFP) transgenes each containing a recognition site for the I-SceI endonuclease, and a tetracycline-inducible I-SceI endonuclease transgene. If interchromosomal HR can be utilized for DSB repair in somatic cells, then I-SceI expression and induction of DSBs within the GFP reporters may result in a functional GFP+ gene. Strikingly, GFP+ recombinant cells were observed in multiple organs with highest numbers in thymus, kidney, and lung. Additionally, bone marrow cultures demonstrated interchromosomal HR within multiple hematopoietic subpopulations including multi-lineage colony forming unit-granulocyte-erythrocyte-monocyte-megakaryocte (CFU-GEMM) colonies. This is a direct demonstration that somatic cells in vivo search genome-wide for homologous sequences suitable for DSB repair, and this type of repair can occur within early developmental populations capable of multi-lineage differentiation.	[White, Ryan R.; Vestal, C. Greer; Benedetto, Gregory; Cornelio, Noelle; Richardson, Christine] Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA; [Sung, Patricia] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, New York, NY 10021 USA	University of North Carolina; University of North Carolina Charlotte; Memorial Sloan Kettering Cancer Center	Richardson, C (corresponding author), Univ N Carolina, Dept Biol, Charlotte, NC 28223 USA.	caricha2@uncc.edu	Richardson, Christine/AAP-6472-2020		North Carolina Biotechnology Center Undergraduate Biotechnology Research Fellowship; Concern Foundation; National Institutes of Health/National Cancer Institute [CA100159]; Alexander and Margaret Stewart Trust; Columbia University; University of North Carolina-Charlotte; NATIONAL CANCER INSTITUTE [R01CA100159, R56CA100159] Funding Source: NIH RePORTER	North Carolina Biotechnology Center Undergraduate Biotechnology Research Fellowship; Concern Foundation; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alexander and Margaret Stewart Trust; Columbia University; University of North Carolina-Charlotte; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	RW was a recipient of the North Carolina Biotechnology Center Undergraduate Biotechnology Research Fellowship. This work was supported in part by funds provided to CR by the Concern Foundation, National Institutes of Health/National Cancer Institute CA100159, the Alexander and Margaret Stewart Trust, Columbia University, and University of North Carolina-Charlotte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Ashley T, 2006, AM J HUM GENET, V79, P524, DOI 10.1086/507652; Bandele OJ, 2007, BIOCHEMISTRY-US, V46, P6097, DOI 10.1021/bi7000664; Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633; Blanc G, 2000, PLANT CELL, V12, P1093, DOI 10.1105/tpc.12.7.1093; Boubakour-Azzouz I, 2008, DNA REPAIR, V7, P149, DOI 10.1016/j.dnarep.2007.09.005; Brown AD, 2011, MOL CELL BIOL, V31, P3593, DOI 10.1128/MCB.00848-10; Celsing E, 1998, ANN ONCOL, V9, P1213, DOI 10.1023/A:1008446430765; Cheng Y, 2010, MUTAT RES-FUND MOL M, V683, P115, DOI 10.1016/j.mrfmmm.2009.10.016; CHOULIKA A, 1995, MOL CELL BIOL, V15, P1968; Clejan I, 2006, GENETICS, V173, P1301, DOI 10.1534/genetics.106.058628; Cooper DN, 1998, GENETIC BASIS HUMAN, P65; Costes SV, 2007, PLOS COMPUT BIOL, V3, P1477, DOI 10.1371/journal.pcbi.0030155; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Delacote F, 2008, CELL CYCLE, V7, P33, DOI 10.4161/cc.7.1.5149; Derijck A, 2008, HUM MOL GENET, V17, P1922, DOI 10.1093/hmg/ddn090; Dolle MET, 2000, P NATL ACAD SCI USA, V97, P8403, DOI 10.1073/pnas.97.15.8403; Elliott B, 2005, MOL CELL, V17, P885, DOI 10.1016/j.molcel.2005.02.028; Elliott B, 2002, CELL MOL LIFE SCI, V59, P373, DOI 10.1007/s00018-002-8429-3; Francis R, 2007, GENE DEV, V21, P1064, DOI 10.1101/gad.1522807; Gatto B, 1999, CURR PHARM DESIGN, V5, P195; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Har-Vardi I, 2007, HUM REPROD, V22, P2183, DOI 10.1093/humrep/dem170; Hartlerode A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016501; Hendricks CA, 2004, DNA REPAIR, V3, P1255, DOI 10.1016/j.dnarep.2004.04.006; Hendricks CA, 2003, P NATL ACAD SCI USA, V100, P6325, DOI 10.1073/pnas.1232231100; Honma M, 2007, DNA REPAIR, V6, P781, DOI 10.1016/j.dnarep.2007.01.004; HUMPHRIES RK, 1981, P NATL ACAD SCI-BIOL, V78, P3629, DOI 10.1073/pnas.78.6.3629; HWU HR, 1986, P NATL ACAD SCI USA, V83, P3875, DOI 10.1073/pnas.83.11.3875; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; KADYK LC, 1992, GENETICS, V132, P387; Kantidze OL, 2009, BIOESSAYS, V31, P278, DOI 10.1002/bies.200800165; Kollmannsberger C, 1998, J CLIN ONCOL, V16, P3386, DOI 10.1200/JCO.1998.16.10.3386; Kolomietz E, 2002, GENE CHROMOSOME CANC, V35, P97, DOI 10.1002/gcc.10111; Kovalchuk O, 2004, MOL CANCER RES, V2, P567; Li WR, 2011, CANCER RES, V71, P4130, DOI 10.1158/0008-5472.CAN-10-2540; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; LIEBER MR, 1992, CELL, V70, P873, DOI 10.1016/0092-8674(92)90237-7; Lightfoot TJ, 2004, TOXICOL APPL PHARM, V199, P104, DOI 10.1016/j.taap.2003.12.032; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lovett BD, 2001, P NATL ACAD SCI USA, V98, P9802, DOI 10.1073/pnas.171309898; Meaburn KJ, 2007, SEMIN CANCER BIOL, V17, P80, DOI 10.1016/j.semcancer.2006.10.008; Misteli T, 2009, P NATL ACAD SCI USA, V106, P6885, DOI 10.1073/pnas.0902010106; Moynahan ME, 1997, P NATL ACAD SCI USA, V94, P8988, DOI 10.1073/pnas.94.17.8988; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Neumaier T, 2012, P NATL ACAD SCI USA, V109, P443, DOI 10.1073/pnas.1117849108; NYSTROMLAHTI M, 1995, NAT MED, V1, P1203, DOI 10.1038/nm1195-1203; Ono T, 2002, MECH AGEING DEV, V123, P1543, DOI 10.1016/S0047-6374(02)00090-8; Osheroff N, 1994, Adv Pharmacol, V29B, P105; Pacher M, 2007, GENETICS, V175, P21, DOI 10.1534/genetics.106.065185; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; Pontier DB, 2009, CURR BIOL, V19, P1384, DOI 10.1016/j.cub.2009.06.045; Puchta H, 1999, GENETICS, V152, P1173; Reichel M, 1998, ONCOGENE, V17, P3035, DOI 10.1038/sj.onc.1202229; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; Richardson C, 2000, COLD SPRING HARB SYM, V65, P553, DOI 10.1101/sqb.2000.65.553; Richardson C, 1998, GENE DEV, V12, P3831, DOI 10.1101/gad.12.24.3831; Rong YS, 2003, GENETICS, V165, P1831; ROSENBERG N, 1976, J EXP MED, V143, P1453, DOI 10.1084/jem.143.6.1453; Ross JA, 1996, CANCER CAUSE CONTROL, V7, P581, DOI 10.1007/BF00051700; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Rowley JD, 1999, SEMIN HEMATOL, V36, P59; Rubtsov MA, 2008, J CELL BIOCHEM, V104, P692, DOI 10.1002/jcb.21656; RUDIGER NS, 1995, NUCLEIC ACIDS RES, V23, P256, DOI 10.1093/nar/23.2.256; Saintigny Y, 2007, ONCOGENE, V26, P2769, DOI 10.1038/sj.onc.1210075; Saleh-Gohari N, 2004, NUCLEIC ACIDS RES, V32, P3683, DOI 10.1093/nar/gkh703; Scandura JM, 2002, ONCOGENE, V21, P3422, DOI 10.1038/sj.onc.1205315; Schmid CW, 1996, PROG NUCLEIC ACID RE, V53, P283, DOI 10.1016/S0079-6603(08)60148-8; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shalev G, 1997, GENETICS, V146, P1143; Small K, 1997, NAT GENET, V16, P96, DOI 10.1038/ng0597-96; Small K, 1997, MAMM GENOME, V8, P337, DOI 10.1007/s003359900435; Soutoglou E, 2007, NAT CELL BIOL, V9, P675, DOI 10.1038/ncb1591; Stark JM, 2003, MOL CELL BIOL, V23, P733, DOI 10.1128/MCB.23.2.733-743.2003; Strathdee CA, 1999, GENE, V229, P21, DOI 10.1016/S0378-1119(99)00045-1; Strick R, 2000, P NATL ACAD SCI USA, V97, P4790, DOI 10.1073/pnas.070061297; Sung PA, 2006, DNA REPAIR, V5, P1109, DOI 10.1016/j.dnarep.2006.05.018; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; TYCKO B, 1990, CANCER CELL-MON REV, V2, P1; Udall JA, 2005, GENETICS, V169, P967, DOI 10.1534/genetics.104.033209; van Doorn-Khosrovani SBV, 2007, CARCINOGENESIS, V28, P1703, DOI 10.1093/carcin/bgm102; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Varga T, 2005, DNA REPAIR, V4, P1038, DOI 10.1016/j.dnarep.2005.05.004; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Waris G, 2006, J CARCINOG, V5, P14, DOI [10.1186/1477-3163-5-14, DOI 10.1186/1477-3163-5-14]; Wehrkamp-Richter S, 2009, PLANT PHYSIOL BIOCH, V47, P248, DOI 10.1016/j.plaphy.2008.11.014; Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028; Wiktor-Brown DM, 2006, CELL CYCLE, V5, P2715, DOI 10.4161/cc.5.23.3527; Wiktor-Brown DM, 2006, P NATL ACAD SCI USA, V103, P11862, DOI 10.1073/pnas.0604943103; Witherspoon DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-530	96	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e84379	10.1371/journal.pone.0084379	http://dx.doi.org/10.1371/journal.pone.0084379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349572	gold, Green Submitted, Green Published			2022-12-27	WOS:000328734200113
J	Ali, YM; Kenawy, HI; Muhammad, A; Sim, RB; Andrew, PW; Schwaeble, WJ				Ali, Youssif M.; Kenawy, Hany I.; Muhammad, Adnan; Sim, Robert B.; Andrew, Peter W.; Schwaeble, Wilhelm J.			Human L-ficolin, a Recognition Molecule of the Lectin Activation Pathway of Complement, Activates Complement by Binding to Pneumolysin, the Major Toxin of Streptococcus pneumoniae	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; PNEUMOCOCCAL DISEASE; STRUCTURAL BASIS; FACTOR-H; PSPA; ANTIBODIES; INFECTION; VIRULENCE; ANTIGEN; PROTEIN	The complement system is an essential component of the immune response, providing a critical line of defense against different pathogens including S. pneumoniae. Complement is activated via three distinct pathways: the classical (CP), the alternative (AP) and the lectin pathway (LP). The role of Pneumolysin (PLY), a bacterial toxin released by S. pneumoniae, in triggering complement activation has been studied in vitro. Our results demonstrate that in both human and mouse sera complement was activated via the CP, initiated by direct binding of even non-specific IgM and IgG3 to PLY. Absence of CP activity in C1q(-/-) mouse serum completely abolished any C3 deposition. However, C1q depleted human serum strongly opsonized PLY through abundant deposition of C3 activation products, indicating that the LP may have a vital role in activating the human complement system on PLY. We identified that human L-ficolin is the critical LP recognition molecule that drives LP activation on PLY, while all of the murine LP recognition components fail to bind and activate complement on PLY. This work elucidates the detailed interactions between PLY and complement and shows for the first time a specific role of the LP in PLY-mediated complement activation in human serum.	[Ali, Youssif M.; Kenawy, Hany I.; Muhammad, Adnan; Sim, Robert B.; Andrew, Peter W.; Schwaeble, Wilhelm J.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Ali, Youssif M.; Kenawy, Hany I.] Mansoura Univ, Fac Pharm, Dept Microbiol, Mansoura, Egypt	University of Leicester; Egyptian Knowledge Bank (EKB); Mansoura University	Schwaeble, WJ (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.	ws5@le.ac.uk	Adnan, Muhammad/Y-2913-2019; Kenawy, Hany/AAV-5877-2021; Andrew, Peter W/G-7526-2012; Ali, Youssif M./P-9593-2018; Sim, Bob/A-1354-2008; Kenawy, Hany/I-2752-2018	Adnan, Muhammad/0000-0001-7105-4768; Ali, Youssif M./0000-0003-3124-9848; Sim, Bob/0000-0002-2855-7455; Kenawy, Hany/0000-0002-8548-6649; Schwaeble, Wilhelm/0000-0001-8927-0864	UK Medical Research Council, MRC [G0801952]; Medical Research Council [G0801952] Funding Source: researchfish; MRC [G0801952] Funding Source: UKRI	UK Medical Research Council, MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the UK Medical Research Council, MRC grant reference number # G0801952. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; Berry AM, 1999, INFECT IMMUN, V67, P981, DOI 10.1128/IAI.67.2.981-985.1999; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; El Aswad BEW, 2011, IMMUNOBIOLOGY, V216, P379, DOI 10.1016/j.imbio.2010.06.014; FELDMAN C, 1990, MICROB PATHOGENESIS, V9, P275, DOI 10.1016/0882-4010(90)90016-J; Fujimori Y, 1998, BIOCHEM BIOPH RES CO, V244, P796, DOI 10.1006/bbrc.1998.8344; GADD KJ, 1981, BIOCHEM J, V195, P471, DOI 10.1042/bj1950471; Gilbert RJC, 2010, ADV EXP MED BIOL, V677, P56; Girija UV, 2013, P NATL ACAD SCI USA, V110, P13916, DOI 10.1073/pnas.1311113110; Jarva H, 2002, J IMMUNOL, V168, P1886, DOI 10.4049/jimmunol.168.4.1886; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; KALIN M, 1987, J CLIN MICROBIOL, V25, P226, DOI 10.1128/JCM.25.2.226-229.1987; Kyaw MH, 2003, CLIN INFECT DIS, V37, P1283, DOI 10.1086/379016; Li J, 2007, INFECT IMMUN, V75, P5877, DOI 10.1128/IAI.00839-07; Lynch NJ, 2004, J IMMUNOL, V172, P1198, DOI 10.4049/jimmunol.172.2.1198; Matsushita M, 2010, J INNATE IMMUN, V2, P24, DOI 10.1159/000228160; Miller E, 2000, ACTA PAEDIATR, V89, P11, DOI 10.1080/080352500300051477; MITCHELL TJ, 1991, MOL MICROBIOL, V5, P1883, DOI 10.1111/j.1365-2958.1991.tb00812.x; Ohashi T, 1998, ARCH BIOCHEM BIOPHYS, V360, P223, DOI 10.1006/abbi.1998.0957; PATON JC, 1984, INFECT IMMUN, V43, P1085, DOI 10.1128/IAI.43.3.1085-1087.1984; PHILLIPS ML, 1994, MOL IMMUNOL, V31, P1201, DOI 10.1016/0161-5890(94)90034-5; Quin LR, 2007, INFECT IMMUN, V75, P2067, DOI 10.1128/IAI.01727-06; Rossjohn J, 1998, J MOL BIOL, V284, P449, DOI 10.1006/jmbi.1998.2167; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Tan LA, 2010, PROTEIN CELL, V1, P1033, DOI 10.1007/s13238-010-0125-8; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Tsujimura M, 2001, CLIN DIAGN LAB IMMUN, V8, P454, DOI 10.1128/CDLI.8.2.454-459.2001; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Yuste J, 2005, J IMMUNOL, V175, P1813, DOI 10.4049/jimmunol.175.3.1813	29	19	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82583	10.1371/journal.pone.0082583	http://dx.doi.org/10.1371/journal.pone.0082583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349316	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800069
J	Li, XP; Rossen, N; Sinn, PL; Hornick, AL; Steines, BR; Karp, PH; Ernst, SE; Adam, RJ; Moninger, TO; Levasseur, DN; Zabner, J				Li, Xiaopeng; Rossen, Nathan; Sinn, Patrick L.; Hornick, Andrew L.; Steines, Benjamin R.; Karp, Philip H.; Ernst, Sarah E.; Adam, Ryan J.; Moninger, Thomas O.; Levasseur, Dana N.; Zabner, Joseph			Integrin alpha 6 beta 4 Identifies Human Distal Lung Epithelial Progenitor Cells with Potential as a Cell-Based Therapy for Cystic Fibrosis Lung Disease	PLOS ONE			English	Article							AIRWAY EPITHELIA; IN-VITRO; ADENOASSOCIATED VIRUS; PRIMARY CULTURE; CL-TRANSPORT; STEM-CELLS; ALVEOLAR; EXPRESSION; GENE; CFTR	To develop stem/progenitor cell-based therapy for cystic fibrosis (CF) lung disease, it is first necessary to identify markers of human lung epithelial progenitor/stem cells and to better understand the potential for differentiation into distinct lineages. Here we investigated integrin alpha 6 beta 4 as an epithelial progenitor cell marker in the human distal lung. We identified a subpopulation of alpha 6 beta 4(+) cells that localized in distal small airways and alveolar walls and were devoid of pro-surfactant protein C expression. The alpha 6 beta 4(+) epithelial cells demonstrated key properties of stem cells ex vivo as compared to alpha 6 beta 4(-) epithelial cells, including higher colony forming efficiency, expression of stem cell-specific transcription factor Nanog, and the potential to differentiate into multiple distinct lineages including basal and Clara cells. Co-culture of alpha 6 beta 4(+) epithelial cells with endothelial cells enhanced proliferation. We identified a subset of adeno-associated virus (AAVs) serotypes, AAV2 and AAV8, capable of transducing alpha 6 beta 4(+) cells. In addition, reconstitution of bronchi epithelial cells from CF patients with only 5% normal alpha 6 beta 4(+) epithelial cells significantly rescued defects in Cl-transport. Therefore, targeting the alpha 6 beta 4(+) epithelial population via either gene delivery or progenitor cell-based reconstitution represents a potential new strategy to treat CF lung disease.	[Li, Xiaopeng; Rossen, Nathan; Steines, Benjamin R.; Karp, Philip H.; Ernst, Sarah E.; Adam, Ryan J.; Moninger, Thomas O.; Levasseur, Dana N.; Zabner, Joseph] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Sinn, Patrick L.; Hornick, Andrew L.] Univ Iowa, Dept Pediat, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Li, XP (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	Xiaopeng-Li@uiowa.edu; Joseph-Zabner@uiowa.edu	Sinn, Patrick/M-8026-2018	Sinn, Patrick/0000-0002-9746-966X; Zabner, Joseph/0000-0002-9606-1339; Adam, Ryan/0000-0001-8602-8263	NIH [DK54759, HL07638-24]; Cystic Fibrosis Foundation; NIH National Heart, Lung, and Blood Institute [HL091842, HL51670]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051670, T32HL007638, P01HL091842, R01HL105821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the NIH (DK54759 to JZ and HL07638-24 to XL) and the Cystic Fibrosis Foundation to JZ. University of Iowa In Vitro Models and Cell Culture Core, the Flow Cytometry Core, and the Gene Transfer Vector Core were supported, in part, by NIH National Heart, Lung, and Blood Institute Grants HL091842 and HL51670. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruscia EM, 2006, P NATL ACAD SCI USA, V103, P2965, DOI 10.1073/pnas.0510758103; BYRNE C, 1993, MOL CELL BIOL, V13, P3176, DOI 10.1128/MCB.13.6.3176; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Chen H, 2012, STEM CELLS; Dickey DD, 2012, J GENE MED, V14, P366, DOI 10.1002/jgm.2632; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; ENGELHARDT JF, 1994, J CLIN INVEST, V93, P737, DOI 10.1172/JCI117028; Excoffon KJDA, 2009, P NATL ACAD SCI USA, V106, P3865, DOI 10.1073/pnas.0813365106; Farmen SL, 2005, AM J PHYSIOL-LUNG C, V289, pL1123, DOI 10.1152/ajplung.00049.2005; Franzdottir SR, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-162; Fuchs S, 2003, CELL TISSUE RES, V311, P31, DOI 10.1007/s00441-002-0653-5; Gioannini TL, 2002, J BIOL CHEM, V277, P47818, DOI 10.1074/jbc.M206404200; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Kotton DN, 2012, AM J RESP CRIT CARE, V185, P1255, DOI 10.1164/rccm.201202-0228PP; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Li XP, 2012, AM J PHYSIOL-LUNG C, V303, pL152, DOI 10.1152/ajplung.00116.2012; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Liu YR, 2011, J EXP MED, V208, P1473, DOI 10.1084/jem.20102041; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; Oakland M, 2012, MOL THER, V20, P1108, DOI 10.1038/mt.2012.32; Oeztuerk-Winder F, 2012, EMBO J, V31, P3431, DOI 10.1038/emboj.2012.192; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; Rawlins EL, 2008, COLD SH Q B, V73, P291, DOI 10.1101/sqb.2008.73.037; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Reynolds Susan D, 2012, Proc Am Thorac Soc, V9, P27, DOI 10.1513/pats.201201-008MS; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Saunders A, 2013, STEM CELLS, V31, P1227, DOI 10.1002/stem.1384; Sheppard D, 1996, BIOESSAYS, V18, P655, DOI 10.1002/bies.950180809; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; SMITH JJ, 1994, J CLIN INVEST, V93, P1307, DOI 10.1172/JCI117087; Steimer A, 2006, PHARM RES-DORDR, V23, P2078, DOI 10.1007/s11095-006-9057-7; Tiddens HAWM, 2010, PEDIATR PULM, V45, P107, DOI 10.1002/ppul.21154; Yamamoto H, 2007, DEV BIOL, V308, P44, DOI 10.1016/j.ydbio.2007.04.042; Zabner J, 1996, GENE THER, V3, P458; Zhang LQ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000155	36	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83624	10.1371/journal.pone.0083624	http://dx.doi.org/10.1371/journal.pone.0083624			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349537	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800130
J	Schmid, R; Meyer, K; Spang, R; Schittek, B; Bosserhoff, AK				Schmid, Rainer; Meyer, Katharina; Spang, Rainer; Schittek, Birgit; Bosserhoff, Anja Katrin			YBX1 Is a Modulator of MIA/CD-RAP-Dependent Chondrogenesis	PLOS ONE			English	Article							MELANOMA INHIBITORY-ACTIVITY; MALIGNANT-MELANOMA; PROTEIN YB-1; CHONDROCYTE DIFFERENTIATION; GENE-EXPRESSION; DEFICIENT MICE; RNA; CARTILAGE; TRANSCRIPTION; CLONING	MIA/CD-RAP is a small, secreted protein involved in cartilage differentiation and melanoma progression. We recently revealed that p54(nrb) acts as a mediator of MIA/CD-RAP action to promote chondrogenesis and the progression of malignant melanoma. As the molecular mechanism of MIA/CD-RAP action in cartilage has not been defined in detail until now, we aimed to understand the regulation of p54(nrb) transcription in chondrogenesis. We concentrated on the previously described MIA/CD-RAP-dependent regulatory region in the p54(nrb) promoter and characterized the transcriptional regulation of p54(nrb) by MIA/CD-RAP in cartilage. A series of truncated p54(nrb) promoter constructs and mutagenesis analysis revealed that the transcription factor YBX1, which has not been investigated in chondrogenesis thus far, is the mediator of MIA/CD-RAP dependent activation of p54(nrb) transcription. A systematic analysis of genes carrying this binding site in their promoter region revealed further potential MIA/CD-RAP-regulated genes that have been implicated in cartilage differentiation. In summary, we described the effects of MIA/CD-RAP on transcriptional regulation in chondrocytes. Understanding the regulation of p54(nrb) via YBX1 contributes to the understanding of chondrogenesis. Uncovering new downstream effectors that function via the activation of YBX1 supports the important role of MIA/CD-RAP in these processes.	[Schmid, Rainer; Bosserhoff, Anja Katrin] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany; [Meyer, Katharina; Spang, Rainer] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Schittek, Birgit] Univ Tubingen, Inst Dermatol, Tubingen, Germany	University of Regensburg; University of Regensburg; Eberhard Karls University of Tubingen	Bosserhoff, AK (corresponding author), Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany.	anja.bosserhoff@klinik.uni-regensburg.de	Bosserhoff, Anja/GNH-4801-2022	Schittek, Birgit/0000-0003-0081-2001; Bosserhoff, Anja/0000-0001-8147-394X; Spang, Rainer/0000-0002-1326-4297	Deutsche Forschungsgemeinschaft to AKB; Melanoma Research Network of the Deutsche Krebshilfe eV. (German Cancer Aid)	Deutsche Forschungsgemeinschaft to AKB; Melanoma Research Network of the Deutsche Krebshilfe eV. (German Cancer Aid)(Deutsche Krebshilfe)	This work was supported by grants from the Deutsche Forschungsgemeinschaft to AKB. BS and AKB were supported by the Melanoma Research Network of the Deutsche Krebshilfe eV. (German Cancer Aid). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastepe M, 2004, P NATL ACAD SCI USA, V101, P14794, DOI 10.1073/pnas.0405091101; Basu A, 1997, MOL CELL BIOL, V17, P677, DOI 10.1128/MCB.17.2.677; BLESCH A, 1994, CANCER RES, V54, P5695; BOGDAHN U, 1989, CANCER RES, V49, P5358; Bond CS, 2009, J CELL BIOL, V186, P637, DOI 10.1083/jcb.200906113; Bosserhoff AK, 2003, BIOMATERIALS, V24, P3229, DOI 10.1016/S0142-9612(03)00184-4; Bosserhoff AK, 1997, DEV DYNAM, V208, P516, DOI 10.1002/(SICI)1097-0177(199704)208:4<516::AID-AJA7>3.0.CO;2-L; Canady J, 2013, J INVEST DERMATOL, V133, P647, DOI 10.1038/jid.2012.389; Dietz UH, 1996, J BIOL CHEM, V271, P3311, DOI 10.1074/jbc.271.6.3311; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DONG BH, 1993, NUCLEIC ACIDS RES, V21, P4085, DOI 10.1093/nar/21.17.4085; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Fan L, 2006, J CELL BIOCHEM, V99, P140, DOI 10.1002/jcb.20911; Fukada T, 2003, EMBO J, V22, P479, DOI 10.1093/emboj/cdg067; GRANT CE, 1993, MOL CELL BIOL, V13, P4186, DOI 10.1128/MCB.13.7.4186; Hata K, 2008, J CLIN INVEST, V118, P3098, DOI 10.1172/JCI31373; Higashi K, 2003, J BIOL CHEM, V278, P5156, DOI 10.1074/jbc.M208724200; Holm PS, 2002, J BIOL CHEM, V277, P10427, DOI 10.1074/jbc.M106955200; Lu ZH, 2005, MOL CELL BIOL, V25, P4625, DOI 10.1128/MCB.25.11.4625-4637.2005; Mertens PR, 1997, J BIOL CHEM, V272, P22905, DOI 10.1074/jbc.272.36.22905; Moser M, 2002, MOL CELL BIOL, V22, P1438, DOI 10.1128/MCB.22.5.1438-1445.2002; Norman JT, 2001, J BIOL CHEM, V276, P29880, DOI 10.1074/jbc.M103145200; Onoue K, 2011, J BIOSCI BIOENG, V111, P594, DOI 10.1016/j.jbiosc.2010.12.023; Poser I, 2004, ONCOGENE, V23, P6115, DOI 10.1038/sj.onc.1207797; Schiffnery S, 2011, CARCINOGENESIS, V32, P1176, DOI 10.1093/carcin/bgr103; Schmid R, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.78; Schmid R, 2013, PIGMENT CEL IN PRESS; Schubert T, 2010, EXP MOL MED, V42, P166, DOI 10.3858/emm.2010.42.3.017; Skabkin MA, 2004, NUCLEIC ACIDS RES, V32, P5621, DOI 10.1093/nar/gkh889; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; Tatzel J, 2005, PIGM CELL RES, V18, P92, DOI 10.1111/j.1600-0749.2005.00212.x; Tscheudschilsuren G, 2006, EXP CELL RES, V312, P63, DOI 10.1016/j.yexcr.2005.09.017; Wenke AK, 2009, FEBS J, V276, P2494, DOI 10.1111/j.1742-4658.2009.06973.x	34	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82166	10.1371/journal.pone.0082166	http://dx.doi.org/10.1371/journal.pone.0082166			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349210	gold, Green Submitted, Green Published			2022-12-27	WOS:000328731800043
J	Stefanatos, RK; Bauer, C; Vidal, M				Stefanatos, Rhoda K.; Bauer, Christin; Vidal, Marcos			p120 Catenin Is Required for the Stress Response in Drosophila	PLOS ONE			English	Article							E-CADHERIN; IMMUNE-RESPONSE; DELTA-CATENIN; UP-REGULATION; PROTEIN; P120-CATENIN; CANCER; ADHESION; FAMILY; EXPRESSION	p120ctn is a ubiquitously expressed core component of cadherin junctions and essential for vertebrate development. Surprisingly, Drosophila p120ctn (dp120ctn) is dispensable for adherens junctions and development, which has discouraged Drosophila researchers from further pursuing the biological role of dp120ctn. Here we demonstrate that dp120ctn loss results in increased heat shock sensitivity and reduced animal lifespan, which are completely rescued by ectopic expression of a dp120ctn-GFP transgene. Transcriptomic analysis revealed multiple relish/NF-kappa B target genes differentially expressed upon loss of dp120ctn. Importantly, this aberrant gene expression was rescued by overexpression of dp120ctn-GFP or heterozygosity for relish. Our results uncover a novel role for dp120ctn in the regulation of animal stress response and immune signalling. This may represent an ancient role of p120ctn and can influence further studies in Drosophila and mammals.	[Stefanatos, Rhoda K.; Bauer, Christin; Vidal, Marcos] Beatson Inst Canc Res, Drosophila Approaches Canc Lab, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Vidal, M (corresponding author), Beatson Inst Canc Res, Drosophila Approaches Canc Lab, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.	m.vidal@beatson.gla.ac.uk		Vidal, Marcos/0000-0001-5042-3480; Bauer, Christin/0000-0003-3466-7076; Stefanatos, Rhoda/0000-0002-9072-7224	Cancer Research UK [C596/A17196]	Cancer Research UK(Cancer Research UK)	Cancer Research UK supported this work (grant number C596/A17196). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiadis PZ, 2000, J CELL SCI, V113, P1319; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Carnahan RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015747; Casagolda D, 2010, J CELL SCI, V123, P2621, DOI 10.1242/jcs.067512; Dai SD, 2011, CANCER SCI, V102, P95, DOI 10.1111/j.1349-7006.2010.01766.x; DANIEL JM, 1995, MOL CELL BIOL, V15, P4819; Davies SA, 2012, J INSECT PHYSIOL, V58, P488, DOI 10.1016/j.jinsphys.2012.01.008; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; del Valle-Perez B, 2011, J CELL SCI, V124, P2298, DOI 10.1242/jcs.082693; Elia LP, 2006, NEURON, V51, P43, DOI 10.1016/j.neuron.2006.05.018; Fei Y, 2009, BOSNIAN J BASIC MED, V9, P191, DOI 10.17305/bjbms.2009.2805; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Kurley SJ, 2012, DEVELOPMENT, V139, P1754, DOI 10.1242/dev.072769; Larson DE, 2008, MECH DEVELOP, V125, P223, DOI 10.1016/j.mod.2007.11.007; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lu Q, 2010, J PATHOL, V222, P119, DOI 10.1002/path.2755; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Marciano DK, 2011, DEVELOPMENT, V138, P2099, DOI 10.1242/dev.056564; Mayerle J, 2003, GASTROENTEROLOGY, V124, P949, DOI 10.1053/gast.2003.50142; Miao YA, 2010, MED ONCOL, V27, P880, DOI 10.1007/s12032-009-9300-2; Mortazavi F, 2010, MOL CANCER RES, V8, P762, DOI 10.1158/1541-7786.MCR-10-0004; Myster SH, 2003, J CELL BIOL, V160, P433, DOI 10.1083/jcb.200211083; Pacquelet A, 2003, J CELL BIOL, V160, P313, DOI 10.1083/jcb.200207160; Pece S, 2002, NAT CELL BIOL, V4, pE72, DOI 10.1038/ncb0402-e72; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; REYNOLDS AB, 1989, MOL CELL BIOL, V9, P629, DOI 10.1128/MCB.9.2.629; REYNOLDS AB, 1994, MOL CELL BIOL, V14, P8333, DOI 10.1128/MCB.14.12.8333; Smalley-Freed WG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019880; Smalley-Freed WG, 2010, J CLIN INVEST, V120, P1824, DOI 10.1172/JCI41414; Smith AL, 2012, MOL BIOL CELL, V23, P99, DOI 10.1091/mbc.E11-06-0497; Stairs DB, 2011, CANCER CELL, V19, P470, DOI 10.1016/j.ccr.2011.02.007; Talvinen K, 2010, J CANCER RES CLIN, V136, P1377, DOI 10.1007/s00432-010-0789-8; Thoreson MA, 2002, DIFFERENTIATION, V70, P583, DOI 10.1046/j.1432-0436.2002.700911.x; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Wang YL, 2011, J IMMUNOL, V186, P3180, DOI 10.4049/jimmunol.1001252; Zhang JH, 2010, MICROVASC RES, V80, P233, DOI 10.1016/j.mvr.2010.04.001; Zhao ZM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-198	40	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83942	10.1371/journal.pone.0083942	http://dx.doi.org/10.1371/journal.pone.0083942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349561	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000328731800134
J	Ho, LJ; Hung, LF; Liu, FC; Hou, TY; Lin, LC; Huang, CY; Lai, JH				Ho, Ling-Jun; Hung, Li-Feng; Liu, Feng-Cheng; Hou, Tsung-Yun; Lin, Leou-Chyr; Huang, Chuan-Yueh; Lai, Jenn-Haung			Ginkgo biloba Extract Individually Inhibits JNK Activation and Induces c-Jun Degradation in Human Chondrocytes: Potential Therapeutics for Osteoarthritis	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE; ARTICULAR CHONDROCYTES; NEUROPSYCHIATRIC FEATURES; IN-VITRO; EXPRESSION; CARTILAGE; PATHWAY; PROTEIN-1; DISEASE	Osteoarthritis (OA) is a common joint disorder with varying degrees of inflammation. The ideal anti-OA drug should have immunomodulatory effects while at the same time having limited or no toxicity. We examined the anti-inflammatory effects of Ginkgo biloba extract (EGb) in interleukin-1 (IL-1)-stimulated human chondrocytes. Chondrocytes were prepared from cartilage specimens taken from patients with osteoarthritis who had received total hip or total knee replacement. The concentrations of chemokines and the degree of cell migration were determined by ELISA and chemotaxis assays, respectively. The activation of inducible nitric oxide synthase (iNOS), mitogen-activated protein kinases (MAPKs), activator protein-1 (AP-1), and nuclear factor-kappaB (NF-kappa B) was determined by immunoblotting, immunohistochemistry, and electrophoretic mobility shift assay. We found that EGb inhibited IL-1-induced production of chemokines, which in turn resulted in attenuation of THP-1 cell migration toward EGb-treated cell culture medium. EGb also suppressed IL-1-stimulated iNOS expression and release of nitric oxide (NO). The EGb-mediated suppression of the iNOS-NO pathway correlated with the attenuation of activator protein-1 (AP-1) but not nuclear factor-kappaB (NF-kappa B) DNA-binding activity. Of the mitogen-activated protein kinases (MAPKs), EGb inhibited only c-Jun N-terminal kinase (JNK). Unexpectedly, EGb selectively caused degradation of c-Jun protein. Further investigation revealed that EGb-mediated c-Jun degradation was preceded by ubiquitination of c-Jun and could be prevented by the proteosome inhibitor MG-132. The results imply that EGb protects against chondrocyte degeneration by inhibiting JNK activation and inducing ubiquitination-dependent c-Jun degradation. Although additional research is needed, our results suggest that EGb is a potential therapeutic agent for the treatment of OA.	[Ho, Ling-Jun; Hung, Li-Feng; Huang, Chuan-Yueh] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Ho, Ling-Jun] China Med Univ, PhD Program Aging, Grad Inst Basic Med Sci, Taichung, Taiwan; [Liu, Feng-Cheng; Hou, Tsung-Yun] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Med, Taipei, Taiwan; [Lin, Leou-Chyr] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Orthopaed, Taipei, Taiwan; [Lai, Jenn-Haung] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Lai, Jenn-Haung] Chang Gung Univ, Chang Gung Mem Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Tao Yuan, Taiwan	National Health Research Institutes - Taiwan; China Medical University Taiwan; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Chang Gung Memorial Hospital; Chang Gung University	Lai, JH (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	laiandho@gmail.com	Ho, Ling-Jun/B-1087-2010	Ho, Ling-Jun/0000-0003-3453-2913	National Health Research Institute [CS-102-PP-08]; National Science Council [NSC 101-2320-B-400-006-MY3, NSC 101-2314-B-182A-103-MY3]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	The authors' work was supported in part by grants from National Health Research Institute (CS-102-PP-08) and National Science Council (NSC 101-2320-B-400-006-MY3 and NSC 101-2314-B-182A-103-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson SB, 2008, OSTEOARTHR CARTILAGE, V16, pS15, DOI 10.1016/S1063-4584(08)60008-4; Abulencia JP, 2003, J BIOL CHEM, V278, P28388, DOI 10.1074/jbc.M301378200; Alaaeddine N, 2001, ARTHRITIS RHEUM-US, V44, P1633, DOI 10.1002/1529-0131(200107)44:7<1633::AID-ART286>3.0.CO;2-Z; Amieva H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052755; Arkin MR, 2009, CURR OPIN CHEM BIOL, V13, P284, DOI 10.1016/j.cbpa.2009.05.125; Borzi RM, 2000, ARTHRITIS RHEUM, V43, P1734, DOI 10.1002/1529-0131(200008)43:8<1734::AID-ANR9>3.0.CO;2-B; Cheng SM, 2003, BIOCHEM PHARMACOL, V66, P679, DOI 10.1016/S0006-2952(03)00388-5; Chu CR, 2004, AM J SPORT MED, V32, P191, DOI 10.1177/0363546503260743; Cybulska-Heinrich AK, 2012, MOL VIS, V18, P390; Fanning PJ, 2003, J BIOL CHEM, V278, P50940, DOI 10.1074/jbc.M305107200; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Hashimoto S, 1998, ARTHRITIS RHEUM-US, V41, P1266, DOI 10.1002/1529-0131(199807)41:7<1266::AID-ART18>3.0.CO;2-Y; Herrschaft H, 2012, J PSYCHIATR RES, V46, P716, DOI 10.1016/j.jpsychires.2012.03.003; Ho LJ, 2005, BIOCHEM PHARMACOL, V70, P200, DOI 10.1016/j.bcp.2005.04.039; Huang CY, 2009, EUR J CLIN INVEST, V39, P417, DOI 10.1111/j.1365-2362.2009.02106.x; Hung LF, 2008, IMMUNOL INVEST, V37, P675, DOI 10.1080/08820130802307237; Ishibashi Y, 2008, J CARD FAIL, V14, P724, DOI 10.1016/j.cardfail.2008.06.450; ISMAIEL S, 1992, BRIT J RHEUMATOL, V31, P369; Joshi-Barve S, 2003, HEPATOLOGY, V38, P1178, DOI 10.1053/jhep.2003.50470; Lim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020301; Liu FC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3127; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; Melchiorri C, 1998, ARTHRITIS RHEUM-US, V41, P2165, DOI 10.1002/1529-0131(199812)41:12<2165::AID-ART11>3.3.CO;2-F; Mendes AF, 2002, INFLAMM RES, V51, P369, DOI 10.1007/PL00000317; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nakayama K, 2001, J IMMUNOL, V167, P1145, DOI 10.4049/jimmunol.167.3.1145; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Nishitani K, 2010, J CELL BIOCHEM, V109, P425, DOI 10.1002/jcb.22421; Ou HC, 2009, J APPL PHYSIOL, V106, P1674, DOI 10.1152/japplphysiol.91415.2008; Papachristou DJ, 2009, ARCH ORAL BIOL, V54, P1035, DOI 10.1016/j.archoralbio.2009.08.010; PELLETIER JP, 1993, AM J PATHOL, V142, P95; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Peng SL, 2008, FRONT BIOSCI-LANDMRK, V13, P4218, DOI 10.2741/3001; Scanzello CR, 2011, ARTHRITIS RHEUM-US, V63, P391, DOI 10.1002/art.30137; Sohn DH, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3555; Weinmann S, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-14; Wolter S, 2008, MOL CELL BIOL, V28, P4407, DOI 10.1128/MCB.00535-07; Wu WL, 2009, EUR J IMMUNOL, V39, P3413, DOI 10.1002/eji.200939306; Yancheva S, 2009, AGING MENT HEALTH, V13, P183, DOI 10.1080/13607860902749057; Yuan GH, 2001, ARTHRITIS RHEUM-US, V44, P1056, DOI 10.1002/1529-0131(200105)44:5<1056::AID-ANR186>3.3.CO;2-L; Zadoyan G, 2012, EUR J CLIN PHARMACOL, V68, P553, DOI 10.1007/s00228-011-1174-5; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338	42	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82033	10.1371/journal.pone.0082033	http://dx.doi.org/10.1371/journal.pone.0082033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349175	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300071
J	Kashiwagi, S; Yuan, JP; Forbes, B; Hibert, ML; Lee, ELQ; Whicher, L; Goudie, C; Yang, Y; Chen, T; Edelblute, B; Collette, B; Edington, L; Trussler, J; Nezivar, J; Leblanc, P; Bronson, R; Tsukada, K; Suematsu, M; Dover, J; Brauns, T; Gelfand, J; Poznansky, MC				Kashiwagi, Satoshi; Yuan, Jianping; Forbes, Benjamin; Hibert, Mathew L.; Lee, Eugene L. Q.; Whicher, Laura; Goudie, Calum; Yang, Yuan; Chen, Tao; Edelblute, Beth; Collette, Brian; Edington, Laurel; Trussler, James; Nezivar, Jean; Leblanc, Pierre; Bronson, Roderick; Tsukada, Kosuke; Suematsu, Makoto; Dover, Jeffrey; Brauns, Timothy; Gelfand, Jeffrey; Poznansky, Mark C.			Near-Infrared Laser Adjuvant for Influenza Vaccine	PLOS ONE			English	Article							INTRADERMAL VACCINE; MF59-ADJUVANTED INFLUENZA; PROTECTIVE IMMUNITY; VIRUS VACCINE; MUCOSAL; IMMUNOGENICITY; IMMUNIZATION; DELIVERY; SAFETY; MICE	Safe and effective immunologic adjuvants are often essential for vaccines. However, the choice of adjuvant for licensed vaccines is limited, especially for those that are administered intradermally. We show that non-tissue damaging, near-infrared (NIR) laser light given in short exposures to small areas of skin, without the use of additional chemical or biological agents, significantly increases immune responses to intradermal influenza vaccination without augmenting IgE. The NIR laser-adjuvanted vaccine confers increased protection in a murine influenza lethal challenge model as compared to unadjuvanted vaccine. We show that NIR laser treatment induces the expression of specific chemokines in the skin resulting in recruitment and activation of dendritic cells and is safe to use in both mice and humans. The NIR laser adjuvant technology provides a novel, safe, low-cost, simple-to-use, potentially broadly applicable and clinically feasible approach to enhancing vaccine efficacy as an alternative to chemical and biological adjuvants.	[Kashiwagi, Satoshi; Yuan, Jianping; Forbes, Benjamin; Hibert, Mathew L.; Lee, Eugene L. Q.; Whicher, Laura; Goudie, Calum; Yang, Yuan; Chen, Tao; Edelblute, Beth; Collette, Brian; Edington, Laurel; Trussler, James; Nezivar, Jean; Leblanc, Pierre; Brauns, Timothy; Gelfand, Jeffrey; Poznansky, Mark C.] Massachusetts Gen Hosp, Dept Med, Vaccine & Immunotherapy Ctr, Div Infect Dis, Charlestown, MA 02129 USA; [Bronson, Roderick] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Tsukada, Kosuke] Keio Univ, Fac Sci & Technol, Dept Appl Phys & Physicoinformat, Kohoku Ku, Yokohama, Kanagawa 223, Japan; [Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Shinjuku Ku, Tokyo, Japan; [Dover, Jeffrey] SkinCare Phys Chestnut Hill, Chestnut Hill, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Keio University; Keio University	Kashiwagi, S (corresponding author), Massachusetts Gen Hosp, Dept Med, Vaccine & Immunotherapy Ctr, Div Infect Dis, Charlestown, MA 02129 USA.	skashiwagi@partners.org; mpoznansky@partners.org	Kashiwagi, Satoshi/T-2420-2019; Poznansky, Mark C/M-4996-2015; Suematsu, Makoto/O-5762-2018; Gelfand, Jeffrey A/G-1885-2018; Tsukada, Kosuke/C-9986-2014; Leblanc, Pierre/AAB-3554-2020; Suematsu, Makoto/I-8135-2013	Poznansky, Mark C/0000-0003-1344-7103; Suematsu, Makoto/0000-0002-7165-6336; Gelfand, Jeffrey A/0000-0002-4118-5676; Tsukada, Kosuke/0000-0003-1463-2204; Leblanc, Pierre/0000-0001-8756-2396; Suematsu, Makoto/0000-0002-7165-6336; Lee, Eugene Li Qun/0000-0003-4725-4959; Collette, Brian/0000-0002-9993-8423	National Institute of Allergy and Infectious Diseases grant [R01AI105131]; Bill & Melinda Gates Foundation (Grand Challenges Explorations) [OPP1046276]; Defense Advanced Research Projects Agency [DARPA-BAA-09-31]; Edmund C. Lynch, Jr. Cancer Research Fund; Friends of VIC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105131] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases grant; Bill & Melinda Gates Foundation (Grand Challenges Explorations); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Edmund C. Lynch, Jr. Cancer Research Fund; Friends of VIC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institute of Allergy and Infectious Diseases grant (R01AI105131), the Bill & Melinda Gates Foundation (Grand Challenges Explorations OPP1046276), the Defense Advanced Research Projects Agency (DARPA-BAA-09-31), the Edmund C. Lynch, Jr. Cancer Research Fund and the Friends of VIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Ansaldi F, 2012, EXPERT REV VACCINES, V11, P17, DOI [10.1586/ERV.11.154, 10.1586/erv.11.154]; ASHINOFF R, 1995, DERMATOL SURG, V21, P291, DOI 10.1111/j.1524-4725.1995.tb00175.x; Atmar RL, 2006, CLIN INFECT DIS, V43, P1135, DOI 10.1086/508174; Atmar RL, 2010, EXPERT REV VACCINES, V9, P1399, DOI [10.1586/erv.10.134, 10.1586/ERV.10.134]; Batista-Duharte A, 2011, TOXICOL LETT, V203, P97, DOI 10.1016/j.toxlet.2011.03.001; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466; Bernstein DI, 2008, J INFECT DIS, V197, P667, DOI 10.1086/527489; BOULNOIS J-L, 1986, Lasers in Medical Science, V1, P47, DOI 10.1007/BF02030737; Brady RC, 2009, VACCINE, V27, P5091, DOI 10.1016/j.vaccine.2009.06.057; Bungener L, 2008, VACCINE, V26, P2350, DOI 10.1016/j.vaccine.2008.02.063; Chen XY, 2012, VACCINE, V31, P159, DOI 10.1016/j.vaccine.2012.10.069; Chen XY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013776; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; England RW, 2002, ANN ALLERG ASTHMA IM, V89, P215, DOI 10.1016/S1081-1206(10)61942-4; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7; Furuya Y, 2011, IMMUNOL CELL BIOL; Guebre-Xabier M, 2003, J VIROL, V77, P5218, DOI 10.1128/JVI.77.9.5218-5225.2003; Gupta R K, 1995, Pharm Biotechnol, V6, P229; Harandi AM, 2009, EXPERT REV VACCINES, V8, P293, DOI 10.1586/14760584.8.3.293; Hauge S, 2007, CLIN VACCINE IMMUNOL, V14, P978, DOI 10.1128/CVI.00033-07; Hickling JK, 2011, B WORLD HEALTH ORGAN, V89, P221, DOI 10.2471/BLT.10.079426; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hovden AO, 2005, SCAND J IMMUNOL, V62, P36, DOI 10.1111/j.1365-3083.2005.01633.x; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Karande P, 2010, ANNU REV CHEM BIOMOL, V1, P175, DOI 10.1146/annurev-chembioeng-073009-100948; Kim YC, 2009, VACCINE, V27, P6932, DOI 10.1016/j.vaccine.2009.08.108; Koutsonanos DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004773; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Lambert PH, 2008, VACCINE, V26, P3197, DOI 10.1016/j.vaccine.2008.03.095; Leroux-Roels G, 2010, VACCINE, V28, pC25, DOI 10.1016/j.vaccine.2010.07.021; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Marconescu PS, 2010, VACCINE, V28, P5315, DOI 10.1016/j.vaccine.2010.05.045; Martin-Fontecha Alfonso, 2009, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-540-71029-5_2; Matsuoka Yumiko, 2009, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g03s13, 10.1002/9780471729259.mc15g02s13]; Morefield Garry L, 2008, J Immune Based Ther Vaccines, V6, P5, DOI 10.1186/1476-8518-6-5; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Ng LG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000222; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Nicholson KG, 2009, VACCINE, V28, P171, DOI 10.1016/j.vaccine.2009.09.103; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Niemz M. H., 2007, LASER TISSUE INTERAC, V3; Onikienko S. B., 2007, DONOSOLOGIYA ST PETE, V1, P32; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; PALLADINO G, 1995, J VIROL, V69, P2075, DOI 10.1128/JVI.69.4.2075-2081.1995; Platt AM, 2013, ADV IMMUNOL, V120, P51, DOI 10.1016/B978-0-12-417028-5.00002-8; Prausnitz MR, 2009, CURR TOP MICROBIOL, V333, P369, DOI 10.1007/978-3-540-92165-3_18; Quan FS, 2010, J VIROL, V84, P7760, DOI 10.1128/JVI.01849-09; Rahman F, 2000, HEPATOLOGY, V31, P521, DOI 10.1002/hep.510310237; Rappuoli R, 2011, NAT REV IMMUNOL, V11, P865, DOI 10.1038/nri3085; SLINEY DH, 1968, AM IND HYG ASSOC J, V29, P425, DOI 10.1080/00028896809343029; Sticchi L, 2010, J Prev Med Hyg, V51, P7; Sullivan SP, 2010, NAT MED, V16, P915, DOI 10.1038/nm.2182; Swain SL, 2012, NAT REV IMMUNOL, V12, P136, DOI 10.1038/nri3152; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vilanova M, 2004, IMMUNOLOGY, V111, P334, DOI 10.1111/j.1365-2567.2004.01819.x; Villadangos JA, 2007, NAT REV IMMUNOL, V7, P543, DOI 10.1038/nri2103; Vitoriano-Souza J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040745; Vogel FR, 2009, EXPERT REV VACCINES, V8, P483, DOI [10.1586/erv.09.5, 10.1586/ERV.09.5]; Young F, 2011, VACCINE, V29, P8788, DOI 10.1016/j.vaccine.2011.09.077	67	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82899	10.1371/journal.pone.0082899	http://dx.doi.org/10.1371/journal.pone.0082899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349390	Green Published, gold			2022-12-27	WOS:000328730300112
J	Lee, U; Frankenberger, C; Yun, J; Bevilacqua, E; Caldas, C; Chin, SF; Rueda, OM; Reinitz, J; Rosner, MR				Lee, UnJin; Frankenberger, Casey; Yun, Jieun; Bevilacqua, Elena; Caldas, Carlos; Chin, Suet-Feung; Rueda, Oscar M.; Reinitz, John; Rosner, Marsha Rich			A Prognostic Gene Signature for Metastasis-Free Survival of Triple Negative Breast Cancer Patients	PLOS ONE			English	Article							BACH1; IDENTIFICATION; PROGRESSION	Although triple negative breast cancers (TNBC) are the most aggressive subtype of breast cancer, they currently lack targeted therapies. Because this classification still includes a heterogeneous collection of tumors, new tools to classify TNBCs are urgently required in order to improve our prognostic capability for high risk patients and predict response to therapy. We previously defined a gene expression signature, RKIP Pathway Metastasis Signature (RPMS), based upon a metastasis-suppressive signaling pathway initiated by Raf Kinase Inhibitory Protein (RKIP). We have now generated a new BACH1 Pathway Metastasis gene signature (BPMS) that utilizes targets of the metastasis regulator BACH1. Specifically, we substituted experimentally validated target genes to generate a new BACH1 metagene, developed an approach to optimize patient tumor stratification, and reduced the number of signature genes to 30. The BPMS significantly and selectively stratified metastasis-free survival in basal-like and, in particular, TNBC patients. In addition, the BPMS further stratified patients identified as having a good or poor prognosis by other signatures including the Mammaprint (R) and Oncotype (R) clinical tests. The BPMS is thus complementary to existing signatures and is a prognostic tool for high risk ER-HER2-patients. We also demonstrate the potential clinical applicability of the BPMS as a single sample predictor. Together, these results reveal the potential of this pathway-based BPMS gene signature to identify high risk TNBC patients that can respond effectively to targeted therapy, and highlight BPMS genes as novel drug targets for therapeutic development.	[Lee, UnJin; Frankenberger, Casey; Yun, Jieun; Bevilacqua, Elena; Rosner, Marsha Rich] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Caldas, Carlos; Chin, Suet-Feung; Rueda, Oscar M.] Univ Cambridge, Dept Oncol, Cambridge, England; [Reinitz, John] Univ Chicago, Dept Stat Ecol & Evolut, Chicago, IL 60637 USA; [Reinitz, John] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	University of Chicago; University of Cambridge; University of Chicago; University of Chicago	Rosner, MR (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	m-rosner@uchicago.edu	Rueda, Oscar/ABF-5479-2020; Caldas, Carlos/U-7250-2019	Rueda, Oscar/0000-0003-0008-4884; Caldas, Carlos/0000-0003-3547-1489; chin, suet-feung/0000-0001-5697-1082; Lee, UnJin/0000-0003-2424-650X	NIH [GM 87630]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087630] Funding Source: NIH RePORTER; Cancer Research UK [16942] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by NIH grant GM 87630 to MRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertucci F, 2012, CURR MOL MED, V12, P96, DOI 10.2174/156652412798376134; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Huo DZ, 2009, J CLIN ONCOL, V27, P4515, DOI 10.1200/JCO.2008.19.6873; Ishikawa M, 2005, FREE RADICAL BIO MED, V38, P1344, DOI 10.1016/j.freeradbiomed.2005.01.021; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Ladas EJ, 2004, J CLIN ONCOL, V22, P517, DOI 10.1200/JCO.2004.03.086; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liang YJ, 2012, J BIOL CHEM, V287, P33533, DOI 10.1074/jbc.M112.392332; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Melhem-Bertrandt A, 2011, J CLIN ONCOL, V29, P2645, DOI 10.1200/JCO.2010.33.4441; Minn AJ, 2012, CELL CYCLE, V11, P2452, DOI 10.4161/cc.20624; Mira A, 2009, ONCOGENE, V28, P4444, DOI 10.1038/onc.2009.296; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pan D, 2011, CANCER RES, V71, P6360, DOI 10.1158/0008-5472.CAN-11-0362; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sabatier R, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-86; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venet D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002240; Vera-Ramirez L, 2011, CRIT REV ONCOL HEMAT, V80, P347, DOI 10.1016/j.critrevonc.2011.01.004; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Warnatz HJ, 2011, J BIOL CHEM, V286, P23521, DOI 10.1074/jbc.M111.220178; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Yamasaki C, 2005, J BIOCHEM, V137, P287, DOI 10.1093/jb/mvi031; Yun JU, 2011, EMBO J, V30, P4500, DOI 10.1038/emboj.2011.312; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06	31	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82125	10.1371/journal.pone.0082125	http://dx.doi.org/10.1371/journal.pone.0082125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349199	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300075
J	Zhou, Y; Liu, SX; Song, JN; Zhang, ZD				Zhou, Yuan; Liu, Sixue; Song, Jiangning; Zhang, Ziding			Structural Propensities of Human Ubiquitination Sites: Accessibility, Centrality and Local Conformation	PLOS ONE			English	Article							PROTEIN-STRUCTURE; POSTTRANSLATIONAL MODIFICATIONS; PREDICTION; BINDING; PHOSPHORYLATION; IDENTIFICATION; PROTEASOME; RESIDUES; RESOURCE; DATABASE	The existence and function of most proteins in the human proteome are regulated by the ubiquitination process. To date, tens of thousands human ubiquitination sites have been identified from high-throughput proteomic studies. However, the mechanism of ubiquitination site selection remains elusive because of the complicated sequence pattern flanking the ubiquitination sites. In this study, we perform a systematic analysis of 1,330 ubiquitination sites in 505 protein structures and quantify the significantly high accessibility and unexpectedly high centrality of human ubiquitination sites. Further analysis suggests that the higher centrality of ubiquitination sites is associated with the multi-functionality of ubiquitination sites, among which protein-protein interaction sites are common targets of ubiquitination. Moreover, we demonstrate that ubiquitination sites are flanked by residues with non-random local conformation. Finally, we provide quantitative and unambiguous evidence that most of the structural propensities contain specific information about ubiquitination site selection that is not represented by the sequence pattern. Therefore, the hypothesis about the structural level of the ubiquitination site selection mechanism has been substantially approved.	[Zhou, Yuan; Liu, Sixue; Zhang, Ziding] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Song, Jiangning] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin, Peoples R China; [Song, Jiangning] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China; [Song, Jiangning] Monash Univ, Fac Med, Dept Biochem & Mol Biol, Melbourne, Vic 3004, Australia	China Agricultural University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Monash University	Song, JN (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin, Peoples R China.	jiangning.song@monash.edu; zidingzhang@cau.edu.cn	Song, Jiangning/F-9787-2010; , zidingzhang/E-9320-2011	Song, Jiangning/0000-0001-8031-9086; , zidingzhang/0000-0002-9296-571X	National Key Basic Research Program of China [2009CB918802]; National Natural Science Foundation of China [31070259, 61202167]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partially supported by the National Key Basic Research Program of China (2009CB918802) and the National Natural Science Foundation of China (31070259 and 61202167). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Cai YD, 2012, AMINO ACIDS, V42, P1387, DOI 10.1007/s00726-011-0835-0; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; Chen X, 2013, BIOINFORMATICS, V29, P1614, DOI 10.1093/bioinformatics/btt196; Chen Z, 2013, BBA-PROTEINS PROTEOM, V1834, P1461, DOI 10.1016/j.bbapap.2013.04.006; Chen Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022930; Chennubhotla C, 2007, PLOS COMPUT BIOL, V3, P1716, DOI 10.1371/journal.pcbi.0030172; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Danielsen JMR, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003590; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Durek P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-117; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Hagai T, 2012, MOL BIOSYST, V8, P1865, DOI 10.1039/c2mb25052g; Hagai T, 2011, J MOL BIOL, V412, P319, DOI 10.1016/j.jmb.2011.07.024; Hagai T, 2010, P NATL ACAD SCI USA, V107, P2001, DOI 10.1073/pnas.0912335107; Han L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041370; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Jahnke W, 2010, NAT CHEM BIOL, V6, P660, DOI [10.1038/NCHEMBIO.421, 10.1038/nchembio.421]; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Khare SD, 2003, J MOL BIOL, V334, P515, DOI 10.1016/j.jmb.2003.09.069; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LEVITT DG, 1992, J MOL GRAPH MODEL, V10, P229, DOI 10.1016/0263-7855(92)80074-N; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; Liu ZX, 2011, NUCLEIC ACIDS RES, V39, pD1029, DOI 10.1093/nar/gkq939; Mihel J, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-21; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NELSON D, 2005, LEHNINGER PRINCIPLE; Nishi H, 2011, STRUCTURE, V19, P1807, DOI 10.1016/j.str.2011.09.021; Pfleger CM, 2000, GENE DEV, V14, P655; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rondeau JM, 2006, CHEMMEDCHEM, V1, P267, DOI 10.1002/cmdc.200500059; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Sharifi HJ, 2012, CURR OPIN HIV AIDS, V7, P187, DOI 10.1097/COH.0b013e32835049e0; Shih CH, 2012, PROTEINS, V80, P1647, DOI 10.1002/prot.24058; Tung CH, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r31; Udeshi ND, 2012, MOL CELL PROTEOMICS, V11, P148, DOI 10.1074/mcp.M111.016857; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Vlahovicek K, 2005, NUCLEIC ACIDS RES, V33, pW252, DOI 10.1093/nar/gki362; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Xin FX, 2012, BIOINFORMATICS, V28, P2905, DOI 10.1093/bioinformatics/bts541; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	56	10	11	8	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83167	10.1371/journal.pone.0083167	http://dx.doi.org/10.1371/journal.pone.0083167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349449	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300135
J	Gee, F; Fisher, K; Klemstein, U; Poulin, GB				Gee, Fiona; Fisher, Kate; Klemstein, Ulrike; Poulin, Gino B.			An RNAi-Based Dimorphic Genetic Screen Identified the Double Bromodomain Protein BET-1 as a Sumo-Dependent Attenuator of RAS-Mediated Signalling	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; VULVAL DEVELOPMENT; TRANSCRIPTIONAL REPRESSION; CHROMATIN-STRUCTURE; MODIFIER SUMO; CELL LINEAGES; SYNMUV GENES; SUMOYLATION; INHIBITION	Attenuation of RAS/RAF/MAPK signalling is essential to prevent hyperactivation of this oncogenic pathway. In C. elegans, the sumoylation pathway and a combination of histone tail modifications regulate gene expression to attenuate the LET-60 (RAS) signalling pathway. We hypothesised that a number of chromatin regulators are likely to depend on sumoylation to attenuate the pathway. To reveal these, we designed an RNAi-based dimorphic genetic screen that selects candidates based on their ability to act as enhancers of a sumo mutant phenotype, such interactions would suggest that the candidates may be physically associated with sumoylation. We found 16 enhancers, one of which BET-1, is a conserved double bromodomain containing protein. We further characterised BET-1 and showed that it can physically associate with SMO-1 and UBC-9, and that it can be sumoylated in vitro within the second bromodomain at lysine 252. Previous work has shown that BET-1 can bind acetyl-lysines on histone tails to influence gene expression. In conclusion, our screening approach has identified BET-1 as a Sumo-dependent attenuator of LET-60-mediated signalling and our characterisation suggests that BET-1 can be sumoylated.	[Gee, Fiona; Fisher, Kate; Klemstein, Ulrike; Poulin, Gino B.] Univ Manchester, Fac Life Sci, Manchester, Greater Manches, England	University of Manchester	Poulin, GB (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Greater Manches, England.	Gino.Poulin@manchester.ac.uk		Poulin, Gino/0000-0003-1016-348X	MRC [G0600127]; Biotechnology and Biological Sciences Research Council; Wellcome Trust [097820/Z/11/Z]; Medical Research Council [G0600127] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	GBP is funded by the MRC (Career Development Award G0600127). FG is supported by a Biotechnology and Biological Sciences Research Council studentship. GBP and KF are also supported by the Wellcome Trust (097820/Z/11/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Andersen EC, 2007, DEVELOPMENT, V134, P2991, DOI 10.1242/dev.009373; BRENNER S, 1974, GENETICS, V77, P71; Broday L, 2004, GENE DEV, V18, P2380, DOI 10.1101/gad.1227104; Cheng Z, 2008, ONCOGENE, V27, P931, DOI 10.1038/sj.onc.1210710; Chowdhuri SR, 2006, DEV BIOL, V295, P664, DOI 10.1016/j.ydbio.2006.04.001; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Cui MX, 2006, DEV CELL, V10, P667, DOI 10.1016/j.devcel.2006.04.001; David G, 2002, J BIOL CHEM, V277, P23658, DOI 10.1074/jbc.M203690200; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Droescher M, 2011, J BIOL CHEM, V286, P18731, DOI 10.1074/jbc.M111.235978; Fay DS, 2007, DEV BIOL, V306, P1, DOI 10.1016/j.ydbio.2007.03.016; FERGUSON EL, 1989, GENETICS, V123, P109; FERGUSON EL, 1987, NATURE, V326, P259, DOI 10.1038/326259a0; FERGUSON EL, 1985, GENETICS, V110, P17; Fisher K, 2010, DEV BIOL, V341, P142, DOI 10.1016/j.ydbio.2010.02.023; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Gong ZH, 2006, MOL CELL BIOL, V26, P4519, DOI 10.1128/MCB.00409-06; Goodarzi AA, 2011, NAT STRUCT MOL BIOL, V18, P831, DOI 10.1038/nsmb.2077; Hajnal A, 1997, GENE DEV, V11, P2715, DOI 10.1101/gad.11.20.2715; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HILL RJ, 1992, NATURE, V358, P470, DOI 10.1038/358470a0; Inoue T, 2002, MECH DEVELOP, V119, pS203, DOI 10.1016/S0925-4773(03)00117-5; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KATZ WS, 1995, CELL, V82, P297, DOI 10.1016/0092-8674(95)90317-8; Kirsh O, 2002, EMBO J, V21, P2682, DOI 10.1093/emboj/21.11.2682; Kroetz Mary B., 2009, V497, P107, DOI 10.1007/978-1-59745-566-4_7; Leight ER, 2005, DEVELOPMENT, V132, P1047, DOI 10.1242/dev.01664; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Maison C, 2011, NAT GENET, V43, P220, DOI 10.1038/ng.765; Makhnevych T, 2009, MOL CELL, V33, P124, DOI 10.1016/j.molcel.2008.12.025; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Morgan CT, 2010, NAT CHEM BIOL, V6, P102, DOI [10.1038/nchembio.282, 10.1038/NCHEMBIO.282]; Ouyang J, 2009, EPIGENETICS-US, V4, P440, DOI 10.4161/epi.4.7.9807; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Poulin G, 2005, EMBO J, V24, P2613, DOI 10.1038/sj.emboj.7600726; Riising EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002704; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shibata Y, 2010, DEVELOPMENT, V137, P1045, DOI 10.1242/dev.042812; Stielow B, 2008, MOL CELL, V29, P742, DOI 10.1016/j.molcel.2007.12.032; Sundaram Meera V, 2013, WormBook, P1, DOI 10.1895/wormbook.1.80.2; Tiefenbach J, 2006, MOL BIOL CELL, V17, P1643, DOI 10.1091/mbc.E05-07-0610; Waddington C, 1940, ORANISERS GENES; Welchman DP, 2007, DEV BIOL, V305, P347, DOI 10.1016/j.ydbio.2007.02.022; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yang SH, 2013, GENE, V513, P1, DOI 10.1016/j.gene.2012.10.033; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6; Zhao R, 2011, NAT CELL BIOL, V13, P1295, DOI 10.1038/ncb2341	58	1	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83659	10.1371/journal.pone.0083659	http://dx.doi.org/10.1371/journal.pone.0083659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24349540	gold, Green Published, Green Submitted			2022-12-27	WOS:000328707400138
J	El Bcheraoui, C; Gomez, AIN; Abrego, MAD; Gagnier, MC; Sutton, MY; Mokdad, AH				El Bcheraoui, Charbel; Nieto Gomez, Ana I.; Dubon Abrego, Maria A.; Gagnier, Marielle C.; Sutton, Madeline Y.; Mokdad, Ali H.			Disparities in HIV Screening among Pregnant Women - El Salvador, 2011	PLOS ONE			English	Article								Objectives: To provide an accurate estimate of antenatal HIV screening and its determinants among pregnant women in El Salvador and help local authorities make informed decisions for targeted interventions around mother-to-child transmission (MTCT). Methods: A total sample of 4,730 women aged 15-49 years were interviewed from a random sample of 3,625 households. We collected data on antenatal care services, including HIV screening, during last pregnancy through a pre-established questionnaire. We used a backward elimination multivariate logistic regression model to examine the association between HIV screening and sociodemographic and health care-related factors. Results: A total of 2,929 women were included in this analysis. About 98% of participants reported receiving antenatal care, but only 83% of these reported being screened for HIV. Screening was lower in geographic areas with higher HIV incidence and ranged from 69.1% among women who were not seen by a physician during antenatal care, to 93.7% among those who attended or completed college. Odds for screening varied also by age, employment status, household economic expenditure, possession of health care coverage, health care settings, and number of antenatal care visits. Conclusions: We found disparities in HIV screening during antenatal care at the environmental, social, demographic, and structural levels despite a high uptake of antenatal care in El Salvador. Our findings should urge health authorities to tailor and enhance current strategies implemented to eliminate MTCT and reduce inequities and HIV morbidity among women in El Salvador.	[El Bcheraoui, Charbel; Gagnier, Marielle C.; Mokdad, Ali H.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Nieto Gomez, Ana I.] Minist Hlth, STD HIV AIDS Program, San Salvador, El Salvador; [Dubon Abrego, Maria A.] Minist Hlth, San Salvador, El Salvador; [Sutton, Madeline Y.] Morehouse Sch Med, Dept Obstet & Gynecol, Atlanta, GA 30310 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Morehouse School of Medicine	El Bcheraoui, C (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.	charbel@uw.edu	Mokdad, Ali H./AAD-1232-2022	Mokdad, Ali H./0000-0002-4994-3339	Bill & Melinda Gates Foundation; Carlos Slim Health Institute; Government of Spain	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Carlos Slim Health Institute; Government of Spain(Spanish Government)	Salud Mesoamerica 2015 is funded by the Bill & Melinda Gates Foundation, the Carlos Slim Health Institute, and the Government of Spain, and is administered by the Inter-American Development Bank. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders or the Inter-American Development Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PREV INF PREGN; [Anonymous], RECOMMENDATIONS USAI; [Anonymous], REPROD MATERNAL CHIL; [Anonymous], ONE TEST 2 LIV; [Anonymous], B INFORM INDICADORES; [Anonymous], PMTCT STRAT VISION; [Anonymous], COUNTR HLTH PFO; [Anonymous], INFORM NACL ESTADO; [Anonymous], 2005, SUMM COUNTR PROF HIV; [Anonymous], HIV SCREEN PREGN WOM; [Anonymous], B INDICADORES SALUD; [Anonymous], B INDICADORD SALUD; [Anonymous], B INDICADORS SALUD; [Anonymous], GBD ARR DIAGR; [Anonymous], OBSTET GYNECOL; [Anonymous], SALV PAS AD; [Anonymous], ESTRATEGIA ELIMACION; [Anonymous], B INFORM; [Anonymous], SEG DECL POL VIH; [Anonymous], STRAT 4 FURTH; [Anonymous], B INCIDADORS ALUD; [Anonymous], SCRREN HIV REC STAT; Bannink-Mbazzi F, 2013, JAIDS-J ACQ IMM DEF, V62, pE138, DOI 10.1097/QAI.0b013e318282d27f; Becker J, 2009, PAN AFR MED J, V3, P1; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Chin T, 2013, AIDS PATIENT CARE ST, V27, P392, DOI 10.1089/apc.2013.0099; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Nielsen-Saines K, 2012, NEW ENGL J MED, V366, P2368, DOI 10.1056/NEJMoa1108275; Remis RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048077; Steinberg M, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-39; Teva I, 2012, REV MED CHILE, V140, P50, DOI /S0034-98872012000100007	32	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82760	10.1371/journal.pone.0082760	http://dx.doi.org/10.1371/journal.pone.0082760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349356	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200098
J	Gomez, CR; Kosari, F; Munz, JM; Schreiber, CA; Knutson, GJ; Ida, CM; El Khattouti, A; Karnes, RJ; Cheville, JC; Vasmatzis, G; Vuk-Pavlovic, S				Gomez, Christian R.; Kosari, Farhad; Munz, Jan-Marie; Schreiber, Claire A.; Knutson, Gaylord J.; Ida, Cristiane M.; El Khattouti, Abdelouahid; Karnes, R. Jeffrey; Cheville, John C.; Vasmatzis, George; Vuk-Pavlovic, Stanimir			Prognostic Value of Discs Large Homolog 7 Transcript Levels in Prostate Cancer	PLOS ONE			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; CYCLIN B1; RADICAL PROSTATECTOMY; SYSTEMIC PROGRESSION; CELL CARCINOMA; GLEASON SCORE; HIGH-RISK; HYPOXIA; TUMOR	Hypoxia has been associated with malignant progression, metastasis and resistance to therapy. Hence, we studied expression of hypoxia-regulated genes in 100 prostate cancer (CaP) bulk tissues and 71 adjacent benign tissues. We found 24 transcripts significantly overexpressed (p=0.02). Importantly, higher transcript levels of disc large (drosophila) homolog-associated protein 5 (DLGAP5)/discs large homolog 7 (DLG7)/hepatoma up-regulated protein (HURP), hyaluronan-mediated motility receptor (HMMR) and cyclin B1 (CCNB1) were associated with higher Gleason score and more advanced systemic progression. Since the products of HMMR and CCNB1 have been identified recently as molecular markers of CaP progression, we postulated that DLG7 has prognostic value too. To test this hypothesis, we measured transcript levels for DLG7 in a 150-pair case-control cohort. The cases (progression to systemic disease within six years of surgery) and controls (no progression within eight years) were matched for clinical and pathologic prognostic variables, including grade, stage, and preoperative serum levels of PSA. The overall prognostic ability of DLG7, as tested in receiver operating characteristic analysis was of 0.74 (95% CI, 0.68 to 0.8). Overall, our data indicate that expression of DLG7, a hypoxia-controlled gene, holds prognostic potential in high-risk CaP; this also demonstrates that variation of oxygen tension may constitute a tool for identification of novel biomarkers for CaP.	[Gomez, Christian R.; Schreiber, Claire A.; Knutson, Gaylord J.; Vuk-Pavlovic, Stanimir] Mayo Clin, Ctr Canc, Stem Cell Lab, Rochester, MN USA; [Gomez, Christian R.; Vuk-Pavlovic, Stanimir] Mayo Clin, Dept Internal Med, Div Hematol, Rochester, MN USA; [Gomez, Christian R.; Vuk-Pavlovic, Stanimir] Mayo Clin, Dept Internal Med, Div Prevent & Occupat Med, Rochester, MN USA; [Kosari, Farhad; Munz, Jan-Marie; Vasmatzis, George] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Ida, Cristiane M.; Cheville, John C.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [El Khattouti, Abdelouahid] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Karnes, R. Jeffrey] Mayo Clin, Dept Urol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Mississippi; University of Mississippi Medical Center; Mayo Clinic	Gomez, CR (corresponding author), Univ Mississippi, Med Ctr, Jackson, MS 39216 USA.	crgomez@umc.edu			DOD [PC094680]; PCF Creativity Award; Minnesota Partnership for Biotechnology and Medical Genomics; Mayo Clinic Prostate [SPORE 5P50CA091956]; NATIONAL CANCER INSTITUTE [P50CA091956] Funding Source: NIH RePORTER	DOD(United States Department of Defense); PCF Creativity Award; Minnesota Partnership for Biotechnology and Medical Genomics; Mayo Clinic Prostate; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by DOD PC094680 (CRG), PCF Creativity Award (CRG), Minnesota Partnership for Biotechnology and Medical Genomics (GV), and Mayo Clinic Prostate SPORE 5P50CA091956 (FK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassal S, 2001, GENOMICS, V77, P5, DOI 10.1006/geno.2001.6570; Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Bismar TA, 2006, NEOPLASIA, V8, P59, DOI 10.1593/neo.05664; Blute ML, 2001, J UROLOGY, V165, P119, DOI 10.1097/00005392-200101000-00030; Bostwick DG, 2000, ARCH PATHOL LAB MED, V124, P995; Carnell DM, 2006, INT J RADIAT ONCOL, V65, P91, DOI 10.1016/j.ijrobp.2005.11.044; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Chen X, 2012, CANCER RES, V72, P2294, DOI 10.1158/0008-5472.CAN-11-2181; Cheville JC, 2008, J CLIN ONCOL, V26, P3930, DOI 10.1200/JCO.2007.15.6752; Chiu AW, 2002, UROLOGY, V60, P181, DOI 10.1016/S0090-4295(02)01672-2; Cuzick J, 2012, BRIT J CANCER, V106, P1095, DOI 10.1038/bjc.2012.39; Danza G, 2012, MOL CANCER RES, V10, P230, DOI 10.1158/1541-7786.MCR-11-0296; de Resende MF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-36; de Reynies A, 2009, J CLIN ONCOL, V27, P1108, DOI 10.1200/JCO.2008.18.5678; Giesing M, 2010, BJU INT, V105, P1000, DOI 10.1111/j.1464-410X.2009.08920.x; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Gomez LA, 2007, MOL CANCER THER, V6, P1534, DOI 10.1158/1535-7163.MCT-06-0727; Gudmundsson KO, 2007, STEM CELLS, V25, P1498, DOI 10.1634/stemcells.2005-0479; Gust KM, 2009, NEOPLASIA, V11, P956, DOI 10.1593/neo.09694; Hassan KA, 2002, CANCER RES, V62, P6414; Humphrey PA, 2004, MODERN PATHOL, V17, P292, DOI 10.1038/modpathol.3800054; Ishigami S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-106; Jakubickova L, 2005, INT J ONCOL, V26, P1121; Karnes RJ, 2010, CANCER RES, V70, P8994, DOI 10.1158/0008-5472.CAN-10-1358; Koffa MD, 2006, CURR BIOL, V16, P743, DOI 10.1016/j.cub.2006.03.056; Kosari F, 2008, CLIN CANCER RES, V14, P1734, DOI 10.1158/1078-0432.CCR-07-1494; Kube DM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-25; Kuo TC, 2012, BIOCHEM PHARMACOL, V83, P758, DOI 10.1016/j.bcp.2011.12.034; Lendahl U, 2009, NAT REV GENET, V10, P821, DOI 10.1038/nrg2665; Loo LWM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030477; Malhotra S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020293; Mogal AP, 2012, PROSTATE, V72, P931, DOI 10.1002/pros.21494; Movsas B, 2000, CANCER, V89, P2018, DOI 10.1002/1097-0142(20001101)89:9<2018::AID-CNCR19>3.3.CO;2-P; Murphy AJ, 2007, CANCER RES, V67, P2893, DOI 10.1158/0008-5472.CAN-06-2962; Shin JU, 2012, TUMOR BIOL, V33, P1645, DOI 10.1007/s13277-012-0420-5; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Soria JC, 2000, CANCER RES, V60, P4000; Stewart GD, 2010, BJU INT, V105, P8, DOI 10.1111/j.1464-410X.2009.08921.x; Stewart GD, 2008, ONCOL REP, V20, P1561, DOI 10.3892/or_00000180; Stuart JE, 2011, J NEUROPATH EXP NEUR, V70, P1, DOI 10.1097/NEN.0b013e3182018f1c; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; Tzankov A, 2011, ANN HEMATOL, V90, P901, DOI 10.1007/s00277-011-1159-6; Vaupel P, 2001, SEMIN ONCOL, V28, P29, DOI 10.1016/S0093-7754(01)90210-6; Wang YC, 2006, BIOCHEM BIOPH RES CO, V340, P244, DOI 10.1016/j.bbrc.2005.12.005; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Yamasaki M, 2007, ONCOL REP, V18, P1145; Zhao L, 2004, J CANCER RES CLIN, V130, P719, DOI 10.1007/s00432-004-0595-2	49	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82833	10.1371/journal.pone.0082833	http://dx.doi.org/10.1371/journal.pone.0082833			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349376	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200107
J	Kunz, M; Peter, J; Huster, S; Lautenbacher, S				Kunz, Miriam; Peter, Jessica; Huster, Sonja; Lautenbacher, Stefan			Pain and Disgust: The Facial Signaling of Two Aversive Bodily Experiences	PLOS ONE			English	Article							EXPRESSIONS; EMOTION; FACE	The experience of pain and disgust share many similarities, given that both are aversive experiences resulting from bodily threat and leading to defensive reactions. The aim of the present study was to investigate whether facial expressions are distinct enough to encode the specific quality of pain and disgust or whether they just encode the similar negative valence and arousal level of both states. In sixty participants pain and disgust were induced by heat stimuli and pictures, respectively. Facial responses (Facial Action Coding System) as well as subjective responses were assessed. Our main findings were that nearly the same single facial actions were elicited during pain and disgust experiences. However, these single facial actions were displayed with different strength and were differently combined depending on whether pain or disgust was experienced. Whereas pain was mostly encoded by contraction of the muscles surrounding the eyes (by itself or in combination with contraction of the eyebrows); disgust was mainly accompanied by contraction of the eyebrows and-in contrast to pain-by raising of the upper lip as well as the combination of upper lip raise and eyebrow contraction. Our data clearly suggests that facial expressions seem to be distinct enough to encode not only the general valence and arousal associated with these two bodily aversive experiences, namely pain and disgust, but also the specific origin of the threat to the body. This implies that the differential decoding of these two states by an observer is possible without additional verbal or contextual information, which is of special interest for clinical practice, given that raising awareness in observers about these distinct differences could help to improve the detection of pain in patients who are not able to provide a self-report of pain (e.g., patients with dementia).	[Kunz, Miriam; Peter, Jessica; Huster, Sonja; Lautenbacher, Stefan] Univ Bamberg, Bamberg, Germany; [Peter, Jessica] Univ Med Ctr Freiburg, Dept Neurol, Freiburg, Germany	Otto Friedrich University Bamberg; University of Freiburg	Lautenbacher, S (corresponding author), Univ Bamberg, Bamberg, Germany.	stefan.lautenbacher@uni-bamberg.de	Kunz, Miriam/P-8160-2016	Kunz, Miriam/0000-0002-0740-6738; Peter, Jessica/0000-0002-0817-8431; , Stefan/0000-0002-2829-347X	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	The study was funded by the German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviezer H, 2008, PSYCHOL SCI, V19, P724, DOI 10.1111/j.1467-9280.2008.02148.x; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Carroll JM, 1996, J PERS SOC PSYCHOL, V70, P205, DOI 10.1037/0022-3514.70.2.205; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Craig K. D., 2011, HDB PAIN ASSESSMENT, V3rd, P117; Curtis V, 2004, P ROY SOC B-BIOL SCI, V271, pS131, DOI 10.1098/rsbl.2003.0144; Curtis V, 2001, PERSPECT BIOL MED, V44, P17, DOI 10.1353/pbm.2001.0001; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Ekman P., 2003, UNMASKING FACE GUIDE; Fridlund JA, 1994, HUMAN FACIAL EXPRESS; Friesen E., 1978, FACIAL ACTION CODING, V3, P5; Hale CJ., 1997, PAIN RES MANAG, V2, P217, DOI [10.1155/1997/283582, DOI 10.1155/1997/283582]; Kappesser J, 2002, PAIN, V99, P197, DOI 10.1016/S0304-3959(02)00101-X; Keltner D, 1996, COGNITION EMOTION, V10, P155, DOI 10.1080/026999396380312; Kunz M, 2004, J PAIN, V5, P368, DOI 10.1016/j.jpain.2004.06.002; Kunz M, 2008, PAIN, V140, P127, DOI 10.1016/j.pain.2008.07.019; Kunz M, 2008, J PSYCHOSOM RES, V64, P311, DOI 10.1016/j.jpsychores.2007.09.010; Kunz M, 2012, PAIN, V153, P350, DOI 10.1016/j.pain.2011.10.027; Kunz M, 2011, J NEUROSCI, V31, P8730, DOI 10.1523/JNEUROSCI.0217-11.2011; Lang PJ, 1995, INT AFFECTIVE PICTUR; Merskey H., 2002, CLASSIFICATION CHRON; Prkachin KM, 2008, PAIN, V139, P267, DOI 10.1016/j.pain.2008.04.010; PRKACHIN KM, 1992, PAIN, V51, P297, DOI 10.1016/0304-3959(92)90213-U; Rohrmann S, 2009, ANXIETY STRESS COPIN, V22, P215, DOI 10.1080/10615800802016591; ROZIN P, 1994, J PERS SOC PSYCHOL, V66, P870, DOI 10.1037//0022-3514.66.5.870; Russell J. A., 1997, PSYCHOL FACIAL EXPRE, P295, DOI [10.1017/CBO9780511659911.015, DOI 10.1017/CBO9780511659911.015, 10.1017/cbo9780511659911.015]; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Simon D, 2008, PAIN, V135, P55, DOI 10.1016/j.pain.2007.05.008; Smith C, 1997, PSYCHOL FACIAL EXPRE; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080; Wolf K, 2005, SCAND J PSYCHOL, V46, P403, DOI 10.1111/j.1467-9450.2005.00471.x	31	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e83277	10.1371/journal.pone.0083277	http://dx.doi.org/10.1371/journal.pone.0083277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VD	24349479	Green Submitted, gold, Green Published			2022-12-27	WOS:000328705200128
J	Zhang, J; Dublin, P; Griemsmann, S; Klein, A; Brehm, R; Bedner, P; Fleischmann, BK; Steinhauser, C; Theis, M				Zhang, Jiong; Dublin, Pavel; Griemsmann, Stephanie; Klein, Alexandra; Brehm, Ralph; Bedner, Peter; Fleischmann, Bernd K.; Steinhaeuser, Christian; Theis, Martin			Germ-Line Recombination Activity of the Widely Used hGFAP-Cre and Nestin-Cre Transgenes	PLOS ONE			English	Article							NEONATAL MICE LACKING; IN-VIVO; NERVOUS-SYSTEM; GENE; CONNEXIN43; MOUSE; EXPRESSION; OLIGODENDROCYTES; INACTIVATION; DISRUPTION	Herein we demonstrate with PCR, immunodetection and reporter gene approaches that the widely used human Glial Fibrillary Acidic Protein (hGFAP)-Cre transgene exhibits spontaneous germ-line recombination activity in leading to deletion in brain, heart and tail tissue with high frequency. The ectopic activity of hGFAP-Cre requires a rigorous control. We likewise observed that a second widely used nestin-Cre transgene shows germ-line deletion. Here we describe procedures to identify mice with germ-line recombination mediated by the hGFAP-Cre and nestin-Cre transgenes. Such control is essential to avoid pleiotropic effects due to germ-line deletion of loxP-flanked target genes and to maintain the CNS-restricted deletion status in transgenic mouse colonies.	[Zhang, Jiong; Dublin, Pavel; Griemsmann, Stephanie; Bedner, Peter; Steinhaeuser, Christian; Theis, Martin] Univ Bonn, Fac Med, Inst Cellular Neurosci, Bonn, Germany; [Klein, Alexandra; Fleischmann, Bernd K.] Fac Med, Life & Brain Ctr, Inst Physiol 1, Bonn, Germany; [Brehm, Ralph] Tierarztliche Hsch Hannover, Anat Inst, Hannover, Germany	University of Bonn; University of Bonn; University of Veterinary Medicine Hannover, Foundation	Steinhauser, C (corresponding author), Univ Bonn, Fac Med, Inst Cellular Neurosci, Bonn, Germany.	christian.steinhaeuser@ukb.uni-bonn.de; martin.theis@ukb.uni-bonn.de		Zhang, Jiong/0000-0001-8709-1141	German Research Foundation [SFB/TR3, C1, C9, SPP1172 SE 774/3, N01, SPP1172 TH1350/1-1]; European Community [FP7-202167]	German Research Foundation(German Research Foundation (DFG)); European Community(European Commission)	This work was supported by grants of the German Research Foundation SFB/TR3, C1 and C9; SPP1172 SE 774/3 (to CS); SFB/TR3, N01 and C9; SPP1172 TH1350/1-1 (to MT) and of the European Community FP7-202167 (to CS and MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajenaru ML, 2002, MOL CELL BIOL, V22, P5100, DOI 10.1128/MCB.22.14.5100-5113.2002; Casper KB, 2006, MOL CELL NEUROSCI, V31, P676, DOI 10.1016/j.mcn.2005.12.006; Cina C, 2009, J NEUROSCI, V29, P2009, DOI 10.1523/JNEUROSCI.5025-08.2009; Dobrowolski R, 2008, HUM MOL GENET, V17, P539, DOI 10.1093/hmg/ddm329; Eckardt D, 2004, GENESIS, V38, P159, DOI 10.1002/gene.20011; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487; Ganat YM, 2006, J NEUROSCI, V26, P8609, DOI 10.1523/JNEUROSCI.2532-06.2006; Gaveriaux-Ruff C, 2007, PHARMACOL THERAPEUT, V113, P619, DOI 10.1016/j.pharmthera.2006.12.003; Giaume C, 2010, BRAIN RES REV, V63, P160, DOI 10.1016/j.brainresrev.2009.11.005; Gosejacob D, 2011, GLIA, V59, P511, DOI 10.1002/glia.21120; Hirrlinger PG, 2006, GLIA, V54, P11, DOI 10.1002/glia.20342; Korets-Smith E, 2004, GENESIS, V40, P131, DOI 10.1002/gene.20074; Kunze A, 2009, P NATL ACAD SCI USA, V106, P11336, DOI 10.1073/pnas.0813160106; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Liu YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013533; Maass K, 2004, MOL BIOL CELL, V15, P4597, DOI 10.1091/mbc.E04-04-0324; Maass K, 2007, CIRC RES, V101, P1283, DOI 10.1161/CIRCRESAHA.107.162818; Maglione M, 2010, GLIA, V58, P1104, DOI 10.1002/glia.20991; Magnotti LM, 2011, GLIA, V59, P1064, DOI 10.1002/glia.21179; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Pannasch U, 2011, P NATL ACAD SCI USA, V108, P8467, DOI 10.1073/pnas.1016650108; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Requardt RP, 2009, GLIA, V57, P680, DOI 10.1002/glia.20796; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; Schulz TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001013; Teubner B, 2003, HUM MOL GENET, V12, P13, DOI 10.1093/hmg/ddg001; Theis M, 2004, GLIA, V46, P130, DOI 10.1002/glia.10350; Theis M, 2003, J NEUROSCI, V23, P766; Theis M, 2001, GENESIS, V29, P1, DOI 10.1002/1526-968X(200101)29:1<1::AID-GENE1000>3.0.CO;2-0; Theis M, 2005, TRENDS NEUROSCI, V28, P188, DOI 10.1016/j.tins.2005.02.006; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wallraff A, 2006, J NEUROSCI, V26, P5438, DOI 10.1523/JNEUROSCI.0037-06.2006; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	40	24	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82818	10.1371/journal.pone.0082818	http://dx.doi.org/10.1371/journal.pone.0082818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349371	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200104
J	Brodbeck, FC; Kugler, KG; Reif, JAM; Maier, MA				Brodbeck, Felix C.; Kugler, Katharina G.; Reif, Julia A. M.; Maier, Markus A.			Morals Matter in Economic Games	PLOS ONE			English	Article							STRONG RECIPROCITY; HUMAN COOPERATION; NEGATIVE AFFECT; NEURAL BASIS; EVOLUTION; DECISION; PUNISHMENT; FAIRNESS; BEHAVIOR; UNCERTAINTY	Contrary to predictions from Expected Utility Theory and Game Theory, when making economic decisions in interpersonal situations, people take the interest of others into account and express various forms of solidarity, even in one-shot interactions with anonymous strangers. Research in other-regarding behavior is dominated by behavioral economical and evolutionary biological approaches. Psychological theory building, which addresses mental processes underlying other-regarding behavior, is rare. Based on Relational Models Theory (RMT, [1]) and Relationship Regulation Theory (RRT, [2]) it is proposed that moral motives influence individuals' decision behavior in interpersonal situations via conscious and unconscious (automatic) processes. To test our propositions we developed the 'Dyadic Solidarity Game' and its solitary equivalent, the 'Self-Insurance Game'. Four experiments, in which the moral motives "Unity" and "Proportionality" were manipulated, support the propositions made. First, it was shown that consciously activated moral motives (via framing of the overall goal of the experiment) and unconsciously activated moral motives (via subliminal priming) influence other-regarding behavior. Second, this influence was only found in interpersonal, not in solitary situations. Third, by combining the analyses of the two experimental games the extent to which participants apply the Golden Rule ("treat others how you wish to be treated") could be established. Individuals with a "Unity" motive treated others like themselves, whereas individuals with a "Proportionality" motive gave others less then they gave themselves. The four experiments not only support the assumption that morals matter in economic games, they also deliver new insights in how morals matter in economic decision making.	[Brodbeck, Felix C.; Kugler, Katharina G.; Reif, Julia A. M.; Maier, Markus A.] Univ Munich, Munich, Germany	University of Munich	Brodbeck, FC (corresponding author), Univ Munich, Munich, Germany.	brodbeck@psy.lmu.de			German Research Foundation (DFG) in the context of the Excellence Initiative "LMUexcellent"	German Research Foundation (DFG) in the context of the Excellence Initiative "LMUexcellent"(German Research Foundation (DFG))	This research was conducted at the "Munich Experimental Laboratory for Economic and Social Sciences" as well as the "Virtual Lab" of the Ludwig-Maximilians-Universitaet Muenchen, Munich, Germany. Both laboratories were funded by the German Research Foundation (DFG) in the context of the Excellence Initiative "LMUexcellent". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal P, 2004, J CONSUM RES, V31, P87, DOI 10.1086/383426; AKERLOF GA, 1970, Q J ECON, V84, P488, DOI 10.2307/1879431; [Anonymous], 1979, DICT PHILOS; BALDWIN MW, 1992, PSYCHOL BULL, V112, P461, DOI 10.1037/0033-2909.112.3.461; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; Bazerman M. H., 2006, SOCIAL PSYCHOL EC, P263; Bischoff I, 2011, ECON BULL, V31, P3221; Borenstein M., 2009, INTRO METAANALYSIS, DOI [10. 1002/9780470743386, DOI 10.1002/9780470743386]; Brosig-Koch J, 2011, J PUBLIC ECON, V95, P1373, DOI 10.1016/j.jpubeco.2011.06.002; Brosnan S.F., 2006, SOC JUSTICE RES, V19, P153, DOI [10.1007/s11211-006-0002-z, DOI 10.1007/S11211-006-0002-Z]; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Brown D. E., 1991, HUMAN UNIVERSALS; Charness G, 2009, ECON J, V119, P796, DOI 10.1111/j.1468-0297.2009.02248.x; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cushman F, 2006, PSYCHOL SCI, V17, P1082, DOI 10.1111/j.1467-9280.2006.01834.x; Dawkins Richard, 1976, SELFISH GENE; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Devoe SE, 2010, PSYCHOL SCI, V21, P159, DOI 10.1177/0956797609357749; Dunbar RIM, 1996, GROOMING GOSSIP EVOL; Falk A, 2008, GAME ECON BEHAV, V62, P287, DOI 10.1016/j.geb.2007.06.001; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fehr E., 2006, HDB EC GIVING ALTRUI, P615, DOI DOI 10.1016/S1574-0714(06)01008-6; Fiddick L, 2007, Q J EXP PSYCHOL, V60, P16, DOI 10.1080/17470210600577266; FISKE AP, 1990, ETHOS, V18, P180, DOI 10.1525/eth.1990.18.2.02a00040; FISKE AP, 1992, PSYCHOL REV, V99, P689, DOI 10.1037/0033-295X.99.4.689; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Gachter S, 2009, PHILOS T R SOC B, V364, P791, DOI 10.1098/rstb.2008.0275; Gigerenzer G, 1996, PSYCHOL REV, V103, P650, DOI 10.1037/0033-295X.103.4.650; Gigerenzer G, 2011, ANNU REV PSYCHOL, V62, P451, DOI 10.1146/annurev-psych-120709-145346; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Glassman NS, 1999, J PERS SOC PSYCHOL, V77, P1146, DOI 10.1037/0022-3514.77.6.1146; Haidt J, 2001, PSYCHOL REV, V108, P814, DOI 10.1037//0033-295X.108.4.814; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Hamann K, 2011, NATURE, V476, P328, DOI 10.1038/nature10278; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; HASLAM N, 1994, COGNITION, V53, P59, DOI 10.1016/0010-0277(94)90077-9; HASLAM N, 1992, J EXP SOC PSYCHOL, V28, P441, DOI 10.1016/0022-1031(92)90041-H; Haslam N, 2006, PERS SOC PSYCHOL REV, V10, P252, DOI 10.1207/s15327957pspr1003_4; Haslem N., 2004, RELATIONAL MODELS TH; HAUSER MD, 2006, MORAL MINDS NATURE D, P13934, DOI DOI 10.1007/S10818-010-9081-X; Henrich J, 2006, SCIENCE, V312, P60, DOI 10.1126/science.1126398; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Heyman J, 2004, PSYCHOL SCI, V15, P787, DOI 10.1111/j.0956-7976.2004.00757.x; Jensen K, 2007, SCIENCE, V318, P107, DOI 10.1126/science.1145850; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kahneman D., 2011, THINKING FAST SLOW; Knobe J, 2010, BEHAV BRAIN SCI, V33, P315, DOI 10.1017/S0140525X10000907; Krohne HW, 1996, DIAGNOSTICA, V42, P139; Luo QA, 2006, NEUROIMAGE, V30, P1449, DOI 10.1016/j.neuroimage.2005.11.005; McGraw AP, 2005, J CONSUM PSYCHOL, V15, P2, DOI 10.1207/s15327663jcp1501_2; McGraw AP, 2003, J CONSUM RES, V30, P219, DOI 10.1086/376805; Mellers BA, 2010, J EXP PSYCHOL GEN, V139, P743, DOI 10.1037/a0020280; Mikhail J, 2007, TRENDS COGN SCI, V11, P143, DOI 10.1016/j.tics.2006.12.007; Mikulincer M, 2000, J PERS SOC PSYCHOL, V78, P509, DOI 10.1037/0022-3514.78.3.509; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Penner LA, 2005, ANNU REV PSYCHOL, V56, P365, DOI 10.1146/annurev.psych.56.091103.070141; Rai TS, 2011, PSYCHOL REV, V118, P57, DOI 10.1037/a0021867; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rasmusen E., 2007, GAMES INFORM INTRO G; ROGERS JL, 1993, PSYCHOL BULL, V113, P553, DOI 10.1037/0033-2909.113.3.553; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Selten R, 1998, J ECON BEHAV ORGAN, V34, P517, DOI 10.1016/S0167-2681(97)00107-8; Shah JY, 2002, J EXP SOC PSYCHOL, V38, P368, DOI 10.1016/S0022-1031(02)00005-7; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; TAJFEL H, 1970, SCI AM, V223, P96, DOI 10.1038/scientificamerican1170-96; Thompson ER, 2007, J CROSS CULT PSYCHOL, V38, P227, DOI 10.1177/0022022106297301; Tomasello M, 2013, ANNU REV PSYCHOL, V64, P231, DOI 10.1146/annurev-psych-113011-143812; TRIVERS R, 1978, EVOLUTION RECIPROCAL, P13934; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Turiel E., 1983, DEV SOCIAL KNOWLEDGE; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Vohs KD, 2008, CURR DIR PSYCHOL SCI, V17, P208, DOI 10.1111/j.1467-8721.2008.00576.x; von Neumann J, 1928, MATH ANN, V100, P295, DOI DOI 10.1007/BF01448847; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	80	11	11	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81558	10.1371/journal.pone.0081558	http://dx.doi.org/10.1371/journal.pone.0081558			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276GD	24358115	gold, Green Published, Green Submitted			2022-12-27	WOS:000328735700011
J	Akazawa, Y; Isomoto, H; Matsushima, K; Kanda, T; Minami, H; Yamaghchi, N; Taura, N; Shiozawa, K; Ohnita, K; Takeshima, F; Nakano, M; Moss, J; Hirayama, T; Nakao, K				Akazawa, Yuko; Isomoto, Hajime; Matsushima, Kayoko; Kanda, Tsutomu; Minami, Hitomi; Yamaghchi, Naoyuki; Taura, Naota; Shiozawa, Ken; Ohnita, Ken; Takeshima, Fuminao; Nakano, Masayuki; Moss, Joel; Hirayama, Toshiya; Nakao, Kazuhiko			Endoplasmic Reticulum Stress Contributes to Helicobacter Pylori VacA-Induced Apoptosis	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; VACUOLATING CYTOTOXIN; ER STRESS; MOLECULAR-MECHANISMS; CELL APOPTOSIS; UP-REGULATION; TOXIN; PROTEIN; CHOP; ACTIVATION	Vacuolating cytotoxin A (VacA) is one of the important virulence factors produced by H. pylori. VacA induces apoptotic cell death, which is potentiated by ammonia. VacA also causes cell death by mitochondrial damage, via signaling pathways that are not fully defined. Our aim was to determine whether endoplasmic reticulum (ER) stress is associated with VacA-induced mitochondrial dysfunction and apoptosis. We found that C/EBP homologous protein (CHOP), a key signaling protein of ER stress-induced apoptosis, was transcriptionally up-regulated following incubation of gastric epithelial cells with VacA. The effect of VacA on CHOP induction was significantly enhanced by co-incubation with ammonium chloride. Phosphorylation of eukaryotic initiation factor 2 (eIF2)-alpha, which is known to occur downstream of the ER stress sensor PKR-like ER-localized eIF2-alpha kinase (PERK) and to regulate CHOP expression, was also observed following incubation with VacA in the presence of ammonium chloride. Knockdown of CHOP by siRNA resulted in inhibition of VacA-induced apoptosis. Further studies showed that silencing of the PERK gene with siRNA attenuated VacA-mediated phosphorylation of eIF2-alpha, CHOP induction, expression of BH3-only protein Bim and Bax activation, and cell death induced by VacA with ammonium chloride, indicating that ER stress may lead to mitochondrial dysfunction during VacA-induced toxicity. Activation of ER stress and up-regulation of BH3-only proteins were also observed in human H. pylori-infected gastric mucosa. Collectively, this study reveals a possible association between VacA-induced apoptosis in gastric epithelial cells, and activation of ER stress in H. pylori-positive gastric mucosa.	[Akazawa, Yuko; Isomoto, Hajime; Matsushima, Kayoko; Kanda, Tsutomu; Minami, Hitomi; Yamaghchi, Naoyuki; Taura, Naota; Shiozawa, Ken; Ohnita, Ken; Takeshima, Fuminao; Nakao, Kazuhiko] Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, Nagasaki, Japan; [Nakano, Masayuki; Hirayama, Toshiya] Nagasaki Univ, Dept Bacteriol, Inst Trop Med, Nagasaki 852, Japan; [Moss, Joel] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA	Nagasaki University; Nagasaki University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Akazawa, Y (corresponding author), Nagasaki Univ Hosp, Dept Gastroenterol & Hepatol, Nagasaki, Japan.	akazaway@nagassaki-u.ac.jp		Kanda, Tsutomu/0000-0003-0409-9258	MEXT/JSPS KAKENHI [22890138]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL000659] Funding Source: NIH RePORTER	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by MEXT/JSPS KAKENHI Grant Number 22890138. http://www.mext.go.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer T, 2010, HELICOBACTER, V15, P21, DOI 10.1111/j.1523-5378.2010.00777.x; Akazawa Y, 2010, J HEPATOL, V52, P586, DOI 10.1016/j.jhep.2010.01.003; Ashktorab H, 2004, GUT, V53, P805, DOI 10.1136/gut.2003.024372; Boquet P, 2003, TRENDS MICROBIOL, V11, P410, DOI 10.1016/S0966-842X(03)00211-7; Boquet P, 2012, TRENDS MICROBIOL, V20, P165, DOI 10.1016/j.tim.2012.01.008; Cazanave SC, 2010, AM J PHYSIOL-GASTR L, V299, pG236, DOI 10.1152/ajpgi.00091.2010; Cazanave SC, 2009, J BIOL CHEM, V284, P26591, DOI 10.1074/jbc.M109.022491; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; Chiozzi V, 2009, J PHYSIOL PHARMACOL, V60, P23; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; COVER TL, 1992, J INFECT DIS, V166, P1073, DOI 10.1093/infdis/166.5.1073; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; Cover TL, 2003, CANCER RES, V63, P951; Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062; Domanska G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000878; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; Galmiche A, 2000, EMBO J, V19, P6361, DOI 10.1093/emboj/19.23.6361; Ghosh AP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039586; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Jain P, 2011, P NATL ACAD SCI USA, V108, P16032, DOI 10.1073/pnas.1105175108; Kim IJ, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00037; Lee MS, 2010, INFECT IMMUN, V78, P3378, DOI 10.1128/IAI.00342-10; Liao Y, 2013, J VIROL, V87, P8124, DOI 10.1128/JVI.00626-13; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Matsumoto A, 2011, DIGEST DIS SCI, V56, P999, DOI 10.1007/s10620-010-1420-1; Nakayama Y, 2010, J BIOCHEM, V147, P471, DOI 10.1093/jb/mvp189; NEITHERCUT WD, 1991, GUT, V32, P973, DOI 10.1136/gut.32.9.973; Nguyen VQ, 2001, INFECT IMMUN, V69, P543, DOI 10.1128/IAI.69.1.543-546.2001; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Pagliassotti MJ, 2012, ANNU REV NUTR, V32, P17, DOI 10.1146/annurev-nutr-071811-150644; Palframan SL, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00092; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Rassow J, 2012, MICROBES INFECT, V14, P1026, DOI 10.1016/j.micinf.2012.07.002; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Sommi P, 1998, AM J PHYSIOL-GASTR L, V275, pG681, DOI 10.1152/ajpgi.1998.275.4.G681; Szabo I, 1999, EMBO J, V18, P5517, DOI 10.1093/emboj/18.20.5517; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tsutsumi S, 2004, CELL DEATH DIFFER, V11, P1009, DOI 10.1038/sj.cdd.4401436; Verfaillie T, 2012, CELL DEATH DIFFER, V19, P1880, DOI 10.1038/cdd.2012.74; Wei A, 2008, GASTROENTEROLOGY, V134, P1412, DOI 10.1053/j.gastro.2008.01.072; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wen SC, 2009, CANCER LETT, V282, P1, DOI 10.1016/j.canlet.2008.11.016; Willhite DC, 2004, CELL MICROBIOL, V6, P143, DOI 10.1046/j.1462-5822.2003.00347.x; Willhite DC, 2003, J BIOL CHEM, V278, P48204, DOI 10.1074/jbc.M304131200; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Yahiro K, 2004, J BIOL CHEM, V279, P51013, DOI 10.1074/jbc.M406473200; Yahiro K, 2012, J BIOL CHEM, V287, P31104, DOI 10.1074/jbc.M112.387498; Yamasaki E, 2006, J BIOL CHEM, V281, P11250, DOI 10.1074/jbc.M509404200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	50	46	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82322	10.1371/journal.pone.0082322	http://dx.doi.org/10.1371/journal.pone.0082322			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349255	Green Submitted, Green Published, gold			2022-12-27	WOS:000328734200037
J	Harju, SM; Olson, CV; Dzialak, MR; Mudd, JP; Winstead, JB				Harju, Seth M.; Olson, Chad V.; Dzialak, Matthew R.; Mudd, James P.; Winstead, Jeff B.			A Flexible Approach for Assessing Functional Landscape Connectivity, with Application to Greater Sage-Grouse (Centrocercus urophasianus)	PLOS ONE			English	Article							RESOURCE SELECTION FUNCTIONS; HABITAT SELECTION; ENERGY DEVELOPMENT; ANIMAL MOVEMENTS; BEHAVIOR; CONSERVATION; POPULATIONS; CORRIDORS; PATTERN; MODELS	Connectivity of animal populations is an increasingly prominent concern in fragmented landscapes, yet existing methodological and conceptual approaches implicitly assume the presence of, or need for, discrete corridors. We tested this assumption by developing a flexible conceptual approach that does not assume, but allows for, the presence of discrete movement corridors. We quantified functional connectivity habitat for greater sage-grouse (Centrocercus urophasianus) across a large landscape in central western North America. We assigned sample locations to a movement state (encamped, traveling and relocating), and used Global Positioning System (GPS) location data and conditional logistic regression to estimate state-specific resource selection functions. Patterns of resource selection during different movement states reflected selection for sagebrush and general avoidance of rough topography and anthropogenic features. Distinct connectivity corridors were not common in the 5,625 km(2) study area. Rather, broad areas functioned as generally high or low quality connectivity habitat. A comprehensive map predicting the quality of connectivity habitat across the study area validated well based on a set of GPS locations from independent greater sage-grouse. The functional relationship between greater sage-grouse and the landscape did not always conform to the idea of a discrete corridor. A more flexible consideration of landscape connectivity may improve the efficacy of management actions by aligning those actions with the spatial patterns by which animals interact with the landscape.	[Harju, Seth M.; Olson, Chad V.; Dzialak, Matthew R.; Mudd, James P.; Winstead, Jeff B.] Hayden Wing Associates LLC, Nat Resource Consultants, Laramie, WY USA		Harju, SM (corresponding author), Hayden Wing Associates LLC, Nat Resource Consultants, Laramie, WY USA.	seth@haydenwing.com			ConocoPhillips; EnCana Corporation; Noble Energy	ConocoPhillips; EnCana Corporation; Noble Energy	This study was funded by ConocoPhillips, EnCana Corporation and Noble Energy. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge CL, 2008, DIVERS DISTRIB, V14, P983, DOI 10.1111/j.1472-4642.2008.00502.x; Aldridge CL, 2007, ECOL APPL, V17, P508, DOI 10.1890/05-1871; Arthur SM, 1996, ECOLOGY, V77, P215, DOI 10.2307/2265671; Baguette M, 2007, LANDSCAPE ECOL, V22, P1117, DOI 10.1007/s10980-007-9108-4; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Bedrosian Bryan, 2007, Northwestern Naturalist, V88, P1, DOI 10.1898/1051-1733(2007)88[1:EOTFAT]2.0.CO;2; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Blackwood J, 2010, ECOL ECON, V69, P519, DOI 10.1016/j.ecolecon.2009.08.029; Bush KL, 2010, AUK, V127, P343, DOI 10.1525/auk.2009.09035; Carpenter J, 2010, J WILDLIFE MANAGE, V74, P1806, DOI 10.2193/2009-368; Chetkiewicz CLB, 2006, ANNU REV ECOL EVOL S, V37, P317, DOI 10.1146/annurev.ecolsys.37.091305.110050; Chetkiewicz CLB, 2009, J APPL ECOL, V46, P1036, DOI 10.1111/j.1365-2664.2009.01686.x; Compton BW, 2002, ECOLOGY, V83, P833, DOI 10.1890/0012-9658(2002)083[0833:HSBWTC]2.0.CO;2; Connelly JW, 1997, WILDLIFE BIOL, V3, P229, DOI 10.2981/wlb.1997.028; CONNELLY JW, 1988, J WILDLIFE MANAGE, V52, P116, DOI 10.2307/3801070; Connelly JW, 2000, WILDLIFE SOC B, V28, P967; Cooper AB, 1999, ECOLOGY, V80, P566, DOI 10.1890/0012-9658(1999)080[0566:TAODCM]2.0.CO;2; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; Duchesne T, 2010, J ANIM ECOL, V79, P548, DOI 10.1111/j.1365-2656.2010.01670.x; Dzialak MR, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00315.1; Dzialak MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026273; Dzialak MR, 2005, ANIM CONSERV, V8, P421, DOI 10.1017/S1367943005002441; Fedy BC, 2012, J WILDLIFE MANAGE, V76, P1062, DOI 10.1002/jwmg.337; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Harju SM, 2011, ANIM CONSERV, V14, P502, DOI 10.1111/j.1469-1795.2011.00456.x; Harju SM, 2010, J WILDLIFE MANAGE, V74, P437, DOI 10.2193/2008-289; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Johnson CJ, 2002, J ANIM ECOL, V71, P225, DOI 10.1046/j.1365-2656.2002.00595.x; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; Knick ST, 2011, STUD AVIAN BIOL, P383; Lendrum PE, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00165.1; Manly B.F.J., 2002, RESOURCE SELECTION A; Nams VO, 2006, J ANIM ECOL, V75, P298, DOI 10.1111/j.1365-2656.2006.01047.x; Rayfield B, 2011, ECOLOGY, V92, P847, DOI 10.1890/09-2190.1; Richard Y, 2010, J APPL ECOL, V47, P603, DOI 10.1111/j.1365-2664.2010.01806.x; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Rowland MM, 2006, BIOL CONSERV, V129, P323, DOI 10.1016/j.biocon.2005.10.048; Sawyer H, 2009, ECOL APPL, V19, P2016, DOI 10.1890/08-2034.1; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Schroeder MA, 2004, CONDOR, V106, P363, DOI 10.1650/7425; SIMBERLOFF D, 1987, Conservation Biology, V1, P63, DOI 10.1111/j.1523-1739.1987.tb00010.x; Tack JD, 2012, ORYX, V46, P64, DOI 10.1017/S003060531000147X; United States Bureau of Land Management, 2012, WY2012019 US BUR LAN; Van Moorter B, 2010, J WILDLIFE MANAGE, V74, P588, DOI 10.2193/2009-155; WAKKINEN WL, 1992, WILDLIFE SOC B, V20, P425; Wilson RR, 2012, WILDLIFE BIOL, V18, P424, DOI 10.2981/12-044; 2010, FED REG, V75, P13910	52	12	13	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82271	10.1371/journal.pone.0082271	http://dx.doi.org/10.1371/journal.pone.0082271			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349241	Green Submitted, Green Published, gold			2022-12-27	WOS:000328734200036
J	Hayashi, M; Zhao, CF; Thoreson, AR; Chikenji, T; Jay, GD; An, KN; Amadio, PC				Hayashi, Masanori; Zhao, Chunfeng; Thoreson, Andrew R.; Chikenji, Takako; Jay, Gregory D.; An, Kai-Nan; Amadio, Peter C.			The Effect of Lubricin on the Gliding Resistance of Mouse Intrasynovial Tendon	PLOS ONE			English	Article							BOVINE SYNOVIAL-FLUID; PROTEOGLYCAN SYNTHESIS; A1 PULLEY; SURFACE; IDENTIFICATION; LUBRICATION; EXPRESSION; FRICTION; REPAIR	The purpose of this study was to investigate the role of lubricin on the gliding resistance of intrasynovial tendons by comparing lubricin knockout, heterozygous, and wild type mice. A total of thirty-six deep digital flexor (DDF) tendons in the third digits of each hind paw from eighteen adult mice were used, including six lubricin knockout mice (Prg4 -/-), six heterozygous mice (Prg4 +/-), and six wild type mice (Prg4 +/+). The tendon gliding resistance was measured using a custom-made device. Tendon structural changes were evaluated by scanning electron and light microscopy. The gliding resistance of intrasynovial tendons from lubricin knockout mice was significantly higher than the gliding resistance of either wild type or heterozygous mice. The surface of the lubricin knockout tendons appeared to be rougher, compared to the wild type and heterozygous tendons. Synovial hyperplasia was found in the lubricin knockout mice. Cartilage-like tissue was found in the tendon and pulley of the lubricin knockout mice. Our findings confirm the importance of lubricin in intrasynovial tendon lubrication. This knockout model may be useful in determining the effect of lubricin on tendon healing and the response to injury.	[Hayashi, Masanori; Zhao, Chunfeng; Thoreson, Andrew R.; Chikenji, Takako; An, Kai-Nan; Amadio, Peter C.] Mayo Clin, Biomech Lab, Div Orthoped Res, Rochester, MN 55905 USA; [Jay, Gregory D.] Rhode Isl Hosp, Dept Emergency Med, Providence, RI USA; [Jay, Gregory D.] Brown Univ, Providence, RI 02912 USA	Mayo Clinic; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Amadio, PC (corresponding author), Mayo Clin, Biomech Lab, Div Orthoped Res, Rochester, MN 55905 USA.	pamadio@mayo.edu	Takako, Chikenji/AAT-8342-2021	Takako, Chikenji/0000-0003-2832-3656; Jay, Gregory/0000-0003-1517-8488	Mayo Foundation	Mayo Foundation	No external funding was received to support this study. This study was supported by Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Carvalho HF, 2006, CELL TISSUE RES, V325, P315, DOI 10.1007/s00441-006-0161-0; Drewniak EI, 2012, ARTHRITIS RHEUM-US, V64, P465, DOI 10.1002/art.33337; Ehlers TW, 1998, COMP BIOCHEM PHYS A, V121, P355, DOI 10.1016/S1095-6433(98)10144-7; Englert C, 2005, ARTHRITIS RHEUM-US, V52, P1091, DOI 10.1002/art.20986; Estrella RP, 2010, BIOCHEM J, V429, P359, DOI 10.1042/BJ20100360; Jay GD, 2001, GLYCOCONJUGATE J, V18, P807, DOI 10.1023/A:1021159619373; JAY GD, 1992, CONNECT TISSUE RES, V28, P71, DOI 10.3109/03008209209014228; Jay GD, 1998, J BIOMED MATER RES, V40, P414, DOI 10.1002/(SICI)1097-4636(19980605)40:3<414::AID-JBM11>3.0.CO;2-J; Kohrs RT, 2011, J ORTHOP RES, V29, P384, DOI 10.1002/jor.21247; KOOB TJ, 1992, ARCH BIOCHEM BIOPHYS, V298, P303, DOI 10.1016/0003-9861(92)90127-I; KOSTROMINOVA TY, 2013, AGE, P71222; Marcelino J, 1999, NAT GENET, V23, P319, DOI 10.1038/15496; Rees SG, 2002, MATRIX BIOL, V21, P593, DOI 10.1016/S0945-053X(02)00056-2; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Sbernardori MC, 2007, J HAND SURG-EUR VOL, V32E, P556, DOI 10.1016/j.jhse.2007.06.002; Sbernardori MC, 2007, J HAND SURG-BRIT EUR, V32E, P384, DOI 10.1016/j.jhsb.2007.01.013; Schaefer DB, 2004, BIORHEOLOGY, V41, P503; Sun YL, 2008, J ORTHOP RES, V26, P1225, DOI 10.1002/jor.20624; Sun YL, 2006, CONNECT TISSUE RES, V47, P215, DOI 10.1080/03008200600846754; Sun YL, 2006, J ORTHOP RES, V24, P1861, DOI 10.1002/jor.20239; SWANN DA, 1981, J BIOL CHEM, V256, P5921; SWANN DA, 1981, ARTHRITIS RHEUM, V24, P22, DOI 10.1002/art.1780240104; SWANN DA, 1977, BIOCHEM J, V161, P473, DOI 10.1042/bj1610473; Taguchi M, 2008, J BONE JOINT SURG AM, V90A, P129, DOI 10.2106/JBJS.G.00045; Taguchi M, 2009, J HAND SURG-AM, V34A, P1276, DOI 10.1016/j.jhsa.2009.04.011; Taguchi M, 2009, J ORTHOP RES, V27, P257, DOI 10.1002/jor.20731; UCHIYAMA S, 1995, J ORTHOPAED RES, V13, P83, DOI 10.1002/jor.1100130113; Wong J, 2006, J ANAT, V209, P533, DOI 10.1111/j.1469-7580.2006.00625.x; Wong JKF, 2009, AM J PATHOL, V175, P1938, DOI 10.2353/ajpath.2009.090380	30	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83836	10.1371/journal.pone.0083836	http://dx.doi.org/10.1371/journal.pone.0083836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349551	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200102
J	Soga, K; Teruya, F; Tateno, H; Hirabayashi, J; Yamamoto, K				Soga, Keisuke; Teruya, Futaba; Tateno, Hiroaki; Hirabayashi, Jun; Yamamoto, Kazuo			Terminal N-Acetylgalactosamine-Specific Leguminous Lectin from Wisteria japonica as a Probe for Human Lung Squamous Cell Carcinoma	PLOS ONE			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; PITUITARY GLYCOPROTEIN HORMONES; FRONTAL AFFINITY-CHROMATOGRAPHY; WISTARIA-FLORIBUNDA; SIALYLATED OLIGOSACCHARIDES; MOLECULAR-CLONING; DOLICHOS-BIFLORUS; COMBINING SITE; HELIX-POMATIA; SUGAR CHAINS	Millettia japonica was recently reclassified into the genus Wisteria japonica based on chloroplast and nuclear DNA sequences. Because the seed of Wisteria floribunda expresses leguminous lectins with unique N-acetylgalactosamine-binding specificity, we purified lectin from Wisteria japonica seeds using ion exchange and gel filtration chromatography. Glycan microarray analysis demonstrated that unlike Wisteria floribunda and Wisteria brachybotrys lectins, which bind to both terminal N-acetylgalactosamine and galactose residues, Wisteria japonica lectin (WJA) specifically bound to both alpha- and beta-linked terminal N-acetylgalactosamine, but not galactose residues on oligosaccharides and glycoproteins. Further, frontal affinity chromatography using more than 100 2-aminopyridine-labeled and p-nitrophenyl-derivatized oligosaccharides demonstrated that the ligands with the highest affinity for Wisteria japonica lectin were GalNAc beta 1-3GlcNAc and GalNAc beta 1-4GlcNAc, with K-a values of 9.5 x 10(4) and 1.4 x 10(5) M-1, respectively. In addition, when binding was assessed in a variety of cell lines, Wisteria japonica lectin bound specifically to EBC-1 and HEK293 cells while other Wisteria lectins bound equally to all of the cell lines tested. Wisteria japonica lectin binding to EBC-1 and HEK293 cells was dramatically decreased in the presence of N-acetylgalactosamine, but not galactose, mannose, or N-acetylglucosamine, and was completely abrogated by beta-hexosaminidase-digestion of these cells. These results clearly demonstrate that Wisteria japonica lectin binds to terminal N-acetylgalactosamine but not galactose. In addition, histochemical analysis of human squamous cell carcinoma tissue sections demonstrated that Wisteria japonica lectin specifically bound to differentiated cancer tissues but not normal tissue. This novel binding characteristic of Wisteria japonica lectin has the potential to become a powerful tool for clinical applications.	[Soga, Keisuke; Teruya, Futaba; Yamamoto, Kazuo] Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan; [Tateno, Hiroaki; Hirabayashi, Jun] AIST, Res Ctr Med Glycosci, Tsukuba, Ibaraki, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST)	Yamamoto, K (corresponding author), Univ Tokyo, Dept Integrated Biosci, Grad Sch Frontier Sci, Kashiwa, Chiba, Japan.	yamamoto@k.u-tokyo.ac.jp	Tateno, Hiroaki/M-2706-2018; Hirabayashi, Jun/M-3998-2018	Tateno, Hiroaki/0000-0003-3006-1659; Hirabayashi, Jun/0000-0002-8571-359X; SOGA, Keisuke/0000-0001-7387-468X	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24390015, 24659026, 25117710]; Naito Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation)	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (http://www.jsps.go.jp) (24390015, 24659026, and 25117710, to KY) and by a Grant-in-Aid from The Naito Foundation (https://www.naito-f.or.jp) (to KY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED H, 1988, CARBOHYD RES, V177, P173, DOI 10.1016/0008-6215(88)85051-1; BAKER DA, 1983, BIOCHEMISTRY-US, V22, P2741, DOI 10.1021/bi00280a023; Compton JA, 2013, WILLDENOWIA, V43, P113, DOI 10.3372/wi.43.43113; Do KY, 1997, GLYCOBIOLOGY, V7, P183, DOI 10.1093/glycob/7.2.183; Gotoh M, 2004, FEBS LETT, V562, P134, DOI 10.1016/S0014-5793(04)00219-4; GREEN ED, 1988, J BIOL CHEM, V263, P25; GREEN ED, 1988, J BIOL CHEM, V263, P36; Hanisch FG, 2013, GLYCOBIOLOGY, V23, P2, DOI 10.1093/glycob/cws131; Hirabayashi J, 2003, METHOD ENZYMOL, V362, P353; Hiruma T, 2004, J BIOL CHEM, V279, P14087, DOI 10.1074/jbc.M310614200; Hsu WM, 2011, AM J PATHOL, V179, P1394, DOI 10.1016/j.ajpath.2011.05.025; Hu JM, 2000, AM J BOT, V87, P418, DOI 10.2307/2656638; Hu JM, 2002, SYST BOT, V27, P722; Huang JZ, 2012, DNA RES, V19, P195, DOI 10.1093/dnares/dss004; Huang J, 2007, MOL CANCER RES, V5, P543, DOI 10.1158/1541-7786.MCR-06-0431; Ikehara Y, 2006, GLYCOBIOLOGY, V16, P777, DOI 10.1093/glycob/cwl005; Kitamura N, 2003, INT J CANCER, V105, P533, DOI 10.1002/ijc.11115; Matsuda A, 2013, J PROTEOMICS, V85, P1, DOI 10.1016/j.jprot.2013.04.017; Matsuda A, 2010, HEPATOLOGY, V52, P174, DOI 10.1002/hep.23654; NAKATA N, 1993, BIOCHEMISTRY-US, V32, P4369, DOI 10.1021/bi00067a029; Nimtz M, 2004, BBA-GEN SUBJECTS, V1675, P71, DOI 10.1016/j.bbagen.2004.08.007; Sasaki N, 2011, STEM CELLS, V29, P641, DOI 10.1002/stem.615; Sato T, 2003, J BIOL CHEM, V278, P47534, DOI 10.1074/jbc.M308857200; Song SC, 1999, EUR J BIOCHEM, V266, P778, DOI 10.1046/j.1432-1327.1999.00908.x; SUGII S, 1980, BIOCHEMISTRY-US, V19, P1192, DOI 10.1021/bi00547a024; Tateno H, 2008, GLYCOBIOLOGY, V18, P789, DOI 10.1093/glycob/cwn068; Tateno H, 2007, NAT PROTOC, V2, P2529, DOI 10.1038/nprot.2007.357; TORRES BV, 1988, ARCH BIOCHEM BIOPHYS, V262, P1, DOI 10.1016/0003-9861(88)90161-0; TOYOSHIMA S, 1971, BIOCHEMISTRY-US, V10, P4457, DOI 10.1021/bi00800a016; TSUJI T, 1982, CARBOHYD RES, V109, P259, DOI 10.1016/0008-6215(82)84043-3; YAN SB, 1993, GLYCOBIOLOGY, V3, P597, DOI 10.1093/glycob/3.6.597	31	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83886	10.1371/journal.pone.0083886	http://dx.doi.org/10.1371/journal.pone.0083886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349556	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200104
J	Wang, MP; Wang, X; Lam, TH; Viswanath, K; Chan, SS				Wang, Man Ping; Wang, Xin; Lam, Tai Hing; Viswanath, Kasisomayajula; Chan, Sophia S.			Health Information Seeking Partially Mediated the Association between Socioeconomic Status and Self-Rated Health among Hong Kong Chinese	PLOS ONE			English	Article							COMMUNICATION; INEQUALITIES; DISPARITIES; BEHAVIORS; MORTALITY; RISK	Background: Poor self-rated health (SRH) is socially patterned with health communication inequalities, arguably, serving as one mechanisms. This study investigated the effects of health information seeking on SRH, and its mediation effects on disparities in SRH. Methods: We conducted probability-based telephone surveys administered over telephone in 2009, 2010/11 and 2012 to monitor health information use among 4553 Chinese adults in Hong Kong. Frequency of information seeking from television, radio, newspapers/magazines and Internet was dichotomised as < 1 time/month and >= 1 time/month. Adjusted odds ratios (aOR) for poor SRH were calculated for health information seeking from different sources and socioeconomic status (education and income). Mediation effects of health information seeking on the association between SES and poor SRH was estimated. Results: Poor SRH was associated with lower socioeconomic status (P for trend < 0.001), and less than monthly health information seeking from newspapers/magazines (aOR = 1.23, 95% CI 1.07-1.42) and Internet (aOR = 1.13, 95% CI 0.98-1.31). Increasing combined frequency of health information seeking from newspapers/magazines and Internet was linearly associated with better SRH (P for trend < 0.01). Health information seeking from these two sources contributed 9.2% and 7.9% of the total mediation effects of education and household income on poor SRH, respectively. Conclusions: Poor SRH was associated with lower socioeconomic status, and infrequent health information seeking from newspapers/magazines and Internet among Hong Kong Chinese. Disparities in SRH may be partially mediated by health information seeking from newspapers/magazines and Internet.	[Wang, Man Ping; Wang, Xin; Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Viswanath, Kasisomayajula] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Ctr Community Based Res,Dept Social & Behav Sci, Boston, MA 02115 USA; [Chan, Sophia S.] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; University of Hong Kong	Lam, TH (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	hrmrlth@hku.hk		Wang, Man Ping/0000-0003-4000-2388	Hong Kong Jockey Club Charities Trust	Hong Kong Jockey Club Charities Trust	This study was a part of the project "FAMILY: A Jockey Club Initiative for a Harmonious Society,'' which was funded by The Hong Kong Jockey Club Charities Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandura A., 1986, SOCIAL FDN THOUGHT A; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beaudoin CE, 2011, INT J MED INFORM, V80, P586, DOI 10.1016/j.ijmedinf.2011.04.003; Bennett IM, 2009, ANN FAM MED, V7, P204, DOI 10.1370/afm.940; Census and Statistics Department, 2013, HONG KONG INF SOC; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cott CA, 1999, J EPIDEMIOL COMMUN H, V53, P731, DOI 10.1136/jech.53.11.731; Delpierre C, 2009, J EPIDEMIOL COMMUN H, V63, P426, DOI 10.1136/jech.2008.080085; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Rutten LJF, 2006, J HEALTH COMMUN, V11, P147, DOI 10.1080/10810730600637574; Hosseinpoor AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034799; IDLER EL, 1990, AM J EPIDEMIOL, V131, P91, DOI 10.1093/oxfordjournals.aje.a115489; Information Sevices Department, 2012, HONG KONG FACTS; Ishikawa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040664; Johnson JD, 1997, CANC RELATED INFORM; Jung M, 2013, PATIENT EDUC COUNS, V92, P100, DOI 10.1016/j.pec.2013.02.008; Kondo N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4471; Kontos EZ, 2012, AM J PUBLIC HEALTH, V102, P1911, DOI 10.2105/AJPH.2011.300435; Kreps GL, 2012, GLOB HLTH 2012 1 INT, P119; Kreuter MW, 2004, ANNU REV PUBL HEALTH, V25, P439, DOI 10.1146/annurev.publhealth.25.101802.123000; Lee SY, 2008, COMMUN RES, V35, P358, DOI 10.1177/0093650208315962; MACKINNON DP, 1993, EVALUATION REV, V17, P144, DOI 10.1177/0193841X9301700202; Manderbacka K, 1999, SOC SCI MED, V48, P1713, DOI 10.1016/S0277-9536(99)00068-4; Nielsen, 2011, FREE NEWSP NEW MED S; Ramanadhan S, 2006, HEALTH COMMUN, V20, P131, DOI 10.1207/s15327027hc2002_4; Rimal RN, 2009, B WORLD HEALTH ORGAN, V87, P247, DOI 10.2471/BLT.08.056713; Rutten LJF, 2009, NICOTINE TOB RES, V11, P190, DOI 10.1093/ntr/ntn019; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI 10.2307/270723; UNESCO, 2000, PUBL REP COMM NEWSP; Viswanath K, 2006, EXAMING HLTH DISPARI; Viswanath K., 2007, MACROSOCIAL DETERMIN, P275, DOI DOI 10.1007/978-0-387-70812-6_13; Viswanath K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014550; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; Wang MP, 2013, TOB CONTROL IN PRESS; Wangberg SC, 2008, HEALTH PROMOT INT, V23, P70, DOI 10.1093/heapro/dam039	35	9	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82720	10.1371/journal.pone.0082720	http://dx.doi.org/10.1371/journal.pone.0082720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276FP	24349347	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200052
J	Wang, Y; Hong, Y; Li, M; Long, J; Zhao, YP; Zhang, JX; Li, Q; You, H; Tong, WM; Jia, JD; Huang, J				Wang, Yan; Hong, Yu; Li, Man; Long, Jiang; Zhao, Yan-Ping; Zhang, Jun-Xia; Li, Qian; You, Hong; Tong, Wei-Min; Jia, Ji-Dong; Huang, Jian			Mutation Inactivation of Nijmegen Breakage Syndrome Gene (NBS1) in Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma	PLOS ONE			English	Article							DNA-DAMAGE; CANCER; P53; SUSCEPTIBILITY; PATHOGENESIS; ASSOCIATION; DOMAINS; TARGETS; RISK	Nijmegen breakage syndrome (NBS) with NBS1 germ-line mutation is a human autosomal recessive disease characterized by genomic instability and enhanced cancer predisposition. The NBS1 gene codes for a protein, Nbs1(p95/Nibrin), involved in the processing/repair of DNA double-strand breaks. Hepatocellular carcinoma (HCC) is a complex and heterogeneous tumor with several genomic alterations. Recent studies have shown that heterozygous NBS1 mice exhibited a higher incidence of HCC than did wild-type mice. The objective of the present study is to assess whether NBS1 mutations play a role in the pathogenesis of human primary liver cancer, including HBV-associated HCC and intrahepatic cholangiocarcinoma (ICC). Eight missense NBS1 mutations were identified in six of 64 (9.4%) HCCs and two of 18 (11.1%) ICCs, whereas only one synonymous mutation was found in 89 control cases of cirrhosis and chronic hepatitis B. Analysis of the functional consequences of the identified NBS1 mutations in Mre11-binding domain showed loss of nuclear localization of Nbs1 partner Mre11, one of the hallmarks for Nbs1 deficiency, in one HCC and two ICCs with NBS1 mutations. Moreover, seven of the eight tumors with NBS1 mutations had at least one genetic alteration in the TP53 pathway, including TP53 mutation, MDM2 amplification, p14ARF homozygous deletion and promoter methylation, implying a synergistic effect of Nbs1 disruption and p53 inactivation. Our findings provide novel insight on the molecular pathogenesis of primary liver cancer characterized by mutation inactivation of NBS1, a DNA repair associated gene.	[Wang, Yan; Hong, Yu; Zhao, Yan-Ping; You, Hong; Jia, Ji-Dong; Huang, Jian] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing, Peoples R China; [Li, Man; Tong, Wei-Min] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Pathol, Beijing 100730, Peoples R China; [Li, Man; Tong, Wei-Min] Peking Union Med Coll, Beijing 100021, Peoples R China; [Long, Jiang] Capital Med Univ, Minimally Invas Hepatobiliary Canc Ctr, Beijing You An Hosp, Beijing, Peoples R China; [Zhang, Jun-Xia] Tianjin Infect Dis Specialty Hosp, Dept Hepatol, Tianjin, Peoples R China; [Li, Qian] Mt Sinai Sch Med, Dept Prevent Med, New York, NY USA	Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Icahn School of Medicine at Mount Sinai	Jia, JD (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing, Peoples R China.	jia_jd@ccmu.edu.cn; huangj1966@hotmail.com	You, Hong/G-6686-2011; zhao, yan/GWC-9174-2022		National Natural Science Foundation of China [81071973, 30970602]; Beijing Municipal Natural Science Foundation [7132058]; Beijing Friendship Hospital, Capital Medical University [200936]; 111 project	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Beijing Friendship Hospital, Capital Medical University; 111 project(Ministry of Education, China - 111 Project)	This work was supported by grants from the National Natural Science Foundation of China (81071973), Beijing Municipal Natural Science Foundation (7132058) and a grant from Beijing Friendship Hospital, Capital Medical University (200936). Dr Wei-Min Tong was supported in part by National Natural Science Foundation of China (30970602) and 111 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt JR, 2005, J BIOL CHEM, V280, P18771, DOI 10.1074/jbc.M413387200; Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Bill CA, 2004, P NATL ACAD SCI USA, V101, P11135, DOI 10.1073/pnas.0403925101; Bogdanova N, 2008, INT J CANCER, V122, P802, DOI 10.1002/ijc.23168; Chrzanowska KH, 2006, INT J CANCER, V118, P1269, DOI 10.1002/ijc.21439; Dandri M, 2002, HEPATOLOGY, V35, P217, DOI 10.1053/jhep.2002.30203; Desai-Mehta A, 2001, MOL CELL BIOL, V21, P2184, DOI 10.1128/MCB.21.6.2184-2191.2001; Di YM, 2009, AAPS J, V11, P469, DOI 10.1208/s12248-009-9126-z; Dumon-Jones V, 2003, CANCER RES, V63, P7263; Ebi H, 2007, CANCER RES, V67, P11158, DOI 10.1158/0008-5472.CAN-07-1749; Heikkinen K, 2006, CARCINOGENESIS, V27, P1593, DOI 10.1093/carcin/bgi360; Huang J, 2008, CLIN CANCER RES, V14, P4053, DOI 10.1158/1078-0432.CCR-08-0098; Huang J, 2012, PROG BIOCHEM BIOPHYS, V39, P678, DOI 10.3724/SP.J.1206.2011.00536; Iijima K, 2008, DNA REPAIR, V7, P1705, DOI 10.1016/j.dnarep.2008.06.013; Kang J, 2005, MOL CELL BIOL, V25, P661, DOI 10.1128/MCB.25.2.661-670.2005; Lee JH, 2006, FEBS J, V273, P1630, DOI 10.1111/j.1742-4658.2006.05191.x; Minguez B, 2009, CURR OPIN GASTROEN, V25, P186, DOI 10.1097/MOG.0b013e32832962a1; Nakanuma Y., 2010, WHO CLASSIFICATION T, P217; Nowak J, 2008, EUR J CANCER, V44, P627, DOI 10.1016/j.ejca.2008.01.006; OZTURK M, 1991, LANCET, V338, P1356, DOI 10.1016/0140-6736(91)92236-U; Paterlini-Brechot P, 2003, ONCOGENE, V22, P3911, DOI 10.1038/sj.onc.1206492; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Theise ND, 2010, WHO CLASSIFICATION T, V4, P205; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Varon R, 2000, EUR J HUM GENET, V8, P900, DOI 10.1038/sj.ejhg.5200554; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Watanabe T, 2009, J NEUROPATH EXP NEUR, V68, P210, DOI 10.1097/NEN.0b013e31819724c2; Yang YG, 2006, DNA REPAIR, V5, P885, DOI 10.1016/j.dnarep.2006.05.004; Zhao S, 2002, NUCLEIC ACIDS RES, V30, P4815, DOI 10.1093/nar/gkf612; Zhu DQ, 2007, WORLD CHINESE J DIGE, V15, P1775	31	8	10	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82426	10.1371/journal.pone.0082426	http://dx.doi.org/10.1371/journal.pone.0082426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349281	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200042
J	Gottschalk, S; Yu, F; Ji, MJ; Kakarla, S; Song, XT				Gottschalk, Stephen; Yu, Feng; Ji, Minjun; Kakarla, Sunitha; Song, Xiao-Tong			A Vaccine That Co-Targets Tumor Cells and Cancer Associated Fibroblasts Results in Enhanced Antitumor Activity by Inducing Antigen Spreading	PLOS ONE			English	Article							ACTIVATION PROTEIN-ALPHA; DENDRITIC CELLS; IMMUNOTHERAPY; GROWTH; STROMA; IMMUNITY; SUPPRESSION; INHIBITION; MELANOMA; SURVIVAL	Dendritic cell (DC) vaccines targeting only cancer cells have produced limited antitumor activity in most clinical studies. Targeting cancer-associated fibroblasts (CAFs) in addition to cancer cells may enhance antitumor effects, since CAFs, the central component of the tumor stroma, directly support tumor growth and contribute to the immunosuppressive tumor microenvironment. To co-target CAFs and tumor cells we developed a new compound DC vaccine that encodes an A20-specific shRNA to enhance DC function, and targets fibroblast activation protein (FAP) expressed in CAFs and the tumor antigen tyrosine-related protein (TRP) 2 (DC-shA20-FAP-TRP2). DC-shA20-FAP-TRP2 vaccination induced robust FAP- and TRP2-specific T-cell responses, resulting in greater antitumor activity in the B16 melanoma model in comparison to monovalent vaccines or a vaccine encoding antigens and a control shRNA. DC-shA20-FAP-TRP2 vaccination enhanced tumor infiltration of CD8-positive T cells, and induced antigen-spreading resulting in potent antitumor activity. Thus, co-targeting of tumor cells and CAFs results in the induction of broad-based tumor-specific T-cell responses and has the potential to improve current vaccine approaches for cancer.	[Gottschalk, Stephen; Yu, Feng; Ji, Minjun; Kakarla, Sunitha; Song, Xiao-Tong] Texas Childrens Hosp, Baylor Coll Med, Houston Methodist Hosp, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Gottschalk, Stephen; Song, Xiao-Tong] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Gottschalk, Stephen; Kakarla, Sunitha] Baylor Coll Med, Interdept Program Translat Biol & Mol Med, Houston, TX 77030 USA; [Gottschalk, Stephen] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Gottschalk, Stephen] Texas Childrens Hosp, Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center	Gottschalk, S (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Houston Methodist Hosp, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.	smgottsc@txch.org; xxtongso@txch.org	Song, Xiao-Tong/AAI-8424-2020; Gottschalk, Stephen/M-9343-2018	Gottschalk, Stephen/0000-0003-3991-7468	DAMD [W81XWH-10-1-0281]; NIH [P50 CA126752, 1R01CA148748-01A1]; NATIONAL CANCER INSTITUTE [R01CA148748, P50CA126752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	DAMD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by DAMD W81XWH-10-1-0281, NIH grants P50 CA126752 and 1R01CA148748-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Butterfield LH, 2003, CLIN CANCER RES, V9, P998; Chometon G, 2009, CLIN TRANSL ONCOL, V11, P75, DOI 10.1007/s12094-009-0317-y; Cirri P, 2011, AM J CANCER RES, V1, P482; Cunningham CC, 2007, EXPERT OPIN INV DRUG, V16, P1459, DOI 10.1517/13543784.16.9.1459; Disis ML, 2002, J CLIN ONCOL, V20, P2624, DOI 10.1200/JCO.2002.06.171; Dolznig Helmut, 2005, Cancer Immun, V5, P10; Giannoni E, 2010, CANCER RES, V70, P6945, DOI 10.1158/0008-5472.CAN-10-0785; Gottschalk S, 2001, BLOOD, V97, P835, DOI 10.1182/blood.V97.4.835; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Kakarla S, 2012, IMMUNOTHERAPY-UK, V4, P1129, DOI [10.2217/IMT.12.112, 10.2217/imt.12.112]; Kelly T, 2005, DRUG RESIST UPDATE, V8, P51, DOI 10.1016/j.drup.2005.03.002; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Lee J, 2005, CANCER RES, V65, P11156, DOI 10.1158/0008-5472.CAN-05-2805; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Loeffler M, 2006, J CLIN INVEST, V116, P1955, DOI 10.1172/JCI26532; Marx J, 2008, SCIENCE, V320, P38, DOI 10.1126/science.320.5872.38; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Nencioni A, 2008, CRIT REV ONCOL HEMAT, V65, P191, DOI 10.1016/j.critrevonc.2007.10.002; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Polyak K, 2009, TRENDS GENET, V25, P30, DOI 10.1016/j.tig.2008.10.012; RETTIG WJ, 1994, INT J CANCER, V58, P385, DOI 10.1002/ijc.2910580314; Sampson JH, 2010, J CLIN ONCOL, V28, P4722, DOI 10.1200/JCO.2010.28.6963; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; Scott AM, 2003, CLIN CANCER RES, V9, P1639; Shen L, 2004, NAT BIOTECHNOL, V22, P1546, DOI 10.1038/nbt1035; Song XT, 2008, NAT MED, V14, P258, DOI 10.1038/nm1721; Song XT, 2006, PLOS MED, V3, P76, DOI 10.1371/journal.pmed.0030011; Spiotto MT, 2004, NAT MED, V10, P294, DOI 10.1038/nm999; Tchou J, 2012, ADV PHARMACOL, V65, P45, DOI 10.1016/B978-0-12-397927-8.00003-8; Wen YA, 2010, CANCER SCI, V101, P2325, DOI 10.1111/j.1349-7006.2010.01695.x; Wierecky J, 2006, CANCER RES, V66, P5910, DOI 10.1158/0008-5472.CAN-05-3905; Zhang B, 2007, J EXP MED, V204, P49, DOI 10.1084/jem.20062056	32	35	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82658	10.1371/journal.pone.0082658	http://dx.doi.org/10.1371/journal.pone.0082658			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349329	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800071
J	Goyal, A; Chavez, SL; Pera, RAR				Goyal, Akshi; Chavez, Shawn L.; Pera, Renee A. Reijo			Generation of Human Induced Pluripotent Stem Cells Using Epigenetic Regulators Reveals a Germ Cell-Like Identity in Partially Reprogrammed Colonies	PLOS ONE			English	Article							SOMATIC-CELLS; HUMAN FIBROBLASTS; INDUCTION; MOUSE; DIFFERENTIATION; VECTOR; ADULT; NANOG	Previous studies have shown that induced pluripotent stem cells (iPSCs) can be derived from fibroblasts by ectopic expression of four transcription factors, OCT4, SOX2, KLF4 and c-MYC using various methods. More recent studies have focused on identifying alternative approaches and factors that can be used to increase reprogramming efficiency of fibroblasts to pluripotency. Here, we use nucleofection, morpholino technologies and novel epigenetic factors, which were chosen based on their expression profile in human embryos, fibroblasts and undifferentiated/differentiated human embryonic stem cells (hESCs) and conventionally generated iPSCs, to reprogram human fibroblasts into iPSCs. By over expressing DNMT3B, AURKB, PRMT5 and/or silencing SETD7 in human fibroblasts with and without NANOG, hTERT and/or SV40 overexpression, we observed the formation of colonies resembling iPSCs that were positive for certain pluripotency markers, but exhibited minimal proliferation. More importantly, we also demonstrate that these partially-reprogrammed colonies express high levels of early to mid germ cell-specific genes regardless of the transfection approach, which suggests conversion to a germ cell-like identity is associated with early reprogramming. These findings may provide an additional means to evaluate human germ cell differentiation in vitro, particularly in the context of pluripotent stem cell-derived germ cell development, and contribute to our understanding of the epigenetic requirements of the reprogramming process.	[Goyal, Akshi; Chavez, Shawn L.; Pera, Renee A. Reijo] Inst Stem Cell Biol & Regenerat Med, Ctr Reprod & Stem Cell Biol, Stanford, CA USA; [Goyal, Akshi; Chavez, Shawn L.; Pera, Renee A. Reijo] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Stanford, CA 94305 USA	Stanford University	Chavez, SL (corresponding author), Oregon Hlth & Sci Univ, Div Reprod & Dev Sci, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA.	chavesh@ohsu.edu	Chavez, Shawn L./ABF-6125-2021	Chavez, Shawn L./0000-0002-8285-0222; Reijo Pera, Renee/0000-0002-6487-1329	National Institutes of Health (NIH) National Heart, Lung and Blood Institute (NHLBI) [1U01HL100397]; NICHD as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research, CIRM (SJSU SCILL) [U54HD068158]; NICHD National Research Service Award (NRSA) [1F32HD055792]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD068158] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD055792] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research, CIRM (SJSU SCILL); NICHD National Research Service Award (NRSA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The non-human embryo of this work was supported by the National Institutes of Health (NIH) National Heart, Lung and Blood Institute (NHLBI) #1U01HL100397, National Institute of Child Health and Human Development (NICHD) #U54HD068158 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research, California Institute for Regenerative Medicine (CIRM) San Jose State University Stem Cell Internship in Laboratory-based Learning (SJSU SCILL) all to RARP and NICHD National Research Service Award (NRSA) Postdoctoral Fellowship #1F32HD055792 to SLC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; BUEHR M, 1993, DEV DYNAM, V198, P182, DOI 10.1002/aja.1001980304; Byrne JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007118; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chavez SL, 2008, STEM CELLS DEV, V17, P535, DOI 10.1089/scd.2007.0216; Chavez SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2249; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Ferreira LMR, 2013, GENE, V520, P1, DOI 10.1016/j.gene.2013.02.037; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gomyo Y, 2004, ONCOGENE, V23, P6779, DOI 10.1038/sj.onc.1207381; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Han JN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012297; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Kalista T, 2011, CELL STEM CELL, V8, P360, DOI 10.1016/j.stem.2011.02.018; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Marchion DC, 2005, CANCER RES, V65, P3815, DOI 10.1158/0008-5472.CAN-04-2478; Meyer JR, 2008, J MED ETHICS, V34, P849, DOI 10.1136/jme.2008.024786; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Owen LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033576; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Rashid ST, 2013, J HEPATOL, V58, P625, DOI 10.1016/j.jhep.2012.10.026; Si-Tayeb K, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-81; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Theunissen TW, 2011, CURR BIOL, V21, P65, DOI 10.1016/j.cub.2010.11.074; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yamaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041007; Ye L, 2013, CURR CARDIOL REV, V9, P63, DOI 10.2174/1573403X11309010008; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	48	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82838	10.1371/journal.pone.0082838	http://dx.doi.org/10.1371/journal.pone.0082838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349377	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800082
J	Vasquez, HE; Hashimoto, K; Yoshida, A; Hara, K; Imai, CC; Kitamura, H; Satuito, CG				Vasquez, Hebert Ely; Hashimoto, Kyotaro; Yoshida, Asami; Hara, Kenji; Imai, Chisato Chris; Kitamura, Hitoshi; Satuito, Cyril Glenn			A Glycoprotein in Shells of Conspecifics Induces Larval Settlement of the Pacific Oyster Crassostrea gigas	PLOS ONE			English	Article							MUSSEL MYTILUS-GALLOPROVINCIALIS; POLYACRYLAMIDE-GELS; CHEMICAL CUES; NATURAL CUE; METAMORPHOSIS; BARNACLE; BEHAVIOR; INDUCTION; PROTEINS; CONSEQUENCES	Settlement of larvae of Crassostrea gigas on shell chips (SC) prepared from shells of 11 different species of mollusks was investigated. Furthermore, the settlement inducing compound in the shell of C. gigas was extracted and subjected to various treatments to characterize the chemical cue. C. gigas larvae settled on SC of all species tested except on Patinopecten yessoensis and Atrina pinnata. In SC of species that induced C. gigas larvae to settle, settlement was proportionate to the amount of SC supplied to the larvae. When compared to C. gigas SC, all species except Crassostrea nippona showed lower settlement inducing activities, suggesting that the cue may be more abundant or in a more available form to the larvae in shells of conspecific and C. nippona than in other species. The settlement inducing activity of C. gigas SC remained intact after antibiotic treatment. Extraction of C. gigas SC with diethyl ether (Et2O-ex), ethanol (EtOH-ex), and water (Aq-ex) did not induce larval settlement of C. gigas larvae. However, extraction of C. gigas SC with 2N of hydrochloric acid (HCl-ex) induced larval settlement that was at the same level as the SC. The settlement inducing compound in the HCl-ex was stable at 100 degrees C but was destroyed or degraded after pepsin, trypsin, PNGase F and trifluoromethanesulfonic acid treatments. This chemical cue eluted between the molecular mass range of 45 and 150 kDa after gel filtration and revealed a major band at 55 kDa on the SDS-PAGE gel after staining with Stains-all. Thus, a 55 kDa glycoprotein component in the organic matrix of C. gigas shells is hypothesized to be the chemical basis of larval settlement on conspecifics.	[Vasquez, Hebert Ely; Hashimoto, Kyotaro; Yoshida, Asami; Hara, Kenji; Kitamura, Hitoshi; Satuito, Cyril Glenn] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 852, Japan; [Imai, Chisato Chris] Nagasaki Univ, Inst Trop Med, Dept Pediat Infect Dis, Nagasaki 852, Japan	Nagasaki University; Nagasaki University	Vasquez, HE (corresponding author), Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki 852, Japan.	hebertely@gmail.com	Vasquez, Hebert/AAI-6671-2021; Imai, Chrissy/AAJ-7789-2021; Satuito, Cyril Glenn/AAA-5753-2020	Satuito, Cyril Glenn/0000-0002-9287-2660; Imai, Chisato/0000-0002-0080-1487	MEXT; Japanese Ministry of Education, Culture, Sports, Science and Technology	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The corresponding first author was supported by the MEXT scholarship granted by the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken Alastair, 1996, P3, DOI 10.1007/978-1-60327-259-9_1; AKIYAMA M, 1978, Journal of the Faculty of Science Hokkaido University Series IV Geology and Mineralogy, V18, P117; ALLEN SK, 1992, AQUACULTURE, V103, P241, DOI 10.1016/0044-8486(92)90170-P; Baltazar P., 1999, REV PERU BIOL, V6, P123; Bao WY, 2007, MAR BIOL, V152, P657, DOI 10.1007/s00227-007-0720-2; Bao WY, 2007, MAR BIOL, V150, P565, DOI 10.1007/s00227-006-0383-4; BAYNE BL, 1969, J MAR BIOL ASSOC UK, V49, P327, DOI 10.1017/S0025315400035943; BERTNESS MD, 1985, OECOLOGIA, V67, P192, DOI 10.1007/BF00384283; BONAR DB, 1990, B MAR SCI, V46, P484; Breese WP, 1975, SEA GRANT PROGRAM PU; BURKE RD, 1986, B MAR SCI, V39, P323; BUSHEK D, 1988, J EXP MAR BIOL ECOL, V122, P1, DOI 10.1016/0022-0981(88)90208-0; CAMPBELL KP, 1983, J BIOL CHEM, V258, P1267; Cole H. A., 1939, Journal du Conseil Copenhague, V14, P86; COON SL, 1990, BIOL BULL, V179, P297, DOI 10.2307/1542321; Crisp D.J., 1974, pUnpaginated; CRISP DJ, 1967, J ANIM ECOL, V36, P329, DOI 10.2307/2916; DENNY MW, 1989, AM NAT, V134, P859, DOI 10.1086/285018; Diederich S, 2005, J SEA RES, V53, P269, DOI 10.1016/j.seares.2005.01.002; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Dreanno C, 2006, P ROY SOC B-BIOL SCI, V273, P2721, DOI 10.1098/rspb.2006.3649; DWEK RA, 1993, ANNU REV BIOCHEM, V62, P65, DOI 10.1146/annurev.bi.62.070193.000433; Dworjanyn SA, 2008, AQUACULTURE, V274, P268, DOI 10.1016/j.aquaculture.2007.11.030; FITT WK, 1989, MICROBIAL ECOL, V17, P287, DOI 10.1007/BF02012841; FITT WK, 1992, BIOL BULL, V182, P401, DOI 10.2307/1542259; FITT WK, 1990, MAR BIOL, V106, P389, DOI 10.1007/BF01344317; Fleck J, 1999, J EXP MAR BIOL ECOL, V234, P83, DOI 10.1016/S0022-0981(98)00140-3; Goldberg HA, 1997, ANAL BIOCHEM, V251, P227, DOI 10.1006/abio.1997.2252; GREEN MR, 1973, ANAL BIOCHEM, V56, P43, DOI 10.1016/0003-2697(73)90167-X; Hadfield MG, 2001, CRC MAR SCI, P431; HANNAN CA, 1984, LIMNOL OCEANOGR, V29, P1108, DOI 10.4319/lo.1984.29.5.1108; Hay ME, 2009, ANNU REV MAR SCI, V1, P193, DOI 10.1146/annurev.marine.010908.163708; HIDU H, 1969, Chesapeake Science, V10, P85, DOI 10.2307/1350836; HIGHSMITH RC, 1982, ECOLOGY, V63, P329, DOI 10.2307/1938950; Hirata Y, 2005, NIPPON SUISAN GAKK, V71, P725, DOI 10.2331/suisan.71.725; Hirata Y, 1998, NIPPON SUISAN GAKK, V64, P610; Hirata Y, 2008, NIPPON SUISAN GAKKAI, V74; Jones G., 1988, ADV REMOTE SETTING O; Jouuchi T, 2007, MAR BIOL, V152, P1065, DOI 10.1007/s00227-007-0753-6; Kato-Yoshinaga Y, 2000, COMP BIOCHEM PHYS A, V125, P511, DOI 10.1016/S1095-6433(00)00179-3; KECK R, 1971, Proceedings National Shellfisheries Association, V61, P24; KIRCHMAN D, 1981, J EXP MAR BIOL ECOL, V56, P153, DOI 10.1016/0022-0981(81)90186-6; KNIGHTJONES EW, 1953, J EXP BIOL, V30, P584; Kobayashi I, 2006, MAT SCI ENG C-BIO S, V26, P692, DOI 10.1016/j.msec.2005.09.101; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert WJ, 1997, INVERTEBR BIOL, V116, P71, DOI 10.2307/3226971; Lau SCK, 2001, MAR BIOL, V138, P321, DOI 10.1007/s002270000453; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mann K, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-28; Marie B, 2011, MAR BIOTECHNOL, V13, P1159, DOI 10.1007/s10126-011-9379-2; Marin F, 2005, MAT SCI ENG C-BIO S, V25, P105, DOI 10.1016/j.msec.2005.01.003; Matsumura K, 1998, J EXP ZOOL, V281, P12, DOI 10.1002/(SICI)1097-010X(19980501)281:1<12::AID-JEZ3>3.3.CO;2-L; MEADOWS PS, 1972, ADV MAR BIOL, V10, P271, DOI 10.1016/S0065-2881(08)60418-6; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; PAWLIK JR, 1992, OCEANOGR MAR BIOL, V30, P273; PEARCE CM, 1990, MAR BIOL, V107, P363, DOI 10.1007/BF01319838; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; PENNINGTON JT, 1985, BIOL BULL-US, V169, P417, DOI 10.2307/1541492; Prendergast G.S., 2009, BIOFOULING, P30, DOI [10.1002/9781444315462.ch3, DOI 10.1002/9781444315462.CH3]; R Development Core Team, 2006, R LANG ENV STAT COMP; RICE ME, 1986, B MAR SCI, V39, P362; Robert R, 1999, AQUAT LIVING RESOUR, V12, P121, DOI 10.1016/S0990-7440(99)80021-7; SATUITO CG, 1995, FISHERIES SCI, V61, P223, DOI 10.2331/fishsci.61.223; SCHELTEMA RS, 1971, BIOL BULL-US, V140, P284, DOI 10.2307/1540075; Steinberg PD, 2002, J CHEM ECOL, V28, P1935, DOI 10.1023/A:1020789625989; Tamburri MN, 2008, J SHELLFISH RES, V27, P601, DOI 10.2983/0730-8000(2008)27[601:SOCALE]2.0.CO;2; Tamburri MN, 2007, ECOL MONOGR, V77, P255, DOI 10.1890/06-1074; TAMBURRI MN, 1992, BIOL BULL, V183, P327, DOI 10.2307/1542218; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Toonen RJ, 1996, MAR BIOL, V126, P725, DOI 10.1007/BF00351339; TOTTEN DK, 1972, P NATL ACAD SCI USA, V69, P784, DOI 10.1073/pnas.69.4.784; TURNER EJ, 1994, LIMNOL OCEANOGR, V39, P1579, DOI 10.4319/lo.1994.39.7.1579; Unabia CRC, 1999, MAR BIOL, V133, P55, DOI 10.1007/s002270050442; VEITCH F P, 1971, Chesapeake Science, V12, P173, DOI 10.2307/1350777; Yang JL, 2007, MAR BIOL, V152, P1121, DOI 10.1007/s00227-007-0759-0; YOUNG CM, 1982, MAR BIOL, V69, P195, DOI 10.1007/BF00396899; ZIMMERFAUST RK, 1994, LIMNOL OCEANOGR, V39, P1075, DOI 10.4319/lo.1994.39.5.1075	77	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82358	10.1371/journal.pone.0082358	http://dx.doi.org/10.1371/journal.pone.0082358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349261	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800057
J	Yu, FY; Liu, Y; Xu, YY; Shang, YP; Lou, DP; Qin, ZQ; Parsons, C; Zhou, W; Huang, XY; Li, YP; Hu, LH; Wang, LX				Yu, Fangyou; Liu, Ying; Xu, Yuanyuan; Shang, Yongpeng; Lou, Danping; Qin, Zhiqiang; Parsons, Chris; Zhou, Wu; Huang, Xiaoying; Li, Yuping; Hu, Longhua; Wang, Liangxing			Expression of Panton-Valentine Leukocidin mRNA among Staphylococcus aureus Isolates Associates with Specific Clinical Presentations	PLOS ONE			English	Article							METHICILLIN-RESISTANT; INFECTIONS; PNEUMONIA; SKIN; LEUCOCIDIN; DISEASE; CLONES; ADULTS; RISK	Panton-Valentine leukocidin (PVL; gene designation lukF/S-PV) is likely an important virulence factor for Staphylococcus aureus (S. aureus), as qualitative expression of the protein correlates with severity for specific clinical presentations, including skin and soft tissue infections (SSTIs). Development of genetic approaches for risk-assessment of patients with S. aureus infections may prove clinically useful, and whether lukF/S-PV gene expression correlates with specific clinical presentations for S. aureus has been largely unexplored. In the present study, we quantified lukS-PV mRNA among 96 S. aureus isolates to determine whether expression levels correlated with specific clinical presentations in adults and children. Expression level of lukS-PV mRNA among isolates from skin and soft tissue infections (SSTIs) was significantly greater than among isolates from blood stream infection (BSIs), and expression level of lukS-PV mRNA among BSI isolates from children was significantly greater than for BSI isolates among adults. Moreover, expression level of lukS-PV mRNA among community-acquired (CA) isolates was significantly greater than for hospital-acquired (HA) isolates. These data justify additional studies to determine the potential clinical utility for lukS-PV mRNA quantification as a predictive tool for severity of S. aureus infection.	[Yu, Fangyou; Shang, Yongpeng; Zhou, Wu] Wenzhou Med Univ, Affiliated Hosp 1, Dept Clin Lab, Wenzhou, Zhejiang, Peoples R China; [Liu, Ying; Xu, Yuanyuan; Lou, Danping; Huang, Xiaoying; Li, Yuping; Wang, Liangxing] Wenzhou Med Univ, Affiliated Hosp 1, Dept Resp Med, Wenzhou, Zhejiang, Peoples R China; [Qin, Zhiqiang; Parsons, Chris] Louisiana State Univ, Hlth Sci Ctr, Dept Med, New Orleans, LA USA; [Qin, Zhiqiang; Parsons, Chris] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol, New Orleans, LA USA; [Hu, Longhua] Nanchang Univ, Affiliated Hosp 2, Dept Clin Lab, Nanchang, Jiangxi, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Nanchang University	Wang, LX (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Resp Med, Wenzhou, Zhejiang, Peoples R China.	wzyxywlx@163.com	li, yu/HGL-9518-2022; Li, yu/HHZ-5236-2022		Natural Science fund of China [81271906H2002]; Zhejiang Provincial Natural Science Foundation [Y2100716]; Wenzhou Municipal Science and Technology Bureau, China [H2010064, Y20110043, Y20100096]; Lucheng Science and Technology Bureau [S5]	Natural Science fund of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Wenzhou Municipal Science and Technology Bureau, China; Lucheng Science and Technology Bureau	This study was supported by grants from Natural Science fund of China (81271906H2002), Zhejiang Provincial Natural Science Foundation (Y2100716), Wenzhou Municipal Science and Technology Bureau, China (H2010064, Y20110043 and Y20100096), and Lucheng Science and Technology Bureau (S5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae IG, 2009, J CLIN MICROBIOL, V47, P3952, DOI 10.1128/JCM.01643-09; Boakes E, 2012, J CLIN MICROBIOL, V50, P1773, DOI 10.1128/JCM.06421-11; Boussaud V, 2003, INTENS CARE MED, V29, P1840, DOI 10.1007/s00134-003-1918-5; Chiu YK, 2012, J MICROBIOL IMMUNOL, V45, P208, DOI 10.1016/j.jmii.2011.11.011; Crawford SE, 2009, J AM BOARD FAM MED, V22, P647, DOI 10.3122/jabfm.2009.06.090025; Cupane L, 2012, INT J MOL EPIDEMIOL, V3, P48; Daskalaki M, 2010, CLIN MICROBIOL INFEC, V16, P74, DOI 10.1111/j.1469-0691.2009.02830.x; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Duquenne M, 2010, APPL ENVIRON MICROB, V76, P1367, DOI 10.1128/AEM.01736-09; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; Garnier F, 2006, EMERG INFECT DIS, V12, P498, DOI 10.3201/eid1203.051040; Genestier AL, 2005, J CLIN INVEST, V115, P3117, DOI 10.1172/JCI22684; Hamilton SM, 2007, CLIN INFECT DIS, V45, P1550, DOI 10.1086/523581; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; McClure JA, 2006, J CLIN MICROBIOL, V44, P1141, DOI 10.1128/JCM.44.3.1141-1144.2006; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Said-Salim B, 2005, J CLIN MICROBIOL, V43, P3373, DOI 10.1128/JCM.43.7.3373-3379.2005; Said-Salim B, 2003, INFECT CONT HOSP EP, V24, P451, DOI 10.1086/502231; Shallcross LJ, 2013, LANCET INFECT DIS, V13, P43, DOI 10.1016/S1473-3099(12)70238-4; Tong A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037212; Varshney AK, 2010, J INFECT DIS, V201, P92, DOI 10.1086/648613; Voyich JM, 2006, J INFECT DIS, V194, P1761, DOI 10.1086/509506; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Yu F, 2011, J HOSP INFECT, V77, P89, DOI 10.1016/j.jhin.2010.07.019; Zanger P, 2012, CLIN INFECT DIS, V54, P483, DOI 10.1093/cid/cir822	28	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83368	10.1371/journal.pone.0083368	http://dx.doi.org/10.1371/journal.pone.0083368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349495	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800113
J	Yue, MH; Li, QL; Zhang, Y; Zhao, Y; Zhang, ZL; Bao, SL				Yue, Minghui; Li, Qiuling; Zhang, Ya; Zhao, Yan; Zhang, Zhaoliang; Bao, Shilai			Histone H4R3 Methylation Catalyzed by SKB1/PRMT5 Is Required for Maintaining Shoot Apical Meristem	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE; STEM-CELL FATE; PROTEIN ARGININE METHYLATION; ARABIDOPSIS SHOOT; GENE ENCODES; FLORAL MERISTEMS; FLOWERING-TIME; FISSION YEAST; WUSCHEL GENE; MAINTENANCE	The shoot apical meristem (SAM) is the source of all of the above-ground tissues and organs in post-embryonic development in higher plants. Studies have proven that the expression of genes constituting the WUSCHEL (WUS)-CLAVATA (CLV) feedback loop is critical for the SAM maintenance. Several histone lysine acetylation and methylation markers have been proven to regulate the transcription level of WUS. However, little is known about how histone arginine methylation regulates the expression of WUS and other genes. Here, we report that H4R3 symmetric dimethylation (H4R3sme2) mediated by SKB1/PRMT5 represses the expression of CORYNE (CRN) to maintain normal SAM geometrics. SKB1 lesion results in small SAM size in Arabidopsis, as well as down-regulated expression of WUS and CLV3. Up-regulation of WUS expression enlarges SAM size in skb1 mutant plants. We find that SKB1 and H4R3sme2 associate with the chromatin of the CRN locus to down-regulate its transcription. Mutation of CRN rescues the expression of WUS and the small SAM size of skb1. Thus, SKB1 and SKB1-mediated H4R3sme2 are required for the maintenance of SAM in Arabidopsis seedlings.	[Yue, Minghui; Li, Qiuling; Zhang, Ya; Zhao, Yan; Zhang, Zhaoliang; Bao, Shilai] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China; [Yue, Minghui; Zhang, Zhaoliang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Bao, SL (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China.	slbao@genetics.ac.cn	ZHANG, YA/M-3758-2016; Yue, Minghui/ABH-7143-2020	ZHANG, YA/0000-0001-9060-3777; Yue, Minghui/0000-0001-8325-4222	National Basic Research Program of China [2007CB948202]; Chinese National Natural and Sciences Foundation [31071120, 91019018, 31071121]	National Basic Research Program of China(National Basic Research Program of China); Chinese National Natural and Sciences Foundation(National Natural Science Foundation of China (NSFC))	This research was supported by the National Basic Research Program of China, grant 2007CB948202 (to Shilai Bao), and the Chinese National Natural and Sciences Foundation, grants 31071120, 91019018 (to Shilai Bao), and 31071121 (to Yan Zhao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2012, J GENET GENOMICS, V39, P195, DOI 10.1016/j.jgg.2012.04.001; BARTON MK, 1993, DEVELOPMENT, V119, P823; Baurle I, 2005, PLANT CELL, V17, P2271, DOI 10.1105/tpc.105.032623; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Betsuyaku S, 2011, PLANT CELL PHYSIOL, V52, P14, DOI 10.1093/pcp/pcq157; Bleckmann A, 2010, PLANT PHYSIOL, V152, P166, DOI 10.1104/pp.109.149930; Bowler C, 2004, PLANT J, V39, P776, DOI 10.1111/j.1365-313X.2004.02169.x; Bowman JL, 2000, TRENDS PLANT SCI, V5, P110, DOI 10.1016/S1360-1385(00)01569-7; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Carles CC, 2003, TRENDS PLANT SCI, V8, P394, DOI 10.1016/S1360-1385(03)00164-X; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; CLARK SE, 1993, DEVELOPMENT, V119, P397; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 2001, NAT REV MOL CELL BIO, V2, P276, DOI 10.1038/35067079; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Deng XA, 2010, P NATL ACAD SCI USA, V107, P19114, DOI 10.1073/pnas.1009669107; Endrizzi K, 1996, PLANT J, V10, P967, DOI 10.1046/j.1365-313X.1996.10060967.x; Fletcher JC, 2002, ANNU REV PLANT BIOL, V53, P45, DOI 10.1146/annurev.arplant.53.092701.143332; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Gilbreth M, 1998, P NATL ACAD SCI USA, V95, P14781, DOI 10.1073/pnas.95.25.14781; Gilbreth M, 1996, P NATL ACAD SCI USA, V93, P13802, DOI 10.1073/pnas.93.24.13802; Guo SS, 2010, J BIOL CHEM, V285, P35133, DOI 10.1074/jbc.M110.153429; Guo YF, 2010, PLANT J, V63, P889, DOI 10.1111/j.1365-313X.2010.04295.x; He YH, 2005, TRENDS PLANT SCI, V10, P30, DOI 10.1016/j.tplants.2004.11.003; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; Kinoshita A, 2010, DEVELOPMENT, V137, P3911, DOI 10.1242/dev.048199; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Laux T, 1996, DEVELOPMENT, V122, P87; Lenhard M, 1999, CURR OPIN PLANT BIOL, V2, P44, DOI 10.1016/S1369-5266(99)80009-0; Lenhard M, 2001, CELL, V105, P805, DOI 10.1016/S0092-8674(01)00390-7; Li W, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002243; Liu CY, 2010, ANNU REV PLANT BIOL, V61, P395, DOI 10.1146/annurev.arplant.043008.091939; Liu XG, 2011, PLANT CELL, V23, P3654, DOI 10.1105/tpc.111.091538; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Miwa H, 2008, PLANT CELL PHYSIOL, V49, P1752, DOI 10.1093/pcp/pcn148; Muller R, 2008, PLANT CELL, V20, P934, DOI 10.1105/tpc.107.057547; Ogawa M, 2008, SCIENCE, V319, P294, DOI 10.1126/science.1150083; Ohyama K, 2009, NAT CHEM BIOL, V5, P578, DOI 10.1038/nchembio.182; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Pei YX, 2007, PLANT PHYSIOL, V144, P1913, DOI 10.1104/pp.107.099531; Sanchez SE, 2010, NATURE, V468, P112, DOI 10.1038/nature09470; Scarpella E, 2004, DEVELOPMENT, V131, P3445, DOI 10.1242/dev.01182; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Trotochaud AE, 1999, PLANT CELL, V11, P393, DOI 10.1105/tpc.11.3.393; Tsiantis M, 2003, NAT REV GENET, V4, P169, DOI 10.1038/nrg1002; Wang X, 2007, EMBO J, V26, P1934, DOI 10.1038/sj.emboj.7601647; Yadav RK, 2011, GENE DEV, V25, P2025, DOI 10.1101/gad.17258511; Zhang ZL, 2011, PLANT CELL, V23, P396, DOI 10.1105/tpc.110.081356; Zhou ZW, 2010, CELL RES, V20, P1023, DOI 10.1038/cr.2010.56; Zhu YF, 2010, PLANT J, V61, P223, DOI 10.1111/j.1365-313X.2009.04049.x; Zuo JR, 2002, PLANT J, V30, P349, DOI 10.1046/j.1365-313X.2002.01289.x	55	12	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83258	10.1371/journal.pone.0083258	http://dx.doi.org/10.1371/journal.pone.0083258			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349476	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800108
J	Gaglio, D; D'Alfonso, A; Camilloni, G				Gaglio, Davide; D'Alfonso, Anna; Camilloni, Giorgio			Functional Complementation of sir2 Delta Yeast Mutation by the Human Orthologous Gene SIRT1	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; RDNA; SIRTUINS; RECOMBINATION; TRANSCRIPTION; DEACETYLASE; ACTIVATORS; NUCLEOLAR; CIRCLES	Sirtuins, class III histone deacetylases, are proteins homologous to the yeast protein Sir2p. Mammalian Sirt1 has been shown to be involved in energy metabolism, brain functions, inflammation and aging through its deacetylase activity, acting on both histone and non-histone substrates. In order to verify whether Sirt1 can replace Sir2p in the yeast cells, we expressed the full-length human Sirt1 protein in S. cerevisiae sir2 Delta mutant strain. The structure of chromatin is basically maintained from yeast to human. Thus, yeast chromatin is a favourable environment to evaluate, inhibit or activate an ectopic histone deacetylase activity in an in vivo substrate. Mutant sir2 Delta shows a series of different phenotypes, all dependent on the deacetylase activity of Sir2p. We analyzed the three silent loci where normally Sir2p acts: ribosomal DNA, telomeres and the mating type loci. Moreover, we verified extrachromosomal ribosomal DNA circles production and histone hyperacetylation levels, typical marks of sir2 Delta strains. By strong SIRT1 overexpression in sir2 Delta cells, we found that specific molecular phenotypes of the mutant revert almost to a wild-type condition. In particular, transcriptional silencing at rDNA was restored, extrachromosomal rDNA circles formation was repressed and histone acetylation at H3K9 and H4K16 decreased. The complementation at the other studied loci: HM loci, telomere and sub-telomere does not occur. Overall, our observations indicate that: i) SIRT1 gene is able to complement different molecular phenotypes of the sir2 Delta mutant at rDNA ii) the in vivo screening of Sirt1 activity is possible in yeast.	[Gaglio, Davide; D'Alfonso, Anna; Camilloni, Giorgio] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy; [Gaglio, Davide; Camilloni, Giorgio] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Camilloni, Giorgio] CNR, Inst Mol Biol & Pathol, Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Camilloni, G (corresponding author), Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	giorgio.camilloni@uniroma1.it		Camilloni, Giorgio/0000-0002-1195-6142	Istituto Pasteur-Fondazione Cenci Bolognetti, Universita di Roma La Sapienza; Epigenomics Flagship Project EpiGen, the Italian Ministry of Education and Research, National Research Council	Istituto Pasteur-Fondazione Cenci Bolognetti, Universita di Roma La Sapienza(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Epigenomics Flagship Project EpiGen, the Italian Ministry of Education and Research, National Research Council	This work was partially supported by: the Istituto Pasteur-Fondazione Cenci Bolognetti, Universita di Roma La Sapienza (http://www.istitutopasteur.it/) and by the Epigenomics Flagship Project EpiGen, the Italian Ministry of Education and Research, National Research Council (http://www.epigen.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Cesarini E, 2012, MOL BIOL CELL, V23, P2770, DOI 10.1091/mbc.E12-02-0095; Ehrentraut S, 2010, P NATL ACAD SCI USA, V107, P5522, DOI 10.1073/pnas.0909169107; Fang YJ, 2011, CANCER LETT, V306, P10, DOI 10.1016/j.canlet.2011.02.019; Forsburg SL, 2001, NAT REV GENET, V2, P659, DOI 10.1038/35088500; Ganley ARD, 2009, MOL CELL, V35, P683, DOI 10.1016/j.molcel.2009.07.012; Gartenberg MR, 2000, CURR OPIN MICROBIOL, V3, P132, DOI 10.1016/S1369-5274(00)00064-3; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Grubisha O, 2005, FEBS J, V272, P4607, DOI 10.1111/j.1742-4658.2005.04862.x; Grunstein M, 1997, CURR OPIN CELL BIOL, V9, P383, DOI 10.1016/S0955-0674(97)80011-7; HARASHIMA S, 1989, MOL CELL BIOL, V9, P4523, DOI 10.1128/MCB.9.10.4523; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Imai S, 2010, TRENDS PHARMACOL SCI, V31, P212, DOI 10.1016/j.tips.2010.02.003; Kobayashi T, 2004, CELL, V117, P441, DOI 10.1016/S0092-8674(04)00414-3; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Li CH, 2006, MOL BIOL CELL, V17, P3848, DOI 10.1091/mbc.E06-03-0205; Li XL, 2013, ACTA BIOCH BIOPH SIN, V45, P51, DOI 10.1093/abbs/gms108; Lieb JD, 2001, NAT GENET, V29, P100; Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8; Matecic M, 2006, GENETICS, V173, P1939, DOI 10.1534/genetics.106.055491; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067; Park PU, 1999, MOL CELL BIOL, V19, P3848; Pasero P, 2002, GENE DEV, V16, P2479, DOI 10.1101/gad.232902; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; SANTANGELO GM, 1988, MOL CELL BIOL, V8, P4217, DOI 10.1128/MCB.8.10.4217; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Sherman F., 1983, METHODS YEAST GENETI; Sherman JM, 1999, MOL BIOL CELL, V10, P3045, DOI 10.1091/mbc.10.9.3045; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith E, 2007, GENE DEV, V21, P1141, DOI 10.1101/gad.1559407; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2009, INT J DEV BIOL, V53, P303, DOI 10.1387/ijdb.082675av; Verdone L, 1996, MOL CELL BIOL, V16, P1978; Villalba JM, 2012, BIOFACTORS, V38, P349, DOI 10.1002/biof.1032; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022	47	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83114	10.1371/journal.pone.0083114	http://dx.doi.org/10.1371/journal.pone.0083114			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349441	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300133
J	Hamdoun, S; Liu, Z; Gill, M; Yao, N; Lu, H				Hamdoun, Safae; Liu, Zhe; Gill, Manroop; Yao, Nan; Lu, Hua			Dynamics of Defense Responses and Cell Fate Change during Arabidopsis-Pseudomonas syringae Interactions	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; SALICYLIC-ACID; DISEASE RESISTANCE; OXIDATIVE BURST; XANTHOMONAS-CAMPESTRIS; TRANSCRIPTION FACTOR; HYDROGEN-PEROXIDE; GENE; THALIANA; EFFECTOR	Plant-pathogen interactions involve sophisticated action and counteraction strategies from both parties. Plants can recognize pathogen derived molecules, such as conserved pathogen associated molecular patterns (PAMPs) and effector proteins, and subsequently activate PAMP-triggered immunity (PTI) and effector-triggered immunity (ETI), respectively. However, pathogens can evade such recognitions and suppress host immunity with effectors, causing effector-triggered susceptibility (ETS). The differences among PTI, ETS, and ETI have not been completely understood. Toward a better understanding of PTI, ETS, and ETI, we systematically examined various defense-related phenotypes of Arabidopsis infected with different Pseudomonas syringae pv. maculicola ES4326 strains, using the virulence strain DG3 to induce ETS, the avirulence strain DG34 that expresses avrRpm1 (recognized by the resistance protein RPM1) to induce ETI, and HrcC-that lacks the type three secretion system to activate PTI. We found that plants infected with different strains displayed dynamic differences in the accumulation of the defense signaling molecule salicylic acid, expression of the defense marker gene PR1, cell death formation, and accumulation/localization of the reactive oxygen species, H2O2. The differences between PTI, ETS, and ETI are dependent on the doses of the strains used. These data support the quantitative nature of PTI, ETS, and ETI and they also reveal qualitative differences between PTI, ETS, and ETI. Interestingly, we observed the induction of large cells in the infected leaves, most obviously with HrcC-at later infection stages. The enlarged cells have increased DNA content, suggesting a possible activation of endoreplication. Consistent with strong induction of abnormal cell growth by HrcC-, we found that the PTI elicitor flg22 also activates abnormal cell growth, depending on a functional flg22-receptor FLS2. Thus, our study has revealed a comprehensive picture of dynamic changes of defense phenotypes and cell fate determination during Arabidopsis-P. syringae interactions, contributing to a better understanding of plant defense mechanisms.	[Hamdoun, Safae; Gill, Manroop; Lu, Hua] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA; [Liu, Zhe; Yao, Nan] Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Plant Resources, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	University System of Maryland; University of Maryland Baltimore County; Sun Yat Sen University	Lu, H (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA.	hualu@umbc.edu	yao, nan/F-2095-2011	yao, nan/0000-0002-2045-5462	National Natural Science Foundation of China [31170247]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Nan Yao was supported by the National Natural Science Foundation of China (Grants 31170247) to NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Bao ZL, 2013, P NATL ACAD SCI USA, V110, P2407, DOI 10.1073/pnas.1217024110; Bertout J, 2006, CANC TREAT, V130, P167; Bestwick CS, 1997, PLANT CELL, V9, P209, DOI 10.1105/tpc.9.2.209; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; BRAUN AC, 1956, CANCER RES, V16, P53; Brown I, 1998, PLANT J, V15, P333, DOI 10.1046/j.1365-313X.1998.00215.x; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Cazale AC, 1998, PLANT PHYSIOL, V116, P659, DOI 10.1104/pp.116.2.659; Chalupowicz L, 2006, PLANTA, V224, P429, DOI 10.1007/s00425-006-0229-9; Chandran D, 2010, P NATL ACAD SCI USA, V107, P460, DOI 10.1073/pnas.0912492107; Cohen JJ, 1999, J ALLERGY CLIN IMMUN, V103, P548, DOI 10.1016/S0091-6749(99)70222-8; De Veylder L, 2011, TRENDS PLANT SCI, V16, P624, DOI 10.1016/j.tplants.2011.07.001; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Duan YP, 1999, MOL PLANT MICROBE IN, V12, P556, DOI 10.1094/MPMI.1999.12.6.556; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Engler JD, 1999, PLANT CELL, V11, P793, DOI 10.1105/tpc.11.5.793; Fauth M, 1996, PLANT PHYSIOL, V110, P347, DOI 10.1104/pp.110.2.347; Friedrich L, 1996, PLANT J, V10, P61, DOI 10.1046/j.1365-313X.1996.10010061.x; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; Grant M, 2000, PLANT J, V23, P441, DOI 10.1046/j.1365-313x.2000.00804.x; GRANT MR, 1995, SCIENCE, V269, P843, DOI 10.1126/science.7638602; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; HammondKosack KE, 1996, PLANT CELL, V8, P1773, DOI 10.1105/tpc.8.10.1773; HANSEN CE, 1986, P NATL ACAD SCI USA, V83, P2492, DOI 10.1073/pnas.83.8.2492; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kasili R, 2010, GENETICS, V185, P257, DOI 10.1534/genetics.109.113274; KAUSS H, 1995, PLANT PHYSIOL, V108, P1171, DOI 10.1104/pp.108.3.1171; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Kondorosi E, 2000, CURR OPIN PLANT BIOL, V3, P488, DOI 10.1016/S1369-5266(00)00118-7; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; LEGENDRE L, 1993, PLANT PHYSIOL, V102, P233, DOI 10.1104/pp.102.1.233; Lu H, 2003, PLANT CELL, V15, P2408, DOI 10.1105/tpc.015412; Lu H, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00157; Lu H, 2009, PLANT J, V58, P401, DOI 10.1111/j.1365-313X.2009.03791.x; Maleck K, 2000, NAT GENET, V26, P403, DOI 10.1038/82521; Marois E, 2002, MOL PLANT MICROBE IN, V15, P637, DOI 10.1094/MPMI.2002.15.7.637; May MJ, 1996, PLANT PHYSIOL, V110, P1367, DOI 10.1104/pp.110.4.1367; Melillo MT, 2006, NEW PHYTOL, V170, P501, DOI 10.1111/j.1469-8137.2006.001724.x; METRAUX JP, 1991, INDUCED RESISTANCE C; Mudgett MB, 2005, ANNU REV PLANT BIOL, V56, P509, DOI 10.1146/annurev.arplant.56.032604.144218; Ng GN, 2011, GENETICS, V189, P851, DOI 10.1534/genetics.111.132332; Niebel A, 1996, PLANT J, V10, P1037, DOI 10.1046/j.1365-313X.1996.10061037.x; Nissan G, 2012, MOL PLANT MICROBE IN, V25, P231, DOI 10.1094/MPMI-06-11-0173; Olmos E, 2003, J EXP BOT, V54, P291, DOI [10.1093/jxb/54.381.291, 10.1093/jxb/erg028]; Otulak K, 2010, MICRON, V41, P327, DOI 10.1016/j.micron.2009.12.004; Rate DN, 1999, PLANT CELL, V11, P1695, DOI 10.1105/tpc.11.9.1695; Rate DN, 2001, PLANT J, V27, P203, DOI 10.1046/j.0960-7412.2001.1075umedoc.x; Rubio MC, 2004, MOL PLANT MICROBE IN, V17, P1294, DOI 10.1094/MPMI.2004.17.12.1294; Ruzin S.E., 1999, PLANT MICROTECHNIQUE; Ryals J, 1997, PLANT CELL, V9, P425, DOI 10.1105/tpc.9.3.425; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Scheideler M, 2002, J BIOL CHEM, V277, P10555, DOI 10.1074/jbc.M104863200; Schouten A, 2002, MOL PLANT PATHOL, V3, P227, DOI 10.1046/j.1364-3703.2002.00114.x; Shah J, 1997, MOL PLANT MICROBE IN, V10, P69, DOI 10.1094/MPMI.1997.10.1.69; SWARUP S, 1991, PHYTOPATHOLOGY, V81, P802, DOI 10.1094/Phyto-81-802; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Tapinos N, 2005, P NATL ACAD SCI USA, V102, P9188, DOI 10.1073/pnas.0501196102; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Tsuda K, 2008, PLANT SIGNAL BEHAV, V3, P359, DOI 10.4161/psb.3.6.5702; Vanacker H, 2001, PLANT J, V28, P209, DOI 10.1046/j.1365-313X.2001.01158.x; Walker JD, 2000, DEVELOPMENT, V127, P3931; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Wang GF, 2011, PLANT PHYSIOL, V156, P1508, DOI 10.1104/pp.111.176776; Wang GY, 2011, MOL PLANT, V4, P516, DOI 10.1093/mp/ssr016; Wang L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000301; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Yao N, 2002, PLANT J, V30, P567, DOI 10.1046/j.1365-313X.2002.01314.x; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	74	19	19	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83219	10.1371/journal.pone.0083219	http://dx.doi.org/10.1371/journal.pone.0083219			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349466	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300140
J	Malone, AN; Fletcher, DM; Vogt, MB; Meyer, SK; Hess, AM; Eckstein, TM				Malone, Alyssa N.; Fletcher, Darcy M.; Vogt, Megan B.; Meyer, Stephen K.; Hess, Ann M.; Eckstein, Torsten M.			Early Weight Development of Goats Experimentally Infected with Mycobacterium avium subsp paratuberculosis	PLOS ONE			English	Article							SLAUGHTER WEIGHT; JOHNES-DISEASE; ANGORA-GOATS; DAIRY-CATTLE; BEEF-CATTLE; FEED-INTAKE; LONG-TERM; GROWTH; CULTURE; TRAITS	Johne's disease is an infectious chronic inflammatory bowel disease in ruminants. The key factor for the management of this disease is an early positive diagnosis. Unfortunately, most diagnostics detect animals with Johne's disease in the clinical stage with positive serology and/or positive fecal cultures. However, for effective management of the disease within herds, it is important to detect infected animals as early as possible. This might only be possible with the help of parameters not specific for Johne's disease but that give an early indication for chronic infections such as weight development. Here we report our findings on the development of total body weight and weight gain during the first six months of goats experimentally infected to induce Johne's disease. Twenty dairy goat kids age 2 to 5 days were included in this study. Goats were divided into two groups: a negative control group and a positive infected group. The weight was obtained weekly throughout the study. Goats of the positive group were infected at the age of seven weeks. We detected significant changes in weight gain and total body weight as early as one week after infection. Differences are significant throughout the six month time period. Weight as a nonspecific parameter should be used to monitor infection especially in studies on Johne's disease using the goat model. Our study suggests that goats with Johne's disease have a reduced weight gain and reduced weight when compared with healthy goats of the same age.	[Malone, Alyssa N.; Fletcher, Darcy M.; Vogt, Megan B.; Meyer, Stephen K.; Eckstein, Torsten M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Hess, Ann M.] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Eckstein, TM (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	eckstein@mail.colostate.edu		Vogt, Megan/0000-0002-4520-3077	USDA National Institute of Food and Agriculture [2012-67015-19379]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This research was funded by the Agriculture and Food Research Initiative (AFRI) competitive grant no. 2012-67015-19379 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Hearn M, 2012, J DAIRY SCI, V95, P618, DOI 10.3168/jds.2009-2860; Bastida Felix, 2011, J Immune Based Ther Vaccines, V9, P8, DOI 10.1186/1476-8518-9-8; BENEDICTUS G, 1987, VET REC, V121, P142, DOI 10.1136/vr.121.7.142; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cho J, 2012, J DAIRY SCI, V95, P1855, DOI 10.3168/jds.2011-4787; Clarke CJ, 1997, J COMP PATHOL, V116, P217, DOI 10.1016/S0021-9975(97)80001-1; Elzo MA, 2009, TROP ANIM HEALTH PRO, V41, P851, DOI 10.1007/s11250-008-9262-y; GALYEAN ML, 1995, J ANIM SCI, V73, P1219; Hines ME, 2007, VET MICROBIOL, V122, P197, DOI 10.1016/j.vetmic.2007.03.009; Kudahl AB, 2009, J DAIRY SCI, V92, P4340, DOI 10.3168/jds.2009-2039; LAMBRECHT RS, 1988, APPL ENVIRON MICROB, V54, P910, DOI 10.1128/AEM.54.4.910-916.1988; LU CD, 1990, J ANIM SCI, V68, P1751; Nielsen SS, 2009, PREV VET MED, V88, P1, DOI 10.1016/j.prevetmed.2008.07.003; [NRC] National Research Council, 2003, DIAGN CONTR JOHN DIS; RUVUNA F, 1992, SMALL RUMINANT RES, V7, P175, DOI 10.1016/0921-4488(92)90206-J; Solaiman S, 2012, J ANIM SCI, V90, P2092, DOI 10.2527/jas.2011-3945; Stabel JR, 2000, VET MICROBIOL, V77, P465, DOI 10.1016/S0378-1135(00)00331-X; Stewart DJ, 2007, VET MICROBIOL, V122, P83, DOI 10.1016/j.vetmic.2006.12.030; Stewart DJ, 2006, VET MICROBIOL, V113, P13, DOI 10.1016/j.vetmic.2005.09.015; Su A, 2012, NEW ENGL REV-MIDDLEB, V33, P44; Sweeney RW, 1996, VET CLIN N AM-FOOD A, V12, P305, DOI 10.1016/S0749-0720(15)30408-4; Thompson PN, 2006, J ANIM SCI, V84, P488, DOI 10.2527/2006.842488x; Tiwari A, 2006, CAN VET J, V47, P874; USDA, 2008, JOHN DIS US DAIR 199; Whitlock R. H., 1985, Proceedings of the United States Animal Health Association, V89, P484	25	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e84049	10.1371/journal.pone.0084049	http://dx.doi.org/10.1371/journal.pone.0084049			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349564	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300155
J	Shabanpoor, F; Bathgate, RAD; Wade, JD; Hossain, MA				Shabanpoor, Fazel; Bathgate, Ross A. D.; Wade, John D.; Hossain, Mohammed Akhter			C-Terminus of the B-Chain of Relaxin-3 Is Important for Receptor Activity	PLOS ONE			English	Article							SOLID-PHASE SYNTHESIS; BIOLOGICAL-ACTIVITY; IN-VITRO; INSULIN SUPERFAMILY; CHEMICAL-SYNTHESIS; BINDING AFFINITY; NUCLEUS INCERTUS; FAMILY PEPTIDES; MOUSE RELAXIN; ANALOGS	Human relaxin-3 is a neuropeptide that is structurally similar to human insulin with two chains (A and B) connected by three disulfide bonds. It is expressed primarily in the brain and has modulatory roles in stress and anxiety, feeding and metabolism, and arousal and behavioural activation. Structure-activity relationship studies have shown that relaxin-3 interacts with its cognate receptor RXFP3 primarily through its B-chain and that its A-chain does not have any functional role. In this study, we have investigated the effect of modification of the B-chain C-terminus on the binding and activity of the peptide. We have chemically synthesised and characterized H3 relaxin as C-termini acid (both A and B chains having free C-termini; native form) and amide forms (both chains' C-termini were amidated). We have confirmed that the acid form of the peptide is more potent than its amide form at both RXFP3 and RXFP4 receptors. We further investigated the effects of amidation at the C-terminus of individual chains. We report here for the first time that amidation at the C-terminus of the B-chain of H3 relaxin leads to significant drop in the binding and activity of the peptide at RXFP3/RXFP4 receptors. However, modification of the A-chain C-terminus does not have any effect on the activity. We have confirmed using circular dichroism spectroscopy that there is no secondary structural change between the acid and amide form of the peptide, and it is likely that it is the local C-terminal carboxyl group orientation that is crucial for interacting with the receptors.	[Shabanpoor, Fazel; Bathgate, Ross A. D.; Wade, John D.; Hossain, Mohammed Akhter] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Shabanpoor, Fazel; Wade, John D.; Hossain, Mohammed Akhter] Univ Melbourne, Sch Chem, Melbourne, Vic, Australia; [Bathgate, Ross A. D.; Wade, John D.; Hossain, Mohammed Akhter] Univ Melbourne, Florey Dept Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Bathgate, Ross A. D.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne	Wade, JD (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia.	john.wade@unimelb.edu.au; akhter.hossain@unimelb.edu.au	Bathgate, Ross/ABE-6471-2020	Bathgate, Ross/0000-0001-6301-861X; Hossain, Mohammed/0000-0002-9961-0006; Wade, John/0000-0002-1352-6568	NHMRC (Australia) [508995, 1023078]; Victorian Government Operational Infrastructure Support Program	NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government Operational Infrastructure Support Program	This research was partially funded by NHMRC (Australia) project grants 508995, and 1023078 to JDW, MAH and RADB. Research at the Florey Institute of Neuroscience and Mental Health is supported by the Victorian Government Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Jaimes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030792; AUMELAS A, 1985, P NATL ACAD SCI USA, V82, P1881, DOI 10.1073/pnas.82.7.1881; Banerjee A, 2010, NEUROPHARMACOLOGY, V58, P145, DOI 10.1016/j.neuropharm.2009.06.019; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Bathgate RAD, 2006, BIOCHEMISTRY-US, V45, P1043, DOI 10.1021/bi052233e; Bathgate Ross A D, 2013, Front Endocrinol (Lausanne), V4, P13, DOI 10.3389/fendo.2013.00013; Begi A, 2011, BIOCHEMISTRY-US, V50, P8352, DOI 10.1021/bi201093m; Bullesbach EE, 2012, BIOCHEMISTRY-US, V51, P4198, DOI 10.1021/bi300352x; Dennison SR, 2011, BIOCHEMISTRY-US, V50, P1514, DOI 10.1021/bi101687t; Haugaard-Kedstrom LM, 2011, J AM CHEM SOC, V133, P4965, DOI 10.1021/ja110567j; Hida T, 2006, J RECEPT SIG TRANSD, V26, P147, DOI 10.1080/10799890600623373; Hossain MA, 2008, J BIOL CHEM, V283, P17287, DOI 10.1074/jbc.M801911200; Hossain MA, 2006, INT J PEPT RES THER, V12, P211, DOI 10.1007/s10989-006-9020-9; Hossain MA, 2011, J BIOL CHEM, V286, P37555, DOI 10.1074/jbc.M111.282194; Hossain MA, 2009, BIOCONJUGATE CHEM, V20, P1390, DOI 10.1021/bc900181a; Katayama H, 2002, PEPTIDES, V23, P1537, DOI 10.1016/S0196-9781(02)00094-3; KRSTENANSKY JL, 1989, THROMB RES, V54, P319, DOI 10.1016/0049-3848(89)90090-X; Kuei C, 2007, J BIOL CHEM, V282, P25425, DOI 10.1074/jbc.M701416200; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Ma S, 2009, J COMP NEUROL, V517, P856, DOI 10.1002/cne.22197; Ma S, 2009, LEARN MEMORY, V16, P730, DOI 10.1101/lm.1438109; MARUYAMA K, 1992, J PROTEIN CHEM, V11, P1, DOI 10.1007/BF01025086; McGowan BM, 2006, REGUL PEPTIDES, V136, P72, DOI 10.1016/j.regpep.2006.04.009; Mosco A, 2008, REGUL PEPTIDES, V147, P88, DOI 10.1016/j.regpep.2008.01.005; Rosengren KJ, 2006, J BIOL CHEM, V281, P5845, DOI 10.1074/jbc.M511210200; Samuel CS, 2007, BIOCHEMISTRY-US, V46, P5374, DOI 10.1021/bi700238h; Sandvik AK, 1999, EUR J PHARMACOL, V364, P199, DOI 10.1016/S0014-2999(98)00846-2; SCHOLTZ JM, 1991, BIOPOLYMERS, V31, P1463, DOI 10.1002/bip.360311304; Shabanpoor F, 2008, BIOCONJUGATE CHEM, V19, P1456, DOI 10.1021/bc800127p; Shabanpoor F, 2012, BIOCHEM BIOPH RES CO, V420, P253, DOI 10.1016/j.bbrc.2012.02.141; Shabanpoor F, 2012, J MED CHEM, V55, P1671, DOI 10.1021/jm201505p; Shabanpoor F, 2011, J PEPT SCI, V17, P169, DOI 10.1002/psc.1307; Shabanpoor F, 2010, AMINO ACIDS, V38, P121, DOI 10.1007/s00726-008-0219-2; Shabanpoor F, 2009, VITAM HORM, V80, P1, DOI 10.1016/S0083-6729(08)00601-8; Smith CM, 2011, J CHEM NEUROANAT, V42, P262, DOI 10.1016/j.jchemneu.2011.05.013; Smith CM, 2010, J COMP NEUROL, V518, P4016, DOI 10.1002/cne.22442; Sutton SW, 2004, NEUROENDOCRINOLOGY, V80, P298, DOI 10.1159/000083656; THOMAS KA, 1982, P NATL ACAD SCI-BIOL, V79, P4843, DOI 10.1073/pnas.79.16.4843; Wang CL, 2008, BIOORGAN MED CHEM, V16, P6415, DOI 10.1016/j.bmc.2008.05.001; Wilkinson TN, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-14	41	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82567	10.1371/journal.pone.0082567	http://dx.doi.org/10.1371/journal.pone.0082567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349312	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300098
J	Wu, C; Yan, H; Sun, JZ; Yang, F; Song, C; Jiang, F; Li, Y; Dong, J; Zheng, GY; Tian, XL; Cao, HQ				Wu, Chong; Yan, Han; Sun, Jingzhi; Yang, Fan; Song, Chun; Jiang, Feng; Li, Yang; Dong, Jie; Zheng, Gu-Yan; Tian, Xiao-Li; Cao, Huiqing			NEXN Is a Novel Susceptibility Gene for Coronary Artery Disease in Han Chinese	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; CARDIOMYOPATHY; TRANSCRIPTION; CYTOSKELETON; EXPRESSION; MUTATIONS; MYOCARDIN; INJURY; MICE	Coronary artery disease (CAD) is the leading cause of death and disability in the world. Genome-wide association studies have implicated the importance of the genetic contribution of vascular smooth muscle cells (VSMCs) function in CAD susceptibility. The aberrant phenotypicmodulation of VSMC is responsible for the pathological vascular intima hyperplasia that is the hallmark for atherosclerotic morphology. NEXN is a muscle-specific F-actin binding protein and is regulated by inflammatory cytokines in VSMCs. Whether NEXN contributes to human vascular disorders is still unknown. In this study, we genotyped 5 SNPs, tagging all of the 17 common SNPs within 54 kilobases (kb) covering NEXN gene and its flanking region, in 1883 patients with CAD and 1973 healthy individuals from Han Chinese, and identified one SNP, rs1780050, which was strongly associated with CAD trait. The Bonferroni corrected P-value was 7.65x10(-5). The odds ratio (95% confidence interval) was 1.23 (1.12-1.36) with statistical power of 0.994. Functional analysis showed that NEXN promotes VSMC to a contractile phenotype in vitro and inhibits balloon-injury induced neointima formation in vivo. Further eQTL analysis demonstrated that the risk allele T of rs1780050 is associated with decreased expression of NEXN, thus contributing to a higher risk of CAD susceptibility in the population. This is, to our knowledge, the first study to identify NEXN as a novel CAD susceptibility gene with both genetic and functional evidence.	[Wu, Chong; Yan, Han; Yang, Fan; Song, Chun; Li, Yang; Dong, Jie; Zheng, Gu-Yan; Tian, Xiao-Li; Cao, Huiqing] Peking Univ, Inst Mol Med, Dept Human Populat Genet, Beijing 100871, Peoples R China; [Sun, Jingzhi] Jining Med Univ, Affiliated Hosp, Dept Cardiolody, Jining, Peoples R China; [Jiang, Feng] Capital Med Univ, Chaoyang Hosp, Dept Cardiol, Beijing, Peoples R China	Peking University; Jining Medical University; Capital Medical University	Tian, XL (corresponding author), Peking Univ, Inst Mol Med, Dept Human Populat Genet, Beijing 100871, Peoples R China.	tianxiaoli@pku.edu.cn; caohuiqing@pku.edu.cn			National Natural Science Foundation of China (NSFC) [81170097]; National Basic Research Program of the Chinese Ministry of Science and Technology (973) [2013CB530700]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of the Chinese Ministry of Science and Technology (973)(National Basic Research Program of China)	This study was supported by grants from the National Natural Science Foundation of China (NSFC Grant No. 81170097) and the National Basic Research Program of the Chinese Ministry of Science and Technology (973 Grant No. 2013CB530700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, PLOS GENET, V7; Cao HQ, 2006, AM J PHYSIOL-CELL PH, V290, pC172, DOI 10.1152/ajpcell.00284.2005; Delves GH, 2005, PROSTATE CANCER P D, V8, P174, DOI 10.1038/sj.pcan.4500790; Guo DC, 2009, AM J HUM GENET, V84, P617, DOI 10.1016/j.ajhg.2009.04.007; Hassel D, 2009, NAT MED, V15, P1281, DOI 10.1038/nm.2037; Jiang F, 2011, ATHEROSCLEROSIS, V218, P397, DOI 10.1016/j.atherosclerosis.2011.06.017; Kaplan-Albuquerque N, 2005, J BIOL CHEM, V280, P19966, DOI 10.1074/jbc.M500917200; Kessler T, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0368-0; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mathur P, 2005, AM J PHYSIOL-HEART C, V288, pH3006, DOI 10.1152/ajpheart.01203.2004; Morita T, 2007, EXP CELL RES, V313, P3432, DOI 10.1016/j.yexcr.2007.07.008; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Pu XY, 2013, AM J HUM GENET, V92, P366, DOI 10.1016/j.ajhg.2013.01.012; Reilly MP, 2011, LANCET, V377, P383, DOI 10.1016/S0140-6736(10)61996-4; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Tian Xiao-Li, 2006, V129, P69; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Wang D, 2007, CIRC RES, V100, P807, DOI 10.1161/01.RES.0000261350.61711.9e; Wang H, 2010, AM J HUM GENET, V87, P687, DOI 10.1016/j.ajhg.2010.10.002; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhao Y, 2001, ACTA BIOCH BIOPH SIN, V33, P19	24	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82135	10.1371/journal.pone.0082135	http://dx.doi.org/10.1371/journal.pone.0082135			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349201	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300077
J	Camfield, DA; Silber, BY; Scholey, AB; Nolidin, K; Goh, A; Stough, C				Camfield, David A.; Silber, Beata Y.; Scholey, Andrew B.; Nolidin, Karen; Goh, Antionette; Stough, Con			A Randomised Placebo-Controlled Trial to Differentiate the Acute Cognitive and Mood Effects of Chlorogenic Acid from Decaffeinated Coffee	PLOS ONE			English	Article							ANTIOXIDANT CAPACITY; CAFFEINE; PERFORMANCE; HUMANS; PLASMA; PSYCHOMOTOR; EQUIVALENTS; CONSUMPTION; ATTENTION; CONSUMERS	In the current study, sixty healthy older adults aged 50 years or older, and who were light to moderate coffee drinkers, were administered 6g of a decaffeinated green coffee blend (NESCAFE Green Blend coffee; GB) or 540mg pure chlorogenic acids (CGA) or placebo in a double-blind acute cross-over design, with cognitive and mood assessments pre-dose, 40-mins and 120-mins post-dose. The primary outcome measure was accuracy in Rapid Visual Information Processing (RVIP). Secondary cognitive outcome measures included RVIP reaction time as well as Inspection time (IT), Jensen Box decision/reaction times, serial subtraction and N-Back working memory. Secondary mood measures included Bond-Lader and caffeine Research visual analogue scales (VAS). No significant treatment effects were found for the primary outcome measure, although significant effects were found amongst secondary measures. Overall, CGA in isolation was not found to significantly improve cognitive function relative to placebo whereas the GB was found to improve sustained attention as measured by the N-Back task in comparison to placebo overall (t=2.45, p=.05), as well as decision time on a 2-choice reaction time task (Jensen box) in comparison to placebo at 40 minutes post-dose (t=2.45, p=.05). Similarly, GB was found to improve alertness on both the Bond-Lader at 120 minutes relative to CGA (t=2.86, p=0.02) and the caffeine Research VAS relative to CGA (t=3.09, p=0.009) and placebo (t=2.75, p=0.02) at 120 minutes post-dose. Both the GB and CGA were also found to significantly improve symptoms of headache at 120 minutes relative to placebo (t=2.51, p=0.03 and t=2.43, p=.04 respectively), whilst there was a trend towards a reduction in jitteriness with GB and CGA in comparison to placebo at 40 minutes post-dose (t=2.24, p=0.06 and t=2.20, p=0.06 respectively). These findings suggest that the improvements in mood observed with GB, but not the improvements in cognitive function, are likely to some extent to be attributable to CGAs.	[Camfield, David A.; Silber, Beata Y.; Scholey, Andrew B.; Nolidin, Karen; Goh, Antionette; Stough, Con] Swinburne Univ, Ctr Human Psychopharmacol, Melbourne, Vic, Australia; [Silber, Beata Y.] Nestle Res Ctr, CH-1000 Lausanne, Switzerland	Nestle SA	Stough, C (corresponding author), Swinburne Univ, Ctr Human Psychopharmacol, Melbourne, Vic, Australia.	cstough@swin.edu.au	Scholey, Andrew/C-5940-2015; Stough, Con/A-6492-2015; Scholey, Andrew/GWV-0066-2022	Scholey, Andrew/0000-0003-4484-5462; stough, con/0000-0002-3628-3220; Camfield, David/0000-0001-7925-2566	Nestle Research Center; Nestec Ltd (Nestle Research Center, Lausanne, Switzerland)	Nestle Research Center(Nestle SA); Nestec Ltd (Nestle Research Center, Lausanne, Switzerland)(Nestle SA)	The coffee products were provided free of charge by Nestle Research Center. This research was funded by Nestec Ltd (Nestle Research Center, Lausanne, Switzerland). Dr. Beata Silber is an employee of Nestle. Nestec, through Dr Silber, was involved in the concept of the study, the trial design, monitoring of data, interpretation and the writing, and approval of the report. The authors have full control of all primary data.	Almeida IF, 2009, J MED FOOD, V12, P175, DOI 10.1089/jmf.2008.0046; Bernatoniene J, 2008, MEDICINA-LITHUANIA, V44, P706, DOI 10.3390/medicina44090091; Bouayed J, 2007, J NEUROL SCI, V262, P77, DOI 10.1016/j.jns.2007.06.028; Cropley V, 2012, PSYCHOPHARMACOLOGY, V219, P737, DOI 10.1007/s00213-011-2395-0; de Paulis T, 2004, NUTR BRAIN BEHAV, P187; FREWER LJ, 1991, HUM PSYCHOPHARM CLIN, V6, P119, DOI 10.1002/hup.470060206; Frost-Meyer NJ, 2012, J FUNCT FOODS, V4, P819, DOI 10.1016/j.jff.2012.05.010; George SE, 2008, CRIT REV FOOD SCI, V48, P464, DOI 10.1080/10408390701522445; Haskell CF, 2005, PSYCHOPHARMACOLOGY, V179, P813, DOI 10.1007/s00213-004-2104-3; Haskell CF, 2008, BIOL PSYCHOL, V77, P113, DOI 10.1016/j.biopsycho.2007.09.008; Heatherley SV, 2005, PSYCHOPHARMACOLOGY, V178, P461, DOI 10.1007/s00213-005-2159-9; KENEMANS JL, 1995, PHARMACOL BIOCHEM BE, V52, P461, DOI 10.1016/0091-3057(95)00159-T; Kim J, 2012, NEUROCHEM INT, V60, P466, DOI 10.1016/j.neuint.2012.02.004; Kwon SH, 2010, EUR J PHARMACOL, V649, P210, DOI 10.1016/j.ejphar.2010.09.001; LIEBERMAN HR, 1987, PSYCHOPHARMACOLOGY, V92, P308, DOI 10.1007/BF00210835; LORIST MM, 1995, EVOKED POTENTIAL, V96, P453, DOI 10.1016/0168-5597(95)00069-5; Maas M, 2009, MOLECULES, V14, P36, DOI 10.3390/molecules14010036; McCusker RR, 2006, J ANAL TOXICOL, V30, P611, DOI 10.1093/jat/30.8.611; McIntyre KL, 2009, PLANTA MED, V75, P286, DOI 10.1055/s-0028-1088394; Namba Tsuneo, 2002, Yakushigaku Zasshi, V37, P65; Nardini M, 2002, J AGR FOOD CHEM, V50, P5735, DOI 10.1021/jf0257547; Natella F, 2002, J AGR FOOD CHEM, V50, P6211, DOI 10.1021/jf025768c; Nehlig A, 2010, J ALZHEIMERS DIS, V20, pS85, DOI 10.3233/JAD-2010-091315; Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66; Pellegrini N, 2003, J NUTR, V133, P2812, DOI 10.1093/jn/133.9.2812; Rees K, 1999, PSYCHOPHARMACOLOGY, V145, P181, DOI 10.1007/s002130051047; Renouf M, 2010, MOL NUTR FOOD RES, V54, P760, DOI 10.1002/mnfr.200900056; Renouf M, 2010, J NUTR, V140, P259, DOI 10.3945/jn.109.113027; Ruijter J, 2000, PSYCHOPHYSIOLOGY, V37, P427, DOI 10.1111/1469-8986.3740427; Smit HJ, 2000, PSYCHOPHARMACOLOGY, V152, P167, DOI 10.1007/s002130000506; SWIFT CG, 1988, PSYCHOPHARMACOLOGY, V94, P29, DOI 10.1007/BF00735876; Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123; Votavova L, 2009, CZECH J FOOD SCI, V27, pS49, DOI 10.17221/1105-CJFS; YU G, 1991, BRIT J CLIN PHARMACO, V32, P341, DOI 10.1111/j.1365-2125.1991.tb03909.x	34	50	50	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82897	10.1371/journal.pone.0082897	http://dx.doi.org/10.1371/journal.pone.0082897			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349389	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200110
J	Glinskii, OV; Huxley, VH; Glinskii, VV; Rubin, LJ; Glinsky, VV				Glinskii, Olga V.; Huxley, Virginia H.; Glinskii, Vladimir V.; Rubin, Leona J.; Glinsky, Vladislav V.			Pulsed Estrogen Therapy Prevents Post-OVX Porcine Dura Mater Microvascular Network Weakening via a PDGF-BB-Dependent Mechanism	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; BETA-RECEPTOR; ARTERIOVENOUS-MALFORMATION; INTRACRANIAL ANEURYSMS; POSTMENOPAUSAL WOMEN; RISK-FACTORS; MAST-CELLS; MICE; ACTIVATION; DEFICIENT	In postmenopausal women, estrogen (E2) deficiencies are frequently associated with higher risk of intracranial hemorrhage, increased incidence of stroke, cerebral aneurysm, and decline in cognitive abilities. In younger postpartum women and those using oral contraceptives, perturbations in E2 are associated with higher risk of cerebral venous thrombosis. A number of serious intracranial pathologic conditions linked to E2 deficiencies, such as dural sinus thrombosis, dural fistulae, non-parenchymal intracranial hemorrhages, migraines, and spontaneous cerebrospinal fluid leaks, involve the vessels not of the brain itself, but of the outer fibrous membrane of the brain, the dura mater (DM). The pathogenesis of these disorders remains mysterious and how estrogen regulates structural and functional integrity of DM vasculature is largely unknown. Here, we demonstrate that post ovariectomy (OVX) DM vascular remodeling is manifested by microvessel destabilization, capillary rarefaction, increased vascular permeability, and aberrant angio-architecture, and is the result of disrupted E2-regulated PDGF-BB signaling within dura microvasculature. These changes, associated with the reduction in systemic PDGF-BB levels, are not corrected by a flat-dose E2 hormone replacement therapy (HRT), but are largely prevented using HRT schedules mimicking physiological E2 fluctuations. We demonstrate that 1) E2 regulates PDGF-BB production by endothelial cells in a dose-dependent manner and 2) optimization of PDGF-BB levels and induction of robust PDGF-mediated endothelial cell-vascular pericyte interactions require high (estrous) E2 concentrations. We conclude that high (estrous) levels of E2 are important in controlling PDGF-mediated crosstalk between endothelial cells and pericytes, a fundamental mechanism governing microvessel stability and essential for preserving intracranial homeostasis.	[Glinskii, Olga V.; Glinsky, Vladislav V.] Harry S Truman Mem Vet Hosp, Res Serv, Columbia, MO 65201 USA; [Glinskii, Olga V.; Huxley, Virginia H.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO USA; [Glinsky, Vladislav V.] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO USA; [Rubin, Leona J.] Univ Missouri, Dept Biomed Sci, Columbia, MO USA; [Glinskii, Olga V.; Huxley, Virginia H.; Rubin, Leona J.; Glinsky, Vladislav V.] Univ Missouri, Ctr Gender Physiol & Environm Adaptat, Columbia, MO USA; [Glinskii, Vladimir V.] Yale Univ, Sch Med, New Haven, CT USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Yale University	Glinsky, VV (corresponding author), Harry S Truman Mem Vet Hosp, Res Serv, Columbia, MO 65201 USA.	glinskiivl@health.missouri.edu	Huxley, Virginia H/R-5030-2019	Glinsky, Vladislav/0000-0003-0893-4388	American Heart Association [SDG 0830287N]; Biomedical Laboratory Research & Development Service of the VA Office of Research and Development [1I01BX000609]; National Cancer Institute of the National Institutes of Health [R01CA160461]; NATIONAL CANCER INSTITUTE [R01CA160461] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078816] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Biomedical Laboratory Research & Development Service of the VA Office of Research and Development; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the American Heart Association National SDG 0830287N (OVG), Award Number 1I01BX000609 from the Biomedical Laboratory Research & Development Service of the VA Office of Research and Development (VVG), National Cancer Institute of the National Institutes of Health Award R01CA160461 (VVG). The content is solely the responsibility of the authors and does not necessarily represent the official views of the American Heart Association, National Institutes of Health, or VA Office of Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboian MS, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.8.FOCUS09161; Boes T, 2012, CEPHALALGIA, V32, P924, DOI 10.1177/0333102412454947; Brass LM, 2004, STROKE, V35, P2644, DOI 10.1161/01.STR.0000143218.20061.ac; Clarke M, 2008, NEURORADIOLOGY, V50, P653, DOI 10.1007/s00234-008-0411-9; COGAN DG, 1961, ARCH OPHTHALMOL-CHIC, V66, P366, DOI 10.1001/archopht.1961.00960010368014; Cognard C, 1998, J NEUROL NEUROSUR PS, V65, P308, DOI 10.1136/jnnp.65.3.308; Crosby JR, 1998, NAT GENET, V18, P385, DOI 10.1038/ng0498-385; Ellamushi HE, 2001, J NEUROSURG, V94, P728, DOI 10.3171/jns.2001.94.5.0728; ELLIS EF, 1979, AM J PHYSIOL, V237, pH381, DOI 10.1152/ajpheart.1979.237.3.H381; Eng E, 2005, KIDNEY INT, V68, P695, DOI 10.1111/j.1523-1755.2005.00448.x; Fox RJ, 1996, NEUROSURGERY, V39, P84, DOI 10.1097/00006123-199607000-00017; Glinskii OV, 2008, CELL CYCLE, V7, P1385, DOI 10.4161/cc.7.10.5819; Glinskii OV, 2007, AM J PHYSIOL-HEART C, V293, pH1131, DOI 10.1152/ajpheart.01156.2006; Glinskii OV, 2004, J PHYSIOL-LONDON, V554, P89, DOI 10.1113/jphysiol.2003.054783; Glinskii OV, 2003, CLIN EXP METASTAS, V20, P451, DOI 10.1023/A:1025449031136; Glinskii VV, 2006, J VASC RES, V43, P43; Gordon N, 2009, DEV MED CHILD NEUROL, V51, P932, DOI 10.1111/j.1469-8749.2009.03514.x; GREENE AS, 1989, AM J PHYSIOL, V256, pH126, DOI 10.1152/ajpheart.1989.256.1.H126; Gupta Ak, 2009, Indian J Radiol Imaging, V19, P43, DOI 10.4103/0971-3026.45344; Harrod CG, 2006, MED HYPOTHESES, V66, P736, DOI 10.1016/j.mehy.2005.09.051; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hirschi KK, 1999, CIRC RES, V84, P298, DOI 10.1161/01.RES.84.3.298; HOUSER OW, 1979, MAYO CLIN PROC, V54, P651; Johnston KD, 2007, J NEUROSURG, V107, P841, DOI 10.3171/JNS-07/10/0841; Kandere-Grzybowska K, 2003, BRAIN RES, V980, P213, DOI 10.1016/S0006-8993(03)02975-5; Klinghoffer RA, 2001, MOL CELL, V7, P343, DOI 10.1016/S1097-2765(01)00182-4; KOSTELJANETZ M, 1987, ACTA NEUROL SCAND, V75, P1; Kurata A, 1999, NEUROL RES, V21, P631, DOI 10.1080/01616412.1999.11740988; KURATA A, 1994, J NEUROSURG, V80, P552, DOI 10.3171/jns.1994.80.3.0552; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lindahl P, 1998, DEVELOPMENT, V125, P3313; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lloyd KM, 2008, RADIOLOGY, V248, P725, DOI 10.1148/radiol.2483070362; Mack J, 2009, PEDIATR RADIOL, V39, P200, DOI 10.1007/s00247-008-1084-6; MARKOWITZ S, 1989, BRAIN RES, V477, P157, DOI 10.1016/0006-8993(89)91403-0; Nishimura H, 2001, PROSTAG OTH LIPID M, V66, P1, DOI 10.1016/S0090-6980(01)00115-0; Ohlsson R, 1999, DEV BIOL, V212, P124, DOI 10.1006/dbio.1999.9306; Pae CU, 2008, NEUROENDOCRINOL LETT, V29, P500; Papanek PE, 1998, AM J HYPERTENS, V11, P998, DOI 10.1016/S0895-7061(98)00114-9; PRASAD A, 1995, J HYPERTENS, V13, P265; Rajkumar VS, 2006, AM J PATHOL, V169, P2254, DOI 10.2353/ajpath.2006.060196; Saposnik G, 2011, STROKE, V42, P1158, DOI 10.1161/STR.0b013e31820a8364; Scallan J., 2010, FLUID EXCHANGE REGUL; SHAPIRO K, 1985, J NEUROSURG, V63, P76, DOI 10.3171/jns.1985.63.1.0076; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Tallquist MD, 2000, GENE DEV, V14, P3179, DOI 10.1101/gad.844700; Uranishi R, 1999, J NEUROSURG, V91, P781, DOI 10.3171/jns.1999.91.5.0781; Vaghela V, 2011, NEUROL INDIA, V59, P17, DOI 10.4103/0028-3886.84328; Winkler EA, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-32; WOODWARD DF, 1993, EUR J PHARMACOL, V230, P327, DOI 10.1016/0014-2999(93)90569-4; Zhang XC, 2007, J PHARMACOL EXP THER, V322, P806, DOI 10.1124/jpet.107.123745	52	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82900	10.1371/journal.pone.0082900	http://dx.doi.org/10.1371/journal.pone.0082900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349391	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200111
J	Ward, PR; Mamerow, L; Meyer, SB				Ward, Paul R.; Mamerow, Loreen; Meyer, Samantha B.			Identifying Vulnerable Populations Using a Social Determinants of Health Framework: Analysis of National Survey Data across Six Asia-Pacific Countries	PLOS ONE			English	Article							SELF-RATED HEALTH; NONRESPONSE; COMMUNITY; RESOURCE; TRUST; US	Background: In order to improve the health of the most vulnerable groups in society, the WHO called for research on the multiple and inter-linking factors shaping the social determinants of health (SDH). This paper analyses four key SDH (social cohesion, social inclusion, social empowerment and socioeconomic security) across six Asia-Pacific countries: Australia, Hong Kong, Japan, South Korea, Taiwan, and Thailand. Methods: Population surveys were undertaken using a validated instrument in 2009-10, with sample sizes around 1000 in each country. The four SDH were analysed using multivariate binomial logistic regression to identify socio-demographic predictors in each country. Results: Low socio-economic security was associated with low income in all six study countries and with poor subjective health in Japan, South Korea and Thailand and with being married or cohabiting in Australia and Hong Kong. Low social cohesion was associated with low income in all countries and with undertaking household duties in South Korea, Thailand and Taiwan. Low social inclusion was associated with low income in Australia, South Korea and Taiwan and with poor subjective health in Australia, Japan and South Korea. Older people had lower social inclusion in Taiwan (50-59 years) and Hong Kong (retired), younger people in Japan and South Korea (20-29 years in both countries) and younger and middle-aged people in Australia. Low social empowerment was associated with low income in Australia, Thailand and Taiwan, with being aged 60 years or over in Australia, Hong Kong and South Korea, and over 50 years in Thailand. Conclusions: This paper provides baseline measures for identifying where and how policy should be altered to improve the SDH. Furthermore, these data can be used for future policy evaluation to identify whether changes in policy have indeed improved the SDH, particularly for marginalised and vulnerable populations.	[Ward, Paul R.; Mamerow, Loreen] Flinders Univ S Australia, Discipline Publ Hlth, Adelaide, SA 5001, Australia; [Meyer, Samantha B.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada	Flinders University South Australia; University of Waterloo	Ward, PR (corresponding author), Flinders Univ S Australia, Discipline Publ Hlth, Adelaide, SA 5001, Australia.	paul.ward@flinders.edu.au		Ward, Paul/0000-0002-5559-9714; Tisdall, Loreen/0000-0001-6303-6148	Flinders University Faculty of Health Sciences	Flinders University Faculty of Health Sciences	Flinders University Faculty of Health Sciences for funding this research via a faculty seeding grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson J, 2003, SOC SCI MED, V57, P895, DOI 10.1016/S0277-9536(02)00458-6; Ahern MM, 2003, SOC SCI MED, V57, P1195, DOI 10.1016/S0277-9536(02)00494-X; [Anonymous], 1976, NEW RULES SOCIOLOGIC; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; [Anonymous], 1993, BANGK DECL; [Anonymous], 1978, DECL ALM AT; [Anonymous], 2001, SOCIAL QUALITY VISIO; [Anonymous], 1986, OTTAWA CHARTER HLTH; Archer M. S., 2003, STRUCTURE AGENCY INT, DOI [10.1017/cbo9781139087315.001, DOI 10.1017/CBO9781139087315.001]; Beck U, 1994, REFLEXIVE MODERNIZAT; Beck Ulrich, 2005, WORLD RISK SOC; Beck Ulrich., 1992, RISK SOC NEW MODERNI; Beck W., 1998, SOCIAL QUALITY EUROP; Bourdieu P., 1984, DISTINCTION SOCIAL C; Bower P, 2003, BRIT MED J, V326, P258, DOI 10.1136/bmj.326.7383.258; Bowling A, 2009, RES METHODS HLTH; Bureekul T, 2013, INT J SOCIAL QUALITY, V2; Carpiano RM, 2006, SOC SCI MED, V62, P165, DOI 10.1016/j.socscimed.2005.05.020; Chen F-1, 2013, INT J SOCIAL QUALITY, V2; Colclough G, 2005, SOCIOL INQ, V75, P474, DOI 10.1111/j.1475-682X.2005.00133.x; Commission on Social Determinants of Health, 2007, ACH HLTH EQ ROOT CAU; Commission on Social Determinants of Health (CSDH, 2005, ACT SOC DET HLTH LEA; Cummings SM, 2001, HEALTH SERV RES, V35, P1347; Curtin R, 2005, PUBLIC OPIN QUART, V69, P87, DOI 10.1093/poq/nfi002; Durkheim E., 1951, SUICIDE STUDY SOCIOL, DOI 10.2307/2088294; Ferriss A.L., 2004, AM SOCIOL, V35, P37, DOI DOI 10.1007/S12108-004-1016-3; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Freedman LP, 2005, WHOS GOT POWER TRANS; Giddens A., 1994, REFLEXIVE MODERNISAT; Giddens A., 1991, MODERNITY SELF IDENT; Giddens A., 1994, LEFT RIGHT; Giddens Anthony, 1990, CONSEQUENCES MODERNI; Gilson L, 2007, WHO COMM SOC DET HLT; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Habermas J., 1997, THEORY COMMUNICATIVE, VI; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hu K, 2013, INT J SOCIAL QUALIYT, V2; Kim D, 2006, J EPIDEMIOL COMMUN H, V60, P116, DOI 10.1136/jech.2005.038281; Kondro W, 2012, CAN MED ASSOC J, V184, P1456, DOI 10.1503/cmaj.109-4271; Laverack G, 2004, HLTH PROMOTION PRAC; Laverack G, 2006, J HEALTH POPUL NUTR, V24, P113; Lee K, HLTH POLICY GLOBALIS; Legge D, 1996, BEST PRACTICE PRIMAR; Lochner KA, 2003, SOC SCI MED, V56, P1797, DOI 10.1016/S0277-9536(02)00177-6; Low L, 1998, BRIT MED J, V317, P1632, DOI 10.1136/bmj.317.7173.1632; Lu JR, 2007, ASIAN EC SOCIAL SCI, V64, P166; Luhmann N., 2000, TRUST MAKING BREAKIN; LUHMANN Niklas, 1979, TRUST POWER; Makinen M, 2000, B WORLD HEALTH ORGAN, V78, P55; Marmot MG., 2006, SOCIAL DETERMINANTS; Meyer S, 2012, INT J SOCIAL QUALITY, V2, P3, DOI DOI 10.3167/IJSQ.2012.020202; Meyer S, 2008, HEALTH SOCIOL REV, V17, P177, DOI 10.5172/hesr.451.17.2.177; Meyer SB, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-238; Meyer SB, 2010, DEV SOC, V39, P327; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Ostlin P, 2005, B WORLD HEALTH ORGAN, V83, P948; Ostlin P., 2010, PRIORITIES RES EQUIT; Parsons T., 1951, SOCIAL SYSTEM; Pittman PM, 2006, J HEALTH POLIT POLIC, V31, P33, DOI 10.1215/03616878-31-1-33; Poortinga W, 2006, SOC SCI MED, V62, P292, DOI 10.1016/j.socscimed.2005.06.008; Poortinga W, 2006, SOCIAL SCI MED; RICE N., 2010, EVALUATION-US, V16, P81, DOI [DOI 10.1177/1356389009350127, 10.1177/1356389009350127]; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Scambler G, 2001, HABERMAS CRTITIAL TH; Scambler Graham, 2001, HABERMAS CRITICAL TH; Spicer N, 2009, J ETHN MIGR STUD, V34, P491; Subramanian SV, 2003, HEALTH PLACE, V9, P33, DOI 10.1016/S1353-8292(02)00028-X; Taylor-Gooby Peter, 2006, EUROPEAN J SOCIAL QU, V6, P121, DOI [DOI 10.3167/EJSQ.2006.060207, 10.3167/ejsq.2006.060207]; Vajirakachorn S, 2013, INT J SOCIAL QUALITY, V2; van der Maesen L, 2005, SOCIAL QUALITY FINAL; van der Maesen L.J.G., 2005, EUROPEAN J SOCIAL QU, V5, p8, DOI [10.3167/146179105780337431, DOI 10.3167/146179105780337431]; Vermunt JK, 2005, MULTIVAR BEHAV RES, V40, P281, DOI 10.1207/s15327906mbr4003_1; WALKER A., 2004, CHALLENGES QUALITY L; Wallerstein N., 2006, WHAT IS EVIDENCE EFF; Ward P, 2006, EUROPEAN J SOCIAL QU, V6, P1, DOI [DOI 10.3167/146179106780246576, 10.3167/146179106780246576]; Ward P., 2006, EUROPEAN J SOCIAL QU, V6, P121, DOI [DOI 10.3167/EJSQ.2006.060207, 10.3167/ejsq.2006.060207]; Ward P, 2006, HEALTH, V10, P283, DOI 10.1177/1363459306064481; Ward Paul, 2009, Journal of Asian Sociology, V38, P339; Ward PR, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-630; Ward PR, 2006, EUROPEAN J SOCIAL QU, V6, P9, DOI [10.3167/ejsq.2006.060202, DOI 10.3167/EJSQ.2006.060202]; Wilkinson RG, 2006, SOC SCI MED, V62, P1768, DOI 10.1016/j.socscimed.2005.08.036; Wilkinson RG, 2007, SOC SCI MED, V65, P1965, DOI 10.1016/j.socscimed.2007.05.041; Williams G, 2001, HABERMAS CRITICAL TH; World Health Organization, 2005, BANGK CHART HLTH PRO; World Value Survey, 2005, WORLD VAL SURV	86	19	19	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e83000	10.1371/journal.pone.0083000	http://dx.doi.org/10.1371/journal.pone.0083000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VD	24349417	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200121
J	Nascimento, FF; Lazar, A; Menezes, AN; Durans, AD; Moreira, JC; Salazar-Bravo, J; D'Andrea, PS; Bonvicino, CR				Nascimento, Fabricia F.; Lazar, Ana; Menezes, Albert N.; Durans, Andressa da Matta; Moreira, Janio C.; Salazar-Bravo, Jorge; D'Andrea, Paulo S.; Bonvicino, Cibele R.			The Role of Historical Barriers in the Diversification Processes in Open Vegetation Formations during the Miocene/Pliocene Using an Ancient Rodent Lineage as a Model	PLOS ONE			English	Article							DISPERSAL-VICARIANCE ANALYSIS; GENUS THRICHOMYS RODENTIA; SPINY RATS RODENTIA; CYTOCHROME-B GENE; MITOCHONDRIAL-DNA; SOUTH-AMERICA; INFERRING PHYLOGENIES; MTDNA VARIATION; SPECIES LIMITS; LATE MIOCENE	The Neotropics harbors a high diversity of species and several hypotheses have been proposed to account for this pattern. However, while species of forested domains are frequently studied, less is known of species from open vegetation formations occupying, altogether, a larger area than the Amazon Forest. Here we evaluate the role of historical barriers and the riverine hypothesis in the speciation patterns of small mammals by analyzing an ancient rodent lineage (Thrichomys, Hystricomorpha). Phylogenetic and biogeographic analyses were carried out with mitochondrial and nuclear DNA markers to analyze the evolutionary relationships between Thrichomys lineages occurring in dry domains along both banks of the Rio Sao Francisco. This river is one of the longest of South America whose course and water flow have been modified by inland tectonic activities and climate changes. Molecular data showed a higher number of lineages than previously described. The T. inermis species complex with 2n = 26, FN = 48 was observed in both banks of the river showing a paraphyletic arrangement, suggesting that river crossing had occurred, from east to west. A similar pattern was also observed for the T. apereoides complex. Thrichomys speciation occurred in Late Miocene when the river followed a different course. The current geographic distribution of Thrichomys species and their phylogenetic relationships suggested the existence of frequent past connections between both banks in the middle section of the Rio Sao Francisco. The extensive palaeodune region found in this area has been identified as a centre of endemism of several vertebrate species and is likely to be a center of Thrichomys diversification.	[Nascimento, Fabricia F.; Lazar, Ana; D'Andrea, Paulo S.; Bonvicino, Cibele R.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, BR-21045900 Rio De Janeiro, RJ, Brazil; [Menezes, Albert N.; Bonvicino, Cibele R.] Inst Nacl Canc, Div Genet, Rio De Janeiro, RJ, Brazil; [Durans, Andressa da Matta] Univ Estado Rio De Janeiro, Programa Pos Grad Biociencias, Rio De Janeiro, RJ, Brazil; [Durans, Andressa da Matta] Fiocruz MS, Inst Oswaldo Cruz, Lab Genom Func & Bioinformat, BR-21045900 Rio De Janeiro, RJ, Brazil; [Moreira, Janio C.] Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, Setor Mastozool, Rio De Janeiro, RJ, Brazil; [Moreira, Janio C.] Univ Fed Rio de Janeiro, Ilha Fundao, Programa Posgrad Biodiversidade & Biol Evolut, Rio de Janeiro, RJ, Brazil; [Salazar-Bravo, Jorge] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	Fundacao Oswaldo Cruz; National Cancer Institute (Inca); Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Texas Tech University System; Texas Tech University	Bonvicino, CR (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol & Parasitol Mamiferos Silvestres Reserva, BR-21045900 Rio De Janeiro, RJ, Brazil.	cibelerb@inca.gov.br	D'Andrea, Paulo S./G-6820-2011; Bonvicino, Cibele/O-3390-2014; Salazar-Bravo, Jorge/T-3349-2019; Salazar-Bravo, Jorge/AAO-7207-2021; Moreira, Janio C/I-3351-2012	Salazar-Bravo, Jorge/0000-0001-5905-2532; Moreira, Janio C/0000-0002-8382-427X; D'Andrea, Paulo Sergio/0000-0001-7880-8761; Durans, Andressa/0000-0002-0608-5813; Nascimento, Fabricia/0000-0001-9426-6835	CNPq; FAPERJ; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Work supported by CNPq (http://www.cnpq.br/) fellowships to FFN, CRB and PSD; FAPERJ (http://www.faperj.br/) to CRB, ALGS, ANM and JCM; and CAPES (http://www.capes.gov.br/) to ALGS and JCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida FC, 2007, MOL PHYLOGENET EVOL, V42, P449, DOI 10.1016/j.ympev.2006.07.005; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Anthony NM, 2007, P NATL ACAD SCI USA, V104, P20432, DOI 10.1073/pnas.0704816105; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barreto A.M.F., 2002, SITIOS GEOLOGICOS PA, P223; Barreto AMF, 1996, INTERPRETACAO PALEOA; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2010, TUTORIAL COMP GENE F; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Bezerra Alexandra M.R., 2010, Zootaxa, V2724, P29; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Bonvicino CR, 2002, CYTOGENET GENOME RES, V97, P200, DOI 10.1159/000066613; Bonvicino CR, 2008, GUIA ROEDORES BRASIL; Borodin PM, 2006, GENOME, V49, P159, DOI 10.1139/G05-096; Braggio E, 2004, J MAMMAL, V85, P316, DOI 10.1644/1545-1542(2004)085<0316:MDITGT>2.0.CO;2; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; Candela AM, 2012, ZOOL J LINN SOC-LOND, V164, P451, DOI 10.1111/j.1096-3642.2011.00762.x; Carvalho-Junior OA, 2006, REV BRAS GEOFIS, V24, P319, DOI DOI 10.1590/S0102-261X2006000300002; Coutinho-Abreu IV, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-16; D'Elia G, 2008, J MAMMAL, V89, P778, DOI 10.1644/07-MAMM-A-246R1.1; da Rocha PLB, 1995, MAMMALIA, V59, P537, DOI 10.1515/mamm.1995.59.4.537; Da Silva JMC, 2002, BIOSCIENCE, V52, P225, DOI 10.1641/0006-3568(2002)052[0225:BPACIT]2.0.CO;2; Do Nascimento FF, 2011, J HERED, V102, P260, DOI 10.1093/jhered/esr012; Domingues AJP., 1948, REV BRAS GEOGR, V10, P255; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duputie A, 2011, J BIOGEOGR, V38, P1033, DOI 10.1111/j.1365-2699.2011.02474.x; Flynn JJ, 2003, PALAEOGEOGR PALAEOCL, V195, P229, DOI 10.1016/S0031-0182(03)00360-2; Galewski T, 2005, MOL PHYLOGENET EVOL, V34, P601, DOI 10.1016/j.ympev.2004.11.015; Gamble T, 2012, MOL PHYLOGENET EVOL, V62, P943, DOI 10.1016/j.ympev.2011.11.033; Gascon C, 2000, P NATL ACAD SCI USA, V97, P13672, DOI 10.1073/pnas.230136397; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Godinho AL, 2003, AGUAS PEIXES PESCADO, P15; Grabert H., 1968, GEOL RUNDSCH, V58, P166, DOI [10.1007/BF01820602, DOI 10.1007/BF01820602]; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hare MP, 2001, TRENDS ECOL EVOL, V16, P700, DOI 10.1016/S0169-5347(01)02326-6; HARRISON RG, 1989, TRENDS ECOL EVOL, V4, P6, DOI 10.1016/0169-5347(89)90006-2; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Herrmann G., 2012, ANNOTATED CHECKLIST, V2nd; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Ho SYW, 2009, SYST BIOL, V58, P367, DOI 10.1093/sysbio/syp035; Hoelzer GA, 1997, EVOLUTION, V51, P622, DOI 10.1111/j.1558-5646.1997.tb02451.x; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; Olivares AI, 2012, J MAMMAL, V93, P76, DOI 10.1644/11-MAMM-A-176.1; Jalil MF, 2008, MOL ECOL, V17, P2898, DOI 10.1111/j.1365-294X.2008.03793.x; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; King L.C., 1956, REV BRAS GEOGR, V18, P147; Kodandaramaiah U, 2010, J BIOGEOGR, V37, P3, DOI 10.1111/j.1365-2699.2009.02221.x; KOHLER HC, 2003, AGUAS PEIXES PESCADO, P25; LACHER TE, 1989, J MAMMAL, V70, P396, DOI 10.2307/1381526; Leite YLR, 2002, MOL PHYLOGENET EVOL, V25, P455, DOI 10.1016/S1055-7903(02)00279-8; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Lencioni-Neto Frederico, 1994, Alauda, V62, P241; Lessa EP, 2003, P NATL ACAD SCI USA, V100, P10331, DOI 10.1073/pnas.1730921100; Mabesoone JM, 1994, SEDIMENATRY BASINS N; MARES MA, 1992, SCIENCE, V255, P976, DOI 10.1126/science.255.5047.976; Matocq MD, 2007, MOL PHYLOGENET EVOL, V42, P637, DOI 10.1016/j.ympev.2006.08.011; Mills JN, 1999, EMERG INFECT DIS, V5, P135, DOI 10.3201/eid0501.990116; Moojen Joao, 1997, Boletim do Museu Nacional Rio de Janeiro Zoologia, V377, P1; Moore WS, 1997, EVOLUTION, V51, P627, DOI 10.1111/j.1558-5646.1997.tb02452.x; MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.1111/j.1558-5646.1995.tb02308.x; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Oliveira-Filho A., 2002, CERRADOS BRAZIL, P91, DOI [10.1590/1519-6984.02016, DOI 10.7312/OLIV12042-007]; Pachaly Jose Ricardo, 2001, P475; Passoni JC, 2008, MOL PHYLOGENET EVOL, V46, P403, DOI 10.1016/j.ympev.2007.10.022; Patton JL, 1998, ENDLESS FORMS, P202; Pennington RT, 2000, J BIOGEOGR, V27, P261, DOI 10.1046/j.1365-2699.2000.00397.x; Pessoa LM, 2004, MAMM BIOL, V69, P258, DOI 10.1078/1616-5047-00141; Potter PE, 1997, J S AM EARTH SCI, V10, P331, DOI 10.1016/S0895-9811(97)00031-X; Prado CPA, 2012, MOL ECOL, V21, P921, DOI 10.1111/j.1365-294X.2011.05409.x; PRADO DE, 1993, ANN MO BOT GARD, V80, P902, DOI 10.2307/2399937; Prychitko TM, 2000, MOL BIOL EVOL, V17, P1101, DOI 10.1093/oxfordjournals.molbev.a026391; Rambaut A., 2007, TRACER V1 4; Rocha Rita G., 2011, Zootaxa, V2789, P1; Rodrigues M. T., 2003, ECOLOGIA CONSERVACAO, P181; Rodrigues Miguel Trefaut, 2002, Pap. Avulsos Zool. (São Paulo), V42, P325, DOI 10.1590/S0031-10492002001300001; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Siedchlag AC, 2010, MOL PHYLOGENET EVOL, V56, P622, DOI 10.1016/j.ympev.2010.04.027; Silva Luciana Álvares da, 2003, Acta Bot. Bras., V17, P305; Silva MN, 1993, MOL PHYLOGENET EVOL, V2, P243; STREILEIN K E, 1982, Annals of Carnegie Museum, V51, P79; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Tamura K, 2002, MOL BIOL EVOL, V19, P1727, DOI 10.1093/oxfordjournals.molbev.a003995; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Upham NS, 2012, MOL PHYLOGENET EVOL, V63, P417, DOI 10.1016/j.ympev.2012.01.020; Verzi DH, 2008, GEOBIOS-LYON, V41, P145, DOI 10.1016/j.geobios.2006.09.005; Verzi Diego H., 1995, Ameghiniana, V32, P191; Vilela RV, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-29; Vilela RV, 2005, THESIS U SAO PAULO S; WALLACE A. R., 1852, P ZOOL SOC LOND, V20, P107, DOI DOI 10.1080/037454809494374; Werneck FP, 2006, J BIOGEOGR, V33, P1983, DOI 10.1111/j.1365-2699.2006.01553.x; Werneck FP, 2011, QUATERNARY SCI REV, V30, P1630, DOI 10.1016/j.quascirev.2011.03.009; Werneck FP, 2006, THESIS U BRASILIA; Woods CA, 2005, MAMMAL SPECIES WORLD, P1538; WYSS AR, 1993, NATURE, V365, P434, DOI 10.1038/365434a0; Yu Y, 2010, MOL PHYLOGENET EVOL, V56, P848, DOI 10.1016/j.ympev.2010.04.011	110	64	69	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2013	8	4							e61924	10.1371/journal.pone.0061924	http://dx.doi.org/10.1371/journal.pone.0061924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IU	24349576	Green Submitted, Green Published, gold			2022-12-27	WOS:000317908700066
J	Thriemer, K; Ley, B; Menten, J; Jacobs, J; van den Ende, J				Thriemer, Kamala; Ley, Benedikt; Menten, Joris; Jacobs, Jan; van den Ende, Jef			A Systematic Review and Meta-Analysis of the Performance of Two Point of Care Typhoid Fever Tests, Tubex TF and Typhidot, in Endemic Countries	PLOS ONE			English	Review							AUTOMATED BLOOD CULTURE; RAPID DIAGNOSTIC-TESTS; BONE-MARROW; WIDAL TEST; SALMONELLA-TYPHI; ENTERIC FEVER; CHILDREN; SPECIFICITY; SENSITIVITY; AREA	Background: In the absence of well-equipped laboratory infrastructure in many developing countries the accurate diagnosis of typhoid fever is challenging. Rapid diagnostic tests (RDT) with good performance indicators would be helpful to improve clinical management of suspected cases. We performed a systematic literature review and meta-analysis to determine the performance of TUBEX TF and Typhidot for the diagnosis of typhoid fever using PRISMA guidelines. Methods: Titles and abstracts were reviewed for relevance. Articles were screened for language, reference method and completeness. Studies were categorized according to control groups used. Meta-analysis was performed only for categories where enough data was available to combine sensitivity and specificity estimates. Sub-analysis was performed for the Typhidot test to determine the influence of indeterminate results on test performance. Results: A total of seven studies per test were included. The sensitivity of TUBEX TF ranged between 56% and 95%, Specificity between 72% and 95%. Meta-analysis showed an average sensitivity of 69% (95%CI: 45-85) and an average specificity of 88% (CI95%: 83-91). A formal meta-analysis for Typhidot was not possible due to limited data available. Across the extracted studies, sensitivity and specificity estimates ranged from 56% to 84% and 31% to 97% respectively. Conclusion: The observed performance does not support the use of either rapid diagnostic test exclusively as the basis for diagnosis and treatment. There is a need to develop an RDT for typhoid fever that has a performance level comparable to malaria RDTs.	[Thriemer, Kamala; Ley, Benedikt; Menten, Joris; Jacobs, Jan; van den Ende, Jef] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM)	Thriemer, K (corresponding author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	kthriemer@itg.be	Jacobs, Jan/GRX-7316-2022	Ley, Benedikt/0000-0002-5734-0845; Thriemer, Kamala/0000-0001-7536-7497	ITM	ITM	All authors are supported through institutional funds of the ITM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anusha R, 2011, ANN TROP PAEDIATR, V31, P231, DOI 10.1179/1465328111Y.0000000030; Bakr Wafaa M, 2010, J Egypt Public Health Assoc, V85, P285; Begum Z, 2009, Mymensingh Med J, V18, P13; Beig FK, 2010, BRAZ J INFECT DIS, V14, P589, DOI 10.1016/S1413-8670(10)70116-1; Bhutta ZA, 1999, AM J TROP MED HYG, V61, P654, DOI 10.4269/ajtmh.1999.61.654; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P78, DOI 10.1136/bmj.333.7558.78; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Choo KE, 1999, ACTA TROP, V72, P175, DOI 10.1016/S0001-706X(98)00095-3; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2012, CLIN INFECT DIS, V54, P1107, DOI 10.1093/cid/cis024; Deeks JJ, 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; Dong B, 2007, EPIDEMIOL INFECT, V135, P1014, DOI 10.1017/S0950268806007801; Dutta S, 2006, DIAGN MICR INFEC DIS, V56, P359, DOI 10.1016/j.diagmicrobio.2006.06.024; Fadeel MA, 2011, J INFECT DEV COUNTR, V5, P169, DOI 10.3855/jidc.1339; FAROOQUI BJ, 1991, J CLIN PATHOL, V44, P258, DOI 10.1136/jcp.44.3.258; GILMAN RH, 1975, LANCET, V1, P1211; Gopalakrishnan V., 2002, SMJ Singapore Medical Journal, V43, P354; House D, 2001, J CLIN MICROBIOL, V39, P1002, DOI 10.1128/JCM.39.3.1002-1007.2001; Jesudason M, 2002, INDIAN J MED RES, V116, P70; Jesudason MV, 2006, INDIAN J MED RES, V123, P513; Kawano RL, 2007, J CLIN MICROBIOL, V45, P246, DOI 10.1128/JCM.01403-06; Keddy KH, 2011, B WORLD HEALTH ORGAN, V89, P640, DOI 10.2471/BLT.11.087627; Ley B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-147; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mtove G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009244; Naheed A, 2008, DIAGN MICR INFEC DIS, V61, P381, DOI 10.1016/j.diagmicrobio.2008.03.018; Narayanappa D, 2010, INDIAN PEDIATR, V47, P331, DOI 10.1007/s13312-010-0062-x; Olsen SJ, 2004, J CLIN MICROBIOL, V42, P1885, DOI 10.1128/JCM.42.5.1885-1889.2004; Parry CM, 2011, EXPERT REV ANTI-INFE, V9, P711, DOI [10.1586/eri.11.47, 10.1586/ERI.11.47]; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Prakash P, 2007, J TROP PEDIATRICS, V53, P216, DOI 10.1093/tropej/fmm008; Program WGM, 2011, GOOD PRACT SEL PROC; Rahman M, 2007, DIAGN MICR INFEC DIS, V58, P275, DOI 10.1016/j.diagmicrobio.2007.01.010; RMRC, 2011, VERS 5 1; Siba V, 2012, CLIN VACCINE IMMUNOL, V19, P1833, DOI 10.1128/CVI.00380-12; Thriemer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051823; Thriemer K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030350; Wain J, 2001, J CLIN MICROBIOL, V39, P1571, DOI 10.1128/JCM.39.4.1571-1576.2001; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; WHO, 2012, INF NOR REC SEL CRIT; WHO, 2011, OV PREQ DIAGN ASS PR; Willke A, 2002, CLIN DIAGN LAB IMMUN, V9, P938, DOI 10.1128/CDLI.9.4.938-941.2002; Ziegler R, 1998, J CLIN MICROBIOL, V36, P657, DOI 10.1128/JCM.36.3.657-661.1998	43	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2013	8	12							e81263	10.1371/journal.pone.0081263	http://dx.doi.org/10.1371/journal.pone.0081263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276GD	24358109	Green Published, Green Submitted, gold			2022-12-27	WOS:000328735700005
J	Makunin, IV; Shloma, VV; Stephen, SJ; Pheasant, M; Belyakin, SN				Makunin, Igor V.; Shloma, Viktor V.; Stephen, Stuart J.; Pheasant, Michael; Belyakin, Stepan N.			Comparison of Ultra-Conserved Elements in Drosophilids and Vertebrates	PLOS ONE			English	Article							KEY DEVELOPMENTAL GENES; TRANSPOSON-FREE REGIONS; ULTRACONSERVED ELEMENTS; NONCODING ELEMENTS; MESSENGER-RNA; GENOME; ENHANCER; EVOLUTION; DATABASE; EXAPTATION	Metazoan genomes contain many ultra-conserved elements (UCEs), long sequences identical between distant species. In this study we identified UCEs in drosophilid and vertebrate species with a similar level of phylogenetic divergence measured at protein-coding regions, and demonstrated that both the length and number of UCEs are larger in vertebrates. The proportion of non-exonic UCEs declines in distant drosophilids whilst an opposite trend was observed in vertebrates. We generated a set of 2,126 Sophophora UCEs by merging elements identified in several drosophila species and compared these to the eutherian UCEs identified in placental mammals. In contrast to vertebrates, the Sophophora UCEs are depleted around transcription start sites. Analysis of 52,954 P-element, piggyBac and Minos insertions in the D. melanogaster genome revealed depletion of the P-element and piggyBac insertions in and around the Sophophora UCEs. We examined eleven fly strains with transposon insertions into the intergenic UCEs and identified associated phenotypes in five strains. Four insertions behave as recessive lethals, and in one case we observed a suppression of the marker gene within the transgene, presumably by silenced chromatin around the integration site. To confirm the lethality is caused by integration of transposons we performed a phenotype rescue experiment for two stocks and demonstrated that the excision of the transposons from the intergenic UCEs restores viability. Sequencing of DNA after the transposon excision in one fly strain with the restored viability revealed a 47 bp insertion at the original transposon integration site suggesting that the nature of the mutation is important for the appearance of the phenotype. Our results suggest that the UCEs in flies and vertebrates have both common and distinct features, and demonstrate that a significant proportion of intergenic drosophila UCEs are sensitive to disruption.	[Makunin, Igor V.; Pheasant, Michael] Univ Queensland, Ctr Res Comp, Brisbane, Qld, Australia; [Makunin, Igor V.; Shloma, Viktor V.; Belyakin, Stepan N.] Inst Mol & Cellular Biol SD RAS, Novosibirsk, Russia; [Stephen, Stuart J.] CSIRO Plant Ind, Computat Biol Grp, Canberra, ACT, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Makunin, IV (corresponding author), Univ Queensland, Ctr Res Comp, Brisbane, Qld, Australia.	makunin@hotmail.com	Pheasant, Michael/A-7564-2008; Shloma, Victor/N-7979-2015; Belyakin, Stepan/N-5921-2015	Pheasant, Michael/0000-0001-9781-7655; Belyakin, Stepan/0000-0002-2315-4382	Genomics Virtual Lab (GVL) project, the Australian Government project as part of the Super Science initiative; NeCTAR, the Australian Government project as part of the Super Science initiative; Education Investment Fund; Russian Foundation for Basic Research [11-04-01344, 12-04-01007, 12-04-00160, 12-04-01030, 12-04-00874-a]	Genomics Virtual Lab (GVL) project, the Australian Government project as part of the Super Science initiative; NeCTAR, the Australian Government project as part of the Super Science initiative; Education Investment Fund; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	IMV and MP were supported by the Genomics Virtual Lab (GVL) project and NeCTAR, the Australian Government projects conducted as part of the Super Science initiative and financed by the Education Investment Fund. The work in Novosibirsk was supported by grants from Russian Foundation for Basic Research #11-04-01344, 12-04-01007, 12-04-00160, 12-04-01030, 12-04-00874-a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Amaral PP, 2009, RNA, V15, P2013, DOI 10.1261/rna.1705309; Babenko VN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-318; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Belyakin SN, 2005, P NATL ACAD SCI USA, V102, P8269, DOI 10.1073/pnas.0502702102; Belyakin SN, 2010, CHROMOSOMA, V119, P589, DOI 10.1007/s00412-010-0280-y; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Calin GA, 2007, CANCER CELL, V12, P215, DOI 10.1016/j.ccr.2007.07.027; Catucci I, 2009, CARCINOGENESIS, V30, P544, DOI 10.1093/carcin/bgn289; Chiang CWK, 2012, GENETICS, V192, P253, DOI 10.1534/genetics.112.141945; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Derti A, 2006, NAT GENET, V38, P1216, DOI 10.1038/ng1888; Dong XJ, 2010, NUCLEIC ACIDS RES, V38, P1071, DOI 10.1093/nar/gkp1124; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Glazov EA, 2005, GENOME RES, V15, P800, DOI 10.1101/gr.3545105; Glazov Evgeny A, 2006, RNA Biol, V3, P36; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kim SY, 2007, PLOS GENET, V3, P1572, DOI 10.1371/journal.pgen.0030147; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Kumar S, 2011, BIOINFORMATICS, V27, P2023, DOI 10.1093/bioinformatics/btr315; Lareau LF, 2007, NATURE, V446, P926, DOI 10.1038/nature05676; Lettice LA, 2008, HUM MOL GENET, V17, P978, DOI 10.1093/hmg/ddm370; Lewejohann L, 2004, BEHAV BRAIN RES, V154, P273, DOI 10.1016/j.bbr.2004.02.015; Licastro D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-151; Liu X, 2007, NEURON, V56, P1090, DOI 10.1016/j.neuron.2007.10.036; Martinez F, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-54; McLean C, 2008, GENOME RES, V18, P1743, DOI 10.1101/gr.080184.108; McQuilton P, 2012, NUCLEIC ACIDS RES, V40, pD706, DOI 10.1093/nar/gkr1030; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Morales-Hojas R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049552; Ni JZ, 2007, GENE DEV, V21, P708, DOI 10.1101/gad.1525507; Nobrega MA, 2004, NATURE, V431, P988, DOI 10.1038/nature03022; Papatsenko D, 2006, GENOMICS, V88, P431, DOI 10.1016/j.ygeno.2006.03.012; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Poitras L, 2010, DEVELOPMENT, V137, P3089, DOI 10.1242/dev.051052; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Reneker J, 2012, P NATL ACAD SCI USA, V109, pE1183, DOI 10.1073/pnas.1121356109; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Ryu T, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-236; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Sanges R, 2013, NUCL ACIDS RES; Santangelo AM, 2007, PLOS GENET, V3, P1813, DOI 10.1371/journal.pgen.0030166; Scaruffi P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-149; SHIELDS DC, 1988, MOL BIOL EVOL, V5, P704; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simons C, 2006, GENOME RES, V16, P164, DOI 10.1101/gr4624306; Simons C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-470; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Stephen S, 2008, MOL BIOL EVOL, V25, P402, DOI 10.1093/molbev/msm268; Sun H, 2006, HUM MOL GENET, V15, P2911, DOI 10.1093/hmg/ddl232; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Vavouri T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r15; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; von Grotthuss M, 2010, GENOME RES, V20, P1084, DOI 10.1101/gr.103713.109; Wang JL, 2009, MOL BIOL EVOL, V26, P487, DOI 10.1093/molbev/msn278; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yang RX, 2008, CARCINOGENESIS, V29, P351, DOI 10.1093/carcin/bgm290; Zhimulev IF, 2003, GENETICA, V117, P259, DOI 10.1023/A:1022912716376	70	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e82362	10.1371/journal.pone.0082362	http://dx.doi.org/10.1371/journal.pone.0082362			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349264	Green Submitted, gold, Green Published			2022-12-27	WOS:000328734200038
J	Uguccioni, G; Pallanca, O; Golmard, JL; Dodet, P; Herlin, B; Leu-Semenescu, S; Arnulf, I				Uguccioni, Ginevra; Pallanca, Olivier; Golmard, Jean-Louis; Dodet, Pauline; Herlin, Bastien; Leu-Semenescu, Smaranda; Arnulf, Isabelle			Sleep-Related Declarative Memory Consolidation and Verbal Replay during Sleep Talking in Patients with REM Sleep Behavior Disorder	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; PRIMARY INSOMNIA; DEPENDENT CHANGES; DISEASE	Objective: To determine if sleep talkers with REM sleep behavior disorder (RBD) would utter during REM sleep sentences learned before sleep, and to evaluate their verbal memory consolidation during sleep. Methods: Eighteen patients with RBD and 10 controls performed two verbal memory tasks (16 words from the Free and Cued Selective Reminding Test and a 220-263 word long modified Story Recall Test) in the evening, followed by nocturnal video-polysomnography and morning recall (night-time consolidation). In 9 patients with RBD, daytime consolidation (morning learning/recall, evening recall) was also evaluated with the modified Story Recall Test in a cross-over order. Two RBD patients with dementia were studied separately. Sleep talking was recorded using video-polysomnography, and the utterances were compared to the studied texts by two external judges. Results: Sleep-related verbal memory consolidation was maintained in patients with RBD (+24 +/- 36% words) as in controls (+9 +/- 18%, p=0.3). The two demented patients with RBD also exhibited excellent nighttime consolidation. The post-sleep performance was unrelated to the sleep measures (including continuity, stages, fragmentation and apnea-hypopnea index). Daytime consolidation (-9 +/- 19%) was worse than night-time consolidation (+29 +/- 45%, p=0.03) in the subgroup of 9 patients with RBD. Eleven patients with RBD spoke during REM sleep and pronounced a median of 20 words, which represented 0.0003% of sleep with spoken language. A single patient uttered a sentence that was judged to be semantically (but not literally) related to the text learned before sleep. Conclusion: Verbal declarative memory normally consolidates during sleep in patients with RBD. The incorporation of learned material within REM sleep-associated sleep talking in one patient (unbeknownst to himself) at the semantic level suggests a replay at a highly cognitive creative level.	[Uguccioni, Ginevra; Pallanca, Olivier; Dodet, Pauline; Herlin, Bastien; Leu-Semenescu, Smaranda; Arnulf, Isabelle] Pitie Salpetriere Univ Hosp, AP HP, Sleep Disorder Unit, Paris, France; [Uguccioni, Ginevra; Pallanca, Olivier; Dodet, Pauline; Herlin, Bastien; Leu-Semenescu, Smaranda; Arnulf, Isabelle] Univ Paris 06, INSERM, U975, Ctr Rech,Inst Cerveau Moelle Epiniere, Paris, France; [Uguccioni, Ginevra; Pallanca, Olivier; Dodet, Pauline; Herlin, Bastien; Leu-Semenescu, Smaranda; Arnulf, Isabelle] CNRS, Unites Mixtes Rech 7225, INSERM, Unites Mixtes Rech 975, Paris, France; [Golmard, Jean-Louis] Univ Paris 06, Pitie Salpetriere Hosp, ER4, Dept Biostat, Paris, France; [Arnulf, Isabelle] INSERM, U975, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Arnulf, I (corresponding author), Pitie Salpetriere Univ Hosp, AP HP, Sleep Disorder Unit, Paris, France.	isabelle.arnulf@psl.aphp.fr		Arnulf, Isabelle/0000-0002-2240-2516	Fondation pour la Recherche Medicale; NRJ-Institut de France Prize	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NRJ-Institut de France Prize	The study was financed in part by a grant obtained from the Fondation pour la Recherche Medicale to PD and by an NRJ-Institut de France Prize to IA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Arnulf I, 2012, MOVEMENT DISORD, V27, P677, DOI 10.1002/mds.24957; Backhaus J, 2006, BIOL PSYCHIAT, V60, P1324, DOI 10.1016/j.biopsych.2006.03.051; Born J, 2012, PSYCHOL RES-PSYCH FO, V76, P192, DOI 10.1007/s00426-011-0335-6; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; Cipolli C, 2004, J SLEEP RES, V13, P317, DOI 10.1111/j.1365-2869.2004.00420.x; Cipolli C, 2013, SLEEP MED REV, V17, P91, DOI 10.1016/j.smrv.2012.01.004; Cipolli C, 2009, J SLEEP RES, V18, P209, DOI 10.1111/j.1365-2869.2008.00712.x; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Djonlagic I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034106; Fogel SM, 2007, BEHAV BRAIN RES, V180, P48, DOI 10.1016/j.bbr.2007.02.037; Gagnon JF, 2009, ANN NEUROL, V66, P39, DOI 10.1002/ana.21680; Gais S, 2004, LEARN MEMORY, V11, P679, DOI 10.1101/lm.80504; Gais S, 2006, LEARN MEMORY, V13, P259, DOI 10.1101/lm.132106; GROBER E, 1988, NEUROLOGY, V38, P900, DOI 10.1212/WNL.38.6.900; Hu P, 2006, PSYCHOL SCI, V17, P891, DOI 10.1111/j.1467-9280.2006.01799.x; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Iber C., 2007, AASM MANUAL SCORING; Iranzo A, 2010, SLEEP MED, V11, P534, DOI 10.1016/j.sleep.2010.03.006; Kloepfer C, 2009, J CLIN SLEEP MED, V5, P540; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Montplaisir J, 2010, MOVEMENT DISORD, V25, P2044, DOI 10.1002/mds.23257; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nissen C, 2006, SLEEP, V29, P1068, DOI 10.1093/sleep/29.8.1068; Nissen C, 2011, J SLEEP RES, V20, P129, DOI 10.1111/j.1365-2869.2010.00872.x; Orban P, 2006, P NATL ACAD SCI USA, V103, P7124, DOI 10.1073/pnas.0510198103; Oudiette D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018056; Rauchs G, 2008, NEUROREPORT, V19, P1159, DOI 10.1097/WNR.0b013e32830867c4; Rechstchaffen A., 1968, MANUAL STANDARDIZED; Schmidt C, 2006, J NEUROSCI, V26, P8976, DOI 10.1523/JNEUROSCI.2464-06.2006; Sixel-Doring F, 2011, NEUROLOGY, V77, P1048, DOI 10.1212/WNL.0b013e31822e560e; Sterpenich V, 2007, PLOS BIOL, V5, P2709, DOI 10.1371/journal.pbio.0050282; Stickgold R, 2000, SCIENCE, V290, P350, DOI 10.1126/science.290.5490.350; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Stickgold R, 2001, SCIENCE, V294, P1052, DOI 10.1126/science.1063530; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Wamsley EJ, 2010, CURR BIOL, V20, P850, DOI 10.1016/j.cub.2010.03.027; Wamsley EJ, 2010, SLEEP, V33, P59, DOI 10.1093/sleep/33.1.59; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	42	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e83352	10.1371/journal.pone.0083352	http://dx.doi.org/10.1371/journal.pone.0083352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276FP	24349492	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200079
J	Zampieri, TT; Pedroso, JAB; Furigo, IC; Tirapegui, J; Donato, J				Zampieri, Thais T.; Pedroso, Joao A. B.; Furigo, Isadora C.; Tirapegui, Julio; Donato, Jose, Jr.			Oral Leucine Supplementation Is Sensed by the Brain but neither Reduces Food Intake nor Induces an Anorectic Pattern of Gene Expression in the Hypothalamus	PLOS ONE			English	Article							DIET-INDUCED OBESITY; HIGH-FAT DIET; MESSENGER-RNA TRANSLATION; MUSCLE PROTEIN-SYNTHESIS; AMINO-ACID CATABOLISM; GLUCOSE-HOMEOSTASIS; SKELETAL-MUSCLE; AREA POSTREMA; POSTABSORPTIVE RATS; IMPROVES GLUCOSE	Leucine activates the intracellular mammalian target of the rapamycin (mTOR) pathway, and hypothalamic mTOR signaling regulates food intake. Although central infusion of leucine reduces food intake, it is still uncertain whether oral leucine supplementation is able to affect the hypothalamic circuits that control energy balance. We observed increased phosphorylation of p70s6k in the mouse hypothalamus after an acute oral gavage of leucine. We then assessed whether acute oral gavage of leucine induces the activation of neurons in several hypothalamic nuclei and in the brainstem. Leucine did not induce the expression of Fos in hypothalamic nuclei, but it increased the number of Fos-immunoreactive neurons in the area postrema. In addition, oral gavage of leucine acutely increased the 24 h food intake of mice. Nonetheless, chronic leucine supplementation in the drinking water did not change the food intake and the weight gain of ob/ob mice and of wild-type mice consuming a low- or a high-fat diet. We assessed the hypothalamic gene expression and observed that leucine supplementation increased the expression of enzymes (BCAT1, BCAT2 and BCKDK) that metabolize branched-chain amino acids. Despite these effects, leucine supplementation did not induce an anorectic pattern of gene expression in the hypothalamus. In conclusion, our data show that the brain is able to sense oral leucine intake. However, the food intake is not modified by chronic oral leucine supplementation. These results question the possible efficacy of leucine supplementation as an appetite suppressant to treat obesity.	[Zampieri, Thais T.; Pedroso, Joao A. B.; Furigo, Isadora C.; Donato, Jose, Jr.] Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci, Sao Paulo, Brazil; [Tirapegui, Julio] Univ Sao Paulo, Dept Food Sci & Expt Nutr, Fac Pharmaceut Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Donato, J (corresponding author), Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci, Sao Paulo, Brazil.	jdonato@icb.usp.br	Donato, Jose/A-9662-2010; Tirapegui, Julio/I-4363-2012; Donato, Jose/ABB-3686-2020; Furigo, Isadora/G-3575-2016	Donato, Jose/0000-0002-4166-7608; Furigo, Isadora/0000-0002-4387-3878; pedroso, Joao/0000-0001-8378-5242	Sao Paulo Research Foundation (FAPESP-Brazil) [2010/18086-0, 2012/15517-6]; International Brain Research Organization (IBRO)	Sao Paulo Research Foundation (FAPESP-Brazil)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); International Brain Research Organization (IBRO)	This study was financed by Sao Paulo Research Foundation (FAPESP-Brazil, 2010/18086-0 and 2012/15517-6) and the International Brain Research Organization (IBRO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony JC, 2000, J NUTR, V130, P2413; Anthony JC, 2000, J NUTR, V130, P139, DOI 10.1093/jn/130.2.139; Anthony JC, 2001, J NUTR, V131, p856S, DOI 10.1093/jn/131.3.856S; Anthony TG, 2001, J NUTR, V131, P1171, DOI 10.1093/jn/131.4.1171; BERNSTEIN IL, 1992, BRAIN RES, V575, P132, DOI 10.1016/0006-8993(92)90432-9; Binder E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074705; Blouet C, 2012, CELL METAB, V16, P579, DOI 10.1016/j.cmet.2012.10.003; Blouet C, 2009, J NEUROSCI, V29, P8302, DOI 10.1523/JNEUROSCI.1668-09.2009; Chen H, 2012, J NEUROENDOCRINOL, V24, P1356, DOI 10.1111/j.1365-2826.2012.02339.x; COIL JD, 1981, BRAIN RES, V212, P425, DOI 10.1016/0006-8993(81)90474-1; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Dardevet D, 2002, J NUTR, V132, P95, DOI 10.1093/jn/132.1.95; Donato J, 2006, NUTRITION, V22, P520, DOI 10.1016/j.nut.2005.12.008; Donato J, 2007, LIFE SCI, V81, P31, DOI 10.1016/j.lfs.2007.04.015; Donato J, 2010, PHYSIOL BEHAV, V99, P67, DOI 10.1016/j.physbeh.2009.10.012; Drgonova J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068245; Freudenberg A, 2013, AMINO ACIDS, V44, P519, DOI 10.1007/s00726-012-1363-2; Freudenberg A, 2012, J NUTR BIOCHEM, V23, P1524, DOI 10.1016/j.jnutbio.2011.10.005; Garcia-Espinosa MA, 2007, J NEUROCHEM, V100, P1458, DOI 10.1111/j.1471-4159.2006.04332.x; Garlick PJ, 2005, J NUTR, V135, p1553S, DOI 10.1093/jn/135.6.1553S; Guo KY, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-57; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Harris RA, 2004, BIOCHEM BIOPH RES CO, V313, P391, DOI 10.1016/j.bbrc.2003.11.007; Hoffman GE, 2002, J NEUROENDOCRINOL, V14, P259, DOI 10.1046/j.1365-2826.2002.00775.x; Imamura W, 2013, J NUTR SCI VITAMINOL, V59, P45, DOI 10.3177/jnsv.59.45; Karnani MM, 2011, NEURON, V72, P616, DOI 10.1016/j.neuron.2011.08.027; Koch C, 2012, J COMP PHYSIOL B, P1; Lam TKT, 2005, NAT MED, V11, P320, DOI 10.1038/nm1201; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Layman DK, 2006, J NUTR, V136, p319S, DOI 10.1093/jn/136.1.319S; Levin BE, 1999, AM J PHYSIOL-REG I, V276, pR1223; Li HL, 2012, AM J PHYSIOL-ENDOC M, V303, pE1234, DOI 10.1152/ajpendo.00198.2012; Li X, 2013, MOL NUTR FOOD RES, V57, P1067, DOI 10.1002/mnfr.201200311; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez N, 2010, PEPTIDES, V31, P1361, DOI 10.1016/j.peptides.2010.03.028; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Lynch CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE503, DOI 10.1152/ajpendo.00084.2002; Lynch CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE824, DOI 10.1152/ajpendo.00085.2002; Macotela Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021187; Magne H, 2012, J PHYSIOL-LONDON, V590, P2035, DOI 10.1113/jphysiol.2011.226266; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Myers MG, 2012, NATURE, V491, P357, DOI 10.1038/nature11705; Nairizi A, 2009, J NUTR, V139, P715, DOI 10.3945/jn.108.100081; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PAXTON R, 1984, ARCH BIOCHEM BIOPHYS, V231, P48, DOI 10.1016/0003-9861(84)90361-8; Pedrosa RG, 2010, APPL PHYSIOL NUTR ME, V35, P180, DOI 10.1139/H09-132; Reiter AK, 2004, INT J BIOCHEM CELL B, V36, P2169, DOI 10.1016/j.biocel.2004.04.004; Teodoro GFR, 2012, J NUTR, V142, P924, DOI 10.3945/jn.111.146266; Rieu I, 2003, J NUTR, V133, P1198, DOI 10.1093/jn/133.4.1198; RITTER S, 1980, BRAIN RES, V201, P501, DOI 10.1016/0006-8993(80)91061-6; Ropelle ER, 2008, DIABETES, V57, P594, DOI 10.2337/db07-0573; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; Sugawara T, 2007, J NUTR SCI VITAMINOL, V53, P552, DOI 10.3177/jnsv.53.552; Sweatt AJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE64, DOI 10.1152/ajpendo.00276.2003; Torres-Leal FL, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-62; Verhoeven S, 2009, AM J CLIN NUTR, V89, P1468, DOI 10.3945/ajcn.2008.26668; Vianna D, 2012, NUTRITION, V28, P182, DOI 10.1016/j.nut.2011.04.004; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Yue JTY, 2012, CELL METAB, V15, P646, DOI 10.1016/j.cmet.2012.01.013; Zeanandin G, 2012, AGE, V34, P371, DOI 10.1007/s11357-011-9246-0; Zemel MB, 2012, NUTRIENTS, V4, P529, DOI 10.3390/nu4060529; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	65	19	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e84094	10.1371/journal.pone.0084094	http://dx.doi.org/10.1371/journal.pone.0084094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349566	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200107
J	Elbroch, LM; Lendrum, PE; Newby, J; Quigley, H; Craighead, D				Elbroch, L. Mark; Lendrum, Patrick E.; Newby, Jesse; Quigley, Howard; Craighead, Derek			Seasonal Foraging Ecology of Non-Migratory Cougars in a System with Migrating Prey	PLOS ONE			English	Article							MULE DEER; RESOURCE SELECTION; HABITAT SELECTION; NORTH-AMERICAN; PREDATION; PATTERNS; WOLVES; ELK; HETEROGENEITY; TELEMETRY	We tested for seasonal differences in cougar (Puma concolor) foraging behaviors in the Southern Yellowstone Ecosystem, a multi-prey system in which ungulate prey migrate, and cougars do not. We recorded 411 winter prey and 239 summer prey killed by 28 female and 10 male cougars, and an additional 37 prey items by unmarked cougars. Deer composed 42.4% of summer cougar diets but only 7.2% of winter diets. Males and females, however, selected different proportions of different prey; male cougars selected more elk (Cervus elaphus) and moose (Alces alces) than females, while females killed greater proportions of bighorn sheep (Ovis canadensis), pronghorn (Antilocapra americana), mule deer (Odocoileus hemionus) and small prey than males. Kill rates did not vary by season or between males and females. In winter, cougars were more likely to kill prey on the landscape as: 1) elevation decreased, 2) distance to edge habitat decreased, 3) distance to large bodies of water decreased, and 4) steepness increased, whereas in summer, cougars were more likely to kill in areas as: 1) elevation decreased, 2) distance to edge habitat decreased, and 3) distance from large bodies of water increased. Our work highlighted that seasonal prey selection exhibited by stationary carnivores in systems with migratory prey is not only driven by changing prey vulnerability, but also by changing prey abundances. Elk and deer migrations may also be sustaining stationary cougar populations and creating apparent competition scenarios that result in higher predation rates on migratory bighorn sheep in winter and pronghorn in summer. Nevertheless, cougar predation on rare ungulates also appeared to be influenced by individual prey selection.	[Elbroch, L. Mark; Lendrum, Patrick E.; Quigley, Howard] Panthera, New York, NY 10018 USA; [Newby, Jesse; Craighead, Derek] Craighead Beringia South, Kelly, WY USA		Elbroch, LM (corresponding author), Panthera, New York, NY 10018 USA.	melbroch@panthera.org			Summerlee Foundation; Richard King Mellon Foundation; Charles Engelhard Foundation; Laura Moore Cunningham Foundation; Tim and Karen Hixon Foundation; National Geographic Society; Norcross Wildlife Foundation, Inc.; Earth Friends Conservation Fund; Cougar Fund; Bay Foundation; Michael Cline Foundation; Eugene V. & Clare E. Thaw Charitable Trust; Connemara Fund; Hogan Films; Community Foundation of Jackson Hole; Oregon Zoo Foundation; Global Felid Genetics Program of the Sackler Institute for Comparative Genomics at the American Museum of Natural History	Summerlee Foundation; Richard King Mellon Foundation; Charles Engelhard Foundation; Laura Moore Cunningham Foundation; Tim and Karen Hixon Foundation; National Geographic Society(National Geographic Society); Norcross Wildlife Foundation, Inc.; Earth Friends Conservation Fund; Cougar Fund; Bay Foundation; Michael Cline Foundation; Eugene V. & Clare E. Thaw Charitable Trust; Connemara Fund; Hogan Films; Community Foundation of Jackson Hole; Oregon Zoo Foundation; Global Felid Genetics Program of the Sackler Institute for Comparative Genomics at the American Museum of Natural History	Funding was provided by the Summerlee Foundation, The Richard King Mellon Foundation, The Charles Engelhard Foundation, The Laura Moore Cunningham Foundation, Tim and Karen Hixon Foundation, National Geographic Society, The Norcross Wildlife Foundation, Inc., Earth Friends Conservation Fund, The Cougar Fund, The Bay Foundation, Michael Cline Foundation, Eugene V. & Clare E. Thaw Charitable Trust, Connemara Fund, Hogan Films, Community Foundation of Jackson Hole, The Oregon Zoo Foundation, the Global Felid Genetics Program of the Sackler Institute for Comparative Genomics at the American Museum of Natural History, Mr. and Mrs. G. Ordway, Mr. and Mrs. M. Manship, Mr. and Mrs. N. Jannotta, Mr. L. Westbrook, Mr. and Mrs. S. Robertson, and several anonymous donors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CR, 2003, J WILDLIFE MANAGE, V67, P307, DOI 10.2307/3802772; Atwood TC, 2007, J WILDLIFE MANAGE, V71, P1098, DOI 10.2193/2006-102; Ballard WB, 1997, WILDLIFE MONOGR, P5; Ballard WB, 2001, WILDLIFE SOC B, V29, P99; Bartnick TD, 2013, CAN J ZOOL, V91, P82, DOI 10.1139/cjz-2012-0147; Beyer H. L., 2009, GEOSPATIAL MODELING; Boyce MS, 2003, ECOSCIENCE, V10, P421, DOI 10.1080/11956860.2003.11682790; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; Bump JK, 2009, ECOLOGY, V90, P3159, DOI 10.1890/09-0292.1; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Compton BW, 2002, ECOLOGY, V83, P833, DOI 10.1890/0012-9658(2002)083[0833:HSBWTC]2.0.CO;2; Cooley HS, 2008, J WILDLIFE MANAGE, V72, P99, DOI 10.2193/2007-060; Eberhardt LL, 2007, J WILDLIFE MANAGE, V71, P594, DOI 10.2193/2005-770; Elbroch LM, 2013, J MAMMAL, V94, P259, DOI 10.1644/12-MAMM-A-041.1; Elbroch LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053595; Festa-Bianchet M, 2006, P ROY SOC B-BIOL SCI, V273, P1537, DOI 10.1098/rspb.2006.3467; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; Giroux MA, 2012, J ANIM ECOL, V81, P533, DOI 10.1111/j.1365-2656.2011.01944.x; Heffelfinger J.D., 2010, 19 AR GAM FISH DEP; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Husseman JS, 2003, OIKOS, V101, P591, DOI 10.1034/j.1600-0706.2003.12230.x; Johnson HE, 2013, OECOLOGIA, V171, P295, DOI 10.1007/s00442-012-2397-6; Kauffman MJ, 2007, ECOL LETT, V10, P690, DOI 10.1111/j.1461-0248.2007.01059.x; Kie JG, 2010, PHILOS T R SOC B, V365, P2221, DOI 10.1098/rstb.2010.0093; KNIGHT D.H., 1996, MOUNTAINS PLAINS ECO; Knopff KH, 2010, J WILDLIFE MANAGE, V74, P1435, DOI 10.2193/2009-314; Knopff KH, 2009, J WILDLIFE MANAGE, V73, P586, DOI 10.2193/2008-294; Kunkel KE, 2013, ANIM CONSERV, V16, P32, DOI 10.1111/j.1469-1795.2012.00568.x; Lendrum PE, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00165.1; Loader CR, 1999, ANN STAT, V27, P415, DOI 10.1214/aos/1018031201; Logan KA., 2010, COUGAR ECOLOGY CONSE, P105; Long RA, 2009, WILDLIFE BIOL, V15, P288, DOI 10.2981/09-003; Manly B., 1993, RESOURCE SELECTION A; Metz MC, 2012, J ANIM ECOL, V81, P553, DOI 10.1111/j.1365-2656.2011.01945.x; Miller CS, 2013, J MAMM IN PRESS; Nelson AA, 2012, ECOL APPL, V22, P2293, DOI 10.1890/11-1829.1; Owen-Smith N, 2008, OIKOS, V117, P602, DOI 10.1111/j.0030-1299.2008.16309.x; Pierce BM, 1999, J MAMMAL, V80, P986, DOI 10.2307/1383269; Quigley K., 2000, IMMOBILIZATION BIOL; Ruth Toni K., 2010, P138; Ruth TK, 2010, J WILDLIFE MANAGE, V74, P1122, DOI 10.2193/2009-058; Sand H, 2008, OECOLOGIA, V156, P53, DOI 10.1007/s00442-008-0969-2; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; SAS Institute Inc, 1990, SAS STAT US GUID 6 0; Sawyer H, 2005, WILDLIFE SOC B, V33, P1266, DOI 10.2193/0091-7648(2005)33[1266:MDAPMI]2.0.CO;2; Schaller G. B., 1972, SERENGETI LION STUDY; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Smith BL, 2007, NORTHWEST SCI, V81, P251, DOI 10.3955/0029-344X-81.4.251; Stewart KM, 2010, AM MIDL NAT, V163, P400, DOI 10.1674/0003-0031-163.2.400; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	50	43	44	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83375	10.1371/journal.pone.0083375	http://dx.doi.org/10.1371/journal.pone.0083375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349498	gold, Green Submitted, Green Published			2022-12-27	WOS:000328731800115
J	Jiang, ZY; Liang, MG; Wu, JJ				Jiang, Zhong-Yuan; Liang, Man-Gui; Wu, Jia-Jing			Dynamic Source Routing Strategy for Two-Level Flows on Scale-Free Networks	PLOS ONE			English	Article							BANDWIDTH ALLOCATION; SMALL-WORLD	Packets transmitting in real communication networks such as the Internet can be classified as time-sensitive or time-insensitive. To better support the real-time and time-insensitive applications, we propose a two-level flow traffic model in which packets are labeled as level-1 or level-2, and those with level-1 have higher priority to be transmitted. In order to enhance the traffic capacity of the two-level flow traffic model, we expand the global dynamic routing strategy and propose a new dynamic source routing which supports no routing-flaps, high traffic capacity, and diverse traffic flows. As shown in this paper, the proposed dynamic source routing can significantly enhance the traffic capacity and quality of time-sensitive applications compared with the global shortest path routing strategy.	[Jiang, Zhong-Yuan; Liang, Man-Gui] Beijing Jiaotong Univ, Inst Informat Sci, Beijing, Peoples R China; [Jiang, Zhong-Yuan; Liang, Man-Gui] Beijing Key Lab Adv Informat Sci & Network Techno, Beijing, Peoples R China; [Wu, Jia-Jing] Hong Kong Polytech Univ, Dept Elect & Informat Engn, Kowloon, Hong Kong, Peoples R China	Beijing Jiaotong University; Beijing Jiaotong University; Hong Kong Polytechnic University	Liang, MG (corresponding author), Beijing Jiaotong Univ, Inst Informat Sci, Beijing, Peoples R China.	mgliang58@gmail.com	Jiang, Zhongyuan/B-3847-2012	Jiang, Zhongyuan/0000-0001-8249-9711	Ministry of Science and Technology of China [2007AA01Z203]	Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work is supported by the Ministry of Science and Technology of China under Grant No. 2007AA01Z203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic LA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046135; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Arenas A, 2001, PHYS REV LETT, V86, P3196, DOI 10.1103/PhysRevLett.86.3196; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Danila B, 2007, CHAOS, V17, DOI 10.1063/1.2731718; Danila B, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.046106; Echenique P, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056105; Fekete Attila, 2006, ComPlexUs, V3, P97, DOI 10.1159/000094192; Guimera R, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026704; Guimera R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248701; Herrero CP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016103; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066109; Hu K, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/17/175101; Huang W, 2010, CHAOS, V20, DOI 10.1063/1.3490745; Huang W, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/01/P01016; Jiang ZY, 2013, PHYSICA A, V392, P1256, DOI 10.1016/j.physa.2012.11.045; Jiang ZY, 2013, PHYSICA A, V392, P1894, DOI 10.1016/j.physa.2012.12.026; Jiang ZY, 2012, INT J MOD PHYS C, V23, DOI 10.1142/S0129183112500659; Jiang ZY, 2011, INT J MOD PHYS C, V22, P1211, DOI 10.1142/S0129183111016841; Kim BJ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.027103; Kleinberg JM, 2000, NATURE, V406, P845, DOI 10.1038/35022643; Lawniczak AT, 2006, EUR PHYS J B, V50, P231, DOI 10.1140/epjb/e2006-00141-x; Ling X, 2008, PHYSICA A, V387, P4709, DOI 10.1016/j.physa.2008.03.022; Ling XA, 2010, PHYS LETT A, V374, P4825, DOI 10.1016/j.physleta.2010.10.029; Ling X, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016113; Liu Z, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.037101; Liu ZH, 2006, PHYSICA A, V370, P843, DOI 10.1016/j.physa.2006.02.021; Tadic B, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036102; Toroczkai Z, 2004, NATURE, V428, P716, DOI 10.1038/428716a; Wang WX, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016101; Wang WX, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026111; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xian-Bin C., 2011, CHINESE PHYS LETT, V28; Yan G, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046108; Yang SJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016107; Yin CY, 2006, PHYS LETT A, V351, P220, DOI 10.1016/j.physleta.2005.10.104; Zhang GQ, 2011, PHYSICA A, V390, P387, DOI 10.1016/j.physa.2010.09.022; Zhang GQ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.017101; Zhao L, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.026125; Zhao L, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.035101	40	10	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82162	10.1371/journal.pone.0082162	http://dx.doi.org/10.1371/journal.pone.0082162			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349207	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800042
J	Nozawa, Y; Umemura, T; Joshita, S; Katsuyama, Y; Shibata, S; Kimura, T; Morita, S; Komatsu, M; Matsumoto, A; Tanaka, E; Ota, M				Nozawa, Yuichi; Umemura, Takeji; Joshita, Satoru; Katsuyama, Yoshihiko; Shibata, Soichiro; Kimura, Takefumi; Morita, Susumu; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji; Ota, Masao			KIR, HLA, and IL28B Variant Predict Response to Antiviral Therapy in Genotype 1 Chronic Hepatitis C Patients in Japan	PLOS ONE			English	Article							INHIBITORY RECEPTOR GENES; KILLER-CELL RECEPTOR; HEPATOCELLULAR-CARCINOMA; PEGYLATED INTERFERON; RIBAVIRIN THERAPY; POLYMORPHISMS; ASSOCIATION; CLEARANCE; ALLELES; TRANSPLANTATION	Natural killer cell responses play a crucial role in virus clearance by the innate immune system. Although the killer immunoglobulin-like receptor (KIR) in combination with its cognate human leukocyte antigen (HLA) ligand, especially KIR2DL3-HLA-C1, is associated with both treatment-induced and spontaneous clearance of hepatitis C virus (HCV) infection in Caucasians, these innate immunity genes have not been fully clarified in Japanese patients. We therefore investigated 16 KIR genotypes along with HLA-B and -C ligands and a genetic variant of interleukin (IL) 28B (rs8099917) in 115 chronic hepatitis C genotype 1 patients who underwent pegylated-interferon-alpha 2b (PEG-IFN) and ribavirin therapy. HLA-Bw4 was significantly associated with a sustained virological response (SVR) to treatment (P = 0.017; odds ratio [OR] = 2.50,), as was the centromeric A/A haplotype of KIR (P = 0.015; OR 3.37). In contrast, SVR rates were significantly decreased in patients with KIR2DL2 or KIR2DS2 (P = 0.015; OR = 0.30, and P = 0.025; OR = 0.32, respectively). Multivariate logistic regression analysis subsequently identified the IL28B TT genotype (P = 0.00009; OR = 6.87, 95% confidence interval [CI] = 2.62 - 18.01), KIR2DL2/HLA-C1 (P = 0.014; OR = 0.24, 95% CI = 0.08 - 0.75), KIR3DL1/HLA-Bw4 (P = 0.008, OR = 3.32, 95% CI = 1.37 - 8.05), and white blood cell count at baseline (P = 0.009; OR = 3.32, 95% CI = 1.35 - 8.16) as independent predictive factors of an SVR. We observed a significant association between the combination of IL28B TT genotype and KIR3DL1-HLA-Bw4 in responders (P = 0.0019), whereas IL28B TT along with KIR2DL2-HLA-C1 was related to a non-response (P = 0.0067). In conclusion, combinations of KIR3DL1/HLA-Bw4, KIR2DL2/HLA-C1, and a genetic variant of the IL28B gene are predictive of the response to PEG-IFN and ribavirin therapy in Japanese patients infected with genotype 1b HCV.	[Nozawa, Yuichi; Umemura, Takeji; Joshita, Satoru; Shibata, Soichiro; Kimura, Takefumi; Morita, Susumu; Komatsu, Michiharu; Matsumoto, Akihiro; Tanaka, Eiji] Shinshu Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Matsumoto, Nagano 390, Japan; [Katsuyama, Yoshihiko] Shinshu Univ Hosp, Dept Pharm, Matsumoto, Nagano, Japan; [Ota, Masao] Shinshu Univ, Sch Med, Dept Legal Med, Matsumoto, Nagano 390, Japan	Shinshu University; Shinshu University; Shinshu University	Umemura, T (corresponding author), Shinshu Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Matsumoto, Nagano 390, Japan.	tumemura@shinshu-u.ac.jp; otamasao@shinshu-u.ac.jp	Joshita, Satoru/K-5679-2019	Joshita, Satoru/0000-0002-6364-9654; Ota, Masao/0000-0002-6400-5658	Ministry of Health, Labor, and Welfare of Japan; MSD	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); MSD	This work was supported by a grant from the Ministry of Health, Labor, and Welfare of Japan. Takeji Umemura and Eiji Tanaka report receiving grant support from MSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel G, 2008, J CLIN INVEST, V118, P1017, DOI 10.1172/JCI32400; Akuta N, 2010, HEPATOLOGY, V52, P421, DOI 10.1002/hep.23690; al Basatena NKS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002270; Barber LD, 1996, J EXP MED, V184, P735, DOI 10.1084/jem.184.2.735; Bibert S, 2013, J EXP MED, V210, P1109, DOI 10.1084/jem.20130012; Carneiro VL, 2010, LIVER INT, V30, P567, DOI 10.1111/j.1478-3231.2010.02212.x; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Chu TW, 2012, GASTROENTEROLOGY, V142, P790, DOI 10.1053/j.gastro.2011.12.057; Cooley S, 2010, BLOOD, V116, P2411, DOI 10.1182/blood-2010-05-283051; Cooley S, 2009, BLOOD, V113, P726, DOI 10.1182/blood-2008-07-171926; Dring MM, 2011, P NATL ACAD SCI USA, V108, P5736, DOI 10.1073/pnas.1016358108; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Knapp S, 2011, GASTROENTEROLOGY, V141, P320, DOI 10.1053/j.gastro.2011.04.005; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lopez-Vazquez A, 2005, J INFECT DIS, V192, P162, DOI 10.1086/430351; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; Marangon AV, 2011, HUM IMMUNOL, V72, P1074, DOI 10.1016/j.humimm.2011.08.017; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; NOZAWA Y, 2013, TISSUE ANTI IN PRESS; Paladino N, 2007, TISSUE ANTIGENS, V69, P109, DOI 10.1111/j.1399-0039.2006.762_7.x; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Romero V, 2008, MOL IMMUNOL, V45, P2429, DOI 10.1016/j.molimm.2008.01.002; Suppiah V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001092; Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Umemura T, 2006, HEPATOLOGY, V43, P91, DOI 10.1002/hep.20917; Umemura T, 2009, J GASTROENTEROL, V44, P102, DOI 10.1007/s00535-008-2251-0; Umemura T, 2007, HEPATOLOGY, V46, P463, DOI 10.1002/hep.21700; Umemura T, 2012, HEPATOLOGY, V55, P506, DOI 10.1002/hep.24705; Umemura T, 2011, ANTIVIR THER, V16, P1073, DOI 10.3851/IMP1869; Vidal-Castineira JR, 2010, J VIROL, V84, P475, DOI 10.1128/JVI.01285-09; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Yawata M, 2002, CRIT REV IMMUNOL, V22, P463; Yoneda S, 2011, J INFECT DIS, V203, P1087, DOI 10.1093/infdis/jiq165	41	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83381	10.1371/journal.pone.0083381	http://dx.doi.org/10.1371/journal.pone.0083381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349500	gold, Green Published, Green Submitted			2022-12-27	WOS:000328731800117
J	Singh, NB; Konig, N; Arampatzis, A; Taylor, WR				Singh, Navrag B.; Koenig, Niklas; Arampatzis, Adamantios; Taylor, William R.			Age-Related Modifications to the Magnitude and Periodicity of Neuromuscular Noise	PLOS ONE			English	Article							MOTOR-UNIT SYNCHRONIZATION; SIGNAL-DEPENDENT NOISE; FORCE FLUCTUATIONS; MUSCLE-ACTIVITY; YOUNG-ADULTS; OLDER-ADULTS; CONTRACTIONS; FATIGUE; PERFORMANCE; VARIABILITY	Background: Evaluation of task related outcomes within geriatric and fall-prone populations is essential not only for identification of neuromuscular deficits, but also for effective implementation of fall prevention strategies. As most tasks and activities of daily living are performed at submaximal force levels, restoration of muscle strength often does not produce the expected benefit in functional capacity. However, it is known that muscular control plays a key role in the performance of functional tasks, but it remains unclear to what degree muscular control and the associated neuromuscular noise (NmN) is age-related, particularly in the lower-extremities. Objectives: The aim of this study was to determine the effects of age and fall-pathology on the magnitude as well as the frequency of NmN during lower extremity force production. Methods: Sixteen young healthy adults, as well as seventy elderly women (36 healthy, 34 elderly fallers), performed force production tests at moderate levels (15% of maximum voluntary isometric contractions). Results: Elderly fallers exhibited the highest magnitude of NmN, while the highest frequency components of NmN tended to occur in the healthy elderly. Young subjects exhibited significantly more power in the low frequency ranges than either of the elderly groups, and had the lowest levels of NmN. Conclusion: These data suggest increased degeneration of muscular control through greater NmN in elderly fallers compared to healthy elderly or young subjects. This could possibly be associated with muscle atrophy and lower levels of motor unit synchronisation.	[Singh, Navrag B.; Koenig, Niklas; Taylor, William R.] ETH, Inst Biomech, Dept Hlth Sci & Technol, Zurich, Switzerland; [Arampatzis, Adamantios] Humboldt Univ, Dept Training & Movement Sci, D-10099 Berlin, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Humboldt University of Berlin	Taylor, WR (corresponding author), ETH, Inst Biomech, Dept Hlth Sci & Technol, Zurich, Switzerland.	taylorb@ethz.ch	Singh, Navrag/F-5305-2012; Ignasiak, Niklas/F-8617-2014; Taylor, William R./F-8692-2010	Singh, Navrag/0000-0001-8074-041X; Ignasiak, Niklas/0000-0001-9065-3344; Taylor, William R./0000-0003-4060-4098; Arampatzis, Adamantios/0000-0002-4985-0335	EU framework 7 VPHOP project [FP7-223864]	EU framework 7 VPHOP project	This research was supported by the EU framework 7 VPHOP project FP7-223864. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2010, SCAND J MED SCI SPOR, V20, P49, DOI 10.1111/j.1600-0838.2009.01084.x; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; Bigland-Ritchie B, 1986, J ELECTROMYOGR KINES, V556, P137; BIGLANDRITCHIE BR, 1986, J PHYSIOL-LONDON, V379, P451, DOI 10.1113/jphysiol.1986.sp016263; Chandler JM, 1998, ARCH PHYS MED REHAB, V79, P24, DOI 10.1016/S0003-9993(98)90202-7; Christou EA, 2001, J GERONTOL A-BIOL, V56, pB524, DOI 10.1093/gerona/56.12.B524; Contessa P, 2009, J APPL PHYSIOL, V107, P235, DOI 10.1152/japplphysiol.00035.2009; Damiano AM, 1999, QUAL LIFE RES, V8, P235, DOI 10.1023/A:1008823222574; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; Enoka RM, 2001, MUSCLE NERVE, V24, P4, DOI 10.1002/1097-4598(200101)24:1<4::AID-MUS13>3.0.CO;2-F; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; FREUND HJ, 1983, PHYSIOL REV, V63, P387, DOI 10.1152/physrev.1983.63.2.387; FUGLEVAND AJ, 1993, J NEUROPHYSIOL, V70, P2470, DOI 10.1152/jn.1993.70.6.2470; Grabiner M D, 1995, Exerc Sport Sci Rev, V23, P65; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; Hunter SK, 2003, J APPL PHYSIOL, V94, P2439, DOI 10.1152/japplphysiol.01038.2002; Kouzaki M, 2004, J APPL PHYSIOL, V97, P2121, DOI 10.1152/japplphysiol.00418.2004; Latash M., 2008, NEUROPHYSIOLOGICAL B, V2nd; Liang N, 2008, HUM MOVEMENT SCI, V27, P12, DOI 10.1016/j.humov.2007.05.007; Missenard O, 2008, NEUROSCI LETT, V437, P154, DOI 10.1016/j.neulet.2008.03.090; Mochizuki G, 2005, J NEUROPHYSIOL, V94, P62, DOI 10.1152/jn.01322.2004; OLOUGHLIN JL, 1993, AM J EPIDEMIOL, V137, P342, DOI 10.1093/oxfordjournals.aje.a116681; Parkkari J, 1999, CALCIFIED TISSUE INT, V65, P183; Semmler JG, 2002, J PHYSIOL-LONDON, V545, P681, DOI 10.1113/jphysiol.2002.026948; Singh NB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048449; Singh NB, 2010, PHILOS T R SOC A, V368, P2783, DOI 10.1098/rsta.2010.0091; Tracy BL, 2005, MUSCLE NERVE, V32, P533, DOI 10.1002/mus.20392; Tracy BL, 2007, MED SCI SPORT EXER, V39, P469, DOI 10.1249/mss.0b013e31802d3ad3; Yao WX, 2000, J NEUROPHYSIOL, V83, P441, DOI 10.1152/jn.2000.83.1.441	30	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e82791	10.1371/journal.pone.0082791	http://dx.doi.org/10.1371/journal.pone.0082791			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349362	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800078
J	Sommerfelt, RM; Feuerherm, AJ; Jones, K; Johansen, B				Sommerfelt, Randi M.; Feuerherm, Astrid J.; Jones, Kymry; Johansen, Berit			Cytosolic Phospholipase A2 Regulates TNF-Induced Production of Joint Destructive Effectors in Synoviocytes	PLOS ONE			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; KAPPA-B; ARACHIDONIC-ACID; GROUP-IIA; GROUP-V; A(2); CYCLOOXYGENASE-2; ACTIVATION	Introduction: Rheumatoid arthritis (RA) is an inflammatory disease of the joint characterized by chronic synovitis causing pain, swelling and loss of function due to destruction of cartilage and bone. The complex series of pathological events occurring in RA is largely regulated via excessive production of pro-inflammatory cytokines, the most prominent being tumor necrosis factor (TNF). The objective of this work was to elucidate possible involvement of group IVA cytosolic phospholipase A2 (cPLA2 alpha) in TNF-induced regulation of synovitis and joint destructive effectors in RA, to evaluate the potential of cPLA2 alpha as a future therapeutic target. Methods: The involvement of cPLA2 alpha in tumor necrosis factor (TNF)-induced intracellular signaling cascades in synoviocytes (synovial fibroblast-like cells) was analyzed by arachidonic acid (AA) release assay, synoviocyte enzyme activity assay, gene expression analysis by real-time PCR and ELISA immunoassay for the detection of prostaglandin E2 (PGE2), interleukin 8 (IL8) and stromelysin-1 (MMP3), respectively. Results: Inhibitors of cPLA2 alpha enzyme activity (AVX002, ATK) significantly reduced TNF-induced cellular release of AA, PGE2, IL8 and MMP3. This reduction was evident both at transcriptional, protein or metabolite levels. Interestingly, cPLA2 alpha inhibition affected several key points of the arachidonyl cascade; AA-release, cyclooxygenase-2 (COX2) expression and PGE2 production. Furthermore, the results suggest that cPLA2 alpha is subject to transcriptional auto-regulation as inhibition of cPLA2 alpha resulted in reduced PLA2G4A gene expression in TNF-stimulated synoviocytes. Conclusions: cPLA2 alpha appears to be an important regulator of central effectors of inflammation and joint destruction, namely MMP3, IL8, COX2, and PGE2. Decreased transcription of the PLA2G4A and COX2 genes in response to cPLA2 alpha enzyme inhibition further suggest a self-reinforcing effect of cPLA2 alpha inhibition in response to TNF. Collectively, these results support that cPLA2 alpha is an attractive therapeutic target candidate as its inhibition reduces the production of multiple key pro-inflammatory factors involved in RA pathogenesis.	[Sommerfelt, Randi M.; Feuerherm, Astrid J.; Jones, Kymry; Johansen, Berit] Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Johansen, B (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway.	berit.johansen@ntnu.no			Norwegian Research Council, BIA program; Health Region Mid-Norway; Avexxin AS	Norwegian Research Council, BIA program; Health Region Mid-Norway; Avexxin AS	This work was supported by the Norwegian Research Council, BIA program; Health Region Mid-Norway and Avexxin AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthonsen MW, 2001, J BIOL CHEM, V276, P30527, DOI 10.1074/jbc.M008481200; Anthonsen MW, 2001, J BIOL CHEM, V276, P35344, DOI 10.1074/jbc.M105264200; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Chenevier-Gobeaux C, 2007, LIFE SCI, V81, P1050, DOI 10.1016/j.lfs.2007.08.018; Chi PL, 2012, ARTHRITIS RHEUM-US, V64, P2114, DOI 10.1002/art.34371; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Courties G, 2011, ARTHRITIS RHEUM-US, V63, P681, DOI 10.1002/art.30174; Crofford LJ, 2002, CURR OPIN RHEUMATOL, V14, P225, DOI 10.1097/00002281-200205000-00005; Cunnane G, 2001, ARTHRITIS RHEUM, V44, P2263, DOI 10.1002/1529-0131(200110)44:10<2263::AID-ART389>3.3.CO;2-T; Das ST, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011754; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Dieter P, 2002, CELL SIGNAL, V14, P199, DOI 10.1016/S0898-6568(01)00243-1; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gentile LB, 2010, PROSTAG LEUKOTR ESS, V82, P131, DOI 10.1016/j.plefa.2009.11.005; Gosset M, 2010, J IMMUNOL, V185, P6244, DOI 10.4049/jimmunol.0903315; Haeggstrom JZ, 2010, BIOCHEM BIOPH RES CO, V396, P135, DOI 10.1016/j.bbrc.2010.03.140; HARRIS ED, 2005, KELLEYS TXB RHEUMATO, V1; Hegen M, 2003, J EXP MED, V197, P1297, DOI 10.1084/jem.20030016; HULKOWER KI, 1994, ARTHRITIS RHEUM-US, V37, P653, DOI 10.1002/art.1780370508; Huwiler A, 2012, BRIT J PHARMACOL, V167, P1691, DOI 10.1111/j.1476-5381.2012.02114.x; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Laine L, 2002, GASTROENTEROLOGY, V123, P1006, DOI 10.1053/gast.2002.36013; Lee J, 2011, MOL CELL ENDOCRINOL, V332, P306, DOI 10.1016/j.mce.2010.11.022; Lucas KK, 2005, PROSTAG OTH LIPID M, V77, P235, DOI 10.1016/j.prostaglandins.2005.02.004; Malaviya R, 2006, EUR J PHARMACOL, V539, P195, DOI 10.1016/j.ejphar.2006.03.018; McCoy JM, 2002, J CLIN INVEST, V110, P651, DOI 10.1172/JCI200215528; Miyaura C, 2003, J EXP MED, V197, P1303, DOI 10.1084/jem.20030015; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Pawliczak R, 2004, J BIOL CHEM, V279, P48550, DOI 10.1074/jbc.M408926200; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Raichel L, 2008, EUR J IMMUNOL, V38, P2905, DOI 10.1002/eji.200838545; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sacco K, 2012, GYNECOL ENDOCRINOL, V28, P134, DOI 10.3109/09513590.2011.588753; Sapirstein A, 2000, BBA-MOL CELL BIOL L, V1488, P139, DOI 10.1016/S1388-1981(00)00116-5; Sapirstein A, 2005, AM J PHYSIOL-REG I, V288, pR1774, DOI 10.1152/ajpregu.00815.2004; Sjursen W, 2000, CYTOKINE, V12, P1189, DOI 10.1006/cyto.1999.0727; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Suryaprasad AG, 2003, AUTOIMMUN REV, V2, P346, DOI 10.1016/S1568-9972(03)00048-X; Tai N, 2010, INFLAMM RES, V59, P53, DOI 10.1007/s00011-009-0069-8; Tchetverikov I, 2004, ANN RHEUM DIS, V63, P881, DOI 10.1136/ard.2003.013243; Thommesen L, 1998, J IMMUNOL, V161, P3421; Tian J, 2013, RHEUMATOL INT, V33, P1829, DOI 10.1007/s00296-012-2657-0; Vuolteenaho K, 2008, BASIC CLIN PHARMACOL, V102, P10, DOI 10.1111/j.1742-7843.2007.00149.x; Walters JN, 2011, CELL SIGNAL, V23, P1944, DOI 10.1016/j.cellsig.2011.07.002; WIJKANDER J, 1991, EUR J BIOCHEM, V202, P873, DOI 10.1111/j.1432-1033.1991.tb16445.x; Yamanaka H, 2000, ARTHRITIS RHEUM, V43, P852, DOI 10.1002/1529-0131(200004)43:4<852::AID-ANR16>3.0.CO;2-7	52	24	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e83555	10.1371/journal.pone.0083555	http://dx.doi.org/10.1371/journal.pone.0083555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349530	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800127
J	Ando, K; Ozaki, T; Hirota, T; Nakagawara, A				Ando, Kiyohiro; Ozaki, Toshinori; Hirota, Toru; Nakagawara, Akira			NFBD1/MDC1 Is Phosphorylated by PLK1 and Controls G2/M Transition through the Regulation of a TOPOII alpha-Mediated Decatenation Checkpoint	PLOS ONE			English	Article							POLO-LIKE KINASE-1; DNA-DAMAGE RESPONSE; TOPOISOMERASE-II-ALPHA; MAMMALIAN-CELLS; MITOTIC ENTRY; SOLID TUMORS; PHASE-I; MDC1; CYTOKINESIS; DOMAIN	Although it has been established that nuclear factor with BRCT domain 1/mediator of the DNA damage checkpoint protein 1 (NFBD1/MDC1) is closely involved in DNA damage response, its possible contribution to the regulation of cell-cycle progression is unclear. In the present study, we have found for the first time that NFBD1 is phosphorylated by polo-like kinase 1 (PLK1) and has an important role in G2/M transition. Both NFBD1 and PLK1 are co-expressed in cellular nuclei throughout G2/M transition, and binding assays demonstrated direct interaction between NFBD1 and PLK1. Indeed, in vitro kinase reactions revealed that the PST domain of NFBD1 contains a potential amino acid sequence (845-DVTGEE-850) targeted by PLK1. Furthermore, enforced expression of GFP-PST but not GFP-PST(T847A) where threonine at 847 was substituted by alanine inhibited the phosphorylation levels of histone H3, suggesting a defect of M phase entry. Because PLK1 has been implicated in promoting the G2/M transition, we reasoned that overexpressed PST might serve as a pseudosubstrate for PLK1 and thus interfere with phosphorylation of endogenous PLK1 substrates. Interestingly, siRNA-mediated knockdown of NFBD1 resulted in early M phase entry and accelerated M phase progression, raising the possibility that NFBD1 is a PLK1 substrate for regulating the G2/M transition. Moreover, the constitutive active form of PLK1(T210D) overcame the ICRF-193-induced decatenation checkpoint and inhibited the interaction between NFBD1 and topoisomerase II alpha, but kinase-deficient PLK1 did not. Based on these observations, we propose that PLK1-mediated phosphorylation of NFBD1 is involved in the regulation of G2/M transition by recovering a decatenation checkpoint.	[Ando, Kiyohiro; Nakagawara, Akira] Chiba Canc Ctr, Res Inst, Div Biochem & Innovat Canc Therapeut, Chiba 2608717, Japan; [Ozaki, Toshinori] Chiba Canc Ctr, Res Inst, Lab Antitumor Res, Chiba 2608717, Japan; [Hirota, Toru] Japanese Fdn Canc Res, Inst Canc, Dept Expt Pathol, Tokyo 170, Japan	Chiba Cancer Center; Chiba Cancer Center; Japanese Foundation for Cancer Research	Nakagawara, A (corresponding author), Chiba Canc Ctr, Res Inst, Div Biochem & Innovat Canc Therapeut, 666-2 Nitonacho, Chiba 2608717, Japan.	akiranak@chiba-cc.jp			Ministry of Health, Labour and Welfare for Third Term Comprehensive Control Research for Cancer; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science; Foundation for Promotion of Cancer Research (Japan) for the 3rd Term Comprehensive 10-Year Strategy for Cancer Control in Japan; Grants-in-Aid for Scientific Research [24114517] Funding Source: KAKEN	Ministry of Health, Labour and Welfare for Third Term Comprehensive Control Research for Cancer; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Foundation for Promotion of Cancer Research (Japan) for the 3rd Term Comprehensive 10-Year Strategy for Cancer Control in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid from the Ministry of Health, Labour and Welfare for Third Term Comprehensive Control Research for Cancer, a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science. Dr. Kiyohiro Ando is an awardee of Research Resident Fellowship from the Foundation for Promotion of Cancer Research (Japan) for the 3rd Term Comprehensive 10-Year Strategy for Cancer Control in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrieu A, 1998, J CELL SCI, V111, P1751; Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Archambault V, 2009, NAT REV MOL CELL BIO, V10, P265, DOI 10.1038/nrm2653; Bartkova J, 2007, ONCOGENE, V26, P7414, DOI 10.1038/sj.onc.1210553; Bu YQ, 2010, BIOCHEM BIOPH RES CO, V397, P157, DOI 10.1016/j.bbrc.2010.05.063; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; Goldberg M, 2003, NATURE, V421, P952, DOI 10.1038/nature01445; Jimeno A, 2008, J CLIN ONCOL, V26, P5504, DOI 10.1200/JCO.2008.17.9788; Kumagai A, 1996, SCIENCE, V273, P1377, DOI 10.1126/science.273.5280.1377; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Li H, 2008, J BIOL CHEM, V283, P6209, DOI 10.1074/jbc.M709007200; Liu JP, 2012, NUCLEIC ACIDS RES, V40, P3898, DOI 10.1093/nar/gkr1296; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lou ZK, 2003, NATURE, V421, P957, DOI 10.1038/nature01447; Lu LY, 2008, MOL CELL BIOL, V28, P6870, DOI 10.1128/MCB.00392-08; Lu LY, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-4; Luo KT, 2009, NAT CELL BIOL, V11, P204, DOI 10.1038/ncb1828; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Mross K, 2008, J CLIN ONCOL, V26, P5511, DOI 10.1200/JCO.2008.16.1547; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nakanishi M, 2007, J BIOL CHEM, V282, P22993, DOI 10.1074/jbc.M611412200; Ozaki T, 2000, DNA CELL BIOL, V19, P475, DOI 10.1089/10445490050128403; Peng AM, 2003, J BIOL CHEM, V278, P8873, DOI 10.1074/jbc.C300001200; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Qian YW, 1998, MOL CELL BIOL, V18, P4262, DOI 10.1128/MCB.18.7.4262; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Seong YS, 2002, J BIOL CHEM, V277, P32282, DOI 10.1074/jbc.M202602200; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Takaki T, 2008, CURR OPIN CELL BIOL, V20, P650, DOI 10.1016/j.ceb.2008.10.005; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Wilson K, 2011, BRIT DENT J, V210, P53, DOI 10.1038/sj.bdj.2011.13; Xu XZ, 2003, FASEB J, V17, P1842, DOI 10.1096/fj.03-0310com; Xu XZ, 2003, J BIOL CHEM, V278, P8795, DOI 10.1074/jbc.M211392200	41	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82744	10.1371/journal.pone.0082744	http://dx.doi.org/10.1371/journal.pone.0082744			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349352	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300105
J	Ding, J; Romani, J; Zaborski, M; MacLeod, RAF; Nagel, S; Drexler, HG; Quentmeier, H				Ding, Jie; Romani, Julia; Zaborski, Margarete; MacLeod, Roderick A. F.; Nagel, Stefan; Drexler, Hans G.; Quentmeier, Hilmar			Inhibition of PI3K/mTOR Overcomes Nilotinib Resistance in BCR-ABL1 Positive Leukemia Cells through Translational Down-Regulation of MDM2	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; PHOSPHATIDYLINOSITOL 3-KINASE/MAMMALIAN TARGET; WILD-TYPE P53; BCR-ABL; ANTAGONIST NUTLIN-3; THERAPEUTIC STRATEGY; RAPAMYCIN INHIBITOR; NVP-BEZ235; IMATINIB; GAB2	Chronic myeloid leukemia (CML) is a cytogenetic disorder resulting from formation of the Philadelphia chromosome (Ph), that is, the t(9; 22) chromosomal translocation and the formation of the BCR-ABL1 fusion protein. Tyrosine kinase inhibitors (TKI), such as imatinib and nilotinib, have emerged as leading compounds with which to treat CML. t(9; 22) is not restricted to CML, 20-30% of acute lymphoblastic leukemia (ALL) cases also carry the Ph. However, TKIs are not as effective in the treatment of Ph+ ALL as in CML. In this study, the Ph+ cell lines JURL-MK2 and SUP-B15 were used to investigate TKI resistance mechanisms and the sensitization of Ph+ tumor cells to TKI treatment. The annexin V/PI (propidium iodide) assay revealed that nilotinib induced apoptosis in JURL-MK2 cells, but not in SUP-B15 cells. Since there was no mutation in the tyrosine kinase domain of BCR-ABL1 in cell line SUP-B15, the cells were not generally unresponsive to TKI, as evidenced by dephosphorylation of the BCR-ABL1 downstream targets, Crk-like protein (CrkL) and Grb-associated binder-2 (GAB2). Resistance to apoptosis after nilotinib treatment was accompanied by the constitutive and nilotinib unresponsive activation of the phosphoinositide 3-kinase (PI3K) pathway. Treatment of SUP-B15 cells with the dual PI3K/mammalian target of rapamycin (mTOR) inhibitor BEZ235 alone induced apoptosis in a low percentage of cells, while combining nilotinib and BEZ235 led to a synergistic effect. The main role of PI3K/mTOR inhibitor BEZ235 and the reason for apoptosis in the nilotinib-resistant cells was the block of the translational machinery, leading to the rapid downregulation of the anti-apoptotic protein MDM2 (human homolog of the murine double minute-2). These findings highlight MDM2 as a potential therapeutic target to increase TKI-mediated apoptosis and imply that the combination of PI3K/mTOR inhibitor and TKI might form a novel strategy to combat TKI-resistant BCR-ABL1 positive leukemia.	[Ding, Jie; Romani, Julia; Zaborski, Margarete; MacLeod, Roderick A. F.; Nagel, Stefan; Drexler, Hans G.; Quentmeier, Hilmar] Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany	Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Ding, J (corresponding author), Leibniz Inst DSMZ German Collect Microorganisms &, Dept Human & Anim Cell Lines, Braunschweig, Germany.	jid12@dsmz.de						Adams SJ, 2012, MOL CANCER RES, V10, P1265, DOI 10.1158/1541-7786.MCR-12-0352; Aumann K, 2011, HUM PATHOL, V42, P719, DOI 10.1016/j.humpath.2010.09.012; Camgoz A, 2013, LEUKEMIA LYMPHOMA, V54, P1279, DOI 10.3109/10428194.2012.737919; Chapuis N, 2010, CLIN CANCER RES, V16, P5424, DOI 10.1158/1078-0432.CCR-10-1102; Chiarini F, 2010, CANCER RES, V70, P8097, DOI 10.1158/0008-5472.CAN-10-1814; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Coll-Mulet L, 2006, BLOOD, V107, P4109, DOI 10.1182/blood-2005-08-3273; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; Drexler HG, 2010, GUIDE LEUKEMIA LYMPH; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Giles FJ, 2013, LEUKEMIA, V27, P107, DOI 10.1038/leu.2012.181; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Griffin JD, 2013, CURR MED RES OPIN, V29, P623, DOI 10.1185/03007995.2013.789012; Gu L, 2008, LEUKEMIA, V22, P730, DOI 10.1038/leu.2008.11; Gu LB, 2009, CANCER CELL, V15, P363, DOI 10.1016/j.ccr.2009.03.002; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Jabbour E, 2009, CORE EVID, V4, P207; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Logan IR, 2007, PROSTATE, V67, P900, DOI 10.1002/pros.20568; Lundgren K, 1997, GENE DEV, V11, P714, DOI 10.1101/gad.11.6.714; Mahon FX, 2008, CANCER RES, V68, P9809, DOI 10.1158/0008-5472.CAN-08-1008; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Manara MC, 2010, CLIN CANCER RES, V16, P530, DOI 10.1158/1078-0432.CCR-09-0816; Manfredi JJ, 2010, GENE DEV, V24, P1580, DOI 10.1101/gad.1941710; Manley PW, 2010, BIOORGAN MED CHEM, V18, P6977, DOI 10.1016/j.bmc.2010.08.026; Manley PW, 2005, BBA-PROTEINS PROTEOM, V1754, P3, DOI 10.1016/j.bbapap.2005.07.040; Manley PW, 2004, BIOORG MED CHEM LETT, V14, P5793, DOI 10.1016/j.bmcl.2004.09.042; Marone R, 2009, MOL CANCER RES, V7, P601, DOI 10.1158/1541-7786.MCR-08-0366; Martelli AM, 2012, ONCOTARGET, V3, P371, DOI 10.18632/oncotarget.477; Parker WT, 2013, BRIT J CANCER, V109, P1593, DOI 10.1038/bjc.2013.318; Polak R, 2012, BLOOD, V119, P911, DOI 10.1182/blood-2011-07-366203; Quentmeier H, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-6; Quentmeier H, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-3; Santiskulvong C, 2011, CLIN CANCER RES, V17, P2373, DOI 10.1158/1078-0432.CCR-10-2289; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Scherr M, 2006, BLOOD, V107, P3279, DOI 10.1182/blood-2005-08-3087; Schult C, 2012, ANTICANCER RES, V32, P463; Secchiero P, 2006, BLOOD, V107, P4122, DOI 10.1182/blood-2005-11-4465; Tabe Y, 2009, CLIN CANCER RES, V15, P933, DOI 10.1158/1078-0432.CCR-08-0399; VanderBorght A, 2006, ONCOGENE, V25, P6672, DOI 10.1038/sj.onc.1209667; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Wohrle FU, 2013, LEUKEMIA, V27, P118, DOI 10.1038/leu.2012.222; ZHOU MX, 1995, BLOOD, V85, P1608, DOI 10.1182/blood.V85.6.1608.bloodjournal8561608	49	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e83510	10.1371/journal.pone.0083510	http://dx.doi.org/10.1371/journal.pone.0083510			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349524	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300149
J	Wang, KK; Lei, J; Zou, J; Xiao, H; Chen, AL; Liu, XL; Liu, Y; Jiang, L; Xiao, ZH; Xiao, XZ				Wang, Kangkai; Lei, Jian; Zou, Jiang; Xiao, Hui; Chen, Anlan; Liu, Xiaoliu; Liu, Ying; Jiang, Lei; Xiao, Zihui; Xiao, Xianzhong			Mipu1, a Novel Direct Target Gene, Is Involved in Hypoxia Inducible Factor 1-Mediated Cytoprotection	PLOS ONE			English	Article							PEROXIDE-INDUCED APOPTOSIS; ZINC-FINGER PROTEIN; FACTOR-I; OXIDATIVE STRESS; NEGATIVE REGULATOR; ACTIVATION; HIF-1-ALPHA; EXPRESSION; CARDIOMYOCYTES; ERYTHROPOIETIN	Mipu1 (myocardial ischemic preconditioning up-regulated protein 1), recently identified in our lab, is a novel zinc-finger transcription factor which is up-regulated during ischemic preconditioning. However, it is not clear what transcription factor contributes to its inducible expression. In the present study, we reported that HIF-1 regulates the inducible expression of Mipu1 which is involved in the cytoprotection of HIF-1 alpha against oxidative stress by inhibiting Bax expression. Our results showed that the inducible expression of Mipu1 was associated with the expression and activation of transcription factor HIF-1 as indicated by cobalt chloride (CoCl2) treatment, HIF-1 alpha overexpression and knockdown assays. EMSA and luciferase reporter gene assays showed that HIF-1a bound to the hypoxia response element (HRE) within Mipu1 promoter region and promoted its transcription. Moreover, our results revealed that Mipu1 inhibited the expression of Bax, an important pro-apoptosis protein associated with the intrinsic pathway of apoptosis, elevating the cytoprotection of HIF-1 against hydrogen peroxide (H2O2)-mediated injury in H9C2 cells. Our findings implied that Bax may be a potential target gene of transcription factor Mipu1, and provided a novel insight for understanding the cytoprotection of HIF-1 and new clues for further elucidating the mechanisms by which Mipu1 protects cell against pathological stress.	[Wang, Kangkai; Lei, Jian; Zou, Jiang; Xiao, Hui; Chen, Anlan; Liu, Xiaoliu; Liu, Ying; Jiang, Lei; Xiao, Zihui; Xiao, Xianzhong] Cent South Univ, Dept Pathophysiol, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Lei, Jian] Cent South Univ, Affiliated Tumor Hosp, Xiangya Sch Med, Dept Pathol, Changsha, Hunan, Peoples R China; [Liu, Xiaoliu] Cent South Univ, Xiangya Hosp 2, Dept Endocrinol, Xiangya Sch Med, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Xiao, ZH (corresponding author), Cent South Univ, Dept Pathophysiol, Xiangya Sch Med, Changsha, Hunan, Peoples R China.	zihuixiao@yahoo.com; xiaoxianzhong@csu.edu.cn	xiao, xiang/GWU-6035-2022		Major National Basic Research Program of China [2007CB512007]; National Natural Science Foundation of China [30770855, 30971205, 81270201]; Hunan province Nature Science Foundation [11JJ2047]	Major National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan province Nature Science Foundation	This work was supported partially by the following grants: the Major National Basic Research Program of China (2007CB512007 for X.X. and K.W.) and the National Natural Science Foundation of China (30770855 for X.X.; 30971205 for L.J.; 81270201 for K.W.) and the Hunan province Nature Science Foundation (11JJ2047 for K.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Dai Y, 2007, J MOL CELL CARDIOL, V42, P1036, DOI 10.1016/j.yjmcc.2007.04.001; Dawn B, 2005, AM J PHYSIOL-HEART C, V289, pH522, DOI 10.1152/ajpheart.00274.2005; Dewson G, 2012, CELL DEATH DIFFER, V19, P661, DOI 10.1038/cdd.2011.138; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Foxler DE, 2012, NAT CELL BIOL, V14, P201, DOI 10.1038/ncb2424; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Harten SK, 2010, ANTIOXID REDOX SIGN, V12, P459, DOI 10.1089/ars.2009.2870; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Jiang BM, 2009, ATHEROSCLEROSIS, V204, P353, DOI 10.1016/j.atherosclerosis.2008.09.009; Jiang BM, 2005, FREE RADICAL BIO MED, V39, P658, DOI 10.1016/j.freeradbiomed.2005.04.018; Jiang L, 2007, BIOCHEM BIOPH RES CO, V356, P829, DOI 10.1016/j.bbrc.2007.02.138; Jiang L, 2009, MOL CELL BIOCHEM, V328, P137, DOI 10.1007/s11010-009-0083-8; Jung F, 2000, CIRC RES, V86, P319, DOI 10.1161/01.RES.86.3.319; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Liu S, 2007, BIOCHEM BIOPH RES CO, V354, P109, DOI 10.1016/j.bbrc.2006.12.152; Lv B, 2009, ACTA BIOCH BIOPH SIN, V41, P309, DOI 10.1093/abbs/gmp019; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.e02-12-0791; Minamishima YA, 2010, SCIENCE, V329, P407, DOI 10.1126/science.1192811; Miura T, 2010, CARDIOVASC RES, V88, P7, DOI 10.1093/cvr/cvq206; Natarajan R, 2008, J CARDIOVASC PHARM, V51, P178, DOI 10.1097/FJC.0b013e31815f248d; Ong SG, 2012, PHARMACOL THERAPEUT, V136, P69, DOI 10.1016/j.pharmthera.2012.07.005; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Qu SL, 2010, FREE RADICAL BIO MED, V49, P580, DOI 10.1016/j.freeradbiomed.2010.05.004; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tang DL, 2007, J IMMUNOL, V178, P7376, DOI 10.4049/jimmunol.178.11.7376; Wang G, 2010, BRAZ J MED BIOL RES, V43, P43, DOI 10.1590/S0100-879X2009005000010; Wang GL, 2009, INT J MOL SCI, V10, P492, DOI 10.3390/ijms10020492; Wang GL, 2009, MOL CELL BIOCHEM, V322, P93, DOI 10.1007/s11010-008-9944-9; Wang KK, 2011, J MOL CELL BIOL, V3, P360, DOI 10.1093/jmcb/mjr021; Wang KK, 2012, CELL STRESS CHAPERON, V17, P121, DOI 10.1007/s12192-011-0292-4; Xi L, 2004, AM J PHYSIOL-HEART C, V287, pH2369, DOI 10.1152/ajpheart.00422.2004; Yuan C, 2004, PROG BIOCHEM BIOPHYS, V31, P231; Zhang B, 2010, CELL STRESS CHAPERON, V15, P249, DOI 10.1007/s12192-009-0138-5	38	20	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e82827	10.1371/journal.pone.0082827	http://dx.doi.org/10.1371/journal.pone.0082827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349374	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300109
J	Boukhris, SA; Amarti, A; El Rhazi, K; El Khadir, M; Benajah, DA; Ibrahimi, SA; Nejjari, C; Mahmoud, M; Souleimani, A; Bennani, B				Boukhris, Samia Alaoui; Amarti, Afaf; El Rhazi, Karima; El Khadir, Mounia; Benajah, Dafr-Allah; Ibrahimi, Sidi Adil; Nejjari, Chakib; Mahmoud, Mustapha; Souleimani, Abdellah; Bennani, Bahia			Helicobacter pylori Genotypes Associated with Gastric Histo-Pathological Damages in a Moroccan Population	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; POLYMERASE-CHAIN-REACTION; HISTOLOGICAL PARAMETERS; VACA GENOTYPES; INFECTION; CAGA; STRAINS; EXPRESSION; DIAGNOSIS; CANCERS	H. pylori persistent infection induces chronic gastritis and is associated with peptic ulcer disease and gastric carcinoma development. The severity of these diseases is related to human's genetic diversity, H. pylori genetic variability and environmental factors. To identify the prevalence of histo-pathological damages caused by H. pylori infection in Moroccan population, and to determine their association to H. pylori genotypes, a prospective study has been conducted during 3 years on patients attending the gastroenterology department of Hassan II University Hospital (CHU) of Fez, Morocco. A total of 801 Moroccan adults' patients were recruited; H. pylori was diagnosed and genotyped by PCR in biopsy specimens and histological exam was performed. We found a high rate of glandular atrophy. Chronic inflammation, neutrophil activity and glandular atrophy showed statistically significant association with H. pylori infection. However, intestinal metaplasia was inversely associated to this infection and no association was observed with gastric cancer cases. A statistically significant association was found between intestinal metaplasia and vacAs1 and vac Am1 genotypes in patients aged 50 years and more but not in younger. This last genotype is also associated to gastric cancer. In this study, gastric cancer showed no significant association with H. pylori. Further studies are warranted to determine the role of other etiological agents such as Epstein-Barr virus, human papillomavirus and possibly environmental and dietetic factors in the occurrence of this pathology.	[Boukhris, Samia Alaoui; El Khadir, Mounia; Bennani, Bahia] USMBA, FMPF, Lab Microbiol & Biol Mol, Equipe Microorganismes & Facteurs Oncogenes, Fes, Morocco; [Amarti, Afaf] CHU Hassan II, Serv Anat Pathol, Fes, Morocco; [El Rhazi, Karima; Nejjari, Chakib] USMBA, FMPF, Lab Epidemiol & Rech Clin, Fes, Morocco; [Benajah, Dafr-Allah; Ibrahimi, Sidi Adil] CHU Hassan II Fes, Serv Hepato Gastroenterol, Equipe Malad Appareil Digestif FMPF, Fes, Morocco; [Mahmoud, Mustapha] CHU Hassan II, Serv Bacteriol, Fes, Morocco; [Boukhris, Samia Alaoui; El Khadir, Mounia; Souleimani, Abdellah; Bennani, Bahia] USMBA, Fac Sci Dhar el Mehraz, Lab Biotechnol, Fes, Morocco; [Amarti, Afaf; Benajah, Dafr-Allah; Ibrahimi, Sidi Adil; Mahmoud, Mustapha] USMBA, FMPF, Lab Biol Canc, Fes, Morocco	Sidi Mohamed Ben Abdellah University of Fez; Hassan II University Hospital Center of Fez; Sidi Mohamed Ben Abdellah University of Fez; Hassan II University Hospital Center of Fez; Hassan II University Hospital Center of Fez; Sidi Mohamed Ben Abdellah University of Fez; Sidi Mohamed Ben Abdellah University of Fez	Bennani, B (corresponding author), USMBA, FMPF, Lab Microbiol & Biol Mol, Equipe Microorganismes & Facteurs Oncogenes, Fes, Morocco.	bahia_bc@yahoo.fr		, bahia/0000-0002-5509-3991; EL RHAZI, Karima/0000-0002-8135-9044; EL KHADIR, Mounia/0000-0002-8426-5078	Faculty of Medicine of Fez; Hassan II University Hospital of Fez	Faculty of Medicine of Fez; Hassan II University Hospital of Fez	Financial support for this work was provided by the Faculty of Medicine of Fez and Hassan II University Hospital of Fez. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Audibert C, 2001, INFECT IMMUN, V69, P1625, DOI 10.1128/IAI.69.3.1625-1629.2001; Badmos K B, 2009, Niger Postgrad Med J, V16, P264; BLASER MJ, 1995, CANCER RES, V55, P2111; Bolek BK, 2007, DIAGN MICR INFEC DIS, V58, P67, DOI 10.1016/j.diagmicrobio.2006.12.001; Boukhris SA, 2012, EUR J CLIN MICROBIOL, V31, P1775, DOI 10.1007/s10096-011-1501-x; Chattopadhyay S, 2004, J CLIN MICROBIOL, V42, P2821, DOI 10.1128/JCM.42.6.2821-2824.2004; Chung C, 2010, J CLIN MICROBIOL, V48, P690, DOI 10.1128/JCM.01815-09; De Korwin JD, 2010, ENCYCL MED CHIR, P1; de Martel C, 2010, INT J CANCER, V126, P1992, DOI 10.1002/ijc.24898; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Elzouki Abdel-Naser Y, 2012, Arab J Gastroenterol, V13, P85, DOI 10.1016/j.ajg.2012.06.002; Fukayama Masashi, 2012, Nihon Rinsho, V70, P1715; Fukayama M, 2010, PATHOL INT, V60, P337, DOI 10.1111/j.1440-1827.2010.02533.x; Jmaa Rafik, 2010, Tunis Med, V88, P147; Kalebi A, 2007, WORLD J GASTROENTERO, V13, P4117, DOI 10.3748/wjg.v13.i30.4117; Khedmat Hossein, 2012, J Infect Public Health, V5, P153, DOI 10.1016/j.jiph.2011.10.009; Kisa O, 2002, DIAGN MICR INFEC DIS, V43, P251, DOI 10.1016/S0732-8893(02)00409-1; KUIPERS EJ, 1995, J NATL CANCER I, V87, P1777, DOI 10.1093/jnci/87.23.1777; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; LAGE AP, 1995, J CLIN MICROBIOL, V33, P2752, DOI 10.1128/JCM.33.10.2752-2756.1995; Lima VP, 2011, CANCER EPIDEMIOL, V35, pE32, DOI 10.1016/j.canep.2011.02.017; Lunet N, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-98; Luo B, 2006, WORLD J GASTROENTERO, V12, P1842, DOI 10.3748/wjg.v12.i12.1842; Luo B, 2005, WORLD J GASTROENTERO, V11, P629, DOI 10.3748/wjg.v11.i5.629; MacDonald WC, 1991, PREMALIGNANT CONDITI, P145; Mitchell HM, 1998, GASTROENTEROLOGY, V114, P256, DOI 10.1016/S0016-5085(98)70475-5; Nogueira C, 2001, AM J PATHOL, V158, P647, DOI 10.1016/S0002-9440(10)64006-0; Ortiz-Princz D, 2010, MEM I OSWALDO CRUZ, V105, P331, DOI 10.1590/S0074-02762010000300016; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Plummer M, 2007, J NATL CANCER I, V99, P1328, DOI 10.1093/jnci/djm120; Scholte GHA, 2002, AM J GASTROENTEROL, V97, P1687, DOI 10.1111/j.1572-0241.2002.05775.x; Shukla SK, 2011, J MICROBIOL METH, V86, P231, DOI 10.1016/j.mimet.2011.05.012; Shukla SK, 2011, BRAZ J INFECT DIS, V15, P583, DOI 10.1590/S1413-86702011000600014; Shukla S, 2009, INDIAN J MED RES, V130, P222; Soltermann A, 2007, MODERN PATHOL, V20, P878, DOI 10.1038/modpathol.3800832; Zhang C, 2005, WORLD J GASTROENTERO, V11, P791, DOI 10.3748/wjg.v11.i6.791	39	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82646	10.1371/journal.pone.0082646	http://dx.doi.org/10.1371/journal.pone.0082646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349327	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200088
J	Czynski, AJ; Terry, MH; Deming, DD; Power, GG; Buchholz, JN; Blood, AB				Czynski, Adam J.; Terry, Michael H.; Deming, Douglas D.; Power, Gordon G.; Buchholz, John N.; Blood, Arlin B.			Cerebral Autoregulation Is Minimally Influenced by the Superior Cervical Ganglion in Two- Week-Old Lambs, and Absent in Preterm Lambs Immediately Following Delivery	PLOS ONE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; BLOOD-FLOW AUTOREGULATION; FETAL LAMB; ARTERIAL-PRESSURE; PIAL-ARTERIES; CEREBROVASCULAR AUTOREGULATION; DEVELOPMENTAL-CHANGES; AUTO-REGULATION; NEWBORN PIGLET; STIMULATION	Cerebral vessels in the premature newborn brain are well supplied with adrenergic nerves, stemming from the superior cervical ganglia (SCG), but their role in regulation of blood flow remains uncertain. To test this function twelve premature or two-week-old lambs were instrumented with laser Doppler flow probes in the parietal cortices to measure changes in blood flow during changes in systemic blood pressure and electrical stimulation of the SCG. In lambs delivered prematurely at,129 days gestation cerebral perfusion and driving pressure demonstrated a direct linear relationship throughout the physiologic range, indicating lack of autoregulation. In contrast, in lambs two-weeks of age, surgical removal of one SCG resulted in ipsilateral loss of autoregulation during pronounced hypertension. Electrical stimulation of one SCG elicited unilateral increases in cerebral resistance to blood flow in both pre-term and two-week-old lambs, indicating functioning neural pathways in the instrumented, anesthetized lambs. We conclude cerebral autoregulation is non-functional in preterm lambs following cesarean delivery. Adrenergic control of cerebral vascular resistance becomes effective in newborn lambs within two-weeks after birth but SCG-dependent autoregulation is essential only during pronounced hypertension, well above the normal range of blood pressure.	[Czynski, Adam J.; Deming, Douglas D.; Blood, Arlin B.] Loma Linda Univ, Sch Med, Dept Pediat, Div Neonatol, Loma Linda, CA USA; [Power, Gordon G.; Blood, Arlin B.] Loma Linda Univ, Sch Med, Ctr Perinatal Biol, Loma Linda, CA USA; [Buchholz, John N.] Loma Linda Univ, Sch Med, Dept Physiol & Pharmacol, Loma Linda, CA USA; [Terry, Michael H.] Loma Linda Univ, Med Ctr, Dept Resp Care, Pulm Physiol Labs, Loma Linda, CA USA	Loma Linda University; Loma Linda University; Loma Linda University; Loma Linda University	Blood, AB (corresponding author), Loma Linda Univ, Sch Med, Dept Pediat, Div Neonatol, Loma Linda, CA USA.	ablood@llu.edu	Buchholz, John/AAY-3443-2020; Blood, Arlin/AAG-8897-2020	Blood, Arlin/0000-0002-4803-5021; Deming, Douglas/0000-0002-1751-5188	American Heart Association [2320047]	American Heart Association(American Heart Association)	Research was funded by a grant from American Heart Association Award # 2320047 to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballabh P, 2010, PEDIATR RES, V67, P1, DOI 10.1203/PDR.0b013e3181c1b176; Bevan RD, 1998, PEDIATR RES, V43, P20, DOI 10.1203/00006450-199801000-00004; Bishai JM, 2003, J PHYSIOL-LONDON, V546, P869, DOI 10.1113/jphysiol.2002.025270; Blankenberg FG, 1997, RADIOLOGY, V205, P563, DOI 10.1148/radiology.205.2.9356646; Boylan GB, 2000, PEDIATR RES, V48, P12, DOI 10.1203/00006450-200007000-00005; BUSIJA DW, 1985, PEDIATR RES, V19, P1210, DOI 10.1203/00006450-198511000-00020; BUSIJA DW, 1984, J PHYSIOL-LONDON, V347, P35, DOI 10.1113/jphysiol.1984.sp015051; BUSIJA DW, 1980, CIRC RES, V46, P696, DOI 10.1161/01.RES.46.5.696; Cassaglia PA, 2008, AM J PHYSIOL-REG I, V294, pR1255, DOI 10.1152/ajpregu.00332.2007; Cassaglia PA, 2009, J APPL PHYSIOL, V106, P1050, DOI 10.1152/japplphysiol.91349.2008; CHEMTOB S, 1992, ANESTHESIOLOGY, V76, P236, DOI 10.1097/00000542-199202000-00013; DUCKLES SP, 1984, ANNU REV PHARMACOL, V24, P65; EKLOF B, 1971, ACTA PHYSIOL SCAND, V82, P172, DOI 10.1111/j.1748-1716.1971.tb04956.x; Fog M, 1939, ARCH NEURO PSYCHIATR, V41, P260, DOI 10.1001/archneurpsyc.1939.02270140046003; HARPER AM, 1972, ARCH NEUROL-CHICAGO, V27, P1; Harris A, 1998, ARCH OPHTHALMOL-CHIC, V116, P1491, DOI 10.1001/archopht.116.11.1491; HAYASHI S, 1984, LIFE SCI, V35, P253, DOI 10.1016/0024-3205(84)90108-5; HERNANDEZPEREZ MJ, 1974, BRAIN RES, V80, P507, DOI 10.1016/0006-8993(74)91034-8; HERNANDEZPEREZ MJ, 1975, STROKE, V6, P284, DOI 10.1161/01.STR.6.3.284; Inage YW, 2000, PEDIATR NEUROL, V22, P204, DOI 10.1016/S0887-8994(99)00153-8; MACKENZIE ET, 1979, STROKE, V10, P711, DOI 10.1161/01.STR.10.6.711; MACKENZIE ET, 1979, PFLUG ARCH EUR J PHY, V378, P189, DOI 10.1007/BF00592735; MEYER JS, 1967, NEUROLOGY, V17, P638, DOI 10.1212/WNL.17.7.638; MONIN P, 1990, BIOL NEONATE, V58, P192; Morrell P, 1999, BASIC NEUROCHEMISTRY; Muller T, 2002, J PHYSIOL-LONDON, V539, P957, DOI 10.1013/jphysiol.2001.012590; NELSON E, 1970, BRAIN, V93, P475, DOI 10.1093/brain/93.3.475; NIELSEN KAI C., 1967, BRAIN RES, V6, P773, DOI 10.1016/0006-8993(67)90134-5; Nishimura N, 2007, AVIAT SPACE ENVIR MD, V78, P1121, DOI 10.3357/ASEM.2177.2007; PAPILE LA, 1985, PEDIATR RES, V19, P159, DOI 10.1203/00006450-198502000-00001; Paulson O. B., 1990, BRAIN METAB REV, V2, P161; Pearce WJ, 1999, AM J PHYSIOL-REG I, V277, pR931, DOI 10.1152/ajpregu.1999.277.4.R931; PEARCE WJ, 1991, AM J PHYSIOL, V261, pR458, DOI 10.1152/ajpregu.1991.261.2.R458; PURVES MJ, 1969, CIRC RES, V25, P651, DOI 10.1161/01.RES.25.6.651; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; Schmidt A, 2003, ACTA ANAESTH SCAND, V47, P569, DOI 10.1034/j.1399-6576.2003.00089.x; SERCOMBE R, 1975, NEUROLOGY, V25, P954, DOI 10.1212/WNL.25.10.954; Skinhoj E, 1972, STROKE, V3, P711, DOI 10.1161/01.STR.3.6.711; TWEED WA, 1983, PEDIATR RES, V17, P246, DOI 10.1203/00006450-198304000-00002; van Lieshout JJ, 2008, J APPL PHYSIOL, V105, P1364, DOI 10.1152/japplphysiol.90597.2008; WAGERLE LC, 1983, AM J PHYSIOL, V245, pH487, DOI 10.1152/ajpheart.1983.245.3.H487; WAGERLE LC, 1990, AM J PHYSIOL, V258, pH1432, DOI 10.1152/ajpheart.1990.258.5.H1432; WAGERLE LC, 1986, PEDIATR RES, V20, P131, DOI 10.1203/00006450-198602000-00007; WALTZ AG, 1971, AM J PHYSIOL, V221, P298, DOI 10.1152/ajplegacy.1971.221.1.298; WEI EP, 1975, STROKE, V6, P654, DOI 10.1161/01.STR.6.6.654	45	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82326	10.1371/journal.pone.0082326	http://dx.doi.org/10.1371/journal.pone.0082326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349256	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200076
J	Sherwood, CL; Liguori, AE; Olsen, CE; Lantz, RC; Burgess, JL; Boitano, S				Sherwood, Cara L.; Liguori, Andrew E.; Olsen, Colin E.; Lantz, R. Clark; Burgess, Jefferey L.; Boitano, Scott			Arsenic Compromises Conducting Airway Epithelial Barrier Properties in Primary Mouse and Immortalized Human Cell Cultures	PLOS ONE			English	Article							DRINKING-WATER; TIGHT JUNCTIONS; IN-UTERO; WOUND RESPONSE; LUNG-CANCER; EXPOSURE; BANGLADESH; OCCLUDIN; PHOSPHORYLATION; EXPRESSION	Arsenic is a lung toxicant that can lead to respiratory illness through inhalation and ingestion, although the most common exposure is through contaminated drinking water. Lung effects reported from arsenic exposure include lung cancer and obstructive lung disease, as well as reductions in lung function and immune response. As part of their role in innate immune function, airway epithelial cells provide a barrier that protects underlying tissue from inhaled particulates, pathogens, and toxicants frequently found in inspired air. We evaluated the effects of a five-day exposure to environmentally relevant levels of arsenic {<4 mu M [similar to 300 mu g/L (ppb)] as NaAsO2} on airway epithelial barrier function and structure. In a primary mouse tracheal epithelial (MTE) cell model we found that both micromolar (3.9 mu M) and submicromolar (0.8 mu M) arsenic concentrations reduced transepithelial resistance, a measure of barrier function. Immunofluorescent staining of arsenic-treated MTE cells showed altered patterns of localization of the transmembrane tight junction proteins claudin (Cl) Cl-1, Cl-4, Cl-7 and occludin at cell-cell contacts when compared with untreated controls. To better quantify arsenic-induced changes in tight junction transmembrane proteins we conducted arsenic exposure experiments with an immortalized human bronchial epithelial cell line (16HBE14o-). We found that arsenic exposure significantly increased the protein expression of Cl-4 and occludin as well as the mRNA levels of Cl-4 and Cl-7 in these cells. Additionally, arsenic exposure resulted in altered phosphorylation of occludin. In summary, exposure to environmentally relevant levels of arsenic can alter both the function and structure of airway epithelial barrier constituents. These changes likely contribute to the observed arsenic-induced loss in basic innate immune defense and increased infection in the airway.	[Sherwood, Cara L.; Liguori, Andrew E.; Olsen, Colin E.; Boitano, Scott] Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85719 USA; [Sherwood, Cara L.; Lantz, R. Clark; Boitano, Scott] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA; [Boitano, Scott] Univ Arizona, Arizona Hlth Sci Ctr, Dept Physiol, Tucson, AZ USA; [Sherwood, Cara L.; Liguori, Andrew E.; Olsen, Colin E.; Lantz, R. Clark; Burgess, Jefferey L.; Boitano, Scott] Univ Arizona, Southwest Environm Hlth Sci Ctr, Tucson, AZ USA; [Sherwood, Cara L.; Lantz, R. Clark; Boitano, Scott] Univ Arizona, Collaborat Res Inst Bio5, Tucson, AZ USA; [Burgess, Jefferey L.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Arizona; University of Arizona	Boitano, S (corresponding author), Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85719 USA.	sboitano@email.arizona.edu		Lantz, R Clark/0000-0002-8248-447X	National Institute of Environmental Health Sciences [ES 04940, ES 06694, ES 007091]; United States Environmental Protection Agency [RD832095]; National Heart Lung and Blood Institute [T32-HL007249]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694, P42ES004940, T32ES007091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073664] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); United States Environmental Protection Agency(United States Environmental Protection Agency); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Environmental Health Sciences [(Superfund Research Grant ES 04940), (Center Grant ES 06694), (Training grant ES 007091) (CLS)]; United States Environmental Protection Agency (STAR grant RD832095) and National Heart Lung and Blood Institute [Training grant T32-HL007249 (CLS)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Angelow S, 2008, AM J PHYSIOL-RENAL, V295, pF867, DOI 10.1152/ajprenal.90264.2008; ATSDR, 2007, TOX PROF ARS; Bomberger JM, 2012, J BIOL CHEM, V287, P17130, DOI 10.1074/jbc.M111.338855; Chen Y, 2009, TOXICOL APPL PHARM, V239, P184, DOI 10.1016/j.taap.2009.01.010; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Daugherty BL, 2007, J BIOL CHEM, V282, P30005, DOI 10.1074/jbc.M703547200; Dauphine DC, 2011, INT ARCH OCC ENV HEA, V84, P591, DOI 10.1007/s00420-010-0591-6; Davidson DJ, 2000, AM J PHYSIOL-LUNG C, V279, pL766, DOI 10.1152/ajplung.2000.279.4.L766; Davidson Donald J, 2004, J Cyst Fibros, V3 Suppl 2, P59, DOI 10.1016/j.jcf.2004.05.013; Elias BC, 2009, J BIOL CHEM, V284, P1559, DOI 10.1074/jbc.M804783200; EPA, 2001, FED REGISTER, V66, P6975; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; Guha Mazumder, 2007, J ENV SCI HLTH A, V42, P1859, DOI [DOI 10.1080/10934520701566926.PUBMED:17952787, 10.1080/10934520701566926]; Guo JX, 2007, J ENVIRON SCI HEAL A, V42, P1853, DOI 10.1080/10934520701566918; Halatek T, 2009, TOXICOL APPL PHARM, V239, P193, DOI 10.1016/j.taap.2009.04.022; Hou JH, 2006, J BIOL CHEM, V281, P36117, DOI 10.1074/jbc.M608853200; Hughes MF, 2011, TOXICOL SCI, V123, P305, DOI 10.1093/toxsci/kfr184; Josyula AB, 2006, ENVIRON RES, V102, P283, DOI 10.1016/j.envres.2006.01.003; Kaarteenaho R, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-59; Kerem E, 1999, NEW ENGL J MED, V341, P156, DOI 10.1056/NEJM199907153410304; KOEFOEDJOHNSEN V, 1958, ACTA PHYSIOL SCAND, V42, P298, DOI 10.1111/j.1748-1716.1958.tb01563.x; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1108, DOI 10.1289/ehp.0800199; Liao CM, 2011, RISK ANAL, V31, P1281, DOI 10.1111/j.1539-6924.2010.01575.x; Lubin JH, 2008, ENVIRON HEALTH PERSP, V116, P1661, DOI 10.1289/ehp.11515; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; Mazumder DNG, 2005, EPIDEMIOLOGY, V16, P760, DOI 10.1097/01.ede.0000181637.10978.e6; Mazumder DNG, 2000, INT J EPIDEMIOL, V29, P1047, DOI 10.1093/ije/29.6.1047; Merikallio H, 2011, EUR J CANCER, V47, P620, DOI 10.1016/j.ejca.2010.10.017; Milton AH, 2002, INT J ENVIRON HEAL R, V12, P175, DOI 10.1080/09603120220129346; Olsen CE, 2008, AM J PHYSIOL-LUNG C, V295, pL293, DOI 10.1152/ajplung.00134.2007; Palmer LG, 2008, J GEN PHYSIOL, V132, P607, DOI 10.1085/jgp.200810149; Parvez F, 2008, ENVIRON HEALTH PERSP, V116, P190, DOI 10.1289/ehp.9507; Rahman A, 2011, ENVIRON HEALTH PERSP, V119, P719, DOI 10.1289/ehp.1002265; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; Rao R, 2009, ANN NY ACAD SCI, V1165, P62, DOI 10.1111/j.1749-6632.2009.04054.x; Raqib R, 2009, TOXICOL LETT, V185, P197, DOI 10.1016/j.toxlet.2009.01.001; Sallee JL, 2009, J BIOL CHEM, V284, P14997, DOI 10.1074/jbc.M901901200; Sherwood CL, 2013, TOXICOL SCI, V132, P222, DOI 10.1093/toxsci/kfs331; Sherwood CL, 2011, TOXICOL SCI, V121, P191, DOI 10.1093/toxsci/kfr044; Smith AH, 2006, ENVIRON HEALTH PERSP, V114, P1293, DOI 10.1289/ehp.8832; Smith AH, 2011, AM J EPIDEMIOL, V173, P414, DOI 10.1093/aje/kwq383; Smith AH, 2009, J EXPO SCI ENV EPID, V19, P343, DOI 10.1038/jes.2008.73; Soini Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-70; Vermeer PD, 2009, AM J PHYSIOL-LUNG C, V296, pL751, DOI 10.1152/ajplung.90578.2008; Wan H, 2000, EUR RESPIR J, V15, P1058, DOI 10.1034/j.1399-3003.2000.01514.x; Wang FS, 2003, AM J RESP CELL MOL, V29, P62, DOI 10.1165/rcmb.2002-0180OC; Wen HJ, 2004, MOL CELL BIOL, V24, P8408, DOI 10.1128/MCB.24.19.8408-8417.2004; Wray C, 2009, AM J PHYSIOL-LUNG C, V297, pL219, DOI 10.1152/ajplung.00043.2009; You YJ, 2002, AM J PHYSIOL-LUNG C, V283, pL1315, DOI 10.1152/ajplung.00169.2002	53	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82970	10.1371/journal.pone.0082970	http://dx.doi.org/10.1371/journal.pone.0082970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24349408	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566700119
J	Wang, HB; Zou, ZR; Wang, SS; Gong, M				Wang, Haibo; Zou, Zhurong; Wang, Shasha; Gong, Ming			Global Analysis of Transcriptome Responses and Gene Expression Profiles to Cold Stress of Jatropha curcas L.	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; LOW-TEMPERATURE; FREEZING TOLERANCE; LIPID-COMPOSITION; PLASMA-MEMBRANE; PHOSPHOLIPASE-D; CBF GENES; ACCLIMATION; MULTIPLE; DEHYDRIN	Background: Jatropha curcas L., also called the Physic nut, is an oil-rich shrub with multiple uses, including biodiesel production, and is currently exploited as a renewable energy resource in many countries. Nevertheless, because of its origin from the tropical MidAmerican zone, J. curcas confers an inherent but undesirable characteristic (low cold resistance) that may seriously restrict its large-scale popularization. This adaptive flaw can be genetically improved by elucidating the mechanisms underlying plant tolerance to cold temperatures. The newly developed Illumina Hiseq(TM) 2000 RNA-seq and Digital Gene Expression (DGE) are deep high-throughput approaches for gene expression analysis at the transcriptome level, using which we carefully investigated the gene expression profiles in response to cold stress to gain insight into the molecular mechanisms of cold response in J. curcas. Results: In total, 45,251 unigenes were obtained by assembly of clean data generated by RNA-seq analysis of the J. curcas transcriptome. A total of 33,363 and 912 complete or partial coding sequences (CDSs) were determined by protein database alignments and ESTScan prediction, respectively. Among these unigenes, more than 41.52% were involved in approximately 128 known metabolic or signaling pathways, and 4,185 were possibly associated with cold resistance. DGE analysis was used to assess the changes in gene expression when exposed to cold condition (12 degrees C) for 12, 24, and 48 h. The results showed that 3,178 genes were significantly upregulated and 1,244 were downregulated under cold stress. These genes were then functionally annotated based on the transcriptome data from RNA-seq analysis. Conclusions: This study provides a global view of transcriptome response and gene expression profiling of J. curcas in response to cold stress. The results can help improve our current understanding of the mechanisms underlying plant cold resistance and favor the screening of crucial genes for genetically enhancing cold resistance in J. curcas.	[Wang, Haibo; Zou, Zhurong; Wang, Shasha; Gong, Ming] Yunnan Normal Univ, Key Lab Biomass Energy & Environm Biotechnol Yunn, Engn Res Ctr Sustainable Dev & Utilizat Biomass E, Sch Life Sci,Minist Educ, Kunming, Yunnan, Peoples R China; [Wang, Haibo] Qujing Normal Univ, Coll Biol Resources & Environm Sci, Qujing, Yunnan, Peoples R China	Yunnan Normal University	Gong, M (corresponding author), Yunnan Normal Univ, Key Lab Biomass Energy & Environm Biotechnol Yunn, Engn Res Ctr Sustainable Dev & Utilizat Biomass E, Sch Life Sci,Minist Educ, Kunming, Yunnan, Peoples R China.	gongming6307@163.com	Wang, Huanan/N-1971-2013; Leeuwenburgh, S.C.G./L-4483-2015; Oner, FC/L-7769-2013	Leeuwenburgh, S.C.G./0000-0003-1471-6133; Oner, FC/0000-0003-0858-8243; Alblas, Jacqueline/0000-0002-2996-9697; Dhert, Wouter/0000-0001-9150-6143; Weinans, Harrie/0000-0002-2275-6170	National Foundations of Natural Sciences, China [31260064, 31060160, 31160169]; Education Bureau of Yunnan Province [ZD2010004, 2010Z087]	National Foundations of Natural Sciences, China; Education Bureau of Yunnan Province	This work was supported by several grants from the National Foundations of Natural Sciences, China (No. 31260064 to MG, No. 31060160, 31160169 to ZZ) and the Education Bureau of Yunnan Province (No. ZD2010004 to MG, No. 2010Z087 to ZZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Anisimov SV, 2008, CURR PHARM BIOTECHNO, V9, P338, DOI 10.2174/138920108785915148; Ao PX, 2013, ACTA PHYSIOL PLANT, V35, P153, DOI 10.1007/s11738-012-1058-z; Asif MH, 2010, TREE GENET GENOMES, V6, P941, DOI 10.1007/s11295-010-0303-0; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Biello D, 2009, SCI AM, V19, P68; Bies-Etheve N, 2008, PLANT MOL BIOL, V67, P107, DOI 10.1007/s11103-008-9304-x; Bogdanovic J, 2008, EUR BIOPHYS J BIOPHY, V37, P1241, DOI 10.1007/s00249-008-0260-9; Bravo LA, 2003, PHYSIOL PLANTARUM, V118, P262, DOI 10.1034/j.1399-3054.2003.00060.x; Carels N, 2009, ADV BOT RES, V50, P39, DOI 10.1016/S0065-2296(08)00802-1; Carvalho CR, 2008, PLANT SCI, V174, P613, DOI 10.1016/j.plantsci.2008.03.010; Chinnusamy V, 2003, GENE DEV, V17, P1043, DOI 10.1101/gad.1077503; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; Costa GGL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-462; Dahmer N, 2009, CROP BREED APPL BIOT, V9, P386, DOI 10.12702/1984-7033.v09n04a14; Danyluk J, 1998, PLANT CELL, V10, P623, DOI 10.1105/tpc.10.4.623; Deore AC, 2008, PLANT BIOTECHNOL REP, V2, P7, DOI 10.1007/s11816-008-0042-y; Dhonukshe P, 2003, PLANT CELL, V15, P2666, DOI 10.1105/tpc.014977; Dong CH, 2006, P NATL ACAD SCI USA, V103, P8281, DOI 10.1073/pnas.0602874103; Fairless D, 2007, NATURE, V449, P652, DOI 10.1038/449652a; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fursova OV, 2009, GENE, V429, P98, DOI 10.1016/j.gene.2008.10.016; Gardiner JC, 2001, PLANT CELL, V13, P2143, DOI 10.1105/tpc.13.9.2143; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Gong ZZ, 2002, P NATL ACAD SCI USA, V99, P11507, DOI 10.1073/pnas.172399299; Goulas E, 2006, PLANT J, V47, P720, DOI 10.1111/j.1365-313X.2006.02821.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo Z, 2006, PLANT PHYSIOL BIOCH, V44, P828, DOI 10.1016/j.plaphy.2006.10.024; Hendrickson L, 2006, FEBS LETT, V580, P4959, DOI 10.1016/j.febslet.2006.07.081; Hurry V, 2000, PLANT J, V24, P383, DOI 10.1046/j.1365-313x.2000.00888.x; Ivanov AG, 2006, PLANT CELL PHYSIOL, V47, P1146, DOI 10.1093/pcp/pcj089; Jha TB, 2007, PLANT BIOTECHNOL REP, V1, P135, DOI 10.1007/s11816-007-0027-2; Johnson TS, 2011, PLANT CELL REP, V30, P1573, DOI 10.1007/s00299-011-1083-1; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; Kiegle E, 2000, PLANT J, V23, P267, DOI 10.1046/j.1365-313x.2000.00786.x; Korn M, 2008, PLANT CELL ENVIRON, V31, P813, DOI 10.1111/j.1365-3040.2008.01800.x; KOSTER KL, 1992, PLANT PHYSIOL, V98, P108, DOI 10.1104/pp.98.1.108; Krinke O, 2007, J EXP BOT, V58, P361, DOI 10.1093/jxb/erl220; Kumar GRK, 2011, ANAL BIOCHEM, V413, P63, DOI 10.1016/j.ab.2011.01.046; Lee H, 2002, EMBO J, V21, P2692, DOI 10.1093/emboj/21.11.2692; Lee HJ, 2001, GENE DEV, V15, P912, DOI 10.1101/gad.866801; Li ZhongGuang, 2011, Seed, V30, P4; Mangelsen E, 2011, MOL PLANT, V4, P97, DOI 10.1093/mp/ssq058; Miranda JA, 2007, PLANTA, V226, P1411, DOI 10.1007/s00425-007-0579-y; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Nakaminami K, 2006, P NATL ACAD SCI USA, V103, P10122, DOI 10.1073/pnas.0603168103; Natarajan P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-191; Natarajan P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-606; Openshaw K, 2000, BIOMASS BIOENERG, V19, P1, DOI 10.1016/S0961-9534(00)00019-2; PAPAGEORGIOU GC, 1995, PHOTOSYNTH RES, V44, P243, DOI 10.1007/BF00048597; Pramanik MHR, 2005, PLANT MOL BIOL, V58, P751, DOI 10.1007/s11103-005-7404-4; Puhakainen T, 2004, PLANT MOL BIOL, V54, P743, DOI 10.1023/B:PLAN.0000040903.66496.a4; Ruelland E, 2009, ADV BOT RES, V49, P35, DOI 10.1016/S0065-2296(08)00602-2; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Sasaki K, 2007, BIOCHEM BIOPH RES CO, V364, P633, DOI 10.1016/j.bbrc.2007.10.059; Sato S, 2011, DNA RES, V18, P65, DOI 10.1093/dnares/dsq030; SIMINOVITCH D, 1981, CRYOBIOLOGY, V18, P166, DOI 10.1016/0011-2240(81)90088-2; Soontornchainaksaeng P., 2003, Thai Forest Bulletin (Botany), P105; Strand A, 2003, PLANT CELL ENVIRON, V26, P523, DOI 10.1046/j.1365-3040.2003.00983.x; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; Uemura M, 1997, PLANT PHYSIOL, V114, P1493, DOI 10.1104/pp.114.4.1493; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; Wang CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023632; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; Yang CY, 2012, RENEW SUST ENERG REV, V16, P2178, DOI 10.1016/j.rser.2012.01.043; Ye J, 2009, PLANT BIOTECHNOL J, V7, P964, DOI 10.1111/j.1467-7652.2009.00457.x; Yoav Benjamini, 2001, Behavioural Brain Research, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Zarka DG, 2003, PLANT PHYSIOL, V133, P910, DOI 10.1104/pp.103.027169; Zhu J, 2008, P NATL ACAD SCI USA, V105, P4945, DOI 10.1073/pnas.0801029105; Zuther E, 2004, FEBS LETT, V576, P169, DOI 10.1016/j.febslet.2004.09.006	72	175	202	9	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82817	10.1371/journal.pone.0082817	http://dx.doi.org/10.1371/journal.pone.0082817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349370	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200103
J	Cunningham, SJ; Kruger, AC; Nxumalo, MP; Hockey, PAR				Cunningham, Susan J.; Kruger, Andries C.; Nxumalo, Mthobisi P.; Hockey, Philip A. R.			Identifying Biologically Meaningful Hot-Weather Events Using Threshold Temperatures That Affect Life-History	PLOS ONE			English	Article							CLIMATE-CHANGE; MORTALITY; EXTREMES; FITNESS; RANGE; BIRDS	Increases in the frequency, duration and intensity of heat waves are frequently evoked in climate change predictions. However, there is no universal definition of a heat wave. Recent, intense hot weather events have caused mass mortalities of birds, bats and even humans, making the definition and prediction of heat wave events that have the potential to impact populations of different species an urgent priority. One possible technique for defining biologically meaningful heat waves is to use threshold temperatures (T-thresh) above which known fitness costs are incurred by species of interest. We set out to test the utility of this technique using T-thresh values that, when exceeded, affect aspects of the fitness of two focal southern African bird species: the southern pied babbler Turdiodes bicolor (T-thresh = 35.5 degrees C) and the common fiscal Lanius collaris (T-thresh = 33 degrees C). We used these T-thresh values to analyse trends in the frequency, duration and intensity of heat waves of magnitude relevant to the focal species, as well as the annual number of hot days (maximum air temperature > T-thresh), in north-western South Africa between 1961 and 2010. Using this technique, we were able to show that, while all heat wave indices increased during the study period, most rapid increases for both species were in the annual number of hot days and in the maximum intensity (and therefore intensity variance) of biologically meaningful heat waves. Importantly, we also showed that warming trends were not uniform across the study area and that geographical patterns in warming allowed both areas of high risk and potential climate refugia to be identified. We discuss the implications of the trends we found for our focal species, and the utility of the T-thresh technique as a conservation tool.	[Cunningham, Susan J.; Hockey, Philip A. R.] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa; [Kruger, Andries C.; Nxumalo, Mthobisi P.] South African Weather Serv, Climate Serv, Pretoria, South Africa	National Research Foundation - South Africa; University of Cape Town; South African Weather Service (SAWS)	Cunningham, SJ (corresponding author), Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa.	susie.j.c@gmail.com	Iwaniuk, Andrew/H-7255-2019; Cunningham, Susan/AAR-3915-2020; Castro, Isabel C/B-4447-2011; Castro, Isabel/L-7653-2019	Iwaniuk, Andrew/0000-0001-9273-3655; Cunningham, Susan/0000-0001-9934-2585; Castro, Isabel C/0000-0002-3335-2024; Castro, Isabel/0000-0002-3335-2024; Parsons, Stuart/0000-0003-1025-5616	DST/NRF Centre of Excellence grant	DST/NRF Centre of Excellence grant(Department of Science & Technology (India))	The work was supported by DST/NRF Centre of Excellence grant to PARH and SJC. www.fitzpatrick.uct.ac.za. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoon I., 2011, S AFRICAN RISK VULNE; Angert AL, 2011, INTEGR COMP BIOL, V51, P733, DOI 10.1093/icb/icr048; Angilletta MJ, 2011, INTEGR COMP BIOL, V51, P653, DOI 10.1093/icb/icr091; Angilletta Michael J Jr, 2010, Front Biosci (Elite Ed), V2, P861; Bolger DT, 2005, OECOLOGIA, V142, P398, DOI 10.1007/s00442-004-1734-9; Both C, 2004, P ROY SOC B-BIOL SCI, V271, P1657, DOI 10.1098/rspb.2004.2770; Calder W.A., 1974, AVIAN BIOL, V4, P259; Cunningham SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074613; Dean W. R. J., 2005, ROBERTS BIRDS SO AFR, P811; Donald PF, 2012, J ORNITHOL, V153, P1031, DOI 10.1007/s10336-012-0832-4; du Plessis KL, 2012, GLOBAL CHANGE BIOL, V18, P3063, DOI 10.1111/j.1365-2486.2012.02778.x; Dunn PO, 1999, P ROY SOC B-BIOL SCI, V266, P2487, DOI 10.1098/rspb.1999.0950; FINLAYSON H. H., 1932, SO AUSTRALIAN ORNITHOL, V11, P158; Harrison J. A., 1997, ATLAS SO AFRICAN BIR, VII; Herremans M, 1997, ATLAS SO AFRICAN BIR, V2, P128; Immelmann K., 1973, P121; Jiguet F, 2010, GLOBAL CHANGE BIOL, V16, P497, DOI 10.1111/j.1365-2486.2009.01963.x; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Klein Tank A.M.G., 2009, 72 WCDMP, P49; Kruger AC, 2013, INT J CLIMATOL, V33, P661, DOI 10.1002/joc.3455; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; McKechnie AE, 2012, EMU, V112, pI, DOI 10.1071/MUv112n2_ED; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Moise AF, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009250; Moses MR, 2012, OECOLOGIA, V168, P257, DOI 10.1007/s00442-011-2073-2; New M, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006289; Parry M., 2007, CLIMATE CHANGE 2007, P7, DOI DOI 10.2134/JEQ2008.0015BR; Schwagmeyer PL, 2008, ANIM BEHAV, V75, P291, DOI 10.1016/j.anbehav.2007.05.023; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Towie N, 2009, 1000 BIRDS DIE SWELT; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Whitman S, 1997, AM J PUBLIC HEALTH, V87, P1515, DOI 10.2105/AJPH.87.9.1515; Wolf BO, 1996, J EXP BIOL, V199, P451; [No title captured]	35	73	75	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82492	10.1371/journal.pone.0082492	http://dx.doi.org/10.1371/journal.pone.0082492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24244601	Green Published, gold, Green Submitted			2022-12-27	WOS:000327949300156
J	Gao, YR; Choe, AS; Stepniewska, I; Li, X; Avison, MJ; Anderson, AW				Gao, Yurui; Choe, Ann S.; Stepniewska, Iwona; Li, Xia; Avison, Malcolm J.; Anderson, Adam W.			Validation of DTI Tractography-Based Measures of Primary Motor Area Connectivity in the Squirrel Monkey Brain	PLOS ONE			English	Article							WHITE-MATTER; DIFFUSION; TRACKING; MRI; RESOLUTION; PATHWAYS; SEGMENTATION; ACCURACY; DORSAL; TRACTS	Diffusion tensor imaging (DTI) tractography provides noninvasive measures of structural cortico-cortical connectivity of the brain. However, the agreement between DTI-tractography-based measures and histological 'ground truth' has not been quantified. In this study, we reconstructed the 3D density distribution maps (DDM) of fibers labeled with an anatomical tracer, biotinylated dextran amine (BDA), as well as DTI tractography-derived streamlines connecting the primary motor (M1) cortex to other cortical regions in the squirrel monkey brain. We evaluated the agreement in M1-cortical connectivity between the fibers labeled in the brain tissue and DTI streamlines on a regional and voxel-by-voxel basis. We found that DTI tractography is capable of providing inter-regional connectivity comparable to the neuroanatomical connectivity, but is less reliable measuring voxel-to-voxel variations within regions.	[Gao, Yurui; Choe, Ann S.; Anderson, Adam W.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Gao, Yurui; Choe, Ann S.; Li, Xia; Avison, Malcolm J.; Anderson, Adam W.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA; [Stepniewska, Iwona] Vanderbilt Univ, Dept Psychol, Nashville, TN 37235 USA; [Avison, Malcolm J.; Anderson, Adam W.] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA; [Avison, Malcolm J.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA; [Avison, Malcolm J.] Vanderbilt Univ, Dept Neurol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Gao, YR (corresponding author), Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA.	yurui.gao@vanderbilt.edu	AS, Choe/I-2637-2019; Gao, Yurui/W-4327-2017	AS, Choe/0000-0001-7352-1489; 	National Institutes of Health [R01-NS58639, R01-DA028303, 1S10 RR 17789]; NIH [CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, U24DK059637, P30DK058404, P60DK020593, U2CDK059637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by National Institutes of Health grants R01-NS58639, R01-DA028303 and 1S10 RR 17789. Experiments were performed in part through the use of the VUMC Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637 and EY08126). The funders has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Alexander DC, 2001, IEEE T MED IMAGING, V20, P1131, DOI 10.1109/42.963816; Anderson AW, 2001, MAGNET RESON MED, V46, P1174, DOI 10.1002/mrm.1315; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Cho KH, 2008, NEUROIMAGE, V42, P262, DOI 10.1016/j.neuroimage.2008.03.053; Choe AS, 2011, MAGN RESON IMAGING, V29, P683, DOI 10.1016/j.mri.2011.02.022; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; D'Arceuil HE, 2007, NEUROIMAGE, V35, P553, DOI 10.1016/j.neuroimage.2006.12.028; Dauguet J, 2007, NEUROIMAGE, V37, P530, DOI 10.1016/j.neuroimage.2007.04.067; Dyrby TB, 2007, NEUROIMAGE, V37, P1267, DOI 10.1016/j.neuroimage.2007.06.022; Friman O, 2006, IEEE T MED IMAGING, V25, P965, DOI 10.1109/TMI.2006.877093; Hagmann P, 2003, NEUROIMAGE, V19, P545, DOI 10.1016/S1053-8119(03)00142-3; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Huang H, 2004, MAGN RESON MED, V52, P559, DOI 10.1002/mrm.20147; Hubbard PL, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P353, DOI 10.1016/B978-0-12-374709-9.00016-X; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Lawes INC, 2008, NEUROIMAGE, V39, P62, DOI 10.1016/j.neuroimage.2007.06.041; Lazar M, 2005, NEUROIMAGE, V24, P524, DOI 10.1016/j.neuroimage.2004.08.050; Lazar M, 2003, NEUROIMAGE, V20, P1140, DOI 10.1016/S1053-8119(03)00277-5; Li CM, 2008, LECT NOTES COMPUT SC, V5242, P1083; Marchi V., 1885, RIV SPER FRENIATRIA, V11, P492; Morecraft RJ, 2009, CLASSIC CONT NEURAL, P274; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; NAUTA WJH, 1993, J NEUROSCI, V13, P1337; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Parker GJM, 2005, NEUROIMAGE, V24, P656, DOI 10.1016/j.neuroimage.2004.08.047; Parker GJM, 2003, J MAGN RESON IMAGING, V18, P242, DOI 10.1002/jmri.10350; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Poupon C, 2000, NEUROIMAGE, V12, P184, DOI 10.1006/nimg.2000.0607; Preuss TM, 1996, J COMP NEUROL, V371, P649, DOI 10.1002/(SICI)1096-9861(19960805)371:4<649::AID-CNE12>3.0.CO;2-E; Reiner A, 2000, J NEUROSCI METH, V103, P23, DOI 10.1016/S0165-0270(00)00293-4; Rohde GK, 2003, IEEE T MED IMAGING, V22, P1470, DOI 10.1109/TMI.2003.819299; Seehaus AK, 2013, CEREB CORTEX, V23, P442, DOI 10.1093/cercor/bhs036; Singer C., 1952, VESALIUS HUMAN BRAIN; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; STEPNIEWSKA I, 1993, J COMP NEUROL, V330, P238, DOI 10.1002/cne.903300207; TOGA AW, 1994, NEUROIMAGE, V1, P334, DOI 10.1006/nimg.1994.1018; Vercelli A, 2000, BRAIN RES B, V51; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Westin CF, 2002, MED IMAGE ANAL, V6, P93, DOI 10.1016/S1361-8415(02)00053-1	50	80	80	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2013	8	10							e75065	10.1371/journal.pone.0075065	http://dx.doi.org/10.1371/journal.pone.0075065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	231OR	24349360	Green Published, Green Submitted, gold			2022-12-27	WOS:000325427100015
J	Debieu, M; Tang, C; Stich, B; Sikosek, T; Effgen, S; Josephs, E; Schmitt, J; Nordborg, M; Koornneef, M; de Meaux, J				Debieu, Marilyne; Tang, Chunlao; Stich, Benjamin; Sikosek, Tobias; Effgen, Sigi; Josephs, Emily; Schmitt, Johanna; Nordborg, Magnus; Koornneef, Maarten; de Meaux, Juliette			Co-Variation between Seed Dormancy, Growth Rate and Flowering Time Changes with Latitude in Arabidopsis thaliana	PLOS ONE			English	Article							NATURAL ALLELIC VARIATION; GENOME-WIDE ASSOCIATION; LIFE-HISTORY; GENETIC-VARIATION; CLINAL VARIATION; PLANT-GROWTH; LOCUS-C; GERMINATION; ADAPTATION; SELECTION	Life-history traits controlling the duration and timing of developmental phases in the life cycle jointly determine fitness. Therefore, life-history traits studied in isolation provide an incomplete view on the relevance of life-cycle variation for adaptation. In this study, we examine genetic variation in traits covering the major life history events of the annual species Arabidopsis thaliana: seed dormancy, vegetative growth rate and flowering time. In a sample of 112 genotypes collected throughout the European range of the species, both seed dormancy and flowering time follow a latitudinal gradient independent of the major population structure gradient. This finding confirms previous studies reporting the adaptive evolution of these two traits. Here, however, we further analyze patterns of co-variation among traits. We observe that co-variation between primary dormancy, vegetative growth rate and flowering time also follows a latitudinal cline. At higher latitudes, vegetative growth rate is positively correlated with primary dormancy and negatively with flowering time. In the South, this trend disappears. Patterns of trait co-variation change, presumably because major environmental gradients shift with latitude. This pattern appears unrelated to population structure, suggesting that changes in the coordinated evolution of major life history traits is adaptive. Our data suggest that A. thaliana provides a good model for the evolution of trade-offs and their genetic basis.	[Debieu, Marilyne] CNRS UMR2594, Lab Interact Plantes Microorganismes, Castanet Tolosan, France; [Debieu, Marilyne; Effgen, Sigi; Koornneef, Maarten; de Meaux, Juliette] Max Planck Inst Plant Breeding Res, Dept Plant Breeding & Genet, Cologne, Germany; [Tang, Chunlao] Univ So Calif, Los Angeles, CA USA; [Stich, Benjamin] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Sikosek, Tobias; de Meaux, Juliette] Univ Munster, Inst Evolut & Biodivers, D-48149 Munster, Germany; [Josephs, Emily] Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA; [Schmitt, Johanna] Univ Calif Davis, Davis, CA USA; [Nordborg, Magnus] Gregor Mendel Inst Mol Plant Biol, Vienna, Austria; [Koornneef, Maarten] Wageningen Univ, Genet Lab, NL-6700 AP Wageningen, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Max Planck Society; University of Southern California; Max Planck Society; University of Munster; Brown University; University of California System; University of California Davis; Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); Wageningen University & Research	Debieu, M (corresponding author), CNRS UMR2594, Lab Interact Plantes Microorganismes, Castanet Tolosan, France.	marilyne.debieu@gmail.com	Sikosek, Tobias/E-4939-2014	Sikosek, Tobias/0000-0001-9929-3525; de Meaux, Juliette/0000-0002-2942-4750; Nordborg, Magnus/0000-0001-7178-9748; Koornneef, Maarten/0000-0002-7759-4869	Max Planck Gesellschaft; Deutsche Forschungsgemeinschaft [SFB680]	Max Planck Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Max Planck Gesellschaft and the Deutsche Forschungsgemeinschaft (SFB680). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSSEN LW, 1992, J ECOL, V80, P109, DOI 10.2307/2261067; Agren J, 2012, NEW PHYTOL, V194, P1112, DOI 10.1111/j.1469-8137.2012.04112.x; Alonso-Blanco C, 2003, GENETICS, V164, P711; Alonso-Blanco C, 2009, PLANT CELL, V21, P1877, DOI 10.1105/tpc.109.068114; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Baskin CC, 1998, SEEDS, P1, DOI 10.1016/B978-012080260-9/50001-4; Baskin JM, 2004, SEED SCI RES, V14, P1, DOI 10.1079/SSR2003150; BASKIN JM, 1983, BOT GAZ, V144, P540, DOI 10.1086/337408; Beck JB, 2008, MOL ECOL, V17, P902, DOI 10.1111/j.1365-294X.2007.03615.x; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; BIERE A, 1991, J EVOLUTION BIOL, V4, P447, DOI 10.1046/j.1420-9101.1991.4030447.x; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Burke S, 2005, ECOL ENTOMOL, V30, P613, DOI 10.1111/j.0307-6946.2005.00741.x; Cadman CSC, 2006, PLANT J, V46, P805, DOI 10.1111/j.1365-313X.2006.02738.x; Caicedo AL, 2004, P NATL ACAD SCI USA, V101, P15670, DOI 10.1073/pnas.0406232101; Chiang GCK, 2009, P NATL ACAD SCI USA, V106, P11661, DOI 10.1073/pnas.0901367106; de Casas RR, 2012, NEW PHYTOL, V194, P868, DOI 10.1111/j.1469-8137.2012.04097.x; Donohue K, 2005, EVOLUTION, V59, P758, DOI 10.1111/j.0014-3820.2005.tb01751.x; Donohue K, 2005, EVOLUTION, V59, P771, DOI 10.1111/j.0014-3820.2005.tb01752.x; Donohue K, 2002, ECOLOGY, V83, P1006, DOI 10.1890/0012-9658(2002)083[1006:GTINSO]2.0.CO;2; El-Lithy ME, 2004, PLANT PHYSIOL, V135, P444, DOI 10.1104/pp.103.036822; Endler J.A., 1977, Monographs in Population Biology, pi; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Fournier-Level A, 2011, SCIENCE, V334, P86, DOI 10.1126/science.1209271; Francois O, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000075; GEBER MA, 1990, EVOLUTION, V44, P799, DOI 10.1111/j.1558-5646.1990.tb03806.x; Griffith C, 2004, AM J BOT, V91, P837, DOI 10.3732/ajb.91.6.837; GROSS KL, 1991, OECOLOGIA, V87, P270, DOI 10.1007/BF00325266; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; HILHORST HWM, 1995, SEED SCI RES, V5, P61, DOI 10.1017/S0960258500002634; Hoffmann MH, 2005, EVOLUTION, V59, P1425; Hopkins R, 2008, NEW PHYTOL, V179, P155, DOI 10.1111/j.1469-8137.2008.02447.x; Huang XQ, 2010, MOL ECOL, V19, P1335, DOI 10.1111/j.1365-294X.2010.04557.x; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; KALISZ S, 1989, EVOLUTION, V43, P1263, DOI 10.1111/j.1558-5646.1989.tb02573.x; KING D, 1982, THEOR POPUL BIOL, V22, P1, DOI 10.1016/0040-5809(82)90032-6; Kivela SM, 2009, AM NAT, V174, P526, DOI 10.1086/605371; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Korte A, 2012, NAT GENET, V44, P1066, DOI 10.1038/ng.2376; Korves TM, 2007, AM NAT, V169, pE141, DOI 10.1086/513111; Kronholm I, 2012, EVOLUTION, V66, P2287, DOI 10.1111/j.1558-5646.2012.01590.x; Leister D, 1999, PLANT PHYSIOL BIOCH, V37, P671, DOI 10.1016/S0981-9428(00)80097-2; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; Li B, 1998, OECOLOGIA, V115, P293, DOI 10.1007/s004420050519; MASUDA M, 1992, OECOLOGIA, V89, P42, DOI 10.1007/BF00319013; MAYR E, 1956, EVOLUTION, V10, P105, DOI 10.2307/2406103; MCGRAW JB, 1990, TRENDS ECOL EVOL, V5, P251, DOI 10.1016/0169-5347(90)90065-L; Mendez-Vigo B, 2011, PLANT PHYSIOL, V157, P1942, DOI 10.1104/pp.111.183426; Meng PH, 2008, MOL PLANT, V1, P145, DOI 10.1093/mp/ssm014; Metcalf CJE, 2009, ECOL LETT, V12, P593, DOI 10.1111/j.1461-0248.2009.01320.x; Michaels SD, 2009, CURR OPIN PLANT BIOL, V12, P75, DOI 10.1016/j.pbi.2008.09.005; Miller MR, 2007, EVOLUTION, V61, P2, DOI 10.1111/j.1558-5646.2007.00001.x; MitchellOlds T, 1996, EVOLUTION, V50, P140, DOI [10.2307/2410788, 10.1111/j.1558-5646.1996.tb04480.x]; Montesinos A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007213; Montesinos-Navarro A, 2012, EVOLUTION, V66, P3417, DOI 10.1111/j.1558-5646.2012.01689.x; Montesinos-Navarro A, 2011, NEW PHYTOL, V189, P282, DOI 10.1111/j.1469-8137.2010.03479.x; Munguia-Rosas MA, 2011, ECOL LETT, V14, P511, DOI 10.1111/j.1461-0248.2011.01601.x; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Perez-Perez JM, 2002, GENETICS, V162, P893; Pritchard JK, 2000, GENETICS, V155, P945; Rees M, 2006, AM NAT, V168, pE53, DOI 10.1086/505762; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; Rutter MT, 2007, ANN BOT-LONDON, V99, P529, DOI 10.1093/aob/mcl282; Salome PA, 2011, GENETICS, V188, P421, DOI 10.1534/genetics.111.126607; Samis KE, 2012, ECOL EVOL, V2, P1162, DOI 10.1002/ece3.262; Schmuths H, 2006, ANN BOT-LONDON, V97, P623, DOI 10.1093/aob/mcl012; Sharbel TF, 2000, MOL ECOL, V9, P2109, DOI 10.1046/j.1365-294X.2000.01122.x; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Stearns S.C., 1992, pi; Stillwell RC, 2007, AM NAT, V170, P358, DOI 10.1086/520118; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; Stratton DA, 1998, HEREDITY, V81, P144, DOI 10.1046/j.1365-2540.1998.00369.x; Vleeshouwers LM, 1995, J ECOL, V83, P1031, DOI 10.2307/2261184; Wagmann K, 2012, ANN BOT, P1; Warthmann N, 2007, BIOINFORMATICS, V23, P2784, DOI 10.1093/bioinformatics/btm428; Weinig C, 2002, GENETICS, V162, P1875; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826	80	171	182	2	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2013	8	5							e61075	10.1371/journal.pone.0061075	http://dx.doi.org/10.1371/journal.pone.0061075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	151BM	24349402	Green Published, Green Submitted, gold			2022-12-27	WOS:000319435600002
J	Zeng, JG; Liu, YS; Liu, W; Liu, XB; Liu, FQ; Huang, P; Zhu, PC; Chen, JJ; Shi, MM; Guo, F; Cheng, P; Zeng, J; Liao, YF; Gong, J; Zhang, HM; Wang, DP; Guo, AY; Xiong, XY				Zeng, Jianguo; Liu, Yisong; Liu, Wei; Liu, Xiubing; Liu, Fuqing; Huang, Peng; Zhu, Pengcheng; Chen, Jinjun; Shi, Mingming; Guo, Fang; Cheng, Pi; Zeng, Jing; Liao, Yifang; Gong, Jing; Zhang, Hong-Mei; Wang, Depeng; Guo, An-Yuan; Xiong, Xingyao			Integration of Transcriptome, Proteome and Metabolism Data Reveals the Alkaloids Biosynthesis in Macleaya cordata and Macleaya microcarpa	PLOS ONE			English	Article							CANADENSIS CELL-CULTURES; RNA-SEQ DATA; OPIUM POPPY; DIHYDROBENZOPHENANTHRIDINE OXIDASE; SANGUINARINE REDUCTASE; MASS-SPECTROMETRY; MOLECULAR-CLONING; SAFETY ASSESSMENT; REFERENCE GENOME; SIEVE ELEMENTS	Background: The Macleaya spp., including Macleaya cordata and Macleaya microcarpa, are traditional anti-virus, inflammation eliminating, and insecticide herb medicines for their isoquinoline alkaloids. They are also known as the basis of the popular natural animal food addictive in Europe. However, few studies especially at genomics level were conducted on them. Hence, we performed the Macleaya spp. transcriptome and integrated it with iTRAQ proteome analysis in order to identify potential genes involved in alkaloids biosynthesis. Methodology and Principal Findings: We elaborately designed the transcriptome, proteome and metabolism profiling for 10 samples of both species to explore their alkaloids biosynthesis. From the transcriptome data, we obtained 69367 and 78255 unigenes for M. cordata and M. microcarpa, in which about two thirds of them were similar to sequences in public databases. By metabolism profiling, reverse patterns for alkaloids sanguinarine, chelerythrine, protopine, and allocryptopine were observed in different organs of two species. We characterized the expressions of enzymes in alkaloid biosynthesis pathways. We also identified more than 1000 proteins from iTRAQ proteome data. Our results strongly suggest that the root maybe the organ for major alkaloids biosynthesis of Macleaya spp. Except for biosynthesis, the alkaloids storage and transport were also important for their accumulation. The ultrastructure of laticifers by SEM helps us to prove the alkaloids maybe accumulated in the mature roots. Conclusions/Significance: To our knowledge this is the first study to elucidate the genetic makeup of Macleaya spp. This work provides clues to the identification of the potential modulate genes involved in alkaloids biosynthesis in Macleaya spp., and sheds light on researches for non-model medicinal plants by integrating different high-throughput technologies.	[Zeng, Jianguo; Liu, Yisong; Liu, Xiubing; Zhu, Pengcheng; Chen, Jinjun; Xiong, Xingyao] Hunan Agr Univ, Hunan Prov Key Lab Crop Germplasm Innovat & Utili, Changsha, Hunan, Peoples R China; [Zeng, Jianguo; Liu, Yisong; Liu, Xiubing; Zhu, Pengcheng; Chen, Jinjun; Xiong, Xingyao] Hunan Agr Univ, Natl Chinese Med Herbs Hunan Technol Ctr, Changsha, Hunan, Peoples R China; [Liu, Wei; Liao, Yifang; Gong, Jing; Zhang, Hong-Mei; Guo, An-Yuan] Huazhong Univ Sci & Technol, Dept Biomed Engn, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Liu, Wei; Liao, Yifang; Gong, Jing; Zhang, Hong-Mei; Wang, Depeng] Next Biosci Co Ltd, Wuhan, Peoples R China; [Shi, Mingming; Guo, Fang] BGI Shenzhen, Shenzhen, Peoples R China	Hunan Agricultural University; Hunan Agricultural University; Huazhong University of Science & Technology; Beijing Genomics Institute (BGI)	Guo, AY (corresponding author), Huazhong Univ Sci & Technol, Dept Biomed Engn, Coll Life Sci & Technol, Wuhan 430074, Peoples R China.	zengjianguo@hunau.net; guoay@mail.hust.edu.cn; xiongxy@hunau.net	Huang, Peng/AAJ-9432-2021; Guo, An-Yuan/K-3656-2012; Feng, Yuan/F-7295-2012	Huang, Peng/0000-0002-8367-8196; Chen, Wei/0000-0003-2275-4527; , Jinjun/0000-0001-5495-051X; Feng, Yuan/0000-0002-6369-0737	China-Belgium Cooperation Research on Plants Medicine Utilization & Crop Pests Forecasting and Control Technology [2010DFA32810]; National Key technology R&D Program for demonstration of neotype Chinese herbal veterinary drugs [2011BAD34B02]; National Natural Science Foundation of China [31171271]; Young Teachers' Fund for Doctor Stations; Ministry of Education of China [20110142120042]	China-Belgium Cooperation Research on Plants Medicine Utilization & Crop Pests Forecasting and Control Technology; National Key technology R&D Program for demonstration of neotype Chinese herbal veterinary drugs(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Teachers' Fund for Doctor Stations; Ministry of Education of China(Ministry of Education, China)	This work was supported by China-Belgium Cooperation Research on Plants Medicine Utilization & Crop Pests Forecasting and Control Technology (2010DFA32810), the National Key technology R&D Program (2011BAD34B02) for demonstration of neotype Chinese herbal veterinary drugs, National Natural Science Foundation of China (31171271), Young Teachers' Fund for Doctor Stations, Ministry of Education of China (20110142120042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKAWA H, 1992, ARCH BIOCHEM BIOPHYS, V299, P1, DOI 10.1016/0003-9861(92)90236-P; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barkan A, 2009, METHODS MOL BIOL, V553, P13, DOI 10.1007/978-1-60327-563-7_2; Bird DA, 2003, PLANT CELL, V15, P2626, DOI 10.1105/tpc.015396; Chen YZ, 2009, J CHROMATOGR A, V1216, P2104, DOI 10.1016/j.chroma.2008.08.066; Chow KS, 2011, J EXP BOT; Desgagne-Penix I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-252; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Facchini Peter J., 2007, Phytochemistry Reviews, V6, P97, DOI 10.1007/s11101-006-9042-0; Franz C, 2005, CFTEFSAFEEDAP200501; Fuchino H, 2010, CHEM PHARM BULL, V58, P1047, DOI 10.1248/cpb.58.1047; Glen A, 2008, J PROTEOME RES, V7, P897, DOI 10.1021/pr070378x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Ignatov A, 1996, PHYTOCHEMISTRY, V43, P1141, DOI 10.1016/S0031-9422(96)00540-7; Ikezawa N, 2009, PLANT CELL REP, V28, P123, DOI 10.1007/s00299-008-0624-8; Ikezawa N, 2007, FEBS J, V274, P1019, DOI 10.1111/j.1742-4658.2007.05652.x; Jensen K, 2010, PHYTOCHEMISTRY, V71, P132, DOI 10.1016/j.phytochem.2009.10.017; Juskiewicz J, 2011, J ANIM PHYSIOL AN N, V95, P171, DOI 10.1111/j.1439-0396.2010.01037.x; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kosina P, 2010, FITOTERAPIA, V81, P1006, DOI 10.1016/j.fitote.2010.06.020; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Liu H, 2009, NAT PROD COMMUN, V4, P1557; NESSLER CL, 1992, PLANT MOL BIOL, V20, P749, DOI 10.1007/BF00046460; Park SU, 2002, PLANT PHYSIOL, V128, P696, DOI 10.1104/pp.010741; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Psotova J, 2006, VET MED-CZECH, V51, P145, DOI 10.17221/5534-VETMED; RUEFFER M, 1987, TETRAHEDRON LETT, V28, P5307, DOI 10.1016/S0040-4039(00)96715-7; Samanani N, 2006, PLANT J, V47, P547, DOI 10.1111/j.1365-313X.2006.02801.x; Shitan N, 2007, CURR PHARM BIOTECHNO, V8, P244; Stiborova M, 2008, BIOMED PAP, V152, P35, DOI 10.5507/bp.2008.005; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Urbanczyk-Wochniak E, 2003, EMBO REP, V4, P989, DOI 10.1038/sj.embor.embor944; Verrier PJ, 2008, TRENDS PLANT SCI, V13, P151, DOI 10.1016/j.tplants.2008.02.001; Vichkanova S.A., 1982, PHARM CHEM J+, V16, P925, DOI [10.1007/BF00767855, DOI 10.1007/BF00767855]; Vogel M, 2010, J BIOL CHEM, V285, P18397, DOI 10.1074/jbc.M109.088989; Vrba J, 2011, TOXICOL LETT, V203, P135, DOI 10.1016/j.toxlet.2011.03.015; Weiss D, 2006, PLANT CELL ENVIRON, V29, P291, DOI 10.1111/j.1365-3040.2005.01421.x; Yang J, 1999, Zhong Yao Cai, V22, P82; Yao JY, 2010, PARASITOL RES, V107, P1035, DOI 10.1007/s00436-010-1966-z; Yazaki K, 2006, FEBS LETT, V580, P1183, DOI 10.1016/j.febslet.2005.12.009; Ye Fengzhi, 2009, Zhongguo Zhong Yao Za Zhi, V34, P1683; Ye HG, 2010, MOL CELL BIOCHEM, V343, P91, DOI 10.1007/s11010-010-0502-x; Zdarilova A, 2008, FOOD CHEM TOXICOL, V46, P3721, DOI 10.1016/j.fct.2008.09.054; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730; Zulak KG, 2007, PLANTA, V225, P1085, DOI 10.1007/s00425-006-0419-5	47	86	103	3	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2013	8	1							e53409	10.1371/journal.pone.0053409	http://dx.doi.org/10.1371/journal.pone.0053409			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	070YR	23326424	Green Submitted, Green Published, gold			2022-12-27	WOS:000313551500068
J	Cunningham, SJ; Corfield, JR; Iwaniuk, AN; Castro, I; Alley, MR; Birkhead, TR; Parsons, S				Cunningham, Susan J.; Corfield, Jeremy R.; Iwaniuk, Andrew N.; Castro, Isabel; Alley, Maurice R.; Birkhead, Tim R.; Parsons, Stuart			The Anatomy of the bill Tip of Kiwi and Associated Somatosensory Regions of the Brain: Comparisons with Shorebirds	PLOS ONE			English	Article							ANAS-PLATYRHYNCHOS L; OYSTERCATCHERS HAEMATOPUS-OSTRALEGUS; NUCLEUS BASALIS PROSENCEPHALI; PIGEON COLUMBA-LIVIA; TRIGEMINAL SYSTEM; FORAGING BEHAVIOR; PREY-DETECTION; FRONTAL TELENCEPHALON; SENSORY PROJECTIONS; PRIMARY AFFERENTS	Three families of probe-foraging birds, Scolopacidae (sandpipers and snipes), Apterygidae (kiwi), and Threskiornithidae (ibises, including spoonbills) have independently evolved long, narrow bills containing clusters of vibration-sensitive mechanoreceptors (Herbst corpuscles) within pits in the bill-tip. These 'bill-tip organs' allow birds to detect buried or submerged prey via substrate-borne vibrations and/or interstitial pressure gradients. Shorebirds, kiwi and ibises are only distantly related, with the phylogenetic divide between kiwi and the other two taxa being particularly deep. We compared the bill-tip structure and associated somatosensory regions in the brains of kiwi and shorebirds to understand the degree of convergence of these systems between the two taxa. For comparison, we also included data from other taxa including waterfowl (Anatidae) and parrots (Psittaculidae and Cacatuidae), non-apterygid ratites, and other probe-foraging and non probe-foraging birds including non-scolopacid shorebirds (Charadriidae, Haematopodidae, Recurvirostridae and Sternidae). We show that the bill-tip organ structure was broadly similar between the Apterygidae and Scolopacidae, however some inter-specific variation was found in the number, shape and orientation of sensory pits between the two groups. Kiwi, scolopacid shorebirds, waterfowl and parrots all shared hypertrophy or near-hypertrophy of the principal sensory trigeminal nucleus. Hypertrophy of the nucleus basorostralis, however, occurred only in waterfowl, kiwi, three of the scolopacid species examined and a species of oystercatcher (Charadriiformes: Haematopodidae). Hypertrophy of the principal sensory trigeminal nucleus in kiwi, Scolopacidae, and other tactile specialists appears to have co-evolved alongside bill-tip specializations, whereas hypertrophy of nucleus basorostralis may be influenced to a greater extent by other sensory inputs. We suggest that similarities between kiwi and scolopacid bill-tip organs and associated somatosensory brain regions are likely a result of similar ecological selective pressures, with inter-specific variations reflecting finer-scale niche differentiation.	[Cunningham, Susan J.] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, ZA-7700 Rondebosch, South Africa; [Cunningham, Susan J.; Castro, Isabel] Massey Univ, Inst Nat Resources, Palmerston North, New Zealand; [Corfield, Jeremy R.; Iwaniuk, Andrew N.] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada; [Alley, Maurice R.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Birkhead, Tim R.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Corfield, Jeremy R.; Parsons, Stuart] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	National Research Foundation - South Africa; University of Cape Town; Massey University; University of Lethbridge; Massey University; University of Sheffield; University of Auckland	Corfield, JR (corresponding author), Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada.	jr.corfield@gmail.com	Iwaniuk, Andrew/H-7255-2019; Cunningham, Susan/AAR-3915-2020; Castro, Isabel C/B-4447-2011; Castro, Isabel/L-7653-2019	Iwaniuk, Andrew/0000-0001-9273-3655; Cunningham, Susan/0000-0001-9934-2585; Castro, Isabel C/0000-0002-3335-2024; Castro, Isabel/0000-0002-3335-2024; Parsons, Stuart/0000-0003-1025-5616	NSERC Discovery Grant [372237]; Tertiary Education Commission New Zealand grant;  [380284-2009]	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Tertiary Education Commission New Zealand grant; 	Funding for this study was provided in part by an NSERC Discovery Grant (372237) and Accelerator Supplement (380284-2009) to ANI and in part through a Tertiary Education Commission New Zealand grant to SJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDS JJA, 1984, NEUROSCIENCE, V13, P781, DOI 10.1016/0306-4522(84)90096-4; ARENDS JJA, 1986, BRAIN RES, V398, P375, DOI 10.1016/0006-8993(86)91499-X; Bancroft J.D., 1996, THEORY PRACTICE HIST, VVolume 6; BANG BG, 1968, AUK, V85, P55; Barbosa A, 1999, AUK, V116, P712; Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; BERKHOUDT H, 1981, J COMP NEUROL, V196, P407, DOI 10.1002/cne.901960305; BERKHOUDT H, 1980, NETH J ZOOL, V30, P1; BOATES JS, 1992, CAN J ZOOL, V70, P2398, DOI 10.1139/z92-321; BOATES JS, 1989, CAN J ZOOL, V67, P2225, DOI 10.1139/z89-314; BOIRE D, 1989, COMP QUANTITATIVE EN; BOLZE G, 1968, Zoologischer Anzeiger, V181, P313; Corfield J, 2008, AUK, V125, P326, DOI 10.1525/auk.2008.06234; Corfield J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023771; Corfield JR, 2008, BRAIN BEHAV EVOLUT, V71, P87, DOI 10.1159/000111456; Corfield JR, 2012, BRAIN BEHAV EVOLUT, V80, P181, DOI 10.1159/000339828; Corfield JR, 2012, JARO-J ASSOC RES OTO, V13, P629, DOI 10.1007/s10162-012-0341-4; Craigie EH, 1940, J COMP NEUROL, V73, P179, DOI 10.1002/cne.900730202; Craigie EH, 1930, J COMP NEUROL, V49, P223, DOI 10.1002/cne.900490202; Cramp S., 1983, BIRDS W PALEARCTIC, V3, P444; Cunningham S, 2007, J ANAT, V211, P493, DOI 10.1111/j.1469-7580.2007.00786.x; Cunningham SJ, 2011, J MORPHOL, V272, P118, DOI 10.1002/jmor.10908; Cunningham SJ, 2010, J AVIAN BIOL, V41, P350, DOI 10.1111/j.1600-048X.2010.05138.x; Cunningham SJ, 2010, AUK, V127, P308, DOI 10.1525/auk.2009.09117; Cunningham SJ, 2009, ANIM BEHAV, V78, P899, DOI 10.1016/j.anbehav.2009.07.015; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; DELIUS JD, 1979, EXP NEUROL, V63, P594, DOI 10.1016/0014-4886(79)90174-2; Demery ZP, 2011, P ROY SOC B-BIOL SCI, V278, P3687, DOI 10.1098/rspb.2011.0374; DUBBELDAM JL, 1978, J COMP NEUROL, V180, P661, DOI 10.1002/cne.901800402; DUBBELDAM JL, 1980, J COMP NEUROL, V191, P557, DOI 10.1002/cne.901910404; DUBBELDAM JL, 1990, NETH J ZOOL, V40, P241; Dubbeldam JL, 1998, ARCH PHYSIOL BIOCHEM, V106, P338, DOI 10.1076/apab.106.5.338.4367; DUBBELDAM JL, 1981, J COMP NEUROL, V196, P391, DOI 10.1002/cne.901960304; Elner RW, 2005, MAR BIOL, V146, P1223, DOI 10.1007/s00227-004-1521-5; Eo SH, 2009, ZOOL SCR, V38, P465, DOI 10.1111/j.1463-6409.2008.00382.x; FUNKE K, 1989, EXP BRAIN RES, V76, P603, DOI 10.1007/BF00248917; Garland T, 2000, AM NAT, V155, P346, DOI 10.1086/303327; GERRITSEN AFC, 1986, NETH J ZOOL, V36, P530, DOI 10.1163/002829686X00216; Gill F, 2013, IOC WORLD BIRD LIST; Gooders J, 1982, COLLINS BRIT BIRDS; Gottschaldt K.-M., 1985, P375; GOTTSCHALDT KM, 1974, CELL TISSUE RES, V153, P477; Goujon D, 1869, J ANAT PHYSL, V6, P449; Gutierrez-Ibanez C, 2011, BRAIN BEHAV EVOLUT, V78, P286, DOI 10.1159/000330359; Gutierrez-Ibanez C, 2009, BRAIN BEHAV EVOLUT, V74, P280, DOI 10.1159/000270904; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HALL WS, 1993, BRAIN BEHAV EVOLUT, V41, P97, DOI 10.1159/000113827; Harshman J, 2008, P NATL ACAD SCI USA, V105, P13462, DOI 10.1073/pnas.0803242105; Heather B., 2005, FIELD GUIDE BIRDS NZ; IGGO A, 1974, P153; Iwaniuk AN, 2006, BEHAV BRAIN RES, V167, P305, DOI 10.1016/j.bbr.2005.09.015; Jerison HJ., 1973, EVOLUTION BRAIN INTE; KEPPIE DM, 1994, BIRDS N AM NUMBER 10; Kubke MF, 2004, BRAIN BEHAV EVOLUT, V63, P169, DOI 10.1159/000076242; Lavin SR, 2008, PHYSIOL BIOCHEM ZOOL, V81, P526, DOI 10.1086/590395; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Luna LG, 1968, MANUAL HISTOLOGIC ST, V3; Maddison WP, 2011, MESQUITE MODULAR SYS; MAEKAWA M, 1987, HEARING RES, V27, P231, DOI 10.1016/0378-5955(87)90004-9; MARTIN GR, 1994, J COMP PHYSIOL A, V174, P787; Martin GR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000198; Martin GR, 2009, P ROY SOC B-BIOL SCI, V276, P437, DOI 10.1098/rspb.2008.1110; Midford P. E., 2010, PDAP PDTREE PACKAGE; MOURITSEN KN, 1994, J AVIAN BIOL, V25, P55, DOI 10.2307/3677294; Nebel S, 2005, ECOL RES, V20, P503, DOI 10.1007/s11284-005-0061-x; Nisbet I.C, 2002, COMMON TERN STERNA H; PETTIGREW JD, 1985, BRAIN BEHAV EVOLUT, V26, P185, DOI 10.1159/000118775; Piersma T, 1998, P ROY SOC B-BIOL SCI, V265, P1377, DOI 10.1098/rspb.1998.0445; Piersma T, 1996, HDB BIRDS WORLD, V3, P444; Piersma T, 2011, IBIS, V153, P659, DOI 10.1111/j.1474-919X.2011.01170.x; Puelles L., 2007, CHICK BRAIN STEREOTA, V1st; RASBAND WS, 1997, MAGEJ; SANTOS ESA, 2010, SO LAPWING VANELLUS; SCHALL U, 1986, CELL TISSUE RES, V245, P539; STINGELI.W, 1965, BIBL ANAT, P1; Swennen Cornelis, 2004, Ornithological Science, V3, P119, DOI 10.2326/osj.3.119; Thomas GH, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-28; Tuckwell J, 1997, CAN J ZOOL, V75, P170, DOI 10.1139/z97-024; Ward BJ, 2012, BIOL LETTERS, V8, P657, DOI 10.1098/rsbl.2011.1180; Wild JM, 2008, J COMP NEUROL, V509, P156, DOI 10.1002/cne.21731; Wild JM, 1996, J COMP NEUROL, V368, P136, DOI 10.1002/(SICI)1096-9861(19960422)368:1<136::AID-CNE9>3.0.CO;2-4; Wild JM, 1997, BRAIN RES, V759, P122, DOI 10.1016/S0006-8993(97)00253-9; Wild JM, 1996, J COMP NEUROL, V365, P306, DOI 10.1002/(SICI)1096-9861(19960205)365:2<306::AID-CNE8>3.0.CO;2-9; WILD JM, 1987, BRAIN RES, V412, P205; WILD JM, 1985, J COMP NEUROL, V234, P441, DOI 10.1002/cne.902340404; Wild JM, 2001, BRAIN BEHAV EVOLUT, V57, P39, DOI 10.1159/000047225; WILD JM, 1981, J COMP NEUROL, V203, P351, DOI 10.1002/cne.902030304; Wild JM, 1997, BRAIN RES, V755, P137, DOI 10.1016/S0006-8993(97)00026-7; WITKOVSKY P, 1973, J COMP NEUROL, V147, P119, DOI 10.1002/cne.901470106; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160; Zweers G.A, 1977, Contributions vert. Evol., V3, P1; Zweers GA, 1997, NETH J ZOOL, V47, P161, DOI 10.1163/156854297X00166	92	73	75	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80036	10.1371/journal.pone.0080036	http://dx.doi.org/10.1371/journal.pone.0080036			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24244601	Green Published, Green Accepted, gold			2022-12-27	WOS:000327143800110
J	Tsai, HH; Lin, HW; Lu, YH; Chen, YL; Mahady, GB				Tsai, Hsin-Hui; Lin, Hsiang-Wen; Lu, Ying-Hung; Chen, Yi-Ling; Mahady, Gail B.			A Review of Potential Harmful Interactions between Anticoagulant/Antiplatelet Agents and Chinese Herbal Medicines	PLOS ONE			English	Article							ST-JOHNS-WORT; PRODUCT-DRUG INTERACTIONS; IN-VIVO ASSESSMENT; ALTERNATIVE MEDICINE; PRESCRIPTION MEDICATIONS; DIETARY-SUPPLEMENTS; HEALTHY-SUBJECTS; GINKGO-BILOBA; PHARMACOKINETIC INTERACTIONS; NUTRITIONAL SUPPLEMENTS	Background: The risks attributed to drug-herb interactions, even when known, are often ignored or underestimated, especially for those involving anti-clotting drugs and Chinese medicines. The aim of this study was to structurally search and evaluate the existing evidence-based data associated with potential drug interactions between anticoagulant/antiplatelet drugs and Chinese herbal medicines (CHMs) and evaluate the documented mechanisms, consequences, and/or severity of interactions. Methodology and Findings: Information related to anticoagulant/antiplatelet drug-CHM interactions was retrieved from eight interaction-based textbooks, four web resources and available primary biomedical literature. The primary literature searches were conducted in English and/or Chinese from January 2000 through December 2011 using the secondary databases (e.g., PubMed, Airiti Library, China Journal full-text database). The search terms included the corresponding medical subject headings and key words. Herbs or natural products not used as a single entity CHM or in Chinese Medicinal Prescriptions were excluded from further review. The corresponding mechanisms and severity ratings of interactions were retrieved using MicroMedex (R), Lexicomp (R) and Natural Medicines Comprehensive Database (R). Finally, we found 90 single entity CHMs contributed to 306 documented drug-CHM interactions. A total of 194 (63.4%) interactions were verified for its evidence describing possible mechanisms and severity. Of them, 155 interactions (79.9%) were attributable to pharmacodynamic interactions, and almost all were rated as moderate to severe interactions. The major consequences of these interactions were increased bleeding risks due to the additive anticoagulant or antiplatelet effects of the CHMs, specifically danshen, dong quai, ginger, ginkgo, licorice, and turmeric. Conclusions/Significance: Conventional anticoagulants and antiplatelet drugs were documented to have harmful interactions with some commonly used single entity CHMs. For those patients who are taking conventional anti-clotting medications with CHMs for cardiovascular or cerebrovascular diseases, the potential risks of increased bleeding due to drug-CHM interactions should not be ignored.	[Tsai, Hsin-Hui; Lin, Hsiang-Wen; Lu, Ying-Hung; Chen, Yi-Ling] China Med Univ, Coll Pharm, Sch Pharm, Taichung, Taiwan; [Tsai, Hsin-Hui; Lin, Hsiang-Wen; Lu, Ying-Hung; Chen, Yi-Ling] China Med Univ, Coll Pharm, Grad Inst, Taichung, Taiwan; [Tsai, Hsin-Hui; Lin, Hsiang-Wen] China Med Univ Hosp, Dept Pharm, Taichung, Taiwan; [Lin, Hsiang-Wen] Univ Illinois, Coll Pharm, Dept Pharm Adm, Chicago, IL USA; [Mahady, Gail B.] Univ Illinois, Coll Pharm, Dept Pharm Practice, PAHO WHO Collaborating Ctr Tradit Med, Chicago, IL USA	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lin, HW (corresponding author), China Med Univ, Coll Pharm, Sch Pharm, Taichung, Taiwan.	hsiangwl@mail.cmu.edu.tw	Chen, Yi/HIR-2608-2022	Tsai, Hsiu Ting/0000-0003-1137-9274	Committee on Chinese medicine and Pharmacy, Department of Health, Executive Yuan, Taiwan, R.O.C. [CCMP99-RD-016]; National Science Council [NSC 99-2320-B-039 -031 -MY3]	Committee on Chinese medicine and Pharmacy, Department of Health, Executive Yuan, Taiwan, R.O.C.; National Science Council(Ministry of Science and Technology, Taiwan)	This study was fully supported by the Committee on Chinese medicine and Pharmacy, Department of Health, Executive Yuan, Taiwan, R.O.C. ( grant number: CCMP99-RD-016) and partially supported by National Science Council (grant number: NSC 99-2320-B-039 -031 -MY3). Those founders have no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abarca Jacob, 2004, J Am Pharm Assoc (2003), V44, P136, DOI 10.1331/154434504773062582; Abdul MIM, 2010, BRIT J CLIN PHARMACO, V69, P508, DOI 10.1111/j.1365-2125.2010.03620.x; Al Faraj S, 2005, ANN TROP MED PARASIT, V99, P219, DOI 10.1179/136485905X17434; Alherbish A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019623; Awang Dennis V C, 2002, J Cardiovasc Nurs, V16, P64; Blalock SJ, 2009, ALTERN THER HEALTH M, V15, P26; Bone KM, 2008, MOL NUTR FOOD RES, V52, P764, DOI 10.1002/mnfr.200700098; Borrelli F, 2009, AAPS J, V11, P710, DOI 10.1208/s12248-009-9146-8; Brazier Nicole C, 2003, Am J Ther, V10, P163, DOI 10.1097/00045391-200305000-00003; Bressler R, 2005, GERIATRICS, V60, P32; Bressler R, 2005, GERIATRICS, V60, P16; Bressler R, 2005, GERIATRICS, V60, P21; Bressler R, 2005, GERIATRICS-US, V60, P30; Bush TM, 2007, ALTERN THER HEALTH M, V13, P30; Butterweck V, 2008, CLIN PHARMACOKINET, V47, P383, DOI 10.2165/00003088-200847060-00003; Canter PH, 2004, DRUG AGING, V21, P597, DOI 10.2165/00002512-200421090-00004; Cassileth BR, 2003, HERB DRUG INTERACTIO; Chan ALF, 2011, J ALTERN COMPLEM MED, V17, P513, DOI 10.1089/acm.2010.0295; Chan E, 2010, CURR OPIN DRUG DISC, V13, P50; Chan HT, 2011, J CARDIOVASC PHARM, V58, P87, DOI 10.1097/FJC.0b013e31821cd888; Chang HC, 2003, CHINESE MED HERBS PR; Chang LC, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-170; Charrois TL, 2007, ANN PHARMACOTHER, V41, P1124, DOI 10.1345/aph.1H463; Chavez ML, 2006, LIFE SCI, V78, P2146, DOI 10.1016/j.lfs.2005.12.009; Chen FN, 2008, J INT CHIN W MED, V10, P25; Chen FP, 2011, FAMILY MED PRIMARY M, V26, P168; Chen J., 2007, CHIN J CLIN PHARM TH, V12, P1348; Choi YH, 2011, ARCH PHARM RES, V34, P1843, DOI 10.1007/s12272-011-1106-z; Clauson KA, 2008, ALTERN THER HEALTH M, V14, P36; Clauson KA, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-42; Cohen PA, 2010, CARDIOVASC THER, V28, P246, DOI 10.1111/j.1755-5922.2010.00193.x; Colalto C, 2010, PHARMACOL RES, V62, P207, DOI 10.1016/j.phrs.2010.04.001; Committee on Chinese Medicine and Pharmacy, 2004, TAIW HERB PHARM; Committee on Chinese Medicine and Pharmacy Department of Health Executive Yuan, ABSTR YB; Coxeter PD, 2004, CURR MED CHEM, V11, P1513, DOI 10.2174/0929867043365198; De Smet PAGM, 2008, CURR DRUG METAB, V9, P1055, DOI 10.2174/138920008786927730; Department of Health Executive Yuan R.O.C. (TAIWAN), DEP HLTH GOV RES B; Dergal JM, 2002, DRUG AGING, V19, P879, DOI 10.2165/00002512-200219110-00005; Di Carlo G, 2001, TRENDS PHARMACOL SCI, V22, P292, DOI 10.1016/S0165-6147(00)01716-8; Di YM, 2008, CURR PHARM DESIGN, V14, P1723, DOI 10.2174/138161208784746798; Dunn Steven P., 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P231; Ernst E, 2000, EUR J CLIN PHARMACOL, V56, P523, DOI 10.1007/s002280000194; Ernst E, 2004, PHARMACOEPIDEM DR S, V13, P767, DOI 10.1002/pds.1014; Ernst E, 2000, B WORLD HEALTH ORGAN, V78, P252; Fugh-Berman A, 2000, LANCET, V355, P134, DOI 10.1016/S0140-6736(99)06457-0; Fugh-Berman A, 2001, BRIT J CLIN PHARMACO, V52, P587, DOI 10.1046/j.0306-5251.2001.01469.x; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Gardiner P, 2008, AM FAM PHYSICIAN, V77, P73; Goldman RD, 2008, J PEDIATR-US, V152, P521, DOI 10.1016/j.jpeds.2007.09.026; Greenblatt DJ, 2005, J CLIN PHARMACOL, V45, P127, DOI 10.1177/0091270004271404; Greeson JM, 2001, PSYCHOPHARMACOLOGY, V153, P402, DOI 10.1007/s002130000625; Haller CA, 2006, CLIN TOXICOL, V44, P605, DOI 10.1080/15563650600795545; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; Holcomb SS, 2009, NURSE PRACT, V34, P21, DOI 10.1097/01.NPR.0000350567.61353.2b; Hsieh SC, 2008, PHARMACOEPIDEM DR S, V17, P609, DOI 10.1002/pds.1611; Hu ZP, 2005, DRUGS, V65, P1239, DOI 10.2165/00003495-200565090-00005; Huang SM, 2004, J CLIN PHARMACOL, V44, P559, DOI 10.1177/0091270004265367; Izzo AA, 2001, DRUGS, V61, P2163, DOI 10.2165/00003495-200161150-00002; Izzo AA, 2005, FUND CLIN PHARMACOL, V19, P1, DOI 10.1111/j.1472-8206.2004.00301.x; Izzo AA, 2005, INT J CARDIOL, V98, P1, DOI 10.1016/j.ijcard.2003.06.039; Izzo AA, 2009, DRUGS, V69, P1777, DOI 10.2165/11317010-000000000-00000; Javed F, 2008, J LARYNGOL OTOL, V122, P116, DOI 10.1017/S0022215107000011; Jennes F, 2007, HERB TOXICITIES DRUG; Jiang XM, 2004, BRIT J CLIN PHARMACO, V57, P592, DOI 10.1111/j.1365-2125.2003.02051.x; Jiang XM, 2006, J CLIN PHARMACOL, V46, P1370, DOI 10.1177/0091270006292124; Ko Richard J, 2004, J Chin Med Assoc, V67, P109; Kuhn Merrily A, 2002, Crit Care Nurse, V22, P22; Kuo YF, 2006, J PHARM PHARMACOL, V58, P521, DOI 10.1211/jpp.58.4.0012; Lai D, 2007, FAM PRACT, V24, P56, DOI 10.1093/fampra/cml058; Lai JN, 2010, YB CHINESE MED PHARM, V28, P291; Lai YC, 2007, CHUNG SHAN MED J, V18, P343; Lee GBW, 2004, FAM PRACT, V21, P654, DOI 10.1093/fampra/cmh613; Lexicomp, 2012, LEX INT ONL; Li JY, 2008, J TAIWAN PHARM, V24, P135; Li YH, 2010, J ETHNOPHARMACOL, V128, P623, DOI 10.1016/j.jep.2010.02.003; Lim MK, 2005, COMPLEMENT THER MED, V13, P16, DOI 10.1016/j.ctim.2004.11.002; Lin JJ, 2003, SHOW CHWAN MED J, V4, P1; Madabushi R, 2006, EUR J CLIN PHARMACOL, V62, P225, DOI 10.1007/s00228-006-0096-0; Mahady GB, 2001, BOT DIETARY SUPPLEME, V1; Makino T, 2002, J ETHNOPHARMACOL, V82, P35, DOI 10.1016/S0378-8741(02)00175-7; Mao XQ, 2007, CHIN J CLIN PHARM TH, V12, P728; Markowitz J S, 2001, Psychopharmacol Bull, V35, P53; McFadden Roger, 2011, Nurs Stand, V25, P65; Mills E, 2005, THER DRUG MONIT, V27, P549, DOI 10.1097/01.ftd.0000170880.95267.90; Mousa SA, 2010, METHODS MOL BIOL, V663, P229, DOI 10.1007/978-1-60761-803-4_9; National Center for Complementary and Alternative Medicine, 2010, TRAD CHIN MED INTR; National Center for Complementary and Alternative Medicine, HERBS GLANC; Natural Medicines Comprehensive Database, NAT PROD DRUG INT CH; Norred CL, 2001, ALTERN THER HEALTH M, V7, P58; Nutescu E, 2011, J THROMB THROMBOLYS, V31, P326, DOI 10.1007/s11239-011-0561-1; Nutescu EA, 2006, EXPERT OPIN DRUG SAF, V5, P433, DOI 10.1517/14740338.5.3.433; *OFF DIET SUPPL, DIET SUPPL FACT SHEE; Ohnishi Noriaki, 2004, Keio Journal of Medicine, V53, P137, DOI 10.2302/kjm.53.137; Pal D, 2006, LIFE SCI, V78, P2131, DOI 10.1016/j.lfs.2005.12.010; Peng B, 2010, WORLD SCI TECHNOLOGY, DOI [10.3969/j.issn.1674-3849.2010.02.024, DOI 10.3969/J.ISSN.1674-3849.2010.02.024]; Philp RB, 2004, HERBAL DRUG INTERACT; Poppenga RH, 2002, CLIN TECH SMALL AN P, V17, P6, DOI 10.1053/svms.2002.27785; Rochelle TL, 2010, BRIT J HEALTH PSYCH, V15, P715, DOI 10.1348/135910709X479195; Rossler W, 2007, PSYCHOL MED, V37, P73, DOI 10.1017/S0033291706008841; Rogers EA, 2001, ACAD EMERG MED, V8, P932, DOI 10.1111/j.1553-2712.2001.tb01157.x; Samuels N, 2005, THROMB HAEMOSTASIS, V93, P3, DOI 10.1160/TH04-05-0285; Saw Jun Tze, 2006, Complement Ther Clin Pract, V12, P236, DOI 10.1016/j.ctcp.2006.06.002; Segal R, 2006, CAN MED ASSOC J, V174, P1281, DOI 10.1503/cmaj.051191; Shalansky S, 2007, PHARMACOTHERAPY, V27, P1237, DOI 10.1592/phco.27.9.1237; Singh YN, 2005, J ETHNOPHARMACOL, V100, P108, DOI 10.1016/j.jep.2005.05.014; Skalli S, 2007, THER DRUG MONIT, V29, P679, DOI 10.1097/FTD.0b013e31815c17f6; Stargrove M.B., 2008, HERB NUTR DRUG INTER; State Administration of Traditional Chinese Medicine, 1999, CHIN MAT MED 11; Su DJ, 2011, J HEALTH CARE POOR U, V22, P296, DOI 10.1353/hpu.2011.0002; Su G, 2010, YONSEI MED J, V51, P793, DOI 10.3349/ymj.2010.51.5.793; Suchard JR, 2004, EUR J EMERG MED, V11, P193, DOI 10.1097/01.mej.0000134721.72356.f7; Tachjian A, 2010, J AM COLL CARDIOL, V55, P515, DOI 10.1016/j.jacc.2009.07.074; Tatro D.S., 2011, DRUG INTERACTION FAC; Tirona RG, 2006, BRIT J CLIN PHARMACO, V61, P677, DOI 10.1111/j.1365-2125.2006.02684.x; Tomlinson B, 2008, MOL NUTR FOOD RES, V52, P799, DOI 10.1002/mnfr.200700454; Tsai CH, 2009, TAIPEI J CHINESE MED, V15, P98; Tsai HH, 2013, EUR J CLIN PHARMACOL, V69, P629, DOI 10.1007/s00228-012-1359-6; Ueng Yune-Fang, 2004, Current Pharmacogenomics, V2, P209, DOI 10.2174/1570160043377646; Ulbricht C, 2008, CURR DRUG METAB, V9, P1063, DOI 10.2174/138920008786927785; Ulbricht C., 2009, NATURAL STANDARD HER; Venkataramanan R, 2006, LIFE SCI, V78, P2105, DOI 10.1016/j.lfs.2005.12.021; Wang TY, 2011, J LONG TERM CARE, V15, P24; Wang YY, 2003, J TAIWAN PHARM, V19, P5; Whitten DL, 2006, BRIT J CLIN PHARMACO, V62, P512, DOI 10.1111/j.1365-2125.2006.02755.x; Williamson E., 2009, STOCKLEYS HERBAL MED; Williamson Elizabeth M, 2005, Expert Opin Drug Saf, V4, P355, DOI 10.1517/14740338.4.2.355; Williamson EM, 2003, DRUG SAFETY, V26, P1075, DOI 10.2165/00002018-200326150-00002; Wittkowsky AK, 2008, J THROMB THROMBOLYS, V25, P72, DOI 10.1007/s11239-007-0110-0; Woodward KN, 2005, HUM EXP TOXICOL, V24, P219, DOI 10.1191/0960327105ht529oa; World Health Organization, 2008, 10 LEAD CAUS DEATH B; Wu WWP, 2010, PHYTOMEDICINE, V17, P219, DOI 10.1016/j.phymed.2009.05.005; Xu GL, 2009, PHYTOTHER RES, V23, P1721, DOI 10.1002/ptr.2819; Yamashita H, 2002, COMPLEMENT THER MED, V10, P84, DOI 10.1054/ctim.2002.0519; Yang XX, 2006, CURR PHARM DESIGN, V12, P4649, DOI 10.2174/138161206779010440; Yeh GY, 2006, AM J CARDIOL, V98, P673, DOI 10.1016/j.amjcard.2006.03.051; Yuan CS, 2004, ANN INTERN MED, V141, P23, DOI 10.7326/0003-4819-141-1-200407060-00011; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zhou SF, 2003, DRUG METAB REV, V35, P35, DOI 10.1081/DMR-120018248; Zhou SF, 2004, J PSYCHOPHARMACOL, V18, P262, DOI 10.1177/0269881104042632; Zhou SF, 2007, DRUG DISCOV TODAY, V12, P664, DOI 10.1016/j.drudis.2007.06.004; Zhu Yan-feng, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P318, DOI 10.3736/jcim20120311	141	130	134	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2013	8	5							e64255	10.1371/journal.pone.0064255	http://dx.doi.org/10.1371/journal.pone.0064255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	155HD	23671711	Green Published, Green Submitted, gold			2022-12-27	WOS:000319737700069
J	Chen, PY; Yen, JH; Kao, RH; Chen, JH				Chen, Pei-Yi; Yen, Jui-Hung; Kao, Ruey-Ho; Chen, Ji-Hshiung			Down-Regulation of the Oncogene PTTG1 via the KLF6 Tumor Suppressor during Induction of Myeloid Differentiation	PLOS ONE			English	Article							TRANSFORMING GENE PTTG; DEPENDENT PROTEIN-KINASE; KRUPPEL-LIKE FACTOR-6; BETA-CATENIN/TCF; BINDING-PROTEIN; CYCLIN D1; EXPRESSION; CELLS; GROWTH; HPTTG	The aberrant expression of proto-oncogenes is involved in processes that are responsible for cellular proliferation and the inhibition of myeloid differentiation in acute myeloid leukemia (AML). Pituitary Tumor-Transforming gene 1 (PTTG1), an oncogenic transcription factor, is abundantly expressed in various human cancers and hematopoietic malignancies. However, its expression in normal leukocytes and most normal tissues is very low or undetectable. The mechanism by which PTTG1 overexpression modifies myeloid cell development and promotes leukemogenesis remain unclear. To investigate the mechanistic links between PTTG1 overexpression and leukemia cell differentiation, we utilized phorbol 12-myristate 13-acetate (PMA), a well-known agent that triggers monocyte/macrophage differentiation, to analyze the expression patterns of PTTG1 in PMA-induced myeloid differentiation. We found that PTTG1 is down-regulated at the transcriptional level in PMA-treated HL-60 and THP1 cells. In addition, we identified a binding site for a tumor suppressor protein, Kruppel-like factor 6 (KLF6), in the PTTG1 promoter. We found that KLF6 could directly bind and repress PTTG1 expression. In HL-60 and THP1 cells, KLF6 mRNA and protein levels are up-regulated with a concordant reduction of PTTG1 expression upon treatment with PMA. Furthermore, KLF6 knockdown by shRNA abolished the suppression of PTTG1 and reduced the activation of the differentiation marker CD11b in PMA-primed cells. The protein kinase C (PKC) inhibitor and the MAPK/ERK kinase (MEK) inhibitor significantly blocked the potentiation of PMA-mediated KLF6 induction and the down-regulation of PTTG1, indicating that PTTG1 is suppressed via the activation of PKC/ERK/KLF6 pathway. Our findings suggest that drugs that increase the KLF6 inhibition of PTTG1 may have a therapeutic application in AML treatment strategies.	[Chen, Pei-Yi; Yen, Jui-Hung; Chen, Ji-Hshiung] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Chen, Pei-Yi] Buddhist Tzu Chi Gen Hosp, Ctr Med Genet, Hualien, Taiwan; [Yen, Jui-Hung; Chen, Ji-Hshiung] Tzu Chi Univ, Dept Mol Biol & Human Genet, Hualien, Taiwan; [Kao, Ruey-Ho] Buddhist Tzu Chi Gen Hosp, Dept Hematol Oncol, Hualien, Taiwan	Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Chen, JH (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	jhc@mail.tcu.edu.tw			National Health Research Institute of Taiwan [NHRI-EX101-9929BI]; Buddhist Tzu Chi General Hospital [TCRD-101-62]	National Health Research Institute of Taiwan(National Health Research Institutes - Taiwan); Buddhist Tzu Chi General Hospital	This study was supported by grant NHRI-EX101-9929BI from the National Health Research Institute of Taiwan (http://www.nhri.org.tw/), and by grant TCRD-101-62 from the Buddhist Tzu Chi General Hospital (http://www.tzuchi.com.tw/tzuchi_en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benzeno S, 2004, CANCER RES, V64, P3885, DOI 10.1158/0008-5472.CAN-03-2818; Boelaert K, 2003, J CLIN ENDOCR METAB, V88, P2341, DOI 10.1210/jc.2002-021113; Cao ZX, 2010, BLOOD, V116, P4404, DOI 10.1182/blood-2010-05-285353; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chesnokova V, 2007, CANCER RES, V67, P10564, DOI 10.1158/0008-5472.CAN-07-0974; Clem AL, 2003, GENE, V322, P113, DOI 10.1016/j.gene.2003.08.012; Crans-Vargas HN, 2002, BLOOD, V99, P2617, DOI 10.1182/blood.V99.7.2617; Das D, 2000, FEBS LETT, V472, P50, DOI 10.1016/S0014-5793(00)01416-2; Difeo A, 2006, ONCOGENE, V25, P6026, DOI 10.1038/sj.onc.1209611; Dominguez A, 1998, ONCOGENE, V17, P2187, DOI 10.1038/sj.onc.1202140; Espina AG, 2009, MOL BIOL CELL, V20, P3353, DOI 10.1091/mbc.E08-09-0965; Filippella M, 2006, CLIN ENDOCRINOL, V65, P536, DOI 10.1111/j.1365-2265.2006.02630.x; Hamid T, 2005, J BIOL CHEM, V276, P8484; Heaney AP, 1999, NAT MED, V5, P1317, DOI 10.1038/15275; Heaney AP, 2002, J CLIN INVEST, V109, P277, DOI 10.1172/JCI200214264; Heaney AP, 2000, LANCET, V355, P716, DOI 10.1016/S0140-6736(99)10238-1; Hlubek F, 2006, BRIT J CANCER, V94, P1672, DOI 10.1038/sj.bjc.6603155; Humbert M, 2011, LEUKEMIA RES, V35, P909, DOI 10.1016/j.leukres.2011.03.010; Ishitsuka Y, 2012, J INVEST DERMATOL, V132, P1775, DOI 10.1038/jid.2012.74; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; Lee UE, 2010, FEBS LETT, V584, P1006, DOI 10.1016/j.febslet.2010.01.049; Li D, 2005, J BIOL CHEM, V280, P26941, DOI 10.1074/jbc.M500463200; Liao YC, 2012, ONCOGENE, V31, P3086, DOI 10.1038/onc.2011.476; Matsumoto Eriko, 2006, Kobe Journal of Medical Sciences, V52, P181; Matsumoto N, 2006, BLOOD, V107, P1357, DOI 10.1182/blood-2005-05-1916; Miranda MB, 2002, LEUKEMIA, V16, P683, DOI 10.1038/sj.leu.2402400; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Narla G, 2007, ONCOGENE, V26, P4428, DOI 10.1038/sj.onc.1210223; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ramos-Morales F, 2000, ONCOGENE, V19, P403, DOI 10.1038/sj.onc.1203320; Romero F, 2001, NUCLEIC ACIDS RES, V29, P1300, DOI 10.1093/nar/29.6.1300; ROVERA G, 1980, NATURE, V284, P69, DOI 10.1038/284069a0; Rubinek T, 2007, AM J PHYSIOL-CELL PH, V293, pC1082, DOI 10.1152/ajpcell.00145.2007; Saez C, 2002, ONCOGENE, V21, P8173, DOI 10.1038/sj.onc.1205954; Shima Y, 2011, INT J HEMATOL, V94, P134, DOI 10.1007/s12185-011-0905-9; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; Slavin DA, 2004, ONCOGENE, V23, P8196, DOI 10.1038/sj.onc.1208020; Tahara E, 2009, CANCER BIOL THER, V8, P801, DOI 10.4161/cbt.8.9.8186; Tfelt-Hansen J, 2004, ENDOCRINOLOGY, V145, P4222, DOI 10.1210/en.2003-1661; Thompson AD, 2005, FEBS LETT, V579, P3195, DOI 10.1016/j.febslet.2005.05.008; Tong Y, 2007, ONCOGENE, V26, P5596, DOI 10.1038/sj.onc.1210339; Tong YG, 2009, J MOL ENDOCRINOL, V43, P179, DOI 10.1677/JME-08-0176; Vlotides G, 2006, MOL ENDOCRINOL, V20, P3321, DOI 10.1210/me.2006-0280; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Wang ZY, 2003, P NATL ACAD SCI USA, V100, P3428, DOI 10.1073/pnas.0638052100; Wang ZY, 2001, MOL ENDOCRINOL, V15, P1870, DOI 10.1210/me.15.11.1870; White SL, 2005, LEUKEMIA RES, V29, P1141, DOI 10.1016/j.leukres.2005.02.012; Zhang X, 1999, MOL ENDOCRINOL, V13, P156, DOI 10.1210/me.13.1.156; Zhou CQ, 2005, INT J CANCER, V113, P891, DOI 10.1002/ijc.20642; Zhou YL, 2003, J BIOL CHEM, V278, P462, DOI 10.1074/jbc.M203793200; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	53	50	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 16	2013	8	8							e71282	10.1371/journal.pone.0071282	http://dx.doi.org/10.1371/journal.pone.0071282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	207BA	23977008	Green Published, gold, Green Submitted			2022-12-27	WOS:000323570200030
J	Peng, JX; Jiang, XH; Zhang, JX; Xiao, RX; Song, YY; Feng, X; Zhang, Y; Miao, DM				Peng, Jiaxi; Jiang, Xihua; Zhang, Jiaxi; Xiao, Runxuan; Song, Yunyun; Feng, Xi; Zhang, Yan; Miao, Danmin			The Impact of Psychological Capital on Job Burnout of Chinese Nurses: The Mediator Role of Organizational Commitment	PLOS ONE			English	Article							PERFORMANCE; RESOURCES; WORK	Background: Nursing has a high risk of job burnout, but only a few studies have explored its influencing factors from an organizational perspective. Objective: The present study explores the impact of psychological capital on job burnout by investigating the mediating effect of organizational commitment on this relationship. Methods: A total of 473 female nurses from four large general hospitals in Xi'an City of China were selected as participants. Data were collected via the Psychological Capital Questionnaire, the Maslach Burnout Inventory-General Survey, and the Organizational Commitment Scale. Results: Both psychological capital and organizational commitment were significantly correlated to job burnout. Structural equation modelling indicated that organizational commitment partially mediated the relationship between psychological capital and job burnout. Conclusion: The final model revealed a significant path from psychological capital to job burnout through organizational commitment. These findings extended prior reports and shed some light on the influence of psychological capital on job burnout.	[Peng, Jiaxi; Jiang, Xihua; Zhang, Jiaxi; Xiao, Runxuan; Song, Yunyun; Feng, Xi; Zhang, Yan; Miao, Danmin] Fourth Mil Med Univ, Dept Psychol, Xian, Peoples R China	Air Force Military Medical University	Zhang, Y (corresponding author), Fourth Mil Med Univ, Dept Psychol, Xian, Peoples R China.	zhangyanfmmu@126.com; miaodamin@hotmail.com		su, li/0000-0002-1435-9669				Aiken LH, 2001, HEALTH AFFAIR, V20, P43, DOI 10.1377/hlthaff.20.3.43; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; Avey J.B., 2006, J LEADERSH ORG STUD, V13, P42, DOI [DOI 10.1177/10717919070130020401, 10.1177/10717919070130020401]; Badri S., 2012, INT C ED MAN INN SIN; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Chang EC, 2000, PERS INDIV DIFFER, V29, P255, DOI 10.1016/S0191-8869(99)00191-9; Cheung GW, 2008, ORGAN RES METHODS, V11, P296, DOI 10.1177/1094428107300343; de Jonge J, 2000, SOC SCI MED, V50, P1317, DOI 10.1016/S0277-9536(99)00388-3; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; DUNHAM RB, 1994, J APPL PSYCHOL, V79, P370, DOI 10.1037/0021-9010.79.3.370; Evers WJG, 2002, BRIT J EDUC PSYCHOL, V72, P227, DOI 10.1348/000709902158865; Fan Y, 2012, J XIAN JIAOTONG U SO, V32, P50; FREUDENBERGER HJ, 1974, J SOC ISSUES, V30, P159, DOI 10.1111/j.1540-4560.1974.tb00706.x; Hakanen JJ, 2008, J VOCAT BEHAV, V73, P78, DOI 10.1016/j.jvb.2008.01.003; HOBFOLL SE, 1990, J SOC PERS RELAT, V7, P465, DOI 10.1177/0265407590074004; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jackson D, 2007, J ADV NURS, V60, P1, DOI 10.1111/j.1365-2648.2007.04412.x; Judge TA, 2001, PSYCHOL BULL, V127, P376, DOI 10.1037//0033-2909.127.3.376; King RC, 1997, EUR J INFORM SYST, V6, P86, DOI 10.1057/palgrave.ejis.3000259; Kline R.B., 2011, PRINCIPLES PRACTICE; Larson M., 2006, J LEADERSH ORG STUD, V13, P45, DOI [10.1177/10717919070130020601, DOI 10.1177/10717919070130020601, 10.1177/10717919070130010701, DOI 10.1177/10717919070130010701]; [骆宏 Luo Hong], 2010, [中华护理杂志, Chinese Journal of Nursing], V45, P933; Luthans F, 2004, ORGAN DYN, V33, P143, DOI 10.1016/j.orgdyn.2004.01.003; Luthans F., 2005, MANAGE ORGAN REV, V1, P247, DOI DOI 10.1111/J.1740-8784.2005.00011.X; Luthans F., 2004, BUS HORIZONS, V47, P45, DOI [10.1016/j.bushor.2003.11.007, DOI 10.1016/J.BUSHOR.2003.11.007]; Luthans F., 2006, PSYCHOL CAPITAL DEV; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; MacKinnon DP, 2004, MULTIVAR BEHAV RES, V39, P99, DOI 10.1207/s15327906mbr3901_4; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Meyer J.P., 1991, HUM RESOUR MANAGE R, V1, P61, DOI [10.1016/1053-4822(91)90011-Z, DOI 10.1016/1053-4822(91)90011-Z]; Meyer JP, 2002, J VOCAT BEHAV, V61, P20, DOI 10.1006/jvbe.2001.1842; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Riolli L., 2003, INT J STRESS MANAGE, V10, P235, DOI DOI 10.1037/1072-5245.10.3.235; Schaufeli W.B., 1996, MASLACH BURNOUT INVE, P19; SHELDON ME, 1971, ADMIN SCI QUART, V16, P143, DOI 10.2307/2391824; SHERWIN ED, 1992, J SOC CLIN PSYCHOL, V11, P129, DOI 10.1521/jscp.1992.11.2.129; Sivarajasingam V, 2002, J PUBLIC HEALTH MED, V24, P219, DOI 10.1093/pubmed/24.3.219; SNYDER CR, 1995, J COUNS DEV, V73, P355, DOI 10.1002/j.1556-6676.1995.tb01764.x; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI 10.2307/270723; Tan D., 1998, INT J ORGAN ANAL, V6, P310, DOI DOI 10.1108/EB028889; Wegge J, 2006, WORK STRESS, V20, P60, DOI 10.1080/02678370600655553; Wright T.A., 2004, J BUSINESS MANAGEMEN, V9, P389, DOI DOI 10.1007/s10869-015-9426-5; Wright TA, 2004, ORGAN DYN, V33, P338, DOI 10.1016/j.orgdyn.2004.09.002; Yan X, 2012, SOCIAL INDICATORS RE, V113, P299; Zhang JF, 2013, COMM COM INF SC, V396, P1; Zhao XS, 2010, J CONSUM RES, V37, P197, DOI 10.1086/651257; [仲理峰 Zhong Lifeng], 2007, [心理学报, Acta Psychologica Sinica], V39, P328	49	83	88	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 27	2013	8	12							e84193	10.1371/journal.pone.0084193	http://dx.doi.org/10.1371/journal.pone.0084193			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	281RE	24349292	Green Published, Green Submitted, gold			2022-12-27	WOS:000329117900084
J	Poldervaart, MT; Wang, H; van der Stok, J; Weinans, H; Leeuwenburgh, SCG; Oner, FC; Dhert, WJA; Alblas, J				Poldervaart, Michelle T.; Wang, Huanan; van der Stok, Johan; Weinans, Harrie; Leeuwenburgh, Sander C. G.; Oner, F. Cumhur; Dhert, Wouter J. A.; Alblas, Jacqueline			Sustained Release of BMP-2 in Bioprinted Alginate for Osteogenicity in Mice and Rats	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; GROWTH-FACTOR RELEASE; IN-VITRO; GELATIN; HYDROGELS; DIFFERENTIATION; MICROSPHERES; SCAFFOLDS; REGENERATION; BIOMATERIAL	The design of bioactive three-dimensional (3D) scaffolds is a major focus in bone tissue engineering. Incorporation of growth factors into bioprinted scaffolds offers many new possibilities regarding both biological and architectural properties of the scaffolds. This study investigates whether the sustained release of bone morphogenetic protein 2 (BMP-2) influences osteogenicity of tissue engineered bioprinted constructs. BMP-2 loaded on gelatin microparticles (GMPs) was used as a sustained release system, which was dispersed in hydrogel-based constructs and compared to direct inclusion of BMP-2 in alginate or control GMPs. The constructs were supplemented with goat multipotent stromal cells (gMSCs) and biphasic calcium phosphate to study osteogenic differentiation and bone formation respectively. BMP-2 release kinetics and bioactivity showed continuous release for three weeks coinciding with osteogenicity. Osteogenic differentiation and bone formation of bioprinted GMP containing constructs were investigated after subcutaneous implantation in mice or rats. BMP-2 significantly increased bone formation, which was not influenced by the release timing. We showed that 3D printing of controlled release particles is feasible and that the released BMP-2 directs osteogenic differentiation in vitro and in vivo.	[Poldervaart, Michelle T.; Weinans, Harrie; Oner, F. Cumhur; Dhert, Wouter J. A.; Alblas, Jacqueline] Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands; [Wang, Huanan; Leeuwenburgh, Sander C. G.] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, NL-6525 ED Nijmegen, Netherlands; [van der Stok, Johan; Weinans, Harrie] Erasmus Univ, Med Ctr Rotterdam, Dept Orthopaed, Rotterdam, Netherlands; [Weinans, Harrie] Delft Univ Technol, Dept Biomech Engn, Delft, Netherlands; [Weinans, Harrie] Univ Med Ctr Utrecht, Dept Rheumatol, Utrecht, Netherlands; [Dhert, Wouter J. A.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology; Utrecht University; Utrecht University Medical Center; Utrecht University	Alblas, J (corresponding author), Univ Med Ctr Utrecht, Dept Orthopaed, Utrecht, Netherlands.	j.alblas@umcutrecht.nl	Wang, Huanan/N-1971-2013; Leeuwenburgh, S.C.G./L-4483-2015; Oner, FC/L-7769-2013	Leeuwenburgh, S.C.G./0000-0003-1471-6133; Oner, FC/0000-0003-0858-8243; Alblas, Jacqueline/0000-0002-2996-9697; Dhert, Wouter/0000-0001-9150-6143; Weinans, Harrie/0000-0002-2275-6170	BioMedical Materials institute [P2.04]; Dutch Ministry of Economic Affairs; KNAW; China-Netherlands Programme Strategic Alliances (PSA) [2008DFB50120]; Smart Mix Program of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	BioMedical Materials institute; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); KNAW; China-Netherlands Programme Strategic Alliances (PSA); Smart Mix Program of the Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science	This research forms part of the Project P2.04 BONE-IP of the research program of the BioMedical Materials institute, co-funded by the Dutch Ministry of Economic Affairs. HW was funded by KNAW, China-Netherlands Programme Strategic Alliances (PSA) (No. 2008DFB50120) (http://www.knaw.nl/Pages/DEF/27/261.bGFuZz1FTkc.html). JA gratefully acknowledges the support of the Smart Mix Program of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angle SR, 2012, J MUSCULOSKEL NEURON, V12, P28; Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069; Bigi A, 2001, BIOMATERIALS, V22, P763, DOI 10.1016/S0142-9612(00)00236-2; Boerckel JD, 2011, BIOMATERIALS; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; CROSS M, 1991, CELL, V64, P271, DOI 10.1016/0092-8674(91)90638-F; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Fedorovich NE, 2011, TISSUE ENG PT A, V17, P2113, DOI [10.1089/ten.TEA.2011.0019, 10.1089/ten.tea.2011.0019]; Fedorovich NE, 2011, TISSUE ENG A; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Garrison KR, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006950.pub2; Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072; Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010; Geuze RE, 2012, TISSUE ENG PT A, V18, P2052, DOI [10.1089/ten.tea.2011.0560, 10.1089/ten.TEA.2011.0560]; Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029; Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009; Habraken WJEM, 2009, J BIOMED MATER RES A, V91A, P614, DOI 10.1002/jbm.a.32263; Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031; Lee K, 2011, J R SOC INTERFACE, V8, P153, DOI 10.1098/rsif.2010.0223; Leeuwenburgh SCG, 2010, BIOMACROMOLECULES, V11, P2653, DOI 10.1021/bm1006344; Ogawa T, 2010, J BIOMAT SCI-POLYM E, V21, P609, DOI 10.1163/156856209X434638; Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002; Poynton AR, 2002, SPINE, V27, pS40, DOI 10.1097/00007632-200208151-00010; RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I; Silber JS, 2003, SPINE, V28, P134, DOI 10.1097/00007632-200301150-00008; Stevens MM, 2005, P NATL ACAD SCI USA, V102, P11450, DOI 10.1073/pnas.0504705102; Tabata Y, 1998, ADV DRUG DELIVER REV, V31, P287, DOI 10.1016/S0169-409X(97)00125-7; THOMSON RC, 1995, J BIOMAT SCI-POLYM E, V7, P23, DOI 10.1163/156856295X00805; Varde NK, 2004, EXPERT OPIN BIOL TH, V4, P35, DOI 10.1517/eobt.4.1.35.25256; Wang L, 2003, BIOMATERIALS, V24, P3475, DOI 10.1016/S0142-9612(03)00167-4; Wegman F, 2011, EUR CELLS MATER, V21, P230, DOI 10.22203/eCM.v021a18; Wegman F, 2012, J TISSUE ENG REGEN M; Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5; Young S, 2005, J CONTROL RELEASE, V109, P256, DOI 10.1016/j.jconrel.2005.09.023	39	175	202	9	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2013	8	8							e72610	10.1371/journal.pone.0072610	http://dx.doi.org/10.1371/journal.pone.0072610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	205ER	24349370	Green Published, gold, Green Submitted			2022-12-27	WOS:000323425700181
J	Qin, YW; Peng, J; Liang, BY; Su, L; Chen, Q; Xie, JJ; Gu, L				Qin, Yu-Wang; Peng, Jiao; Liang, Bao-Yun; Su, Li; Chen, Qing; Xie, Juan-Juan; Gu, Lian			The A930G Polymorphism of P22phox (CYBA) Gene but Not C242T Variation Is Associated with Hypertension: A Meta-Analysis	PLOS ONE			English	Article							BLOOD-PRESSURE; NAD(P)H OXIDASE; NITRIC-OXIDE; DIABETES-MELLITUS; OXIDATIVE STRESS; NADPH OXIDASE; GLOBAL BURDEN; DISEASE; MORTALITY; PEROXYNITRITE	Background: Recently, it has been reported that the A930G and C242T polymorphisms within p22phox (CYBA) gene are involved in the pathogenesis of hypertension. However, the results remain controversial. Furthermore, no previous meta-analysis has been conducted to evaluate the relationship between the A930G and C242T polymorphisms and hypertension. Therefore, we performed this meta-analysis to clarify these controversies. Objective and Methods: All of the included articles were retrieved from the PubMed and Embase databases, as well as the CNKI, CBM, Chongqing VIP and Wan Fang databases according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Odds ratios (OR) with corresponding 95% confidence intervals (CI) were used to assess the strength of the association. Accounting for heterogeneity, a fixed or random effects model was respectively adopted. Heterogeneity was checked using the Q test and the I-2 statistic. A cumulative meta-analysis was conducted to estimate the tendency of pooled OR. Funnel plots and Egger's tests were performed to test for possible publication bias. Results: Five articles on A930G with 2003 cases/2434 controls and eight articles on C242T with 2644 cases/1967 controls were identified. A significant association of A930G polymorphisms with the risk of hypertension was found in the dominant model (OR=0.59, 95% CI: 0.38-0.92, p=0.021) and allelic model (OR=0.66, 95% CI: 0.46-0.95, p=0.024). In the stratified analysis, a significant association could be found among the hospital-based and population-based studies. However, no evidence of a significant association of the C242T polymorphism with hypertension was found in the overall analysis and subgroup analysis. Conclusions: This meta-analysis indicates that the A930G polymorphism, but not the C242T variation, might be a protective factor for hypertension.	[Qin, Yu-Wang; Liang, Bao-Yun; Chen, Qing; Xie, Juan-Juan; Gu, Lian] Guangxi Univ Chinese Med, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China; [Peng, Jiao] Guangxi Med Univ, Preclin Fac, Nanning, Guangxi, Peoples R China; [Su, Li] Guangxi Med Univ, Sch Publ Hlth, Nanning, Guangxi, Peoples R China	Guangxi University of Chinese Medicine; Guangxi Medical University; Guangxi Medical University	Gu, L (corresponding author), Guangxi Univ Chinese Med, Affiliated Hosp 1, Nanning, Guangxi, Peoples R China.	gulian2012@163.com		su, li/0000-0002-1435-9669	National Natural Science Foundation of China [81260594]; Guangxi National Natural Science Foundation [2013GXNSFAA019145]; significant scientific research foundation of the Guangxi health department [2012047]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi National Natural Science Foundation(National Natural Science Foundation of Guangxi Province); significant scientific research foundation of the Guangxi health department	This work was supported by grants from the National Natural Science Foundation of China (Grant No. 81260594); the Guangxi National Natural Science Foundation (Grant No. 2013GXNSFAA019145); and the significant scientific research foundation of the Guangxi health department (Grant No. 2012047). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Arima H, 2011, J HYPERTENS, V29, pS3, DOI 10.1097/01.hjh.0000410246.59221.b1; Ballinger SW, 2000, CIRC RES, V86, P960, DOI 10.1161/01.RES.86.9.960; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Clark CE, 2012, LANCET, V379, P905, DOI 10.1016/S0140-6736(11)61710-8; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; Ehret GB, 2013, EUR HEART J, V34, P951, DOI 10.1093/eurheartj/ehs455; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; Gu QP, 2010, AM J HYPERTENS, V23, P38, DOI 10.1038/ajh.2009.191; Guzik TJ, 2002, CIRCULATION, V105, P1656, DOI 10.1161/01.CIR.0000012748.58444.08; [哈黛文 Ha Daiwen], 2004, [中国老年学杂志, Chinese Journal of Gerontology], V24, P1122; Hsueh YM, 2005, J TOXICOL ENV HEAL A, V68, P1471, DOI 10.1080/15287390590967414; Iseki K, 2000, HYPERTENS RES, V23, P143, DOI 10.1291/hypres.23.143; Ji Z LB, 2003, CHIN J GERIATR CARDI, V5, P103; Katsuyama M, 2010, J PHARMACOL SCI, V114, P134, DOI 10.1254/jphs.10R01CR; Kokubo Y, 2005, CIRC J, V69, P138, DOI 10.1253/circj.69.138; Krzesinski J-M, 2012, Rev Med Liege, V67, P279; Kuznetsova TY, 2008, KARDIOLOGIYA, V48, P27; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Ma CH, 2012, J ADV NURS, V68, P1402, DOI 10.1111/j.1365-2648.2011.05835.x; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moreno MU, 2007, J HYPERTENS, V25, P1620, DOI 10.1097/HJH.0b013e3281ac211d; Moreno MU, 2006, J HYPERTENS, V24, P1299, DOI 10.1097/01.hjh.0000234110.54110.56; Moreno MU, 2003, FEBS LETT, V542, P27, DOI 10.1016/S0014-5793(03)00331-4; Pang J HD, 2005, ASS NADPH OXIDASE SU; [庞静 Pang Jing], 2004, [高血压杂志, Chinese Journal of Hypertension], V12, P502; PANZA JA, 1990, NEW ENGL J MED, V323, P22, DOI 10.1056/NEJM199007053230105; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Petrovic D, 2013, CLIN EXP HYPERTENS; Picon RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048255; Rae J, 2000, BLOOD, V96, P1106, DOI 10.1182/blood.V96.3.1106.015k44_1106_1112; Redon J, 2003, HYPERTENSION, V41, P1096, DOI 10.1161/01.HYP.0000068370.21009.38; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sales ML, 2007, J HUM HYPERTENS, V21, P504, DOI 10.1038/sj.jhh.1002170; Schreiber R, 2012, DIABETIC MED, V29, pE55, DOI 10.1111/j.1464-5491.2012.03594.x; Soccio M, 2005, EUR J CLIN INVEST, V35, P305, DOI 10.1111/j.1365-2362.2005.01500.x; Taniyama Y, 2003, HYPERTENSION, V42, P1075, DOI 10.1161/01.HYP.0000100443.09293.4F; Ushio-Fukai M, 2002, CIRC RES, V91, P1160, DOI 10.1161/01.RES.0000046227.65158.F8; UshioFukai M, 1996, J BIOL CHEM, V271, P23317, DOI 10.1074/jbc.271.38.23317; Valderrama Amy L., 2012, Morbidity and Mortality Weekly Report, V61, P703; Wang B WX, 2007, ASS WNK4 GENE CYBA G; Zalba G, 2001, CIRC RES, V88, P217	49	83	88	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e82465	10.1371/journal.pone.0082465	http://dx.doi.org/10.1371/journal.pone.0082465			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349292	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200081
J	Li, SH; Arguelles, L; Jiang, F; Chen, WJ; Jin, XM; Yan, CH; Tian, Y; Hong, XM; Qian, C; Zhang, J; Wang, XB; Shen, XM				Li, Shenghui; Arguelles, Lester; Jiang, Fan; Chen, Wenjuan; Jin, Xingming; Yan, Chonghuai; Tian, Ying; Hong, Xiumei; Qian, Ceng; Zhang, Jun; Wang, Xiaobin; Shen, Xiaoming			Sleep, School Performance, and a School-Based Intervention among School-Aged Children: A Sleep Series Study in China	PLOS ONE			English	Article							DAYTIME SLEEPINESS; ACADEMIC-PERFORMANCE; RISK-FACTORS; DURATION; DISTURBANCES; ADOLESCENTS; PREVALENCE; DISRUPTION; DISORDERS; CHILDHOOD	Background: Sufficient sleep during childhood is essential to ensure a transition into a healthy adulthood. However, chronic sleep loss continues to increase worldwide. In this context, it is imperative to make sleep a high-priority and take action to promote sleep health among children. The present series of studies aimed to shed light on sleep patterns, on the longitudinal association of sleep with school performance, and on practical intervention strategy for Chinese school-aged children. Methods and Findings: A serial sleep researches, including a national cross-sectional survey, a prospective cohort study, and a school-based sleep intervention, were conducted in China from November 2005 through December 2009. The national cross-sectional survey was conducted in 8 cities and a random sample of 20,778 children aged 9.0 +/- 1.61 years participated in the survey. The five-year prospective cohort study included 612 children aged 6.8 +/- 0.31 years. The comparative cross-sectional study (baseline: n = 525, aged 10.80 +/- 0.41; post-intervention follow-up: n = 553, aged 10.81 +/- 0.33) was undertaken in 6 primary schools in Shanghai. A battery of parent and teacher reported questionnaires were used to collect information on children's sleep behaviors, school performance, and sociodemographic characteristics. The mean sleep duration was 9.35 +/- 0.77 hours. The prevalence of daytime sleepiness was 64.4% (sometimes: 37.50%; frequently: 26.94%). Daytime sleepiness was significantly associated with impaired attention, learning motivation, and particularly, academic achievement. By contrast, short sleep duration only related to impaired academic achievement. After delaying school start time 30 minutes and 60 minutes, respectively, sleep duration correspondingly increased by 15.6 minutes and 22.8 minutes, respectively. Moreover, intervention significantly improved the sleep duration and daytime sleepiness. Conclusions: Insufficient sleep and daytime sleepiness commonly existed and positively associated with the impairment of school performance, especially academic achievement, among Chinese school-aged children. The effectiveness of delaying school staring time emphasized the benefits of optimal school schedule regulation to children's sleep health.	[Li, Shenghui; Yan, Chonghuai; Zhang, Jun] Shanghai Jiao Tong Univ, MOE Shanghai Key Lab Childrens Environm Hlth, Sch Med, Xinhua Hosp, Shanghai 200030, Peoples R China; [Li, Shenghui; Tian, Ying; Qian, Ceng] Shanghai Jiao Tong Univ, Sch Publ Hlth, Shanghai 200030, Peoples R China; [Arguelles, Lester; Hong, Xiumei; Wang, Xiaobin] Northwestern Univ, Feinberg Sch Med, Mary Ann & J Milburn Smith Child Hlth Res Program, Chicago, IL 60611 USA; [Arguelles, Lester; Hong, Xiumei; Wang, Xiaobin] Childrens Mem Hosp, Chicago, IL 60614 USA; [Arguelles, Lester; Hong, Xiumei; Wang, Xiaobin] Childrens Mem Res Ctr, Chicago, IL USA; [Jiang, Fan; Chen, Wenjuan; Jin, Xingming] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Shanghai 200030, Peoples R China; [Wang, Xiaobin; Shen, Xiaoming] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Ctr Childhood Origins Dis, Baltimore, MD USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Shanghai Jiao Tong University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Li, SH (corresponding author), Shanghai Jiao Tong Univ, MOE Shanghai Key Lab Childrens Environm Hlth, Sch Med, Xinhua Hosp, Shanghai 200030, Peoples R China.	Lsh9907@163.com; Shenxm9907@126.com	Jiang, Fan/AHA-6297-2022; Jiang, Fan/AGX-9052-2022; CHEN, Haiyong/G-6787-2014; Devreese, Bart/B-2011-2009	Jiang, Fan/0000-0003-0634-101X; Anthony, Arguelles Arias/0000-0003-4359-733X; Fickers, Patrick/0000-0002-2600-5833; CHEN, Haiyong/0000-0002-4889-2752; Devreese, Bart/0000-0002-9764-2581	MOE - Shanghai Key Laboratory of Children's Environmental Health [06DZ22024]; Key Discipline in Public Health of Shanghai Municipal Education Commission; National Natural Science Foundation of China [81072314, 30700670, 81172685]; Innovation Program of Shanghai Municipal Education Commission [13YZ034]; New Bairenjihua in Shanghai Jiaotong University School of Medicine; Shanghai public health academic leader project [GWDTR201222]	MOE - Shanghai Key Laboratory of Children's Environmental Health; Key Discipline in Public Health of Shanghai Municipal Education Commission; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); New Bairenjihua in Shanghai Jiaotong University School of Medicine; Shanghai public health academic leader project	This study was funded by Grants from MOE - Shanghai Key Laboratory of Children's Environmental Health (06DZ22024), the Key Discipline in Public Health of Shanghai Municipal Education Commission, National Natural Science Foundation of China (81072314, 30700670, 81172685), Innovation Program of Shanghai Municipal Education Commission (13YZ034), 2009 New Bairenjihua in Shanghai Jiaotong University School of Medicine, and 2012 Shanghai public health academic leader project (GWDTR201222). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beebe DW, 2010, J ADOLESCENT HEALTH, V47, P523, DOI 10.1016/j.jadohealth.2010.03.005; Bruni O, 2006, SLEEP MED, V7, P43, DOI 10.1016/j.sleep.2005.09.003; Calhoun SL, 2011, SLEEP, V34, P503, DOI 10.1093/sleep/34.4.503; Clinkinbeard SS, 2011, J YOUTH ADOLESCENCE, V40, P916, DOI 10.1007/s10964-010-9594-6; Colten HR, 2006, SLEEP DISORDERS SLEE; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Dexter Donn, 2003, WMJ, V102, P44; Gaina A, 2007, J PEDIATR-US, V151, P518, DOI 10.1016/j.jpeds.2007.04.036; Grandner MA, 2012, SLEEP MED REV, V16, P199, DOI 10.1016/j.smrv.2012.02.001; Gruber R, 2010, SLEEP MED, V11, P289, DOI 10.1016/j.sleep.2009.09.007; Heussler HS, 2005, MED J AUSTRALIA, V182, P484, DOI 10.5694/j.1326-5377.2005.tb06793.x; Holley S, 2010, BEHAV SLEEP MED, V8, P16, DOI 10.1080/15402000903425462; Iglowstein I, 2003, PEDIATRICS, V111, P302, DOI 10.1542/peds.111.2.302; Institute of M. Sleep disorders sleep deprivation, 2006, UNM PUBL HLTH PROBL; Jiang Fan, 2002, Zhonghua Yi Xue Za Zhi, V82, P736; Kerkhof GA, 2010, PROG BRAIN RES, V185, P1, DOI 10.1016/B978-0-444-53702-7.00001-4; Leproult R, 2010, ENDOCR DEV, V17, P11, DOI 10.1159/000262524; Li Sheng-hui, 2007, Zhonghua Er Ke Za Zhi, V45, P176; Li SH, 2007, SLEEP, V30, P361, DOI 10.1093/sleep/30.3.361; Li SH, 2010, SLEEP MED, V11, P907, DOI 10.1016/j.sleep.2010.03.018; Li YC, 2008, SLEEP MED, V9, P142, DOI 10.1016/j.sleep.2007.01.018; Liu XC, 2005, PEDIATRICS, V115, P241, DOI 10.1542/peds.2004-0815F; Matricciani L, 2012, SLEEP MED REV, V16, P203, DOI 10.1016/j.smrv.2011.03.005; Matricciani L, 2011, SLEEP, V34, P651, DOI 10.1093/sleep/34.5.651; Matricciani LA, 2012, PEDIATRICS, V129, P548, DOI 10.1542/peds.2011-2039; Mindell JA, 2003, CLIN GUIDE PEDIAT SL; Mindell JA, 2011, SLEEP MED, V12, P203, DOI 10.1016/j.sleep.2011.01.003; Nieuwenhuis ILC, 2011, BEHAV BRAIN RES, V218, P325, DOI 10.1016/j.bbr.2010.12.009; Nixon GM, 2008, SLEEP, V31, P71, DOI 10.1093/sleep/31.1.71; O'Brien LM, 2009, CHILD ADOL PSYCH CL, V18, P813, DOI 10.1016/j.chc.2009.04.008; Owens JA, 2000, SLEEP, V23, P1043; Owens JA, 2010, ARCH PEDIAT ADOL MED, V164, P608, DOI 10.1001/archpediatrics.2010.96; Perez-Chada D, 2007, SLEEP, V30, P1698, DOI 10.1093/sleep/30.12.1698; Ravid S, 2009, DEV NEUROPSYCHOL, V34, P574, DOI 10.1080/87565640903133533; Ravikiran SR, 2011, INDIAN PEDIATR, V48, P221, DOI 10.1007/s13312-011-0049-2; Seegers V, 2011, AM J EPIDEMIOL, V173, P621, DOI 10.1093/aje/kwq389; Spruyt K, 2005, J SLEEP RES, V14, P163, DOI 10.1111/j.1365-2869.2005.00458.x; Spruyt K, 2011, PEDIATRICS, V127, pE345, DOI 10.1542/peds.2010-0497; Teufel J. A., 2007, American Journal of Health Studies, V22, P10; Wolfson Amy R, 2007, Behav Sleep Med, V5, P194; Yang J., 2007, CHINA J SCH DOCTOR, V21, P379	42	150	156	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 10	2013	8	7							e67928	10.1371/journal.pone.0067928	http://dx.doi.org/10.1371/journal.pone.0067928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	182SU	24349428	Green Published, gold, Green Submitted			2022-12-27	WOS:000321765300017
J	Li, S; Jin, XK; Guo, XN; Yu, AQ; Wu, MH; Tan, SJ; Zhu, YT; Li, WW; Wang, Q				Li, Shuang; Jin, Xing-Kun; Guo, Xiao-Nv; Yu, Ai-Qing; Wu, Min-Hao; Tan, Shang-Jian; Zhu, You-Ting; Li, Wei-Wei; Wang, Qun			A Double WAP Domain-Containing Protein Es-DWD1 from Eriocheir sinensis Exhibits Antimicrobial and Proteinase Inhibitory Activities	PLOS ONE			English	Article							WHEY ACIDIC PROTEIN; CHINESE MITTEN CRAB; CRUSTIN-LIKE GENE; C-TYPE LECTIN; MOLECULAR-CLONING; WHITE SHRIMP; ALPHA-2-MACROGLOBULIN ALPHA-2-M; RECOMBINANT EXPRESSION; ANTIBACTERIAL PROTEINS; PEPTIDE	Whey acidic proteins (WAP) belong to a large gene family of antibacterial peptides, which are critical in the host immune response against microbial invasion. The common feature of these proteins is a single WAP domain maintained by at least one four-disulfide core (4-DSC) structure rich in cysteine residues. In this study, a double WAP domain (DWD)-containing protein, Es-DWD1, was first cloned from the Chinese mitten crab (Eriocheir sinensis). The full-length Es-DWD1cDNA was 1193 bp, including a 411 bp open reading frame (ORF) encoding 136 amino acids with a signal peptide of 22 amino acids in the N-terminus. A comparison with other reported invertebrate and vertebrate sequences revealed the presence of WAP domains characteristic of WAP superfamilies. As determined by quantitative real-time RT-PCR, Es-DWD1 transcripts were ubiquitously expressed in all tissues, but it was upregulated in hemocytes post-challenge with pathogen-associated molecular patterns (PAMPs). The mature recombinant Es-DWD1 (rEs-DWD1) protein exhibited different binding activities to bacteria and fungus. Moreover, rEs-DWD1 could exert agglutination activities against Bacillus subtilis and Pichia pastoris and demonstrated inhibitory activities against the growth of Staphylococcus aureus, Aeromonas hydrophila and P. pastoris. Furthermore, rEs-DWD1 showed a specific protease inhibitory activity in B. subtilis. Coating of rEs-DWD1 onto agarose beads enhanced encapsulation of the beads by crab hemocytes. Collectively, the results suggest that Es-DWD1 is a double WAP domain containing protein with antimicrobial and proteinase inhibitory activities, which play significant roles in the immunity of crustaceans.	[Li, Shuang; Jin, Xing-Kun; Guo, Xiao-Nv; Yu, Ai-Qing; Wu, Min-Hao; Tan, Shang-Jian; Zhu, You-Ting; Li, Wei-Wei; Wang, Qun] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University	Wang, Q (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	qwang@bio.ecnu.edu.cn	Wang, Qun/I-7778-2013; Zhang, Quanfa/H-1922-2011; LI, WEIWEI/J-3538-2013; Jin, Xingkun/H-4366-2013; Li, Siyue/DCN-3040-2022; Li, Siyue/E-8297-2012	Wang, Qun/0000-0001-7929-7692; Jin, Xingkun/0000-0003-2454-1621; Li, Siyue/0000-0002-3097-6819; Li, Siyue/0000-0002-3097-6819; li, si yue/0000-0002-4550-892X	National Natural Science Foundation of China [31172393]; National Science and Technology Support Program of China [2012BAD26B04-04]; Innovation Program of Shanghai Municipal Education Commission [13zz031]; National Research Foundation for the Doctoral Program of Higher Education of China [20110076110016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Support Program of China; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported by grants from the National Natural Science Foundation of China (No. 31172393), the National Science and Technology Support Program of China (2012BAD26B04-04), the Innovation Program of Shanghai Municipal Education Commission (13zz031) and the National Research Foundation for the Doctoral Program of Higher Education of China (20110076110016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparyup P, 2008, DEV COMP IMMUNOL, V32, P1497, DOI 10.1016/j.dci.2008.06.005; Amparyup P, 2008, MOL IMMUNOL, V45, P1085, DOI 10.1016/j.molimm.2007.07.031; ARAKI K, 1989, BIOCHEM BIOPH RES CO, V164, P496, DOI 10.1016/0006-291X(89)91747-6; AVIDOR Y, 1953, J BACTERIOL, V66, P1, DOI 10.1002/path.1700660103; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Chen A, 2008, FISH SHELLFISH IMMUN, V25, P775, DOI 10.1016/j.fsi.2008.02.017; CORONEL CE, 1990, J BIOL CHEM, V265, P6854; Davey GC, 2001, GENE, V263, P121, DOI 10.1016/S0378-1119(00)00587-4; DEAR TN, 1988, CANCER RES, V48, P5203; Du ZQ, 2009, COMP BIOCHEM PHYS B, V154, P203, DOI 10.1016/j.cbpb.2009.06.004; Du ZQ, 2010, FISH SHELLFISH IMMUN, V28, P134, DOI 10.1016/j.fsi.2009.10.009; DYAR MT, 1946, J BACTERIOL, V51, P149, DOI 10.1128/JB.51.2.149-167.1946; Gollas-Galvan T, 2003, COMP BIOCHEM PHYS C, V134, P431, DOI 10.1016/S1532-0456(03)00002-4; Gowda NM, 2008, J INVERTEBR PATHOL, V99, P141, DOI 10.1016/j.jip.2008.04.003; Hagiwara K, 2003, J IMMUNOL, V170, P1973, DOI 10.4049/jimmunol.170.4.1973; HALL M, 1989, FEBS LETT, V254, P111, DOI 10.1016/0014-5793(89)81019-1; Hauton C, 2006, MOL IMMUNOL, V43, P1490, DOI 10.1016/j.molimm.2005.07.029; He L, PLOS ONE, V20127; HENNIGHAUSEN LG, 1982, NUCLEIC ACIDS RES, V10, P2677, DOI 10.1093/nar/10.8.2677; Hiemstra PS, 1996, INFECT IMMUN, V64, P4520, DOI 10.1128/IAI.64.11.4520-4524.1996; Jia YP, 2008, AQUACULTURE, V284, P246, DOI 10.1016/j.aquaculture.2008.07.046; Jiang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011175; Jimenez-Vega F, 2005, DEV COMP IMMUNOL, V29, P385, DOI 10.1016/j.dci.2004.10.001; Jimenez-Vega F, 2007, FISH SHELLFISH IMMUN, V23, P1119, DOI 10.1016/j.fsi.2007.06.006; JOHANSSON MW, 1994, EUR J BIOCHEM, V223, P389, DOI 10.1111/j.1432-1033.1994.tb19005.x; Krusong K, 2012, DEV COMP IMMUNOL, V36, P208, DOI 10.1016/j.dci.2011.08.002; Li FM, 2012, DEV COMP IMMUNOL, V36, P183, DOI 10.1016/j.dci.2011.07.003; Liang ZC, 1997, P NATL ACAD SCI USA, V94, P6682, DOI 10.1073/pnas.94.13.6682; LIANG ZC, 1995, COMP BIOCHEM PHYS B, V112, P385, DOI 10.1016/0305-0491(95)00105-0; Lin YC, 2008, DEV COMP IMMUNOL, V32, P317, DOI 10.1016/j.dci.2007.07.002; Lin YC, 2007, MOL IMMUNOL, V44, P1065, DOI 10.1016/j.molimm.2006.08.002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mu CK, 2011, FISH SHELLFISH IMMUN, V31, P142, DOI 10.1016/j.fsi.2011.04.013; Mu CK, 2010, DEV COMP IMMUNOL, V34, P734, DOI 10.1016/j.dci.2010.02.001; Nile CJ, 2006, MOL IMMUNOL, V43, P388, DOI 10.1016/j.molimm.2005.02.015; Pech LL, 1996, J CELL SCI, V109, P2053; Ranganathan S, 1999, J MOL GRAPH MODEL, V17, P106, DOI 10.1016/S1093-3263(99)00023-6; Rattanachai A, 2004, FISH SHELLFISH IMMUN, V16, P599, DOI 10.1016/j.fsi.2003.09.011; Ren Q, 2009, FISH SHELLFISH IMMUN, V27, P739, DOI 10.1016/j.fsi.2009.09.007; Sallenave JM, 2002, BIOCHEM SOC T, V30, P111, DOI 10.1042/BST0300111; Smith VJ, 2008, DEV COMP IMMUNOL, V32, P758, DOI 10.1016/j.dci.2007.12.002; Smith VJ, 2011, BIOCHEM SOC T, V39, P1403, DOI 10.1042/BST0391403; Smith VJ, 2001, ADV EXP MED BIOL, V484, P95; Snedecor G., 1971, STAT METHODS; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; Somprasong N, 2006, DEV COMP IMMUNOL, V30, P998, DOI 10.1016/j.dci.2006.01.004; Sperstad SV, 2009, DEV COMP IMMUNOL, V33, P583, DOI 10.1016/j.dci.2008.10.010; Supungul P, 2002, MAR BIOTECHNOL, V4, P487, DOI 10.1007/s10126-002-0043-8; Tomee JFC, 1997, J INFECT DIS, V176, P740, DOI 10.1086/514098; Van Harreveld A, 1936, P SOC EXP BIOL MED, V34, P428; Vargas-Albores F, 2004, COMP BIOCHEM PHYS B, V138, P415, DOI 10.1016/j.cbpc.2004.05.007; Wang W, 2004, RES MICROBIOL, V155, P630, DOI 10.1016/j.resmic.2004.04.010; WIEDOW O, 1990, J BIOL CHEM, V265, P14791; Wu HX, 2004, J INVERTEBR PATHOL, V86, P59, DOI 10.1016/j.jip.2004.03.010; Yang JL, 2010, DEV COMP IMMUNOL, V34, P1274, DOI 10.1016/j.dci.2010.07.004; Yang WL, 2005, CHIN J FRESHWATER FI, V35, P62; Yenugu S, 2004, BIOL REPROD, V71, P1484, DOI 10.1095/biolreprod.104.031567; Yu YH, 2007, J IMMUNOL, V179, P8425, DOI 10.4049/jimmunol.179.12.8425; Zhang JQ, 2007, J BIOTECHNOL, V127, P605, DOI 10.1016/j.jbiotec.2006.08.013; Zhang Shu-yong, 2002, Virologica Sinica, V17, P263	61	177	190	4	181	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2013	8	8							e73563	10.1371/journal.pone.0073563	http://dx.doi.org/10.1371/journal.pone.0073563			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	201BN	23967346	gold, Green Published, Green Submitted			2022-12-27	WOS:000323115800122
J	Li, SY; Xia, XL; Tan, X; Zhang, QF				Li, Siyue; Xia, Xiaoling; Tan, Xiang; Zhang, Quanfa			Effects of Catchment and Riparian Landscape Setting on Water Chemistry and Seasonal Evolution of Water Quality in the Upper Han River Basin, China	PLOS ONE			English	Article							MAJOR-ELEMENT CHEMISTRY; LAND-USE; ALPINE/SUBALPINE BASINS; ION COMPOSITIONS; GEOCHEMISTRY; COVER; NITROGEN; IMPACT; FLUXES; RATES	Six-year (2005-2010) evolution of water chemistry (Cl-, NO3-, SO42-, HCO3-, Na+, K+, Ca2+ and Mg2+) and their interactions with morphological properties (i.e., slope and area), land cover, and hydrological seasonality were examined to identify controlling factors and processes governing patterns of stream water quality in the upper Han River, China. Correlation analysis and stepwise multiple regression models revealed significant correlations between ions (i.e., Cl-, SO42-, Na+ and K+) and land cover (i.e., vegetation and bare land) over the entire catchment in both high-and low-flow periods, and in the buffer zone the correlation was much more stronger in the low-flow period. Catchment with steeper slope (>15 degrees) was negatively correlated with major ions, largely due to multicollinearity of basin characteristics. Land cover within the buffer zone explained slightly less of major elements than at catchment scale in the rainy season, whereas in the dry season, land cover along the river networks in particular this within 100 m riparian zone much better explained major elements rather than this over the entire catchment. Anthropogenic land uses (i.e., urban and agriculture) however could not explain water chemical variables, albeit EC, TDS, anthropogenic markers (Cl-, NO3-, SO42), Na+, K+ and Ca2+ significantly increased during 2005-2010, which was corroborated by principal component analyses (PCA) that indicated anthropogenic inputs. Observations demonstrated much higher solute concentrations in the industrial-polluted river. Our results suggested that seasonal evolution of water quality in combined with spatial analysis at multiple scales should be a vital part of identifying the controls on spatio-temporal patterns of water quality.	[Li, Siyue; Xia, Xiaoling; Tan, Xiang; Zhang, Quanfa] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Li, SY (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China.	lisiyue@wbgcas.cn; qzhang@wbgcas.cn	Wang, Qun/I-7778-2013; Zhang, Quanfa/H-1922-2011; LI, WEIWEI/J-3538-2013; Jin, Xingkun/H-4366-2013; Li, Siyue/DCN-3040-2022; Li, Siyue/E-8297-2012	Wang, Qun/0000-0001-7929-7692; Jin, Xingkun/0000-0003-2454-1621; Li, Siyue/0000-0002-3097-6819; Li, Siyue/0000-0002-3097-6819; li, si yue/0000-0002-4550-892X	National Natural Science Foundation of China [31100347, 31130010]; Youth Innovation Promotion Association; Chinese Academy of Sciences, China [Y129431C06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association; Chinese Academy of Sciences, China(Chinese Academy of Sciences)	The research is funded by the National Natural Science Foundation of China (31100347 and 31130010) and Youth Innovation Promotion Association, the Chinese Academy of Sciences, China (Y129431C06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RB, 2000, NATURE, V403, P758, DOI 10.1038/35001562; Anshumali, 2007, APPL GEOCHEM, V22, P1736, DOI 10.1016/j.apgeochem.2007.03.045; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Chang H, 2008, WATER RES, V42, P3285, DOI 10.1016/j.watres.2008.04.006; Chen JS, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002325; Chen JS, 2002, CHEM GEOL, V187, P231, DOI 10.1016/S0009-2541(02)00032-3; Chinese Ministry of Health, 2006, GB5749 CHIN MIN HLTH; Clow DW, 2000, WATER RESOUR RES, V36, P49, DOI 10.1029/1999WR900294; Dodds WK, 1998, WATER RES, V32, P1455, DOI 10.1016/S0043-1354(97)00370-9; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Garcia-Esteves J, 2007, APPL GEOCHEM, V22, P230, DOI 10.1016/j.apgeochem.2006.09.013; GIBBS RJ, 1970, SCIENCE, V170, P1088, DOI 10.1126/science.170.3962.1088; HU MH, 1982, NATURE, V298, P550, DOI 10.1038/298550a0; HUNSAKER CT, 1995, BIOSCIENCE, V45, P193, DOI 10.2307/1312558; Iqbal J, 2011, J HAZARD MATER, V192, P887, DOI 10.1016/j.jhazmat.2011.05.105; Johnson LB, 1997, FRESHWATER BIOL, V37, P193, DOI 10.1046/j.1365-2427.1997.d01-539.x; Li SY, 2009, J HAZARD MATER, V162, P1340, DOI 10.1016/j.jhazmat.2008.06.059; Li SY, 2008, CATENA, V75, P216, DOI 10.1016/j.catena.2008.06.005; Li SY, 2009, J HAZARD MATER, V170, P605, DOI 10.1016/j.jhazmat.2009.05.022; Li SY, 2009, CHEM GEOL, V264, P89, DOI 10.1016/j.chemgeo.2009.02.021; Li SY, 2008, APPL GEOCHEM, V23, P3535, DOI 10.1016/j.apgeochem.2008.08.012; Li SY, 2009, J HAZARD MATER, V165, P317, DOI 10.1016/j.jhazmat.2008.09.123; MEYBECK M, 1987, AM J SCI, V287, P401, DOI 10.2475/ajs.287.5.401; Meybeck M, 2005, TREATISE GEOCHEM, V5, P207; Meynendonckx J, 2006, HYDROL EARTH SYST SC, V10, P913, DOI 10.5194/hess-10-913-2006; OSBORNE LL, 1988, J ENVIRON MANAGE, V26, P9; PEIERLS BL, 1991, NATURE, V350, P386, DOI 10.1038/350386b0; Pratt B, 2012, J HAZARD MATER, V209, P48, DOI 10.1016/j.jhazmat.2011.12.068; PROSPERO JM, 1989, NATURE, V339, P687, DOI 10.1038/339687a0; Sliva L, 2001, WATER RES, V35, P3462, DOI 10.1016/S0043-1354(01)00062-8; STALLARD RF, 1983, J GEOPHYS RES-OCEANS, V88, P9671, DOI 10.1029/JC088iC14p09671; Stark JM, 1997, NATURE, V385, P61, DOI 10.1038/385061a0; Sueker JK, 2001, HYDROL PROCESS, V15, P2749, DOI 10.1002/hyp.265; Varol M, 2011, J HAZARD MATER, V195; Varol M, 2012, CATENA, V92, P11, DOI 10.1016/j.catena.2011.11.013; WHO, 2006, GUID DRINK WAT QUAL, V1; Wu WH, 2008, CHEM GEOL, V249, P307, DOI 10.1016/j.chemgeo.2008.01.025; ZHANG J, 1995, J HYDROL, V168, P173, DOI 10.1016/0022-1694(94)02635-O; Zhang LA, 2011, APPL GEOCHEM, V26, P293, DOI 10.1016/j.apgeochem.2010.12.002; Zhang SR, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000493	40	177	190	4	181	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 22	2013	8	1							e53163	10.1371/journal.pone.0053163	http://dx.doi.org/10.1371/journal.pone.0053163			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	077HS	23967346	Green Published, Green Submitted, gold			2022-12-27	WOS:000314019100016
J	Lin, YL; Tsai, YJ; Liu, YF; Cheng, YC; Hung, CM; Lee, YJ; Pan, HC; Li, C				Lin, Yu-ling; Tsai, Yun-Jung; Liu, Yu-Fang; Cheng, Yi-Chuan; Hung, Chuan-Mao; Lee, Yi-Jen; Pan, Huichin; Li, Chuan			The Critical Role of Protein Arginine Methyltransferase prmt8 in Zebrafish Embryonic and Neural Development Is Non-Redundant with Its Paralogue prmt1	PLOS ONE			English	Article							METHYLATION; PROTEIN-ARGININE-METHYLTRANSFERASE-8; IDENTIFICATION; BINDING; FAMILY; DOMAIN; GENES; BRAIN; REST	Protein arginine methyltransferase (PRMT) 1 is the most conserved and widely distributed PRMT in eukaryotes. PRMT8 is a vertebrate-restricted paralogue of PRMT1 with an extra N-terminal sequence and brain-specific expression. We use zebrafish (Danio rerio) as a vertebrate model to study PRMT8 function and putative redundancy with PRMT1. The transcripts of zebrafish prmt8 were specifically expressed in adult zebrafish brain and ubiquitously expressed from zygotic to early segmentation stage before the neuronal development. Whole-mount in situ hybridization revealed ubiquitous prmt8 expression pattern during early embryonic stages, similar to that of prmt1. Knockdown of prmt8 with antisense morpholino oligonucleotide phenocopied prmt1-knockdown, with convergence/extension defects at gastrulation. Other abnormalities observed later include short body axis, curled tails, small and malformed brain and eyes. Catalytically inactive prmt8 failed to complement the morphants, indicating the importance of methyltransferase activity. Full-length prmt8 but not prmt1 cRNA can rescue the phenotypic changes. Nevertheless, cRNA encoding Prmt1 fused with the N-terminus of Prmt8 can rescue the prmt8 morphants. In contrast, N-terminus-deleted but not full-length prmt8 cRNA can rescue the prmt1 morphants as efficiently as prmt1 cRNA. Abnormal brain morphologies illustrated with brain markers and loss of fluorescent neurons in a transgenic fish upon prmt8 knockdown confirm the critical roles of prmt8 in neural development. In summery, our study is the first report showing the expression and function of prmt8 in early zebrafish embryogenesis. Our results indicate that prmt8 may play important roles non-overlapping with prmt1 in embryonic and neural development depending on its specific N-terminus.	[Lin, Yu-ling; Tsai, Yun-Jung; Liu, Yu-Fang; Hung, Chuan-Mao; Lee, Yi-Jen; Pan, Huichin; Li, Chuan] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Liu, Yu-Fang; Pan, Huichin; Li, Chuan] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Cheng, Yi-Chuan] Chang Gung Univ, Dept Biochem & Mol Biol, Tao Yuan, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chang Gung University	Li, C (corresponding author), Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan.	cli@csmu.edu.tw	van den Berg, Anke/H-1718-2011; Liu, Ying/Q-6444-2017; Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/GLN-6419-2022; Chang, Chin-Kuo/E-4991-2010; Wu, Ping-Hsun/S-8746-2017	van den Berg, Anke/0000-0002-8894-2638; Liu, Ying/0000-0001-5753-4247; Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Yang/0000-0002-2362-9501; Chen, Fanjun/0000-0001-8105-1683; Chang, Chin-Kuo/0000-0002-8338-7196; Wu, Ping-Hsun/0000-0003-1021-8161; Lin, Ming-Yen/0000-0002-8194-4833	National Science Council [95-2320-B-040-042, 96-2320-B-040-022-MY2, 98-2320-B-040-011-MY3]; Chung Shan Medical University [CSMU 94-OM-A-023, 97-OM-A-136, 98OM-A-060]	National Science Council(Ministry of Science and Technology, Taiwan); Chung Shan Medical University	The project was supported by 95-2320-B-040-042, 96-2320-B-040-022-MY2 and 98-2320-B-040-011-MY3 from National Science Council and CSMU 94-OM-A-023, 97-OM-A-136 and 98OM-A-060 from Chung Shan Medical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich C, 1997, EMBO J, V16, P260, DOI 10.1093/emboj/16.2.260; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Balint BL, 2005, MOL CELL BIOL, V25, P5648, DOI 10.1128/MCB.25.13.5648-5663.2005; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Batut J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025427; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; Gates KP, 2010, DEV BIOL, V340, P293, DOI 10.1016/j.ydbio.2010.01.029; Hung CJ, 2007, J BIOCHEM MOL BIOL, V40, P617; Hung CM, 2004, GENE, V340, P179, DOI 10.1016/j.gene.2004.07.039; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kousaka A, 2009, NEUROSCIENCE, V163, P1146, DOI 10.1016/j.neuroscience.2009.06.061; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lin CH, 2002, J PROTEIN CHEM, V21, P447, DOI 10.1023/A:1021394903025; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Lu JG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-246; Nicholson TB, 2009, PHARMACOL RES, V60, P466, DOI 10.1016/j.phrs.2009.07.006; Pahlich S, 2008, PROTEINS, V72, P1125, DOI 10.1002/prot.22004; Pahlich S, 2006, BBA-PROTEINS PROTEOM, V1764, P1890, DOI 10.1016/j.bbapap.2006.08.008; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Taneda T, 2007, BRAIN RES, V1155, P1, DOI 10.1016/j.brainres.2007.03.086; Tsai YJ, 2011, FEBS J, V278, P905, DOI 10.1111/j.1742-4658.2011.08006.x; Wang YC, 2012, FEBS J, V279, P932, DOI 10.1111/j.1742-4658.2012.08490.x; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	29	267	278	15	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 12	2013	8	3							e55221	10.1371/journal.pone.0055221	http://dx.doi.org/10.1371/journal.pone.0055221			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	107WV	24349335	gold, Green Published, Green Submitted			2022-12-27	WOS:000316252500001
J	Liu, Y; Zhang, AQ; Cao, L; Xia, HT; Ma, JJ				Liu, Yong; Zhang, An-Qiang; Cao, Lin; Xia, Hong-Tao; Ma, Jun-Jie			Taurolidine Lock Solutions for the Prevention of Catheter-Related Bloodstream Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							HOME PARENTERAL-NUTRITION; CENTRAL VENOUS CATHETERS; TARGETED USE; HEMODIALYSIS; BACTEREMIA; CITRATE; HEPARIN; SEPSIS; CANCER; TAUROLOCK(R)	Background: Catheter-related bloodstream infections (CRBSIs) are a significant cause of morbidity and mortality in critically ill patients, contributing to prolonged hospital stays and increased costs. Whether taurolidine lock solutions (TLS) are beneficial for the prevention of CRBSIs remains controversial. In this meta-analysis, we aim to assess the efficacy of TLS for preventing CRBSIs. Methods: We conducted a systematic search of PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials. Eligible studies included randomized controlled trials that reported on the effects of TLS for preventing CRBSIs. The primary outcome in these studies was catheter-related bloodstream infections, with microbial distribution of CRBSI and catheter-associated thrombosis as secondary outcomes. Data were combined using random-effects models owing to significant clinical heterogeneity. Results: Six randomized controlled trials (RCTs) conducted from 2004 through 2013 involving 431 patients and 86,078 catheter-days were included in the review. TLS were significantly associated with a lower incidence of CRBSIs when compared to heparin lock solutions (Risk Ratio [RR], 0.34; 95% Confidence Interval [CI], 0.21-0.55). Use of TLS significantly decreased the incidence of CRBSIs from gram-negative (G-) bacteria (P = 0.004; RR, 0.27; CI, 0.11-0.65), and was associated with a non-significant decrease in gram-positive (G+) bacterial infections (P = 0.07; RR, 0.41; CI, 0.15-1.09). No significant association was observed with TLS and catheter-associated thrombosis (RR, 1.99; CI, 0.75-5.28). Conclusions: The use of TLS reduced the incidence of CRBSIs without obvious adverse effects or bacterial resistance. However, the susceptibility of G+ and G- bacteria to taurolidine and the risk for catheter-associated thrombosis of TLS are indeterminate due to limited data. The results should be treated with caution due to the limited sample sizes and methodological deficiencies of included studies. Therefore, additional well-designed and adequately powered RCTs are needed to confirm these findings.	[Liu, Yong; Cao, Lin; Xia, Hong-Tao; Ma, Jun-Jie] Suining Cent Hosp, Intens Care Unit, Suining, Sichuan, Peoples R China; [Zhang, An-Qiang] Third Mil Med Univ, Daping Hosp, Inst Surg Res, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China	Army Medical University	Liu, Y (corresponding author), Suining Cent Hosp, Intens Care Unit, Suining, Sichuan, Peoples R China.	616756156@qq.com	van den Berg, Anke/H-1718-2011; Liu, Ying/Q-6444-2017; Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/GLN-6419-2022; Chang, Chin-Kuo/E-4991-2010; Wu, Ping-Hsun/S-8746-2017	van den Berg, Anke/0000-0002-8894-2638; Liu, Ying/0000-0001-5753-4247; Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Yang/0000-0002-2362-9501; Chen, Fanjun/0000-0001-8105-1683; Chang, Chin-Kuo/0000-0002-8338-7196; Wu, Ping-Hsun/0000-0003-1021-8161; Lin, Ming-Yen/0000-0002-8194-4833				Akyuz C, 2010, PEDIATR BLOOD CANCER, V55, P949; Al-Amin A, 2012, BRIT J SURG, V99, P158; Allon M, 2003, CLIN INFECT DIS, V36, P1539, DOI 10.1086/375234; Betjes MGH, 2004, NEPHROL DIAL TRANSPL, V19, P1546, DOI 10.1093/ndt/gfh014; Bisseling TM, 2010, CLIN NUTR, V29, P464, DOI 10.1016/j.clnu.2009.12.005; Bradshaw JH, 2008, J PEDIATR GASTR NUTR, V47, P179, DOI 10.1097/MPG.0b013e318162c428; Branger B, 2008, ARTIF ORGANS, V32, P918, DOI 10.1111/j.1525-1594.2008.00684.x; Braumann C, 2005, J SURG RES, V129, P129, DOI 10.1016/j.jss.2005.03.012; Chu HP, 2012, J PEDIATR GASTR NUTR, V55, P403, DOI 10.1097/MPG.0b013e31825bb0ae; Dumichen MJ, 2012, J HOSP INFECT, V80, P304, DOI 10.1016/j.jhin.2012.01.003; Filiopoulos V, 2011, AM J NEPHROL, V33, P260, DOI 10.1159/000324685; Geron R, 2006, HAREFUAH, V145, P943; Geron Ronit, 2006, Harefuah, V145, P881; GORMAN SP, 1987, J APPL BACTERIOL, V62, P315, DOI 10.1111/j.1365-2672.1987.tb04926.x; Haag GM, 2011, J VASC ACCESS, V12, P244, DOI 10.5301/JVA.2011.6265; Handrup MM, 2012, APMIS, V120, P794, DOI 10.1111/j.1600-0463.2012.02910.x; Handrup MM, 2013, PEDIAT BLOOD CANC; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hill SM, 2011, J PEDIAT GASTROEN S1, V52, pE64; Jonkers C., 2012, CLIN NUTR S, V7, P203; Jurewitsch B, 2005, CLIN NUTR, V24, P462, DOI 10.1016/j.clnu.2005.02.001; Jurewitsch B, 1998, JPEN-PARENTER ENTER, V22, P242, DOI 10.1177/0148607198022004242; Labriola L, 2008, NEPHROL DIAL TRANSPL, V23, P1666, DOI 10.1093/ndt/gfm847; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Meyer B, 2010, J HOSP INFECT, V76, P200, DOI 10.1016/j.jhin.2010.05.020; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Novikov A, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-40; O'Grady NP, 2011, CLIN INFECT DIS, V52, P1087, DOI 10.1093/cid/cir138; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; O'Horo JC, 2011, AM J NEPHROL, V34, P415, DOI 10.1159/000331262; Oliveira C, 2012, PEDIATRICS, V129, P318, DOI 10.1542/peds.2011-1602; Olthof ED, 2012, CLIN NUTR; Olthof ED, 2012, CLIN NUTR S7, V7, P149; Rafferty GP, 2010, GUT, V59, pA35, DOI 10.1136/gut.2009.208991f; Rommes JH, 2001, CURR ANAESTH CRIT CA, V12, P25; Schiavone PA, 2010, PRACT GASTROENTEROL, V34, P22; Schiffer CA, 2013, J CLIN ONCOL; Shah CB, 2002, ANTIMICROB AGENTS CH, V46, P1674, DOI 10.1128/AAC.46.6.1674-1679.2002; Simon A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-102; Solomon LR, 2012, SEMIN DIALYSIS, V25, P233, DOI 10.1111/j.1525-139X.2011.00951.x; Solomon LR, 2010, AM J KIDNEY DIS, V55, P1060, DOI 10.1053/j.ajkd.2009.11.025; Sweet S, 2009, AM J KIDNEY DIS, V53, pA74; Tacconelli E, 2009, J HOSP INFECT, V72, P97, DOI 10.1016/j.jhin.2008.12.012; Taylor C, 2008, J REN CARE, V34, P116, DOI 10.1111/j.1755-6686.2008.00027.x; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Torres-Viera C, 2000, ANTIMICROB AGENTS CH, V44, P1720, DOI 10.1128/AAC.44.6.1720-1724.2000; Toure A, 2012, CLIN NUTR, V31, P567, DOI 10.1016/j.clnu.2012.01.001; van de Wetering MD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003295.pub2; Vernon MA, 2006, SCOT MED J, V51, P54; Weber M, 2009, ZBL CHIR, V134, P350, DOI 10.1055/s-0028-1098929; Yahav D, 2008, CLIN INFECT DIS, V47, P83, DOI 10.1086/588667; Zwiech R, 2013, AM J THER	53	267	278	15	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e79417	10.1371/journal.pone.0079417	http://dx.doi.org/10.1371/journal.pone.0079417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24349335	Green Published, Green Submitted, gold			2022-12-27	WOS:000327539800007
J	Liu, Y; Lai, NW; Gao, K; Chen, FJ; Yuan, LX; Mi, GH				Liu, Ying; Lai, Ningwei; Gao, Kun; Chen, Fanjun; Yuan, Lixing; Mi, Guohua			Ammonium Inhibits Primary Root Growth by Reducing the Length of Meristem and Elongation Zone and Decreasing Elemental Expansion Rate in the Root Apex in Arabidopsis thaliana	PLOS ONE			English	Article							AUXIN TRANSPORT; GRAVITROPISM; STRESS; EFFLUX; NH4+; ORGANIZATION; SENSITIVITY; MUTATIONS; TOXICITY; NITROGEN	The inhibitory effect of ammonium on primary root growth has been well documented; however the underlying physiological and molecular mechanisms are still controversial. To avoid ammonium toxicity to shoot growth, we used a vertical two-layer split plate system, in which the upper layer contained nitrate and the lower layer contained ammonium. In this way, nitrogen status was maintained and only the apical part of the root system was exposed to ammonium. Using a kinematic approach, we show here that 1 mM ammonium reduces primary root growth, decreasing both elemental expansion and cell production. Ammonium inhibits the length of elongation zone and the maximum elemental expansion rate. Ammonium also decreases the apparent length of the meristem as well as the number of dividing cells without affecting cell division rate. Moreover, ammonium reduces the number of root cap cells but appears to affect neither the status of root stem cell niche nor the distal auxin maximum at the quiescent center. Ammonium also inhibits root gravitropism and concomitantly down-regulates the expression of two pivotal auxin transporters, AUX1 and PIN2. Insofar as ammonium inhibits root growth rate in AUX1 and PIN2 loss-of-function mutants almost as strongly as in wild type, we conclude that ammonium inhibits root growth and gravitropism by largely distinct pathways.	[Liu, Ying; Lai, Ningwei; Gao, Kun; Chen, Fanjun; Yuan, Lixing; Mi, Guohua] China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant Soil Interact, MOE,Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China	China Agricultural University	Mi, GH (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Key Lab Plant Soil Interact, MOE,Ctr Resources Environm & Food Secur, Beijing 100094, Peoples R China.	miguohua@cau.edu.cn	van den Berg, Anke/H-1718-2011; Liu, Ying/Q-6444-2017; Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/GLN-6419-2022; Chang, Chin-Kuo/E-4991-2010; Wu, Ping-Hsun/S-8746-2017	van den Berg, Anke/0000-0002-8894-2638; Liu, Ying/0000-0001-5753-4247; Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Yang/0000-0002-2362-9501; Chen, Fanjun/0000-0001-8105-1683; Chang, Chin-Kuo/0000-0002-8338-7196; Wu, Ping-Hsun/0000-0003-1021-8161; Lin, Ming-Yen/0000-0002-8194-4833	NSFC [30771289, 31121062]	NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by NSFC (No.30771289), the innovative group grant of NSFC (No.31121062) [http://isisn.nsfc.gov.cn]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, SOIL SOLUTION CHEM A; Baskin TI, 2013, WIRES DEV BIOL, V2, P65, DOI 10.1002/wdev.94; Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Britto DT, 2001, P NATL ACAD SCI USA, V98, P4255, DOI 10.1073/pnas.061034698; Britto DT, 2002, J PLANT PHYSIOL, V159, P567, DOI 10.1078/0176-1617-0774; CAO YW, 1993, PLANT PHYSIOL, V102, P983, DOI 10.1104/pp.102.3.983; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; Dello Ioio R, 2007, CURR BIOL, V17, P678, DOI 10.1016/j.cub.2007.02.047; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; Friml J, 2002, NATURE, V415, P806, DOI 10.1038/415806a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Gazzarrini S, 1999, PLANT CELL, V11, P937, DOI 10.1105/tpc.11.5.937; Geisler M, 2002, PLANT PHYSIOL, V130, P1747, DOI 10.1104/pp.011197; Giehl RFH, 2012, PLANT CELL, V24, P33, DOI 10.1105/tpc.111.092973; Jiang K, 2005, ANNU REV CELL DEV BI, V21, P485, DOI 10.1146/annurev.cellbio.21.122303.114753; Kudoyarova GR, 1997, PLANT GROWTH REGUL, V23, P207, DOI 10.1023/A:1005990725068; Lewis DR, 2007, PLANT CELL, V19, P1838, DOI 10.1105/tpc.107.051599; Li Q, 2010, PLANT CELL ENVIRON, V33, P1529, DOI 10.1111/j.1365-3040.2010.02162.x; Ma Z, 2003, PLANT PHYSIOL, V131, P1381, DOI 10.1104/pp.012161; Malamy JE, 1997, DEVELOPMENT, V124, P33; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; MORRIS AK, 1992, B MATH BIOL, V54, P1069, DOI 10.1007/BF02460667; Mosier AR, 2004, AGR NITROGEN CYCLE A; Overvoorde P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001537; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; PICKETT FB, 1990, PLANT PHYSIOL, V94, P1462, DOI 10.1104/pp.94.3.1462; Qin C, 2008, P NATL ACAD SCI USA, V105, P18308, DOI 10.1073/pnas.0806168105; Remans T, 2006, P NATL ACAD SCI USA, V103, P19206, DOI 10.1073/pnas.0605275103; Robert HS, 2009, NAT CHEM BIOL, V5, P325, DOI 10.1038/nchembio.170; Rogato A, 2010, PLANT PHYSIOL, V154, P784, DOI 10.1104/pp.110.160309; ROMAN G, 1995, GENETICS, V139, P1393; SHARP RE, 1988, PLANT PHYSIOL, V87, P50, DOI 10.1104/pp.87.1.50; SILK WK, 1992, INT J PLANT SCI, V153, pS49, DOI 10.1086/297063; Swarup R, 2005, NAT CELL BIOL, V7, P1057, DOI 10.1038/ncb1316; Walch-Liu P, 2000, J EXP BOT, V51, P227, DOI 10.1093/jexbot/51.343.227; West G, 2004, PLANT PHYSIOL, V135, P1050, DOI 10.1104/pp.104.040022; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Yamaguchi M, 2010, PLANT CELL ENVIRON, V33, P223, DOI 10.1111/j.1365-3040.2009.02073.x; Yuan LX, 2007, PLANT CELL, V19, P2636, DOI 10.1105/tpc.107.052134; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zou N, 2012, J EXP BOT, V63, P3777, DOI 10.1093/jxb/ers068	44	267	278	15	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2013	8	4							e61031	10.1371/journal.pone.0061031	http://dx.doi.org/10.1371/journal.pone.0061031			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130FG	24349335	Green Published, gold, Green Submitted			2022-12-27	WOS:000317898000091
J	Liu, YX; van den Berg, A; Veenstra, R; Rutgers, B; Nolte, I; van Imhoff, G; Visser, L; Diepstra, A				Liu, Yuxuan; van den Berg, Anke; Veenstra, Rianne; Rutgers, Bea; Nolte, Ilja; van Imhoff, Gustaaf; Visser, Lydia; Diepstra, Arjan			PML Nuclear Bodies and SATB1 Are Associated with HLA Class I Expression in EBV plus Hodgkin Lymphoma	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; REED-STERNBERG CELLS; ARCHITECTURE; RESPONSES; CHROMATIN	Tumor cells of classical Hodgkin lymphoma (cHL) are characterized by a general loss of B cell phenotype, whereas antigen presenting properties are commonly retained. HLA class I is expressed in most EBV+ cHL cases, with an even enhanced expression in a proportion of the cases. Promyelocytic leukemia protein (PML) and special AT-rich region binding protein 1 (SATB1) are two global chromatin organizing proteins that have been shown to regulate HLA class I expression in Jurkat cells. We analyzed HLA class I, number of PML nuclear bodies (NBs) and SATB1 expression in tumor cells of 54 EBV+ cHL cases and used 27 EBV- cHL cases as controls. There was a significant difference in presence of HLA class I staining between EBV+ and EBV2 cases (p < 0.0001). We observed normal HLA class I expression in 35% of the EBV+ and in 19% of the EBV- cases. A stronger than normal HLA class I expression was observed in approximately 40% of EBV+ cHL and not in EBV- cHL cases. 36 EBV+ cHL cases contained less than 10 PML-NBs per tumor cell, whereas 16 cases contained more than 10 PMLNBs. The number of PML-NBs was positively correlated to the level of HLA class I expression (p < 0.01). The percentage of SATB1 positive cells varied between 0% to 100% in tumor cells and was inversely correlated with the level of HLA class I expression, but only between normal and strong expression (p < 0.05). Multivariable analysis indicated that the number of PML-NBs and the percentage of SATB1+ tumor cells are independent factors affecting HLA class I expression in EBV+ cHL. In conclusion, both PML and SATB1 are correlated to HLA class I expression levels in EBV+ cHL.	[Liu, Yuxuan; van den Berg, Anke; Veenstra, Rianne; Rutgers, Bea; Visser, Lydia; Diepstra, Arjan] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Nolte, Ilja] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Imhoff, Gustaaf] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Diepstra, A (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.	a.diepstra@umcg.nl	van den Berg, Anke/H-1718-2011; Liu, Ying/Q-6444-2017; Yuan, Lixing/I-2727-2012; Liu, Yuxuan/F-4226-2018; Liu, Ying/GLN-6419-2022; Chang, Chin-Kuo/E-4991-2010; Wu, Ping-Hsun/S-8746-2017	van den Berg, Anke/0000-0002-8894-2638; Liu, Ying/0000-0001-5753-4247; Yuan, Lixing/0000-0003-0233-6184; Liu, Ying/0000-0001-5753-4247; Liu, Yang/0000-0002-2362-9501; Chen, Fanjun/0000-0001-8105-1683; Chang, Chin-Kuo/0000-0002-8338-7196; Wu, Ping-Hsun/0000-0003-1021-8161; Lin, Ming-Yen/0000-0002-8194-4833	Abel Tasman Talent Program (ATTP), University Medical Center Groningen; Dutch Cancer Society (KWF) [RUG 2009-4313]	Abel Tasman Talent Program (ATTP), University Medical Center Groningen; Dutch Cancer Society (KWF)(KWF Kankerbestrijding)	This work was supported by grants from Abel Tasman Talent Program (ATTP), University Medical Center Groningen and the Dutch Cancer Society (KWF: RUG 2009-4313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JD, 2000, GENE DEV, V14, P521; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Chang SK, 2002, MOL CELLS, V14, P130; Condemine W, 2006, CANCER RES, V66, P6192, DOI 10.1158/0008-5472.CAN-05-3792; DELABIE J, 1995, LEUKEMIA LYMPHOMA, V18, P35, DOI 10.3109/10428199509064920; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Diepstra A, 2008, TISSUE ANTIGENS, V71, P219, DOI 10.1111/j.1399-0039.2008.01005.x; Diepstra A, 2005, LANCET, V365, P2216, DOI 10.1016/S0140-6736(05)66780-3; Diepstra A, 2009, J CLIN ONCOL, V27, P3815, DOI 10.1200/JCO.2008.20.5138; Hislop AD, 2007, J EXP MED, V204, P1863, DOI 10.1084/jem.20070256; Huang X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010865; Jarrett RF, 2002, ANN ONCOL, V13, P23, DOI 10.1093/annonc/13.S1.23; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kuppers R, 2006, TRENDS IMMUNOL, V27, P203, DOI 10.1016/j.it.2006.03.001; Lallemand-Breitenbach V, COLD SPRING HARB PER, V2; Lee SP, 1997, J IMMUNOL, V158, P3325; Niens M, 2007, BLOOD, V110, P3310, DOI 10.1182/blood-2007-05-086934; Oudejans JJ, 1996, BLOOD, V87, P3844, DOI 10.1182/blood.V87.9.3844.bloodjournal8793844; Rickinson AB, 1997, ANNU REV IMMUNOL, V15, P405, DOI 10.1146/annurev.immunol.15.1.405; ROWE M, 1995, EUR J IMMUNOL, V25, P1374, DOI 10.1002/eji.1830250536; Shiels C, 2001, J CELL SCI, V114, P3705; Sides MD, 2011, VIROLOGY, V416, P86, DOI 10.1016/j.virol.2011.04.005; Steidl C, 2012, BLOOD, V120, P3530, DOI 10.1182/blood-2012-06-439570; Stein H, 2008, WHO CLASSIFICATION T, V2, P321; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Woodberry T, 2005, J INFECT DIS, V192, P1513, DOI 10.1086/491741; Zuo J, 2008, J VIROL, V82, P2385, DOI 10.1128/JVI.01946-07; Zuo JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000255	29	267	278	15	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2013	8	8							e72930	10.1371/journal.pone.0072930	http://dx.doi.org/10.1371/journal.pone.0072930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	209DO	24349335	gold, Green Published, Green Submitted			2022-12-27	WOS:000323734600043
